Citrus Sinensis ID: 039799

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340------
Protein Sequence
QGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNELLCEIVLPLSTIFMIVMILLILRYQKRGKPLPNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPISVMEVVDANLLSQEDEHFTTK
Secondary Structure (PSIPRED)
cccccHHHHccccccEEEcccccccccccHHHHcccccccEEccccccEEEccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHccccccccccccEEEEccccEEEEEEEccccEEEEEEEEcccccccccHHHHHHHHccccccccccEEEEEEcccccEEEEccccccccccccccccccccHHHHHHHHHHHHHHHHHHHccccccEEEccccccccccccccEEEEcccccccccccccccEEEEEcccccccccccccccccccccccccHHHHHHHHHHHccccccccccccccHHHHHHHHcccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccccHHHcccccccEEEccccccEEcccHHHHHcccccEEEccccEEEEEccccccHHHccHHHcccccEEEccccccccccccHHHHHHHccHHHHHHHHccccHHHccccccccEEEEEEcccccEEEEEEEccccccccHHHHHHHHHHHHHHcHcHEEEEEEEcccccEEEEEEEcccccHHHHHccccccccHHHHHHHHHHHHHHHHHHHHcccccEEcccccHHHEEEcccccEEEccccccHccccccccEEEEEEccccccccHHHHHcccccccccHHHHHHHHHHHHcccccccccccccccHHHHHHHHHHccHHHHcccHHcccccHHHHcc
Coil and Loop (DISEMBL)
qgsipdsigdlinlkslnlsnnnlsgtipisLEKLLDLKDINVSFNklegeipregpfrnlsvksfegnELLCEIVLPLSTIFMIVMILLILRYqkrgkplpndanmppligkggfgSVYKAIIQDGMEVAVkvfdpqyegafksFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEymphgslekclyLSNYILDIFQRLDIMIDVASALEYlhfgysapiihcdlkpsnvllddnmvahlsdfgmakplleedqsLTQTQTLATIgymapeygregrvstngdvySFGIMLMEIFtrtkptdeifsgeMTLKRWVNDLLPISVMEVVDAnllsqedehfttk
Flexible Loop (DISEMBL)
QGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKlegeipregpfrNLSVKSFEGNELLCEIVLPLSTIFMIVMILLILRYQKRGKPLPNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYmapeygregrvsTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPISVMEVVDAnllsqedehfttk
Low Complexity Region (SEG)
QGSIPDSIGDlinlkslnlsnnnlsGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNELLCEIVLPLSTIFMIVMILLILRYQKRGKPLPNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPISVMEVVDANLLSQEDEHFTTK
Disordered region (IsUnstruct)
*********DLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNELLCEIVLPLSTIFMIVMILLILRYQKRGKPL****NMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPISVMEVVDANLL**********
Disordered Region (DISOPRED)
QGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNELLCEIVLPLSTIFMIVMILLILRYQKRG***********LIGKGGFGSVYKAIIQDGMEVAVKVFDPQYE*AFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL*********QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPISVMEVVDANLLSQ********
Disordered Region (DISEMBL)
QGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNELLCEIVLPLSTIFMIVMILLILRYQKRGKPLPNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPISVMEVVDANLLSQEDEHFTTK
Disordered Region (DISPRO)
**SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNELLCEIVLPLSTIFMIVMILLILRYQKRGKPLPNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPISVMEVVDANLLSQEDEH****
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
QGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNELLCEIVLPLSTIFMIVMILLILRYQKRGKPLPNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPISVMEVVDANLLSQEDEHFTTK
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	346	2.2.26 [Sep-21-2011]
C0LGP4	1010	Probable LRR receptor-lik	yes	no	0.965	0.330	0.384	4e-69
C0LGT6	1031	LRR receptor-like serine/	no	no	0.927	0.311	0.375	5e-63
Q9ZUI0	980	Putative leucine-rich rep	no	no	0.962	0.339	0.345	6e-58
Q9SD62	1025	Putative receptor-like pr	no	no	0.985	0.332	0.368	5e-54
Q9FL28	1173	LRR receptor-like serine/	no	no	0.919	0.271	0.340	9e-52
C0LGF4	591	LRR receptor-like serine/	no	no	0.887	0.519	0.336	4e-46
C0LGD9	871	Probable LRR receptor-lik	no	no	0.924	0.367	0.344	3e-45
Q9FN94	868	Receptor-like protein kin	no	no	0.956	0.381	0.321	3e-44
Q9M2Z1	1002	Leucine-rich repeat recep	no	no	0.971	0.335	0.324	1e-42
Q9FIZ3	1252	LRR receptor-like serine/	no	no	0.924	0.255	0.313	2e-41

>sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1

 Score =  261 bits (668), Expect = 4e-69,   Method: Compositional matrix adjust.
 Identities = 158/411 (38%), Positives = 231/411 (56%), Gaps = 77/411 (18%)

Query: 2   GSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNL 61
           G IPD  G L+ +K ++LSNN+LSG+IP        L+ +N+SFN LEG++P +G F N 
Sbjct: 543 GDIPDLKG-LVGVKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENA 601

Query: 62  SVKSFEGNELLC---------------------------EIVLPLST-------IFMIVM 87
           +  S  GN  LC                           ++V+ +S        +FM  +
Sbjct: 602 TTVSIVGNNDLCGGIMGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASV 661

Query: 88  ILLILRYQKRGK----PLP-------------------NDANMPPLIGKGGFGSVYKAII 124
            L+ LR +K+ K    P P                   N  +   ++G G FG+VYKA++
Sbjct: 662 TLIWLRKRKKNKETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALL 721

Query: 125 -QDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISS-----YSNDDFKALVL 178
             +   VAVKV + Q  GA KSF  EC+ +K I HRNL+K++++     +  ++F+AL+ 
Sbjct: 722 LTEKKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIY 781

Query: 179 EYMPHGSLEKCLY--------LSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLK 230
           E+MP+GSL+  L+          +  L + +RL+I IDVAS L+YLH     PI HCDLK
Sbjct: 782 EFMPNGSLDMWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLK 841

Query: 231 PSNVLLDDNMVAHLSDFGMAKPLLEEDQ-----SLTQTQTLATIGYMAPEYGREGRVSTN 285
           PSNVLLDD++ AH+SDFG+A+ LL+ D+      L+      TIGY APEYG  G+ S N
Sbjct: 842 PSNVLLDDDLTAHVSDFGLARLLLKFDEESFFNQLSSAGVRGTIGYAAPEYGVGGQPSIN 901

Query: 286 GDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPISVMEVVDANLL 336
           GDVYSFGI+L+E+FT  +PT+E+F G  TL  +    LP  ++++VD ++L
Sbjct: 902 GDVYSFGILLLEMFTGKRPTNELFGGNFTLNSYTKSALPERILDIVDESIL 952

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1

 Score =  241 bits (615), Expect = 5e-63,   Method: Compositional matrix adjust.
 Identities = 150/400 (37%), Positives = 215/400 (53%), Gaps = 79/400 (19%)

Query: 2   GSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNL 61
           G+IPD I  L++LK+++ SNNNLSG IP  L  L  L+++N+S NK EG +P  G FRN 
Sbjct: 551 GAIPD-ISRLVSLKNVDFSNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNA 609

Query: 62  SVKSFEGNELLCE-------------------------------IVLPLSTIFMIVMILL 90
           +  S  GN  +C                                I + ++++ +I+++  
Sbjct: 610 TAVSVFGNTNICGGVREMQLKPCIVQASPRKRKPLSVRKKVVSGICIGIASLLLIIIVAS 669

Query: 91  ILRYQKRGKPL------PNDANM----------------------PPLIGKGGFGSVYKA 122
           +  + KR K        P+D+                          LIG G FG+V+K 
Sbjct: 670 LCWFMKRKKKNNASDGNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSGNFGNVFKG 729

Query: 123 IIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSN-----DDFKAL 176
           ++  +   VAVKV +    GA KSF  EC+  K I HRNL+K+I+  S+     +DF+AL
Sbjct: 730 LLGPENKLVAVKVLNLLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRAL 789

Query: 177 VLEYMPHGSLEKCLYLSN--------YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCD 228
           V E+MP GSL+  L L +          L   ++L+I IDVASALEYLH     P+ HCD
Sbjct: 790 VYEFMPKGSLDMWLQLEDLERVNDHSRSLTPAEKLNIAIDVASALEYLHVHCHDPVAHCD 849

Query: 229 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ-----SLTQTQTLATIGYMAPEYGREGRVS 283
           +KPSN+LLDD++ AH+SDFG+A+ L + D+       +      TIGY APEYG  G+ S
Sbjct: 850 IKPSNILLDDDLTAHVSDFGLAQLLYKYDRESFLNQFSSAGVRGTIGYAAPEYGMGGQPS 909

Query: 284 TNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLL 323
             GDVYSFGI+L+E+F+  KPTDE F+G+  L  +   +L
Sbjct: 910 IQGDVYSFGILLLEMFSGKKPTDESFAGDYNLHSYTKSIL 949

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1

 Score =  224 bits (572), Expect = 6e-58,   Method: Compositional matrix adjust.
 Identities = 138/400 (34%), Positives = 213/400 (53%), Gaps = 67/400 (16%)

Query: 3   SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLS 62
           ++P S+G L  LK L++S N L+G IP S ++   LK +N SFN L G +  +G F  L+
Sbjct: 506 TLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTLKHLNFSFNLLSGNVSDKGSFSKLT 565

Query: 63  VKSFEGNELLCEIV---------------------LPLSTIFMIVMILLILRYQKRGKPL 101
           ++SF G+ LLC  +                       ++T  + V    +++  + GK L
Sbjct: 566 IESFLGDSLLCGSIKGMQACKKKHKYPSVLLPVLLSLIATPVLCVFGYPLVQRSRFGKNL 625

Query: 102 P---------------NDANMP-----------------PLIGKGGFGSVYKAIIQDGME 129
                           ND   P                  LIG G FG VYK ++++  +
Sbjct: 626 TVYAKEEVEDEEKQNQNDPKYPRISYQQLIAATGGFNASSLIGSGRFGHVYKGVLRNNTK 685

Query: 130 VAVKVFDPQYEGAFK-SFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEK 188
           VAVKV DP+    F  SF  EC ++KR  HRNLI+II++ S   F ALVL  MP+GSLE+
Sbjct: 686 VAVKVLDPKTALEFSGSFKRECQILKRTRHRNLIRIITTCSKPGFNALVLPLMPNGSLER 745

Query: 189 CLYLSNYI---LDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLS 245
            LY   Y    LD+ Q ++I  DVA  + YLH      ++HCDLKPSN+LLDD M A ++
Sbjct: 746 HLYPGEYSSKNLDLIQLVNICSDVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALVT 805

Query: 246 DFGMAKPLLEEDQSLTQTQTLA----------TIGYMAPEYGREGRVSTNGDVYSFGIML 295
           DFG+++ +   +++++   +++          ++GY+APEYG   R ST+GDVYSFG++L
Sbjct: 806 DFGISRLVQGVEETVSTDDSVSFGSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLL 865

Query: 296 MEIFTRTKPTDEIFSGEMTLKRWVNDLLPISVMEVVDANL 335
           +EI +  +PTD + +   +L  ++    P S+  +++  L
Sbjct: 866 LEIVSGRRPTDVLVNEGSSLHEFMKSHYPDSLEGIIEQAL 905

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1

 Score =  211 bits (538), Expect = 5e-54,   Method: Compositional matrix adjust.
 Identities = 155/421 (36%), Positives = 216/421 (51%), Gaps = 80/421 (19%)

Query: 2   GSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNL 61
           G IPD I  L  L+ L+LS NNLSGTIP  +     L+++N+S N  +G +P EG FRN 
Sbjct: 559 GPIPD-IRGLTGLRFLDLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNT 617

Query: 62  SVKSFEGNELLC-----------EIVLPL--STIFMIVMILL----------------IL 92
           S  S  GN  LC            + LP   S++  I+ I +                + 
Sbjct: 618 SAMSVFGNINLCGGIPSLQLQPCSVELPRRHSSVRKIITICVSAVMAALLLLCLCVVYLC 677

Query: 93  RYQKRGKPL-----PNDANMPP------------------------LIGKGGFGSVYKAI 123
            Y+ R K +      ND +  P                        LIG G FG+V+K  
Sbjct: 678 WYKLRVKSVRANNNENDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGF 737

Query: 124 I-QDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKII-----SSYSNDDFKALV 177
           +      VA+KV +    GA KSF  EC+ +  I HRNL+K++     S +  +DF+ALV
Sbjct: 738 LGSKNKAVAIKVLNLCKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALV 797

Query: 178 LEYMPHGSLEKCLYLS--------NYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
            E+MP+G+L+  L+          +  L +F RL+I IDVASAL YLH     PI HCD+
Sbjct: 798 YEFMPNGNLDMWLHPDEIEETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDI 857

Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ-----TLATIGYMAPEYGREGRVST 284
           KPSN+LLD ++ AH+SDFG+A+ LL+ D+     Q        TIGY APEYG  G  S 
Sbjct: 858 KPSNILLDKDLTAHVSDFGLAQLLLKFDRDTFHIQFSSAGVRGTIGYAAPEYGMGGHPSI 917

Query: 285 NGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLL-PISVMEVVDANLL-SQEDEH 342
            GDVYSFGI+L+EIFT  +PT+++F   +TL  +    L     +++ D  +L     +H
Sbjct: 918 MGDVYSFGIVLLEIFTGKRPTNKLFVDGLTLHSFTKSALQKRQALDITDETILRGAYAQH 977

Query: 343 F 343
           F
Sbjct: 978 F 978

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1

 Score =  204 bits (518), Expect = 9e-52,   Method: Compositional matrix adjust.
 Identities = 130/382 (34%), Positives = 205/382 (53%), Gaps = 64/382 (16%)

Query: 2    GSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNL 61
            G IP S G++ +L SL+LS+NNL+G IP SL  L  LK + ++ N L+G +P  G F+N+
Sbjct: 712  GEIPQSFGNMTHLVSLDLSSNNLTGEIPESLANLSTLKHLKLASNNLKGHVPESGVFKNI 771

Query: 62   SVKSFEGNELLCEIVLPL------------STIFMIVMILL------------------- 90
            +     GN  LC    PL            S    +++I+L                   
Sbjct: 772  NASDLMGNTDLCGSKKPLKPCTIKQKSSHFSKRTRVILIILGSAAALLLVLLLVLILTCC 831

Query: 91   -----------------------ILRYQKRGKPLPNDA-NMPPLIGKGGFGSVYKAIIQD 126
                                   + R++ +      D+ N   +IG     +VYK  ++D
Sbjct: 832  KKKEKKIENSSESSLPDLDSALKLKRFEPKELEQATDSFNSANIIGSSSLSTVYKGQLED 891

Query: 127  GMEVAVKVFDPQYEGAF--KSFDIECDVMKRICHRNLIKIIS-SYSNDDFKALVLEYMPH 183
            G  +AVKV + +   A   K F  E   + ++ HRNL+KI+  ++ +   KALVL +M +
Sbjct: 892  GTVIAVKVLNLKEFSAESDKWFYTEAKTLSQLKHRNLVKILGFAWESGKTKALVLPFMEN 951

Query: 184  GSLEKCLYLSNY-ILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVA 242
            G+LE  ++ S   I  + +++D+ + +AS ++YLH GY  PI+HCDLKP+N+LLD + VA
Sbjct: 952  GNLEDTIHGSAAPIGSLLEKIDLCVHIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVA 1011

Query: 243  HLSDFGMAKPL-LEEDQSLTQTQTL--ATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIF 299
            H+SDFG A+ L   ED S T + +    TIGY+APE+    +V+T  DV+SFGI++ME+ 
Sbjct: 1012 HVSDFGTARILGFREDGSTTASTSAFEGTIGYLAPEFAYMRKVTTKADVFSFGIIMMELM 1071

Query: 300  TRTKPT--DEIFSGEMTLKRWV 319
            T+ +PT  ++  S +MTL++ V
Sbjct: 1072 TKQRPTSLNDEDSQDMTLRQLV 1093

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGF4|FEI1_ARATH LRR receptor-like serine/threonine-protein kinase FEI 1 OS=Arabidopsis thaliana GN=FEI1 PE=1 SV=1

 Score =  185 bits (470), Expect = 4e-46,   Method: Compositional matrix adjust.
 Identities = 126/375 (33%), Positives = 190/375 (50%), Gaps = 68/375 (18%)

Query: 2   GSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNL 61
           G IP  +GDL  L+ L++S+N LSG IP SL +L  L + NVS N L G+IP +G     
Sbjct: 136 GPIPAEMGDLPGLQKLDMSSNTLSGPIPASLGQLKKLSNFNVSNNFLVGQIPSDGVLSGF 195

Query: 62  SVKSFEGN--------ELLCE-----------------------IVLPLSTIFMIVMILL 90
           S  SF GN        +++C+                       ++   +T+  ++++ L
Sbjct: 196 SKNSFIGNLNLCGKHVDVVCQDDSGNPSSHSQSGQNQKKNSGKLLISASATVGALLLVAL 255

Query: 91  I-----LRYQKRGK---------------------PLPNDA----------NMPPLIGKG 114
           +       Y+K GK                      LP  +          N   +IG G
Sbjct: 256 MCFWGCFLYKKLGKVEIKSLAKDVGGGASIVMFHGDLPYSSKDIIKKLEMLNEEHIIGCG 315

Query: 115 GFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFK 174
           GFG+VYK  + DG   A+K      EG  + F+ E +++  I HR L+ +    ++   K
Sbjct: 316 GFGTVYKLAMDDGKVFALKRILKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSK 375

Query: 175 ALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNV 234
            L+ +Y+P GSL++ L+     LD   R++I+I  A  L YLH   S  IIH D+K SN+
Sbjct: 376 LLLYDYLPGGSLDEALHERGEQLDWDSRVNIIIGAAKGLSYLHHDCSPRIIHRDIKSSNI 435

Query: 235 LLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIM 294
           LLD N+ A +SDFG+AK LLE+++S   T    T GY+APEY + GR +   DVYSFG++
Sbjct: 436 LLDGNLEARVSDFGLAK-LLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVL 494

Query: 295 LMEIFTRTKPTDEIF 309
           ++E+ +  +PTD  F
Sbjct: 495 VLEVLSGKRPTDASF 509

Involved in the signaling pathway that regulates cell wall function, including cellulose biosynthesis, likely via an 1-aminocyclopropane-1-carboxylic acid (ACC)-mediated signal (a precursor of ethylene).

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGD9|Y1756_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g07560 OS=Arabidopsis thaliana GN=At1g07560 PE=2 SV=1

 Score =  182 bits (462), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 125/363 (34%), Positives = 180/363 (49%), Gaps = 43/363 (11%)

Query: 2   GSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE--GPFR 59
           G I   I +L  LK L+ SNNNL+G +P  L K+  L  IN+S N L G +P+      +
Sbjct: 426 GIIVPEIQNLTELKKLDFSNNNLTGGVPEFLAKMKSLLVINLSGNNLSGSVPQALLNKVK 485

Query: 60  NLSVKSFEGNELLC----------EIVLPL-----STIFMIVMILLIL-----RYQKRGK 99
           N    + +GN  LC           I+LP+     S   +I MI L+      R   R  
Sbjct: 486 NGLKLNIQGNPNLCFSSSCNKKKNSIMLPVVASLASLAAIIAMIALLFVCIKRRSSSRKG 545

Query: 100 PLPNDANMPPL-------------------IGKGGFGSVYKAIIQDGMEVAVKVFDPQYE 140
           P P+  ++  +                   +GKGGFG VY   I    EVAVK+  P   
Sbjct: 546 PSPSQQSIETIKKRYTYAEVLAMTKKFERVLGKGGFGMVYHGYINGTEEVAVKLLSPSSA 605

Query: 141 GAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIF 200
             +K F  E +++ R+ H NL+ ++      D  AL+ +YM +G L+K    S+ I+   
Sbjct: 606 QGYKEFKTEVELLLRVYHTNLVSLVGYCDEKDHLALIYQYMVNGDLKKHFSGSS-IISWV 664

Query: 201 QRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL 260
            RL+I +D AS LEYLH G    I+H D+K SN+LLDD + A L+DFG+++     D+S 
Sbjct: 665 DRLNIAVDAASGLEYLHIGCKPLIVHRDVKSSNILLDDQLQAKLADFGLSRSFPIGDESH 724

Query: 261 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN 320
             T    T GY+  EY +  R+S   DVYSFG++L+EI T  KP  +       +  WV 
Sbjct: 725 VSTLVAGTFGYLDHEYYQTNRLSEKSDVYSFGVVLLEIIT-NKPVIDHNRDMPHIAEWVK 783

Query: 321 DLL 323
            +L
Sbjct: 784 LML 786

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FN94|RLK7_ARATH Receptor-like protein kinase At5g59670 OS=Arabidopsis thaliana GN=At5g59670 PE=1 SV=1

 Score =  179 bits (454), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 121/376 (32%), Positives = 195/376 (51%), Gaps = 45/376 (11%)

Query: 2   GSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNL 61
           G+I  +I  +  L++L+LS NNL+G +P  L K+  L  IN+S N L G IP+    R  
Sbjct: 424 GTIAAAIQSITQLETLDLSYNNLTGEVPEFLGKMKSLSVINLSGNNLNGSIPQA--LRKK 481

Query: 62  SVKSF-EGNELLCE-------IVLPLSTIFMIVMILLILRYQKRGKPLPNDANMPP---- 109
            +K + EGN  L +       + +    +F+ V+++L L ++K+   +     +PP    
Sbjct: 482 RLKLYLEGNPRLIKPPKKEFPVAIVTLVVFVTVIVVLFLVFRKKMSTIVKGLRLPPRTSM 541

Query: 110 ---------------------------LIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGA 142
                                      ++GKGGFG VY   ++   +VAVKV        
Sbjct: 542 VDVTFSNKKSKRFTYSEVVQVTKNFQRVLGKGGFGMVYHGTVKGSEQVAVKVLSQSSTQG 601

Query: 143 FKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYL--SNYILDIF 200
            K F  E D++ R+ H NL+ ++      D+ ALV E++P+G L++ L     N I++  
Sbjct: 602 SKEFKAEVDLLLRVHHTNLVSLVGYCCEGDYLALVYEFLPNGDLKQHLSGKGGNSIINWS 661

Query: 201 QRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL 260
            RL I ++ A  LEYLH G + P++H D+K +N+LLD+N  A L+DFG+++    E +S 
Sbjct: 662 IRLRIALEAALGLEYLHIGCTPPMVHRDVKTANILLDENFKAKLADFGLSRSFQGEGESQ 721

Query: 261 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN 320
             T    T+GY+ PE    GR+    DVYSFGI+L+E+ T  +P     SG+  + +WV 
Sbjct: 722 ESTTIAGTLGYLDPECYHSGRLGEKSDVYSFGIVLLEMIT-NQPVINQTSGDSHITQWVG 780

Query: 321 -DLLPISVMEVVDANL 335
             +    ++E++D NL
Sbjct: 781 FQMNRGDILEIMDPNL 796

Probable receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M2Z1|BAME2_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM2 OS=Arabidopsis thaliana GN=BAM2 PE=1 SV=1

 Score =  173 bits (439), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 126/388 (32%), Positives = 183/388 (47%), Gaps = 52/388 (13%)

Query: 1   QGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRN 60
            G IP+ +  +  L  LNLS N+L G+IP+++  +  L  ++ S+N L G +P  G F  
Sbjct: 541 SGDIPNELTGMKILNYLNLSRNHLVGSIPVTIASMQSLTSVDFSYNNLSGLVPSTGQFSY 600

Query: 61  LSVKSFEGNELLC-------------EIVLPLST---------------IFMIVMILLI- 91
            +  SF GN  LC               V PLS                +F IV I+   
Sbjct: 601 FNYTSFVGNSHLCGPYLGPCGKGTHQSHVKPLSATTKLLLVLGLLFCSMVFAIVAIIKAR 660

Query: 92  -LRYQKRGKPLPNDA---------------NMPPLIGKGGFGSVYKAIIQDGMEVAVKVF 135
            LR     K     A                   +IGKGG G VYK  +  G  VAVK  
Sbjct: 661 SLRNASEAKAWRLTAFQRLDFTCDDVLDSLKEDNIIGKGGAGIVYKGTMPKGDLVAVKRL 720

Query: 136 DPQYEGAFK--SFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLY-L 192
                G+     F+ E   + RI HR++++++   SN +   LV EYMP+GSL + L+  
Sbjct: 721 ATMSHGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGK 780

Query: 193 SNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP 252
               L    R  I ++ A  L YLH   S  I+H D+K +N+LLD N  AH++DFG+AK 
Sbjct: 781 KGGHLHWNTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKF 840

Query: 253 LLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE 312
           L +   S   +    + GY+APEY    +V    DVYSFG++L+E+ T  KP  E F   
Sbjct: 841 LQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGKKPVGE-FGDG 899

Query: 313 MTLKRWVNDLLPIS---VMEVVDANLLS 337
           + + +WV  +   +   V++V+D  L S
Sbjct: 900 VDIVQWVRSMTDSNKDCVLKVIDLRLSS 927

Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2

 Score =  170 bits (430), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 124/396 (31%), Positives = 190/396 (47%), Gaps = 76/396 (19%)

Query: 2    GSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNL 61
            G IP +I  L  L+SL+LS+N L G +P  +  +  L  +N+S+N LEG++ ++  F   
Sbjct: 783  GRIPSTISTLPKLESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKLKKQ--FSRW 840

Query: 62   SVKSFEGNELLC--------------------------EIVLPLSTIFMIVMILLILRYQ 95
               +F GN  LC                            +  L+ I ++V+++++   Q
Sbjct: 841  QADAFVGNAGLCGSPLSHCNRAGSKNQRSLSPKTVVIISAISSLAAIALMVLVIILFFKQ 900

Query: 96   K-------RG-------------KPLPNDA------------------NMPPLIGKGGFG 117
                    RG              PL ++                   N   +IG GG G
Sbjct: 901  NHDLFKKVRGGNSAFSSNSSSSQAPLFSNGGAKSDIKWDDIMEATHYLNEEFMIGSGGSG 960

Query: 118  SVYKAIIQDGMEVAVK-VFDPQYEGAFKSFDIECDVMKRICHRNLIKIIS--SYSNDDFK 174
             VYKA +++G  +AVK +       + KSF+ E   +  I HR+L+K++   S   D   
Sbjct: 961  KVYKAELKNGETIAVKKILWKDDLMSNKSFNREVKTLGTIRHRHLVKLMGYCSSKADGLN 1020

Query: 175  ALVLEYMPHGSLEKCLYLS-----NYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
             L+ EYM +GS+   L+ +       +L    RL I + +A  +EYLH+    PI+H D+
Sbjct: 1021 LLIYEYMANGSVWDWLHANENTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVHRDI 1080

Query: 230  KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL--ATIGYMAPEYGREGRVSTNGD 287
            K SNVLLD N+ AHL DFG+AK L     + T++ T+   + GY+APEY    + +   D
Sbjct: 1081 KSSNVLLDSNIEAHLGDFGLAKILTGNYDTNTESNTMFAGSYGYIAPEYAYSLKATEKSD 1140

Query: 288  VYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLL 323
            VYS GI+LMEI T   PT+ +F  E  + RWV  +L
Sbjct: 1141 VYSMGIVLMEIVTGKMPTEAMFDEETDMVRWVETVL 1176

Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	346
359483683	1228	PREDICTED: LRR receptor-like serine/thre	0.994	0.280	0.535	1e-109
359483675	1250	PREDICTED: LRR receptor-like serine/thre	0.994	0.275	0.535	1e-108
359485453	1202	PREDICTED: probable LRR receptor-like se	0.994	0.286	0.534	1e-107
359483677	1229	PREDICTED: LRR receptor-like serine/thre	0.994	0.279	0.522	1e-104
224139658	1019	predicted protein [Populus trichocarpa]	0.997	0.338	0.522	1e-104
359485451	1454	PREDICTED: LRR receptor-like serine/thre	0.994	0.236	0.527	1e-104
359497186	1140	PREDICTED: LRR receptor-like serine/thre	0.994	0.301	0.522	1e-104
147776333	1205	hypothetical protein VITISV_000078 [Viti	0.994	0.285	0.527	1e-103
147769371	1241	hypothetical protein VITISV_010511 [Viti	0.994	0.277	0.525	1e-103
147852480	1229	hypothetical protein VITISV_039533 [Viti	0.994	0.279	0.525	1e-103

>gi|359483683|ref|XP_003633001.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO1-like [Vitis vinifera]

 Score =  399 bits (1026), Expect = e-109,   Method: Compositional matrix adjust.
 Identities = 212/396 (53%), Positives = 272/396 (68%), Gaps = 52/396 (13%)

Query: 1    QGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRN 60
            QGSIP   GDL++L+S++LS NNL GTIP SLE L+ LK +NVSFNKL+GEIP  GPF N
Sbjct: 794  QGSIPVEFGDLLSLESMDLSQNNLFGTIPKSLEALIYLKHLNVSFNKLQGEIPNGGPFVN 853

Query: 61   LSVKSFEGNELLCE---------------------------IVLPL-STIFMIVMILLIL 92
             + +SF  NE LC                            I+LP+ S + ++  I+L +
Sbjct: 854  FTAESFIFNEALCGAPHFQVIACDKNNRTQSWKTKSFILKYILLPVGSAVTLVAFIVLWI 913

Query: 93   RYQKRGK-PLPNDANMPP---------------------LIGKGGFGSVYKAIIQDGMEV 130
            R +   + P P D+ +P                      LIGKG  G VYK ++ +G+ V
Sbjct: 914  RRRDNTEIPAPIDSWLPGAHEKISQQQLLYATNGFGEDNLIGKGSLGMVYKGVLSNGLTV 973

Query: 131  AVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCL 190
            A+KVF+ +++GA +SFD EC+VM+ ICHRNLI+II+  SN DFKALVLEYMP GSL+K L
Sbjct: 974  AIKVFNLEFQGALRSFDSECEVMQGICHRNLIRIITCCSNLDFKALVLEYMPKGSLDKWL 1033

Query: 191  YLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMA 250
            Y  NY LD+FQRL+IMIDVASALEYLH   S+ ++HCDLKPSNVLLD+NMVAH++DFG+A
Sbjct: 1034 YSHNYFLDLFQRLNIMIDVASALEYLHHDCSSLVVHCDLKPSNVLLDNNMVAHVADFGIA 1093

Query: 251  KPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFS 310
            + LL E +S+ QT+TL TIGYMAPEYG +G VST GDVYS+GI+LME+F R KP DE+F+
Sbjct: 1094 R-LLTETESMQQTKTLGTIGYMAPEYGSDGIVSTKGDVYSYGILLMEVFARKKPMDEMFT 1152

Query: 311  GEMTLKRWVNDLLPISVMEVVDANLLSQEDEHFTTK 346
            G++TLK WV   L  SV+EVVDANLL ++DE   TK
Sbjct: 1153 GDVTLKTWVES-LSSSVIEVVDANLLRRDDEDLATK 1187

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483675|ref|XP_003632999.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO1-like [Vitis vinifera]

 Score =  399 bits (1024), Expect = e-108,   Method: Compositional matrix adjust.
 Identities = 212/396 (53%), Positives = 270/396 (68%), Gaps = 52/396 (13%)

Query: 1    QGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRN 60
            QGSIP   GDL++L+S++LS NNLSGTIP SLE L+ LK +NVSFNKL+GEIP  GPF N
Sbjct: 794  QGSIPVEFGDLLSLESMDLSQNNLSGTIPKSLEALIYLKHLNVSFNKLQGEIPDGGPFVN 853

Query: 61   LSVKSFEGNELLCE---------------------------IVLPLSTIFMIV--MILLI 91
             + +SF  NE LC                            I+LP+ +I  +V  ++L I
Sbjct: 854  FTAESFIFNEALCGAPHFQVIACDKNNHTQSWKTKSFILKYILLPVGSIVTLVAFIVLWI 913

Query: 92   LRYQKRGKPLPNDANMPP---------------------LIGKGGFGSVYKAIIQDGMEV 130
             R      P P D+ +P                      LIGKG  G VYK ++ +G+ V
Sbjct: 914  RRQDNTEIPAPIDSWLPGAHEKISQQQLLYATNDFGEDNLIGKGSLGMVYKGVLSNGLTV 973

Query: 131  AVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCL 190
            A+KVF+ +++GA +SFD EC+VM+ ICHRNLI+II+  SN DFKALVLEYMP GSL+K L
Sbjct: 974  AIKVFNLEFQGALRSFDSECEVMQGICHRNLIRIITCCSNLDFKALVLEYMPKGSLDKWL 1033

Query: 191  YLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMA 250
            Y  NY LD+FQRL+IMIDVA ALEYLH   S+ ++HCDLKPSNVLLD+NMVAH++DFG+A
Sbjct: 1034 YSHNYFLDLFQRLNIMIDVALALEYLHHDCSSLVVHCDLKPSNVLLDNNMVAHVADFGIA 1093

Query: 251  KPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFS 310
            + LL E +S+ QT+TL TIGYMAPEYG +G VST GDVYS+GI+LME+F R KP DE+F+
Sbjct: 1094 R-LLTETESMQQTKTLGTIGYMAPEYGSDGIVSTKGDVYSYGILLMEVFARKKPMDEMFT 1152

Query: 311  GEMTLKRWVNDLLPISVMEVVDANLLSQEDEHFTTK 346
            G++TLK WV   L  SV+EVVDANLL +++E   TK
Sbjct: 1153 GDVTLKTWVES-LSSSVIEVVDANLLRRDNEDLATK 1187

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359485453|ref|XP_003633276.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera]

 Score =  394 bits (1012), Expect = e-107,   Method: Compositional matrix adjust.
 Identities = 211/395 (53%), Positives = 269/395 (68%), Gaps = 51/395 (12%)

Query: 1    QGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRN 60
            QG IP + GDL++L+SL+LS NNLSGTIP SLE L  L+ +NVSFNKL+GEIP  GPF N
Sbjct: 765  QGHIPPNFGDLVSLESLDLSGNNLSGTIPKSLEHLKYLEYLNVSFNKLQGEIPNGGPFAN 824

Query: 61   LSVKSFEGNELLC-----------------------EIVLPLS-TIFMIVMILLILRYQK 96
             + +SF  N  LC                       + ++PLS ++  I++++L +++++
Sbjct: 825  FTAESFISNLALCGAPRFQVMACEKDSRKNTKSLLLKCIVPLSVSLSTIILVVLFVQWKR 884

Query: 97   RGK----PLPNDANMPP---------------------LIGKGGFGSVYKAIIQDGMEVA 131
            R      P+  D ++P                      LIGKG  G VYK ++ DG+ VA
Sbjct: 885  RQTKSETPIQVDLSLPRMHRMIPHQELLYATNYFGEDNLIGKGSLGMVYKGVLSDGLIVA 944

Query: 132  VKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLY 191
            VKVF+ + +GAFKSF++EC+VM+ I HRNL KIISS SN DFKALVLEYMP+GSLEK LY
Sbjct: 945  VKVFNLELQGAFKSFEVECEVMRNIRHRNLAKIISSCSNLDFKALVLEYMPNGSLEKWLY 1004

Query: 192  LSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAK 251
              NY LD  QRL IMIDVAS LEYLH  YS P++HCDLKPSNVLLDD+MVAH+SDFG+AK
Sbjct: 1005 SHNYYLDFVQRLKIMIDVASGLEYLHHYYSNPVVHCDLKPSNVLLDDDMVAHISDFGIAK 1064

Query: 252  PLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSG 311
             LL   + + +T+TL T+GYMAPEYG EG VST GD+YS+GI+LME F R KPTDE+F  
Sbjct: 1065 -LLMGSEFMKRTKTLGTVGYMAPEYGSEGIVSTKGDIYSYGILLMETFVRKKPTDEMFVE 1123

Query: 312  EMTLKRWVNDLLPISVMEVVDANLLSQEDEHFTTK 346
            E+TLK WV      ++MEV+DANLL++EDE F  K
Sbjct: 1124 ELTLKSWVESSTN-NIMEVIDANLLTEEDESFALK 1157

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483677|ref|XP_003633000.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Vitis vinifera]

 Score =  385 bits (988), Expect = e-104,   Method: Compositional matrix adjust.
 Identities = 207/396 (52%), Positives = 267/396 (67%), Gaps = 52/396 (13%)

Query: 1    QGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRN 60
            QG IP   GDL++L+SL+LS NNLSGTIP SLE L+ LK +NVS NKL+GEIP  GPF N
Sbjct: 795  QGPIPIEFGDLVSLESLDLSQNNLSGTIPKSLEALIYLKYLNVSLNKLQGEIPNGGPFIN 854

Query: 61   LSVKSFEGNELLCE---------------------------IVLPLSTIFMIV--MILLI 91
             + +SF  NE LC                            I+LP+ +I  +V  ++L I
Sbjct: 855  FTAESFMFNEALCGAPHFQVMACDKNNRTQSWKTKSFILKYILLPVGSIVTLVVFIVLWI 914

Query: 92   LRYQKRGKPLPNDANMPP---------------------LIGKGGFGSVYKAIIQDGMEV 130
             R      P P D+ +P                      LIGKG  G VYK ++ +G+ V
Sbjct: 915  RRRDNMEIPTPIDSWLPGTHEKISHQQLLYATNDFGEDNLIGKGSQGMVYKGVLSNGLTV 974

Query: 131  AVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCL 190
            A+KVF+ +++GA +SFD EC+VM+ I HRNL++II+  SN DFKALVLEYMP+GSLEK L
Sbjct: 975  AIKVFNLEFQGALRSFDSECEVMQGIRHRNLVRIITCCSNLDFKALVLEYMPNGSLEKWL 1034

Query: 191  YLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMA 250
            Y  NY LD+ QRL+IMIDVASALEYLH   S+ ++HCDLKP+NVLLDD+MVAH++DFG+ 
Sbjct: 1035 YSHNYFLDLIQRLNIMIDVASALEYLHHDCSSLVVHCDLKPNNVLLDDDMVAHVADFGIT 1094

Query: 251  KPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFS 310
            K LL + +S+ QT+TL TIGYMAPE+G +G VST  DVYS+GI+LME+F+R KP DE+F+
Sbjct: 1095 K-LLTKTESMQQTKTLGTIGYMAPEHGSDGIVSTKSDVYSYGILLMEVFSRKKPMDEMFT 1153

Query: 311  GEMTLKRWVNDLLPISVMEVVDANLLSQEDEHFTTK 346
            G++TLK WV   L  SV++VVDANLL +EDE   TK
Sbjct: 1154 GDLTLKTWVES-LSNSVIQVVDANLLRREDEDLATK 1188

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224139658|ref|XP_002323215.1| predicted protein [Populus trichocarpa] gi|222867845|gb|EEF04976.1| predicted protein [Populus trichocarpa]

 Score =  384 bits (987), Expect = e-104,   Method: Compositional matrix adjust.
 Identities = 207/396 (52%), Positives = 267/396 (67%), Gaps = 51/396 (12%)

Query: 1   QGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRN 60
           QGSIP++ G L++L+ L+LS NNLSG IP SLE L  L+  +VSFN L+GEIPR GPF N
Sbjct: 577 QGSIPEAFGGLVSLELLDLSQNNLSGEIPKSLEALRYLEFFSVSFNGLQGEIPRGGPFAN 636

Query: 61  LSVKSFEGNELLC-------------------------EIVLPL--STIFMIVMILLIL- 92
            + +SF  N+ LC                            LP   S + ++  I L++ 
Sbjct: 637 FTARSFIMNKGLCGPSRLQVPPCSIESRKDSKTKSRLLRFSLPTVASILLVVAFIFLVMG 696

Query: 93  -RYQKRGKPLP---------------------NDANMPPLIGKGGFGSVYKAIIQDGMEV 130
            R + R  P+P                     N+ +   L+G G FGSVY+  ++DG+ V
Sbjct: 697 CRRRYRKDPIPEALPVTAIQRRISYLELLHATNEFHESNLLGIGSFGSVYQGRLRDGLNV 756

Query: 131 AVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCL 190
           AVK+F+ Q + AF+SFD EC++M+ I HRNL+KII S SN DFKALVLEYMP GSLEK L
Sbjct: 757 AVKIFNLQLQRAFRSFDTECEIMRNIRHRNLVKIICSCSNLDFKALVLEYMPKGSLEKWL 816

Query: 191 YLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMA 250
           Y  NY LDI QR++IMIDVASALEYLH GY +P++HCDLKPSNVLLD++MVAH+ DFG+A
Sbjct: 817 YSHNYCLDIIQRVNIMIDVASALEYLHHGYPSPVVHCDLKPSNVLLDEDMVAHVCDFGIA 876

Query: 251 KPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFS 310
           K LL E++S  QT+TLATIGYMAPEYG +G VST  DVYSFGIMLME+ TR +PTDE+F 
Sbjct: 877 K-LLGENESFAQTRTLATIGYMAPEYGLDGLVSTKIDVYSFGIMLMEMLTRKRPTDEMFE 935

Query: 311 GEMTLKRWVNDLLPISVMEVVDANLLSQEDEHFTTK 346
           GEM+LKR V + LP SV+++VD+N+L++ D +   K
Sbjct: 936 GEMSLKRLVKESLPDSVIDIVDSNMLNRGDGYSVKK 971

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359485451|ref|XP_002276944.2| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Vitis vinifera]

 Score =  384 bits (987), Expect = e-104,   Method: Compositional matrix adjust.
 Identities = 209/396 (52%), Positives = 268/396 (67%), Gaps = 52/396 (13%)

Query: 1    QGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRN 60
            QG IP   GDL++LK L+LS NNLSG IP SL+ L  LK +NVSFNKL+GEIP  GPF N
Sbjct: 1020 QGPIPLEFGDLLSLKFLDLSQNNLSGVIPKSLKALTYLKYLNVSFNKLQGEIPDGGPFMN 1079

Query: 61   LSVKSFEGNELLC--------------------------EIVLP--LSTIFMIVMILLIL 92
             + +SF  NE LC                          + +LP  +S I ++V ++L +
Sbjct: 1080 FTAESFIFNEALCGAPHFQVIACDKSTRSRSWRTKLFILKYILPPVISIITLVVFLVLWI 1139

Query: 93   RYQKRGK-PLPNDANMPP---------------------LIGKGGFGSVYKAIIQDGMEV 130
            R +K  + P P D+ +P                      LIGKG    VYK ++ +G+ V
Sbjct: 1140 RRRKNLEVPTPIDSWLPGSHEKISHQQLLYATNYFGEDNLIGKGSLSMVYKGVLSNGLTV 1199

Query: 131  AVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCL 190
            AVKVF+ +++GAF+SFD EC+VM+ I HRNL+KII+  SN DFKALVLEYMP GSL+K L
Sbjct: 1200 AVKVFNLEFQGAFRSFDSECEVMQSIRHRNLVKIITCCSNLDFKALVLEYMPKGSLDKWL 1259

Query: 191  YLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMA 250
            Y  NY LD+ QRL+IMIDVASALEYLH    + ++HCDLKP+N+LLDD+MVAH+ DFG+A
Sbjct: 1260 YSHNYFLDLIQRLNIMIDVASALEYLHHDCPSLVVHCDLKPNNILLDDDMVAHVGDFGIA 1319

Query: 251  KPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFS 310
            + LL E +S+ QT+TL TIGYMAPEYG +G VST GDV+S+GIMLME+F R KP DE+F+
Sbjct: 1320 R-LLTETESMQQTKTLGTIGYMAPEYGSDGIVSTKGDVFSYGIMLMEVFARKKPMDEMFN 1378

Query: 311  GEMTLKRWVNDLLPISVMEVVDANLLSQEDEHFTTK 346
            G++TLK WV  L   S++EVVDANLL +EDE F TK
Sbjct: 1379 GDLTLKSWVESLAD-SMIEVVDANLLRREDEDFATK 1413

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359497186|ref|XP_003635448.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO1-like [Vitis vinifera]

 Score =  384 bits (985), Expect = e-104,   Method: Compositional matrix adjust.
 Identities = 207/396 (52%), Positives = 266/396 (67%), Gaps = 52/396 (13%)

Query: 1    QGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRN 60
            QG IP   GDL++L+SL+LS NNLSGTIP SLE L+ LK +NVS NKL+GEIP  GPF N
Sbjct: 706  QGPIPIEFGDLVSLESLDLSQNNLSGTIPKSLEALIYLKYLNVSLNKLQGEIPNGGPFIN 765

Query: 61   LSVKSFEGNELLCE---------------------------IVLPLSTIFMIV--MILLI 91
             + +SF  NE LC                            I+LP+ +I  +V  ++L I
Sbjct: 766  FTAESFMFNEALCGAPHFQVMACDKNNRTQSWKTKSFILKYILLPVGSIVTLVVFIVLWI 825

Query: 92   LRYQKRGKPLPNDANMPP---------------------LIGKGGFGSVYKAIIQDGMEV 130
             R      P P D+ +P                      LIGKG  G VYK ++ +G+ V
Sbjct: 826  RRRDNMEIPTPIDSWLPGTHEKISHQQLLYATNDFGEDNLIGKGSQGMVYKGVLSNGLTV 885

Query: 131  AVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCL 190
            A+KVF+ +++GA +SFD EC+VM+ I HRNL++II+  SN DFKALVLEYMP+GSLEK L
Sbjct: 886  AIKVFNLEFQGALRSFDSECEVMQGIRHRNLVRIITCCSNLDFKALVLEYMPNGSLEKWL 945

Query: 191  YLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMA 250
            Y  NY LD+ QRL+IMIDVASALEYLH   S+ ++HCDLKP+NVLLDD+MVAH++DFG+ 
Sbjct: 946  YSHNYFLDLIQRLNIMIDVASALEYLHHDCSSLVVHCDLKPNNVLLDDDMVAHVADFGIT 1005

Query: 251  KPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFS 310
            K LL + +S+ QT+TL TIGYMAPE+G +G VST  DVYS+GI+LME+F+R KP DE+F+
Sbjct: 1006 K-LLTKTESMQQTKTLGTIGYMAPEHGSDGIVSTKSDVYSYGILLMEVFSRKKPMDEMFT 1064

Query: 311  GEMTLKRWVNDLLPISVMEVVDANLLSQEDEHFTTK 346
            G +TLK WV   L  SV++VVDANLL +EDE   TK
Sbjct: 1065 GGLTLKTWVES-LSNSVIQVVDANLLRREDEDLATK 1099

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147776333|emb|CAN72034.1| hypothetical protein VITISV_000078 [Vitis vinifera]

 Score =  382 bits (981), Expect = e-103,   Method: Compositional matrix adjust.
 Identities = 209/396 (52%), Positives = 267/396 (67%), Gaps = 52/396 (13%)

Query: 1    QGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRN 60
            QG I    GDL++L+SL+LS+NNLSGTIP SLE L+ LK +NVSFNKL+GEIP  GPF  
Sbjct: 771  QGPIXVEFGDLVSLESLDLSHNNLSGTIPKSLEALIYLKYLNVSFNKLQGEIPNGGPFVK 830

Query: 61   LSVKSFEGNELLCE---------------------------IVLPL-STIFMIVMILLIL 92
             + +SF  NE LC                            I+LP+ ST+ ++V I+L +
Sbjct: 831  FTAESFMFNEALCGAPHFQVMACDKNNRTQSWKTKSFILKYILLPVGSTVTLVVFIVLWI 890

Query: 93   RYQKRGK-PLP---------------------NDANMPPLIGKGGFGSVYKAIIQDGMEV 130
            R +   + P P                     ND     LIGKG  G VYK ++ +G+ V
Sbjct: 891  RRRDNMEIPTPIDSWLLGTHEKISHQQLLYATNDFGEDNLIGKGSQGMVYKGVLSNGLNV 950

Query: 131  AVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCL 190
            A+KVF+ +++GA +SFD EC+VM+ I HRNL++II+  SN DFKALVLEYMP+GSLEK L
Sbjct: 951  AIKVFNLEFQGALRSFDSECEVMQGIRHRNLVRIITCCSNLDFKALVLEYMPNGSLEKWL 1010

Query: 191  YLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMA 250
            Y  NY LD+ QRL+IMIDVASALEYLH   S+ ++HCDLKPSNVLLDD+MVAH++DFG+A
Sbjct: 1011 YSHNYFLDLIQRLNIMIDVASALEYLHHDCSSLVVHCDLKPSNVLLDDDMVAHVADFGIA 1070

Query: 251  KPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFS 310
            K LL E +S+ QT+TL TIGYMAPE+G  G VST  DVYS+GI+LME+F R KP DE+F+
Sbjct: 1071 K-LLTETESMQQTKTLGTIGYMAPEHGSAGIVSTKSDVYSYGILLMEVFARKKPMDEMFT 1129

Query: 311  GEMTLKRWVNDLLPISVMEVVDANLLSQEDEHFTTK 346
            G++TLK WV   L  SV++VVD NLL +EDE   TK
Sbjct: 1130 GDLTLKTWVES-LSNSVIQVVDVNLLRREDEDLATK 1164

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147769371|emb|CAN72496.1| hypothetical protein VITISV_010511 [Vitis vinifera]

 Score =  382 bits (981), Expect = e-103,   Method: Compositional matrix adjust.
 Identities = 208/396 (52%), Positives = 269/396 (67%), Gaps = 52/396 (13%)

Query: 1    QGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRN 60
            QG IP   GDL++L+SL+LS NNLSGTIP SLE L+ LK +NVS NKL+GEIP  GPF N
Sbjct: 807  QGPIPXEFGDLVSLESLDLSQNNLSGTIPKSLEALIYLKYLNVSSNKLQGEIPNGGPFXN 866

Query: 61   LSVKSFEGNELLCE---------------------------IVLPL-STIFMIVMILLIL 92
             + +SF  NE LC                            I+LP+ STI ++V I+L +
Sbjct: 867  FTAESFMFNEALCGAPHFQVMACDKNNRTQSWKTKSFILKYILLPVGSTITLVVFIVLWI 926

Query: 93   RYQKRGK-PLPNDANMPP---------------------LIGKGGFGSVYKAIIQDGMEV 130
            R +   +   P D+ +P                      LIGKG  G VYK ++ +G+ V
Sbjct: 927  RRRDNMEIXTPIDSWLPGTHEKISHQQLLYATNDFGEDNLIGKGSQGMVYKGVLSNGLIV 986

Query: 131  AVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCL 190
            A+KVF+ +++GA +SFD EC+VM+ I HRNL++II+  SN DFKALVL+YMP+GSLEK L
Sbjct: 987  AIKVFNLEFQGALRSFDSECEVMQGIRHRNLVRIITCCSNLDFKALVLKYMPNGSLEKWL 1046

Query: 191  YLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMA 250
            Y  NY LD+ QRL+IMIDVASALEYLH   S+ ++HCDLKPSNVLLDDBMVAH++DFG+A
Sbjct: 1047 YSHNYFLDLIQRLNIMIDVASALEYLHHDCSSLVVHCDLKPSNVLLDDBMVAHVTDFGIA 1106

Query: 251  KPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFS 310
            K LL + +S+ QT+TL TIGYMAPE+G +G VST  DVYS+GI+LME+F R KP DE+F+
Sbjct: 1107 K-LLTKTESMQQTKTLGTIGYMAPEHGSDGIVSTKSDVYSYGILLMEVFARKKPMDEMFT 1165

Query: 311  GEMTLKRWVNDLLPISVMEVVDANLLSQEDEHFTTK 346
            G++TLK WV   L  SV++VVD NLL +EDE   TK
Sbjct: 1166 GDLTLKTWVES-LSNSVIQVVDVNLLRREDEDLATK 1200

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147852480|emb|CAN78527.1| hypothetical protein VITISV_039533 [Vitis vinifera]

 Score =  382 bits (980), Expect = e-103,   Method: Compositional matrix adjust.
 Identities = 208/396 (52%), Positives = 269/396 (67%), Gaps = 52/396 (13%)

Query: 1    QGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRN 60
            QG IP   GDL++L+SL+LS NNLSGTIP SLE L+ LK +NVS NKL+GEIP  GPF N
Sbjct: 795  QGPIPVEFGDLVSLESLDLSQNNLSGTIPKSLEALIYLKYLNVSSNKLQGEIPNGGPFVN 854

Query: 61   LSVKSFEGNELLCE---------------------------IVLPL-STIFMIVMILLIL 92
             + +SF  NE LC                            I+LP+ STI ++V I+L +
Sbjct: 855  FTAESFMFNEALCGAPHFQVMACDKNNRTQSWKTKSFILKYILLPVGSTITLVVFIVLWI 914

Query: 93   RYQKRGK-PLPNDANMPP---------------------LIGKGGFGSVYKAIIQDGMEV 130
            R +   + P P D+ +P                      LIGKG  G VYK ++ +G+ V
Sbjct: 915  RRRDNMEIPTPIDSWLPGTHEKISHQRLLYATNDFGEDNLIGKGSQGMVYKGVLSNGLIV 974

Query: 131  AVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCL 190
            A+KVF+ +++GA +SFD EC+VM+ I HRNL++II+  SN DFKALVL+YMP+GSLEK L
Sbjct: 975  AIKVFNLEFQGALRSFDSECEVMQGIRHRNLVRIITCCSNLDFKALVLKYMPNGSLEKWL 1034

Query: 191  YLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMA 250
            Y  NY LD+ QRL+IMIDVASALEYLH   S+ ++HCDLKPSNVLLDD+MVAH++DFG+ 
Sbjct: 1035 YSHNYFLDLIQRLNIMIDVASALEYLHHDCSSLVVHCDLKPSNVLLDDDMVAHVADFGIT 1094

Query: 251  KPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFS 310
            K LL + +S+ QT+TL TIGYMAPE+G +G VST  DVYS+GI+LME+F R KP DE+F+
Sbjct: 1095 K-LLTKTESMQQTKTLGTIGYMAPEHGSDGIVSTKSDVYSYGILLMEVFARKKPMDEMFT 1153

Query: 311  GEMTLKRWVNDLLPISVMEVVDANLLSQEDEHFTTK 346
            G++TLK WV   L  SV++VVD NLL +EDE   TK
Sbjct: 1154 GDLTLKTWVES-LSNSVIQVVDVNLLRREDEDLATK 1188

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	346
TAIR|locus:2075631	1009	AT3G47090 [Arabidopsis thalian	0.656	0.224	0.451	1.9e-58
TAIR|locus:2079157	1011	AT3G47580 [Arabidopsis thalian	0.656	0.224	0.447	1.4e-56
TAIR|locus:2149922	1031	EFR "EF-TU receptor" [Arabidop	0.618	0.207	0.472	4.4e-54
TAIR|locus:2047525	980	AT2G24130 [Arabidopsis thalian	0.664	0.234	0.434	1.6e-53
UNIPROTKB|Q40640	1025	Xa21 "Receptor kinase-like pro	0.653	0.220	0.440	1.6e-53
TAIR|locus:2075661	1025	AT3G47110 [Arabidopsis thalian	0.676	0.228	0.427	6.2e-52
TAIR|locus:2175703	502	AT5G39390 [Arabidopsis thalian	0.621	0.428	0.462	5.3e-49
TAIR|locus:2170483	1173	FLS2 "FLAGELLIN-SENSITIVE 2" [	0.667	0.196	0.385	5.5e-48
TAIR|locus:2079142	1010	AT3G47570 [Arabidopsis thalian	0.488	0.167	0.467	1.5e-47
TAIR|locus:2058759	589	FEI2 "FEI 2" [Arabidopsis thal	0.679	0.398	0.386	1.7e-47

TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)]

 Score = 544 (196.6 bits), Expect = 1.9e-58, Sum P(2) = 1.9e-58
 Identities = 111/246 (45%), Positives = 163/246 (66%)

Query:   110 LIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISS- 167
             ++G G FG+V+KA++Q +   VAVKV + Q  GA KSF  EC+ +K I HRNL+K++++ 
Sbjct:   706 IVGSGSFGTVFKALLQTENKIVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTAC 765

Query:   168 ----YSNDDFKALVLEYMPHGSLEKCLYLSNY--------ILDIFQRLDIMIDVASALEY 215
                 +  ++F+AL+ E+MP+GSL+K L+             L + +RL+I IDVAS L+Y
Sbjct:   766 ASIDFQGNEFRALIYEFMPNGSLDKWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDY 825

Query:   216 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS-----LTQTQTLATIG 270
             LH     PI HCDLKPSN+LLDD++ AH+SDFG+A+ LL+ DQ      L+      TIG
Sbjct:   826 LHVHCHEPIAHCDLKPSNILLDDDLTAHVSDFGLARLLLKFDQESFFNQLSSAGVRGTIG 885

Query:   271 YMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPISVMEV 330
             Y APEYG  G+ S +GDVYSFG++++E+FT  +PT+E+F G  TL  +    LP  V+++
Sbjct:   886 YAAPEYGMGGQPSIHGDVYSFGVLVLEMFTGKRPTNELFGGNFTLNSYTKAALPERVLDI 945

Query:   331 VDANLL 336
              D ++L
Sbjct:   946 ADKSIL 951

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009507 "chloroplast" evidence=IDA

TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)]

 Score = 526 (190.2 bits), Expect = 1.4e-56, Sum P(2) = 1.4e-56
 Identities = 110/246 (44%), Positives = 161/246 (65%)

Query:   110 LIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISS- 167
             ++G G FG+V+KA++  +   VAVKV + Q  GA KSF  EC+ +K   HRNL+K++++ 
Sbjct:   708 MVGSGSFGTVFKALLPTESKIVAVKVLNMQRRGAMKSFMAECESLKDTRHRNLVKLLTAC 767

Query:   168 ----YSNDDFKALVLEYMPHGSLEKCLYLSNY--------ILDIFQRLDIMIDVASALEY 215
                 +  ++F+AL+ EY+P+GS++  L+             L + +RL+I+IDVAS L+Y
Sbjct:   768 ASTDFQGNEFRALIYEYLPNGSVDMWLHPEEVEEIRRPPRTLTLLERLNIVIDVASVLDY 827

Query:   216 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS--LTQTQTLA---TIG 270
             LH     PI HCDLKPSNVLL+D++ AH+SDFG+A+ LL+ D+   L Q  +     TIG
Sbjct:   828 LHVHCHEPIAHCDLKPSNVLLEDDLTAHVSDFGLARLLLKFDKESFLNQLSSAGVRGTIG 887

Query:   271 YMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPISVMEV 330
             Y APEYG  G+ S +GDVYSFG++L+E+FT  +PTDE+F G +TL  +    LP  V E+
Sbjct:   888 YAAPEYGMGGQPSIHGDVYSFGVLLLEMFTGKRPTDELFGGNLTLHSYTKLALPEKVFEI 947

Query:   331 VDANLL 336
              D  +L
Sbjct:   948 ADKAIL 953

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)]

 Score = 488 (176.8 bits), Expect = 4.4e-54, Sum P(2) = 4.4e-54
 Identities = 110/233 (47%), Positives = 149/233 (63%)

Query:   110 LIGKGGFGSVYKAII-QDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
             LIG G FG+V+K ++  +   VAVKV +    GA KSF  EC+  K I HRNL+K+I+  
Sbjct:   717 LIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECETFKGIRHRNLVKLITVC 776

Query:   169 SN-----DDFKALVLEYMPHGSLEKCLYLSNY--------ILDIFQRLDIMIDVASALEY 215
             S+     +DF+ALV E+MP GSL+  L L +          L   ++L+I IDVASALEY
Sbjct:   777 SSLDSEGNDFRALVYEFMPKGSLDMWLQLEDLERVNDHSRSLTPAEKLNIAIDVASALEY 836

Query:   216 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS--LTQTQTLA---TIG 270
             LH     P+ HCD+KPSN+LLDD++ AH+SDFG+A+ L + D+   L Q  +     TIG
Sbjct:   837 LHVHCHDPVAHCDIKPSNILLDDDLTAHVSDFGLAQLLYKYDRESFLNQFSSAGVRGTIG 896

Query:   271 YMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLL 323
             Y APEYG  G+ S  GDVYSFGI+L+E+F+  KPTDE F+G+  L  +   +L
Sbjct:   897 YAAPEYGMGGQPSIQGDVYSFGILLLEMFSGKKPTDESFAGDYNLHSYTKSIL 949

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010204 "defense response signaling pathway, resistance gene-independent" evidence=IMP

GO:0016045 "detection of bacterium" evidence=RCA;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0002764 "immune response-regulating signaling pathway" evidence=IMP

GO:0009626 "plant-type hypersensitive response" evidence=IMP

GO:0019199 "transmembrane receptor protein kinase activity" evidence=TAS

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0050776 "regulation of immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)]

 Score = 476 (172.6 bits), Expect = 1.6e-53, Sum P(2) = 1.6e-53
 Identities = 106/244 (43%), Positives = 153/244 (62%)

Query:   106 NMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFK-SFDIECDVMKRICHRNLIKI 164
             N   LIG G FG VYK ++++  +VAVKV DP+    F  SF  EC ++KR  HRNLI+I
Sbjct:   662 NASSLIGSGRFGHVYKGVLRNNTKVAVKVLDPKTALEFSGSFKRECQILKRTRHRNLIRI 721

Query:   165 ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYI---LDIFQRLDIMIDVASALEYLHFGYS 221
             I++ S   F ALVL  MP+GSLE+ LY   Y    LD+ Q ++I  DVA  + YLH    
Sbjct:   722 ITTCSKPGFNALVLPLMPNGSLERHLYPGEYSSKNLDLIQLVNICSDVAEGIAYLHHYSP 781

Query:   222 APIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL--LEE----DQSLT--QTQTL--ATIGY 271
               ++HCDLKPSN+LLDD M A ++DFG+++ +  +EE    D S++   T  L   ++GY
Sbjct:   782 VKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVEETVSTDDSVSFGSTDGLLCGSVGY 841

Query:   272 MAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPISVMEVV 331
             +APEYG   R ST+GDVYSFG++L+EI +  +PTD + +   +L  ++    P S+  ++
Sbjct:   842 IAPEYGMGKRASTHGDVYSFGVLLLEIVSGRRPTDVLVNEGSSLHEFMKSHYPDSLEGII 901

Query:   332 DANL 335
             +  L
Sbjct:   902 EQAL 905

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)]

 Score = 477 (173.0 bits), Expect = 1.6e-53, Sum P(2) = 1.6e-53
 Identities = 107/243 (44%), Positives = 154/243 (63%)

Query:   110 LIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKII---S 166
             L+G G FGSVYK  +     VAVKV   +   A KSF  EC+ ++ + HRNL+KI+   S
Sbjct:   713 LLGSGSFGSVYKGKLNIQDHVAVKVLKLENPKALKSFTAECEALRNMRHRNLVKIVTICS 772

Query:   167 SYSN--DDFKALVLEYMPHGSLEKCLY------LSNYILDIFQRLDIMIDVASALEYLHF 218
             S  N  +DFKA+V ++MP+GSLE  ++           L++ +R+ I++DVA AL+YLH 
Sbjct:   773 SIDNRGNDFKAIVYDFMPNGSLEDWIHPETNDQADQRHLNLHRRVTILLDVACALDYLHR 832

Query:   219 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT-----LATIGYMA 273
                 P++HCD+K SNVLLD +MVAH+ DFG+A+ +L +  SL Q  T     + TIGY A
Sbjct:   833 HGPEPVVHCDIKSSNVLLDSDMVAHVGDFGLAR-ILVDGTSLIQQSTSSMGFIGTIGYAA 891

Query:   274 PEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPISVMEVVDA 333
             PEYG     ST+GD+YS+GI+++EI T  +PTD  F  ++ L+++V   L   V +VVD 
Sbjct:   892 PEYGVGLIASTHGDIYSYGILVLEIVTGKRPTDSTFRPDLGLRQYVELGLHGRVTDVVDT 951

Query:   334 NLL 336
              L+
Sbjct:   952 KLI 954

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)]

 Score = 471 (170.9 bits), Expect = 6.2e-52, Sum P(2) = 6.2e-52
 Identities = 109/255 (42%), Positives = 151/255 (59%)

Query:   110 LIGKGGFGSVYKAII-QDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKII--- 165
             LIG G FG+V+K  +      VA+KV +    GA KSF  EC+ +  I HRNL+K++   
Sbjct:   724 LIGSGNFGAVFKGFLGSKNKAVAIKVLNLCKRGAAKSFIAECEALGGIRHRNLVKLVTIC 783

Query:   166 --SSYSNDDFKALVLEYMPHGSLEKCLYLSNY--------ILDIFQRLDIMIDVASALEY 215
               S +  +DF+ALV E+MP+G+L+  L+             L +F RL+I IDVASAL Y
Sbjct:   784 SSSDFEGNDFRALVYEFMPNGNLDMWLHPDEIEETGNPSRTLGLFARLNIAIDVASALVY 843

Query:   216 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ-----TLATIG 270
             LH     PI HCD+KPSN+LLD ++ AH+SDFG+A+ LL+ D+     Q        TIG
Sbjct:   844 LHTYCHNPIAHCDIKPSNILLDKDLTAHVSDFGLAQLLLKFDRDTFHIQFSSAGVRGTIG 903

Query:   271 YMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPI-SVME 329
             Y APEYG  G  S  GDVYSFGI+L+EIFT  +PT+++F   +TL  +    L     ++
Sbjct:   904 YAAPEYGMGGHPSIMGDVYSFGIVLLEIFTGKRPTNKLFVDGLTLHSFTKSALQKRQALD 963

Query:   330 VVDANLL-SQEDEHF 343
             + D  +L     +HF
Sbjct:   964 ITDETILRGAYAQHF 978

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2175703 AT5G39390 [Arabidopsis thaliana (taxid:3702)]

 Score = 461 (167.3 bits), Expect = 5.3e-49, Sum P(2) = 5.3e-49
 Identities = 110/238 (46%), Positives = 145/238 (60%)

Query:   110 LIGKGGFGSVYKAIIQDGME---VAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIIS 166
             LIG G F  V+K ++  G+E   VAVKV +    GA KSF  EC+  K I HRNL K+I+
Sbjct:   214 LIGSGNFSDVFKGLL--GLEEKLVAVKVLNLLKHGATKSFIAECESFKGIRHRNLAKLIT 271

Query:   167 SYSN-----DDFKALVLEYMPHGSLEKCLY------LSNYI--LDIFQRLDIMIDVASAL 213
               S+     +DF+ALV E+MP GSL+  L        +N+   L   ++++I IDVASAL
Sbjct:   272 VCSSLDSQGNDFRALVYEFMPKGSLDMWLQPEDLESANNHSRSLTFAEKVNIAIDVASAL 331

Query:   214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS--LTQTQTLA---T 268
             EYLH     P+ HCD+KPSNVLLDD++ AH+SDFG+A+ L   D+   L Q  +     T
Sbjct:   332 EYLHVYCHDPVAHCDIKPSNVLLDDDLTAHVSDFGLARLLYNFDEKTFLNQFSSAGVRGT 391

Query:   269 IGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPIS 326
             IGY APEYG   + S  GDVYSFG++L+E+FT  KPTD  F G   L  +   +L  S
Sbjct:   392 IGYAAPEYGMGSKPSIQGDVYSFGVLLLEMFTGKKPTDNSFGGGYNLHGYTKSVLSCS 449

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 424 (154.3 bits), Expect = 5.5e-48, Sum P(2) = 5.5e-48
 Identities = 93/241 (38%), Positives = 152/241 (63%)

Query:    89 LLILRYQKRGKPLPNDA-NMPPLIGKGGFGSVYKAIIQDGMEVAVKVFD-PQYEG-AFKS 145
             L + R++ +      D+ N   +IG     +VYK  ++DG  +AVKV +  ++   + K 
Sbjct:   853 LKLKRFEPKELEQATDSFNSANIIGSSSLSTVYKGQLEDGTVIAVKVLNLKEFSAESDKW 912

Query:   146 FDIECDVMKRICHRNLIKIIS-SYSNDDFKALVLEYMPHGSLEKCLYLSNY-ILDIFQRL 203
             F  E   + ++ HRNL+KI+  ++ +   KALVL +M +G+LE  ++ S   I  + +++
Sbjct:   913 FYTEAKTLSQLKHRNLVKILGFAWESGKTKALVLPFMENGNLEDTIHGSAAPIGSLLEKI 972

Query:   204 DIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LEEDQSLTQ 262
             D+ + +AS ++YLH GY  PI+HCDLKP+N+LLD + VAH+SDFG A+ L   ED S T 
Sbjct:   973 DLCVHIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARILGFREDGSTTA 1032

Query:   263 TQTL--ATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPT--DEIFSGEMTLKRW 318
             + +    TIGY+APE+    +V+T  DV+SFGI++ME+ T+ +PT  ++  S +MTL++ 
Sbjct:  1033 STSAFEGTIGYLAPEFAYMRKVTTKADVFSFGIIMMELMTKQRPTSLNDEDSQDMTLRQL 1092

Query:   319 V 319
             V
Sbjct:  1093 V 1093

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0016020 "membrane" evidence=ISS;IDA

GO:0016045 "detection of bacterium" evidence=IMP

GO:0005886 "plasma membrane" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0042742 "defense response to bacterium" evidence=RCA;IMP

GO:0052544 "defense response by callose deposition in cell wall" evidence=IMP

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0016310 "phosphorylation" evidence=RCA

GO:0005768 "endosome" evidence=IDA

GO:0006898 "receptor-mediated endocytosis" evidence=IDA

TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)]

 Score = 420 (152.9 bits), Expect = 1.5e-47, Sum P(3) = 1.5e-47
 Identities = 85/182 (46%), Positives = 120/182 (65%)

Query:   168 YSNDDFKALVLEYMPHGSLEKCLYLSNY--------ILDIFQRLDIMIDVASALEYLHFG 219
             +  ++F+AL+ E+MP+GSL+  L+             L + +RL+I IDVAS L+YLH  
Sbjct:   771 FQGNEFRALIYEFMPNGSLDMWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVH 830

Query:   220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS-----LTQTQTLATIGYMAP 274
                PI HCDLKPSNVLLDD++ AH+SDFG+A+ LL+ D+      L+      TIGY AP
Sbjct:   831 CHEPIAHCDLKPSNVLLDDDLTAHVSDFGLARLLLKFDEESFFNQLSSAGVRGTIGYAAP 890

Query:   275 EYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPISVMEVVDAN 334
             EYG  G+ S NGDVYSFGI+L+E+FT  +PT+E+F G  TL  +    LP  ++++VD +
Sbjct:   891 EYGVGGQPSINGDVYSFGILLLEMFTGKRPTNELFGGNFTLNSYTKSALPERILDIVDES 950

Query:   335 LL 336
             +L
Sbjct:   951 IL 952

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2058759 FEI2 "FEI 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 402 (146.6 bits), Expect = 1.7e-47, Sum P(2) = 1.7e-47
 Identities = 92/238 (38%), Positives = 138/238 (57%)

Query:   106 NMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKII 165
             N   +IG GGFG+VYK  + DG   A+K      EG  + F+ E +++  I HR L+ + 
Sbjct:   305 NEEHIIGCGGFGTVYKLSMDDGNVFALKRIVKLNEGFDRFFERELEILGSIKHRYLVNLR 364

Query:   166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
                ++   K L+ +Y+P GSL++ L+     LD   R++I+I  A  L YLH   S  II
Sbjct:   365 GYCNSPTSKLLLYDYLPGGSLDEALHKRGEQLDWDSRVNIIIGAAKGLAYLHHDCSPRII 424

Query:   226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
             H D+K SN+LLD N+ A +SDFG+AK LLE+++S   T    T GY+APEY + GR +  
Sbjct:   425 HRDIKSSNILLDGNLEARVSDFGLAK-LLEDEESHITTIVAGTFGYLAPEYMQSGRATEK 483

Query:   286 GDVYSFGIMLMEIFTRTKPTDEIFSGE-MTLKRWVNDLLPIS-VMEVVDANLLSQEDE 341
              DVYSFG++++E+ +   PTD  F  +   +  W+N L+  +   E+VD +    E E
Sbjct:   484 TDVYSFGVLVLEVLSGKLPTDASFIEKGFNIVGWLNFLISENRAKEIVDLSCEGVERE 541

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009664 "plant-type cell wall organization" evidence=RCA;IMP

GO:0009826 "unidimensional cell growth" evidence=IMP

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0000272 "polysaccharide catabolic process" evidence=RCA

GO:0005982 "starch metabolic process" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009832 "plant-type cell wall biogenesis" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.737
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	346
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	6e-48
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	5e-46
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	9e-46
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	6e-41
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	5e-40
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	8e-39
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-36
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	6e-35
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-32
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	6e-32
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	5e-28
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-27
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-27
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-27
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-27
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	4e-27
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	5e-27
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-25
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-25
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	5e-25
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-24
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-24
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-24
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-24
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-23
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	3e-23
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-22
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-22
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-22
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-22
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	3e-22
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	7e-22
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-21
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	6e-21
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	7e-21
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-20
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-20
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-20
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-19
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-19
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-19
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-19
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-19
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-19
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-19
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	4e-19
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	5e-19
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	6e-19
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	7e-19
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-18
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-18
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-18
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-18
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-18
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-18
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-18
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	3e-18
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	4e-18
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	5e-18
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	6e-18
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	7e-18
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-17
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-17
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-17
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-17
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-17
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-17
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-17
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	3e-17
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	3e-17
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-17
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	4e-17
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	5e-17
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	5e-17
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	5e-17
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	7e-17
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	9e-17
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-16
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-16
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-16
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-16
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-16
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	3e-16
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	3e-16
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	4e-16
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	5e-16
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	6e-16
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	6e-16
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	6e-16
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	7e-16
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	9e-16
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-15
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-15
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-15
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-15
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-15
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-15
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-15
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-15
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	4e-15
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	4e-15
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	4e-15
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	5e-15
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	6e-15
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	6e-15
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	6e-15
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	7e-15
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-14
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-14
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-14
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-14
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-14
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-14
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	3e-14
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	3e-14
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-14
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	4e-14
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	4e-14
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	5e-14
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	7e-14
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	7e-14
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	9e-14
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-13
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-13
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-13
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-13
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-13
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-13
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-13
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-13
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-13
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-13
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	5e-13
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	5e-13
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	5e-13
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	6e-13
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	7e-13
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	7e-13
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	7e-13
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	8e-13
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	9e-13
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-12
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-12
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-12
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-12
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-12
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-12
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	3e-12
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-12
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-12
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	4e-12
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	5e-12
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	5e-12
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	5e-12
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	9e-12
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-11
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-11
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-11
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-11
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-11
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-11
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-11
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-11
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-11
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-11
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-11
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-11
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-11
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-11
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-11
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	3e-11
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-11
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	4e-11
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	4e-11
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	5e-11
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	6e-11
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	7e-11
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	8e-11
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-10
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-10
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-10
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-10
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	3e-10
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-10
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-10
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	3e-10
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-10
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	4e-10
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	4e-10
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	4e-10
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	4e-10
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	4e-10
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	5e-10
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	5e-10
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	5e-10
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	6e-10
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	7e-10
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	7e-10
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	8e-10
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	8e-10
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	9e-10
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	9e-10
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-09
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-09
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-09
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-09
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-09
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-09
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-09
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-09
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-09
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-09
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-09
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	3e-09
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	3e-09
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	3e-09
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	4e-09
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	4e-09
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	4e-09
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	4e-09
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	4e-09
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	5e-09
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	6e-09
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	7e-09
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	9e-09
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-08
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-08
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-08
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	1e-08
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-08
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-08
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-08
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-08
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-08
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-08
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-08
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-08
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-08
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-08
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	3e-08
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-08
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-08
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	3e-08
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	3e-08
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	4e-08
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	4e-08
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	5e-08
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	7e-08
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-07
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-07
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-07
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-07
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-07
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-07
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-07
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-07
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-07
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-07
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	2e-07
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-07
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-07
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-07
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	3e-07
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-07
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	3e-07
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-07
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-07
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	5e-07
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	6e-07
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	6e-07
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	7e-07
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	7e-07
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	8e-07
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	9e-07
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-06
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-06
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-06
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-06
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-06
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-06
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	3e-06
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-06
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	4e-06
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	5e-06
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	5e-06
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	9e-06
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	9e-06
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-05
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	1e-05
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-05
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-05
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-05
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-05
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-05
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-05
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-05
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	3e-05
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	3e-05
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	4e-05
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	4e-05
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	4e-05
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	6e-05
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	7e-05
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	8e-05
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-04
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-04
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-04
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-04
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-04
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-04
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	3e-04
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	5e-04
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	6e-04
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	6e-04
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	7e-04
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	0.001
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	0.001
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	0.001
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.002
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	0.002
COG0661	517	COG0661, AarF, Predicted unusual protein kinase [G	0.002
pfam03109	117	pfam03109, ABC1, ABC1 family	0.002
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	0.003
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	0.003
COG2334	331	COG2334, COG2334, Putative homoserine kinase type	0.003
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	0.004
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	0.004
PRK09605	535	PRK09605, PRK09605, bifunctional UGMP family prote	0.004

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  160 bits (407), Expect = 6e-48
 Identities = 66/192 (34%), Positives = 105/192 (54%), Gaps = 9/192 (4%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFK-SFDIECDVMKRICHRNLIKIISSY 168
           +G+GGFG+VY A   + G +VA+K+   +   +       E +++K++ H N++K+   +
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCD 228
            +++   LV+EY   GSL+  L  +   L   + L I++ +   LEYLH   S  IIH D
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRD 117

Query: 229 LKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGR-EGRVSTNG 286
           LKP N+LLD DN    L+DFG++K L            + T  YMAPE    +G  S   
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLL--TSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKS 175

Query: 287 DVYSFGIMLMEI 298
           D++S G++L E+
Sbjct: 176 DIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  157 bits (398), Expect = 5e-46
 Identities = 80/209 (38%), Positives = 108/209 (51%), Gaps = 20/209 (9%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDI----ECDVMKRICHRNLIKII 165
           +G G FG+VYKA     G  VAVK+            D     E  +++R+ H N++++I
Sbjct: 7   LGSGSFGTVYKAKHKGTGKIVAVKILK--KRSEKSKKDQTARREIRILRRLSHPNIVRLI 64

Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNY-ILDIFQRLDIMIDVASALEYLHFGYSAPI 224
            ++ + D   LV+EY   G L    YLS    L   +   I + +   LEYLH   S  I
Sbjct: 65  DAFEDKDHLYLVMEYCEGGDL--FDYLSRGGPLSEDEAKKIALQILRGLEYLH---SNGI 119

Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGR-VS 283
           IH DLKP N+LLD+N V  ++DFG+AK LL+   SLT T    T  YMAPE    G    
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLT-TFV-GTPWYMAPEVLLGGNGYG 177

Query: 284 TNGDVYSFGIMLMEIFTRTKPTDEIFSGE 312
              DV+S G++L E+ T   P    FSGE
Sbjct: 178 PKVDVWSLGVILYELLTGKPP----FSGE 202

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  156 bits (396), Expect = 9e-46
 Identities = 66/210 (31%), Positives = 103/210 (49%), Gaps = 13/210 (6%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISS 167
            +G+G FG VY A   + G  VA+KV   +  +   +    E  ++K++ H N++++   
Sbjct: 6   KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65

Query: 168 YSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHC 227
           + ++D   LV+EY   G L   L      L   +    +  + SALEYLH   S  I+H 
Sbjct: 66  FEDEDKLYLVMEYCEGGDLFDLLK-KRGRLSEDEARFYLRQILSALEYLH---SKGIVHR 121

Query: 228 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGD 287
           DLKP N+LLD++    L+DFG+A+   + D     T  + T  YMAPE           D
Sbjct: 122 DLKPENILLDEDGHVKLADFGLAR---QLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVD 178

Query: 288 VYSFGIMLMEIFTRTKPTDEIFSGEMTLKR 317
           ++S G++L E+ T   P    F G+  L  
Sbjct: 179 IWSLGVILYELLTGKPP----FPGDDQLLE 204

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  143 bits (364), Expect = 6e-41
 Identities = 62/197 (31%), Positives = 103/197 (52%), Gaps = 9/197 (4%)

Query: 111 IGKGGFGSVYKAII-----QDGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKI 164
           +G+G FG VYK  +         +VAVK       E   + F  E  +MK++ H N++++
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66

Query: 165 ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPI 224
           +   +  +   +V EYMP G L   L      L +   L + + +A  +EYL    S   
Sbjct: 67  LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE---SKNF 123

Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVST 284
           +H DL   N L+ +N+V  +SDFG+++ + E+D    +      I +MAPE  ++G+ ++
Sbjct: 124 VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTS 183

Query: 285 NGDVYSFGIMLMEIFTR 301
             DV+SFG++L EIFT 
Sbjct: 184 KSDVWSFGVLLWEIFTL 200

Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  141 bits (357), Expect = 5e-40
 Identities = 64/200 (32%), Positives = 106/200 (53%), Gaps = 10/200 (5%)

Query: 111 IGKGGFGSVYKAIIQD-----GMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKI 164
           +G+G FG VYK  ++       +EVAVK       E   + F  E  +M+++ H N++K+
Sbjct: 7   LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66

Query: 165 ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPI 224
           +   + ++   +V+EYM  G L   L  +   L +   L   + +A  +EYL    S   
Sbjct: 67  LGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE---SKNF 123

Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVST 284
           IH DL   N L+ +N+V  +SDFG+++  L +D    +      I +MAPE  +EG+ ++
Sbjct: 124 IHRDLAARNCLVGENLVVKISDFGLSR-DLYDDDYYRKRGGKLPIRWMAPESLKEGKFTS 182

Query: 285 NGDVYSFGIMLMEIFTRTKP 304
             DV+SFG++L EIFT  + 
Sbjct: 183 KSDVWSFGVLLWEIFTLGEQ 202

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  138 bits (349), Expect = 8e-39
 Identities = 65/201 (32%), Positives = 105/201 (52%), Gaps = 11/201 (5%)

Query: 111 IGKGGFGSVYKAIIQDG-----MEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKI 164
           +G+G FG VYK  ++       +EVAVK       E   + F  E  +M+++ H N++K+
Sbjct: 7   LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66

Query: 165 ISSYSNDDFKALVLEYMPHGSLEKCL-YLSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
           +   + ++   +V+EYMP G L   L       L +   L   + +A  +EYL    S  
Sbjct: 67  LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKN 123

Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVS 283
            IH DL   N L+ +N+V  +SDFG+++  L +D           I +MAPE  +EG+ +
Sbjct: 124 FIHRDLAARNCLVGENLVVKISDFGLSR-DLYDDDYYKVKGGKLPIRWMAPESLKEGKFT 182

Query: 284 TNGDVYSFGIMLMEIFTRTKP 304
           +  DV+SFG++L EIFT  + 
Sbjct: 183 SKSDVWSFGVLLWEIFTLGEE 203

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  131 bits (332), Expect = 3e-36
 Identities = 65/210 (30%), Positives = 106/210 (50%), Gaps = 28/210 (13%)

Query: 111 IGKGGFGSVYKAIIQDG----MEVAVKV-----FDPQYEGAFKSFDIECDVMKRICHRNL 161
           +G+G FG VYK  ++       EVAVK       + + +   K    E  VMK++ H N+
Sbjct: 3   LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLK----EARVMKKLGHPNV 58

Query: 162 IKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNY----------ILDIFQRLDIMIDVAS 211
           ++++   + ++   LVLEYM  G L    YL              L +   L   I +A 
Sbjct: 59  VRLLGVCTEEEPLYLVLEYMEGGDLLD--YLRKSRPVFPSPEKSTLSLKDLLSFAIQIAK 116

Query: 212 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGY 271
            +EYL    S   +H DL   N L+ +++V  +SDFG+++ + ++D    +T     I +
Sbjct: 117 GMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRW 173

Query: 272 MAPEYGREGRVSTNGDVYSFGIMLMEIFTR 301
           MAPE  ++G  ++  DV+SFG++L EIFT 
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFTL 203

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  128 bits (323), Expect = 6e-35
 Identities = 61/204 (29%), Positives = 100/204 (49%), Gaps = 23/204 (11%)

Query: 109 PLIGKGGFGSVYKAIIQD-GMEVAVKV--FDPQYEGAFKSFDIECDVMKRICHRNLIKII 165
            L+G+G FGSVY A+ +D G  +AVK        E   ++ + E  ++  + H N+++  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 166 SSYSNDDFKAL--VLEYMPHGSLEKCLYLSNYILDIFQRLDI------MIDVASALEYLH 217
            S  +++   L   LEY+  GSL         +L  F +L           +   L YLH
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSS-------LLKKFGKLPEPVIRKYTRQILEGLAYLH 118

Query: 218 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA-TIGYMAPEY 276
              S  I+H D+K +N+L+D + V  L+DFG AK  L + ++   T ++  T  +MAPE 
Sbjct: 119 ---SNGIVHRDIKGANILVDSDGVVKLADFGCAK-RLGDIETGEGTGSVRGTPYWMAPEV 174

Query: 277 GREGRVSTNGDVYSFGIMLMEIFT 300
            R        D++S G  ++E+ T
Sbjct: 175 IRGEEYGRAADIWSLGCTVIEMAT 198

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  120 bits (304), Expect = 2e-32
 Identities = 68/202 (33%), Positives = 103/202 (50%), Gaps = 15/202 (7%)

Query: 102 PNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNL 161
             +  +   IGKG FG V     + G +VAVK        A ++F  E  VM  + H NL
Sbjct: 5   SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLK-DDSTAAQAFLAEASVMTTLRHPNL 62

Query: 162 IKIISSYSNDDFKALVLEYMPHGSLEKCLYLSN---YILDIFQRLDIMIDVASALEYLHF 218
           ++++      +   +V EYM  GSL    YL +    ++ + Q+L   +DV   +EYL  
Sbjct: 63  VQLLGVVLQGNPLYIVTEYMAKGSLVD--YLRSRGRAVITLAQQLGFALDVCEGMEYLE- 119

Query: 219 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGR 278
                 +H DL   NVL+ +++VA +SDFG+AK     + S  Q      + + APE  R
Sbjct: 120 --EKNFVHRDLAARNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEALR 172

Query: 279 EGRVSTNGDVYSFGIMLMEIFT 300
           E + ST  DV+SFGI+L EI++
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  119 bits (301), Expect = 6e-32
 Identities = 65/196 (33%), Positives = 95/196 (48%), Gaps = 9/196 (4%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYS 169
           IGKGGFG VYKA   + G EVA+KV   + +   +    E  ++K+  H N++K   SY 
Sbjct: 8   IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67

Query: 170 NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
             D   +V+E+   GSL+  L  +N  L   Q   +  ++   LEYLH   S  IIH D+
Sbjct: 68  KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDI 124

Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA-TIGYMAPEYGREGRVSTNGDV 288
           K +N+LL  +    L DFG++  L           T+  T  +MAPE           D+
Sbjct: 125 KAANILLTSDGEVKLIDFGLSAQL----SDTKARNTMVGTPYWMAPEVINGKPYDYKADI 180

Query: 289 YSFGIMLMEIFTRTKP 304
           +S GI  +E+     P
Sbjct: 181 WSLGITAIELAEGKPP 196

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  112 bits (280), Expect = 5e-28
 Identities = 71/209 (33%), Positives = 103/209 (49%), Gaps = 19/209 (9%)

Query: 110 LIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRI-CHRNLIKII 165
            +G+G FG VY A  +D   VA+KV   + E      + F  E  ++  +    N++K+ 
Sbjct: 7   KLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64

Query: 166 SSYSNDDFKALVLEYMPHGSLEK--CLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
             + ++    LV+EY+  GSLE           L   + L I+  + SALEYLH   S  
Sbjct: 65  DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKG 121

Query: 224 IIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQTLA----TIGYMAPEY-- 276
           IIH D+KP N+LLD D  V  L DFG+AK L +   + +     +    T GYMAPE   
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181

Query: 277 -GREGRVSTNGDVYSFGIMLMEIFTRTKP 304
                  S++ D++S GI L E+ T   P
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPP 210

Length = 384

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  107 bits (271), Expect = 2e-27
 Identities = 65/201 (32%), Positives = 93/201 (46%), Gaps = 24/201 (11%)

Query: 111 IGKGGFGSVYKA-IIQDGMEVAVKVFDPQYEGAFKSFD---IECDVMKRICHRNLIKIIS 166
           +GKG FG V        G   A+KV   +     K  +    E +++ RI H  ++K+  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 167 SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLD------IMIDVASALEYLHFGY 220
           ++  ++   LVLEY P G L    +LS        R           ++  ALEYLH   
Sbjct: 61  AFQTEEKLYLVLEYAPGGELFS--HLSKE-----GRFSEERARFYAAEIVLALEYLH--- 110

Query: 221 SAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA-TIGYMAPEYGRE 279
           S  II+ DLKP N+LLD +    L+DFG+AK L  E     +T T   T  Y+APE    
Sbjct: 111 SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS---RTNTFCGTPEYLAPEVLLG 167

Query: 280 GRVSTNGDVYSFGIMLMEIFT 300
                  D +S G++L E+ T
Sbjct: 168 KGYGKAVDWWSLGVLLYEMLT 188

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  107 bits (270), Expect = 2e-27
 Identities = 68/196 (34%), Positives = 100/196 (51%), Gaps = 12/196 (6%)

Query: 110 LIGKGGFGSVYKAIIQDGMEVAVK---VFDPQYEGAFKSFDIECDVMKRICHRNLIKIIS 166
            IGKG FG VYK +++   EVAVK      P        F  E +++K+  H N++K+I 
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKR--KFLQEAEILKQYDHPNIVKLIG 59

Query: 167 SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIH 226
                    +V+E +P GSL   L      L + + L + +D A+ +EYL    S   IH
Sbjct: 60  VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIH 116

Query: 227 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATI--GYMAPEYGREGRVST 284
            DL   N L+ +N V  +SDFGM++   EE    T +  L  I   + APE    GR ++
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSRE--EEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174

Query: 285 NGDVYSFGIMLMEIFT 300
             DV+S+GI+L E F+
Sbjct: 175 ESDVWSYGILLWETFS 190

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  107 bits (270), Expect = 2e-27
 Identities = 67/205 (32%), Positives = 98/205 (47%), Gaps = 21/205 (10%)

Query: 109 PLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQ--YEGAFKSFDIECDVMKRICHRNLIKII 165
            LIG+G FG VYK + ++ G  VA+K    +   E A KS   E D++K + H N++K I
Sbjct: 6   DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65

Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL------DIMIDVASALEYLHFG 219
            S    D   ++LEY  +GSL +       I+  F           +  V   L YLH  
Sbjct: 66  GSIETSDSLYIILEYAENGSLRQ-------IIKKFGPFPESLVAVYVYQVLQGLAYLH-- 116

Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
               +IH D+K +N+L   + V  L+DFG+A  L   D S      + T  +MAPE    
Sbjct: 117 -EQGVIHRDIKAANILTTKDGVVKLADFGVATKL--NDVSKDDASVVGTPYWMAPEVIEM 173

Query: 280 GRVSTNGDVYSFGIMLMEIFTRTKP 304
              ST  D++S G  ++E+ T   P
Sbjct: 174 SGASTASDIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  107 bits (269), Expect = 3e-27
 Identities = 64/195 (32%), Positives = 101/195 (51%), Gaps = 14/195 (7%)

Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFK--SFDIECDVMKRICHRNLIKIISSY 168
           +G G FG V+        +VAVK   P   G     +F  E  +MK++ H  L+++ +  
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKTLKP---GTMSPEAFLQEAQIMKKLRHDKLVQLYAVC 70

Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSN---YILDIFQRLDIMIDVASALEYLHFGYSAPII 225
           S ++   +V EYM  GSL    +L +     L + Q +D+   +A  + YL    S   I
Sbjct: 71  SEEEPIYIVTEYMSKGSLLD--FLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYI 125

Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
           H DL   N+L+ +N+V  ++DFG+A+ L+E+D+   +      I + APE    GR +  
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLAR-LIEDDEYTAREGAKFPIKWTAPEAANYGRFTIK 184

Query: 286 GDVYSFGIMLMEIFT 300
            DV+SFGI+L EI T
Sbjct: 185 SDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  107 bits (269), Expect = 4e-27
 Identities = 66/213 (30%), Positives = 98/213 (46%), Gaps = 23/213 (10%)

Query: 110 LIGKGGFGSVYKA-IIQDGMEVAVKVFD------PQYEGAFKSFDIECDVMKRICHRNLI 162
            IGKG FG VY      DG    +K  D       + E A      E  ++K++ H N+I
Sbjct: 7   QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALN----EVKILKKLNHPNII 62

Query: 163 KIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIF---QRLDIMIDVASALEYLHFG 219
           K   S+       +V+EY   G L + +         F   Q LD  + +  AL+YLH  
Sbjct: 63  KYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH-- 120

Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
            S  I+H D+KP N+ L  N +  L DFG++K +L     L +T  + T  Y++PE  + 
Sbjct: 121 -SRKILHRDIKPQNIFLTSNGLVKLGDFGISK-VLSSTVDLAKTV-VGTPYYLSPELCQN 177

Query: 280 GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE 312
              +   D++S G +L E+ T   P    F GE
Sbjct: 178 KPYNYKSDIWSLGCVLYELCTLKHP----FEGE 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  107 bits (269), Expect = 5e-27
 Identities = 65/216 (30%), Positives = 96/216 (44%), Gaps = 29/216 (13%)

Query: 111 IGKGGFGSVYKAII------QDGMEVAVKVF-DPQYEGAFKSFDIECDVMKRICHRNLIK 163
           +G+G FG V+           D   VAVK   +     A K F+ E +++    H N++K
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSN-------------YILDIFQRLDIMIDVA 210
                +  D   +V EYM HG L K L                   L + Q L I + +A
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 211 SALEYL---HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA 267
           S + YL   HF      +H DL   N L+  ++V  + DFGM++ +   D       T+ 
Sbjct: 133 SGMVYLASQHF------VHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTML 186

Query: 268 TIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTK 303
            I +M PE     + +T  DV+SFG++L EIFT  K
Sbjct: 187 PIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGK 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  103 bits (259), Expect = 1e-25
 Identities = 62/192 (32%), Positives = 89/192 (46%), Gaps = 13/192 (6%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFD---PQYEGAFKSFDIECDVMKRICHRNLIKIIS 166
           IG+G  G VYKA     G EVA+K         E        E  +MK   H N++    
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN----EILIMKDCKHPNIVDYYD 82

Query: 167 SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIH 226
           SY   D   +V+EYM  GSL   +  +   ++  Q   +  +V   LEYLH   S  +IH
Sbjct: 83  SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIH 139

Query: 227 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNG 286
            D+K  N+LL  +    L+DFG A  L +E     +   + T  +MAPE  +        
Sbjct: 140 RDIKSDNILLSKDGSVKLADFGFAAQLTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKV 197

Query: 287 DVYSFGIMLMEI 298
           D++S GIM +E+
Sbjct: 198 DIWSLGIMCIEM 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  102 bits (257), Expect = 2e-25
 Identities = 66/220 (30%), Positives = 106/220 (48%), Gaps = 31/220 (14%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFDPQY---EGAFKSFDIECDVMKRI-CHRNLIKI 164
           +IG+G F +V  A   +   E A+K+ D +    E   K   IE +V+ R+  H  +IK+
Sbjct: 8   IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67

Query: 165 ISSYSNDDFKALVLEYMPHGSLEKCLYLSNY-ILDIFQRLDIMIDVASALEYLHFGYSAP 223
             ++ +++    VLEY P+G L +  Y+  Y  LD         ++  ALEYLH   S  
Sbjct: 68  YYTFQDEENLYFVLEYAPNGELLQ--YIRKYGSLDEKCTRFYAAEILLALEYLH---SKG 122

Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG------------- 270
           IIH DLKP N+LLD +M   ++DFG AK +L+ + S    +  AT               
Sbjct: 123 IIHRDLKPENILLDKDMHIKITDFGTAK-VLDPNSSPESNKGDATNIDSQIEKNRRRFAS 181

Query: 271 ------YMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKP 304
                 Y++PE   E     + D+++ G ++ ++ T   P
Sbjct: 182 FVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  101 bits (253), Expect = 5e-25
 Identities = 59/194 (30%), Positives = 103/194 (53%), Gaps = 10/194 (5%)

Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSN 170
           +G G FG V++ + ++ + VA+K+         + F  E   +KR+ H++LI + +  S 
Sbjct: 14  LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73

Query: 171 DDFKALVLEYMPHGSLEKCLYLSN---YILDIFQRLDIMIDVASALEYLHFGYSAPIIHC 227
            +   ++ E M  GSL    +L +    +L +   +D+   VA  + YL        IH 
Sbjct: 74  GEPVYIITELMEKGSLLA--FLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHR 128

Query: 228 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGD 287
           DL   N+L+ +++V  ++DFG+A+ L++ED  L+  + +    + APE    G  ST  D
Sbjct: 129 DLAARNILVGEDLVCKVADFGLAR-LIKEDVYLSSDKKIP-YKWTAPEAASHGTFSTKSD 186

Query: 288 VYSFGIMLMEIFTR 301
           V+SFGI+L E+FT 
Sbjct: 187 VWSFGILLYEMFTY 200

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  100 bits (250), Expect = 2e-24
 Identities = 66/232 (28%), Positives = 112/232 (48%), Gaps = 24/232 (10%)

Query: 111 IGKGGFGSVYKA---IIQD--GMEVAVKVFDPQYEGAFKS-FDIECDVMKRICHRNLIKI 164
           +G+G FG V       + D  G +VAVK  +   E   +S F+ E ++++ + H N++K 
Sbjct: 12  LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71

Query: 165 ISSYSNDDFKA--LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSA 222
                    ++  L++EY+P GSL   L      +++ + L     +   ++YL    S 
Sbjct: 72  KGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG---SQ 128

Query: 223 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL--ATIGYMAPEYGREG 280
             IH DL   N+L++   +  +SDFG+AK +L ED+     +    + I + APE  R  
Sbjct: 129 RYIHRDLAARNILVESEDLVKISDFGLAK-VLPEDKDYYYVKEPGESPIFWYAPECLRTS 187

Query: 281 RVSTNGDVYSFGIMLMEIFTRTKPTDE----------IFSGEMTLKRWVNDL 322
           + S+  DV+SFG+ L E+FT   P+            I  G+M + R +  L
Sbjct: 188 KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL 239

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 99.8 bits (249), Expect = 2e-24
 Identities = 64/193 (33%), Positives = 100/193 (51%), Gaps = 10/193 (5%)

Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSN 170
           +G G FG V++ +  +   VAVK   P      K F  E  +MK++ H  LI++ +  + 
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDP-KDFLAEAQIMKKLRHPKLIQLYAVCTL 72

Query: 171 DDFKALVLEYMPHGSLEKCLYLSN---YILDIFQRLDIMIDVASALEYLHFGYSAPIIHC 227
           ++   +V E M +GSL +  YL       L + Q +D+   VAS + YL    +   IH 
Sbjct: 73  EEPIYIVTELMKYGSLLE--YLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHR 127

Query: 228 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGD 287
           DL   NVL+ +N +  ++DFG+A+ +++ED    +      I + APE     R S   D
Sbjct: 128 DLAARNVLVGENNICKVADFGLAR-VIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSD 186

Query: 288 VYSFGIMLMEIFT 300
           V+SFGI+L EI T
Sbjct: 187 VWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 99.3 bits (247), Expect = 3e-24
 Identities = 64/215 (29%), Positives = 105/215 (48%), Gaps = 10/215 (4%)

Query: 102 PNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAF--KSFDIECDVMKRICHR 159
           P++  +   IG G FG V+     +  +VA+K      EGA   + F  E  VM ++ H 
Sbjct: 3   PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIR---EGAMSEEDFIEEAQVMMKLSHP 59

Query: 160 NLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFG 219
            L+++    +      LV E+M HG L   L            L + +DV   + YL   
Sbjct: 60  KLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE-- 117

Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
            S+ +IH DL   N L+ +N V  +SDFGM + +L+ DQ  + T T   + + +PE    
Sbjct: 118 -SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLD-DQYTSSTGTKFPVKWSSPEVFSF 175

Query: 280 GRVSTNGDVYSFGIMLMEIFTRTK-PTDEIFSGEM 313
            + S+  DV+SFG+++ E+F+  K P +   + E+
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV 210

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 99.6 bits (249), Expect = 3e-24
 Identities = 56/206 (27%), Positives = 91/206 (44%), Gaps = 27/206 (13%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRIC----------HR 159
           +G+G  G VYK      G   A+K             D + +  K++             
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKKI---------HVDGDEEFRKQLLRELKTLRSCESP 59

Query: 160 NLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFG 219
            ++K   ++  +   ++VLEYM  GSL   L     I +      I   +   L+YLH  
Sbjct: 60  YVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAY-IARQILKGLDYLH-- 116

Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT-LATIGYMAPEYGR 278
               IIH D+KPSN+L++      ++DFG++K L   + +L Q  T + T+ YM+PE  +
Sbjct: 117 TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVL---ENTLDQCNTFVGTVTYMSPERIQ 173

Query: 279 EGRVSTNGDVYSFGIMLMEIFTRTKP 304
               S   D++S G+ L+E      P
Sbjct: 174 GESYSYAADIWSLGLTLLECALGKFP 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 96.7 bits (241), Expect = 3e-23
 Identities = 69/225 (30%), Positives = 109/225 (48%), Gaps = 25/225 (11%)

Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDI--ECDVMKRICHRNLIKIISSY 168
           +G G FG V+    +  ++VA+K+     EGA    D   E  VM ++ H NL+++    
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIR---EGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC 68

Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCD 228
           +      +V EYM +G L   L      L     LD+  DV  A+EYL    S   IH D
Sbjct: 69  TKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRD 125

Query: 229 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDV 288
           L   N L+ ++ V  +SDFG+A+ +L+ DQ  +   T   + +  PE     R S+  DV
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLD-DQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDV 184

Query: 289 YSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPISVMEVVDA 333
           +SFG+++ E+F+          G+M  +R+ N        EVV++
Sbjct: 185 WSFGVLMWEVFS---------EGKMPYERFSN-------SEVVES 213

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 96.6 bits (240), Expect = 3e-23
 Identities = 64/194 (32%), Positives = 96/194 (49%), Gaps = 9/194 (4%)

Query: 110 LIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFK-SFDIECDVMKRICHRNLIKIISSY 168
           L+GKG FG V+K  ++D   VAVK          K  F  E  ++K+  H N++K+I   
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCD 228
           +      +V+E +P G     L      L   Q +   +D A+ + YL    S   IH D
Sbjct: 62  TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRD 118

Query: 229 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATI--GYMAPEYGREGRVSTNG 286
           L   N L+ +N V  +SDFGM++   +ED  +  +  L  I   + APE    GR S+  
Sbjct: 119 LAARNCLVGENNVLKISDFGMSR---QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175

Query: 287 DVYSFGIMLMEIFT 300
           DV+S+GI+L E F+
Sbjct: 176 DVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 95.7 bits (239), Expect = 1e-22
 Identities = 69/220 (31%), Positives = 104/220 (47%), Gaps = 39/220 (17%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQ--YEGAFKSFDI----ECDVMKRICHRNLIK 163
           IG+G +G VYKA   + G  VA+K    +   EG    F I    E  +++++ H N+++
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEKEG----FPITAIREIKLLQKLRHPNIVR 62

Query: 164 II----SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFG 219
           +     S      +  +V EYM H  L   L          Q    M  +   L+YLH  
Sbjct: 63  LKEIVTSKGKGSIY--MVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH-- 117

Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE---- 275
            S  I+H D+K SN+L++++ V  L+DFG+A+P   +  S   T  + T+ Y  PE    
Sbjct: 118 -SNGILHRDIKGSNILINNDGVLKLADFGLARP-YTKRNSADYTNRVITLWYRPPELLLG 175

Query: 276 ---YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE 312
              YG E  V    D++S G +L E+F   KP   IF G 
Sbjct: 176 ATRYGPE--V----DMWSVGCILAELFLG-KP---IFQGS 205

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 95.0 bits (236), Expect = 1e-22
 Identities = 68/194 (35%), Positives = 101/194 (52%), Gaps = 17/194 (8%)

Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSN 170
           IGKG FG V     + G +VAVK    + +   ++F  E  VM ++ H NL++++     
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70

Query: 171 DDFKA-LVLEYMPHGSLEKCLYLSN---YILDIFQRLDIMIDVASALEYLHFGYSAPIIH 226
           +     +V EYM  GSL    YL +    +L     L   +DV  A+EYL    +   +H
Sbjct: 71  EKGGLYIVTEYMAKGSLVD--YLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVH 125

Query: 227 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNG 286
            DL   NVL+ ++ VA +SDFG+ K     + S TQ      + + APE  RE + ST  
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKS 180

Query: 287 DVYSFGIMLMEIFT 300
           DV+SFGI+L EI++
Sbjct: 181 DVWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 94.7 bits (235), Expect = 2e-22
 Identities = 59/194 (30%), Positives = 102/194 (52%), Gaps = 7/194 (3%)

Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSN 170
           +G+G FG V+         VA+K   P      ++F  E  VMK++ H  L+++ +  S 
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 72

Query: 171 DDFKALVLEYMPHGSLEKCLY-LSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
           +    +V EYM  GSL   L       L + Q +D+   +AS + Y+        +H DL
Sbjct: 73  EPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 128

Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 289
           + +N+L+ +N+V  ++DFG+A+ L+E+++   +      I + APE    GR +   DV+
Sbjct: 129 RAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187

Query: 290 SFGIMLMEIFTRTK 303
           SFGI+L E+ T+ +
Sbjct: 188 SFGILLTELTTKGR 201

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 94.3 bits (235), Expect = 2e-22
 Identities = 68/207 (32%), Positives = 101/207 (48%), Gaps = 22/207 (10%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKV--FDPQYEGAFKSFDIECDVMKRICHRNLIKIISS 167
           IG G FG VY A+ +  G  +AVK            K    E  V++ + H NL+K    
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67

Query: 168 YSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVAS-----ALEYLHFGYSA 222
             + +   + +EY   G+LE+ L     ILD     + +I V +      L YLH   S 
Sbjct: 68  EVHREKVYIFMEYCSGGTLEELLEHGR-ILD-----EHVIRVYTLQLLEGLAYLH---SH 118

Query: 223 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL-TQTQTLA-TIGYMAPEYGREG 280
            I+H D+KP+N+ LD N V  L DFG A  L     ++  + Q+LA T  YMAPE    G
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178

Query: 281 RVSTNG---DVYSFGIMLMEIFTRTKP 304
           +   +G   D++S G +++E+ T  +P
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 94.7 bits (235), Expect = 3e-22
 Identities = 64/216 (29%), Positives = 99/216 (45%), Gaps = 29/216 (13%)

Query: 111 IGKGGFGSVYKAII------QDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKI 164
           +G+G FG V+ A        QD M VAVK      E A + F  E +++  + H+++++ 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 165 ISSYSNDDFKALVLEYMPHGSLEKCLYLSN---YILD-----------IFQRLDIMIDVA 210
               +      +V EYM HG L + L        IL            + Q L I   +A
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 211 SALEYL---HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA 267
           S + YL   HF      +H DL   N L+   +V  + DFGM++ +   D      +T+ 
Sbjct: 133 SGMVYLASLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 186

Query: 268 TIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTK 303
            I +M PE     + +T  D++SFG++L EIFT  K
Sbjct: 187 PIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGK 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 93.5 bits (232), Expect = 7e-22
 Identities = 65/214 (30%), Positives = 97/214 (45%), Gaps = 24/214 (11%)

Query: 111 IGKGGFGSVYKA------IIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKI 164
           +G+G FG V+ A        +D M VAVK        A K F  E +++  + H +++K 
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 165 ISSYSNDDFKALVLEYMPHGSLEKCLYL---------------SNYILDIFQRLDIMIDV 209
                + D   +V EYM HG L K L                 +   L + Q L I   +
Sbjct: 73  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132

Query: 210 ASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATI 269
           AS + YL    S   +H DL   N L+  N++  + DFGM++ +   D       T+  I
Sbjct: 133 ASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189

Query: 270 GYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTK 303
            +M PE     + +T  DV+SFG++L EIFT  K
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK 223

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 92.0 bits (228), Expect = 2e-21
 Identities = 57/206 (27%), Positives = 107/206 (51%), Gaps = 11/206 (5%)

Query: 102 PNDANMPPLIGKGGFGSVYKAIIQ----DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRI 156
           P+      +IG G FG V++ I++      + VA+K   P Y E   + F  E  +M + 
Sbjct: 4   PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQF 63

Query: 157 CHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYL 216
            H N+I++    +      ++ EYM +G+L+K L   +     +Q + ++  +A+ ++YL
Sbjct: 64  SHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL 123

Query: 217 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG--YMAP 274
                   +H DL   N+L++ N+   +SDFG+++ +LE+D   T T +   I   + AP
Sbjct: 124 S---DMNYVHRDLAARNILVNSNLECKVSDFGLSR-VLEDDPEGTYTTSGGKIPIRWTAP 179

Query: 275 EYGREGRVSTNGDVYSFGIMLMEIFT 300
           E     + ++  DV+SFGI++ E+ +
Sbjct: 180 EAIAYRKFTSASDVWSFGIVMWEVMS 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 90.6 bits (225), Expect = 6e-21
 Identities = 58/213 (27%), Positives = 101/213 (47%), Gaps = 27/213 (12%)

Query: 111 IGKGGFGSVYKA-IIQDGME-----VAVKVFDPQYEGAFKS-FDIECDVMKRICHRNLIK 163
           +G+G FG VYK  +           VA+K      E   +  F  E ++M  + H N++ 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSN----------------YILDIFQRLDIMI 207
           ++   + +    ++ EY+ HG L + L + N                  LD    L I I
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFL-VRNSPHSDVGAESGDETVKSSLDCSDFLHIAI 131

Query: 208 DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA 267
            +A+ +EYL    S   +H DL   N L+ + +   +SDFG+++ +   D    Q+++L 
Sbjct: 132 QIAAGMEYLS---SHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLL 188

Query: 268 TIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
            + +M PE    G+ +T  D++SFG++L EIF+
Sbjct: 189 PVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 90.1 bits (223), Expect = 7e-21
 Identities = 60/194 (30%), Positives = 100/194 (51%), Gaps = 7/194 (3%)

Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSN 170
           +G G FG V+        +VAVK   P      +SF  E  +MK++ H  L+++ +  S 
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP-ESFLEEAQIMKKLRHDKLVQLYAVVSE 72

Query: 171 DDFKALVLEYMPHGSLEKCLYLSN-YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
           +    +V EYM  GSL   L       L +   +D+   VA+ + Y+        IH DL
Sbjct: 73  EPI-YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDL 128

Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 289
           + +N+L+ D +V  ++DFG+A+ L+E+++   +      I + APE    GR +   DV+
Sbjct: 129 RSANILVGDGLVCKIADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187

Query: 290 SFGIMLMEIFTRTK 303
           SFGI+L E+ T+ +
Sbjct: 188 SFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 88.9 bits (220), Expect = 2e-20
 Identities = 57/191 (29%), Positives = 104/191 (54%), Gaps = 13/191 (6%)

Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSN 170
           IG+G FG+V +     G +VAVK    + +   ++F  E  VM ++ H+NL++++    +
Sbjct: 14  IGEGEFGAVLQGEYT-GQKVAVKNI--KCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH 70

Query: 171 DDFKALVLEYMPHGSLEKCLYL-SNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
           +    +V+E M  G+L   L      ++ + Q L   +DVA  +EYL    S  ++H DL
Sbjct: 71  NGLY-IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDL 126

Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 289
              N+L+ ++ VA +SDFG+A+       S+    +   + + APE  +  + S+  DV+
Sbjct: 127 AARNILVSEDGVAKVSDFGLARV-----GSMGVDNSKLPVKWTAPEALKHKKFSSKSDVW 181

Query: 290 SFGIMLMEIFT 300
           S+G++L E+F+
Sbjct: 182 SYGVLLWEVFS 192

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 88.9 bits (221), Expect = 2e-20
 Identities = 60/194 (30%), Positives = 98/194 (50%), Gaps = 14/194 (7%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
            +G+G +GSVYKAI  + G  VA+KV     E   +    E  ++K+     ++K   SY
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVV--PVEEDLQEIIKEISILKQCDSPYIVKYYGSY 67

Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCD 228
             +    +V+EY   GS+   + ++N  L   +   I+      LEYLH   S   IH D
Sbjct: 68  FKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRD 124

Query: 229 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG---YMAPEYGREGRVSTN 285
           +K  N+LL++   A L+DFG++  L     ++ +  T+  IG   +MAPE  +E   +  
Sbjct: 125 IKAGNILLNEEGQAKLADFGVSGQL---TDTMAKRNTV--IGTPFWMAPEVIQEIGYNNK 179

Query: 286 GDVYSFGIMLMEIF 299
            D++S GI  +E+ 
Sbjct: 180 ADIWSLGITAIEMA 193

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 88.8 bits (221), Expect = 2e-20
 Identities = 61/207 (29%), Positives = 94/207 (45%), Gaps = 18/207 (8%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEG---AFKSFDI-ECDVMKRICHRNLIKII 165
           IGKG FG+V K     DG  +  K  D  Y       K   + E ++++ + H N+++  
Sbjct: 8   IGKGSFGTVRKVRRKSDGKILVWKEID--YGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65

Query: 166 SSYSNDDFKAL--VLEYMPHGSL----EKCLYLSNYILDIFQRLDIMIDVASALEYLHFG 219
               +   + L  V+EY   G L    +KC     YI + F    I+  +  AL   H  
Sbjct: 66  DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFI-WRILTQLLLALYECHNR 124

Query: 220 YSAP--IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYG 277
                 ++H DLKP+N+ LD N    L DFG+AK +L  D S  +T  + T  YM+PE  
Sbjct: 125 SDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK-ILGHDSSFAKT-YVGTPYYMSPEQL 182

Query: 278 REGRVSTNGDVYSFGIMLMEIFTRTKP 304
                    D++S G ++ E+   + P
Sbjct: 183 NHMSYDEKSDIWSLGCLIYELCALSPP 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 86.6 bits (215), Expect = 1e-19
 Identities = 57/204 (27%), Positives = 93/204 (45%), Gaps = 16/204 (7%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFD-PQYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
           IG G    VY AI + +  +VA+K  D  + + +      E   M +  H N++K  +S+
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68

Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNYI-----LDIFQRLDIMIDVASALEYLHFGYSAP 223
              D   LV+ Y+  GS    L +         LD      ++ +V   LEYLH   S  
Sbjct: 69  VVGDELWLVMPYLSGGS---LLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNG 122

Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE--EDQSLTQTQTLATIGYMAPEYGREGR 281
            IH D+K  N+LL ++    ++DFG++  L +  +     +   + T  +MAPE   +  
Sbjct: 123 QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVH 182

Query: 282 VSTNG-DVYSFGIMLMEIFTRTKP 304
                 D++SFGI  +E+ T   P
Sbjct: 183 GYDFKADIWSFGITAIELATGAAP 206

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 87.0 bits (215), Expect = 1e-19
 Identities = 63/211 (29%), Positives = 95/211 (45%), Gaps = 21/211 (9%)

Query: 111 IGKGGFGSVYKAII------QDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKI 164
           +G+G FG V+ A        QD + VAVK      + A K F  E +++  + H +++K 
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 165 ISSYSNDDFKALVLEYMPHGSLEKCLYLSN------------YILDIFQRLDIMIDVASA 212
                  D   +V EYM HG L K L                  L   Q L I   +A+ 
Sbjct: 73  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132

Query: 213 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYM 272
           + YL    S   +H DL   N L+ +N++  + DFGM++ +   D       T+  I +M
Sbjct: 133 MVYLA---SQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189

Query: 273 APEYGREGRVSTNGDVYSFGIMLMEIFTRTK 303
            PE     + +T  DV+S G++L EIFT  K
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFTYGK 220

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 86.3 bits (213), Expect = 2e-19
 Identities = 58/194 (29%), Positives = 102/194 (52%), Gaps = 7/194 (3%)

Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSN 170
           +G+G FG V+        +VA+K   P      ++F  E  +MK++ H  L+ + +  S 
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMP-EAFLQEAQIMKKLRHDKLVPLYAVVSE 72

Query: 171 DDFKALVLEYMPHGSLEKCLYLSN-YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
           +    +V E+M  GSL   L   +   L + Q +D+   +A  + Y+        IH DL
Sbjct: 73  EPI-YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDL 128

Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 289
           + +N+L+ DN+V  ++DFG+A+ L+E+++   +      I + APE    GR +   DV+
Sbjct: 129 RAANILVGDNLVCKIADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187

Query: 290 SFGIMLMEIFTRTK 303
           SFGI+L E+ T+ +
Sbjct: 188 SFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 85.9 bits (213), Expect = 2e-19
 Identities = 63/214 (29%), Positives = 99/214 (46%), Gaps = 39/214 (18%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVF-----DPQYEGAFKSFDIECDVMKRICHRNLIK 163
           L+G G FGSVY+ + + DG   AVK           + A K  + E  ++ ++ H N+++
Sbjct: 7   LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66

Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCL---------YLSNYILDIFQRLDIMIDVASALE 214
            + +   +D   + LE +P GSL K L          +  Y   I             LE
Sbjct: 67  YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQIL----------LGLE 116

Query: 215 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG---Y 271
           YLH       +H D+K +N+L+D N V  L+DFGMAK      Q +  +   +  G   +
Sbjct: 117 YLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAK------QVVEFSFAKSFKGSPYW 167

Query: 272 MAPEY-GREGRVSTNGDVYSFGIMLMEIFTRTKP 304
           MAPE   ++G      D++S G  ++E+ T  KP
Sbjct: 168 MAPEVIAQQGGYGLAADIWSLGCTVLEMAT-GKP 200

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 85.7 bits (212), Expect = 3e-19
 Identities = 57/199 (28%), Positives = 96/199 (48%), Gaps = 7/199 (3%)

Query: 104 DANMPPLIGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLI 162
           D  M   +G G +G VY+ + +   + VAVK          + F  E  VMK I H NL+
Sbjct: 7   DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLV 65

Query: 163 KIISSYSNDDFKALVLEYMPHGSLEKCLYLSN-YILDIFQRLDIMIDVASALEYLHFGYS 221
           +++   + +    ++ E+M +G+L   L   N   ++    L +   ++SA+EYL     
Sbjct: 66  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---K 122

Query: 222 APIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGR 281
              IH DL   N L+ +N +  ++DFG+++ L+  D           I + APE     +
Sbjct: 123 KNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNK 181

Query: 282 VSTNGDVYSFGIMLMEIFT 300
            S   DV++FG++L EI T
Sbjct: 182 FSIKSDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 86.0 bits (214), Expect = 3e-19
 Identities = 65/212 (30%), Positives = 100/212 (47%), Gaps = 26/212 (12%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKV--FDPQYEGAFKSFDIECDVMKRICHRNLIKIISS 167
           +G+G +G VYKA   + G  VA+K    D + EG   +   E  ++K + H N++K++  
Sbjct: 7   LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDV 66

Query: 168 YSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHC 227
              +    LV EY     L+K L      L       IM  +   L Y H   S  I+H 
Sbjct: 67  IHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---SHRILHR 122

Query: 228 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE-------YGREG 280
           DLKP N+L++ + V  L+DFG+A+      ++   T  + T+ Y APE       Y    
Sbjct: 123 DLKPQNILINRDGVLKLADFGLARAFGIPLRTY--THEVVTLWYRAPEILLGSKHY---- 176

Query: 281 RVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE 312
             ST  D++S G +  E+ T  KP   +F G+
Sbjct: 177 --STAVDIWSVGCIFAEMITG-KP---LFPGD 202

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 85.4 bits (212), Expect = 3e-19
 Identities = 65/221 (29%), Positives = 94/221 (42%), Gaps = 31/221 (14%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVF---DPQYEGAFKSFDIECDVMKRICHRNLIKIIS 166
           I KG +G V+ A     G   A+KV    D   +        E D++ +     ++K+  
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 167 SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLD------IMIDVASALEYLHFGY 220
           S+       LV+EY+P G L         +L+    LD       + ++  ALEYLH   
Sbjct: 61  SFQGKKNLYLVMEYLPGGDLAS-------LLENVGSLDEDVARIYIAEIVLALEYLH--- 110

Query: 221 SAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ------TQTLATIGYMAP 274
           S  IIH DLKP N+L+D N    L+DFG++K  L   Q           + + T  Y+AP
Sbjct: 111 SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP 170

Query: 275 EYGREGRVSTNGDVYSFGIMLMEIFTRTKP-----TDEIFS 310
           E       S   D +S G +L E      P      +EIF 
Sbjct: 171 EVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQ 211

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 85.4 bits (211), Expect = 4e-19
 Identities = 59/217 (27%), Positives = 105/217 (48%), Gaps = 35/217 (16%)

Query: 111 IGKGGFGSVYKA-IIQDGME----VAVKVF----DPQYEGAFKSFDIECDVMKRICHRNL 161
           +G+  FG +YK  +   GM+    VA+K      +PQ  G F+    E  +M  + H N+
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQ---EASLMAELHHPNI 69

Query: 162 IKIISSYSNDDFKALVLEYMPHGSLEKCLYLSN----------------YILDIFQRLDI 205
           + ++   + +    ++ EY+  G L + L + +                  LD    L I
Sbjct: 70  VCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHI 129

Query: 206 MIDVASALEYL--HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 263
            I +A+ +EYL  HF      +H DL   N+L+ + +   +SD G+++ +   D    Q 
Sbjct: 130 AIQIAAGMEYLSSHF-----FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQP 184

Query: 264 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
           ++L  I +M PE    G+ S++ D++SFG++L EIF+
Sbjct: 185 KSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 85.1 bits (211), Expect = 5e-19
 Identities = 62/216 (28%), Positives = 94/216 (43%), Gaps = 12/216 (5%)

Query: 111 IGKGGFGSVYKA-IIQDGMEVAVKVFD-PQYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
           +G G  G V K      G  +AVK       E   K    E D++ +     ++    ++
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68

Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCD 228
            N+   ++ +EYM  GSL+K L      +       I + V   L YLH  +   IIH D
Sbjct: 69  YNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHRD 126

Query: 229 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDV 288
           +KPSN+L++      L DFG++  L+    SL +T    T  YMAPE  +    S   D+
Sbjct: 127 VKPSNILVNSRGQIKLCDFGVSGQLVN---SLAKTFV-GTSSYMAPERIQGNDYSVKSDI 182

Query: 289 YSFGIMLMEIFTRTKPTDEIFSGEMT----LKRWVN 320
           +S G+ L+E+ T   P              L+  VN
Sbjct: 183 WSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN 218

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 85.0 bits (210), Expect = 6e-19
 Identities = 69/235 (29%), Positives = 106/235 (45%), Gaps = 31/235 (13%)

Query: 111 IGKGGFGSV----YKAIIQD-GMEVAVKVFD----PQYEGAFKSFDIECDVMKRICHRNL 161
           +G+G FG V    Y       G  VAVK        Q    +K    E +++K + H N+
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKK---EINILKTLYHENI 68

Query: 162 IKIISSYSNDDFKA--LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFG 219
           +K     S    K   L++EY+P GSL    YL  + L++ Q L     +   + YLH  
Sbjct: 69  VKYKGCCSEQGGKGLQLIMEYVPLGSLRD--YLPKHKLNLAQLLLFAQQICEGMAYLH-- 124

Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE-EDQSLTQTQTLATIGYMAPEYGR 278
            S   IH DL   NVLLD++ +  + DFG+AK + E  +    +    + + + A E  +
Sbjct: 125 -SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK 183

Query: 279 EGRVSTNGDVYSFGIMLMEIFTRTKPTD----------EIFSGEMTLKRWVNDLL 323
           E + S   DV+SFG+ L E+ T                    G+MT+ R + +LL
Sbjct: 184 ENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLI-ELL 237

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 84.6 bits (209), Expect = 7e-19
 Identities = 66/212 (31%), Positives = 103/212 (48%), Gaps = 26/212 (12%)

Query: 110 LIGKGGFGSVYKAIIQ----DGMEVAVKVFDPQYEGAFKSFDIE-----CDVMKRICHRN 160
           ++GKG FGSV +A ++       +VAVK+        F S DIE        MK   H N
Sbjct: 6   MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKAD---IFSSSDIEEFLREAACMKEFDHPN 62

Query: 161 LIKIISSYSNDDFKA------LVLEYMPHGSLEKCLYLSN-----YILDIFQRLDIMIDV 209
           +IK+I        K       ++L +M HG L   L +S      + L +   +  MID+
Sbjct: 63  VIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDI 122

Query: 210 ASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATI 269
           AS +EYL    S   IH DL   N +L++NM   ++DFG++K +   D       +   +
Sbjct: 123 ASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPV 179

Query: 270 GYMAPEYGREGRVSTNGDVYSFGIMLMEIFTR 301
            ++A E   +   +T+ DV++FG+ + EI TR
Sbjct: 180 KWLALESLADNVYTTHSDVWAFGVTMWEIMTR 211

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 84.3 bits (209), Expect = 1e-18
 Identities = 55/209 (26%), Positives = 96/209 (45%), Gaps = 25/209 (11%)

Query: 111 IGKGGFGSVYKAIIQD------GMEVAVK-VFDPQYEGAFKSFDIECDVMKRI-CHRNLI 162
           +G+G FG VY+ + +          VA+K V +         F  E  VMK   CH +++
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCH-HVV 72

Query: 163 KIISSYSNDDFKALVLEYMPHGSLEKCLYL--------SNYILDIFQRLDIM---IDVAS 211
           +++   S      +V+E M  G L+   YL        +N  L        +    ++A 
Sbjct: 73  RLLGVVSTGQPTLVVMELMAKGDLKS--YLRSRRPEAENNPGLGPPTLQKFIQMAAEIAD 130

Query: 212 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGY 271
            + YL    +   +H DL   N ++ +++   + DFGM + + E D      + L  + +
Sbjct: 131 GMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187

Query: 272 MAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
           MAPE  ++G  +T  DV+SFG++L E+ T
Sbjct: 188 MAPESLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 83.2 bits (206), Expect = 2e-18
 Identities = 54/198 (27%), Positives = 79/198 (39%), Gaps = 11/198 (5%)

Query: 110 LIGKGGFGSV----YKAIIQDGMEVAVKVFDP-QYEGAFKSFDIECDVMKRICHRNLIKI 164
            +G G FG V    +       + VAVK     +       F  E  +M  + H NLI++
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 165 ISSYSNDDFKALVLEYMPHGSLEKCLYLSNY-ILDIFQRLDIMIDVASALEYLHFGYSAP 223
                      +V E  P GSL   L         I    D  + +A+ + YL    S  
Sbjct: 62  YGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKR 117

Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT-IGYMAPEYGREGRV 282
            IH DL   N+LL  +    + DFG+ + L + +      + L     + APE  R    
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTF 177

Query: 283 STNGDVYSFGIMLMEIFT 300
           S   DV+ FG+ L E+FT
Sbjct: 178 SHASDVWMFGVTLWEMFT 195

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 83.9 bits (207), Expect = 2e-18
 Identities = 62/217 (28%), Positives = 107/217 (49%), Gaps = 26/217 (11%)

Query: 104 DANMPPLIGKGGFGSVYKAIIQ-DG--MEVAVKVF-DPQYEGAFKSFDIECDVMKRICHR 159
           D     +IG+G FG V +A+I+ DG  M  A+K+  +   E   + F  E +V+ ++ H 
Sbjct: 3   DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHH 62

Query: 160 -NLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYI---------------LDIFQRL 203
            N+I ++ +  N  +  + +EY P+G+L   L  S  +               L   Q L
Sbjct: 63  PNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLL 122

Query: 204 DIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 263
               DVA+ ++YL        IH DL   NVL+ +N+ + ++DFG+++    E+  + +T
Sbjct: 123 QFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKT 176

Query: 264 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
                + +MA E       +T  DV+SFG++L EI +
Sbjct: 177 MGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 83.4 bits (207), Expect = 3e-18
 Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 31/210 (14%)

Query: 109 PLIGKGGFGSVYKAI-IQDGMEVAVK-VFDPQYEGAFKSFDI----ECDVMKRICHRNLI 162
             +G+G +  VYKA   + G  VA+K +   + + A    +     E  +++ + H N+I
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65

Query: 163 KIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYIL---DIFQRLDIMIDVASALEYLHFG 219
            ++  + +     LV E+M    LEK +   + +L   DI      M+     LEYLH  
Sbjct: 66  GLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKS---YMLMTLRGLEYLHSN 121

Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE---- 275
           +   I+H DLKP+N+L+  + V  L+DFG+A+     ++ +T  Q + T  Y APE    
Sbjct: 122 W---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMT-HQ-VVTRWYRAPELLFG 176

Query: 276 ---YGREGRVSTNGDVYSFGIMLMEIFTRT 302
              YG         D++S G +  E+  R 
Sbjct: 177 ARHYG------VGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 82.8 bits (205), Expect = 3e-18
 Identities = 68/211 (32%), Positives = 97/211 (45%), Gaps = 24/211 (11%)

Query: 111 IGKGGFGSVYKAIIQ--DG--MEVAVKVFDPQYEGAFKS-FDIECDVMKRICHRNLIKII 165
           +G G FGSV K +     G  +EVAVK    ++  A K  F  E  VM ++ H  ++++I
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDI---MIDVASALEYL---HFG 219
                +    LV+E  P G L K  YL           D+      VA  + YL   HF 
Sbjct: 63  GVCKGEPL-MLVMELAPLGPLLK--YLKKR--REIPVSDLKELAHQVAMGMAYLESKHF- 116

Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LEEDQSLTQTQTLATIGYMAPEYGR 278
                +H DL   NVLL +   A +SDFGM++ L    D     T     + + APE   
Sbjct: 117 -----VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECIN 171

Query: 279 EGRVSTNGDVYSFGIMLMEIFTR-TKPTDEI 308
            G+ S+  DV+S+G+ L E F+   KP  E+
Sbjct: 172 YGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM 202

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 83.3 bits (206), Expect = 3e-18
 Identities = 60/206 (29%), Positives = 105/206 (50%), Gaps = 23/206 (11%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFD---PQYEGAFKSFDIECDV-----MKRICHRN 160
           LIG+G +G+VY+   +  G  VA+K+ +   P  + +    DI+ +V     +++    N
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVS----DIQREVALLSQLRQSQPPN 63

Query: 161 LIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGY 220
           + K   SY       +++EY   GS+ + L  +  I + +  + I+ +V  AL+Y+H   
Sbjct: 64  ITKYYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISV-IIREVLVALKYIH--- 118

Query: 221 SAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGY-MAPEYGRE 279
              +IH D+K +N+L+ +     L DFG+A  L   +Q+ ++  T     Y MAPE   E
Sbjct: 119 KVGVIHRDIKAANILVTNTGNVKLCDFGVAALL---NQNSSKRSTFVGTPYWMAPEVITE 175

Query: 280 GRV-STNGDVYSFGIMLMEIFTRTKP 304
           G+   T  D++S GI + E+ T   P
Sbjct: 176 GKYYDTKADIWSLGITIYEMATGNPP 201

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 82.6 bits (204), Expect = 3e-18
 Identities = 58/218 (26%), Positives = 99/218 (45%), Gaps = 10/218 (4%)

Query: 102 PNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKS--FDIECDVMKRICHR 159
           P D      +G G FG V     +   +VA+K+     EG+     F  E  VM ++ H 
Sbjct: 3   PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMKLSHE 59

Query: 160 NLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFG 219
            L+++    +      +V EYM +G L   L          Q L++  DV   + YL   
Sbjct: 60  KLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE-- 117

Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
            S   IH DL   N L+DD     +SDFG+++ +L +D+  +   +   + +  PE    
Sbjct: 118 -SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLLY 175

Query: 280 GRVSTNGDVYSFGIMLMEIFTRTK-PTDEIFSGEMTLK 316
            + S+  DV++FG+++ E+++  K P +   + E   K
Sbjct: 176 SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEK 213

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 82.4 bits (203), Expect = 3e-18
 Identities = 60/194 (30%), Positives = 95/194 (48%), Gaps = 9/194 (4%)

Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKS-FDIECDVMKRICHRNLIKIISSY 168
           IG+G FG V+   ++ D   VAVK          K+ F  E  ++K+  H N++++I   
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCD 228
           +      +V+E +  G     L      L + + + ++ + A+ +EYL    S   IH D
Sbjct: 63  TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRD 119

Query: 229 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATI--GYMAPEYGREGRVSTNG 286
           L   N L+ +  V  +SDFGM++   EED     T  +  I   + APE    GR S+  
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSRE--EEDGVYASTGGMKQIPVKWTAPEALNYGRYSSES 177

Query: 287 DVYSFGIMLMEIFT 300
           DV+SFGI+L E F+
Sbjct: 178 DVWSFGILLWEAFS 191

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 82.4 bits (203), Expect = 4e-18
 Identities = 55/194 (28%), Positives = 100/194 (51%), Gaps = 6/194 (3%)

Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSN 170
           +G G FG V+     +  +VAVK   P    + ++F  E ++MK + H  L+++ +  + 
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72

Query: 171 DDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL-DIMIDVASALEYLHFGYSAPIIHCDL 229
           ++   ++ EYM  GSL   L        +  +L D    +A  + Y+        IH DL
Sbjct: 73  EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDL 129

Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 289
           + +NVL+ ++++  ++DFG+A+ ++E+++   +      I + APE    G  +   DV+
Sbjct: 130 RAANVLVSESLMCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 188

Query: 290 SFGIMLMEIFTRTK 303
           SFGI+L EI T  K
Sbjct: 189 SFGILLYEIVTYGK 202

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 82.2 bits (203), Expect = 5e-18
 Identities = 64/216 (29%), Positives = 101/216 (46%), Gaps = 34/216 (15%)

Query: 110 LIGKGGFGSVY----KAIIQDGME---VAVKVFDPQYEGA----FKSFDIECDVMKRICH 158
            +G G FG VY      I+  G     VAVK      +GA     K F  E  +M    H
Sbjct: 2   FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLR---KGATDQEKKEFLKEAHLMSNFNH 58

Query: 159 RNLIKIISSYSNDDFKALVLEYMPHGSL------EKCLYLSNYILDIFQRLDIMIDVASA 212
            N++K++     ++ + +++E M  G L       +       +L + + LDI +DVA  
Sbjct: 59  PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKG 118

Query: 213 LEYL---HFGYSAPIIHCDLKPSNVLL-----DDNMVAHLSDFGMAKPLLEEDQSLTQTQ 264
             YL   HF      IH DL   N L+     D + V  + DFG+A+ + + D    + +
Sbjct: 119 CVYLEQMHF------IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGE 172

Query: 265 TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
            L  + +MAPE   +G+ +T  DV+SFG+++ EI T
Sbjct: 173 GLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 82.3 bits (204), Expect = 6e-18
 Identities = 61/213 (28%), Positives = 99/213 (46%), Gaps = 27/213 (12%)

Query: 111 IGKGGFGSVYKA-IIQDGMEVAVK-VFDPQYEGAF-KSFDIECDVMKRICHRNLIKIISS 167
           IG+G  G V+KA   + G  VA+K V   + EG        E   ++   H  ++K++  
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67

Query: 168 YSNDDFKALVLEYMPHGSLEKCLYLSNYILDI---FQRLDI---MIDVASALEYLHFGYS 221
           + +     LV+EYMP         LS  + D         +   M  +   + Y+H   +
Sbjct: 68  FPHGSGFVLVMEYMPSD-------LSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---A 117

Query: 222 APIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE--YGRE 279
             I+H DLKP+N+L+  + V  ++DFG+A+   EE+  L   Q +AT  Y APE  YG  
Sbjct: 118 NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAPELLYGAR 176

Query: 280 GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE 312
            +     D+++ G +  E+     P   +F GE
Sbjct: 177 -KYDPGVDLWAVGCIFAELL-NGSP---LFPGE 204

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 82.0 bits (203), Expect = 7e-18
 Identities = 54/205 (26%), Positives = 104/205 (50%), Gaps = 10/205 (4%)

Query: 102 PNDANMPPLIGKGGFGSVYKAIIQ----DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRI 156
           P+   +  +IG G FG V +  ++      ++VA+K       +     F  E  +M + 
Sbjct: 3   PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQF 62

Query: 157 CHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYL 216
            H N+I++    +      ++ EYM +GSL+K L  ++    + Q + ++  +AS ++YL
Sbjct: 63  DHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYL 122

Query: 217 -HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE 275
               Y    +H DL   N+L++ N+V  +SDFG+++ L + + + T       I + APE
Sbjct: 123 SEMNY----VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPE 178

Query: 276 YGREGRVSTNGDVYSFGIMLMEIFT 300
                + ++  DV+SFGI++ E+ +
Sbjct: 179 AIAYRKFTSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 81.7 bits (202), Expect = 1e-17
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 11/204 (5%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYS 169
           +G G FG VYKA   + G+  A K+   + E   + F +E D++    H N++ +  +Y 
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 170 NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
            ++   +++E+   G+L+  +      L   Q   +   +  AL +LH   S  +IH DL
Sbjct: 73  YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDL 129

Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEY-----GREGRVST 284
           K  N+LL  +    L+DFG++       Q   +   + T  +MAPE       ++     
Sbjct: 130 KAGNILLTLDGDVKLADFGVSAKNKSTLQK--RDTFIGTPYWMAPEVVACETFKDNPYDY 187

Query: 285 NGDVYSFGIMLMEIFTRTKPTDEI 308
             D++S GI L+E+     P  E+
Sbjct: 188 KADIWSLGITLIELAQMEPPHHEL 211

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 81.4 bits (201), Expect = 1e-17
 Identities = 54/193 (27%), Positives = 101/193 (52%), Gaps = 11/193 (5%)

Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAF--KSFDIECDVMKRICHRNLIKIISSY 168
           +G G FG V+        +VA+K      +G+   ++F  E ++MK++ H  L+++ +  
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLK---QGSMSPEAFLAEANLMKQLQHPRLVRLYAVV 70

Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNYI-LDIFQRLDIMIDVASALEYLHFGYSAPIIHC 227
           + +    ++ EYM +GSL   L     I L I + +D+   +A  + ++        IH 
Sbjct: 71  TQEPI-YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHR 126

Query: 228 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGD 287
           DL+ +N+L+ + +   ++DFG+A+ L+E+++   +      I + APE    G  +   D
Sbjct: 127 DLRAANILVSETLCCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 185

Query: 288 VYSFGIMLMEIFT 300
           V+SFGI+L EI T
Sbjct: 186 VWSFGILLTEIVT 198

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 81.7 bits (202), Expect = 1e-17
 Identities = 61/214 (28%), Positives = 97/214 (45%), Gaps = 26/214 (12%)

Query: 110 LIGKGGFGSVYKAIIQD------GMEVAVKVF-DPQYEGAFKSFDIECDVMKRIC-HRNL 161
            +G+G FG V KA             VAVK+  D   E        E ++MK I  H+N+
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78

Query: 162 IKIISSYSNDDFKALVLEYMPHGSLEKCL-------YLSNYILDI-----FQRLDIM--- 206
           I ++   + +    +V+EY  HG+L   L         ++            + D++   
Sbjct: 79  INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138

Query: 207 IDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL 266
             VA  +E+L    S   IH DL   NVL+ ++ V  ++DFG+A+ +   D     T   
Sbjct: 139 YQVARGMEFLA---SKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGR 195

Query: 267 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
             + +MAPE   +   +   DV+SFG++L EIFT
Sbjct: 196 LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 81.6 bits (201), Expect = 1e-17
 Identities = 64/218 (29%), Positives = 108/218 (49%), Gaps = 26/218 (11%)

Query: 103 NDANMPPLIGKGGFGSVYKA-IIQDG--MEVAVK-VFDPQYEGAFKSFDIECDVMKRIC- 157
           ND     +IG+G FG V KA I +DG  M+ A+K + +   +   + F  E +V+ ++  
Sbjct: 7   NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66

Query: 158 HRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYI---------------LDIFQR 202
           H N+I ++ +  +  +  L +EY PHG+L   L  S  +               L   Q 
Sbjct: 67  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126

Query: 203 LDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ 262
           L    DVA  ++YL        IH DL   N+L+ +N VA ++DFG+++    ++  + +
Sbjct: 127 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKK 180

Query: 263 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
           T     + +MA E       +TN DV+S+G++L EI +
Sbjct: 181 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 81.0 bits (200), Expect = 1e-17
 Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 40/220 (18%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVF---------DPQYEGAFKSFDIECDVMKRICHR 159
           LIG G FGSVY  +    G  +AVK             +      +   E  ++K + H 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 160 NLIKIISSYSNDDFKALVLEYMPHGSLEKCL---------YLSNYILDIFQRLDIMIDVA 210
           N+++ + S  + D   + LEY+P GS+   L          + N++  I +         
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILK--------- 117

Query: 211 SALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA--- 267
             L YLH   +  IIH D+K +N+L+D+     +SDFG++K L  E  SL+     A   
Sbjct: 118 -GLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKL--EANSLSTKTNGARPS 171

Query: 268 ---TIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKP 304
              ++ +MAPE  ++   +   D++S G +++E+ T   P
Sbjct: 172 LQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 80.6 bits (199), Expect = 2e-17
 Identities = 63/224 (28%), Positives = 104/224 (46%), Gaps = 40/224 (17%)

Query: 102 PNDANMPPLIGKGGFGSVYKAIIQD-GMEVAVKVF-----DPQYEGAFKSFDIECDVMKR 155
           P +     L+G+G FG VY     D G E+AVK        P+ +    + + E  ++K 
Sbjct: 1   PTNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKN 60

Query: 156 ICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLY----LSNYILDIFQRLDIMIDVAS 211
           + H  +++      +D+  ++ +EYMP GS++  L     L+  +   + R      +  
Sbjct: 61  LQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTR-----QILE 115

Query: 212 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT-----L 266
            +EYLH   S  I+H D+K +N+L D      L DFG +K L    Q++  + T      
Sbjct: 116 GVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRL----QTICSSGTGMKSVT 168

Query: 267 ATIGYMAPE------YGREGRVSTNGDVYSFGIMLMEIFTRTKP 304
            T  +M+PE      YGR+       DV+S G  ++E+ T  KP
Sbjct: 169 GTPYWMSPEVISGEGYGRK------ADVWSVGCTVVEMLT-EKP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 80.7 bits (200), Expect = 2e-17
 Identities = 64/202 (31%), Positives = 94/202 (46%), Gaps = 27/202 (13%)

Query: 110 LIGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDIECDVMKRI-----CH-RNLI 162
            IGKG FG VYKAI +     VA+KV D   E A    +IE D+ + I     C    + 
Sbjct: 8   CIGKGSFGEVYKAIDKRTNQVVAIKVID--LEEA--EDEIE-DIQQEIQFLSQCRSPYIT 62

Query: 163 KIISSYSNDDFKALVLEYMPHGSLEKCL-YLSNYILDIFQRLDIMIDVASALEYLHFGYS 221
           K   S+       +++EY   GS   CL  L    LD      I+ +V   LEYLH    
Sbjct: 63  KYYGSFLKGSKLWIIMEYCGGGS---CLDLLKPGKLDETYIAFILREVLLGLEYLH---E 116

Query: 222 APIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG---YMAPEYGR 278
              IH D+K +N+LL +     L+DFG++  L     + T ++    +G   +MAPE  +
Sbjct: 117 EGKIHRDIKAANILLSEEGDVKLADFGVSGQL-----TSTMSKRNTFVGTPFWMAPEVIK 171

Query: 279 EGRVSTNGDVYSFGIMLMEIFT 300
           +       D++S GI  +E+  
Sbjct: 172 QSGYDEKADIWSLGITAIELAK 193

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 80.2 bits (198), Expect = 3e-17
 Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 28/203 (13%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVA---VKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIIS 166
           IGKG F  VYKAI + DG  VA   V++F+     A +    E D++K++ H N+IK ++
Sbjct: 10  IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69

Query: 167 SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMID----------VASALEYL 216
           S+  ++   +VLE    G L +       ++  F++   +I           + SALE++
Sbjct: 70  SFIENNELNIVLELADAGDLSR-------MIKHFKKQKRLIPERTIWKYFVQLCSALEHM 122

Query: 217 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL-ATIGYMAPE 275
           H   S  I+H D+KP+NV +    V  L D G+ +    +    T   +L  T  YM+PE
Sbjct: 123 H---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT---TAAHSLVGTPYYMSPE 176

Query: 276 YGREGRVSTNGDVYSFGIMLMEI 298
              E   +   D++S G +L E+
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 80.2 bits (198), Expect = 3e-17
 Identities = 60/209 (28%), Positives = 97/209 (46%), Gaps = 20/209 (9%)

Query: 110 LIGKGGFGSVYKAII--QDG--MEVAVKVF--DPQYEGAFKSFDIECDVMKRICHRNLIK 163
           ++G+G FGSV +  +   DG  ++VAVK    D       + F  E   MK   H N++K
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 164 II------SSYSNDDFKALVLEYMPHGSLEKCLYLSN-----YILDIFQRLDIMIDVASA 212
           +I      SS        ++L +M HG L   L  S        L +   L  M+D+A  
Sbjct: 66  LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125

Query: 213 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYM 272
           +EYL    +   IH DL   N +L ++M   ++DFG++K +   D           + ++
Sbjct: 126 MEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182

Query: 273 APEYGREGRVSTNGDVYSFGIMLMEIFTR 301
           A E   +   ++  DV++FG+ + EI TR
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIATR 211

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 79.9 bits (197), Expect = 3e-17
 Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 19/200 (9%)

Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDI--ECDVMKRICHRNLIKIISSY 168
           +G G FG V+    +  ++VA+K  +   EGA    D   E  VM ++ H  L+++    
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAIN---EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC 68

Query: 169 SNDDFKALVLEYMPHGSL-----EKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
           +      +V E+M +G L     ++   LS  +L     L +  DV   +EYL       
Sbjct: 69  TQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDML-----LSMCQDVCEGMEYLE---RNS 120

Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVS 283
            IH DL   N L+    V  +SDFGM + +L+ D+  + +     + +  PE     + S
Sbjct: 121 FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD-DEYTSSSGAKFPVKWSPPEVFNFSKYS 179

Query: 284 TNGDVYSFGIMLMEIFTRTK 303
           +  DV+SFG+++ E+FT  K
Sbjct: 180 SKSDVWSFGVLMWEVFTEGK 199

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 79.8 bits (197), Expect = 4e-17
 Identities = 60/231 (25%), Positives = 105/231 (45%), Gaps = 51/231 (22%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVK-VFDPQYE---------GAFKSFDIECDVMKRICH 158
           LIGKG +G VY A+ +  G  +AVK V  P               K+   E + +K + H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 159 RNLIKIISSYSNDDFKALVLEYMPHGSLEKCL------------YLSNYILDIFQRLDIM 206
            N+++ +   + +++ ++ LEY+P GS+  CL            + +  +L         
Sbjct: 68  LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVL--------- 118

Query: 207 IDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL 266
                 L YLH   S  I+H DLK  N+L+D + +  +SDFG++K   +   +       
Sbjct: 119 ----EGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ 171

Query: 267 ATIGYMAPE------YGREGRVSTNGDVYSFGIMLMEIFTRTKP--TDEIF 309
            ++ +MAPE       G   +V    D++S G +++E+F   +P   +E  
Sbjct: 172 GSVFWMAPEVIHSYSQGYSAKV----DIWSLGCVVLEMFAGRRPWSDEEAI 218

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 79.9 bits (197), Expect = 5e-17
 Identities = 60/195 (30%), Positives = 94/195 (48%), Gaps = 8/195 (4%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYS 169
           IG+G  G+VY AI +  G EVA+K  + Q +   +    E  VM+   H N++  + SY 
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86

Query: 170 NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
             D   +V+EY+  GSL   +  +   +D  Q   +  +   ALE+LH   S  +IH D+
Sbjct: 87  VGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 141

Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 289
           K  N+LL  +    L+DFG    +  E     ++  + T  +MAPE           D++
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIW 199

Query: 290 SFGIMLMEIFTRTKP 304
           S GIM +E+     P
Sbjct: 200 SLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 79.7 bits (197), Expect = 5e-17
 Identities = 57/196 (29%), Positives = 88/196 (44%), Gaps = 12/196 (6%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFD-PQYEGAFKSFDI-ECDVMKRICHRNLIKIISS 167
           IG+G +G VYKA     G  VA+K               + E  ++K + H N+IK++  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66

Query: 168 YSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHC 227
           + +     LV E+M    L K +      L        +  +   L + H   S  I+H 
Sbjct: 67  FRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHR 122

Query: 228 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE--YGREGRVSTN 285
           DLKP N+L++   V  L+DFG+A+           T  + T  Y APE   G +G  ST 
Sbjct: 123 DLKPENLLINTEGVLKLADFGLARSF--GSPVRPYTHYVVTRWYRAPELLLGDKG-YSTP 179

Query: 286 GDVYSFGIMLMEIFTR 301
            D++S G +  E+ +R
Sbjct: 180 VDIWSVGCIFAELLSR 195

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 79.8 bits (197), Expect = 5e-17
 Identities = 63/203 (31%), Positives = 97/203 (47%), Gaps = 19/203 (9%)

Query: 110 LIGKGGFGSVYKAI---IQD--GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKI 164
            +GKG FGSV       +QD  G  VAVK          + F+ E +++K + H N++K 
Sbjct: 11  QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK- 69

Query: 165 ISSYSNDDFKA------LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHF 218
              Y    + A      LV+EY+P+GSL   L      LD  + L     +   +EYL  
Sbjct: 70  ---YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG- 125

Query: 219 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LEEDQSLTQTQTLATIGYMAPEYG 277
             S   +H DL   N+L++      + DFG+ K L  +++    +    + I + APE  
Sbjct: 126 --SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESL 183

Query: 278 REGRVSTNGDVYSFGIMLMEIFT 300
            E + S   DV+SFG++L E+FT
Sbjct: 184 TESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 79.3 bits (196), Expect = 7e-17
 Identities = 55/194 (28%), Positives = 91/194 (46%), Gaps = 20/194 (10%)

Query: 130 VAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEK 188
           VAVKV  P   + A + F  E  ++ R+   N+ +++   + D    +++EYM +G L  
Sbjct: 49  VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL-- 106

Query: 189 CLYLSNYILDI-----------FQRLDIMI-DVASALEYLHFGYSAPIIHCDLKPSNVLL 236
             +L  ++ +            F  L  M   +AS + YL    S   +H DL   N L+
Sbjct: 107 NQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLV 163

Query: 237 DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLM 296
             N    ++DFGM++ L   D    Q +    I +MA E    G+ +T  DV++FG+ L 
Sbjct: 164 GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLW 223

Query: 297 EIFT--RTKPTDEI 308
           EI T  R +P + +
Sbjct: 224 EILTLCREQPYEHL 237

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 79.5 bits (197), Expect = 9e-17
 Identities = 64/223 (28%), Positives = 103/223 (46%), Gaps = 39/223 (17%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVK----VFDPQYEG--AFKSFDIECDVMKRICHRNLI 162
            IG G +G V  A+  + G +VA+K    VFD   +     +    E  +++ + H N+I
Sbjct: 7   PIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR----EIKLLRHLRHENII 62

Query: 163 K---IISSYSNDDFKAL--VLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLH 217
               I+   S +DF  +  V E M    L K +     + D   +   +  +   L+YLH
Sbjct: 63  GLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQY-FLYQILRGLKYLH 120

Query: 218 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ-TQTLATIGYMAPE- 275
              SA +IH DLKPSN+L++ N    + DFG+A+ +  ++      T+ + T  Y APE 
Sbjct: 121 ---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPEL 177

Query: 276 ------YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE 312
                 Y      +   D++S G +  E+ TR KP   +F G 
Sbjct: 178 LLSSSRY------TKAIDIWSVGCIFAELLTR-KP---LFPGR 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 78.6 bits (194), Expect = 1e-16
 Identities = 54/199 (27%), Positives = 95/199 (47%), Gaps = 10/199 (5%)

Query: 110 LIGKGGFGSVYKAIIQD----GMEVAVKVFDPQYEGAFKS-FDIECDVMKRICHRNLIKI 164
            IG+G FG VY+ +        + VAVK        + +  F  E  +M++  H +++K+
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 165 ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPI 224
           I   + ++   +V+E  P G L   L ++ Y LD+   +     +++AL YL    S   
Sbjct: 73  IGVIT-ENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKRF 128

Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVST 284
           +H D+   NVL+       L DFG+++  LE++     ++    I +MAPE     R ++
Sbjct: 129 VHRDIAARNVLVSSPDCVKLGDFGLSR-YLEDESYYKASKGKLPIKWMAPESINFRRFTS 187

Query: 285 NGDVYSFGIMLMEIFTRTK 303
             DV+ FG+ + EI     
Sbjct: 188 ASDVWMFGVCMWEILMLGV 206

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 79.2 bits (196), Expect = 1e-16
 Identities = 75/226 (33%), Positives = 114/226 (50%), Gaps = 42/226 (18%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVK-VFDPQYEGAF-------KSFDIECDVM---KRICH 158
           +GKG +G V+KAI  +    VA+K +FD     AF       ++F    ++M   +   H
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALKKIFD-----AFRNATDAQRTFR---EIMFLQELGDH 66

Query: 159 RNLIKIISSY--SNDDFKALVLEYMP---HGSLEKCLYLSNYILDIFQRLDIMIDVASAL 213
            N++K+++     ND    LV EYM    H  +       N + D+ +R  IM  +  AL
Sbjct: 67  PNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRA-----NILEDVHKRY-IMYQLLKAL 120

Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ---TQTLATIG 270
           +Y+H   S  +IH DLKPSN+LL+ +    L+DFG+A+ L E +++      T  +AT  
Sbjct: 121 KYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRW 177

Query: 271 YMAPEYGREGRVSTNG-DVYSFGIMLMEIFTRTKPTDEIFSGEMTL 315
           Y APE        T G D++S G +L E+    KP   +F G  TL
Sbjct: 178 YRAPEILLGSTRYTKGVDMWSVGCILGEML-LGKP---LFPGTSTL 219

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 77.8 bits (191), Expect = 2e-16
 Identities = 62/211 (29%), Positives = 105/211 (49%), Gaps = 26/211 (12%)

Query: 110 LIGKGGFGSVYKAIIQ-DG--MEVAVKVF-DPQYEGAFKSFDIECDVMKRICHR-NLIKI 164
           +IG+G FG V KA I+ DG  M+ A+K   +   +   + F  E +V+ ++ H  N+I +
Sbjct: 2   VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61

Query: 165 ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYI---------------LDIFQRLDIMIDV 209
           + +  +  +  L +EY PHG+L   L  S  +               L   Q L    DV
Sbjct: 62  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121

Query: 210 ASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATI 269
           A  ++YL        IH DL   N+L+ +N VA ++DFG+++    ++  + +T     +
Sbjct: 122 ARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPV 175

Query: 270 GYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
            +MA E       +TN DV+S+G++L EI +
Sbjct: 176 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 78.1 bits (192), Expect = 2e-16
 Identities = 55/186 (29%), Positives = 92/186 (49%), Gaps = 15/186 (8%)

Query: 130 VAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSL-- 186
           VAVK+      + A   F  E  +M R+ + N+I+++    +DD   ++ EYM +G L  
Sbjct: 47  VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ 106

Query: 187 -------EKCLYLSNYI--LDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD 237
                  E     +N I  + I   L + + +AS ++YL    S   +H DL   N L+ 
Sbjct: 107 FLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCLVG 163

Query: 238 DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLME 297
           ++    ++DFGM++ L   D    Q + +  I +MA E    G+ +T  DV++FG+ L E
Sbjct: 164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWE 223

Query: 298 IFTRTK 303
           +FT  K
Sbjct: 224 MFTLCK 229

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 77.3 bits (191), Expect = 3e-16
 Identities = 59/204 (28%), Positives = 92/204 (45%), Gaps = 35/204 (17%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYS 169
           IG G +G VYKA  I  G  VA+KV   +    F+    E  ++K   H N++    SY 
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70

Query: 170 NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLD----------IMIDVASALEYLHFG 219
             D   +V+EY   GSL+          DI+Q             +  +    L YLH  
Sbjct: 71  RRDKLWIVMEYCGGGSLQ----------DIYQVTRGPLSELQIAYVCRETLKGLAYLH-- 118

Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG---YMAPEY 276
                IH D+K +N+LL ++    L+DFG++  L     ++ + ++   IG   +MAPE 
Sbjct: 119 -ETGKIHRDIKGANILLTEDGDVKLADFGVSAQL---TATIAKRKSF--IGTPYWMAPEV 172

Query: 277 G---REGRVSTNGDVYSFGIMLME 297
               R+G      D+++ GI  +E
Sbjct: 173 AAVERKGGYDGKCDIWALGITAIE 196

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 78.3 bits (193), Expect = 3e-16
 Identities = 58/206 (28%), Positives = 102/206 (49%), Gaps = 37/206 (17%)

Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFK-SFDIECDVMKRICHRNLIKIISSY 168
           IG G  G+VYK I +  G   A+KV    +E   +     E ++++ + H N++K    +
Sbjct: 82  IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF 141

Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCD 228
            ++    ++LE+M  GSLE       +I D     D+   + S + YLH      I+H D
Sbjct: 142 DHNGEIQVLLEFMDGGSLE-----GTHIADEQFLADVARQILSGIAYLH---RRHIVHRD 193

Query: 229 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT-----QTLATIGYMAPEYGREGRVS 283
           +KPSN+L++      ++DFG+++        L QT      ++ TI YM+PE     R++
Sbjct: 194 IKPSNLLINSAKNVKIADFGVSR-------ILAQTMDPCNSSVGTIAYMSPE-----RIN 241

Query: 284 TN----------GDVYSFGIMLMEIF 299
           T+          GD++S G+ ++E +
Sbjct: 242 TDLNHGAYDGYAGDIWSLGVSILEFY 267

Length = 353

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 77.0 bits (190), Expect = 3e-16
 Identities = 60/204 (29%), Positives = 97/204 (47%), Gaps = 23/204 (11%)

Query: 111 IGKGGFGSVYKAIIQDGMEV-AVKVFDPQ---YEGAFKSFDIECDVMKRICHRNLIKIIS 166
           IGKG FG V     +D  ++ A+K  + Q    +G+ ++   E  +++ + H  L+ +  
Sbjct: 8   IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWY 67

Query: 167 SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLD------IMIDVASALEYLHFGY 220
           S+ +++   LV++ +  G L        Y L    +         + ++  ALEYLH   
Sbjct: 68  SFQDEENMYLVVDLLLGGDLR-------YHLSQKVKFSEEQVKFWICEIVLALEYLH--- 117

Query: 221 SAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREG 280
           S  IIH D+KP N+LLD+    H++DF +A  +     +LT T T  T GYMAPE     
Sbjct: 118 SKGIIHRDIKPDNILLDEQGHVHITDFNIATKV--TPDTLT-TSTSGTPGYMAPEVLCRQ 174

Query: 281 RVSTNGDVYSFGIMLMEIFTRTKP 304
             S   D +S G+   E     +P
Sbjct: 175 GYSVAVDWWSLGVTAYECLRGKRP 198

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 76.9 bits (189), Expect = 4e-16
 Identities = 55/211 (26%), Positives = 99/211 (46%), Gaps = 26/211 (12%)

Query: 110 LIGKGGFGSVYKAIIQDGMEVAVK--VFDPQ----YEGAFKSFDIECDVMKRICHRNLIK 163
           ++GKG +G+VY  +   G  +AVK    D       E  ++    E D++K + H N+++
Sbjct: 7   VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66

Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMI------DVASALEYLH 217
            + +  +D+  ++ +E++P GS+         IL+ F  L   +       +   + YLH
Sbjct: 67  YLGTCLDDNTISIFMEFVPGGSISS-------ILNRFGPLPEPVFCKYTKQILDGVAYLH 119

Query: 218 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG----YMA 273
              +  ++H D+K +NV+L  N +  L DFG A+ L       T +  L ++     +MA
Sbjct: 120 ---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176

Query: 274 PEYGREGRVSTNGDVYSFGIMLMEIFTRTKP 304
           PE   E       D++S G  + E+ T   P
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGKPP 207

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 76.7 bits (189), Expect = 5e-16
 Identities = 53/201 (26%), Positives = 92/201 (45%), Gaps = 20/201 (9%)

Query: 111 IGKGGFGSVYKAI-IQDG----MEVAVKVF----DPQYEGAFKSFDIECDVMKRICHRNL 161
           +G G FG+VYK + I +G    + VA+KV      P+   A K    E  VM  + H ++
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPK---ANKEILDEAYVMASVDHPHV 71

Query: 162 IKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYI--LDIFQRLDIMIDVASALEYLHFG 219
           ++++          L+ + MP G L    Y+ N+   +     L+  + +A  + YL   
Sbjct: 72  VRLLG-ICLSSQVQLITQLMPLGCLLD--YVRNHKDNIGSQYLLNWCVQIAKGMSYLE-- 126

Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
               ++H DL   NVL+       ++DFG+AK L  +++          I +MA E    
Sbjct: 127 -EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILH 185

Query: 280 GRVSTNGDVYSFGIMLMEIFT 300
              +   DV+S+G+ + E+ T
Sbjct: 186 RIYTHKSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 76.6 bits (188), Expect = 6e-16
 Identities = 51/212 (24%), Positives = 98/212 (46%), Gaps = 25/212 (11%)

Query: 111 IGKGGFGSVYKAII------QDGMEVAVKVFDPQYEGAFKS-FDIECDVMKRICHRNLIK 163
           +G+  FG VYK  +      +    VA+K    + EG  +  F  E  +  R+ H N++ 
Sbjct: 13  LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72

Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLD---------------IMID 208
           ++   + +   +++  Y  H  L + L + +   D+    D               I+  
Sbjct: 73  LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132

Query: 209 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 268
           +A+ +E+L    S  ++H DL   NVL+ D +   +SD G+ + +   D       +L  
Sbjct: 133 IAAGMEFLS---SHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLP 189

Query: 269 IGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
           I +M+PE    G+ S + D++S+G++L E+F+
Sbjct: 190 IRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 76.5 bits (188), Expect = 6e-16
 Identities = 58/199 (29%), Positives = 100/199 (50%), Gaps = 13/199 (6%)

Query: 110 LIGKGGFGSV----YKAIIQDGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKI 164
           +IG G FG V     K   +  + VA+K     Y E   + F  E  +M +  H N+I +
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 165 ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLH-FGYSAP 223
               +      +V EYM +GSL+  L   +    + Q + ++  +AS ++YL   GY   
Sbjct: 71  EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGY--- 127

Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG--YMAPEYGREGR 281
            +H DL   N+L++ N+V  +SDFG+++ +LE+D     T     I   + APE     +
Sbjct: 128 -VHRDLAARNILVNSNLVCKVSDFGLSR-VLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 185

Query: 282 VSTNGDVYSFGIMLMEIFT 300
            ++  DV+S+GI++ E+ +
Sbjct: 186 FTSASDVWSYGIVMWEVMS 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 76.4 bits (188), Expect = 6e-16
 Identities = 59/203 (29%), Positives = 100/203 (49%), Gaps = 11/203 (5%)

Query: 110 LIGKGGFGSVYKA--IIQDGMEV--AVKVFDPQYE-GAFKSFDIECDVMKRICHRNLIKI 164
           +IGKG FG VY    I  DG ++  AVK  +   +    + F  E  +MK   H N++ +
Sbjct: 2   VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61

Query: 165 IS-SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
           +     ++    +VL YM HG L   +    +   +   +   + VA  +EYL    S  
Sbjct: 62  LGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---SKK 118

Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAPEYGREGR 281
            +H DL   N +LD++    ++DFG+A+ + +++       T A   + +MA E  +  +
Sbjct: 119 FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQK 178

Query: 282 VSTNGDVYSFGIMLMEIFTRTKP 304
            +T  DV+SFG++L E+ TR  P
Sbjct: 179 FTTKSDVWSFGVLLWELMTRGAP 201

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 75.9 bits (187), Expect = 7e-16
 Identities = 58/201 (28%), Positives = 94/201 (46%), Gaps = 13/201 (6%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDI--ECDVMKRICHRNLIKIIS 166
            +GKG +GSVYK   + D    A+K  D       +  D   E  ++  + H N+I    
Sbjct: 7   KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKE 66

Query: 167 SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDI---MIDVASALEYLHFGYSAP 223
           ++ + +   +V+EY P G L K +        +    +I    I +   L+ LH      
Sbjct: 67  AFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQK 123

Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVS 283
           I+H DLK +N+LL  N +  + D G++K L    +++ +TQ   T  YMAPE  +    S
Sbjct: 124 ILHRDLKSANILLVANDLVKIGDLGISKVL---KKNMAKTQI-GTPHYMAPEVWKGRPYS 179

Query: 284 TNGDVYSFGIMLMEIFTRTKP 304
              D++S G +L E+ T   P
Sbjct: 180 YKSDIWSLGCLLYEMATFAPP 200

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 76.2 bits (187), Expect = 9e-16
 Identities = 59/223 (26%), Positives = 102/223 (45%), Gaps = 39/223 (17%)

Query: 111 IGKGGFGSVYKAI------IQDGMEVAVKVFDPQYEGA----FKSFDIECDVMKRICHRN 160
           +G+G FG V KA             VAVK+     E A     +    E +++K++ H +
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLK---ENASSSELRDLLSEFNLLKQVNHPH 64

Query: 161 LIKIISSYSNDDFKALVLEYMPHGSLEKCLYLS-----NYILDIFQRLDIMID------- 208
           +IK+  + S D    L++EY  +GSL   L  S     +Y+     R    +D       
Sbjct: 65  VIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124

Query: 209 -----------VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED 257
                      ++  ++YL       ++H DL   NVL+ +     +SDFG+++ + EED
Sbjct: 125 TMGDLISFAWQISRGMQYLA---EMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEED 181

Query: 258 QSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
             + +++    + +MA E   +   +T  DV+SFG++L EI T
Sbjct: 182 SYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 76.2 bits (188), Expect = 1e-15
 Identities = 58/201 (28%), Positives = 91/201 (45%), Gaps = 21/201 (10%)

Query: 110 LIGKGGFGSVYKAIIQD-GMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIIS 166
           ++G+G +G V K   +  G  VA+K F      E   K+   E  V++++ H N++ +  
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67

Query: 167 SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIH 226
           ++       LV EY+    LE  L  S   L        +  +  A+ Y H   S  IIH
Sbjct: 68  AFRRKGRLYLVFEYVERTLLEL-LEASPGGLPPDAVRSYIWQLLQAIAYCH---SHNIIH 123

Query: 227 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE-------YGRE 279
            D+KP N+L+ ++ V  L DFG A+ L     S   T  +AT  Y APE       YG+ 
Sbjct: 124 RDIKPENILVSESGVLKLCDFGFARALRARPAS-PLTDYVATRWYRAPELLVGDTNYGKP 182

Query: 280 GRVSTNGDVYSFGIMLMEIFT 300
                  DV++ G ++ E+  
Sbjct: 183 ------VDVWAIGCIMAELLD 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 75.7 bits (186), Expect = 1e-15
 Identities = 52/199 (26%), Positives = 100/199 (50%), Gaps = 11/199 (5%)

Query: 110 LIGKGGFGSVY----KAIIQDGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKI 164
           +IG G FG V     K   +  + VA+K     Y E   + F  E  +M +  H N+I +
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 165 ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPI 224
               +      ++ E+M +G+L+  L  ++    + Q + ++  +A+ ++YL        
Sbjct: 71  EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EMNY 127

Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA---TIGYMAPEYGREGR 281
           +H DL   N+L++ N+V  +SDFG+++ L ++    T T +L     I + APE     +
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRK 187

Query: 282 VSTNGDVYSFGIMLMEIFT 300
            ++  DV+S+GI++ E+ +
Sbjct: 188 FTSASDVWSYGIVMWEVMS 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 75.5 bits (185), Expect = 2e-15
 Identities = 61/200 (30%), Positives = 96/200 (48%), Gaps = 9/200 (4%)

Query: 111 IGKGGFGSVYKAIIQDGMEV-AVKVFD-PQYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
           IGKG FG V+K I     +V A+K+ D  + E   +    E  V+ +     + K   SY
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCD 228
             D    +++EY+  GS    L      LD  Q   I+ ++   L+YLH   S   IH D
Sbjct: 72  LKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH---SEKKIHRD 126

Query: 229 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDV 288
           +K +NVLL ++    L+DFG+A  L   D  + +   + T  +MAPE  ++    +  D+
Sbjct: 127 IKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADI 184

Query: 289 YSFGIMLMEIFTRTKPTDEI 308
           +S GI  +E+     P  E+
Sbjct: 185 WSLGITAIELAKGEPPHSEL 204

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 75.2 bits (185), Expect = 2e-15
 Identities = 54/205 (26%), Positives = 86/205 (41%), Gaps = 23/205 (11%)

Query: 111 IGKGGFGSVYKAIIQD-GMEVAVKVFDPQ-------YEGAFKSFDIECDVMKRICHRNLI 162
           +GKGGFG V    ++  G   A K  D +        + A      E  +++++  R ++
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMAL----NEKKILEKVSSRFIV 56

Query: 163 KIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMI---DVASALEYLHFG 219
            +  ++   D   LV+  M  G L+   ++ N     F     +     +   LE+LH  
Sbjct: 57  SLAYAFETKDDLCLVMTLMNGGDLK--YHIYNVGEPGFPEARAIFYAAQIICGLEHLH-- 112

Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
               I++ DLKP NVLLDD+    +SD G+A  L              T GYMAPE  + 
Sbjct: 113 -QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGRAGTPGYMAPEVLQG 168

Query: 280 GRVSTNGDVYSFGIMLMEIFTRTKP 304
                + D ++ G  L E+     P
Sbjct: 169 EVYDFSVDWFALGCTLYEMIAGRSP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 75.5 bits (186), Expect = 2e-15
 Identities = 63/220 (28%), Positives = 102/220 (46%), Gaps = 27/220 (12%)

Query: 111 IGKGGFGSVYKAIIQDGME-VAVKVFDPQYEGAFKSFDI-----ECDVMKRICHRNLIKI 164
           +G+GG+G V+ A  +D  E VA+K         FK  ++     E D++       L+K+
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSL--LFKLNEVRHVLTERDILTTTKSEWLVKL 66

Query: 165 ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLH-FGYSAP 223
           + ++ +D++  L +EY+P G     L     + +   R   M ++  A++ LH  GY   
Sbjct: 67  LYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARF-YMAEMFEAVDALHELGY--- 122

Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVS 283
            IH DLKP N L+D +    L+DFG++K ++    S+     + +  YMAPE  R     
Sbjct: 123 -IHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSV-----VGSPDYMAPEVLRGKGYD 176

Query: 284 TNGDVYSFGIMLMEIFTRTKP-----TDEIFSGEMTLKRW 318
              D +S G ML E      P      +E +     LK W
Sbjct: 177 FTVDYWSLGCMLYEFLCGFPPFSGSTPNETWE---NLKYW 213

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 74.4 bits (183), Expect = 3e-15
 Identities = 49/209 (23%), Positives = 97/209 (46%), Gaps = 19/209 (9%)

Query: 110 LIGKGGFGSVYKAIIQDGME------VAVKVFDP-QYEGAFKSFDIECDVMKRICHRNLI 162
            +G+G FG V+ A  +   E      V VK     + E     F  E D+ +++ H+N++
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71

Query: 163 KIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYI--------LDIFQRLDIMIDVASALE 214
           +++      +   ++LEY   G L++ L  +           L   Q++ +   +A  ++
Sbjct: 72  RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131

Query: 215 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 274
           +L    +A  +H DL   N L+       +S   ++K +   +    +   L  + ++AP
Sbjct: 132 HL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLR-NALIPLRWLAP 187

Query: 275 EYGREGRVSTNGDVYSFGIMLMEIFTRTK 303
           E  +E   ST  DV+SFG+++ E+FT+ +
Sbjct: 188 EAVQEDDFSTKSDVWSFGVLMWEVFTQGE 216

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 74.5 bits (184), Expect = 3e-15
 Identities = 59/211 (27%), Positives = 88/211 (41%), Gaps = 51/211 (24%)

Query: 111 IGKGGFGSVYKA-IIQDGMEVAVKVFDPQYEGAFKSFDI-----------ECDVMKRICH 158
           +G G FG V        G   A+K+             I           E  +++ I H
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKA--------KIVKLKQVEHVLNEKRILQSIRH 60

Query: 159 RNLIKIISSYSNDDFKALVLEYMPHGS----LEKCLYLSNYILDIFQRLDIMIDVASALE 214
             L+ +  S+ +D    LV+EY+P G     L K       +   +        V  ALE
Sbjct: 61  PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYA-----AQVVLALE 115

Query: 215 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL-ATIGYMA 273
           YLH   S  I++ DLKP N+LLD +    ++DFG AK +        +T TL  T  Y+A
Sbjct: 116 YLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG------RTYTLCGTPEYLA 166

Query: 274 PE------YGREGRVSTNGDVYSFGIMLMEI 298
           PE      YG+        D ++ GI++ E+
Sbjct: 167 PEIILSKGYGKA------VDWWALGILIYEM 191

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 74.8 bits (184), Expect = 3e-15
 Identities = 72/218 (33%), Positives = 111/218 (50%), Gaps = 40/218 (18%)

Query: 111 IGKGGFGSVYKAIIQD-GMEVAVKV--FDPQYEGAFKSFDI----ECDVMKRICHRNLIK 163
           IG+G +G VYKA  +D G  VA+K    D + EG    F I    E  +++++ HRN++ 
Sbjct: 15  IGEGTYGQVYKARDKDTGELVALKKVRLDNEKEG----FPITAIREIKILRQLNHRNIVN 70

Query: 164 IISSYSND----DFKA------LVLEYMPH---GSLEKCL--YLSNYILDIFQRLDIMID 208
           +    ++     DFK       LV EYM H   G LE  L  +  ++I    ++L     
Sbjct: 71  LKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQL----- 125

Query: 209 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 268
               LE L++ +    +H D+K SN+LL++     L+DFG+A+ L   ++S   T  + T
Sbjct: 126 ----LEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLAR-LYNSEESRPYTNKVIT 180

Query: 269 IGYMAPE--YGREGRVSTNGDVYSFGIMLMEIFTRTKP 304
           + Y  PE   G E R     DV+S G +L E+FT+ KP
Sbjct: 181 LWYRPPELLLGEE-RYGPAIDVWSCGCILGELFTK-KP 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 74.3 bits (182), Expect = 4e-15
 Identities = 58/200 (29%), Positives = 95/200 (47%), Gaps = 9/200 (4%)

Query: 111 IGKGGFGSVYKAIIQDGMEV-AVKVFD-PQYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
           IGKG FG V+K I     +V A+K+ D  + E   +    E  V+ +     + K   SY
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCD 228
                  +++EY+  GS    L    +  D FQ   ++ ++   L+YLH   S   IH D
Sbjct: 72  LKGTKLWIIMEYLGGGSALDLLRAGPF--DEFQIATMLKEILKGLDYLH---SEKKIHRD 126

Query: 229 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDV 288
           +K +NVLL +     L+DFG+A  L   D  + +   + T  +MAPE  ++    +  D+
Sbjct: 127 IKAANVLLSEQGDVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADI 184

Query: 289 YSFGIMLMEIFTRTKPTDEI 308
           +S GI  +E+     P  ++
Sbjct: 185 WSLGITAIELAKGEPPNSDM 204

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 73.8 bits (182), Expect = 4e-15
 Identities = 61/242 (25%), Positives = 98/242 (40%), Gaps = 61/242 (25%)

Query: 111 IGKGGFGSVYKAIIQDGMEV-AVK------VFDPQYEGAFKSFDIECDVMKRICHRNLIK 163
           +G GGFG V    ++      A+K      + +   +    S   E ++++   H  ++K
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFS---EKEILEECNHPFIVK 57

Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMID---------VASALE 214
           +  ++ +  +  +++EY   G L            I +   +  +         V  A E
Sbjct: 58  LYRTFKDKKYIYMLMEYCLGGEL----------WTILRDRGLFDEYTARFYIACVVLAFE 107

Query: 215 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL-ATIGYMA 273
           YLH   +  II+ DLKP N+LLD N    L DFG AK L    +S  +T T   T  Y+A
Sbjct: 108 YLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKL----KSGQKTWTFCGTPEYVA 160

Query: 274 PE------YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPISV 327
           PE      Y        + D +S GI+L E+ T   P    F  +        D  P+ +
Sbjct: 161 PEIILNKGYDF------SVDYWSLGILLYELLTGRPP----FGED--------DEDPMEI 202

Query: 328 ME 329
             
Sbjct: 203 YN 204

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 74.3 bits (182), Expect = 4e-15
 Identities = 56/212 (26%), Positives = 102/212 (48%), Gaps = 11/212 (5%)

Query: 111 IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYS 169
           +G G FG VYKA  ++ G   A KV + + E   + + +E +++    H  ++K++ ++ 
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 170 NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
            D    +++E+ P G+++  +   +  L       I +     LE L + +S  IIH DL
Sbjct: 80  WDGKLWIMIEFCPGGAVDAIMLELDRGL---TEPQIQVICRQMLEALQYLHSMKIIHRDL 136

Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEY-----GREGRVST 284
           K  NVLL  +    L+DFG++   ++  Q   +   + T  +MAPE       ++     
Sbjct: 137 KAGNVLLTLDGDIKLADFGVSAKNVKTLQR--RDSFIGTPYWMAPEVVMCETMKDTPYDY 194

Query: 285 NGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLK 316
             D++S GI L+E+     P  E+    + LK
Sbjct: 195 KADIWSLGITLIEMAQIEPPHHELNPMRVLLK 226

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 73.6 bits (181), Expect = 5e-15
 Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 25/209 (11%)

Query: 111 IGKGGFGSVYKAII--QDG----MEVAVK----VFDPQYEGAFKSFDIECDVMKRICHRN 160
           +G G FG VY+ +   +DG    ++VAVK        Q E     F +E  +M +  H+N
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDE---SDFLMEALIMSKFNHQN 70

Query: 161 LIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSN------YILDIFQRLDIMIDVASALE 214
           ++++I        + ++LE M  G L+  L  +         L +   L    DVA   +
Sbjct: 71  IVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCK 130

Query: 215 YLHFGYSAPIIHCDLKPSNVLLDD---NMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGY 271
           YL        IH D+   N LL       VA ++DFGMA+ +          + +  I +
Sbjct: 131 YLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKW 187

Query: 272 MAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
           M PE   +G  ++  DV+SFG++L EIF+
Sbjct: 188 MPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 73.4 bits (180), Expect = 6e-15
 Identities = 55/200 (27%), Positives = 100/200 (50%), Gaps = 23/200 (11%)

Query: 110 LIGKGGFGSVY---------KAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRN 160
           ++G+G FG V+           II+   ++ V+        A ++   EC V+K + H N
Sbjct: 7   VVGRGAFGIVHLCRRKADQKLVIIK---QIPVEQMTKDERLAAQN---ECQVLKLLSHPN 60

Query: 161 LIKIISSYSNDDFKALVLEYMPHGSLEKCLY-LSNYILDIFQRLDIMIDVASALEYLHFG 219
           +I+   ++  D    +V+EY P G+L + +    N +LD    L   + +  AL ++H  
Sbjct: 61  IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH-- 118

Query: 220 YSAPIIHCDLKPSNVLLDDN-MVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGR 278
            +  I+H DLK  N+LLD + MV  + DFG++K L  + ++ T    + T  Y++PE   
Sbjct: 119 -TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT---VVGTPCYISPELCE 174

Query: 279 EGRVSTNGDVYSFGIMLMEI 298
               +   D+++ G +L E+
Sbjct: 175 GKPYNQKSDIWALGCVLYEL 194

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 73.5 bits (180), Expect = 6e-15
 Identities = 60/198 (30%), Positives = 101/198 (51%), Gaps = 21/198 (10%)

Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSN 170
           +G G FG V+ A      +VAVK   P    + ++F  E +VMK + H  L+K+ +  + 
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 72

Query: 171 DDFKALVLEYMPHGSLEKCLYLSNYILDIF-------QRLDIMIDVASAL-EYLHFGYSA 222
           +    ++ E+M  GSL          LD         Q L  +ID ++ + E + F    
Sbjct: 73  EPI-YIITEFMAKGSL----------LDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR 121

Query: 223 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRV 282
             IH DL+ +N+L+  ++V  ++DFG+A+ ++E+++   +      I + APE    G  
Sbjct: 122 NYIHRDLRAANILVSASLVCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGSF 180

Query: 283 STNGDVYSFGIMLMEIFT 300
           +   DV+SFGI+LMEI T
Sbjct: 181 TIKSDVWSFGILLMEIVT 198

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 73.5 bits (180), Expect = 6e-15
 Identities = 58/201 (28%), Positives = 98/201 (48%), Gaps = 12/201 (5%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVK---VFDPQYEGAFKSFDIECDVMKRICHRNLIKIIS 166
           IG+G F  VY+A  + DG+ VA+K   +FD     A      E D++K++ H N+IK  +
Sbjct: 10  IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69

Query: 167 SYSNDDFKALVLEYMPHGSLEKCL-YLSNYILDIFQRL--DIMIDVASALEYLHFGYSAP 223
           S+  D+   +VLE    G L + + +       I ++      + + SALE++H   S  
Sbjct: 70  SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRR 126

Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVS 283
           ++H D+KP+NV +    V  L D G+ +      ++      + T  YM+PE   E   +
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGR--FFSSKTTAAHSLVGTPYYMSPERIHENGYN 184

Query: 284 TNGDVYSFGIMLMEIFTRTKP 304
              D++S G +L E+     P
Sbjct: 185 FKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 73.8 bits (181), Expect = 7e-15
 Identities = 58/225 (25%), Positives = 107/225 (47%), Gaps = 25/225 (11%)

Query: 111 IGKGGFGSVYKAIIQDGME------VAVKVFDPQYEGAFK-SFDIECDVMKR-ICHRNLI 162
           +G+G FG VY+   +D ++      VAVK  +       +  F  E  VMK   CH +++
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH-HVV 72

Query: 163 KIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILD-----------IFQRLDIMIDVAS 211
           +++   S      +V+E M HG L+   YL +   +           + + + +  ++A 
Sbjct: 73  RLLGVVSKGQPTLVVMELMAHGDLKS--YLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 130

Query: 212 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGY 271
            + YL+   +   +H DL   N ++  +    + DFGM + + E D      + L  + +
Sbjct: 131 GMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187

Query: 272 MAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLK 316
           MAPE  ++G  +T+ D++SFG++L EI +  +   +  S E  LK
Sbjct: 188 MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 232

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 73.3 bits (180), Expect = 1e-14
 Identities = 60/224 (26%), Positives = 96/224 (42%), Gaps = 43/224 (19%)

Query: 111 IGKGGFGSVYKAII------QDGMEVAVKVFDPQYEGAF----KSFDIECDVMKRICHRN 160
           IG+G FG V++A        +    VAVK+     E A       F  E  +M    H N
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLK---EEASADMQADFQREAALMAEFDHPN 69

Query: 161 LIKIISSYSNDDFKALVLEYMPHGSLEKCL--------------------YLSNYI-LDI 199
           ++K++   +      L+ EYM +G L + L                       N + L  
Sbjct: 70  IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129

Query: 200 FQRLDIMIDVASALEYL---HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE 256
            ++L I   VA+ + YL    F      +H DL   N L+ +NMV  ++DFG+++ +   
Sbjct: 130 TEQLCIAKQVAAGMAYLSERKF------VHRDLATRNCLVGENMVVKIADFGLSRNIYSA 183

Query: 257 DQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
           D           I +M PE     R +T  DV+++G++L EIF+
Sbjct: 184 DYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 73.2 bits (179), Expect = 1e-14
 Identities = 57/195 (29%), Positives = 94/195 (48%), Gaps = 8/195 (4%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYS 169
           IG+G  G+VY A+ +  G EVA++  + Q +   +    E  VM+   + N++  + SY 
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87

Query: 170 NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
             D   +V+EY+  GSL   +  +   +D  Q   +  +   ALE+LH   S  +IH D+
Sbjct: 88  VGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 142

Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 289
           K  N+LL  +    L+DFG    +  E     ++  + T  +MAPE           D++
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIW 200

Query: 290 SFGIMLMEIFTRTKP 304
           S GIM +E+     P
Sbjct: 201 SLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 72.6 bits (178), Expect = 1e-14
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 33/214 (15%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDI------ECDVMKRICHRNLI 162
            +G G F S Y+A  ++ G  +AVK        + +  ++      E  +M R+ H ++I
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66

Query: 163 KIISSYSNDDFKALVLEYMPHGSLEKCLY---------LSNYILDIFQRLDIMIDVASAL 213
           +++ +   D    L +E+M  GS+   L          + NY   + +           L
Sbjct: 67  RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLR----------GL 116

Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDN-MVAHLSDFGMAKPLLEE--DQSLTQTQTLATIG 270
            YLH      IIH D+K +N+L+D       ++DFG A  L  +       Q Q L TI 
Sbjct: 117 SYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIA 173

Query: 271 YMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKP 304
           +MAPE  R  +   + DV+S G +++E+ T  KP
Sbjct: 174 FMAPEVLRGEQYGRSCDVWSVGCVIIEMAT-AKP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 72.4 bits (177), Expect = 2e-14
 Identities = 63/227 (27%), Positives = 106/227 (46%), Gaps = 37/227 (16%)

Query: 102 PNDANMPPLIGKGGFGSVYKAIIQD-GMEVAVKV--FDPQYEGAFKSFD-IECDV--MKR 155
           P +  +  L+G+G FG VY     D G E+AVK   FDP+     K  + +EC++  +K 
Sbjct: 1   PTNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKN 60

Query: 156 ICHRNLIKIISSYSNDDFKAL--VLEYMPHGSLEKCL----YLSNYILDIFQRLDIMIDV 209
           + H  +++      +   + L   +E+MP GS++  L     L+  +   + R       
Sbjct: 61  LLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTR------- 113

Query: 210 ASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATI 269
              LE + + +S  I+H D+K +N+L D      L DFG +K L  +   L+ T   +  
Sbjct: 114 -QILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRL--QTICLSGTGMKSVT 170

Query: 270 G---YMAPE------YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDE 307
           G   +M+PE      YGR+       D++S G  ++E+ T   P  E
Sbjct: 171 GTPYWMSPEVISGEGYGRK------ADIWSVGCTVVEMLTEKPPWAE 211

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 72.5 bits (178), Expect = 2e-14
 Identities = 61/204 (29%), Positives = 91/204 (44%), Gaps = 32/204 (15%)

Query: 111 IGKGGFGSVYKAII-QDGMEVAVKVF----DPQYEGAFKSFDIECDVMKRICHRNLIKII 165
           +G+G  GSV K  +   GM  A+K      +P  +   K    E ++ K      ++K  
Sbjct: 9   LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQ---KQILRELEINKSCKSPYIVKYY 65

Query: 166 SSYSNDDFK--ALVLEYMPHGSLEKCLY---------LSNYILDIFQRLDIMIDVASALE 214
            ++ ++      + +EY   GSL+  +Y         +   +L       I   V   L 
Sbjct: 66  GAFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEKVL-----GKIAESVLKGLS 119

Query: 215 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 274
           YLH   S  IIH D+KPSN+LL       L DFG++  L+    SL  T T  T  YMAP
Sbjct: 120 YLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN---SLAGTFT-GTSFYMAP 172

Query: 275 EYGREGRVSTNGDVYSFGIMLMEI 298
           E  +    S   DV+S G+ L+E+
Sbjct: 173 ERIQGKPYSITSDVWSLGLTLLEV 196

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 72.5 bits (178), Expect = 2e-14
 Identities = 63/247 (25%), Positives = 101/247 (40%), Gaps = 48/247 (19%)

Query: 96  KRGKPLPNDANMPPLIGKGGFGSVYKAI-IQDGMEVAVK-----------VFDPQYEGA- 142
           +R             +G+G +G V KA     G  VA+K             D Q  G  
Sbjct: 8   ERYIQKGA------HLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMC 61

Query: 143 ---FKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDI 199
              F +   E  +M  I H N++ ++  Y   DF  LV++ M    L+K +      L  
Sbjct: 62  GIHFTTLR-ELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKK-VVDRKIRLTE 118

Query: 200 FQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAK----PLLE 255
            Q   I++ + + L  LH  Y    +H DL P+N+ ++   +  ++DFG+A+    P   
Sbjct: 119 SQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYS 175

Query: 256 EDQS--------LTQTQTLATIGYMAPE--YGREGRVSTNGDVYSFGIMLMEIFTRTKP- 304
           +  S           T  + T+ Y APE   G E +     D++S G +  E+ T  KP 
Sbjct: 176 DTLSKDETMQRREEMTSKVVTLWYRAPELLMGAE-KYHFAVDMWSVGCIFAELLTG-KPL 233

Query: 305 ---TDEI 308
               +EI
Sbjct: 234 FPGENEI 240

Length = 335

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 72.0 bits (176), Expect = 3e-14
 Identities = 58/223 (26%), Positives = 104/223 (46%), Gaps = 21/223 (9%)

Query: 111 IGKGGFGSVY----KAIIQDGMEVAVKVFDPQYEGAFKS---FDIECDVMKRI-CHRNLI 162
           +G+G FG VY    K +++D  E  V +       + +    F  E  VMK   CH +++
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH-HVV 72

Query: 163 KIISSYSNDDFKALVLEYMPHGSLEKCLY-----LSNYILDIFQRLDIMI----DVASAL 213
           +++   S      +++E M  G L+  L      + N  +     L  MI    ++A  +
Sbjct: 73  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132

Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
            YL+   +   +H DL   N ++ ++    + DFGM + + E D      + L  + +M+
Sbjct: 133 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 189

Query: 274 PEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLK 316
           PE  ++G  +T  DV+SFG++L EI T  +   +  S E  L+
Sbjct: 190 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLR 232

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 72.1 bits (176), Expect = 3e-14
 Identities = 59/195 (30%), Positives = 94/195 (48%), Gaps = 8/195 (4%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYS 169
           IG+G  G+VY AI I  G EVA+K  + Q +   +    E  VM+   + N++  + SY 
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86

Query: 170 NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
             D   +V+EY+  GSL   +  +   +D  Q   +  +   AL++LH   S  +IH D+
Sbjct: 87  VGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALDFLH---SNQVIHRDI 141

Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 289
           K  N+LL  +    L+DFG    +  E     ++  + T  +MAPE           D++
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIW 199

Query: 290 SFGIMLMEIFTRTKP 304
           S GIM +E+     P
Sbjct: 200 SLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 71.2 bits (174), Expect = 3e-14
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 19/207 (9%)

Query: 111 IGKGGFGSVYKAII-QDG--MEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKII 165
           +G+G FGSV +  + QD   ++VAVK            + F  E   MK   H N++++I
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 166 ----SSYSNDDFKA--LVLEYMPHGSLEKCLYLSNY-----ILDIFQRLDIMIDVASALE 214
                +  ++ + +  ++L +M HG L   L  S        L     +  M D+AS +E
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 215 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 274
           YL    S   IH DL   N +L++NM   ++DFG++K +   D           + ++A 
Sbjct: 127 YLS---SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183

Query: 275 EYGREGRVSTNGDVYSFGIMLMEIFTR 301
           E   +   +T  DV+SFG+ + EI TR
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATR 210

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 71.2 bits (174), Expect = 4e-14
 Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 15/212 (7%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVK---VFDPQYEGAFKSFDIECDVMKRICHRNLIKIIS 166
           IG+G F  VY+A  + D   VA+K   +F+     A +    E D++K++ H N+IK + 
Sbjct: 10  IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69

Query: 167 SYSNDDFKALVLEYMPHGSLEKCL-YLSNYILDIFQRL--DIMIDVASALEYLHFGYSAP 223
           S+  D+   +VLE    G L + + Y       I +R      + + SA+E++H   S  
Sbjct: 70  SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRR 126

Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVS 283
           ++H D+KP+NV +    V  L D G+ +      ++      + T  YM+PE   E   +
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGR--FFSSKTTAAHSLVGTPYYMSPERIHENGYN 184

Query: 284 TNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTL 315
              D++S G +L E+     P    +  +M L
Sbjct: 185 FKSDIWSLGCLLYEMAALQSP---FYGDKMNL 213

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 71.3 bits (174), Expect = 4e-14
 Identities = 58/195 (29%), Positives = 95/195 (48%), Gaps = 8/195 (4%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYS 169
           IG+G  G+V+ AI +  G EVA+K  + Q +   +    E  VMK + + N++  + S+ 
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86

Query: 170 NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
             D   +V+EY+  GSL     ++   +D  Q   +  +   ALE+LH   +  +IH D+
Sbjct: 87  VGDELFVVMEYLAGGSLTDV--VTETCMDEAQIAAVCRECLQALEFLH---ANQVIHRDI 141

Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 289
           K  NVLL  +    L+DFG    +  E     ++  + T  +MAPE           D++
Sbjct: 142 KSDNVLLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIW 199

Query: 290 SFGIMLMEIFTRTKP 304
           S GIM +E+     P
Sbjct: 200 SLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 71.0 bits (175), Expect = 5e-14
 Identities = 58/223 (26%), Positives = 101/223 (45%), Gaps = 44/223 (19%)

Query: 111 IGKGGFGSVYKAIIQDGME-VAVKVFDPQYEGAFKSFDIECDVMKRI-------CHRNLI 162
           +G G FGSVY A  ++  E VA+K      +  F S++ EC  ++ +        H N++
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKM----KKKFYSWE-ECMNLREVKSLRKLNEHPNIV 61

Query: 163 KIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL-------DIMIDVASALEY 215
           K+   +  +D    V EYM     E  LY    + D   +         I+  +   L +
Sbjct: 62  KLKEVFRENDELYFVFEYM-----EGNLY--QLMKDRKGKPFSESVIRSIIYQILQGLAH 114

Query: 216 LH-FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 274
           +H  G+     H DLKP N+L+    V  ++DFG+A+ +         T  ++T  Y AP
Sbjct: 115 IHKHGF----FHRDLKPENLLVSGPEVVKIADFGLAREIRSRP---PYTDYVSTRWYRAP 167

Query: 275 E-YGREGRVSTNGDVYSFGIMLMEIFTRTKP-------TDEIF 309
           E   R    S+  D+++ G ++ E++T  +P        D+++
Sbjct: 168 EILLRSTSYSSPVDIWALGCIMAELYT-LRPLFPGSSEIDQLY 209

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 70.6 bits (173), Expect = 7e-14
 Identities = 61/209 (29%), Positives = 99/209 (47%), Gaps = 19/209 (9%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
           ++GKG +G VY A  +   + +A+K    +     +    E  +   + HRN+++ + S 
Sbjct: 15  VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74

Query: 169 SNDDFKALVLEYMPHGSLEKCL------YLSNYILDIFQRLDIMIDVASALEYLHFGYSA 222
           S + F  + +E +P GSL   L         N    IF    I+      L+YLH     
Sbjct: 75  SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL----EGLKYLH---DN 127

Query: 223 PIIHCDLKPSNVLLDD-NMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGR 281
            I+H D+K  NVL++  + V  +SDFG +K L   +   T+T T  T+ YMAPE   +G 
Sbjct: 128 QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN-PCTETFT-GTLQYMAPEVIDKGP 185

Query: 282 --VSTNGDVYSFGIMLMEIFTRTKPTDEI 308
                  D++S G  ++E+ T   P  E+
Sbjct: 186 RGYGAPADIWSLGCTIVEMATGKPPFIEL 214

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 70.2 bits (172), Expect = 7e-14
 Identities = 57/216 (26%), Positives = 94/216 (43%), Gaps = 21/216 (9%)

Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDI--ECDVMKRICHRNLIKIISS 167
           IGKG FG V+K + + D    A+K  D       +  +   E  V+ ++    +I+   S
Sbjct: 8   IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67

Query: 168 YSNDDFKALVLEYMPHGSLEKCLYL-------SNYILDIFQRLDIMIDVASALEYLHFGY 220
           + +     +V+EY  +G L K L +        + +   F      I +   L +LH   
Sbjct: 68  FLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFF------IQILLGLAHLH--- 118

Query: 221 SAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREG 280
           S  I+H D+K  N+ LD      + D G+AK L   D +      + T  Y++PE   + 
Sbjct: 119 SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL--SDNTNFANTIVGTPYYLSPELCEDK 176

Query: 281 RVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLK 316
             +   DV++ G++L E  T   P D    G + LK
Sbjct: 177 PYNEKSDVWALGVVLYECCTGKHPFDANNQGALILK 212

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 70.2 bits (172), Expect = 9e-14
 Identities = 55/190 (28%), Positives = 95/190 (50%), Gaps = 10/190 (5%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYS 169
           IG+G  G V  A     G +VAVK  D + +   +    E  +M+   H N++++ SSY 
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86

Query: 170 NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
             D   +V+E++  G+L   +  +   ++  Q   + + V  AL +LH   +  +IH D+
Sbjct: 87  VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLAVLKALSFLH---AQGVIHRDI 141

Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGY-MAPEYGREGRVSTNGDV 288
           K  ++LL  +    LSDFG    + +E   + + ++L    Y MAPE        T  D+
Sbjct: 142 KSDSILLTSDGRVKLSDFGFCAQVSKE---VPRRKSLVGTPYWMAPEVISRLPYGTEVDI 198

Query: 289 YSFGIMLMEI 298
           +S GIM++E+
Sbjct: 199 WSLGIMVIEM 208

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 70.6 bits (173), Expect = 1e-13
 Identities = 67/238 (28%), Positives = 104/238 (43%), Gaps = 53/238 (22%)

Query: 110 LIGKGGFGSVYKAIIQDGME----VAVKVFDP------QYEGAFKSFDIECDVMKRICHR 159
           ++GKGG+G V++     G +     A+KV         Q + A      E ++++ + H 
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTK--AERNILEAVKHP 60

Query: 160 NLIKIISSYSNDDFKALVLEYMPHGSL----EK---------CLYLSNYILDIFQRLDIM 206
            ++ +I ++       L+LEY+  G L    E+         C YLS   L         
Sbjct: 61  FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISL--------- 111

Query: 207 IDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL 266
                ALE+LH      II+ DLKP N+LLD      L+DFG+ K  + E  ++T T   
Sbjct: 112 -----ALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-TVTHT-FC 161

Query: 267 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT---------RTKPTDEIFSGEMTL 315
            TI YMAPE           D +S G ++ ++ T         R K  D+I  G++ L
Sbjct: 162 GTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNL 219

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 69.8 bits (171), Expect = 2e-13
 Identities = 64/207 (30%), Positives = 95/207 (45%), Gaps = 29/207 (14%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAF---KSFDI--ECDVMKRICHRNLIKI 164
           IG G FG+VY A  ++    VA+K     Y G     K  DI  E   ++++ H N I+ 
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMS--YSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80

Query: 165 ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDI----FQRLDIMIDVASALEYLHFGY 220
              Y  +    LV+EY        CL  ++ IL++     Q ++I      AL+ L + +
Sbjct: 81  KGCYLREHTAWLVMEY--------CLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLH 132

Query: 221 SAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEY---G 277
           S   IH D+K  N+LL +     L+DFG A  L+    S      + T  +MAPE     
Sbjct: 133 SHERIHRDIKAGNILLTEPGTVKLADFGSAS-LVSPANSF-----VGTPYWMAPEVILAM 186

Query: 278 REGRVSTNGDVYSFGIMLMEIFTRTKP 304
            EG+     DV+S GI  +E+  R  P
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPP 213

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 69.7 bits (171), Expect = 2e-13
 Identities = 65/216 (30%), Positives = 95/216 (43%), Gaps = 46/216 (21%)

Query: 110 LIGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEG-AFKSFDIECDVMKRICHRNLIKIISS 167
            IG+G FG+V K + +  G  +AVK      +    K   ++ DV+ R    +   I+  
Sbjct: 11  EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMR--SSDCPYIVKF 68

Query: 168 YSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL-----------DIMIDVA----SA 212
           Y      AL  E    G    C+ L +  LD F +            +I+  +A     A
Sbjct: 69  YG-----ALFRE----GDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKA 119

Query: 213 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYM 272
           L YL       IIH D+KPSN+LLD N    L DFG++  L++   S+ +T+      YM
Sbjct: 120 LNYLK--EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD---SIAKTRDAGCRPYM 174

Query: 273 APEYGREGRVSTNG--------DVYSFGIMLMEIFT 300
           APE     R+  +         DV+S GI L E+ T
Sbjct: 175 APE-----RIDPSARDGYDVRSDVWSLGITLYEVAT 205

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 69.3 bits (169), Expect = 2e-13
 Identities = 59/204 (28%), Positives = 93/204 (45%), Gaps = 17/204 (8%)

Query: 111 IGKGGFGSVYKAIIQDGMEV-AVKVFD-PQYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
           IGKG FG VYK I     EV A+K+ D  + E   +    E  V+ +     + +   SY
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71

Query: 169 SNDDFKALVLEYMPHGS----LEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPI 224
                  +++EY+  GS    L+       YI  I +      ++   L+YLH   S   
Sbjct: 72  LKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILR------EILKGLDYLH---SERK 122

Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVST 284
           IH D+K +NVLL +     L+DFG+A  L   D  + +   + T  +MAPE  ++     
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIKQSAYDF 180

Query: 285 NGDVYSFGIMLMEIFTRTKPTDEI 308
             D++S GI  +E+     P  ++
Sbjct: 181 KADIWSLGITAIELAKGEPPNSDL 204

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 69.3 bits (169), Expect = 2e-13
 Identities = 55/200 (27%), Positives = 97/200 (48%), Gaps = 11/200 (5%)

Query: 110 LIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDI---ECDVMKRICHRNLIKII 165
           ++GKGGFG V    ++  G   A K  + +     K   +   E  +++++  R ++ + 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLA 66

Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLY-LSNYILDIFQRLDIMIDVASALEYLHFGYSAPI 224
            +Y   D   LVL  M  G L+  +Y +     +  + +    ++   LE LH      I
Sbjct: 67  YAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QERI 123

Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVST 284
           ++ DLKP N+LLDD+    +SD G+A   + E Q++     + T+GYMAPE  +  R + 
Sbjct: 124 VYRDLKPENILLDDHGHIRISDLGLAVH-VPEGQTI--KGRVGTVGYMAPEVVKNERYTF 180

Query: 285 NGDVYSFGIMLMEIFTRTKP 304
           + D ++ G +L E+     P
Sbjct: 181 SPDWWALGCLLYEMIAGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 69.2 bits (170), Expect = 2e-13
 Identities = 59/208 (28%), Positives = 93/208 (44%), Gaps = 30/208 (14%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRIC-HRNLIKIISS 167
           +IG+G +G VYKA   + G  VA+K+ D   +   +    E +++++   H N+     +
Sbjct: 13  VIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE-EEIKEEYNILRKYSNHPNIATFYGA 71

Query: 168 Y------SNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLD------IMIDVASALEY 215
           +       NDD   LV+E    GS+     L   +    +RL       I+ +    L Y
Sbjct: 72  FIKKNPPGNDDQLWLVMELCGGGSVTD---LVKGLRKKGKRLKEEWIAYILRETLRGLAY 128

Query: 216 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT-LATIGYMAP 274
           LH      +IH D+K  N+LL  N    L DFG++  L   D +L +  T + T  +MAP
Sbjct: 129 LH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL---DSTLGRRNTFIGTPYWMAP 182

Query: 275 E-----YGREGRVSTNGDVYSFGIMLME 297
           E        +       DV+S GI  +E
Sbjct: 183 EVIACDEQPDASYDARSDVWSLGITAIE 210

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 69.3 bits (169), Expect = 2e-13
 Identities = 71/243 (29%), Positives = 108/243 (44%), Gaps = 44/243 (18%)

Query: 98  GKPLPNDANMPPLIGKGGFGSVYKAII--------QDGMEVAVKVF-DPQYEGAFKSFDI 148
           GKPL          G+G FG V  A          ++ + VAVK+  D   E        
Sbjct: 20  GKPL----------GEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVS 69

Query: 149 ECDVMKRIC-HRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLS-----NYILDI--- 199
           E ++MK I  H+N+I ++ + + D    +++EY   G+L + L         Y  DI   
Sbjct: 70  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARV 129

Query: 200 ------FQRL-DIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP 252
                 F+ L      VA  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ 
Sbjct: 130 PDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARD 186

Query: 253 LLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTK------PTD 306
           +   D     T     + +MAPE   +   +   DV+SFG+++ EIFT         P +
Sbjct: 187 VNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 246

Query: 307 EIF 309
           E+F
Sbjct: 247 ELF 249

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 69.2 bits (169), Expect = 2e-13
 Identities = 59/231 (25%), Positives = 106/231 (45%), Gaps = 22/231 (9%)

Query: 111 IGKGGFGSVYKAII-----QDGMEVAVKVFDPQYEGA-FKSFDIECDVMKRICHRNLIKI 164
           +G+G FG V            G +VAVK   P+  G        E ++++ + H N++K 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 165 --ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSA 222
             I +    +   L++E++P GSL++ L  +   +++ Q+L   + +   ++YL    S 
Sbjct: 72  KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SR 128

Query: 223 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL-ATIGYMAPEYGREGR 281
             +H DL   NVL++      + DFG+ K +  + +  T    L + + + APE   + +
Sbjct: 129 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSK 188

Query: 282 VSTNGDVYSFGIMLMEIFT----RTKPTDEIFS------GEMTLKRWVNDL 322
                DV+SFG+ L E+ T     + P            G+MT+ R V  L
Sbjct: 189 FYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL 239

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 68.9 bits (168), Expect = 3e-13
 Identities = 63/213 (29%), Positives = 98/213 (46%), Gaps = 25/213 (11%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKV--FDPQYEGAFKSFD-IECDV--MKRICHRNLIK 163
           L+G+G FG VY    +  G E+A K   FDP+     K    +EC++  +K + H  +++
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68

Query: 164 IISSYSNDDFKALV--LEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYS 221
                 +   K L   +EYMP GS++  L     + +   R      +   + YLH   S
Sbjct: 69  YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTR-KYTRQILEGMSYLH---S 124

Query: 222 APIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGY-MAPE----- 275
             I+H D+K +N+L D      L DFG +K L     S T  +++    Y M+PE     
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGE 184

Query: 276 -YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDE 307
            YGR+       DV+S G  ++E+ T   P  E
Sbjct: 185 GYGRK------ADVWSLGCTVVEMLTEKPPWAE 211

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 70.6 bits (173), Expect = 3e-13
 Identities = 54/188 (28%), Positives = 89/188 (47%), Gaps = 16/188 (8%)

Query: 125 QDGMEVAVKVF---DPQYEGAFKSFDIECDVMKRICHRNLIKIISS-YSNDDFKALVLEY 180
             G EVA+K+     P+ E     F  E  +  R+ H N++ ++ S  +       V EY
Sbjct: 1   MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60

Query: 181 MPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL---D 237
           +P  +L + L  ++  L   +   +M+ V  AL   H   +  I+H DLKP N+++    
Sbjct: 61  VPGRTLREVL-AADGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTG 116

Query: 238 DNMVAHLSDFGMAK--PLLEEDQSLTQTQT---LATIGYMAPEYGREGRVSTNGDVYSFG 292
               A + DFG+    P + +    T T+T   L T  Y APE  R   V+ N D+Y++G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176

Query: 293 IMLMEIFT 300
           ++ +E  T
Sbjct: 177 LIFLECLT 184

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 68.4 bits (167), Expect = 5e-13
 Identities = 62/241 (25%), Positives = 110/241 (45%), Gaps = 49/241 (20%)

Query: 111 IGKGGFGSVYKAIIQDGME-----------------VAVKVFDPQY-EGAFKSFDIECDV 152
           +G+G FG V+   + +  +                 VAVK+  P   + A   F  E  +
Sbjct: 13  LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72

Query: 153 MKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILD-------------- 198
           + R+   N+I+++    ++D   ++ EYM +G L +  +LS++ LD              
Sbjct: 73  LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ--FLSSHHLDDKEENGNDAVPPAH 130

Query: 199 -----IFQRL-DIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP 252
                 +  L  + + +AS ++YL    S   +H DL   N L+ +N+   ++DFGM++ 
Sbjct: 131 CLPAISYSSLLHVALQIASGMKYLS---SLNFVHRDLATRNCLVGENLTIKIADFGMSRN 187

Query: 253 LLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT--RTKP----TD 306
           L   D    Q + +  I +MA E    G+ +T  DV++FG+ L EI    + +P    TD
Sbjct: 188 LYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTD 247

Query: 307 E 307
           E
Sbjct: 248 E 248

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 68.3 bits (167), Expect = 5e-13
 Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 27/204 (13%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKV--FDPQYEGAFKSFDIECDVMKRICHRNLIKIISS 167
           IG+G +G VYKA     G  VA+K    D + EG   +   E  ++K + H N++K++  
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67

Query: 168 YSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASA-----LEYLHFGYSA 222
              ++   LV E++ H  L+K        +D      I + +  +     L+ L F +S 
Sbjct: 68  IHTENKLYLVFEFL-HQDLKK-------FMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119

Query: 223 PIIHCDLKPSNVLLDDNMVAHLSDFGMAK----PLLEEDQSLTQTQTLATIGYMAPEYGR 278
            ++H DLKP N+L++      L+DFG+A+    P+       T T  + T+ Y APE   
Sbjct: 120 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV------RTYTHEVVTLWYRAPEILL 173

Query: 279 EGRV-STNGDVYSFGIMLMEIFTR 301
             +  ST  D++S G +  E+ TR
Sbjct: 174 GCKYYSTAVDIWSLGCIFAEMVTR 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 68.3 bits (167), Expect = 5e-13
 Identities = 52/199 (26%), Positives = 89/199 (44%), Gaps = 12/199 (6%)

Query: 111 IGKGGFGSVYKAII------QDGMEVAVKVFDPQYEGAFK-SFDIECDVMKRI-CHRNLI 162
           +G G FG V +A           M+VAVK+  P    + + +   E  +M  +  H N++
Sbjct: 43  LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102

Query: 163 KIISSYSNDDFKALVLEYMPHGSLEKCLYL-SNYILDIFQRLDIMIDVASALEYLHFGYS 221
            ++ + +      ++ EY  +G L   L       L +   L     VA  + +L    S
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---S 159

Query: 222 APIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGR 281
              IH DL   NVLL    +  + DFG+A+ ++ +   + +      + +MAPE      
Sbjct: 160 KNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV 219

Query: 282 VSTNGDVYSFGIMLMEIFT 300
            +   DV+S+GI+L EIF+
Sbjct: 220 YTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 67.6 bits (165), Expect = 6e-13
 Identities = 48/200 (24%), Positives = 95/200 (47%), Gaps = 17/200 (8%)

Query: 110 LIGKGGFGSVYKAIIQ----DGMEVAVKVF-DPQYEGAFKSFDIECDVMKRICHRNLIKI 164
           ++G G FG + +  ++      + VA+        +   + F  E   + +  H N++++
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71

Query: 165 ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYL-HFGYSAP 223
               +  +   +V EYM +G+L+  L      L   Q + ++  +AS ++YL   GY   
Sbjct: 72  EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGY--- 128

Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL---ATIGYMAPEYGREG 280
            +H  L    VL++ ++V  +S F      L+ED+S     T+   + + + APE  +  
Sbjct: 129 -VHKGLAAHKVLVNSDLVCKISGFRR----LQEDKSEAIYTTMSGKSPVLWAAPEAIQYH 183

Query: 281 RVSTNGDVYSFGIMLMEIFT 300
             S+  DV+SFGI++ E+ +
Sbjct: 184 HFSSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 68.5 bits (168), Expect = 7e-13
 Identities = 69/232 (29%), Positives = 104/232 (44%), Gaps = 61/232 (26%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFD---------IECDVMKRICHR 159
            IG+G +G V  A     G++VA+K   P        F+          E  +++R  H 
Sbjct: 12  YIGEGAYGMVCSATHKPTGVKVAIKKISP--------FEHQTFCQRTLREIKILRRFKHE 63

Query: 160 NLIKI---ISSYSNDDFKA--LVLEYMPHGSLEKCLY---LSN----YILDIFQRLDIMI 207
           N+I I   I   S + F    +V E M    L K +    LSN    Y   ++Q L    
Sbjct: 64  NIIGILDIIRPPSFESFNDVYIVQELME-TDLYKLIKTQHLSNDHIQYF--LYQIL---- 116

Query: 208 DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAK-PLLEEDQSLTQTQTL 266
                L+Y+H   SA ++H DLKPSN+LL+ N    + DFG+A+    E D +   T+ +
Sbjct: 117 ---RGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYV 170

Query: 267 ATIGYMAPE-------YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSG 311
           AT  Y APE       Y      +   D++S G +L E+ +  +P   +F G
Sbjct: 171 ATRWYRAPEIMLNSKGY------TKAIDIWSVGCILAEMLSN-RP---LFPG 212

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 67.7 bits (165), Expect = 7e-13
 Identities = 55/199 (27%), Positives = 95/199 (47%), Gaps = 11/199 (5%)

Query: 111 IGKGGFGSVYKAIIQD-GMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKIIS 166
           +GKGGFG V    +++ G   A K  D +    +   K   +E ++++++    ++ +  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 167 SYSNDDFKALVLEYMPHGSLEKCLY-LSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
           ++ +     LV+  M  G L+  +Y +    L++ + +     +   + +LH   S  I+
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIV 117

Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
           + D+KP NVLLDD     LSD G+A   +E     T TQ   T GYMAPE  +E   S  
Sbjct: 118 YRDMKPENVLLDDQGNCRLSDLGLA---VELKDGKTITQRAGTNGYMAPEILKEEPYSYP 174

Query: 286 GDVYSFGIMLMEIFTRTKP 304
            D ++ G  + E+     P
Sbjct: 175 VDWFAMGCSIYEMVAGRTP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 67.4 bits (164), Expect = 7e-13
 Identities = 65/225 (28%), Positives = 105/225 (46%), Gaps = 33/225 (14%)

Query: 102 PNDANMPPLIGKGGFGSVYKAIIQD-GMEVAVKV--FDPQYEGAFKSFD-IECDV--MKR 155
           P +  +  L+G+G FG VY     D G E+AVK   FDP  +   K  + +EC++  +K 
Sbjct: 1   PVNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKN 60

Query: 156 ICHRNLIKIISSYSNDDFKALVL--EYMPHGSLEKCL----YLSNYILDIFQRLDIMIDV 209
           + H  +++      + + K L +  EYMP GS++  L     L+  +   + R      +
Sbjct: 61  LRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTR-----QI 115

Query: 210 ASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATI 269
              + YLH   S  I+H D+K +N+L D      L DFG +K +     S T  +++   
Sbjct: 116 LQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGT 172

Query: 270 GY-MAPE------YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDE 307
            Y M+PE      YGR+       DV+S    ++E+ T   P  E
Sbjct: 173 PYWMSPEVISGEGYGRK------ADVWSVACTVVEMLTEKPPWAE 211

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 68.5 bits (167), Expect = 8e-13
 Identities = 71/225 (31%), Positives = 111/225 (49%), Gaps = 31/225 (13%)

Query: 110 LIGKGGFGSVYKAIIQDGME-VAVK--VFDPQYEGAFKSFDIECDVMKRICHRNLIKIIS 166
           +IG G FG VY+AI  D  E VA+K  + DPQY+      + E  +MK + H N+I +  
Sbjct: 73  IIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYK------NRELLIMKNLNHINIIFLKD 126

Query: 167 SYSNDDFKA--------LVLEYMPHGSLEKCLYLS--NYILDIFQRLDIMIDVASALEYL 216
            Y  + FK         +V+E++P    +   + +  N+ L +F        +  AL Y+
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYI 186

Query: 217 HFGYSAPIIHCDLKPSNVLLDDNM-VAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE 275
           H   S  I H DLKP N+L+D N     L DFG AK LL   +S++    + +  Y APE
Sbjct: 187 H---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSY---ICSRFYRAPE 240

Query: 276 YGR-EGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV 319
                   +T+ D++S G ++ E+         IFSG+ ++ + V
Sbjct: 241 LMLGATNYTTHIDLWSLGCIIAEMILGYP----IFSGQSSVDQLV 281

Length = 440

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 67.4 bits (164), Expect = 9e-13
 Identities = 57/212 (26%), Positives = 99/212 (46%), Gaps = 11/212 (5%)

Query: 111 IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYS 169
           +G G FG VYKA  ++ G+  A KV D + E   + + +E D++    H N++K++ ++ 
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 170 NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
            ++   +++E+   G+++  +      L   Q   +      AL YLH      IIH DL
Sbjct: 73  YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDL 129

Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEY-----GREGRVST 284
           K  N+L   +    L+DFG++       Q   +   + T  +MAPE       ++     
Sbjct: 130 KAGNILFTLDGDIKLADFGVSAKNTRTIQR--RDSFIGTPYWMAPEVVMCETSKDRPYDY 187

Query: 285 NGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLK 316
             DV+S GI L+E+     P  E+    + LK
Sbjct: 188 KADVWSLGITLIEMAQIEPPHHELNPMRVLLK 219

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 67.4 bits (165), Expect = 1e-12
 Identities = 64/225 (28%), Positives = 98/225 (43%), Gaps = 47/225 (20%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDI---------ECDVMKRICHRN 160
           IG G +G V  AI  + G +VA+K           +FD+         E  +++   H N
Sbjct: 13  IGSGAYGVVCSAIDTRSGKKVAIKKIP-------HAFDVPTLAKRTLRELKILRHFKHDN 65

Query: 161 LIKI--ISSYSNDDFKA--LVLEYMP-------HGSLEKCLYLSNYILDIFQRLDIMIDV 209
           +I I  I      DFK   +V++ M        H           Y L  +Q L      
Sbjct: 66  IIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFL--YQLL------ 117

Query: 210 ASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE--EDQSLTQTQTLA 267
              L+Y+H   SA +IH DLKPSN+L++++    + DFGMA+ L     +     T+ +A
Sbjct: 118 -RGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA 173

Query: 268 TIGYMAPEYGRE-GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSG 311
           T  Y APE        +T  D++S G +  E+  R     ++F G
Sbjct: 174 TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRR----QLFPG 214

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 66.5 bits (162), Expect = 1e-12
 Identities = 52/199 (26%), Positives = 95/199 (47%), Gaps = 14/199 (7%)

Query: 110 LIGKGGFGSVYKAI-IQDG----MEVAVKVFDPQYEGAFKSFDIECDVMKRIC---HRNL 161
           L+G G FG+V+K I I +G    + VA+K    Q     ++F    D M  +    H  +
Sbjct: 14  LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTI--QDRSGRQTFQEITDHMLAMGSLDHAYI 71

Query: 162 IKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYS 221
           ++++        + LV +  P GSL   +      LD  + L+  + +A  + YL     
Sbjct: 72  VRLLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---E 127

Query: 222 APIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGR 281
             ++H +L   N+LL  + +  ++DFG+A  L  +D+    ++    I +MA E    GR
Sbjct: 128 HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGR 187

Query: 282 VSTNGDVYSFGIMLMEIFT 300
            +   DV+S+G+ + E+ +
Sbjct: 188 YTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 66.5 bits (163), Expect = 2e-12
 Identities = 60/217 (27%), Positives = 105/217 (48%), Gaps = 27/217 (12%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVK-VFDPQYEGAFKSFDI-ECDVMKRIC---HRNLIK 163
            IG+G +G+VYKA  +  G  VA+K V  P  E       + E  ++K++    H N+++
Sbjct: 6   EIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVR 65

Query: 164 IIS-SYSNDDFK----ALVLEYMP---HGSLEKCLYLSNYILDIFQRLDIMIDVASALEY 215
           ++   +     +     LV E++       L KC       L      D+M  +   +++
Sbjct: 66  LLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKC---PKPGLPPETIKDLMRQLLRGVDF 122

Query: 216 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE 275
           LH   S  I+H DLKP N+L+  +    ++DFG+A+ +   + +L  T  + T+ Y APE
Sbjct: 123 LH---SHRIVHRDLKPQNILVTSDGQVKIADFGLAR-IYSFEMAL--TSVVVTLWYRAPE 176

Query: 276 YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE 312
              +   +T  D++S G +  E+F R +P   +F G 
Sbjct: 177 VLLQSSYATPVDMWSVGCIFAELFRR-RP---LFRGT 209

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 67.4 bits (164), Expect = 2e-12
 Identities = 69/243 (28%), Positives = 106/243 (43%), Gaps = 44/243 (18%)

Query: 98  GKPLPNDANMPPLIGKGGFGSVYKA----IIQD----GMEVAVKVF-DPQYEGAFKSFDI 148
           GKPL          G+G FG V  A    I +D     + VAVK+  D   +        
Sbjct: 17  GKPL----------GEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVS 66

Query: 149 ECDVMKRIC-HRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLY---------------L 192
           E ++MK I  H+N+I ++ + + D    +++EY   G+L + L                L
Sbjct: 67  EMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKL 126

Query: 193 SNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP 252
               L     +     VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ 
Sbjct: 127 PEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVTEDNVMKIADFGLARD 183

Query: 253 LLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTK------PTD 306
           +   D     T     + +MAPE   +   +   DV+SFG++L EIFT         P +
Sbjct: 184 VHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 243

Query: 307 EIF 309
           E+F
Sbjct: 244 ELF 246

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 66.7 bits (163), Expect = 2e-12
 Identities = 59/203 (29%), Positives = 97/203 (47%), Gaps = 26/203 (12%)

Query: 110 LIGKGGFGSVYKAIIQD-GMEVAVKVF-DPQYEGAFKSFDI-ECDVMKRICHRNLIKIIS 166
           L+G+G +G V K   ++ G  VA+K F + + +   K   + E  ++K++ H NL+ +I 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 167 SYSNDDFKALVLEYMPHGSLEKCLYLSNYI--LDIFQRLDIMIDVASALEYLHFGYSAPI 224
            +       LV E++ H  L+    L  Y   LD  +    +  +   +E+ H   S  I
Sbjct: 68  VFRRKKRLYLVFEFVDHTVLDD---LEKYPNGLDESRVRKYLFQILRGIEFCH---SHNI 121

Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE-------YG 277
           IH D+KP N+L+  + V  L DFG A+ L    +    T  +AT  Y APE       YG
Sbjct: 122 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY--TDYVATRWYRAPELLVGDTKYG 179

Query: 278 REGRVSTNGDVYSFGIMLMEIFT 300
           R        D+++ G ++ E+ T
Sbjct: 180 RA------VDIWAVGCLVTEMLT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 66.4 bits (162), Expect = 2e-12
 Identities = 61/217 (28%), Positives = 107/217 (49%), Gaps = 44/217 (20%)

Query: 110 LIGKGGFGSVY---KAIIQD-GMEVAVKVFDPQYEGAFKSFD-----IECDVMKRICHRN 160
           ++G+G FG V+   K    D G   A+KV     +   K  D     +E D++  + H  
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVLK---KATLKVRDRVRTKMERDILAEVNHPF 59

Query: 161 LIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL--DIMI----------D 208
           ++K+  ++  +    L+L+++  G             D+F RL  ++M           +
Sbjct: 60  IVKLHYAFQTEGKLYLILDFLRGG-------------DLFTRLSKEVMFTEEDVKFYLAE 106

Query: 209 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 268
           +A AL++LH   S  II+ DLKP N+LLD+     L+DFG++K  ++ ++         T
Sbjct: 107 LALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCGT 161

Query: 269 IGYMAPE-YGREGRVSTNGDVYSFGIMLMEIFTRTKP 304
           + YMAPE   R G  + + D +SFG+++ E+ T + P
Sbjct: 162 VEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGSLP 197

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 66.1 bits (161), Expect = 3e-12
 Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 31/218 (14%)

Query: 111 IGKGGFGSVY-----------------KAIIQDGMEVAVKVF-DPQYEGAFKSFDIECDV 152
           +G+G FG V+                        + VAVK+  +   + A   F  E  +
Sbjct: 13  LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72

Query: 153 MKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCL---------YLSNYILDIFQRL 203
           M R+   N+I++++     D   ++ EYM +G L + L           ++ +   +  L
Sbjct: 73  MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132

Query: 204 DIM-IDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ 262
             M   +AS ++YL    S   +H DL   N L+  N    ++DFGM++ L   D    Q
Sbjct: 133 IFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189

Query: 263 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
            + +  I +M+ E    G+ +T  DV++FG+ L EI T
Sbjct: 190 GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 65.8 bits (160), Expect = 3e-12
 Identities = 53/200 (26%), Positives = 93/200 (46%), Gaps = 11/200 (5%)

Query: 110 LIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDI---ECDVMKRICHRNLIKII 165
           ++GKGGFG V    ++  G   A K  + +     K   +   E  +++++  + ++ + 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLA 66

Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLY-LSNYILDIFQRLDIMIDVASALEYLHFGYSAPI 224
            +Y   D   LVL  M  G L+  +Y + N   +  + L    ++   LE LH       
Sbjct: 67  YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENT 123

Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVST 284
           ++ DLKP N+LLDD     +SD G+A  + E +    +   + T+GYMAPE     R + 
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR---VGTVGYMAPEVLNNQRYTL 180

Query: 285 NGDVYSFGIMLMEIFTRTKP 304
           + D +  G ++ E+     P
Sbjct: 181 SPDYWGLGCLIYEMIEGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 65.7 bits (160), Expect = 3e-12
 Identities = 60/216 (27%), Positives = 99/216 (45%), Gaps = 32/216 (14%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRI---------CHRN 160
           +G G  G+VYKA  +     +AVKV            DI  ++ K+I         C   
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVI---------PLDITVELQKQIMSELEILYKCDSP 59

Query: 161 -LIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFG 219
            +I    ++  ++  ++  E+M  GSL+    +  ++L       I + V   L YL   
Sbjct: 60  YIIGFYGAFFVENRISICTEFMDGGSLDVYRKIPEHVLG-----RIAVAVVKGLTYL--- 111

Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
           +S  I+H D+KPSN+L++      L DFG++  L+    S+ +T  + T  YMAPE    
Sbjct: 112 WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV---NSIAKTY-VGTNAYMAPERISG 167

Query: 280 GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTL 315
            +   + DV+S GI  ME+     P  +I   + +L
Sbjct: 168 EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL 203

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 65.5 bits (159), Expect = 4e-12
 Identities = 55/201 (27%), Positives = 93/201 (46%), Gaps = 16/201 (7%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYS 169
           IG G +G VYKA  +  G   A+KV   +    F     E  +MK   H N++    SY 
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76

Query: 170 NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
             D   + +E+   GSL+   +++  +        I       L+ L++ +S   +H D+
Sbjct: 77  RRDKLWICMEFCGGGSLQDIYHVTGPL----SESQIAYVSRETLQGLYYLHSKGKMHRDI 132

Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG---YMAPEYG---REGRVS 283
           K +N+LL DN    L+DFG++  +     + T  +  + IG   +MAPE     R+G  +
Sbjct: 133 KGANILLTDNGHVKLADFGVSAQI-----TATIAKRKSFIGTPYWMAPEVAAVERKGGYN 187

Query: 284 TNGDVYSFGIMLMEIFTRTKP 304
              D+++ GI  +E+     P
Sbjct: 188 QLCDIWAVGITAIELAELQPP 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 65.8 bits (161), Expect = 5e-12
 Identities = 50/187 (26%), Positives = 84/187 (44%), Gaps = 31/187 (16%)

Query: 111 IGKGGFGSVYKAIIQ---DGMEVAVKVFDP---QYEGAFKSFDIECDVMKRICHRNLIKI 164
           IG+G +G VYKA  +   DG E A+K F     QY G  +S   E  +++ + H N++ +
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67

Query: 165 ISSYSNDDFKA--LVLEYMPHGSLEKCLYLSNYILDIFQRL---DIMIDVASALEYLHFG 219
           +  +     K+  L+ +Y  H   +   +                ++  + + + YLH  
Sbjct: 68  VEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH-- 125

Query: 220 YSAPIIHCDLKPSNVLL----DDNMVAHLSDFGMA-------KPLLEEDQSLTQTQTLAT 268
            S  ++H DLKP+N+L+     +  V  + D G+A       KPL + D        + T
Sbjct: 126 -SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD------PVVVT 178

Query: 269 IGYMAPE 275
           I Y APE
Sbjct: 179 IWYRAPE 185

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 64.8 bits (158), Expect = 5e-12
 Identities = 54/210 (25%), Positives = 88/210 (41%), Gaps = 22/210 (10%)

Query: 111 IGKGGFGSVYKA-IIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHR-----NLIKI 164
           I KG FGSVY A     G   A+KV   + +   K+        + I         + K+
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVL-KKSDMIAKNQVTNVKAERAIMMIQGESPYVAKL 62

Query: 165 ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPI 224
             S+ + D+  LV+EY+  G     +     + + + +   + +V   +E LH      I
Sbjct: 63  YYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAK-QYIAEVVLGVEDLH---QRGI 118

Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVST 284
           IH D+KP N+L+D      L+DFG+++  LE        + + T  Y+APE         
Sbjct: 119 IHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKKFVGTPDYLAPETILGVGDDK 172

Query: 285 NGDVYSFGIMLMEIFTRTKP-----TDEIF 309
             D +S G ++ E      P      D +F
Sbjct: 173 MSDWWSLGCVIFEFLFGYPPFHAETPDAVF 202

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 65.4 bits (159), Expect = 5e-12
 Identities = 67/228 (29%), Positives = 101/228 (44%), Gaps = 38/228 (16%)

Query: 98  GKPLPNDANMPPLIGKGGFGSVY--KAIIQDG------MEVAVKVFDPQ-YEGAFKSFDI 148
           GKPL          G+G FG V   +AI  D        +VAVK+      E        
Sbjct: 23  GKPL----------GEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLIS 72

Query: 149 ECDVMKRIC-HRNLIKIISSYSNDDFKALVLEYMPHGSLEKCL---------YLSN---- 194
           E ++MK I  H+N+I ++ + + D    +++EY   G+L + L         Y  N    
Sbjct: 73  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQV 132

Query: 195 --YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP 252
               L     +     VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ 
Sbjct: 133 PEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARD 189

Query: 253 LLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
           +   D     T     + +MAPE   +   +   DV+SFG++L EIFT
Sbjct: 190 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 64.8 bits (158), Expect = 9e-12
 Identities = 65/193 (33%), Positives = 89/193 (46%), Gaps = 11/193 (5%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQY---EGAFKSFDIECDVM-KRICHRNLIKII 165
           IGKG FG V  A    DG   AVKV   +    +   K    E +V+ K + H  L+ + 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
            S+   D    VL+Y+  G L   L       +   R     ++ASAL YLH   S  II
Sbjct: 63  YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASALGYLH---SLNII 118

Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
           + DLKP N+LLD      L+DFG+ K  +E   S T +    T  Y+APE  R+      
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCKEGIE--HSKTTSTFCGTPEYLAPEVLRKQPYDRT 176

Query: 286 GDVYSFGIMLMEI 298
            D +  G +L E+
Sbjct: 177 VDWWCLGAVLYEM 189

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 64.6 bits (157), Expect = 1e-11
 Identities = 69/244 (28%), Positives = 110/244 (45%), Gaps = 44/244 (18%)

Query: 98  GKPLPNDANMPPLIGKGGFGSVYKA----IIQDGME----VAVKVF-DPQYEGAFKSFDI 148
           GKPL          G+G FG V +A    I +   +    VAVK+  D   +        
Sbjct: 17  GKPL----------GEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLIS 66

Query: 149 ECDVMKRIC-HRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLS-----NYILDI--- 199
           E ++MK I  H+N+I ++   + +    +++EY   G+L + L        +Y  DI   
Sbjct: 67  EMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKV 126

Query: 200 ------FQRL-DIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP 252
                 F+ L      VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ 
Sbjct: 127 PEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARG 183

Query: 253 LLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTK------PTD 306
           + + D     +     + +MAPE   +   +   DV+SFGI++ EIFT         P +
Sbjct: 184 VHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE 243

Query: 307 EIFS 310
           E+F 
Sbjct: 244 ELFK 247

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 64.3 bits (157), Expect = 1e-11
 Identities = 55/216 (25%), Positives = 98/216 (45%), Gaps = 38/216 (17%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDI----ECDVMKRICHRNLIKII 165
           IG+G FG V+KA   +    VA+K      E   + F I    E  +++ + H N++ +I
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKV--LMENEKEGFPITALREIKILQLLKHENVVNLI 77

Query: 166 -------SSYSNDDFKA---LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEY 215
                  + Y+   +K    LV E+  H  L   L   N    + +   +M  + + L Y
Sbjct: 78  EICRTKATPYNR--YKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYY 134

Query: 216 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP--LLEEDQSLTQTQTLATIGYMA 273
           +H      I+H D+K +N+L+  + +  L+DFG+A+   L +  +    T  + T+ Y  
Sbjct: 135 IHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRP 191

Query: 274 PE-------YGREGRVSTNGDVYSFGIMLMEIFTRT 302
           PE       YG         D++  G ++ E++TR+
Sbjct: 192 PELLLGERDYG------PPIDMWGAGCIMAEMWTRS 221

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 63.6 bits (155), Expect = 1e-11
 Identities = 40/156 (25%), Positives = 80/156 (51%), Gaps = 6/156 (3%)

Query: 149 ECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSL-EKCLYLSNYILDIFQRLDIMI 207
           E  ++  + H N+I   + + +D+   + +EY   G+L +K +     + +    L  + 
Sbjct: 49  EIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLF 108

Query: 208 DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA 267
            + SA+ Y+H    A I+H D+K  N+ L    +  L DFG++K +L  + S+ +T  + 
Sbjct: 109 QIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISK-ILGSEYSMAET-VVG 163

Query: 268 TIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTK 303
           T  YM+PE  +  + +   D+++ G +L E+ T  +
Sbjct: 164 TPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKR 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 64.3 bits (157), Expect = 1e-11
 Identities = 64/231 (27%), Positives = 105/231 (45%), Gaps = 45/231 (19%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVK--VFDPQYEGAFKSFDI----ECDVMKRICHRNLIK 163
           +G+G FG VYKA  I+ G  VA+K  +   + +G    F I    E  ++K++ H N++ 
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG----FPITALREIKILKKLKHPNVVP 71

Query: 164 IIS---SYSNDDFKA-----LVLEYMPH---GSLEKCLYLSNYILDIFQRLDIMIDVASA 212
           +I       +   +      +V  YM H   G LE      +  L   Q    M+ +   
Sbjct: 72  LIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLEN----PSVKLTESQIKCYMLQLLEG 127

Query: 213 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ---------T 263
           + YLH      I+H D+K +N+L+D+  +  ++DFG+A+P      +            T
Sbjct: 128 INYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYT 184

Query: 264 QTLATIGYMAPEY--GREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE 312
             + T  Y  PE   G E R +T  D++  G +  E+FTR +P   I  G+
Sbjct: 185 NLVVTRWYRPPELLLG-ERRYTTAVDIWGIGCVFAEMFTR-RP---ILQGK 230

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 76/264 (28%), Positives = 118/264 (44%), Gaps = 59/264 (22%)

Query: 107 MPPL-IGKGGFGSVYKAIIQD-GMEVAVK----VFDPQYEGAFKSFDIECDVMKRICHRN 160
           +P   IG+G +G V  A   +   +VA+K     FD + +   K    E  +++ + H N
Sbjct: 8   VPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDA--KRTLREIKLLRHLDHEN 65

Query: 161 LIK---IISSYSNDDFKA--LVLEYMP---HGSLEKCLYLSN----YILDIFQRLDIMID 208
           +I    I+     + F    +V E M    H  +     LS+    Y L  +Q L     
Sbjct: 66  VIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFL--YQLL----- 118

Query: 209 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 268
               L+Y+H   SA ++H DLKPSN+LL+ N    + DFG+A+   E+   +  T+ + T
Sbjct: 119 --RGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFM--TEYVVT 171

Query: 269 IGYMAPE-------YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVND 321
             Y APE       Y       T  DV+S G +  E+  R KP   +F G    K +V+ 
Sbjct: 172 RWYRAPELLLNCSEYT------TAIDVWSVGCIFAELLGR-KP---LFPG----KDYVHQ 217

Query: 322 LLPISVMEVVDANLLSQEDEHFTT 345
           L  I   E++ +   S+ED  F  
Sbjct: 218 LKLI--TELLGSP--SEEDLGFIR 237

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 63.4 bits (154), Expect = 2e-11
 Identities = 51/195 (26%), Positives = 96/195 (49%), Gaps = 9/195 (4%)

Query: 111 IGKGGFGSVYKAIIQ---DGMEVAVKVFDPQYEGAFKSFDI-ECDVMKRICHRNLIKIIS 166
           +G G FG V K + +     ++VA+KV   + E + +   + E ++M ++ +  ++++I 
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 167 SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIH 226
               +    LV+E    G L K L      + +   +++M  V+  ++YL        +H
Sbjct: 63  VCEAEAL-MLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVH 118

Query: 227 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT-QTQTLATIGYMAPEYGREGRVSTN 285
            DL   NVLL +   A +SDFG++K L  +D     ++     + + APE     + S+ 
Sbjct: 119 RDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSR 178

Query: 286 GDVYSFGIMLMEIFT 300
            DV+S+GI + E F+
Sbjct: 179 SDVWSYGITMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 63.9 bits (156), Expect = 2e-11
 Identities = 50/218 (22%), Positives = 89/218 (40%), Gaps = 28/218 (12%)

Query: 110 LIGK----GGFGSVYKAIIQDGMEVAVKVF--DPQYEGAFKSFDIECDVMKRICHRNLIK 163
           LIGK         + K    + + VAVK    D   +   K    E    +++ H N++ 
Sbjct: 5   LIGKCFEDLMIVHLAKHKPTNTL-VAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63

Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDI---MIDVASALEYLHFGY 220
            ++S+  D    +V   M +GS E    L  +  +    L I   + DV +AL+Y+H   
Sbjct: 64  YVTSFIVDSELYVVSPLMAYGSCE--DLLKTHFPEGLPELAIAFILKDVLNALDYIH--- 118

Query: 221 SAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ-----TQTLATIGYMAPE 275
           S   IH  +K S++LL  +    LS    +  +++  +           ++  + +++PE
Sbjct: 119 SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPE 178

Query: 276 YGREGRVSTN--GDVYSFGIMLMEI------FTRTKPT 305
             ++     N   D+YS GI   E+      F     T
Sbjct: 179 VLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT 216

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 63.9 bits (156), Expect = 2e-11
 Identities = 55/190 (28%), Positives = 91/190 (47%), Gaps = 32/190 (16%)

Query: 101 LPNDANMPPLIGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAF--KSFDIECDVMKRIC 157
           +P+       +G G +G V  A     G +VA+K     ++ A   K    E  ++K + 
Sbjct: 13  VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMD 72

Query: 158 HRNLIKIISSY----SNDDFKA--LVLEYMPH--GSLEKCLYLSN----YILDIFQRLDI 205
           H N+I ++  +    S +DF+   LV   M     ++ KC  LS+    ++  ++Q L  
Sbjct: 73  HENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFL--VYQIL-- 128

Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
                  L+Y+H   SA IIH DLKPSN+ ++++    + DFG+A+   +E      T  
Sbjct: 129 -----RGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-----MTGY 175

Query: 266 LATIGYMAPE 275
           +AT  Y APE
Sbjct: 176 VATRWYRAPE 185

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 63.7 bits (155), Expect = 2e-11
 Identities = 55/217 (25%), Positives = 97/217 (44%), Gaps = 27/217 (12%)

Query: 149 ECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYI-LDIFQRLDIMI 207
           E  +M       ++    ++ N++   + +E+M  GSL++       I ++I  +  I +
Sbjct: 53  ELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGK--IAV 110

Query: 208 DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA 267
            V   L YL+      I+H D+KPSN+L++      L DFG++  L+    S+  T  + 
Sbjct: 111 AVVEGLTYLY--NVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI---NSIADT-FVG 164

Query: 268 TIGYMAPEYGREGRVSTNGDVYSFGIMLMEI------FTRTKPTDEIFSGEMT----LKR 317
           T  YM+PE  + G+ +   DV+S GI ++E+      F  +   D+     M     L++
Sbjct: 165 TSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQ 224

Query: 318 WVN--------DLLPISVMEVVDANLLSQEDEHFTTK 346
            V            P  + + VDA LL    E  T +
Sbjct: 225 IVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQ 261

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 63.7 bits (155), Expect = 2e-11
 Identities = 58/235 (24%), Positives = 100/235 (42%), Gaps = 32/235 (13%)

Query: 104 DANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFD---IECDVMKRICHR 159
           D  M   +G G FG V  A  +  G   A+K    +     K       E  ++  + H 
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78

Query: 160 NLIKIISSYSNDDFKALVLEYMPHGS----LEKCLYLSNYILDIFQRLDIMIDVASALEY 215
            ++ ++ S+ +++    +LE++  G     L K     N +   +       ++  A EY
Sbjct: 79  FIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYH-----AELVLAFEY 133

Query: 216 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL-ATIGYMAP 274
           LH   S  II+ DLKP N+LLD+     ++DFG AK + +      +T TL  T  Y+AP
Sbjct: 134 LH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD------RTFTLCGTPEYLAP 184

Query: 275 EYGREGRVSTNGDVYSFGIMLMEIF---------TRTKPTDEIFSGEMTLKRWVN 320
           E  +        D ++ G++L E           T  +  ++I +G +    W +
Sbjct: 185 EVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFD 239

Length = 329

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 63.1 bits (153), Expect = 2e-11
 Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 22/198 (11%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYS 169
           +G G +G VYKA  +  G   AVK+   +    F     E  ++K   H N++    SY 
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76

Query: 170 NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
           + +   + +EY   GSL+   +++  + ++ Q   +  +    L YLH   S   +H D+
Sbjct: 77  SREKLWICMEYCGGGSLQDIYHVTGPLSEL-QIAYVCRETLQGLAYLH---SKGKMHRDI 132

Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG---YMAPEYGREGRVSTNG 286
           K +N+LL DN    L+DFG+A  +     + T  +  + IG   +MAPE      V  NG
Sbjct: 133 KGANILLTDNGDVKLADFGVAAKI-----TATIAKRKSFIGTPYWMAPEV---AAVEKNG 184

Query: 287 ------DVYSFGIMLMEI 298
                 D+++ GI  +E+
Sbjct: 185 GYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 63.2 bits (154), Expect = 3e-11
 Identities = 62/223 (27%), Positives = 98/223 (43%), Gaps = 34/223 (15%)

Query: 104 DANMPPLIGKGGFGSVYKAIIQDGME-VAVK------VFDPQYEGAFKSFDIECDVMKRI 156
           D      +G G FG V+    +      A+K      V   + E    +   E  V+K +
Sbjct: 2   DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHN---EKRVLKEV 58

Query: 157 CHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLS---NYILDIFQRLDIMIDVASAL 213
            H  +I++  +  +  F  +++EY+P G L   L  S   +    +F   +I+     AL
Sbjct: 59  SHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIV----CAL 114

Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL-ATIGYM 272
           EYLH   S  I++ DLKP N+LLD      L+DFG AK L +      +T TL  T  Y+
Sbjct: 115 EYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD------RTWTLCGTPEYL 165

Query: 273 APE-YGREGRVSTNGDVYSFGIMLMEIFT-----RTKPTDEIF 309
           APE    +G  +   D ++ GI++ E+              I+
Sbjct: 166 APEVIQSKGH-NKAVDWWALGILIYEMLVGYPPFFDDNPFGIY 207

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 63.2 bits (154), Expect = 3e-11
 Identities = 39/106 (36%), Positives = 56/106 (52%), Gaps = 9/106 (8%)

Query: 205 IMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ 264
           I + +  ALEYLH   S  +IH D+KPSNVL++ N    L DFG++  L++   S+ +T 
Sbjct: 108 IAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD---SVAKTI 162

Query: 265 TLATIGYMAPEY----GREGRVSTNGDVYSFGIMLMEIFTRTKPTD 306
                 YMAPE       +       DV+S GI ++E+ T   P D
Sbjct: 163 DAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 62.9 bits (153), Expect = 3e-11
 Identities = 56/201 (27%), Positives = 97/201 (48%), Gaps = 13/201 (6%)

Query: 110 LIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY----EGAFKSFDIECDVMKRICHRNLIKI 164
           ++GKGGFG V    ++  G   A K  + +     +G   + + E  +++++  R ++ +
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALN-EKQILEKVNSRFVVSL 65

Query: 165 ISSYSNDDFKALVLEYMPHGSLEKCLY-LSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
             +Y   D   LVL  M  G L+  +Y + N   D  + +    ++   LE LH      
Sbjct: 66  AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RER 122

Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVS 283
           I++ DLKP N+LLDD     +SD G+A  + E +   T    + T+GYMAPE  +  R +
Sbjct: 123 IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE---TIRGRVGTVGYMAPEVVKNERYT 179

Query: 284 TNGDVYSFGIMLMEIFTRTKP 304
            + D +  G ++ E+     P
Sbjct: 180 FSPDWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 63.1 bits (153), Expect = 3e-11
 Identities = 62/222 (27%), Positives = 106/222 (47%), Gaps = 14/222 (6%)

Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYS 169
           IG+G  G V  A  +  G +VAVK  D + +   +    E  +M+   H N++ + +SY 
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89

Query: 170 NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
             D   +V+E++  G+L   +  ++  ++  Q   + + V  AL YLH   +  +IH D+
Sbjct: 90  VGDELWVVMEFLEGGALTDIV--THTRMNEEQIATVCLSVLRALSYLH---NQGVIHRDI 144

Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 289
           K  ++LL  +    LSDFG    + +E     +   + T  +MAPE        T  D++
Sbjct: 145 KSDSILLTSDGRIKLSDFGFCAQVSKEVPK--RKSLVGTPYWMAPEVISRLPYGTEVDIW 202

Query: 290 SFGIMLMEIFTRTKPTDEIFSGEMTLK--RWVNDLLPISVME 329
           S GIM++E+     P    +  E  L+  R + D LP  V +
Sbjct: 203 SLGIMVIEMIDGEPP----YFNEPPLQAMRRIRDNLPPRVKD 240

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 63.0 bits (154), Expect = 3e-11
 Identities = 59/213 (27%), Positives = 105/213 (49%), Gaps = 26/213 (12%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVK--VFDPQYEGAFKSFDI----ECDVMKRICHRNLIK 163
           I +G +G VY+A   + G  VA+K    + + EG    F I    E +++ ++ H N++ 
Sbjct: 13  IEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEG----FPITSLREINILLKLQHPNIVT 68

Query: 164 I--ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYS 221
           +  +   SN D   +V+EY+ H  L+  +          +   +M+ + S + +LH  + 
Sbjct: 69  VKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW- 126

Query: 222 APIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE--YGRE 279
             I+H DLK SN+LL++  +  + DFG+A+      +    TQ + T+ Y APE   G  
Sbjct: 127 --ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY--TQLVVTLWYRAPELLLG-A 181

Query: 280 GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE 312
              ST  D++S G +  E+ T+      +F G+
Sbjct: 182 KEYSTAIDMWSVGCIFAELLTK----KPLFPGK 210

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 64.1 bits (156), Expect = 3e-11
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 16/210 (7%)

Query: 110 LIGKGGFGSVYKA-IIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
           +I +G  G+ YK   I++GM+  VK  +        S   +   M ++ H N++K+I   
Sbjct: 697 VISRGKKGASYKGKSIKNGMQFVVKEIN-DVNSIPSSEIAD---MGKLQHPNIVKLIGLC 752

Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCD 228
            ++    L+ EY+   +L + L   N  L   +R  I I +A AL +LH   S  ++  +
Sbjct: 753 RSEKGAYLIHEYIEGKNLSEVL--RN--LSWERRRKIAIGIAKALRFLHCRCSPAVVVGN 808

Query: 229 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDV 288
           L P  +++D     HL    +   L       T T+   +  Y+APE      ++   D+
Sbjct: 809 LSPEKIIIDGKDEPHLR-LSLPGLLC------TDTKCFISSAYVAPETRETKDITEKSDI 861

Query: 289 YSFGIMLMEIFTRTKPTDEIFSGEMTLKRW 318
           Y FG++L+E+ T   P D  F    ++  W
Sbjct: 862 YGFGLILIELLTGKSPADAEFGVHGSIVEW 891

Length = 968

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 62.3 bits (151), Expect = 4e-11
 Identities = 60/227 (26%), Positives = 105/227 (46%), Gaps = 22/227 (9%)

Query: 111 IGKGGFGSVYKA---------IIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNL 161
           IG+G FG +Y A         +I+   E+ +     + + A K    E  ++ ++ H N+
Sbjct: 8   IGEGSFGKIYLAKAKSDSEHCVIK---EIDLTKMPVKEKEASKK---EVILLAKMKHPNI 61

Query: 162 IKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYIL-DIFQRLDIMIDVASALEYLHFGY 220
           +   +S+  +    +V+EY   G L K +     +L    Q L   + ++  L+++H   
Sbjct: 62  VTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH--- 118

Query: 221 SAPIIHCDLKPSNVLLDDN-MVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
              I+H D+K  N+ L  N MVA L DFG+A+  L +   L  T  + T  Y++PE  + 
Sbjct: 119 DRKILHRDIKSQNIFLSKNGMVAKLGDFGIAR-QLNDSMELAYT-CVGTPYYLSPEICQN 176

Query: 280 GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPIS 326
              +   D++S G +L E+ T   P +     ++ LK       PIS
Sbjct: 177 RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPIS 223

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 62.7 bits (152), Expect = 4e-11
 Identities = 64/200 (32%), Positives = 93/200 (46%), Gaps = 11/200 (5%)

Query: 110 LIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVM-KRICHRNLIKI 164
           +IGKG FG V  A  + DG   AVKV   +    +        E +V+ K + H  L+ +
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61

Query: 165 ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPI 224
             S+   +    VL+Y+  G L   L      L+   R     +VASA+ YLH   S  I
Sbjct: 62  HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIGYLH---SLNI 117

Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVST 284
           I+ DLKP N+LLD      L+DFG+ K  +E ++  T +    T  Y+APE  R+     
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--TTSTFCGTPEYLAPEVLRKEPYDR 175

Query: 285 NGDVYSFGIMLMEIFTRTKP 304
             D +  G +L E+     P
Sbjct: 176 TVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 61.7 bits (150), Expect = 5e-11
 Identities = 64/250 (25%), Positives = 115/250 (46%), Gaps = 35/250 (14%)

Query: 111 IGKGGFGSVYKAIIQD---------GMEVAV--KVFDPQYEGAFKSFDIECDVMKRICHR 159
           +G+G F ++YK +++          G EV+V  KV    +     +F     +M ++ H+
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR-DSLAFFETASLMSQLSHK 61

Query: 160 NLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFG 219
           +L+K+      D+   +V EY+  G L+  L+     + +  +LD+   +ASAL YL   
Sbjct: 62  HLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE-- 118

Query: 220 YSAPIIHCDLKPSNVLL---DDNM----VAHLSDFGMAKPLLEEDQSLTQTQTLATIGYM 272
               ++H ++   N+L+     N        LSD G+   +L  ++ + +      I ++
Sbjct: 119 -DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVER------IPWI 171

Query: 273 APEYGREGRVSTN--GDVYSFGIMLMEIFTRTK-PTDEIFSGEMTLKRWVNDLLPI-SVM 328
           APE  R G+ S     D +SFG  L+EI +  + P   + S E          LP+    
Sbjct: 172 APECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPMPDCA 231

Query: 329 EVVDANLLSQ 338
           E+  ANL++Q
Sbjct: 232 EL--ANLINQ 239

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 62.0 bits (151), Expect = 6e-11
 Identities = 38/129 (29%), Positives = 61/129 (47%), Gaps = 19/129 (14%)

Query: 205 IMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ 264
           + + +  AL YL   +   +IH D+KPSN+LLD +    L DFG++  L++   S  +T+
Sbjct: 119 MTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVD---SKAKTR 173

Query: 265 TLATIGYMAPEYGREGRVSTN---------GDVYSFGIMLMEIFTRTKPTDEIFSGEMTL 315
           +     YMAPE     R+             DV+S GI L+E+ T   P     +    L
Sbjct: 174 SAGCAAYMAPE-----RIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVL 228

Query: 316 KRWVNDLLP 324
            + + +  P
Sbjct: 229 TKILQEEPP 237

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 62.3 bits (151), Expect = 7e-11
 Identities = 43/133 (32%), Positives = 68/133 (51%), Gaps = 12/133 (9%)

Query: 176 LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMI---DVASALEYLHFGYSAPIIHCDLKPS 232
           L+L+Y+  G +   LY  +     F   ++     ++  ALE+LH      I++ D+K  
Sbjct: 82  LILDYVSGGEMFTHLYQRDN----FSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLE 134

Query: 233 NVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGR-EGRVSTNGDVYSF 291
           N+LLD      L+DFG++K  L E++  T +    TI YMAPE  R +G      D +S 
Sbjct: 135 NILLDSEGHVVLTDFGLSKEFLSEEKERTYS-FCGTIEYMAPEIIRGKGGHGKAVDWWSL 193

Query: 292 GIMLMEIFTRTKP 304
           GI++ E+ T   P
Sbjct: 194 GILIFELLTGASP 206

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 61.8 bits (150), Expect = 8e-11
 Identities = 57/206 (27%), Positives = 93/206 (45%), Gaps = 22/206 (10%)

Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ-------YEGAFKSFDIECDVMKRICHRNLI 162
           +GKGGFG V    ++  G   A K  + +       YEGA     +E  ++ ++  R ++
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAM----VEKRILAKVHSRFIV 56

Query: 163 KIISSYSNDDFKALVLEYMPHGSLEKCLY---LSNYILDIFQRLDIMIDVASALEYLHFG 219
            +  ++       LV+  M  G L   +Y     N      +       + S LE+LH  
Sbjct: 57  SLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH-- 114

Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA-TIGYMAPEYGR 278
               II+ DLKP NVLLD++    +SD G+A  L +     ++T+  A T G+MAPE  +
Sbjct: 115 -QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ---SKTKGYAGTPGFMAPELLQ 170

Query: 279 EGRVSTNGDVYSFGIMLMEIFTRTKP 304
                 + D ++ G+ L E+     P
Sbjct: 171 GEEYDFSVDYFALGVTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 61.2 bits (148), Expect = 1e-10
 Identities = 54/200 (27%), Positives = 93/200 (46%), Gaps = 11/200 (5%)

Query: 110 LIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDI---ECDVMKRICHRNLIKII 165
           ++GKGGFG V    ++  G   A K  + +     K   +   E  +++++  R ++ + 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLA 66

Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLY-LSNYILDIFQRLDIMIDVASALEYLHFGYSAPI 224
            +Y   D   LVL  M  G L+  +Y + N   D  + +    ++   LE L       I
Sbjct: 67  YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERI 123

Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVST 284
           ++ DLKP N+LLDD     +SD G+A  + E +   T    + T+GYMAPE     + + 
Sbjct: 124 VYRDLKPENILLDDRGHIRISDLGLAVQIPEGE---TVRGRVGTVGYMAPEVINNEKYTF 180

Query: 285 NGDVYSFGIMLMEIFTRTKP 304
           + D +  G ++ E+     P
Sbjct: 181 SPDWWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 61.0 bits (148), Expect = 2e-10
 Identities = 32/92 (34%), Positives = 52/92 (56%), Gaps = 3/92 (3%)

Query: 209 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 268
           VA  +E+L    S   IH DL   N+LL +N V  + DFG+A+ + ++   + +      
Sbjct: 182 VARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238

Query: 269 IGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
           + +MAPE   +   +T  DV+SFG++L EIF+
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 60.4 bits (146), Expect = 2e-10
 Identities = 59/217 (27%), Positives = 103/217 (47%), Gaps = 14/217 (6%)

Query: 111 IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYS 169
           IG+G  G V  A ++  G  VAVK  D + +   +    E  +M+   H N++++ +SY 
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 170 NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
             D   +V+E++  G+L   +  ++  ++  Q   + + V  AL  LH   +  +IH D+
Sbjct: 88  VGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCLAVLKALSVLH---AQGVIHRDI 142

Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 289
           K  ++LL  +    LSDFG    + +E     +   + T  +MAPE           D++
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKSLVGTPYWMAPELISRLPYGPEVDIW 200

Query: 290 SFGIMLMEIFTRTKPTDEIFSGEMTLK--RWVNDLLP 324
           S GIM++E+     P    +  E  LK  + + D LP
Sbjct: 201 SLGIMVIEMVDGEPP----YFNEPPLKAMKMIRDNLP 233

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 60.9 bits (148), Expect = 2e-10
 Identities = 36/90 (40%), Positives = 53/90 (58%), Gaps = 5/90 (5%)

Query: 213 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYM 272
           L+YLH   SA I+H D+KP N+L++ N V  + DFG+A+ + E D+S   TQ + T  Y 
Sbjct: 116 LKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLAR-VEEPDESKHMTQEVVTQYYR 171

Query: 273 APEYGREGRVSTNG-DVYSFGIMLMEIFTR 301
           APE     R  T+  D++S G +  E+  R
Sbjct: 172 APEILMGSRHYTSAVDIWSVGCIFAELLGR 201

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 60.5 bits (146), Expect = 3e-10
 Identities = 57/213 (26%), Positives = 104/213 (48%), Gaps = 15/213 (7%)

Query: 110 LIGKGGFGSVYKAI-IQDG----MEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIK 163
           ++G G FG+VYK I + +G    + VA+K+ +      A   F  E  +M  + H +L++
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73

Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL--DIMIDVASALEYLHFGYS 221
           ++    +   + LV + MPHG L    Y+  +  +I  +L  +  + +A  + YL     
Sbjct: 74  LLGVCLSPTIQ-LVTQLMPHGCLLD--YVHEHKDNIGSQLLLNWCVQIAKGMMYLE---E 127

Query: 222 APIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGR 281
             ++H DL   NVL+       ++DFG+A+ L  +++          I +MA E     +
Sbjct: 128 RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRK 187

Query: 282 VSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEM 313
            +   DV+S+G+ + E+ T   KP D I + E+
Sbjct: 188 FTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI 220

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 60.2 bits (146), Expect = 3e-10
 Identities = 43/131 (32%), Positives = 67/131 (51%), Gaps = 7/131 (5%)

Query: 176 LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVL 235
           L+L+Y+  G L   LY   +  +   R+ I  ++  AL++LH      II+ D+K  N+L
Sbjct: 82  LILDYVNGGELFTHLYQREHFTESEVRVYIA-EIVLALDHLH---QLGIIYRDIKLENIL 137

Query: 236 LDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNG--DVYSFGI 293
           LD      L+DFG++K  L E++    +    TI YMAPE  R G    +   D +S G+
Sbjct: 138 LDSEGHVVLTDFGLSKEFLAEEEERAYS-FCGTIEYMAPEVIRGGSGGHDKAVDWWSLGV 196

Query: 294 MLMEIFTRTKP 304
           +  E+ T   P
Sbjct: 197 LTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 59.9 bits (145), Expect = 3e-10
 Identities = 59/202 (29%), Positives = 103/202 (50%), Gaps = 24/202 (11%)

Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGA-FKSFDIECDVMKRICHRNLIKIISSY 168
           +GKG +GSVYK + +  G+ +A+K    + + + F    +E D++ +     ++    ++
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68

Query: 169 SNDDFKALVLEYMPHGSLEKCLY---LSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
             +    + +EYM  GSL+K LY   ++   +       I   V   L++L   ++  II
Sbjct: 69  FIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--II 125

Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG---YMAPEYGREGRV 282
           H D+KP+NVL++ N    L DFG++  L+    SL +T     IG   YMAPE  + G  
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVSGNLV---ASLAKTN----IGCQSYMAPERIKSGGP 178

Query: 283 STNG------DVYSFGIMLMEI 298
           + N       DV+S G+ ++E+
Sbjct: 179 NQNPTYTVQSDVWSLGLSILEM 200

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 60.1 bits (146), Expect = 3e-10
 Identities = 56/198 (28%), Positives = 92/198 (46%), Gaps = 16/198 (8%)

Query: 111 IGKGGFGSVYKAIIQDGME-VAVKV--FDPQYEGAFKSFDIECDVMKRICHRNLIK---- 163
           IG+G +G VY+A      E VA+K    D + +G   S   E  ++  + H N+++    
Sbjct: 15  IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEV 74

Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
           ++  + +  F  LV+EY     L   L          Q   +M+ +   L+YLH  +   
Sbjct: 75  VVGKHLDSIF--LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF--- 128

Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVS 283
           IIH DLK SN+LL D     ++DFG+A+      + +  T  + T+ Y APE        
Sbjct: 129 IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM--TPKVVTLWYRAPELLLGCTTY 186

Query: 284 TNG-DVYSFGIMLMEIFT 300
           T   D+++ G +L E+  
Sbjct: 187 TTAIDMWAVGCILAELLA 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 60.0 bits (145), Expect = 3e-10
 Identities = 63/206 (30%), Positives = 93/206 (45%), Gaps = 27/206 (13%)

Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAF---KSFDI--ECDVMKRICHRNLIKII 165
           IG G FG+VY A      EV V V    Y G     K  DI  E   ++++ H N I+  
Sbjct: 29  IGHGSFGAVYFATNSHTNEV-VAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87

Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDI----FQRLDIMIDVASALEYLHFGYS 221
             Y  +    LV+EY        CL  ++ +L++     Q ++I      AL+ L + +S
Sbjct: 88  GCYLKEHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS 139

Query: 222 APIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEY---GR 278
             +IH D+K  N+LL +     L+DFG A       +S      + T  +MAPE      
Sbjct: 140 HNMIHRDIKAGNILLTEPGQVKLADFGSAS------KSSPANSFVGTPYWMAPEVILAMD 193

Query: 279 EGRVSTNGDVYSFGIMLMEIFTRTKP 304
           EG+     DV+S GI  +E+  R  P
Sbjct: 194 EGQYDGKVDVWSLGITCIELAERKPP 219

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 59.6 bits (144), Expect = 4e-10
 Identities = 60/205 (29%), Positives = 93/205 (45%), Gaps = 18/205 (8%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQY--EGAFKSFDIECDVMKRI---CHRNLIKI 164
           IG G +G+VYKA     G  VA+K    Q   +G   S   E  ++KR+    H N++++
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 165 --ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYI---LDIFQRLDIMIDVASALEYLHFG 219
             + + S  D +  V     H   +   YL       L      D+M      L++LH  
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN 127

Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
               I+H DLKP N+L+       L+DFG+A+        +  T  + T+ Y APE   +
Sbjct: 128 C---IVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTLWYRAPEVLLQ 181

Query: 280 GRVSTNGDVYSFGIMLMEIFTRTKP 304
              +T  D++S G +  E+F R KP
Sbjct: 182 STYATPVDMWSVGCIFAEMFRR-KP 205

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 60.4 bits (146), Expect = 4e-10
 Identities = 33/104 (31%), Positives = 54/104 (51%), Gaps = 3/104 (2%)

Query: 197 LDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE 256
           L     L     VA  +E+L    S   +H DL   NVLL    +  + DFG+A+ ++ +
Sbjct: 234 LTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHD 290

Query: 257 DQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
              +++  T   + +MAPE   +   +T  DV+S+GI+L EIF+
Sbjct: 291 SNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 59.7 bits (144), Expect = 4e-10
 Identities = 61/209 (29%), Positives = 92/209 (44%), Gaps = 33/209 (15%)

Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGA-----FKSFDIECDVMKRICHRNLIKII 165
           IG G FG+VY A      EV V +    Y G      ++    E   ++RI H N I+  
Sbjct: 33  IGHGSFGAVYFARDVRTNEV-VAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYK 91

Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDI----FQRLDIMIDVASALEYLHFGYS 221
             Y  +    LV+EY        CL  ++ +L++     Q ++I      AL+ L + +S
Sbjct: 92  GCYLREHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS 143

Query: 222 APIIHCDLKPSNVLLDDNMVAHLSDFG---MAKPLLEEDQSLTQTQTLATIGYMAPEY-- 276
             +IH D+K  N+LL +     L+DFG   +A P             + T  +MAPE   
Sbjct: 144 HNMIHRDIKAGNILLTEPGQVKLADFGSASIASP---------ANSFVGTPYWMAPEVIL 194

Query: 277 -GREGRVSTNGDVYSFGIMLMEIFTRTKP 304
              EG+     DV+S GI  +E+  R  P
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIELAERKPP 223

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 60.0 bits (145), Expect = 4e-10
 Identities = 64/200 (32%), Positives = 91/200 (45%), Gaps = 11/200 (5%)

Query: 110 LIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVM-KRICHRNLIKI 164
           +IGKG FG V  A  + DG   AVKV   +        K    E +V+ K + H  L+ +
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 165 ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPI 224
             S+   +    VL+++  G L   L       +   R     ++ASAL YLH   S  I
Sbjct: 62  HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLH---SINI 117

Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVST 284
           ++ DLKP N+LLD      L+DFG+ K  +   QS T T    T  Y+APE  R+     
Sbjct: 118 VYRDLKPENILLDSQGHVVLTDFGLCKEGIA--QSDTTTTFCGTPEYLAPEVIRKQPYDN 175

Query: 285 NGDVYSFGIMLMEIFTRTKP 304
             D +  G +L E+     P
Sbjct: 176 TVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 59.2 bits (143), Expect = 4e-10
 Identities = 56/212 (26%), Positives = 102/212 (48%), Gaps = 14/212 (6%)

Query: 111 IGKGGFGSVYKAIIQ---DGMEVAVKVF--DPQYEGAFKSFDIECDVMKRICHRNLIKII 165
           +G G FG+V K + +       VAVK+   D            E +VM+++ +  ++++I
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
                + +  LV+E    G L K L  + ++ +     +++  V+  ++YL        +
Sbjct: 63  GICEAESW-MLVMELAELGPLNKFLQKNKHVTE-KNITELVHQVSMGMKYLE---ETNFV 117

Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAPEYGREGRVS 283
           H DL   NVLL     A +SDFG++K  L  D++  + +T     + + APE     + S
Sbjct: 118 HRDLAARNVLLVTQHYAKISDFGLSKA-LGADENYYKAKTHGKWPVKWYAPECMNYYKFS 176

Query: 284 TNGDVYSFGIMLMEIFTR-TKPTDEIFSGEMT 314
           +  DV+SFG+++ E F+   KP   +   E+T
Sbjct: 177 SKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVT 208

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 60.0 bits (145), Expect = 5e-10
 Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 18/211 (8%)

Query: 104 DANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKS----FDIECDVMKRICHR 159
           D ++  +IG+G FG V     +   +V       ++E   +S    F  E D+M      
Sbjct: 44  DYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 103

Query: 160 NLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLD--IMIDVASALEYLH 217
            ++++  ++ +D +  +V+EYMP G L     +SNY  D+ ++       +V  AL+ +H
Sbjct: 104 WVVQLFCAFQDDKYLYMVMEYMPGGDLVN--LMSNY--DVPEKWAKFYTAEVVLALDAIH 159

Query: 218 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEY- 276
              S  +IH D+KP N+LLD +    L+DFG    + E       T  + T  Y++PE  
Sbjct: 160 ---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDT-AVGTPDYISPEVL 215

Query: 277 ---GREGRVSTNGDVYSFGIMLMEIFTRTKP 304
              G +G      D +S G+ L E+     P
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 59.5 bits (144), Expect = 5e-10
 Identities = 58/202 (28%), Positives = 92/202 (45%), Gaps = 15/202 (7%)

Query: 110 LIGKGGFGSVYKAIIQDGMEV-AVKVFDPQYEGAFKSFDIECDVM-KRIC-----HRNLI 162
           ++GKG FG V  A ++   EV A+KV   + +   +  D++C +  KRI      H  L 
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIKVL--KKDVILQDDDVDCTMTEKRILALAAKHPFLT 59

Query: 163 KIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSA 222
            +   +   D    V+EY+  G L   +  S    +   R     +V  AL +LH     
Sbjct: 60  ALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRF-YAAEVTLALMFLH---RH 115

Query: 223 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRV 282
            +I+ DLK  N+LLD      L+DFGM K  +     +T T    T  Y+APE  +E   
Sbjct: 116 GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTTTTFCGTPDYIAPEILQELEY 173

Query: 283 STNGDVYSFGIMLMEIFTRTKP 304
             + D ++ G+++ E+     P
Sbjct: 174 GPSVDWWALGVLMYEMMAGQPP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 59.3 bits (143), Expect = 5e-10
 Identities = 56/196 (28%), Positives = 96/196 (48%), Gaps = 10/196 (5%)

Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYS 169
           IG+G  G V  A  +  G +VAVK+ D + +   +    E  +M+   H+N++++  SY 
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88

Query: 170 NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
             +   +++E++  G+L   +  S   L+  Q   +   V  AL YLH   S  +IH D+
Sbjct: 89  VGEELWVLMEFLQGGALTDIV--SQTRLNEEQIATVCESVLQALCYLH---SQGVIHRDI 143

Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGY-MAPEYGREGRVSTNGDV 288
           K  ++LL  +    LSDFG    +    + + + ++L    Y MAPE        T  D+
Sbjct: 144 KSDSILLTLDGRVKLSDFGFCAQI---SKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDI 200

Query: 289 YSFGIMLMEIFTRTKP 304
           +S GIM++E+     P
Sbjct: 201 WSLGIMVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 59.2 bits (143), Expect = 6e-10
 Identities = 32/92 (34%), Positives = 52/92 (56%), Gaps = 3/92 (3%)

Query: 209 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 268
           VA  +E+L    S   IH DL   N+LL +N V  + DFG+A+ + ++   + +      
Sbjct: 183 VARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239

Query: 269 IGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
           + +MAPE   +   +T  DV+SFG++L EIF+
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 58.9 bits (143), Expect = 7e-10
 Identities = 61/217 (28%), Positives = 103/217 (47%), Gaps = 31/217 (14%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKV--FDPQYEGAFKSFDIECDVMKRICHRNLIKIISS 167
           IG+G +G VYKA     G  VA+K    + + EG   +   E  ++K + H N+++++  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66

Query: 168 YSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDI---MIDVASALEYLHFGYSAPI 224
             +++   LV E++    L+K  Y+ +  L       I   +  +   + Y H   S  +
Sbjct: 67  VHSENKLYLVFEFLDL-DLKK--YMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRV 120

Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAK----PLLEEDQSLTQTQTLATIGYMAPEYGREG 280
           +H DLKP N+L+D      L+DFG+A+    P+       T T  + T+ Y APE     
Sbjct: 121 LHRDLKPQNLLIDREGALKLADFGLARAFGVPV------RTYTHEVVTLWYRAPEILLGS 174

Query: 281 R-VSTNGDVYSFGIMLMEIFTRTKP-------TDEIF 309
           R  ST  D++S G +  E+  R +P        D++F
Sbjct: 175 RQYSTPVDIWSIGCIFAEMVNR-RPLFPGDSEIDQLF 210

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 59.3 bits (143), Expect = 7e-10
 Identities = 31/92 (33%), Positives = 51/92 (55%), Gaps = 3/92 (3%)

Query: 209 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 268
           VA  +E+L    S   IH DL   N+LL +N V  + DFG+A+ + ++   + +      
Sbjct: 188 VAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244

Query: 269 IGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
           + +MAPE   +   +   DV+SFG++L EIF+
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 59.3 bits (143), Expect = 8e-10
 Identities = 32/92 (34%), Positives = 53/92 (57%), Gaps = 3/92 (3%)

Query: 209 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 268
           VA+ +E+L    S   +H DL   NVL+ +  +  + DFG+A+ ++ +   +++  T   
Sbjct: 248 VANGMEFLA---SKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304

Query: 269 IGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
           + +MAPE       +T  DV+SFGI+L EIFT
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 58.9 bits (142), Expect = 8e-10
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 35/210 (16%)

Query: 111 IGKGGFGSVYK-AIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRIC-HRNLIKIISSY 168
           IGKG +G VYK    +DG   AVK+ DP      +  + E ++++ +  H N++K    +
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAVKILDP-ISDVDEEIEAEYNILQSLPNHPNVVKFYGMF 88

Query: 169 SNDDFKA-----LVLEYMPHGSLEKCLYLSNYILDIFQRLD------IMIDVASALEYLH 217
              D        LVLE    GS+ +   L   +L   QRLD      I+      L++LH
Sbjct: 89  YKADKLVGGQLWLVLELCNGGSVTE---LVKGLLICGQRLDEAMISYILYGALLGLQHLH 145

Query: 218 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE-- 275
              +  IIH D+K +N+LL       L DFG++  L      L +  ++ T  +MAPE  
Sbjct: 146 ---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQL--TSTRLRRNTSVGTPFWMAPEVI 200

Query: 276 -------YGREGRVSTNGDVYSFGIMLMEI 298
                  Y  + R     DV+S GI  +E+
Sbjct: 201 ACEQQYDYSYDARC----DVWSLGITAIEL 226

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 58.6 bits (142), Expect = 9e-10
 Identities = 57/221 (25%), Positives = 94/221 (42%), Gaps = 18/221 (8%)

Query: 109 PLIGKGGFGSVYKAIIQDGM-----EVAVK-VFDPQYEGAFKSFDIECDVMKRICHRNLI 162
            L+ +G FG ++  I+ D       EV VK V D   E        E  ++  + H+N++
Sbjct: 12  DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNIL 71

Query: 163 KIISSYSNDDFKALVLE-YMPHGSLEKCLYLSNYI-------LDIFQRLDIMIDVASALE 214
            I+     D     VL  YM  G+L+  L             L   Q + + I +A  + 
Sbjct: 72  PILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMS 131

Query: 215 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 274
           YLH      +IH D+   N ++D+ +   ++D  +++ L   D           + +MA 
Sbjct: 132 YLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMAL 188

Query: 275 EYGREGRVSTNGDVYSFGIMLMEIFTRTK-PTDEIFSGEMT 314
           E       S+  DV+SFG++L E+ T  + P  EI   EM 
Sbjct: 189 ESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMA 229

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 58.9 bits (142), Expect = 9e-10
 Identities = 64/209 (30%), Positives = 94/209 (44%), Gaps = 11/209 (5%)

Query: 110 LIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVM-KRICHRNLIKI 164
           +IGKG FG V  A  + +    AVKV   +    +   K    E +V+ K + H  L+ +
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61

Query: 165 ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPI 224
             S+   D    VL+Y+  G L   L      L+   R     ++ASAL YLH   S  I
Sbjct: 62  HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLH---SLNI 117

Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVST 284
           ++ DLKP N+LLD      L+DFG+ K  +E +   T +    T  Y+APE   +     
Sbjct: 118 VYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TTSTFCGTPEYLAPEVLHKQPYDR 175

Query: 285 NGDVYSFGIMLMEIFTRTKPTDEIFSGEM 313
             D +  G +L E+     P     + EM
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYSRNTAEM 204

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 58.8 bits (143), Expect = 1e-09
 Identities = 58/230 (25%), Positives = 94/230 (40%), Gaps = 53/230 (23%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKV---FD----PQYEGAFKSFDIECDVMKRICHRNL 161
           +IG+G FG V+       G   A+KV    D     Q     ++   E D++       +
Sbjct: 8   VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQ-IAHVRA---ERDILADADSPWI 63

Query: 162 IKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQ----RLDIMIDVASALEYLH 217
           +K+  S+ +++   LV+EYMP G L     L     D+F     R  I  ++  AL+ +H
Sbjct: 64  VKLYYSFQDEEHLYLVMEYMPGGDLMN--LLIRK--DVFPEETARFYIA-ELVLALDSVH 118

Query: 218 -FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ------------ 264
             G+    IH D+KP N+L+D +    L+DFG+ K + +                     
Sbjct: 119 KLGF----IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVL 174

Query: 265 ---------------TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIF 299
                          T+ T  Y+APE  R        D +S G++L E+ 
Sbjct: 175 VRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 57/205 (27%), Positives = 93/205 (45%), Gaps = 25/205 (12%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFD---PQYEGAFKSFDIECDVMKRICHRNLIKIIS 166
           IG G FG+VY A  +++   VA+K       Q    ++    E   ++++ H N I+   
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82

Query: 167 SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDI----FQRLDIMIDVASALEYLHFGYSA 222
            Y  +    LV+EY        CL  ++ +L++     Q ++I      AL+ L + +S 
Sbjct: 83  CYLREHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134

Query: 223 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEY---GRE 279
            +IH D+K  N+LL +  +  L DFG A  ++        T       +MAPE      E
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSAS-IMAPANXFVGTPY-----WMAPEVILAMDE 188

Query: 280 GRVSTNGDVYSFGIMLMEIFTRTKP 304
           G+     DV+S GI  +E+  R  P
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPP 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 16/210 (7%)

Query: 104 DANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKS----FDIECDVMKRICHR 159
           D  +  +IG+G FG V     +   +V       ++E   +S    F  E D+M      
Sbjct: 44  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 103

Query: 160 NLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNY-ILDIFQRLDIMIDVASALEYLHF 218
            ++++  ++ +D +  +V+EYMP G L     +SNY + + + R     +V  AL+ +H 
Sbjct: 104 WVVQLFYAFQDDRYLYMVMEYMPGGDLVN--LMSNYDVPEKWARF-YTAEVVLALDAIH- 159

Query: 219 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEY-- 276
             S   IH D+KP N+LLD +    L+DFG    + +E      T  + T  Y++PE   
Sbjct: 160 --SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISPEVLK 216

Query: 277 --GREGRVSTNGDVYSFGIMLMEIFTRTKP 304
             G +G      D +S G+ L E+     P
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 58.4 bits (141), Expect = 1e-09
 Identities = 63/222 (28%), Positives = 97/222 (43%), Gaps = 40/222 (18%)

Query: 110 LIGKGGFGSVYKA-IIQDGMEVAVKVFDPQYEGAFKSFDIECDVM-KRIC-----HRNLI 162
           ++GKG FG V  A + + G   AVKV   + +   +  D+EC +  KRI      H  L 
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVL--KKDVILQDDDVECTMTEKRILSLARNHPFLT 59

Query: 163 KIISSYSNDDFKALVLEYMPHGSL----EKCLYLSNYILDIFQRLD------IMIDVASA 212
           ++   +   D    V+E++  G L    +K            +R D         ++ SA
Sbjct: 60  QLYCCFQTPDRLFFVMEFVNGGDLMFHIQKS-----------RRFDEARARFYAAEITSA 108

Query: 213 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYM 272
           L +LH      II+ DLK  NVLLD      L+DFGM K  +      T +    T  Y+
Sbjct: 109 LMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GKTTSTFCGTPDYI 163

Query: 273 APEYGREGRVSTNGDVYSFGIMLMEIFTRTKP-----TDEIF 309
           APE  +E     + D ++ G++L E+     P      D++F
Sbjct: 164 APEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLF 205

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 57.8 bits (140), Expect = 1e-09
 Identities = 54/194 (27%), Positives = 83/194 (42%), Gaps = 36/194 (18%)

Query: 93  RYQKRGKPLPNDANMPPLIGKGGFGSVYKAIIQD-GMEVAVKVF-----DPQYEG-AFKS 145
           +Y+K  K           IG+G +G V+K   ++ G  VA+K F     DP  +  A + 
Sbjct: 2   KYEKLSK-----------IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALR- 49

Query: 146 FDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQR--- 202
              E  ++K++ H NL+ +I  +       LV EY  H  L +        L+   R   
Sbjct: 50  ---EIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNE--------LEKNPRGVP 98

Query: 203 -LDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT 261
              I   +   L+ ++F +    IH D+KP N+L+       L DFG A+ L        
Sbjct: 99  EHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY- 157

Query: 262 QTQTLATIGYMAPE 275
            T  +AT  Y APE
Sbjct: 158 -TDYVATRWYRAPE 170

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 59.1 bits (143), Expect = 2e-09
 Identities = 28/72 (38%), Positives = 39/72 (54%)

Query: 2   GSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNL 61
           G IP S  ++  L  L+LS N LSG IP +L  +  L  +N+S N L G +P  G F  +
Sbjct: 537 GQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAI 596

Query: 62  SVKSFEGNELLC 73
           +  +  GN  LC
Sbjct: 597 NASAVAGNIDLC 608

Length = 968

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 57.9 bits (140), Expect = 2e-09
 Identities = 55/215 (25%), Positives = 95/215 (44%), Gaps = 29/215 (13%)

Query: 110 LIGKGGFGSVYKAIIQDGMEV-AVKVFDPQYEGAFKSFDIECDVMKRIC------HRNLI 162
           ++GKG FG V  A ++   E  A+K    + +   +  D+EC +++R        H  L 
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKAL--KKDVVLEDDDVECTMVERRVLALAWEHPFLT 59

Query: 163 KIISSYSNDDFKALVLEYMPHGSL----EKCLYLSNYILDIFQRLDIMIDVASALEYLHF 218
            +  ++   +    V+EY+  G L    +            +       ++   L++LH 
Sbjct: 60  HLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYA-----AEIICGLQFLH- 113

Query: 219 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL-ATIGYMAPEYG 277
                II+ DLK  NVLLD +    ++DFGM K  +  +    +  T   T  Y+APE  
Sbjct: 114 --KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE---GKASTFCGTPDYIAPEIL 168

Query: 278 REGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE 312
           +  + + + D +SFG++L E+     P    F GE
Sbjct: 169 KGQKYNESVDWWSFGVLLYEMLIGQSP----FHGE 199

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 73/257 (28%), Positives = 109/257 (42%), Gaps = 38/257 (14%)

Query: 110 LIGKGGFGSV-YKAIIQDGMEVAVKVFDPQYEGAFKSFDI-----------ECDVMKRI- 156
           ++G G  G+V     + DG   AVKV D   EG     D             CD    + 
Sbjct: 39  VLGSGATGTVLCAKRVSDGEPFAVKVVD--MEG-MSEADKNRAQAEVCCLLNCDFFSIVK 95

Query: 157 CHRNLIKIISSYSNDD---FKALVLEYMPHGSLEKCLYLSNYILDIFQRLD---IMIDVA 210
           CH +  K      N +     ALVL+Y   G L + +         F+  +   + I V 
Sbjct: 96  CHEDFAK--KDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVL 153

Query: 211 SALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAK---PLLEEDQSLTQTQTLA 267
            A+ ++H   S  +IH D+K +N+LL  N +  L DFG +K     + +D   T      
Sbjct: 154 LAVHHVH---SKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRT---FCG 207

Query: 268 TIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN--DLLPI 325
           T  Y+APE  R    S   D++S G++L E+ T  +P D     E+  K      D LP 
Sbjct: 208 TPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPP 267

Query: 326 SV---MEVVDANLLSQE 339
           S+   M+ +   LLS +
Sbjct: 268 SISPEMQEIVTALLSSD 284

Length = 496

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 57.4 bits (139), Expect = 2e-09
 Identities = 67/234 (28%), Positives = 111/234 (47%), Gaps = 34/234 (14%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKV--FDPQYEGAFKSFDIECDVMKRICHRNLIKIISS 167
           IG+G +G VYK    + G  VA+K    + + EG   +   E  ++K + H N++ +   
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67

Query: 168 YSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVAS----ALEYLHFGYSAP 223
              +    L+ E++   S++   YL +  L   Q +D  + V S     L+ + F +S  
Sbjct: 68  LMQESRLYLIFEFL---SMDLKKYLDS--LPKGQYMDAEL-VKSYLYQILQGILFCHSRR 121

Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAK----PLLEEDQSLTQTQTLATIGYMAPE--YG 277
           ++H DLKP N+L+D+  V  L+DFG+A+    P+         T  + T+ Y APE   G
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV------RVYTHEVVTLWYRAPEVLLG 175

Query: 278 REGRVSTNGDVYSFGIMLMEIFTRTKP-------TDEIFSGEMTLKRWVNDLLP 324
              R ST  D++S G +  E+ T+ KP        D++F     L     D+ P
Sbjct: 176 SP-RYSTPVDIWSIGTIFAEMATK-KPLFHGDSEIDQLFRIFRILGTPTEDVWP 227

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 57.3 bits (138), Expect = 2e-09
 Identities = 62/238 (26%), Positives = 108/238 (45%), Gaps = 42/238 (17%)

Query: 110 LIGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISS- 167
           +IG+GGFG VY     D G   A+K  D       K   ++      +  R ++ ++S+ 
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDK------KRIKMKQGETLALNERIMLSLVSTG 54

Query: 168 -----------YSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMI---DVASAL 213
                      +   D    +L+ M  G L    +LS +   +F   ++     ++   L
Sbjct: 55  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLH--YHLSQH--GVFSEKEMRFYATEIILGL 110

Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
           E++H  +   +++ DLKP+N+LLD++    +SD G+A    ++        ++ T GYMA
Sbjct: 111 EHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH----ASVGTHGYMA 163

Query: 274 PEYGREGRV-STNGDVYSFGIMLMEI------FTRTKPTDEIFSGEMTLKRWVNDLLP 324
           PE  ++G    ++ D +S G ML ++      F + K  D+     MTL   VN  LP
Sbjct: 164 PEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--VNVELP 219

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 26/207 (12%)

Query: 106 NMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAF--KSFDIECDVMKRICHRNLI 162
           N+ P +G G +GSV  A   + G+ VAVK     ++     K    E  ++K + H N+I
Sbjct: 21  NLSP-VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 79

Query: 163 KIISSYS--------NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALE 214
            ++  ++        ND +    L      ++ KC  L++   D  Q L  +  +   L+
Sbjct: 80  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQILRGLK 134

Query: 215 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 274
           Y+H   SA IIH DLKPSN+ ++++    + DFG+A+   +E      T  +AT  Y AP
Sbjct: 135 YIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 186

Query: 275 EYGREG-RVSTNGDVYSFGIMLMEIFT 300
           E        +   D++S G ++ E+ T
Sbjct: 187 EIMLNWMHYNQTVDIWSVGCIMAELLT 213

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 57.1 bits (138), Expect = 3e-09
 Identities = 58/232 (25%), Positives = 98/232 (42%), Gaps = 19/232 (8%)

Query: 103 NDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKS---FDIECDVMKRICH 158
            D ++  L+G+G FG V        G   A+KV       A ++   F+ E D++     
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60

Query: 159 RNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHF 218
             + ++  ++ + D   LV+EY P G L   L L N   D F        +A  +  +H 
Sbjct: 61  PWIPQLQYAFQDKDNLYLVMEYQPGGDL---LSLLNRYEDQFDEDMAQFYLAELVLAIHS 117

Query: 219 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEY-- 276
            +    +H D+KP NVL+D      L+DFG A   L  ++ +     + T  Y+APE   
Sbjct: 118 VHQMGYVHRDIKPENVLIDRTGHIKLADFGSAAR-LTANKMVNSKLPVGTPDYIAPEVLT 176

Query: 277 ----GREGRVSTNGDVYSFGIMLMEIFTRTKPTDE-----IFSGEMTLKRWV 319
                 +G      D +S G++  E+     P  E      ++  M  +R++
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFL 228

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 56.7 bits (137), Expect = 3e-09
 Identities = 56/223 (25%), Positives = 103/223 (46%), Gaps = 30/223 (13%)

Query: 110 LIGKGGFGSVYKAIIQDGME--VAVK---VFDPQYEGAFKSFD-------IECDVMK-RI 156
            +G G FG VYK   ++  +  +A+K   V +P +    +  D        E  ++K ++
Sbjct: 7   HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66

Query: 157 CHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL------DIMIDVA 210
            H N+++   ++  +D   +V++ +    L +     N + +  QR       +I + + 
Sbjct: 67  RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGE---HFNSLKEKKQRFTEERIWNIFVQMV 123

Query: 211 SALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG 270
            AL YLH      I+H DL P+N++L ++    ++DFG+AK    E +    T  + TI 
Sbjct: 124 LALRYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK---LTSVVGTIL 178

Query: 271 YMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM 313
           Y  PE  +        DV++FG +L ++ T   P    +S  M
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP---FYSTNM 218

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 56.9 bits (137), Expect = 3e-09
 Identities = 57/203 (28%), Positives = 97/203 (47%), Gaps = 17/203 (8%)

Query: 110 LIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECD-VMKRIC-----HRNLI 162
           ++GKG FG V+ A ++      A+K    + +      D+EC  V KR+      H  L 
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKAL--KKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 59

Query: 163 KIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSA 222
            +  ++   +    V+EY+  G L   +  S +  D+ +      ++   L++LH   S 
Sbjct: 60  HLYCTFQTKENLFFVMEYLNGGDLMFHIQ-SCHKFDLPRATFYAAEIICGLQFLH---SK 115

Query: 223 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL-ATIGYMAPEYGREGR 281
            I++ DLK  N+LLD +    ++DFGM K  +  D    +T T   T  Y+APE     +
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD---AKTCTFCGTPDYIAPEILLGQK 172

Query: 282 VSTNGDVYSFGIMLMEIFTRTKP 304
            +T+ D +SFG++L E+     P
Sbjct: 173 YNTSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 56.6 bits (136), Expect = 4e-09
 Identities = 62/218 (28%), Positives = 105/218 (48%), Gaps = 28/218 (12%)

Query: 100 PLPNDA-NMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRIC 157
           P P+D   +   IGKG +G V+K + + +G + AVK+ DP ++   +  + E +++K + 
Sbjct: 14  PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALS 72

Query: 158 -HRNLIKIISSYSNDDFKA-----LVLEYMPHGSLEKCLYLSNYILDIFQRLD------I 205
            H N++K    Y   D K      LVLE    GS+     L    L   +R++      I
Sbjct: 73  DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTD---LVKGFLKRGERMEEPIIAYI 129

Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
           + +    L++LH   +   IH D+K +N+LL       L DFG++  L      L +  +
Sbjct: 130 LHEALMGLQHLHVNKT---IHRDVKGNNILLTTEGGVKLVDFGVSAQL--TSTRLRRNTS 184

Query: 266 LATIGYMAPEY-GREGRVSTN----GDVYSFGIMLMEI 298
           + T  +MAPE    E ++ +      DV+S GI  +E+
Sbjct: 185 VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIEL 222

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 57.2 bits (138), Expect = 4e-09
 Identities = 34/104 (32%), Positives = 55/104 (52%), Gaps = 3/104 (2%)

Query: 197 LDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE 256
           LD+   L     VA  +++L    S   IH D+   NVLL D  VA + DFG+A+ ++ +
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMND 265

Query: 257 DQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
              + +      + +MAPE   +   +   DV+S+GI+L EIF+
Sbjct: 266 SNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 56.6 bits (136), Expect = 4e-09
 Identities = 56/203 (27%), Positives = 95/203 (46%), Gaps = 18/203 (8%)

Query: 111 IGKGGFGSVYKA--IIQDGMEVAVKVFDPQY--EGAFKSFDIECDVMKRIC---HRNLIK 163
           IG+G +G V+KA  +   G  VA+K    Q   EG   S   E  V++ +    H N+++
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 164 I--ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYI---LDIFQRLDIMIDVASALEYLHF 218
           +  + + S  D +  +     H   +   YL       +      D+M  +   L++LH 
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH- 127

Query: 219 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGR 278
             S  ++H DLKP N+L+  +    L+DFG+A+  +   Q    T  + T+ Y APE   
Sbjct: 128 --SHRVVHRDLKPQNILVTSSGQIKLADFGLAR--IYSFQMAL-TSVVVTLWYRAPEVLL 182

Query: 279 EGRVSTNGDVYSFGIMLMEIFTR 301
           +   +T  D++S G +  E+F R
Sbjct: 183 QSSYATPVDLWSVGCIFAEMFRR 205

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 56.3 bits (136), Expect = 4e-09
 Identities = 56/199 (28%), Positives = 97/199 (48%), Gaps = 12/199 (6%)

Query: 111 IGKGGFGSVYKAIIQDGME-VAVK--VFDPQYEGAFKSFDIECDVMKRICHRNLIKIISS 167
           IG+G +G+V+KA  ++  E VA+K    D   EG   S   E  ++K + H+N++++   
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 168 YSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHC 227
             +D    LV EY     L+K     N  +D       M  +   L + H   S  ++H 
Sbjct: 68  LHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHR 123

Query: 228 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE--YGREGRVSTN 285
           DLKP N+L++ N    L+DFG+A+      +    +  + T+ Y  P+  +G +   ST+
Sbjct: 124 DLKPQNLLINKNGELKLADFGLARAFGIPVRCY--SAEVVTLWYRPPDVLFGAKL-YSTS 180

Query: 286 GDVYSFGIMLMEIFTRTKP 304
            D++S G +  E+    +P
Sbjct: 181 IDMWSAGCIFAELANAGRP 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 56.8 bits (137), Expect = 4e-09
 Identities = 46/186 (24%), Positives = 82/186 (44%), Gaps = 20/186 (10%)

Query: 148 IECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYI--LDIFQRLDI 205
           IE  +++ + H ++I++  +  +     +VL   PH S +   YL+     L I Q L I
Sbjct: 106 IEAMLLQNVNHPSVIRMKDTLVSGAITCMVL---PHYSSDLYTYLTKRSRPLPIDQALII 162

Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              +   L YLH   +  IIH D+K  N+ ++D     + D G A+  +     L    T
Sbjct: 163 EKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGT 219

Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT---------RTKPTDEIFSGEMTLK 316
           + T    APE     + ++  D++S GI+L E+            + P + + S    L 
Sbjct: 220 VET---NAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLL 276

Query: 317 RWVNDL 322
           + ++ L
Sbjct: 277 KIISTL 282

Length = 357

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 56.7 bits (137), Expect = 5e-09
 Identities = 62/219 (28%), Positives = 101/219 (46%), Gaps = 34/219 (15%)

Query: 104 DANMPPLIGKGGFGSVYKAIIQDGMEV-AVKVFDP-----QYEGAFKSFDIECDVMKRIC 157
           D ++  +IG+G FG V     +   +V A+K+        + + AF  F  E D+M    
Sbjct: 44  DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAF--FWEERDIMAHAN 101

Query: 158 HRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNY-ILDIFQRLDIMIDVASALEYL 216
              ++++  ++ +D +  +V+EYMP G L     +SNY I + + R     +V  AL+ +
Sbjct: 102 SEWIVQLHYAFQDDKYLYMVMEYMPGGDLVN--LMSNYDIPEKWARFYTA-EVVLALDAI 158

Query: 217 H-FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE 275
           H  G+    IH D+KP N+LLD +    L+DFG    +         T  + T  Y++PE
Sbjct: 159 HSMGF----IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDT-AVGTPDYISPE 213

Query: 276 ----------YGREGRVSTNGDVYSFGIMLMEIFTRTKP 304
                     YGRE       D +S G+ L E+     P
Sbjct: 214 VLKSQGGDGYYGRE------CDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 56.2 bits (135), Expect = 6e-09
 Identities = 56/216 (25%), Positives = 102/216 (47%), Gaps = 19/216 (8%)

Query: 110 LIGKGGFGSVYKAI-IQDG----MEVAVKVF-DPQYEGAFKSFDIECDVMKRICHRNLIK 163
           ++G G FG+VYK + I +G    + VA+K   +     A K    E  VM  + + ++ +
Sbjct: 14  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 73

Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCL--YLSNYILDIFQR--LDIMIDVASALEYLHFG 219
           ++        + L+ + MP G    CL  Y+  +  +I  +  L+  + +A  + YL   
Sbjct: 74  LLGICLTSTVQ-LITQLMPFG----CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-- 126

Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
               ++H DL   NVL+       ++DFG+AK L  +++          I +MA E    
Sbjct: 127 -ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILH 185

Query: 280 GRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMT 314
              +   DV+S+G+ + E+ T  +KP D I + E++
Sbjct: 186 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 221

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 55.7 bits (134), Expect = 7e-09
 Identities = 62/234 (26%), Positives = 98/234 (41%), Gaps = 34/234 (14%)

Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVF-------DPQYEGAFKSFDIECDVMKRICHRNLIK 163
           IG G FG V       GM  A  V         P  +  F     E    + + H N+++
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQ---EVQPYRELNHPNVLQ 59

Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYL-SNYIL-------DIFQRLDIMIDVASALEY 215
            +          LVLE+ P G L+   YL SN  +       D+ QR+    +VAS L +
Sbjct: 60  CLGQCIESIPYLLVLEFCPLGDLKN--YLRSNRGMVAQMAQKDVLQRM--ACEVASGLLW 115

Query: 216 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE 275
           LH    A  IH DL   N  L  ++   + D+G+A     ED  +T+      + ++APE
Sbjct: 116 LH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPE 172

Query: 276 YGRE-------GRVSTNGDVYSFGIMLMEIFTR-TKPTDEIFSGEMTLKRWVND 321
                         +   +++S G+ + E+FT   +P  ++ S E  LK+ V +
Sbjct: 173 LVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL-SDEQVLKQVVRE 225

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 55.3 bits (133), Expect = 9e-09
 Identities = 60/242 (24%), Positives = 108/242 (44%), Gaps = 45/242 (18%)

Query: 110 LIGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISS- 167
           +IG+GGFG VY     D G   A+K  D       K   ++      +  R ++ ++S+ 
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDK------KRIKMKQGETLALNERIMLSLVSTG 54

Query: 168 -----------YSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMI---DVASAL 213
                      +   D  + +L+ M  G L    +LS +   +F   ++     ++   L
Sbjct: 55  DCPFIVCMSYAFHTPDKLSFILDLMNGGDLH--YHLSQH--GVFSEAEMRFYAAEIILGL 110

Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ-TLATIGYM 272
           E++H  +   +++ DLKP+N+LLD++    +SD G+A      D S  +   ++ T GYM
Sbjct: 111 EHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC-----DFSKKKPHASVGTHGYM 162

Query: 273 APEYGREGRV-STNGDVYSFGIMLMEIFT--------RTKPTDEIFSGEMTLK-RWVNDL 322
           APE  ++G    ++ D +S G ML ++          +TK   EI    +T+     +  
Sbjct: 163 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF 222

Query: 323 LP 324
            P
Sbjct: 223 SP 224

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 55.6 bits (134), Expect = 1e-08
 Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 39/217 (17%)

Query: 109 PLIGKGGFGSVYKAIIQD-GMEVAVK---VFDPQYEGAFKSFDIECDVMKRICHRNLIKI 164
           PL G G  G V+ A+  D    VAVK   + DPQ   + K    E  +++R+ H N++K+
Sbjct: 12  PL-GCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQ---SVKHALREIKIIRRLDHDNIVKV 67

Query: 165 I------SSYSNDDFKAL--------VLEYMP---HGSLEKCLYLSNYILDIFQRLDIMI 207
                   S   +D  +L        V EYM       LE+      +      RL  M 
Sbjct: 68  YEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHA-----RL-FMY 121

Query: 208 DVASALEYLHFGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQ--TQ 264
            +   L+Y+H   SA ++H DLKP+NV ++ +++V  + DFG+A+ +++   S     ++
Sbjct: 122 QLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLAR-IVDPHYSHKGYLSE 177

Query: 265 TLATIGYMAPEYGREGRVSTNG-DVYSFGIMLMEIFT 300
            L T  Y +P         T   D+++ G +  E+ T
Sbjct: 178 GLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLT 214

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 55.2 bits (134), Expect = 1e-08
 Identities = 48/192 (25%), Positives = 74/192 (38%), Gaps = 35/192 (18%)

Query: 151 DVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQ---RLD--- 204
            +MK   + N IK+  S +      L+++Y+  G L           D+ +   +L    
Sbjct: 63  QLMK--DNPNFIKLYYSVTTLKGHVLIMDYIKDGDL----------FDLLKKEGKLSEAE 110

Query: 205 ---IMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV-AHLSDFGMAKPLLEEDQSL 260
              I+  +  AL  LH      IIH D+K  NVL D      +L D+G+ K         
Sbjct: 111 VKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKI---IGTPS 164

Query: 261 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKP----TDEIFSGEMTLK 316
               TL    Y +PE  +      + D ++ G++  E+ T   P     DE    E  LK
Sbjct: 165 CYDGTLD---YFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLK 221

Query: 317 RWVNDLLPISVM 328
           R    L  I  +
Sbjct: 222 RQQKKLPFIKNV 233

Length = 267

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 46/147 (31%), Positives = 72/147 (48%), Gaps = 9/147 (6%)

Query: 161 LIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMI-DVASALEYLHFG 219
           L+ +  ++  D    L+L+Y+  G L    +LS       Q + I   ++  ALE+LH  
Sbjct: 67  LVTLHYAFQTDTKLHLILDYINGGEL--FTHLSQRERFKEQEVQIYSGEIVLALEHLH-- 122

Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
               II+ D+K  N+LLD N    L+DFG++K    ED+         TI YMAP+  R 
Sbjct: 123 -KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH-EDEVERAYSFCGTIEYMAPDIVRG 180

Query: 280 GRVSTNG--DVYSFGIMLMEIFTRTKP 304
           G    +   D +S G+++ E+ T   P
Sbjct: 181 GDGGHDKAVDWWSMGVLMYELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 54.9 bits (132), Expect = 1e-08
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 26/207 (12%)

Query: 111 IGKGGFGSVYKAI---IQDG-----MEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLI 162
           +G+G F  ++K I   + D       EV +KV D  +    +SF     +M ++ H++L+
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 163 KIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSA 222
                    D   +V EY+  GSL+  L  +  +++I  +L++   +A AL +L      
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE---DK 119

Query: 223 PIIHCDLKPSNVLL---DDNMVAH-----LSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 274
            + H ++   NVLL   +D    +     LSD G++  +L ++  L +      I ++ P
Sbjct: 120 GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLER------IPWVPP 173

Query: 275 EYGREGR-VSTNGDVYSFGIMLMEIFT 300
           E     + +S   D +SFG  L EIF+
Sbjct: 174 ECIENPQNLSLAADKWSFGTTLWEIFS 200

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 55.6 bits (134), Expect = 1e-08
 Identities = 45/168 (26%), Positives = 66/168 (39%), Gaps = 29/168 (17%)

Query: 149 ECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMID 208
           E D++K I HR +I +I +Y     K+ V   MP            Y  D+F  +D    
Sbjct: 136 EIDILKTISHRAIINLIHAYRW---KSTVCMVMPK-----------YKCDLFTYVDRSGP 181

Query: 209 VA------------SALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE 256
           +              AL YLH      IIH D+K  N+ LD+   A L DFG A  L   
Sbjct: 182 LPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238

Query: 257 DQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKP 304
             +        T+   +PE           D++S G++L E+  +   
Sbjct: 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286

Length = 392

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 56.0 bits (135), Expect = 1e-08
 Identities = 27/72 (37%), Positives = 43/72 (59%), Gaps = 1/72 (1%)

Query: 1   QGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFR 59
           +G IP+ I  L +L+S+NLS N++ G IP SL  +  L+ +++S+N   G IP   G   
Sbjct: 431 RGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLT 490

Query: 60  NLSVKSFEGNEL 71
           +L + +  GN L
Sbjct: 491 SLRILNLNGNSL 502

Length = 623

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 59/214 (27%), Positives = 94/214 (43%), Gaps = 24/214 (11%)

Query: 110 LIGKGGFGSVYKAIIQDGMEV-AVKVFDPQYEGAFKSFDIECD-VMKRIC-----HRNLI 162
           ++GKG FG V  A ++   E+ AVKV   + +   +  D+EC    KR+      H  L 
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVL--KKDVILQDDDVECTMTEKRVLALAGKHPFLT 59

Query: 163 KIISSYSNDDFKALVLEYMPHGSLEKCLY--LSNYILDIFQRLDIMIDVASALEYLHFGY 220
           ++ S +   D    V+EY+  G L   ++    +   D  +      ++   L++LH   
Sbjct: 60  QLHSCFQTKDRLFFVMEYVNGGDL---MFHIQRSGRFDEPRARFYAAEIVLGLQFLH--- 113

Query: 221 SAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREG 280
              II+ DLK  NVLLD      ++DFGM K  +      T +    T  Y+APE     
Sbjct: 114 ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--TTSTFCGTPDYIAPEILSYQ 171

Query: 281 RVSTNGDVYSFGIMLMEIFTRTKP-----TDEIF 309
                 D ++ G++L E+     P      DE+F
Sbjct: 172 PYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELF 205

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 55.3 bits (133), Expect = 1e-08
 Identities = 62/226 (27%), Positives = 103/226 (45%), Gaps = 54/226 (23%)

Query: 101 LPNDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRI 156
           LP        +G G +GSV  AI  + G +VA+K     ++    A +++  E  ++K +
Sbjct: 13  LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR-ELTLLKHM 71

Query: 157 CHRNLIKII----SSYSNDDFKA--LVLEYM---------PHGSLEKCLYLSNYILDIFQ 201
            H N+I ++    S+ S D+F+   LV+ YM            S +K  YL      ++Q
Sbjct: 72  QHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYL------VYQ 125

Query: 202 RLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT 261
            L         L+Y+H   SA IIH DLKP N+ ++++    + DFG+A+     D  +T
Sbjct: 126 ML-------CGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMT 172

Query: 262 QTQTLATIGYMAPEYGREGRVSTNG-------DVYSFGIMLMEIFT 300
                   GY+   + R   V  N        D++S G ++ E+ T
Sbjct: 173 --------GYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLT 210

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 55.0 bits (132), Expect = 1e-08
 Identities = 50/191 (26%), Positives = 94/191 (49%), Gaps = 11/191 (5%)

Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDI-ECDVMKRICHRNLIKIISSY 168
           +G G  G V+K   +  G+ +A K+   + + A ++  I E  V+       ++    ++
Sbjct: 13  LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72

Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNYILD-IFQRLDIMIDVASALEYLHFGYSAPIIHC 227
            +D   ++ +E+M  GSL++ L  +  I + I  ++ I   V   L YL   +   I+H 
Sbjct: 73  YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREKHK--IMHR 128

Query: 228 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGD 287
           D+KPSN+L++      L DFG++  L++          + T  YM+PE  +    S   D
Sbjct: 129 DVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSD 184

Query: 288 VYSFGIMLMEI 298
           ++S G+ L+E+
Sbjct: 185 IWSMGLSLVEM 195

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 55.6 bits (134), Expect = 2e-08
 Identities = 40/112 (35%), Positives = 55/112 (49%), Gaps = 5/112 (4%)

Query: 2   GSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRN 60
           G +PDS G    L++L+LS N  SG +P  L  L +L  + +S NKL GEIP E    + 
Sbjct: 466 GGLPDSFGS-KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKK 524

Query: 61  LSVKSFEGNELLCEIVLPLSTIFMIVMILLILRY-QKRGKPLPNDANMPPLI 111
           L       N+L  +I  P S   M V+  L L   Q  G+   N  N+  L+
Sbjct: 525 LVSLDLSHNQLSGQI--PASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLV 574

Length = 968

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 50/197 (25%), Positives = 92/197 (46%), Gaps = 14/197 (7%)

Query: 111 IGKGGFGSVYKAII---QDGMEVAVKVFDPQYEGAF--KSFDIECDVMKRICHRNLIKII 165
           +GKG +G V  +++    DG +  +K  + +       K+ + E  ++ ++ H N++   
Sbjct: 8   VGKGSYGEV--SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYR 65

Query: 166 SSYSNDD-FKALVLEYMPHGSL-EKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
            S+  +D    +V+ +   G L  K       +L   Q ++  + +A AL+YLH      
Sbjct: 66  ESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKH 122

Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVS 283
           I+H DLK  NV L    +  + D G+A+ L  E+Q    +  + T  YM+PE       +
Sbjct: 123 ILHRDLKTQNVFLTRTNIIKVGDLGIARVL--ENQCDMASTLIGTPYYMSPELFSNKPYN 180

Query: 284 TNGDVYSFGIMLMEIFT 300
              DV++ G  + E+ T
Sbjct: 181 YKSDVWALGCCVYEMAT 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 54.9 bits (132), Expect = 2e-08
 Identities = 61/204 (29%), Positives = 92/204 (45%), Gaps = 30/204 (14%)

Query: 111 IGKGGFGSVYKAIIQDGMEV-AVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIIS--- 166
           IGKG FG VY+   +D   + A+KV   +   A K      +V   I  RN++       
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKK------EVAHTIGERNILVRTLLDE 54

Query: 167 ---------SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMI-DVASALEYL 216
                    S+  D    LV +YM  G L   L       +   R    I ++  ALE+L
Sbjct: 55  SPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSE--DRAKFYIAELVLALEHL 112

Query: 217 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL-ATIGYMAPE 275
           H      I++ DLKP N+LLD      L DFG++K  L ++++   T T   T  Y+APE
Sbjct: 113 H---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT---TNTFCGTTEYLAPE 166

Query: 276 YGREGRVSTNG-DVYSFGIMLMEI 298
              + +  T   D +S G+++ E+
Sbjct: 167 VLLDEKGYTKHVDFWSLGVLVFEM 190

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 54.2 bits (130), Expect = 2e-08
 Identities = 56/212 (26%), Positives = 98/212 (46%), Gaps = 26/212 (12%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICH-RNLIKIISS 167
           ++G G +G VYK   ++ G   A+KV D   E   +   +E +++K+  H RN+     +
Sbjct: 23  VVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIATYYGA 81

Query: 168 Y------SNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQR---LDIMIDVASALEYLHF 218
           +       +DD   LV+E+   GS+     + N   +  +      I  ++   L +LH 
Sbjct: 82  FIKKSPPGHDDQLWLVMEFCGAGSVTD--LVKNTKGNALKEDWIAYICREILRGLAHLH- 138

Query: 219 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT-LATIGYMAPEY- 276
             +  +IH D+K  NVLL +N    L DFG++  L   D+++ +  T + T  +MAPE  
Sbjct: 139 --AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGTPYWMAPEVI 193

Query: 277 ----GREGRVSTNGDVYSFGIMLMEIFTRTKP 304
                 +       D++S GI  +E+     P
Sbjct: 194 ACDENPDATYDYRSDIWSLGITAIEMAEGAPP 225

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 54.8 bits (132), Expect = 3e-08
 Identities = 22/53 (41%), Positives = 38/53 (71%)

Query: 1   QGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIP 53
           +G+IP S+G + +L+ L+LS N+ +G+IP SL +L  L+ +N++ N L G +P
Sbjct: 455 RGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVP 507

Length = 623

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 54.3 bits (130), Expect = 3e-08
 Identities = 58/200 (29%), Positives = 92/200 (46%), Gaps = 27/200 (13%)

Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDI-ECDVMKRICHRNLIKIISSY 168
           +G+G + +VYK   + +G  VA+KV   Q E       I E  ++K + H N++ +    
Sbjct: 13  LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72

Query: 169 SNDDFKALVLEYMPHGSLEKCLYLS---------NYILDIFQRLDIMIDVASALEYLHFG 219
              +   LV EY+ H  L  C Y+          N  L +FQ L         L Y+H  
Sbjct: 73  HTKETLTLVFEYV-HTDL--CQYMDKHPGGLHPENVKLFLFQLL-------RGLSYIHQR 122

Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE-YGR 278
           Y   I+H DLKP N+L+ D     L+DFG+A+   +   S T +  + T+ Y  P+    
Sbjct: 123 Y---ILHRDLKPQNLLISDTGELKLADFGLARA--KSVPSHTYSNEVVTLWYRPPDVLLG 177

Query: 279 EGRVSTNGDVYSFGIMLMEI 298
               ST  D++  G + +E+
Sbjct: 178 STEYSTCLDMWGVGCIFVEM 197

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 43/159 (27%), Positives = 68/159 (42%), Gaps = 24/159 (15%)

Query: 158 HRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLD------------I 205
           H  ++K    + +DD   L++EY   G L K          I QRL             +
Sbjct: 124 HFGIVKHFDDFKSDDKLLLIMEYGSGGDLNK---------QIKQRLKEHLPFQEYEVGLL 174

Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              +  AL+ +H   S  ++H DLK +N+ L    +  L DFG +K   +       +  
Sbjct: 175 FYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSF 231

Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKP 304
             T  Y+APE     R S   D++S G++L E+ T  +P
Sbjct: 232 CGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270

Length = 478

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 54.2 bits (130), Expect = 3e-08
 Identities = 58/217 (26%), Positives = 100/217 (46%), Gaps = 30/217 (13%)

Query: 110 LIGKGGFGSVYKAIIQDGME-VAVKVFDPQYEGAFKSFDIECD-VMKRIC-----HRNLI 162
           ++GKG FG V  A ++   E  AVK    + +      D+EC  V KR+      +  L 
Sbjct: 2   VLGKGSFGKVLLAELKGKGEYFAVKAL--KKDVVLIDDDVECTMVEKRVLALAWENPFLT 59

Query: 163 KIISSYSNDDFKALVLEYMPHGSL-----EKCLYLSNYILDIFQRLDIMIDVASALEYLH 217
            +  ++   +    V+E++  G L     +K  +      D+++      ++   L++LH
Sbjct: 60  HLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRF------DLYRATFYAAEIVCGLQFLH 113

Query: 218 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYG 277
              S  II+ DLK  NV+LD +    ++DFGM K  +  D     +    T  Y+APE  
Sbjct: 114 ---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDYIAPEIL 168

Query: 278 REGRVSTNGDVYSFGIMLMEIFTRTKP-----TDEIF 309
           +  + + + D +SFG++L E+     P      DE+F
Sbjct: 169 QGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELF 205

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 54.8 bits (132), Expect = 3e-08
 Identities = 65/230 (28%), Positives = 97/230 (42%), Gaps = 43/230 (18%)

Query: 110 LIGKGGFGSVYKAIIQD---GMEVAVKVFDP---QYEGAFKSFDIECDVMKRICHRNLIK 163
           LIGKGG G VY A   D      VA+K       +     K F  E  +   + H  ++ 
Sbjct: 9   LIGKGGMGEVYLA--YDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66

Query: 164 IISSYSNDDFKALVLEYMPH--GSLEKCLYLSNYILDIFQR-----------LDIMIDVA 210
           + S  S+ D    V   MP+  G   K L  S +  +   +           L I   + 
Sbjct: 67  VYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKIC 123

Query: 211 SALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMA--KPLLEEDQ---------- 258
           + +EY+H   S  ++H DLKP N+LL       + D+G A  K L EED           
Sbjct: 124 ATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180

Query: 259 ---SLTQT-QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKP 304
              S+T   + + T  YMAPE       S + D+Y+ G++L ++ T + P
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230

Length = 932

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 53.8 bits (129), Expect = 3e-08
 Identities = 51/207 (24%), Positives = 84/207 (40%), Gaps = 24/207 (11%)

Query: 111 IGKGGFGSVYKAIIQDGM---EVAVKVF----DPQYEGAFKSFDIECDVMKRICHRNLIK 163
           IG G FG V    +  G    +V VK        Q +  F     E    + + H NL++
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLE---EAQPYRSLQHSNLLQ 59

Query: 164 IISSYSNDDFKALVLEYMPHGS----LEKCLYLSNYILDIFQRLDIMIDVASALEYLHFG 219
            +   +      LV+E+ P G     L  C        D      +  ++A  L +LH  
Sbjct: 60  CLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH-- 117

Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
                IH DL   N LL  ++   + D+G++    +ED  +T  Q    + ++APE   E
Sbjct: 118 -KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDE 176

Query: 280 --GRV-----STNGDVYSFGIMLMEIF 299
             G +     +   +V+S G+ + E+F
Sbjct: 177 VHGNLLVVDQTKESNVWSLGVTIWELF 203

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 53.5 bits (128), Expect = 4e-08
 Identities = 57/211 (27%), Positives = 96/211 (45%), Gaps = 11/211 (5%)

Query: 110 LIGKGGFGSVYKAI-IQDG----MEVAVKVF-DPQYEGAFKSFDIECDVMKRICHRNLIK 163
           ++G G FG+VYK I I DG    + VA+KV  +     A K    E  VM  +    + +
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73

Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
           ++        + LV + MP+G L   +  +   +     L+  + +A  + YL       
Sbjct: 74  LLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVR 129

Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVS 283
           ++H DL   NVL+       ++DFG+A+ L  ++           I +MA E     R +
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFT 189

Query: 284 TNGDVYSFGIMLMEIFT-RTKPTDEIFSGEM 313
              DV+S+G+ + E+ T   KP D I + E+
Sbjct: 190 HQSDVWSYGVTVWELMTFGAKPYDGIPAREI 220

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 53.6 bits (129), Expect = 4e-08
 Identities = 39/131 (29%), Positives = 70/131 (53%), Gaps = 8/131 (6%)

Query: 168 YSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHC 227
           YS+ +  ++ +E+M  GSL++ L  +  I +      I I V   L YL   +   I+H 
Sbjct: 69  YSDGEI-SICMEHMDGGSLDQVLKKAGRIPENILG-KISIAVLRGLTYLREKHK--IMHR 124

Query: 228 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGD 287
           D+KPSN+L++      L DFG++  L++   S+  +  + T  YM+PE  +    +   D
Sbjct: 125 DVKPSNILVNSRGEIKLCDFGVSGQLID---SMANS-FVGTRSYMSPERLQGTHYTVQSD 180

Query: 288 VYSFGIMLMEI 298
           ++S G+ L+E+
Sbjct: 181 IWSLGLSLVEM 191

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 53.6 bits (129), Expect = 5e-08
 Identities = 36/104 (34%), Positives = 57/104 (54%), Gaps = 10/104 (9%)

Query: 212 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE--EDQSLTQTQTLATI 269
            L+Y+H   SA ++H DLKP N+L++ +    + DFG+A+   E   + +   T+ +AT 
Sbjct: 117 GLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR 173

Query: 270 GYMAPEYGREGRVSTNG-DVYSFGIMLMEIFTRTKPTDEIFSGE 312
            Y APE     +  T   DV+S G +L E+  R KP   +F G+
Sbjct: 174 WYRAPEIMLSFQSYTKAIDVWSVGCILAELLGR-KP---VFKGK 213

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 53.1 bits (127), Expect = 7e-08
 Identities = 60/220 (27%), Positives = 97/220 (44%), Gaps = 24/220 (10%)

Query: 95  QKRGKPLPNDANMPPLIGKGGFGSVYKAIIQDG--MEVAVKVFDPQYEGAFKSFD---IE 149
           +++ K    D N    +G G FG V  A  ++     VA+K F+       K  D    E
Sbjct: 22  KRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSE 81

Query: 150 CDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGS----LEKCLYLSNYILDIFQRLDI 205
             ++  I H   + +  S+ ++ +  LVLE++  G     L +     N +   +    +
Sbjct: 82  RKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIV 141

Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
           +I      EYL    S  I++ DLKP N+LLD +    ++DFG AK +++     T+T T
Sbjct: 142 LI-----FEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAK-VVD-----TRTYT 187

Query: 266 L-ATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKP 304
           L  T  Y+APE           D ++ GI + EI     P
Sbjct: 188 LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227

Length = 340

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 55/215 (25%), Positives = 99/215 (46%), Gaps = 14/215 (6%)

Query: 110 LIGKGGFGSVYKAIIQDGME-VAVKVF-DPQYEGAFKSFDI-ECDVMKRICHRNLIKIIS 166
           ++G+G +G V K   ++  E VA+K F D +     K   + E  +++ +   N++++  
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67

Query: 167 SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIH 226
           ++       LV EY+    LE    + N +     R  I       ++ +H+ +   I+H
Sbjct: 68  AFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIY----QLIKAIHWCHKNDIVH 123

Query: 227 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNG 286
            D+KP N+L+  N V  L DFG A+  L E  +   T+ +AT  Y +PE           
Sbjct: 124 RDIKPENLLISHNDVLKLCDFGFARN-LSEGSNANYTEYVATRWYRSPELLLGAPYGKAV 182

Query: 287 DVYSFGIMLME------IFTRTKPTDEIFSGEMTL 315
           D++S G +L E      +F      D++F+ +  L
Sbjct: 183 DMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVL 217

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 62/222 (27%), Positives = 99/222 (44%), Gaps = 20/222 (9%)

Query: 104 DANMPPLIGKGGFGSVYKAIIQDGMEV-AVKVFDPQYEGAFKSFDIECD-VMKRICHRN- 160
           D N   ++GKG FG V  A  +   E+ A+K+   + +   +  D+EC  V KR+   + 
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKIL--KKDVVIQDDDVECTMVEKRVLALSG 58

Query: 161 ----LIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYL 216
               L ++ S +   D    V+EY+  G L   +Y    +   F+    +   A     L
Sbjct: 59  KPPFLTQLHSCFQTMDRLYFVMEYVNGGDL---MYQIQQV-GRFKEPHAVFYAAEIAIGL 114

Query: 217 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEY 276
            F +S  II+ DLK  NV+LD      ++DFGM K  + +   +T      T  Y+APE 
Sbjct: 115 FFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD--GVTTKTFCGTPDYIAPEI 172

Query: 277 GREGRVSTNGDVYSFGIMLMEIFTRTKP-----TDEIFSGEM 313
                   + D ++FG++L E+     P      DE+F   M
Sbjct: 173 IAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 214

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 52.3 bits (126), Expect = 1e-07
 Identities = 66/264 (25%), Positives = 103/264 (39%), Gaps = 92/264 (34%)

Query: 110 LIGKGGFGSVYKAIIQDGMEV-AVKVFDPQYEGAFKSFDIECDVMKRIC----------H 158
           L+GKG  G V+   ++   ++ A+KV D       K   I+ + +KR+           H
Sbjct: 8   LLGKGDVGRVFLVRLKGTGKLFALKVLD-------KKEMIKRNKVKRVLTEQEILATLDH 60

Query: 159 RNLIKIISSYSNDDFKALVLEYMPHGSL--------EKCL-------YLSNYILDIFQRL 203
             L  + +S+  + +  LV++Y P G L         KCL       Y +          
Sbjct: 61  PFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAA---------- 110

Query: 204 DIMIDVASALEYLH-FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED----- 257
               +V  ALEYLH  G    I++ DLKP N+LL ++    LSDF ++K    E      
Sbjct: 111 ----EVLLALEYLHLLG----IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSK 162

Query: 258 ----------QSLTQTQTLATIG------------YMAPE----YGREGRVSTNGDVYSF 291
                      +   ++T +               Y+APE     G    V    D ++ 
Sbjct: 163 ALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV----DWWTL 218

Query: 292 GIMLME-IFTRT----KPTDEIFS 310
           GI+L E ++  T       DE FS
Sbjct: 219 GILLYEMLYGTTPFKGSNRDETFS 242

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 52.4 bits (125), Expect = 1e-07
 Identities = 50/191 (26%), Positives = 93/191 (48%), Gaps = 11/191 (5%)

Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDI-ECDVMKRICHRNLIKIISSY 168
           +G G  G V K   +  G+ +A K+   + + A ++  I E  V+       ++    ++
Sbjct: 13  LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72

Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNYI-LDIFQRLDIMIDVASALEYLHFGYSAPIIHC 227
            +D   ++ +E+M  GSL++ L  +  I  +I  ++ I   V   L YL   +   I+H 
Sbjct: 73  YSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA--VLRGLAYLREKHQ--IMHR 128

Query: 228 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGD 287
           D+KPSN+L++      L DFG++  L++          + T  YM+PE  +    S   D
Sbjct: 129 DVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSD 184

Query: 288 VYSFGIMLMEI 298
           ++S G+ L+E+
Sbjct: 185 IWSMGLSLVEL 195

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 52.4 bits (125), Expect = 1e-07
 Identities = 55/183 (30%), Positives = 89/183 (48%), Gaps = 29/183 (15%)

Query: 106 NMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDI--ECDVMKRICHRNLI 162
           N+ P +G G +GSV  A   +   +VAVK     ++    +     E  ++K + H N+I
Sbjct: 19  NLTP-VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVI 77

Query: 163 KIISSY----SNDDFKALVLEYMPHGS----LEKCLYLSNYILD--IFQRLDIMIDVASA 212
            ++  +    S ++F  + L     G+    + KC  LS+  +   I+Q L         
Sbjct: 78  GLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLL-------RG 130

Query: 213 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYM 272
           L+Y+H   SA IIH DLKPSNV ++++    + DFG+A+   +E      T  +AT  Y 
Sbjct: 131 LKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE-----MTGYVATRWYR 182

Query: 273 APE 275
           APE
Sbjct: 183 APE 185

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 59/226 (26%), Positives = 102/226 (45%), Gaps = 41/226 (18%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRICHRNLIKIIS 166
           IG G  G V  A     G+ VAVK     ++    A +++  E  ++K + H+N+I +++
Sbjct: 29  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLN 87

Query: 167 SYSNDDFKALVLEYMPHGSLEKC--LYLSNYILD------IFQRLD------IMIDVASA 212
            ++            P  SLE+   +YL   ++D      I   LD      ++  +   
Sbjct: 88  VFT------------PQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCG 135

Query: 213 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYM 272
           +++LH   SA IIH DLKPSN+++  +    + DFG+A+       +   T  + T  Y 
Sbjct: 136 IKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TACTNFMMTPYVVTRYYR 189

Query: 273 APEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRW 318
           APE         N D++S G ++ E+   +     IF G   + +W
Sbjct: 190 APEVILGMGYKENVDIWSVGCIMGELVKGSV----IFQGTDHIDQW 231

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 52.2 bits (125), Expect = 1e-07
 Identities = 31/104 (29%), Positives = 49/104 (47%), Gaps = 3/104 (2%)

Query: 197 LDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE 256
           LD    L     VA  + +L    S   IH DL   N+LL    +  + DFG+A+ +  +
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRND 267

Query: 257 DQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
              + +      + +MAPE       +   DV+S+GI+L EIF+
Sbjct: 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 51.7 bits (124), Expect = 1e-07
 Identities = 54/201 (26%), Positives = 93/201 (46%), Gaps = 23/201 (11%)

Query: 111 IGKGGFGSVYKAIIQDGME-VAVKVFDPQYEGAFKSFDI-ECDVMKRICHRNLIKIISSY 168
           +G+G + +VYK   +   E VA+K      E    S  I E  +MK + H N++++    
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67

Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNY----ILDIFQRLDIMIDVASALEYLHFGYSAPI 224
             ++   LV EYM    L+K  Y+  +     LD          +   + + H      +
Sbjct: 68  HTENKLMLVFEYM-DKDLKK--YMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRV 121

Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAK----PLLEEDQSLTQTQTLATIGYMAPEYGREG 280
           +H DLKP N+L++      L+DFG+A+    P+       T +  + T+ Y AP+     
Sbjct: 122 LHRDLKPQNLLINKRGELKLADFGLARAFGIPV------NTFSNEVVTLWYRAPDVLLGS 175

Query: 281 RV-STNGDVYSFGIMLMEIFT 300
           R  ST+ D++S G ++ E+ T
Sbjct: 176 RTYSTSIDIWSVGCIMAEMIT 196

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 51.7 bits (124), Expect = 1e-07
 Identities = 62/222 (27%), Positives = 103/222 (46%), Gaps = 44/222 (19%)

Query: 111 IGKGGFGSVYKAIIQDGME-VAVKV--FDPQYEGAFKSFDIECDVMKRICHRNLIKIISS 167
           IG+G +G VYKA  +   E +A+K    + + EG   +   E  ++K + H N++++   
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69

Query: 168 YSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALE----YLH------ 217
             ++    LV EY+               LD+ + +D   D A        YL+      
Sbjct: 70  VHSEKRLYLVFEYLD--------------LDLKKHMDSSPDFAKNPRLIKTYLYQILRGI 115

Query: 218 -FGYSAPIIHCDLKPSNVLLDDNMVA-HLSDFGMAK----PLLEEDQSLTQTQTLATIGY 271
            + +S  ++H DLKP N+L+D    A  L+DFG+A+    P+       T T  + T+ Y
Sbjct: 116 AYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV------RTFTHEVVTLWY 169

Query: 272 MAPEYGREGR-VSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE 312
            APE     R  ST  D++S G +  E+  + KP   +F G+
Sbjct: 170 RAPEILLGSRHYSTPVDIWSVGCIFAEMVNQ-KP---LFPGD 207

Length = 294

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 51.7 bits (124), Expect = 2e-07
 Identities = 63/242 (26%), Positives = 113/242 (46%), Gaps = 32/242 (13%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDI--ECDVMKRICHRNLIK--- 163
           +IGKG +G V  AI    G +VA+K  +  +E    +  I  E  +++ + H ++++   
Sbjct: 7   VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66

Query: 164 IISSYSNDDFKAL--VLEYMP---HGSLEKC--LYLSNYILDIFQRLDIMIDVASALEYL 216
           I+   S  +FK +  V E M    H  ++    L   ++   ++Q L        AL+Y+
Sbjct: 67  IMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLL-------RALKYI 119

Query: 217 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP-LLEEDQSLTQTQTLATIGYMAPE 275
           H   +A + H DLKP N+L + +    + DFG+A+    +   ++  T  +AT  Y APE
Sbjct: 120 H---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 176

Query: 276 YGRE--GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRW--VNDLLPISVMEVV 331
                  + +   D++S G +  E+ T  KP   +F G+  + +   + DLL     E +
Sbjct: 177 LCGSFFSKYTPAIDIWSIGCIFAEVLT-GKP---LFPGKNVVHQLDLITDLLGTPSPETI 232

Query: 332 DA 333
             
Sbjct: 233 SR 234

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 51.3 bits (123), Expect = 2e-07
 Identities = 51/196 (26%), Positives = 86/196 (43%), Gaps = 18/196 (9%)

Query: 118 SVYKAIIQDGMEVAVKVFDPQYEGAFKSFDI---ECDVMKRICHRNLIKIISSYSN--DD 172
           S+YK I  +  EV ++ F   ++G     DI   E   ++RI   N++KI     +  DD
Sbjct: 35  SIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93

Query: 173 FK--ALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLK 230
               +L+LEY   G L + L      L    +LD+ ID    L  L+   + P  + +L 
Sbjct: 94  LPRLSLILEYCTRGYLREVLD-KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLT 150

Query: 231 PSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE--GRVSTNGDV 288
             + L+ +N    +   G+ K L     S    + +  + Y + +   +     +   D+
Sbjct: 151 SVSFLVTENYKLKIICHGLEKIL-----SSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDI 205

Query: 289 YSFGIMLMEIFTRTKP 304
           YS G++L EIFT   P
Sbjct: 206 YSLGVVLWEIFTGKIP 221

Length = 283

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 51.1 bits (122), Expect = 2e-07
 Identities = 55/205 (26%), Positives = 92/205 (44%), Gaps = 35/205 (17%)

Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDI-ECDVMKRICHRNLIKIISSY 168
           +G+G + +VYK I + +G  VA+KV   + E       I E  ++K + H N++ +    
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72

Query: 169 SNDDFKALVLEYMPHGSLEKC-------LYLSNYILDIFQRLDIMIDVASALEYLHFGYS 221
              +    V EYM H  L +        L+  N  L +FQ L         L Y+H  + 
Sbjct: 73  HTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLL-------RGLAYIHGQH- 123

Query: 222 APIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP------- 274
             I+H DLKP N+L+       L+DFG+A+   +   S T +  + T+ Y  P       
Sbjct: 124 --ILHRDLKPQNLLISYLGELKLADFGLARA--KSIPSQTYSSEVVTLWYRPPDVLLGAT 179

Query: 275 EYGREGRVSTNGDVYSFGIMLMEIF 299
           +Y      S+  D++  G + +E+ 
Sbjct: 180 DY------SSALDIWGAGCIFIEML 198

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 51.1 bits (122), Expect = 2e-07
 Identities = 51/200 (25%), Positives = 92/200 (46%), Gaps = 21/200 (10%)

Query: 111 IGKGGFGSVY-----KAIIQDGM----EVAVKVFDPQYEGAFKSFDIECDVMKRICHRNL 161
           +GKG FG+VY     KA+ ++ +    E+ V   +P         + E  ++ ++ H  +
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNET---VQANQEAQLLSKLDHPAI 64

Query: 162 IKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIF---QRLDIMIDVASALEYLHF 218
           +K  +S+   D   ++ EY     L+  L    +        Q  +  I +   + Y+H 
Sbjct: 65  VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH- 123

Query: 219 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGR 278
                I+H DLK  N+ L +N++  + DFG+++ LL     L  T T  T  YM+PE  +
Sbjct: 124 --QRRILHRDLKAKNIFLKNNLL-KIGDFGVSR-LLMGSCDLATTFT-GTPYYMSPEALK 178

Query: 279 EGRVSTNGDVYSFGIMLMEI 298
                +  D++S G +L E+
Sbjct: 179 HQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 51.8 bits (124), Expect = 3e-07
 Identities = 31/75 (41%), Positives = 42/75 (56%), Gaps = 1/75 (1%)

Query: 2   GSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRN 60
           G IP+ IG   +LK L+L  N L G IP SL  L  L+ + ++ N+L G+IPRE G  ++
Sbjct: 154 GEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKS 213

Query: 61  LSVKSFEGNELLCEI 75
           L       N L  EI
Sbjct: 214 LKWIYLGYNNLSGEI 228

Length = 968

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 51.2 bits (122), Expect = 3e-07
 Identities = 51/214 (23%), Positives = 103/214 (48%), Gaps = 21/214 (9%)

Query: 104 DANMPPLIGKGGFGSVYKAIIQDGMEV-AVKVFDPQYEGAFKS----FDIECDVMKRICH 158
           D  +  +IG+G FG V    +++  +V A+K+ + ++E   ++    F  E DV+    +
Sbjct: 2   DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILN-KWEMLKRAETACFREERDVLVNGDN 60

Query: 159 RNLIKIISSYSNDDFKALVLEYMPHGSLEKCLY-LSNYILDIFQR--LDIMIDVASALEY 215
           + +  +  ++ +++   LV++Y   G L   L    + + +   R  L  M+    ++  
Sbjct: 61  QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120

Query: 216 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE 275
           LH+      +H D+KP N+L+D N    L+DFG    L+ ED ++  +  + T  Y++PE
Sbjct: 121 LHY------VHRDIKPDNILMDMNGHIRLADFGSCLKLM-EDGTVQSSVAVGTPDYISPE 173

Query: 276 YGR-----EGRVSTNGDVYSFGIMLMEIFTRTKP 304
             +     +G+     D +S G+ + E+     P
Sbjct: 174 ILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 51.4 bits (123), Expect = 3e-07
 Identities = 58/202 (28%), Positives = 89/202 (44%), Gaps = 32/202 (15%)

Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVK-VFDPQYEGAF-KSFDIECDVMKRICHRNLI---KI 164
           +G G FG V  A  Q  G  VA+K +  P       K    E  ++K + H N+I    I
Sbjct: 18  VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDI 77

Query: 165 ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPI 224
             S   D +   V E +  G+    L  S  +   F +   +  +   L+Y+H   SA +
Sbjct: 78  FISPLEDIY--FVTELL--GTDLHRLLTSRPLEKQFIQY-FLYQILRGLKYVH---SAGV 129

Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE-------YG 277
           +H DLKPSN+L+++N    + DFG+A+      Q    T  ++T  Y APE       Y 
Sbjct: 130 VHRDLKPSNILINENCDLKICDFGLARI-----QDPQMTGYVSTRYYRAPEIMLTWQKYD 184

Query: 278 REGRVSTNGDVYSFGIMLMEIF 299
            E       D++S G +  E+ 
Sbjct: 185 VE------VDIWSAGCIFAEML 200

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 50.7 bits (121), Expect = 3e-07
 Identities = 51/197 (25%), Positives = 88/197 (44%), Gaps = 26/197 (13%)

Query: 128 MEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLE 187
           + V +KV DP +     +F     +M ++ H +L  +           +V E++ HG L+
Sbjct: 45  LRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLD 104

Query: 188 KCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAH---- 243
            CL      + +  ++ +   +ASAL YL       ++H ++   N+LL    +A     
Sbjct: 105 VCLRKEKGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEGTSP 161

Query: 244 ---LSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMEIF 299
              LSD G++   L  ++ + +      I ++APE    G  +ST  D +SFG  L+EI 
Sbjct: 162 FIKLSDPGVSFTALSREERVER------IPWIAPECVPGGNSLSTAADKWSFGTTLLEI- 214

Query: 300 TRTKPTDEIFSGEMTLK 316
                    F GE+ LK
Sbjct: 215 --------CFDGEVPLK 223

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 50.5 bits (120), Expect = 3e-07
 Identities = 55/209 (26%), Positives = 92/209 (44%), Gaps = 20/209 (9%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICH-RNLIKIISS 167
           L+G G +G VYK   ++ G   A+KV D   +   +    E +++K+  H RN+     +
Sbjct: 13  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRNIATYYGA 71

Query: 168 Y------SNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYS 221
           +        DD   LV+E+   GS+     + N   +  +   I       L  L   + 
Sbjct: 72  FIKKNPPGMDDQLWLVMEFCGAGSVTD--LIKNTKGNTLKEEWIAYICREILRGLSHLHQ 129

Query: 222 APIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT-LATIGYMAPEY---- 276
             +IH D+K  NVLL +N    L DFG++  L   D+++ +  T + T  +MAPE     
Sbjct: 130 HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGTPYWMAPEVIACD 186

Query: 277 -GREGRVSTNGDVYSFGIMLMEIFTRTKP 304
              +       D++S GI  +E+     P
Sbjct: 187 ENPDATYDFKSDLWSLGITAIEMAEGAPP 215

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 51.4 bits (123), Expect = 4e-07
 Identities = 36/86 (41%), Positives = 47/86 (54%), Gaps = 10/86 (11%)

Query: 2   GSIPDSIGDLI-NLKSLNLSNNNLSGTIP---ISLEKLLDLKDINVSFNKLEGEIPRE-G 56
           G IPD I     +L+ LNLSNNN +G+IP   I   + LDL     S N L GEIP + G
Sbjct: 107 GPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDL-----SNNMLSGEIPNDIG 161

Query: 57  PFRNLSVKSFEGNELLCEIVLPLSTI 82
            F +L V    GN L+ +I   L+ +
Sbjct: 162 SFSSLKVLDLGGNVLVGKIPNSLTNL 187

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 51.0 bits (122), Expect = 5e-07
 Identities = 24/54 (44%), Positives = 35/54 (64%)

Query: 2   GSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE 55
           G IP+S+ +L +L+ L L++N L G IP  L ++  LK I + +N L GEIP E
Sbjct: 178 GKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYE 231

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 51.0 bits (122), Expect = 6e-07
 Identities = 30/75 (40%), Positives = 43/75 (57%), Gaps = 1/75 (1%)

Query: 2   GSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRN 60
           G IP+ +  L NL+ L+L +NN +G IP++L  L  L+ + +  NK  GEIP+  G   N
Sbjct: 298 GEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNN 357

Query: 61  LSVKSFEGNELLCEI 75
           L+V     N L  EI
Sbjct: 358 LTVLDLSTNNLTGEI 372

Length = 968

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 50.1 bits (120), Expect = 6e-07
 Identities = 45/157 (28%), Positives = 82/157 (52%), Gaps = 18/157 (11%)

Query: 149 ECDVMKRICHRNLIKIISSY----SNDDFKA--LVLEYMPHGSLEKCLYLSNYILDIFQR 202
           E  +MK + H+N+I +++ +    S ++F+   LV+E M   +L + + +    LD  +R
Sbjct: 65  ELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMD---LD-HER 119

Query: 203 LDIMI-DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT 261
           +  ++  +   +++LH   SA IIH DLKPSN+++  +    + DFG+A+       S  
Sbjct: 120 MSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFM 173

Query: 262 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEI 298
            T  + T  Y APE         N D++S G ++ E+
Sbjct: 174 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 210

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 49.4 bits (118), Expect = 7e-07
 Identities = 54/203 (26%), Positives = 96/203 (47%), Gaps = 27/203 (13%)

Query: 111 IGKGGFGSVYKAII----QDGMEVAVK------VFDPQYEGAFKSFDIECDVMKRICHRN 160
           IG+G FG   KAI+    +DG +  +K      +   + E + K    E  V+  + H N
Sbjct: 8   IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRK----EVAVLSNMKHPN 60

Query: 161 LIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIF---QRLDIMIDVASALEYLH 217
           +++   S+  +    +V++Y   G L K +     +L  F   Q LD  + +  AL+++H
Sbjct: 61  IVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVL--FPEDQILDWFVQICLALKHVH 118

Query: 218 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYG 277
                 I+H D+K  N+ L  +    L DFG+A+ +L     L +T  + T  Y++PE  
Sbjct: 119 ---DRKILHRDIKSQNIFLTKDGTIKLGDFGIAR-VLNSTVELART-CIGTPYYLSPEIC 173

Query: 278 REGRVSTNGDVYSFGIMLMEIFT 300
                +   D+++ G +L E+ T
Sbjct: 174 ENRPYNNKSDIWALGCVLYEMCT 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 49.9 bits (119), Expect = 7e-07
 Identities = 58/204 (28%), Positives = 99/204 (48%), Gaps = 29/204 (14%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVK-VFDP-QYEGAFKSFDIECDVMKRICHRNLIKIISS 167
           +G G +G+V  A+  + G +VA+K ++ P Q E   K    E  ++K + H N+I ++  
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82

Query: 168 YSND-------DFKALVLEYMPH--GSLEKCLYLSNYILDIFQRLDIMI-DVASALEYLH 217
           ++ D       DF  LV+ +M    G L K   LS        R+  ++  +   L+Y+H
Sbjct: 83  FTPDLSLDRFHDF-YLVMPFMGTDLGKLMKHEKLSE------DRIQFLVYQMLKGLKYIH 135

Query: 218 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYG 277
              +A IIH DLKP N+ ++++    + DFG+A+    E      T  + T  Y APE  
Sbjct: 136 ---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE-----MTGYVVTRWYRAPEVI 187

Query: 278 REG-RVSTNGDVYSFGIMLMEIFT 300
                 +   D++S G ++ E+ T
Sbjct: 188 LNWMHYTQTVDIWSVGCIMAEMLT 211

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 49.8 bits (119), Expect = 8e-07
 Identities = 65/235 (27%), Positives = 103/235 (43%), Gaps = 46/235 (19%)

Query: 104 DANMPPLIGKGGFGSVYKAIIQDGMEV-AVKVFDPQYEGAFKSFDIECD-VMKRICHRN- 160
           D N   ++GKG FG V  A  +   E+ A+K+   + +   +  D+EC  V KR+     
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKIL--KKDVIIQDDDVECTMVEKRVLALPG 58

Query: 161 ----LIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLD------IMIDVA 210
               L ++ S +   D    V+EY+  G L        Y +    +           ++A
Sbjct: 59  KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLM-------YHIQQVGKFKEPHAVFYAAEIA 111

Query: 211 SALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL-ATI 269
             L +LH   S  II+ DLK  NV+LD      ++DFGM K  +   ++   T+T   T 
Sbjct: 112 IGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT---TRTFCGTP 165

Query: 270 GYMAPE------YGREGRVSTNGDVYSFGIMLMEIFTRTKP-----TDEIFSGEM 313
            Y+APE      YG+      + D ++FG++L E+     P      DE+F   M
Sbjct: 166 DYIAPEIIAYQPYGK------SVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM 214

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 49.7 bits (118), Expect = 9e-07
 Identities = 54/205 (26%), Positives = 89/205 (43%), Gaps = 22/205 (10%)

Query: 110 LIGKGGFGSVYKAIIQD---GMEVAVKVFDPQYEGAFKSFD---IECDVMKRICHRNLIK 163
           L+GKG FG V   ++++   G   A+K+   +   A         E  V+K   H  L  
Sbjct: 2   LLGKGTFGKV--ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTS 59

Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
           +  S+   D    V+EY+  G L   L       +   R     ++ SAL+YLH   S  
Sbjct: 60  LKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRF-YGAEIVSALDYLH---SGK 115

Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATI----GYMAPEYGRE 279
           I++ DLK  N++LD +    ++DFG+ K      + +T   T+ T      Y+APE   +
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCK------EGITDAATMKTFCGTPEYLAPEVLED 169

Query: 280 GRVSTNGDVYSFGIMLMEIFTRTKP 304
                  D +  G+++ E+     P
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 50.2 bits (120), Expect = 1e-06
 Identities = 30/75 (40%), Positives = 38/75 (50%), Gaps = 1/75 (1%)

Query: 2   GSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRN 60
           G IP  IG L +L  L+L  NNL+G IP SL  L +L+ + +  NKL G IP      + 
Sbjct: 226 GEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQK 285

Query: 61  LSVKSFEGNELLCEI 75
           L       N L  EI
Sbjct: 286 LISLDLSDNSLSGEI 300

Length = 968

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 49.9 bits (119), Expect = 1e-06
 Identities = 37/115 (32%), Positives = 59/115 (51%), Gaps = 9/115 (7%)

Query: 176 LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVL 235
           LV+EY+  G ++  L++  Y  D    +  + +VA AL+YLH      IIH DLKP N+L
Sbjct: 81  LVMEYLIGGDVKSLLHIYGY-FDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNML 136

Query: 236 LDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYS 290
           + +     L+DFG++K  L  + ++    T  ++     +Y R     T G V S
Sbjct: 137 ISNEGHIKLTDFGLSKVTLNRELNMMDILTTPSMAKPKNDYSR-----TPGQVLS 186

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 49.3 bits (117), Expect = 1e-06
 Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 42/213 (19%)

Query: 106 NMPPLIGKGGFGSV---YKAIIQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRICHR 159
           N+ P IG G  G V   Y AI++    VA+K     ++    A +++  E  +MK + H+
Sbjct: 28  NLKP-IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHK 83

Query: 160 NLIKIISSYSNDDFKALVLEYMPHGSLEKC--LYLSNYILD------IFQRLD------I 205
           N+I +++ ++            P  SLE+   +Y+   ++D      I   LD      +
Sbjct: 84  NIIGLLNVFT------------PQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL 131

Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
           +  +   +++LH   SA IIH DLKPSN+++  +    + DFG+A+       S   T  
Sbjct: 132 LYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPY 185

Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEI 298
           + T  Y APE         N D++S G ++ E+
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 49.5 bits (118), Expect = 2e-06
 Identities = 26/52 (50%), Positives = 33/52 (63%)

Query: 2   GSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIP 53
           G IP S+G+L NL+ L L  N LSG IP S+  L  L  +++S N L GEIP
Sbjct: 250 GPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIP 301

Length = 968

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 61/223 (27%), Positives = 108/223 (48%), Gaps = 26/223 (11%)

Query: 106 NMPPLIGKGGFGSV---YKAIIQDGMEVAVKVFDP-QYEGAFKSFDIECDVMKRICHRNL 161
           N+ P IG G  G V   Y A++   + +  K+  P Q +   K    E  +MK + H+N+
Sbjct: 21  NLKP-IGSGAQGIVCAAYDAVLDRNVAIK-KLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78

Query: 162 IKIISSYSN----DDFKA--LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEY 215
           I +++ ++     ++F+   LV+E M   +L + + +    LD  +   ++  +   +++
Sbjct: 79  ISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQME---LDHERMSYLLYQMLCGIKH 134

Query: 216 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE 275
           LH   SA IIH DLKPSN+++  +    + DFG+A+       S   T  + T  Y APE
Sbjct: 135 LH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPE 188

Query: 276 YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRW 318
                    N D++S G ++ E+  R K    +F G   + +W
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEM-VRHKI---LFPGRDYIDQW 227

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 61/224 (27%), Positives = 99/224 (44%), Gaps = 24/224 (10%)

Query: 104 DANMPPLIGKGGFGSVYKAIIQDGMEV-AVKVFDPQYEGAFKSFDIECD-VMKRICHRN- 160
           D N   ++GKG FG V  A  +   E+ A+K+   + +   +  D+EC  V KR+     
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKIL--KKDVVIQDDDVECTMVEKRVLALQD 58

Query: 161 ----LIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDI--FQRLDIMIDVASALE 214
               L ++ S +   D    V+EY+  G L   +Y   +I  +  F+    +   A    
Sbjct: 59  KPPFLTQLHSCFQTVDRLYFVMEYVNGGDL---MY---HIQQVGKFKEPQAVFYAAEISV 112

Query: 215 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 274
            L F +   II+ DLK  NV+LD      ++DFGM K  + +   +T      T  Y+AP
Sbjct: 113 GLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD--GVTTRTFCGTPDYIAP 170

Query: 275 EYGREGRVSTNGDVYSFGIMLMEIFTRTKP-----TDEIFSGEM 313
           E         + D +++G++L E+     P      DE+F   M
Sbjct: 171 EIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM 214

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 48.3 bits (115), Expect = 3e-06
 Identities = 53/194 (27%), Positives = 76/194 (39%), Gaps = 46/194 (23%)

Query: 110 LIGKGGFGSVY-----------------KAIIQDGMEVAVKVFDPQYEGAFKSFDIECDV 152
           L+GKG FG V                  K +I    EVA  +              E  V
Sbjct: 2   LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTL-------------TESRV 48

Query: 153 MKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIM-IDVAS 211
           ++   H  L  +  S+   D    V+EY   G L    +LS   +    R      ++ S
Sbjct: 49  LQNTRHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVS 106

Query: 212 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL-ATIG 270
           AL YLH   S  +++ DLK  N++LD +    ++DFG+ K   E        +T   T  
Sbjct: 107 ALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPE 160

Query: 271 YMAPE------YGR 278
           Y+APE      YGR
Sbjct: 161 YLAPEVLEDNDYGR 174

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 48.1 bits (114), Expect = 3e-06
 Identities = 43/155 (27%), Positives = 69/155 (44%), Gaps = 6/155 (3%)

Query: 158 HRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLH 217
           H  L+ + S +  +     V+EY+  G L   +     + +   R     +++ AL YLH
Sbjct: 55  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH 113

Query: 218 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYG 277
                 II+ DLK  NVLLD      L+D+GM K  L      T +    T  Y+APE  
Sbjct: 114 ---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEIL 168

Query: 278 REGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE 312
           R      + D ++ G+++ E+     P D + S +
Sbjct: 169 RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 203

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 47.6 bits (113), Expect = 4e-06
 Identities = 52/223 (23%), Positives = 95/223 (42%), Gaps = 37/223 (16%)

Query: 110 LIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNL-----IKI 164
           LIG GGFG VY+        +     + Q     ++ + E  VM+ + + N+     I +
Sbjct: 19  LIGCGGFGCVYETQCASDHCI-----NNQAVAKIENLENETIVMETLVYNNIYDIDKIAL 73

Query: 165 ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYIL---------DIFQRL---------DIM 206
             +  N D   +   Y   GS ++C     +IL         +IF+R+         +IM
Sbjct: 74  WKNIHNIDHLGIPK-YYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIM 132

Query: 207 IDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT- 265
            D+ + LEY+H      I H D+KP N+++D N   ++ D+G+A   +   + +  ++  
Sbjct: 133 KDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQ 189

Query: 266 ----LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKP 304
                 T+ Y   +      V+  GD+ S G  +++      P
Sbjct: 190 KDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLP 232

Length = 294

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 48.3 bits (115), Expect = 5e-06
 Identities = 23/53 (43%), Positives = 34/53 (64%)

Query: 2   GSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPR 54
           G IP SI  L  L SL+LS+N+LSG IP  + +L +L+ +++  N   G+IP 
Sbjct: 274 GPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPV 326

Length = 968

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 46.9 bits (111), Expect = 5e-06
 Identities = 48/210 (22%), Positives = 90/210 (42%), Gaps = 20/210 (9%)

Query: 104 DANMPPLIGKGGFGS--VYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNL 161
             N+  ++G+G FG   + + +  D      ++  P+   A +    E  ++ ++ H N+
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60

Query: 162 IKIISSYSNDDFKALVLEYMPHGSLEKC-------LYLSNYILDIFQRLDIMIDVASALE 214
           +    S+  D    +V+EY   G L +        L+  + IL  F      + +   ++
Sbjct: 61  VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWF------VQMCLGVQ 114

Query: 215 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 274
           ++H      ++H D+K  N+ L  N    L DFG A+ LL    +   T  + T  Y+ P
Sbjct: 115 HIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSAR-LLTSPGAYACTY-VGTPYYVPP 169

Query: 275 EYGREGRVSTNGDVYSFGIMLMEIFTRTKP 304
           E       +   D++S G +L E+ T   P
Sbjct: 170 EIWENMPYNNKSDIWSLGCILYELCTLKHP 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 46.5 bits (110), Expect = 9e-06
 Identities = 52/197 (26%), Positives = 86/197 (43%), Gaps = 18/197 (9%)

Query: 110 LIGKGGFGSVY----KAIIQDGMEVAVKVFDPQYEGAFKSFD---IECDVMKRICHRNLI 162
           L+GKG FG V     KA    G   A+K+   +   A         E  V++   H  L 
Sbjct: 2   LLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 58

Query: 163 KIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIM-IDVASALEYLHFGYS 221
            +  ++   D    V+EY   G L    +LS   +   +R      ++ SALEYLH   S
Sbjct: 59  ALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLH---S 113

Query: 222 APIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGR 281
             +++ D+K  N++LD +    ++DFG+ K  + +    T      T  Y+APE   +  
Sbjct: 114 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDND 171

Query: 282 VSTNGDVYSFGIMLMEI 298
                D +  G+++ E+
Sbjct: 172 YGRAVDWWGLGVVMYEM 188

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 46.5 bits (110), Expect = 9e-06
 Identities = 52/200 (26%), Positives = 94/200 (47%), Gaps = 23/200 (11%)

Query: 111 IGKGGFGSVYK--AIIQDGMEVAVKVFDPQYE-GAFKSFDIECDVMKRICHRNLIKIISS 167
           +G+G + +VYK  + + D + VA+K    ++E GA  +   E  ++K + H N++ +   
Sbjct: 14  LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 168 YSNDDFKALVLEYMPHG---SLEKC---LYLSNYILDIFQRLDIMIDVASALEYLHFGYS 221
              +    LV EY+       L+ C   + + N  L +FQ L         L Y H    
Sbjct: 73  IHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLL-------RGLNYCH---R 122

Query: 222 APIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE-YGREG 280
             ++H DLKP N+L+++     L+DFG+A+   +   + T +  + T+ Y  P+      
Sbjct: 123 RKVLHRDLKPQNLLINERGELKLADFGLARA--KSIPTKTYSNEVVTLWYRPPDILLGST 180

Query: 281 RVSTNGDVYSFGIMLMEIFT 300
             ST  D++  G +  E+ T
Sbjct: 181 DYSTQIDMWGVGCIFYEMST 200

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 46.8 bits (111), Expect = 1e-05
 Identities = 21/52 (40%), Positives = 30/52 (57%)

Query: 2   GSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIP 53
           G IP  +G + +LK + L  NNLSG IP  +  L  L  +++ +N L G IP
Sbjct: 202 GQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIP 253

Length = 968

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 44.3 bits (105), Expect = 1e-05
 Identities = 32/144 (22%), Positives = 67/144 (46%), Gaps = 19/144 (13%)

Query: 110 LIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLI--KIISS 167
           L+  G    VY    +D  +  +K+   + +GA    + E  +++ +  + L   K+++S
Sbjct: 5   LLKGGLTNRVYLLGTKDE-DYVLKINPSREKGAD--REREVAILQLLARKGLPVPKVLAS 61

Query: 168 YSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPI--- 224
             +D +  L++E++   +L++        +   ++ DI   +A  L  LH     P+   
Sbjct: 62  GESDGWSYLLMEWIEGETLDE--------VSEEEKEDIAEQLAELLAKLH---QLPLLVL 110

Query: 225 IHCDLKPSNVLLDDNMVAHLSDFG 248
            H DL P N+L+DD  +  + D+ 
Sbjct: 111 CHGDLHPGNILVDDGKILGIIDWE 134

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 45.7 bits (109), Expect = 1e-05
 Identities = 53/220 (24%), Positives = 93/220 (42%), Gaps = 42/220 (19%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDV-------MKRIC-HRNL 161
           IG+G F  V KA   + G   A+K     ++       +E          ++R+  H N+
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK------SLEQVNNLREIQALRRLSPHPNI 60

Query: 162 IKIISSYSNDDFK--ALVLEYMPHGSLEKCLYLSNYILDIFQRLD------IMIDVASAL 213
           +++I    +      ALV E M     +  LY    I    + L        M  +  +L
Sbjct: 61  LRLIEVLFDRKTGRLALVFELM-----DMNLY--ELIKGRKRPLPEKRVKSYMYQLLKSL 113

Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
           +++H      I H D+KP N+L+ D+++  L+DFG  + +         T+ ++T  Y A
Sbjct: 114 DHMH---RNGIFHRDIKPENILIKDDIL-KLADFGSCRGI---YSKPPYTEYISTRWYRA 166

Query: 274 PE-YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE 312
           PE    +G      D+++ G +  EI +   P   +F G 
Sbjct: 167 PECLLTDGYYGPKMDIWAVGCVFFEILS-LFP---LFPGT 202

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 45.8 bits (108), Expect = 1e-05
 Identities = 54/203 (26%), Positives = 93/203 (45%), Gaps = 29/203 (14%)

Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSY 168
           +G+G + +V+K   +     VA+K    ++ EGA  +   E  ++K + H N++ +    
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72

Query: 169 SNDDFKALVLEYMPHG---SLEKCLYL-SNYILDIFQRLDIMIDVASALEYLHFGYSAPI 224
             +    LV EY+       L+ C  L S + + IF     M  +   L Y H      I
Sbjct: 73  HTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIF-----MFQLLRGLSYCH---KRKI 124

Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP-------EYG 277
           +H DLKP N+L+++     L+DFG+A+   +   + T +  + T+ Y  P       EY 
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLARA--KSVPTKTYSNEVVTLWYRPPDVLLGSTEY- 181

Query: 278 REGRVSTNGDVYSFGIMLMEIFT 300
                ST  D++  G +L E+ T
Sbjct: 182 -----STPIDMWGVGCILYEMAT 199

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 42/148 (28%), Positives = 66/148 (44%), Gaps = 6/148 (4%)

Query: 161 LIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGY 220
           L+ + S +       LV+EY+  G L   +     + +   R     ++  AL +LH   
Sbjct: 58  LVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARF-YAAEICIALNFLH--- 113

Query: 221 SAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREG 280
              II+ DLK  NVLLD +    L+D+GM K  L      T +    T  Y+APE  R  
Sbjct: 114 ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--TTSTFCGTPNYIAPEILRGE 171

Query: 281 RVSTNGDVYSFGIMLMEIFTRTKPTDEI 308
               + D ++ G+++ E+     P D I
Sbjct: 172 EYGFSVDWWALGVLMFEMMAGRSPFDII 199

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 45.6 bits (108), Expect = 2e-05
 Identities = 54/258 (20%), Positives = 96/258 (37%), Gaps = 71/258 (27%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVK--VFDPQYEGAFKSFDIECDVMKRICHRNLIKIISS 167
           IG+G +G VYKA     G  VA+K    +   EG   +   E  +++ +     I     
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYI----- 63

Query: 168 YSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLD----------------------- 204
                 + L +E++   + +  LYL      +F+ LD                       
Sbjct: 64  -----VRLLDVEHVEEKNGKPSLYL------VFEYLDSDLKKFMDSNGRGPGRPLPAKTI 112

Query: 205 --IMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDN-MVAHLSDFGMAKPLLEEDQSLT 261
              M  +   + + H      ++H DLKP N+L+D    +  ++D G+ +      +S  
Sbjct: 113 KSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY- 168

Query: 262 QTQTLATIGYMAPEYGREGR-VSTNGDVYSFGIMLMEIFTRT------------------ 302
            T  + T+ Y APE        ST  D++S G +  E+  +                   
Sbjct: 169 -THEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKL 227

Query: 303 --KPTDEIFSGEMTLKRW 318
              PT++++ G   L+ W
Sbjct: 228 LGTPTEQVWPGVSKLRDW 245

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 45.5 bits (108), Expect = 2e-05
 Identities = 56/220 (25%), Positives = 96/220 (43%), Gaps = 45/220 (20%)

Query: 110 LIGKGGFGSVYKAIIQDGMEV-AVKVFDPQYE----GAFKSFDIECDVMKRICHRNLIKI 164
           +IG+G FG V    +++  +V A+K+ + ++E         F  E DV+     R +  +
Sbjct: 8   VIGRGAFGEVAVVKMKNTGQVYAMKILN-KWEMLKRAETACFREERDVLVNGDRRWITNL 66

Query: 165 ISSYSNDDFKALVLEYMPHGSLEKCL--------------YLSNYILDIFQRLDIMIDVA 210
             ++ +++   LV++Y   G L   L              YL+  +L             
Sbjct: 67  HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVL------------- 113

Query: 211 SALEYLH-FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATI 269
            A++ +H  GY    +H D+KP NVLLD N    L+DFG    LL  D ++     + T 
Sbjct: 114 -AIDSVHQLGY----VHRDIKPDNVLLDKNGHIRLADFGSCLRLL-ADGTVQSNVAVGTP 167

Query: 270 GYMAPEYGR-----EGRVSTNGDVYSFGIMLMEIFTRTKP 304
            Y++PE  +     +GR     D +S G+ + E+     P
Sbjct: 168 DYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 45.2 bits (107), Expect = 2e-05
 Identities = 29/91 (31%), Positives = 44/91 (48%), Gaps = 2/91 (2%)

Query: 216 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE 275
           L+F +   II+ DLK  NVLLD      L+D+GM K  +      T +    T  Y+APE
Sbjct: 109 LNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--TTSTFCGTPNYIAPE 166

Query: 276 YGREGRVSTNGDVYSFGIMLMEIFTRTKPTD 306
             R      + D ++ G+++ E+     P D
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 45.0 bits (106), Expect = 3e-05
 Identities = 47/195 (24%), Positives = 92/195 (47%), Gaps = 17/195 (8%)

Query: 111 IGKGGFGSVYK--AIIQDGMEVAVKVFDPQYE-GAFKSFDIECDVMKRICHRNLIKIISS 167
           +G+G + +V+K  + + + + VA+K    ++E GA  +   E  ++K + H N++ +   
Sbjct: 14  LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 168 YSNDDFKALVLEYMPHGSLEKCLYLSNYILD---IFQRLDIMIDVASALEYLHFGYSAPI 224
              D    LV EY+          L  Y+ D   I    ++ I +   L  L + +   +
Sbjct: 73  VHTDKSLTLVFEYLDKD-------LKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKV 125

Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGR-EGRVS 283
           +H DLKP N+L+++     L+DFG+A+   +   + T +  + T+ Y  P+        S
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARA--KSVPTKTYSNEVVTLWYRPPDVLLGSSEYS 183

Query: 284 TNGDVYSFGIMLMEI 298
           T  D++  G +  E+
Sbjct: 184 TQIDMWGVGCIFFEM 198

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 44.7 bits (106), Expect = 3e-05
 Identities = 43/150 (28%), Positives = 69/150 (46%), Gaps = 20/150 (13%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSY 168
           +G+G + +VYK      G  VA+K    ++ EGA  +   E  ++K + H N++ +    
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII 72

Query: 169 SNDDFKALVLEYMPHGSL----EKC---LYLSNYILDIFQRLDIMIDVASALEYLHFGYS 221
                  LV EY+    L    + C   L + N  L +FQ L         L Y H    
Sbjct: 73  HTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLFQLL-------RGLAYCH---Q 121

Query: 222 APIIHCDLKPSNVLLDDNMVAHLSDFGMAK 251
             ++H DLKP N+L+ +     L+DFG+A+
Sbjct: 122 RRVLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 44.9 bits (106), Expect = 3e-05
 Identities = 55/205 (26%), Positives = 88/205 (42%), Gaps = 24/205 (11%)

Query: 111 IGKGGFGSVYKAIIQDGMEV-AVKVFDPQYEGAFKSFD---IECDVMKRICHRNLIKIIS 166
           IGKG FG V +   +D   + A+K     +  +         E  V+ ++    ++ +  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 167 SYSNDDFKALVLEYMPHGSL------EKCLYLSNYILDIFQRLDIMIDVASALEYLHFGY 220
           S+ + +   LVL ++  G L      E    LS       + L        ALE LH   
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELL-------CALENLH--- 110

Query: 221 SAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL-ATIGYMAPEYGRE 279
              +I+ DLKP N+LLD      L DFG+ K  +++D    +T T   T  Y+APE    
Sbjct: 111 KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD---KTNTFCGTPEYLAPELLLG 167

Query: 280 GRVSTNGDVYSFGIMLMEIFTRTKP 304
              +   D ++ G++L E+ T   P
Sbjct: 168 HGYTKAVDWWTLGVLLYEMLTGLPP 192

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 44.7 bits (105), Expect = 4e-05
 Identities = 59/223 (26%), Positives = 98/223 (43%), Gaps = 53/223 (23%)

Query: 111 IGKGGFGSVYKAIIQDGM---EVAVKVFDPQYEGAFKSFDI--ECDVMKRICHRNLIKII 165
           +G+G +G VYKA  +DG    E A+K    Q EG   S     E  +++ + H N+I + 
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALK----QIEGTGISMSACREIALLRELKHPNVIALQ 64

Query: 166 SSY-SNDDFKA-LVLEYMPHG------------SLEKCLYLSNYILD--IFQRLDIMIDV 209
             + S+ D K  L+ +Y  H             + +K + L   ++   ++Q LD     
Sbjct: 65  KVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILD----- 119

Query: 210 ASALEYLHFGYSAPIIHCDLKPSNVLL----DDNMVAHLSDFGMA-------KPLLEEDQ 258
              + YLH  +   ++H DLKP+N+L+     +     ++D G A       KPL + D 
Sbjct: 120 --GIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD- 173

Query: 259 SLTQTQTLATIGYMAPEYGREGRVSTNG-DVYSFGIMLMEIFT 300
                  + T  Y APE     R  T   D+++ G +  E+ T
Sbjct: 174 -----PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 45.1 bits (106), Expect = 4e-05
 Identities = 55/236 (23%), Positives = 96/236 (40%), Gaps = 56/236 (23%)

Query: 111 IGKGGFGSVY-------------KAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRIC 157
           IG G FG V+             KAI   G++          E       IE +VM+ + 
Sbjct: 21  IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK----------EREKSQLVIEVNVMRELK 70

Query: 158 HRNLIKIISSYSNDDFKAL--VLEYMPHGSL----EKCLYLSNYILDIFQRLDIMIDVAS 211
           H+N+++ I  + N   + L  ++E+   G L    +KC  +   I +    +DI   +  
Sbjct: 71  HKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEE-HAIVDITRQLLH 129

Query: 212 ALEYLHFGYSAP----IIHCDLKPSNVLLDDNM-----------------VAHLSDFGMA 250
           AL Y H     P    ++H DLKP N+ L   +                 +A + DFG++
Sbjct: 130 ALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLS 189

Query: 251 KPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN--GDVYSFGIMLMEIFTRTKP 304
           K +  E  + +    + T  Y +PE       S +   D+++ G ++ E+ +   P
Sbjct: 190 KNIGIESMAHS---CVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242

Length = 1021

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 44.7 bits (106), Expect = 4e-05
 Identities = 41/164 (25%), Positives = 74/164 (45%), Gaps = 40/164 (24%)

Query: 110 LIGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDIECDVMKR--ICH----RNL- 161
           +IG+G FG V     +D G   A+K               + +++++  + H    R++ 
Sbjct: 8   VIGRGAFGEVRLVQKKDTGHIYAMKKLR------------KSEMLEKEQVAHVRAERDIL 55

Query: 162 --------IKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIF---QRLDIMIDVA 210
                   +K+  S+ ++++  L++EY+P G +   L       D F   +    + +  
Sbjct: 56  AEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKK----DTFTEEETRFYIAETI 111

Query: 211 SALEYLH-FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL 253
            A++ +H  GY    IH D+KP N+LLD      LSDFG+   L
Sbjct: 112 LAIDSIHKLGY----IHRDIKPDNLLLDAKGHIKLSDFGLCTGL 151

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 44.2 bits (104), Expect = 6e-05
 Identities = 42/157 (26%), Positives = 70/157 (44%), Gaps = 16/157 (10%)

Query: 149 ECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYI-LDIFQRLDIMI 207
           E  +++ I H ++I++  +++ + F  L+L   P    +   YL+    + I   L I  
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLIL---PRYKTDLYCYLAAKRNIAICDILAIER 189

Query: 208 DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMA-KPLLEEDQSLTQTQTL 266
            V  A++YLH      IIH D+K  N+ ++      L DFG A  P+      +   +  
Sbjct: 190 SVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPV-----DINANKYY 241

Query: 267 ---ATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
               TI   APE           D++S GI+L E+ T
Sbjct: 242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMAT 278

Length = 391

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 43.4 bits (102), Expect = 7e-05
 Identities = 46/197 (23%), Positives = 91/197 (46%), Gaps = 26/197 (13%)

Query: 128 MEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLE 187
           ++V +KV DP +     +F     +M+++ H++++ +      D    +V E++  G L+
Sbjct: 33  IKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLD 92

Query: 188 KCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL-------DDNM 240
             ++  + +L    +  +   +ASAL YL       ++H ++   N+LL       +   
Sbjct: 93  LFMHRKSDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGP 149

Query: 241 VAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMEIF 299
              LSD G+  P+      L++ + +  I ++APE   + +  S   D +SFG  L EI 
Sbjct: 150 FIKLSDPGI--PI----TVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI- 202

Query: 300 TRTKPTDEIFSGEMTLK 316
                    ++GE+ LK
Sbjct: 203 --------CYNGEIPLK 211

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 43.6 bits (103), Expect = 8e-05
 Identities = 36/123 (29%), Positives = 53/123 (43%), Gaps = 33/123 (26%)

Query: 212 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL-------------EEDQ 258
           ALEYLH   +  I+H DLKP N+L+       L+DFG++K  L             ++ +
Sbjct: 113 ALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169

Query: 259 SLTQTQTLATIGYMAPE------YGREGRVSTNGDVYSFGIMLMEIFTRTKP-----TDE 307
                Q   T  Y+APE      YG+        D ++ GI+L E      P      +E
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQGYGKP------VDWWAMGIILYEFLVGCVPFFGDTPEE 223

Query: 308 IFS 310
           +F 
Sbjct: 224 LFG 226

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 43.3 bits (102), Expect = 1e-04
 Identities = 17/31 (54%), Positives = 25/31 (80%)

Query: 2   GSIPDSIGDLINLKSLNLSNNNLSGTIPISL 32
           GSIP+S+G L +L+ LNL+ N+LSG +P +L
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 43.1 bits (101), Expect = 1e-04
 Identities = 41/173 (23%), Positives = 72/173 (41%), Gaps = 47/173 (27%)

Query: 152 VMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILD----------IFQ 201
            + R+ H N++KI     ++        YM     +  LY  +++ D          + Q
Sbjct: 216 ALGRLNHENILKIEEILRSEANT-----YMITQKYDFDLY--SFMYDEAFDWKDRPLLKQ 268

Query: 202 RLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT 261
              IM  +  A+EY+H      +IH D+K  N+ L+ +    L DFG A P  +E +   
Sbjct: 269 TRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKERE--- 322

Query: 262 QTQTLATIGYMAPEYGREGRVSTNG-------------DVYSFGIMLMEIFTR 301
                      A +YG  G V+TN              D++S G++L+++ + 
Sbjct: 323 -----------AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSH 364

Length = 501

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 49/215 (22%), Positives = 100/215 (46%), Gaps = 21/215 (9%)

Query: 103 NDANMPPLIGKGGFGSVYKAIIQDGMEV-AVKVFDPQYEGAFKS----FDIECDVMKRIC 157
           +D  +  +IG+G FG V    ++    + A+K+ + ++E   ++    F  E +V+    
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILN-KWEMLKRAETACFREERNVLVNGD 59

Query: 158 HRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLY-LSNYILDIFQRLDI--MIDVASALE 214
            + +  +  ++ ++++  LV++Y   G L   L    + + +   R  I  M+    ++ 
Sbjct: 60  CQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH 119

Query: 215 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 274
            LH+      +H D+KP NVLLD N    L+DFG    +  +D ++  +  + T  Y++P
Sbjct: 120 QLHY------VHRDIKPDNVLLDMNGHIRLADFGSCLKMN-QDGTVQSSVAVGTPDYISP 172

Query: 275 EYGRE-----GRVSTNGDVYSFGIMLMEIFTRTKP 304
           E  +      G+     D +S G+ + E+     P
Sbjct: 173 EILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 42.5 bits (100), Expect = 2e-04
 Identities = 47/170 (27%), Positives = 76/170 (44%), Gaps = 26/170 (15%)

Query: 110 LIGKGGFGSVYKAIIQ---DGMEVAVKVFDPQYEGAFKSFDI-----ECDVMKRICHRNL 161
           +IGKG FG V   ++Q    G   A+K         FK   +     E DV+       +
Sbjct: 8   VIGKGAFGEV--RLVQKKDTGKIYAMKTL--LKSEMFKKDQLAHVKAERDVLAESDSPWV 63

Query: 162 IKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDI----MIDVASALEYLH 217
           + +  S+ +  +  L++E++P G L   L    Y  D F   D+    M +   A+E +H
Sbjct: 64  VSLYYSFQDAQYLYLIMEFLPGGDLMTMLI--KY--DTFSE-DVTRFYMAECVLAIEAVH 118

Query: 218 -FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL 266
             G+    IH D+KP N+L+D      LSDFG++    ++  S    + L
Sbjct: 119 KLGF----IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLL 164

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 51/202 (25%), Positives = 88/202 (43%), Gaps = 15/202 (7%)

Query: 110 LIGKGGFGSVYKAIIQD---GMEVAVKVFDPQYEGAFKSFD---IECDVMKRICHRNLIK 163
           L+GKG FG V   ++++   G   A+K+   +   A         E  V++   H  L  
Sbjct: 2   LLGKGTFGKV--ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 59

Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIM-IDVASALEYLHFGYSA 222
           +  S+   D    V+EY   G L    +LS   +    R      ++ SAL+YLH     
Sbjct: 60  LKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALDYLH--SEK 115

Query: 223 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRV 282
            +++ DLK  N++LD +    ++DFG+ K  +++    T      T  Y+APE   +   
Sbjct: 116 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMKTFCGTPEYLAPEVLEDNDY 173

Query: 283 STNGDVYSFGIMLMEIFTRTKP 304
               D +  G+++ E+     P
Sbjct: 174 GRAVDWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 42.1 bits (99), Expect = 2e-04
 Identities = 39/147 (26%), Positives = 66/147 (44%), Gaps = 16/147 (10%)

Query: 111 IGKGGFGSVYKAIIQDGMEV-AVK------VFDPQYEGAFKSFDIECDVMKRICHRNLIK 163
           IG G FG V      D   + A+K      V         K+   E D++    +  ++K
Sbjct: 9   IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKA---ERDILAEADNEWVVK 65

Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLH-FGYSA 222
           +  S+ + D    V++Y+P G +   L       +   R  I  ++  A+E +H  G+  
Sbjct: 66  LYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIA-ELTCAIESVHKMGF-- 122

Query: 223 PIIHCDLKPSNVLLDDNMVAHLSDFGM 249
             IH D+KP N+L+D +    L+DFG+
Sbjct: 123 --IHRDIKPDNILIDRDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 42.0 bits (98), Expect = 3e-04
 Identities = 58/223 (26%), Positives = 98/223 (43%), Gaps = 53/223 (23%)

Query: 111 IGKGGFGSVYKAIIQDGME---VAVKVFDPQYEGAFKSFDI--ECDVMKRICHRNLIKII 165
           +G+G +G VYKA  +DG +    A+K    Q EG   S     E  +++ + H N+I + 
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALK----QIEGTGISMSACREIALLRELKHPNVISLQ 64

Query: 166 SSY-SNDDFKA-LVLEYMPHG------------SLEKCLYLSNYILD--IFQRLDIMIDV 209
             + S+ D K  L+ +Y  H             + +K + L   ++   ++Q LD     
Sbjct: 65  KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD----- 119

Query: 210 ASALEYLHFGYSAPIIHCDLKPSNVLL----DDNMVAHLSDFGMA-------KPLLEEDQ 258
              + YLH  +   ++H DLKP+N+L+     +     ++D G A       KPL + D 
Sbjct: 120 --GIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD- 173

Query: 259 SLTQTQTLATIGYMAPEYGREGRVSTNG-DVYSFGIMLMEIFT 300
                  + T  Y APE     R  T   D+++ G +  E+ T
Sbjct: 174 -----PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 41.8 bits (98), Expect = 5e-04
 Identities = 24/53 (45%), Positives = 32/53 (60%)

Query: 2   GSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPR 54
           G IP ++G   NL  L+LS NNL+G IP  L    +L  + +  N LEGEIP+
Sbjct: 346 GEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPK 398

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 41.4 bits (97), Expect = 6e-04
 Identities = 22/52 (42%), Positives = 31/52 (59%)

Query: 2   GSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIP 53
           G IP ++  L  L+ L L +N  SG IP +L K  +L  +++S N L GEIP
Sbjct: 322 GKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIP 373

Length = 968

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 40.6 bits (95), Expect = 6e-04
 Identities = 31/137 (22%), Positives = 59/137 (43%), Gaps = 19/137 (13%)

Query: 176 LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMI------DVASALEYLHFGYSAPIIHCDL 229
           LV EY   G L+   YLS       +   +++      ++A+ + ++H       +H DL
Sbjct: 72  LVFEYCELGDLKS--YLSQE-QWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDL 125

Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEY--GREGRVSTN-- 285
              N  L  ++   + D+G+     +ED   T+      + ++APE      G + T   
Sbjct: 126 ALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQ 185

Query: 286 ---GDVYSFGIMLMEIF 299
               +V++ G+ L E+F
Sbjct: 186 TKPSNVWALGVTLWELF 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 40.8 bits (95), Expect = 7e-04
 Identities = 28/102 (27%), Positives = 53/102 (51%), Gaps = 6/102 (5%)

Query: 149 ECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMID 208
           E D++    +  ++K+  S+ + D    V++Y+P G +   L       ++  R  I  +
Sbjct: 51  ERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA-E 109

Query: 209 VASALEYLH-FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGM 249
           +  A+E +H  G+    IH D+KP N+L+D +    L+DFG+
Sbjct: 110 LTLAIESVHKMGF----IHRDIKPDNILIDLDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 40.1 bits (94), Expect = 0.001
 Identities = 56/223 (25%), Positives = 88/223 (39%), Gaps = 43/223 (19%)

Query: 111 IGKGGFGSVYKAIIQDGMEV-AVKVFDPQYEGAFKSFDIECD------VMKRIC------ 157
           +G+G FG V  A  +   E+ A+K          K   I  D        KRI       
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALK-------KGDIIARDEVESLMCEKRIFETANSE 59

Query: 158 -HRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVAS---AL 213
            H  L+ + + +  +D    V+EY   G L     + +   D+F     +   A     L
Sbjct: 60  RHPFLVNLFACFQTEDHVCFVMEYAAGGDL-----MMHIHTDVFSEPRAVFYAACVVLGL 114

Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ-TQTL-ATIGY 271
           +YLH      I++ DLK  N+LLD      ++DFG+ K    E       T T   T  +
Sbjct: 115 QYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCK----EGMGFGDRTSTFCGTPEF 167

Query: 272 MAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKP-----TDEIF 309
           +APE   E   +   D +  G+++ E+     P      +E+F
Sbjct: 168 LAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVF 210

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 40.0 bits (93), Expect = 0.001
 Identities = 39/149 (26%), Positives = 69/149 (46%), Gaps = 10/149 (6%)

Query: 110 LIGKGGFGSVYKAIIQD-GMEVAVKVF---DPQYEGAFKSFDIECDVMKRICHRNLIKII 165
           +IG+G FG V     +D G   A+K+    D   +        E D++       ++K+ 
Sbjct: 8   VIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMF 67

Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLH-FGYSAPI 224
            S+ +     L++E++P G +   L   + + +   +  I  +   A++ +H  G+    
Sbjct: 68  YSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA-ETVLAIDSIHQLGF---- 122

Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPL 253
           IH D+KP N+LLD      LSDFG+   L
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGL 151

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 40.0 bits (93), Expect = 0.001
 Identities = 20/73 (27%), Positives = 37/73 (50%), Gaps = 1/73 (1%)

Query: 3   SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLS 62
            +P  + +L NL +L+LS N +S  +P  +E L  L+++++S N +   +      +NLS
Sbjct: 177 DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLS 235

Query: 63  VKSFEGNELLCEI 75
                 N+L    
Sbjct: 236 GLELSNNKLEDLP 248

Length = 394

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 36.0 bits (84), Expect = 0.002
 Identities = 16/44 (36%), Positives = 24/44 (54%)

Query: 5  PDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKL 48
            +   L NLK L+LS NNL+   P +   L  L+ +++S N L
Sbjct: 17 DGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 39.2 bits (91), Expect = 0.002
 Identities = 26/101 (25%), Positives = 50/101 (49%), Gaps = 4/101 (3%)

Query: 149 ECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMID 208
           E D++    +  ++++  S+ + D    V++Y+P G +   L       +   R  I  +
Sbjct: 51  ERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIA-E 109

Query: 209 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGM 249
           +  A+E +H       IH D+KP N+L+D +    L+DFG+
Sbjct: 110 LTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|223733 COG0661, AarF, Predicted unusual protein kinase [General function prediction only]

 Score = 39.6 bits (93), Expect = 0.002
 Identities = 33/198 (16%), Positives = 64/198 (32%), Gaps = 72/198 (36%)

Query: 117 GSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRI-------------------- 156
             V++A+++ G EVAVKV   Q  G  +  + +  +++R+                    
Sbjct: 139 AQVHRAVLKSGEEVAVKV---QRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVV 195

Query: 157 --CHRNLI----------------------------KIISSYSNDDFKALVLEYMPHGSL 186
               + L                             K+   Y+      L +E++    +
Sbjct: 196 DEFEKRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRV--LTMEWIDGIKI 253

Query: 187 EKCLYLSNYILDIFQRLDIMIDVASAL------EYLHFGYSAPIIHCDLKPSNVLLDDNM 240
                L +  +D         ++A  L      + L  G+     H D  P N+L+  + 
Sbjct: 254 SDIAALKSAGID-------RKELAELLVRAFLRQLLRDGF----FHADPHPGNILVRSDG 302

Query: 241 VAHLSDFGMAKPLLEEDQ 258
              L DFG+   L  + +
Sbjct: 303 RIVLLDFGIVGRLDPKFR 320

Length = 517

>gnl|CDD|111949 pfam03109, ABC1, ABC1 family

 Score = 37.2 bits (87), Expect = 0.002
 Identities = 15/46 (32%), Positives = 24/46 (52%), Gaps = 3/46 (6%)

Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRI 156
           I       V++A+++DG EVAVKV   Q  G  K    +  ++K +
Sbjct: 19  IAAASIAQVHRAVLKDGEEVAVKV---QRPGVKKRIRSDLKLLKFL 61

This family includes ABC1 from yeast and AarF from E. coli. These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex and E. coli AarF is required for ubiquinone production. It has been suggested that members of the ABC1 family are novel chaperonins. These proteins are unrelated to the ABC transporter proteins. Length = 117

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 39.0 bits (91), Expect = 0.003
 Identities = 17/37 (45%), Positives = 21/37 (56%)

Query: 17  LNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIP 53
           L L N  L G IP  + KL  L+ IN+S N + G IP
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIP 459

Length = 623

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 38.9 bits (90), Expect = 0.003
 Identities = 39/149 (26%), Positives = 69/149 (46%), Gaps = 10/149 (6%)

Query: 110 LIGKGGFGSVYKAIIQD-GMEVAVKVF---DPQYEGAFKSFDIECDVMKRICHRNLIKII 165
           +IG+G FG V     +D G   A+K+    D   +        E D++       ++K+ 
Sbjct: 8   VIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMF 67

Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLH-FGYSAPI 224
            S+ +     L++E++P G +   L   + + +   +  I  +   A++ +H  G+    
Sbjct: 68  YSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIA-ETVLAIDAIHQLGF---- 122

Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPL 253
           IH D+KP N+LLD      LSDFG+   L
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGL 151

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|225213 COG2334, COG2334, Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

 Score = 38.9 bits (91), Expect = 0.003
 Identities = 22/80 (27%), Positives = 31/80 (38%), Gaps = 14/80 (17%)

Query: 177 VLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHF-------GYSAPIIHCDL 229
            LE+            +   LD+ +  D+   + +AL+ L              IIH DL
Sbjct: 151 RLEWDILEPR------ALLRLDLVEPEDLRAALLAALDRLLARLPAHLPALGDQIIHGDL 204

Query: 230 KPSNVLLD-DNMVAHLSDFG 248
            P NVL D D  V+   DF 
Sbjct: 205 HPDNVLFDDDTDVSGFIDFD 224

Length = 331

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 38.7 bits (90), Expect = 0.004
 Identities = 23/74 (31%), Positives = 35/74 (47%), Gaps = 6/74 (8%)

Query: 2   GSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGP---- 57
           G IP+ +    NL  L L +N+L G IP SL     L+ + +  N   GE+P E      
Sbjct: 370 GEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPL 429

Query: 58  --FRNLSVKSFEGN 69
             F ++S  + +G 
Sbjct: 430 VYFLDISNNNLQGR 443

Length = 968

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 38.4 bits (89), Expect = 0.004
 Identities = 26/80 (32%), Positives = 45/80 (56%), Gaps = 4/80 (5%)

Query: 3   SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPF-RNL 61
           S+P  + +L NLK+L+LS N+LS  +P  L  L +L ++++S NK+  ++P E      L
Sbjct: 154 SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSAL 211

Query: 62  SVKSFEGNELLCEIVLPLST 81
                  N ++ E++  LS 
Sbjct: 212 EELDLSNNSII-ELLSSLSN 230

Length = 394

>gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated

 Score = 38.7 bits (91), Expect = 0.004
 Identities = 16/53 (30%), Positives = 28/53 (52%), Gaps = 4/53 (7%)

Query: 199 IFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAK 251
           +    +++  V   +  LH    A I+H DL  SN ++ D+ + +L DFG+ K
Sbjct: 427 LEGNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIVRDDRL-YLIDFGLGK 475

Length = 535

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	346
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.98
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.98
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG1152	772	consensus Signal transduction serine/threonine kin	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.96
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.96
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.96
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.95
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.95
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.94
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.94
PLN00181	793	protein SPA1-RELATED; Provisional	99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.93
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.93
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.92
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.92
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.92
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.91
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.9
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.89
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.89
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.88
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.86
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.86
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.85
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.85
PRK12274	218	serine/threonine protein kinase; Provisional	99.85
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.84
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.83
PRK10345	210	hypothetical protein; Provisional	99.82
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.82
PRK14879	211	serine/threonine protein kinase; Provisional	99.81
smart00090	237	RIO RIO-like kinase.	99.8
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.79
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.79
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.78
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.75
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.74
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.72
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.71
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.68
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.67
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.62
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.57
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.47
KOG1243	690	consensus Protein kinase [General function predict	99.47
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.43
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.42
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.42
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.4
KOG3087	229	consensus Serine/threonine protein kinase [General	99.4
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.33
PLN03150	623	hypothetical protein; Provisional	99.18
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.18
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.18
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.16
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.15
PLN03150	623	hypothetical protein; Provisional	99.07
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.04
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.02
COG4248	637	Uncharacterized protein with protein kinase and he	98.94
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.93
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.88
PRK09902	216	hypothetical protein; Provisional	98.84
PF12799	44	LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_	98.78
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.72
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	98.72
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.7
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.67
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.65
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.63
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.63
KOG0617	264	consensus Ras suppressor protein (contains leucine	98.62
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.52
KOG0472	565	consensus Leucine-rich repeat protein [Function un	98.51
PF01636	239	APH: Phosphotransferase enzyme family This family	98.45
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.39
KOG0617	264	consensus Ras suppressor protein (contains leucine	98.31
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.29
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.26
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.26
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.24
PLN02876	822	acyl-CoA dehydrogenase	98.23
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.18
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	98.16
KOG0472	565	consensus Leucine-rich repeat protein [Function un	98.15
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	98.14
PRK10593	297	hypothetical protein; Provisional	98.12
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.11
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	98.11
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.09
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	98.08
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.91
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.89
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	97.86
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	97.83
PRK05231	319	homoserine kinase; Provisional	97.82
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.79
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.79
PF00560	22	LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Le	97.76
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.68
KOG2270	520	consensus Serine/threonine protein kinase involved	97.65
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.62
PLN02236	344	choline kinase	97.56
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.51
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	97.45
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	97.4
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	97.38

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-51  Score=372.11  Aligned_cols=232  Identities=41%  Similarity=0.677  Sum_probs=199.4

Q ss_pred             CCCCCCCcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCC-ceeEEEecC
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDD-FKALVLEYM  181 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~  181 (346)
                      +.|...+.||+|+||.||+|.+++|..||||++........++|..|++++.+++|||+|+++|||.+.+ ..+||||||
T Consensus        75 ~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym  154 (361)
T KOG1187|consen   75 NNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYM  154 (361)
T ss_pred             hCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEcc
Confidence            6788899999999999999999999999999987654331456999999999999999999999999999 499999999


Q ss_pred             CCCChhhhhhhcCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccc
Q 039799          182 PHGSLEKCLYLSNY-ILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  260 (346)
Q Consensus       182 ~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~  260 (346)
                      ++|+|.++++.... .++|.+|++||.++|+||+|||+.+.++|+||||||+|||+|+++++||+|||+|+.....  ..
T Consensus       155 ~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~--~~  232 (361)
T KOG1187|consen  155 PNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG--DT  232 (361)
T ss_pred             CCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc--cc
Confidence            99999999987766 8999999999999999999999999999999999999999999999999999999754331  11


Q ss_pred             ccccc-cCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccc-cCcccHHHHHhhhcCC-Chhhhhchhcc
Q 039799          261 TQTQT-LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIF-SGEMTLKRWVNDLLPI-SVMEVVDANLL  336 (346)
Q Consensus       261 ~~~~~-~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~-~~~~~~~~~~~~~~~~-~~~~~~d~~l~  336 (346)
                      ..... .||.+|+|||+...+..+.|+|||||||+|+|++||++|.+... .++..+..|+...+.. .+.+++|+.|.
T Consensus       233 ~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~  311 (361)
T KOG1187|consen  233 SVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLK  311 (361)
T ss_pred             ceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCcc
Confidence            11112 79999999999999999999999999999999999999998754 4455688887666544 55555555543

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=6.6e-50  Score=409.36  Aligned_cols=226  Identities=24%  Similarity=0.382  Sum_probs=186.0

Q ss_pred             CCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecCCC
Q 039799          105 ANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPH  183 (346)
Q Consensus       105 ~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  183 (346)
                      +...+.||+|+||.||+|... ++..||+|.+......    ...|++.+++++||||++++++|.+.+..++||||+++
T Consensus       692 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~  767 (968)
T PLN00113        692 LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEG  767 (968)
T ss_pred             CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCC
Confidence            345568999999999999974 7899999998643321    23468899999999999999999999999999999999


Q ss_pred             CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccccc
Q 039799          184 GSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT  263 (346)
Q Consensus       184 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~~  263 (346)
                      |+|.++++    .++|..+.+++.++++|++|||+.++++|+||||||+||+++.++.+++. ||.......      ..
T Consensus       768 g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~------~~  836 (968)
T PLN00113        768 KNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT------DT  836 (968)
T ss_pred             CcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc------CC
Confidence            99999885    38999999999999999999998878899999999999999999888875 665543211      12


Q ss_pred             cccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHhhhcC-------------C-----
Q 039799          264 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLP-------------I-----  325 (346)
Q Consensus       264 ~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~-------------~-----  325 (346)
                      ...++..|+|||+..+..++.++|||||||++|||+||+.||+..........+|++....             .     
T Consensus       837 ~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  916 (968)
T PLN00113        837 KCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVN  916 (968)
T ss_pred             CccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCcc
Confidence            2357899999999999999999999999999999999999997655544555555543221             0     


Q ss_pred             -----ChhhhhchhccCCccccccc
Q 039799          326 -----SVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       326 -----~~~~~~d~~l~~~p~~R~~~  345 (346)
                           .+.+++.+|+..+|++||++
T Consensus       917 ~~~~~~~~~l~~~Cl~~~P~~RPt~  941 (968)
T PLN00113        917 QNEIVEVMNLALHCTATDPTARPCA  941 (968)
T ss_pred             HHHHHHHHHHHHhhCcCCchhCcCH
Confidence                 24567789999999999986

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-49  Score=340.27  Aligned_cols=236  Identities=28%  Similarity=0.406  Sum_probs=198.7

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC--CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEE
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ--YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALV  177 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  177 (346)
                      ...+|...+.||.|+|++||+|+++ ++.+||||.+...  .....+.+..|+++|+.++|||||.+++++..++..+||
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV   87 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV   87 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence            3467889999999999999999976 7899999999765  455677888999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCC------CcEEEeeecCCc
Q 039799          178 LEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDN------MVAHLSDFGMAK  251 (346)
Q Consensus       178 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~------~~~~l~Dfg~~~  251 (346)
                      ||||.||+|.++++..+ .++..+...++.|+|.|+++||   +.+|+||||||.|||++..      -.+||+|||+|+
T Consensus        88 MEyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR  163 (429)
T KOG0595|consen   88 MEYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR  163 (429)
T ss_pred             EEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence            99999999999997544 6889999999999999999999   9999999999999999764      468999999999


Q ss_pred             cCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCc--------ccHHHHHhhhc
Q 039799          252 PLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE--------MTLKRWVNDLL  323 (346)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~--------~~~~~~~~~~~  323 (346)
                      .+.+.   ....+.+|++-|||||+.+.++|+.|+|+||.|+|+||+++|+.||+.....+        .+..+.....+
T Consensus       164 ~L~~~---~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~  240 (429)
T KOG0595|consen  164 FLQPG---SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAEL  240 (429)
T ss_pred             hCCch---hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhc
Confidence            88643   33456789999999999999999999999999999999999999998533221        12222223333


Q ss_pred             CCChhhhhchhccCCccccc
Q 039799          324 PISVMEVVDANLLSQEDEHF  343 (346)
Q Consensus       324 ~~~~~~~~d~~l~~~p~~R~  343 (346)
                      .....+++-+.+..++++|.
T Consensus       241 s~~~~~Ll~~ll~~~~~~~~  260 (429)
T KOG0595|consen  241 SNPLRELLISLLQRNPKDRI  260 (429)
T ss_pred             cCchhhhhhHHHhcCccccC
Confidence            34556777777777777664

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-48  Score=348.19  Aligned_cols=236  Identities=30%  Similarity=0.449  Sum_probs=199.3

Q ss_pred             CCCCCCcccccCceEEEEEEEcCCCEEEEEEecCCCch--hHHHHHHHHHHHHhcCCCCceeeEEEEecCC-ceeEEEec
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEG--AFKSFDIECDVMKRICHRNLIKIISSYSNDD-FKALVLEY  180 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~  180 (346)
                      +..+.+.+|+|+||+||+|.|+....||||++......  ..+.|.+|+.++.+++|||||+++|+|.+.. ...+||||
T Consensus        42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy  121 (362)
T KOG0192|consen   42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY  121 (362)
T ss_pred             HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence            34556669999999999999995555999999765322  2568999999999999999999999999887 78999999


Q ss_pred             CCCCChhhhhhh-cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-eeecCCCCCceEECCCC-cEEEeeecCCccCCccc
Q 039799          181 MPHGSLEKCLYL-SNYILDIFQRLDIMIDVASALEYLHFGYSAP-IIHCDLKPSNVLLDDNM-VAHLSDFGMAKPLLEED  257 (346)
Q Consensus       181 ~~~gsL~~~l~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-i~H~dik~~NIll~~~~-~~~l~Dfg~~~~~~~~~  257 (346)
                      +++|+|.++++. ....+++..+++++.+||+|+.|||   +.+ |+||||||+|||++.++ ++||+|||+++......
T Consensus       122 ~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~  198 (362)
T KOG0192|consen  122 MPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK  198 (362)
T ss_pred             CCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence            999999999987 4788999999999999999999999   888 99999999999999997 99999999998754321


Q ss_pred             cccccccccCCcccccCCCCC--CCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH--------hhhcCCCh
Q 039799          258 QSLTQTQTLATIGYMAPEYGR--EGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV--------NDLLPISV  327 (346)
Q Consensus       258 ~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~--------~~~~~~~~  327 (346)
                        ...+...||..|||||.+.  ...++.|+||||||+++|||+||+.||..... .......+        ....+..+
T Consensus       199 --~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~~~~v~~~~~Rp~~p~~~~~~l  275 (362)
T KOG0192|consen  199 --TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQVASAVVVGGLRPPIPKECPPHL  275 (362)
T ss_pred             --ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHhcCCCCCCCccCCHHH
Confidence              2333467999999999999  56899999999999999999999999988654 22222222        22244588


Q ss_pred             hhhhchhccCCccccccc
Q 039799          328 MEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       328 ~~~~d~~l~~~p~~R~~~  345 (346)
                      .+++++||..||+.||+-
T Consensus       276 ~~l~~~CW~~dp~~RP~f  293 (362)
T KOG0192|consen  276 SSLMERCWLVDPSRRPSF  293 (362)
T ss_pred             HHHHHHhCCCCCCcCCCH
Confidence            999999999999999973

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-48  Score=335.77  Aligned_cols=237  Identities=24%  Similarity=0.295  Sum_probs=201.8

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCC-ceeEEEe
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDD-FKALVLE  179 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e  179 (346)
                      ++....+.||+|..|+||++.++ +++.+|+|++..+. +...+++.+|+++++.++||+||.++|.|.... ...++||
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE  158 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME  158 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence            35566788999999999999987 78899999995443 455788999999999999999999999999888 4999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccc
Q 039799          180 YMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  259 (346)
Q Consensus       180 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~  259 (346)
                      ||++|||.+++... ..+++...-+++.++++||.|||+  ++.|+||||||+|||++..|++||+|||.++.+...   
T Consensus       159 YMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---  232 (364)
T KOG0581|consen  159 YMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---  232 (364)
T ss_pred             hcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence            99999999988643 668899999999999999999993  389999999999999999999999999999976432   


Q ss_pred             cccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCcccc---CcccHHHHHhh---------hcCCCh
Q 039799          260 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFS---GEMTLKRWVND---------LLPISV  327 (346)
Q Consensus       260 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~---~~~~~~~~~~~---------~~~~~~  327 (346)
                       ...+.+||..|||||.+.+..|+.++||||||+.++|+.+|+.|+.....   +..++..++-.         .+++++
T Consensus       233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef  311 (364)
T KOG0581|consen  233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEF  311 (364)
T ss_pred             -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHH
Confidence             34567899999999999999999999999999999999999999976411   22233333322         133358


Q ss_pred             hhhhchhccCCcccccccC
Q 039799          328 MEVVDANLLSQEDEHFTTK  346 (346)
Q Consensus       328 ~~~~d~~l~~~p~~R~~~k  346 (346)
                      .++++.||..||.+|++++
T Consensus       312 ~~FV~~CL~Kdp~~R~s~~  330 (364)
T KOG0581|consen  312 RSFVSCCLRKDPSERPSAK  330 (364)
T ss_pred             HHHHHHHhcCCcccCCCHH
Confidence            9999999999999999874

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-48  Score=338.27  Aligned_cols=238  Identities=24%  Similarity=0.372  Sum_probs=195.8

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCch-------hHHHHHHHHHHHHhcCCCCceeeEEEEecCC
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEG-------AFKSFDIECDVMKRICHRNLIKIISSYSNDD  172 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  172 (346)
                      .++.|-+.+.||+|+||.|-+|..+ +|+.||||++++..-.       ......+|+++|++++|||||++.+++...+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            4567889999999999999999855 8999999999765311       1233568999999999999999999999999


Q ss_pred             ceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCC---CcEEEeeecC
Q 039799          173 FKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDN---MVAHLSDFGM  249 (346)
Q Consensus       173 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~---~~~~l~Dfg~  249 (346)
                      +.||||||++||.|.+.+-. ...+....-..++.|++.|+.|||   ++||+||||||+|||+..+   ..+||+|||+
T Consensus       250 s~YmVlE~v~GGeLfd~vv~-nk~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDFGl  325 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVA-NKYLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDFGL  325 (475)
T ss_pred             ceEEEEEEecCccHHHHHHh-ccccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEecccch
Confidence            99999999999999998753 344555666779999999999999   9999999999999999755   7899999999


Q ss_pred             CccCCccccccccccccCCcccccCCCCCCCCC---CcchhHHHHHHHHHHHHcCCCCCCccccCcc----------cHH
Q 039799          250 AKPLLEEDQSLTQTQTLATIGYMAPEYGREGRV---STNGDVYSFGIMLMEIFTRTKPTDEIFSGEM----------TLK  316 (346)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Dv~s~G~il~elltg~~p~~~~~~~~~----------~~~  316 (346)
                      |+...   ......+.+||+.|.|||++.+..+   ..++|+||+||+||-+++|.+||.+......          ...
T Consensus       326 AK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~  402 (475)
T KOG0615|consen  326 AKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFG  402 (475)
T ss_pred             hhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCccccc
Confidence            99864   2344567889999999999876543   4478999999999999999999987433321          112


Q ss_pred             HHHhhhcCCChhhhhchhccCCccccccc
Q 039799          317 RWVNDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       317 ~~~~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ......+.++..++|+.+|..||++||++
T Consensus       403 p~~w~~Iseea~dlI~~mL~VdP~~R~s~  431 (475)
T KOG0615|consen  403 PLQWDRISEEALDLINWMLVVDPENRPSA  431 (475)
T ss_pred             ChhhhhhhHHHHHHHHHhhEeCcccCcCH
Confidence            22233345578899999999999999986

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.2e-47  Score=343.53  Aligned_cols=236  Identities=25%  Similarity=0.346  Sum_probs=205.5

Q ss_pred             CCCCCCCcccccCceEEEEEEE-cCCCEEEEEEecCC---CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEE
Q 039799          103 NDANMPPLIGKGGFGSVYKAII-QDGMEVAVKVFDPQ---YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVL  178 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  178 (346)
                      ..|...++||+|+|+.+|.++. ..|+.||+|++.+.   .....+...+|+++.++|+|||||+++++|++.++.|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            4689999999999999999997 78999999999753   3455678899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccc
Q 039799          179 EYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  258 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~  258 (346)
                      |+|++++|-.+++ ....+++..+..+..||+.|+.|||   +.+|+|||||..|+|++++.++||+|||+|..+..++.
T Consensus        98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E  173 (592)
T KOG0575|consen   98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE  173 (592)
T ss_pred             EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecCccc
Confidence            9999999999887 7788999999999999999999999   99999999999999999999999999999998865432


Q ss_pred             ccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH------hhhcCCChhhhhc
Q 039799          259 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV------NDLLPISVMEVVD  332 (346)
Q Consensus       259 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~------~~~~~~~~~~~~d  332 (346)
                        ...+.+||+-|+|||++.....+..+||||+||+||-|++|++||+...-.+ .+....      ...+.....++|.
T Consensus       174 --rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke-ty~~Ik~~~Y~~P~~ls~~A~dLI~  250 (592)
T KOG0575|consen  174 --RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE-TYNKIKLNEYSMPSHLSAEAKDLIR  250 (592)
T ss_pred             --ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH-HHHHHHhcCcccccccCHHHHHHHH
Confidence              2345689999999999999999999999999999999999999998742111 111111      1123347789999


Q ss_pred             hhccCCccccccc
Q 039799          333 ANLLSQEDEHFTT  345 (346)
Q Consensus       333 ~~l~~~p~~R~~~  345 (346)
                      ++|..+|.+|||.
T Consensus       251 ~lL~~~P~~Rpsl  263 (592)
T KOG0575|consen  251 KLLRPNPSERPSL  263 (592)
T ss_pred             HHhcCCcccCCCH
Confidence            9999999999985

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-47  Score=340.49  Aligned_cols=242  Identities=26%  Similarity=0.442  Sum_probs=205.5

Q ss_pred             CCCCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhc-CCCCceeeEEEEecCCc
Q 039799           99 KPLPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRI-CHRNLIKIISSYSNDDF  173 (346)
Q Consensus        99 ~~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  173 (346)
                      +..+++|.+++.||+|+|++|++|+.. .+++||||++.+..   +...+....|-+.|.+| .||.|++++..|.+...
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            556789999999999999999999855 79999999997542   23345677899999999 89999999999999999


Q ss_pred             eeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccC
Q 039799          174 KALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  253 (346)
Q Consensus       174 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~  253 (346)
                      +|+|+||+++|+|.+++... ..+++.....++.+|+.||+|||   +.|||||||||+|||+|++++++|+|||.|+.+
T Consensus       149 LYFvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l  224 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKIL  224 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccC
Confidence            99999999999999999754 55777778889999999999999   999999999999999999999999999999988


Q ss_pred             Cccccc---------cc--cccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH---
Q 039799          254 LEEDQS---------LT--QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV---  319 (346)
Q Consensus       254 ~~~~~~---------~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~---  319 (346)
                      .+....         ..  ....+||..|.+||++.++..+..+|+|+||||+|+|+.|++||...- +-..+.+.+   
T Consensus       225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N-eyliFqkI~~l~  303 (604)
T KOG0592|consen  225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN-EYLIFQKIQALD  303 (604)
T ss_pred             ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc-HHHHHHHHHHhc
Confidence            653221         11  144789999999999999999999999999999999999999997621 111222222   


Q ss_pred             ---hhhcCCChhhhhchhccCCccccccc
Q 039799          320 ---NDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       320 ---~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                         ...+++.+.+++++.|..||++|+++
T Consensus       304 y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~  332 (604)
T KOG0592|consen  304 YEFPEGFPEDARDLIKKLLVRDPSDRLTS  332 (604)
T ss_pred             ccCCCCCCHHHHHHHHHHHccCccccccH
Confidence               23345688999999999999999986

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-46  Score=323.44  Aligned_cols=236  Identities=27%  Similarity=0.369  Sum_probs=199.9

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeE
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKAL  176 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  176 (346)
                      .+++|++.++||+|+||.||.++.+ +++-+|+|++++..   ....+....|..++.+++||.||+++..|.+.+.+||
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl  102 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL  102 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence            4578999999999999999999865 78999999997653   3345678889999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcc
Q 039799          177 VLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  256 (346)
Q Consensus       177 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~  256 (346)
                      |+||+.||.|..+|+. +..+++..+.-++..|+.||.|||   +.+|+|||+||+|||+|++|+++|+|||+|+.....
T Consensus       103 Vld~~~GGeLf~hL~~-eg~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~  178 (357)
T KOG0598|consen  103 VLDYLNGGELFYHLQR-EGRFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD  178 (357)
T ss_pred             EEeccCCccHHHHHHh-cCCcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence            9999999999999874 455777777789999999999999   999999999999999999999999999999964332


Q ss_pred             ccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH-------hhhcCCChhh
Q 039799          257 DQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV-------NDLLPISVME  329 (346)
Q Consensus       257 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~  329 (346)
                      +  ....+.+||+.|+|||++.+..|+..+|.||+|+++|||++|.+||....... ......       ...++....+
T Consensus       179 ~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~-~~~~I~~~k~~~~p~~ls~~ard  255 (357)
T KOG0598|consen  179 G--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK-MYDKILKGKLPLPPGYLSEEARD  255 (357)
T ss_pred             C--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH-HHHHHhcCcCCCCCccCCHHHHH
Confidence            2  23345789999999999999999999999999999999999999997622111 111111       1123447799


Q ss_pred             hhchhccCCccccc
Q 039799          330 VVDANLLSQEDEHF  343 (346)
Q Consensus       330 ~~d~~l~~~p~~R~  343 (346)
                      ++.+.|..+|++|.
T Consensus       256 ll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  256 LLKKLLKRDPRQRL  269 (357)
T ss_pred             HHHHHhccCHHHhc
Confidence            99999999999997

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-46  Score=333.91  Aligned_cols=231  Identities=29%  Similarity=0.452  Sum_probs=199.0

Q ss_pred             CCCcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecCCCCCh
Q 039799          107 MPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSL  186 (346)
Q Consensus       107 ~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  186 (346)
                      ..+.||+|.||+||.|.|+....||+|.+.... ...+.|.+|+++|++|+|+|||++++.|...+.++||||||+.|+|
T Consensus       210 l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsL  288 (468)
T KOG0197|consen  210 LIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSL  288 (468)
T ss_pred             HHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcH
Confidence            345799999999999999988899999998652 3457888999999999999999999999999999999999999999


Q ss_pred             hhhhhh-cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccccccc
Q 039799          187 EKCLYL-SNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT  265 (346)
Q Consensus       187 ~~~l~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~  265 (346)
                      .++|.. ....+...+.+.++.|||+|++||+   ++++|||||.+.|||++++..+||+|||+|+...++ ........
T Consensus       289 l~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~-~Y~~~~~~  364 (468)
T KOG0197|consen  289 LDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDD-EYTASEGG  364 (468)
T ss_pred             HHHhhhcCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccccCCC-ceeecCCC
Confidence            999986 5577899999999999999999999   999999999999999999999999999999954332 22223333


Q ss_pred             cCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHh--------hhcCCChhhhhchhcc
Q 039799          266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVN--------DLLPISVMEVVDANLL  336 (346)
Q Consensus       266 ~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~d~~l~  336 (346)
                      .-...|.|||.+..+.++.|||||||||+||||+| |+.|+..+...  ++.+.+.        ...|+.+.+++..|+.
T Consensus       365 kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~--ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~  442 (468)
T KOG0197|consen  365 KFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE--EVLELLERGYRLPRPEGCPDEVYELMKSCWH  442 (468)
T ss_pred             CCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH--HHHHHHhccCcCCCCCCCCHHHHHHHHHHhh
Confidence            45778999999999999999999999999999998 99998775422  2333333        2345689999999999


Q ss_pred             CCcccccc
Q 039799          337 SQEDEHFT  344 (346)
Q Consensus       337 ~~p~~R~~  344 (346)
                      .+|++|||
T Consensus       443 ~~P~~RPt  450 (468)
T KOG0197|consen  443 EDPEDRPT  450 (468)
T ss_pred             CCcccCCC
Confidence            99999998

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.3e-47  Score=315.57  Aligned_cols=239  Identities=23%  Similarity=0.350  Sum_probs=199.4

Q ss_pred             CCCCCCCCcccccCceEEEEEE-EcCCCEEEEEEecCC--CchhHHHHHHHHHHHHhcCCCCceeeEE-EEecCCc-eeE
Q 039799          102 PNDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQ--YEGAFKSFDIECDVMKRICHRNLIKIIS-SYSNDDF-KAL  176 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~-~~~~~~~-~~l  176 (346)
                      -.+|.+.+.||.|.||+||++. ..+|..+|.|.++-.  .....+.+..|+.+|++|+|||||++++ .+.++.. .++
T Consensus        18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni   97 (375)
T KOG0591|consen   18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI   97 (375)
T ss_pred             HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence            3468888999999999999997 458999999987632  3456778899999999999999999998 5555554 889


Q ss_pred             EEecCCCCChhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeecCCCCCceEECCCCcEEEeeecCCc
Q 039799          177 VLEYMPHGSLEKCLYL---SNYILDIFQRLDIMIDVASALEYLHFGYSAP--IIHCDLKPSNVLLDDNMVAHLSDFGMAK  251 (346)
Q Consensus       177 v~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~dik~~NIll~~~~~~~l~Dfg~~~  251 (346)
                      |||++.+|+|.+.++.   ....+++..+|+++.|+++||..+|.-+ +.  |+||||||.||+++.+|.+||+|||+++
T Consensus        98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r  176 (375)
T KOG0591|consen   98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGR  176 (375)
T ss_pred             HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHh
Confidence            9999999999998853   3467999999999999999999999322 44  8999999999999999999999999999


Q ss_pred             cCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh---------hh
Q 039799          252 PLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN---------DL  322 (346)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~---------~~  322 (346)
                      .+....  ......+|||.||+||.+.+.+|+.|+||||+||++|||+.-+.||...  .-..+.+.+.         ..
T Consensus       177 ~l~s~~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~--n~~~L~~KI~qgd~~~~p~~~  252 (375)
T KOG0591|consen  177 FLSSKT--TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD--NLLSLCKKIEQGDYPPLPDEH  252 (375)
T ss_pred             Hhcchh--HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc--cHHHHHHHHHcCCCCCCcHHH
Confidence            875432  2344568999999999999999999999999999999999999999763  1122222221         33


Q ss_pred             cCCChhhhhchhccCCccccccc
Q 039799          323 LPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       323 ~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ++..+.+++.-|+..||+.||+|
T Consensus       253 YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  253 YSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             hhhHHHHHHHHHccCCcccCCCc
Confidence            34588999999999999999985

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-45  Score=317.68  Aligned_cols=241  Identities=29%  Similarity=0.410  Sum_probs=197.4

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCC--ceeEEE
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDD--FKALVL  178 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv~  178 (346)
                      ..++...+.||+|+||+||++... +|...|||..........+.+.+|+.+|++++|||||+++|......  .+++.|
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m   95 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM   95 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence            345778899999999999999966 58999999987654333677899999999999999999999855444  688999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC-CCcEEEeeecCCccCCc-c
Q 039799          179 EYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD-NMVAHLSDFGMAKPLLE-E  256 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~-~~~~~l~Dfg~~~~~~~-~  256 (346)
                      ||+++|+|.+++...+..++...+..+..++++||+|||   +++|+||||||+|||++. ++.+||+|||+++.... .
T Consensus        96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~  172 (313)
T KOG0198|consen   96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG  172 (313)
T ss_pred             eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence            999999999999866557999999999999999999999   999999999999999999 79999999999997653 1


Q ss_pred             ccccccccccCCcccccCCCCCCC-CCCcchhHHHHHHHHHHHHcCCCCCCcc-ccCcccH-------HHHHhhhcCCCh
Q 039799          257 DQSLTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMEIFTRTKPTDEI-FSGEMTL-------KRWVNDLLPISV  327 (346)
Q Consensus       257 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~-~~~~~~~-------~~~~~~~~~~~~  327 (346)
                      ..........||+.|+|||+...+ ....++||||+||++.||+||+.||..- ......+       .+.+...+++..
T Consensus       173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a  252 (313)
T KOG0198|consen  173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEA  252 (313)
T ss_pred             ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHH
Confidence            112223346799999999999854 3345999999999999999999999862 1111111       112333345578


Q ss_pred             hhhhchhccCCccccccc
Q 039799          328 MEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       328 ~~~~d~~l~~~p~~R~~~  345 (346)
                      .+++.+|+..+|++|||+
T Consensus       253 ~~Fl~~C~~~~p~~Rpta  270 (313)
T KOG0198|consen  253 KDFLRKCFKRDPEKRPTA  270 (313)
T ss_pred             HHHHHHHhhcCcccCcCH
Confidence            999999999999999986

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-44  Score=320.58  Aligned_cols=239  Identities=29%  Similarity=0.357  Sum_probs=199.1

Q ss_pred             CCCCCCCCcccccCceEEEEEE-EcCCCEEEEEEecCC--CchhHHHHHHHHHHHHhcCCCCceeeEEEEecC--CceeE
Q 039799          102 PNDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQ--YEGAFKSFDIECDVMKRICHRNLIKIISSYSND--DFKAL  176 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l  176 (346)
                      .+.|+....||+|+||.||+|+ ..+|+.||+|++...  .++...-..+|+.+|+++.||||+++.+...+.  ...||
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            3568888999999999999998 458999999987643  355566778899999999999999999988766  68999


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcc
Q 039799          177 VLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  256 (346)
Q Consensus       177 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~  256 (346)
                      |+|||++ +|.-++......++..++..++.|++.||+|+|   +++|+|||||.+|||+|.+|.+||+|||+|+++...
T Consensus       196 VFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~  271 (560)
T KOG0600|consen  196 VFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS  271 (560)
T ss_pred             EEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence            9999977 788877777788999999999999999999999   999999999999999999999999999999987654


Q ss_pred             ccccccccccCCcccccCCCCCCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccCcc----------------------
Q 039799          257 DQSLTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM----------------------  313 (346)
Q Consensus       257 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~----------------------  313 (346)
                      . ....+..+-|.+|.|||++.+. .|+..+|+||.||||.||++|++.+....+-++                      
T Consensus       272 ~-~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP  350 (560)
T KOG0600|consen  272 G-SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLP  350 (560)
T ss_pred             C-CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCC
Confidence            3 2336677889999999988765 699999999999999999999998864221110                      


Q ss_pred             ---------cHHHHHh---hhcCCChhhhhchhccCCccccccc
Q 039799          314 ---------TLKRWVN---DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       314 ---------~~~~~~~---~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                               ...+.+.   ..++....++++++|..||++|.|+
T Consensus       351 ~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA  394 (560)
T KOG0600|consen  351 HATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTA  394 (560)
T ss_pred             cccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccH
Confidence                     1111111   1233466789999999999999886

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=7.4e-45  Score=303.57  Aligned_cols=236  Identities=23%  Similarity=0.285  Sum_probs=194.4

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC--CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEec
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ--YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEY  180 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  180 (346)
                      .|+....+|+|+||.||+++.+ +|+.||||+|...  .+...+...+|+++|++++|+|+|.+++.|..+...+||+||
T Consensus         3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~   82 (396)
T KOG0593|consen    3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY   82 (396)
T ss_pred             HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence            4677788999999999999977 7999999999643  344567788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccc
Q 039799          181 MPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  260 (346)
Q Consensus       181 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~  260 (346)
                      ++..-|. -++.....++.....+++.|++.|+.|+|   +.+++||||||+|||++.++.+||+|||+|+.+..++.. 
T Consensus        83 ~dhTvL~-eLe~~p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~-  157 (396)
T KOG0593|consen   83 CDHTVLH-ELERYPNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDN-  157 (396)
T ss_pred             cchHHHH-HHHhccCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcCCcch-
Confidence            9885554 45556667888899999999999999999   999999999999999999999999999999988653332 


Q ss_pred             ccccccCCcccccCCCCCC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccCcc--------------------------
Q 039799          261 TQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM--------------------------  313 (346)
Q Consensus       261 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~--------------------------  313 (346)
                       .+..+.|.+|.|||.+.+ .+|+..+||||.||++.||+||.+-|....+-++                          
T Consensus       158 -YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~  236 (396)
T KOG0593|consen  158 -YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH  236 (396)
T ss_pred             -hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence             345578999999999887 6899999999999999999999998754221111                          


Q ss_pred             -------cHHHHHhhhcCC---ChhhhhchhccCCccccccc
Q 039799          314 -------TLKRWVNDLLPI---SVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       314 -------~~~~~~~~~~~~---~~~~~~d~~l~~~p~~R~~~  345 (346)
                             .-.+-.+..+|.   -+.+++.+||..||++|+++
T Consensus       237 Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc  278 (396)
T KOG0593|consen  237 GVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSC  278 (396)
T ss_pred             eeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccH
Confidence                   000011111222   55799999999999999985

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-43  Score=318.83  Aligned_cols=237  Identities=24%  Similarity=0.353  Sum_probs=200.4

Q ss_pred             CCCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC----Cc-hhHHHHHHHHHHHHhcC-CCCceeeEEEEecCC
Q 039799          100 PLPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ----YE-GAFKSFDIECDVMKRIC-HRNLIKIISSYSNDD  172 (346)
Q Consensus       100 ~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~  172 (346)
                      .....|.+.+.||+|+||+|+.|... +++.||+|+++..    .. ...+.+.+|+.++++++ ||||+++++++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            34567999999999999999999855 7899999987653    12 23456678999999999 999999999999999


Q ss_pred             ceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCC-CcEEEeeecCCc
Q 039799          173 FKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDN-MVAHLSDFGMAK  251 (346)
Q Consensus       173 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~-~~~~l~Dfg~~~  251 (346)
                      ..++||||+.+|+|.+++.. ...+.+.....++.|+++|++|||   +.+|+||||||+|||+|.+ +++||+|||++.
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~  169 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLSA  169 (370)
T ss_pred             eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence            99999999999999999987 667888889999999999999999   9999999999999999999 999999999999


Q ss_pred             cCCccccccccccccCCcccccCCCCCCCC-C-CcchhHHHHHHHHHHHHcCCCCCCccc---------cCcccHHHHHh
Q 039799          252 PLLEEDQSLTQTQTLATIGYMAPEYGREGR-V-STNGDVYSFGIMLMEIFTRTKPTDEIF---------SGEMTLKRWVN  320 (346)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~-~~~~Dv~s~G~il~elltg~~p~~~~~---------~~~~~~~~~~~  320 (346)
                      ...  .........+||+.|+|||++.+.. | +.++||||+||+||.|++|+.||++..         .+...+..|+.
T Consensus       170 ~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~  247 (370)
T KOG0583|consen  170 ISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLL  247 (370)
T ss_pred             ccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcC
Confidence            763  1223345677999999999999876 6 478999999999999999999998721         11122222222


Q ss_pred             hhcCCChhhhhchhccCCccccccc
Q 039799          321 DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       321 ~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                         .....+++.++|..+|.+|++.
T Consensus       248 ---S~~~~~Li~~mL~~~P~~R~t~  269 (370)
T KOG0583|consen  248 ---SPEARSLIEKMLVPDPSTRITL  269 (370)
T ss_pred             ---CHHHHHHHHHHcCCCcccCCCH
Confidence               4566999999999999999985

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-44  Score=320.89  Aligned_cols=235  Identities=27%  Similarity=0.353  Sum_probs=203.6

Q ss_pred             CCCCCCCcccccCceEEEEEE-EcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecC
Q 039799          103 NDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYM  181 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  181 (346)
                      ..|.....||+|+.|.||.|. ..+++.||||+++.......+-+.+|+.+|+..+|+|||++++.|..++..+.|||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            457888899999999999997 4578999999998776666778889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccc
Q 039799          182 PHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT  261 (346)
Q Consensus       182 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~  261 (346)
                      +||+|.+.+..  ..+++.++..|+.++++||+|||   .++|+|||||++|||++.+|.+||+|||+|..+.....  .
T Consensus       353 ~ggsLTDvVt~--~~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--K  425 (550)
T KOG0578|consen  353 EGGSLTDVVTK--TRMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--K  425 (550)
T ss_pred             CCCchhhhhhc--ccccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccccC--c
Confidence            99999998753  34889999999999999999999   99999999999999999999999999999998865443  4


Q ss_pred             cccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHH----------HhhhcCCChhhhh
Q 039799          262 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRW----------VNDLLPISVMEVV  331 (346)
Q Consensus       262 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~----------~~~~~~~~~~~~~  331 (346)
                      ....+||+.|||||......|++|.||||||++.+||+-|.+||-.  +........          ....+...+.|++
T Consensus       426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln--E~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL  503 (550)
T KOG0578|consen  426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN--ENPLRALYLIATNGTPKLKNPEKLSPELKDFL  503 (550)
T ss_pred             cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC--CChHHHHHHHhhcCCCCcCCccccCHHHHHHH
Confidence            4567899999999999999999999999999999999999999853  111111111          1223445889999


Q ss_pred             chhccCCcccccccC
Q 039799          332 DANLLSQEDEHFTTK  346 (346)
Q Consensus       332 d~~l~~~p~~R~~~k  346 (346)
                      ++||..|+++|++++
T Consensus       504 ~~cL~~dv~~RasA~  518 (550)
T KOG0578|consen  504 DRCLVVDVEQRASAK  518 (550)
T ss_pred             HHHhhcchhcCCCHH
Confidence            999999999999975

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-43  Score=320.92  Aligned_cols=233  Identities=25%  Similarity=0.402  Sum_probs=198.6

Q ss_pred             CCCCCcccccCceEEEEEEEcCCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecCC
Q 039799          105 ANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMP  182 (346)
Q Consensus       105 ~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  182 (346)
                      ..+.+.||+|.||+||+|.|.  -.||||+++...  ....+.|..|+..+++-+|-||+-+.|+|..... .+|+.+++
T Consensus       394 v~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCe  470 (678)
T KOG0193|consen  394 VLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCE  470 (678)
T ss_pred             hhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhcc
Confidence            456788999999999999987  369999997553  4467899999999999999999999999998887 89999999


Q ss_pred             CCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccccc
Q 039799          183 HGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ  262 (346)
Q Consensus       183 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~  262 (346)
                      |.+|..+++.....++..+.++||.|+|+|+.|||   .++|+|||+|+.||++.+++++||+|||++..-.........
T Consensus       471 GsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~  547 (678)
T KOG0193|consen  471 GSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQL  547 (678)
T ss_pred             CchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccceeeeeeecccccc
Confidence            99999999988899999999999999999999999   999999999999999999999999999999865444444445


Q ss_pred             ccccCCcccccCCCCCCC---CCCcchhHHHHHHHHHHHHcCCCCCCccccCcccH-----------HHHHhhhcCCChh
Q 039799          263 TQTLATIGYMAPEYGREG---RVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTL-----------KRWVNDLLPISVM  328 (346)
Q Consensus       263 ~~~~~~~~y~aPE~~~~~---~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~-----------~~~~~~~~~~~~~  328 (346)
                      ...-|...|+|||+++.+   +|++.+||||||+++|||+||..||.. ...++.+           .-.+....+.++.
T Consensus       548 ~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi-~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk  626 (678)
T KOG0193|consen  548 EQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI-QNRDQIIFMVGRGYLMPDLSKIRSNCPKAMK  626 (678)
T ss_pred             CCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC-CChhheEEEecccccCccchhhhccCHHHHH
Confidence            566688999999987654   689999999999999999999999973 2222111           1122233345889


Q ss_pred             hhhchhccCCcccccc
Q 039799          329 EVVDANLLSQEDEHFT  344 (346)
Q Consensus       329 ~~~d~~l~~~p~~R~~  344 (346)
                      ++++.|+..++++||+
T Consensus       627 ~Ll~~C~~~~~~eRP~  642 (678)
T KOG0193|consen  627 RLLSDCWKFDREERPL  642 (678)
T ss_pred             HHHHHHHhcCcccCcc
Confidence            9999999999999996

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-42  Score=289.07  Aligned_cols=232  Identities=26%  Similarity=0.335  Sum_probs=199.1

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCc---hhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEE
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYE---GAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVL  178 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  178 (346)
                      ++|+..+.||.|+||.|.+++.+ +|..+|+|+++...-   ...+...+|..+|+.+.||+++++++.|.+.+..+|||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            56889999999999999999976 788999999986532   23456678999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccc
Q 039799          179 EYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  258 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~  258 (346)
                      ||++||-|.++++.. ..++.+...-+|.+|+.||+|||   +.+|++||+||+|||+|.+|.+||+|||+|+.....  
T Consensus       124 eyv~GGElFS~Lrk~-~rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--  197 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKS-GRFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--  197 (355)
T ss_pred             eccCCccHHHHHHhc-CCCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecCc--
Confidence            999999999998744 45788888889999999999999   999999999999999999999999999999976432  


Q ss_pred             ccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH------hhhcCCChhhhhc
Q 039799          259 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV------NDLLPISVMEVVD  332 (346)
Q Consensus       259 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~------~~~~~~~~~~~~d  332 (346)
                         .-+.+||+.|+|||.++...++..+|-|||||++|||+.|.+||.+... .......+      ...+...+.+++.
T Consensus       198 ---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-~~iY~KI~~~~v~fP~~fs~~~kdLl~  273 (355)
T KOG0616|consen  198 ---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-IQIYEKILEGKVKFPSYFSSDAKDLLK  273 (355)
T ss_pred             ---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-HHHHHHHHhCcccCCcccCHHHHHHHH
Confidence               3456799999999999999999999999999999999999999976332 11122222      2334558899999


Q ss_pred             hhccCCcccccc
Q 039799          333 ANLLSQEDEHFT  344 (346)
Q Consensus       333 ~~l~~~p~~R~~  344 (346)
                      +.|.+|-.+|+.
T Consensus       274 ~LL~vD~t~R~g  285 (355)
T KOG0616|consen  274 KLLQVDLTKRFG  285 (355)
T ss_pred             HHHhhhhHhhhc
Confidence            999999999964

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=2.1e-42  Score=314.11  Aligned_cols=240  Identities=24%  Similarity=0.371  Sum_probs=192.3

Q ss_pred             CCCCCCCCcccccCceEEEEEEE------cCCCEEEEEEecCCC-chhHHHHHHHHHHHHhc-CCCCceeeEEEEecCC-
Q 039799          102 PNDANMPPLIGKGGFGSVYKAII------QDGMEVAVKVFDPQY-EGAFKSFDIECDVMKRI-CHRNLIKIISSYSNDD-  172 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~-  172 (346)
                      .++|.+.+.||+|+||.||+|.+      .++..||+|++.... ....+.+.+|++++.++ +||||+++++++...+ 
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            35688999999999999999974      235689999987543 23456788999999999 8999999999887644 


Q ss_pred             ceeEEEecCCCCChhhhhhhcC----------------------------------------------------------
Q 039799          173 FKALVLEYMPHGSLEKCLYLSN----------------------------------------------------------  194 (346)
Q Consensus       173 ~~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------  194 (346)
                      ..+++|||+++|+|.+++....                                                          
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            5789999999999999886421                                                          


Q ss_pred             ---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccccccccCCccc
Q 039799          195 ---YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGY  271 (346)
Q Consensus       195 ---~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y  271 (346)
                         ..+++.....++.|+++||+|||   +.+|+||||||+|||++.++.++|+|||+++.+.............++..|
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence               23778888999999999999999   999999999999999999999999999999865433222222233467889


Q ss_pred             ccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHh--------hhcCCChhhhhchhccCCcccc
Q 039799          272 MAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVN--------DLLPISVMEVVDANLLSQEDEH  342 (346)
Q Consensus       272 ~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~d~~l~~~p~~R  342 (346)
                      +|||++.+..++.++||||||+++|||++ |..||......+. ......        ...+..+.+++.+||..||++|
T Consensus       243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R  321 (338)
T cd05102         243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-FCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKER  321 (338)
T ss_pred             cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH-HHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhC
Confidence            99999988889999999999999999997 9999976332211 111111        1223468899999999999999


Q ss_pred             ccc
Q 039799          343 FTT  345 (346)
Q Consensus       343 ~~~  345 (346)
                      |+.
T Consensus       322 Ps~  324 (338)
T cd05102         322 PTF  324 (338)
T ss_pred             cCH
Confidence            985

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=9.9e-43  Score=285.95  Aligned_cols=238  Identities=25%  Similarity=0.344  Sum_probs=198.1

Q ss_pred             CCCCCCCcccccCceEEEEEEE-cCCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEe
Q 039799          103 NDANMPPLIGKGGFGSVYKAII-QDGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLE  179 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  179 (346)
                      .+|...+.+|+|.||.||+|+. ++|+.||||+++...  .+......+|++.|+.++|+||+.+++.|...+...+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            4577788999999999999984 489999999987542  3345677899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccc
Q 039799          180 YMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  259 (346)
Q Consensus       180 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~  259 (346)
                      ||+. +|+..++.+...++......++.++++|++|||   +..|+||||||+|+|++++|.+||+|||+|+.+.+.+..
T Consensus        82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~  157 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI  157 (318)
T ss_pred             eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence            9955 999999988889999999999999999999999   999999999999999999999999999999998765544


Q ss_pred             cccccccCCcccccCCCCCCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccC--------------cc------cHHHH
Q 039799          260 LTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMEIFTRTKPTDEIFSG--------------EM------TLKRW  318 (346)
Q Consensus       260 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~--------------~~------~~~~~  318 (346)
                      .  +..+-|.+|.|||.+.+. .|+...||||.|||+.||+-|.+-|....+-              +.      .+.++
T Consensus       158 ~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY  235 (318)
T KOG0659|consen  158 Q--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY  235 (318)
T ss_pred             c--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence            3  333789999999988765 6899999999999999999998866431111              00      11222


Q ss_pred             Hhhh-------------cCCChhhhhchhccCCcccccccC
Q 039799          319 VNDL-------------LPISVMEVVDANLLSQEDEHFTTK  346 (346)
Q Consensus       319 ~~~~-------------~~~~~~~~~d~~l~~~p~~R~~~k  346 (346)
                      ++-.             .+++..|++.+++..+|.+|++++
T Consensus       236 ~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~  276 (318)
T KOG0659|consen  236 VKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITAS  276 (318)
T ss_pred             HHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHH
Confidence            2111             123668999999999999999863

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=3.2e-42  Score=307.91  Aligned_cols=242  Identities=24%  Similarity=0.349  Sum_probs=199.1

Q ss_pred             CCCCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCce
Q 039799           99 KPLPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFK  174 (346)
Q Consensus        99 ~~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  174 (346)
                      +..-++|++.+.||+|+||.||+++-+ +|..+|+|++++..   .+..+....|-.+|....+|.||+++..|.+.+++
T Consensus       137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L  216 (550)
T KOG0605|consen  137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL  216 (550)
T ss_pred             cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence            445578999999999999999999865 79999999997642   33456677899999999999999999999999999


Q ss_pred             eEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCC
Q 039799          175 ALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  254 (346)
Q Consensus       175 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~  254 (346)
                      ||||||++||++...|... ..++......++.+++-|+..+|   +.|++||||||+|+|+|..|++||+|||+|..+.
T Consensus       217 YLiMEylPGGD~mTLL~~~-~~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~  292 (550)
T KOG0605|consen  217 YLIMEYLPGGDMMTLLMRK-DTLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD  292 (550)
T ss_pred             EEEEEecCCccHHHHHHhc-CcCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccchhh
Confidence            9999999999999988644 45677777778899999999999   9999999999999999999999999999997442


Q ss_pred             cc----------------------cccc----c-------------------cccccCCcccccCCCCCCCCCCcchhHH
Q 039799          255 EE----------------------DQSL----T-------------------QTQTLATIGYMAPEYGREGRVSTNGDVY  289 (346)
Q Consensus       255 ~~----------------------~~~~----~-------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~  289 (346)
                      ..                      +...    .                   ....+|||-|+|||++.+..|+..+|.|
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW  372 (550)
T KOG0605|consen  293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW  372 (550)
T ss_pred             hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence            10                      0000    0                   0124699999999999999999999999


Q ss_pred             HHHHHHHHHHcCCCCCCccccCc--ccHHHHHhhh-------cCCChhhhhchhccCCccccccc
Q 039799          290 SFGIMLMEIFTRTKPTDEIFSGE--MTLKRWVNDL-------LPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       290 s~G~il~elltg~~p~~~~~~~~--~~~~~~~~~~-------~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      |+|||+||||.|.+||......+  ..+..|....       ..++.+|+|.++|. ||++|+-+
T Consensus       373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~  436 (550)
T KOG0605|consen  373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGS  436 (550)
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCc
Confidence            99999999999999997643322  2344444222       23478999999999 99999864

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=7e-42  Score=303.38  Aligned_cols=234  Identities=24%  Similarity=0.345  Sum_probs=193.7

Q ss_pred             CCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEec
Q 039799          105 ANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEY  180 (346)
Q Consensus       105 ~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  180 (346)
                      |...+.||+|+||.||++... +|+.||+|.+....   ......+.+|++++++++|+|++++.+.+.+.+..++||||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            566788999999999999865 78999999986432   22234577899999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccc
Q 039799          181 MPHGSLEKCLYLS-NYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  259 (346)
Q Consensus       181 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~  259 (346)
                      +++|+|.+++... ...+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.++|+|||++.......  
T Consensus        82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~--  156 (285)
T cd05631          82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE--  156 (285)
T ss_pred             cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC--
Confidence            9999998877543 346899999999999999999999   9999999999999999999999999999998653221  


Q ss_pred             cccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCc--ccHHHHH-------hhhcCCChhhh
Q 039799          260 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE--MTLKRWV-------NDLLPISVMEV  330 (346)
Q Consensus       260 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~--~~~~~~~-------~~~~~~~~~~~  330 (346)
                       ......|+..|+|||++.+..++.++|||||||++|||++|+.||.......  ......+       ...++..+.++
T Consensus       157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  235 (285)
T cd05631         157 -TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSI  235 (285)
T ss_pred             -eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHH
Confidence             1234468999999999999999999999999999999999999997633211  1111111       11234478899


Q ss_pred             hchhccCCcccccc
Q 039799          331 VDANLLSQEDEHFT  344 (346)
Q Consensus       331 ~d~~l~~~p~~R~~  344 (346)
                      +.+||..||++||+
T Consensus       236 i~~~l~~~P~~R~~  249 (285)
T cd05631         236 CRMLLTKNPKERLG  249 (285)
T ss_pred             HHHHhhcCHHHhcC
Confidence            99999999999997

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.6e-42  Score=310.80  Aligned_cols=230  Identities=28%  Similarity=0.429  Sum_probs=198.6

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC--CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEe
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ--YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLE  179 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  179 (346)
                      ++|.+.+.||+|+||.||+|+-+ +.+.||+|.+.+.  .+...+.+.+|+++++.++||||+.+++.|+...+.++|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            45778889999999999999855 7889999998754  34456788899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccc
Q 039799          180 YMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  259 (346)
Q Consensus       180 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~  259 (346)
                      |+.| +|..++. .+..+++..+..++.++..||.|||   +.+|.|||+||.|||++..+.+|++|||+|+.+...  .
T Consensus        82 ~a~g-~L~~il~-~d~~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~--t  154 (808)
T KOG0597|consen   82 YAVG-DLFTILE-QDGKLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN--T  154 (808)
T ss_pred             hhhh-hHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhcccC--c
Confidence            9977 9999886 5667999999999999999999999   999999999999999999999999999999977542  2


Q ss_pred             cccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHhhh----------cCCChhh
Q 039799          260 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDL----------LPISVME  329 (346)
Q Consensus       260 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~----------~~~~~~~  329 (346)
                      ...+...||+.|||||...++.|+..+|+||+|||+||+++|++||-..     .+.+.++..          ....+..
T Consensus       155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-----si~~Lv~~I~~d~v~~p~~~S~~f~n  229 (808)
T KOG0597|consen  155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-----SITQLVKSILKDPVKPPSTASSSFVN  229 (808)
T ss_pred             eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-----HHHHHHHHHhcCCCCCcccccHHHHH
Confidence            3345567999999999999999999999999999999999999999641     122222222          1226789


Q ss_pred             hhchhccCCcccccc
Q 039799          330 VVDANLLSQEDEHFT  344 (346)
Q Consensus       330 ~~d~~l~~~p~~R~~  344 (346)
                      +++..|..||.+|.+
T Consensus       230 fl~gLL~kdP~~Rlt  244 (808)
T KOG0597|consen  230 FLQGLLIKDPAQRLT  244 (808)
T ss_pred             HHHHHhhcChhhccc
Confidence            999999999999986

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-42  Score=298.77  Aligned_cols=241  Identities=25%  Similarity=0.341  Sum_probs=202.6

Q ss_pred             CCCCCCCCcccccCceEEEEEEE-cCCCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEe
Q 039799          102 PNDANMPPLIGKGGFGSVYKAII-QDGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLE  179 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  179 (346)
                      .++|++...||.|..++||+|.. ..++.||||+++-+. ....+.+.+|+..++.++||||++++..|..+..+++||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            46799999999999999999984 478999999998543 3346888999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccc
Q 039799          180 YMPHGSLEKCLYLS-NYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  258 (346)
Q Consensus       180 ~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~  258 (346)
                      ||.+||+.+++... ...+++..+..|++++++||.|||   ..|.+|||||+.|||++++|.++|+|||.+-.+.+.+.
T Consensus       105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~  181 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD  181 (516)
T ss_pred             hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence            99999999998654 345888999999999999999999   99999999999999999999999999999887765432


Q ss_pred             c-ccc-ccccCCcccccCCCCCC--CCCCcchhHHHHHHHHHHHHcCCCCCCccccCcc---------------cHHHHH
Q 039799          259 S-LTQ-TQTLATIGYMAPEYGRE--GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM---------------TLKRWV  319 (346)
Q Consensus       259 ~-~~~-~~~~~~~~y~aPE~~~~--~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~---------------~~~~~~  319 (346)
                      . ... ....||+.|+|||.+..  ..|+.|+||||||++.+|+.+|..||........               ....-.
T Consensus       182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~  261 (516)
T KOG0582|consen  182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDE  261 (516)
T ss_pred             eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHH
Confidence            1 112 45579999999998543  4689999999999999999999999986432221               112222


Q ss_pred             hhhcCCChhhhhchhccCCccccccc
Q 039799          320 NDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       320 ~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ...++..+.+++..||..||.+|||+
T Consensus       262 ~k~~~ksf~e~i~~CL~kDP~kRptA  287 (516)
T KOG0582|consen  262 DKKFSKSFREMIALCLVKDPSKRPTA  287 (516)
T ss_pred             hhhhcHHHHHHHHHHhhcCcccCCCH
Confidence            33445578899999999999999986

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.5e-41  Score=306.45  Aligned_cols=229  Identities=22%  Similarity=0.289  Sum_probs=189.6

Q ss_pred             CcccccCceEEEEEEEc-CCCEEEEEEecCC---CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecCCCC
Q 039799          109 PLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ---YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHG  184 (346)
Q Consensus       109 ~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  184 (346)
                      +.||+|+||.||++... +|..||+|++...   .......+.+|++++++++||||+++++.+...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46899999999999865 7899999998643   2233456778999999999999999999999999999999999999


Q ss_pred             ChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccccccc
Q 039799          185 SLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ  264 (346)
Q Consensus       185 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  264 (346)
                      +|..++.. ...+++.....++.|++.||+|||   +.+|+||||||+|||++.++.++|+|||++.......  .....
T Consensus        81 ~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~~  154 (323)
T cd05595          81 ELFFHLSR-ERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKT  154 (323)
T ss_pred             cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccccc
Confidence            99887754 346889999999999999999999   9999999999999999999999999999987542221  12233


Q ss_pred             ccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH------hhhcCCChhhhhchhccCC
Q 039799          265 TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV------NDLLPISVMEVVDANLLSQ  338 (346)
Q Consensus       265 ~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~------~~~~~~~~~~~~d~~l~~~  338 (346)
                      ..|++.|+|||++.+..++.++|||||||++|||++|+.||....... ......      ...++..+.+++.+||..|
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-~~~~~~~~~~~~p~~~~~~~~~li~~~L~~d  233 (323)
T cd05595         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-LFELILMEEIRFPRTLSPEAKSLLAGLLKKD  233 (323)
T ss_pred             ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH-HHHHHhcCCCCCCCCCCHHHHHHHHHHccCC
Confidence            568999999999998899999999999999999999999996532111 111111      1233457889999999999


Q ss_pred             cccccc
Q 039799          339 EDEHFT  344 (346)
Q Consensus       339 p~~R~~  344 (346)
                      |++|++
T Consensus       234 P~~R~~  239 (323)
T cd05595         234 PKQRLG  239 (323)
T ss_pred             HHHhCC
Confidence            999983

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=6.8e-42  Score=308.77  Aligned_cols=228  Identities=23%  Similarity=0.295  Sum_probs=189.9

Q ss_pred             CcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecCCCC
Q 039799          109 PLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHG  184 (346)
Q Consensus       109 ~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  184 (346)
                      +.||+|+||.||++... +|+.+|+|++....   ......+..|++++++++||||+++.+.+...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46899999999999865 78999999987432   233456778999999999999999999999999999999999999


Q ss_pred             ChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccccccc
Q 039799          185 SLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ  264 (346)
Q Consensus       185 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  264 (346)
                      +|.+++.. ...+++.....++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||+++......  .....
T Consensus        81 ~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~  154 (323)
T cd05571          81 ELFFHLSR-ERVFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKT  154 (323)
T ss_pred             cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Ccccc
Confidence            99988864 356889999999999999999999   9999999999999999999999999999988542221  12234


Q ss_pred             ccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH-------hhhcCCChhhhhchhccC
Q 039799          265 TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV-------NDLLPISVMEVVDANLLS  337 (346)
Q Consensus       265 ~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~d~~l~~  337 (346)
                      ..||+.|+|||.+.+..++.++||||+||++|||+||+.||......  .....+       ...++..+.+++.+||..
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~  232 (323)
T cd05571         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFELILMEEIRFPRTLSPEAKSLLAGLLKK  232 (323)
T ss_pred             eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH--HHHHHHHcCCCCCCCCCCHHHHHHHHHHccC
Confidence            56899999999999889999999999999999999999999652211  111111       122345789999999999


Q ss_pred             Ccccccc
Q 039799          338 QEDEHFT  344 (346)
Q Consensus       338 ~p~~R~~  344 (346)
                      ||++||+
T Consensus       233 dP~~R~~  239 (323)
T cd05571         233 DPKQRLG  239 (323)
T ss_pred             CHHHcCC
Confidence            9999994

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=6.6e-42  Score=309.57  Aligned_cols=232  Identities=22%  Similarity=0.306  Sum_probs=194.8

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEE
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALV  177 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  177 (346)
                      .++|.+.+.||+|+||.||+|... +++.||+|++....   ....+.+.+|++++++++||||+++++++...+..++|
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            367888999999999999999976 68999999986431   22346688899999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccc
Q 039799          178 LEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  257 (346)
Q Consensus       178 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~  257 (346)
                      |||+++++|.+++... ..+++.....++.|++.||+|||   +.+|+||||||+|||++.++.++|+|||+++......
T Consensus        97 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  172 (329)
T PTZ00263         97 LEFVVGGELFTHLRKA-GRFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT  172 (329)
T ss_pred             EcCCCCChHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc
Confidence            9999999999988643 45788888889999999999999   9999999999999999999999999999998653221


Q ss_pred             cccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH-------hhhcCCChhhh
Q 039799          258 QSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV-------NDLLPISVMEV  330 (346)
Q Consensus       258 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~  330 (346)
                           ....|++.|+|||.+.+..++.++|||||||++|||+||+.||.....  ....+.+       ...++..+.++
T Consensus       173 -----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--~~~~~~i~~~~~~~p~~~~~~~~~l  245 (329)
T PTZ00263        173 -----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP--FRIYEKILAGRLKFPNWFDGRARDL  245 (329)
T ss_pred             -----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH--HHHHHHHhcCCcCCCCCCCHHHHHH
Confidence                 234689999999999988899999999999999999999999965221  1111111       11133467899


Q ss_pred             hchhccCCcccccc
Q 039799          331 VDANLLSQEDEHFT  344 (346)
Q Consensus       331 ~d~~l~~~p~~R~~  344 (346)
                      +.+||..||.+|++
T Consensus       246 i~~~L~~dP~~R~~  259 (329)
T PTZ00263        246 VKGLLQTDHTKRLG  259 (329)
T ss_pred             HHHHhhcCHHHcCC
Confidence            99999999999997

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-43  Score=309.19  Aligned_cols=237  Identities=24%  Similarity=0.312  Sum_probs=194.8

Q ss_pred             CCCCCCCcccccCceEEEEEEE-cCCCEEEEEEecCCCchhHH-HHHHHHHHHHhcC-CCCceeeEEEEecCC-ceeEEE
Q 039799          103 NDANMPPLIGKGGFGSVYKAII-QDGMEVAVKVFDPQYEGAFK-SFDIECDVMKRIC-HRNLIKIISSYSNDD-FKALVL  178 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~-~~~~e~~~l~~l~-h~niv~~~~~~~~~~-~~~lv~  178 (346)
                      ++|.+.+.||.|+||.||+|+- .+|..||||.++.......+ .-.+|++.|+++. ||||+++.+.+.+.+ .+++||
T Consensus        10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVf   89 (538)
T KOG0661|consen   10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVF   89 (538)
T ss_pred             HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeH
Confidence            4577888999999999999984 47999999999866443221 2347999999998 999999999998888 999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccc
Q 039799          179 EYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  258 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~  258 (346)
                      ||| ..+|.+.++.++..++...+..|+.||++||+|+|   ..|+.|||+||+|||+.....+||+|||+|+.+..   
T Consensus        90 E~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S---  162 (538)
T KOG0661|consen   90 EFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVRS---  162 (538)
T ss_pred             Hhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEeccccccccccc---
Confidence            999 56999999988999999999999999999999999   99999999999999999999999999999997643   


Q ss_pred             ccccccccCCcccccCCCCC-CCCCCcchhHHHHHHHHHHHHcCCCCCCccccC--------------c------ccHHH
Q 039799          259 SLTQTQTLATIGYMAPEYGR-EGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSG--------------E------MTLKR  317 (346)
Q Consensus       259 ~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~--------------~------~~~~~  317 (346)
                      ....+.-+.|.+|.|||++. .+.|+.+.||||+|||++|+.+-++-|....+-              .      ..+..
T Consensus       163 kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~  242 (538)
T KOG0661|consen  163 KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLAS  242 (538)
T ss_pred             CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHH
Confidence            33455667899999999764 567899999999999999999999877541110              0      01111


Q ss_pred             HHhh---------------hcCCChhhhhchhccCCcccccccC
Q 039799          318 WVND---------------LLPISVMEVVDANLLSQEDEHFTTK  346 (346)
Q Consensus       318 ~~~~---------------~~~~~~~~~~d~~l~~~p~~R~~~k  346 (346)
                      ...-               ..+.+..+++.+++.=||++|||++
T Consensus       243 ~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~  286 (538)
T KOG0661|consen  243 AMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTAS  286 (538)
T ss_pred             HhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHH
Confidence            1110               1233678899999999999999973

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-42  Score=304.21  Aligned_cols=232  Identities=25%  Similarity=0.315  Sum_probs=194.1

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEE
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVL  178 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  178 (346)
                      ++|.+.+.||+|+||.||+|... +++.+|+|++....   ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            36888999999999999999976 78999999986432   123456788999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccc
Q 039799          179 EYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  258 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~  258 (346)
                      ||+++++|.+++... ..+++.....++.|++.||+|||   +.+++||||||+|||++.++.++|+|||+++.....  
T Consensus        81 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--  154 (291)
T cd05612          81 EYVPGGELFSYLRNS-GRFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--  154 (291)
T ss_pred             eCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--
Confidence            999999999988643 45788889999999999999999   999999999999999999999999999999865321  


Q ss_pred             ccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh------hhcCCChhhhhc
Q 039799          259 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN------DLLPISVMEVVD  332 (346)
Q Consensus       259 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~------~~~~~~~~~~~d  332 (346)
                         .....|++.|+|||.+.+..++.++||||||+++|||++|+.||......+ .......      ..++..+.+++.
T Consensus       155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~li~  230 (291)
T cd05612         155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG-IYEKILAGKLEFPRHLDLYAKDLIK  230 (291)
T ss_pred             ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCcCCCccCCHHHHHHHH
Confidence               123458999999999988889999999999999999999999997532111 1111111      122347789999


Q ss_pred             hhccCCcccccc
Q 039799          333 ANLLSQEDEHFT  344 (346)
Q Consensus       333 ~~l~~~p~~R~~  344 (346)
                      +||..||.+|++
T Consensus       231 ~~l~~dp~~R~~  242 (291)
T cd05612         231 KLLVVDRTRRLG  242 (291)
T ss_pred             HHcCCCHHHccC
Confidence            999999999996

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-41  Score=304.32  Aligned_cols=227  Identities=23%  Similarity=0.281  Sum_probs=188.9

Q ss_pred             ccccCceEEEEEEEc-CCCEEEEEEecCC---CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecCCCCCh
Q 039799          111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ---YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSL  186 (346)
Q Consensus       111 lg~G~~g~vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  186 (346)
                      ||+|+||.||++... +++.||+|++...   .......+..|++++++++||||+++++.+...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999876 6889999998642   233456678899999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccccccccc
Q 039799          187 EKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL  266 (346)
Q Consensus       187 ~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~  266 (346)
                      .+++.. ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||+++......  .......
T Consensus        81 ~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~  154 (312)
T cd05585          81 FHHLQR-EGRFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTFC  154 (312)
T ss_pred             HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccccc
Confidence            998864 345889999999999999999999   9999999999999999999999999999998543222  1223456


Q ss_pred             CCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh------hhcCCChhhhhchhccCCcc
Q 039799          267 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN------DLLPISVMEVVDANLLSQED  340 (346)
Q Consensus       267 ~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~------~~~~~~~~~~~d~~l~~~p~  340 (346)
                      ||+.|+|||.+.+..++.++|||||||++|||+||+.||......+ .......      ..++..+.+++.+||..||+
T Consensus       155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~  233 (312)
T cd05585         155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE-MYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPT  233 (312)
T ss_pred             CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH-HHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHH
Confidence            8999999999998899999999999999999999999996532111 1111111      22344788999999999999


Q ss_pred             cccc
Q 039799          341 EHFT  344 (346)
Q Consensus       341 ~R~~  344 (346)
                      +||+
T Consensus       234 ~R~~  237 (312)
T cd05585         234 RRLG  237 (312)
T ss_pred             HcCC
Confidence            9986

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.6e-42  Score=325.67  Aligned_cols=235  Identities=29%  Similarity=0.465  Sum_probs=201.1

Q ss_pred             CCCcccccCceEEEEEEEc------CCCEEEEEEecCCCch-hHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEe
Q 039799          107 MPPLIGKGGFGSVYKAIIQ------DGMEVAVKVFDPQYEG-AFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLE  179 (346)
Q Consensus       107 ~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  179 (346)
                      ..+.||+|+||+||+|+..      +...||||.++..... ..++|.+|+++++.++|||||+++|.|.+++..+||+|
T Consensus       490 ~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFE  569 (774)
T KOG1026|consen  490 FKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFE  569 (774)
T ss_pred             ehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEE
Confidence            3457999999999999843      3457999999876655 78899999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcC-------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEee
Q 039799          180 YMPHGSLEKCLYLSN-------------YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSD  246 (346)
Q Consensus       180 ~~~~gsL~~~l~~~~-------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~D  246 (346)
                      ||..|+|.++|....             ..++..+.+.||.|||.|+.||-   +..+|||||-.+|+|+.++..+||+|
T Consensus       570 Ym~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l~VKIsD  646 (774)
T KOG1026|consen  570 YMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENLVVKISD  646 (774)
T ss_pred             ecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccceEEEecc
Confidence            999999999986432             23788899999999999999999   99999999999999999999999999


Q ss_pred             ecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHH------
Q 039799          247 FGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWV------  319 (346)
Q Consensus       247 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~------  319 (346)
                      ||+++.+...+.........-..+|||||.+..++++.+||||||||+|||++| |+.||......+  ..+.+      
T Consensus       647 fGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E--VIe~i~~g~lL  724 (774)
T KOG1026|consen  647 FGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE--VIECIRAGQLL  724 (774)
T ss_pred             cccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH--HHHHHHcCCcc
Confidence            999998765554444445556889999999999999999999999999999998 999998744332  22222      


Q ss_pred             --hhhcCCChhhhhchhccCCcccccccC
Q 039799          320 --NDLLPISVMEVVDANLLSQEDEHFTTK  346 (346)
Q Consensus       320 --~~~~~~~~~~~~d~~l~~~p~~R~~~k  346 (346)
                        .+..|.++.+++-.|+...|++||+-|
T Consensus       725 ~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~  753 (774)
T KOG1026|consen  725 SCPENCPTEVYSLMLECWNENPKRRPSFK  753 (774)
T ss_pred             cCCCCCCHHHHHHHHHHhhcCcccCCCHH
Confidence              233455999999999999999999854

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=2.6e-41  Score=305.50  Aligned_cols=228  Identities=24%  Similarity=0.322  Sum_probs=189.8

Q ss_pred             CcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecCCCC
Q 039799          109 PLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHG  184 (346)
Q Consensus       109 ~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  184 (346)
                      +.||+|+||.||++... +++.||+|++....   ......+.+|+++++.++||||+++.+.+...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46899999999999865 78999999987432   234567788999999999999999999999999999999999999


Q ss_pred             ChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccccccc
Q 039799          185 SLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ  264 (346)
Q Consensus       185 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  264 (346)
                      +|.+++.. ...+++.....++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++......  .....
T Consensus        81 ~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~  154 (328)
T cd05593          81 ELFFHLSR-ERVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATMKT  154 (328)
T ss_pred             CHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc--ccccc
Confidence            99888754 346889999999999999999999   9999999999999999999999999999988543221  12234


Q ss_pred             ccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH-------hhhcCCChhhhhchhccC
Q 039799          265 TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV-------NDLLPISVMEVVDANLLS  337 (346)
Q Consensus       265 ~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~d~~l~~  337 (346)
                      ..||+.|+|||.+.+..++.++|||||||++|||++|+.||......  .....+       ...++..+.+++.+||..
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~--~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~  232 (328)
T cd05593         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFELILMEDIKFPRTLSADAKSLLSGLLIK  232 (328)
T ss_pred             ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH--HHHHHhccCCccCCCCCCHHHHHHHHHHcCC
Confidence            56899999999998889999999999999999999999999653211  111111       122344788999999999


Q ss_pred             Ccccccc
Q 039799          338 QEDEHFT  344 (346)
Q Consensus       338 ~p~~R~~  344 (346)
                      ||++|++
T Consensus       233 dP~~R~~  239 (328)
T cd05593         233 DPNKRLG  239 (328)
T ss_pred             CHHHcCC
Confidence            9999984

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=3.4e-41  Score=310.00  Aligned_cols=239  Identities=23%  Similarity=0.363  Sum_probs=194.6

Q ss_pred             CCCCCCCcccccCceEEEEEEE------cCCCEEEEEEecCCC-chhHHHHHHHHHHHHhc-CCCCceeeEEEEecCCce
Q 039799          103 NDANMPPLIGKGGFGSVYKAII------QDGMEVAVKVFDPQY-EGAFKSFDIECDVMKRI-CHRNLIKIISSYSNDDFK  174 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  174 (346)
                      ++|.+.+.||+|+||.||+|++      .++..||+|+++... ....+.+.+|+++++.+ +||||++++++|...+..
T Consensus        35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~  114 (375)
T cd05104          35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT  114 (375)
T ss_pred             HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence            4688999999999999999974      245689999987432 33456788899999999 899999999999999999


Q ss_pred             eEEEecCCCCChhhhhhhcC------------------------------------------------------------
Q 039799          175 ALVLEYMPHGSLEKCLYLSN------------------------------------------------------------  194 (346)
Q Consensus       175 ~lv~e~~~~gsL~~~l~~~~------------------------------------------------------------  194 (346)
                      ++||||+++|+|.+++....                                                            
T Consensus       115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (375)
T cd05104         115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY  194 (375)
T ss_pred             eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence            99999999999998875321                                                            


Q ss_pred             --------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccc
Q 039799          195 --------------YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  260 (346)
Q Consensus       195 --------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~  260 (346)
                                    ..+++..+..++.++++||+|||   +.+++||||||+|||++.++.++|+|||+++.........
T Consensus       195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  271 (375)
T cd05104         195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV  271 (375)
T ss_pred             cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence                          24788889999999999999999   9999999999999999999999999999998664332211


Q ss_pred             ccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHhhh--------cCCChhhhh
Q 039799          261 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVNDL--------LPISVMEVV  331 (346)
Q Consensus       261 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~--------~~~~~~~~~  331 (346)
                      ......++..|+|||...+..++.++||||||+++|||++ |..||...... ....+++...        .+..+.+++
T Consensus       272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li  350 (375)
T cd05104         272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD-SKFYKMIKEGYRMLSPECAPSEMYDIM  350 (375)
T ss_pred             ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch-HHHHHHHHhCccCCCCCCCCHHHHHHH
Confidence            1222335678999999998899999999999999999998 89998764322 1222333221        234788999


Q ss_pred             chhccCCccccccc
Q 039799          332 DANLLSQEDEHFTT  345 (346)
Q Consensus       332 d~~l~~~p~~R~~~  345 (346)
                      .+|+..||++||+.
T Consensus       351 ~~cl~~dP~~RPs~  364 (375)
T cd05104         351 KSCWDADPLKRPTF  364 (375)
T ss_pred             HHHccCChhHCcCH
Confidence            99999999999986

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=5.5e-41  Score=300.29  Aligned_cols=239  Identities=22%  Similarity=0.286  Sum_probs=192.5

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEe
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLE  179 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  179 (346)
                      .++|.+.+.||+|+||.||+|... +++.+|+|++.... ......+.+|+++++.++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            467999999999999999999976 78999999986442 2223456789999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccc
Q 039799          180 YMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  259 (346)
Q Consensus       180 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~  259 (346)
                      |+. ++|.+++......++...+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||++.......  
T Consensus        84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--  157 (303)
T cd07869          84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS--  157 (303)
T ss_pred             CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC--
Confidence            995 6787777665567888899999999999999999   9999999999999999999999999999987543221  


Q ss_pred             cccccccCCcccccCCCCCC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHH----------------------
Q 039799          260 LTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLK----------------------  316 (346)
Q Consensus       260 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~----------------------  316 (346)
                      .......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||....+....+.                      
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (303)
T cd07869         158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH  237 (303)
T ss_pred             ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence            12234567899999998765 4578899999999999999999999975321110000                      


Q ss_pred             ----------------HHHhhhcCCChhhhhchhccCCcccccccC
Q 039799          317 ----------------RWVNDLLPISVMEVVDANLLSQEDEHFTTK  346 (346)
Q Consensus       317 ----------------~~~~~~~~~~~~~~~d~~l~~~p~~R~~~k  346 (346)
                                      .|-...++..+.+++++||..||++|||++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~  283 (303)
T cd07869         238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQ  283 (303)
T ss_pred             cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHH
Confidence                            011111223567999999999999999863

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=8.5e-41  Score=299.18  Aligned_cols=239  Identities=25%  Similarity=0.402  Sum_probs=192.9

Q ss_pred             CCCCCCCCcccccCceEEEEEEEcC-----------------CCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCcee
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQD-----------------GMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIK  163 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~  163 (346)
                      ..+|.+.+.||+|+||.||++.+++                 +..||+|++.... ......+.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            3568889999999999999998542                 3369999987643 334567889999999999999999


Q ss_pred             eEEEEecCCceeEEEecCCCCChhhhhhhcC------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCee
Q 039799          164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSN------------------YILDIFQRLDIMIDVASALEYLHFGYSAPII  225 (346)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~  225 (346)
                      +++++...+..++||||+++++|.+++....                  ..+++...+.++.+++.||+|||   +.+|+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~iv  160 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFV  160 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCcc
Confidence            9999999999999999999999999875421                  24678889999999999999999   99999


Q ss_pred             ecCCCCCceEECCCCcEEEeeecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc--CCC
Q 039799          226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT--RTK  303 (346)
Q Consensus       226 H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt--g~~  303 (346)
                      ||||||+|||++.++.+||+|||+++.+.............++..|+|||+...+.++.++||||||+++|||++  +..
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence            999999999999999999999999986543322222223345788999999888889999999999999999986  566


Q ss_pred             CCCccccCcccHHHHHh---------------hhcCCChhhhhchhccCCccccccc
Q 039799          304 PTDEIFSGEMTLKRWVN---------------DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       304 p~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ||......+  ....+.               ...+..+.+++.+|+..+|++||+.
T Consensus       241 p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~  295 (304)
T cd05096         241 PYGELTDEQ--VIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSF  295 (304)
T ss_pred             CCCcCCHHH--HHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCH
Confidence            776532111  111111               1223478899999999999999986

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=4e-41  Score=318.48  Aligned_cols=237  Identities=22%  Similarity=0.269  Sum_probs=196.9

Q ss_pred             CCCCCCcccccCceEEEEEEEc-C-CCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecC
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQ-D-GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYM  181 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  181 (346)
                      .|.+.+.||+|++|.||+|... + +..||+|.+..........+..|+++++.++||||+++++++...+..++||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            3788899999999999999854 4 6788999876555555567788999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhc---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccc
Q 039799          182 PHGSLEKCLYLS---NYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  258 (346)
Q Consensus       182 ~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~  258 (346)
                      ++|+|.+++...   ...+++.....++.|++.||.|||   +.+|+||||||+|||++.++.++|+|||+++.+.....
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            999999887532   345788889999999999999999   99999999999999999999999999999987643322


Q ss_pred             ccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH--------hhhcCCChhhh
Q 039799          259 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV--------NDLLPISVMEV  330 (346)
Q Consensus       259 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~  330 (346)
                      ........||++|+|||++.+..++.++|||||||++|||+||+.||......  .....+        ...++..+.++
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~--~~~~~~~~~~~~~~~~~~s~~~~~l  302 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR--EIMQQVLYGKYDPFPCPVSSGMKAL  302 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCCCCCCCccCCHHHHHH
Confidence            22233456899999999999889999999999999999999999999653211  111111        11234478999


Q ss_pred             hchhccCCccccccc
Q 039799          331 VDANLLSQEDEHFTT  345 (346)
Q Consensus       331 ~d~~l~~~p~~R~~~  345 (346)
                      +.+||..+|++||++
T Consensus       303 i~~~L~~dP~~Rps~  317 (478)
T PTZ00267        303 LDPLLSKNPALRPTT  317 (478)
T ss_pred             HHHHhccChhhCcCH
Confidence            999999999999985

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.2e-40  Score=301.76  Aligned_cols=198  Identities=24%  Similarity=0.340  Sum_probs=174.3

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEe
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLE  179 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  179 (346)
                      .++|++.+.||+|+||.||++... ++..+|+|++.... ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            467899999999999999999976 68899999987543 2345678899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeeecCCCCCceEECCCCcEEEeeecCCccCCcccc
Q 039799          180 YMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSA-PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  258 (346)
Q Consensus       180 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~  258 (346)
                      |+++++|.+++... ..+++..+..++.+++.||.|||   +. +|+||||||+||+++.++.++|+|||++......  
T Consensus        84 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  157 (331)
T cd06649          84 HMDGGSLDQVLKEA-KRIPEEILGKVSIAVLRGLAYLR---EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  157 (331)
T ss_pred             cCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHh---hcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence            99999999988643 45888899999999999999999   65 6999999999999999999999999999865322  


Q ss_pred             ccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 039799          259 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDE  307 (346)
Q Consensus       259 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~  307 (346)
                        ......++..|+|||++.+..++.++||||||+++|||+||+.||..
T Consensus       158 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~  204 (331)
T cd06649         158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP  204 (331)
T ss_pred             --ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence              12334689999999999988899999999999999999999999964

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=6.5e-41  Score=297.63  Aligned_cols=238  Identities=22%  Similarity=0.302  Sum_probs=192.4

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEec
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEY  180 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  180 (346)
                      ++|.+.+.||+|+||.||+|..+ +++.||+|++.... ......+.+|++++++++||||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            46888999999999999999866 78999999986432 22345677899999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccc
Q 039799          181 MPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  260 (346)
Q Consensus       181 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~  260 (346)
                      +++ +|.+++......+++.....++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++......  .
T Consensus        85 ~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~--~  158 (288)
T cd07871          85 LDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT--K  158 (288)
T ss_pred             CCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC--c
Confidence            975 898888766666889999999999999999999   9999999999999999999999999999987543221  1


Q ss_pred             ccccccCCcccccCCCCCC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccCcc--------------------cHHHHH
Q 039799          261 TQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM--------------------TLKRWV  319 (346)
Q Consensus       261 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~--------------------~~~~~~  319 (346)
                      ......+++.|+|||.+.+ ..++.++||||+|+++|||+||+.||......+.                    ....+.
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd07871         159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR  238 (288)
T ss_pred             cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence            2233457899999998765 5689999999999999999999999864221100                    000000


Q ss_pred             h---------------hhcCCChhhhhchhccCCcccccccC
Q 039799          320 N---------------DLLPISVMEVVDANLLSQEDEHFTTK  346 (346)
Q Consensus       320 ~---------------~~~~~~~~~~~d~~l~~~p~~R~~~k  346 (346)
                      .               ..++....+++.+||..||.+|+|++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~  280 (288)
T cd07871         239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAE  280 (288)
T ss_pred             ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHH
Confidence            0               11233668999999999999999863

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-41  Score=309.42  Aligned_cols=234  Identities=26%  Similarity=0.333  Sum_probs=199.6

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEE
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVL  178 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  178 (346)
                      ..|+.++.||.|+.|.|-+|++. +|+..|||++.+..   ......+.+|+-+|+-+.|||++.+++.|+++.++|+|.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            35888999999999999999865 89999999997552   233567888999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccc
Q 039799          179 EYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  258 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~  258 (346)
                      ||+++|-|.+++-.++ .++.....++++||..|+.|+|   ..+|+|||+||+|+|+|..+.+||+|||+|..-.+   
T Consensus        92 Eyv~gGELFdylv~kG-~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~---  164 (786)
T KOG0588|consen   92 EYVPGGELFDYLVRKG-PLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEVP---  164 (786)
T ss_pred             EecCCchhHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecccC---
Confidence            9999999999986544 4677778889999999999999   99999999999999999999999999999986433   


Q ss_pred             ccccccccCCcccccCCCCCCCCC-CcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHhh-------hcCCChhhh
Q 039799          259 SLTQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVND-------LLPISVMEV  330 (346)
Q Consensus       259 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~-------~~~~~~~~~  330 (346)
                      .....+.+|++-|.|||+..+.+| +.++||||.|||||.|+||+.||++  ++-..+...|..       .++.+..++
T Consensus       165 gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD--dNir~LLlKV~~G~f~MPs~Is~eaQdL  242 (786)
T KOG0588|consen  165 GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD--DNIRVLLLKVQRGVFEMPSNISSEAQDL  242 (786)
T ss_pred             CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC--ccHHHHHHHHHcCcccCCCcCCHHHHHH
Confidence            233456689999999999999887 6889999999999999999999985  222233333332       234478899


Q ss_pred             hchhccCCccccccc
Q 039799          331 VDANLLSQEDEHFTT  345 (346)
Q Consensus       331 ~d~~l~~~p~~R~~~  345 (346)
                      +.+||.+||..|+|+
T Consensus       243 Lr~ml~VDp~~RiT~  257 (786)
T KOG0588|consen  243 LRRMLDVDPSTRITT  257 (786)
T ss_pred             HHHHhccCccccccH
Confidence            999999999999986

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=6.1e-41  Score=297.59  Aligned_cols=238  Identities=22%  Similarity=0.277  Sum_probs=193.4

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEe
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLE  179 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  179 (346)
                      ++|.+.+.||+|+||.||++..+ +++.+|+|++....  ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            35888999999999999999976 68899999986432  2334677889999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccc
Q 039799          180 YMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  259 (346)
Q Consensus       180 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~  259 (346)
                      |++++++..+. .....+++..+..++.|++.||+|||   +.+++||||||+||+++.++.++|+|||++........ 
T Consensus        81 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-  155 (287)
T cd07848          81 YVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN-  155 (287)
T ss_pred             cCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc-
Confidence            99988776543 33456888999999999999999999   99999999999999999999999999999987643221 


Q ss_pred             cccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCccc--HH---------------------
Q 039799          260 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMT--LK---------------------  316 (346)
Q Consensus       260 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~--~~---------------------  316 (346)
                      .......++..|+|||++.+..++.++|||||||++|||++|+.||......+..  ..                     
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07848         156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH  235 (287)
T ss_pred             ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence            1223346899999999998888999999999999999999999999652210000  00                     


Q ss_pred             --------------HHHhhhcCCChhhhhchhccCCccccccc
Q 039799          317 --------------RWVNDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       317 --------------~~~~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                                    ......++..+.+++.+||..||++|||+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~  278 (287)
T cd07848         236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLT  278 (287)
T ss_pred             ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCH
Confidence                          00001133458899999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=6.8e-41  Score=296.63  Aligned_cols=225  Identities=23%  Similarity=0.307  Sum_probs=186.9

Q ss_pred             CcccccCceEEEEEEEcCCCEEEEEEecCCCch---hHHHHHHHHHHHHhcCCCCceeeEEEEec----CCceeEEEecC
Q 039799          109 PLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRICHRNLIKIISSYSN----DDFKALVLEYM  181 (346)
Q Consensus       109 ~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~  181 (346)
                      ..||+|+++.||+|.+. |+.||+|.+......   ..+.+.+|++++++++||||+++++++.+    ....++||||+
T Consensus        26 ~~i~~g~~~~v~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIFN-NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEEC-CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            67999999999999984 889999998754322   24678899999999999999999999876    45778999999


Q ss_pred             CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccc
Q 039799          182 PHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYS-APIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  260 (346)
Q Consensus       182 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~  260 (346)
                      ++|+|.+++... ..+++...+.++.+++.|++|||   + .+++||||||+||++++++.+||+|||+++.....    
T Consensus       105 ~~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~----  176 (283)
T PHA02988        105 TRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLY---KYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP----  176 (283)
T ss_pred             CCCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHH---hcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc----
Confidence            999999998743 46889999999999999999999   6 48889999999999999999999999998865322    


Q ss_pred             ccccccCCcccccCCCCCC--CCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH-hh--------hcCCChhh
Q 039799          261 TQTQTLATIGYMAPEYGRE--GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV-ND--------LLPISVME  329 (346)
Q Consensus       261 ~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~-~~--------~~~~~~~~  329 (346)
                       .....++..|+|||.+.+  ..++.++|||||||++|||+||+.||......  .....+ ..        ..+..+.+
T Consensus       177 -~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~l~~  253 (283)
T PHA02988        177 -PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK--EIYDLIINKNNSLKLPLDCPLEIKC  253 (283)
T ss_pred             -cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHhcCCCCCCCCcCcHHHHH
Confidence             123457899999999876  67899999999999999999999999764221  111111 11        23347889


Q ss_pred             hhchhccCCccccccc
Q 039799          330 VVDANLLSQEDEHFTT  345 (346)
Q Consensus       330 ~~d~~l~~~p~~R~~~  345 (346)
                      ++.+||..||++||+.
T Consensus       254 li~~cl~~dp~~Rps~  269 (283)
T PHA02988        254 IVEACTSHDSIKRPNI  269 (283)
T ss_pred             HHHHHhcCCcccCcCH
Confidence            9999999999999986

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-42  Score=301.99  Aligned_cols=240  Identities=28%  Similarity=0.373  Sum_probs=204.6

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC-CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEE
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ-YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVL  178 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  178 (346)
                      ....|+..+.||+|+||.||+|... .++.||+|+++.. .+...+.+++|+.++.+++++||.++++.+..+..+.++|
T Consensus        11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM   90 (467)
T KOG0201|consen   11 PELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM   90 (467)
T ss_pred             cccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence            3456888899999999999999855 7899999999854 3455678899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccc
Q 039799          179 EYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  258 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~  258 (346)
                      ||+.||++.+.+.... .++.....-+++++..|+.|||   ..+.+|||||+.|||+..+|.+|++|||.+..+.... 
T Consensus        91 ey~~gGsv~~lL~~~~-~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~-  165 (467)
T KOG0201|consen   91 EYCGGGSVLDLLKSGN-ILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV-  165 (467)
T ss_pred             HHhcCcchhhhhccCC-CCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeechh-
Confidence            9999999999887544 3366666778999999999999   9999999999999999999999999999999875433 


Q ss_pred             ccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCc------ccHHHHHhhhcCCChhhhhc
Q 039799          259 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE------MTLKRWVNDLLPISVMEVVD  332 (346)
Q Consensus       259 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~~d  332 (346)
                       ......+||+.|||||+.....|+.|+||||+|++.+||.+|.+|+.+.....      ....+.....+...+.|+++
T Consensus       166 -~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~  244 (467)
T KOG0201|consen  166 -KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVE  244 (467)
T ss_pred             -hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHH
Confidence             22366789999999999998899999999999999999999999998755422      12222223345557999999


Q ss_pred             hhccCCcccccccC
Q 039799          333 ANLLSQEDEHFTTK  346 (346)
Q Consensus       333 ~~l~~~p~~R~~~k  346 (346)
                      .||..+|+.||+++
T Consensus       245 ~CL~k~P~~RpsA~  258 (467)
T KOG0201|consen  245 ACLDKNPEFRPSAK  258 (467)
T ss_pred             HHhhcCcccCcCHH
Confidence            99999999999985

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-41  Score=305.19  Aligned_cols=233  Identities=25%  Similarity=0.371  Sum_probs=195.1

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEe
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLE  179 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  179 (346)
                      +|.+.+.||+|+||.||+|... +++.||+|++....   ......+..|++++..++||||+++++++...+..++|||
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e   81 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME   81 (333)
T ss_pred             CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence            5788899999999999999976 68999999986432   2334667889999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccc
Q 039799          180 YMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  259 (346)
Q Consensus       180 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~  259 (346)
                      |+++++|.+++... ..+++.....++.+++.||.|||   +.+|+||||||+||+++.++.++|+|||++.....    
T Consensus        82 ~~~g~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----  153 (333)
T cd05600          82 YVPGGDFRTLLNNL-GVLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----  153 (333)
T ss_pred             CCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc----
Confidence            99999999988643 45788889999999999999999   99999999999999999999999999999986533    


Q ss_pred             cccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcc--cHHHHHh-----------hhcCCC
Q 039799          260 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM--TLKRWVN-----------DLLPIS  326 (346)
Q Consensus       260 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~--~~~~~~~-----------~~~~~~  326 (346)
                       ......|++.|+|||++.+..++.++|||||||++|||++|+.||......+.  .+..|..           ..++..
T Consensus       154 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~  232 (333)
T cd05600         154 -YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDE  232 (333)
T ss_pred             -ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHH
Confidence             22345689999999999988999999999999999999999999975322110  1111110           122447


Q ss_pred             hhhhhchhccCCccccccc
Q 039799          327 VMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       327 ~~~~~d~~l~~~p~~R~~~  345 (346)
                      +.+++.+||..+|++|++.
T Consensus       233 ~~~li~~~l~~~~~rr~s~  251 (333)
T cd05600         233 AWDLITKLINDPSRRFGSL  251 (333)
T ss_pred             HHHHHHHHhhChhhhcCCH
Confidence            7899999999999999875

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=7.4e-41  Score=307.49  Aligned_cols=239  Identities=24%  Similarity=0.406  Sum_probs=194.2

Q ss_pred             CCCCCCCcccccCceEEEEEEEc------CCCEEEEEEecCCC-chhHHHHHHHHHHHHhc-CCCCceeeEEEEecCCce
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ------DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRI-CHRNLIKIISSYSNDDFK  174 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  174 (346)
                      ++|.+.+.||+|+||.||+|.+.      ++..||+|++.... ......+.+|+++++.+ +|+||++++++|...+..
T Consensus        38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~  117 (374)
T cd05106          38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV  117 (374)
T ss_pred             HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence            46889999999999999998742      34579999997543 33456788899999999 899999999999999999


Q ss_pred             eEEEecCCCCChhhhhhhcC------------------------------------------------------------
Q 039799          175 ALVLEYMPHGSLEKCLYLSN------------------------------------------------------------  194 (346)
Q Consensus       175 ~lv~e~~~~gsL~~~l~~~~------------------------------------------------------------  194 (346)
                      ++||||+++|+|.+++....                                                            
T Consensus       118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (374)
T cd05106         118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS  197 (374)
T ss_pred             EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence            99999999999998875321                                                            


Q ss_pred             ---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccccccc
Q 039799          195 ---------YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT  265 (346)
Q Consensus       195 ---------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~  265 (346)
                               ..+++...++++.|+++||+|||   +.+++||||||+|||+++++.++|+|||+++.+............
T Consensus       198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~  274 (374)
T cd05106         198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA  274 (374)
T ss_pred             cchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence                     24678888999999999999999   999999999999999999999999999999865433222222223


Q ss_pred             cCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHhh--------hcCCChhhhhchhcc
Q 039799          266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVND--------LLPISVMEVVDANLL  336 (346)
Q Consensus       266 ~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~d~~l~  336 (346)
                      .++..|+|||+..+..++.++||||||+++|||++ |+.||....... ........        ..+..+.+++.+||.
T Consensus       275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  353 (374)
T cd05106         275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KFYKMVKRGYQMSRPDFAPPEIYSIMKMCWN  353 (374)
T ss_pred             CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HHHHHHHcccCccCCCCCCHHHHHHHHHHcC
Confidence            35678999999988899999999999999999997 999997643222 12222211        234578999999999


Q ss_pred             CCccccccc
Q 039799          337 SQEDEHFTT  345 (346)
Q Consensus       337 ~~p~~R~~~  345 (346)
                      .||++||+.
T Consensus       354 ~dp~~RPs~  362 (374)
T cd05106         354 LEPTERPTF  362 (374)
T ss_pred             CChhhCcCH
Confidence            999999985

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-41  Score=308.24  Aligned_cols=237  Identities=22%  Similarity=0.327  Sum_probs=198.7

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhc-CCCCceeeEEEEecCCcee
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRI-CHRNLIKIISSYSNDDFKA  175 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  175 (346)
                      .-++|.+.++||+|.||+|+++..+ +++.+|||++++..   ....+..+.|.+++... +||.+++++..|...++.+
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~  445 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF  445 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence            3467999999999999999999977 78899999998753   44567778888888877 5999999999999999999


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCc
Q 039799          176 LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  255 (346)
Q Consensus       176 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~  255 (346)
                      .||||+.||++..+.  ....++...+.-++..++.||+|||   +.+|++||||.+|||||.+|++||+|||+|+.-..
T Consensus       446 fvmey~~Ggdm~~~~--~~~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~  520 (694)
T KOG0694|consen  446 FVMEYVAGGDLMHHI--HTDVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG  520 (694)
T ss_pred             EEEEecCCCcEEEEE--ecccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccccccCC
Confidence            999999999954433  3466899999999999999999999   99999999999999999999999999999996532


Q ss_pred             cccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh------hhcCCChhh
Q 039799          256 EDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN------DLLPISVME  329 (346)
Q Consensus       256 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~------~~~~~~~~~  329 (346)
                        ......+.+||+.|+|||.+.++.|+..+|-|||||+||||+.|+.||.... ++......+.      ..++.+..+
T Consensus       521 --~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gdd-Eee~FdsI~~d~~~yP~~ls~ea~~  597 (694)
T KOG0694|consen  521 --QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDD-EEEVFDSIVNDEVRYPRFLSKEAIA  597 (694)
T ss_pred             --CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHhcCCCCCCCcccHHHHH
Confidence              2234567899999999999999999999999999999999999999997521 1111222222      222347789


Q ss_pred             hhchhccCCccccccc
Q 039799          330 VVDANLLSQEDEHFTT  345 (346)
Q Consensus       330 ~~d~~l~~~p~~R~~~  345 (346)
                      ++++.|..+|++|.-+
T Consensus       598 il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  598 IMRRLLRKNPEKRLGS  613 (694)
T ss_pred             HHHHHhccCcccccCC
Confidence            9999999999999753

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.2e-40  Score=299.87  Aligned_cols=238  Identities=23%  Similarity=0.341  Sum_probs=195.2

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCC----EEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCcee
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGM----EVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKA  175 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  175 (346)
                      ..+|...+.||+|+||.||+|.+. ++.    .||+|++.... ....+++.+|+.+++.++||||+++++++... ..+
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~   84 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ   84 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence            467999999999999999999864 343    38999987543 34457788999999999999999999998765 567


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCc
Q 039799          176 LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  255 (346)
Q Consensus       176 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~  255 (346)
                      +++||+++|+|.+++......+++...+.++.+++.||+|||   +.+|+||||||+||++++++.++|+|||+++.+..
T Consensus        85 ~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~  161 (316)
T cd05108          85 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  161 (316)
T ss_pred             eeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccccccccC
Confidence            999999999999999876667899999999999999999999   99999999999999999999999999999997654


Q ss_pred             cccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHhh--------hcCCC
Q 039799          256 EDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVND--------LLPIS  326 (346)
Q Consensus       256 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~--------~~~~~  326 (346)
                      ............+..|+|||++.+..++.++||||||+++|||++ |+.||+.....+  .......        ..+..
T Consensus       162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  239 (316)
T cd05108         162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSILEKGERLPQPPICTID  239 (316)
T ss_pred             CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHhCCCCCCCCCCCCHH
Confidence            332222223335678999999998899999999999999999998 999997632211  1222211        12336


Q ss_pred             hhhhhchhccCCccccccc
Q 039799          327 VMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       327 ~~~~~d~~l~~~p~~R~~~  345 (346)
                      +.+++.+|+..+|++||+.
T Consensus       240 ~~~li~~cl~~~p~~Rps~  258 (316)
T cd05108         240 VYMIMVKCWMIDADSRPKF  258 (316)
T ss_pred             HHHHHHHHccCChhhCcCH
Confidence            7899999999999999985

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.1e-40  Score=301.13  Aligned_cols=233  Identities=21%  Similarity=0.304  Sum_probs=189.4

Q ss_pred             CCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHH---HhcCCCCceeeEEEEecCCceeEE
Q 039799          105 ANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVM---KRICHRNLIKIISSYSNDDFKALV  177 (346)
Q Consensus       105 ~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l---~~l~h~niv~~~~~~~~~~~~~lv  177 (346)
                      |.+.+.||+|++|.||+|... +++.||||++....   ....+.+..|++++   +.++||||+++++++...+..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            567789999999999999866 68999999986432   22345566666554   567899999999999999999999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccc
Q 039799          178 LEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  257 (346)
Q Consensus       178 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~  257 (346)
                      |||+++++|...+..  ..+++.....++.+++.||+|||   +.+++||||||+||+++.++.+||+|||+++......
T Consensus        81 ~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05589          81 MEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG  155 (324)
T ss_pred             EcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence            999999999887753  46899999999999999999999   9999999999999999999999999999987543221


Q ss_pred             cccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH------hhhcCCChhhhh
Q 039799          258 QSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV------NDLLPISVMEVV  331 (346)
Q Consensus       258 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~------~~~~~~~~~~~~  331 (346)
                        .......|++.|+|||.+.+..++.++|||||||++|||++|+.||......+ ......      ...++..+.+++
T Consensus       156 --~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~-~~~~i~~~~~~~p~~~~~~~~~li  232 (324)
T cd05589         156 --DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE-VFDSIVNDEVRYPRFLSREAISIM  232 (324)
T ss_pred             --CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCCCCCCCCHHHHHHH
Confidence              12234568999999999998899999999999999999999999997532111 111111      122345778999


Q ss_pred             chhccCCccccccc
Q 039799          332 DANLLSQEDEHFTT  345 (346)
Q Consensus       332 d~~l~~~p~~R~~~  345 (346)
                      .+||..||++||++
T Consensus       233 ~~~L~~dP~~R~~~  246 (324)
T cd05589         233 RRLLRRNPERRLGS  246 (324)
T ss_pred             HHHhhcCHhHcCCC
Confidence            99999999999963

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=3.4e-41  Score=305.84  Aligned_cols=232  Identities=23%  Similarity=0.296  Sum_probs=193.1

Q ss_pred             CCCCCCCcccccCceEEEEEEEcC--CCEEEEEEecCC---CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEE
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQD--GMEVAVKVFDPQ---YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALV  177 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~~--~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  177 (346)
                      ++|.+.+.||+|+||.||+|.++.  +..+|+|++...   .....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv  109 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV  109 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence            568889999999999999998653  368999998532   123346678899999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccc
Q 039799          178 LEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  257 (346)
Q Consensus       178 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~  257 (346)
                      |||+++|+|.+++... ..+++..+..++.+++.||+|||   +.+|+||||||+|||++.++.++|+|||++...... 
T Consensus       110 ~Ey~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~-  184 (340)
T PTZ00426        110 LEFVIGGEFFTFLRRN-KRFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-  184 (340)
T ss_pred             EeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC-
Confidence            9999999999988643 46888999999999999999999   999999999999999999999999999999865321 


Q ss_pred             cccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH------hhhcCCChhhhh
Q 039799          258 QSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV------NDLLPISVMEVV  331 (346)
Q Consensus       258 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~------~~~~~~~~~~~~  331 (346)
                          .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .......      ...++..+.+++
T Consensus       185 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-~~~~~i~~~~~~~p~~~~~~~~~li  259 (340)
T PTZ00426        185 ----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL-LIYQKILEGIIYFPKFLDNNCKHLM  259 (340)
T ss_pred             ----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH-HHHHHHhcCCCCCCCCCCHHHHHHH
Confidence                22346899999999998888999999999999999999999999753211 1111111      122344778999


Q ss_pred             chhccCCcccccc
Q 039799          332 DANLLSQEDEHFT  344 (346)
Q Consensus       332 d~~l~~~p~~R~~  344 (346)
                      .+||..+|.+|++
T Consensus       260 ~~~l~~dp~~R~~  272 (340)
T PTZ00426        260 KKLLSHDLTKRYG  272 (340)
T ss_pred             HHHcccCHHHcCC
Confidence            9999999999973

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.6e-42  Score=277.58  Aligned_cols=237  Identities=24%  Similarity=0.321  Sum_probs=203.4

Q ss_pred             CCCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCcee
Q 039799          100 PLPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKA  175 (346)
Q Consensus       100 ~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  175 (346)
                      ..-++|++++.||+|.||.||.|+.+ ++-.||+|++.+..   .+...++.+|+++-+.|+||||++++++|.+....|
T Consensus        19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riy   98 (281)
T KOG0580|consen   19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIY   98 (281)
T ss_pred             cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeE
Confidence            34578999999999999999999866 67889999986432   334567888999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCC
Q 039799          176 LVLEYMPHGSLEKCLYLSN-YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  254 (346)
Q Consensus       176 lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~  254 (346)
                      |++||.++|++...|.... ..++......+..|+|.|+.|+|   .+.++||||||+|+|++.++..|++|||.+..-.
T Consensus        99 LilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p  175 (281)
T KOG0580|consen   99 LILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP  175 (281)
T ss_pred             EEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence            9999999999999887554 45888888999999999999999   9999999999999999999999999999988532


Q ss_pred             ccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH------hhhcCCChh
Q 039799          255 EEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV------NDLLPISVM  328 (346)
Q Consensus       255 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~------~~~~~~~~~  328 (346)
                          .....+.+||.-|.+||...+...+..+|+|++|++.||++.|.+||.... .+....+..      ...++....
T Consensus       176 ----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkrI~k~~~~~p~~is~~a~  250 (281)
T KOG0580|consen  176 ----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKRIRKVDLKFPSTISGGAA  250 (281)
T ss_pred             ----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHHHHHccccCCcccChhHH
Confidence                333456789999999999999999999999999999999999999998754 222222222      233455889


Q ss_pred             hhhchhccCCcccccc
Q 039799          329 EVVDANLLSQEDEHFT  344 (346)
Q Consensus       329 ~~~d~~l~~~p~~R~~  344 (346)
                      |+|.+++..+|.+|.+
T Consensus       251 dlI~~ll~~~p~~r~~  266 (281)
T KOG0580|consen  251 DLISRLLVKNPIERLA  266 (281)
T ss_pred             HHHHHHhccCcccccc
Confidence            9999999999999975

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.2e-40  Score=300.32  Aligned_cols=229  Identities=25%  Similarity=0.322  Sum_probs=188.8

Q ss_pred             CcccccCceEEEEEEEc-CCCEEEEEEecCC---CchhHHHHHHHHHHHHhc-CCCCceeeEEEEecCCceeEEEecCCC
Q 039799          109 PLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ---YEGAFKSFDIECDVMKRI-CHRNLIKIISSYSNDDFKALVLEYMPH  183 (346)
Q Consensus       109 ~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  183 (346)
                      +.||+|+||.||+|..+ +++.||+|++...   .......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46899999999999976 6889999998643   123345667788888876 699999999999999999999999999


Q ss_pred             CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccccc
Q 039799          184 GSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT  263 (346)
Q Consensus       184 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~~  263 (346)
                      |+|.+++... ..+++..+..++.|++.||+|||   +.+++||||||+|||++.++.++|+|||+++......  ....
T Consensus        81 g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~~~  154 (320)
T cd05590          81 GDLMFHIQKS-RRFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTTS  154 (320)
T ss_pred             chHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cccc
Confidence            9999887643 46888999999999999999999   9999999999999999999999999999988542221  1223


Q ss_pred             cccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh-------hhcCCChhhhhchhcc
Q 039799          264 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN-------DLLPISVMEVVDANLL  336 (346)
Q Consensus       264 ~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~-------~~~~~~~~~~~d~~l~  336 (346)
                      ...||+.|+|||.+.+..++.++||||||+++|||++|+.||......  .....+.       ..++..+.+++.+||.
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~li~~~L~  232 (320)
T cd05590         155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED--DLFEAILNDEVVYPTWLSQDAVDILKAFMT  232 (320)
T ss_pred             ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH--HHHHHHhcCCCCCCCCCCHHHHHHHHHHcc
Confidence            456899999999998888999999999999999999999999753211  1111111       1234477899999999


Q ss_pred             CCccccccc
Q 039799          337 SQEDEHFTT  345 (346)
Q Consensus       337 ~~p~~R~~~  345 (346)
                      .||++|+++
T Consensus       233 ~dP~~R~~~  241 (320)
T cd05590         233 KNPTMRLGS  241 (320)
T ss_pred             cCHHHCCCC
Confidence            999999986

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.1e-40  Score=289.21  Aligned_cols=236  Identities=24%  Similarity=0.367  Sum_probs=196.3

Q ss_pred             CCCCCCCcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecCC
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMP  182 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  182 (346)
                      ++|.+.+.||+|+||.||++.++++..+|+|.+.... ...+.+.+|++++++++||||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            4688889999999999999999888899999886442 234678889999999999999999999999999999999999


Q ss_pred             CCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccccc
Q 039799          183 HGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ  262 (346)
Q Consensus       183 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~  262 (346)
                      +|+|.+++......+++..+..++.+++.||+|||   +.+++||||+|+||++++++.++|+|||.++....... ...
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~~~  158 (256)
T cd05114          83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TSS  158 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCce-ecc
Confidence            99999988765557899999999999999999999   99999999999999999999999999999986533221 111


Q ss_pred             ccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHhh--------hcCCChhhhhch
Q 039799          263 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVND--------LLPISVMEVVDA  333 (346)
Q Consensus       263 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~d~  333 (346)
                      ....++..|+|||......++.++||||||+++|||++ |+.||.....  ......+..        ..+..+.+++.+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~li~~  236 (256)
T cd05114         159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN--YEVVEMISRGFRLYRPKLASMTVYEVMYS  236 (256)
T ss_pred             CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHCCCCCCCCCCCCHHHHHHHHH
Confidence            22335678999999988889999999999999999999 8999865321  112222211        123367899999


Q ss_pred             hccCCccccccc
Q 039799          334 NLLSQEDEHFTT  345 (346)
Q Consensus       334 ~l~~~p~~R~~~  345 (346)
                      |+..+|++||+.
T Consensus       237 c~~~~p~~Rps~  248 (256)
T cd05114         237 CWHEKPEGRPTF  248 (256)
T ss_pred             HccCCcccCcCH
Confidence            999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=6.5e-41  Score=301.39  Aligned_cols=230  Identities=22%  Similarity=0.316  Sum_probs=186.2

Q ss_pred             CcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHh-cCCCCceeeEEEEecCCceeEEEecCCC
Q 039799          109 PLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKR-ICHRNLIKIISSYSNDDFKALVLEYMPH  183 (346)
Q Consensus       109 ~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~  183 (346)
                      +.||+|+||.||+|... +++.||+|++....   ....+.+..|.+++.. .+||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46899999999999976 68899999986431   2233445566677765 4899999999999999999999999999


Q ss_pred             CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccccc
Q 039799          184 GSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT  263 (346)
Q Consensus       184 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~~  263 (346)
                      |+|.+++... ..++......++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||+++......  ....
T Consensus        81 g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~  154 (316)
T cd05592          81 GDLMFHIQSS-GRFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKAS  154 (316)
T ss_pred             CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cccc
Confidence            9999888643 45888889999999999999999   9999999999999999999999999999998643222  2223


Q ss_pred             cccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHH------HhhhcCCChhhhhchhccC
Q 039799          264 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRW------VNDLLPISVMEVVDANLLS  337 (346)
Q Consensus       264 ~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~------~~~~~~~~~~~~~d~~l~~  337 (346)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .....      ....++..+.+++.+||..
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~  233 (316)
T cd05592         155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE-LFDSILNDRPHFPRWISKEAKDCLSKLFER  233 (316)
T ss_pred             cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHcCCCCCCCCCCHHHHHHHHHHccC
Confidence            4568999999999988889999999999999999999999997532111 11111      1122344678999999999


Q ss_pred             Cccccccc
Q 039799          338 QEDEHFTT  345 (346)
Q Consensus       338 ~p~~R~~~  345 (346)
                      +|++||++
T Consensus       234 ~P~~R~~~  241 (316)
T cd05592         234 DPTKRLGV  241 (316)
T ss_pred             CHHHcCCC
Confidence            99999975

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.1e-40  Score=299.03  Aligned_cols=229  Identities=25%  Similarity=0.355  Sum_probs=187.2

Q ss_pred             CcccccCceEEEEEEE----cCCCEEEEEEecCC----CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEec
Q 039799          109 PLIGKGGFGSVYKAII----QDGMEVAVKVFDPQ----YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEY  180 (346)
Q Consensus       109 ~~lg~G~~g~vy~~~~----~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  180 (346)
                      +.||+|+||.||+++.    .+++.||+|++...    .......+..|+++++.++||||+++++.+..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            5799999999999985    35789999998642    122345677899999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccc
Q 039799          181 MPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  260 (346)
Q Consensus       181 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~  260 (346)
                      +++++|.+++... ..+.+.....++.|++.||+|||   +.+|+||||||+|||++.++.++|+|||+++......  .
T Consensus        82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~  155 (323)
T cd05584          82 LSGGELFMHLERE-GIFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG--T  155 (323)
T ss_pred             CCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC--C
Confidence            9999999988643 45677888889999999999999   9999999999999999999999999999987543222  1


Q ss_pred             ccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH------hhhcCCChhhhhchh
Q 039799          261 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV------NDLLPISVMEVVDAN  334 (346)
Q Consensus       261 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~------~~~~~~~~~~~~d~~  334 (346)
                      ......|++.|+|||++.+..++.++||||||+++|||++|+.||....... ......      ...++..+.+++.+|
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~  234 (323)
T cd05584         156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK-TIDKILKGKLNLPPYLTPEARDLLKKL  234 (323)
T ss_pred             cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH-HHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence            1233468999999999988889999999999999999999999997532111 111111      112344778999999


Q ss_pred             ccCCcccccc
Q 039799          335 LLSQEDEHFT  344 (346)
Q Consensus       335 l~~~p~~R~~  344 (346)
                      |..+|++||+
T Consensus       235 l~~~p~~R~~  244 (323)
T cd05584         235 LKRNPSSRLG  244 (323)
T ss_pred             cccCHhHcCC
Confidence            9999999994

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.9e-40  Score=291.32  Aligned_cols=237  Identities=20%  Similarity=0.313  Sum_probs=194.8

Q ss_pred             CCCCCCCcccccCceEEEEEEEc----CCCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEE
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ----DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALV  177 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  177 (346)
                      ++|.+.+.||+|+||.||+|++.    .+..+|+|.++... ......+.+|+..+++++||||+++++++...+..++|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            46888999999999999999854    35689999987653 23346788999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccc
Q 039799          178 LEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  257 (346)
Q Consensus       178 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~  257 (346)
                      |||+++|+|.+++......+++..++.++.+++.||+|||   +.+++||||||+||+++.++.++++|||.+.......
T Consensus        85 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~  161 (266)
T cd05064          85 TEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA  161 (266)
T ss_pred             EEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence            9999999999998766667899999999999999999999   9999999999999999999999999999877532211


Q ss_pred             cccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHh--------hhcCCChh
Q 039799          258 QSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVN--------DLLPISVM  328 (346)
Q Consensus       258 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~  328 (346)
                      . .......++..|+|||...+..++.++||||||+++||+++ |..||......  ...+.+.        ...+..+.
T Consensus       162 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  238 (266)
T cd05064         162 I-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--DVIKAVEDGFRLPAPRNCPNLLH  238 (266)
T ss_pred             h-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHHHCCCCCCCCCCCCHHHH
Confidence            1 11112235678999999988899999999999999999875 99999753221  1222222        12344788


Q ss_pred             hhhchhccCCccccccc
Q 039799          329 EVVDANLLSQEDEHFTT  345 (346)
Q Consensus       329 ~~~d~~l~~~p~~R~~~  345 (346)
                      +++.+|+..+|++||+.
T Consensus       239 ~li~~c~~~~p~~RP~~  255 (266)
T cd05064         239 QLMLDCWQKERGERPRF  255 (266)
T ss_pred             HHHHHHcCCCchhCCCH
Confidence            99999999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=5.9e-40  Score=289.85  Aligned_cols=229  Identities=26%  Similarity=0.377  Sum_probs=188.0

Q ss_pred             ccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecCCCCCh
Q 039799          111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSL  186 (346)
Q Consensus       111 lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  186 (346)
                      ||+|+||.||++..+ +|+.+|+|.+....   ......+..|++++++++||||+++.+.+......++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999865 68999999986421   12234456699999999999999999999999999999999999999


Q ss_pred             hhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccccccc
Q 039799          187 EKCLYLSN-YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT  265 (346)
Q Consensus       187 ~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~  265 (346)
                      .+++.... ..+++..+..++.|++.|++|||   +.+++||||||+||++++++.++|+|||++.......   .....
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~  154 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQR  154 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeecc
Confidence            88875433 45889999999999999999999   9999999999999999999999999999988654321   12234


Q ss_pred             cCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCc--ccHHH-HH-------hhhcCCChhhhhchhc
Q 039799          266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE--MTLKR-WV-------NDLLPISVMEVVDANL  335 (346)
Q Consensus       266 ~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~--~~~~~-~~-------~~~~~~~~~~~~d~~l  335 (346)
                      .++..|+|||++.+..++.++||||+||++|||++|+.||.......  ....+ ..       ...++..+.+++.+||
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  234 (277)
T cd05607         155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFL  234 (277)
T ss_pred             CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHh
Confidence            58999999999988889999999999999999999999996532111  01111 01       1224457899999999


Q ss_pred             cCCccccccc
Q 039799          336 LSQEDEHFTT  345 (346)
Q Consensus       336 ~~~p~~R~~~  345 (346)
                      ..+|++||++
T Consensus       235 ~~~P~~R~~~  244 (277)
T cd05607         235 AKKPEDRLGS  244 (277)
T ss_pred             ccCHhhCCCC
Confidence            9999999987

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.1e-40  Score=301.70  Aligned_cols=231  Identities=23%  Similarity=0.308  Sum_probs=188.9

Q ss_pred             CcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhc-CCCCceeeEEEEecCCceeEEEecCCC
Q 039799          109 PLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRI-CHRNLIKIISSYSNDDFKALVLEYMPH  183 (346)
Q Consensus       109 ~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  183 (346)
                      +.||+|+||.||++... +++.||+|++....   ....+.+..|..++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46899999999999876 68899999997532   23345677899999888 799999999999999999999999999


Q ss_pred             CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccccc
Q 039799          184 GSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT  263 (346)
Q Consensus       184 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~~  263 (346)
                      |+|.+++.. ...+++..+..++.|++.||+|||   +.+++||||||+||+++.++.++|+|||+++......  ....
T Consensus        81 g~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~~~  154 (329)
T cd05588          81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DTTS  154 (329)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccCC--Cccc
Confidence            999888753 356899999999999999999999   9999999999999999999999999999987532211  1223


Q ss_pred             cccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccC---cccHHHHH-----------hhhcCCChhh
Q 039799          264 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSG---EMTLKRWV-----------NDLLPISVME  329 (346)
Q Consensus       264 ~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~---~~~~~~~~-----------~~~~~~~~~~  329 (346)
                      ...||..|+|||++.+..++.++|+||||+++|||+||+.||+.....   ......+.           ...++..+.+
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~  234 (329)
T cd05588         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASS  234 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            456899999999999889999999999999999999999999742211   11111111           1122336789


Q ss_pred             hhchhccCCccccccc
Q 039799          330 VVDANLLSQEDEHFTT  345 (346)
Q Consensus       330 ~~d~~l~~~p~~R~~~  345 (346)
                      ++.+||..||.+|++.
T Consensus       235 li~~~L~~dP~~R~~~  250 (329)
T cd05588         235 VLKGFLNKDPKERLGC  250 (329)
T ss_pred             HHHHHhccCHHHcCCC
Confidence            9999999999999973

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=7.4e-41  Score=302.06  Aligned_cols=231  Identities=29%  Similarity=0.356  Sum_probs=187.0

Q ss_pred             CcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHH-HHHhcCCCCceeeEEEEecCCceeEEEecCCC
Q 039799          109 PLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECD-VMKRICHRNLIKIISSYSNDDFKALVLEYMPH  183 (346)
Q Consensus       109 ~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  183 (346)
                      +.||+|+||+||+|... +|+.||+|++....   ......+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46899999999999976 78999999986431   122334445544 56789999999999999999999999999999


Q ss_pred             CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccccc
Q 039799          184 GSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT  263 (346)
Q Consensus       184 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~~  263 (346)
                      |+|.+++.. ...+++.....++.|++.||+|||   +.+|+||||||+|||++.++.++|+|||+++......  ....
T Consensus        81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~  154 (323)
T cd05575          81 GELFFHLQR-ERSFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KTTS  154 (323)
T ss_pred             CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Cccc
Confidence            999988864 346888889999999999999999   9999999999999999999999999999987542221  2233


Q ss_pred             cccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHH------HhhhcCCChhhhhchhccC
Q 039799          264 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRW------VNDLLPISVMEVVDANLLS  337 (346)
Q Consensus       264 ~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~------~~~~~~~~~~~~~d~~l~~  337 (346)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .....      ....++..+.+++.+||..
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~li~~~l~~  233 (323)
T cd05575         155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE-MYDNILNKPLRLKPNISVSARHLLEGLLQK  233 (323)
T ss_pred             cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH-HHHHHHcCCCCCCCCCCHHHHHHHHHHhhc
Confidence            4568999999999998899999999999999999999999996532111 11111      1122345789999999999


Q ss_pred             CcccccccC
Q 039799          338 QEDEHFTTK  346 (346)
Q Consensus       338 ~p~~R~~~k  346 (346)
                      ||.+||+++
T Consensus       234 ~p~~R~~~~  242 (323)
T cd05575         234 DRTKRLGAK  242 (323)
T ss_pred             CHHhCCCCC
Confidence            999999863

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.6e-40  Score=300.02  Aligned_cols=234  Identities=24%  Similarity=0.275  Sum_probs=190.9

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC---CchhHHHHHHHHHHHHhcCCC-CceeeEEEEecCCceeEEE
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ---YEGAFKSFDIECDVMKRICHR-NLIKIISSYSNDDFKALVL  178 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~lv~  178 (346)
                      +|.+.+.||+|+||.||+|... +++.||+|++...   .....+.+..|.+++..++|+ +++++.+++...+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4778899999999999999866 6789999998643   223456677899999999765 5778889999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccc
Q 039799          179 EYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  258 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~  258 (346)
                      ||+++|+|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.++|+|||++....... 
T Consensus        81 E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-  155 (324)
T cd05587          81 EYVNGGDLMYHIQQV-GKFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG-  155 (324)
T ss_pred             cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-
Confidence            999999999888643 45788999999999999999999   9999999999999999999999999999987532111 


Q ss_pred             ccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH-------hhhcCCChhhhh
Q 039799          259 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV-------NDLLPISVMEVV  331 (346)
Q Consensus       259 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~  331 (346)
                       .......||+.|+|||++.+..++.++||||+||++|||+||+.||......  .....+       ...++..+.+++
T Consensus       156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~li  232 (324)
T cd05587         156 -KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED--ELFQSIMEHNVSYPKSLSKEAVSIC  232 (324)
T ss_pred             -CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHHcCCCCCCCCCCHHHHHHH
Confidence             1223456899999999999888999999999999999999999999753211  111111       112334677999


Q ss_pred             chhccCCccccccc
Q 039799          332 DANLLSQEDEHFTT  345 (346)
Q Consensus       332 d~~l~~~p~~R~~~  345 (346)
                      .+||..+|.+|++.
T Consensus       233 ~~~l~~~P~~R~~~  246 (324)
T cd05587         233 KGLLTKHPAKRLGC  246 (324)
T ss_pred             HHHhhcCHHHcCCC
Confidence            99999999999974

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=5.1e-41  Score=293.73  Aligned_cols=233  Identities=33%  Similarity=0.524  Sum_probs=187.5

Q ss_pred             CCcccccCceEEEEEEEc-----CCCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecC
Q 039799          108 PPLIGKGGFGSVYKAIIQ-----DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYM  181 (346)
Q Consensus       108 ~~~lg~G~~g~vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  181 (346)
                      .+.||.|.||.||+|.+.     .+..|+||.++... ....+.+.+|++.+++++||||++++|++...+..++|+||+
T Consensus         4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~   83 (259)
T PF07714_consen    4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC   83 (259)
T ss_dssp             EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred             eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence            467999999999999977     35689999996543 334788999999999999999999999999888899999999


Q ss_pred             CCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccc
Q 039799          182 PHGSLEKCLYLS-NYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  260 (346)
Q Consensus       182 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~  260 (346)
                      ++|+|.+++... ...+++..++.++.|+++||+|||   +.+++|+||+++||++++++.+||+|||++..........
T Consensus        84 ~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~  160 (259)
T PF07714_consen   84 PGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK  160 (259)
T ss_dssp             TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred             ccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccccc
Confidence            999999999876 577999999999999999999999   8999999999999999999999999999998763322222


Q ss_pred             ccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHH--------hhhcCCChhhhh
Q 039799          261 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWV--------NDLLPISVMEVV  331 (346)
Q Consensus       261 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~~  331 (346)
                      ..........|+|||.+....++.++||||||+++|||+| |+.|+.+...  ..+...+        ...++..+.+++
T Consensus       161 ~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li  238 (259)
T PF07714_consen  161 NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN--EEIIEKLKQGQRLPIPDNCPKDIYSLI  238 (259)
T ss_dssp             ESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH--HHHHHHHHTTEETTSBTTSBHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccccccccccceeccchhHHHHHHH
Confidence            2333457788999999988889999999999999999999 7899876421  1121222        112334789999


Q ss_pred             chhccCCccccccc
Q 039799          332 DANLLSQEDEHFTT  345 (346)
Q Consensus       332 d~~l~~~p~~R~~~  345 (346)
                      ..||..+|++||+.
T Consensus       239 ~~C~~~~p~~RPs~  252 (259)
T PF07714_consen  239 QQCWSHDPEKRPSF  252 (259)
T ss_dssp             HHHT-SSGGGS--H
T ss_pred             HHHcCCChhhCcCH
Confidence            99999999999985

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=4.8e-41  Score=303.52  Aligned_cols=228  Identities=23%  Similarity=0.297  Sum_probs=188.6

Q ss_pred             CcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecCCCC
Q 039799          109 PLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHG  184 (346)
Q Consensus       109 ~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  184 (346)
                      +.||+|+||.||++... +|+.||+|++....   ......+..|++++..++||||+++.+.+...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46899999999999865 78999999987532   233456678999999999999999999999999999999999999


Q ss_pred             ChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccccc
Q 039799          185 SLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYS-APIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT  263 (346)
Q Consensus       185 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~~  263 (346)
                      +|..++.. ...+++..+..++.|++.||+|||   + .+|+||||||+|||++.++.++|+|||+++......  ....
T Consensus        81 ~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~  154 (325)
T cd05594          81 ELFFHLSR-ERVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATMK  154 (325)
T ss_pred             cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cccc
Confidence            99887753 346889999999999999999999   7 799999999999999999999999999987543221  1123


Q ss_pred             cccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH-------hhhcCCChhhhhchhcc
Q 039799          264 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV-------NDLLPISVMEVVDANLL  336 (346)
Q Consensus       264 ~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~d~~l~  336 (346)
                      ...||+.|+|||++.+..++.++||||||+++|||+||+.||......  .....+       ...++..+.+++.+||.
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~--~~~~~i~~~~~~~p~~~~~~~~~li~~~L~  232 (325)
T cd05594         155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFELILMEEIRFPRTLSPEAKSLLSGLLK  232 (325)
T ss_pred             cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH--HHHHHHhcCCCCCCCCCCHHHHHHHHHHhh
Confidence            346899999999998889999999999999999999999999653211  111111       12234578999999999


Q ss_pred             CCcccccc
Q 039799          337 SQEDEHFT  344 (346)
Q Consensus       337 ~~p~~R~~  344 (346)
                      .||++|++
T Consensus       233 ~dP~~R~~  240 (325)
T cd05594         233 KDPKQRLG  240 (325)
T ss_pred             cCHHHhCC
Confidence            99999983

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=2.7e-40  Score=297.36  Aligned_cols=230  Identities=23%  Similarity=0.335  Sum_probs=187.4

Q ss_pred             CcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHh-cCCCCceeeEEEEecCCceeEEEecCCC
Q 039799          109 PLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKR-ICHRNLIKIISSYSNDDFKALVLEYMPH  183 (346)
Q Consensus       109 ~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~  183 (346)
                      +.||+|+||.||+|... +++.||+|++....   .........|..++.. .+||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46899999999999976 57899999987531   2234556667778876 4899999999999999999999999999


Q ss_pred             CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccccc
Q 039799          184 GSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT  263 (346)
Q Consensus       184 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~~  263 (346)
                      |+|.+++.. ...+++.....++.|++.||+|||   +.+++||||||+|||++.++.++|+|||+++......  ....
T Consensus        81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~  154 (316)
T cd05619          81 GDLMFHIQS-CHKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AKTC  154 (316)
T ss_pred             CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Ccee
Confidence            999998864 345788899999999999999999   9999999999999999999999999999987532211  1123


Q ss_pred             cccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh-------hhcCCChhhhhchhcc
Q 039799          264 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN-------DLLPISVMEVVDANLL  336 (346)
Q Consensus       264 ~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~-------~~~~~~~~~~~d~~l~  336 (346)
                      ...||..|+|||++.+..++.++|||||||++|||++|+.||.....  ....+.+.       ..++..+.+++.+||.
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~  232 (316)
T cd05619         155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE--EELFQSIRMDNPCYPRWLTREAKDILVKLFV  232 (316)
T ss_pred             eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhCCCCCCccCCHHHHHHHHHHhc
Confidence            44689999999999888899999999999999999999999975321  11111111       1133367899999999


Q ss_pred             CCcccccccC
Q 039799          337 SQEDEHFTTK  346 (346)
Q Consensus       337 ~~p~~R~~~k  346 (346)
                      .+|++||+++
T Consensus       233 ~~P~~R~~~~  242 (316)
T cd05619         233 REPERRLGVK  242 (316)
T ss_pred             cCHhhcCCCh
Confidence            9999999863

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=4.1e-40  Score=291.36  Aligned_cols=229  Identities=24%  Similarity=0.347  Sum_probs=188.3

Q ss_pred             ccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecCCCCCh
Q 039799          111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSL  186 (346)
Q Consensus       111 lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  186 (346)
                      ||+|+||+||++... +++.+|+|.+....   ....+.+..|++++++++|+|++++.+.+......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999866 78999999986432   22335677899999999999999999999999999999999999999


Q ss_pred             hhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccccc
Q 039799          187 EKCLYL---SNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT  263 (346)
Q Consensus       187 ~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~~  263 (346)
                      .+.+..   ....+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||++..+.....  ...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence            887743   2356899999999999999999999   99999999999999999999999999999986543221  123


Q ss_pred             cccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCc--ccHHHHH-------hhhcCCChhhhhchh
Q 039799          264 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE--MTLKRWV-------NDLLPISVMEVVDAN  334 (346)
Q Consensus       264 ~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~--~~~~~~~-------~~~~~~~~~~~~d~~  334 (346)
                      ...|++.|+|||.+.+..++.++||||||+++|||++|+.||.......  ......+       ...++..+.+++.+|
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  235 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEAL  235 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHH
Confidence            3468999999999999999999999999999999999999997532211  1111111       112344788999999


Q ss_pred             ccCCcccccc
Q 039799          335 LLSQEDEHFT  344 (346)
Q Consensus       335 l~~~p~~R~~  344 (346)
                      |..||++||+
T Consensus       236 l~~~P~~R~~  245 (280)
T cd05608         236 LAKDPEKRLG  245 (280)
T ss_pred             hcCCHHHhcC
Confidence            9999999995

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.4e-40  Score=300.88  Aligned_cols=231  Identities=24%  Similarity=0.321  Sum_probs=188.0

Q ss_pred             CcccccCceEEEEEEEc-CCCEEEEEEecCC---CchhHHHHHHHHHHHHhc-CCCCceeeEEEEecCCceeEEEecCCC
Q 039799          109 PLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ---YEGAFKSFDIECDVMKRI-CHRNLIKIISSYSNDDFKALVLEYMPH  183 (346)
Q Consensus       109 ~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  183 (346)
                      +.||+|+||.||++... +++.+|+|++...   .....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999976 6889999998753   223345677888888776 799999999999999999999999999


Q ss_pred             CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccccc
Q 039799          184 GSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT  263 (346)
Q Consensus       184 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~~  263 (346)
                      ++|..++.. ...+++..+..++.+++.||+|||   +.+|+||||||+||+++.++.++|+|||+++......  ....
T Consensus        81 ~~L~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~~~  154 (329)
T cd05618          81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTS  154 (329)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Cccc
Confidence            999887753 346889999999999999999999   9999999999999999999999999999988543221  1223


Q ss_pred             cccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccC---cccHHHHH-----------hhhcCCChhh
Q 039799          264 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSG---EMTLKRWV-----------NDLLPISVME  329 (346)
Q Consensus       264 ~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~---~~~~~~~~-----------~~~~~~~~~~  329 (346)
                      ...||..|+|||++.+..++.++||||||+++|||++|+.||+.....   ......++           ...++..+.+
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~  234 (329)
T cd05618         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAAS  234 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHH
Confidence            456899999999999999999999999999999999999999642211   11111111           1112336679


Q ss_pred             hhchhccCCccccccc
Q 039799          330 VVDANLLSQEDEHFTT  345 (346)
Q Consensus       330 ~~d~~l~~~p~~R~~~  345 (346)
                      ++.+||..||++|+++
T Consensus       235 ll~~~L~~dP~~R~~~  250 (329)
T cd05618         235 VLKSFLNKDPKERLGC  250 (329)
T ss_pred             HHHHHhcCCHHHcCCC
Confidence            9999999999999974

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=2.5e-40  Score=298.57  Aligned_cols=235  Identities=23%  Similarity=0.284  Sum_probs=191.5

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhc-CCCCceeeEEEEecCCceeEEE
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRI-CHRNLIKIISSYSNDDFKALVL  178 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  178 (346)
                      +|.+.+.||+|+||.||+|... +++.+|+|++....   ......+..|..++..+ .|++++++.+++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4778899999999999999876 67899999987532   22334566677888777 5889999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccc
Q 039799          179 EYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  258 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~  258 (346)
                      ||+++|+|.+.+... ..+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.++|+|||+++...... 
T Consensus        81 E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~-  155 (323)
T cd05616          81 EYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG-  155 (323)
T ss_pred             cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC-
Confidence            999999999887643 45888999999999999999999   9999999999999999999999999999988543211 


Q ss_pred             ccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh------hhcCCChhhhhc
Q 039799          259 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN------DLLPISVMEVVD  332 (346)
Q Consensus       259 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~------~~~~~~~~~~~d  332 (346)
                       .......||+.|+|||++.+..++.++|||||||++|||+||+.||......+ .......      ..++..+.+++.
T Consensus       156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~-~~~~i~~~~~~~p~~~s~~~~~li~  233 (323)
T cd05616         156 -VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-LFQSIMEHNVAYPKSMSKEAVAICK  233 (323)
T ss_pred             -CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCCCCCcCCHHHHHHHH
Confidence             12234568999999999999999999999999999999999999997532211 1111111      123447789999


Q ss_pred             hhccCCccccccc
Q 039799          333 ANLLSQEDEHFTT  345 (346)
Q Consensus       333 ~~l~~~p~~R~~~  345 (346)
                      +||..+|++|++.
T Consensus       234 ~~l~~~p~~R~~~  246 (323)
T cd05616         234 GLMTKHPGKRLGC  246 (323)
T ss_pred             HHcccCHHhcCCC
Confidence            9999999999974

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=5.9e-41  Score=283.67  Aligned_cols=237  Identities=23%  Similarity=0.258  Sum_probs=192.4

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEe--cCCceeEE
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYS--NDDFKALV  177 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~lv  177 (346)
                      ++|...+.|++|+||.||+|+.+ +++.||+|+++...  .+..-.-.+|+.+|.+++|||||.+-....  +-+..|+|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            56888899999999999999966 78999999987543  232334568999999999999999988764  45579999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccc
Q 039799          178 LEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  257 (346)
Q Consensus       178 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~  257 (346)
                      |||+++ +|...++.-...+...+...+..|+++|++|||   ...|+|||+|++|+|++..|.+||+|||+|+.+... 
T Consensus       156 Me~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp-  230 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP-  230 (419)
T ss_pred             HHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhhcCC-
Confidence            999977 899988877778888999999999999999999   899999999999999999999999999999988544 


Q ss_pred             cccccccccCCcccccCCCCCCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccCc--------------------ccHH
Q 039799          258 QSLTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE--------------------MTLK  316 (346)
Q Consensus       258 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~--------------------~~~~  316 (346)
                       ....+..+-|.+|.|||.+.+. .|+...|+||+|||+.|++++++-|.....-+                    ..+.
T Consensus       231 -~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp  309 (419)
T KOG0663|consen  231 -LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP  309 (419)
T ss_pred             -cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccc
Confidence             3345666789999999988775 58999999999999999999998875421110                    1111


Q ss_pred             HHHhhh-----------------cCCChhhhhchhccCCccccccc
Q 039799          317 RWVNDL-----------------LPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       317 ~~~~~~-----------------~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      -|-...                 +.+.-.+++...|..||++|.|+
T Consensus       310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA  355 (419)
T KOG0663|consen  310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITA  355 (419)
T ss_pred             hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccH
Confidence            111011                 22344688999999999999986

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=2.2e-40  Score=298.70  Aligned_cols=228  Identities=24%  Similarity=0.311  Sum_probs=187.7

Q ss_pred             CcccccCceEEEEEEEc-CCCEEEEEEecCC---CchhHHHHHHHHHHHHhc-CCCCceeeEEEEecCCceeEEEecCCC
Q 039799          109 PLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ---YEGAFKSFDIECDVMKRI-CHRNLIKIISSYSNDDFKALVLEYMPH  183 (346)
Q Consensus       109 ~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  183 (346)
                      +.||+|+||.||+|+.. +++.||+|++...   .......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46899999999999876 6789999998643   123345667788888866 799999999999999999999999999


Q ss_pred             CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccccc
Q 039799          184 GSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT  263 (346)
Q Consensus       184 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~~  263 (346)
                      ++|...+... ..+++..+..++.+++.||+|||   +.+|+||||||+||+++.++.++|+|||++.......  ....
T Consensus        81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~~  154 (321)
T cd05591          81 GDLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTTT  154 (321)
T ss_pred             CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCC--cccc
Confidence            9999887643 46888899999999999999999   9999999999999999999999999999988543222  1223


Q ss_pred             cccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH-h------hhcCCChhhhhchhcc
Q 039799          264 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV-N------DLLPISVMEVVDANLL  336 (346)
Q Consensus       264 ~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~-~------~~~~~~~~~~~d~~l~  336 (346)
                      ...|++.|+|||++.+..++.++||||||+++|||+||+.||......  ...+.+ .      ..++..+.+++.+||.
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~--~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~  232 (321)
T cd05591         155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED--DLFESILHDDVLYPVWLSKEAVSILKAFMT  232 (321)
T ss_pred             ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH--HHHHHHHcCCCCCCCCCCHHHHHHHHHHhc
Confidence            456899999999998889999999999999999999999999753211  111111 1      1134477899999999


Q ss_pred             CCcccccc
Q 039799          337 SQEDEHFT  344 (346)
Q Consensus       337 ~~p~~R~~  344 (346)
                      .||++|++
T Consensus       233 ~dp~~R~~  240 (321)
T cd05591         233 KNPNKRLG  240 (321)
T ss_pred             cCHHHcCC
Confidence            99999994

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-40  Score=292.45  Aligned_cols=237  Identities=28%  Similarity=0.419  Sum_probs=189.9

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC--------------chhHHHHHHHHHHHHhcCCCCceeeEE
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY--------------EGAFKSFDIECDVMKRICHRNLIKIIS  166 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~--------------~~~~~~~~~e~~~l~~l~h~niv~~~~  166 (346)
                      -+.|.+.+.||+|.||.|-+|... +++.||||++.+..              ....+...+|+.++++++|||||++++
T Consensus        96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE  175 (576)
T KOG0585|consen   96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE  175 (576)
T ss_pred             hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence            367999999999999999999855 79999999996531              112357889999999999999999999


Q ss_pred             EEec--CCceeEEEecCCCCChhhhhhhcCCC-CCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEE
Q 039799          167 SYSN--DDFKALVLEYMPHGSLEKCLYLSNYI-LDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAH  243 (346)
Q Consensus       167 ~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~-l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~  243 (346)
                      +..+  .+..|||+||+..|.+...=  .... ++..+..+++.++..||+|||   .++|+||||||+|+|++++|++|
T Consensus       176 vLDDP~s~~~YlVley~s~G~v~w~p--~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~~g~VK  250 (576)
T KOG0585|consen  176 VLDDPESDKLYLVLEYCSKGEVKWCP--PDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSSDGTVK  250 (576)
T ss_pred             eecCcccCceEEEEEeccCCccccCC--CCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcCCCcEE
Confidence            9865  56899999999998876421  2233 889999999999999999999   99999999999999999999999


Q ss_pred             EeeecCCccCCcc---ccccccccccCCcccccCCCCCCCC----CCcchhHHHHHHHHHHHHcCCCCCCccccCcccH-
Q 039799          244 LSDFGMAKPLLEE---DQSLTQTQTLATIGYMAPEYGREGR----VSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTL-  315 (346)
Q Consensus       244 l~Dfg~~~~~~~~---~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~-  315 (346)
                      |+|||.+......   +.........||+.|+|||...++.    .+.+.||||+||+||.++.|+.||-+.+  +..+ 
T Consensus       251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~--~~~l~  328 (576)
T KOG0585|consen  251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF--ELELF  328 (576)
T ss_pred             eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch--HHHHH
Confidence            9999999876321   1112223467999999999887632    3677899999999999999999996522  2222 


Q ss_pred             HHHHhhhc--------CCChhhhhchhccCCccccccc
Q 039799          316 KRWVNDLL--------PISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       316 ~~~~~~~~--------~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ...++..+        .+.+.++|.++|..||+.|++.
T Consensus       329 ~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l  366 (576)
T KOG0585|consen  329 DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITL  366 (576)
T ss_pred             HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeeh
Confidence            22222222        2367899999999999999875

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=3.7e-40  Score=296.47  Aligned_cols=229  Identities=22%  Similarity=0.318  Sum_probs=186.8

Q ss_pred             CcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhc-CCCCceeeEEEEecCCceeEEEecCCC
Q 039799          109 PLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRI-CHRNLIKIISSYSNDDFKALVLEYMPH  183 (346)
Q Consensus       109 ~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  183 (346)
                      +.||+|+||.||+|... +|+.||+|++....   .........|.+++... +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999976 68899999986431   22344566677777754 899999999999999999999999999


Q ss_pred             CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccccc
Q 039799          184 GSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT  263 (346)
Q Consensus       184 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~~  263 (346)
                      ++|.+++.. ...+++.....++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||+++......  ....
T Consensus        81 g~L~~~i~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~  154 (316)
T cd05620          81 GDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NRAS  154 (316)
T ss_pred             CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Ccee
Confidence            999988764 345788899999999999999999   9999999999999999999999999999987532111  1223


Q ss_pred             cccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh-------hhcCCChhhhhchhcc
Q 039799          264 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN-------DLLPISVMEVVDANLL  336 (346)
Q Consensus       264 ~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~-------~~~~~~~~~~~d~~l~  336 (346)
                      ...||..|+|||++.+..++.++||||+|+++|||++|+.||.....  ....+.+.       ..++..+.+++.+||.
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  232 (316)
T cd05620         155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE--DELFESIRVDTPHYPRWITKESKDILEKLFE  232 (316)
T ss_pred             ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--HHHHHHHHhCCCCCCCCCCHHHHHHHHHHcc
Confidence            45689999999999988999999999999999999999999965321  11111111       1123367899999999


Q ss_pred             CCccccccc
Q 039799          337 SQEDEHFTT  345 (346)
Q Consensus       337 ~~p~~R~~~  345 (346)
                      .||++|+++
T Consensus       233 ~dP~~R~~~  241 (316)
T cd05620         233 RDPTRRLGV  241 (316)
T ss_pred             CCHHHcCCC
Confidence            999999985

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=5.9e-40  Score=303.01  Aligned_cols=240  Identities=24%  Similarity=0.387  Sum_probs=194.5

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc------CCCEEEEEEecCCC-chhHHHHHHHHHHHHhcC-CCCceeeEEEEecCCc
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ------DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRIC-HRNLIKIISSYSNDDF  173 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~  173 (346)
                      .++|.+.+.||+|+||.||+|+..      .+..||+|++.... ....+.+.+|+++++++. ||||++++++|.+.+.
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~  115 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP  115 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence            456888999999999999999853      23469999997543 334567889999999996 9999999999999999


Q ss_pred             eeEEEecCCCCChhhhhhhcC-----------------------------------------------------------
Q 039799          174 KALVLEYMPHGSLEKCLYLSN-----------------------------------------------------------  194 (346)
Q Consensus       174 ~~lv~e~~~~gsL~~~l~~~~-----------------------------------------------------------  194 (346)
                      .++||||+++|+|.+++....                                                           
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (400)
T cd05105         116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK  195 (400)
T ss_pred             eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence            999999999999998875321                                                           


Q ss_pred             ------------------------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC
Q 039799          195 ------------------------------------YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD  238 (346)
Q Consensus       195 ------------------------------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~  238 (346)
                                                          ..+++..+..++.++++||+|||   +.+++||||||+|||+++
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~~  272 (400)
T cd05105         196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEeC
Confidence                                                23678888999999999999999   999999999999999999


Q ss_pred             CCcEEEeeecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHH
Q 039799          239 NMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKR  317 (346)
Q Consensus       239 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~  317 (346)
                      ++.++|+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||........ ...
T Consensus       273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~-~~~  351 (400)
T cd05105         273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST-FYN  351 (400)
T ss_pred             CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH-HHH
Confidence            99999999999986643322222233456788999999988889999999999999999997 9999876432221 111


Q ss_pred             HHh--------hhcCCChhhhhchhccCCccccccc
Q 039799          318 WVN--------DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       318 ~~~--------~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      .+.        ...+..+.+++.+||..+|++||+.
T Consensus       352 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~  387 (400)
T cd05105         352 KIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSF  387 (400)
T ss_pred             HHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCH
Confidence            111        1234478999999999999999984

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-41  Score=304.52  Aligned_cols=235  Identities=28%  Similarity=0.412  Sum_probs=197.9

Q ss_pred             CCCCCCcccccCceEEEEEEEcC--C--CE-EEEEEecC---CCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCcee
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQD--G--ME-VAVKVFDP---QYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKA  175 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~~--~--~~-vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  175 (346)
                      +....+.||+|+||.||+|.++.  +  .. ||+|....   .......++.+|.+++++++|||||+++|++.....++
T Consensus       158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~  237 (474)
T KOG0194|consen  158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM  237 (474)
T ss_pred             CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence            45667899999999999999663  2  23 89999874   23556789999999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCc
Q 039799          176 LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  255 (346)
Q Consensus       176 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~  255 (346)
                      +|||++.||+|.++|......++...++.++.++|.||+|||   +.+++||||-++|+|++.++.+||+|||+++.-..
T Consensus       238 ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~  314 (474)
T KOG0194|consen  238 LVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ  314 (474)
T ss_pred             EEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCccccccCCcc
Confidence            999999999999999877778999999999999999999999   99999999999999999999999999999885421


Q ss_pred             cccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHH-hhhc--------CC
Q 039799          256 EDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWV-NDLL--------PI  325 (346)
Q Consensus       256 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~-~~~~--------~~  325 (346)
                      ..  .......-...|+|||.+....++.++|||||||++||+++ |..||......  ....++ ...+        |.
T Consensus       315 ~~--~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--~v~~kI~~~~~r~~~~~~~p~  390 (474)
T KOG0194|consen  315 YV--MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--EVKAKIVKNGYRMPIPSKTPK  390 (474)
T ss_pred             ee--eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--HHHHHHHhcCccCCCCCCCHH
Confidence            11  11111235688999999999999999999999999999998 89999874432  455555 2222        23


Q ss_pred             ChhhhhchhccCCccccccc
Q 039799          326 SVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       326 ~~~~~~d~~l~~~p~~R~~~  345 (346)
                      .+..++++|+..+|++||+.
T Consensus       391 ~~~~~~~~c~~~~p~~R~tm  410 (474)
T KOG0194|consen  391 ELAKVMKQCWKKDPEDRPTM  410 (474)
T ss_pred             HHHHHHHHhccCChhhccCH
Confidence            77889999999999999985

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=3.5e-40  Score=292.95  Aligned_cols=239  Identities=27%  Similarity=0.426  Sum_probs=196.9

Q ss_pred             CCCCCCCcccccCceEEEEEEEc------CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeE
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ------DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKAL  176 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  176 (346)
                      ++|.+.+.||+|+||.||++...      ++..+|+|.+........+.+.+|++++++++|||++++++++...+..++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            56888999999999999999742      345689999876655566788999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhcC------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEE
Q 039799          177 VLEYMPHGSLEKCLYLSN------------YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHL  244 (346)
Q Consensus       177 v~e~~~~gsL~~~l~~~~------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l  244 (346)
                      ||||+++++|.+++....            ..+++..++.++.+++.||+|||   +.+++||||||+||++++++.++|
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEEe
Confidence            999999999999886432            24899999999999999999999   999999999999999999999999


Q ss_pred             eeecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHH----
Q 039799          245 SDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWV----  319 (346)
Q Consensus       245 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~----  319 (346)
                      +|||+++...............++..|+|||...+..++.++||||||++++||+| |..||......+ ......    
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-~~~~i~~~~~  240 (288)
T cd05093         162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-VIECITQGRV  240 (288)
T ss_pred             ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHcCCc
Confidence            99999986543322222223345778999999988889999999999999999998 999986543211 111111    


Q ss_pred             ---hhhcCCChhhhhchhccCCccccccc
Q 039799          320 ---NDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       320 ---~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                         ....+..+.+++.+|+..+|.+||+.
T Consensus       241 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~  269 (288)
T cd05093         241 LQRPRTCPKEVYDLMLGCWQREPHMRLNI  269 (288)
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhhCCCH
Confidence               11234488999999999999999985

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2.3e-40  Score=292.68  Aligned_cols=238  Identities=27%  Similarity=0.427  Sum_probs=196.7

Q ss_pred             CCCCCCCcccccCceEEEEEEEcC------CCEEEEEEecCCCch-hHHHHHHHHHHHHhcCCCCceeeEEEEecCCcee
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQD------GMEVAVKVFDPQYEG-AFKSFDIECDVMKRICHRNLIKIISSYSNDDFKA  175 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  175 (346)
                      .+|.+.+.||+|++|.||+|...+      +..+|+|.+...... ..+.+.+|++++++++|+|++++++++......+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            458888999999999999998643      478999998765443 4578899999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhhhcC-------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcE
Q 039799          176 LVLEYMPHGSLEKCLYLSN-------------YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVA  242 (346)
Q Consensus       176 lv~e~~~~gsL~~~l~~~~-------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~  242 (346)
                      +||||+++++|.+++....             ..+++.....++.+++.|++|||   +.+++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCeE
Confidence            9999999999999986432             34788899999999999999999   9999999999999999999999


Q ss_pred             EEeeecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHh-
Q 039799          243 HLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVN-  320 (346)
Q Consensus       243 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~-  320 (346)
                      +|+|||++..+.............++..|+|||++.+..++.++||||||+++|||++ |..||......  ...+.+. 
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~--~~~~~~~~  239 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE--EVIECITQ  239 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHHc
Confidence            9999999986533222122223345788999999998999999999999999999998 99998653221  1122221 


Q ss_pred             -------hhcCCChhhhhchhccCCccccccc
Q 039799          321 -------DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       321 -------~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                             ...+..+.+++.+||..+|++||+.
T Consensus       240 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~  271 (280)
T cd05049         240 GRLLQRPRTCPSEVYDIMLGCWKRDPQQRINI  271 (280)
T ss_pred             CCcCCCCCCCCHHHHHHHHHHcCCCcccCCCH
Confidence                   1234478999999999999999985

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=3.6e-40  Score=298.77  Aligned_cols=237  Identities=22%  Similarity=0.319  Sum_probs=191.0

Q ss_pred             CCCCCCcccccCceEEEEEEE----cCCCEEEEEEecCC----CchhHHHHHHHHHHHHhc-CCCCceeeEEEEecCCce
Q 039799          104 DANMPPLIGKGGFGSVYKAII----QDGMEVAVKVFDPQ----YEGAFKSFDIECDVMKRI-CHRNLIKIISSYSNDDFK  174 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~----~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  174 (346)
                      +|.+.+.||+|+||.||+++.    .+++.+|+|++...    .....+.+..|+++++.+ +|+||+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            377888999999999999875    35789999998642    123345677899999999 599999999999999999


Q ss_pred             eEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCC
Q 039799          175 ALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  254 (346)
Q Consensus       175 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~  254 (346)
                      ++||||+++|+|.+++.. ...+++.....++.+++.||+|||   +.+|+||||||+|||++.++.++|+|||+++...
T Consensus        81 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~  156 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQ-RDNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (332)
T ss_pred             EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence            999999999999998864 345888999999999999999999   9999999999999999999999999999998654


Q ss_pred             ccccccccccccCCcccccCCCCCCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccCc--ccHHHHHh-------hhcC
Q 039799          255 EEDQSLTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE--MTLKRWVN-------DLLP  324 (346)
Q Consensus       255 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~--~~~~~~~~-------~~~~  324 (346)
                      ..... ......||..|+|||.+.+. .++.++|||||||++|||+||+.||.......  ......+.       ..++
T Consensus       157 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (332)
T cd05614         157 SEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIG  235 (332)
T ss_pred             ccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Confidence            32221 12235689999999988765 47889999999999999999999996432111  11111111       1233


Q ss_pred             CChhhhhchhccCCccccccc
Q 039799          325 ISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       325 ~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ..+.+++.+||..||++||++
T Consensus       236 ~~~~~li~~~l~~dp~~R~~~  256 (332)
T cd05614         236 PEAQDLLHKLLRKDPKKRLGA  256 (332)
T ss_pred             HHHHHHHHHHcCCCHHHcCCC
Confidence            467899999999999999953

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=4e-40  Score=300.86  Aligned_cols=233  Identities=24%  Similarity=0.388  Sum_probs=187.4

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEec
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEY  180 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  180 (346)
                      .+|...+.||+|+||.||+|... +++.||+|++.... ......+.+|+++++.++|+||+++++++...+..++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            45777889999999999999866 78999999986543 33456788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccc
Q 039799          181 MPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  260 (346)
Q Consensus       181 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~  260 (346)
                      +++++|.+..     ..+......++.+++.||+|||   +.+|+||||||+|||+++++.+||+|||+++.+.....  
T Consensus       154 ~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--  223 (353)
T PLN00034        154 MDGGSLEGTH-----IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD--  223 (353)
T ss_pred             CCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc--
Confidence            9999986532     3456777889999999999999   99999999999999999999999999999986543211  


Q ss_pred             ccccccCCcccccCCCCCC-----CCCCcchhHHHHHHHHHHHHcCCCCCCccccCcc-cHHHHH--------hhhcCCC
Q 039799          261 TQTQTLATIGYMAPEYGRE-----GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM-TLKRWV--------NDLLPIS  326 (346)
Q Consensus       261 ~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~-~~~~~~--------~~~~~~~  326 (346)
                      ......|+..|+|||++..     ...+.++|||||||++|||++|+.||......+. .....+        ...++..
T Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (353)
T PLN00034        224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASRE  303 (353)
T ss_pred             cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHH
Confidence            1233468999999998743     2345689999999999999999999973221111 111111        1123347


Q ss_pred             hhhhhchhccCCccccccc
Q 039799          327 VMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       327 ~~~~~d~~l~~~p~~R~~~  345 (346)
                      +.+++.+||..||++||++
T Consensus       304 l~~li~~~l~~~P~~Rpt~  322 (353)
T PLN00034        304 FRHFISCCLQREPAKRWSA  322 (353)
T ss_pred             HHHHHHHHccCChhhCcCH
Confidence            8999999999999999986

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=5.2e-40  Score=286.04  Aligned_cols=232  Identities=25%  Similarity=0.392  Sum_probs=190.3

Q ss_pred             CcccccCceEEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecCCCCCh
Q 039799          109 PLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSL  186 (346)
Q Consensus       109 ~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  186 (346)
                      +.||+|+||.||+|... +++.+|+|.+.... ......+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            36899999999999875 78999999876443 33456788999999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccccccccc
Q 039799          187 EKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL  266 (346)
Q Consensus       187 ~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~  266 (346)
                      .+++......+++..++.++.+++.||+|||   +.+++||||+|+||+++.++.++|+|||++................
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  157 (252)
T cd05084          81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ  157 (252)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence            9998766667899999999999999999999   9999999999999999999999999999988653221111111122


Q ss_pred             CCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHH--------hhhcCCChhhhhchhccC
Q 039799          267 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWV--------NDLLPISVMEVVDANLLS  337 (346)
Q Consensus       267 ~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~~d~~l~~  337 (346)
                      .+..|+|||.+.+..++.++||||||+++||+++ |..||.......  ....+        ....+..+.+++.+|+..
T Consensus       158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  235 (252)
T cd05084         158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ--TREAIEQGVRLPCPELCPDAVYRLMERCWEY  235 (252)
T ss_pred             CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH--HHHHHHcCCCCCCcccCCHHHHHHHHHHcCC
Confidence            3467999999988889999999999999999998 999986532211  11111        122345788999999999


Q ss_pred             Cccccccc
Q 039799          338 QEDEHFTT  345 (346)
Q Consensus       338 ~p~~R~~~  345 (346)
                      +|++||++
T Consensus       236 ~p~~Rps~  243 (252)
T cd05084         236 DPGQRPSF  243 (252)
T ss_pred             ChhhCcCH
Confidence            99999985

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-41  Score=325.36  Aligned_cols=235  Identities=28%  Similarity=0.451  Sum_probs=198.4

Q ss_pred             CCCCcccccCceEEEEEEEc--CCC----EEEEEEecCC-CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEE
Q 039799          106 NMPPLIGKGGFGSVYKAIIQ--DGM----EVAVKVFDPQ-YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVL  178 (346)
Q Consensus       106 ~~~~~lg~G~~g~vy~~~~~--~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  178 (346)
                      .....||+|+||.||.|...  +|.    .||+|.+.+. ..+....|.+|..+|++++|||||+++|.|......++++
T Consensus       695 ~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~l  774 (1025)
T KOG1095|consen  695 TLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILL  774 (1025)
T ss_pred             EeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEe
Confidence            34567999999999999865  343    3899998765 3556789999999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhc------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCcc
Q 039799          179 EYMPHGSLEKCLYLS------NYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  252 (346)
Q Consensus       179 e~~~~gsL~~~l~~~------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~  252 (346)
                      |||++|+|..+|...      ...++....+.++.+||+|+.||+   ++.+|||||.++|+|+++...+||+|||+|+.
T Consensus       775 eyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArD  851 (1025)
T KOG1095|consen  775 EYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFGLARD  851 (1025)
T ss_pred             hhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccchhHh
Confidence            999999999999877      567999999999999999999999   99999999999999999999999999999996


Q ss_pred             CCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHH-------hhhcC
Q 039799          253 LLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWV-------NDLLP  324 (346)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~-------~~~~~  324 (346)
                      +...+.........-...|||||.+.++.++.|+|||||||++||++| |..||......+ ....+.       ..+.|
T Consensus       852 iy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~-v~~~~~~ggRL~~P~~CP  930 (1025)
T KOG1095|consen  852 IYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE-VLLDVLEGGRLDPPSYCP  930 (1025)
T ss_pred             hhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH-HHHHHHhCCccCCCCCCC
Confidence            544333222222244678999999999999999999999999999998 899997643221 222222       23456


Q ss_pred             CChhhhhchhccCCcccccc
Q 039799          325 ISVMEVVDANLLSQEDEHFT  344 (346)
Q Consensus       325 ~~~~~~~d~~l~~~p~~R~~  344 (346)
                      +.+.+++..|+..+|++||+
T Consensus       931 ~~ly~lM~~CW~~~pe~RP~  950 (1025)
T KOG1095|consen  931 EKLYQLMLQCWKHDPEDRPS  950 (1025)
T ss_pred             hHHHHHHHHHccCChhhCcc
Confidence            79999999999999999997

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=4.9e-40  Score=297.79  Aligned_cols=198  Identities=24%  Similarity=0.353  Sum_probs=173.6

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEe
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLE  179 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  179 (346)
                      .++|++.+.||+|+||.||++... ++..+|+|++.... ......+.+|++++++++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            467999999999999999999977 68889999887543 3345678899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeeecCCCCCceEECCCCcEEEeeecCCccCCcccc
Q 039799          180 YMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSA-PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  258 (346)
Q Consensus       180 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~  258 (346)
                      |+++++|.+++... ..+++.....++.+++.|+.|||   +. +++||||||+|||++.++.++|+|||++..+...  
T Consensus        84 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH---~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--  157 (333)
T cd06650          84 HMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  157 (333)
T ss_pred             cCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence            99999999988643 45788888999999999999999   64 7999999999999999999999999998865322  


Q ss_pred             ccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 039799          259 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDE  307 (346)
Q Consensus       259 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~  307 (346)
                        ......++..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       158 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~  204 (333)
T cd06650         158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP  204 (333)
T ss_pred             --ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence              12234588999999999888899999999999999999999999864

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-40  Score=304.59  Aligned_cols=237  Identities=22%  Similarity=0.332  Sum_probs=192.3

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC---CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEE
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ---YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVL  178 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  178 (346)
                      ++|.+.+.||+|+||.||+|... +++.||||++...   .......+.+|++++..++||||+++++.+...+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            36888999999999999999976 6899999998643   1233456778999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccc
Q 039799          179 EYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  258 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~  258 (346)
                      ||+++|+|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.++|+|||++..+.....
T Consensus        81 E~~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  156 (364)
T cd05599          81 EYLPGGDMMTLLMKK-DTFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR  156 (364)
T ss_pred             CCCCCcHHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence            999999999988643 45889999999999999999999   99999999999999999999999999999876532110


Q ss_pred             cc------------------------------------ccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCC
Q 039799          259 SL------------------------------------TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRT  302 (346)
Q Consensus       259 ~~------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~  302 (346)
                      ..                                    ......||+.|+|||++....++.++|||||||++|||++|.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~  236 (364)
T cd05599         157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY  236 (364)
T ss_pred             ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence            00                                    011235899999999998889999999999999999999999


Q ss_pred             CCCCccccCcc--cHHHHHh-------hhcCCChhhhhchhccCCcccccc
Q 039799          303 KPTDEIFSGEM--TLKRWVN-------DLLPISVMEVVDANLLSQEDEHFT  344 (346)
Q Consensus       303 ~p~~~~~~~~~--~~~~~~~-------~~~~~~~~~~~d~~l~~~p~~R~~  344 (346)
                      .||......+.  ....|..       ..++..+.+++.+++. +|.+|++
T Consensus       237 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~  286 (364)
T cd05599         237 PPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLG  286 (364)
T ss_pred             CCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCC
Confidence            99975321110  0111111       0123467899999886 9999987

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=4.3e-40  Score=297.47  Aligned_cols=231  Identities=24%  Similarity=0.333  Sum_probs=189.1

Q ss_pred             CcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhc-CCCCceeeEEEEecCCceeEEEecCCC
Q 039799          109 PLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRI-CHRNLIKIISSYSNDDFKALVLEYMPH  183 (346)
Q Consensus       109 ~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  183 (346)
                      +.||+|+||.||++... +++.+|+|++....   ....+.+..|..++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999866 67899999997532   23345677899999888 699999999999999999999999999


Q ss_pred             CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccccc
Q 039799          184 GSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT  263 (346)
Q Consensus       184 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~~  263 (346)
                      ++|..++.. ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.++|+|||+++......  ....
T Consensus        81 ~~L~~~~~~-~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~  154 (327)
T cd05617          81 GDLMFHMQR-QRKLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DTTS  154 (327)
T ss_pred             CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Ccee
Confidence            999887753 346899999999999999999999   9999999999999999999999999999987532211  1223


Q ss_pred             cccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCc-ccHHHHH-----------hhhcCCChhhhh
Q 039799          264 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE-MTLKRWV-----------NDLLPISVMEVV  331 (346)
Q Consensus       264 ~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~-~~~~~~~-----------~~~~~~~~~~~~  331 (346)
                      ...||+.|+|||++.+..++.++||||||+++|||+||+.||+...... .....+.           ...++..+.+++
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li  234 (327)
T cd05617         155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVL  234 (327)
T ss_pred             cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            4568999999999998999999999999999999999999996532211 1111111           112233678999


Q ss_pred             chhccCCccccccc
Q 039799          332 DANLLSQEDEHFTT  345 (346)
Q Consensus       332 d~~l~~~p~~R~~~  345 (346)
                      .+||..||++|++.
T Consensus       235 ~~~L~~dP~~R~~~  248 (327)
T cd05617         235 KGFLNKDPKERLGC  248 (327)
T ss_pred             HHHhccCHHHcCCC
Confidence            99999999999974

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=5.5e-41  Score=303.84  Aligned_cols=237  Identities=24%  Similarity=0.339  Sum_probs=194.8

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEE
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVL  178 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  178 (346)
                      ++|.+.+.||+|+||+||++... +++.+|+|++....   ....+.+.+|+.+++.++|+||+++.+++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            35888899999999999999866 78999999987432   223456788999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccc
Q 039799          179 EYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  258 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~  258 (346)
                      ||+++++|.+++......+++.....++.|++.||.|||   +.+|+||||||+||+++.++.++|+|||++..+.....
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  157 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM  157 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence            999999999998766667899999999999999999999   99999999999999999999999999999987643222


Q ss_pred             ccccccccCCcccccCCCCC------CCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh----------hh
Q 039799          259 SLTQTQTLATIGYMAPEYGR------EGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN----------DL  322 (346)
Q Consensus       259 ~~~~~~~~~~~~y~aPE~~~------~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~----------~~  322 (346)
                      . ......||+.|+|||++.      ...++.++||||||+++|||++|+.||....... .......          ..
T Consensus       158 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~  235 (330)
T cd05601         158 V-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK-TYNNIMNFQRFLKFPEDPK  235 (330)
T ss_pred             e-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH-HHHHHHcCCCccCCCCCCC
Confidence            1 223346899999999876      4567899999999999999999999996532111 1111110          12


Q ss_pred             cCCChhhhhchhccCCccccccc
Q 039799          323 LPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       323 ~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ++..+.+++.++|. +|++||+.
T Consensus       236 ~~~~~~~li~~ll~-~p~~R~t~  257 (330)
T cd05601         236 VSSDFLDLIQSLLC-GQKERLGY  257 (330)
T ss_pred             CCHHHHHHHHHHcc-ChhhCCCH
Confidence            33467899999997 99999985

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-40  Score=283.61  Aligned_cols=239  Identities=25%  Similarity=0.309  Sum_probs=194.0

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecC--CCchhHHHHHHHHHHHHhcCCCCceeeEEEEec-----CCc
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDP--QYEGAFKSFDIECDVMKRICHRNLIKIISSYSN-----DDF  173 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-----~~~  173 (346)
                      +..|...+.||+|+||.|+.+... +|+.||||++..  ......++..+|+++++.++|+||+.+.+.+..     -+.
T Consensus        21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D  100 (359)
T KOG0660|consen   21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND  100 (359)
T ss_pred             cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence            345666789999999999999866 899999999872  345567889999999999999999999998855     347


Q ss_pred             eeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccC
Q 039799          174 KALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  253 (346)
Q Consensus       174 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~  253 (346)
                      .|+|+|+| ..+|.+.++. +..++......++.|+++||.|+|   +.+++|||+||+|++++.+..+||+|||+|+..
T Consensus       101 vYiV~elM-etDL~~iik~-~~~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~  175 (359)
T KOG0660|consen  101 VYLVFELM-ETDLHQIIKS-QQDLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLARYL  175 (359)
T ss_pred             eEEehhHH-hhHHHHHHHc-CccccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccceeec
Confidence            89999999 6689888863 444888888899999999999999   999999999999999999999999999999987


Q ss_pred             CccccccccccccCCcccccCCCCC-CCCCCcchhHHHHHHHHHHHHcCCCCCCccc--------------cCcc-----
Q 039799          254 LEEDQSLTQTQTLATIGYMAPEYGR-EGRVSTNGDVYSFGIMLMEIFTRTKPTDEIF--------------SGEM-----  313 (346)
Q Consensus       254 ~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~s~G~il~elltg~~p~~~~~--------------~~~~-----  313 (346)
                      .........+.-+.|.+|.|||.+. ...|+...||||.|||+.||++|++-|....              .++.     
T Consensus       176 ~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i  255 (359)
T KOG0660|consen  176 DKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKI  255 (359)
T ss_pred             cccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHh
Confidence            5443334456677899999999764 4679999999999999999999999875411              1111     


Q ss_pred             ---cHHHHHhhh-----------c---CCChhhhhchhccCCccccccc
Q 039799          314 ---TLKRWVNDL-----------L---PISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       314 ---~~~~~~~~~-----------~---~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                         ....+++..           +   .+...++++++|..||++|+|+
T Consensus       256 ~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita  304 (359)
T KOG0660|consen  256 RSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITA  304 (359)
T ss_pred             ccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCH
Confidence               122233211           1   2266899999999999999986

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.3e-40  Score=285.24  Aligned_cols=236  Identities=26%  Similarity=0.397  Sum_probs=196.2

Q ss_pred             CCCCCCCcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecCC
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMP  182 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  182 (346)
                      .+|.+.+.||+|++|.||++.++++..+|+|.+..... ....+.+|++++++++|||++++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            46888999999999999999988778899999865432 33567889999999999999999999999999999999999


Q ss_pred             CCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccccc
Q 039799          183 HGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ  262 (346)
Q Consensus       183 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~  262 (346)
                      +++|.+++......+++...+.++.+++.|++|||   +.+++||||||+||++++++.++|+|||+++....... ...
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-~~~  158 (256)
T cd05059          83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-TSS  158 (256)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceecccccc-ccc
Confidence            99999998766667899999999999999999999   99999999999999999999999999999986543211 111


Q ss_pred             ccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHhh--------hcCCChhhhhch
Q 039799          263 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVND--------LLPISVMEVVDA  333 (346)
Q Consensus       263 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~d~  333 (346)
                      ....++..|+|||...+..++.++||||||+++||++| |+.||+.....  .....+..        ..+..+.+++.+
T Consensus       159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~  236 (256)
T cd05059         159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS--EVVESVSAGYRLYRPKLAPTEVYTIMYS  236 (256)
T ss_pred             CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH--HHHHHHHcCCcCCCCCCCCHHHHHHHHH
Confidence            12224567999999988889999999999999999999 89998653221  11222221        234478999999


Q ss_pred             hccCCccccccc
Q 039799          334 NLLSQEDEHFTT  345 (346)
Q Consensus       334 ~l~~~p~~R~~~  345 (346)
                      |+..+|++||+.
T Consensus       237 cl~~~p~~Rpt~  248 (256)
T cd05059         237 CWHEKPEDRPAF  248 (256)
T ss_pred             HhcCChhhCcCH
Confidence            999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=4e-40  Score=312.07  Aligned_cols=240  Identities=26%  Similarity=0.327  Sum_probs=195.5

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC--CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCC------
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ--YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDD------  172 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  172 (346)
                      ..+|.+.+.||+|+||+||+|... +|+.||+|++...  .......+.+|+..+..++|+|++++.+.+...+      
T Consensus        31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~  110 (496)
T PTZ00283         31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPEN  110 (496)
T ss_pred             CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCccc
Confidence            467999999999999999999855 7999999998654  2344567788999999999999999988765432      


Q ss_pred             --ceeEEEecCCCCChhhhhhhc---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeee
Q 039799          173 --FKALVLEYMPHGSLEKCLYLS---NYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDF  247 (346)
Q Consensus       173 --~~~lv~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Df  247 (346)
                        ..++||||+++|+|.+++...   ...+++.....++.|++.||.|||   +.+|+||||||+|||++.++.+||+||
T Consensus       111 ~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vkL~DF  187 (496)
T PTZ00283        111 VLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVKLGDF  187 (496)
T ss_pred             ceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEEEEec
Confidence              367999999999999988643   246888899999999999999999   999999999999999999999999999


Q ss_pred             cCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHH-------Hh
Q 039799          248 GMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRW-------VN  320 (346)
Q Consensus       248 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~-------~~  320 (346)
                      |+++.+.............||+.|+|||++.+..++.++||||||+++|||++|+.||......+ .....       ..
T Consensus       188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~-~~~~~~~~~~~~~~  266 (496)
T PTZ00283        188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE-VMHKTLAGRYDPLP  266 (496)
T ss_pred             ccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHhcCCCCCCC
Confidence            99987643322222334568999999999998899999999999999999999999997532111 01111       11


Q ss_pred             hhcCCChhhhhchhccCCccccccc
Q 039799          321 DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       321 ~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ..++..+.+++.+||..+|++||+.
T Consensus       267 ~~~~~~l~~li~~~L~~dP~~RPs~  291 (496)
T PTZ00283        267 PSISPEMQEIVTALLSSDPKRRPSS  291 (496)
T ss_pred             CCCCHHHHHHHHHHcccChhhCcCH
Confidence            2234478999999999999999985

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.5e-40  Score=305.13  Aligned_cols=238  Identities=20%  Similarity=0.268  Sum_probs=188.4

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEe
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLE  179 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  179 (346)
                      .|...+.||+|+||+||+|... +++.||+|++....   ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            4778889999999999999865 78899999986432   2335678889999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccc-
Q 039799          180 YMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ-  258 (346)
Q Consensus       180 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~-  258 (346)
                      |+++|+|.+++... ..+++.....++.|++.||+|||   +.+|+||||||+|||++.++.++|+|||+++.+..... 
T Consensus        82 ~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~  157 (381)
T cd05626          82 YIPGGDMMSLLIRM-EVFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS  157 (381)
T ss_pred             cCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence            99999999988643 45788888889999999999999   99999999999999999999999999999864321000 


Q ss_pred             --------------------------------------------ccccccccCCcccccCCCCCCCCCCcchhHHHHHHH
Q 039799          259 --------------------------------------------SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIM  294 (346)
Q Consensus       259 --------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~i  294 (346)
                                                                  ........||+.|+|||.+.+..++.++|||||||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i  237 (381)
T cd05626         158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI  237 (381)
T ss_pred             ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence                                                        000123468999999999988889999999999999


Q ss_pred             HHHHHcCCCCCCccccCccc--HHHHHhh-------hcCCChhhhhchhcc--CCccccccc
Q 039799          295 LMEIFTRTKPTDEIFSGEMT--LKRWVND-------LLPISVMEVVDANLL--SQEDEHFTT  345 (346)
Q Consensus       295 l~elltg~~p~~~~~~~~~~--~~~~~~~-------~~~~~~~~~~d~~l~--~~p~~R~~~  345 (346)
                      +|||+||+.||......+..  ...|...       .++....+++.+++.  .+|..|+++
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~  299 (381)
T cd05626         238 LFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGA  299 (381)
T ss_pred             HHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCH
Confidence            99999999999763322111  1111110       123467889998554  455558764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=9.6e-40  Score=290.35  Aligned_cols=236  Identities=24%  Similarity=0.315  Sum_probs=185.9

Q ss_pred             CCCCCCcccccCceEEEEEEEc--CCCEEEEEEecCCC--chhHHHHHHHHHHHHhc---CCCCceeeEEEEe-----cC
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQ--DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRI---CHRNLIKIISSYS-----ND  171 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~-----~~  171 (346)
                      +|.+.+.||+|+||.||+|...  +++.+|+|++....  ......+.+|+.+++.+   +||||+++++++.     ..
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            5888999999999999999863  46789999886432  22234555677776665   6999999999885     34


Q ss_pred             CceeEEEecCCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCC
Q 039799          172 DFKALVLEYMPHGSLEKCLYLS-NYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMA  250 (346)
Q Consensus       172 ~~~~lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~  250 (346)
                      ...++||||++ ++|.+++... ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.++|+|||++
T Consensus        82 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~  157 (290)
T cd07862          82 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLA  157 (290)
T ss_pred             CcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccccce
Confidence            56889999996 5898887643 345889999999999999999999   999999999999999999999999999999


Q ss_pred             ccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcc--cH---------HHH-
Q 039799          251 KPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM--TL---------KRW-  318 (346)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~--~~---------~~~-  318 (346)
                      +.....   .......+++.|+|||.+.+..++.++||||||+++|||++|++||......+.  ..         ..| 
T Consensus       158 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~  234 (290)
T cd07862         158 RIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP  234 (290)
T ss_pred             EeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence            865322   122345689999999999888899999999999999999999999975321110  00         000 


Q ss_pred             --------------------HhhhcCCChhhhhchhccCCcccccccC
Q 039799          319 --------------------VNDLLPISVMEVVDANLLSQEDEHFTTK  346 (346)
Q Consensus       319 --------------------~~~~~~~~~~~~~d~~l~~~p~~R~~~k  346 (346)
                                          ....++..+.+++.+||..||++||+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~  282 (290)
T cd07862         235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAY  282 (290)
T ss_pred             hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHH
Confidence                                0112344668999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-41  Score=302.92  Aligned_cols=223  Identities=26%  Similarity=0.369  Sum_probs=194.3

Q ss_pred             CCcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecCCCCChh
Q 039799          108 PPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLE  187 (346)
Q Consensus       108 ~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~  187 (346)
                      .+-||+|+.|.||+|+++ ++.||||+++...+       .+++-|++|+||||+.+.|+|.....+++|||||..|.|.
T Consensus       129 LeWlGSGaQGAVF~Grl~-netVAVKKV~elkE-------TdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~  200 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLH-NETVAVKKVRELKE-------TDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY  200 (904)
T ss_pred             hhhhccCcccceeeeecc-CceehhHHHhhhhh-------hhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence            456999999999999998 68999998754322       3788999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccccccccC
Q 039799          188 KCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA  267 (346)
Q Consensus       188 ~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~  267 (346)
                      .+|+..+ .+.......+..+||.|+.|||   ...|||||||+-|||+..+..+||+|||.++...+.   .+.-..+|
T Consensus       201 ~VLka~~-~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSFaG  273 (904)
T KOG4721|consen  201 EVLKAGR-PITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSFAG  273 (904)
T ss_pred             HHHhccC-ccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhhhh
Confidence            9997554 4666778899999999999999   999999999999999999999999999999976443   33345679


Q ss_pred             CcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccC-------cccHHHHHhhhcCCChhhhhchhccCCcc
Q 039799          268 TIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSG-------EMTLKRWVNDLLPISVMEVVDANLLSQED  340 (346)
Q Consensus       268 ~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~d~~l~~~p~  340 (346)
                      |..|||||++...++++|+|||||||+||||+||..||.+....       ...+.--|....|+.+.-++..||...|.
T Consensus       274 TVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpR  353 (904)
T KOG4721|consen  274 TVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPR  353 (904)
T ss_pred             hHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHhcCCC
Confidence            99999999999999999999999999999999999999874322       22445566777888999999999999999


Q ss_pred             ccccc
Q 039799          341 EHFTT  345 (346)
Q Consensus       341 ~R~~~  345 (346)
                      .||+-
T Consensus       354 NRPSF  358 (904)
T KOG4721|consen  354 NRPSF  358 (904)
T ss_pred             CCccH
Confidence            99973

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=3.2e-40  Score=288.21  Aligned_cols=236  Identities=24%  Similarity=0.374  Sum_probs=196.3

Q ss_pred             CCCCCCCcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecCC
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMP  182 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  182 (346)
                      .+|.+.+.||+|++|.||+|.+.++..+|+|.+.... ...+.+.+|+.++++++||||+++++++...+..+++|||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            4678889999999999999998877789999887543 234678899999999999999999999999999999999999


Q ss_pred             CCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccccc
Q 039799          183 HGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ  262 (346)
Q Consensus       183 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~  262 (346)
                      +++|.+++......+++..++.++.+++.||+|||   +.+++|+||+|+||++++++.++|+|||.++....... ...
T Consensus        83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~~  158 (256)
T cd05113          83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TSS  158 (256)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCce-eec
Confidence            99999998765557899999999999999999999   99999999999999999999999999999886543221 112


Q ss_pred             ccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHh--------hhcCCChhhhhch
Q 039799          263 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVN--------DLLPISVMEVVDA  333 (346)
Q Consensus       263 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~d~  333 (346)
                      ....++..|+|||...+..++.++||||||+++|||+| |+.||......+  ....+.        ...+..+.+++.+
T Consensus       159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~  236 (256)
T cd05113         159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE--TVEKVSQGLRLYRPHLASEKVYAIMYS  236 (256)
T ss_pred             CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHHHhcCCCCCCCCCCCHHHHHHHHH
Confidence            22345678999999988889999999999999999999 999986532211  111111        1223478899999


Q ss_pred             hccCCccccccc
Q 039799          334 NLLSQEDEHFTT  345 (346)
Q Consensus       334 ~l~~~p~~R~~~  345 (346)
                      ||..+|++||++
T Consensus       237 cl~~~p~~Rp~~  248 (256)
T cd05113         237 CWHEKAEERPTF  248 (256)
T ss_pred             HcCCCcccCCCH
Confidence            999999999985

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=3.7e-40  Score=297.78  Aligned_cols=230  Identities=27%  Similarity=0.315  Sum_probs=185.1

Q ss_pred             CcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHH-HHHHhcCCCCceeeEEEEecCCceeEEEecCCC
Q 039799          109 PLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIEC-DVMKRICHRNLIKIISSYSNDDFKALVLEYMPH  183 (346)
Q Consensus       109 ~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~-~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  183 (346)
                      +.||+|+||.||+|... +++.+|+|++....   ......+..|. .+++.++||||+++++.+...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46899999999999976 67889999986432   11223334443 456788999999999999999999999999999


Q ss_pred             CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccccc
Q 039799          184 GSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT  263 (346)
Q Consensus       184 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~~  263 (346)
                      ++|.+++... ..++......++.|+++||+|||   +.+|+||||||+|||++.++.++|+|||+++......  ....
T Consensus        81 ~~L~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~~~  154 (325)
T cd05602          81 GELFYHLQRE-RCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GTTS  154 (325)
T ss_pred             CcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CCcc
Confidence            9999988643 45677788889999999999999   9999999999999999999999999999998543222  1223


Q ss_pred             cccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH-------hhhcCCChhhhhchhcc
Q 039799          264 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV-------NDLLPISVMEVVDANLL  336 (346)
Q Consensus       264 ~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~d~~l~  336 (346)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||......+  ..+.+       ...++..+.+++.+||.
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~li~~~l~  232 (325)
T cd05602         155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE--MYDNILNKPLQLKPNITNSARHLLEGLLQ  232 (325)
T ss_pred             cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH--HHHHHHhCCcCCCCCCCHHHHHHHHHHcc
Confidence            4568999999999998899999999999999999999999997532111  11111       12344578899999999


Q ss_pred             CCcccccccC
Q 039799          337 SQEDEHFTTK  346 (346)
Q Consensus       337 ~~p~~R~~~k  346 (346)
                      .+|.+|++++
T Consensus       233 ~~p~~R~~~~  242 (325)
T cd05602         233 KDRTKRLGAK  242 (325)
T ss_pred             cCHHHCCCCC
Confidence            9999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-39  Score=286.12  Aligned_cols=239  Identities=24%  Similarity=0.403  Sum_probs=198.3

Q ss_pred             CCCCCCCCcccccCceEEEEEEEcC----CCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeE
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQD----GMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKAL  176 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  176 (346)
                      +++|++.+.||+|+||.||+|.+..    ...+|+|.+.... ......+..|+..+++++||||+++++.+...+..++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            3568899999999999999998752    4579999987543 3345678889999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcc
Q 039799          177 VLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  256 (346)
Q Consensus       177 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~  256 (346)
                      +|||+++++|.+++......+++..++.++.+++.|++|||   +.+|+|+||+|+||++++++.++|+|||++......
T Consensus        83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  159 (266)
T cd05033          83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS  159 (266)
T ss_pred             EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence            99999999999998766667899999999999999999999   999999999999999999999999999999977422


Q ss_pred             ccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHh--------hhcCCCh
Q 039799          257 DQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVN--------DLLPISV  327 (346)
Q Consensus       257 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~--------~~~~~~~  327 (346)
                      ..........++..|+|||...+..++.++||||||+++||+++ |..||......  .....+.        ...+..+
T Consensus       160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l  237 (266)
T cd05033         160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ--DVIKAVEDGYRLPPPMDCPSAL  237 (266)
T ss_pred             ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH--HHHHHHHcCCCCCCCCCCCHHH
Confidence            22222222335678999999988889999999999999999998 99998653221  1222221        1234578


Q ss_pred             hhhhchhccCCccccccc
Q 039799          328 MEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       328 ~~~~d~~l~~~p~~R~~~  345 (346)
                      .+++.+|+..+|++||+.
T Consensus       238 ~~li~~cl~~~p~~Rp~~  255 (266)
T cd05033         238 YQLMLDCWQKDRNERPTF  255 (266)
T ss_pred             HHHHHHHcCCCcccCcCH
Confidence            999999999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-41  Score=305.72  Aligned_cols=236  Identities=24%  Similarity=0.377  Sum_probs=196.0

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEE
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVL  178 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  178 (346)
                      ++|.+.+.||+|+||.||+|... +++.||+|++....   ......+..|++++..++||||+++++.+.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            36888899999999999999976 78999999986431   234567888999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccc-
Q 039799          179 EYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED-  257 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~-  257 (346)
                      ||+++++|.+++... ..++......++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||++..+.... 
T Consensus        81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  156 (350)
T cd05573          81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD  156 (350)
T ss_pred             cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence            999999999988754 56888999999999999999999   9999999999999999999999999999998764332 


Q ss_pred             --------------------------cccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccC
Q 039799          258 --------------------------QSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSG  311 (346)
Q Consensus       258 --------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~  311 (346)
                                                .........||+.|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~  236 (350)
T cd05573         157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ  236 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence                                      001223456899999999999999999999999999999999999999763311


Q ss_pred             cccHHHHHh----------hhcCCChhhhhchhccCCcccccc
Q 039799          312 EMTLKRWVN----------DLLPISVMEVVDANLLSQEDEHFT  344 (346)
Q Consensus       312 ~~~~~~~~~----------~~~~~~~~~~~d~~l~~~p~~R~~  344 (346)
                      + .......          ..++..+.+++.+||. +|.+|++
T Consensus       237 ~-~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~  277 (350)
T cd05573         237 E-TYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLG  277 (350)
T ss_pred             H-HHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCC
Confidence            1 1111111          1124577899999997 9999998

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=3e-40  Score=297.41  Aligned_cols=229  Identities=24%  Similarity=0.299  Sum_probs=188.9

Q ss_pred             CcccccCceEEEEEEEc-CCCEEEEEEecCC---CchhHHHHHHHHHHHHhc-CCCCceeeEEEEecCCceeEEEecCCC
Q 039799          109 PLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ---YEGAFKSFDIECDVMKRI-CHRNLIKIISSYSNDDFKALVLEYMPH  183 (346)
Q Consensus       109 ~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  183 (346)
                      +.||+|+||.||++... +++.||+|++...   .......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46899999999999876 6889999998643   123345667788888887 699999999999999999999999999


Q ss_pred             CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccccc
Q 039799          184 GSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT  263 (346)
Q Consensus       184 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~~  263 (346)
                      ++|.+++... ..+++.....++.+++.||+|||   +.+++||||||+||++++++.++|+|||+++......  ....
T Consensus        81 ~~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~  154 (318)
T cd05570          81 GDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VTTS  154 (318)
T ss_pred             CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Cccc
Confidence            9999887643 46899999999999999999999   9999999999999999999999999999987532211  1122


Q ss_pred             cccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH-------hhhcCCChhhhhchhcc
Q 039799          264 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV-------NDLLPISVMEVVDANLL  336 (346)
Q Consensus       264 ~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~d~~l~  336 (346)
                      ...|+..|+|||++.+..++.++|||||||++|||++|+.||......  .....+       ...++..+.+++.+||.
T Consensus       155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~li~~~l~  232 (318)
T cd05570         155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED--ELFQSILEDEVRYPRWLSKEAKSILKSFLT  232 (318)
T ss_pred             ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH--HHHHHHHcCCCCCCCcCCHHHHHHHHHHcc
Confidence            346899999999999899999999999999999999999999753211  111111       12234577899999999


Q ss_pred             CCccccccc
Q 039799          337 SQEDEHFTT  345 (346)
Q Consensus       337 ~~p~~R~~~  345 (346)
                      .||++||++
T Consensus       233 ~dP~~R~s~  241 (318)
T cd05570         233 KNPEKRLGC  241 (318)
T ss_pred             CCHHHcCCC
Confidence            999999986

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=9.5e-41  Score=300.75  Aligned_cols=229  Identities=24%  Similarity=0.358  Sum_probs=189.4

Q ss_pred             CcccccCceEEEEEEE----cCCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecCC
Q 039799          109 PLIGKGGFGSVYKAII----QDGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMP  182 (346)
Q Consensus       109 ~~lg~G~~g~vy~~~~----~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  182 (346)
                      +.||+|+||.||++..    .+|+.+|+|++....  ......+..|++++++++||||+++++++...+..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999874    367899999987432  1223456789999999999999999999999999999999999


Q ss_pred             CCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccccc
Q 039799          183 HGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ  262 (346)
Q Consensus       183 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~  262 (346)
                      +++|.+++.. ...+++..+..++.|++.||+|||   +.+|+||||||+||++++++.++|+|||++.......  ...
T Consensus        82 ~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~  155 (318)
T cd05582          82 GGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKA  155 (318)
T ss_pred             CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--Cce
Confidence            9999998854 346899999999999999999999   9999999999999999999999999999988653321  122


Q ss_pred             ccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH-------hhhcCCChhhhhchhc
Q 039799          263 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV-------NDLLPISVMEVVDANL  335 (346)
Q Consensus       263 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~d~~l  335 (346)
                      ....|++.|+|||...+..++.++||||||+++|||+||+.||......  .....+       ...++..+.+++.+||
T Consensus       156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~--~~~~~i~~~~~~~p~~~~~~~~~li~~~l  233 (318)
T cd05582         156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK--ETMTMILKAKLGMPQFLSPEAQSLLRALF  233 (318)
T ss_pred             ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH--HHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Confidence            3456899999999998888899999999999999999999999753211  111111       1123447789999999


Q ss_pred             cCCccccccc
Q 039799          336 LSQEDEHFTT  345 (346)
Q Consensus       336 ~~~p~~R~~~  345 (346)
                      ..||++||++
T Consensus       234 ~~~P~~R~~a  243 (318)
T cd05582         234 KRNPANRLGA  243 (318)
T ss_pred             hcCHhHcCCC
Confidence            9999999984

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=5.2e-40  Score=301.16  Aligned_cols=236  Identities=21%  Similarity=0.307  Sum_probs=188.1

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEE
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVL  178 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  178 (346)
                      ++|++.+.||+|+||+||++... +++.||+|++....   ......+..|++++.+++|+||+++++.+.+.+..++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            36888999999999999999865 68999999986432   223456778999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccc
Q 039799          179 EYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  258 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~  258 (346)
                      ||+++|+|.+++.. ...+++.....++.|++.||+|||   +.+|+||||||+|||++.++.++|+|||+++.+.....
T Consensus        81 E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~  156 (363)
T cd05628          81 EFLPGGDMMTLLMK-KDTLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR  156 (363)
T ss_pred             cCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence            99999999998864 346889999999999999999999   99999999999999999999999999999986532110


Q ss_pred             c---------------------------------cccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCC
Q 039799          259 S---------------------------------LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPT  305 (346)
Q Consensus       259 ~---------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~  305 (346)
                      .                                 ......+||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf  236 (363)
T cd05628         157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF  236 (363)
T ss_pred             ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence            0                                 0012346999999999998889999999999999999999999999


Q ss_pred             CccccCcc--cHHHHHhh-------hcCCChhhhhchhccCCccccc
Q 039799          306 DEIFSGEM--TLKRWVND-------LLPISVMEVVDANLLSQEDEHF  343 (346)
Q Consensus       306 ~~~~~~~~--~~~~~~~~-------~~~~~~~~~~d~~l~~~p~~R~  343 (346)
                      ......+.  .+..|...       .+++...+++.+++. +|++|.
T Consensus       237 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~  282 (363)
T cd05628         237 CSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRI  282 (363)
T ss_pred             CCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcC
Confidence            75322110  11111100       123366778877664 566553

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=7.2e-40  Score=319.86  Aligned_cols=240  Identities=24%  Similarity=0.311  Sum_probs=195.4

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEE
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVL  178 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  178 (346)
                      .+|.+.+.||+|+||.||+|... +|+.||+|++....   ....+++.+|++++++++|||++++++++.+.+..+++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            46888999999999999999876 68999999986432   233567889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhc----------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeec
Q 039799          179 EYMPHGSLEKCLYLS----------NYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFG  248 (346)
Q Consensus       179 e~~~~gsL~~~l~~~----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg  248 (346)
                      ||+++++|.+++...          ....++...+.++.++++||+|||   +.+|+||||||+||+++.++.++|+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecC
Confidence            999999999988531          134567788999999999999999   9999999999999999999999999999


Q ss_pred             CCccCCcccc----------------ccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCc
Q 039799          249 MAKPLLEEDQ----------------SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE  312 (346)
Q Consensus       249 ~~~~~~~~~~----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~  312 (346)
                      +++.......                ........||+.|+|||+..+..++.++|||||||+++||+||+.||.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            9986621110                001122468999999999998899999999999999999999999997532211


Q ss_pred             ccHHHHH--------hhhcCCChhhhhchhccCCccccccc
Q 039799          313 MTLKRWV--------NDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       313 ~~~~~~~--------~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      .......        ...++..+.+++.+||..||++|+++
T Consensus       239 i~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss  279 (932)
T PRK13184        239 ISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSS  279 (932)
T ss_pred             hhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCH
Confidence            1111111        11344578899999999999999874

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=5.8e-40  Score=291.96  Aligned_cols=238  Identities=29%  Similarity=0.450  Sum_probs=196.4

Q ss_pred             CCCCCCCcccccCceEEEEEEEc------CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeE
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ------DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKAL  176 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  176 (346)
                      .+|.+.+.||+|++|.||+|...      ++..+++|.+........+.+.+|++.+++++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            45778899999999999999743      345689999876655556778899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCc
Q 039799          177 VLEYMPHGSLEKCLYLSN---------------YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV  241 (346)
Q Consensus       177 v~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~  241 (346)
                      ||||+++++|.+++....               ..+++..++.++.+++.|++|||   +.+++||||||+||+++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCc
Confidence            999999999999986432               34789999999999999999999   999999999999999999999


Q ss_pred             EEEeeecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHH-
Q 039799          242 AHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWV-  319 (346)
Q Consensus       242 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~-  319 (346)
                      ++|+|||++................++..|+|||+..+..++.++||||||+++|||+| |+.||......+  ..+.. 
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~~~~~  239 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE--VIECIT  239 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHh
Confidence            99999999986544322222233446788999999988889999999999999999999 999986532211  11111 


Q ss_pred             -------hhhcCCChhhhhchhccCCccccccc
Q 039799          320 -------NDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       320 -------~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                             ....+..+.+++.+|+..+|++||+.
T Consensus       240 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~  272 (291)
T cd05094         240 QGRVLERPRVCPKEVYDIMLGCWQREPQQRLNI  272 (291)
T ss_pred             CCCCCCCCccCCHHHHHHHHHHcccChhhCcCH
Confidence                   11234478899999999999999985

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.3e-39  Score=288.44  Aligned_cols=238  Identities=25%  Similarity=0.442  Sum_probs=196.4

Q ss_pred             CCCCCCCcccccCceEEEEEEEcC------CCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCcee
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQD------GMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKA  175 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  175 (346)
                      ++|.+.+.||+|++|.||+|....      ...+|+|.+.... ......+.+|++.+++++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            468889999999999999998642      2579999987543 334567889999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCC
Q 039799          176 LVLEYMPHGSLEKCLYLSN---------------YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM  240 (346)
Q Consensus       176 lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~  240 (346)
                      ++|||+++++|.+++....               ..+++...+.++.+++.||+|||   +.+++|+||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCCC
Confidence            9999999999999886432               45788899999999999999999   99999999999999999999


Q ss_pred             cEEEeeecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHH
Q 039799          241 VAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWV  319 (346)
Q Consensus       241 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~  319 (346)
                      .++|+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |..||......  +....+
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~--~~~~~i  239 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ--EVIEMI  239 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHH
Confidence            999999999986543322222333456788999999988889999999999999999998 99998753321  222222


Q ss_pred             h--------hhcCCChhhhhchhccCCccccccc
Q 039799          320 N--------DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       320 ~--------~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      .        ..++..+.+++.+|+..+|++||+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~  273 (283)
T cd05048         240 RSRQLLPCPEDCPARVYALMIECWNEIPARRPRF  273 (283)
T ss_pred             HcCCcCCCcccCCHHHHHHHHHHccCChhhCcCH
Confidence            1        2234588999999999999999986

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=4.8e-40  Score=296.99  Aligned_cols=231  Identities=27%  Similarity=0.330  Sum_probs=186.2

Q ss_pred             CcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHH-HHHhcCCCCceeeEEEEecCCceeEEEecCCC
Q 039799          109 PLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECD-VMKRICHRNLIKIISSYSNDDFKALVLEYMPH  183 (346)
Q Consensus       109 ~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  183 (346)
                      +.||+|+||.||+|... +|+.+|+|++....   ......+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46899999999999865 78999999986431   222344555554 56779999999999999999999999999999


Q ss_pred             CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccccc
Q 039799          184 GSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT  263 (346)
Q Consensus       184 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~~  263 (346)
                      |+|..++.. ...+++.....++.|++.||+|||   +.+|+||||||+|||+++++.++|+|||+++......  ....
T Consensus        81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~  154 (325)
T cd05604          81 GELFFHLQR-ERSFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DTTT  154 (325)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CCcc
Confidence            999887753 456889999999999999999999   9999999999999999999999999999987532211  1223


Q ss_pred             cccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh------hhcCCChhhhhchhccC
Q 039799          264 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN------DLLPISVMEVVDANLLS  337 (346)
Q Consensus       264 ~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~------~~~~~~~~~~~d~~l~~  337 (346)
                      ...|+..|+|||.+.+..++.++|||||||++|||++|+.||......+ .......      ...+..+.+++.++|..
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~  233 (325)
T cd05604         155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE-MYDNILHKPLVLRPGASLTAWSILEELLEK  233 (325)
T ss_pred             cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH-HHHHHHcCCccCCCCCCHHHHHHHHHHhcc
Confidence            4568999999999998899999999999999999999999996532111 1111111      11233678999999999


Q ss_pred             CcccccccC
Q 039799          338 QEDEHFTTK  346 (346)
Q Consensus       338 ~p~~R~~~k  346 (346)
                      +|.+||+.+
T Consensus       234 ~p~~R~~~~  242 (325)
T cd05604         234 DRQRRLGAK  242 (325)
T ss_pred             CHHhcCCCC
Confidence            999999863

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=6.5e-40  Score=297.75  Aligned_cols=237  Identities=22%  Similarity=0.317  Sum_probs=186.9

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEecC-----Ccee
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSND-----DFKA  175 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~  175 (346)
                      +|.+.+.||+|+||.||+|... +++.||+|++....  ......+.+|++++++++||||+++++++...     ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            3677889999999999999865 78999999986432  23345688899999999999999999987543     2478


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCc
Q 039799          176 LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  255 (346)
Q Consensus       176 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~  255 (346)
                      +||||+. ++|.+++.. ...+++..+..++.|+++||+|||   +.+|+||||||+|||++.++.++|+|||+++....
T Consensus        81 lv~e~~~-~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~  155 (338)
T cd07859          81 VVFELME-SDLHQVIKA-NDDLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFN  155 (338)
T ss_pred             EEEecCC-CCHHHHHHh-cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence            9999995 688887753 345889999999999999999999   99999999999999999999999999999986533


Q ss_pred             ccc-ccccccccCCcccccCCCCCC--CCCCcchhHHHHHHHHHHHHcCCCCCCccccCc--------------ccHHH-
Q 039799          256 EDQ-SLTQTQTLATIGYMAPEYGRE--GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE--------------MTLKR-  317 (346)
Q Consensus       256 ~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~--------------~~~~~-  317 (346)
                      ... ........++..|+|||++.+  ..++.++|||||||++|||+||+.||.......              ..... 
T Consensus       156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i  235 (338)
T cd07859         156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRV  235 (338)
T ss_pred             ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence            221 112234568999999998765  578999999999999999999999996421100              00000 


Q ss_pred             -------HH---h-----------hhcCCChhhhhchhccCCccccccc
Q 039799          318 -------WV---N-----------DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       318 -------~~---~-----------~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                             ..   .           ...+..+.+++.+||..+|++||++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~  284 (338)
T cd07859         236 RNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTA  284 (338)
T ss_pred             hhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCH
Confidence                   00   0           1123456899999999999999986

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=5.2e-40  Score=296.45  Aligned_cols=234  Identities=23%  Similarity=0.286  Sum_probs=190.7

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhcC-CCCceeeEEEEecCCceeEEE
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRIC-HRNLIKIISSYSNDDFKALVL  178 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~  178 (346)
                      +|+..+.||+|+||.||+|... +|+.||+|++....   ....+.+..|.+++..+. |++++++.+++...+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            3677889999999999999866 78999999986431   233456777888888885 567788999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccc
Q 039799          179 EYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  258 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~  258 (346)
                      ||+++|+|.+++... ..+++..+..++.+++.||+|||   +.+|+||||||+|||+++++.++|+|||+++...... 
T Consensus        81 Ey~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~-  155 (323)
T cd05615          81 EYVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG-  155 (323)
T ss_pred             cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC-
Confidence            999999999888543 45889999999999999999999   9999999999999999999999999999988543221 


Q ss_pred             ccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH-h------hhcCCChhhhh
Q 039799          259 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV-N------DLLPISVMEVV  331 (346)
Q Consensus       259 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~-~------~~~~~~~~~~~  331 (346)
                       .......||+.|+|||++.+..++.++||||+|+++|||+||+.||......  ...+.+ .      ..++..+.+++
T Consensus       156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--~~~~~i~~~~~~~p~~~~~~~~~li  232 (323)
T cd05615         156 -VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED--ELFQSIMEHNVSYPKSLSKEAVSIC  232 (323)
T ss_pred             -ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCCCCCCccCCHHHHHHH
Confidence             1123345899999999998888999999999999999999999999763221  111111 1      12344678999


Q ss_pred             chhccCCccccccc
Q 039799          332 DANLLSQEDEHFTT  345 (346)
Q Consensus       332 d~~l~~~p~~R~~~  345 (346)
                      .+||..+|.+|++.
T Consensus       233 ~~~l~~~p~~R~~~  246 (323)
T cd05615         233 KGLMTKHPSKRLGC  246 (323)
T ss_pred             HHHcccCHhhCCCC
Confidence            99999999999974

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-40  Score=290.79  Aligned_cols=234  Identities=25%  Similarity=0.350  Sum_probs=193.1

Q ss_pred             CCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEec
Q 039799          105 ANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEY  180 (346)
Q Consensus       105 ~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  180 (346)
                      |++.+.||+|+||.||++... +++.||+|++....   ......+.+|++++++++||||+++++.+...+..++||||
T Consensus         2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05605           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence            677889999999999999865 68999999986432   12234567899999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccc
Q 039799          181 MPHGSLEKCLYLS-NYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  259 (346)
Q Consensus       181 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~  259 (346)
                      +++++|.+++... ...+++..+..++.|++.|++|||   +.+++||||||+||++++++.++|+|||++.......  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--  156 (285)
T cd05605          82 MNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE--  156 (285)
T ss_pred             cCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC--
Confidence            9999999887644 346899999999999999999999   9999999999999999999999999999988653221  


Q ss_pred             cccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCc--ccHHHHHh-------hhcCCChhhh
Q 039799          260 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE--MTLKRWVN-------DLLPISVMEV  330 (346)
Q Consensus       260 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~--~~~~~~~~-------~~~~~~~~~~  330 (346)
                       ......|+..|+|||.+.+..++.++||||+|+++||+++|+.||.......  ......+.       ..++..+.++
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  235 (285)
T cd05605         157 -TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSI  235 (285)
T ss_pred             -ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHH
Confidence             1223468999999999988889999999999999999999999997532211  01111111       1234477899


Q ss_pred             hchhccCCcccccc
Q 039799          331 VDANLLSQEDEHFT  344 (346)
Q Consensus       331 ~d~~l~~~p~~R~~  344 (346)
                      +.+||..||++||+
T Consensus       236 i~~~l~~~P~~R~~  249 (285)
T cd05605         236 CRQLLTKDPGFRLG  249 (285)
T ss_pred             HHHHccCCHHHhcC
Confidence            99999999999994

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-40  Score=304.35  Aligned_cols=236  Identities=23%  Similarity=0.336  Sum_probs=188.8

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC---CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEE
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ---YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVL  178 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  178 (346)
                      ++|.+.+.||+|+||.||++... +++.||+|++...   .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            36888899999999999999865 7899999998542   1233467788999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccc
Q 039799          179 EYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  258 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~  258 (346)
                      ||+++|+|.+++.. ...+++.....++.|++.||+|||   +.+|+||||||+|||++.++.++|+|||+++.+.....
T Consensus        81 E~~~gg~L~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~  156 (377)
T cd05629          81 EFLPGGDLMTMLIK-YDTFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD  156 (377)
T ss_pred             eCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence            99999999998864 345788888889999999999999   99999999999999999999999999999964321100


Q ss_pred             c---------------------------------------------cccccccCCcccccCCCCCCCCCCcchhHHHHHH
Q 039799          259 S---------------------------------------------LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGI  293 (346)
Q Consensus       259 ~---------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~  293 (346)
                      .                                             .......||+.|+|||++.+..++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv  236 (377)
T cd05629         157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA  236 (377)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence            0                                             0001245899999999998888999999999999


Q ss_pred             HHHHHHcCCCCCCccccCcc--cHHHHHh-h------hcCCChhhhhchhccCCccccc
Q 039799          294 MLMEIFTRTKPTDEIFSGEM--TLKRWVN-D------LLPISVMEVVDANLLSQEDEHF  343 (346)
Q Consensus       294 il~elltg~~p~~~~~~~~~--~~~~~~~-~------~~~~~~~~~~d~~l~~~p~~R~  343 (346)
                      ++|||+||+.||......+.  ....|.. .      .++..+.+++.++|. +|.+|+
T Consensus       237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~  294 (377)
T cd05629         237 IMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRL  294 (377)
T ss_pred             hhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcC
Confidence            99999999999965322110  0111111 1      123367899999997 788875

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=3.4e-40  Score=304.51  Aligned_cols=236  Identities=20%  Similarity=0.265  Sum_probs=188.8

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEe
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLE  179 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  179 (346)
                      .|...+.||+|+||.||+|... +++.+|+|++....   ......+.+|++++++++||||+++++.+.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            4778899999999999999865 68899999986432   2334678889999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccc-
Q 039799          180 YMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ-  258 (346)
Q Consensus       180 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~-  258 (346)
                      |+++|+|.+++... ..++......++.|++.||+|||   +.+|+||||||+|||++.++.++|+|||++..+..... 
T Consensus        82 ~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~  157 (382)
T cd05625          82 YIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  157 (382)
T ss_pred             CCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence            99999999988643 45788888889999999999999   99999999999999999999999999999764311000 


Q ss_pred             --------------------------------------------ccccccccCCcccccCCCCCCCCCCcchhHHHHHHH
Q 039799          259 --------------------------------------------SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIM  294 (346)
Q Consensus       259 --------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~i  294 (346)
                                                                  ........||+.|+|||++.+..++.++||||+||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi  237 (382)
T cd05625         158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI  237 (382)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence                                                        000112468999999999998899999999999999


Q ss_pred             HHHHHcCCCCCCccccCcc--cHHHHHh-------hhcCCChhhhhchhccCCcccccc
Q 039799          295 LMEIFTRTKPTDEIFSGEM--TLKRWVN-------DLLPISVMEVVDANLLSQEDEHFT  344 (346)
Q Consensus       295 l~elltg~~p~~~~~~~~~--~~~~~~~-------~~~~~~~~~~~d~~l~~~p~~R~~  344 (346)
                      +|||++|+.||......+.  ....|..       ..+++...+++.+++ .+|++|++
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~  295 (382)
T cd05625         238 LYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLG  295 (382)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCC
Confidence            9999999999975322111  1111111       123346778888865 59999986

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-40  Score=297.34  Aligned_cols=237  Identities=23%  Similarity=0.338  Sum_probs=202.6

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC--CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCc-eeEEE
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ--YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDF-KALVL  178 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~lv~  178 (346)
                      +.|...+.+|+|+||.++..+.+ ++..+++|.+...  .........+|+.++++++|||||.+.+.|.+++. .++||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            46888899999999999999866 6789999988643  33345577889999999999999999999999888 99999


Q ss_pred             ecCCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccc
Q 039799          179 EYMPHGSLEKCLYLSN-YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  257 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~  257 (346)
                      +|++||++.+.+.... ..++....++++.|++.|+.|||   +..|+|||||+.||+++.+..++|+|||+|+.+....
T Consensus        84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~  160 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED  160 (426)
T ss_pred             eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence            9999999999987666 67899999999999999999999   9999999999999999999999999999999886543


Q ss_pred             cccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh-------hhcCCChhhh
Q 039799          258 QSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN-------DLLPISVMEV  330 (346)
Q Consensus       258 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~-------~~~~~~~~~~  330 (346)
                        ....+..||+.|++||.+.+.+|+.|+||||+||++|||++-+++|+...... ...+..+       ..+...+..+
T Consensus       161 --~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~-Li~ki~~~~~~Plp~~ys~el~~l  237 (426)
T KOG0589|consen  161 --SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE-LILKINRGLYSPLPSMYSSELRSL  237 (426)
T ss_pred             --hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH-HHHHHhhccCCCCCccccHHHHHH
Confidence              23455679999999999999999999999999999999999999997632111 1112222       1223388999


Q ss_pred             hchhccCCccccccc
Q 039799          331 VDANLLSQEDEHFTT  345 (346)
Q Consensus       331 ~d~~l~~~p~~R~~~  345 (346)
                      +..++..+|..||++
T Consensus       238 v~~~l~~~P~~RPsa  252 (426)
T KOG0589|consen  238 VKSMLRKNPEHRPSA  252 (426)
T ss_pred             HHHHhhcCCccCCCH
Confidence            999999999999985

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-40  Score=297.69  Aligned_cols=235  Identities=26%  Similarity=0.428  Sum_probs=199.2

Q ss_pred             CCCcccccCceEEEEEEEcCCCEEEEEEecCCCc-hhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecCCCCC
Q 039799          107 MPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYE-GAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGS  185 (346)
Q Consensus       107 ~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  185 (346)
                      +.+.||+|-||.|.++....+..||||.+++... .....|..|+++|.+++||||++++|.|..++.+.+|+|||++|+
T Consensus       542 ~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGD  621 (807)
T KOG1094|consen  542 FKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGD  621 (807)
T ss_pred             hhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCc
Confidence            3457999999999999999889999999987643 445899999999999999999999999999999999999999999


Q ss_pred             hhhhhhhcCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccccccc
Q 039799          186 LEKCLYLSNY-ILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ  264 (346)
Q Consensus       186 L~~~l~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  264 (346)
                      |.+++..... ...-...++|+.|||.|++||.   +.+++|||+.++|+|+|.++++||+|||+++-+...+.......
T Consensus       622 LnqFl~aheapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr  698 (807)
T KOG1094|consen  622 LNQFLSAHELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGR  698 (807)
T ss_pred             HHHHHHhccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCCceeeecc
Confidence            9999976642 2455667789999999999999   99999999999999999999999999999997665554444445


Q ss_pred             ccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHH--cCCCCCCccccCcc--cHH-----------HHHhhhcCCChhh
Q 039799          265 TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIF--TRTKPTDEIFSGEM--TLK-----------RWVNDLLPISVME  329 (346)
Q Consensus       265 ~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ell--tg~~p~~~~~~~~~--~~~-----------~~~~~~~~~~~~~  329 (346)
                      .+-..+|+|+|.+..++++.++|||+||+++||++  +...||++..++..  +..           .-.....|..+.+
T Consensus       699 ~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~lye  778 (807)
T KOG1094|consen  699 AVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQGLYE  778 (807)
T ss_pred             eeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHHHHH
Confidence            56689999999999999999999999999999986  48899987553321  111           1112334568899


Q ss_pred             hhchhccCCcccccc
Q 039799          330 VVDANLLSQEDEHFT  344 (346)
Q Consensus       330 ~~d~~l~~~p~~R~~  344 (346)
                      ++-+|+..|-++||+
T Consensus       779 lml~Cw~~es~~RPs  793 (807)
T KOG1094|consen  779 LMLRCWRRESEQRPS  793 (807)
T ss_pred             HHHHHhchhhhcCCC
Confidence            999999999999997

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.6e-39  Score=284.52  Aligned_cols=237  Identities=24%  Similarity=0.404  Sum_probs=197.6

Q ss_pred             CCCCCCCCcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecC
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYM  181 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  181 (346)
                      .++|.+.+.||+|++|.||+|...++..+|+|.+.... ...+.+.+|+.++++++|+|++++++.+...+..+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            35688899999999999999998888899999986543 23577889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccc
Q 039799          182 PHGSLEKCLYLS-NYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  260 (346)
Q Consensus       182 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~  260 (346)
                      ++++|.+++... ...+++..++.++.+++.||+|||   +.+++||||+|+||++++++.++|+|||++........ .
T Consensus        84 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~  159 (261)
T cd05072          84 AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-T  159 (261)
T ss_pred             CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCce-e
Confidence            999999988654 356889999999999999999999   89999999999999999999999999999987543221 1


Q ss_pred             ccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHhh--------hcCCChhhhh
Q 039799          261 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVND--------LLPISVMEVV  331 (346)
Q Consensus       261 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~  331 (346)
                      ......++..|+|||+.....++.++||||||+++|||+| |+.||......  .....+..        .++..+.+++
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li  237 (261)
T cd05072         160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--DVMSALQRGYRMPRMENCPDELYDIM  237 (261)
T ss_pred             ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--HHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence            1222335678999999988889999999999999999998 99999653211  12222221        2344788999


Q ss_pred             chhccCCccccccc
Q 039799          332 DANLLSQEDEHFTT  345 (346)
Q Consensus       332 d~~l~~~p~~R~~~  345 (346)
                      .+|+..+|++||+.
T Consensus       238 ~~~l~~~p~~Rp~~  251 (261)
T cd05072         238 KTCWKEKAEERPTF  251 (261)
T ss_pred             HHHccCCcccCcCH
Confidence            99999999999985

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-39  Score=285.39  Aligned_cols=236  Identities=28%  Similarity=0.400  Sum_probs=196.1

Q ss_pred             CCCCCCCcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecCC
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMP  182 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  182 (346)
                      ++|.+.+.||+|++|.||+|...+++.||+|.+.... ...+.+.+|++++++++|||++++++++...+..+++|||++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (261)
T cd05068           6 TSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK   84 (261)
T ss_pred             hheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence            5688899999999999999998878899999987543 234678889999999999999999999999999999999999


Q ss_pred             CCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccc
Q 039799          183 HGSLEKCLYLSN-YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT  261 (346)
Q Consensus       183 ~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~  261 (346)
                      +++|.+++.... ..+++.....++.+++.|+.|||   +.+++||||||+||++++++.++|+|||++........ ..
T Consensus        85 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~~  160 (261)
T cd05068          85 YGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY-EA  160 (261)
T ss_pred             CCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc-cc
Confidence            999999986543 56899999999999999999999   99999999999999999999999999999987642211 11


Q ss_pred             cccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHh--------hhcCCChhhhhc
Q 039799          262 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVN--------DLLPISVMEVVD  332 (346)
Q Consensus       262 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~d  332 (346)
                      ......+..|+|||+..+..++.++||||||++++||+| |+.||......  .....+.        ...+..+.+++.
T Consensus       161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (261)
T cd05068         161 REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA--EVLQQVDQGYRMPCPPGCPKELYDIML  238 (261)
T ss_pred             cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHHcCCCCCCCCcCCHHHHHHHH
Confidence            112223467999999988889999999999999999999 99999753211  1111111        123457899999


Q ss_pred             hhccCCccccccc
Q 039799          333 ANLLSQEDEHFTT  345 (346)
Q Consensus       333 ~~l~~~p~~R~~~  345 (346)
                      +|+..+|++||+.
T Consensus       239 ~~l~~~P~~Rp~~  251 (261)
T cd05068         239 DCWKEDPDDRPTF  251 (261)
T ss_pred             HHhhcCcccCCCH
Confidence            9999999999985

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.2e-39  Score=293.91  Aligned_cols=230  Identities=27%  Similarity=0.318  Sum_probs=184.2

Q ss_pred             CcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHH-HHHhcCCCCceeeEEEEecCCceeEEEecCCC
Q 039799          109 PLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECD-VMKRICHRNLIKIISSYSNDDFKALVLEYMPH  183 (346)
Q Consensus       109 ~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  183 (346)
                      +.||+|+||.||+|+.. +++.||+|++....   ......+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46899999999999976 68899999986432   122334445544 67889999999999999999999999999999


Q ss_pred             CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccccc
Q 039799          184 GSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT  263 (346)
Q Consensus       184 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~~  263 (346)
                      ++|...+.. ...++......++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~  154 (321)
T cd05603          81 GELFFHLQR-ERCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ETTS  154 (321)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Cccc
Confidence            999887753 345778888889999999999999   9999999999999999999999999999988532221  1223


Q ss_pred             cccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHhh------hcCCChhhhhchhccC
Q 039799          264 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVND------LLPISVMEVVDANLLS  337 (346)
Q Consensus       264 ~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~------~~~~~~~~~~d~~l~~  337 (346)
                      ...|++.|+|||.+.+..++.++|||||||++|||++|+.||...... .........      ..+..+.+++.+||..
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~  233 (321)
T cd05603         155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS-QMYDNILHKPLQLPGGKTVAACDLLVGLLHK  233 (321)
T ss_pred             cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH-HHHHHHhcCCCCCCCCCCHHHHHHHHHHccC
Confidence            456899999999998888999999999999999999999999653211 111111111      1222578999999999


Q ss_pred             Cccccccc
Q 039799          338 QEDEHFTT  345 (346)
Q Consensus       338 ~p~~R~~~  345 (346)
                      +|.+|+++
T Consensus       234 ~p~~R~~~  241 (321)
T cd05603         234 DQRRRLGA  241 (321)
T ss_pred             CHhhcCCC
Confidence            99999975

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.6e-39  Score=282.07  Aligned_cols=235  Identities=25%  Similarity=0.342  Sum_probs=197.6

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC--CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEec
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ--YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEY  180 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  180 (346)
                      +|.+.+.||+|++|.||+|..+ +++.+++|.+...  .......+.+|++++++++|||++++++++.+.+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4677889999999999999976 6899999998643  234467788899999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccc
Q 039799          181 MPHGSLEKCLYLS-NYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  259 (346)
Q Consensus       181 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~  259 (346)
                      +++++|.+++... ...+++..++.++.+++.||.|||   +.+++|+||+|+||++++++.++|+|||+++.+..... 
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~-  156 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN-  156 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence            9999999998764 457899999999999999999999   99999999999999999999999999999887643321 


Q ss_pred             cccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH-h-------hhcCCChhhhh
Q 039799          260 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV-N-------DLLPISVMEVV  331 (346)
Q Consensus       260 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~-~-------~~~~~~~~~~~  331 (346)
                       ......++..|+|||+..+..++.++|+||||++++||++|+.||.....  ....+.+ .       ..++..+.+++
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~i  233 (256)
T cd08529         157 -FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ--GALILKIIRGVFPPVSQMYSQQLAQLI  233 (256)
T ss_pred             -hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHcCCCCCCccccCHHHHHHH
Confidence             12234578899999999988899999999999999999999999975331  1111111 1       12344789999


Q ss_pred             chhccCCccccccc
Q 039799          332 DANLLSQEDEHFTT  345 (346)
Q Consensus       332 d~~l~~~p~~R~~~  345 (346)
                      .+|+..+|++||++
T Consensus       234 ~~~l~~~p~~Rp~~  247 (256)
T cd08529         234 DQCLTKDYRQRPDT  247 (256)
T ss_pred             HHHccCCcccCcCH
Confidence            99999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=2.6e-39  Score=286.10  Aligned_cols=237  Identities=23%  Similarity=0.357  Sum_probs=192.6

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCC----EEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeE
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGM----EVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKAL  176 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  176 (346)
                      .+|.+.+.||+|+||.||+|.+. +++    .+++|.+.... .....++..|+..++++.||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            57888999999999999999864 444    47788875432 2334677788889999999999999998754 45778


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcc
Q 039799          177 VLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  256 (346)
Q Consensus       177 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~  256 (346)
                      ++||+++|+|.+++......+++.....++.|++.|++|||   +.+++||||||+||++++++.++|+|||+++.....
T Consensus        86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~  162 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD  162 (279)
T ss_pred             EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence            99999999999999876677899999999999999999999   999999999999999999999999999999876443


Q ss_pred             ccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHhh--------hcCCCh
Q 039799          257 DQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVND--------LLPISV  327 (346)
Q Consensus       257 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~--------~~~~~~  327 (346)
                      ..........++..|+|||...+..++.++||||||+++||++| |+.||......  ...+.+..        ..+..+
T Consensus       163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  240 (279)
T cd05111         163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH--EVPDLLEKGERLAQPQICTIDV  240 (279)
T ss_pred             CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHCCCcCCCCCCCCHHH
Confidence            33223334457788999999988889999999999999999998 99999764221  12222221        122356


Q ss_pred             hhhhchhccCCccccccc
Q 039799          328 MEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       328 ~~~~d~~l~~~p~~R~~~  345 (346)
                      .+++.+|+..+|++||+.
T Consensus       241 ~~li~~c~~~~p~~Rps~  258 (279)
T cd05111         241 YMVMVKCWMIDENVRPTF  258 (279)
T ss_pred             HHHHHHHcCCCcccCcCH
Confidence            789999999999999985

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2e-39  Score=287.59  Aligned_cols=235  Identities=23%  Similarity=0.324  Sum_probs=193.0

Q ss_pred             CCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEec
Q 039799          105 ANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEY  180 (346)
Q Consensus       105 ~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  180 (346)
                      |...+.||+|+||+||+|.+. +++.+|+|.+....   ......+.+|++++++++|+|++++.+.+..++..+++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            556678999999999999875 78999999986532   22234567899999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccc
Q 039799          181 MPHGSLEKCLYLS-NYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  259 (346)
Q Consensus       181 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~  259 (346)
                      +++++|.+++... ...+++.....++.|++.||.|||   +.+|+||||||+||++++++.++|+|||++.......  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~--  156 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE--  156 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence            9999999887643 346899999999999999999999   9999999999999999999999999999987643221  


Q ss_pred             cccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcc--cHHH-------HHhhhcCCChhhh
Q 039799          260 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM--TLKR-------WVNDLLPISVMEV  330 (346)
Q Consensus       260 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~--~~~~-------~~~~~~~~~~~~~  330 (346)
                       ......|+..|+|||...+..++.++|+||||+++||+++|..||........  ....       .....++..+.++
T Consensus       157 -~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  235 (285)
T cd05632         157 -SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSI  235 (285)
T ss_pred             -cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHH
Confidence             12234689999999999888899999999999999999999999975321110  1111       1112234467899


Q ss_pred             hchhccCCccccccc
Q 039799          331 VDANLLSQEDEHFTT  345 (346)
Q Consensus       331 ~d~~l~~~p~~R~~~  345 (346)
                      +.+|+..+|++||++
T Consensus       236 i~~~l~~~P~~R~~~  250 (285)
T cd05632         236 CKMLLTKDPKQRLGC  250 (285)
T ss_pred             HHHHccCCHhHcCCC
Confidence            999999999999984

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.7e-39  Score=287.38  Aligned_cols=238  Identities=27%  Similarity=0.431  Sum_probs=196.2

Q ss_pred             CCCCCCCcccccCceEEEEEEEc------CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeE
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ------DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKAL  176 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  176 (346)
                      .++...+.||+|+||.||++...      ++..+|+|.+........+.+.+|+++++.++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            45778899999999999999642      356799999876666666789999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhcC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcE
Q 039799          177 VLEYMPHGSLEKCLYLSN--------------YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVA  242 (346)
Q Consensus       177 v~e~~~~gsL~~~l~~~~--------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~  242 (346)
                      ++||+++++|.+++....              ..+++..++.++.|++.|++|||   +.+++||||||+||++++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCCE
Confidence            999999999999886432              35789999999999999999999   9999999999999999999999


Q ss_pred             EEeeecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHH--
Q 039799          243 HLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWV--  319 (346)
Q Consensus       243 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~--  319 (346)
                      +|+|||++................+++.|+|||...+..++.++||||||+++|||++ |+.||......+  ....+  
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~~~~~  239 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE--AIECITQ  239 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH--HHHHHHc
Confidence            9999999986543222111222335678999999988889999999999999999998 999986533211  11111  


Q ss_pred             ------hhhcCCChhhhhchhccCCccccccc
Q 039799          320 ------NDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       320 ------~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                            ....+..+.+++.+||..||.+||+.
T Consensus       240 ~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~  271 (280)
T cd05092         240 GRELERPRTCPPEVYAIMQGCWQREPQQRMVI  271 (280)
T ss_pred             CccCCCCCCCCHHHHHHHHHHccCChhhCCCH
Confidence                  12234578999999999999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=3.1e-39  Score=286.06  Aligned_cols=238  Identities=24%  Similarity=0.417  Sum_probs=194.3

Q ss_pred             CCCCCCCcccccCceEEEEEEE-----cCCCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeE
Q 039799          103 NDANMPPLIGKGGFGSVYKAII-----QDGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKAL  176 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  176 (346)
                      ++|.+.+.||+|+||.||+|.+     ..+..+++|.+.... ......+.+|++++++++|||++++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4678889999999999999984     246789999987433 3334678899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhc----------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCC
Q 039799          177 VLEYMPHGSLEKCLYLS----------------NYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM  240 (346)
Q Consensus       177 v~e~~~~gsL~~~l~~~----------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~  240 (346)
                      +|||+++++|.+++...                ...+++...+.++.+++.||+|||   +.+++||||||+||++++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCC
Confidence            99999999999988532                124788889999999999999999   99999999999999999999


Q ss_pred             cEEEeeecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHH
Q 039799          241 VAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWV  319 (346)
Q Consensus       241 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~  319 (346)
                      .++|+|||+++...............++..|+|||+..+..++.++||||||+++|||++ |..||.....  ....+.+
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--~~~~~~~  239 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--QEVIEMV  239 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHH
Confidence            999999999987643332222233445778999999988889999999999999999998 9999865221  1112222


Q ss_pred             h--------hhcCCChhhhhchhccCCccccccc
Q 039799          320 N--------DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       320 ~--------~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      .        ..++..+.+++.+|+..+|.+||+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~  273 (283)
T cd05090         240 RKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRF  273 (283)
T ss_pred             HcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCH
Confidence            1        1234478899999999999999985

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=4.5e-39  Score=282.50  Aligned_cols=238  Identities=24%  Similarity=0.345  Sum_probs=196.1

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC---CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEE
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ---YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVL  178 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  178 (346)
                      .+|.+.+.||+|+||.||+|+.. +++.+|+|.+...   .......+.+|++++++++|||++++++++...+..++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            46889999999999999999865 7899999987532   2333457888999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCc
Q 039799          179 EYMPHGSLEKCLYL---SNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  255 (346)
Q Consensus       179 e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~  255 (346)
                      ||+++++|.+++..   ....++......++.+++.||+|||   +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            99999999988753   2345788899999999999999999   99999999999999999999999999999887643


Q ss_pred             cccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHhh---------hcCCC
Q 039799          256 EDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVND---------LLPIS  326 (346)
Q Consensus       256 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~---------~~~~~  326 (346)
                      ...  ......++..|+|||...+..++.++|+||||+++|||++|+.||...........+.+..         ..+..
T Consensus       159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (267)
T cd08228         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEK  236 (267)
T ss_pred             hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHH
Confidence            221  1223458889999999988889999999999999999999999986432221222222211         22346


Q ss_pred             hhhhhchhccCCccccccc
Q 039799          327 VMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       327 ~~~~~d~~l~~~p~~R~~~  345 (346)
                      +.+++.+|+..+|++||+.
T Consensus       237 ~~~li~~cl~~~p~~Rp~~  255 (267)
T cd08228         237 LRELVSMCIYPDPDQRPDI  255 (267)
T ss_pred             HHHHHHHHCCCCcccCcCH
Confidence            8999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=8.1e-40  Score=286.30  Aligned_cols=238  Identities=25%  Similarity=0.423  Sum_probs=200.4

Q ss_pred             CCCCCCCCcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecC
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYM  181 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  181 (346)
                      ..+|.+.+.||+|++|.||+|...++..+|+|++..........+..|+.+++.++|+|++++++++...+..++||||+
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   84 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM   84 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence            35688899999999999999998889999999998665545678889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccc
Q 039799          182 PHGSLEKCLYLS-NYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  260 (346)
Q Consensus       182 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~  260 (346)
                      ++++|.+++... ...+++..+..++.+++.|++|||   +.+++|+||+|+||++++++.++|+|||.+........  
T Consensus        85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~--  159 (261)
T cd05148          85 EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY--  159 (261)
T ss_pred             ccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCccc--
Confidence            999999998753 356899999999999999999999   99999999999999999999999999999987643221  


Q ss_pred             ccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHh--------hhcCCChhhhh
Q 039799          261 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVN--------DLLPISVMEVV  331 (346)
Q Consensus       261 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~  331 (346)
                      ......++..|+|||...+..++.++||||||+++++|++ |+.||......  ...+.+.        ...+..+.+++
T Consensus       160 ~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~i  237 (261)
T cd05148         160 LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH--EVYDQITAGYRMPCPAKCPQEIYKIM  237 (261)
T ss_pred             cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH--HHHHHHHhCCcCCCCCCCCHHHHHHH
Confidence            1123346778999999888889999999999999999998 89999653221  1112221        12234788999


Q ss_pred             chhccCCcccccccC
Q 039799          332 DANLLSQEDEHFTTK  346 (346)
Q Consensus       332 d~~l~~~p~~R~~~k  346 (346)
                      .+|+..+|.+||+++
T Consensus       238 ~~~l~~~p~~Rpt~~  252 (261)
T cd05148         238 LECWAAEPEDRPSFK  252 (261)
T ss_pred             HHHcCCCchhCcCHH
Confidence            999999999999863

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.4e-39  Score=287.48  Aligned_cols=239  Identities=23%  Similarity=0.391  Sum_probs=193.0

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc------CCCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCce
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ------DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFK  174 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  174 (346)
                      .++|++.+.||+|++|.||+|.+.      .+..+|+|++.... ......+.+|+.+++.++||||+++++++......
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~   84 (277)
T cd05062           5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   84 (277)
T ss_pred             HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCe
Confidence            456889999999999999999753      35679999986432 23445688899999999999999999999999999


Q ss_pred             eEEEecCCCCChhhhhhhcC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEe
Q 039799          175 ALVLEYMPHGSLEKCLYLSN---------YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLS  245 (346)
Q Consensus       175 ~lv~e~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~  245 (346)
                      ++||||+++++|.+++....         ..+++..+..++.+++.||+|||   +.+++|+||||+||++++++.++|+
T Consensus        85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l~  161 (277)
T cd05062          85 LVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEEEC
Confidence            99999999999999886432         23578889999999999999999   9999999999999999999999999


Q ss_pred             eecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHH-----
Q 039799          246 DFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWV-----  319 (346)
Q Consensus       246 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~-----  319 (346)
                      |||+++...............++..|+|||+..+..++.++||||||+++|||++ |..||......  ...+.+     
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~--~~~~~~~~~~~  239 (277)
T cd05062         162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE--QVLRFVMEGGL  239 (277)
T ss_pred             CCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHcCCc
Confidence            9999886543222111222345788999999988889999999999999999999 78888653211  111111     


Q ss_pred             ---hhhcCCChhhhhchhccCCccccccc
Q 039799          320 ---NDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       320 ---~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                         ....+..+.+++.+|+..+|++||+.
T Consensus       240 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~  268 (277)
T cd05062         240 LDKPDNCPDMLFELMRMCWQYNPKMRPSF  268 (277)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCcCH
Confidence               11233468899999999999999985

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=3.2e-39  Score=287.92  Aligned_cols=238  Identities=25%  Similarity=0.296  Sum_probs=197.9

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEe
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLE  179 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  179 (346)
                      ...+|.+.+.||+|++|.||+|... +++.+|+|.+........+.+.+|+.+++.++|+|++++++.+......++|||
T Consensus        18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e   97 (296)
T cd06654          18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (296)
T ss_pred             cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence            3467899999999999999999864 789999999876555556778899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccc
Q 039799          180 YMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  259 (346)
Q Consensus       180 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~  259 (346)
                      |+++++|.+++..  ..+++..+..++.+++.||+|||   +.+++||||||+||+++.++.++|+|||++........ 
T Consensus        98 ~~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-  171 (296)
T cd06654          98 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  171 (296)
T ss_pred             ccCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc-
Confidence            9999999998753  34788899999999999999999   99999999999999999999999999999886533221 


Q ss_pred             cccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH--------hhhcCCChhhhh
Q 039799          260 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV--------NDLLPISVMEVV  331 (346)
Q Consensus       260 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~~  331 (346)
                       ......++..|+|||...+..++.++||||||+++|||++|+.||............+.        ...++..+.+++
T Consensus       172 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  250 (296)
T cd06654         172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFL  250 (296)
T ss_pred             -ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHH
Confidence             12234588899999999888889999999999999999999999965332111111111        112234678999


Q ss_pred             chhccCCccccccc
Q 039799          332 DANLLSQEDEHFTT  345 (346)
Q Consensus       332 d~~l~~~p~~R~~~  345 (346)
                      .+||..+|++||++
T Consensus       251 ~~~l~~~p~~Rpt~  264 (296)
T cd06654         251 NRCLDMDVEKRGSA  264 (296)
T ss_pred             HHHCcCCcccCcCH
Confidence            99999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.9e-39  Score=289.94  Aligned_cols=237  Identities=21%  Similarity=0.293  Sum_probs=191.3

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEec
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEY  180 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  180 (346)
                      ++|.+.+.||+|+||.||+|..+ +++.+|+|.+.... ......+.+|++++++++|||++++++++...+..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            56888999999999999999876 67889999986432 22334677899999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccc
Q 039799          181 MPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  260 (346)
Q Consensus       181 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~  260 (346)
                      +++ +|.+++......+++..+..++.+++.||+|||   +.+|+||||||+||+++.++.++|+|||++.......  .
T Consensus        86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~  159 (309)
T cd07872          86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT--K  159 (309)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCCc--c
Confidence            975 888877666667889999999999999999999   9999999999999999999999999999987543221  1


Q ss_pred             ccccccCCcccccCCCCCC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccCcc--------------------cHHHHH
Q 039799          261 TQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM--------------------TLKRWV  319 (346)
Q Consensus       261 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~--------------------~~~~~~  319 (346)
                      ......++..|+|||.+.+ ..++.++||||+|+++|||+||+.||......+.                    ....+.
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
T cd07872         160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK  239 (309)
T ss_pred             ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence            1223457899999998764 4578999999999999999999999964321100                    000000


Q ss_pred             h---------------hhcCCChhhhhchhccCCccccccc
Q 039799          320 N---------------DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       320 ~---------------~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      .               ..++..+.+++.+||..||.+|||+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~  280 (309)
T cd07872         240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISA  280 (309)
T ss_pred             hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCH
Confidence            0               1134467899999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=3e-39  Score=281.73  Aligned_cols=238  Identities=26%  Similarity=0.373  Sum_probs=200.4

Q ss_pred             CCCCCCCCcccccCceEEEEEEEcC-CCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEec
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEY  180 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  180 (346)
                      .++|.+.+.||+|++|.||+|.+.+ ++.+++|.+.....  .+.+.+|++++++++|||++++++++......++++||
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   79 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY   79 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence            3678999999999999999999874 88999999865432  67889999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccc
Q 039799          181 MPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  260 (346)
Q Consensus       181 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~  260 (346)
                      +++++|.+++......+++.....++.+++.|+.|||   +.+++|+||+|+||++++++.++|+|||++........  
T Consensus        80 ~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--  154 (256)
T cd06612          80 CGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--  154 (256)
T ss_pred             CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--
Confidence            9999999998766777899999999999999999999   99999999999999999999999999999987643221  


Q ss_pred             ccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHH--HH------HhhhcCCChhhhhc
Q 039799          261 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLK--RW------VNDLLPISVMEVVD  332 (346)
Q Consensus       261 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~--~~------~~~~~~~~~~~~~d  332 (346)
                      ......++..|+|||++.+..++.++||||||++++||++|+.||...........  ..      ....++..+.+++.
T Consensus       155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  234 (256)
T cd06612         155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVK  234 (256)
T ss_pred             ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHH
Confidence            22334578899999999888899999999999999999999999975322111000  00      11123447889999


Q ss_pred             hhccCCcccccccC
Q 039799          333 ANLLSQEDEHFTTK  346 (346)
Q Consensus       333 ~~l~~~p~~R~~~k  346 (346)
                      +|+..+|++||+.+
T Consensus       235 ~~l~~~P~~Rps~~  248 (256)
T cd06612         235 KCLVKDPEERPSAI  248 (256)
T ss_pred             HHHhcChhhCcCHH
Confidence            99999999999863

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-42  Score=278.51  Aligned_cols=239  Identities=22%  Similarity=0.367  Sum_probs=197.3

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC--CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEE
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ--YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALV  177 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  177 (346)
                      +.+.|++-+.||+|.|+.||+.... +|+.+|+|+++..  .....+.+.+|+++.+.++||||+++...+.+....|+|
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv   88 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   88 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence            4567888899999999999998754 7999999988643  334678889999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEEC---CCCcEEEeeecCCccCC
Q 039799          178 LEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFGMAKPLL  254 (346)
Q Consensus       178 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~---~~~~~~l~Dfg~~~~~~  254 (346)
                      +|+|+|++|-.-+-.+ ...++...-....||+++|.|+|   ..+|+|||+||+|+++-   ..--+||+|||+|..+.
T Consensus        89 Fe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~  164 (355)
T KOG0033|consen   89 FDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN  164 (355)
T ss_pred             EecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence            9999999996544322 44666777788999999999999   99999999999999994   34478999999999875


Q ss_pred             ccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccc---------cCcccHHHHHhhhcCC
Q 039799          255 EEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIF---------SGEMTLKRWVNDLLPI  325 (346)
Q Consensus       255 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~---------~~~~~~~~~~~~~~~~  325 (346)
                         .........||++|+|||.....+|+..+|||+.|||||-++.|.+||.+..         .+..+........+.+
T Consensus       165 ---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~  241 (355)
T KOG0033|consen  165 ---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTP  241 (355)
T ss_pred             ---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCH
Confidence               3344567889999999999999999999999999999999999999996511         1111111111233455


Q ss_pred             ChhhhhchhccCCcccccccC
Q 039799          326 SVMEVVDANLLSQEDEHFTTK  346 (346)
Q Consensus       326 ~~~~~~d~~l~~~p~~R~~~k  346 (346)
                      +..+++.+||..||.+|+|++
T Consensus       242 ~Ak~LvrrML~~dP~kRIta~  262 (355)
T KOG0033|consen  242 EAKSLIRRMLTVNPKKRITAD  262 (355)
T ss_pred             HHHHHHHHHhccChhhhccHH
Confidence            889999999999999999874

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=4.5e-40  Score=303.11  Aligned_cols=237  Identities=21%  Similarity=0.273  Sum_probs=189.1

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEE
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVL  178 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  178 (346)
                      ++|.+.+.||+|+||.||+++.. +++.||+|++....   ......+.+|++++++++|+||+++++.+.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            36888999999999999999865 68999999986431   223456778999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccc-
Q 039799          179 EYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED-  257 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~-  257 (346)
                      ||+++|+|.+++... ..++......++.|++.||+|||   +.+|+||||||+|||++.++.++|+|||++..+.... 
T Consensus        81 E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~  156 (376)
T cd05598          81 DYIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  156 (376)
T ss_pred             eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence            999999999988643 45788888889999999999999   9999999999999999999999999999985331000 


Q ss_pred             ----------------------------------------cccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHH
Q 039799          258 ----------------------------------------QSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLME  297 (346)
Q Consensus       258 ----------------------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~e  297 (346)
                                                              .........||+.|+|||++.+..++.++|||||||++||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye  236 (376)
T cd05598         157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE  236 (376)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence                                                    0000113468999999999998899999999999999999


Q ss_pred             HHcCCCCCCccccCcc--cHHHHHh-------hhcCCChhhhhchhccCCcccccc
Q 039799          298 IFTRTKPTDEIFSGEM--TLKRWVN-------DLLPISVMEVVDANLLSQEDEHFT  344 (346)
Q Consensus       298 lltg~~p~~~~~~~~~--~~~~~~~-------~~~~~~~~~~~d~~l~~~p~~R~~  344 (346)
                      |++|+.||......+.  ....|..       ..++....+++.+++ .+|.+|+.
T Consensus       237 ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~  291 (376)
T cd05598         237 MLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLG  291 (376)
T ss_pred             hhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCC
Confidence            9999999975332111  1111111       112336678888855 69999983

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.5e-39  Score=297.50  Aligned_cols=194  Identities=23%  Similarity=0.268  Sum_probs=167.2

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEe
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLE  179 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  179 (346)
                      ....|.+.+.||+|+||.||++... +++.||+|...      .+.+.+|++++++++||||+++++++......++|+|
T Consensus        90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e  163 (391)
T PHA03212         90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP  163 (391)
T ss_pred             ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence            3457999999999999999999865 78999999743      2346789999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccc
Q 039799          180 YMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  259 (346)
Q Consensus       180 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~  259 (346)
                      ++. ++|..++... ..+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.++|+|||+++....... 
T Consensus       164 ~~~-~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~-  237 (391)
T PHA03212        164 RYK-TDLYCYLAAK-RNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA-  237 (391)
T ss_pred             cCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc-
Confidence            995 6888777533 45889999999999999999999   99999999999999999999999999999975432211 


Q ss_pred             cccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCC
Q 039799          260 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTD  306 (346)
Q Consensus       260 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~  306 (346)
                      .......||+.|+|||++.+..++.++|||||||++|||+||+.|+-
T Consensus       238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~  284 (391)
T PHA03212        238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLF  284 (391)
T ss_pred             cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence            12234569999999999998899999999999999999999998763

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=4.6e-39  Score=285.35  Aligned_cols=234  Identities=24%  Similarity=0.341  Sum_probs=193.2

Q ss_pred             CCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEec
Q 039799          105 ANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEY  180 (346)
Q Consensus       105 ~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  180 (346)
                      |...+.||+|+||.||++... +++.+|+|.+....   ......+..|+.++++++|++++++.+.+...+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            667788999999999999866 78999999986432   12234567899999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccc
Q 039799          181 MPHGSLEKCLYLSN-YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  259 (346)
Q Consensus       181 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~  259 (346)
                      +++++|.+++.... ..+++..+..++.|++.||.|||   +.+++||||||+||++++++.++|+|||++.......  
T Consensus        82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~--  156 (285)
T cd05630          82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ--  156 (285)
T ss_pred             cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--
Confidence            99999999885433 46889999999999999999999   9999999999999999999999999999987643221  


Q ss_pred             cccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCc--ccH-------HHHHhhhcCCChhhh
Q 039799          260 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE--MTL-------KRWVNDLLPISVMEV  330 (346)
Q Consensus       260 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~--~~~-------~~~~~~~~~~~~~~~  330 (346)
                       ......|+..|+|||.+.+..++.++||||||+++|||++|+.||.......  ...       .......++..+.++
T Consensus       157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  235 (285)
T cd05630         157 -TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSL  235 (285)
T ss_pred             -cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHH
Confidence             1223468999999999988889999999999999999999999997532211  011       111112244478999


Q ss_pred             hchhccCCcccccc
Q 039799          331 VDANLLSQEDEHFT  344 (346)
Q Consensus       331 ~d~~l~~~p~~R~~  344 (346)
                      +.+||..||++|++
T Consensus       236 i~~~l~~~p~~R~s  249 (285)
T cd05630         236 CKMLLCKDPKERLG  249 (285)
T ss_pred             HHHHhhcCHHHccC
Confidence            99999999999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-40  Score=270.99  Aligned_cols=243  Identities=21%  Similarity=0.276  Sum_probs=199.0

Q ss_pred             CCCCCCCCcccccCceEEEEEE-EcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecC-----Ccee
Q 039799          102 PNDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSND-----DFKA  175 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~  175 (346)
                      .++|.+.+.+|+|+|+.||+++ ..++..||+|++.-......+...+|++..++++|||+++++++...+     ...|
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y   99 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY   99 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence            4579999999999999999998 668899999998876666778899999999999999999999877543     3589


Q ss_pred             EEEecCCCCChhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCcc
Q 039799          176 LVLEYMPHGSLEKCLYL---SNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  252 (346)
Q Consensus       176 lv~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~  252 (346)
                      ++++|...|||.+.+..   ++..++..+.+.++.++.+||++||.. .++++||||||.|||+.+++.+++.|||.+..
T Consensus       100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~  178 (302)
T KOG2345|consen  100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQ  178 (302)
T ss_pred             EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccc
Confidence            99999999999998864   345789999999999999999999922 33599999999999999999999999999987


Q ss_pred             CCccc-------cccccccccCCcccccCCCCC---CCCCCcchhHHHHHHHHHHHHcCCCCCCccccCccc--------
Q 039799          253 LLEED-------QSLTQTQTLATIGYMAPEYGR---EGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMT--------  314 (346)
Q Consensus       253 ~~~~~-------~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~--------  314 (346)
                      ..-.-       .-........|..|.|||.+.   +...++++|||||||+||+|+.|..||+.....+..        
T Consensus       179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~  258 (302)
T KOG2345|consen  179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNA  258 (302)
T ss_pred             cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeecc
Confidence            53110       011122334789999999875   345689999999999999999999999876543321        


Q ss_pred             -HHHHHhhhcCCChhhhhchhccCCccccccc
Q 039799          315 -LKRWVNDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       315 -~~~~~~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                       ..-|-...+++.+.+++..||..||.+||++
T Consensus       259 q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i  290 (302)
T KOG2345|consen  259 QISIPNSSRYSEALHQLIKSMLQVDPNQRPTI  290 (302)
T ss_pred             ccccCCCCCccHHHHHHHHHHhcCCcccCCCH
Confidence             1222233456689999999999999999985

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=3.8e-39  Score=288.22  Aligned_cols=239  Identities=23%  Similarity=0.385  Sum_probs=195.6

Q ss_pred             CCCCCCCcccccCceEEEEEEEc------CCCEEEEEEecCCC-chhHHHHHHHHHHHHhc-CCCCceeeEEEEecCCce
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ------DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRI-CHRNLIKIISSYSNDDFK  174 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  174 (346)
                      ++|.+.+.||+|+||.||++...      .+..+|+|.+.... ....+.+.+|+++++++ +||||+++++++...+..
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  114 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI  114 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence            56888999999999999999742      34579999987543 33456788999999999 799999999999999999


Q ss_pred             eEEEecCCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccC
Q 039799          175 ALVLEYMPHGSLEKCLYLSN-YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  253 (346)
Q Consensus       175 ~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~  253 (346)
                      +++|||+++++|.+++.... ..+++.++..++.+++.||+|||   +.+++|+||||+||+++.++.++++|||+++.+
T Consensus       115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~  191 (302)
T cd05055         115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARDI  191 (302)
T ss_pred             EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCcccccc
Confidence            99999999999999986543 34899999999999999999999   999999999999999999999999999999866


Q ss_pred             CccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHhh--------hcC
Q 039799          254 LEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVND--------LLP  324 (346)
Q Consensus       254 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~--------~~~  324 (346)
                      .............++..|+|||.+.+..++.++||||||+++|||+| |..||......+ .....+..        ..+
T Consensus       192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~  270 (302)
T cd05055         192 MNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS-KFYKLIKEGYRMAQPEHAP  270 (302)
T ss_pred             cCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH-HHHHHHHcCCcCCCCCCCC
Confidence            43322112222345778999999988889999999999999999998 999987543221 12222221        223


Q ss_pred             CChhhhhchhccCCccccccc
Q 039799          325 ISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       325 ~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ..+.+++.+|+..+|++||+.
T Consensus       271 ~~~~~li~~cl~~~p~~Rpt~  291 (302)
T cd05055         271 AEIYDIMKTCWDADPLKRPTF  291 (302)
T ss_pred             HHHHHHHHHHcCCCchhCcCH
Confidence            477899999999999999986

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.7e-39  Score=280.00  Aligned_cols=238  Identities=23%  Similarity=0.324  Sum_probs=194.9

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC-----chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeE
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY-----EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKAL  176 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  176 (346)
                      +.|...+.||+|++|.||.+... +++.+|+|.+....     ....+.+.+|++++++++||||+++++++...+..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            46889999999999999999865 68999999886432     1224567889999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcc
Q 039799          177 VLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  256 (346)
Q Consensus       177 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~  256 (346)
                      ++||+++++|.+.+... ..++......++.+++.|++|||   +.+++|+||+|+||++++++.++|+|||+++.....
T Consensus        82 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~  157 (263)
T cd06625          82 FMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI  157 (263)
T ss_pred             EEEECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence            99999999999988643 45788888999999999999999   999999999999999999999999999999865332


Q ss_pred             cccc-ccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHH--------HhhhcCCCh
Q 039799          257 DQSL-TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRW--------VNDLLPISV  327 (346)
Q Consensus       257 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~--------~~~~~~~~~  327 (346)
                      .... ......++..|+|||...+..++.++||||+|+++||+++|+.||....... .....        .....+..+
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  236 (263)
T cd06625         158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA-AIFKIATQPTNPQLPSHVSPDA  236 (263)
T ss_pred             ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH-HHHHHhccCCCCCCCccCCHHH
Confidence            1111 1123457889999999998889999999999999999999999996532111 11111        112234477


Q ss_pred             hhhhchhccCCccccccc
Q 039799          328 MEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       328 ~~~~d~~l~~~p~~R~~~  345 (346)
                      .+++.+|+..+|++||+.
T Consensus       237 ~~li~~~l~~~p~~Rpt~  254 (263)
T cd06625         237 RNFLRRTFVENAKKRPSA  254 (263)
T ss_pred             HHHHHHHhhcCcccCCCH
Confidence            899999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.7e-39  Score=285.02  Aligned_cols=241  Identities=26%  Similarity=0.373  Sum_probs=193.4

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-----CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEec--CCcee
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-----DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSN--DDFKA  175 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~  175 (346)
                      .+|.+.+.||+|+||.||++..+     ++..||+|.+........+.+.+|++++++++|||++++.+++..  ....+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            46788899999999999999742     578999999876665666788999999999999999999998743  44688


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCc
Q 039799          176 LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  255 (346)
Q Consensus       176 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~  255 (346)
                      +|+||+++++|.+++......+++..+..++.+++.||+|||   +.+++||||||+||++++++.++|+|||++.....
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  160 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ  160 (284)
T ss_pred             EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence            999999999999998766667899999999999999999999   99999999999999999999999999999997643


Q ss_pred             ccccccc-ccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccC-------c----cc---HHHHHh
Q 039799          256 EDQSLTQ-TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSG-------E----MT---LKRWVN  320 (346)
Q Consensus       256 ~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~-------~----~~---~~~~~~  320 (346)
                      ....... ....++..|+|||+..+..++.++||||||++++||++|..|+......       .    ..   +...+.
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05081         161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK  240 (284)
T ss_pred             CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHh
Confidence            3221111 1122345699999998888999999999999999999988775432110       0    00   111111


Q ss_pred             --------hhcCCChhhhhchhccCCcccccccC
Q 039799          321 --------DLLPISVMEVVDANLLSQEDEHFTTK  346 (346)
Q Consensus       321 --------~~~~~~~~~~~d~~l~~~p~~R~~~k  346 (346)
                              ..++..+.+++.+|+..+|++|||++
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~  274 (284)
T cd05081         241 NNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFS  274 (284)
T ss_pred             cCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHH
Confidence                    12234789999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=7.8e-40  Score=299.71  Aligned_cols=238  Identities=21%  Similarity=0.319  Sum_probs=191.2

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC---CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEE
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ---YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVL  178 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  178 (346)
                      ++|++.+.||+|+||.||++... +++.||+|++...   .......+..|++++.+++|||++++++.+...+..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            36788899999999999999866 6899999998642   1233467778999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccc
Q 039799          179 EYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  258 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~  258 (346)
                      ||+++|+|.+++.. ...++......++.|++.||+|||   +.+|+||||||+|||++.++.++|+|||++..+.....
T Consensus        81 E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~  156 (360)
T cd05627          81 EFLPGGDMMTLLMK-KDTLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR  156 (360)
T ss_pred             eCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence            99999999998864 345888889999999999999999   99999999999999999999999999999875532110


Q ss_pred             c---------------------------------cccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCC
Q 039799          259 S---------------------------------LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPT  305 (346)
Q Consensus       259 ~---------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~  305 (346)
                      .                                 .......||+.|+|||++.+..++.++|||||||++|||+||+.||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf  236 (360)
T cd05627         157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF  236 (360)
T ss_pred             cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence            0                                 0011346899999999999899999999999999999999999999


Q ss_pred             CccccCcc--cHHHHHhh-------hcCCChhhhhchhccCCccccccc
Q 039799          306 DEIFSGEM--TLKRWVND-------LLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       306 ~~~~~~~~--~~~~~~~~-------~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ......+.  ....|...       .++....+++.+++ .+|++|++.
T Consensus       237 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~  284 (360)
T cd05627         237 CSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGS  284 (360)
T ss_pred             CCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCC
Confidence            75332111  01111100       12336678888866 599999863

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=6.6e-39  Score=283.86  Aligned_cols=235  Identities=25%  Similarity=0.361  Sum_probs=195.1

Q ss_pred             CCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecCCC
Q 039799          105 ANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPH  183 (346)
Q Consensus       105 ~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  183 (346)
                      |++.+.||+|++|.||+|... ++..+++|.+........+.+.+|+++++.++|||++++++++...+..++|+||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            567788999999999999976 5788999998766555667888999999999999999999999999999999999999


Q ss_pred             CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccccc
Q 039799          184 GSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT  263 (346)
Q Consensus       184 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~~  263 (346)
                      ++|..++......+++..+..++.+++.||.|||   +.+++||||+|+||+++.++.++|+|||++.......  ....
T Consensus        87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~~~  161 (282)
T cd06643          87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRD  161 (282)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEccccccccccccc--cccc
Confidence            9999887665667899999999999999999999   9999999999999999999999999999987653221  1123


Q ss_pred             cccCCcccccCCCCC-----CCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH---------hhhcCCChhh
Q 039799          264 QTLATIGYMAPEYGR-----EGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV---------NDLLPISVME  329 (346)
Q Consensus       264 ~~~~~~~y~aPE~~~-----~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~---------~~~~~~~~~~  329 (346)
                      ...++..|+|||++.     +..++.++|||||||++|||++|+.||......+. .....         ...++..+.+
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  240 (282)
T cd06643         162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV-LLKIAKSEPPTLAQPSRWSSEFKD  240 (282)
T ss_pred             cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH-HHHHhhcCCCCCCCccccCHHHHH
Confidence            345889999999873     34577899999999999999999999875322111 11111         1123457899


Q ss_pred             hhchhccCCccccccc
Q 039799          330 VVDANLLSQEDEHFTT  345 (346)
Q Consensus       330 ~~d~~l~~~p~~R~~~  345 (346)
                      ++.+||..+|.+||+.
T Consensus       241 li~~~l~~~p~~Rp~~  256 (282)
T cd06643         241 FLKKCLEKNVDARWTT  256 (282)
T ss_pred             HHHHHccCChhhCcCH
Confidence            9999999999999985

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=9e-39  Score=282.60  Aligned_cols=230  Identities=25%  Similarity=0.330  Sum_probs=190.7

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecC
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYM  181 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  181 (346)
                      +|.+.+.||+|++|.||+|... +++.+|+|++.... ....+.+.+|++++++++|||++++++++...+..++||||+
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   81 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM   81 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence            5778899999999999999864 78999999986542 334467889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccc
Q 039799          182 PHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT  261 (346)
Q Consensus       182 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~  261 (346)
                      ++++|..+.     .+++.....++.+++.|+.|||   +.+++|+||||+||+++.++.++|+|||++......    .
T Consensus        82 ~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~----~  149 (279)
T cd06619          82 DGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----I  149 (279)
T ss_pred             CCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc----c
Confidence            999996542     3678888899999999999999   999999999999999999999999999999865322    1


Q ss_pred             cccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcc-----cHHHHHh---------hhcCCCh
Q 039799          262 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM-----TLKRWVN---------DLLPISV  327 (346)
Q Consensus       262 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~-----~~~~~~~---------~~~~~~~  327 (346)
                      .....++..|+|||++.+..++.++||||||+++|||++|+.||........     ...+...         ...+..+
T Consensus       150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (279)
T cd06619         150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKF  229 (279)
T ss_pred             ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHH
Confidence            2335688999999999988899999999999999999999999975432211     1111111         1123367


Q ss_pred             hhhhchhccCCccccccc
Q 039799          328 MEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       328 ~~~~d~~l~~~p~~R~~~  345 (346)
                      .+++.+|+..+|++||+.
T Consensus       230 ~~li~~~l~~~P~~Rp~~  247 (279)
T cd06619         230 VHFITQCMRKQPKERPAP  247 (279)
T ss_pred             HHHHHHHhhCChhhCCCH
Confidence            899999999999999985

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-38  Score=278.44  Aligned_cols=232  Identities=30%  Similarity=0.499  Sum_probs=196.3

Q ss_pred             CcccccCceEEEEEEEcC----CCEEEEEEecCCCch-hHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecCCC
Q 039799          109 PLIGKGGFGSVYKAIIQD----GMEVAVKVFDPQYEG-AFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPH  183 (346)
Q Consensus       109 ~~lg~G~~g~vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  183 (346)
                      +.||+|+||.||+|....    +..+++|.+...... ..+.+.+|++.+..++|+|++++++++......+++|||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            468999999999999763    789999998765433 367888999999999999999999999999999999999999


Q ss_pred             CChhhhhhhc--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCc
Q 039799          184 GSLEKCLYLS--------NYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  255 (346)
Q Consensus       184 gsL~~~l~~~--------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~  255 (346)
                      ++|.+++...        ...+++..++.++.+++.|++|||   +.+++|+||+|+||++++++.++|+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999998765        467899999999999999999999   99999999999999999999999999999997654


Q ss_pred             cccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHh--------hhcCCC
Q 039799          256 EDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVN--------DLLPIS  326 (346)
Q Consensus       256 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~--------~~~~~~  326 (346)
                      ...........++..|+|||......++.++||||+|++++||++ |..||+....  ....+.+.        ..++..
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  235 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN--EEVLEYLRKGYRLPKPEYCPDE  235 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHHcCCCCCCCccCChH
Confidence            332222334557889999999888889999999999999999999 6999976421  12222222        223458


Q ss_pred             hhhhhchhccCCccccccc
Q 039799          327 VMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       327 ~~~~~d~~l~~~p~~R~~~  345 (346)
                      +.+++.+|+..+|++||++
T Consensus       236 ~~~li~~~l~~~p~~Rps~  254 (262)
T cd00192         236 LYELMLSCWQLDPEDRPTF  254 (262)
T ss_pred             HHHHHHHHccCCcccCcCH
Confidence            8999999999999999986

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-39  Score=280.67  Aligned_cols=238  Identities=25%  Similarity=0.329  Sum_probs=199.4

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEec
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEY  180 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  180 (346)
                      .++|.+.+.||+|++|.||+|... +++.+++|++........+.+.+|++++++++|||++++++++...+..+++|||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            357888999999999999999875 6789999999866555667889999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccc
Q 039799          181 MPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  260 (346)
Q Consensus       181 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~  260 (346)
                      +++++|.+++......++...+..++.+++.|++|||   +.+++|+||+|+||++++++.++|+|||.+.......  .
T Consensus        82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~  156 (262)
T cd06613          82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--A  156 (262)
T ss_pred             CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhhh--h
Confidence            9999999988766567899999999999999999999   9999999999999999999999999999988654321  1


Q ss_pred             ccccccCCcccccCCCCCCC---CCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH-----------hhhcCCC
Q 039799          261 TQTQTLATIGYMAPEYGREG---RVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV-----------NDLLPIS  326 (346)
Q Consensus       261 ~~~~~~~~~~y~aPE~~~~~---~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~-----------~~~~~~~  326 (346)
                      ......++..|+|||.....   .++.++|+||||++++||+||+.||........ .....           ...++..
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  235 (262)
T cd06613         157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA-LFLISKSNFPPPKLKDKEKWSPV  235 (262)
T ss_pred             ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhccCCCccccchhhhhHH
Confidence            12334578899999998776   788999999999999999999999975321111 11111           1122346


Q ss_pred             hhhhhchhccCCccccccc
Q 039799          327 VMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       327 ~~~~~d~~l~~~p~~R~~~  345 (346)
                      +.+++.+|+..+|.+||+.
T Consensus       236 ~~~li~~~l~~~p~~Rpt~  254 (262)
T cd06613         236 FHDFIKKCLTKDPKKRPTA  254 (262)
T ss_pred             HHHHHHHHcCCChhhCCCH
Confidence            7899999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.4e-39  Score=298.82  Aligned_cols=239  Identities=22%  Similarity=0.271  Sum_probs=192.0

Q ss_pred             CCCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC---CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCcee
Q 039799          100 PLPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ---YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKA  175 (346)
Q Consensus       100 ~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  175 (346)
                      ...++|.+.+.||+|+||.||++... +++.||+|++...   .......+.+|+++++.++||||+++++++...+..+
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~  119 (370)
T cd05596          40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY  119 (370)
T ss_pred             CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            34567999999999999999999876 6889999998642   1223355778999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCc
Q 039799          176 LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  255 (346)
Q Consensus       176 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~  255 (346)
                      +||||+++|+|.+++...  .++......++.+++.||+|||   +.+|+||||||+|||++.++.++|+|||++.....
T Consensus       120 lv~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~  194 (370)
T cd05596         120 MVMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA  194 (370)
T ss_pred             EEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence            999999999999988543  4777788889999999999999   99999999999999999999999999999986543


Q ss_pred             cccccccccccCCcccccCCCCCCC----CCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh----------h
Q 039799          256 EDQSLTQTQTLATIGYMAPEYGREG----RVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN----------D  321 (346)
Q Consensus       256 ~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~----------~  321 (346)
                      ... .......||+.|+|||.+.+.    .++.++|||||||++|||++|+.||...... ........          .
T Consensus       195 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~  272 (370)
T cd05596         195 NGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-GTYSKIMDHKNSLTFPDDI  272 (370)
T ss_pred             CCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH-HHHHHHHcCCCcCCCCCcC
Confidence            221 122345699999999987643    4788999999999999999999999753211 11111111          0


Q ss_pred             hcCCChhhhhchhccCCccc--cccc
Q 039799          322 LLPISVMEVVDANLLSQEDE--HFTT  345 (346)
Q Consensus       322 ~~~~~~~~~~d~~l~~~p~~--R~~~  345 (346)
                      .++..+.+++.++|..+|++  |+++
T Consensus       273 ~~s~~~~~li~~~L~~~p~r~~R~s~  298 (370)
T cd05596         273 EISKQAKDLICAFLTDREVRLGRNGV  298 (370)
T ss_pred             CCCHHHHHHHHHHccChhhccCCCCH
Confidence            12346788999999988876  7764

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-39  Score=282.70  Aligned_cols=235  Identities=26%  Similarity=0.328  Sum_probs=196.6

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecC
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYM  181 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  181 (346)
                      +|.+.+.||.|++|.||+|... +++.+|+|++.... ......+.+|+++++.++|+|++++.+++.+....++|+||+
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC   81 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence            5778899999999999999876 68899999987543 344567888999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccc
Q 039799          182 PHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT  261 (346)
Q Consensus       182 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~  261 (346)
                      ++++|.+++...  .+++.....++.+++.|+.|||   +.+++|+||+|+||++++++.++|+|||+++.+....  ..
T Consensus        82 ~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~  154 (274)
T cd06609          82 GGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--SK  154 (274)
T ss_pred             CCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeecccc--cc
Confidence            999999988654  6899999999999999999999   9999999999999999999999999999998764322  12


Q ss_pred             cccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccH------HHHHhhh-cCCChhhhhchh
Q 039799          262 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTL------KRWVNDL-LPISVMEVVDAN  334 (346)
Q Consensus       262 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~------~~~~~~~-~~~~~~~~~d~~  334 (346)
                      .....++..|+|||+..+..++.++||||||+++|||+||+.||..........      ...+... ++..+.+++.+|
T Consensus       155 ~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  234 (274)
T cd06609         155 RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLC  234 (274)
T ss_pred             cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHH
Confidence            233457889999999988889999999999999999999999997532211100      0000111 445689999999


Q ss_pred             ccCCccccccc
Q 039799          335 LLSQEDEHFTT  345 (346)
Q Consensus       335 l~~~p~~R~~~  345 (346)
                      |..+|++||+.
T Consensus       235 l~~~p~~Rpt~  245 (274)
T cd06609         235 LNKDPKERPSA  245 (274)
T ss_pred             hhCChhhCcCH
Confidence            99999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=8.2e-39  Score=278.13  Aligned_cols=231  Identities=28%  Similarity=0.391  Sum_probs=191.1

Q ss_pred             CcccccCceEEEEEEEcCCCEEEEEEecCCCc-hhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecCCCCChh
Q 039799          109 PLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYE-GAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLE  187 (346)
Q Consensus       109 ~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~  187 (346)
                      ++||+|++|.||+|...++..+|+|.+..... .....+.+|++++++++|||++++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            36899999999999988889999999876543 23456888999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccccccccC
Q 039799          188 KCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA  267 (346)
Q Consensus       188 ~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~  267 (346)
                      +++......+++..+..++.+++.+|.|||   +.+++||||+|+||++++++.++|+|||++........ .......+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~  156 (250)
T cd05085          81 SFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGLKQI  156 (250)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceecccccc-ccCCCCCC
Confidence            988766667899999999999999999999   99999999999999999999999999999875432211 11112234


Q ss_pred             CcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHH--------hhhcCCChhhhhchhccCC
Q 039799          268 TIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWV--------NDLLPISVMEVVDANLLSQ  338 (346)
Q Consensus       268 ~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~~d~~l~~~  338 (346)
                      +..|+|||+.....++.++||||||+++||+++ |..||.......  ....+        ...++..+.+++.+|+..+
T Consensus       157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  234 (250)
T cd05085         157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ--AREQVEKGYRMSCPQKCPDDVYKVMQRCWDYK  234 (250)
T ss_pred             cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH--HHHHHHcCCCCCCCCCCCHHHHHHHHHHcccC
Confidence            667999999988889999999999999999998 999996532211  11111        1123457899999999999


Q ss_pred             ccccccc
Q 039799          339 EDEHFTT  345 (346)
Q Consensus       339 p~~R~~~  345 (346)
                      |++||+.
T Consensus       235 p~~Rp~~  241 (250)
T cd05085         235 PENRPKF  241 (250)
T ss_pred             cccCCCH
Confidence            9999985

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=7.7e-39  Score=281.09  Aligned_cols=238  Identities=24%  Similarity=0.322  Sum_probs=194.8

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEec
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEY  180 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  180 (346)
                      ..+|.+.+.||+|+||.||+|... +++.+|+|++..........+.+|+.++++++|||++++++++...+..++|+||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            457999999999999999999964 7889999998755444556778899999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccc
Q 039799          181 MPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  260 (346)
Q Consensus       181 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~  260 (346)
                      +++++|.+++.. ...+++..+..++.|++.|+.|||   +.+|+|||++|+||++++++.++|+|||++.......  .
T Consensus        88 ~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--~  161 (267)
T cd06646          88 CGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI--A  161 (267)
T ss_pred             CCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeecccc--c
Confidence            999999998864 346789999999999999999999   9999999999999999999999999999998653221  1


Q ss_pred             ccccccCCcccccCCCCC---CCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccH---------HHH-HhhhcCCCh
Q 039799          261 TQTQTLATIGYMAPEYGR---EGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTL---------KRW-VNDLLPISV  327 (346)
Q Consensus       261 ~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~---------~~~-~~~~~~~~~  327 (346)
                      ......++..|+|||.+.   ...++.++||||||++++||++|+.|+......+...         ..+ ....++..+
T Consensus       162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (267)
T cd06646         162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTF  241 (267)
T ss_pred             ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHH
Confidence            122345788999999874   3457789999999999999999999985432111100         000 011234578


Q ss_pred             hhhhchhccCCccccccc
Q 039799          328 MEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       328 ~~~~d~~l~~~p~~R~~~  345 (346)
                      .+++.+||..+|++||+.
T Consensus       242 ~~li~~~l~~~P~~Rp~~  259 (267)
T cd06646         242 HNFVKISLTKNPKKRPTA  259 (267)
T ss_pred             HHHHHHHhhCChhhCcCH
Confidence            899999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2.9e-39  Score=283.20  Aligned_cols=236  Identities=26%  Similarity=0.389  Sum_probs=194.9

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecC
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYM  181 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  181 (346)
                      .+|.+.+.||+|++|.||+|.++ .++.+|+|++.... ...+.+.+|++++++++|||++++++++...+..+++|||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            45778889999999999999866 58899999987543 34567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccc
Q 039799          182 PHGSLEKCLYLSN-YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  260 (346)
Q Consensus       182 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~  260 (346)
                      ++++|.+++.... ..+++..++.++.|+++||+|||   +.+++||||||+||++++++.++|+|||++......... 
T Consensus        85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~-  160 (263)
T cd05052          85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-  160 (263)
T ss_pred             CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCccccccccceee-
Confidence            9999999886543 46899999999999999999999   999999999999999999999999999999876432211 


Q ss_pred             ccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHh--------hhcCCChhhhh
Q 039799          261 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVN--------DLLPISVMEVV  331 (346)
Q Consensus       261 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~  331 (346)
                      .......+..|+|||...+..++.++||||||+++|||++ |..|+......  ...+...        ...+..+.+++
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li  238 (263)
T cd05052         161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYELLEKGYRMERPEGCPPKVYELM  238 (263)
T ss_pred             ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHCCCCCCCCCCCCHHHHHHH
Confidence            1112234668999999988889999999999999999998 99998652211  1111111        12334788999


Q ss_pred             chhccCCccccccc
Q 039799          332 DANLLSQEDEHFTT  345 (346)
Q Consensus       332 d~~l~~~p~~R~~~  345 (346)
                      .+|+..+|++||+.
T Consensus       239 ~~cl~~~p~~Rp~~  252 (263)
T cd05052         239 RACWQWNPSDRPSF  252 (263)
T ss_pred             HHHccCCcccCCCH
Confidence            99999999999986

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=8.7e-39  Score=284.24  Aligned_cols=237  Identities=25%  Similarity=0.365  Sum_probs=193.1

Q ss_pred             CCCCCCcccccCceEEEEEEEc------CCCEEEEEEecCCCc-hhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeE
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQ------DGMEVAVKVFDPQYE-GAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKAL  176 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  176 (346)
                      +|.+.+.||+|+||.||+|...      ....+++|.+..... .....+.+|+.+++.++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            3677889999999999999853      235789998865432 345678899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCc
Q 039799          177 VLEYMPHGSLEKCLYLSN-----------------------YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSN  233 (346)
Q Consensus       177 v~e~~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~N  233 (346)
                      ++||+.+++|.+++....                       ..+++...+.++.+++.||+|||   +.+++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhhe
Confidence            999999999999875321                       34788999999999999999999   9999999999999


Q ss_pred             eEECCCCcEEEeeecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCc
Q 039799          234 VLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGE  312 (346)
Q Consensus       234 Ill~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~  312 (346)
                      |++++++.++|+|||+++...............++..|+|||...+..++.++||||||++++||+| |..||.....  
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--  235 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP--  235 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH--
Confidence            9999999999999999986543322222233345778999999888889999999999999999999 9999965321  


Q ss_pred             ccHHHHHhh--------hcCCChhhhhchhccCCccccccc
Q 039799          313 MTLKRWVND--------LLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       313 ~~~~~~~~~--------~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ..+..++..        ..+..+.+++.+|+..+|++||+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~  276 (290)
T cd05045         236 ERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTF  276 (290)
T ss_pred             HHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCH
Confidence            122223222        123478899999999999999986

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=6.1e-39  Score=290.94  Aligned_cols=240  Identities=24%  Similarity=0.394  Sum_probs=192.2

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc------CCCEEEEEEecCCC-chhHHHHHHHHHHHHhc-CCCCceeeEEEEec-CC
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ------DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRI-CHRNLIKIISSYSN-DD  172 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~-~~  172 (346)
                      .++|.+.+.||+|+||.||+|...      +++.||+|++.... ....+.+..|+.++.++ +|+||++++++|.. +.
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            356899999999999999999632      35789999987432 23345677899999999 89999999998764 45


Q ss_pred             ceeEEEecCCCCChhhhhhhcC----------------------------------------------------------
Q 039799          173 FKALVLEYMPHGSLEKCLYLSN----------------------------------------------------------  194 (346)
Q Consensus       173 ~~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------  194 (346)
                      ..++++||+++++|.+++....                                                          
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            6789999999999998875321                                                          


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccccccccCCcccc
Q 039799          195 --YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYM  272 (346)
Q Consensus       195 --~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~  272 (346)
                        ..+++..+..++.+++.||+|||   +.+|+||||||+||++++++.++|+|||+++.+.............++..|+
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence              25789999999999999999999   9999999999999999999999999999998764333222223344677899


Q ss_pred             cCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHh--------hhcCCChhhhhchhccCCccccc
Q 039799          273 APEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVN--------DLLPISVMEVVDANLLSQEDEHF  343 (346)
Q Consensus       273 aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~d~~l~~~p~~R~  343 (346)
                      |||++.+..++.++|||||||++|||++ |..||......+ .......        ...+..+.+++.+|+..+|++||
T Consensus       243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RP  321 (337)
T cd05054         243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-EFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRP  321 (337)
T ss_pred             CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-HHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCc
Confidence            9999999999999999999999999998 999996532221 1111111        11234678999999999999999


Q ss_pred             cc
Q 039799          344 TT  345 (346)
Q Consensus       344 ~~  345 (346)
                      ++
T Consensus       322 s~  323 (337)
T cd05054         322 TF  323 (337)
T ss_pred             CH
Confidence            85

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=8.6e-39  Score=282.69  Aligned_cols=238  Identities=24%  Similarity=0.334  Sum_probs=193.2

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCC----EEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCcee
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGM----EVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKA  175 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  175 (346)
                      .++|.+.+.||+|+||+||+|.+. ++.    .||+|++.... ......+.+|+.+++.+.|||++++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence            457888999999999999999854 444    48999986543 33456788899999999999999999998754 567


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCc
Q 039799          176 LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  255 (346)
Q Consensus       176 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~  255 (346)
                      +++||+++|+|.+++......+++..++.++.+++.||+|||   +.+++||||||+||++++++.++|+|||+++....
T Consensus        85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~  161 (279)
T cd05109          85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI  161 (279)
T ss_pred             EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence            999999999999998766667899999999999999999999   99999999999999999999999999999987643


Q ss_pred             cccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHhhh--------cCCC
Q 039799          256 EDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVNDL--------LPIS  326 (346)
Q Consensus       256 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~--------~~~~  326 (346)
                      ...........++..|+|||...+..++.++||||||+++||+++ |..||+.....  ....++...        .+..
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  239 (279)
T cd05109         162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR--EIPDLLEKGERLPQPPICTID  239 (279)
T ss_pred             ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHCCCcCCCCccCCHH
Confidence            222111222335678999999988889999999999999999998 99998753221  122222221        2336


Q ss_pred             hhhhhchhccCCccccccc
Q 039799          327 VMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       327 ~~~~~d~~l~~~p~~R~~~  345 (346)
                      +.+++.+||..||++||+.
T Consensus       240 ~~~li~~~l~~dp~~Rp~~  258 (279)
T cd05109         240 VYMIMVKCWMIDSECRPRF  258 (279)
T ss_pred             HHHHHHHHcCCChhhCcCH
Confidence            7799999999999999985

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=5e-39  Score=300.98  Aligned_cols=234  Identities=27%  Similarity=0.362  Sum_probs=183.1

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecC--------
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSND--------  171 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--------  171 (346)
                      ...+|.+.+.||+|+||.||+|... +++.||||++....    ....+|+.++++++||||+++.+++...        
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            3457999999999999999999875 68899999885432    2334699999999999999998876432        


Q ss_pred             CceeEEEecCCCCChhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCC-cEEEeee
Q 039799          172 DFKALVLEYMPHGSLEKCLYL---SNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM-VAHLSDF  247 (346)
Q Consensus       172 ~~~~lv~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~-~~~l~Df  247 (346)
                      ...++||||+++ ++.+++..   ....+++.....++.|++.||+|||   +.+|+||||||+|||++.++ .+||+||
T Consensus       140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeecc
Confidence            246689999975 67665542   3456889999999999999999999   99999999999999999654 7999999


Q ss_pred             cCCccCCccccccccccccCCcccccCCCCCC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccCcc-------------
Q 039799          248 GMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM-------------  313 (346)
Q Consensus       248 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~-------------  313 (346)
                      |+++.+.....   .....+|+.|+|||++.+ ..++.++|||||||++|||+||++||......+.             
T Consensus       216 Gla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~  292 (440)
T PTZ00036        216 GSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE  292 (440)
T ss_pred             ccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            99986643221   223467999999998765 4689999999999999999999999965321100             


Q ss_pred             ---------------------cHHHHHhhhcCCChhhhhchhccCCccccccc
Q 039799          314 ---------------------TLKRWVNDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       314 ---------------------~~~~~~~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                                           .+........+..+.+++.+||..||.+||++
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta  345 (440)
T PTZ00036        293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNP  345 (440)
T ss_pred             HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCH
Confidence                                 00111111234467899999999999999986

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.3e-38  Score=285.58  Aligned_cols=197  Identities=24%  Similarity=0.342  Sum_probs=171.9

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEec
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEY  180 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  180 (346)
                      ++|.+.+.||+|+||.||++... ++..+|+|.+.... .....++.+|++++++++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            36888999999999999999866 68889999886543 23346688899999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeeecCCCCCceEECCCCcEEEeeecCCccCCccccc
Q 039799          181 MPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYS-APIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  259 (346)
Q Consensus       181 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~  259 (346)
                      +++++|.+++... ..+++.....++.++++||.|||   + .+++|+||+|+||+++.++.++|+|||++.......  
T Consensus        81 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--  154 (308)
T cd06615          81 MDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--  154 (308)
T ss_pred             cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc--
Confidence            9999999998644 55788889999999999999999   6 589999999999999999999999999987653221  


Q ss_pred             cccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 039799          260 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDE  307 (346)
Q Consensus       260 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~  307 (346)
                        .....++..|+|||...+..++.++|+||||++++||++|+.||..
T Consensus       155 --~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~  200 (308)
T cd06615         155 --ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPP  200 (308)
T ss_pred             --cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence              2234688999999998888899999999999999999999999853

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.5e-40  Score=283.77  Aligned_cols=238  Identities=24%  Similarity=0.346  Sum_probs=202.3

Q ss_pred             CCCCCCCCCCCCcccccCceEEEEEEE-cCCCEEEEEEecCC---CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCc
Q 039799           98 GKPLPNDANMPPLIGKGGFGSVYKAII-QDGMEVAVKVFDPQ---YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDF  173 (346)
Q Consensus        98 ~~~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  173 (346)
                      +..+...|++.+.||+|+||.|-+|.. ..|+.||||.+.+.   .++..-.+.+|+++++.++||||+.+++.|+..+.
T Consensus        48 khnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdK  127 (668)
T KOG0611|consen   48 KHNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDK  127 (668)
T ss_pred             ccchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCce
Confidence            344567799999999999999999984 68999999988654   34455677889999999999999999999999999


Q ss_pred             eeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccC
Q 039799          174 KALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  253 (346)
Q Consensus       174 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~  253 (346)
                      ..+||||..+|.|.+++..+ ..++......+++||.+|+.|+|   ..+++|||+|.+|||+|.++++||+|||++..+
T Consensus       128 IvivMEYaS~GeLYDYiSer-~~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly  203 (668)
T KOG0611|consen  128 IVIVMEYASGGELYDYISER-GSLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLY  203 (668)
T ss_pred             EEEEEEecCCccHHHHHHHh-ccccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhh
Confidence            99999999999999999744 56888888999999999999999   999999999999999999999999999999977


Q ss_pred             CccccccccccccCCcccccCCCCCCCCC-CcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH-hhhc-----CCC
Q 039799          254 LEEDQSLTQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV-NDLL-----PIS  326 (346)
Q Consensus       254 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~-~~~~-----~~~  326 (346)
                      ...   ....+.+|++.|.+||...+.+| ++.+|-||+||+||-++.|..|||..  +...+.+.+ +..+     |..
T Consensus       204 ~~~---kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~--Dhk~lvrQIs~GaYrEP~~PSd  278 (668)
T KOG0611|consen  204 ADK---KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR--DHKRLVRQISRGAYREPETPSD  278 (668)
T ss_pred             ccc---cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc--hHHHHHHHhhcccccCCCCCch
Confidence            543   33456789999999999998887 68999999999999999999999872  122222222 2222     336


Q ss_pred             hhhhhchhccCCcccccc
Q 039799          327 VMEVVDANLLSQEDEHFT  344 (346)
Q Consensus       327 ~~~~~d~~l~~~p~~R~~  344 (346)
                      ..-+|.-+|.++|+.|-|
T Consensus       279 A~gLIRwmLmVNP~RRAT  296 (668)
T KOG0611|consen  279 ASGLIRWMLMVNPERRAT  296 (668)
T ss_pred             HHHHHHHHHhcCcccchh
Confidence            778999999999999876

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.4e-39  Score=277.97  Aligned_cols=236  Identities=28%  Similarity=0.391  Sum_probs=192.0

Q ss_pred             CCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCC-ceeeEEEEecCC------ce
Q 039799          105 ANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRN-LIKIISSYSNDD------FK  174 (346)
Q Consensus       105 ~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~------~~  174 (346)
                      |...+.||+|+||+||+|..+ +|+.||+|++.-..  ++......+|+.+++.++|+| |+.+.+++...+      ..
T Consensus        13 ~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l   92 (323)
T KOG0594|consen   13 YEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKL   92 (323)
T ss_pred             HHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceE
Confidence            555567999999999999865 78999999986543  345667788999999999999 999999998776      88


Q ss_pred             eEEEecCCCCChhhhhhhcC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCc
Q 039799          175 ALVLEYMPHGSLEKCLYLSN---YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAK  251 (346)
Q Consensus       175 ~lv~e~~~~gsL~~~l~~~~---~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~  251 (346)
                      ++|+||+ ..+|..++....   ..++...+..++.|+++|++|||   +.+|+||||||.|||++++|.+||+|||+|+
T Consensus        93 ~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAr  168 (323)
T KOG0594|consen   93 YLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFGLAR  168 (323)
T ss_pred             EEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccchHH
Confidence            8999999 458999887655   35777889999999999999999   9999999999999999999999999999999


Q ss_pred             cCCccccccccccccCCcccccCCCCCCC-CCCcchhHHHHHHHHHHHHcCCCCCCcccc--------------Ccc---
Q 039799          252 PLLEEDQSLTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMEIFTRTKPTDEIFS--------------GEM---  313 (346)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~--------------~~~---  313 (346)
                      ...-+.  ...+..++|.+|.|||.+.+. .|+...||||+|||+.||+++++-|....+              ++.   
T Consensus       169 a~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp  246 (323)
T KOG0594|consen  169 AFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWP  246 (323)
T ss_pred             HhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCC
Confidence            654222  224556789999999998877 689999999999999999999988754211              111   


Q ss_pred             ----------cHHHHH-----hhhcC---CChhhhhchhccCCcccccccC
Q 039799          314 ----------TLKRWV-----NDLLP---ISVMEVVDANLLSQEDEHFTTK  346 (346)
Q Consensus       314 ----------~~~~~~-----~~~~~---~~~~~~~d~~l~~~p~~R~~~k  346 (346)
                                ...+|.     ...++   .+..|++.++|..+|.+|.|++
T Consensus       247 ~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~  297 (323)
T KOG0594|consen  247 GVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAK  297 (323)
T ss_pred             CccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHH
Confidence                      111221     11122   2778999999999999999874

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.9e-38  Score=277.19  Aligned_cols=230  Identities=23%  Similarity=0.397  Sum_probs=187.0

Q ss_pred             cccccCceEEEEEEEc---CCCEEEEEEecCCCc-hhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecCCCCC
Q 039799          110 LIGKGGFGSVYKAIIQ---DGMEVAVKVFDPQYE-GAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGS  185 (346)
Q Consensus       110 ~lg~G~~g~vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  185 (346)
                      .||+|+||.||+|.+.   .+..+|+|++..... ...+.+.+|+.++++++||||+++++.+. .+..++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            3899999999999864   355799999875533 33467889999999999999999999885 457789999999999


Q ss_pred             hhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccc-ccccc
Q 039799          186 LEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS-LTQTQ  264 (346)
Q Consensus       186 L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~  264 (346)
                      |.+++......+++..+++++.+++.|++|||   +.+++||||||+||+++.++.++|+|||++......... .....
T Consensus        81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  157 (257)
T cd05115          81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA  157 (257)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence            99998766677899999999999999999999   999999999999999999999999999999865432221 11122


Q ss_pred             ccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHhh--------hcCCChhhhhchhc
Q 039799          265 TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVND--------LLPISVMEVVDANL  335 (346)
Q Consensus       265 ~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~d~~l  335 (346)
                      ..++..|+|||......++.++||||||+++||+++ |+.||......  .....+..        ..+..+.+++.+|+
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~c~  235 (257)
T cd05115         158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP--EVMSFIEQGKRLDCPAECPPEMYALMKDCW  235 (257)
T ss_pred             CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHHHCCCCCCCCCCCCHHHHHHHHHHc
Confidence            224578999999888889999999999999999996 99999764321  12222221        22447889999999


Q ss_pred             cCCccccccc
Q 039799          336 LSQEDEHFTT  345 (346)
Q Consensus       336 ~~~p~~R~~~  345 (346)
                      ..+|++||+.
T Consensus       236 ~~~~~~Rp~~  245 (257)
T cd05115         236 IYKWEDRPNF  245 (257)
T ss_pred             CCChhhCcCH
Confidence            9999999984

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.6e-39  Score=285.34  Aligned_cols=239  Identities=26%  Similarity=0.402  Sum_probs=191.7

Q ss_pred             CCCCCCCcccccCceEEEEEEEcC---------------CCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEE
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQD---------------GMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIIS  166 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~~---------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~  166 (346)
                      ++|.+.+.||+|+||.||++....               ...||+|.+.... ......+.+|++++++++|+|++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            568899999999999999987542               2358999987543 334567889999999999999999999


Q ss_pred             EEecCCceeEEEecCCCCChhhhhhhcC-----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceE
Q 039799          167 SYSNDDFKALVLEYMPHGSLEKCLYLSN-----------YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVL  235 (346)
Q Consensus       167 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIl  235 (346)
                      ++...+..++||||+++++|.+++....           ..+++..++.++.+++.|++|||   +.+++||||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhEE
Confidence            9999999999999999999999885432           24688899999999999999999   999999999999999


Q ss_pred             ECCCCcEEEeeecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc--CCCCCCccccCcc
Q 039799          236 LDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT--RTKPTDEIFSGEM  313 (346)
Q Consensus       236 l~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt--g~~p~~~~~~~~~  313 (346)
                      +++++.++|+|||++................++..|+|||....+.++.++||||||++++||++  |..||+...... 
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~-  240 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ-  240 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH-
Confidence            99999999999999986543322222223345778999999988889999999999999999998  667776532211 


Q ss_pred             cHHHH---H-----------hhhcCCChhhhhchhccCCccccccc
Q 039799          314 TLKRW---V-----------NDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       314 ~~~~~---~-----------~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      .....   .           ....+..+.+++.+|+..+|++||+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~  286 (295)
T cd05097         241 VIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTF  286 (295)
T ss_pred             HHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCH
Confidence            11100   0           11123468899999999999999985

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=9e-39  Score=281.85  Aligned_cols=225  Identities=23%  Similarity=0.347  Sum_probs=182.4

Q ss_pred             cccccCceEEEEEEEcC-------------------------CCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceee
Q 039799          110 LIGKGGFGSVYKAIIQD-------------------------GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKI  164 (346)
Q Consensus       110 ~lg~G~~g~vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~  164 (346)
                      .||+|+||.||+|.+..                         ...|++|++..........+.+|+.++++++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            58999999999997531                         13588999876544455678889999999999999999


Q ss_pred             EEEEecCCceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCC----
Q 039799          165 ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM----  240 (346)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~----  240 (346)
                      ++++.+....++||||+++++|..++......+++..+..++.|+++||+|||   +.+|+||||||+||+++..+    
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccCcccC
Confidence            99999999999999999999999988766667899999999999999999999   99999999999999997543    


Q ss_pred             ---cEEEeeecCCccCCccccccccccccCCcccccCCCCCC-CCCCcchhHHHHHHHHHHHH-cCCCCCCccccCcccH
Q 039799          241 ---VAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMEIF-TRTKPTDEIFSGEMTL  315 (346)
Q Consensus       241 ---~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~G~il~ell-tg~~p~~~~~~~~~~~  315 (346)
                         .++++|||.+......      ....++..|+|||.+.+ ..++.++||||||+++||++ +|+.||......+  .
T Consensus       159 ~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~  230 (274)
T cd05076         159 TSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE--K  230 (274)
T ss_pred             ccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH--H
Confidence               4799999988643221      12346788999998865 56899999999999999994 7999997643222  1


Q ss_pred             HHHHhhh------cCCChhhhhchhccCCccccccc
Q 039799          316 KRWVNDL------LPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       316 ~~~~~~~------~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ..+....      ....+.+++.+||..+|++||+.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~  266 (274)
T cd05076         231 ERFYEKKHRLPEPSCKELATLISQCLTYEPTQRPSF  266 (274)
T ss_pred             HHHHHhccCCCCCCChHHHHHHHHHcccChhhCcCH
Confidence            1222211      12368899999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-39  Score=282.91  Aligned_cols=234  Identities=29%  Similarity=0.405  Sum_probs=183.6

Q ss_pred             CCCCcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHh--cCCCCceeeEEEEecCC----ceeEEEe
Q 039799          106 NMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKR--ICHRNLIKIISSYSNDD----FKALVLE  179 (346)
Q Consensus       106 ~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~----~~~lv~e  179 (346)
                      ...+++|+|.||.||+|.+. ++.||||+|...   ..+.|..|-++.+.  ++|+||+++++.-....    .+.||++
T Consensus       213 ~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~  288 (534)
T KOG3653|consen  213 QLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE  288 (534)
T ss_pred             hhHHHhhcCccceeehhhcc-CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence            44567999999999999988 599999999754   45677777776664  58999999999876655    8889999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcC------CCCCeeecCCCCCceEECCCCcEEEeeecCCccC
Q 039799          180 YMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFG------YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  253 (346)
Q Consensus       180 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~------~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~  253 (346)
                      |.+.|+|.++|.  ....+|....+|+..+++||+|||++      ++++|+|||||++|||+.+|+++.|+|||+|..+
T Consensus       289 fh~kGsL~dyL~--~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~  366 (534)
T KOG3653|consen  289 FHPKGSLCDYLK--ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRL  366 (534)
T ss_pred             eccCCcHHHHHH--hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEe
Confidence            999999999985  45689999999999999999999964      4778999999999999999999999999999988


Q ss_pred             CccccccccccccCCcccccCCCCCCCCC------CcchhHHHHHHHHHHHHcCCCCCC--------ccccCcc------
Q 039799          254 LEEDQSLTQTQTLATIGYMAPEYGREGRV------STNGDVYSFGIMLMEIFTRTKPTD--------EIFSGEM------  313 (346)
Q Consensus       254 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~------~~~~Dv~s~G~il~elltg~~p~~--------~~~~~~~------  313 (346)
                      .+..........+||.+|||||++.+.--      -.+.||||+|.+||||+++-.-++        ..|..+.      
T Consensus       367 ~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~  446 (534)
T KOG3653|consen  367 EPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTL  446 (534)
T ss_pred             cCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCH
Confidence            75443333445789999999998865421      235799999999999998654332        1121111      


Q ss_pred             -cH-----HHHHhhhcC---------CChhhhhchhccCCccccccc
Q 039799          314 -TL-----KRWVNDLLP---------ISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       314 -~~-----~~~~~~~~~---------~~~~~~~d~~l~~~p~~R~~~  345 (346)
                       +.     .+..+..++         .-+.+.++.|+-.|++-|.|+
T Consensus       447 e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA  493 (534)
T KOG3653|consen  447 EEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTA  493 (534)
T ss_pred             HHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhh
Confidence             11     111122222         256899999999999999986

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=7.3e-39  Score=279.60  Aligned_cols=231  Identities=25%  Similarity=0.373  Sum_probs=191.4

Q ss_pred             CcccccCceEEEEEEEcC--C--CEEEEEEecCCCc-hhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecCCC
Q 039799          109 PLIGKGGFGSVYKAIIQD--G--MEVAVKVFDPQYE-GAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPH  183 (346)
Q Consensus       109 ~~lg~G~~g~vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  183 (346)
                      +.||+|++|.||+|.+.+  +  ..+|+|.+..... ...+.+.+|++.+++++|||++++++.+.. ...++++||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998753  3  3689999986655 556788999999999999999999999988 889999999999


Q ss_pred             CChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccc-c
Q 039799          184 GSLEKCLYLSN-YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL-T  261 (346)
Q Consensus       184 gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~-~  261 (346)
                      ++|.+++.... ..+++...+.++.+++.||+|||   +.+++|+||+|+||+++.++.++|+|||+++.+....... .
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  156 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM  156 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence            99999987654 56899999999999999999999   9999999999999999999999999999998764422211 1


Q ss_pred             cccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHH---------hhhcCCChhhhh
Q 039799          262 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWV---------NDLLPISVMEVV  331 (346)
Q Consensus       262 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~---------~~~~~~~~~~~~  331 (346)
                      .....++..|+|||+..+..++.++||||||++++||+| |+.||......+  ....+         ....+..+.+++
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li  234 (257)
T cd05040         157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ--ILKKIDKEGERLERPEACPQDIYNVM  234 (257)
T ss_pred             ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHhcCCcCCCCccCCHHHHHHH
Confidence            123446788999999988889999999999999999999 999996532211  11111         112345788999


Q ss_pred             chhccCCccccccc
Q 039799          332 DANLLSQEDEHFTT  345 (346)
Q Consensus       332 d~~l~~~p~~R~~~  345 (346)
                      .+|+..+|++||+.
T Consensus       235 ~~~l~~~p~~Rps~  248 (257)
T cd05040         235 LQCWAHNPADRPTF  248 (257)
T ss_pred             HHHCCCCcccCCCH
Confidence            99999999999985

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-39  Score=290.29  Aligned_cols=238  Identities=24%  Similarity=0.314  Sum_probs=201.8

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCc---hhHHHHHHHHHHHHhcC-CCCceeeEEEEecCCcee
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYE---GAFKSFDIECDVMKRIC-HRNLIKIISSYSNDDFKA  175 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~  175 (346)
                      ....|.+.+.||+|.||.||++..+ +|+.+|+|++.+...   .....+.+|+.+|+++. ||||+.+.+.++..+..+
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            3456888999999999999999977 599999999976533   23468889999999998 999999999999999999


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC----CCcEEEeeecCCc
Q 039799          176 LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD----NMVAHLSDFGMAK  251 (346)
Q Consensus       176 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~----~~~~~l~Dfg~~~  251 (346)
                      +|||+++||.|.+.+...  .++......++.+++.++.|||   +.+++|||+||+|+|+..    ++.++++|||++.
T Consensus       113 lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~  187 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK  187 (382)
T ss_pred             EEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence            999999999999988765  3899999999999999999999   999999999999999963    3579999999999


Q ss_pred             cCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCccc---------HHHHHhhh
Q 039799          252 PLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMT---------LKRWVNDL  322 (346)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~---------~~~~~~~~  322 (346)
                      ....   .......+||+.|+|||.+....|+..+||||+|+++|.|++|..||......+..         +..-....
T Consensus       188 ~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~  264 (382)
T KOG0032|consen  188 FIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDD  264 (382)
T ss_pred             EccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccc
Confidence            8754   33456678999999999999999999999999999999999999999764322211         11111122


Q ss_pred             cCCChhhhhchhccCCcccccccC
Q 039799          323 LPISVMEVVDANLLSQEDEHFTTK  346 (346)
Q Consensus       323 ~~~~~~~~~d~~l~~~p~~R~~~k  346 (346)
                      +...+.+++.++|..||.+|++++
T Consensus       265 is~~akd~i~~ll~~dp~~R~ta~  288 (382)
T KOG0032|consen  265 ISESAKDFIRKLLEFDPRKRLTAA  288 (382)
T ss_pred             cCHHHHHHHHHhcccCcccCCCHH
Confidence            344789999999999999999863

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1e-38  Score=294.64  Aligned_cols=239  Identities=24%  Similarity=0.376  Sum_probs=192.8

Q ss_pred             CCCCCCCcccccCceEEEEEEEc------CCCEEEEEEecCCC-chhHHHHHHHHHHHHhcC-CCCceeeEEEEecCCce
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ------DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRIC-HRNLIKIISSYSNDDFK  174 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~  174 (346)
                      +++.+.+.||+|+||.||+|++.      .++.||+|++.... ....+.+..|++++.++. ||||+++++++...+..
T Consensus        37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~  116 (401)
T cd05107          37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI  116 (401)
T ss_pred             HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence            45777899999999999999864      34689999997542 333457889999999997 99999999999999999


Q ss_pred             eEEEecCCCCChhhhhhhcC------------------------------------------------------------
Q 039799          175 ALVLEYMPHGSLEKCLYLSN------------------------------------------------------------  194 (346)
Q Consensus       175 ~lv~e~~~~gsL~~~l~~~~------------------------------------------------------------  194 (346)
                      ++|+||+++|+|.++++...                                                            
T Consensus       117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (401)
T cd05107         117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK  196 (401)
T ss_pred             EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence            99999999999999886421                                                            


Q ss_pred             -------------------------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEEC
Q 039799          195 -------------------------------------YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD  237 (346)
Q Consensus       195 -------------------------------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~  237 (346)
                                                           ..+++...+.++.+++.||+|||   +.+++||||||+|||++
T Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~NiLl~  273 (401)
T cd05107         197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVLIC  273 (401)
T ss_pred             hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcceEEEe
Confidence                                                 23677788899999999999999   99999999999999999


Q ss_pred             CCCcEEEeeecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHH
Q 039799          238 DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLK  316 (346)
Q Consensus       238 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~  316 (346)
                      +++.++|+|||+++.+.............++..|+|||.+....++.++||||||+++|||++ |..||......+. ..
T Consensus       274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~-~~  352 (401)
T cd05107         274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ-FY  352 (401)
T ss_pred             CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH-HH
Confidence            999999999999986543222222223456788999999988889999999999999999998 8999865432221 11


Q ss_pred             HHHhh--------hcCCChhhhhchhccCCccccccc
Q 039799          317 RWVND--------LLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       317 ~~~~~--------~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ..+..        ..+..+.+++.+|+..+|.+||+.
T Consensus       353 ~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~  389 (401)
T cd05107         353 NAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDF  389 (401)
T ss_pred             HHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCH
Confidence            11111        123477899999999999999985

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=9.1e-39  Score=279.99  Aligned_cols=236  Identities=27%  Similarity=0.429  Sum_probs=193.1

Q ss_pred             CCCCCCCcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecCC
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMP  182 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  182 (346)
                      .+|.+.+.||+|++|.||+|.+.++..+|+|++..... ..+.+.+|++++++++|||++++++.+. .+..++||||++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS   83 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence            46889999999999999999988777899999875332 3467888999999999999999999875 456789999999


Q ss_pred             CCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccc
Q 039799          183 HGSLEKCLYLS-NYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT  261 (346)
Q Consensus       183 ~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~  261 (346)
                      +++|.+++... ...+++..+..++.++++||+|||   +.+++||||||+||++++++.++|+|||.+..+..... ..
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~-~~  159 (262)
T cd05071          84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TA  159 (262)
T ss_pred             CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeecccccc-cc
Confidence            99999998753 346789999999999999999999   99999999999999999999999999999986543221 11


Q ss_pred             cccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHH-------hhhcCCChhhhhch
Q 039799          262 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWV-------NDLLPISVMEVVDA  333 (346)
Q Consensus       262 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~d~  333 (346)
                      .....++..|+|||+..+..++.++||||||+++||++| |..||......+. .....       ....+..+.+++.+
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~  238 (262)
T cd05071         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-LDQVERGYRMPCPPECPESLHDLMCQ  238 (262)
T ss_pred             ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH-HHHHhcCCCCCCccccCHHHHHHHHH
Confidence            123346778999999988889999999999999999999 8889875432211 11100       11234578999999


Q ss_pred             hccCCccccccc
Q 039799          334 NLLSQEDEHFTT  345 (346)
Q Consensus       334 ~l~~~p~~R~~~  345 (346)
                      |+..+|++||+.
T Consensus       239 ~l~~~p~~Rp~~  250 (262)
T cd05071         239 CWRKEPEERPTF  250 (262)
T ss_pred             HccCCcccCCCH
Confidence            999999999985

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9e-39  Score=277.53  Aligned_cols=240  Identities=25%  Similarity=0.346  Sum_probs=199.9

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEE
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVL  178 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  178 (346)
                      +.|+..+.||+|.-|+||++..+ ++..+|+|++++..   .....+.+.|-++|+.++||.++.+++.++.++..+++|
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            45777889999999999999987 46899999998653   334567778999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCc--
Q 039799          179 EYMPHGSLEKCLYLSN-YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE--  255 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~--  255 (346)
                      |||+||+|....+.+. ..++...+.-++..++-||+|||   -.|||.|||||+|||+.++|++.|+||.++.....  
T Consensus       157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~P  233 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP  233 (459)
T ss_pred             ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence            9999999999887665 56888888899999999999999   99999999999999999999999999999765421  


Q ss_pred             -----cc------------------------c-c----------------------cccccccCCcccccCCCCCCCCCC
Q 039799          256 -----ED------------------------Q-S----------------------LTQTQTLATIGYMAPEYGREGRVS  283 (346)
Q Consensus       256 -----~~------------------------~-~----------------------~~~~~~~~~~~y~aPE~~~~~~~~  283 (346)
                           ..                        . .                      ......+||-.|.|||++.+...+
T Consensus       234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg  313 (459)
T KOG0610|consen  234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG  313 (459)
T ss_pred             eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence                 00                        0 0                      001123589999999999999999


Q ss_pred             cchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHhhhc--------CCChhhhhchhccCCcccccccC
Q 039799          284 TNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLL--------PISVMEVVDANLLSQEDEHFTTK  346 (346)
Q Consensus       284 ~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~--------~~~~~~~~d~~l~~~p~~R~~~k  346 (346)
                      ..+|-|+|||++|||+.|.-||.... .+..+...+.+.+        .....|+|.+.|..||.+|+..|
T Consensus       314 sAVDWWtfGIflYEmLyG~TPFKG~~-~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~  383 (459)
T KOG0610|consen  314 SAVDWWTFGIFLYEMLYGTTPFKGSN-NKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSK  383 (459)
T ss_pred             chhhHHHHHHHHHHHHhCCCCcCCCC-chhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccc
Confidence            99999999999999999999998743 3334444443332        23679999999999999998753

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=6.9e-39  Score=281.32  Aligned_cols=238  Identities=24%  Similarity=0.350  Sum_probs=196.0

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC---CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEE
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ---YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVL  178 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  178 (346)
                      ++|.+.+.||+|++|.||++... +++.+|+|.+...   .......+.+|+++++.++|||++++++++...+..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            46788899999999999999964 7899999987542   2233467888999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCc
Q 039799          179 EYMPHGSLEKCLYL---SNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  255 (346)
Q Consensus       179 e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~  255 (346)
                      ||+++++|.+++..   ....+++...+.++.+++.|++|||   +.+++|+||+|+||+++.++.++++|||++..+..
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            99999999998753   2356899999999999999999999   99999999999999999999999999999886543


Q ss_pred             cccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh---------hhcCCC
Q 039799          256 EDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN---------DLLPIS  326 (346)
Q Consensus       256 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~---------~~~~~~  326 (346)
                      ...  ......++..|+|||+..+..++.++|+||||+++|||++|..||.....+.....+.+.         ...+..
T Consensus       159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (267)
T cd08229         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEE  236 (267)
T ss_pred             CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHH
Confidence            221  122345888999999998888999999999999999999999998643222112211111         123347


Q ss_pred             hhhhhchhccCCccccccc
Q 039799          327 VMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       327 ~~~~~d~~l~~~p~~R~~~  345 (346)
                      +.+++.+|+..+|++|||.
T Consensus       237 ~~~li~~~l~~~p~~Rpt~  255 (267)
T cd08229         237 LRQLVNMCINPDPEKRPDI  255 (267)
T ss_pred             HHHHHHHhcCCCcccCCCH
Confidence            8899999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.6e-38  Score=278.38  Aligned_cols=226  Identities=21%  Similarity=0.343  Sum_probs=183.6

Q ss_pred             CcccccCceEEEEEEEcC-------------CCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCcee
Q 039799          109 PLIGKGGFGSVYKAIIQD-------------GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKA  175 (346)
Q Consensus       109 ~~lg~G~~g~vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  175 (346)
                      +.||+|++|.||+|++..             ...+++|.+..........+.+|+.+++.++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            368999999999998542             2358999987665555667888999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCc-------EEEeeec
Q 039799          176 LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV-------AHLSDFG  248 (346)
Q Consensus       176 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~-------~~l~Dfg  248 (346)
                      ++|||+++++|..++......+++..++.++.|+++|++|||   +.+++||||||+|||++.++.       ++++|||
T Consensus        81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            999999999999988766667899999999999999999999   999999999999999986654       8999999


Q ss_pred             CCccCCccccccccccccCCcccccCCCCC-CCCCCcchhHHHHHHHHHHHH-cCCCCCCccccCcccHHHHHhhh----
Q 039799          249 MAKPLLEEDQSLTQTQTLATIGYMAPEYGR-EGRVSTNGDVYSFGIMLMEIF-TRTKPTDEIFSGEMTLKRWVNDL----  322 (346)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~s~G~il~ell-tg~~p~~~~~~~~~~~~~~~~~~----  322 (346)
                      ++......      ....++..|+|||... +..++.++||||||+++|||+ +|+.|+......+  ........    
T Consensus       158 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--~~~~~~~~~~~~  229 (262)
T cd05077         158 IPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE--KERFYEGQCMLV  229 (262)
T ss_pred             CCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH--HHHHHhcCccCC
Confidence            98754321      2234778899999876 466889999999999999997 6888886532111  11111111    


Q ss_pred             --cCCChhhhhchhccCCccccccc
Q 039799          323 --LPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       323 --~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                        .+..+.+++.+||..||++||+.
T Consensus       230 ~~~~~~~~~li~~cl~~dp~~Rp~~  254 (262)
T cd05077         230 TPSCKELADLMTHCMNYDPNQRPFF  254 (262)
T ss_pred             CCChHHHHHHHHHHcCCChhhCcCH
Confidence              12367899999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=2.4e-38  Score=281.73  Aligned_cols=238  Identities=24%  Similarity=0.349  Sum_probs=196.7

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEec
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEY  180 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  180 (346)
                      .+.|.+.+.||+|++|.||+|... +++.+++|.+........+.+.+|++++++++|||++++++.+..+...++||||
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF   90 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence            355889999999999999999976 5899999999876666677888999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccc
Q 039799          181 MPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  260 (346)
Q Consensus       181 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~  260 (346)
                      +++++|..++......+++..+..++.|++.+++|||   +.+++||||+|+||+++.++.++|+|||++.......  .
T Consensus        91 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~--~  165 (292)
T cd06644          91 CPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL--Q  165 (292)
T ss_pred             CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceeccccc--c
Confidence            9999998887665667899999999999999999999   9999999999999999999999999999987542211  1


Q ss_pred             ccccccCCcccccCCCCC-----CCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh---------hhcCCC
Q 039799          261 TQTQTLATIGYMAPEYGR-----EGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN---------DLLPIS  326 (346)
Q Consensus       261 ~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~---------~~~~~~  326 (346)
                      ......++..|+|||++.     ...++.++||||||+++|||++|..||..... .........         ..++..
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  244 (292)
T cd06644         166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-MRVLLKIAKSEPPTLSQPSKWSME  244 (292)
T ss_pred             ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH-HHHHHHHhcCCCccCCCCcccCHH
Confidence            123345788999999874     34567899999999999999999999865321 111111111         112336


Q ss_pred             hhhhhchhccCCccccccc
Q 039799          327 VMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       327 ~~~~~d~~l~~~p~~R~~~  345 (346)
                      +.+++.+||..+|++||+.
T Consensus       245 ~~~li~~~l~~~p~~Rp~~  263 (292)
T cd06644         245 FRDFLKTALDKHPETRPSA  263 (292)
T ss_pred             HHHHHHHHhcCCcccCcCH
Confidence            7889999999999999985

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=3e-39  Score=296.30  Aligned_cols=240  Identities=23%  Similarity=0.276  Sum_probs=189.5

Q ss_pred             CCCCCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC---CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCc
Q 039799           98 GKPLPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ---YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDF  173 (346)
Q Consensus        98 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  173 (346)
                      .....++|.+.+.||+|+||.||++... +++.+|+|++...   .....+.+.+|+.+++.++||||+++++.+...+.
T Consensus        38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~  117 (370)
T cd05621          38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY  117 (370)
T ss_pred             cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence            3445578999999999999999999976 6889999998642   12234567789999999999999999999999999


Q ss_pred             eeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccC
Q 039799          174 KALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  253 (346)
Q Consensus       174 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~  253 (346)
                      .++||||+++|+|.+++...  .++......++.+++.||+|||   +.+|+||||||+|||+++++.+||+|||++...
T Consensus       118 ~~lv~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~  192 (370)
T cd05621         118 LYMVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM  192 (370)
T ss_pred             EEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccceec
Confidence            99999999999999988543  4788888999999999999999   999999999999999999999999999999876


Q ss_pred             CccccccccccccCCcccccCCCCCCC----CCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHhh--------
Q 039799          254 LEEDQSLTQTQTLATIGYMAPEYGREG----RVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVND--------  321 (346)
Q Consensus       254 ~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~--------  321 (346)
                      ..... .......||+.|+|||.+.+.    .++.++||||+||++|||++|+.||...... ......+..        
T Consensus       193 ~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~-~~~~~i~~~~~~~~~p~  270 (370)
T cd05621         193 DETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV-GTYSKIMDHKNSLNFPE  270 (370)
T ss_pred             ccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCcccCCCC
Confidence            43221 122345699999999987653    3788999999999999999999999653211 111111110        


Q ss_pred             --hcCCChhhhhchhccCCccc--ccc
Q 039799          322 --LLPISVMEVVDANLLSQEDE--HFT  344 (346)
Q Consensus       322 --~~~~~~~~~~d~~l~~~p~~--R~~  344 (346)
                        .++..+.+++.++|..+++.  |++
T Consensus       271 ~~~~s~~~~~li~~~L~~~~~r~~R~~  297 (370)
T cd05621         271 DVEISKHAKNLICAFLTDREVRLGRNG  297 (370)
T ss_pred             cccCCHHHHHHHHHHccCchhccCCCC
Confidence              12335678888888744422  554

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.5e-38  Score=278.17  Aligned_cols=236  Identities=28%  Similarity=0.431  Sum_probs=194.0

Q ss_pred             CCCCCCCCcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecC
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYM  181 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  181 (346)
                      .++|.+.+.||+|++|.||+|...++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++. .+..+++|||+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM   82 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence            356889999999999999999988888999999875433 3467889999999999999999999885 45678999999


Q ss_pred             CCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccc
Q 039799          182 PHGSLEKCLYLSN-YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  260 (346)
Q Consensus       182 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~  260 (346)
                      ++++|.+++.... ..+++..+..++.+++.||+|||   +.+++||||+|+||++++++.++|+|||.+..+..... .
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~-~  158 (260)
T cd05070          83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY-T  158 (260)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc-c
Confidence            9999999886543 45899999999999999999999   99999999999999999999999999999986543221 1


Q ss_pred             ccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHhh--------hcCCChhhhh
Q 039799          261 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVND--------LLPISVMEVV  331 (346)
Q Consensus       261 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~  331 (346)
                      ......++..|+|||...+..++.++|+||||+++||+++ |..||......  ........        ..+..+.+++
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li  236 (260)
T cd05070         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR--EVLEQVERGYRMPCPQDCPISLHELM  236 (260)
T ss_pred             cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHHcCCCCCCCCcCCHHHHHHH
Confidence            1122335678999999888889999999999999999999 89999653221  12222221        1234778999


Q ss_pred             chhccCCccccccc
Q 039799          332 DANLLSQEDEHFTT  345 (346)
Q Consensus       332 d~~l~~~p~~R~~~  345 (346)
                      .+|+..+|++|||.
T Consensus       237 ~~~l~~~p~~Rpt~  250 (260)
T cd05070         237 LQCWKKDPEERPTF  250 (260)
T ss_pred             HHHcccCcccCcCH
Confidence            99999999999985

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.9e-38  Score=279.34  Aligned_cols=236  Identities=25%  Similarity=0.371  Sum_probs=187.4

Q ss_pred             CCCCCcccccCceEEEEEEEcC-CC--EEEEEEecCC--CchhHHHHHHHHHHHHhcCCCCceeeEEEEecC------Cc
Q 039799          105 ANMPPLIGKGGFGSVYKAIIQD-GM--EVAVKVFDPQ--YEGAFKSFDIECDVMKRICHRNLIKIISSYSND------DF  173 (346)
Q Consensus       105 ~~~~~~lg~G~~g~vy~~~~~~-~~--~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~  173 (346)
                      +.+.+.||+|+||.||+|.+.+ +.  .+|+|.++..  .....+.+..|+++++.++||||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3567899999999999999764 33  5899988653  234467788899999999999999999987432      25


Q ss_pred             eeEEEecCCCCChhhhhhh-----cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeec
Q 039799          174 KALVLEYMPHGSLEKCLYL-----SNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFG  248 (346)
Q Consensus       174 ~~lv~e~~~~gsL~~~l~~-----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg  248 (346)
                      .++++||+++|+|.+++..     ....+++.....++.+++.||+|||   +.+|+||||||+||++++++.++|+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCC
Confidence            6899999999999887642     2245889999999999999999999   9999999999999999999999999999


Q ss_pred             CCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHh-------
Q 039799          249 MAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVN-------  320 (346)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~-------  320 (346)
                      +++.+.............++..|+|||+..+..++.++||||||+++|||++ |+.||......  .....+.       
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~~~~~~~~~  235 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS--EIYDYLRQGNRLKQ  235 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHcCCCCCC
Confidence            9987643322111222345678999999998889999999999999999999 88998653211  1111111       


Q ss_pred             -hhcCCChhhhhchhccCCccccccc
Q 039799          321 -DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       321 -~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                       ..++..+.+++.+||..+|++||++
T Consensus       236 ~~~~~~~~~~li~~~l~~~p~~Rps~  261 (272)
T cd05075         236 PPDCLDGLYSLMSSCWLLNPKDRPSF  261 (272)
T ss_pred             CCCCCHHHHHHHHHHcCCCcccCcCH
Confidence             1233468899999999999999985

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.4e-40  Score=282.99  Aligned_cols=231  Identities=26%  Similarity=0.415  Sum_probs=181.7

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCC-----ceeEE
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDD-----FKALV  177 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~lv  177 (346)
                      .|...+++|.|+||.||+|... +++.||||+.-....    .-.+|+++|+.++|||||++.-+|....     +..+|
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            4777889999999999999966 679999998754432    2235999999999999999998885432     44589


Q ss_pred             EecCCCCChhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCC-CcEEEeeecCCccC
Q 039799          178 LEYMPHGSLEKCLYL---SNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDN-MVAHLSDFGMAKPL  253 (346)
Q Consensus       178 ~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~-~~~~l~Dfg~~~~~  253 (346)
                      ||||+. +|.+.++.   .+..++...+.-+..|+.+||+|||   +.+|+||||||.|+|+|.+ |.+||+|||.|+.+
T Consensus       101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            999966 88887763   2455666667779999999999999   9999999999999999965 99999999999988


Q ss_pred             CccccccccccccCCcccccCCCCCCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccCcc-------------------
Q 039799          254 LEEDQSLTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM-------------------  313 (346)
Q Consensus       254 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~-------------------  313 (346)
                      .......   .-..|..|.|||.+.+. .|+.+.||||.||++.||+-|++-|......++                   
T Consensus       177 ~~~epni---SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m  253 (364)
T KOG0658|consen  177 VKGEPNI---SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM  253 (364)
T ss_pred             ccCCCce---eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence            6544332   23468889999988765 689999999999999999999998854111100                   


Q ss_pred             ------------cHHHH---HhhhcCCChhhhhchhccCCccccccc
Q 039799          314 ------------TLKRW---VNDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       314 ------------~~~~~---~~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                                  ....|   .....+.+..|++.++|.-+|++|.++
T Consensus       254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~  300 (364)
T KOG0658|consen  254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSA  300 (364)
T ss_pred             CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCH
Confidence                        00111   223345578899999999999999875

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.1e-38  Score=282.10  Aligned_cols=239  Identities=23%  Similarity=0.356  Sum_probs=196.5

Q ss_pred             CCCCCCCCcccccCceEEEEEEEcC-----CCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEec-CCce
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQD-----GMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSN-DDFK  174 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~  174 (346)
                      .++|.+.+.||+|+||.||+|.+.+     +..|++|.+.... ....+.+.+|+.++++++|+|++++++++.. ....
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            4568889999999999999999765     6889999886543 3345678889999999999999999998766 5678


Q ss_pred             eEEEecCCCCChhhhhhhcC-------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeee
Q 039799          175 ALVLEYMPHGSLEKCLYLSN-------YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDF  247 (346)
Q Consensus       175 ~lv~e~~~~gsL~~~l~~~~-------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Df  247 (346)
                      +++++|+++++|.+++....       ..+++..++.++.+++.||+|||   +.+++||||||+||++++++.++|+||
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECCC
Confidence            89999999999999886532       45889999999999999999999   999999999999999999999999999


Q ss_pred             cCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHhh-----
Q 039799          248 GMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVND-----  321 (346)
Q Consensus       248 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~-----  321 (346)
                      |+++.+.............++..|+|||+..+..++.++||||||+++||+++ |+.||+...  ......++..     
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--~~~~~~~~~~~~~~~  239 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID--PFEMAAYLKDGYRLA  239 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC--HHHHHHHHHcCCCCC
Confidence            99987644332222223346778999999988889999999999999999999 999997532  1223333222     


Q ss_pred             ---hcCCChhhhhchhccCCccccccc
Q 039799          322 ---LLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       322 ---~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                         ..+..+.+++.+|+..+|++||+.
T Consensus       240 ~~~~~~~~~~~li~~~l~~~p~~Rps~  266 (280)
T cd05043         240 QPINCPDELFAVMACCWALDPEERPSF  266 (280)
T ss_pred             CCCcCCHHHHHHHHHHcCCChhhCCCH
Confidence               224478999999999999999985

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=5.2e-39  Score=295.57  Aligned_cols=236  Identities=25%  Similarity=0.310  Sum_probs=188.3

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEecCC-----cee
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSNDD-----FKA  175 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~  175 (346)
                      +|.+.+.||+|+||.||++... +++.||+|++....  ....+++.+|+++++.++||||+++++++...+     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4778899999999999999865 78999999986432  234567889999999999999999999998776     789


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCc
Q 039799          176 LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  255 (346)
Q Consensus       176 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~  255 (346)
                      +|+||+. ++|.+.+. ....+++..+..++.|++.||+|||   +.+++||||||+|||++.++.++|+|||+++....
T Consensus        81 lv~e~~~-~~l~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~  155 (372)
T cd07853          81 VVTELMQ-SDLHKIIV-SPQPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP  155 (372)
T ss_pred             EEeeccc-cCHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence            9999996 57777664 3456889999999999999999999   99999999999999999999999999999986532


Q ss_pred             cccccccccccCCcccccCCCCCCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccCcc-----------cHH-------
Q 039799          256 EDQSLTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM-----------TLK-------  316 (346)
Q Consensus       256 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~-----------~~~-------  316 (346)
                      .. ........++..|+|||.+.+. .++.++||||+||+++||++|+.||........           ...       
T Consensus       156 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  234 (372)
T cd07853         156 DE-SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE  234 (372)
T ss_pred             Cc-cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence            21 1222334578999999988764 478999999999999999999999965321100           000       


Q ss_pred             ---HH----------------HhhhcCCChhhhhchhccCCccccccc
Q 039799          317 ---RW----------------VNDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       317 ---~~----------------~~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                         .+                .....++.+.+++.+||..||++|||+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~  282 (372)
T cd07853         235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISA  282 (372)
T ss_pred             HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCH
Confidence               00                001123366799999999999999986

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=2.1e-38  Score=278.10  Aligned_cols=238  Identities=26%  Similarity=0.351  Sum_probs=196.2

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC---CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEE
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ---YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVL  178 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  178 (346)
                      ++|.+.+.||+|++|.||+|... +|+.+|+|.+...   .....+.+.+|++++++++|+|++++++++...+..+++|
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            46888999999999999999977 8999999988532   2233567889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCc
Q 039799          179 EYMPHGSLEKCLYL---SNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  255 (346)
Q Consensus       179 e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~  255 (346)
                      ||+++++|.+++..   ....+++..++.++.+++.|+.|||   +.+++||||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            99999999998753   2345889999999999999999999   99999999999999999999999999999886533


Q ss_pred             cccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH---------hhhcCCC
Q 039799          256 EDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV---------NDLLPIS  326 (346)
Q Consensus       256 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~---------~~~~~~~  326 (346)
                      ...  ......++..|.|||...+..++.++||||||+++|||++|+.||...........+..         ....+..
T Consensus       159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (267)
T cd08224         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEE  236 (267)
T ss_pred             CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHH
Confidence            211  12234578899999999888899999999999999999999999854321111111111         1133447


Q ss_pred             hhhhhchhccCCccccccc
Q 039799          327 VMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       327 ~~~~~d~~l~~~p~~R~~~  345 (346)
                      +.+++.+|+..+|++||+.
T Consensus       237 ~~~~i~~cl~~~p~~Rp~~  255 (267)
T cd08224         237 LRDLVSRCINPDPEKRPDI  255 (267)
T ss_pred             HHHHHHHHcCCCcccCCCH
Confidence            8899999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=2.2e-38  Score=278.40  Aligned_cols=236  Identities=24%  Similarity=0.341  Sum_probs=192.1

Q ss_pred             CCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecCCC
Q 039799          105 ANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPH  183 (346)
Q Consensus       105 ~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  183 (346)
                      +.....||+|+||.||+|... ++..|++|.+........+.+.+|++++++++|+||+++++++...+..++++||+++
T Consensus        10 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   89 (268)
T cd06624          10 NGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPG   89 (268)
T ss_pred             CCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCC
Confidence            445568999999999999865 6788999998766555667889999999999999999999999999999999999999


Q ss_pred             CChhhhhhhcCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC-CCcEEEeeecCCccCCcccccc
Q 039799          184 GSLEKCLYLSNYIL--DIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD-NMVAHLSDFGMAKPLLEEDQSL  260 (346)
Q Consensus       184 gsL~~~l~~~~~~l--~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~-~~~~~l~Dfg~~~~~~~~~~~~  260 (346)
                      ++|.+++......+  ++..+..++.+++.|++|||   +.+|+||||||+||+++. ++.++|+|||.+..+.....  
T Consensus        90 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~--  164 (268)
T cd06624          90 GSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP--  164 (268)
T ss_pred             CCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC--
Confidence            99999987654444  78888899999999999999   999999999999999986 67999999999886533221  


Q ss_pred             ccccccCCcccccCCCCCCCC--CCcchhHHHHHHHHHHHHcCCCCCCccccCcccH--------HHHHhhhcCCChhhh
Q 039799          261 TQTQTLATIGYMAPEYGREGR--VSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTL--------KRWVNDLLPISVMEV  330 (346)
Q Consensus       261 ~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~--------~~~~~~~~~~~~~~~  330 (346)
                      ......++..|+|||+.....  ++.++||||||+++|||++|+.||..........        ...+...++..+.++
T Consensus       165 ~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  244 (268)
T cd06624         165 CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNF  244 (268)
T ss_pred             ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHH
Confidence            122335788999999876543  7889999999999999999999997532211111        011122234477889


Q ss_pred             hchhccCCccccccc
Q 039799          331 VDANLLSQEDEHFTT  345 (346)
Q Consensus       331 ~d~~l~~~p~~R~~~  345 (346)
                      +.+||..+|++||+.
T Consensus       245 i~~~l~~~p~~Rpt~  259 (268)
T cd06624         245 ILRCFEPDPDKRASA  259 (268)
T ss_pred             HHHHcCCCchhCCCH
Confidence            999999999999985

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-39  Score=294.20  Aligned_cols=228  Identities=25%  Similarity=0.286  Sum_probs=182.1

Q ss_pred             ccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhc---CCCCceeeEEEEecCCceeEEEecCCC
Q 039799          111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRI---CHRNLIKIISSYSNDDFKALVLEYMPH  183 (346)
Q Consensus       111 lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~  183 (346)
                      ||+|+||+||+|+.. +++.||+|++....   .........|..++...   .||||+++++.+...+..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999866 68999999986421   12223445566666655   699999999999999999999999999


Q ss_pred             CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccccc
Q 039799          184 GSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT  263 (346)
Q Consensus       184 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~~  263 (346)
                      |+|.+++.. ...+++..+..++.|+++||+|||   +.+|+||||||+|||++.++.++|+|||++.......  ....
T Consensus        81 g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~~~  154 (330)
T cd05586          81 GELFWHLQK-EGRFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KTTN  154 (330)
T ss_pred             ChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CCcc
Confidence            999988764 456889999999999999999999   9999999999999999999999999999987543221  1223


Q ss_pred             cccCCcccccCCCCCCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH-------hhhcCCChhhhhchhc
Q 039799          264 QTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV-------NDLLPISVMEVVDANL  335 (346)
Q Consensus       264 ~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~d~~l  335 (346)
                      ...||..|+|||.+.+. .++.++||||+||++|||+||+.||......+ ......       ...++..+.+++.+||
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~li~~~L  233 (330)
T cd05586         155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ-MYRNIAFGKVRFPKNVLSDEGRQFVKGLL  233 (330)
T ss_pred             CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH-HHHHHHcCCCCCCCccCCHHHHHHHHHHc
Confidence            45689999999988654 47899999999999999999999996532111 011111       1123457789999999


Q ss_pred             cCCccccccc
Q 039799          336 LSQEDEHFTT  345 (346)
Q Consensus       336 ~~~p~~R~~~  345 (346)
                      ..+|++||++
T Consensus       234 ~~~P~~R~~~  243 (330)
T cd05586         234 NRNPQHRLGA  243 (330)
T ss_pred             CCCHHHCCCC
Confidence            9999999964

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1e-38  Score=284.82  Aligned_cols=238  Identities=26%  Similarity=0.300  Sum_probs=197.8

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEe
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLE  179 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  179 (346)
                      ...+|.+.+.||+|++|.||++... +++.||+|.+........+.+.+|+.+++.++|+|++++++++...+..++|||
T Consensus        17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   96 (297)
T cd06656          17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   96 (297)
T ss_pred             hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence            3467999999999999999999864 799999999976555555778889999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccc
Q 039799          180 YMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  259 (346)
Q Consensus       180 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~  259 (346)
                      |+++++|.+++..  ..+++..+..++.+++.||.|||   +.+++||||+|+||+++.++.++|+|||++........ 
T Consensus        97 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-  170 (297)
T cd06656          97 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  170 (297)
T ss_pred             ccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc-
Confidence            9999999998753  34788899999999999999999   99999999999999999999999999999886533221 


Q ss_pred             cccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH--------hhhcCCChhhhh
Q 039799          260 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV--------NDLLPISVMEVV  331 (346)
Q Consensus       260 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~~  331 (346)
                       ......+++.|+|||...+..++.++|+||||+++|++++|+.||............+.        ...++..+.+++
T Consensus       171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  249 (297)
T cd06656         171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFL  249 (297)
T ss_pred             -CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHH
Confidence             12234578899999999888899999999999999999999999965322111111110        112334678999


Q ss_pred             chhccCCccccccc
Q 039799          332 DANLLSQEDEHFTT  345 (346)
Q Consensus       332 d~~l~~~p~~R~~~  345 (346)
                      .+||..+|++||++
T Consensus       250 ~~~l~~~p~~Rps~  263 (297)
T cd06656         250 NRCLEMDVDRRGSA  263 (297)
T ss_pred             HHHccCChhhCcCH
Confidence            99999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.8e-39  Score=283.06  Aligned_cols=237  Identities=24%  Similarity=0.350  Sum_probs=198.2

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecC
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYM  181 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  181 (346)
                      +.|.+.+.||+|++|.||++... ++..+|+|++........+.+..|++++++++|||++++++.+......++||||+
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC   84 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence            45888899999999999999975 68999999997665566678889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccc
Q 039799          182 PHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT  261 (346)
Q Consensus       182 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~  261 (346)
                      ++++|.+++......+++.....++.+++.|+.|||   +.+++|+||+|+||+++.++.++|+|||++.......  ..
T Consensus        85 ~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--~~  159 (280)
T cd06611          85 DGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL--QK  159 (280)
T ss_pred             CCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhcccc--cc
Confidence            999999998766667999999999999999999999   9999999999999999999999999999987643221  12


Q ss_pred             cccccCCcccccCCCCC-----CCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh---------hhcCCCh
Q 039799          262 QTQTLATIGYMAPEYGR-----EGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN---------DLLPISV  327 (346)
Q Consensus       262 ~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~---------~~~~~~~  327 (346)
                      .....++..|+|||...     ...++.++|+||||+++|||++|+.||...... .....+..         ..++..+
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  238 (280)
T cd06611         160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM-RVLLKILKSEPPTLDQPSKWSSSF  238 (280)
T ss_pred             cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH-HHHHHHhcCCCCCcCCcccCCHHH
Confidence            23345889999999864     345678999999999999999999999753211 11111211         1234478


Q ss_pred             hhhhchhccCCccccccc
Q 039799          328 MEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       328 ~~~~d~~l~~~p~~R~~~  345 (346)
                      .+++.+||..+|.+||+.
T Consensus       239 ~~li~~~l~~~p~~Rps~  256 (280)
T cd06611         239 NDFLKSCLVKDPDDRPTA  256 (280)
T ss_pred             HHHHHHHhccChhhCcCH
Confidence            899999999999999985

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=5.9e-39  Score=284.29  Aligned_cols=237  Identities=23%  Similarity=0.374  Sum_probs=192.3

Q ss_pred             CCCCCCcccccCceEEEEEEEc------CCCEEEEEEecCCCch-hHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeE
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQ------DGMEVAVKVFDPQYEG-AFKSFDIECDVMKRICHRNLIKIISSYSNDDFKAL  176 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  176 (346)
                      +|.+.+.||+|+||.||+|.+.      ++..+|+|++...... ....+.+|+.++.+++||||+++++++...+..++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            4666788999999999999864      2578999999754332 34668889999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhc---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCc
Q 039799          177 VLEYMPHGSLEKCLYLS---------------NYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV  241 (346)
Q Consensus       177 v~e~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~  241 (346)
                      ++||+++++|.+++...               ...+++..++.++.|++.||+|||   +.+++||||||+||++++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCCc
Confidence            99999999999987532               134788889999999999999999   999999999999999999999


Q ss_pred             EEEeeecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHh
Q 039799          242 AHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVN  320 (346)
Q Consensus       242 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~  320 (346)
                      ++|+|||+++...............+++.|+|||....+.++.++||||||+++|||++ |..||......  .....+.
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~~~~i~  240 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ--DVIEMIR  240 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHH
Confidence            99999999887643332222233446788999999988889999999999999999998 88888653221  1222221


Q ss_pred             --------hhcCCChhhhhchhccCCccccccc
Q 039799          321 --------DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       321 --------~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                              ...+..+.+++.+|+..+|++||+.
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~  273 (283)
T cd05091         241 NRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRF  273 (283)
T ss_pred             cCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCH
Confidence                    1233467899999999999999985

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-39  Score=291.25  Aligned_cols=234  Identities=23%  Similarity=0.320  Sum_probs=187.2

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC---CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEE
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ---YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVL  178 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  178 (346)
                      ++|.+.+.||+|+||.||++... +++.||+|++...   .....+.+.+|..++..++|+||+++++.+.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            36888999999999999999966 6899999998642   1223456788999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccc
Q 039799          179 EYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  258 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~  258 (346)
                      ||+++|+|.+++......++...+..++.|++.||+|||   +.+|+||||||+|||++.++.++|+|||++..+.....
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  157 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT  157 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence            999999999998765667889999999999999999999   99999999999999999999999999999876543221


Q ss_pred             ccccccccCCcccccCCCCCC-----CCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH-----------hhh
Q 039799          259 SLTQTQTLATIGYMAPEYGRE-----GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV-----------NDL  322 (346)
Q Consensus       259 ~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~-----------~~~  322 (346)
                       .......||+.|+|||++..     ..++.++|||||||++|||++|+.||......+ ......           ...
T Consensus       158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~  235 (331)
T cd05597         158 -VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE-TYGKIMNHKEHFQFPPDVTD  235 (331)
T ss_pred             -ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHH-HHHHHHcCCCcccCCCccCC
Confidence             11223458999999998763     457889999999999999999999996521111 001111           011


Q ss_pred             cCCChhhhhchhccCCcccc
Q 039799          323 LPISVMEVVDANLLSQEDEH  342 (346)
Q Consensus       323 ~~~~~~~~~d~~l~~~p~~R  342 (346)
                      ++..+.+++.++|.. |.+|
T Consensus       236 ~~~~~~~li~~ll~~-~~~r  254 (331)
T cd05597         236 VSEEAKDLIRRLICS-PETR  254 (331)
T ss_pred             CCHHHHHHHHHHccC-cccc
Confidence            344678899888864 3343

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.5e-38  Score=280.86  Aligned_cols=238  Identities=26%  Similarity=0.388  Sum_probs=192.1

Q ss_pred             CCCCCCCcccccCceEEEEEEEcC------CCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCcee
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQD------GMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKA  175 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  175 (346)
                      +.|.+.+.||+|++|.||+|.+..      +..+|+|.+.... ......+..|+.++++++|+||+++++++.+.+..+
T Consensus         6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   85 (277)
T cd05036           6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRF   85 (277)
T ss_pred             HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcE
Confidence            457888999999999999998753      5678999886443 333456888999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhhhcC------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCC---cEEEee
Q 039799          176 LVLEYMPHGSLEKCLYLSN------YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM---VAHLSD  246 (346)
Q Consensus       176 lv~e~~~~gsL~~~l~~~~------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~---~~~l~D  246 (346)
                      +||||+++++|.+++....      ..+++..++.++.+++.|++|||   +.+++||||||+||+++.++   .++|+|
T Consensus        86 lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl~d  162 (277)
T cd05036          86 ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIAD  162 (277)
T ss_pred             EEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEecc
Confidence            9999999999999886543      25899999999999999999999   99999999999999998654   699999


Q ss_pred             ecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHh-----
Q 039799          247 FGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVN-----  320 (346)
Q Consensus       247 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~-----  320 (346)
                      ||+++................+..|+|||+..+..++.++|||||||++|||++ |..||+.....  .....+.     
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~--~~~~~~~~~~~~  240 (277)
T cd05036         163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ--EVMEFVTGGGRL  240 (277)
T ss_pred             CccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHcCCcC
Confidence            999987633221111122234568999999988889999999999999999997 99999753221  1111111     


Q ss_pred             ---hhcCCChhhhhchhccCCccccccc
Q 039799          321 ---DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       321 ---~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                         ..++..+.+++.+|+..+|++||+.
T Consensus       241 ~~~~~~~~~~~~~i~~cl~~~p~~Rps~  268 (277)
T cd05036         241 DPPKGCPGPVYRIMTDCWQHTPEDRPNF  268 (277)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCcccCcCH
Confidence               1234477899999999999999985

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.1e-39  Score=298.99  Aligned_cols=193  Identities=22%  Similarity=0.235  Sum_probs=167.0

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecC
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYM  181 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  181 (346)
                      ..|.+.+.||+|+||.||++... .++.||+|...      ...+.+|++++++++|+||+++++++...+..++|||++
T Consensus       169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~  242 (461)
T PHA03211        169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY  242 (461)
T ss_pred             CCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence            35888899999999999999976 57889999642      234567999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccc
Q 039799          182 PHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT  261 (346)
Q Consensus       182 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~  261 (346)
                      . ++|.+++......+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.++|+|||+++..........
T Consensus       243 ~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~  318 (461)
T PHA03211        243 R-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF  318 (461)
T ss_pred             C-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccccc
Confidence            4 6888887665567999999999999999999999   99999999999999999999999999999986543222222


Q ss_pred             cccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCC
Q 039799          262 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPT  305 (346)
Q Consensus       262 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~  305 (346)
                      .....||..|+|||++.+..++.++|||||||++|||++|..|+
T Consensus       319 ~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l  362 (461)
T PHA03211        319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL  362 (461)
T ss_pred             ccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence            23456899999999999889999999999999999999987654

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=5.7e-40  Score=270.81  Aligned_cols=236  Identities=28%  Similarity=0.447  Sum_probs=195.2

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC--------chhHHHHHHHHHHHHhc-CCCCceeeEEEEecC
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY--------EGAFKSFDIECDVMKRI-CHRNLIKIISSYSND  171 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  171 (346)
                      -..|.-.+.+|.|..++|-++.++ +|..+|+|++....        ....+.-.+|+.+|+++ .||+|+++.++++.+
T Consensus        16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~   95 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD   95 (411)
T ss_pred             HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence            345777889999999999998766 78899999885321        12234556799999998 699999999999999


Q ss_pred             CceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCc
Q 039799          172 DFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAK  251 (346)
Q Consensus       172 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~  251 (346)
                      ...++|+|.|+.|.|.+++. +...++.....+|++++.+|++|||   ..+|+|||+||+|||+|++.+++|+|||+++
T Consensus        96 sF~FlVFdl~prGELFDyLt-s~VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDFGFa~  171 (411)
T KOG0599|consen   96 AFVFLVFDLMPRGELFDYLT-SKVTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDFGFAC  171 (411)
T ss_pred             chhhhhhhhcccchHHHHhh-hheeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEeccceee
Confidence            99999999999999999996 4456888888899999999999999   9999999999999999999999999999999


Q ss_pred             cCCccccccccccccCCcccccCCCCC------CCCCCcchhHHHHHHHHHHHHcCCCCCCc---------cccCcc--c
Q 039799          252 PLLEEDQSLTQTQTLATIGYMAPEYGR------EGRVSTNGDVYSFGIMLMEIFTRTKPTDE---------IFSGEM--T  314 (346)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~Dv~s~G~il~elltg~~p~~~---------~~~~~~--~  314 (346)
                      .+.+..   .....+||++|.|||.+.      ...|+...|+||.|||+|-++.|.+||--         +..+.-  .
T Consensus       172 ~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~  248 (411)
T KOG0599|consen  172 QLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFR  248 (411)
T ss_pred             ccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccC
Confidence            875433   345678999999999764      23578899999999999999999999842         111111  2


Q ss_pred             HHHHHhhhcCCChhhhhchhccCCcccccccC
Q 039799          315 LKRWVNDLLPISVMEVVDANLLSQEDEHFTTK  346 (346)
Q Consensus       315 ~~~~~~~~~~~~~~~~~d~~l~~~p~~R~~~k  346 (346)
                      ..+|.+  .+....+++.++|..||.+|+|+|
T Consensus       249 speWad--is~~~KdLIsrlLqVdp~~Ritak  278 (411)
T KOG0599|consen  249 SPEWAD--ISATVKDLISRLLQVDPTKRITAK  278 (411)
T ss_pred             Ccchhh--ccccHHHHHHHHHeeCchhcccHH
Confidence            234433  345789999999999999999975

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.2e-38  Score=280.16  Aligned_cols=238  Identities=22%  Similarity=0.401  Sum_probs=195.0

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CC---CEEEEEEecCC-CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEE
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DG---MEVAVKVFDPQ-YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALV  177 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  177 (346)
                      .+|++.+.||+|+||.||+|.+. ++   ..||+|.+... .....+.+..|+.++++++|||++++.+++...+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            35778899999999999999865 33   36999998754 334467889999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccc
Q 039799          178 LEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  257 (346)
Q Consensus       178 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~  257 (346)
                      |||+++++|.+++......+++..++.++.+++.|++|||   +.+++|+||+|+||+++.++.++++|||++..+....
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~  160 (269)
T cd05065          84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  160 (269)
T ss_pred             EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence            9999999999998766677899999999999999999999   9999999999999999999999999999988654322


Q ss_pred             ccccccccc---CCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHhh--------hcCC
Q 039799          258 QSLTQTQTL---ATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVND--------LLPI  325 (346)
Q Consensus       258 ~~~~~~~~~---~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~--------~~~~  325 (346)
                      .........   .+..|+|||+.....++.++||||||+++||+++ |..||.....  .....++..        ..+.
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~--~~~~~~i~~~~~~~~~~~~~~  238 (269)
T cd05065         161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--QDVINAIEQDYRLPPPMDCPT  238 (269)
T ss_pred             cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH--HHHHHHHHcCCcCCCcccCCH
Confidence            211111111   2457999999988889999999999999999986 9999965322  122233322        1233


Q ss_pred             ChhhhhchhccCCccccccc
Q 039799          326 SVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       326 ~~~~~~d~~l~~~p~~R~~~  345 (346)
                      .+.+++.+|+..+|++||+.
T Consensus       239 ~~~~li~~~l~~~p~~Rp~~  258 (269)
T cd05065         239 ALHQLMLDCWQKDRNARPKF  258 (269)
T ss_pred             HHHHHHHHHcCCChhhCcCH
Confidence            67899999999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=7.1e-39  Score=285.18  Aligned_cols=239  Identities=28%  Similarity=0.391  Sum_probs=193.9

Q ss_pred             CCCCCCCcccccCceEEEEEEEc------CCCEEEEEEecCCC-chhHHHHHHHHHHHHhc-CCCCceeeEEEEecCCce
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ------DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRI-CHRNLIKIISSYSNDDFK  174 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  174 (346)
                      ++|++.+.||+|++|.||++.+.      ....+|+|.+.... ......+.+|++++.++ +|+||+++++++...+..
T Consensus        12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~   91 (293)
T cd05053          12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPL   91 (293)
T ss_pred             hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCe
Confidence            56888899999999999999864      23679999987542 33446688899999999 899999999999999999


Q ss_pred             eEEEecCCCCChhhhhhhc---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCC
Q 039799          175 ALVLEYMPHGSLEKCLYLS---------------NYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDN  239 (346)
Q Consensus       175 ~lv~e~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~  239 (346)
                      +++|||+++++|.+++...               ...+++..++.++.|++.||+|||   +.+|+||||||+||+++++
T Consensus        92 ~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil~~~~  168 (293)
T cd05053          92 YVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLVTED  168 (293)
T ss_pred             EEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEEEcCC
Confidence            9999999999999988632               246889999999999999999999   9999999999999999999


Q ss_pred             CcEEEeeecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHH
Q 039799          240 MVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRW  318 (346)
Q Consensus       240 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~  318 (346)
                      +.++|+|||+++.+.............++..|+|||...+..++.++||||||+++||+++ |..||......+  ..+.
T Consensus       169 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~~  246 (293)
T cd05053         169 HVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE--LFKL  246 (293)
T ss_pred             CeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH--HHHH
Confidence            9999999999987644322111222335678999999888889999999999999999997 999986532111  1111


Q ss_pred             Hhh--------hcCCChhhhhchhccCCcccccccC
Q 039799          319 VND--------LLPISVMEVVDANLLSQEDEHFTTK  346 (346)
Q Consensus       319 ~~~--------~~~~~~~~~~d~~l~~~p~~R~~~k  346 (346)
                      ...        ..+..+.+++.+|+..+|++|||++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  282 (293)
T cd05053         247 LKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFK  282 (293)
T ss_pred             HHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHH
Confidence            111        1234788999999999999999863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=3e-38  Score=278.04  Aligned_cols=236  Identities=24%  Similarity=0.384  Sum_probs=190.2

Q ss_pred             CCCCCcccccCceEEEEEEEc-C---CCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCc-----
Q 039799          105 ANMPPLIGKGGFGSVYKAIIQ-D---GMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDF-----  173 (346)
Q Consensus       105 ~~~~~~lg~G~~g~vy~~~~~-~---~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-----  173 (346)
                      |.+.+.||+|+||.||+|.+. +   +..+|+|++....  ......+.+|++.++.++|||++++++++...+.     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            567889999999999999865 2   3679999987532  2335678899999999999999999998866554     


Q ss_pred             -eeEEEecCCCCChhhhhhhc-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeee
Q 039799          174 -KALVLEYMPHGSLEKCLYLS-----NYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDF  247 (346)
Q Consensus       174 -~~lv~e~~~~gsL~~~l~~~-----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Df  247 (346)
                       .++++||+++++|..++...     ...+++.....++.+++.||+|||   +.+++||||||+||++++++.++|+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCc
Confidence             78999999999999887432     246899999999999999999999   999999999999999999999999999


Q ss_pred             cCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHh------
Q 039799          248 GMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVN------  320 (346)
Q Consensus       248 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~------  320 (346)
                      |+++................+..|+|||...+..++.++||||||+++|||++ |..||......  ...+++.      
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~--~~~~~~~~~~~~~  235 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH--EIYDYLRHGNRLK  235 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCCCC
Confidence            99987643322222222335678999999988889999999999999999999 89998653221  1222222      


Q ss_pred             --hhcCCChhhhhchhccCCccccccc
Q 039799          321 --DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       321 --~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                        ...+..+.+++.+|+..||++||+.
T Consensus       236 ~~~~~~~~~~~li~~~l~~~p~~Rp~~  262 (273)
T cd05035         236 QPEDCLDELYDLMYSCWRADPKDRPTF  262 (273)
T ss_pred             CCcCCCHHHHHHHHHHcCCChhhCcCH
Confidence              1233478999999999999999985

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.7e-38  Score=283.97  Aligned_cols=238  Identities=21%  Similarity=0.264  Sum_probs=192.2

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEec
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEY  180 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  180 (346)
                      ++|.+.+.||+|++|.||+|..+ +++.||+|.+.... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            56888999999999999999876 68899999986432 22345677899999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccc
Q 039799          181 MPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  260 (346)
Q Consensus       181 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~  260 (346)
                      ++ ++|.+++......+++.....++.++++||+|||   +.+++|+||||+||++++++.++|+|||++.......  .
T Consensus        86 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--~  159 (301)
T cd07873          86 LD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT--K  159 (301)
T ss_pred             cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC--C
Confidence            97 5898888766667889999999999999999999   9999999999999999999999999999997543221  1


Q ss_pred             ccccccCCcccccCCCCCC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccCcc--------------cHHH--------
Q 039799          261 TQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM--------------TLKR--------  317 (346)
Q Consensus       261 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~--------------~~~~--------  317 (346)
                      ......++..|+|||.+.+ ..++.++||||||+++|||+||+.||......+.              ....        
T Consensus       160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (301)
T cd07873         160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK  239 (301)
T ss_pred             cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccc
Confidence            1223457889999998765 4578899999999999999999999964221000              0000        


Q ss_pred             -------------HHhhhcCCChhhhhchhccCCcccccccC
Q 039799          318 -------------WVNDLLPISVMEVVDANLLSQEDEHFTTK  346 (346)
Q Consensus       318 -------------~~~~~~~~~~~~~~d~~l~~~p~~R~~~k  346 (346)
                                   -....++..+.+++.+||..||.+|||++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~  281 (301)
T cd07873         240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAE  281 (301)
T ss_pred             ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHH
Confidence                         00112344678999999999999999863

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.1e-38  Score=279.16  Aligned_cols=237  Identities=24%  Similarity=0.394  Sum_probs=195.4

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEec
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEY  180 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  180 (346)
                      ..++|.+.+.||+|+||.||+|..++++.+|+|.+..... ....+.+|+.++++++|+|++++++++. .+..+++|||
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~   81 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY   81 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence            3467889999999999999999988899999999875433 3467889999999999999999999874 5578999999


Q ss_pred             CCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccc
Q 039799          181 MPHGSLEKCLYLS-NYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  259 (346)
Q Consensus       181 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~  259 (346)
                      +++++|.+++... ...+++..+..++.+++.||+|||   +.+++||||+|+||++++++.++|+|||++........ 
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-  157 (260)
T cd05067          82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-  157 (260)
T ss_pred             CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc-
Confidence            9999999987643 356899999999999999999999   99999999999999999999999999999986542211 


Q ss_pred             cccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHh--------hhcCCChhhh
Q 039799          260 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVN--------DLLPISVMEV  330 (346)
Q Consensus       260 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~  330 (346)
                      .......++..|+|||+.....++.++||||||++++|+++ |+.||......  ...+...        ...+..+.++
T Consensus       158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l  235 (260)
T cd05067         158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP--EVIQNLERGYRMPRPDNCPEELYEL  235 (260)
T ss_pred             ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH--HHHHHHHcCCCCCCCCCCCHHHHHH
Confidence            11223345678999999988889999999999999999999 99999753221  1111111        1234478999


Q ss_pred             hchhccCCccccccc
Q 039799          331 VDANLLSQEDEHFTT  345 (346)
Q Consensus       331 ~d~~l~~~p~~R~~~  345 (346)
                      +.+|+..+|++||+.
T Consensus       236 i~~~l~~~p~~Rp~~  250 (260)
T cd05067         236 MRLCWKEKPEERPTF  250 (260)
T ss_pred             HHHHccCChhhCCCH
Confidence            999999999999985

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.2e-38  Score=279.95  Aligned_cols=237  Identities=25%  Similarity=0.304  Sum_probs=194.1

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecC
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYM  181 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  181 (346)
                      ++|.+.+.||+|++|.||+|... +++.+|+|.+..........+.+|+.+++.++|||++++++.+...+..++++||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            46788889999999999999865 68999999987665555567888999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccc
Q 039799          182 PHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT  261 (346)
Q Consensus       182 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~  261 (346)
                      ++++|.+++.. ...+++.....++.+++.|+.|||   +.+++|+||||+||+++.++.++|+|||++.......  ..
T Consensus        89 ~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--~~  162 (267)
T cd06645          89 GGGSLQDIYHV-TGPLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI--AK  162 (267)
T ss_pred             CCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc--cc
Confidence            99999998754 346889999999999999999999   9999999999999999999999999999987653221  11


Q ss_pred             cccccCCcccccCCCCC---CCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHH--------Hh--hhcCCChh
Q 039799          262 QTQTLATIGYMAPEYGR---EGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRW--------VN--DLLPISVM  328 (346)
Q Consensus       262 ~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~--------~~--~~~~~~~~  328 (346)
                      .....|+..|+|||.+.   ...++.++|+|||||++|||++|..|+.............        ..  ..++..+.
T Consensus       163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (267)
T cd06645         163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFH  242 (267)
T ss_pred             cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHH
Confidence            23346889999999874   4567889999999999999999999985432211110000        00  11334577


Q ss_pred             hhhchhccCCccccccc
Q 039799          329 EVVDANLLSQEDEHFTT  345 (346)
Q Consensus       329 ~~~d~~l~~~p~~R~~~  345 (346)
                      +++.+||..+|++||+.
T Consensus       243 ~li~~~l~~~P~~R~~~  259 (267)
T cd06645         243 HFVKMALTKNPKKRPTA  259 (267)
T ss_pred             HHHHHHccCCchhCcCH
Confidence            89999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.2e-38  Score=284.10  Aligned_cols=235  Identities=26%  Similarity=0.323  Sum_probs=196.8

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecC
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYM  181 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  181 (346)
                      ..|.+.+.||.|++|.||+|... +++.+++|.+........+.+.+|++.++.++|||++++++++...+..++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            45888999999999999999854 78999999987655555677889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccc
Q 039799          182 PHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT  261 (346)
Q Consensus       182 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~  261 (346)
                      ++++|.+++..  ..+++..+..++.+++.|++|||   +.+++||||+|+||+++.++.++|+|||++........  .
T Consensus        99 ~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~  171 (296)
T cd06655          99 AGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--K  171 (296)
T ss_pred             CCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc--c
Confidence            99999998753  35889999999999999999999   99999999999999999999999999999886543321  1


Q ss_pred             cccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH---------hhhcCCChhhhhc
Q 039799          262 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV---------NDLLPISVMEVVD  332 (346)
Q Consensus       262 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~---------~~~~~~~~~~~~d  332 (346)
                      .....++..|+|||...+..++.++||||||+++|++++|+.||........ .....         ...++..+.+++.
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~  250 (296)
T cd06655         172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LYLIATNGTPELQNPEKLSPIFRDFLN  250 (296)
T ss_pred             CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhcCCcccCCcccCCHHHHHHHH
Confidence            2234588899999999888899999999999999999999999975322111 11111         1112346789999


Q ss_pred             hhccCCccccccc
Q 039799          333 ANLLSQEDEHFTT  345 (346)
Q Consensus       333 ~~l~~~p~~R~~~  345 (346)
                      +||..+|.+||+.
T Consensus       251 ~~l~~dp~~Rpt~  263 (296)
T cd06655         251 RCLEMDVEKRGSA  263 (296)
T ss_pred             HHhhcChhhCCCH
Confidence            9999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.1e-38  Score=273.90  Aligned_cols=232  Identities=28%  Similarity=0.433  Sum_probs=191.5

Q ss_pred             CcccccCceEEEEEEEcCCCEEEEEEecCCCch-hHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecCCCCChh
Q 039799          109 PLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEG-AFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLE  187 (346)
Q Consensus       109 ~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~  187 (346)
                      +.||+|++|.||++...+++.+|+|.+...... ....+.+|++++++++|+||+++++++......++|+||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            468999999999999877999999998755433 4567889999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccccccccC
Q 039799          188 KCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA  267 (346)
Q Consensus       188 ~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~  267 (346)
                      +++......+++.....++.+++.+++|||   +.+++||||+|+||+++.++.++|+|||++.................
T Consensus        81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (251)
T cd05041          81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI  157 (251)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence            998765567889999999999999999999   99999999999999999999999999999986532211111112224


Q ss_pred             CcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHh--------hhcCCChhhhhchhccCC
Q 039799          268 TIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVN--------DLLPISVMEVVDANLLSQ  338 (346)
Q Consensus       268 ~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~d~~l~~~  338 (346)
                      +..|+|||.+.++.++.++|+||||++++||+| |..||......  .....+.        ...+..+.+++.+|+..+
T Consensus       158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  235 (251)
T cd05041         158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ--QTRERIESGYRMPAPQLCPEEIYRLMLQCWAYD  235 (251)
T ss_pred             eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH--HHHHHHhcCCCCCCCccCCHHHHHHHHHHhccC
Confidence            567999999988889999999999999999999 88888653221  1112221        123347889999999999


Q ss_pred             ccccccc
Q 039799          339 EDEHFTT  345 (346)
Q Consensus       339 p~~R~~~  345 (346)
                      |++||++
T Consensus       236 p~~Rp~~  242 (251)
T cd05041         236 PENRPSF  242 (251)
T ss_pred             hhhCcCH
Confidence            9999985

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.5e-38  Score=282.41  Aligned_cols=239  Identities=23%  Similarity=0.390  Sum_probs=192.1

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc------CCCEEEEEEecCCCc-hhHHHHHHHHHHHHhcCCCCceeeEEEEecCCce
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ------DGMEVAVKVFDPQYE-GAFKSFDIECDVMKRICHRNLIKIISSYSNDDFK  174 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  174 (346)
                      .++|.+.+.||+|+||.||+|..+      .+..||+|.+..... .....+.+|+..++.++|||++++++++...+..
T Consensus         5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (288)
T cd05061           5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT   84 (288)
T ss_pred             HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence            457899999999999999999754      245799998864432 2334677899999999999999999999999999


Q ss_pred             eEEEecCCCCChhhhhhhcC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEe
Q 039799          175 ALVLEYMPHGSLEKCLYLSN---------YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLS  245 (346)
Q Consensus       175 ~lv~e~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~  245 (346)
                      ++||||+++|+|.+++....         ...++.....++.+++.||+|||   +.+++||||||+||++++++.++|+
T Consensus        85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~L~  161 (288)
T cd05061          85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIG  161 (288)
T ss_pred             EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEEEC
Confidence            99999999999999986421         33567788899999999999999   9999999999999999999999999


Q ss_pred             eecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHh----
Q 039799          246 DFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVN----  320 (346)
Q Consensus       246 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~----  320 (346)
                      |||+++...............++..|+|||...++.++.++||||||+++|||++ |..||......+  ....+.    
T Consensus       162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~--~~~~~~~~~~  239 (288)
T cd05061         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ--VLKFVMDGGY  239 (288)
T ss_pred             cCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCC
Confidence            9999986543322222222345678999999988889999999999999999998 788886532211  111111    


Q ss_pred             ----hhcCCChhhhhchhccCCccccccc
Q 039799          321 ----DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       321 ----~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                          ...+..+.+++.+|+..+|++||+.
T Consensus       240 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~  268 (288)
T cd05061         240 LDQPDNCPERVTDLMRMCWQFNPKMRPTF  268 (288)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhHCcCH
Confidence                1223468899999999999999986

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=3.1e-38  Score=281.71  Aligned_cols=235  Identities=28%  Similarity=0.426  Sum_probs=190.1

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCC--EEEEEEecCC-CchhHHHHHHHHHHHHhc-CCCCceeeEEEEecCCceeEE
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGM--EVAVKVFDPQ-YEGAFKSFDIECDVMKRI-CHRNLIKIISSYSNDDFKALV  177 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  177 (346)
                      ++|.+.+.||+|+||.||+|..+ ++.  .+++|.+... .....+.+.+|++++.++ +||||+++++++...+..+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            57889999999999999999875 333  4788888643 233456788999999999 799999999999999999999


Q ss_pred             EecCCCCChhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcE
Q 039799          178 LEYMPHGSLEKCLYLSN---------------YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVA  242 (346)
Q Consensus       178 ~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~  242 (346)
                      +||+++++|.+++....               ..+++..+..++.|++.||+|||   +.+++||||||+||++++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeE
Confidence            99999999999886432               24788999999999999999999   9999999999999999999999


Q ss_pred             EEeeecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHh-
Q 039799          243 HLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVN-  320 (346)
Q Consensus       243 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~-  320 (346)
                      +|+|||++......   ........+..|+|||+.....++.++||||||+++|||+| |..||......+  ...... 
T Consensus       159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~--~~~~~~~  233 (297)
T cd05089         159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE--LYEKLPQ  233 (297)
T ss_pred             EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHhc
Confidence            99999998743211   11111223567999999988889999999999999999997 999996532211  111111 


Q ss_pred             -------hhcCCChhhhhchhccCCccccccc
Q 039799          321 -------DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       321 -------~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                             ..++..+.+++.+|+..+|.+||+.
T Consensus       234 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~  265 (297)
T cd05089         234 GYRMEKPRNCDDEVYELMRQCWRDRPYERPPF  265 (297)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCH
Confidence                   1234478899999999999999985

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3e-38  Score=279.20  Aligned_cols=237  Identities=24%  Similarity=0.339  Sum_probs=194.5

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCC----EEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeE
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGM----EVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKAL  176 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  176 (346)
                      .+|.+.+.||+|+||.||+|.++ +|.    .+|+|.+.... ......+.+|+..+++++|||++++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            56888899999999999999865 333    58999887553 3345678899999999999999999999887 78889


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcc
Q 039799          177 VLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  256 (346)
Q Consensus       177 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~  256 (346)
                      |+||+++|+|.+++......+++...+.++.|++.|++|||   +.+++||||+|+||++++++.++|+|||.++.....
T Consensus        86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~  162 (279)
T cd05057          86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD  162 (279)
T ss_pred             EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence            99999999999998876667999999999999999999999   899999999999999999999999999999876533


Q ss_pred             ccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHhhh--------cCCCh
Q 039799          257 DQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVNDL--------LPISV  327 (346)
Q Consensus       257 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~--------~~~~~  327 (346)
                      ..........++..|+|||......++.++|+||||++++|++| |+.||+.....  ...+.+...        .+..+
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  240 (279)
T cd05057         163 EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV--EIPDLLEKGERLPQPPICTIDV  240 (279)
T ss_pred             ccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH--HHHHHHhCCCCCCCCCCCCHHH
Confidence            22222222224567999999888889999999999999999999 99999764221  222333221        12367


Q ss_pred             hhhhchhccCCccccccc
Q 039799          328 MEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       328 ~~~~d~~l~~~p~~R~~~  345 (346)
                      .+++.+|+..+|++||+.
T Consensus       241 ~~~~~~~l~~~p~~Rp~~  258 (279)
T cd05057         241 YMVLVKCWMIDAESRPTF  258 (279)
T ss_pred             HHHHHHHcCCChhhCCCH
Confidence            889999999999999985

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-38  Score=277.79  Aligned_cols=238  Identities=27%  Similarity=0.423  Sum_probs=197.4

Q ss_pred             CCCCCCCCcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecC
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYM  181 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  181 (346)
                      .++|.+.+.||+|++|.||+|..+++..+|+|.+..... ..+.+.+|++++++++|+|++++++++......+++|||+
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   83 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM   83 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence            467889999999999999999988888999999875433 3467889999999999999999999999989999999999


Q ss_pred             CCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccc
Q 039799          182 PHGSLEKCLYLSN-YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  260 (346)
Q Consensus       182 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~  260 (346)
                      ++++|.+++.... ..+++..+..++.+++.|++|||   +.+++|+||+|+||++++++.++++|||.+........ .
T Consensus        84 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~-~  159 (261)
T cd05034          84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY-T  159 (261)
T ss_pred             CCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccchhh-h
Confidence            9999999986543 56899999999999999999999   99999999999999999999999999999986643211 1


Q ss_pred             ccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHh-------hhcCCChhhhhc
Q 039799          261 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVN-------DLLPISVMEVVD  332 (346)
Q Consensus       261 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~-------~~~~~~~~~~~d  332 (346)
                      .......+..|+|||...+..++.++|+||+|++++|++| |+.||...... ........       ...+..+.+++.
T Consensus       160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~i~  238 (261)
T cd05034         160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR-EVLEQVERGYRMPRPPNCPEELYDLML  238 (261)
T ss_pred             hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence            1122234678999999988889999999999999999998 99999653221 11111111       112347899999


Q ss_pred             hhccCCccccccc
Q 039799          333 ANLLSQEDEHFTT  345 (346)
Q Consensus       333 ~~l~~~p~~R~~~  345 (346)
                      +|+..+|++||+.
T Consensus       239 ~~l~~~p~~Rp~~  251 (261)
T cd05034         239 QCWDKDPEERPTF  251 (261)
T ss_pred             HHcccCcccCCCH
Confidence            9999999999986

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=3.1e-38  Score=289.11  Aligned_cols=196  Identities=27%  Similarity=0.319  Sum_probs=165.7

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC--CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCC------
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ--YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDD------  172 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  172 (346)
                      .++|.+.+.||+|+||.||++... +|..+|+|++...  .......+.+|+.+++.++||||+++++++...+      
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            367899999999999999999865 6899999998643  2334567788999999999999999999886443      


Q ss_pred             ceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCcc
Q 039799          173 FKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  252 (346)
Q Consensus       173 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~  252 (346)
                      ..++||||+++ ++.+.+.   ..++...+..++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||+++.
T Consensus       100 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~  172 (359)
T cd07876         100 DVYLVMELMDA-NLCQVIH---MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART  172 (359)
T ss_pred             eeEEEEeCCCc-CHHHHHh---ccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCCccc
Confidence            46899999975 5555443   24778888899999999999999   99999999999999999999999999999985


Q ss_pred             CCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 039799          253 LLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDE  307 (346)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~  307 (346)
                      ....   .......+|..|+|||.+.+..++.++||||+|+++|||+||+.||..
T Consensus       173 ~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~  224 (359)
T cd07876         173 ACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQG  224 (359)
T ss_pred             cccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence            4322   122334689999999999988999999999999999999999999964

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=2.3e-38  Score=282.29  Aligned_cols=238  Identities=27%  Similarity=0.403  Sum_probs=194.6

Q ss_pred             CCCCCCCcccccCceEEEEEEEcC-----------------CCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceee
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQD-----------------GMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKI  164 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~  164 (346)
                      .+|.+.+.||+|+||.||++...+                 +..+|+|.+.... ....+.+.+|++++++++|||++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~   84 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL   84 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            568999999999999999998542                 2458999987543 3345678899999999999999999


Q ss_pred             EEEEecCCceeEEEecCCCCChhhhhhhcC----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCce
Q 039799          165 ISSYSNDDFKALVLEYMPHGSLEKCLYLSN----------YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNV  234 (346)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NI  234 (346)
                      ++++..++..++++|++++++|.+++....          ..+++..++.++.+++.||+|||   +.+++|+||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~Ni  161 (296)
T cd05051          85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhce
Confidence            999999999999999999999999886433          26899999999999999999999   99999999999999


Q ss_pred             EECCCCcEEEeeecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc--CCCCCCccccCc
Q 039799          235 LLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT--RTKPTDEIFSGE  312 (346)
Q Consensus       235 ll~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt--g~~p~~~~~~~~  312 (346)
                      +++.++.++|+|||+++...............++..|+|||+.....++.++||||||+++|||++  |..||......+
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05051         162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ  241 (296)
T ss_pred             eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH
Confidence            999999999999999986543332222233446788999999888889999999999999999998  777876532111


Q ss_pred             ccHHHHHh---------------hhcCCChhhhhchhccCCccccccc
Q 039799          313 MTLKRWVN---------------DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       313 ~~~~~~~~---------------~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                        ......               ...+..+.+++.+|+..+|++||++
T Consensus       242 --~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~  287 (296)
T cd05051         242 --VIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTF  287 (296)
T ss_pred             --HHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCH
Confidence              111111               1123478999999999999999986

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1e-38  Score=278.36  Aligned_cols=236  Identities=19%  Similarity=0.282  Sum_probs=195.0

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC-CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecC
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ-YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYM  181 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  181 (346)
                      +|.+.+.||+|++|.||++... +++.+|+|.+... .....+.+..|+.++++++|+|++++.+.+...+..+++|||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4677889999999999999866 7899999998643 2344567888999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccc
Q 039799          182 PHGSLEKCLYLS-NYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  260 (346)
Q Consensus       182 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~  260 (346)
                      ++++|.+++... ...++......++.+++.|+.|||   +.+++|+||+|+||++++++.++++|||.+........  
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--  155 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA--  155 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc--
Confidence            999999887543 345788899999999999999999   99999999999999999999999999999886533221  


Q ss_pred             ccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHH-------HhhhcCCChhhhhch
Q 039799          261 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRW-------VNDLLPISVMEVVDA  333 (346)
Q Consensus       261 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~-------~~~~~~~~~~~~~d~  333 (346)
                      ......++..|+|||...+..++.++|+||||+++|+|++|+.||....... .....       +...++..+.+++.+
T Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~  234 (255)
T cd08219         156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN-LILKVCQGSYKPLPSHYSYELRSLIKQ  234 (255)
T ss_pred             ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH-HHHHHhcCCCCCCCcccCHHHHHHHHH
Confidence            1223458889999999988889999999999999999999999997532111 01111       112234467899999


Q ss_pred             hccCCccccccc
Q 039799          334 NLLSQEDEHFTT  345 (346)
Q Consensus       334 ~l~~~p~~R~~~  345 (346)
                      ||..+|++||+.
T Consensus       235 ~l~~~P~~Rp~~  246 (255)
T cd08219         235 MFKRNPRSRPSA  246 (255)
T ss_pred             HHhCCcccCCCH
Confidence            999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.5e-38  Score=280.34  Aligned_cols=236  Identities=27%  Similarity=0.390  Sum_probs=188.5

Q ss_pred             CCCCcccccCceEEEEEEE-----cCCCEEEEEEecCCCc-hhHHHHHHHHHHHHhcCCCCceeeEEEEecC--CceeEE
Q 039799          106 NMPPLIGKGGFGSVYKAII-----QDGMEVAVKVFDPQYE-GAFKSFDIECDVMKRICHRNLIKIISSYSND--DFKALV  177 (346)
Q Consensus       106 ~~~~~lg~G~~g~vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv  177 (346)
                      .+.+.||+|+||+||++..     .++..+|+|.+..... .....+.+|++++++++|||++++++++...  ...+++
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI   86 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence            7889999999999988653     3578899999875432 3456788899999999999999999988653  367899


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccc
Q 039799          178 LEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  257 (346)
Q Consensus       178 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~  257 (346)
                      |||+++++|.+++...  .+++..+..++.+++.|+.|||   +.+++||||||+||++++++.++|+|||+++.+....
T Consensus        87 ~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  161 (283)
T cd05080          87 MEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH  161 (283)
T ss_pred             ecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccccCCcc
Confidence            9999999999988643  4899999999999999999999   9999999999999999999999999999998764322


Q ss_pred             ccc-ccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccC----------cccHHHHH-------
Q 039799          258 QSL-TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSG----------EMTLKRWV-------  319 (346)
Q Consensus       258 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~----------~~~~~~~~-------  319 (346)
                      ... ......++..|+|||......++.++||||||++++||+||..|+......          ......+.       
T Consensus       162 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (283)
T cd05080         162 EYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGM  241 (283)
T ss_pred             hhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCC
Confidence            111 112223566799999998888999999999999999999999998643211          00111111       


Q ss_pred             ----hhhcCCChhhhhchhccCCcccccccC
Q 039799          320 ----NDLLPISVMEVVDANLLSQEDEHFTTK  346 (346)
Q Consensus       320 ----~~~~~~~~~~~~d~~l~~~p~~R~~~k  346 (346)
                          ....+..+.+++.+|+..+|++||+.+
T Consensus       242 ~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~  272 (283)
T cd05080         242 RLPCPKNCPQEVYILMKNCWETEAKFRPTFR  272 (283)
T ss_pred             CCCCCCCCCHHHHHHHHHHhccChhhCCCHH
Confidence                112345889999999999999999863

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.5e-38  Score=278.02  Aligned_cols=239  Identities=25%  Similarity=0.458  Sum_probs=194.8

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CC---CEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeE
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DG---MEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKAL  176 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  176 (346)
                      +++|+..+.||+|++|.||+|... ++   ..+|+|.+.... ....+.+..|++++++++|||++++.+++...+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            356788899999999999999875 33   379999987543 3345678899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcc
Q 039799          177 VLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  256 (346)
Q Consensus       177 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~  256 (346)
                      ||||+++++|.+++......+++..+..++.+++.|++|||   +.+++|+||||+||++++++.++++|||++......
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  160 (268)
T cd05063          84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD  160 (268)
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence            99999999999998766667899999999999999999999   999999999999999999999999999999865432


Q ss_pred             cccc-ccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHhh--------hcCCC
Q 039799          257 DQSL-TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVND--------LLPIS  326 (346)
Q Consensus       257 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~--------~~~~~  326 (346)
                      .... .......+..|+|||+.....++.++||||||+++||+++ |+.||......  .....+..        ..+..
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~--~~~~~i~~~~~~~~~~~~~~~  238 (268)
T cd05063         161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH--EVMKAINDGFRLPAPMDCPSA  238 (268)
T ss_pred             cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH--HHHHHHhcCCCCCCCCCCCHH
Confidence            2111 1111223567999999988889999999999999999997 99999653221  12122111        12347


Q ss_pred             hhhhhchhccCCccccccc
Q 039799          327 VMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       327 ~~~~~d~~l~~~p~~R~~~  345 (346)
                      +.+++.+|+..+|++||+.
T Consensus       239 ~~~li~~c~~~~p~~Rp~~  257 (268)
T cd05063         239 VYQLMLQCWQQDRARRPRF  257 (268)
T ss_pred             HHHHHHHHcCCCcccCcCH
Confidence            7899999999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=8.7e-39  Score=286.59  Aligned_cols=239  Identities=26%  Similarity=0.355  Sum_probs=192.6

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc--------CCCEEEEEEecCCC-chhHHHHHHHHHHHHhc-CCCCceeeEEEEecC
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ--------DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRI-CHRNLIKIISSYSND  171 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  171 (346)
                      .++|.+.+.||+|+||.||++...        ++..+|+|.+.... ......+..|+++++++ +|||++++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            356889999999999999999753        23569999987542 33456788899999999 799999999999999


Q ss_pred             CceeEEEecCCCCChhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEE
Q 039799          172 DFKALVLEYMPHGSLEKCLYLSN---------------YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL  236 (346)
Q Consensus       172 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll  236 (346)
                      +..++||||+++++|.+++....               ..+++..+++++.+++.||+|||   +.+++||||||+||++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEE
Confidence            99999999999999999986532               24889999999999999999999   9999999999999999


Q ss_pred             CCCCcEEEeeecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccH
Q 039799          237 DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTL  315 (346)
Q Consensus       237 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~  315 (346)
                      +.++.++|+|||.++...............++..|+|||...+..++.++||||||+++|||++ |..||......  ..
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~--~~  251 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--EL  251 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH--HH
Confidence            9999999999999986543221111122234568999999988889999999999999999998 88888653211  11


Q ss_pred             HHHHh--------hhcCCChhhhhchhccCCccccccc
Q 039799          316 KRWVN--------DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       316 ~~~~~--------~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ...+.        ...+..+.+++.+|+..+|++||+.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  289 (307)
T cd05098         252 FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTF  289 (307)
T ss_pred             HHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCH
Confidence            11111        1123477899999999999999985

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-38  Score=280.36  Aligned_cols=239  Identities=23%  Similarity=0.388  Sum_probs=195.5

Q ss_pred             CCCCCCCCcccccCceEEEEEEEcC------CCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCce
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQD------GMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFK  174 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  174 (346)
                      .++|.+.+.||+|+||.||+|....      +..+|+|.+.... ......+.+|+.+++.++|||++++++++......
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            3568889999999999999998642      3689999986543 23345788899999999999999999999999999


Q ss_pred             eEEEecCCCCChhhhhhhcC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEe
Q 039799          175 ALVLEYMPHGSLEKCLYLSN---------YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLS  245 (346)
Q Consensus       175 ~lv~e~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~  245 (346)
                      ++||||+++++|.+++....         ..+++..++.++.+++.||.|||   +.+++||||+|+||+++.++.++|+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEEC
Confidence            99999999999999886432         24688899999999999999999   9999999999999999999999999


Q ss_pred             eecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHh----
Q 039799          246 DFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVN----  320 (346)
Q Consensus       246 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~----  320 (346)
                      |||+++.+.............++..|+|||......++.++||||||+++||++| |..||......  ...++..    
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~~~~~~~~~~~  239 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE--EVLKFVIDGGH  239 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH--HHHHHHhcCCC
Confidence            9999986644332222233446788999999988889999999999999999998 99998653211  1112221    


Q ss_pred             ----hhcCCChhhhhchhccCCccccccc
Q 039799          321 ----DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       321 ----~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                          ...+..+.+++.+|+..+|++|||.
T Consensus       240 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~  268 (277)
T cd05032         240 LDLPENCPDKLLELMRMCWQYNPKMRPTF  268 (277)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCCCH
Confidence                1123477899999999999999985

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2.5e-38  Score=278.31  Aligned_cols=237  Identities=24%  Similarity=0.390  Sum_probs=193.7

Q ss_pred             CCCCCCCCcccccCceEEEEEEEcC----CCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeE
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQD----GMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKAL  176 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  176 (346)
                      ..+|.+.+.||+|++|.||+|.+.+    ...+++|...... ....+.+.+|+.++++++|||++++++++.. +..++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l   83 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI   83 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence            3567888999999999999998653    2468999887554 3445688899999999999999999998875 45679


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcc
Q 039799          177 VLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  256 (346)
Q Consensus       177 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~  256 (346)
                      ||||+++++|.+++......+++..++.++.+++.||+|||   +.+++|+||||+||+++.++.++++|||+++.....
T Consensus        84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  160 (270)
T cd05056          84 VMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE  160 (270)
T ss_pred             EEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence            99999999999999766667899999999999999999999   999999999999999999999999999999865433


Q ss_pred             ccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHH--------hhhcCCCh
Q 039799          257 DQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWV--------NDLLPISV  327 (346)
Q Consensus       257 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~--------~~~~~~~~  327 (346)
                      .. ...+...++..|+|||......++.++||||||++++|+++ |..||......+  ...++        ....+..+
T Consensus       161 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  237 (270)
T cd05056         161 SY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND--VIGRIENGERLPMPPNCPPTL  237 (270)
T ss_pred             cc-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHcCCcCCCCCCCCHHH
Confidence            21 11222334568999999888889999999999999999996 999997643221  11111        12234588


Q ss_pred             hhhhchhccCCccccccc
Q 039799          328 MEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       328 ~~~~d~~l~~~p~~R~~~  345 (346)
                      .+++.+|+..+|++||++
T Consensus       238 ~~li~~~l~~~P~~Rpt~  255 (270)
T cd05056         238 YSLMTKCWAYDPSKRPRF  255 (270)
T ss_pred             HHHHHHHcCCChhhCcCH
Confidence            999999999999999986

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=8.9e-39  Score=293.41  Aligned_cols=235  Identities=23%  Similarity=0.291  Sum_probs=188.0

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC---CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeE
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ---YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKAL  176 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  176 (346)
                      ..++|.+.+.||+|+||.||++... +++.+|+|++...   .....+.+.+|+.+++.++||||+++++.+...+..++
T Consensus        41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l  120 (371)
T cd05622          41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM  120 (371)
T ss_pred             chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence            4478999999999999999999976 6889999998632   12234567789999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcc
Q 039799          177 VLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  256 (346)
Q Consensus       177 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~  256 (346)
                      ||||+++|+|.+++...  .++...+..++.+++.||+|||   +.+|+||||||+|||++.++.++|+|||++..+...
T Consensus       121 v~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~  195 (371)
T cd05622         121 VMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE  195 (371)
T ss_pred             EEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC
Confidence            99999999999988543  4778888889999999999999   999999999999999999999999999999876432


Q ss_pred             ccccccccccCCcccccCCCCCCC----CCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh----------hh
Q 039799          257 DQSLTQTQTLATIGYMAPEYGREG----RVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN----------DL  322 (346)
Q Consensus       257 ~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~----------~~  322 (346)
                      .. .......||+.|+|||++...    .++.++|||||||++|||++|+.||...... ........          ..
T Consensus       196 ~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~  273 (371)
T cd05622         196 GM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-GTYSKIMNHKNSLTFPDDND  273 (371)
T ss_pred             Cc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH-HHHHHHHcCCCcccCCCcCC
Confidence            21 122345699999999987653    3788999999999999999999999753211 11111111          12


Q ss_pred             cCCChhhhhchhccCCccccc
Q 039799          323 LPISVMEVVDANLLSQEDEHF  343 (346)
Q Consensus       323 ~~~~~~~~~d~~l~~~p~~R~  343 (346)
                      ++..+.+++.++|. +|..|+
T Consensus       274 ~s~~~~~li~~~L~-~~~~r~  293 (371)
T cd05622         274 ISKEAKNLICAFLT-DREVRL  293 (371)
T ss_pred             CCHHHHHHHHHHcC-Chhhhc
Confidence            33366789999997 555553

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.6e-38  Score=279.70  Aligned_cols=238  Identities=24%  Similarity=0.308  Sum_probs=191.4

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhc-CCCCceeeEEEEecC------Cc
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRI-CHRNLIKIISSYSND------DF  173 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~------~~  173 (346)
                      ...|.+.+.||+|+||.||+|... +++.+|+|++..... ....+..|+.++.++ +|+|++++.+++...      ..
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (272)
T cd06637           5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ   83 (272)
T ss_pred             hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc-cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence            356888899999999999999865 688999999865432 345678899999998 699999999998653      45


Q ss_pred             eeEEEecCCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCcc
Q 039799          174 KALVLEYMPHGSLEKCLYLS-NYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  252 (346)
Q Consensus       174 ~~lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~  252 (346)
                      .+++|||+.+++|.+++... ...+++..+..++.|++.|++|||   +.+++|+||+|+||++++++.++|+|||++..
T Consensus        84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~  160 (272)
T cd06637          84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  160 (272)
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence            78999999999999988753 356889999999999999999999   89999999999999999999999999999886


Q ss_pred             CCccccccccccccCCcccccCCCCC-----CCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHH-------Hh
Q 039799          253 LLEEDQSLTQTQTLATIGYMAPEYGR-----EGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRW-------VN  320 (346)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~-------~~  320 (346)
                      .....  .......|+..|+|||++.     +..++.++|||||||++|||++|+.||+...........+       ..
T Consensus       161 ~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  238 (272)
T cd06637         161 LDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKS  238 (272)
T ss_pred             ccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCC
Confidence            53221  1223456889999999875     3457889999999999999999999996532111111000       11


Q ss_pred             hhcCCChhhhhchhccCCccccccc
Q 039799          321 DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       321 ~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ..++..+.+++.+||..+|.+||++
T Consensus       239 ~~~~~~~~~li~~~l~~~p~~Rpt~  263 (272)
T cd06637         239 KKWSKKFQSFIESCLVKNHSQRPTT  263 (272)
T ss_pred             CCcCHHHHHHHHHHcCCChhhCCCH
Confidence            1234478899999999999999985

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.4e-38  Score=274.21  Aligned_cols=230  Identities=28%  Similarity=0.396  Sum_probs=186.5

Q ss_pred             CcccccCceEEEEEEEc-C---CCEEEEEEecCCCc-hhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecCCC
Q 039799          109 PLIGKGGFGSVYKAIIQ-D---GMEVAVKVFDPQYE-GAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPH  183 (346)
Q Consensus       109 ~~lg~G~~g~vy~~~~~-~---~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  183 (346)
                      +.||+|+||.||+|.+. .   +..+|+|.+..... ...+.+.+|+++++++.|+|++++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            46899999999999754 2   26899999875543 34567889999999999999999999876 4567899999999


Q ss_pred             CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccc-c
Q 039799          184 GSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT-Q  262 (346)
Q Consensus       184 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~-~  262 (346)
                      ++|.+++.... .+++..++.++.+++.+++|||   ..+++|+||||+||+++.++.++|+|||+++.......... .
T Consensus        80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~  155 (257)
T cd05060          80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT  155 (257)
T ss_pred             CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence            99999987543 6899999999999999999999   99999999999999999999999999999987643322111 1


Q ss_pred             ccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHhh--------hcCCChhhhhch
Q 039799          263 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVND--------LLPISVMEVVDA  333 (346)
Q Consensus       263 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~d~  333 (346)
                      ....++..|+|||...+..++.++||||||+++||+++ |+.||+....  .....++..        ..+..+.+++.+
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~  233 (257)
T cd05060         156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVIAMLESGERLPRPEECPQEIYSIMLS  233 (257)
T ss_pred             cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHHcCCcCCCCCCCCHHHHHHHHH
Confidence            11223567999999988889999999999999999998 9999976322  222222211        223467899999


Q ss_pred             hccCCccccccc
Q 039799          334 NLLSQEDEHFTT  345 (346)
Q Consensus       334 ~l~~~p~~R~~~  345 (346)
                      |+..+|++||+.
T Consensus       234 cl~~~p~~Rp~~  245 (257)
T cd05060         234 CWKYRPEDRPTF  245 (257)
T ss_pred             HhcCChhhCcCH
Confidence            999999999985

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.1e-38  Score=278.39  Aligned_cols=236  Identities=25%  Similarity=0.406  Sum_probs=195.9

Q ss_pred             CCCCCCCcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecCC
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMP  182 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  182 (346)
                      .+|.+.+.||+|++|.||++.+.++..+|+|.+..... ....+.+|++++++++|||++++++++......++++||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            56788899999999999999988788999999865432 24578889999999999999999999999999999999999


Q ss_pred             CCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccccc
Q 039799          183 HGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ  262 (346)
Q Consensus       183 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~  262 (346)
                      +++|.+++......+++..+..++.+++.+++|||   +.+++|+||+|+||+++.++.++|+|||.+........ ...
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~  158 (256)
T cd05112          83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-TSS  158 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCcc-ccc
Confidence            99999988766666889999999999999999999   99999999999999999999999999999886533211 111


Q ss_pred             ccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHH--------hhhcCCChhhhhch
Q 039799          263 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWV--------NDLLPISVMEVVDA  333 (346)
Q Consensus       263 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~~d~  333 (346)
                      ....++.+|+|||...++.++.++||||||+++||+++ |+.||......  ...+..        ....+..+.+++.+
T Consensus       159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~~  236 (256)
T cd05112         159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS--EVVETINAGFRLYKPRLASQSVYELMQH  236 (256)
T ss_pred             CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH--HHHHHHhCCCCCCCCCCCCHHHHHHHHH
Confidence            22335678999999988889999999999999999998 99998753221  111111        11234478899999


Q ss_pred             hccCCccccccc
Q 039799          334 NLLSQEDEHFTT  345 (346)
Q Consensus       334 ~l~~~p~~R~~~  345 (346)
                      |+..+|++||+.
T Consensus       237 ~l~~~p~~Rp~~  248 (256)
T cd05112         237 CWKERPEDRPSF  248 (256)
T ss_pred             HcccChhhCCCH
Confidence            999999999986

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.8e-38  Score=293.63  Aligned_cols=233  Identities=23%  Similarity=0.244  Sum_probs=189.8

Q ss_pred             CCCCCCCcccccCceEEEEEEEc---CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEe
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ---DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLE  179 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  179 (346)
                      .+|.+.+.||+|+||.||++...   .+..||+|.+...     ....+|++++++++||||+++++.+......+++||
T Consensus        92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e  166 (392)
T PHA03207         92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP  166 (392)
T ss_pred             CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence            46899999999999999999753   4578999987643     234579999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccc
Q 039799          180 YMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  259 (346)
Q Consensus       180 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~  259 (346)
                      ++. ++|.+++. ....+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.++|+|||+++.+......
T Consensus       167 ~~~-~~l~~~l~-~~~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~  241 (392)
T PHA03207        167 KYK-CDLFTYVD-RSGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT  241 (392)
T ss_pred             hcC-CCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCccccc
Confidence            995 68888773 4456899999999999999999999   999999999999999999999999999999876443332


Q ss_pred             cccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCc------------------------ccH
Q 039799          260 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE------------------------MTL  315 (346)
Q Consensus       260 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~------------------------~~~  315 (346)
                      .......||+.|+|||++....++.++|||||||++|||++|+.||.......                        ..+
T Consensus       242 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~  321 (392)
T PHA03207        242 PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNL  321 (392)
T ss_pred             ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhH
Confidence            23334569999999999998899999999999999999999999985422110                        000


Q ss_pred             HHHH------------------hhhcCCChhhhhchhccCCccccccc
Q 039799          316 KRWV------------------NDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       316 ~~~~------------------~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      .+..                  +..++..+.+++.+||..||++||++
T Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa  369 (392)
T PHA03207        322 CKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSA  369 (392)
T ss_pred             HHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCH
Confidence            0000                  01123366789999999999999986

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.2e-38  Score=274.12  Aligned_cols=232  Identities=31%  Similarity=0.456  Sum_probs=195.9

Q ss_pred             CCCCCCCCcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecC
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYM  181 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  181 (346)
                      .++|.+.+.||+|++|.||+|... |+.+|+|.+..... ..+++.+|+.++++++|+|++++++++...+..++||||+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            357888999999999999999876 78999999976543 4678889999999999999999999999899999999999


Q ss_pred             CCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccc
Q 039799          182 PHGSLEKCLYLSN-YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  260 (346)
Q Consensus       182 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~  260 (346)
                      ++++|.+++.... ..+++.....++.+++.|+.|||   +.+++|+||||+||++++++.++|+|||.++......   
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~---  156 (256)
T cd05039          83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ---  156 (256)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEccccccccccccc---
Confidence            9999999886554 36899999999999999999999   9999999999999999999999999999998763211   


Q ss_pred             ccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHh--------hhcCCChhhhh
Q 039799          261 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVN--------DLLPISVMEVV  331 (346)
Q Consensus       261 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~  331 (346)
                        .....+..|.|||+.....++.++||||||++++|+++ |+.||......  .....+.        ...+..+.+++
T Consensus       157 --~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li  232 (256)
T cd05039         157 --DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPHVEKGYRMEAPEGCPPEVYKVM  232 (256)
T ss_pred             --ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHhcCCCCCCccCCCHHHHHHH
Confidence              12234677999999988889999999999999999997 99998653211  1111111        12345789999


Q ss_pred             chhccCCccccccc
Q 039799          332 DANLLSQEDEHFTT  345 (346)
Q Consensus       332 d~~l~~~p~~R~~~  345 (346)
                      .+|+..+|++||++
T Consensus       233 ~~~l~~~p~~Rp~~  246 (256)
T cd05039         233 KDCWELDPAKRPTF  246 (256)
T ss_pred             HHHhccChhhCcCH
Confidence            99999999999986

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2.4e-38  Score=277.51  Aligned_cols=235  Identities=26%  Similarity=0.326  Sum_probs=197.3

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecC
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYM  181 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  181 (346)
                      +|++.+.||+|++|.||++... +++.+|+|.+.... ....+.+.+|++++++++|||++++++.+...+..++++||+
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM   81 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence            5778889999999999999976 68999999987653 344567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccc
Q 039799          182 PHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYS-APIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  260 (346)
Q Consensus       182 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~  260 (346)
                      ++++|.+++......++......++.+++.+++|||   + .+++|+||+|+||++++++.++|+|||.+........  
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--  156 (265)
T cd06605          82 DGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA--  156 (265)
T ss_pred             CCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh--
Confidence            999999998765567889999999999999999999   8 9999999999999999999999999999876532211  


Q ss_pred             ccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHhh-------h-----cCCChh
Q 039799          261 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVND-------L-----LPISVM  328 (346)
Q Consensus       261 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~-------~-----~~~~~~  328 (346)
                        ....++..|+|||...+..++.++||||||++++++++|+.||.............+..       .     ++..+.
T Consensus       157 --~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (265)
T cd06605         157 --KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQ  234 (265)
T ss_pred             --hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHH
Confidence              11557889999999988899999999999999999999999997542211212121111       1     344688


Q ss_pred             hhhchhccCCccccccc
Q 039799          329 EVVDANLLSQEDEHFTT  345 (346)
Q Consensus       329 ~~~d~~l~~~p~~R~~~  345 (346)
                      +++.+|+..+|++||+.
T Consensus       235 ~li~~~l~~~p~~Rpt~  251 (265)
T cd06605         235 DFVNLCLIKDPRERPSY  251 (265)
T ss_pred             HHHHHHcCCCchhCcCH
Confidence            99999999999999985

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.1e-38  Score=277.22  Aligned_cols=236  Identities=24%  Similarity=0.372  Sum_probs=193.0

Q ss_pred             CCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCch---------hHHHHHHHHHHHHhcCCCCceeeEEEEecCCce
Q 039799          105 ANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEG---------AFKSFDIECDVMKRICHRNLIKIISSYSNDDFK  174 (346)
Q Consensus       105 ~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  174 (346)
                      |.+...||+|++|.||+|... +++.+|+|.+......         ..+.+.+|++++++++||||+++++++.+.+..
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL   81 (267)
T ss_pred             ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence            677889999999999999865 6889999988643221         235677899999999999999999999999999


Q ss_pred             eEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCC
Q 039799          175 ALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  254 (346)
Q Consensus       175 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~  254 (346)
                      ++++||+++++|.+++... ..+++..+..++.+++.|++|||   +.+++||||+|+||++++++.++|+|||.++...
T Consensus        82 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~  157 (267)
T cd06628          82 NIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLE  157 (267)
T ss_pred             EEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence            9999999999999988643 45788889999999999999999   9999999999999999999999999999998765


Q ss_pred             ccccc----cccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHH---HHH----hhhc
Q 039799          255 EEDQS----LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLK---RWV----NDLL  323 (346)
Q Consensus       255 ~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~---~~~----~~~~  323 (346)
                      .....    .......++..|+|||...+..++.++|+||+|+++|||++|+.||....... ...   ...    ...+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~  236 (267)
T cd06628         158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ-AIFKIGENASPEIPSNI  236 (267)
T ss_pred             cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH-HHHHHhccCCCcCCccc
Confidence            32111    11122347889999999988889999999999999999999999997632211 111   111    1223


Q ss_pred             CCChhhhhchhccCCccccccc
Q 039799          324 PISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       324 ~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      +..+.+++.+||..+|++||+.
T Consensus       237 ~~~~~~li~~~l~~~p~~Rp~~  258 (267)
T cd06628         237 SSEAIDFLEKTFEIDHNKRPTA  258 (267)
T ss_pred             CHHHHHHHHHHccCCchhCcCH
Confidence            4477899999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=5.7e-38  Score=275.95  Aligned_cols=234  Identities=23%  Similarity=0.314  Sum_probs=181.8

Q ss_pred             CcccccCceEEEEEEEcC---CCEEEEEEecCCCc-hhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecCCCC
Q 039799          109 PLIGKGGFGSVYKAIIQD---GMEVAVKVFDPQYE-GAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHG  184 (346)
Q Consensus       109 ~~lg~G~~g~vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  184 (346)
                      +.||+|+||.||+|.+.+   +..+|+|.+..... .....+.+|+.++++++|||++++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            368999999999998653   45789998865432 33457888999999999999999999999999999999999999


Q ss_pred             ChhhhhhhcC----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccc
Q 039799          185 SLEKCLYLSN----YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  260 (346)
Q Consensus       185 sL~~~l~~~~----~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~  260 (346)
                      +|.+++....    ...++..+..++.+++.|++|||   +.+++|+||||+||+++.++.++|+|||++..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            9999886432    34677788889999999999999   9999999999999999999999999999997543322222


Q ss_pred             ccccccCCcccccCCCCCCC-------CCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHH-----------Hhh
Q 039799          261 TQTQTLATIGYMAPEYGREG-------RVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRW-----------VND  321 (346)
Q Consensus       261 ~~~~~~~~~~y~aPE~~~~~-------~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~-----------~~~  321 (346)
                      ......++..|+|||+....       .++.++|+||||+++|||++ |+.||......+.....+           ...
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKL  237 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCC
Confidence            22334577889999987532       35789999999999999996 999997533221100000           011


Q ss_pred             hcCCChhhhhchhccCCcccccccC
Q 039799          322 LLPISVMEVVDANLLSQEDEHFTTK  346 (346)
Q Consensus       322 ~~~~~~~~~~d~~l~~~p~~R~~~k  346 (346)
                      ..++.+.+++..|+ .+|++||+.+
T Consensus       238 ~~~~~~~~l~~~c~-~~P~~Rpt~~  261 (269)
T cd05087         238 PLSDRWYEVMQFCW-LQPEQRPSAE  261 (269)
T ss_pred             CCChHHHHHHHHHh-cCcccCCCHH
Confidence            12335678999998 6899999863

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.7e-38  Score=277.93  Aligned_cols=235  Identities=28%  Similarity=0.434  Sum_probs=192.5

Q ss_pred             CCCCCCCcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecCC
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMP  182 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  182 (346)
                      .+|.+...||+|++|.||+|.+..+..+|+|.+.... ...+.+.+|++++++++|+|++++++++. .+..+++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence            4578888999999999999998877789999876543 23467888999999999999999998875 456789999999


Q ss_pred             CCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccc
Q 039799          183 HGSLEKCLYLSN-YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT  261 (346)
Q Consensus       183 ~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~  261 (346)
                      +++|.+++.... ..+++..+..++.+++.||+|||   +.+++|+||+|+||++++++.++|+|||++........ ..
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~-~~  159 (260)
T cd05069          84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-TA  159 (260)
T ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc-cc
Confidence            999999986543 45889999999999999999999   99999999999999999999999999999986533221 11


Q ss_pred             cccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHhh--------hcCCChhhhhc
Q 039799          262 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVND--------LLPISVMEVVD  332 (346)
Q Consensus       262 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~d  332 (346)
                      .....++..|+|||...+..++.++||||||+++|||+| |+.||......+  ...+...        ..+..+.+++.
T Consensus       160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~  237 (260)
T cd05069         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE--VLEQVERGYRMPCPQGCPESLHELMK  237 (260)
T ss_pred             cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCCCCCCcccCHHHHHHHH
Confidence            122345678999999988889999999999999999999 999997643221  1122211        23347889999


Q ss_pred             hhccCCccccccc
Q 039799          333 ANLLSQEDEHFTT  345 (346)
Q Consensus       333 ~~l~~~p~~R~~~  345 (346)
                      +||..+|++||+.
T Consensus       238 ~~l~~~p~~Rp~~  250 (260)
T cd05069         238 LCWKKDPDERPTF  250 (260)
T ss_pred             HHccCCcccCcCH
Confidence            9999999999985

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=3.1e-38  Score=276.95  Aligned_cols=237  Identities=24%  Similarity=0.348  Sum_probs=194.2

Q ss_pred             CCCCCCcccccCceEEEEEEEcCCCEEEEEEecCCC------chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEE
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQY------EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALV  177 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  177 (346)
                      +|...+.||+|+||.||+|...+++.+|+|.+....      ......+.+|++++++++|+|++++++++.+.+..+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            477889999999999999998889999999886432      12235688899999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccc
Q 039799          178 LEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  257 (346)
Q Consensus       178 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~  257 (346)
                      +||+++++|.+++... ..+++.....++.+++.|++|||   +.+++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  156 (265)
T cd06631          81 MEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG  156 (265)
T ss_pred             EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence            9999999999988643 45788889999999999999999   9999999999999999999999999999988653211


Q ss_pred             c----ccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHH---------HhhhcC
Q 039799          258 Q----SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRW---------VNDLLP  324 (346)
Q Consensus       258 ~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~---------~~~~~~  324 (346)
                      .    ........++..|+|||...+..++.++||||||++++|+++|+.||....... .....         +...++
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  235 (265)
T cd06631         157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA-AMFYIGAHRGLMPRLPDSFS  235 (265)
T ss_pred             ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-HHHHhhhccCCCCCCCCCCC
Confidence            1    111223458899999999988889999999999999999999999997532111 11111         111233


Q ss_pred             CChhhhhchhccCCccccccc
Q 039799          325 ISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       325 ~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ..+.+++.+||..+|++||+.
T Consensus       236 ~~~~~~i~~~l~~~p~~Rp~~  256 (265)
T cd06631         236 AAAIDFVTSCLTRDQHERPSA  256 (265)
T ss_pred             HHHHHHHHHHhcCCcccCCCH
Confidence            467899999999999999985

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.9e-38  Score=283.96  Aligned_cols=239  Identities=26%  Similarity=0.369  Sum_probs=193.5

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc--------CCCEEEEEEecCCC-chhHHHHHHHHHHHHhc-CCCCceeeEEEEecC
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ--------DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRI-CHRNLIKIISSYSND  171 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  171 (346)
                      ..+|.+.+.||+|+||.||+|.+.        ++..+|+|.+.... ....+.+.+|+.+++.+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            356888999999999999999742        24579999986542 33456788999999999 899999999999999


Q ss_pred             CceeEEEecCCCCChhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEE
Q 039799          172 DFKALVLEYMPHGSLEKCLYLSN---------------YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL  236 (346)
Q Consensus       172 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll  236 (346)
                      ...+++|||+++++|.+++....               ..+++..+..++.|+++||+|||   +.+++||||||+||++
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nili  170 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVLV  170 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceEEE
Confidence            99999999999999999986432               35788899999999999999999   9999999999999999


Q ss_pred             CCCCcEEEeeecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccH
Q 039799          237 DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTL  315 (346)
Q Consensus       237 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~  315 (346)
                      ++++.++|+|||+++...............++..|+|||+..+..++.++||||||+++||+++ |..||......  ..
T Consensus       171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~  248 (304)
T cd05101         171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--EL  248 (304)
T ss_pred             cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--HH
Confidence            9999999999999987643322222223345678999999988889999999999999999998 78888653211  11


Q ss_pred             HHHHhh--------hcCCChhhhhchhccCCccccccc
Q 039799          316 KRWVND--------LLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       316 ~~~~~~--------~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ...+..        ..+..+.+++.+|+..+|++||+.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~  286 (304)
T cd05101         249 FKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTF  286 (304)
T ss_pred             HHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCH
Confidence            111111        123478899999999999999985

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=2.3e-38  Score=283.25  Aligned_cols=236  Identities=28%  Similarity=0.422  Sum_probs=190.3

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCC--EEEEEEecCCC-chhHHHHHHHHHHHHhc-CCCCceeeEEEEecCCceeE
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGM--EVAVKVFDPQY-EGAFKSFDIECDVMKRI-CHRNLIKIISSYSNDDFKAL  176 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  176 (346)
                      .++|.+.+.||+|+||.||+|.++ ++.  .+++|.+.... ......+.+|++++.++ +|+|++++++++...+..++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            357889999999999999999975 454  45777776432 33456788899999999 89999999999999999999


Q ss_pred             EEecCCCCChhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCc
Q 039799          177 VLEYMPHGSLEKCLYLSN---------------YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV  241 (346)
Q Consensus       177 v~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~  241 (346)
                      |+||+++++|.+++....               ..+++..++.++.+++.|++|||   +.+++||||||+|||+++++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCc
Confidence            999999999999886432               35789999999999999999999   999999999999999999999


Q ss_pred             EEEeeecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHh
Q 039799          242 AHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVN  320 (346)
Q Consensus       242 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~  320 (346)
                      ++|+|||++......   ........+..|+|||+.....++.++||||||++++||+| |..||......  ...+.+.
T Consensus       163 ~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~~~  237 (303)
T cd05088         163 AKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--ELYEKLP  237 (303)
T ss_pred             EEeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH--HHHHHHh
Confidence            999999998743111   11111224667999999888888999999999999999998 99998653221  1111121


Q ss_pred             h--------hcCCChhhhhchhccCCccccccc
Q 039799          321 D--------LLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       321 ~--------~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      .        ..+..+.+++.+|+..+|++||+.
T Consensus       238 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~  270 (303)
T cd05088         238 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSF  270 (303)
T ss_pred             cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCH
Confidence            1        134477899999999999999985

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=7.3e-38  Score=273.41  Aligned_cols=229  Identities=24%  Similarity=0.368  Sum_probs=186.0

Q ss_pred             cccccCceEEEEEEEc---CCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecCCCC
Q 039799          110 LIGKGGFGSVYKAIIQ---DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHG  184 (346)
Q Consensus       110 ~lg~G~~g~vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  184 (346)
                      .||+|+||.||+|.++   ++..+|+|++....  ....+.+..|+.+++.++||||+++++++. .+..++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            5899999999999753   57889999986443  234567889999999999999999999885 45678999999999


Q ss_pred             ChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccc-ccc
Q 039799          185 SLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL-TQT  263 (346)
Q Consensus       185 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~-~~~  263 (346)
                      +|.+++... ..+++.....++.|++.|++|||   +.+++||||||+||++++++.++|+|||+++.+....... ...
T Consensus        81 ~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05116          81 PLNKFLQKN-KHVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT  156 (257)
T ss_pred             cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence            999988643 46889999999999999999999   9999999999999999999999999999998764332211 112


Q ss_pred             cccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHh--------hhcCCChhhhhchh
Q 039799          264 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVN--------DLLPISVMEVVDAN  334 (346)
Q Consensus       264 ~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~d~~  334 (346)
                      ...++..|+|||......++.++|+||||+++|||+| |+.||......  .....+.        ...+..+.+++.+|
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~i~~~~~~~~~~~~~~~l~~li~~~  234 (257)
T cd05116         157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--EVTQMIESGERMECPQRCPPEMYDLMKLC  234 (257)
T ss_pred             CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHCCCCCCCCCCCCHHHHHHHHHH
Confidence            2234578999999888888999999999999999998 99999763221  1222222        12345889999999


Q ss_pred             ccCCccccccc
Q 039799          335 LLSQEDEHFTT  345 (346)
Q Consensus       335 l~~~p~~R~~~  345 (346)
                      +..+|++||+.
T Consensus       235 ~~~~p~~Rp~~  245 (257)
T cd05116         235 WTYGVDERPGF  245 (257)
T ss_pred             hccCchhCcCH
Confidence            99999999984

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=6.9e-39  Score=290.10  Aligned_cols=232  Identities=22%  Similarity=0.306  Sum_probs=187.3

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC---CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEE
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ---YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVL  178 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  178 (346)
                      ++|.+.+.||+|+||.||+++.. +++.+|+|++...   .......+.+|..++..++|+||+++.+++...+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888899999999999999976 6889999998642   1223455778999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccc
Q 039799          179 EYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  258 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~  258 (346)
                      ||+++|+|.+++......+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.++|+|||++..+.....
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  157 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT  157 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence            999999999999765667889999999999999999999   99999999999999999999999999999986543221


Q ss_pred             ccccccccCCcccccCCCCCC-----CCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh-----------hh
Q 039799          259 SLTQTQTLATIGYMAPEYGRE-----GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN-----------DL  322 (346)
Q Consensus       259 ~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~-----------~~  322 (346)
                       .......|++.|+|||++.+     +.++.++||||||+++|||++|+.||......+ .......           ..
T Consensus       158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-~~~~i~~~~~~~~~p~~~~~  235 (331)
T cd05624         158 -VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE-TYGKIMNHEERFQFPSHITD  235 (331)
T ss_pred             -eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH-HHHHHHcCCCcccCCCcccc
Confidence             12233568999999998765     457889999999999999999999996522111 0111100           11


Q ss_pred             cCCChhhhhchhccCCc
Q 039799          323 LPISVMEVVDANLLSQE  339 (346)
Q Consensus       323 ~~~~~~~~~d~~l~~~p  339 (346)
                      ++..+.+++.++|..++
T Consensus       236 ~~~~~~~li~~ll~~~~  252 (331)
T cd05624         236 VSEEAKDLIQRLICSRE  252 (331)
T ss_pred             CCHHHHHHHHHHccCch
Confidence            24467889999887654

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.1e-38  Score=280.89  Aligned_cols=240  Identities=24%  Similarity=0.407  Sum_probs=192.5

Q ss_pred             CCCCCCcccccCceEEEEEEE-----cCCCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecC--Ccee
Q 039799          104 DANMPPLIGKGGFGSVYKAII-----QDGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSND--DFKA  175 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~  175 (346)
                      -|.+.+.||+|+||.||.+..     .++..||+|.+.... ......+.+|++++++++|||++++.+++...  ...+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK   84 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence            367788999999999999974     257889999987543 33346788999999999999999999998775  5788


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCc
Q 039799          176 LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  255 (346)
Q Consensus       176 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~  255 (346)
                      +||||+++++|.+++......+++..++.++.+++.||+|||   +.+++||||||+||+++.++.++|+|||+++.+..
T Consensus        85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05079          85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET  161 (284)
T ss_pred             EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence            999999999999998765557899999999999999999999   99999999999999999999999999999987643


Q ss_pred             ccccc-ccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCcccc----------CcccHHHHH-----
Q 039799          256 EDQSL-TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFS----------GEMTLKRWV-----  319 (346)
Q Consensus       256 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~----------~~~~~~~~~-----  319 (346)
                      ..... ......++..|+|||...+..++.++||||||+++||++|++.|......          .+.....++     
T Consensus       162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (284)
T cd05079         162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEE  241 (284)
T ss_pred             CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHc
Confidence            22211 11233467789999998888899999999999999999998876532111          111111111     


Q ss_pred             ------hhhcCCChhhhhchhccCCcccccccC
Q 039799          320 ------NDLLPISVMEVVDANLLSQEDEHFTTK  346 (346)
Q Consensus       320 ------~~~~~~~~~~~~d~~l~~~p~~R~~~k  346 (346)
                            ...++..+.+++.+||..+|++||+++
T Consensus       242 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~  274 (284)
T cd05079         242 GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQ  274 (284)
T ss_pred             CccCCCCCCCCHHHHHHHHHHccCCcccCcCHH
Confidence                  112334788999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=5.7e-38  Score=281.05  Aligned_cols=238  Identities=24%  Similarity=0.309  Sum_probs=193.5

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEE
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVL  178 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  178 (346)
                      ++|.+.+.||+|+||.||++... .++.|++|.+....   ....+.+.+|+++++.++||||+++++.+...+..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            35788899999999999999976 67899999986543   223457778999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccc-
Q 039799          179 EYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED-  257 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~-  257 (346)
                      ||+++++|.+++... ..+++.....++.+++.|++|||   +.+++||||+|+||+++.++.++++|||+++...... 
T Consensus        81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~  156 (305)
T cd05609          81 EYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT  156 (305)
T ss_pred             ecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence            999999999998654 45888889999999999999999   9999999999999999999999999999987421100 


Q ss_pred             ------------cccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHhh----
Q 039799          258 ------------QSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVND----  321 (346)
Q Consensus       258 ------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~----  321 (346)
                                  .........++..|+|||++....++.++|+||||+++||+++|..||...... .........    
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~-~~~~~~~~~~~~~  235 (305)
T cd05609         157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE-ELFGQVISDDIEW  235 (305)
T ss_pred             ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcccCC
Confidence                        000111235788899999998888999999999999999999999999643211 111222211    


Q ss_pred             -----hcCCChhhhhchhccCCccccccc
Q 039799          322 -----LLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       322 -----~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                           .++..+.+++.+||..+|++||++
T Consensus       236 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~  264 (305)
T cd05609         236 PEGDEALPADAQDLISRLLRQNPLERLGT  264 (305)
T ss_pred             CCccccCCHHHHHHHHHHhccChhhccCc
Confidence                 234468999999999999999973

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=2.5e-38  Score=279.41  Aligned_cols=235  Identities=26%  Similarity=0.359  Sum_probs=195.2

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecC
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYM  181 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  181 (346)
                      .|...+.||+|++|.||+|... ++..+|+|++.... ....+.+.+|+++++++.|||++++++++...+..++||||+
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence            4677888999999999999976 68899999987543 345677889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccc
Q 039799          182 PHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT  261 (346)
Q Consensus       182 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~  261 (346)
                      ++++|.+++..  ..+++.....++.+++.|++|||   +.+++|+||+|+||+++.++.++++|||++........  .
T Consensus        85 ~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~  157 (277)
T cd06640          85 GGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--K  157 (277)
T ss_pred             CCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc--c
Confidence            99999998853  35788888999999999999999   99999999999999999999999999999986543221  1


Q ss_pred             cccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccH------HHHHhhhcCCChhhhhchhc
Q 039799          262 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTL------KRWVNDLLPISVMEVVDANL  335 (346)
Q Consensus       262 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~------~~~~~~~~~~~~~~~~d~~l  335 (346)
                      .....++..|.|||...+..++.++|+||||+++|||+||+.|+..........      ...+...++..+.+++.+|+
T Consensus       158 ~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  237 (277)
T cd06640         158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACL  237 (277)
T ss_pred             cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHc
Confidence            223457889999999988889999999999999999999999997543221100      11112223447889999999


Q ss_pred             cCCccccccc
Q 039799          336 LSQEDEHFTT  345 (346)
Q Consensus       336 ~~~p~~R~~~  345 (346)
                      ..+|++||+.
T Consensus       238 ~~~p~~Rp~~  247 (277)
T cd06640         238 NKDPSFRPTA  247 (277)
T ss_pred             ccCcccCcCH
Confidence            9999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=6.7e-39  Score=280.06  Aligned_cols=235  Identities=30%  Similarity=0.485  Sum_probs=193.1

Q ss_pred             CCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHH--HHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecC
Q 039799          105 ANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFK--SFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYM  181 (346)
Q Consensus       105 ~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~--~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  181 (346)
                      |.+.+.||+|+||+||++... +++.+|+|++.........  ...+|+.++++++||||+++++++......++|||++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            456678999999999999977 5678999999876533222  3355999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccc
Q 039799          182 PHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT  261 (346)
Q Consensus       182 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~  261 (346)
                      ++++|.+++. ....+++..++.++.++++||++||   +.+++|+||||+||++++++.++|+|||.+....  .....
T Consensus        81 ~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~~~  154 (260)
T PF00069_consen   81 PGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENNEN  154 (260)
T ss_dssp             TTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEEST--STTSE
T ss_pred             cccccccccc-ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc--ccccc
Confidence            9999999987 4566899999999999999999999   8999999999999999999999999999998641  12223


Q ss_pred             cccccCCcccccCCCCC-CCCCCcchhHHHHHHHHHHHHcCCCCCCcccc-Cc-ccHHHHH----hhhc------CCChh
Q 039799          262 QTQTLATIGYMAPEYGR-EGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFS-GE-MTLKRWV----NDLL------PISVM  328 (346)
Q Consensus       262 ~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~-~~-~~~~~~~----~~~~------~~~~~  328 (346)
                      .....++..|.|||... +..++.++||||+|+++++|++|..||..... +. ....+..    ....      +..+.
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  234 (260)
T PF00069_consen  155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELR  234 (260)
T ss_dssp             BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHH
Confidence            34556899999999988 78899999999999999999999999986411 11 1111111    1111      14789


Q ss_pred             hhhchhccCCccccccc
Q 039799          329 EVVDANLLSQEDEHFTT  345 (346)
Q Consensus       329 ~~~d~~l~~~p~~R~~~  345 (346)
                      +++.+||..||++||+.
T Consensus       235 ~li~~~l~~~p~~R~~~  251 (260)
T PF00069_consen  235 DLIKKMLSKDPEQRPSA  251 (260)
T ss_dssp             HHHHHHSSSSGGGSTTH
T ss_pred             HHHHHHccCChhHCcCH
Confidence            99999999999999985

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=5.1e-38  Score=275.95  Aligned_cols=238  Identities=24%  Similarity=0.411  Sum_probs=195.0

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-C---CCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEE
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-D---GMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALV  177 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  177 (346)
                      .+|++.+.||+|+||.||+|.+. +   +..+|+|.+.... ....+.+..|+.++++++||||+++++++...+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            46788899999999999999864 2   3379999986543 23456788999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccc
Q 039799          178 LEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  257 (346)
Q Consensus       178 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~  257 (346)
                      |||+++++|.+++......+++...+.++.+++.|++|||   +.+++||||||+||+++.++.++++|||++..+....
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd05066          84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  160 (267)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence            9999999999999766667899999999999999999999   9999999999999999999999999999998764322


Q ss_pred             ccc-ccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHhh--------hcCCCh
Q 039799          258 QSL-TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVND--------LLPISV  327 (346)
Q Consensus       258 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~--------~~~~~~  327 (346)
                      ... ......++..|+|||+..+..++.++|+||||+++||+++ |..||......  .....+..        ..+..+
T Consensus       161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  238 (267)
T cd05066         161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ--DVIKAIEEGYRLPAPMDCPAAL  238 (267)
T ss_pred             ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH--HHHHHHhCCCcCCCCCCCCHHH
Confidence            111 1112223568999999988889999999999999999886 99998653221  11222221        124477


Q ss_pred             hhhhchhccCCccccccc
Q 039799          328 MEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       328 ~~~~d~~l~~~p~~R~~~  345 (346)
                      .+++.+|+..+|.+||+.
T Consensus       239 ~~li~~~l~~~p~~Rp~~  256 (267)
T cd05066         239 HQLMLDCWQKDRNERPKF  256 (267)
T ss_pred             HHHHHHHcccCchhCCCH
Confidence            899999999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=3.9e-38  Score=279.64  Aligned_cols=235  Identities=26%  Similarity=0.321  Sum_probs=183.7

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHHhc---CCCCceeeEEEEec-----CC
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRI---CHRNLIKIISSYSN-----DD  172 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~-----~~  172 (346)
                      +|.+.+.||+|++|.||+|... +++.+|+|.+....  ......+.+|+++++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            3778889999999999999876 68999999986432  22223455677766655   79999999998754     34


Q ss_pred             ceeEEEecCCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCc
Q 039799          173 FKALVLEYMPHGSLEKCLYLSN-YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAK  251 (346)
Q Consensus       173 ~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~  251 (346)
                      ..++++||+++ +|.+++.... ..+++..+..++.|++.||.|||   +.+++||||||+||+++.++.++|+|||++.
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLAR  156 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence            57899999974 8888776543 45899999999999999999999   9999999999999999999999999999998


Q ss_pred             cCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcc--c---------HHHH--
Q 039799          252 PLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM--T---------LKRW--  318 (346)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~--~---------~~~~--  318 (346)
                      ......   ......++..|+|||.+.+..++.++||||+||++|||++|++||......+.  .         ...|  
T Consensus       157 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07863         157 IYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR  233 (288)
T ss_pred             cccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence            653221   12234578999999999888899999999999999999999999854211100  0         0000  


Q ss_pred             -------------------HhhhcCCChhhhhchhccCCccccccc
Q 039799          319 -------------------VNDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       319 -------------------~~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                                         ....++..+.+++.+||..||++||++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  279 (288)
T cd07863         234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISA  279 (288)
T ss_pred             cccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCH
Confidence                               011233456899999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=3.6e-38  Score=285.03  Aligned_cols=198  Identities=21%  Similarity=0.291  Sum_probs=165.2

Q ss_pred             CCCccccc--CceEEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecC
Q 039799          107 MPPLIGKG--GFGSVYKAIIQ-DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYM  181 (346)
Q Consensus       107 ~~~~lg~G--~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  181 (346)
                      +..+||+|  ++++||++..+ +|+.||+|++....  ....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            45789999  67899999865 78999999987542  233456778999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccc
Q 039799          182 PHGSLEKCLYLS-NYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  260 (346)
Q Consensus       182 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~  260 (346)
                      ++++|.+++... ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.++++||+.+..........
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence            999999988643 345899999999999999999999   9999999999999999999999999998765442211110


Q ss_pred             -----ccccccCCcccccCCCCCC--CCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 039799          261 -----TQTQTLATIGYMAPEYGRE--GRVSTNGDVYSFGIMLMEIFTRTKPTDE  307 (346)
Q Consensus       261 -----~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~s~G~il~elltg~~p~~~  307 (346)
                           ......++..|+|||++.+  ..++.++|||||||++|||++|+.||..
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  212 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD  212 (327)
T ss_pred             cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence                 1112346778999999875  4588999999999999999999999975

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=5e-38  Score=278.49  Aligned_cols=236  Identities=24%  Similarity=0.321  Sum_probs=189.0

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEec
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEY  180 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  180 (346)
                      +|.+.+.||+|++|.||+|... ++..||+|.+....  ....+.+.+|+.++++++|||++++++++..++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4777889999999999999976 78999999986432  22346778899999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccc
Q 039799          181 MPHGSLEKCLYLSN--YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  258 (346)
Q Consensus       181 ~~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~  258 (346)
                      ++ ++|.+++....  ..+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||++....... 
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  155 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-  155 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence            97 68888775432  56899999999999999999999   9999999999999999999999999999998653221 


Q ss_pred             ccccccccCCcccccCCCCCCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccCc--------------------ccHHH
Q 039799          259 SLTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE--------------------MTLKR  317 (346)
Q Consensus       259 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~--------------------~~~~~  317 (346)
                       .......+++.|+|||.+.+. .++.++||||||++++||+||+.||.......                    .....
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
T cd07861         156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD  234 (285)
T ss_pred             -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence             112233568899999987654 46889999999999999999999996421100                    00000


Q ss_pred             HH--------------hhhcCCChhhhhchhccCCccccccc
Q 039799          318 WV--------------NDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       318 ~~--------------~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      +.              ...++.++.+++.+||..||.+||+.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~  276 (285)
T cd07861         235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISA  276 (285)
T ss_pred             HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCH
Confidence            00              11234466799999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-39  Score=302.20  Aligned_cols=241  Identities=26%  Similarity=0.310  Sum_probs=194.5

Q ss_pred             CCCCCCcccccCceEEEEEEEcCC-CEEEEEEecCCCchhHHHHHHHHHHHHhcC-CCCceeeEEE-Eec------CCce
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQDG-MEVAVKVFDPQYEGAFKSFDIECDVMKRIC-HRNLIKIISS-YSN------DDFK  174 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~-~~~------~~~~  174 (346)
                      .+.+.+.|.+|||+.||.|....+ ..||+|++-...+...+.+.+|++++++|+ |+|||.+++. ...      .-+.
T Consensus        38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev  117 (738)
T KOG1989|consen   38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV  117 (738)
T ss_pred             EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence            467788999999999999997755 999999987777888899999999999997 9999999993 321      1366


Q ss_pred             eEEEecCCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccC
Q 039799          175 ALVLEYMPHGSLEKCLYLS-NYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  253 (346)
Q Consensus       175 ~lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~  253 (346)
                      +|.||||.||+|-+++..+ ...++...+++|+.++++|+++|| .++++|||||||.+|||++.++..||+|||.+.-.
T Consensus       118 llLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH-~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~  196 (738)
T KOG1989|consen  118 LLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMH-YLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTK  196 (738)
T ss_pred             EeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHh-cCCCccchhhhhhhheEEcCCCCEEeCcccccccc
Confidence            7999999999999998643 345999999999999999999999 45778999999999999999999999999999854


Q ss_pred             Ccccc-cccc------ccccCCcccccCCCC---CCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh---
Q 039799          254 LEEDQ-SLTQ------TQTLATIGYMAPEYG---REGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN---  320 (346)
Q Consensus       254 ~~~~~-~~~~------~~~~~~~~y~aPE~~---~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~---  320 (346)
                      ..... ....      -....|+.|.|||.+   .+...++|+||||+||+||-|+....||++...-.+.-..+.-   
T Consensus       197 ~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIlng~Y~~P~~  276 (738)
T KOG1989|consen  197 ILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILNGNYSFPPF  276 (738)
T ss_pred             cCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEeccccCCCC
Confidence            32211 1000      012369999999964   5678899999999999999999999999874222222222222   


Q ss_pred             hhcCCChhhhhchhccCCccccccc
Q 039799          321 DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       321 ~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ..+.+.+.++|..||..+|++||..
T Consensus       277 p~ys~~l~~LI~~mL~~nP~~RPnI  301 (738)
T KOG1989|consen  277 PNYSDRLKDLIRTMLQPNPDERPNI  301 (738)
T ss_pred             ccHHHHHHHHHHHHhccCcccCCCH
Confidence            2234488999999999999999974

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=7.8e-38  Score=274.65  Aligned_cols=238  Identities=21%  Similarity=0.300  Sum_probs=189.9

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC-----chhHHHHHHHHHHHHhcCCCCceeeEEEEec--CCce
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY-----EGAFKSFDIECDVMKRICHRNLIKIISSYSN--DDFK  174 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~  174 (346)
                      ..|...+.||+|++|.||+|... ++..+++|++....     ......+.+|+.++++++|||++++++++..  ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            56889999999999999999865 68999999875331     2234568889999999999999999998865  3577


Q ss_pred             eEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCC
Q 039799          175 ALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  254 (346)
Q Consensus       175 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~  254 (346)
                      ++++||+++++|.+++... ..+++...+.++.+++.||+|||   +.+++||||+|+||+++.++.++|+|||++....
T Consensus        82 ~l~~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~  157 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ  157 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence            8999999999999988643 34788889999999999999999   9999999999999999999999999999998653


Q ss_pred             cccc-ccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH--------hhhcCC
Q 039799          255 EEDQ-SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV--------NDLLPI  325 (346)
Q Consensus       255 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~--------~~~~~~  325 (346)
                      .... ........++..|+|||+..+..++.++||||||+++||+++|+.||........ .....        ....+.
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~  236 (266)
T cd06651         158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA-IFKIATQPTNPQLPSHISE  236 (266)
T ss_pred             cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH-HHHHhcCCCCCCCchhcCH
Confidence            2211 1111234578899999999888899999999999999999999999975422111 11111        112233


Q ss_pred             ChhhhhchhccCCcccccccC
Q 039799          326 SVMEVVDANLLSQEDEHFTTK  346 (346)
Q Consensus       326 ~~~~~~d~~l~~~p~~R~~~k  346 (346)
                      .+.+++ +|+..+|++||+.+
T Consensus       237 ~~~~li-~~~~~~p~~Rp~~~  256 (266)
T cd06651         237 HARDFL-GCIFVEARHRPSAE  256 (266)
T ss_pred             HHHHHH-HHhcCChhhCcCHH
Confidence            567777 78889999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=9.7e-39  Score=279.16  Aligned_cols=226  Identities=26%  Similarity=0.375  Sum_probs=182.9

Q ss_pred             CcccccCceEEEEEEEcC--------CCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEec
Q 039799          109 PLIGKGGFGSVYKAIIQD--------GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEY  180 (346)
Q Consensus       109 ~~lg~G~~g~vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  180 (346)
                      +.||+|+||.||+|....        ...+++|.+........+.+.+|+.+++.++|||++++++++...+..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            368999999999998642        234888887655445567788899999999999999999999998999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCc--------EEEeeecCCcc
Q 039799          181 MPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV--------AHLSDFGMAKP  252 (346)
Q Consensus       181 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~--------~~l~Dfg~~~~  252 (346)
                      +++|+|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.        ++++|||.+..
T Consensus        81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence            9999999999766667899999999999999999999   999999999999999987665        69999999875


Q ss_pred             CCccccccccccccCCcccccCCCCCCC-CCCcchhHHHHHHHHHHHHcCC-CCCCccccCcccHHHHHh--hhcC----
Q 039799          253 LLEEDQSLTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMEIFTRT-KPTDEIFSGEMTLKRWVN--DLLP----  324 (346)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~-~p~~~~~~~~~~~~~~~~--~~~~----  324 (346)
                      ....      ....++..|+|||++.+. .++.++||||||+++||+++|. .|+.......  ......  ..++    
T Consensus       158 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~  229 (258)
T cd05078         158 VLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK--KLQFYEDRHQLPAPKW  229 (258)
T ss_pred             cCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH--HHHHHHccccCCCCCc
Confidence            4321      223578889999998764 5789999999999999999995 5654422111  111111  1122    


Q ss_pred             CChhhhhchhccCCccccccc
Q 039799          325 ISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       325 ~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ..+.+++.+||..+|++||+.
T Consensus       230 ~~~~~li~~~l~~~p~~Rps~  250 (258)
T cd05078         230 TELANLINQCMDYEPDFRPSF  250 (258)
T ss_pred             HHHHHHHHHHhccChhhCCCH
Confidence            367899999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.2e-38  Score=288.72  Aligned_cols=233  Identities=22%  Similarity=0.318  Sum_probs=186.8

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC---CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEE
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ---YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVL  178 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  178 (346)
                      ++|.+.+.||+|+||.||++..+ +++.+|+|++...   .......+..|+.++..++|++|+++.+.+...+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            36888899999999999999976 5788999998532   1222345778999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccc
Q 039799          179 EYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  258 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~  258 (346)
                      ||+++|+|.+++......+++..+..++.|++.|++|||   +.+|+||||||+|||++.++.++|+|||++........
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~  157 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT  157 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence            999999999999765667899999999999999999999   99999999999999999999999999999876533221


Q ss_pred             ccccccccCCcccccCCCCC-----CCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh-----------hh
Q 039799          259 SLTQTQTLATIGYMAPEYGR-----EGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN-----------DL  322 (346)
Q Consensus       259 ~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~-----------~~  322 (346)
                       .......||+.|+|||++.     ...++.++|||||||++|||++|+.||......+ .......           ..
T Consensus       158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~-~~~~i~~~~~~~~~p~~~~~  235 (332)
T cd05623         158 -VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE-TYGKIMNHKERFQFPAQVTD  235 (332)
T ss_pred             -ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH-HHHHHhCCCccccCCCcccc
Confidence             1223356899999999875     3457889999999999999999999996532111 1111110           12


Q ss_pred             cCCChhhhhchhccCCcc
Q 039799          323 LPISVMEVVDANLLSQED  340 (346)
Q Consensus       323 ~~~~~~~~~d~~l~~~p~  340 (346)
                      ++..+.+++.+++..+++
T Consensus       236 ~s~~~~~li~~ll~~~~~  253 (332)
T cd05623         236 VSEDAKDLIRRLICSREH  253 (332)
T ss_pred             CCHHHHHHHHHHccChhh
Confidence            344678899998866443

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=9.4e-39  Score=282.15  Aligned_cols=233  Identities=26%  Similarity=0.342  Sum_probs=193.3

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecC
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYM  181 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  181 (346)
                      .|...+.||+|++|.||+|... +++.+|+|.+.... ....+.+.+|++++++++|||++++++.+...+..++|+||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            3556678999999999999865 67899999987443 344567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccc
Q 039799          182 PHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT  261 (346)
Q Consensus       182 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~  261 (346)
                      ++++|.+++..  ..+++..+..++.++++|+.|||   +.+++|+||+|+||++++++.++++|||++..+....  ..
T Consensus        85 ~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~  157 (277)
T cd06642          85 GGGSALDLLKP--GPLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IK  157 (277)
T ss_pred             CCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcc--hh
Confidence            99999988753  45788999999999999999999   9999999999999999999999999999998654322  11


Q ss_pred             cccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh--------hhcCCChhhhhch
Q 039799          262 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN--------DLLPISVMEVVDA  333 (346)
Q Consensus       262 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~d~  333 (346)
                      .....++..|+|||+..+..++.++||||||++++||+||+.|+.......  ...++.        ...+..+.+++.+
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~  235 (277)
T cd06642         158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR--VLFLIPKNSPPTLEGQYSKPFKEFVEA  235 (277)
T ss_pred             hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh--HHhhhhcCCCCCCCcccCHHHHHHHHH
Confidence            223457889999999988889999999999999999999999987543221  111111        1223367899999


Q ss_pred             hccCCccccccc
Q 039799          334 NLLSQEDEHFTT  345 (346)
Q Consensus       334 ~l~~~p~~R~~~  345 (346)
                      |+..+|++||+.
T Consensus       236 ~l~~~p~~Rp~~  247 (277)
T cd06642         236 CLNKDPRFRPTA  247 (277)
T ss_pred             HccCCcccCcCH
Confidence            999999999985

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=5.4e-38  Score=279.18  Aligned_cols=233  Identities=24%  Similarity=0.306  Sum_probs=195.0

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEE
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVL  178 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  178 (346)
                      ++|.+.+.||+|++|.||++... +++.+|+|++....   ....+.+.+|++++++++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            35788899999999999999876 68999999986432   233467888999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccc
Q 039799          179 EYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  258 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~  258 (346)
                      ||+++++|.+++... ..++...+..++.+++.||.|||   +.+++|+||+|+||+++.++.++|+|||++......  
T Consensus        81 e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--  154 (290)
T cd05580          81 EYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--  154 (290)
T ss_pred             ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence            999999999988654 56889999999999999999999   999999999999999999999999999999875432  


Q ss_pred             ccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH------hhhcCCChhhhhc
Q 039799          259 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV------NDLLPISVMEVVD  332 (346)
Q Consensus       259 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~------~~~~~~~~~~~~d  332 (346)
                         .....+++.|+|||...+...+.++||||||+++++|++|+.||...... .......      ...++..+.+++.
T Consensus       155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~  230 (290)
T cd05580         155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI-QIYEKILEGKVRFPSFFSPDAKDLIR  230 (290)
T ss_pred             ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhcCCccCCccCCHHHHHHHH
Confidence               23345889999999998888899999999999999999999999653211 1111111      1223457889999


Q ss_pred             hhccCCccccccc
Q 039799          333 ANLLSQEDEHFTT  345 (346)
Q Consensus       333 ~~l~~~p~~R~~~  345 (346)
                      +||..+|++|+++
T Consensus       231 ~~l~~~p~~R~~~  243 (290)
T cd05580         231 NLLQVDLTKRLGN  243 (290)
T ss_pred             HHccCCHHHccCc
Confidence            9999999999953

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=2.9e-38  Score=280.56  Aligned_cols=239  Identities=26%  Similarity=0.402  Sum_probs=194.3

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc------CCCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCce
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ------DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFK  174 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  174 (346)
                      .++|.+.+.||+|+||.||++...      ++..+|+|++.... ....+.+.+|+.++++++|||++++++++...+..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            356889999999999999999853      46789999987543 23356788899999999999999999999999999


Q ss_pred             eEEEecCCCCChhhhhhhcC---------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCc
Q 039799          175 ALVLEYMPHGSLEKCLYLSN---------------------YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSN  233 (346)
Q Consensus       175 ~lv~e~~~~gsL~~~l~~~~---------------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~N  233 (346)
                      ++++||+++++|.+++....                     ..+++..++.++.+++.||+|||   +.+++||||+|+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHhh
Confidence            99999999999999886321                     24778889999999999999999   9999999999999


Q ss_pred             eEECCCCcEEEeeecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCc
Q 039799          234 VLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGE  312 (346)
Q Consensus       234 Ill~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~  312 (346)
                      |++++++.++|+|||++..+..............+..|+|||...+..++.++||||||+++|||++ |..||...... 
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~-  239 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE-  239 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence            9999999999999999886543222111222335677999999888889999999999999999997 88888543221 


Q ss_pred             ccHHHHH--------hhhcCCChhhhhchhccCCccccccc
Q 039799          313 MTLKRWV--------NDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       313 ~~~~~~~--------~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                       .....+        ....+..+.+++.+|+..+|++||++
T Consensus       240 -~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~  279 (288)
T cd05050         240 -EVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSF  279 (288)
T ss_pred             -HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCH
Confidence             111111        12234578999999999999999986

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=8.7e-38  Score=277.02  Aligned_cols=238  Identities=23%  Similarity=0.309  Sum_probs=194.3

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEec
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEY  180 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  180 (346)
                      +|.+.+.||+|++|.||+|... +|+.+|+|++....  ....+.+.+|+.++++++|||++++++++......++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4778889999999999999975 78999999987543  33456788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccc
Q 039799          181 MPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  260 (346)
Q Consensus       181 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~  260 (346)
                      + +++|.+++......+++..+..++.+++++|+|||   +.+++|+||+|+||+++.++.++|+|||++........ .
T Consensus        81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~  155 (286)
T cd07832          81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-R  155 (286)
T ss_pred             c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-C
Confidence            9 99999998766677999999999999999999999   99999999999999999999999999999987643321 1


Q ss_pred             ccccccCCcccccCCCCCCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccCcc--------------------cHHHH-
Q 039799          261 TQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM--------------------TLKRW-  318 (346)
Q Consensus       261 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~--------------------~~~~~-  318 (346)
                      ......++..|+|||...+. .++.++||||+|++++||+||++||......+.                    ....| 
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07832         156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYN  235 (286)
T ss_pred             ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhh
Confidence            22334688999999987654 468999999999999999999888754211000                    00000 


Q ss_pred             --------------HhhhcCCChhhhhchhccCCcccccccC
Q 039799          319 --------------VNDLLPISVMEVVDANLLSQEDEHFTTK  346 (346)
Q Consensus       319 --------------~~~~~~~~~~~~~d~~l~~~p~~R~~~k  346 (346)
                                    .....+..+.+++.+||..+|.+||+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~  277 (286)
T cd07832         236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAA  277 (286)
T ss_pred             cccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHH
Confidence                          0012234778999999999999999863

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=6e-38  Score=274.60  Aligned_cols=232  Identities=25%  Similarity=0.424  Sum_probs=184.0

Q ss_pred             CcccccCceEEEEEEEc----CCCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEe-cCCceeEEEecCC
Q 039799          109 PLIGKGGFGSVYKAIIQ----DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYS-NDDFKALVLEYMP  182 (346)
Q Consensus       109 ~~lg~G~~g~vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~  182 (346)
                      +.||+|+||.||+|.+.    +...+|+|.+.... ....+.+.+|+.+++.++|||++++++++. .+...++++||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999854    23579999986432 334567888999999999999999999775 4556889999999


Q ss_pred             CCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccc--c
Q 039799          183 HGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS--L  260 (346)
Q Consensus       183 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~--~  260 (346)
                      +++|.+++.......++.....++.++++||+|||   +.+++||||||+||++++++.++|+|||+++.+......  .
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  157 (262)
T cd05058          81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH  157 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence            99999998766666788888999999999999999   999999999999999999999999999999865432111  1


Q ss_pred             ccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcC-CCCCCccccCcccHHHHHh--------hhcCCChhhhh
Q 039799          261 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTR-TKPTDEIFSGEMTLKRWVN--------DLLPISVMEVV  331 (346)
Q Consensus       261 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg-~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~  331 (346)
                      ......++..|+|||......++.++||||||+++|||++| .+||....  .......+.        ...+..+.+++
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li  235 (262)
T cd05058         158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD--SFDITVYLLQGRRLLQPEYCPDPLYEVM  235 (262)
T ss_pred             ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHhcCCCCCCCCcCCHHHHHHH
Confidence            11223456789999998888899999999999999999995 55665421  111222221        11344788999


Q ss_pred             chhccCCccccccc
Q 039799          332 DANLLSQEDEHFTT  345 (346)
Q Consensus       332 d~~l~~~p~~R~~~  345 (346)
                      .+||..+|++||+.
T Consensus       236 ~~cl~~~p~~Rp~~  249 (262)
T cd05058         236 LSCWHPKPEMRPTF  249 (262)
T ss_pred             HHHcCCChhhCCCH
Confidence            99999999999985

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.7e-38  Score=279.20  Aligned_cols=232  Identities=28%  Similarity=0.449  Sum_probs=188.5

Q ss_pred             CcccccCceEEEEEEEcC-------CCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEec
Q 039799          109 PLIGKGGFGSVYKAIIQD-------GMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEY  180 (346)
Q Consensus       109 ~~lg~G~~g~vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  180 (346)
                      +.||+|++|.||+|+..+       ++.+|+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            468999999999998652       2579999876443 23456788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhc------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCC-----cEEEeeecC
Q 039799          181 MPHGSLEKCLYLS------NYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM-----VAHLSDFGM  249 (346)
Q Consensus       181 ~~~gsL~~~l~~~------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~-----~~~l~Dfg~  249 (346)
                      +++++|.+++...      ...+++..++.++.+++.||+|||   +.+++|+||+|+||+++.++     .++++|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            9999999988642      234788999999999999999999   99999999999999999877     899999999


Q ss_pred             CccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHh--------
Q 039799          250 AKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVN--------  320 (346)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~--------  320 (346)
                      +................++..|+|||.+.+..++.++||||||+++|||+| |+.||.....  ......+.        
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~--~~~~~~~~~~~~~~~~  235 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN--QEVLQHVTAGGRLQKP  235 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH--HHHHHHHhcCCccCCc
Confidence            986643322222223345788999999998899999999999999999998 9999865321  11222211        


Q ss_pred             hhcCCChhhhhchhccCCccccccc
Q 039799          321 DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       321 ~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ...+..+.+++.+||..+|++||+.
T Consensus       236 ~~~~~~~~~li~~~l~~~p~~Rp~~  260 (269)
T cd05044         236 ENCPDKIYQLMTNCWAQDPSERPTF  260 (269)
T ss_pred             ccchHHHHHHHHHHcCCCcccCCCH
Confidence            2234478999999999999999985

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=6.7e-38  Score=282.10  Aligned_cols=194  Identities=22%  Similarity=0.306  Sum_probs=158.3

Q ss_pred             CCcccccCceEEEEEEEc---CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEec--CCceeEEEecCC
Q 039799          108 PPLIGKGGFGSVYKAIIQ---DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSN--DDFKALVLEYMP  182 (346)
Q Consensus       108 ~~~lg~G~~g~vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~  182 (346)
                      ...||+|+||+||+|...   +++.+|+|.+....  ....+.+|++++++++||||+++++.+..  ....++++||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            468999999999999864   46789999986542  23456789999999999999999998854  456789999985


Q ss_pred             CCChhhhhhhc--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEE----CCCCcEEEeeecCC
Q 039799          183 HGSLEKCLYLS--------NYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL----DDNMVAHLSDFGMA  250 (346)
Q Consensus       183 ~gsL~~~l~~~--------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll----~~~~~~~l~Dfg~~  250 (346)
                       ++|.+++...        ...+++.....++.|++.||+|||   +.+|+||||||+|||+    +.++.+||+|||++
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence             4787766422        135888889999999999999999   9999999999999999    45679999999999


Q ss_pred             ccCCcccc-ccccccccCCcccccCCCCCC-CCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 039799          251 KPLLEEDQ-SLTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMEIFTRTKPTDE  307 (346)
Q Consensus       251 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~  307 (346)
                      +....... ........+|+.|+|||++.+ ..++.++||||+||+++||++|++||..
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~  218 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence            87643221 112234568999999998876 4588999999999999999999999964

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.1e-37  Score=272.05  Aligned_cols=237  Identities=22%  Similarity=0.297  Sum_probs=196.8

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC--CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEec
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ--YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEY  180 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  180 (346)
                      .|+..+.||+|++|.||.++.. +++.+++|.+...  .....+.+.+|++++++++|+|++++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            3677899999999999999854 6889999987643  234456788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccc
Q 039799          181 MPHGSLEKCLYLS-NYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  259 (346)
Q Consensus       181 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~  259 (346)
                      +++++|.+++... ...+++..+..++.+++.+++|||   +.+++|+||+|+||++++++.++|+|||++........ 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-  156 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-  156 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence            9999999988754 456899999999999999999999   99999999999999999999999999999986643321 


Q ss_pred             cccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh-------hhcCCChhhhhc
Q 039799          260 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN-------DLLPISVMEVVD  332 (346)
Q Consensus       260 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~-------~~~~~~~~~~~d  332 (346)
                       ......++..|.|||...+..++.++||||||++++||++|..||+.....+ .......       ...+..+.+++.
T Consensus       157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~  234 (256)
T cd08221         157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN-LVVKIVQGNYTPVVSVYSSELISLVH  234 (256)
T ss_pred             -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHcCCCCCCccccCHHHHHHHH
Confidence             2234568899999999988888999999999999999999999986532111 1111111       122447899999


Q ss_pred             hhccCCcccccccC
Q 039799          333 ANLLSQEDEHFTTK  346 (346)
Q Consensus       333 ~~l~~~p~~R~~~k  346 (346)
                      +|+..+|++||+++
T Consensus       235 ~~l~~~p~~R~s~~  248 (256)
T cd08221         235 SLLQQDPEKRPTAD  248 (256)
T ss_pred             HHcccCcccCCCHH
Confidence            99999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-39  Score=298.79  Aligned_cols=232  Identities=25%  Similarity=0.350  Sum_probs=194.7

Q ss_pred             cccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecCCCCChhh
Q 039799          110 LIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEK  188 (346)
Q Consensus       110 ~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~  188 (346)
                      +||+|+||+||.|+.. +...+|||.+........+-+..|+.+-++++|.|||+++|.+.++++.-+.||.++||||.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            6999999999999965 567899999987766667788899999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEEC-CCCcEEEeeecCCccCCccccccccccc
Q 039799          189 CLYLSNYIL--DIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQT  265 (346)
Q Consensus       189 ~l~~~~~~l--~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~~  265 (346)
                      .+...-..+  .+.+.-.+.+||++||.|||   +..|+|||||-+|+|++ ..|.+||+|||.++.+...  .....+.
T Consensus       662 LLrskWGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--nP~TETF  736 (1226)
T KOG4279|consen  662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--NPCTETF  736 (1226)
T ss_pred             HHHhccCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhccC--Ccccccc
Confidence            998765555  67777789999999999999   99999999999999997 6899999999999987432  3344566


Q ss_pred             cCCcccccCCCCCCC--CCCcchhHHHHHHHHHHHHcCCCCCCccccCccc--------HHHHHhhhcCCChhhhhchhc
Q 039799          266 LATIGYMAPEYGREG--RVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMT--------LKRWVNDLLPISVMEVVDANL  335 (346)
Q Consensus       266 ~~~~~y~aPE~~~~~--~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~--------~~~~~~~~~~~~~~~~~d~~l  335 (346)
                      .||..|||||++..+  .|+..+|||||||++.||.||++||-+..+....        ..+-+...+..+...++-+|+
T Consensus       737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcF  816 (1226)
T KOG4279|consen  737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCF  816 (1226)
T ss_pred             ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHc
Confidence            799999999998765  4889999999999999999999999764332211        111112222236678999999


Q ss_pred             cCCcccccccC
Q 039799          336 LSQEDEHFTTK  346 (346)
Q Consensus       336 ~~~p~~R~~~k  346 (346)
                      ..||.+||++|
T Consensus       817 epd~~~R~sA~  827 (1226)
T KOG4279|consen  817 EPDPCDRPSAK  827 (1226)
T ss_pred             CCCcccCccHH
Confidence            99999999985

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=8.6e-38  Score=272.99  Aligned_cols=224  Identities=25%  Similarity=0.416  Sum_probs=183.0

Q ss_pred             CcccccCceEEEEEEEcCCC-----------EEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEE
Q 039799          109 PLIGKGGFGSVYKAIIQDGM-----------EVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALV  177 (346)
Q Consensus       109 ~~lg~G~~g~vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  177 (346)
                      +.||+|+||.||+|.+.+..           .+++|++...... ...+.+|+.++++++|||++++++++.. +..++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            46899999999999976432           5788887654333 5788899999999999999999999988 778999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCC-------cEEEeeecCC
Q 039799          178 LEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM-------VAHLSDFGMA  250 (346)
Q Consensus       178 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~-------~~~l~Dfg~~  250 (346)
                      +||+++++|.+++......+++..++.++.+++.||+|||   +.+++||||||+||+++.++       .++|+|||++
T Consensus        79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence            9999999999998766557899999999999999999999   99999999999999999887       7999999999


Q ss_pred             ccCCccccccccccccCCcccccCCCCCCC--CCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHhhh--c--
Q 039799          251 KPLLEEDQSLTQTQTLATIGYMAPEYGREG--RVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVNDL--L--  323 (346)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~--~--  323 (346)
                      .....      .....++..|+|||++.+.  .++.++||||||+++||+++ |..|+......+  ...+....  .  
T Consensus       156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~--~~~~~~~~~~~~~  227 (259)
T cd05037         156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE--KERFYQDQHRLPM  227 (259)
T ss_pred             ccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh--HHHHHhcCCCCCC
Confidence            86533      1223466789999998776  78999999999999999999 577876643111  11111111  1  


Q ss_pred             --CCChhhhhchhccCCccccccc
Q 039799          324 --PISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       324 --~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                        ...+.+++.+||..+|.+||+.
T Consensus       228 ~~~~~~~~li~~~l~~~p~~Rpt~  251 (259)
T cd05037         228 PDCAELANLINQCWTYDPTKRPSF  251 (259)
T ss_pred             CCchHHHHHHHHHhccChhhCCCH
Confidence              1377899999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=5.8e-38  Score=285.44  Aligned_cols=240  Identities=23%  Similarity=0.373  Sum_probs=190.1

Q ss_pred             CCCCCCCCcccccCceEEEEEEE------cCCCEEEEEEecCCC-chhHHHHHHHHHHHHhc-CCCCceeeEEEEecC-C
Q 039799          102 PNDANMPPLIGKGGFGSVYKAII------QDGMEVAVKVFDPQY-EGAFKSFDIECDVMKRI-CHRNLIKIISSYSND-D  172 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-~  172 (346)
                      .++|.+.+.||+|+||.||+|.+      .+++.||||++.... ......+.+|+.++.++ +||||+++++++... .
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            35789999999999999999973      357889999987543 23346788899999999 689999999988654 4


Q ss_pred             ceeEEEecCCCCChhhhhhhcC----------------------------------------------------------
Q 039799          173 FKALVLEYMPHGSLEKCLYLSN----------------------------------------------------------  194 (346)
Q Consensus       173 ~~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------  194 (346)
                      ..+++|||+++|+|.+++....                                                          
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            6789999999999999875421                                                          


Q ss_pred             --------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccccccccc
Q 039799          195 --------YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL  266 (346)
Q Consensus       195 --------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~  266 (346)
                              ..+++..+..++.++++||+|||   +.+|+||||||+||++++++.++|+|||++................
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                    23678888999999999999999   9999999999999999999999999999998654322212222234


Q ss_pred             CCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHh--------hhcCCChhhhhchhccC
Q 039799          267 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVN--------DLLPISVMEVVDANLLS  337 (346)
Q Consensus       267 ~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~d~~l~~  337 (346)
                      ++..|+|||...+..++.++||||||+++|||++ |..||....... .....+.        ...+..+.+++.+|+..
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~  321 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHG  321 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-HHHHHHhccCCCCCCCCCCHHHHHHHHHHccC
Confidence            5678999999888889999999999999999997 999986532211 1111111        11234678999999999


Q ss_pred             Cccccccc
Q 039799          338 QEDEHFTT  345 (346)
Q Consensus       338 ~p~~R~~~  345 (346)
                      +|++||+.
T Consensus       322 ~p~~Rps~  329 (343)
T cd05103         322 EPSQRPTF  329 (343)
T ss_pred             ChhhCcCH
Confidence            99999985

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=6e-38  Score=279.69  Aligned_cols=240  Identities=25%  Similarity=0.383  Sum_probs=191.2

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-----------------CCCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceee
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-----------------DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKI  164 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~  164 (346)
                      ++|.+.+.||+|+||.||++...                 ++..+|+|++.... ....+.+.+|++++++++|+|++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            46889999999999999998643                 23468999987543 3345678899999999999999999


Q ss_pred             EEEEecCCceeEEEecCCCCChhhhhhhcC----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCce
Q 039799          165 ISSYSNDDFKALVLEYMPHGSLEKCLYLSN----------YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNV  234 (346)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NI  234 (346)
                      ++++...+..+++|||+++++|.+++....          ..+++.....++.+++.|++|||   +.+++|+||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChheE
Confidence            999999999999999999999999886432          24778889999999999999999   99999999999999


Q ss_pred             EECCCCcEEEeeecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc--CCCCCCccccCc
Q 039799          235 LLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT--RTKPTDEIFSGE  312 (346)
Q Consensus       235 ll~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt--g~~p~~~~~~~~  312 (346)
                      +++.++.++|+|||+++.+.............++..|+|||....+.++.++||||||+++|||+|  |..||......+
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ  241 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence            999999999999999986543222111222334678999998888889999999999999999998  778886532111


Q ss_pred             c--cHHHHHh-----------hhcCCChhhhhchhccCCccccccc
Q 039799          313 M--TLKRWVN-----------DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       313 ~--~~~~~~~-----------~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      .  ....+..           ...+..+.+++..||..+|++||+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~  287 (296)
T cd05095         242 VIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSF  287 (296)
T ss_pred             HHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCH
Confidence            0  0011110           1123477899999999999999985

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.6e-38  Score=286.45  Aligned_cols=190  Identities=23%  Similarity=0.285  Sum_probs=164.5

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecC
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYM  181 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  181 (346)
                      ..|.+.+.||+|+||.||+|... ++..||+|+....      ....|+.++++++||||+++++++...+..++|+|++
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  139 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY  139 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc
Confidence            46999999999999999999976 5788999985432      2345899999999999999999999999999999999


Q ss_pred             CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccc
Q 039799          182 PHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT  261 (346)
Q Consensus       182 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~  261 (346)
                      . ++|.+++......+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.++|+|||+++.....   ..
T Consensus       140 ~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---~~  212 (357)
T PHA03209        140 S-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA---PA  212 (357)
T ss_pred             C-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccccC---cc
Confidence            4 6888888766678999999999999999999999   999999999999999999999999999999753221   11


Q ss_pred             cccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCC
Q 039799          262 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPT  305 (346)
Q Consensus       262 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~  305 (346)
                      .....||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus       213 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        213 FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            23345899999999999889999999999999999999865543

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1e-37  Score=273.58  Aligned_cols=239  Identities=26%  Similarity=0.350  Sum_probs=197.9

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEec
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEY  180 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  180 (346)
                      ++|++.+.||+|++|+||+|... ++..+++|++.... ....+.+.+|++.++.++|+|++++++.+...+..++++|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            36888999999999999999865 68899999986432 33567888999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccc
Q 039799          181 MPHGSLEKCLYLSN--YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  258 (346)
Q Consensus       181 ~~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~  258 (346)
                      +++++|.+++....  ..+++.....++.+++.|++|||   +.+++|+||+|+||++++++.++|+|||++..+.....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            99999999986542  46899999999999999999999   99999999999999999999999999999987654332


Q ss_pred             cc--ccccccCCcccccCCCCCCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHhh------------hc
Q 039799          259 SL--TQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVND------------LL  323 (346)
Q Consensus       259 ~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~------------~~  323 (346)
                      ..  ......++..|+|||++... .++.++|+||||++++||++|+.||....... ........            .+
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  236 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-VLMLTLQNDPPSLETGADYKKY  236 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-hHHHHhcCCCCCcCCccccccc
Confidence            21  12334588999999988776 78999999999999999999999997532211 11111111            23


Q ss_pred             CCChhhhhchhccCCccccccc
Q 039799          324 PISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       324 ~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      +..+.+++.+|+..+|++||+.
T Consensus       237 ~~~~~~li~~~l~~~p~~Rp~~  258 (267)
T cd06610         237 SKSFRKMISLCLQKDPSKRPTA  258 (267)
T ss_pred             cHHHHHHHHHHcCCChhhCcCH
Confidence            3467899999999999999985

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=6.6e-38  Score=273.50  Aligned_cols=236  Identities=22%  Similarity=0.319  Sum_probs=192.8

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEec-CCceeEEEe
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSN-DDFKALVLE  179 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e  179 (346)
                      .|.+.+.||+|++|.||++... +++.+|+|.+....  ....+.+.+|++++++++|+|++++.+.+.. +...+++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            3778899999999999999866 67899999986432  2345678889999999999999999998764 446789999


Q ss_pred             cCCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccc
Q 039799          180 YMPHGSLEKCLYLS-NYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  258 (346)
Q Consensus       180 ~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~  258 (346)
                      |+++++|.+++... ...+++.++..++.+++.|++|||   +.+++||||+|+||+++.++.++|+|||++..+.... 
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~-  156 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC-  156 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEecccC-
Confidence            99999999988753 345899999999999999999999   9999999999999999999999999999998653221 


Q ss_pred             ccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh-------hhcCCChhhhh
Q 039799          259 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN-------DLLPISVMEVV  331 (346)
Q Consensus       259 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~-------~~~~~~~~~~~  331 (346)
                       .......+++.|+|||...+..++.++||||||++++|+++|+.||+...... .......       ...+..+.+++
T Consensus       157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li  234 (257)
T cd08223         157 -DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS-LVYRIIEGKLPPMPKDYSPELGELI  234 (257)
T ss_pred             -CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHhcCCCCCccccCHHHHHHH
Confidence             12233457899999999998889999999999999999999999987532111 1111111       12234788999


Q ss_pred             chhccCCccccccc
Q 039799          332 DANLLSQEDEHFTT  345 (346)
Q Consensus       332 d~~l~~~p~~R~~~  345 (346)
                      .+|+..+|++||+.
T Consensus       235 ~~~l~~~p~~Rp~~  248 (257)
T cd08223         235 ATMLSKRPEKRPSV  248 (257)
T ss_pred             HHHhccCcccCCCH
Confidence            99999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4e-38  Score=279.38  Aligned_cols=236  Identities=24%  Similarity=0.362  Sum_probs=192.2

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC-CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEec
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ-YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEY  180 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  180 (346)
                      ++|++.+.||+|++|.||++... ++..+|+|.+... .......+.+|++++++++|||++++++.+...+..++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            35788899999999999999976 7899999988654 233456788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhc--CCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeeecCCCCCceEECCCCcEEEeeecCCccCCccc
Q 039799          181 MPHGSLEKCLYLS--NYILDIFQRLDIMIDVASALEYLHFGYS-APIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  257 (346)
Q Consensus       181 ~~~gsL~~~l~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~  257 (346)
                      +++++|.+++...  ...+++..+..++.+++.|+.|||   + .+++|+||+|+||+++.++.++|+|||++..+... 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-  156 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK---EEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-  156 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence            9999999887654  236899999999999999999999   5 58999999999999999999999999998865322 


Q ss_pred             cccccccccCCcccccCCCCCCCC------CCcchhHHHHHHHHHHHHcCCCCCCccccCcc-c-HHH-------HHhhh
Q 039799          258 QSLTQTQTLATIGYMAPEYGREGR------VSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM-T-LKR-------WVNDL  322 (346)
Q Consensus       258 ~~~~~~~~~~~~~y~aPE~~~~~~------~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~-~-~~~-------~~~~~  322 (346)
                         ......++..|+|||...+..      ++.++|+||||+++|||++|+.||........ . ...       .+...
T Consensus       157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd06622         157 ---LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSG  233 (286)
T ss_pred             ---ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcc
Confidence               122345788999999875443      47899999999999999999999965321110 0 000       11112


Q ss_pred             cCCChhhhhchhccCCccccccc
Q 039799          323 LPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       323 ~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ++..+.+++.+|+..+|++||+.
T Consensus       234 ~~~~~~~li~~~l~~~p~~Rp~~  256 (286)
T cd06622         234 YSDDAQDFVAKCLNKIPNRRPTY  256 (286)
T ss_pred             cCHHHHHHHHHHcccCcccCCCH
Confidence            34477899999999999999985

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.5e-38  Score=280.36  Aligned_cols=235  Identities=25%  Similarity=0.307  Sum_probs=188.7

Q ss_pred             CCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecC
Q 039799          105 ANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYM  181 (346)
Q Consensus       105 ~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  181 (346)
                      |.+.+.||+|++|.||+|... +|+.+|+|.+....  ......+.+|++++++++|||++++++++.+....++++||+
T Consensus         2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (284)
T cd07839           2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC   81 (284)
T ss_pred             ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence            677889999999999999976 78999999986432  222356778999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccc
Q 039799          182 PHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT  261 (346)
Q Consensus       182 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~  261 (346)
                      + ++|.+++......+++.....++.|+++||.|||   +.+++||||+|+||+++.++.++|+|||+++......  ..
T Consensus        82 ~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~--~~  155 (284)
T cd07839          82 D-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV--RC  155 (284)
T ss_pred             C-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC--CC
Confidence            6 5788877655667899999999999999999999   9999999999999999999999999999998653221  11


Q ss_pred             cccccCCcccccCCCCCCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccCcccH------------HHH----------
Q 039799          262 QTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTL------------KRW----------  318 (346)
Q Consensus       262 ~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~------------~~~----------  318 (346)
                      .....++..|+|||.+.+. .++.++||||||+++|||+||..|+....+.+..+            ..|          
T Consensus       156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd07839         156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK  235 (284)
T ss_pred             cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccc
Confidence            2234578899999987664 46899999999999999999998864321111000            000          


Q ss_pred             -------------HhhhcCCChhhhhchhccCCccccccc
Q 039799          319 -------------VNDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       319 -------------~~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                                   ....++..+.+++.+||..||.+|||+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~  275 (284)
T cd07839         236 PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISA  275 (284)
T ss_pred             ccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCH
Confidence                         011234467899999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=7.9e-38  Score=277.31  Aligned_cols=236  Identities=23%  Similarity=0.264  Sum_probs=191.6

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEec
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEY  180 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  180 (346)
                      .|++...||+|++|.||+|..+ +++.+|+|++....  ....+.+.+|++++++++|||++++++++......++||||
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~   81 (286)
T cd07847           2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEY   81 (286)
T ss_pred             ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEec
Confidence            5788899999999999999977 68999999886432  22345678899999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccc
Q 039799          181 MPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  260 (346)
Q Consensus       181 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~  260 (346)
                      +++++|..+.. ....+++..+..++.+++.+|+|||   +.+++||||+|+||+++.++.++|+|||++........  
T Consensus        82 ~~~~~l~~~~~-~~~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--  155 (286)
T cd07847          82 CDHTVLNELEK-NPRGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD--  155 (286)
T ss_pred             cCccHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCCcc--
Confidence            99988887654 3446899999999999999999999   99999999999999999999999999999987643221  


Q ss_pred             ccccccCCcccccCCCCCC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccH--H---------------------
Q 039799          261 TQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTL--K---------------------  316 (346)
Q Consensus       261 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~--~---------------------  316 (346)
                      ......++..|+|||...+ ..++.++||||||++++||++|+.||......+...  .                     
T Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07847         156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK  235 (286)
T ss_pred             cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccc
Confidence            1223457888999998765 457889999999999999999999996532111000  0                     


Q ss_pred             -------------HHHhhhcCCChhhhhchhccCCccccccc
Q 039799          317 -------------RWVNDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       317 -------------~~~~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                                   ......++..+.+++.+||..+|++||+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~  277 (286)
T cd07847         236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSC  277 (286)
T ss_pred             cccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCH
Confidence                         00011234567899999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=3.8e-38  Score=288.14  Aligned_cols=196  Identities=26%  Similarity=0.289  Sum_probs=165.8

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC--CchhHHHHHHHHHHHHhcCCCCceeeEEEEecC------C
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ--YEGAFKSFDIECDVMKRICHRNLIKIISSYSND------D  172 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~  172 (346)
                      .++|.+.+.||+|+||.||++... .++.+|+|++...  .......+.+|+.+++.++||||+++++++...      .
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   95 (355)
T cd07874          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ   95 (355)
T ss_pred             hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence            367889999999999999999865 6889999998753  233456777899999999999999999988543      3


Q ss_pred             ceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCcc
Q 039799          173 FKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  252 (346)
Q Consensus       173 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~  252 (346)
                      ..++||||+++ ++.+.+.   ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||+++.
T Consensus        96 ~~~lv~e~~~~-~l~~~~~---~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~~~~  168 (355)
T cd07874          96 DVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART  168 (355)
T ss_pred             eeEEEhhhhcc-cHHHHHh---hcCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCccccc
Confidence            56899999965 5655553   24788889999999999999999   99999999999999999999999999999986


Q ss_pred             CCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 039799          253 LLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDE  307 (346)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~  307 (346)
                      ....   .......+|..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       169 ~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  220 (355)
T cd07874         169 AGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG  220 (355)
T ss_pred             CCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            4322   122334689999999999888899999999999999999999999964

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.1e-37  Score=272.85  Aligned_cols=236  Identities=25%  Similarity=0.397  Sum_probs=194.6

Q ss_pred             CCCCCCCCcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecC
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYM  181 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  181 (346)
                      ..+|.+.+.||+|+||.||++...++..+|+|.+.... ...+.+.+|++++++++|+|++++.+.+.. ...+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            45788999999999999999998878889999886542 335678889999999999999999999887 7789999999


Q ss_pred             CCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccc
Q 039799          182 PHGSLEKCLYLS-NYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  260 (346)
Q Consensus       182 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~  260 (346)
                      ++++|.+++... ...+++..+..++.+++.||+|||   +.+++|+||+|+||+++.++.++|+|||.+........ .
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~  158 (260)
T cd05073          83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-T  158 (260)
T ss_pred             CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc-c
Confidence            999999998653 356889999999999999999999   89999999999999999999999999999986533211 1


Q ss_pred             ccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHhh--------hcCCChhhhh
Q 039799          261 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVND--------LLPISVMEVV  331 (346)
Q Consensus       261 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~  331 (346)
                      ......++..|+|||+.....++.++|+||||+++++++| |+.||.....  ....++...        ..+..+.+++
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~i  236 (260)
T cd05073         159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--PEVIRALERGYRMPRPENCPEELYNIM  236 (260)
T ss_pred             cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHhCCCCCCCcccCCHHHHHHH
Confidence            1222335677999999988889999999999999999999 9999975321  112222222        1234788999


Q ss_pred             chhccCCccccccc
Q 039799          332 DANLLSQEDEHFTT  345 (346)
Q Consensus       332 d~~l~~~p~~R~~~  345 (346)
                      .+|+..+|++||+.
T Consensus       237 ~~~l~~~p~~Rp~~  250 (260)
T cd05073         237 MRCWKNRPEERPTF  250 (260)
T ss_pred             HHHcccCcccCcCH
Confidence            99999999999985

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=7.6e-38  Score=279.96  Aligned_cols=238  Identities=24%  Similarity=0.366  Sum_probs=192.1

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCC----EEEEEEecCCCc-hhHHHHHHHHHHHHhcCCCCceeeEEEEecCCcee
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGM----EVAVKVFDPQYE-GAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKA  175 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  175 (346)
                      ..+|...+.||+|+||.||+|.+. +|.    .+|+|.+..... .....+.+|+.++++++||||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~   84 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ   84 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence            356788899999999999999864 444    478898865432 3344678899999999999999999998654 467


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCc
Q 039799          176 LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  255 (346)
Q Consensus       176 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~  255 (346)
                      +++||+++|+|.+++......+++..++.++.+++.||+|||   +.+++||||||+||++++++.+||+|||+++.+..
T Consensus        85 ~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~  161 (303)
T cd05110          85 LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG  161 (303)
T ss_pred             eeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccccccccC
Confidence            899999999999998766667899999999999999999999   99999999999999999999999999999987643


Q ss_pred             cccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHhhh--------cCCC
Q 039799          256 EDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVNDL--------LPIS  326 (346)
Q Consensus       256 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~--------~~~~  326 (346)
                      ...........++..|+|||+..+..++.++||||||+++||+++ |+.||.....  ....+++...        .+..
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  239 (303)
T cd05110         162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--REIPDLLEKGERLPQPPICTID  239 (303)
T ss_pred             cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHCCCCCCCCCCCCHH
Confidence            322222223345778999999988889999999999999999997 9999865321  1122222211        2236


Q ss_pred             hhhhhchhccCCccccccc
Q 039799          327 VMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       327 ~~~~~d~~l~~~p~~R~~~  345 (346)
                      +.+++.+|+..+|++||+.
T Consensus       240 ~~~li~~c~~~~p~~Rp~~  258 (303)
T cd05110         240 VYMVMVKCWMIDADSRPKF  258 (303)
T ss_pred             HHHHHHHHcCCChhhCcCH
Confidence            7899999999999999985

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=8.2e-38  Score=286.84  Aligned_cols=196  Identities=26%  Similarity=0.282  Sum_probs=166.2

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC--CchhHHHHHHHHHHHHhcCCCCceeeEEEEecC------C
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ--YEGAFKSFDIECDVMKRICHRNLIKIISSYSND------D  172 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~  172 (346)
                      .++|.+.+.||+|+||.||++... .++.||||++...  .....+.+.+|+.+++.++||||+++++.+...      .
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            367899999999999999999865 6889999998653  233456778899999999999999999987543      3


Q ss_pred             ceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCcc
Q 039799          173 FKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  252 (346)
Q Consensus       173 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~  252 (346)
                      ..++||||+++ +|.+.+.   ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||+++.
T Consensus       103 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~  175 (364)
T cd07875         103 DVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART  175 (364)
T ss_pred             eEEEEEeCCCC-CHHHHHH---hcCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCCccc
Confidence            57899999965 6666553   24788889999999999999999   99999999999999999999999999999986


Q ss_pred             CCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 039799          253 LLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDE  307 (346)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~  307 (346)
                      ....   .......++..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       176 ~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~  227 (364)
T cd07875         176 AGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG  227 (364)
T ss_pred             cCCC---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Confidence            5322   122334689999999999988999999999999999999999999964

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1e-37  Score=272.24  Aligned_cols=233  Identities=27%  Similarity=0.326  Sum_probs=193.5

Q ss_pred             CCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC-----chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEE
Q 039799          105 ANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY-----EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVL  178 (346)
Q Consensus       105 ~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  178 (346)
                      |...+.||+|++|.||+|... ++..|++|.+....     ....+.+.+|++++++++|+|++++.+++......++++
T Consensus         2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   81 (258)
T cd06632           2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL   81 (258)
T ss_pred             ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence            667789999999999999976 78999999886432     234567889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccc
Q 039799          179 EYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  258 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~  258 (346)
                      ||+++++|.+++... ..+++..+..++.+++.|++|||   +.+++|+||+|+||+++.++.++|+|||.+....... 
T Consensus        82 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-  156 (258)
T cd06632          82 ELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-  156 (258)
T ss_pred             EecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceeccccc-
Confidence            999999999988643 45789999999999999999999   9999999999999999999999999999988653322 


Q ss_pred             ccccccccCCcccccCCCCCCCC-CCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh--------hhcCCChhh
Q 039799          259 SLTQTQTLATIGYMAPEYGREGR-VSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN--------DLLPISVME  329 (346)
Q Consensus       259 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~  329 (346)
                        ......++..|+|||...... ++.++|+||||++++++++|+.||....... ....+..        ..++..+.+
T Consensus       157 --~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  233 (258)
T cd06632         157 --FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA-AVFKIGRSKELPPIPDHLSDEAKD  233 (258)
T ss_pred             --cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH-HHHHHHhcccCCCcCCCcCHHHHH
Confidence              123445888999999887666 8999999999999999999999997643111 1111111        123346788


Q ss_pred             hhchhccCCccccccc
Q 039799          330 VVDANLLSQEDEHFTT  345 (346)
Q Consensus       330 ~~d~~l~~~p~~R~~~  345 (346)
                      ++.+||..+|++||+.
T Consensus       234 li~~~l~~~p~~Rp~~  249 (258)
T cd06632         234 FILKCLQRDPSLRPTA  249 (258)
T ss_pred             HHHHHhhcCcccCcCH
Confidence            9999999999999985

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=7.7e-38  Score=281.32  Aligned_cols=239  Identities=25%  Similarity=0.358  Sum_probs=191.6

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc--------CCCEEEEEEecCCC-chhHHHHHHHHHHHHhc-CCCCceeeEEEEecC
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ--------DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRI-CHRNLIKIISSYSND  171 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  171 (346)
                      ..+|.+.+.||+|++|.||++...        ....+|+|.+.... ......+..|+++++++ +||||+++++++...
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            356888999999999999999742        24578999987543 23456788899999999 699999999999999


Q ss_pred             CceeEEEecCCCCChhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEE
Q 039799          172 DFKALVLEYMPHGSLEKCLYLSN---------------YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL  236 (346)
Q Consensus       172 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll  236 (346)
                      +..+++|||+++++|.+++....               ..+++.....++.+++.||.|||   +.+++||||||+||++
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill  167 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLV  167 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEEE
Confidence            99999999999999999986432               35889999999999999999999   9999999999999999


Q ss_pred             CCCCcEEEeeecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccH
Q 039799          237 DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTL  315 (346)
Q Consensus       237 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~  315 (346)
                      ++++.++|+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||......  ..
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~--~~  245 (314)
T cd05099         168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE--EL  245 (314)
T ss_pred             cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH--HH
Confidence            9999999999999986643221111112224567999999888889999999999999999999 88998653211  11


Q ss_pred             HHHHh--------hhcCCChhhhhchhccCCccccccc
Q 039799          316 KRWVN--------DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       316 ~~~~~--------~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      .....        ...+..+.+++.+|+..+|++||+.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~  283 (314)
T cd05099         246 FKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTF  283 (314)
T ss_pred             HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCH
Confidence            11111        1123368899999999999999985

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1e-37  Score=272.31  Aligned_cols=230  Identities=31%  Similarity=0.422  Sum_probs=190.1

Q ss_pred             CCCCCCCcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEe-cCCceeEEEecC
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYS-NDDFKALVLEYM  181 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~  181 (346)
                      .+|.+.+.||+|++|.||++... |..+|+|.+....  ..+.+.+|+.++++++|+|++++++++. ..+..++++||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            46888899999999999999876 7889999986443  3467889999999999999999999754 556789999999


Q ss_pred             CCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccc
Q 039799          182 PHGSLEKCLYLSN-YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  260 (346)
Q Consensus       182 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~  260 (346)
                      ++++|.+++.... ..+++..++.++.+++.||+|||   +.+++||||||+||++++++.++|+|||+++......   
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---  156 (256)
T cd05082          83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---  156 (256)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence            9999999987544 35889999999999999999999   9999999999999999999999999999988543221   


Q ss_pred             ccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHh--------hhcCCChhhhh
Q 039799          261 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVN--------DLLPISVMEVV  331 (346)
Q Consensus       261 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~  331 (346)
                        .....+..|+|||+..+..++.++||||||+++|||++ |+.||.....  ....+.+.        ...+..+.+++
T Consensus       157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li  232 (256)
T cd05082         157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPRVEKGYKMDAPDGCPPVVYDVM  232 (256)
T ss_pred             --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHhcCCCCCCCCCCCHHHHHHH
Confidence              12234668999999988889999999999999999997 9999864211  11222221        12344789999


Q ss_pred             chhccCCccccccc
Q 039799          332 DANLLSQEDEHFTT  345 (346)
Q Consensus       332 d~~l~~~p~~R~~~  345 (346)
                      .+|+..+|++||+.
T Consensus       233 ~~~l~~~p~~Rpt~  246 (256)
T cd05082         233 KQCWHLDAATRPSF  246 (256)
T ss_pred             HHHhcCChhhCcCH
Confidence            99999999999985

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1e-37  Score=274.26  Aligned_cols=233  Identities=24%  Similarity=0.320  Sum_probs=179.3

Q ss_pred             CcccccCceEEEEEEEcC---CCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecCCCC
Q 039799          109 PLIGKGGFGSVYKAIIQD---GMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHG  184 (346)
Q Consensus       109 ~~lg~G~~g~vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  184 (346)
                      +.||+|+||.||+|....   ...+++|.+.... ......+.+|++.++.++|+||+++++.+......++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            358999999999997543   3568888875433 333456788999999999999999999999999999999999999


Q ss_pred             ChhhhhhhcC----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccc
Q 039799          185 SLEKCLYLSN----YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  260 (346)
Q Consensus       185 sL~~~l~~~~----~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~  260 (346)
                      +|.+++....    ...++.....++.|++.|++|||   +.+|+||||||+||++++++.++|+|||++..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            9999986543    23467778899999999999999   9999999999999999999999999999987543322111


Q ss_pred             ccccccCCcccccCCCCC-------CCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHH------------h
Q 039799          261 TQTQTLATIGYMAPEYGR-------EGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWV------------N  320 (346)
Q Consensus       261 ~~~~~~~~~~y~aPE~~~-------~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~------------~  320 (346)
                      ......++..|+|||+..       ...++.++||||||+++|||++ |..||......+ .+...+            .
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~  236 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-VLKQVVREQDIKLPKPQLD  236 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH-HHHHHhhccCccCCCCccc
Confidence            223334677899999753       3456889999999999999999 788886532211 111111            1


Q ss_pred             hhcCCChhhhhchhccCCcccccccC
Q 039799          321 DLLPISVMEVVDANLLSQEDEHFTTK  346 (346)
Q Consensus       321 ~~~~~~~~~~~d~~l~~~p~~R~~~k  346 (346)
                      ..++..+.+++..|+ .||++||+++
T Consensus       237 ~~~~~~~~~~~~~~~-~dp~~Rpt~~  261 (269)
T cd05042         237 LKYSDRWYEVMQFCW-LDPETRPTAE  261 (269)
T ss_pred             ccCCHHHHHHHHHHh-cCcccccCHH
Confidence            122335567887777 5999999863

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=2e-37  Score=271.36  Aligned_cols=237  Identities=24%  Similarity=0.297  Sum_probs=199.7

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCc-hhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEec
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYE-GAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEY  180 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  180 (346)
                      ++|.+.+.||+|++|.||+|... +++.+++|++..... ...+.+..|++.+.+++|+|++++++++...+..++|+||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            35788899999999999999977 599999999876543 4567888999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeeecCCCCCceEECCCCcEEEeeecCCccCCccccc
Q 039799          181 MPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYS-APIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  259 (346)
Q Consensus       181 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~  259 (346)
                      +++++|.+++... ..++...++.++.++++|++|||   + .+++|+||+|+||+++.++.++|+|||.+.........
T Consensus        81 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~  156 (264)
T cd06623          81 MDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ  156 (264)
T ss_pred             cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence            9999999998644 56899999999999999999999   8 99999999999999999999999999999876432221


Q ss_pred             cccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCcccc-CcccHHHHHhh--------h-cCCChhh
Q 039799          260 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFS-GEMTLKRWVND--------L-LPISVME  329 (346)
Q Consensus       260 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~-~~~~~~~~~~~--------~-~~~~~~~  329 (346)
                        .....++..|+|||...+..++.++|+||||+++|||+||+.||..... .......++..        . ++..+.+
T Consensus       157 --~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  234 (264)
T cd06623         157 --CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRD  234 (264)
T ss_pred             --ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHH
Confidence              1234578899999999888899999999999999999999999976532 11122222211        1 3446899


Q ss_pred             hhchhccCCccccccc
Q 039799          330 VVDANLLSQEDEHFTT  345 (346)
Q Consensus       330 ~~d~~l~~~p~~R~~~  345 (346)
                      ++.+||..+|++||+.
T Consensus       235 li~~~l~~~p~~R~~~  250 (264)
T cd06623         235 FISACLQKDPKKRPSA  250 (264)
T ss_pred             HHHHHccCChhhCCCH
Confidence            9999999999999985

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=5.3e-38  Score=308.10  Aligned_cols=243  Identities=21%  Similarity=0.291  Sum_probs=190.9

Q ss_pred             CCCCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC--CchhHHHHHHHHHHHHhcCCCCceeeEEEEec--CCc
Q 039799           99 KPLPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ--YEGAFKSFDIECDVMKRICHRNLIKIISSYSN--DDF  173 (346)
Q Consensus        99 ~~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~  173 (346)
                      .....+|.+.+.||+|+||+||++... .+..+|+|++...  .......+..|+.++++++||||++++++|..  ...
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~   88 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK   88 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence            344568999999999999999999976 6778999988643  23345678899999999999999999998854  456


Q ss_pred             eeEEEecCCCCChhhhhhhc---CCCCCHHHHHHHHHHHHHHHHHHhcCC----CCCeeecCCCCCceEECC--------
Q 039799          174 KALVLEYMPHGSLEKCLYLS---NYILDIFQRLDIMIDVASALEYLHFGY----SAPIIHCDLKPSNVLLDD--------  238 (346)
Q Consensus       174 ~~lv~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~----~~~i~H~dik~~NIll~~--------  238 (346)
                      .++||||+++++|.+++...   ...+++..++.|+.||+.||+|||...    ..+|+||||||+|||++.        
T Consensus        89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i  168 (1021)
T PTZ00266         89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI  168 (1021)
T ss_pred             EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence            88999999999999988642   246899999999999999999999321    146999999999999964        


Q ss_pred             ---------CCcEEEeeecCCccCCccccccccccccCCcccccCCCCCC--CCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 039799          239 ---------NMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE--GRVSTNGDVYSFGIMLMEIFTRTKPTDE  307 (346)
Q Consensus       239 ---------~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~s~G~il~elltg~~p~~~  307 (346)
                               ...++|+|||++..+....   ......||+.|+|||++.+  ..++.++|||||||++|||+||+.||..
T Consensus       169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~  245 (1021)
T PTZ00266        169 TAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK  245 (1021)
T ss_pred             cccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence                     2358999999998653221   1233468999999998754  4578999999999999999999999965


Q ss_pred             cccCcccHHHHHh-------hhcCCChhhhhchhccCCccccccc
Q 039799          308 IFSGEMTLKRWVN-------DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       308 ~~~~~~~~~~~~~-------~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ..... .+...+.       ...+..+.+++..||..+|.+||++
T Consensus       246 ~~~~~-qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa  289 (1021)
T PTZ00266        246 ANNFS-QLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSA  289 (1021)
T ss_pred             CCcHH-HHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCH
Confidence            22111 1111111       1123378999999999999999985

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.4e-37  Score=273.89  Aligned_cols=238  Identities=26%  Similarity=0.364  Sum_probs=191.5

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC----------chhHHHHHHHHHHHHhcCCCCceeeEEEEecCC
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY----------EGAFKSFDIECDVMKRICHRNLIKIISSYSNDD  172 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  172 (346)
                      .|...+.||+|++|.||+|... +|+.+|+|.+....          ....+.+..|+.++++++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            3667889999999999999865 68999999875321          112346778999999999999999999999999


Q ss_pred             ceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCcc
Q 039799          173 FKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  252 (346)
Q Consensus       173 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~  252 (346)
                      ..++|+||+++++|.+++... ..+++..+..++.+++.|+.|||   +.+++||||+|+||++++++.++++|||++..
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~  157 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKK  157 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence            999999999999999988654 46888889999999999999999   89999999999999999999999999999986


Q ss_pred             CCccccccccccccCCcccccCCCCCCCC--CCcchhHHHHHHHHHHHHcCCCCCCccccCcc-----------cHHHHH
Q 039799          253 LLEEDQSLTQTQTLATIGYMAPEYGREGR--VSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM-----------TLKRWV  319 (346)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~-----------~~~~~~  319 (346)
                      ..............++..|+|||......  ++.++|+||||++++|+++|..||......+.           ......
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (272)
T cd06629         158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDV  237 (272)
T ss_pred             ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccc
Confidence            53322222223345788999999877654  78999999999999999999999964221110           001111


Q ss_pred             hhhcCCChhhhhchhccCCccccccc
Q 039799          320 NDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       320 ~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ...++..+.+++.+|+..+|++||+.
T Consensus       238 ~~~~~~~~~~li~~~l~~~p~~Rps~  263 (272)
T cd06629         238 SMNLSPVALDFLNACFTINPDNRPTA  263 (272)
T ss_pred             cccCCHHHHHHHHHHhcCChhhCCCH
Confidence            12234578899999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.3e-37  Score=275.60  Aligned_cols=240  Identities=25%  Similarity=0.397  Sum_probs=196.0

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-----CCCEEEEEEecCCCch-hHHHHHHHHHHHHhcCCCCceeeEEEEec--CCce
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-----DGMEVAVKVFDPQYEG-AFKSFDIECDVMKRICHRNLIKIISSYSN--DDFK  174 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~  174 (346)
                      ..|.+.+.||+|+||.||++.+.     ++..+|+|++...... ..+.+.+|++.+++++|+|++++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            45777899999999999999864     3688999999765443 46788999999999999999999999877  5678


Q ss_pred             eEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCC
Q 039799          175 ALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  254 (346)
Q Consensus       175 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~  254 (346)
                      +++|||+++++|.+++......+++..+..++.+++.||+|||   +.+++|+||+|+||+++.++.++|+|||.+....
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLP  160 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence            9999999999999999766667999999999999999999999   9999999999999999999999999999999765


Q ss_pred             ccccccc-cccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCccc----------H---HHHHh
Q 039799          255 EEDQSLT-QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMT----------L---KRWVN  320 (346)
Q Consensus       255 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~----------~---~~~~~  320 (346)
                      ....... .....++..|+|||......++.++||||||++++||+||..|+.........          .   ..+..
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05038         161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK  240 (284)
T ss_pred             cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence            3222111 11223556799999988888999999999999999999999998653322211          1   11111


Q ss_pred             h--------hcCCChhhhhchhccCCccccccc
Q 039799          321 D--------LLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       321 ~--------~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      .        ..+..+.+++.+|+..+|++||++
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~  273 (284)
T cd05038         241 EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSF  273 (284)
T ss_pred             cCCcCCCCccCCHHHHHHHHHHhccChhhCCCH
Confidence            1        123367899999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-37  Score=280.54  Aligned_cols=238  Identities=26%  Similarity=0.347  Sum_probs=195.5

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCc---hhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEe
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYE---GAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLE  179 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  179 (346)
                      +|...+.||+|++|.||++... +++.+|+|.+.....   ...+.+..|+++++.++|+||+++++.+...+..++|||
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   81 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD   81 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence            5778899999999999999876 589999999875432   245678889999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccc
Q 039799          180 YMPHGSLEKCLYLS-NYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  258 (346)
Q Consensus       180 ~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~  258 (346)
                      |+.+++|.+++... ...+++.....++.+++.||+|||   +.+++|+||||+||+++.++.++|+|||++........
T Consensus        82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~  158 (316)
T cd05574          82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP  158 (316)
T ss_pred             ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence            99999999988654 356899999999999999999999   99999999999999999999999999999876532111


Q ss_pred             c---------------------------cccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccC
Q 039799          259 S---------------------------LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSG  311 (346)
Q Consensus       259 ~---------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~  311 (346)
                      .                           .......|+..|+|||...+..++.++||||||+++|+|++|+.||......
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~  238 (316)
T cd05574         159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD  238 (316)
T ss_pred             ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence            0                           0111235788999999998888999999999999999999999999653221


Q ss_pred             cccHHHHHhhh--------cCCChhhhhchhccCCccccccc
Q 039799          312 EMTLKRWVNDL--------LPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       312 ~~~~~~~~~~~--------~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      . .........        .+..+.+++.+|+..+|++||++
T Consensus       239 ~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~  279 (316)
T cd05574         239 E-TFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGS  279 (316)
T ss_pred             H-HHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCc
Confidence            1 111111111        34478999999999999999983

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.5e-37  Score=275.13  Aligned_cols=236  Identities=26%  Similarity=0.328  Sum_probs=187.2

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHH-HHhcCCCCceeeEEEEecCCceeEEEe
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY-EGAFKSFDIECDV-MKRICHRNLIKIISSYSNDDFKALVLE  179 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e  179 (346)
                      ++|.+.+.||+|+||.||++... +|+.||+|++.... ......+..|+.. ++..+|||++++++++..++..+++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            36788899999999999999976 69999999987543 2223445556654 566789999999999999999999999


Q ss_pred             cCCCCChhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeeecCCCCCceEECCCCcEEEeeecCCccCCc
Q 039799          180 YMPHGSLEKCLYL---SNYILDIFQRLDIMIDVASALEYLHFGYSA-PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  255 (346)
Q Consensus       180 ~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~  255 (346)
                      |++ ++|.+++..   ....+++..++.++.|++.||+|||   +. +++||||||+||+++.++.++|+|||++..+..
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            996 688777643   2356899999999999999999999   76 999999999999999999999999999986532


Q ss_pred             cccccccccccCCcccccCCCCCC----CCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh--------hhc
Q 039799          256 EDQSLTQTQTLATIGYMAPEYGRE----GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN--------DLL  323 (346)
Q Consensus       256 ~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~--------~~~  323 (346)
                      ..   ..+...++..|+|||.+.+    ..++.++|+||||+++|||++|+.||.........+.....        ..+
T Consensus       157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd06617         157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKF  233 (283)
T ss_pred             cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCcccc
Confidence            21   1223457889999998754    44688999999999999999999999753222122222221        123


Q ss_pred             CCChhhhhchhccCCccccccc
Q 039799          324 PISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       324 ~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      +..+.+++.+||..+|++||+.
T Consensus       234 ~~~l~~li~~~l~~~p~~Rp~~  255 (283)
T cd06617         234 SPEFQDFVNKCLKKNYKERPNY  255 (283)
T ss_pred             CHHHHHHHHHHccCChhhCcCH
Confidence            4578899999999999999985

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2.5e-37  Score=269.68  Aligned_cols=235  Identities=28%  Similarity=0.500  Sum_probs=194.2

Q ss_pred             CCCCCcccccCceEEEEEEEcC-----CCEEEEEEecCCCch-hHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEE
Q 039799          105 ANMPPLIGKGGFGSVYKAIIQD-----GMEVAVKVFDPQYEG-AFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVL  178 (346)
Q Consensus       105 ~~~~~~lg~G~~g~vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  178 (346)
                      +.+.+.||+|+||.||++.+.+     +..+|+|++...... ..+.+..|++++..++|+|++++++++...+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            3567889999999999999763     388999999755433 5678889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCC-CCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccc
Q 039799          179 EYMPHGSLEKCLYLSNYI-LDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  257 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~~~-l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~  257 (346)
                      ||+++++|.+++...... +++..+..++.+++.|++|||   +.+++|+||+|+||++++++.++|+|||++.......
T Consensus        81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  157 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD  157 (258)
T ss_pred             eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence            999999999998755444 899999999999999999999   9999999999999999999999999999998765432


Q ss_pred             cccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHH--------hhhcCCChh
Q 039799          258 QSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWV--------NDLLPISVM  328 (346)
Q Consensus       258 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~--------~~~~~~~~~  328 (346)
                      .... ....++..|+|||......++.++||||+|++++||++ |..||.....  ....+.+        ....+..+.
T Consensus       158 ~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  234 (258)
T smart00219      158 YYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN--EEVLEYLKKGYRLPKPENCPPEIY  234 (258)
T ss_pred             cccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHhcCCCCCCCCcCCHHHH
Confidence            2111 12236789999999888889999999999999999998 8888865211  1111111        112345788


Q ss_pred             hhhchhccCCccccccc
Q 039799          329 EVVDANLLSQEDEHFTT  345 (346)
Q Consensus       329 ~~~d~~l~~~p~~R~~~  345 (346)
                      +++.+|+..+|++|||+
T Consensus       235 ~~i~~~l~~~p~~Rpt~  251 (258)
T smart00219      235 KLMLQCWAEDPEDRPTF  251 (258)
T ss_pred             HHHHHHCcCChhhCcCH
Confidence            99999999999999986

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=9.8e-38  Score=276.66  Aligned_cols=235  Identities=26%  Similarity=0.338  Sum_probs=194.6

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEec
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEY  180 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  180 (346)
                      ++|++.+.||+|++|+||++... +++.+|+|++.... ....+.+.+|+++++.++|||++++++++...+..++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            56788899999999999999865 68899999876543 34457888999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeeecCCCCCceEECCCCcEEEeeecCCccCCccccc
Q 039799          181 MPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYS-APIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  259 (346)
Q Consensus       181 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~  259 (346)
                      +++++|.+++.. ...+++.....++.+++.++.|||   + .+++||||+|+||++++++.++|+|||++.......  
T Consensus        85 ~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH---~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~--  158 (284)
T cd06620          85 MDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLY---NVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI--  158 (284)
T ss_pred             CCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHH---HhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc--
Confidence            999999988764 345889999999999999999999   5 589999999999999999999999999987542211  


Q ss_pred             cccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCc------ccHHHHHhh------------
Q 039799          260 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE------MTLKRWVND------------  321 (346)
Q Consensus       260 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~------~~~~~~~~~------------  321 (346)
                        .....++..|+|||++.+..++.++|+||||+++||++||+.||+.....+      .....+...            
T Consensus       159 --~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd06620         159 --ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSS  236 (284)
T ss_pred             --cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCch
Confidence              123468999999999888889999999999999999999999997533210      111111111            


Q ss_pred             hcCCChhhhhchhccCCccccccc
Q 039799          322 LLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       322 ~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      .++..+.+++.+|+..+|++||+.
T Consensus       237 ~~~~~~~~li~~~l~~dp~~Rpt~  260 (284)
T cd06620         237 DFPEDLRDFVDACLLKDPTERPTP  260 (284)
T ss_pred             hcCHHHHHHHHHHhcCCcccCcCH
Confidence            133467899999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=9.1e-38  Score=275.46  Aligned_cols=237  Identities=21%  Similarity=0.365  Sum_probs=194.7

Q ss_pred             CCCCCCCcccccCceEEEEEEEc------CCCEEEEEEecCCCch-hHHHHHHHHHHHHhcCCCCceeeEEEEecCCcee
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ------DGMEVAVKVFDPQYEG-AFKSFDIECDVMKRICHRNLIKIISSYSNDDFKA  175 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  175 (346)
                      ++|.....||+|+||.||+|+.+      +.+.+++|.+...... ..+.+.+|++++++++|+|++++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            56888899999999999999864      3467999998755433 4578899999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhhhcC--------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeee
Q 039799          176 LVLEYMPHGSLEKCLYLSN--------YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDF  247 (346)
Q Consensus       176 lv~e~~~~gsL~~~l~~~~--------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Df  247 (346)
                      +||||+++++|.+++....        ..+++..+..++.+++.||+|||   +.+++||||||+||+++.++.++++||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEccc
Confidence            9999999999999986443        15899999999999999999999   999999999999999999999999999


Q ss_pred             cCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHH-------
Q 039799          248 GMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWV-------  319 (346)
Q Consensus       248 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~-------  319 (346)
                      |++....... ........++..|+|||...+..++.++||||||++++|+++ |..||.......  .....       
T Consensus       162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~--~~~~~~~~~~~~  238 (275)
T cd05046         162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE--VLNRLQAGKLEL  238 (275)
T ss_pred             ccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH--HHHHHHcCCcCC
Confidence            9987543221 112223346778999999888888999999999999999998 888986532211  11111       


Q ss_pred             --hhhcCCChhhhhchhccCCccccccc
Q 039799          320 --NDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       320 --~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                        ...++..+.+++.+||..+|.+||++
T Consensus       239 ~~~~~~~~~l~~~i~~~l~~~p~~Rp~~  266 (275)
T cd05046         239 PVPEGCPSRLYKLMTRCWAVNPKDRPSF  266 (275)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCcccCCCH
Confidence              12234578999999999999999985

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5e-39  Score=292.33  Aligned_cols=232  Identities=26%  Similarity=0.410  Sum_probs=189.6

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEE---EEec-CCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCc--eeEEE
Q 039799          106 NMPPLIGKGGFGSVYKAIIQ-DGMEVAV---KVFD-PQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDF--KALVL  178 (346)
Q Consensus       106 ~~~~~lg~G~~g~vy~~~~~-~~~~vav---K~~~-~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~--~~lv~  178 (346)
                      .+...||+|+|-+||+|.+. +|.+||-   |.-+ ...+...++|..|+.+|+.|+||||++++.+|.+...  ..+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            55678999999999999866 6777773   3221 1234556899999999999999999999999987664  77999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEEC-CCCcEEEeeecCCccCCccc
Q 039799          179 EYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEED  257 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~-~~~~~~l~Dfg~~~~~~~~~  257 (346)
                      |.+..|+|..|+... ...+......+++||++||.|||. ..++|+|||||.+||+++ ..|.+||+|+|+|.......
T Consensus       123 EL~TSGtLr~Y~kk~-~~vn~kaik~W~RQILkGL~yLHs-~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~  200 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKH-RRVNIKAIKSWCRQILKGLVYLHS-QDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH  200 (632)
T ss_pred             ecccCCcHHHHHHHh-ccCCHHHHHHHHHHHHHHhhhhhc-CCCCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence            999999999988643 457788899999999999999995 478999999999999998 46899999999999764322


Q ss_pred             cccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHhhhc---------CCChh
Q 039799          258 QSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLL---------PISVM  328 (346)
Q Consensus       258 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~---------~~~~~  328 (346)
                          ....+|||.|||||... ..|++.+||||||++++||+|+..||.+.... ..+.+.|....         .+.+.
T Consensus       201 ----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~-AQIYKKV~SGiKP~sl~kV~dPevr  274 (632)
T KOG0584|consen  201 ----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP-AQIYKKVTSGIKPAALSKVKDPEVR  274 (632)
T ss_pred             ----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCH-HHHHHHHHcCCCHHHhhccCCHHHH
Confidence                23467999999999876 78999999999999999999999999874433 23333333222         22789


Q ss_pred             hhhchhccCCcccccccC
Q 039799          329 EVVDANLLSQEDEHFTTK  346 (346)
Q Consensus       329 ~~~d~~l~~~p~~R~~~k  346 (346)
                      ++|++||.. ..+|+|+|
T Consensus       275 ~fIekCl~~-~~~R~sa~  291 (632)
T KOG0584|consen  275 EFIEKCLAT-KSERLSAK  291 (632)
T ss_pred             HHHHHHhcC-chhccCHH
Confidence            999999999 88999875

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-37  Score=276.54  Aligned_cols=237  Identities=22%  Similarity=0.278  Sum_probs=190.0

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCc-hhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEec
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYE-GAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEY  180 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  180 (346)
                      ++|.+.+.||+|++|.||+|..+ +++.||+|.+..... .....+.+|++++++++|+||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            56888999999999999999976 689999999864322 2234566899999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccc
Q 039799          181 MPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  260 (346)
Q Consensus       181 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~  260 (346)
                      +++ +|.+++......+++.....++.++++||.|||   +.+++||||+|+||+++.++.++|+|||+++.......  
T Consensus        85 ~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~--  158 (291)
T cd07844          85 LDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK--  158 (291)
T ss_pred             CCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc--
Confidence            975 899988766667899999999999999999999   99999999999999999999999999999875422111  


Q ss_pred             ccccccCCcccccCCCCCC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHH-----------------------
Q 039799          261 TQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLK-----------------------  316 (346)
Q Consensus       261 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~-----------------------  316 (346)
                      ......++..|+|||...+ ..++.++||||+|+++|||++|+.||.........+.                       
T Consensus       159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (291)
T cd07844         159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF  238 (291)
T ss_pred             cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence            1122346788999998765 4578899999999999999999999964321000000                       


Q ss_pred             ----------HHHhh---hcC--CChhhhhchhccCCccccccc
Q 039799          317 ----------RWVND---LLP--ISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       317 ----------~~~~~---~~~--~~~~~~~d~~l~~~p~~R~~~  345 (346)
                                +-...   .+.  ....+++.+||..+|++||++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~  282 (291)
T cd07844         239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISA  282 (291)
T ss_pred             ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCH
Confidence                      00000   112  355699999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.1e-37  Score=278.30  Aligned_cols=236  Identities=25%  Similarity=0.338  Sum_probs=189.6

Q ss_pred             CCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCc-----hhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEE
Q 039799          105 ANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYE-----GAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVL  178 (346)
Q Consensus       105 ~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  178 (346)
                      |.+.+.||+|++|.||+|... +++.||+|.+.....     .....+..|++++++++|+|++++++++...+..++||
T Consensus         2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   81 (298)
T cd07841           2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF   81 (298)
T ss_pred             ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence            677889999999999999976 689999999865432     23455678999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccc
Q 039799          179 EYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  258 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~  258 (346)
                      ||+ +++|.+++......+++..+..++.|+++||+|||   +.+++|+||+|+||+++.++.++|+|||++........
T Consensus        82 e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~  157 (298)
T cd07841          82 EFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR  157 (298)
T ss_pred             ccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence            999 99999998755447899999999999999999999   99999999999999999999999999999987643221


Q ss_pred             ccccccccCCcccccCCCCCC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccCcc-----------cHHHHH-------
Q 039799          259 SLTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM-----------TLKRWV-------  319 (346)
Q Consensus       259 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~-----------~~~~~~-------  319 (346)
                        ......++..|+|||.+.+ ..++.++||||||++++||++|.+||......+.           ....|.       
T Consensus       158 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (298)
T cd07841         158 --KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD  235 (298)
T ss_pred             --cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccc
Confidence              1223346788999998754 4578899999999999999999887754221100           000000       


Q ss_pred             ---------------hhhcCCChhhhhchhccCCcccccccC
Q 039799          320 ---------------NDLLPISVMEVVDANLLSQEDEHFTTK  346 (346)
Q Consensus       320 ---------------~~~~~~~~~~~~d~~l~~~p~~R~~~k  346 (346)
                                     ....+..+.+++.+||..+|++||+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~  277 (298)
T cd07841         236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITAR  277 (298)
T ss_pred             cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHH
Confidence                           011233567899999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-40  Score=278.36  Aligned_cols=234  Identities=25%  Similarity=0.364  Sum_probs=203.7

Q ss_pred             CCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecCCC
Q 039799          105 ANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPH  183 (346)
Q Consensus       105 ~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  183 (346)
                      |++...||+|+||.||+|.++ .|+.+|||.+...  ...+++..|+.++.+++.|++|+++|.|.....+++|||||..
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA  112 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA  112 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence            677788999999999999876 7999999998654  4578899999999999999999999999999999999999999


Q ss_pred             CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccccc
Q 039799          184 GSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT  263 (346)
Q Consensus       184 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~~  263 (346)
                      ||+.+.+..+++.++...+..++.+.++||+|||   ...-+|||||+.|||++.+|.+||+|||.|..+.+  .-....
T Consensus       113 GSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--TMAKRN  187 (502)
T KOG0574|consen  113 GSISDIMRARRKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--TMAKRN  187 (502)
T ss_pred             CcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhh--hHHhhC
Confidence            9999999999999999999999999999999999   88889999999999999999999999999997743  223345


Q ss_pred             cccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccH-------HHH-HhhhcCCChhhhhchhc
Q 039799          264 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTL-------KRW-VNDLLPISVMEVVDANL  335 (346)
Q Consensus       264 ~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~-------~~~-~~~~~~~~~~~~~d~~l  335 (346)
                      ...||+.|+|||++..-.|+.++||||+|+...||..|++||.++......+       ..+ ..+.+++++.|++.+||
T Consensus       188 TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CL  267 (502)
T KOG0574|consen  188 TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCL  267 (502)
T ss_pred             ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHh
Confidence            6789999999999998899999999999999999999999998865332111       001 12234558899999999


Q ss_pred             cCCccccccc
Q 039799          336 LSQEDEHFTT  345 (346)
Q Consensus       336 ~~~p~~R~~~  345 (346)
                      ...|++|-++
T Consensus       268 iK~PE~R~TA  277 (502)
T KOG0574|consen  268 IKKPEERKTA  277 (502)
T ss_pred             cCCHHHHHHH
Confidence            9999999764

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.2e-37  Score=271.65  Aligned_cols=238  Identities=22%  Similarity=0.298  Sum_probs=189.4

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC-----chhHHHHHHHHHHHHhcCCCCceeeEEEEecC--Cc
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY-----EGAFKSFDIECDVMKRICHRNLIKIISSYSND--DF  173 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~  173 (346)
                      +.+|.+.+.||+|+||.||+|... ++..||+|.+....     ....+.+.+|+.++++++|||++++++++.+.  ..
T Consensus         1 ~~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   80 (265)
T cd06652           1 PTNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERT   80 (265)
T ss_pred             CCcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCce
Confidence            357889999999999999999865 68999999875321     22346788899999999999999999988763  46


Q ss_pred             eeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccC
Q 039799          174 KALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  253 (346)
Q Consensus       174 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~  253 (346)
                      .+++|||+++++|.+++... ..+++.....++.+++.||+|||   +.+++|+||+|+||+++.++.++|+|||++...
T Consensus        81 ~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~  156 (265)
T cd06652          81 LSIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRL  156 (265)
T ss_pred             EEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence            78999999999999988644 44788888999999999999999   999999999999999999999999999999865


Q ss_pred             Cccccc-cccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH--------hhhcC
Q 039799          254 LEEDQS-LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV--------NDLLP  324 (346)
Q Consensus       254 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~--------~~~~~  324 (346)
                      ...... .......++..|+|||...+..++.++||||||+++||+++|+.||...... .......        ...++
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~  235 (265)
T cd06652         157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM-AAIFKIATQPTNPVLPPHVS  235 (265)
T ss_pred             ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH-HHHHHHhcCCCCCCCchhhC
Confidence            322111 1122345888999999998888999999999999999999999999653111 1111111        11223


Q ss_pred             CChhhhhchhccCCccccccc
Q 039799          325 ISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       325 ~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ..+.+++.+|+. +|++||+.
T Consensus       236 ~~~~~~i~~~l~-~p~~Rp~~  255 (265)
T cd06652         236 DHCRDFLKRIFV-EAKLRPSA  255 (265)
T ss_pred             HHHHHHHHHHhc-ChhhCCCH
Confidence            356788999884 99999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.9e-37  Score=279.11  Aligned_cols=194  Identities=23%  Similarity=0.328  Sum_probs=157.7

Q ss_pred             CCcccccCceEEEEEEEc---CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEe--cCCceeEEEecCC
Q 039799          108 PPLIGKGGFGSVYKAIIQ---DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYS--NDDFKALVLEYMP  182 (346)
Q Consensus       108 ~~~lg~G~~g~vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~lv~e~~~  182 (346)
                      ...||+|+||.||+|...   ++..+|+|.+....  ....+.+|++++++++|||++++++++.  .+...++|+||++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            357999999999999865   45789999986542  2345778999999999999999999885  3557789999986


Q ss_pred             CCChhhhhhhc--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEE----CCCCcEEEeeecCC
Q 039799          183 HGSLEKCLYLS--------NYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL----DDNMVAHLSDFGMA  250 (346)
Q Consensus       183 ~gsL~~~l~~~--------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll----~~~~~~~l~Dfg~~  250 (346)
                      + +|.+++...        ...+++..+..++.|++.||+|||   +.+|+||||||+||++    +.++.++|+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            5 776665321        235788889999999999999999   9999999999999999    46679999999999


Q ss_pred             ccCCccccc-cccccccCCcccccCCCCCC-CCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 039799          251 KPLLEEDQS-LTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMEIFTRTKPTDE  307 (346)
Q Consensus       251 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~  307 (346)
                      +........ .......+|..|+|||.+.+ ..++.++||||||+++|||+||++||..
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~  218 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence            876432211 12233468999999998876 4578999999999999999999999864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=2.7e-37  Score=274.75  Aligned_cols=238  Identities=23%  Similarity=0.311  Sum_probs=189.0

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEec
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEY  180 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  180 (346)
                      .+|.+.+.||+|++|.||+|... ++..+|+|++.... ......+.+|+++++.++|+|++++.+++...+..++|+||
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEY   84 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEec
Confidence            56888999999999999999865 68999999986442 22234667899999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccc
Q 039799          181 MPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  260 (346)
Q Consensus       181 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~  260 (346)
                      +. +++.+.+......+++.....++.+++.||.|||   +.+++|+||||+||+++.++.++|+|||+++.......  
T Consensus        85 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--  158 (291)
T cd07870          85 MH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ--  158 (291)
T ss_pred             cc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC--
Confidence            95 6777766555556788888899999999999999   89999999999999999999999999999886432221  


Q ss_pred             ccccccCCcccccCCCCCCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHH-----------------------
Q 039799          261 TQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLK-----------------------  316 (346)
Q Consensus       261 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~-----------------------  316 (346)
                      ......++..|+|||...+. .++.++||||||+++|||+||+.||+........+.                       
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (291)
T cd07870         159 TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNY  238 (291)
T ss_pred             CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccc
Confidence            12334578899999988654 478899999999999999999999965321100000                       


Q ss_pred             -------------HHHhhh--cCCChhhhhchhccCCcccccccC
Q 039799          317 -------------RWVNDL--LPISVMEVVDANLLSQEDEHFTTK  346 (346)
Q Consensus       317 -------------~~~~~~--~~~~~~~~~d~~l~~~p~~R~~~k  346 (346)
                                   .+....  .+..+.+++.+|+..||.+|||++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~  283 (291)
T cd07870         239 KPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQ  283 (291)
T ss_pred             cchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHH
Confidence                         000001  123677999999999999999863

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=6.9e-38  Score=278.71  Aligned_cols=235  Identities=25%  Similarity=0.319  Sum_probs=193.3

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecC
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYM  181 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  181 (346)
                      +.|.....||+|++|.||++... ++..+|||.+........+.+.+|+..+++++|+|++++++.+...+..++||||+
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~  101 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL  101 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence            33555677999999999999865 68899999987655555677889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccc
Q 039799          182 PHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT  261 (346)
Q Consensus       182 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~  261 (346)
                      ++++|.+++..  ..+++.....++.+++.|++|||   +.+++||||+|+||++++++.++|+|||++........  .
T Consensus       102 ~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~  174 (292)
T cd06658         102 EGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--K  174 (292)
T ss_pred             CCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--c
Confidence            99999998743  35788999999999999999999   99999999999999999999999999999876532221  1


Q ss_pred             cccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHH---Hhh------hcCCChhhhhc
Q 039799          262 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRW---VND------LLPISVMEVVD  332 (346)
Q Consensus       262 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~---~~~------~~~~~~~~~~d  332 (346)
                      .....++..|+|||...+..++.++||||||+++||+++|+.||....... .....   ...      ..+..+.+++.
T Consensus       175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~  253 (292)
T cd06658         175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ-AMRRIRDNLPPRVKDSHKVSSVLRGFLD  253 (292)
T ss_pred             CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhcCCCccccccccCHHHHHHHH
Confidence            223458899999999988889999999999999999999999986422111 01111   111      12335788999


Q ss_pred             hhccCCccccccc
Q 039799          333 ANLLSQEDEHFTT  345 (346)
Q Consensus       333 ~~l~~~p~~R~~~  345 (346)
                      +|+..+|.+||++
T Consensus       254 ~~l~~~P~~Rpt~  266 (292)
T cd06658         254 LMLVREPSQRATA  266 (292)
T ss_pred             HHccCChhHCcCH
Confidence            9999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=7.6e-38  Score=279.13  Aligned_cols=234  Identities=24%  Similarity=0.294  Sum_probs=194.0

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecC
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYM  181 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  181 (346)
                      ..|.....||+|+||.||++... +++.+|+|++........+.+.+|+.+++.++|||++++++++...+..++++||+
T Consensus        21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~  100 (297)
T cd06659          21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL  100 (297)
T ss_pred             hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecC
Confidence            44666678999999999999865 78999999987554445567888999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccc
Q 039799          182 PHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT  261 (346)
Q Consensus       182 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~  261 (346)
                      ++++|.+++..  ..+++..+..++.+++.||+|||   +.+++||||+|+||+++.++.++|+|||++........  .
T Consensus       101 ~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~  173 (297)
T cd06659         101 QGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--K  173 (297)
T ss_pred             CCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc--c
Confidence            99999987643  45789999999999999999999   99999999999999999999999999999875533221  1


Q ss_pred             cccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh----------hhcCCChhhhh
Q 039799          262 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN----------DLLPISVMEVV  331 (346)
Q Consensus       262 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~----------~~~~~~~~~~~  331 (346)
                      .....++..|+|||++.+..++.++||||||++++||++|+.||......  .....+.          ..++..+.+++
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~~i  251 (297)
T cd06659         174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV--QAMKRLRDSPPPKLKNAHKISPVLRDFL  251 (297)
T ss_pred             ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHhccCCCCccccCCCCHHHHHHH
Confidence            23345889999999998888999999999999999999999998642211  1111111          12334678999


Q ss_pred             chhccCCccccccc
Q 039799          332 DANLLSQEDEHFTT  345 (346)
Q Consensus       332 d~~l~~~p~~R~~~  345 (346)
                      .+|+..+|++||+.
T Consensus       252 ~~~l~~~P~~Rps~  265 (297)
T cd06659         252 ERMLTREPQERATA  265 (297)
T ss_pred             HHHhcCCcccCcCH
Confidence            99999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=3.2e-37  Score=271.06  Aligned_cols=235  Identities=22%  Similarity=0.366  Sum_probs=191.6

Q ss_pred             CCCCCCcccccCceEEEEEEEcC--CCEEEEEEecCC----------CchhHHHHHHHHHHHHh-cCCCCceeeEEEEec
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQD--GMEVAVKVFDPQ----------YEGAFKSFDIECDVMKR-ICHRNLIKIISSYSN  170 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~  170 (346)
                      .|.+.+.||+|++|.||+|....  ++.+|+|.+...          ......++..|+.++.+ ++|||++++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            37788899999999999999764  688999987532          22334567778888875 799999999999999


Q ss_pred             CCceeEEEecCCCCChhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeeecCCCCCceEECCCCcEEEee
Q 039799          171 DDFKALVLEYMPHGSLEKCLYL---SNYILDIFQRLDIMIDVASALEYLHFGYS-APIIHCDLKPSNVLLDDNMVAHLSD  246 (346)
Q Consensus       171 ~~~~~lv~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~i~H~dik~~NIll~~~~~~~l~D  246 (346)
                      ++..+++|||+++++|.+++..   ....+++..++.++.+++.++.|||   + .+++|+||+|+||+++.++.++|+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLH---KEKRIVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhc---cCCceeecCCCHHHEEECCCCcEEEec
Confidence            9999999999999999988743   3456889999999999999999999   5 6899999999999999999999999


Q ss_pred             ecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH-------
Q 039799          247 FGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV-------  319 (346)
Q Consensus       247 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~-------  319 (346)
                      ||.+.......   ......++..|+|||...+..++.++||||||+++|||++|+.||...... .......       
T Consensus       158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~  233 (269)
T cd08528         158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML-SLATKIVEAVYEPL  233 (269)
T ss_pred             ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH-HHHHHHhhccCCcC
Confidence            99998654332   233456889999999998888999999999999999999999998652211 0011111       


Q ss_pred             -hhhcCCChhhhhchhccCCccccccc
Q 039799          320 -NDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       320 -~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                       ...++..+.+++.+|+..||++||+.
T Consensus       234 ~~~~~~~~l~~li~~cl~~~p~~Rp~~  260 (269)
T cd08528         234 PEGMYSEDVTDVITSCLTPDAEARPDI  260 (269)
T ss_pred             CcccCCHHHHHHHHHHCCCCCccCCCH
Confidence             11234578999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=3.9e-37  Score=272.96  Aligned_cols=234  Identities=25%  Similarity=0.302  Sum_probs=194.4

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecC
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYM  181 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  181 (346)
                      ..|...+.||+|++|.||++... +++.+++|++........+.+.+|+.+++.++|||++++++++...+..++++||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~   98 (285)
T cd06648          19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL   98 (285)
T ss_pred             HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEecc
Confidence            34666789999999999999865 78899999987554455567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccc
Q 039799          182 PHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT  261 (346)
Q Consensus       182 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~  261 (346)
                      ++++|.+++..  ..+++..+..++.+++.|++|||   +.+++||||+|+||+++.++.++|+|||.+.......  ..
T Consensus        99 ~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~--~~  171 (285)
T cd06648          99 EGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV--PR  171 (285)
T ss_pred             CCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC--cc
Confidence            99999998865  45888999999999999999999   9999999999999999999999999999887543221  11


Q ss_pred             cccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh----------hhcCCChhhhh
Q 039799          262 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN----------DLLPISVMEVV  331 (346)
Q Consensus       262 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~----------~~~~~~~~~~~  331 (346)
                      .....++..|+|||...+..++.++||||||++++||++|+.||.......  ....+.          ..++..+.+++
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li  249 (285)
T cd06648         172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQ--AMKRIRDNLPPKLKNLHKVSPRLRSFL  249 (285)
T ss_pred             cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHH--HHHHHHhcCCCCCcccccCCHHHHHHH
Confidence            223458899999999988889999999999999999999999986522111  001011          11344788999


Q ss_pred             chhccCCccccccc
Q 039799          332 DANLLSQEDEHFTT  345 (346)
Q Consensus       332 d~~l~~~p~~R~~~  345 (346)
                      .+||..+|++||+.
T Consensus       250 ~~~l~~~p~~Rpt~  263 (285)
T cd06648         250 DRMLVRDPAQRATA  263 (285)
T ss_pred             HHHcccChhhCcCH
Confidence            99999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=2.4e-37  Score=277.27  Aligned_cols=235  Identities=26%  Similarity=0.278  Sum_probs=190.8

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeE
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKAL  176 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  176 (346)
                      ....|...+.||+|++|.||+|... +++.||+|++....   ....+.+.+|+++++.++|||++++.+++...+..++
T Consensus        13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l   92 (307)
T cd06607          13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL   92 (307)
T ss_pred             cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence            3456889999999999999999875 68999999886332   2334678889999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcc
Q 039799          177 VLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  256 (346)
Q Consensus       177 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~  256 (346)
                      |+||++ |++.+.+......+++..+..++.|++.||.|||   +.+++||||+|+||++++++.++|+|||++......
T Consensus        93 v~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~  168 (307)
T cd06607          93 VMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA  168 (307)
T ss_pred             EHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence            999996 5777776655567899999999999999999999   999999999999999999999999999998754322


Q ss_pred             ccccccccccCCcccccCCCCC---CCCCCcchhHHHHHHHHHHHHcCCCCCCccccCccc-------HHHHHhhhcCCC
Q 039799          257 DQSLTQTQTLATIGYMAPEYGR---EGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMT-------LKRWVNDLLPIS  326 (346)
Q Consensus       257 ~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~-------~~~~~~~~~~~~  326 (346)
                            ....++..|+|||...   ...++.++||||||+++|||+||+.||.........       ........++..
T Consensus       169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (307)
T cd06607         169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDY  242 (307)
T ss_pred             ------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHH
Confidence                  2345788999999864   456788999999999999999999998643211100       000001123446


Q ss_pred             hhhhhchhccCCccccccc
Q 039799          327 VMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       327 ~~~~~d~~l~~~p~~R~~~  345 (346)
                      +.+++.+||..+|++||+.
T Consensus       243 ~~~li~~~l~~~p~~Rp~~  261 (307)
T cd06607         243 FRNFVDSCLQKIPQDRPSS  261 (307)
T ss_pred             HHHHHHHHhcCChhhCcCH
Confidence            7899999999999999985

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1e-37  Score=283.93  Aligned_cols=235  Identities=23%  Similarity=0.301  Sum_probs=186.4

Q ss_pred             CCCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCc--hhHHHHHHHHHHHHhcCCCCceeeEEEEecC-----
Q 039799          100 PLPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYE--GAFKSFDIECDVMKRICHRNLIKIISSYSND-----  171 (346)
Q Consensus       100 ~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----  171 (346)
                      ..++.|.+.+.||+|+||.||+|... +++.||+|++.....  ...+.+.+|++++++++||||+++++++...     
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            34577999999999999999999865 788999999865322  2345677899999999999999999877533     


Q ss_pred             -CceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCC
Q 039799          172 -DFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMA  250 (346)
Q Consensus       172 -~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~  250 (346)
                       ...+++++++ +++|.+++.  ...+++..+..++.|++.||+|||   +.+|+||||||+||++++++.+||+|||++
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~  165 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLA  165 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCCccc
Confidence             3568999988 789988764  345889999999999999999999   999999999999999999999999999999


Q ss_pred             ccCCccccccccccccCCcccccCCCCCC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccCc-------------cc--
Q 039799          251 KPLLEEDQSLTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE-------------MT--  314 (346)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~-------------~~--  314 (346)
                      +.....     .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.......             ..  
T Consensus       166 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  240 (343)
T cd07878         166 RQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVL  240 (343)
T ss_pred             eecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            865321     223468999999998876 568899999999999999999999996421100             00  


Q ss_pred             -------HHHHHh--------------hhcCCChhhhhchhccCCccccccc
Q 039799          315 -------LKRWVN--------------DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       315 -------~~~~~~--------------~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                             ...+..              ...++.+.+++.+||..||++|||+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~  292 (343)
T cd07878         241 KKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISA  292 (343)
T ss_pred             HhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCH
Confidence                   000000              0112246789999999999999986

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2.4e-37  Score=273.21  Aligned_cols=233  Identities=28%  Similarity=0.366  Sum_probs=193.5

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecC
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYM  181 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  181 (346)
                      -|...+.||+|+||.||+|... ++..+|+|.+.... ....+.+.+|++.+++++|||++++++++...+..++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            4677889999999999999865 68899999986432 334567888999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccc
Q 039799          182 PHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT  261 (346)
Q Consensus       182 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~  261 (346)
                      ++++|.+++..  ..+++.....++.+++.++.|||   +.+++|+||+|+||+++.++.++++|||++..+....  ..
T Consensus        85 ~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~--~~  157 (277)
T cd06641          85 GGGSALDLLEP--GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IK  157 (277)
T ss_pred             CCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccch--hh
Confidence            99999988753  35789999999999999999999   9999999999999999999999999999987654321  11


Q ss_pred             cccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH--------hhhcCCChhhhhch
Q 039799          262 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV--------NDLLPISVMEVVDA  333 (346)
Q Consensus       262 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~~d~  333 (346)
                      .....++..|+|||...+...+.++|+||||++++||++|..|+......  .....+        ...++..+.+++.+
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~i~~  235 (277)
T cd06641         158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM--KVLFLIPKNNPPTLEGNYSKPLKEFVEA  235 (277)
T ss_pred             hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH--HHHHHHhcCCCCCCCcccCHHHHHHHHH
Confidence            22345788999999998888899999999999999999999999753211  111111        11234478899999


Q ss_pred             hccCCccccccc
Q 039799          334 NLLSQEDEHFTT  345 (346)
Q Consensus       334 ~l~~~p~~R~~~  345 (346)
                      |+..+|++||+.
T Consensus       236 ~l~~~p~~Rp~~  247 (277)
T cd06641         236 CLNKEPSFRPTA  247 (277)
T ss_pred             HccCChhhCcCH
Confidence            999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-37  Score=271.23  Aligned_cols=229  Identities=28%  Similarity=0.428  Sum_probs=183.8

Q ss_pred             CcccccCceEEEEEEEc-CCC--EEEEEEecCCC-chhHHHHHHHHHHHHhc-CCCCceeeEEEEecCCceeEEEecCCC
Q 039799          109 PLIGKGGFGSVYKAIIQ-DGM--EVAVKVFDPQY-EGAFKSFDIECDVMKRI-CHRNLIKIISSYSNDDFKALVLEYMPH  183 (346)
Q Consensus       109 ~~lg~G~~g~vy~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  183 (346)
                      +.||+|+||.||+|.++ ++.  .+++|.+.... ....+.+.+|++++.++ +|||++++++++...+..+++|||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            36899999999999976 344  46888886432 34456788899999999 799999999999999999999999999


Q ss_pred             CChhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeec
Q 039799          184 GSLEKCLYLSN---------------YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFG  248 (346)
Q Consensus       184 gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg  248 (346)
                      ++|.+++....               ..+++..+..++.+++.|++|||   +.+++||||||+||++++++.++++|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCC
Confidence            99999886432               24789999999999999999999   9999999999999999999999999999


Q ss_pred             CCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHhh------
Q 039799          249 MAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVND------  321 (346)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~------  321 (346)
                      ++......   ........+..|+|||+.....++.++||||||++++||++ |..||......  ...+.+..      
T Consensus       158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--~~~~~~~~~~~~~~  232 (270)
T cd05047         158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--ELYEKLPQGYRLEK  232 (270)
T ss_pred             Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH--HHHHHHhCCCCCCC
Confidence            98632111   11111224567999999988889999999999999999997 99999653211  11111111      


Q ss_pred             --hcCCChhhhhchhccCCccccccc
Q 039799          322 --LLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       322 --~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                        ..+..+.+++.+|+..+|.+||+.
T Consensus       233 ~~~~~~~~~~li~~~l~~~p~~Rps~  258 (270)
T cd05047         233 PLNCDDEVYDLMRQCWREKPYERPSF  258 (270)
T ss_pred             CCcCCHHHHHHHHHHcccChhhCCCH
Confidence              123468899999999999999985

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=6.6e-38  Score=273.79  Aligned_cols=234  Identities=25%  Similarity=0.340  Sum_probs=196.5

Q ss_pred             CCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEec
Q 039799          105 ANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEY  180 (346)
Q Consensus       105 ~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  180 (346)
                      |.+.+.||+|++|.||++... ++..+|+|++....   ....+.+.+|++++++++|||++++++.+.+.+..++|+||
T Consensus         2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   81 (258)
T cd05578           2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL   81 (258)
T ss_pred             ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence            677889999999999999976 68999999986432   23457888999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccc
Q 039799          181 MPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  260 (346)
Q Consensus       181 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~  260 (346)
                      +++++|.+++... ..++......++.++++||.|||   +.+++|+||+|+||++++++.++|+|||.+.......   
T Consensus        82 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~---  154 (258)
T cd05578          82 LLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---  154 (258)
T ss_pred             CCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc---
Confidence            9999999988654 56889999999999999999999   9999999999999999999999999999988654322   


Q ss_pred             ccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcc-cHHHH-------HhhhcCCChhhhhc
Q 039799          261 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM-TLKRW-------VNDLLPISVMEVVD  332 (346)
Q Consensus       261 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~-~~~~~-------~~~~~~~~~~~~~d  332 (346)
                      ......++..|+|||......++.++|+||||+++|+|++|+.||........ .....       ....++..+.+++.
T Consensus       155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  234 (258)
T cd05578         155 LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAIN  234 (258)
T ss_pred             cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHH
Confidence            12334578899999999888899999999999999999999999976432110 11111       11123458899999


Q ss_pred             hhccCCccccccc
Q 039799          333 ANLLSQEDEHFTT  345 (346)
Q Consensus       333 ~~l~~~p~~R~~~  345 (346)
                      +||..+|++||+.
T Consensus       235 ~~l~~~p~~R~~~  247 (258)
T cd05578         235 KLLERDPQKRLGD  247 (258)
T ss_pred             HHccCChhHcCCc
Confidence            9999999999986

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=2.4e-37  Score=269.87  Aligned_cols=236  Identities=19%  Similarity=0.296  Sum_probs=194.6

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC--CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEec
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ--YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEY  180 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  180 (346)
                      +|.+.+.||+|+||.+|++... +|+.+|+|.+...  .....+.+.+|++++++++|||++++.+++...+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            3778889999999999999865 7899999998643  233456788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccc
Q 039799          181 MPHGSLEKCLYLSN-YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  259 (346)
Q Consensus       181 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~  259 (346)
                      +++++|.+++.... ..+++...+.++.+++.|+.|||   +.+++|+||+|+||+++.++.++++|||++........ 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~-  156 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-  156 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence            99999999886543 45789999999999999999999   99999999999999999999999999999986533221 


Q ss_pred             cccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh-------hhcCCChhhhhc
Q 039799          260 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN-------DLLPISVMEVVD  332 (346)
Q Consensus       260 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~-------~~~~~~~~~~~d  332 (346)
                       ......++..|+|||+..+..++.++|+||||++++++++|+.||......+ .......       ..++..+.+++.
T Consensus       157 -~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~  234 (256)
T cd08218         157 -LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN-LVLKIIRGSYPPVSSHYSYDLRNLVS  234 (256)
T ss_pred             -hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH-HHHHHhcCCCCCCcccCCHHHHHHHH
Confidence             1123357888999999988889999999999999999999999986421111 1111111       122346789999


Q ss_pred             hhccCCccccccc
Q 039799          333 ANLLSQEDEHFTT  345 (346)
Q Consensus       333 ~~l~~~p~~R~~~  345 (346)
                      +|+..+|++||+.
T Consensus       235 ~~l~~~p~~Rp~~  247 (256)
T cd08218         235 QLFKRNPRDRPSV  247 (256)
T ss_pred             HHhhCChhhCcCH
Confidence            9999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=2.6e-37  Score=274.12  Aligned_cols=239  Identities=25%  Similarity=0.333  Sum_probs=190.5

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhc-CCCCceeeEEEEe-----cCCc
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRI-CHRNLIKIISSYS-----NDDF  173 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~-----~~~~  173 (346)
                      ..++|.+.+.||+|++|.||++... +++.+|+|++.... .....+..|+.+++++ +|||++++++++.     ..+.
T Consensus        16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   94 (286)
T cd06638          16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQ   94 (286)
T ss_pred             cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCe
Confidence            4567999999999999999999865 68899999886532 2345677899999999 6999999999874     3457


Q ss_pred             eeEEEecCCCCChhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCC
Q 039799          174 KALVLEYMPHGSLEKCLYL---SNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMA  250 (346)
Q Consensus       174 ~~lv~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~  250 (346)
                      .++||||+++++|.+++..   ....+++..+..++.++++|+.|||   +.+++||||||+||++++++.++|+|||++
T Consensus        95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~  171 (286)
T cd06638          95 LWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVKLVDFGVS  171 (286)
T ss_pred             EEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCEEEccCCce
Confidence            8999999999999988753   2356788899999999999999999   999999999999999999999999999998


Q ss_pred             ccCCccccccccccccCCcccccCCCCCC-----CCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH------
Q 039799          251 KPLLEEDQSLTQTQTLATIGYMAPEYGRE-----GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV------  319 (346)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~------  319 (346)
                      ..+....  .......++..|+|||++..     ..++.++||||+|+++|||++|+.|+....... ......      
T Consensus       172 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~-~~~~~~~~~~~~  248 (286)
T cd06638         172 AQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR-ALFKIPRNPPPT  248 (286)
T ss_pred             eecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH-HHhhccccCCCc
Confidence            8654321  12233458899999998753     447889999999999999999999986532111 111110      


Q ss_pred             ---hhhcCCChhhhhchhccCCcccccccC
Q 039799          320 ---NDLLPISVMEVVDANLLSQEDEHFTTK  346 (346)
Q Consensus       320 ---~~~~~~~~~~~~d~~l~~~p~~R~~~k  346 (346)
                         ...++..+.+++.+||..+|++||+.+
T Consensus       249 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  278 (286)
T cd06638         249 LHQPELWSNEFNDFIRKCLTKDYEKRPTVS  278 (286)
T ss_pred             ccCCCCcCHHHHHHHHHHccCCcccCCCHH
Confidence               011233688999999999999999863

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-37  Score=273.05  Aligned_cols=235  Identities=25%  Similarity=0.354  Sum_probs=192.6

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHHhcC---CCCceeeEEEEecCCceeEEE
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRIC---HRNLIKIISSYSNDDFKALVL  178 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~  178 (346)
                      .|...+.||+|++|.||+|.+. +++.+|+|.+.... ....+.+.+|++++++++   |||++++++++......++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            3677889999999999999964 78999999986542 334567888999999997   999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccc
Q 039799          179 EYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  258 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~  258 (346)
                      ||+++++|.+++...  .+++...+.++.+++.|+.|||   +.+++|+||+|+||++++++.++|+|||++..+.... 
T Consensus        82 e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-  155 (277)
T cd06917          82 EYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS-  155 (277)
T ss_pred             ecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc-
Confidence            999999999987543  6889999999999999999999   9999999999999999999999999999998765432 


Q ss_pred             ccccccccCCcccccCCCCCCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccCccc-------HHHHHhhhcCCChhhh
Q 039799          259 SLTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMT-------LKRWVNDLLPISVMEV  330 (346)
Q Consensus       259 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~-------~~~~~~~~~~~~~~~~  330 (346)
                       .......++..|+|||....+ .++.++|+||||+++|+|++|+.||.........       ...+....++..+.++
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (277)
T cd06917         156 -SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREF  234 (277)
T ss_pred             -cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHH
Confidence             122334688899999987654 4688999999999999999999999753211100       0001111234478899


Q ss_pred             hchhccCCccccccc
Q 039799          331 VDANLLSQEDEHFTT  345 (346)
Q Consensus       331 ~d~~l~~~p~~R~~~  345 (346)
                      +.+||..+|++||++
T Consensus       235 i~~~l~~~p~~R~~~  249 (277)
T cd06917         235 VAACLDEEPKERLSA  249 (277)
T ss_pred             HHHHcCCCcccCcCH
Confidence            999999999999985

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.2e-37  Score=276.14  Aligned_cols=236  Identities=25%  Similarity=0.301  Sum_probs=190.3

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEec
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEY  180 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  180 (346)
                      +|.+.+.||+|++|.||+|.++ +++.+|+|++....  ....+.+.+|+++++.++|||++++++++...+..++|+||
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   81 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF   81 (286)
T ss_pred             ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence            5778899999999999999976 58999999886432  22346678899999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccc
Q 039799          181 MPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  260 (346)
Q Consensus       181 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~  260 (346)
                      +++++|..+.. ....+++..++.++.+++.|++|||   +.+++|+||+|+||++++++.++|+|||++.......  .
T Consensus        82 ~~~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~--~  155 (286)
T cd07846          82 VDHTVLDDLEK-YPNGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--E  155 (286)
T ss_pred             CCccHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc--c
Confidence            99998887654 3345899999999999999999999   9999999999999999999999999999988654322  1


Q ss_pred             ccccccCCcccccCCCCCC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccCcc--cHHH--------------------
Q 039799          261 TQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM--TLKR--------------------  317 (346)
Q Consensus       261 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~--~~~~--------------------  317 (346)
                      ......++..|+|||+..+ ..++.++||||||++++||++|++||......+.  ....                    
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07846         156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA  235 (286)
T ss_pred             ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhh
Confidence            1223457889999998765 3468899999999999999999999853211000  0000                    


Q ss_pred             --------------HHhhhcCCChhhhhchhccCCccccccc
Q 039799          318 --------------WVNDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       318 --------------~~~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                                    -....++..+.+++.+||..+|++||+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~  277 (286)
T cd07846         236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSS  277 (286)
T ss_pred             ccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhH
Confidence                          0011234468899999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-37  Score=272.27  Aligned_cols=237  Identities=23%  Similarity=0.295  Sum_probs=192.4

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhc-CCCCceeeEEEEecCC------c
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRI-CHRNLIKIISSYSNDD------F  173 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~------~  173 (346)
                      .++|.+.+.||+|++|.||+|..+ +++.+++|++..... ..+.+.+|+++++++ .|+|++++++++....      .
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ   83 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence            467999999999999999999976 678999999875533 346788999999999 6999999999996544      4


Q ss_pred             eeEEEecCCCCChhhhhhhc---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCC
Q 039799          174 KALVLEYMPHGSLEKCLYLS---NYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMA  250 (346)
Q Consensus       174 ~~lv~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~  250 (346)
                      .++||||+++++|.+++...   ...+++..+..++.|++.||.|||   +.+++|+||+|+||++++++.++|+|||++
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~  160 (275)
T cd06608          84 LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVS  160 (275)
T ss_pred             EEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence            88999999999999987643   357899999999999999999999   999999999999999999999999999998


Q ss_pred             ccCCccccccccccccCCcccccCCCCCC-----CCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHhh----
Q 039799          251 KPLLEEDQSLTQTQTLATIGYMAPEYGRE-----GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVND----  321 (346)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~----  321 (346)
                      .......  .......++..|+|||.+..     ..++.++||||||++++|+++|+.||...... ....+....    
T Consensus       161 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~  237 (275)
T cd06608         161 AQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM-RALFKIPRNPPPT  237 (275)
T ss_pred             eecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH-HHHHHhhccCCCC
Confidence            8653321  12233458889999997643     34678999999999999999999999753211 111111111    


Q ss_pred             -----hcCCChhhhhchhccCCccccccc
Q 039799          322 -----LLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       322 -----~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                           .++..+.+++.+||..||++|||+
T Consensus       238 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~  266 (275)
T cd06608         238 LKSPENWSKKFNDFISECLIKNYEQRPFM  266 (275)
T ss_pred             CCchhhcCHHHHHHHHHHhhcChhhCcCH
Confidence                 133467899999999999999986

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2e-37  Score=293.03  Aligned_cols=195  Identities=23%  Similarity=0.313  Sum_probs=160.0

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCC------CceeeEEEEecC-Cc
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHR------NLIKIISSYSND-DF  173 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~------niv~~~~~~~~~-~~  173 (346)
                      ..+|.+.+.||+|+||+||+|... .++.||||++.... ........|+++++.++|.      +++++.+++... ..
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~  206 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGH  206 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCce
Confidence            356888899999999999999865 67889999986432 2234456677777777554      588888888754 46


Q ss_pred             eeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeeecCCCCCceEECCCC------------
Q 039799          174 KALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYS-APIIHCDLKPSNVLLDDNM------------  240 (346)
Q Consensus       174 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~i~H~dik~~NIll~~~~------------  240 (346)
                      .++|||++ +++|.+++... ..+++..+..++.|++.||+|||   + .+|+||||||+|||++.++            
T Consensus       207 ~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~  281 (467)
T PTZ00284        207 MCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSDTVVDPVTNRALP  281 (467)
T ss_pred             EEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCCcccccccccccC
Confidence            78899988 77888877543 46889999999999999999999   7 5999999999999998665            


Q ss_pred             ----cEEEeeecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 039799          241 ----VAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDE  307 (346)
Q Consensus       241 ----~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~  307 (346)
                          .+||+|||.+....     .......||+.|+|||++.+..++.++|||||||++|||+||+.||+.
T Consensus       282 ~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~  347 (467)
T PTZ00284        282 PDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDT  347 (467)
T ss_pred             CCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence                49999999886422     122345689999999999999999999999999999999999999965

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=3.9e-37  Score=267.20  Aligned_cols=236  Identities=29%  Similarity=0.388  Sum_probs=198.7

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecCC
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMP  182 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  182 (346)
                      +|...+.||+|++|.||++... +++.+++|++........+.+.+|++.+++++|+|++++.+.+......++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            4777889999999999999976 788999999976654456788899999999999999999999999999999999999


Q ss_pred             CCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccccc
Q 039799          183 HGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ  262 (346)
Q Consensus       183 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~  262 (346)
                      +++|.+++......+++..+..++.+++.+++|||   +.+++||||+|+||++++++.++|+|||.+........   .
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~  154 (253)
T cd05122          81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---R  154 (253)
T ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---c
Confidence            99999988766567899999999999999999999   89999999999999999999999999999987644321   2


Q ss_pred             ccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHH-------HHHh-hhcCCChhhhhchh
Q 039799          263 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLK-------RWVN-DLLPISVMEVVDAN  334 (346)
Q Consensus       263 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~-------~~~~-~~~~~~~~~~~d~~  334 (346)
                      ....++..|+|||......++.++||||||+++++|++|+.||+..........       .... ..++..+.+++.+|
T Consensus       155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  234 (253)
T cd05122         155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKC  234 (253)
T ss_pred             cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHH
Confidence            334588899999999888889999999999999999999999975311110000       0000 11144678999999


Q ss_pred             ccCCccccccc
Q 039799          335 LLSQEDEHFTT  345 (346)
Q Consensus       335 l~~~p~~R~~~  345 (346)
                      +..+|++||++
T Consensus       235 l~~~p~~R~t~  245 (253)
T cd05122         235 LQKNPEKRPTA  245 (253)
T ss_pred             ccCChhhCCCH
Confidence            99999999986

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=5.4e-37  Score=272.14  Aligned_cols=240  Identities=27%  Similarity=0.311  Sum_probs=200.7

Q ss_pred             CCCCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEE
Q 039799           99 KPLPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALV  177 (346)
Q Consensus        99 ~~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  177 (346)
                      ....+.|...+.||+|++|.||+|..+ ++..+++|++..... ..+.+..|++.+++++|+|++++++.+...+..+++
T Consensus        15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   93 (286)
T cd06614          15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV   93 (286)
T ss_pred             CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence            345567888999999999999999977 789999999976544 456788899999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccc
Q 039799          178 LEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  257 (346)
Q Consensus       178 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~  257 (346)
                      +||+++++|.+++......+++..+..++.+++.||+|||   +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus        94 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  170 (286)
T cd06614          94 MEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK  170 (286)
T ss_pred             EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence            9999999999999765557999999999999999999999   9999999999999999999999999999987654322


Q ss_pred             cccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh---------hhcCCChh
Q 039799          258 QSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN---------DLLPISVM  328 (346)
Q Consensus       258 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~---------~~~~~~~~  328 (346)
                      .  ......++..|+|||...+..++.++|+||||+++|||++|+.||...... ........         ..++..+.
T Consensus       171 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~  247 (286)
T cd06614         171 S--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL-RALFLITTKGIPPLKNPEKWSPEFK  247 (286)
T ss_pred             h--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcCCCCCcchhhCCHHHH
Confidence            1  122334788999999988888999999999999999999999998652211 11111111         11445689


Q ss_pred             hhhchhccCCccccccc
Q 039799          329 EVVDANLLSQEDEHFTT  345 (346)
Q Consensus       329 ~~~d~~l~~~p~~R~~~  345 (346)
                      +++.+|+..+|.+||+.
T Consensus       248 ~li~~~l~~~p~~Rpt~  264 (286)
T cd06614         248 DFLNKCLVKDPEKRPSA  264 (286)
T ss_pred             HHHHHHhccChhhCcCH
Confidence            99999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=2.8e-37  Score=280.07  Aligned_cols=238  Identities=26%  Similarity=0.368  Sum_probs=191.0

Q ss_pred             CCCCCCCcccccCceEEEEEEEc--------CCCEEEEEEecCCC-chhHHHHHHHHHHHHhc-CCCCceeeEEEEecCC
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ--------DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRI-CHRNLIKIISSYSNDD  172 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  172 (346)
                      .+|.+.+.||+|+||.||++...        .+..+|+|.+.... ....+.+.+|+++++++ +||||+++++++...+
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            35888999999999999999742        12368999887543 33457788999999999 7999999999999999


Q ss_pred             ceeEEEecCCCCChhhhhhhc---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEEC
Q 039799          173 FKALVLEYMPHGSLEKCLYLS---------------NYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD  237 (346)
Q Consensus       173 ~~~lv~e~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~  237 (346)
                      ..++++||+++++|.+++...               ...+++..++.++.|++.||+|||   +.+++||||||+||+++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nill~  168 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVT  168 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEc
Confidence            999999999999999988642               135788999999999999999999   99999999999999999


Q ss_pred             CCCcEEEeeecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHH
Q 039799          238 DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLK  316 (346)
Q Consensus       238 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~  316 (346)
                      +++.++|+|||+++...............++..|+|||...+..++.++||||||+++|||++ |..||......  ...
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~  246 (334)
T cd05100         169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE--ELF  246 (334)
T ss_pred             CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH--HHH
Confidence            999999999999986543221111222234567999999988889999999999999999998 88888653211  111


Q ss_pred             HHHhh--------hcCCChhhhhchhccCCccccccc
Q 039799          317 RWVND--------LLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       317 ~~~~~--------~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ..+..        ..+..+.+++.+|+..+|++||+.
T Consensus       247 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~  283 (334)
T cd05100         247 KLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTF  283 (334)
T ss_pred             HHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCH
Confidence            11111        112367899999999999999985

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=5.8e-37  Score=269.17  Aligned_cols=238  Identities=26%  Similarity=0.341  Sum_probs=193.1

Q ss_pred             CCCCCCcccccCceEEEEEEE-cCCCEEEEEEecCCC------chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeE
Q 039799          104 DANMPPLIGKGGFGSVYKAII-QDGMEVAVKVFDPQY------EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKAL  176 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  176 (346)
                      .|...+.||+|++|.||++.. .+++.+|+|++....      ....+.+.+|++++++++|+|++++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            367789999999999999986 478999999986432      1235678899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCC-cEEEeeecCCccCCc
Q 039799          177 VLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM-VAHLSDFGMAKPLLE  255 (346)
Q Consensus       177 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~-~~~l~Dfg~~~~~~~  255 (346)
                      |+||+++++|.+++... ..+++.....++.+++.||.|||   +.+++|+||+|+||+++.++ .++|+|||.+..+..
T Consensus        81 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~  156 (268)
T cd06630          81 FVEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA  156 (268)
T ss_pred             EEeccCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence            99999999999988643 45788999999999999999999   99999999999999998765 699999999987654


Q ss_pred             cccc--cccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCc-ccHHHH---------Hhhhc
Q 039799          256 EDQS--LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE-MTLKRW---------VNDLL  323 (346)
Q Consensus       256 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~-~~~~~~---------~~~~~  323 (346)
                      ....  .......++..|+|||...+..++.++||||+|++++++++|..||....... ......         +...+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (268)
T cd06630         157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHL  236 (268)
T ss_pred             ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhh
Confidence            3111  11123457889999999988888999999999999999999999996432111 111101         11123


Q ss_pred             CCChhhhhchhccCCccccccc
Q 039799          324 PISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       324 ~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      +..+.+++.+||..+|++||++
T Consensus       237 ~~~~~~~i~~~l~~~p~~R~~~  258 (268)
T cd06630         237 SPGLRDVTLRCLELQPEDRPPS  258 (268)
T ss_pred             CHHHHHHHHHHcCCCcccCcCH
Confidence            3467889999999999999986

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=3.7e-37  Score=271.98  Aligned_cols=228  Identities=25%  Similarity=0.331  Sum_probs=187.2

Q ss_pred             ccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecCCCCCh
Q 039799          111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSL  186 (346)
Q Consensus       111 lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  186 (346)
                      ||+|+||+||++... +|+.+|+|.+....   ......+..|++++++++|||++++.+.+...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999865 78999999986432   22344567899999999999999999999999999999999999999


Q ss_pred             hhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccccccc
Q 039799          187 EKCLYLSN-YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT  265 (346)
Q Consensus       187 ~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~  265 (346)
                      .+++.... ..+++..+..++.+++.|+.|||   +.+++||||+|+||++++++.++|+|||.+......   ......
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~  154 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIKGR  154 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC---Cccccc
Confidence            99886544 36899999999999999999999   999999999999999999999999999998865331   112234


Q ss_pred             cCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCc--ccHHH-------HHhhhcCCChhhhhchhcc
Q 039799          266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE--MTLKR-------WVNDLLPISVMEVVDANLL  336 (346)
Q Consensus       266 ~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~--~~~~~-------~~~~~~~~~~~~~~d~~l~  336 (346)
                      .++..|+|||...+..++.++||||||+++++|++|+.||.......  ..+..       .....++..+.+++.+||.
T Consensus       155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  234 (277)
T cd05577         155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQ  234 (277)
T ss_pred             cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHcc
Confidence            57889999999888889999999999999999999999996532210  00111       1112234578999999999


Q ss_pred             CCcccccc
Q 039799          337 SQEDEHFT  344 (346)
Q Consensus       337 ~~p~~R~~  344 (346)
                      .+|.+||+
T Consensus       235 ~~p~~R~~  242 (277)
T cd05577         235 KDPEKRLG  242 (277)
T ss_pred             CChhHccC
Confidence            99999995

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=3.4e-37  Score=274.43  Aligned_cols=236  Identities=26%  Similarity=0.313  Sum_probs=195.8

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecC
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYM  181 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  181 (346)
                      .+|.+.+.||+|+||.||++... ++..+|+|.+........+.+.+|+.++++++|||++++++++...+..++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            57889999999999999999864 68899999987554555677888999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccc
Q 039799          182 PHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT  261 (346)
Q Consensus       182 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~  261 (346)
                      ++++|.+++..  ..+++..+..++.+++.|+.|||   +.+++|+||+|+||+++.++.++|+|||++........  .
T Consensus        99 ~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--~  171 (293)
T cd06647          99 AGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--K  171 (293)
T ss_pred             CCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc--c
Confidence            99999998753  34788899999999999999999   99999999999999999999999999999876543322  2


Q ss_pred             cccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH--------hhhcCCChhhhhch
Q 039799          262 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV--------NDLLPISVMEVVDA  333 (346)
Q Consensus       262 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~~d~  333 (346)
                      .....+++.|+|||......++.++|+||||+++||+++|+.||..............        ...++..+.+++.+
T Consensus       172 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  251 (293)
T cd06647         172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR  251 (293)
T ss_pred             cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHH
Confidence            2334588899999999888889999999999999999999999975322111110000        11123468899999


Q ss_pred             hccCCccccccc
Q 039799          334 NLLSQEDEHFTT  345 (346)
Q Consensus       334 ~l~~~p~~R~~~  345 (346)
                      ||..+|++||+.
T Consensus       252 ~l~~~p~~Rp~~  263 (293)
T cd06647         252 CLEMDVEKRGSA  263 (293)
T ss_pred             HccCChhhCcCH
Confidence            999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=6.5e-37  Score=268.03  Aligned_cols=239  Identities=24%  Similarity=0.330  Sum_probs=195.7

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC--CchhHHHHHHHHHHHHhcCCCCceeeEEEEec--CCceeEEE
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ--YEGAFKSFDIECDVMKRICHRNLIKIISSYSN--DDFKALVL  178 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~  178 (346)
                      +|++.+.||+|++|.||++... ++..+|+|++...  .....+.+..|++++++++|||++++++++..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            4778899999999999999865 7889999998643  23345678889999999999999999998754  45678999


Q ss_pred             ecCCCCChhhhhhhc---CCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeeecCCCCCceEECCCCcEEEeeecCCccC
Q 039799          179 EYMPHGSLEKCLYLS---NYILDIFQRLDIMIDVASALEYLHFGY--SAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  253 (346)
Q Consensus       179 e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~  253 (346)
                      ||+++++|.+++...   ...+++...+.++.+++.||.|||..+  +.+++|+||+|+||++++++.++|+|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999988643   457899999999999999999999554  778999999999999999999999999999876


Q ss_pred             CccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh--------hhcCC
Q 039799          254 LEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN--------DLLPI  325 (346)
Q Consensus       254 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~  325 (346)
                      .....  ......++..|+|||...+..++.++|+||||+++++|++|+.||+...  .....+.+.        ...+.
T Consensus       161 ~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~  236 (265)
T cd08217         161 GHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN--QLQLASKIKEGKFRRIPYRYSS  236 (265)
T ss_pred             cCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC--HHHHHHHHhcCCCCCCccccCH
Confidence            43221  1223458899999999988889999999999999999999999997632  112222222        22334


Q ss_pred             ChhhhhchhccCCcccccccC
Q 039799          326 SVMEVVDANLLSQEDEHFTTK  346 (346)
Q Consensus       326 ~~~~~~d~~l~~~p~~R~~~k  346 (346)
                      .+.+++.+|+..+|++||+.+
T Consensus       237 ~~~~l~~~~l~~~p~~Rp~~~  257 (265)
T cd08217         237 ELNEVIKSMLNVDPDKRPSTE  257 (265)
T ss_pred             HHHHHHHHHccCCcccCCCHH
Confidence            788999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=4.7e-37  Score=267.84  Aligned_cols=234  Identities=24%  Similarity=0.361  Sum_probs=193.8

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEec
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEY  180 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  180 (346)
                      +|...+.||+|++|.||++... +++.+|+|.+....  ....+.+.+|++++++++|||++++++.+...+..++|+||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            3677889999999999999865 78899999986532  33456788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCC-CcEEEeeecCCccCCcccc
Q 039799          181 MPHGSLEKCLYLSN-YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDN-MVAHLSDFGMAKPLLEEDQ  258 (346)
Q Consensus       181 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~-~~~~l~Dfg~~~~~~~~~~  258 (346)
                      +++++|.+++.... ..+++..+..++.+++.+++|||   +.+++|+||+|+||+++++ +.++++|||.+........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK  157 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence            99999999987543 45899999999999999999999   9999999999999999854 5689999999987643221


Q ss_pred             ccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH--------hhhcCCChhhh
Q 039799          259 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV--------NDLLPISVMEV  330 (346)
Q Consensus       259 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~  330 (346)
                         .....++..|+|||...+..++.++||||||+++++|++|+.||+.....  .....+        ...++..+.++
T Consensus       158 ---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~l  232 (256)
T cd08220         158 ---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP--ALVLKIMSGTFAPISDRYSPDLRQL  232 (256)
T ss_pred             ---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH--HHHHHHHhcCCCCCCCCcCHHHHHH
Confidence               12345788999999998888899999999999999999999999653211  111111        11234478899


Q ss_pred             hchhccCCccccccc
Q 039799          331 VDANLLSQEDEHFTT  345 (346)
Q Consensus       331 ~d~~l~~~p~~R~~~  345 (346)
                      +..||..+|++||+.
T Consensus       233 i~~~l~~~p~~Rpt~  247 (256)
T cd08220         233 ILSMLNLDPSKRPQL  247 (256)
T ss_pred             HHHHccCChhhCCCH
Confidence            999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=7.3e-37  Score=270.37  Aligned_cols=227  Identities=22%  Similarity=0.323  Sum_probs=179.4

Q ss_pred             cccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHH---HhcCCCCceeeEEEEecCCceeEEEecCC
Q 039799          110 LIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVM---KRICHRNLIKIISSYSNDDFKALVLEYMP  182 (346)
Q Consensus       110 ~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l---~~l~h~niv~~~~~~~~~~~~~lv~e~~~  182 (346)
                      +||+|+||.||++... +++.+|+|.+....   ......+.+|..++   ...+|||++.+.+++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999865 68999999886432   11122333444333   33479999999999999999999999999


Q ss_pred             CCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccccc
Q 039799          183 HGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ  262 (346)
Q Consensus       183 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~  262 (346)
                      +++|.+++... ..+++.....++.|++.||+|||   +.+++||||||+||++++++.++|+|||++......    ..
T Consensus        81 ~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~----~~  152 (279)
T cd05633          81 GGDLHYHLSQH-GVFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KP  152 (279)
T ss_pred             CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc----Cc
Confidence            99999887643 45899999999999999999999   999999999999999999999999999998754321    12


Q ss_pred             ccccCCcccccCCCCCC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccCccc-HHHHH-------hhhcCCChhhhhch
Q 039799          263 TQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMT-LKRWV-------NDLLPISVMEVVDA  333 (346)
Q Consensus       263 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~-~~~~~-------~~~~~~~~~~~~d~  333 (346)
                      ....++..|+|||...+ ..++.++||||+|++++||++|..||......... .....       ...++..+.+++.+
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  232 (279)
T cd05633         153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEG  232 (279)
T ss_pred             cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHH
Confidence            23458999999998764 55789999999999999999999999754322211 11111       12234578899999


Q ss_pred             hccCCcccccc
Q 039799          334 NLLSQEDEHFT  344 (346)
Q Consensus       334 ~l~~~p~~R~~  344 (346)
                      ||..||.+|++
T Consensus       233 ~l~~~p~~R~~  243 (279)
T cd05633         233 LLQRDVSKRLG  243 (279)
T ss_pred             HhcCCHHHhcC
Confidence            99999999994

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-37  Score=273.55  Aligned_cols=237  Identities=26%  Similarity=0.320  Sum_probs=193.2

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC--CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEec
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ--YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEY  180 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  180 (346)
                      +|++.+.||+|++|.||+|..+ +++.||+|+++..  .....+.+.+|++++++++|+|++++++++...+..++++||
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   81 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY   81 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence            5788899999999999999976 6889999998643  233456788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccc
Q 039799          181 MPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  260 (346)
Q Consensus       181 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~  260 (346)
                      ++++.+..+.. ....+++.....++.+++.|++|||   +.+++|+|++|+||++++++.++|+|||++......... 
T Consensus        82 ~~~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~-  156 (288)
T cd07833          82 VERTLLELLEA-SPGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS-  156 (288)
T ss_pred             CCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc-
Confidence            99877765443 4455899999999999999999999   999999999999999999999999999999876543221 


Q ss_pred             ccccccCCcccccCCCCCCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccCc---------------------------
Q 039799          261 TQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE---------------------------  312 (346)
Q Consensus       261 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~---------------------------  312 (346)
                      ......++..|+|||+..+. .++.++||||||+++|||++|+.||......+                           
T Consensus       157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07833         157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA  236 (288)
T ss_pred             cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccc
Confidence            12234578899999998887 78999999999999999999999986421100                           


Q ss_pred             ------c----cHHHHHhhhcCCChhhhhchhccCCccccccc
Q 039799          313 ------M----TLKRWVNDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       313 ------~----~~~~~~~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                            .    .........++..+.+++.+||..+|++||+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  279 (288)
T cd07833         237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTC  279 (288)
T ss_pred             ccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccH
Confidence                  0    00111122235578899999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=8.1e-37  Score=267.57  Aligned_cols=237  Identities=30%  Similarity=0.371  Sum_probs=194.9

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCc--hhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEec
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYE--GAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEY  180 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  180 (346)
                      +|...+.||+|++|.||+|... +++.+++|.+.....  ...+.+..|++++++++|+||+++++.+...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            3777899999999999999865 789999999875543  3567888999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccc
Q 039799          181 MPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  260 (346)
Q Consensus       181 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~  260 (346)
                      +++++|.+++... ..+++..+..++.++++|++|||   +.+++|+||+|+||++++++.++|+|||++..........
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~  156 (264)
T cd06626          81 CSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM  156 (264)
T ss_pred             CCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence            9999999988643 45788889999999999999999   9999999999999999999999999999998764432211


Q ss_pred             c--cccccCCcccccCCCCCCCC---CCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh----------hhcCC
Q 039799          261 T--QTQTLATIGYMAPEYGREGR---VSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN----------DLLPI  325 (346)
Q Consensus       261 ~--~~~~~~~~~y~aPE~~~~~~---~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~----------~~~~~  325 (346)
                      .  .....++..|+|||++.+..   .+.++||||||++++|+++|+.||....... .....+.          ..++.
T Consensus       157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  235 (264)
T cd06626         157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-QIMFHVGAGHKPPIPDSLQLSP  235 (264)
T ss_pred             cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH-HHHHHHhcCCCCCCCcccccCH
Confidence            1  11345788999999987766   8899999999999999999999996532111 1111111          01134


Q ss_pred             ChhhhhchhccCCccccccc
Q 039799          326 SVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       326 ~~~~~~d~~l~~~p~~R~~~  345 (346)
                      .+.+++.+|+..+|++||+.
T Consensus       236 ~~~~li~~~l~~~p~~R~~~  255 (264)
T cd06626         236 EGKDFLDRCLESDPKKRPTA  255 (264)
T ss_pred             HHHHHHHHHccCCcccCCCH
Confidence            66899999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=4.2e-37  Score=273.84  Aligned_cols=238  Identities=24%  Similarity=0.302  Sum_probs=190.9

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEecC--CceeEE
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSND--DFKALV  177 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv  177 (346)
                      ++|.+.+.||+|++|.||+|... +++.+|+|.++...  ......+.+|+.++++++|||++++.+++...  +..++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            46888899999999999999976 68899999986432  22234567899999999999999999998777  899999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccc
Q 039799          178 LEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  257 (346)
Q Consensus       178 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~  257 (346)
                      +||+++ +|.+.+......+++.....++.|++.||+|||   +.+++|+||+|+||++++++.++|+|||++.......
T Consensus        85 ~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  160 (293)
T cd07843          85 MEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL  160 (293)
T ss_pred             ehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence            999974 998888766667899999999999999999999   9999999999999999999999999999998764332


Q ss_pred             cccccccccCCcccccCCCCCCCC-CCcchhHHHHHHHHHHHHcCCCCCCccccCcc-----------------------
Q 039799          258 QSLTQTQTLATIGYMAPEYGREGR-VSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM-----------------------  313 (346)
Q Consensus       258 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~-----------------------  313 (346)
                      .  ......++..|+|||.+.+.. ++.++|+||+|++++||++|..||........                       
T Consensus       161 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
T cd07843         161 K--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP  238 (293)
T ss_pred             c--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence            1  122345788899999876544 68899999999999999999999864211000                       


Q ss_pred             -------------cHHHHHhhh-cCCChhhhhchhccCCcccccccC
Q 039799          314 -------------TLKRWVNDL-LPISVMEVVDANLLSQEDEHFTTK  346 (346)
Q Consensus       314 -------------~~~~~~~~~-~~~~~~~~~d~~l~~~p~~R~~~k  346 (346)
                                   .+.+..... ++..+.+++.+||..+|++||+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~  285 (293)
T cd07843         239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAE  285 (293)
T ss_pred             hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHH
Confidence                         000001111 244678999999999999999863

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=7e-39  Score=296.73  Aligned_cols=234  Identities=24%  Similarity=0.436  Sum_probs=198.4

Q ss_pred             CCCCcccccCceEEEEEEEc-CC---CEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEec
Q 039799          106 NMPPLIGKGGFGSVYKAIIQ-DG---MEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEY  180 (346)
Q Consensus       106 ~~~~~lg~G~~g~vy~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  180 (346)
                      .+.++||.|.||.||+|.++ .|   ..||||.++... +....+|..|+.+|.+..||||+++.|.........+|+||
T Consensus       632 ~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEy  711 (996)
T KOG0196|consen  632 KIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEY  711 (996)
T ss_pred             EEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhh
Confidence            45678999999999999976 23   469999998664 44567899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccc-c
Q 039799          181 MPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ-S  259 (346)
Q Consensus       181 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~-~  259 (346)
                      |++|+|..+|...+.++++.+...|+++||.|+.||-   +.++|||||.++|||++.+..+|++|||+++.+.++.. .
T Consensus       712 MENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~  788 (996)
T KOG0196|consen  712 MENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA  788 (996)
T ss_pred             hhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheeeccceEEEeccccceeecccCCCcc
Confidence            9999999999998899999999999999999999999   99999999999999999999999999999997755431 1


Q ss_pred             cccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHhhh--------cCCChhhh
Q 039799          260 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVNDL--------LPISVMEV  330 (346)
Q Consensus       260 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~--------~~~~~~~~  330 (346)
                      .+...-.-..+|.|||.+...+++..+||||||++|||+++ |.+||=++...  +.-.-+.+.        .|..+.++
T Consensus       789 ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ--dVIkaIe~gyRLPpPmDCP~aL~qL  866 (996)
T KOG0196|consen  789 YTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--DVIKAIEQGYRLPPPMDCPAALYQL  866 (996)
T ss_pred             ccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH--HHHHHHHhccCCCCCCCCcHHHHHH
Confidence            11111123688999999999999999999999999999986 99998664422  222333322        34488999


Q ss_pred             hchhccCCcccccc
Q 039799          331 VDANLLSQEDEHFT  344 (346)
Q Consensus       331 ~d~~l~~~p~~R~~  344 (346)
                      +-.|++.|-.+||.
T Consensus       867 MldCWqkdR~~RP~  880 (996)
T KOG0196|consen  867 MLDCWQKDRNRRPK  880 (996)
T ss_pred             HHHHHHHHhhcCCC
Confidence            99999999999985

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-37  Score=275.30  Aligned_cols=237  Identities=22%  Similarity=0.338  Sum_probs=188.4

Q ss_pred             CCCCCcccccCceEEEEEEEc---CCCEEEEEEecCCC---chhHHHHHHHHHHHHhcCCCCceeeEEEEecC--CceeE
Q 039799          105 ANMPPLIGKGGFGSVYKAIIQ---DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKIISSYSND--DFKAL  176 (346)
Q Consensus       105 ~~~~~~lg~G~~g~vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l  176 (346)
                      |.+.+.||+|++|.||+|...   ++..||+|.+....   ......+.+|+.++++++|||++++++++...  +..++
T Consensus         2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   81 (316)
T cd07842           2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL   81 (316)
T ss_pred             ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence            677889999999999999965   47899999987632   33446677899999999999999999999888  78999


Q ss_pred             EEecCCCCChhhhhhhc----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC----CCcEEEeeec
Q 039799          177 VLEYMPHGSLEKCLYLS----NYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD----NMVAHLSDFG  248 (346)
Q Consensus       177 v~e~~~~gsL~~~l~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~----~~~~~l~Dfg  248 (346)
                      ||||+++ ++.+.+...    ...++......++.|++.||+|||   +.+++||||||+||+++.    ++.++|+|||
T Consensus        82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg  157 (316)
T cd07842          82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLG  157 (316)
T ss_pred             EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence            9999975 666555322    136788899999999999999999   999999999999999999    9999999999


Q ss_pred             CCccCCcccc-ccccccccCCcccccCCCCCC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccCc--------------
Q 039799          249 MAKPLLEEDQ-SLTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE--------------  312 (346)
Q Consensus       249 ~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~--------------  312 (346)
                      ++........ ........++..|+|||...+ ..++.++||||||++++||++|+.||.......              
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
T cd07842         158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI  237 (316)
T ss_pred             cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence            9987643222 112233457889999997765 457899999999999999999999996532221              


Q ss_pred             -----------------------------------ccHHHHHhh--hcCCChhhhhchhccCCccccccc
Q 039799          313 -----------------------------------MTLKRWVND--LLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       313 -----------------------------------~~~~~~~~~--~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                                                         ..+..|...  ..+..+.+++.+||..+|++|||+
T Consensus       238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~  307 (316)
T cd07842         238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITA  307 (316)
T ss_pred             HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCH
Confidence                                               011122222  233467889999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=5.4e-37  Score=271.57  Aligned_cols=239  Identities=23%  Similarity=0.319  Sum_probs=191.1

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhc-CCCCceeeEEEEec------CC
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRI-CHRNLIKIISSYSN------DD  172 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~------~~  172 (346)
                      ....|.+.+.||+|+||.||+|... +++.+|+|++.... .....+..|+.++.++ +|+|++++++++..      .+
T Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   92 (282)
T cd06636          14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDD   92 (282)
T ss_pred             hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCC
Confidence            3456888999999999999999975 68899999986543 3345678899999998 69999999998853      45


Q ss_pred             ceeEEEecCCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCc
Q 039799          173 FKALVLEYMPHGSLEKCLYLS-NYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAK  251 (346)
Q Consensus       173 ~~~lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~  251 (346)
                      ..+++|||+++++|.+++... ...+++..+..++.|++.|++|||   +.+++|+||+|+||++++++.++|+|||++.
T Consensus        93 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~l~dfg~~~  169 (282)
T cd06636          93 QLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSA  169 (282)
T ss_pred             EEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCcchh
Confidence            788999999999999988653 345788888999999999999999   9999999999999999999999999999988


Q ss_pred             cCCccccccccccccCCcccccCCCCC-----CCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccH-------HHHH
Q 039799          252 PLLEEDQSLTQTQTLATIGYMAPEYGR-----EGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTL-------KRWV  319 (346)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~-------~~~~  319 (346)
                      ......  .......++..|+|||.+.     ...++.++||||||+++|||++|+.||..........       ....
T Consensus       170 ~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  247 (282)
T cd06636         170 QLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLK  247 (282)
T ss_pred             hhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCc
Confidence            653211  1223355889999999875     3457889999999999999999999996532211110       0111


Q ss_pred             hhhcCCChhhhhchhccCCccccccc
Q 039799          320 NDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       320 ~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ...++..+.+++.+||..+|.+||++
T Consensus       248 ~~~~~~~~~~li~~cl~~~p~~Rp~~  273 (282)
T cd06636         248 SKKWSKKFIDFIEGCLVKNYLSRPST  273 (282)
T ss_pred             ccccCHHHHHHHHHHhCCChhhCcCH
Confidence            11234578899999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.3e-36  Score=266.15  Aligned_cols=227  Identities=26%  Similarity=0.359  Sum_probs=189.4

Q ss_pred             ccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecCCCCCh
Q 039799          111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSL  186 (346)
Q Consensus       111 lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  186 (346)
                      ||.|++|.||++... +++.+|+|++....   ....+.+.+|+++++.++|||++++++.+.+.+..++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999976 58999999986432   23456788999999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccccccccc
Q 039799          187 EKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL  266 (346)
Q Consensus       187 ~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~  266 (346)
                      .+++... ..+++..+..++.+++.||+|||   +.+++|+||+|+||+++.++.++|+|||++.......   ......
T Consensus        81 ~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~  153 (262)
T cd05572          81 WTILRDR-GLFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFC  153 (262)
T ss_pred             HHHHhhc-CCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccccc
Confidence            9988643 45888999999999999999999   9999999999999999999999999999998764322   122345


Q ss_pred             CCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh---------hhcCCChhhhhchhccC
Q 039799          267 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN---------DLLPISVMEVVDANLLS  337 (346)
Q Consensus       267 ~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~---------~~~~~~~~~~~d~~l~~  337 (346)
                      ++..|+|||...+..++.++|+||+|+++||+++|..||.....+.....+.+.         ...+..+.+++.+||..
T Consensus       154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  233 (262)
T cd05572         154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRR  233 (262)
T ss_pred             CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccC
Confidence            788999999988888999999999999999999999999764321111111111         11234789999999999


Q ss_pred             Ccccccc
Q 039799          338 QEDEHFT  344 (346)
Q Consensus       338 ~p~~R~~  344 (346)
                      +|++||+
T Consensus       234 ~p~~R~~  240 (262)
T cd05572         234 NPEERLG  240 (262)
T ss_pred             ChhhCcC
Confidence            9999998

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=9.5e-37  Score=268.07  Aligned_cols=232  Identities=21%  Similarity=0.315  Sum_probs=177.5

Q ss_pred             CcccccCceEEEEEEEcCC---CEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecCCCC
Q 039799          109 PLIGKGGFGSVYKAIIQDG---MEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHG  184 (346)
Q Consensus       109 ~~lg~G~~g~vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  184 (346)
                      +.||+|+||.||+|...++   ..+++|.+.... ....+.+.+|+..++.++|||++++++.+......++||||+++|
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            3689999999999975533   346677766443 334578889999999999999999999999999999999999999


Q ss_pred             ChhhhhhhcC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccc
Q 039799          185 SLEKCLYLSN---YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT  261 (346)
Q Consensus       185 sL~~~l~~~~---~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~  261 (346)
                      +|.+++....   ...++.....++.++++||+|||   +.+++||||||+|||++.++.++|+|||++...........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            9999886532   34566777889999999999999   99999999999999999999999999999864322211112


Q ss_pred             cccccCCcccccCCCCCC-------CCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHH------------hh
Q 039799          262 QTQTLATIGYMAPEYGRE-------GRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWV------------ND  321 (346)
Q Consensus       262 ~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~------------~~  321 (346)
                      .....++..|+|||+...       ..++.++||||||+++|||++ |..||......+ ......            ..
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  236 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE-VLNHVIKDQQVKLFKPQLEL  236 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHhhcccccCCCccCC
Confidence            233457889999998743       245789999999999999997 577876422111 111111            11


Q ss_pred             hcCCChhhhhchhccCCccccccc
Q 039799          322 LLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       322 ~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      .+++.+.+++..|+ .+|++||++
T Consensus       237 ~~~~~~~~l~~~c~-~~P~~Rp~~  259 (268)
T cd05086         237 PYSERWYEVLQFCW-LSPEKRATA  259 (268)
T ss_pred             CCcHHHHHHHHHHh-hCcccCCCH
Confidence            12335678898898 679999986

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.8e-37  Score=267.67  Aligned_cols=237  Identities=22%  Similarity=0.303  Sum_probs=190.9

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC-----CchhHHHHHHHHHHHHhcCCCCceeeEEEEecC--Cce
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ-----YEGAFKSFDIECDVMKRICHRNLIKIISSYSND--DFK  174 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~  174 (346)
                      .+|.+.+.||+|++|.||+|... ++..+|+|.+...     .......+.+|++++++++|+|++++++++...  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            57889999999999999999865 6899999987432     223456788899999999999999999998654  457


Q ss_pred             eEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCC
Q 039799          175 ALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  254 (346)
Q Consensus       175 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~  254 (346)
                      ++++||+++++|.+++... ..+++.....++.+++.|+.|||   +.+++|+||+|+||+++.++.++|+|||+++...
T Consensus        82 ~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  157 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ  157 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence            8999999999999988643 34788889999999999999999   9999999999999999999999999999998653


Q ss_pred             cccc-ccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH--------hhhcCC
Q 039799          255 EEDQ-SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV--------NDLLPI  325 (346)
Q Consensus       255 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~--------~~~~~~  325 (346)
                      .... ........++..|+|||+..+..++.++|+||||++++|+++|+.||....... ...+..        ...+++
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~p~~~~~  236 (264)
T cd06653         158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA-AIFKIATQPTKPMLPDGVSD  236 (264)
T ss_pred             cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH-HHHHHHcCCCCCCCCcccCH
Confidence            2111 111223458899999999988888999999999999999999999997632211 111111        122334


Q ss_pred             ChhhhhchhccCCccccccc
Q 039799          326 SVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       326 ~~~~~~d~~l~~~p~~R~~~  345 (346)
                      .+.+++++|+. +|+.||++
T Consensus       237 ~~~~~i~~~l~-~~~~r~~~  255 (264)
T cd06653         237 ACRDFLKQIFV-EEKRRPTA  255 (264)
T ss_pred             HHHHHHHHHhc-CcccCccH
Confidence            67899999999 57999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.1e-36  Score=270.44  Aligned_cols=235  Identities=25%  Similarity=0.297  Sum_probs=191.7

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEec--CCceeEEEe
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSN--DDFKALVLE  179 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e  179 (346)
                      +|...+.||.|++|.||++... +++.+|+|.+.... ......+.+|++++++++||||+++++++..  .+..++|||
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e   81 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME   81 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence            4677889999999999999975 68899999987543 2345678899999999999999999998864  346899999


Q ss_pred             cCCCCChhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcc
Q 039799          180 YMPHGSLEKCLYL---SNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  256 (346)
Q Consensus       180 ~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~  256 (346)
                      |+++++|.+++..   ....++......++.+++.||+|||   +.+++|+||+|+||++++++.++|+|||++......
T Consensus        82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  158 (287)
T cd06621          82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS  158 (287)
T ss_pred             ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence            9999999887643   2355788899999999999999999   999999999999999999999999999998765322


Q ss_pred             ccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCcccc---CcccHHHHHhhh-----------
Q 039799          257 DQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFS---GEMTLKRWVNDL-----------  322 (346)
Q Consensus       257 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~---~~~~~~~~~~~~-----------  322 (346)
                      .    .....++..|+|||...+..++.++||||+|+++|||++|+.||+....   .......+....           
T Consensus       159 ~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd06621         159 L----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGN  234 (287)
T ss_pred             c----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCC
Confidence            1    1233478889999999888899999999999999999999999976421   112233333221           


Q ss_pred             ---cCCChhhhhchhccCCccccccc
Q 039799          323 ---LPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       323 ---~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                         ++..+.+++.+|+..+|.+||+.
T Consensus       235 ~~~~~~~~~~li~~~l~~~p~~Rpt~  260 (287)
T cd06621         235 GIKWSEEFKDFIKQCLEKDPTRRPTP  260 (287)
T ss_pred             CCchHHHHHHHHHHHcCCCcccCCCH
Confidence               11246799999999999999986

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.3e-36  Score=264.96  Aligned_cols=238  Identities=26%  Similarity=0.342  Sum_probs=198.9

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCc--hhHHHHHHHHHHHHhcCCCCceeeEEEEecC--CceeEEE
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYE--GAFKSFDIECDVMKRICHRNLIKIISSYSND--DFKALVL  178 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~  178 (346)
                      +|...+.||+|++|.||+|... +++.+++|++.....  ...+.+.+|++.+++++|||++++++.+...  +..++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            3667789999999999999977 789999999875542  4467888999999999999999999999988  8999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccc
Q 039799          179 EYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  258 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~  258 (346)
                      ||+++++|.+++.... .+++..++.++.+++.+++|||   +.+++|+||+|+||+++.++.++|+|||.+........
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  156 (260)
T cd06606          81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET  156 (260)
T ss_pred             EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence            9999999999887544 7899999999999999999999   89999999999999999999999999999987654332


Q ss_pred             ccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCccc--------HHHHHhhhcCCChhhh
Q 039799          259 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMT--------LKRWVNDLLPISVMEV  330 (346)
Q Consensus       259 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~--------~~~~~~~~~~~~~~~~  330 (346)
                      ........++..|.|||...+...+.++||||||++++++++|+.||.........        ........++..+.++
T Consensus       157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  236 (260)
T cd06606         157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDF  236 (260)
T ss_pred             cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHH
Confidence            11123456888999999998888999999999999999999999999763311000        1111222335588999


Q ss_pred             hchhccCCccccccc
Q 039799          331 VDANLLSQEDEHFTT  345 (346)
Q Consensus       331 ~d~~l~~~p~~R~~~  345 (346)
                      +.+|+..+|++||+.
T Consensus       237 i~~~l~~~p~~Rp~~  251 (260)
T cd06606         237 LRKCLRRDPKKRPTA  251 (260)
T ss_pred             HHHhCcCChhhCCCH
Confidence            999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=9.1e-37  Score=268.72  Aligned_cols=236  Identities=27%  Similarity=0.415  Sum_probs=187.7

Q ss_pred             CCCCCcccccCceEEEEEEEc----CCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEecCC------
Q 039799          105 ANMPPLIGKGGFGSVYKAIIQ----DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSNDD------  172 (346)
Q Consensus       105 ~~~~~~lg~G~~g~vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  172 (346)
                      |.+.+.||+|++|.||+|.+.    +++.+|+|++....  ....+++.+|++++++++|||++++++++...+      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567789999999999999854    36889999986542  334567888999999999999999999886432      


Q ss_pred             ceeEEEecCCCCChhhhhhhc-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeee
Q 039799          173 FKALVLEYMPHGSLEKCLYLS-----NYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDF  247 (346)
Q Consensus       173 ~~~lv~e~~~~gsL~~~l~~~-----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Df  247 (346)
                      ..++++||+++|+|.+++...     ...+++.....++.+++.|++|||   +.+|+||||||+||+++.++.++++||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcc
Confidence            246889999999998876432     135788899999999999999999   999999999999999999999999999


Q ss_pred             cCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHhh-----
Q 039799          248 GMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVND-----  321 (346)
Q Consensus       248 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~-----  321 (346)
                      |+++...............++..|++||......++.++||||||+++|||++ |+.||.....  .....++..     
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--~~~~~~~~~~~~~~  235 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--SEIYNYLIKGNRLK  235 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--HHHHHHHHcCCcCC
Confidence            99986643222222223345678999999888888999999999999999999 8899865321  122222211     


Q ss_pred             ---hcCCChhhhhchhccCCccccccc
Q 039799          322 ---LLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       322 ---~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                         ..+..+.+++.+|+..+|++||+.
T Consensus       236 ~~~~~~~~~~~l~~~~l~~~p~~Rps~  262 (273)
T cd05074         236 QPPDCLEDVYELMCQCWSPEPKCRPSF  262 (273)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCH
Confidence               123478999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=9.8e-37  Score=269.99  Aligned_cols=236  Identities=26%  Similarity=0.325  Sum_probs=189.0

Q ss_pred             CCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecC
Q 039799          105 ANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYM  181 (346)
Q Consensus       105 ~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  181 (346)
                      |++.+.||.|++|.||+|... +|..||+|++....  ......+.+|++++++++|||++++++++...+..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            567789999999999999865 79999999986443  223456788999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccc
Q 039799          182 PHGSLEKCLYLSN-YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  260 (346)
Q Consensus       182 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~  260 (346)
                      + ++|.+++.... ..+++..++.++.++++||+|||   +.+++||||+|+||+++.++.++|+|||++........  
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--  154 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR--  154 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--
Confidence            5 68988876543 46899999999999999999999   89999999999999999999999999999976532211  


Q ss_pred             ccccccCCcccccCCCCCCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccCcc--c------------------HHH--
Q 039799          261 TQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM--T------------------LKR--  317 (346)
Q Consensus       261 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~--~------------------~~~--  317 (346)
                      ......++..|+|||++.+. .++.++||||||+++|||++|+.||........  .                  ...  
T Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07835         155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK  234 (283)
T ss_pred             ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence            11223468899999987654 468899999999999999999999864221000  0                  000  


Q ss_pred             ------------HHhhhcCCChhhhhchhccCCcccccccC
Q 039799          318 ------------WVNDLLPISVMEVVDANLLSQEDEHFTTK  346 (346)
Q Consensus       318 ------------~~~~~~~~~~~~~~d~~l~~~p~~R~~~k  346 (346)
                                  -....++..+.+++.+|+..+|.+||+.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~  275 (283)
T cd07835         235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAK  275 (283)
T ss_pred             hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHH
Confidence                        00112334678899999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.2e-36  Score=269.58  Aligned_cols=236  Identities=22%  Similarity=0.291  Sum_probs=190.0

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecC
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYM  181 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  181 (346)
                      +|++.+.||+|++|.||+|+.. +|..+|+|++.... ......+.+|++++++++|||++++++++...+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            3778899999999999999976 68899999987543 223456778999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccc
Q 039799          182 PHGSLEKCLYLSN--YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  259 (346)
Q Consensus       182 ~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~  259 (346)
                      ++ +|.+++....  ..+++..+..++.++++||+|||   +.+++||||+|+||++++++.++++|||++........ 
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-  155 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-  155 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence            85 8888775443  46899999999999999999999   99999999999999999999999999999975532211 


Q ss_pred             cccccccCCcccccCCCCCCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccCcc--------------cH---------
Q 039799          260 LTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM--------------TL---------  315 (346)
Q Consensus       260 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~--------------~~---------  315 (346)
                       ......++..|++||.+.+. .++.++||||||+++||+++|+.||......+.              ..         
T Consensus       156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07836         156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY  234 (284)
T ss_pred             -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence             12234568899999987654 468899999999999999999999865321110              00         


Q ss_pred             -----------HHHHhhhcCCChhhhhchhccCCccccccc
Q 039799          316 -----------KRWVNDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       316 -----------~~~~~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                                 ...+....+..+.+++.+|+..+|.+||+.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~  275 (284)
T cd07836         235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISA  275 (284)
T ss_pred             cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCH
Confidence                       000111234577899999999999999985

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-36  Score=263.74  Aligned_cols=235  Identities=28%  Similarity=0.376  Sum_probs=196.7

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCc--hhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEec
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYE--GAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEY  180 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  180 (346)
                      +|.+.+.||+|++|.||++... +++.+++|.+.....  ...+.+.+|++++++++|+|++++++++...+..++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            3678899999999999999866 678999999876543  4567888999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccc
Q 039799          181 MPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  260 (346)
Q Consensus       181 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~  260 (346)
                      +++++|.+++... ..+++..+..++.+++.++.|||   +.+++||||+|+||+++.++.++|+|||.+......... 
T Consensus        81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-  155 (254)
T cd06627          81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-  155 (254)
T ss_pred             CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-
Confidence            9999999988644 56899999999999999999999   999999999999999999999999999999876443221 


Q ss_pred             ccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHH-------HhhhcCCChhhhhch
Q 039799          261 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRW-------VNDLLPISVMEVVDA  333 (346)
Q Consensus       261 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~-------~~~~~~~~~~~~~d~  333 (346)
                       .....++..|+|||...+..++.++||||+|+++++|++|+.|+....... .....       ....++..+.+++.+
T Consensus       156 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~  233 (254)
T cd06627         156 -DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA-ALFRIVQDDHPPLPEGISPELKDFLMQ  233 (254)
T ss_pred             -ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH-HHHHHhccCCCCCCCCCCHHHHHHHHH
Confidence             233457889999999887788999999999999999999999986532111 01111       112234578899999


Q ss_pred             hccCCccccccc
Q 039799          334 NLLSQEDEHFTT  345 (346)
Q Consensus       334 ~l~~~p~~R~~~  345 (346)
                      ||..+|++||++
T Consensus       234 ~l~~~p~~R~~~  245 (254)
T cd06627         234 CFQKDPNLRPTA  245 (254)
T ss_pred             HHhCChhhCcCH
Confidence            999999999985

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=5.2e-37  Score=271.89  Aligned_cols=235  Identities=25%  Similarity=0.340  Sum_probs=187.9

Q ss_pred             CCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecC
Q 039799          105 ANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYM  181 (346)
Q Consensus       105 ~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  181 (346)
                      |+..+.||+|++|.||+|... +++.+|+|.+....  ......+.+|++++++++|||++++++++...+..++||||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (284)
T cd07860           2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL   81 (284)
T ss_pred             ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeecc
Confidence            677889999999999999876 68999999886432  223457888999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccc
Q 039799          182 PHGSLEKCLYLS-NYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  260 (346)
Q Consensus       182 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~  260 (346)
                      . ++|.+++... ...+++..+..++.+++.|++|||   +.+++|+||+|+||++++++.++|+|||++.......  .
T Consensus        82 ~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~--~  155 (284)
T cd07860          82 H-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--R  155 (284)
T ss_pred             c-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc--c
Confidence            5 5888877543 356899999999999999999999   9999999999999999999999999999988653221  1


Q ss_pred             ccccccCCcccccCCCCCCCC-CCcchhHHHHHHHHHHHHcCCCCCCccccCcc--------------------cHH---
Q 039799          261 TQTQTLATIGYMAPEYGREGR-VSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM--------------------TLK---  316 (346)
Q Consensus       261 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~--------------------~~~---  316 (346)
                      ......++..|+|||...+.. ++.++||||||+++|||+||+.||........                    ...   
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd07860         156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYK  235 (284)
T ss_pred             ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHH
Confidence            122334688899999876544 58899999999999999999999854211000                    000   


Q ss_pred             ----HHH-------hhhcCCChhhhhchhccCCccccccc
Q 039799          317 ----RWV-------NDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       317 ----~~~-------~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                          +|.       ...++..+.+++.+||..||.+||++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~  275 (284)
T cd07860         236 PSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISA  275 (284)
T ss_pred             hhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCH
Confidence                000       01123466789999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=2.3e-36  Score=268.73  Aligned_cols=238  Identities=25%  Similarity=0.308  Sum_probs=190.8

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhc-CCCCceeeEEEEecC-----Cc
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRI-CHRNLIKIISSYSND-----DF  173 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-----~~  173 (346)
                      ..++|.+...||+|++|.||++... +++.+|+|++.... .....+.+|+.++.++ +|||++++++++...     +.
T Consensus        20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~   98 (291)
T cd06639          20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQ   98 (291)
T ss_pred             CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCe
Confidence            3567999999999999999999875 78899999986542 2345677899999998 899999999988653     35


Q ss_pred             eeEEEecCCCCChhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCC
Q 039799          174 KALVLEYMPHGSLEKCLYL---SNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMA  250 (346)
Q Consensus       174 ~~lv~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~  250 (346)
                      .++|+||+++++|.++++.   ....+++..++.++.+++.||.|||   +.+++|+||||+||++++++.++|+|||++
T Consensus        99 ~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~kl~dfg~~  175 (291)
T cd06639          99 LWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVS  175 (291)
T ss_pred             eEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEeecccc
Confidence            8899999999999988753   3456899999999999999999999   999999999999999999999999999999


Q ss_pred             ccCCccccccccccccCCcccccCCCCCCC-----CCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHhh----
Q 039799          251 KPLLEEDQSLTQTQTLATIGYMAPEYGREG-----RVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVND----  321 (346)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~----  321 (346)
                      ........  ......++..|+|||.+...     .++.++||||||+++|||++|+.||...... ..+.++.+.    
T Consensus       176 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~-~~~~~~~~~~~~~  252 (291)
T cd06639         176 AQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV-KTLFKIPRNPPPT  252 (291)
T ss_pred             hhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH-HHHHHHhcCCCCC
Confidence            86543221  12234578899999987543     3688999999999999999999999754221 112222111    


Q ss_pred             -----hcCCChhhhhchhccCCccccccc
Q 039799          322 -----LLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       322 -----~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                           .+...+.+++.+|+..+|++||+.
T Consensus       253 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~  281 (291)
T cd06639         253 LLHPEKWCRSFNHFISQCLIKDFEARPSV  281 (291)
T ss_pred             CCcccccCHHHHHHHHHHhhcChhhCcCH
Confidence                 122257789999999999999985

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=8.9e-37  Score=266.04  Aligned_cols=229  Identities=27%  Similarity=0.442  Sum_probs=188.4

Q ss_pred             CCCCCCCcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecCC
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMP  182 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  182 (346)
                      .+|.+.+.||+|+||.||++.. +++.+|+|.+....  ..+.+.+|+.++++++|||++++++++... ..+++|||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            4588899999999999999975 57889999986532  346788899999999999999999998665 4689999999


Q ss_pred             CCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccc
Q 039799          183 HGSLEKCLYLSN-YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT  261 (346)
Q Consensus       183 ~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~  261 (346)
                      +++|.+++.... ..+++..++.++.+++.|+.|||   +.+++||||||+||+++.++.++|+|||++......     
T Consensus        82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-----  153 (254)
T cd05083          82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-----  153 (254)
T ss_pred             CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceecccc-----
Confidence            999999987543 45889999999999999999999   999999999999999999999999999998754221     


Q ss_pred             cccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHhh--------hcCCChhhhhc
Q 039799          262 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVND--------LLPISVMEVVD  332 (346)
Q Consensus       262 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~d  332 (346)
                      ......+..|+|||...+..++.++|+||||++++||++ |+.||......  .....+..        ..+..+.+++.
T Consensus       154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~  231 (254)
T cd05083         154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK--EVKECVEKGYRMEPPEGCPADVYVLMT  231 (254)
T ss_pred             CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH--HHHHHHhCCCCCCCCCcCCHHHHHHHH
Confidence            112234578999999988889999999999999999997 99998653221  11122211        22346789999


Q ss_pred             hhccCCccccccc
Q 039799          333 ANLLSQEDEHFTT  345 (346)
Q Consensus       333 ~~l~~~p~~R~~~  345 (346)
                      +|+..+|++||+.
T Consensus       232 ~~l~~~p~~Rp~~  244 (254)
T cd05083         232 SCWETEPKKRPSF  244 (254)
T ss_pred             HHcCCChhhCcCH
Confidence            9999999999985

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.1e-36  Score=266.49  Aligned_cols=230  Identities=28%  Similarity=0.381  Sum_probs=190.0

Q ss_pred             ccccCceEEEEEEEc-CCCEEEEEEecCCCc---hhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecCCCCCh
Q 039799          111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYE---GAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSL  186 (346)
Q Consensus       111 lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  186 (346)
                      ||+|++|.||++... +|+.+++|++.....   ...+.+.+|++++++++|||++++++.+...+..++++||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999987 599999999865432   3456788899999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccc------cc
Q 039799          187 EKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ------SL  260 (346)
Q Consensus       187 ~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~------~~  260 (346)
                      .+++.... .+++..+..++.|+++||+|||   +.+++|+||+|+||++++++.++|+|||++........      ..
T Consensus        81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  156 (265)
T cd05579          81 ASLLENVG-SLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK  156 (265)
T ss_pred             HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence            99887544 6899999999999999999999   99999999999999999999999999999886433211      11


Q ss_pred             ccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh------hh--cCCChhhhhc
Q 039799          261 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN------DL--LPISVMEVVD  332 (346)
Q Consensus       261 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~------~~--~~~~~~~~~d  332 (346)
                      ......++..|+|||.......+.++||||||++++|+++|+.||......+ .......      ..  ++..+.+++.
T Consensus       157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~i~  235 (265)
T cd05579         157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE-IFQNILNGKIEWPEDVEVSDEAIDLIS  235 (265)
T ss_pred             cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHhcCCcCCCccccCCHHHHHHHH
Confidence            2233457889999999888888999999999999999999999997532111 0111110      01  2457799999


Q ss_pred             hhccCCccccccc
Q 039799          333 ANLLSQEDEHFTT  345 (346)
Q Consensus       333 ~~l~~~p~~R~~~  345 (346)
                      +|+..+|++||+.
T Consensus       236 ~~l~~~p~~Rpt~  248 (265)
T cd05579         236 KLLVPDPEKRLGA  248 (265)
T ss_pred             HHhcCCHhhcCCC
Confidence            9999999999987

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.6e-36  Score=273.15  Aligned_cols=234  Identities=27%  Similarity=0.299  Sum_probs=191.3

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC---CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeE
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ---YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKAL  176 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  176 (346)
                      ....|...+.||+|+||.||++... ++..+|+|++...   .......+..|++++++++|||++++++++...+..++
T Consensus        23 ~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  102 (317)
T cd06635          23 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWL  102 (317)
T ss_pred             chhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEE
Confidence            3345888999999999999999865 6889999998643   22334578889999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcc
Q 039799          177 VLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  256 (346)
Q Consensus       177 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~  256 (346)
                      ||||+. |++.+.+......+++..+..++.+++.|+.|||   +.+++||||+|+||+++.++.++|+|||++......
T Consensus       103 v~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (317)
T cd06635         103 VMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA  178 (317)
T ss_pred             EEeCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence            999996 4787777655667899999999999999999999   999999999999999999999999999998754321


Q ss_pred             ccccccccccCCcccccCCCCC---CCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh--------hhcCC
Q 039799          257 DQSLTQTQTLATIGYMAPEYGR---EGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN--------DLLPI  325 (346)
Q Consensus       257 ~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~  325 (346)
                            ....++..|+|||+..   .+.++.++||||||+++|||++|+.||...... .....+..        ..++.
T Consensus       179 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  251 (317)
T cd06635         179 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQNESPTLQSNEWSD  251 (317)
T ss_pred             ------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHhccCCCCCCccccH
Confidence                  2345788999999863   456889999999999999999999998653211 11122221        12233


Q ss_pred             ChhhhhchhccCCccccccc
Q 039799          326 SVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       326 ~~~~~~d~~l~~~p~~R~~~  345 (346)
                      .+.+++.+|+..+|.+||+.
T Consensus       252 ~l~~li~~~l~~~p~~Rpt~  271 (317)
T cd06635         252 YFRNFVDSCLQKIPQDRPTS  271 (317)
T ss_pred             HHHHHHHHHccCCcccCcCH
Confidence            67899999999999999985

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-36  Score=265.19  Aligned_cols=227  Identities=24%  Similarity=0.318  Sum_probs=182.8

Q ss_pred             CcccccCceEEEEEEEc-CCCEEEEEEecCCCc---hhHHHHHHHHHH-HHhcCCCCceeeEEEEecCCceeEEEecCCC
Q 039799          109 PLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYE---GAFKSFDIECDV-MKRICHRNLIKIISSYSNDDFKALVLEYMPH  183 (346)
Q Consensus       109 ~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  183 (346)
                      +.||+|++|.||+|... +++.+|+|++.....   .....+..|..+ ....+|+|++++++.+...+..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            46899999999999865 689999999864321   112233444444 3455899999999999999999999999999


Q ss_pred             CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccccc
Q 039799          184 GSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT  263 (346)
Q Consensus       184 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~~  263 (346)
                      ++|.+++... ..+++..+..++.|++.||.|||   +.+++||||+|+||++++++.++|+|||++.....      ..
T Consensus        82 ~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~  151 (260)
T cd05611          82 GDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NK  151 (260)
T ss_pred             CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc------cc
Confidence            9999988643 45788889999999999999999   99999999999999999999999999999875422      12


Q ss_pred             cccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHH----------HhhhcCCChhhhhch
Q 039799          264 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRW----------VNDLLPISVMEVVDA  333 (346)
Q Consensus       264 ~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~----------~~~~~~~~~~~~~d~  333 (346)
                      ...++..|+|||...+..++.++||||||+++||++||..||....... .....          +...++..+.+++.+
T Consensus       152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  230 (260)
T cd05611         152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA-VFDNILSRRINWPEEVKEFCSPEAVDLINR  230 (260)
T ss_pred             cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhcccCCCCcccccCCHHHHHHHHH
Confidence            3457889999999988888999999999999999999999996532211 11111          111245588999999


Q ss_pred             hccCCcccccccC
Q 039799          334 NLLSQEDEHFTTK  346 (346)
Q Consensus       334 ~l~~~p~~R~~~k  346 (346)
                      ||..+|++||+++
T Consensus       231 ~l~~~p~~R~~~~  243 (260)
T cd05611         231 LLCMDPAKRLGAN  243 (260)
T ss_pred             HccCCHHHccCCC
Confidence            9999999999863

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.4e-36  Score=267.28  Aligned_cols=233  Identities=23%  Similarity=0.286  Sum_probs=184.8

Q ss_pred             CCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHHhcC-CCCceeeEEEEecC--CceeEEEe
Q 039799          105 ANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRIC-HRNLIKIISSYSND--DFKALVLE  179 (346)
Q Consensus       105 ~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~e  179 (346)
                      |.+.+.||+|++|.||+|... +++.+|+|++.... .........|+..+.++. |+|++++++++.+.  +..++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            566788999999999999865 78999999987542 222233456888888885 99999999999877  88999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccc
Q 039799          180 YMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  259 (346)
Q Consensus       180 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~  259 (346)
                      |++ +++.+.+......+++..+..++.+++.||+|||   +.+++||||+|+||+++. +.++|+|||++........ 
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~-  154 (282)
T cd07831          81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP-  154 (282)
T ss_pred             cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccccCCC-
Confidence            996 5887777655567899999999999999999999   999999999999999999 9999999999986643221 


Q ss_pred             cccccccCCcccccCCCCC-CCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcc----------cHH------------
Q 039799          260 LTQTQTLATIGYMAPEYGR-EGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM----------TLK------------  316 (346)
Q Consensus       260 ~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~----------~~~------------  316 (346)
                        .....++..|+|||+.. +..++.++||||+||++|||++|..||......+.          ...            
T Consensus       155 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
T cd07831         155 --YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHM  232 (282)
T ss_pred             --cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccc
Confidence              12234788999999754 45578899999999999999999999964221000          000            


Q ss_pred             ------------HHHhhhcCCChhhhhchhccCCccccccc
Q 039799          317 ------------RWVNDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       317 ------------~~~~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                                  ......++..+.+++.+||..+|++||++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~  273 (282)
T cd07831         233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITA  273 (282)
T ss_pred             cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCH
Confidence                        01112334578899999999999999986

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-36  Score=268.80  Aligned_cols=236  Identities=27%  Similarity=0.377  Sum_probs=190.6

Q ss_pred             CCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEecC--CceeEEEe
Q 039799          105 ANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSND--DFKALVLE  179 (346)
Q Consensus       105 ~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e  179 (346)
                      |.+.+.||+|++|.||+|... +++.+|+|++....  ......+.+|++++++++|+|++++++++...  +..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            566788999999999999977 58899999997652  33446678899999999999999999999887  89999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccc
Q 039799          180 YMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  259 (346)
Q Consensus       180 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~  259 (346)
                      |+++ +|.+++......+++..++.++.++++|++|||   +.+++|+||+|+||++++++.++|+|||.+........ 
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-  155 (287)
T cd07840          81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-  155 (287)
T ss_pred             cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-
Confidence            9975 888887655567899999999999999999999   89999999999999999999999999999987644321 


Q ss_pred             cccccccCCcccccCCCCCC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccCcc-------------------------
Q 039799          260 LTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM-------------------------  313 (346)
Q Consensus       260 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~-------------------------  313 (346)
                      .......++..|+|||...+ ..++.++||||||++++||+||+.||+.......                         
T Consensus       156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07840         156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF  235 (287)
T ss_pred             ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhh
Confidence            12233456788999997654 4578999999999999999999999864221000                         


Q ss_pred             -----------cHHHHHhhhcCCChhhhhchhccCCccccccc
Q 039799          314 -----------TLKRWVNDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       314 -----------~~~~~~~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                                 .+........+..+.+++.+||..+|.+||++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~  278 (287)
T cd07840         236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISA  278 (287)
T ss_pred             hhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCH
Confidence                       00011111124467899999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=2e-36  Score=271.48  Aligned_cols=238  Identities=25%  Similarity=0.295  Sum_probs=188.7

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEecC--CceeE
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSND--DFKAL  176 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l  176 (346)
                      .++|++.+.||+|++|.||+|... +|+.||+|++....  ......+.+|+.++++++|+|++++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            367999999999999999999975 68999999986432  22233456799999999999999999998754  56899


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcc
Q 039799          177 VLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  256 (346)
Q Consensus       177 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~  256 (346)
                      ||||+++ +|.+++......+++..+..++.|++.|++|||   +.+++||||+|+||++++++.++|+|||.+......
T Consensus        86 v~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~  161 (309)
T cd07845          86 VMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP  161 (309)
T ss_pred             EEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence            9999964 888887765567899999999999999999999   999999999999999999999999999999876432


Q ss_pred             ccccccccccCCcccccCCCCCC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccCcc--cHHH---------H------
Q 039799          257 DQSLTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM--TLKR---------W------  318 (346)
Q Consensus       257 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~--~~~~---------~------  318 (346)
                      ..  ......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||......+.  ....         |      
T Consensus       162 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
T cd07845         162 AK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL  239 (309)
T ss_pred             cC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcc
Confidence            21  1222345788999998765 4578999999999999999999999864221100  0000         0      


Q ss_pred             ------------------HhhhcCCChhhhhchhccCCccccccc
Q 039799          319 ------------------VNDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       319 ------------------~~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                                        .....+....+++.+||..||++||++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~  284 (309)
T cd07845         240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATA  284 (309)
T ss_pred             cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCH
Confidence                              001123466789999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-37  Score=273.16  Aligned_cols=239  Identities=24%  Similarity=0.337  Sum_probs=200.9

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeE
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKAL  176 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  176 (346)
                      ..+.|..-++||+|+||.||-++.+ +|+.+|+|.+.+..   .....-..+|-.+|.++..+.||.+-..|+..+.+++
T Consensus       183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl  262 (591)
T KOG0986|consen  183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL  262 (591)
T ss_pred             cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence            4567889999999999999999876 79999999886542   2223445678999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCc
Q 039799          177 VLEYMPHGSLEKCLYLSN-YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  255 (346)
Q Consensus       177 v~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~  255 (346)
                      |+..|.||+|.-+++.-+ ..++.....-++.+|+.||++||   ...||.||+||+|||+|+.|+++|+|.|+|..+.+
T Consensus       263 VLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~  339 (591)
T KOG0986|consen  263 VLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE  339 (591)
T ss_pred             EEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence            999999999999887544 57899999999999999999999   99999999999999999999999999999998754


Q ss_pred             cccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCc--ccHHHHH-------hhhcCCC
Q 039799          256 EDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE--MTLKRWV-------NDLLPIS  326 (346)
Q Consensus       256 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~--~~~~~~~-------~~~~~~~  326 (346)
                      ..   .....+||.||||||++....|+...|-||+||++|||+.|+.||...-...  .++.+.+       ...++++
T Consensus       340 g~---~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~e  416 (591)
T KOG0986|consen  340 GK---PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEE  416 (591)
T ss_pred             CC---ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHH
Confidence            33   3345589999999999999999999999999999999999999997632211  1122222       1234447


Q ss_pred             hhhhhchhccCCccccccc
Q 039799          327 VMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       327 ~~~~~d~~l~~~p~~R~~~  345 (346)
                      ..++....|..||.+|.-.
T Consensus       417 akslc~~LL~Kdp~~RLGc  435 (591)
T KOG0986|consen  417 AKSLCEGLLTKDPEKRLGC  435 (591)
T ss_pred             HHHHHHHHHccCHHHhccC
Confidence            7889999999999999864

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-37  Score=274.14  Aligned_cols=235  Identities=23%  Similarity=0.297  Sum_probs=201.0

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEe
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLE  179 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  179 (346)
                      .-|+..+.||+|.|+.|-+|++- +|..||||++++..  .-....+.+|++.++-++|||||++++.......+|||+|
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            45899999999999999999855 89999999998653  2334678889999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEEC-CCCcEEEeeecCCccCCcccc
Q 039799          180 YMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQ  258 (346)
Q Consensus       180 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~-~~~~~~l~Dfg~~~~~~~~~~  258 (346)
                      .=++|+|.+++-.....+.+....+++.||..|+.|+|   +.-++|||+||+|+.+. .-|-+||.|||++..+.+.. 
T Consensus        98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~-  173 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK-  173 (864)
T ss_pred             ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc-
Confidence            99999999999888888999999999999999999999   99999999999998775 67899999999999875543 


Q ss_pred             ccccccccCCcccccCCCCCCCCCC-cchhHHHHHHHHHHHHcCCCCCCccccCcccHHHH------HhhhcCCChhhhh
Q 039799          259 SLTQTQTLATIGYMAPEYGREGRVS-TNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRW------VNDLLPISVMEVV  331 (346)
Q Consensus       259 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~------~~~~~~~~~~~~~  331 (346)
                        ..+..+|+..|.|||.+.+..|+ +.+||||+|||||.+++|++||...-+.+ .+...      |...+..+-.++|
T Consensus       174 --kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE-TLTmImDCKYtvPshvS~eCrdLI  250 (864)
T KOG4717|consen  174 --KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE-TLTMIMDCKYTVPSHVSKECRDLI  250 (864)
T ss_pred             --hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh-hhhhhhcccccCchhhhHHHHHHH
Confidence              34567899999999999998875 67899999999999999999998744333 22222      2333444778999


Q ss_pred             chhccCCcccccc
Q 039799          332 DANLLSQEDEHFT  344 (346)
Q Consensus       332 d~~l~~~p~~R~~  344 (346)
                      ..||..||++|-+
T Consensus       251 ~sMLvRdPkkRAs  263 (864)
T KOG4717|consen  251 QSMLVRDPKKRAS  263 (864)
T ss_pred             HHHHhcCchhhcc
Confidence            9999999999965

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=6.1e-36  Score=262.81  Aligned_cols=227  Identities=22%  Similarity=0.266  Sum_probs=182.8

Q ss_pred             CCCCCCcc--cccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhc-CCCCceeeEEEEecCCceeEEEe
Q 039799          104 DANMPPLI--GKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRI-CHRNLIKIISSYSNDDFKALVLE  179 (346)
Q Consensus       104 ~~~~~~~l--g~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  179 (346)
                      .|.+.+.+  |+|+||.||++..+ ++..+|+|++........     |......+ +|||++++++.+...+..++|||
T Consensus        15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e   89 (267)
T PHA03390         15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMD   89 (267)
T ss_pred             hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEE
Confidence            45565555  99999999999865 788999999865322111     22222222 69999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCC-cEEEeeecCCccCCcccc
Q 039799          180 YMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM-VAHLSDFGMAKPLLEEDQ  258 (346)
Q Consensus       180 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~-~~~l~Dfg~~~~~~~~~~  258 (346)
                      |+++++|.+++.... .+++..+..++.|+++|+.|||   +.+++||||+|+||+++.++ .++|+|||++......  
T Consensus        90 ~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~--  163 (267)
T PHA03390         90 YIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP--  163 (267)
T ss_pred             cCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC--
Confidence            999999999886543 7899999999999999999999   99999999999999999888 9999999998865321  


Q ss_pred             ccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh---------hhcCCChhh
Q 039799          259 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN---------DLLPISVME  329 (346)
Q Consensus       259 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~---------~~~~~~~~~  329 (346)
                          ....++..|+|||++.+..++.++||||||++++||++|+.||......+.....+..         ...+..+.+
T Consensus       164 ----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (267)
T PHA03390        164 ----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNAND  239 (267)
T ss_pred             ----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHH
Confidence                1235788999999998888999999999999999999999999854433332222221         123447789


Q ss_pred             hhchhccCCccccccc
Q 039799          330 VVDANLLSQEDEHFTT  345 (346)
Q Consensus       330 ~~d~~l~~~p~~R~~~  345 (346)
                      ++.+||..+|.+|+++
T Consensus       240 li~~~l~~~p~~R~~~  255 (267)
T PHA03390        240 FVQSMLKYNINYRLTN  255 (267)
T ss_pred             HHHHHhccChhhCCch
Confidence            9999999999999964

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=2.7e-36  Score=262.97  Aligned_cols=236  Identities=26%  Similarity=0.362  Sum_probs=197.9

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCc--hhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEec
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYE--GAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEY  180 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  180 (346)
                      +|.+.+.||.|++|.||++... ++..+++|++.....  ...+.+..|++.+++++|||++++.+.+...+..++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            3677889999999999999976 689999999875432  4567788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhc---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccc
Q 039799          181 MPHGSLEKCLYLS---NYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  257 (346)
Q Consensus       181 ~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~  257 (346)
                      +++++|.+++...   ...+++..+..++.+++.|+.|||   +.+++|+||+|+||++++++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            9999999988765   367899999999999999999999   8999999999999999999999999999998654332


Q ss_pred             cccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh-------hhcCCChhhh
Q 039799          258 QSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN-------DLLPISVMEV  330 (346)
Q Consensus       258 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~-------~~~~~~~~~~  330 (346)
                        .......+++.|+|||...+..++.++|+||+|+++++|++|+.||+...... .......       ..++..+.++
T Consensus       158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  234 (258)
T cd08215         158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE-LALKILKGQYPPIPSQYSSELRNL  234 (258)
T ss_pred             --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH-HHHHHhcCCCCCCCCCCCHHHHHH
Confidence              12233457889999999888889999999999999999999999986532111 1111111       1344578999


Q ss_pred             hchhccCCccccccc
Q 039799          331 VDANLLSQEDEHFTT  345 (346)
Q Consensus       331 ~d~~l~~~p~~R~~~  345 (346)
                      +.+||..+|++||++
T Consensus       235 i~~~l~~~p~~Rp~~  249 (258)
T cd08215         235 VSSLLQKDPEERPSI  249 (258)
T ss_pred             HHHHcCCChhhCcCH
Confidence            999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-38  Score=286.55  Aligned_cols=231  Identities=27%  Similarity=0.314  Sum_probs=193.9

Q ss_pred             CCCCCcccccCceEEEEEEEc-CCCEEEEEEecC---CCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEec
Q 039799          105 ANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDP---QYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEY  180 (346)
Q Consensus       105 ~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  180 (346)
                      |.-.+.||.|+||.||.|... +.+.||||.+.-   .....++.+..|++.|.+++|||++.+-|+|......+|||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            566678999999999999854 788999999863   3344568899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccc
Q 039799          181 MPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  260 (346)
Q Consensus       181 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~  260 (346)
                      | -||-.+++....+.+....+..|..+.+.||+|||   +.+.||||||+.|||+++.|.+||+|||.|....+     
T Consensus       108 C-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-----  178 (948)
T KOG0577|consen  108 C-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP-----  178 (948)
T ss_pred             H-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCc-----
Confidence            9 56888888777778888888999999999999999   99999999999999999999999999999987644     


Q ss_pred             ccccccCCcccccCCCCC---CCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcc-------cHHHHHhhhcCCChhhh
Q 039799          261 TQTQTLATIGYMAPEYGR---EGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM-------TLKRWVNDLLPISVMEV  330 (346)
Q Consensus       261 ~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~-------~~~~~~~~~~~~~~~~~  330 (346)
                       ....+|||.|||||++.   .+.|+-|+||||+|++..|+.-+++|.-.+-....       +........|++.+..+
T Consensus       179 -AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~F  257 (948)
T KOG0577|consen  179 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNF  257 (948)
T ss_pred             -hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHH
Confidence             34567999999999764   56799999999999999999999999643211110       00111123344477899


Q ss_pred             hchhccCCccccccc
Q 039799          331 VDANLLSQEDEHFTT  345 (346)
Q Consensus       331 ~d~~l~~~p~~R~~~  345 (346)
                      +|.||..=|.+|||+
T Consensus       258 vd~CLqKipqeRpts  272 (948)
T KOG0577|consen  258 VDSCLQKIPQERPTS  272 (948)
T ss_pred             HHHHHhhCcccCCcH
Confidence            999999999999985

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-37  Score=270.77  Aligned_cols=234  Identities=27%  Similarity=0.435  Sum_probs=184.1

Q ss_pred             CCCCcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHh--cCCCCceeeEEEEecCC----ceeEEEe
Q 039799          106 NMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKR--ICHRNLIKIISSYSNDD----FKALVLE  179 (346)
Q Consensus       106 ~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~----~~~lv~e  179 (346)
                      .+.+.||+|.||+||+|.|+ |+.||||+|....+   +.+.+|.++.+.  ++|+||+.+++.-..+.    +++||++
T Consensus       214 ~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTd  289 (513)
T KOG2052|consen  214 VLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTD  289 (513)
T ss_pred             EEEEEecCccccceeecccc-CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeee
Confidence            44567999999999999999 89999999986544   445567777665  59999999998765443    7889999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhc-----CCCCCeeecCCCCCceEECCCCcEEEeeecCCccCC
Q 039799          180 YMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHF-----GYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  254 (346)
Q Consensus       180 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~-----~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~  254 (346)
                      |.++|||.|+|..  ..++....++++..+|.||++||.     ..++.|.|||||+.|||+..++.+.|+|+|+|....
T Consensus       290 YHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~  367 (513)
T KOG2052|consen  290 YHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD  367 (513)
T ss_pred             cccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEec
Confidence            9999999999964  568889999999999999999994     347889999999999999999999999999999765


Q ss_pred             ccc--cccccccccCCcccccCCCCCCCC------CCcchhHHHHHHHHHHHHcC----------CCCCCccccCcccHH
Q 039799          255 EED--QSLTQTQTLATIGYMAPEYGREGR------VSTNGDVYSFGIMLMEIFTR----------TKPTDEIFSGEMTLK  316 (346)
Q Consensus       255 ~~~--~~~~~~~~~~~~~y~aPE~~~~~~------~~~~~Dv~s~G~il~elltg----------~~p~~~~~~~~~~~~  316 (346)
                      ...  -....+..+||-+|||||++...-      .-..+||||||.++||+.-+          +.||.+..+.+-...
T Consensus       368 ~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~e  447 (513)
T KOG2052|consen  368 SDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFE  447 (513)
T ss_pred             ccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHH
Confidence            442  233445678999999999876432      23468999999999998752          467776554433222


Q ss_pred             HH--------HhhhcCC---------ChhhhhchhccCCccccccc
Q 039799          317 RW--------VNDLLPI---------SVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       317 ~~--------~~~~~~~---------~~~~~~d~~l~~~p~~R~~~  345 (346)
                      +.        .+..+|.         .+.+++..|+..+|.-|.|+
T Consensus       448 eMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltA  493 (513)
T KOG2052|consen  448 EMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTA  493 (513)
T ss_pred             HHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHH
Confidence            11        1222222         56789999999999999875

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=4.2e-36  Score=269.89  Aligned_cols=231  Identities=27%  Similarity=0.297  Sum_probs=188.0

Q ss_pred             CCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEec
Q 039799          105 ANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEY  180 (346)
Q Consensus       105 ~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  180 (346)
                      |...+.||+|++|.||+|+.. +++.+++|++....   ....+.+..|+++++.++|||++++.+++.+.+..++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            566677999999999999865 68899999986432   23345678899999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccc
Q 039799          181 MPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  260 (346)
Q Consensus       181 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~  260 (346)
                      +. +++.+.+......+++..+..++.+++.+++|||   +.+++|+||+|+||+++.++.++|+|||++.....     
T Consensus       103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-----  173 (313)
T cd06633         103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-----  173 (313)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccCC-----
Confidence            95 5787777666667899999999999999999999   99999999999999999999999999999874321     


Q ss_pred             ccccccCCcccccCCCCC---CCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcc-------cHHHHHhhhcCCChhhh
Q 039799          261 TQTQTLATIGYMAPEYGR---EGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM-------TLKRWVNDLLPISVMEV  330 (346)
Q Consensus       261 ~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~-------~~~~~~~~~~~~~~~~~  330 (346)
                       .....++..|+|||++.   ...++.++||||||+++|||++|..|+........       .........++..+.++
T Consensus       174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  252 (313)
T cd06633         174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGF  252 (313)
T ss_pred             -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHH
Confidence             12345788999999874   45678899999999999999999999865321110       00111112233468899


Q ss_pred             hchhccCCccccccc
Q 039799          331 VDANLLSQEDEHFTT  345 (346)
Q Consensus       331 ~d~~l~~~p~~R~~~  345 (346)
                      +.+||..+|++||++
T Consensus       253 i~~~l~~~P~~Rp~~  267 (313)
T cd06633         253 VDYCLQKIPQERPAS  267 (313)
T ss_pred             HHHHccCChhhCcCH
Confidence            999999999999985

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=2.5e-36  Score=269.02  Aligned_cols=236  Identities=21%  Similarity=0.261  Sum_probs=186.2

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHHhcC-CCCceeeEEEEecCCc-----e
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRIC-HRNLIKIISSYSNDDF-----K  174 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~-----~  174 (346)
                      +|++.+.||+|++|.||+|... +++.||+|.+....  ......+.+|+.++++++ |||++++++++...+.     .
T Consensus         2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~   81 (295)
T cd07837           2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL   81 (295)
T ss_pred             CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence            5788899999999999999976 78999999876432  223456788999999995 6999999998877665     8


Q ss_pred             eEEEecCCCCChhhhhhhcC----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC-CCcEEEeeecC
Q 039799          175 ALVLEYMPHGSLEKCLYLSN----YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD-NMVAHLSDFGM  249 (346)
Q Consensus       175 ~lv~e~~~~gsL~~~l~~~~----~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~-~~~~~l~Dfg~  249 (346)
                      ++||||+++ +|.+++....    ..+++...+.++.|++.||+|||   +.+++||||+|+||+++. ++.++|+|||+
T Consensus        82 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg~  157 (295)
T cd07837          82 YLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGL  157 (295)
T ss_pred             EEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeeccc
Confidence            999999986 7888775432    35799999999999999999999   999999999999999998 88999999999


Q ss_pred             CccCCccccccccccccCCcccccCCCCCC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccCcc---------------
Q 039799          250 AKPLLEEDQSLTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM---------------  313 (346)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~---------------  313 (346)
                      +..+.....  ......+++.|+|||.+.+ ..++.++|+||||+++|||++|..||........               
T Consensus       158 ~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (295)
T cd07837         158 GRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQV  235 (295)
T ss_pred             ceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence            986533211  1122346888999998755 4578999999999999999999999864211000               


Q ss_pred             -----cHH-------------HHHhhhcCCChhhhhchhccCCccccccc
Q 039799          314 -----TLK-------------RWVNDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       314 -----~~~-------------~~~~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                           ...             ......++..+.+++.+||..+|.+||+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~  285 (295)
T cd07837         236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISA  285 (295)
T ss_pred             CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCH
Confidence                 000             00012245578899999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=5.1e-36  Score=266.65  Aligned_cols=230  Identities=25%  Similarity=0.319  Sum_probs=190.6

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecCCCCC
Q 039799          107 MPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGS  185 (346)
Q Consensus       107 ~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  185 (346)
                      ....||+|++|.||++..+ +++.+|+|.+..........+.+|+.+++.++|+|++++++++...+..+++|||+++++
T Consensus        24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  103 (292)
T cd06657          24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA  103 (292)
T ss_pred             hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence            3457999999999999875 789999999865555556778899999999999999999999999999999999999999


Q ss_pred             hhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccccccc
Q 039799          186 LEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT  265 (346)
Q Consensus       186 L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~  265 (346)
                      |.+++..  ..+++.....++.+++.+++|||   +.+++||||+|+||++++++.++|+|||++........  .....
T Consensus       104 L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~  176 (292)
T cd06657         104 LTDIVTH--TRMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSL  176 (292)
T ss_pred             HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceecccccc--ccccc
Confidence            9987643  35788999999999999999999   99999999999999999999999999999876543221  12234


Q ss_pred             cCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHhh----------hcCCChhhhhchhc
Q 039799          266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVND----------LLPISVMEVVDANL  335 (346)
Q Consensus       266 ~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~----------~~~~~~~~~~d~~l  335 (346)
                      .++..|+|||...+..++.++|+||+|+++|||++|+.||.....  ......+..          .++..+.+++++||
T Consensus       177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  254 (292)
T cd06657         177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLL  254 (292)
T ss_pred             ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhhCCcccCCcccCCHHHHHHHHHHH
Confidence            578999999998888889999999999999999999999864211  111111111          12346789999999


Q ss_pred             cCCccccccc
Q 039799          336 LSQEDEHFTT  345 (346)
Q Consensus       336 ~~~p~~R~~~  345 (346)
                      ..+|.+||+.
T Consensus       255 ~~~P~~R~~~  264 (292)
T cd06657         255 VRDPAQRATA  264 (292)
T ss_pred             hCCcccCcCH
Confidence            9999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=3.3e-36  Score=269.08  Aligned_cols=239  Identities=26%  Similarity=0.336  Sum_probs=190.0

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEecCC------
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSNDD------  172 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  172 (346)
                      .++|.+.+.||+|++|.||+|..+ +|+.+|+|++....  ......+.+|++++++++|||++++++++.+..      
T Consensus         6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~   85 (302)
T cd07864           6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK   85 (302)
T ss_pred             hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence            367889999999999999999976 68899999986432  223356678999999999999999999887654      


Q ss_pred             ----ceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeec
Q 039799          173 ----FKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFG  248 (346)
Q Consensus       173 ----~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg  248 (346)
                          ..++|+||+++ ++.+.+......+++..+..++.+++.||+|||   +.+|+|+||+|+||++++++.++|+|||
T Consensus        86 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl~dfg  161 (302)
T cd07864          86 KDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFG  161 (302)
T ss_pred             ccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEeCccc
Confidence                78999999976 677766655567899999999999999999999   9999999999999999999999999999


Q ss_pred             CCccCCccccccccccccCCcccccCCCCCC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccCc-----------c---
Q 039799          249 MAKPLLEEDQSLTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE-----------M---  313 (346)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~-----------~---  313 (346)
                      ++........ .......++..|+|||...+ ..++.++||||||++++||++|+.||......+           .   
T Consensus       162 ~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (302)
T cd07864         162 LARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA  240 (302)
T ss_pred             ccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence            9987643321 11222346778999997754 356889999999999999999999996421100           0   


Q ss_pred             ------------------cHHHH---HhhhcCCChhhhhchhccCCccccccc
Q 039799          314 ------------------TLKRW---VNDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       314 ------------------~~~~~---~~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                                        ...++   ....++..+.+++++||..+|.+||+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~  293 (302)
T cd07864         241 VWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTA  293 (302)
T ss_pred             hcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCH
Confidence                              00001   111245688999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=3e-36  Score=268.75  Aligned_cols=237  Identities=26%  Similarity=0.311  Sum_probs=188.7

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHHhcC-CCCceeeEEEEecCCceeEEE
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRIC-HRNLIKIISSYSNDDFKALVL  178 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~  178 (346)
                      -++|.+.+.||+|++|.||+|.+. +++.+|+|.+.... ......+..|+.++.+.. ||||+++++++......+++|
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            356889999999999999999987 48999999987542 233455666777676664 999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeeecCCCCCceEECCCCcEEEeeecCCccCCccc
Q 039799          179 EYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYS-APIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  257 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~  257 (346)
                      ||+. +++.+........+++..+..++.+++.|++|||   + .+++||||+|+||++++++.++|+|||++..+....
T Consensus        94 e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~  169 (296)
T cd06618          94 ELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLK---EKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK  169 (296)
T ss_pred             eccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence            9985 4777776655567899999999999999999999   6 589999999999999999999999999988653322


Q ss_pred             cccccccccCCcccccCCCCCCCC----CCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHhh---------hcC
Q 039799          258 QSLTQTQTLATIGYMAPEYGREGR----VSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVND---------LLP  324 (346)
Q Consensus       258 ~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~---------~~~  324 (346)
                      .   .....++..|+|||.+.+..    ++.++||||||+++|||++|+.||.........+......         .++
T Consensus       170 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (296)
T cd06618         170 A---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFS  246 (296)
T ss_pred             c---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCC
Confidence            1   12334778999999886553    7889999999999999999999996522211111121111         123


Q ss_pred             CChhhhhchhccCCccccccc
Q 039799          325 ISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       325 ~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ..+.+++.+||..+|++||+.
T Consensus       247 ~~l~~li~~~l~~~p~~Rp~~  267 (296)
T cd06618         247 PDFCSFVDLCLTKDHRKRPKY  267 (296)
T ss_pred             HHHHHHHHHHccCChhhCCCH
Confidence            467899999999999999985

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.3e-36  Score=265.26  Aligned_cols=235  Identities=21%  Similarity=0.334  Sum_probs=192.1

Q ss_pred             CCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecC
Q 039799          105 ANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYM  181 (346)
Q Consensus       105 ~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  181 (346)
                      |.+.+.||+|++|.||++... +|..+|+|.+....  ....+.+.+|++++++++|+|++++++.+...+..++|+||+
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   81 (257)
T cd08225           2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYC   81 (257)
T ss_pred             ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecC
Confidence            667789999999999999976 68899999986431  223456778999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCC-cEEEeeecCCccCCccccc
Q 039799          182 PHGSLEKCLYLSN-YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM-VAHLSDFGMAKPLLEEDQS  259 (346)
Q Consensus       182 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~-~~~l~Dfg~~~~~~~~~~~  259 (346)
                      ++++|.+++.... ..+++..+..++.++++|++|||   +.+++|+||+|+||++++++ .++++|||.+........ 
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~-  157 (257)
T cd08225          82 DGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME-  157 (257)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc-
Confidence            9999999886543 45799999999999999999999   99999999999999999875 569999999986643221 


Q ss_pred             cccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH-------hhhcCCChhhhhc
Q 039799          260 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV-------NDLLPISVMEVVD  332 (346)
Q Consensus       260 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~d  332 (346)
                       ......++..|+|||+..+..++.++|+||||++++|+++|..||....... ...+..       ...++..+.+++.
T Consensus       158 -~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~  235 (257)
T cd08225         158 -LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ-LVLKICQGYFAPISPNFSRDLRSLIS  235 (257)
T ss_pred             -cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH-HHHHHhcccCCCCCCCCCHHHHHHHH
Confidence             1122357889999999888889999999999999999999999986532111 111111       1122347899999


Q ss_pred             hhccCCccccccc
Q 039799          333 ANLLSQEDEHFTT  345 (346)
Q Consensus       333 ~~l~~~p~~R~~~  345 (346)
                      +|+..+|++||+.
T Consensus       236 ~~l~~~p~~Rpt~  248 (257)
T cd08225         236 QLFKVSPRDRPSI  248 (257)
T ss_pred             HHhccChhhCcCH
Confidence            9999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=8e-36  Score=263.60  Aligned_cols=226  Identities=22%  Similarity=0.323  Sum_probs=179.1

Q ss_pred             cccccCceEEEEEEEc-CCCEEEEEEecCCCc---hhHHHHHHHH---HHHHhcCCCCceeeEEEEecCCceeEEEecCC
Q 039799          110 LIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYE---GAFKSFDIEC---DVMKRICHRNLIKIISSYSNDDFKALVLEYMP  182 (346)
Q Consensus       110 ~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~---~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  182 (346)
                      +||+|+||.||++... +++.||+|.+.....   .....+..|.   +.++...||+++++.+++...+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999865 688999999865321   1112233343   34445679999999999999999999999999


Q ss_pred             CCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccccc
Q 039799          183 HGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ  262 (346)
Q Consensus       183 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~  262 (346)
                      +++|.+++.. ...+++..+..++.++++|+.|||   +.+++||||+|+||++++++.++|+|||++.......    .
T Consensus        81 g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----~  152 (278)
T cd05606          81 GGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----P  152 (278)
T ss_pred             CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----C
Confidence            9999988753 456899999999999999999999   9999999999999999999999999999987653221    2


Q ss_pred             ccccCCcccccCCCCCCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH--------hhhcCCChhhhhch
Q 039799          263 TQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV--------NDLLPISVMEVVDA  333 (346)
Q Consensus       263 ~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~~d~  333 (346)
                      ....|+..|+|||...++ .++.++||||+|++++||++|+.||..............        ...++..+.+++++
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  232 (278)
T cd05606         153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEG  232 (278)
T ss_pred             cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHH
Confidence            234689999999998754 588999999999999999999999976422111111111        11234478899999


Q ss_pred             hccCCccccc
Q 039799          334 NLLSQEDEHF  343 (346)
Q Consensus       334 ~l~~~p~~R~  343 (346)
                      ||..+|.+||
T Consensus       233 ~l~~~p~~R~  242 (278)
T cd05606         233 LLQRDVNRRL  242 (278)
T ss_pred             HhhcCHHhcc
Confidence            9999999999

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=3.6e-36  Score=267.96  Aligned_cols=237  Identities=24%  Similarity=0.312  Sum_probs=186.1

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEe
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLE  179 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  179 (346)
                      ++|.+.+.||+|++|.||+|... +++.+|+|.+....  ....+.+.+|++++++++|||++++++++...+..++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            45788899999999999999976 78999999886432  2334567889999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC-CCcEEEeeecCCccCCccc
Q 039799          180 YMPHGSLEKCLYLSN-YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD-NMVAHLSDFGMAKPLLEED  257 (346)
Q Consensus       180 ~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~-~~~~~l~Dfg~~~~~~~~~  257 (346)
                      |++ ++|.+.+.... ...++.....++.+++.||+|||   +.+++|+||+|+||+++. ++.++|+|||++.......
T Consensus        82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence            996 57777664433 34678888899999999999999   999999999999999985 5679999999997643221


Q ss_pred             cccccccccCCcccccCCCCCCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccCcc--------------------cHH
Q 039799          258 QSLTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM--------------------TLK  316 (346)
Q Consensus       258 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~--------------------~~~  316 (346)
                        .......++..|+|||++.+. .++.++||||+|+++|+|+||+.||......+.                    .+.
T Consensus       158 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (294)
T PLN00009        158 --RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLP  235 (294)
T ss_pred             --cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccch
Confidence              112233568899999987654 578899999999999999999999964211100                    000


Q ss_pred             HH--------------HhhhcCCChhhhhchhccCCccccccc
Q 039799          317 RW--------------VNDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       317 ~~--------------~~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      .+              ....++..+.+++.+||..+|++||+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~  278 (294)
T PLN00009        236 DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITA  278 (294)
T ss_pred             hhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCH
Confidence            00              011234467899999999999999985

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=6.4e-36  Score=268.11  Aligned_cols=239  Identities=23%  Similarity=0.311  Sum_probs=186.6

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEecCC-------
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSNDD-------  172 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-------  172 (346)
                      ++|.+.+.||+|++|.||+|... +++.+|+|.+....  ......+.+|++++++++|||++++++++....       
T Consensus        12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   91 (310)
T cd07865          12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK   91 (310)
T ss_pred             hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence            46888999999999999999876 78999999885432  222345567999999999999999999886544       


Q ss_pred             -ceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCc
Q 039799          173 -FKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAK  251 (346)
Q Consensus       173 -~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~  251 (346)
                       ..++||||+.+ +|.+.+......+++...+.++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||++.
T Consensus        92 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~  167 (310)
T cd07865          92 GSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLAR  167 (310)
T ss_pred             ceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence             45899999964 888877666567899999999999999999999   8999999999999999999999999999998


Q ss_pred             cCCccccc--cccccccCCcccccCCCCCCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccCc----------------
Q 039799          252 PLLEEDQS--LTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE----------------  312 (346)
Q Consensus       252 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~----------------  312 (346)
                      .+......  .......++..|+|||.+.+. .++.++||||||++++||+||+.||.......                
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (310)
T cd07865         168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEV  247 (310)
T ss_pred             cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence            76432211  122334578889999987654 36889999999999999999999985421100                


Q ss_pred             ----c------------cHHHHHhhhc-----CCChhhhhchhccCCccccccc
Q 039799          313 ----M------------TLKRWVNDLL-----PISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       313 ----~------------~~~~~~~~~~-----~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                          .            .........+     ...+.+++.+||..+|.+||++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~  301 (310)
T cd07865         248 WPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDA  301 (310)
T ss_pred             cccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCH
Confidence                0            0000111111     1245689999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.8e-37  Score=274.15  Aligned_cols=237  Identities=22%  Similarity=0.346  Sum_probs=195.3

Q ss_pred             CCCCCCcccccCceEEEEEEEcCCCEEEEEEec--CCCchhHHHHHHHHHHHHhc-CCCCceeeEEEEecCCceeEEEec
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFD--PQYEGAFKSFDIECDVMKRI-CHRNLIKIISSYSNDDFKALVLEY  180 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~  180 (346)
                      .|++.+.||+|+.+.||++.-.+.+.+|+|+..  .........|.+|+..|.++ .|.+|+.+++|-..++++||||||
T Consensus       362 ~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~  441 (677)
T KOG0596|consen  362 EYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMEC  441 (677)
T ss_pred             hhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeec
Confidence            588899999999999999998888889988764  33456678899999999999 499999999999999999999998


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccc
Q 039799          181 MPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  260 (346)
Q Consensus       181 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~  260 (346)
                      = ..+|..+|......++...+..+..|++.++.++|   ..+|||.||||.|+|+-. |.+||+|||.|..+..+....
T Consensus       442 G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTTsI  516 (677)
T KOG0596|consen  442 G-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTTSI  516 (677)
T ss_pred             c-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEEe-eeEEeeeechhcccCccccce
Confidence            6 55999999877665553367789999999999999   999999999999999854 799999999999998887777


Q ss_pred             ccccccCCcccccCCCCCCC-----------CCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHhh----hc--
Q 039799          261 TQTQTLATIGYMAPEYGREG-----------RVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVND----LL--  323 (346)
Q Consensus       261 ~~~~~~~~~~y~aPE~~~~~-----------~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~----~~--  323 (346)
                      .....+||+.||+||.+...           +.+.++||||+|||||+|+-|+.||......-..+......    .+  
T Consensus       517 ~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~  596 (677)
T KOG0596|consen  517 VKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFPD  596 (677)
T ss_pred             eeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccccC
Confidence            77788999999999976532           25688999999999999999999997632111111111111    11  


Q ss_pred             -CC--ChhhhhchhccCCccccccc
Q 039799          324 -PI--SVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       324 -~~--~~~~~~d~~l~~~p~~R~~~  345 (346)
                       ++  .+.+++..||..||++||+.
T Consensus       597 ~~~~~~li~~mK~CL~rdPkkR~si  621 (677)
T KOG0596|consen  597 IPENDELIDVMKCCLARDPKKRWSI  621 (677)
T ss_pred             CCCchHHHHHHHHHHhcCcccCCCc
Confidence             22  37899999999999999985

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=4.3e-36  Score=272.64  Aligned_cols=237  Identities=27%  Similarity=0.352  Sum_probs=187.6

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC--CchhHHHHHHHHHHHHhc-CCCCceeeEEEEecC--Ccee
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ--YEGAFKSFDIECDVMKRI-CHRNLIKIISSYSND--DFKA  175 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~--~~~~  175 (346)
                      .++|.+.+.||+|++|.||+|... +++.+|+|++...  .......+..|+.+++++ +||||+++++++...  ...+
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   85 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY   85 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence            456888999999999999999976 6889999988542  223345677899999999 999999999988653  3679


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCc
Q 039799          176 LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  255 (346)
Q Consensus       176 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~  255 (346)
                      +||||++ ++|.+++...  .+++..+..++.+++.||+|||   +.+|+||||+|+||+++.++.++|+|||++.....
T Consensus        86 lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~  159 (337)
T cd07852          86 LVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSE  159 (337)
T ss_pred             EEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence            9999997 5898877543  6788999999999999999999   99999999999999999999999999999987643


Q ss_pred             cccc---cccccccCCcccccCCCCCC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccCcc------------------
Q 039799          256 EDQS---LTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM------------------  313 (346)
Q Consensus       256 ~~~~---~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~------------------  313 (346)
                      ....   .......++..|+|||.+.+ ..++.++||||||+++|||+||+.||......+.                  
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (337)
T cd07852         160 LEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIES  239 (337)
T ss_pred             ccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            3221   12223457889999997754 4578899999999999999999999864211100                  


Q ss_pred             -------------------cHHHHHhhhcCCChhhhhchhccCCccccccc
Q 039799          314 -------------------TLKRWVNDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       314 -------------------~~~~~~~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                                         ...... ...+..+.+++.+||..+|++||+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~~P~~Rps~  289 (337)
T cd07852         240 IKSPFAATMLDSLPSRPRKPLDELL-PKASDDALDLLKKLLVFNPNKRLTA  289 (337)
T ss_pred             HHhhhHHHhhhhcccccccchhhhc-cCCCHHHHHHHHHhccCCcccccCH
Confidence                               000000 1134467899999999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=6.1e-36  Score=273.30  Aligned_cols=196  Identities=27%  Similarity=0.306  Sum_probs=166.3

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC--CchhHHHHHHHHHHHHhcCCCCceeeEEEEecC------C
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ--YEGAFKSFDIECDVMKRICHRNLIKIISSYSND------D  172 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~  172 (346)
                      ..+|...+.||+|++|.||+|... +++.+|+|++...  .....+.+.+|+.++++++|||++++++++...      .
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   94 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ   94 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence            367889999999999999999865 7899999998643  233445677899999999999999999988643      3


Q ss_pred             ceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCcc
Q 039799          173 FKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  252 (346)
Q Consensus       173 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~  252 (346)
                      ..++||||+. ++|.+.+...   ++......++.|++.||+|||   +.+++||||||+||+++.++.++|+|||+++.
T Consensus        95 ~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~  167 (353)
T cd07850          95 DVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART  167 (353)
T ss_pred             cEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCcccee
Confidence            5689999995 4787766532   788889999999999999999   99999999999999999999999999999986


Q ss_pred             CCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 039799          253 LLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDE  307 (346)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~  307 (346)
                      .....   ......++..|+|||.+.+..++.++||||||+++++|++|+.||..
T Consensus       168 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~  219 (353)
T cd07850         168 AGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPG  219 (353)
T ss_pred             CCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCC
Confidence            53321   12234578899999999988999999999999999999999999864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.6e-35  Score=263.24  Aligned_cols=234  Identities=23%  Similarity=0.306  Sum_probs=187.9

Q ss_pred             CCCCCcccccCceEEEEEEE----cCCCEEEEEEecCCC----chhHHHHHHHHHHHHhc-CCCCceeeEEEEecCCcee
Q 039799          105 ANMPPLIGKGGFGSVYKAII----QDGMEVAVKVFDPQY----EGAFKSFDIECDVMKRI-CHRNLIKIISSYSNDDFKA  175 (346)
Q Consensus       105 ~~~~~~lg~G~~g~vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  175 (346)
                      |.+.+.||+|+||.||++..    .+|..||+|++....    ....+.+..|++++.++ +|+||+++.+.+..+...+
T Consensus         2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (290)
T cd05613           2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH   81 (290)
T ss_pred             ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence            67788999999999999985    368899999986432    22346678899999999 5999999999999999999


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCc
Q 039799          176 LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  255 (346)
Q Consensus       176 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~  255 (346)
                      +|+||+++++|.+++... ..+++.....++.++++||.|||   +.+++||||+|+||++++++.++|+|||++.....
T Consensus        82 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  157 (290)
T cd05613          82 LILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE  157 (290)
T ss_pred             EEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence            999999999999988643 45788888889999999999999   99999999999999999999999999999986543


Q ss_pred             cccccccccccCCcccccCCCCCCC--CCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHhh----------hc
Q 039799          256 EDQSLTQTQTLATIGYMAPEYGREG--RVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVND----------LL  323 (346)
Q Consensus       256 ~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~----------~~  323 (346)
                      ... .......++..|+|||.....  .++.++||||||+++|+|++|..||..... ..........          .+
T Consensus       158 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  235 (290)
T cd05613         158 DEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE-KNSQAEISRRILKSEPPYPQEM  235 (290)
T ss_pred             ccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc-cccHHHHHHHhhccCCCCCccC
Confidence            221 112234588899999988653  467899999999999999999999964211 1111111111          12


Q ss_pred             CCChhhhhchhccCCcccccc
Q 039799          324 PISVMEVVDANLLSQEDEHFT  344 (346)
Q Consensus       324 ~~~~~~~~d~~l~~~p~~R~~  344 (346)
                      +..+.+++.+|+..+|++|++
T Consensus       236 ~~~~~~ll~~~l~~~p~~R~~  256 (290)
T cd05613         236 SALAKDIIQRLLMKDPKKRLG  256 (290)
T ss_pred             CHHHHHHHHHHhcCCHHHhcC
Confidence            335789999999999999984

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.3e-36  Score=287.13  Aligned_cols=241  Identities=19%  Similarity=0.204  Sum_probs=178.9

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEcC--CCEEEEEEec-----------------CCCchhHHHHHHHHHHHHhcCCCCc
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQD--GMEVAVKVFD-----------------PQYEGAFKSFDIECDVMKRICHRNL  161 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~~--~~~vavK~~~-----------------~~~~~~~~~~~~e~~~l~~l~h~ni  161 (346)
                      ...+|.+.+.||+|+||+||++.++.  +...+.|...                 .........+.+|++++++++||||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            34679999999999999999987542  2222222110                 0112234567889999999999999


Q ss_pred             eeeEEEEecCCceeEEEecCCCCChhhhhhhcC----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEEC
Q 039799          162 IKIISSYSNDDFKALVLEYMPHGSLEKCLYLSN----YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD  237 (346)
Q Consensus       162 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~  237 (346)
                      +++++++...+..++|++++. ++|.+++....    ..........++.|++.||+|||   +.+|+||||||+|||++
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl~  301 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLN  301 (501)
T ss_pred             CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEC
Confidence            999999999999999999985 56666654322    22335566789999999999999   99999999999999999


Q ss_pred             CCCcEEEeeecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCC-CCCccccCc-c--
Q 039799          238 DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTK-PTDEIFSGE-M--  313 (346)
Q Consensus       238 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~-p~~~~~~~~-~--  313 (346)
                      .++.+||+|||+++.+..... .......||..|+|||++.+..++.++|||||||++|||++|.. |+....... .  
T Consensus       302 ~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~  380 (501)
T PHA03210        302 CDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL  380 (501)
T ss_pred             CCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence            999999999999987643221 12234568999999999999999999999999999999999875 443211100 0  


Q ss_pred             -------------------cHHHHH----------------h-hhcCCChhhhhchhccCCcccccccC
Q 039799          314 -------------------TLKRWV----------------N-DLLPISVMEVVDANLLSQEDEHFTTK  346 (346)
Q Consensus       314 -------------------~~~~~~----------------~-~~~~~~~~~~~d~~l~~~p~~R~~~k  346 (346)
                                         .+.+++                . ..++..+.+++.+||..||++||+++
T Consensus       381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~  449 (501)
T PHA03210        381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAA  449 (501)
T ss_pred             HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHH
Confidence                               001111                1 11233567789999999999999863

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-36  Score=264.82  Aligned_cols=235  Identities=26%  Similarity=0.300  Sum_probs=192.5

Q ss_pred             CCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCc--hhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecC
Q 039799          105 ANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYE--GAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYM  181 (346)
Q Consensus       105 ~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  181 (346)
                      |.+.+.||+|++|.||++... +++.+++|.+.....  .....+..|++++++++|+|++++++++...+..++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            566788999999999999875 789999999875432  34567888999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccc
Q 039799          182 PHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT  261 (346)
Q Consensus       182 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~  261 (346)
                      ++ ++.+.+......+++..+..++.+++.||.|||   +.+++|+||+|+||++++++.++|+|||.+.......  ..
T Consensus        81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~  154 (283)
T cd05118          81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RP  154 (283)
T ss_pred             CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--cc
Confidence            75 888887766667899999999999999999999   9999999999999999999999999999998764432  11


Q ss_pred             cccccCCcccccCCCCCCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccCcc--------------cH-----------
Q 039799          262 QTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM--------------TL-----------  315 (346)
Q Consensus       262 ~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~--------------~~-----------  315 (346)
                      .....++..|+|||...+. .++.++|+||+|+++++|+||+.||......+.              ..           
T Consensus       155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd05118         155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK  234 (283)
T ss_pred             ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence            2234578889999988766 789999999999999999999999854221000              00           


Q ss_pred             ----------HHHHhhhcCCChhhhhchhccCCccccccc
Q 039799          316 ----------KRWVNDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       316 ----------~~~~~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                                ..-+...++..+.+++.+||..||.+||+.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~  274 (283)
T cd05118         235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITA  274 (283)
T ss_pred             hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCH
Confidence                      001112345578899999999999999985

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=2.2e-36  Score=268.49  Aligned_cols=235  Identities=29%  Similarity=0.346  Sum_probs=185.2

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHHhcC-CCCceeeEEEEecCCceeEEEec
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRIC-HRNLIKIISSYSNDDFKALVLEY  180 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~  180 (346)
                      +|.....||+|+||.||++... +++.+|+|.+.... ......+.+|+.++.++. |+||+++++++...+..+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            4566778999999999999866 68999999986443 234567888999999996 99999999999988899999999


Q ss_pred             CCCCChhhhh---hh-cCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeeecCCCCCceEECCCCcEEEeeecCCccCCc
Q 039799          181 MPHGSLEKCL---YL-SNYILDIFQRLDIMIDVASALEYLHFGYS-APIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  255 (346)
Q Consensus       181 ~~~gsL~~~l---~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~  255 (346)
                      +.. ++.++.   .. ....+++.....++.+++.||+|||   + .+++||||||+||+++.++.++|+|||++..+..
T Consensus        85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  160 (288)
T cd06616          85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLK---EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD  160 (288)
T ss_pred             ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence            864 554432   22 2356899999999999999999999   5 5899999999999999999999999999986533


Q ss_pred             cccccccccccCCcccccCCCCCCC---CCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH-----------hh
Q 039799          256 EDQSLTQTQTLATIGYMAPEYGREG---RVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV-----------ND  321 (346)
Q Consensus       256 ~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~-----------~~  321 (346)
                      ..   ......++..|+|||.+.+.   .++.++||||||+++|||++|+.||...........+..           ..
T Consensus       161 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd06616         161 SI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEER  237 (288)
T ss_pred             CC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCC
Confidence            21   11233578899999988765   688999999999999999999999865321000111111           01


Q ss_pred             hcCCChhhhhchhccCCccccccc
Q 039799          322 LLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       322 ~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      .++..+.+++.+|+..+|++||+.
T Consensus       238 ~~~~~l~~li~~~l~~~p~~Rpt~  261 (288)
T cd06616         238 EFSPSFVNFINLCLIKDESKRPKY  261 (288)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCH
Confidence            133467899999999999999985

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-36  Score=276.06  Aligned_cols=236  Identities=26%  Similarity=0.329  Sum_probs=198.4

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEe
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLE  179 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  179 (346)
                      ..|.+.+.||+|.|+.|.+|++. ++..||+|.+++..  ....+.+.+|++++..+.|||||+++.+......+|+|||
T Consensus        56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~e  135 (596)
T KOG0586|consen   56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVME  135 (596)
T ss_pred             cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEE
Confidence            45889999999999999999866 79999999998653  3334568899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccc
Q 039799          180 YMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  259 (346)
Q Consensus       180 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~  259 (346)
                      |..+|.+.+++......-+ .....++.|+.++++|||   ++.|+|||||++||||+.+.++||+|||++.++....  
T Consensus       136 ya~~ge~~~yl~~~gr~~e-~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~--  209 (596)
T KOG0586|consen  136 YASGGELFDYLVKHGRMKE-KEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGL--  209 (596)
T ss_pred             eccCchhHHHHHhcccchh-hhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeecccc--
Confidence            9999999999976554444 777889999999999999   9999999999999999999999999999999875432  


Q ss_pred             cccccccCCcccccCCCCCCCCC-CcchhHHHHHHHHHHHHcCCCCCCccccCcc-----cHHHHHhhhcCCChhhhhch
Q 039799          260 LTQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMEIFTRTKPTDEIFSGEM-----TLKRWVNDLLPISVMEVVDA  333 (346)
Q Consensus       260 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~s~G~il~elltg~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~d~  333 (346)
                       .....+|++.|.|||++.+.++ ++++|+||+|+++|-|+.|..||+...-.+.     ...-.+...+..+-++++++
T Consensus       210 -~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~lLrk  288 (596)
T KOG0586|consen  210 -MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDLLRK  288 (596)
T ss_pred             -cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHHHHH
Confidence             3345779999999999988765 7899999999999999999999986321111     11111222234477999999


Q ss_pred             hccCCccccccc
Q 039799          334 NLLSQEDEHFTT  345 (346)
Q Consensus       334 ~l~~~p~~R~~~  345 (346)
                      +|..+|.+|++.
T Consensus       289 ~lvl~Pskr~~~  300 (596)
T KOG0586|consen  289 FLVLNPSKRGPC  300 (596)
T ss_pred             hhccCccccCCH
Confidence            999999999875

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=6.1e-36  Score=260.76  Aligned_cols=234  Identities=24%  Similarity=0.344  Sum_probs=194.2

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEec
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEY  180 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  180 (346)
                      +|.+.+.||+|++|.||++... +++.+++|.+....  ......+.+|++++++++|+||+++.+++......++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            3677889999999999999865 78899999986432  33456777899999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhc---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccc
Q 039799          181 MPHGSLEKCLYLS---NYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  257 (346)
Q Consensus       181 ~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~  257 (346)
                      +++++|.+++...   ...+++..++.++.+++.|++|||   +.+++|+||+|+||++++++.++++|||++...... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            9999999987642   356889999999999999999999   999999999999999999999999999999876433 


Q ss_pred             cccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHhh-------hcCCChhhh
Q 039799          258 QSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVND-------LLPISVMEV  330 (346)
Q Consensus       258 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~-------~~~~~~~~~  330 (346)
                         ......++..|+|||...+..++.++|+||+|++++|+++|+.||+.....+ ........       .++..+.++
T Consensus       157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l  232 (256)
T cd08530         157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD-LRYKVQRGKYPPIPPIYSQDLQNF  232 (256)
T ss_pred             ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHhcCCCCCCchhhCHHHHHH
Confidence               1223457889999999988889999999999999999999999997532111 11111111       223468899


Q ss_pred             hchhccCCccccccc
Q 039799          331 VDANLLSQEDEHFTT  345 (346)
Q Consensus       331 ~d~~l~~~p~~R~~~  345 (346)
                      +.+|+..+|++||+.
T Consensus       233 i~~~l~~~p~~Rp~~  247 (256)
T cd08530         233 IRSMLQVKPKLRPNC  247 (256)
T ss_pred             HHHHcCCCcccCCCH
Confidence            999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-37  Score=259.34  Aligned_cols=235  Identities=23%  Similarity=0.277  Sum_probs=196.2

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEE
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALV  177 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  177 (346)
                      -++|++.++||+|.||.|.+++-+ +++.+|+|+++++.   ......-..|-++|...+||.+..+--.|...+.++.|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            356888999999999999999866 79999999998653   22334455688999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccc
Q 039799          178 LEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  257 (346)
Q Consensus       178 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~  257 (346)
                      |||..||.|.-++.. ...++.....-+-..|..||.|||   +++|+.||+|.+|.|+|.+|++||+|||+|+.-..  
T Consensus       247 MeyanGGeLf~HLsr-er~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~--  320 (516)
T KOG0690|consen  247 MEYANGGELFFHLSR-ERVFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK--  320 (516)
T ss_pred             EEEccCceEeeehhh-hhcccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhccc--
Confidence            999999999887764 345666666678899999999999   99999999999999999999999999999995322  


Q ss_pred             cccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHH-------HhhhcCCChhhh
Q 039799          258 QSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRW-------VNDLLPISVMEV  330 (346)
Q Consensus       258 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~-------~~~~~~~~~~~~  330 (346)
                      ...+....+||+.|.|||++.+..|+..+|-|.+||++|||++|+.||.....+  .+-..       ....+.++...+
T Consensus       321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~--kLFeLIl~ed~kFPr~ls~eAktL  398 (516)
T KOG0690|consen  321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE--KLFELILMEDLKFPRTLSPEAKTL  398 (516)
T ss_pred             ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh--HHHHHHHhhhccCCccCCHHHHHH
Confidence            334456788999999999999999999999999999999999999999763222  11111       133445577889


Q ss_pred             hchhccCCcccccc
Q 039799          331 VDANLLSQEDEHFT  344 (346)
Q Consensus       331 ~d~~l~~~p~~R~~  344 (346)
                      +...|..||++|..
T Consensus       399 LsGLL~kdP~kRLG  412 (516)
T KOG0690|consen  399 LSGLLKKDPKKRLG  412 (516)
T ss_pred             HHHHhhcChHhhcC
Confidence            99999999999974

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=4.2e-36  Score=272.36  Aligned_cols=239  Identities=24%  Similarity=0.283  Sum_probs=189.9

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEec----CCce
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSN----DDFK  174 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~  174 (346)
                      ..+|.+.+.||+|++|.||+|... +|+.||+|++....  ....+.+.+|+.++++++||||+++.+++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            367888999999999999999865 69999999987542  2335677789999999999999999987753    3467


Q ss_pred             eEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCC
Q 039799          175 ALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  254 (346)
Q Consensus       175 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~  254 (346)
                      ++|+||+. ++|.+++... ..+++.....++.+++.||+|||   +.+++||||||+||++++++.++|+|||++....
T Consensus        84 ~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~  158 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLS  158 (334)
T ss_pred             EEEEehhh-hhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence            89999995 6898887643 45899999999999999999999   9999999999999999999999999999998654


Q ss_pred             ccccc--cccccccCCcccccCCCCCC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccCc-------------------
Q 039799          255 EEDQS--LTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE-------------------  312 (346)
Q Consensus       255 ~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~-------------------  312 (346)
                      .....  .......++..|+|||.+.. ..++.++||||||+++|||++|+.||.......                   
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~  238 (334)
T cd07855         159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR  238 (334)
T ss_pred             ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhh
Confidence            32211  11223468889999998755 458899999999999999999999996531100                   


Q ss_pred             ---ccHHH--------------HHhhhcCCChhhhhchhccCCccccccc
Q 039799          313 ---MTLKR--------------WVNDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       313 ---~~~~~--------------~~~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                         .....              ......+..+.+++.+||..+|++||++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~  288 (334)
T cd07855         239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITV  288 (334)
T ss_pred             hchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCH
Confidence               00000              0112234578899999999999999985

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-36  Score=271.03  Aligned_cols=238  Identities=25%  Similarity=0.295  Sum_probs=186.9

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCC-----ce
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDD-----FK  174 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~  174 (346)
                      .++|.+.+.||+|++|.||+|... +|+.||+|++.... ......+.+|+.++++++|+|++++++++....     ..
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            467999999999999999999865 78999999986432 334566788999999999999999998775443     57


Q ss_pred             eEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCC
Q 039799          175 ALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  254 (346)
Q Consensus       175 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~  254 (346)
                      ++++||+++ ++.+.+.  ...+++.....++.|++.||+|||   +.+++||||||+||+++.++.++|+|||++....
T Consensus        84 ~lv~e~~~~-~l~~~~~--~~~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~  157 (336)
T cd07849          84 YIVQELMET-DLYKLIK--TQHLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD  157 (336)
T ss_pred             EEEehhccc-CHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence            899999965 7777664  345888999999999999999999   9999999999999999999999999999998654


Q ss_pred             ccccc-cccccccCCcccccCCCCCC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccC--------------cccH---
Q 039799          255 EEDQS-LTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSG--------------EMTL---  315 (346)
Q Consensus       255 ~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~--------------~~~~---  315 (346)
                      ..... .......++..|+|||...+ ..++.++||||+|+++|||++|+.||......              ....   
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
T cd07849         158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI  237 (336)
T ss_pred             ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence            32211 11123457899999997654 56889999999999999999999999542100              0000   


Q ss_pred             -----HHHH--------------hhhcCCChhhhhchhccCCccccccc
Q 039799          316 -----KRWV--------------NDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       316 -----~~~~--------------~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                           ..+.              ....+..+.+++.+||..+|++||+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~  286 (336)
T cd07849         238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITV  286 (336)
T ss_pred             hchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCH
Confidence                 0000              11234567899999999999999985

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=6.4e-36  Score=268.13  Aligned_cols=232  Identities=26%  Similarity=0.317  Sum_probs=189.4

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC---CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEE
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ---YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVL  178 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  178 (346)
                      ..|...+.||+|++|.||+|... ++..+|+|.+...   .....+++.+|+++++.++|+|++++.+++...+..++|+
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            44777889999999999999965 6889999988632   2234467788999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccc
Q 039799          179 EYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  258 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~  258 (346)
                      ||+. +++.+.+......+++..+..++.+++.|+.|||   +.+++||||+|+||+++.++.++|+|||++......  
T Consensus        95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--  168 (308)
T cd06634          95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--  168 (308)
T ss_pred             EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence            9996 6887777655666899999999999999999999   999999999999999999999999999998765321  


Q ss_pred             ccccccccCCcccccCCCCC---CCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH--------hhhcCCCh
Q 039799          259 SLTQTQTLATIGYMAPEYGR---EGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV--------NDLLPISV  327 (346)
Q Consensus       259 ~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~--------~~~~~~~~  327 (346)
                          ....++..|+|||.+.   ...++.++||||||+++|||++|+.|+......+ ....+.        ...++..+
T Consensus       169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  243 (308)
T cd06634         169 ----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNESPALQSGHWSEYF  243 (308)
T ss_pred             ----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH-HHHHHhhcCCCCcCcccccHHH
Confidence                2345788999999864   3567889999999999999999999986532111 111111        11233467


Q ss_pred             hhhhchhccCCccccccc
Q 039799          328 MEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       328 ~~~~d~~l~~~p~~R~~~  345 (346)
                      .+++.+||..+|++||+.
T Consensus       244 ~~li~~cl~~~P~~Rp~~  261 (308)
T cd06634         244 RNFVDSCLQKIPQDRPTS  261 (308)
T ss_pred             HHHHHHHhhCCcccCCCH
Confidence            899999999999999985

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-36  Score=256.11  Aligned_cols=234  Identities=22%  Similarity=0.342  Sum_probs=191.3

Q ss_pred             CCcccccCceEEEEEE-EcCCCEEEEEEecCCCchhHHHHHHHHHHHHhc-CCCCceeeEEEEecCCceeEEEecCCCCC
Q 039799          108 PPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRI-CHRNLIKIISSYSNDDFKALVLEYMPHGS  185 (346)
Q Consensus       108 ~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gs  185 (346)
                      .+.||+|+|+.|--+. +.+|.+||||++.+.......+..+|++++.++ .|+||+.++++|+++...|||||-|.||+
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp  162 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP  162 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence            3579999999999886 778999999999988777888999999999998 59999999999999999999999999999


Q ss_pred             hhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCC---cEEEeeecCCccCCccc-----
Q 039799          186 LEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM---VAHLSDFGMAKPLLEED-----  257 (346)
Q Consensus       186 L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~---~~~l~Dfg~~~~~~~~~-----  257 (346)
                      |.++++. ...++.....++..+|+.||.|||   .+||.|||+||+|||-....   -+||+||.+..-+...+     
T Consensus       163 lLshI~~-~~~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spa  238 (463)
T KOG0607|consen  163 LLSHIQK-RKHFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPA  238 (463)
T ss_pred             HHHHHHH-hhhccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCC
Confidence            9998864 455788888999999999999999   99999999999999996433   58999999988654322     


Q ss_pred             cccccccccCCcccccCCCCC-----CCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcc-------------------
Q 039799          258 QSLTQTQTLATIGYMAPEYGR-----EGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM-------------------  313 (346)
Q Consensus       258 ~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~-------------------  313 (346)
                      ......+.+|+..|||||+..     ...|+.++|.||+|||+|-|++|.+||......+-                   
T Consensus       239 stP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesI  318 (463)
T KOG0607|consen  239 STPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESI  318 (463)
T ss_pred             CCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHH
Confidence            112234567999999999642     23588999999999999999999999976443211                   


Q ss_pred             -----cHHHHHhhhcCCChhhhhchhccCCccccccc
Q 039799          314 -----TLKRWVNDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       314 -----~~~~~~~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                           .+.+.-...++....+++...|..|+.+|.++
T Consensus       319 QEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa  355 (463)
T KOG0607|consen  319 QEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSA  355 (463)
T ss_pred             hccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhh
Confidence                 11111122234466889999999999999875

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=9.9e-36  Score=267.01  Aligned_cols=240  Identities=25%  Similarity=0.328  Sum_probs=185.9

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEecCC------
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSNDD------  172 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  172 (346)
                      .++|.+.+.||+|++|.||+|... +++.+|+|++....  ......+.+|++++++++||||+++++++....      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            367899999999999999999976 68999999885432  222345678999999999999999998775433      


Q ss_pred             --ceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCC
Q 039799          173 --FKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMA  250 (346)
Q Consensus       173 --~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~  250 (346)
                        ..++|+||+.+ ++...+......+++..+..++.++++||+|||   +.+++|+||||+||++++++.++|+|||++
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~  162 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLA  162 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence              46899999965 677666555567999999999999999999999   999999999999999999999999999999


Q ss_pred             ccCCccccc---------cccccccCCcccccCCCCCCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccCcc-------
Q 039799          251 KPLLEEDQS---------LTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM-------  313 (346)
Q Consensus       251 ~~~~~~~~~---------~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~-------  313 (346)
                      .........         ...+...++..|+|||...+. .++.++||||||+++|||++|++||........       
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~  242 (311)
T cd07866         163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL  242 (311)
T ss_pred             hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            865432211         111223467889999987553 578999999999999999999999864211000       


Q ss_pred             -------cHHHH---------------------HhhhcCCChhhhhchhccCCccccccc
Q 039799          314 -------TLKRW---------------------VNDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       314 -------~~~~~---------------------~~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                             ....|                     ....+...+.+++.+||..+|.+|||+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~  302 (311)
T cd07866         243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTA  302 (311)
T ss_pred             hCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCH
Confidence                   00000                     001122366799999999999999985

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=5.7e-36  Score=264.39  Aligned_cols=238  Identities=28%  Similarity=0.436  Sum_probs=197.0

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC---CchhHHHHHHHHHHHHhcC-CCCceeeEEEEecCCceeEE
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ---YEGAFKSFDIECDVMKRIC-HRNLIKIISSYSNDDFKALV  177 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv  177 (346)
                      ++|.+.+.||+|++|.||++... +++.+|+|++...   .....+.+..|.+++++++ ||||+++++.+...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            36888899999999999999976 7999999998652   2233467788999999998 99999999999999999999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccc
Q 039799          178 LEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  257 (346)
Q Consensus       178 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~  257 (346)
                      ||++++++|.+++... ..+++..+..++.+++.||.|||   +.+++|+||+|+||+++.++.++++|||++.......
T Consensus        81 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~  156 (280)
T cd05581          81 LEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS  156 (280)
T ss_pred             EcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence            9999999999988644 46899999999999999999999   9999999999999999999999999999998764332


Q ss_pred             cc------------------cccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH
Q 039799          258 QS------------------LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV  319 (346)
Q Consensus       258 ~~------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~  319 (346)
                      ..                  .......++..|+|||......++.++|+||||++++++++|+.||..... ........
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-~~~~~~~~  235 (280)
T cd05581         157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE-YLTFQKIL  235 (280)
T ss_pred             ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH-HHHHHHHH
Confidence            11                  112234578899999998888899999999999999999999999976431 11111111


Q ss_pred             h------hhcCCChhhhhchhccCCccccccc
Q 039799          320 N------DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       320 ~------~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      .      ..++..+.+++.+||..+|++||+.
T Consensus       236 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~  267 (280)
T cd05581         236 KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGV  267 (280)
T ss_pred             hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCc
Confidence            1      1234477899999999999999986

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-35  Score=261.58  Aligned_cols=233  Identities=25%  Similarity=0.306  Sum_probs=185.0

Q ss_pred             CCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHHhc---CCCCceeeEEEEecCCc-----
Q 039799          105 ANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRI---CHRNLIKIISSYSNDDF-----  173 (346)
Q Consensus       105 ~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~-----  173 (346)
                      |++.+.||+|++|.||+|+.+ +++.+|+|++....  ......+.+|+.+++++   +|+|++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            566788999999999999987 58999999986432  22234555677776665   59999999999988776     


Q ss_pred             eeEEEecCCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCcc
Q 039799          174 KALVLEYMPHGSLEKCLYLSN-YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  252 (346)
Q Consensus       174 ~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~  252 (346)
                      .+++|||+.+ +|.+++.... ..+++..++.++.+++.||+|||   +.+++|+||+|+||++++++.++|+|||.+..
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence            8999999974 8888776543 46899999999999999999999   99999999999999999999999999999987


Q ss_pred             CCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH-------------
Q 039799          253 LLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV-------------  319 (346)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~-------------  319 (346)
                      +.....   .....++..|+|||...+..++.++|+||||++++||++|++||...... .......             
T Consensus       157 ~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07838         157 YSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA-DQLDKIFDVIGLPSEEEWPR  232 (287)
T ss_pred             ccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH-HHHHHHHHHcCCCChHhcCC
Confidence            633221   12234788899999998888999999999999999999999998652211 0111110             


Q ss_pred             --------------------hhhcCCChhhhhchhccCCccccccc
Q 039799          320 --------------------NDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       320 --------------------~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                                          ...++..+.+++.+||..||++||+.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~  278 (287)
T cd07838         233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISA  278 (287)
T ss_pred             CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCH
Confidence                                01123456789999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.3e-35  Score=263.54  Aligned_cols=237  Identities=23%  Similarity=0.328  Sum_probs=189.3

Q ss_pred             CCCCCcccccCceEEEEEEEc----CCCEEEEEEecCCC----chhHHHHHHHHHHHHhc-CCCCceeeEEEEecCCcee
Q 039799          105 ANMPPLIGKGGFGSVYKAIIQ----DGMEVAVKVFDPQY----EGAFKSFDIECDVMKRI-CHRNLIKIISSYSNDDFKA  175 (346)
Q Consensus       105 ~~~~~~lg~G~~g~vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  175 (346)
                      |.+.+.||+|++|.||+++..    +++.+|+|++....    ....+.+.+|++++.++ +|||++++.+.+......+
T Consensus         2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~   81 (288)
T cd05583           2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH   81 (288)
T ss_pred             ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence            677889999999999999743    57889999986431    22345678899999999 5999999999999999999


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCc
Q 039799          176 LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  255 (346)
Q Consensus       176 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~  255 (346)
                      +||||+++++|.+++... ..+++.....++.|++++|.|||   +.+++||||+|+||+++.++.++|+|||+++....
T Consensus        82 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  157 (288)
T cd05583          82 LILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA  157 (288)
T ss_pred             EEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence            999999999999987643 45788889999999999999999   99999999999999999999999999999886543


Q ss_pred             cccccccccccCCcccccCCCCCCCC--CCcchhHHHHHHHHHHHHcCCCCCCccccC--cccHHHHH-------hhhcC
Q 039799          256 EDQSLTQTQTLATIGYMAPEYGREGR--VSTNGDVYSFGIMLMEIFTRTKPTDEIFSG--EMTLKRWV-------NDLLP  324 (346)
Q Consensus       256 ~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~s~G~il~elltg~~p~~~~~~~--~~~~~~~~-------~~~~~  324 (346)
                      ... .......++..|+|||...+..  .+.++||||||++++||++|..||......  .....+.+       ...++
T Consensus       158 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd05583         158 EEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMS  236 (288)
T ss_pred             ccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccC
Confidence            321 1122345788999999887654  688999999999999999999998532111  01111111       11234


Q ss_pred             CChhhhhchhccCCcccccccC
Q 039799          325 ISVMEVVDANLLSQEDEHFTTK  346 (346)
Q Consensus       325 ~~~~~~~d~~l~~~p~~R~~~k  346 (346)
                      ..+.+++.+||..+|++|||++
T Consensus       237 ~~l~~li~~~l~~~p~~R~t~~  258 (288)
T cd05583         237 AEARDFIQKLLEKDPKKRLGAN  258 (288)
T ss_pred             HHHHHHHHHHhcCCHhhccCcc
Confidence            4779999999999999999853

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.8e-35  Score=263.45  Aligned_cols=239  Identities=18%  Similarity=0.226  Sum_probs=175.5

Q ss_pred             CCCCCCCCcccccCceEEEEEEEcC----CCEEEEEEecCCCchhH-----------HHHHHHHHHHHhcCCCCceeeEE
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQD----GMEVAVKVFDPQYEGAF-----------KSFDIECDVMKRICHRNLIKIIS  166 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~~----~~~vavK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~niv~~~~  166 (346)
                      ..+|.+.+.||+|+||.||+|.+.+    +..+|+|+.........           .....+...+..+.|+|++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            4679999999999999999999764    45667776432221110           11222334556678999999998


Q ss_pred             EEecCC----ceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcE
Q 039799          167 SYSNDD----FKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVA  242 (346)
Q Consensus       167 ~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~  242 (346)
                      .+....    ..+++++++. .++.+.+... ...++..+..++.|++.|++|||   +.+|+||||||+|||++.++.+
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~~~  165 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRG  165 (294)
T ss_pred             eeeEecCCceEEEEEEehhc-cCHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCcE
Confidence            765443    3467777764 3565555432 33567788899999999999999   9999999999999999999999


Q ss_pred             EEeeecCCccCCccccc-----cccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccH--
Q 039799          243 HLSDFGMAKPLLEEDQS-----LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTL--  315 (346)
Q Consensus       243 ~l~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~--  315 (346)
                      +|+|||+++.+......     .......||+.|+|||...+..++.++|||||||+++||++|+.||..........  
T Consensus       166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~  245 (294)
T PHA02882        166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA  245 (294)
T ss_pred             EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence            99999999876432211     11223458999999999999999999999999999999999999997642221110  


Q ss_pred             --HHHHhh---------hcCCChhhhhchhccCCccccccc
Q 039799          316 --KRWVND---------LLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       316 --~~~~~~---------~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                        .++...         ..+..+.++++.|+..+|++||+.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~  286 (294)
T PHA02882        246 AKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDY  286 (294)
T ss_pred             hHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCH
Confidence              111111         223468899999999999999974

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-35  Score=257.22  Aligned_cols=227  Identities=28%  Similarity=0.354  Sum_probs=189.6

Q ss_pred             ccccCceEEEEEEEc-CCCEEEEEEecCCCc---hhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecCCCCCh
Q 039799          111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYE---GAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSL  186 (346)
Q Consensus       111 lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  186 (346)
                      ||+|++|.||++... +++.+|+|++.....   .....+..|++++++++|||++++++.+..++..+++|||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999976 689999999875432   2455788899999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccccccccc
Q 039799          187 EKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL  266 (346)
Q Consensus       187 ~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~  266 (346)
                      .+++... ..+++.....++.+++.|+.|||   +.+++|+||+|+||+++.++.++|+|||++.......  .......
T Consensus        81 ~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~  154 (250)
T cd05123          81 FSHLSKE-GRFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFC  154 (250)
T ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCc
Confidence            9988644 35889999999999999999999   8999999999999999999999999999998754321  1223445


Q ss_pred             CCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH-------hhhcCCChhhhhchhccCCc
Q 039799          267 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV-------NDLLPISVMEVVDANLLSQE  339 (346)
Q Consensus       267 ~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~d~~l~~~p  339 (346)
                      ++..|+|||...+...+.++|+||||++++|+++|+.||+....  ....+.+       ....+..+.+++.+||..||
T Consensus       155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p  232 (250)
T cd05123         155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--KEIYEKILKDPLRFPEFLSPEARDLISGLLQKDP  232 (250)
T ss_pred             CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCH
Confidence            78899999999888889999999999999999999999965321  1111111       11224477999999999999


Q ss_pred             cccccc
Q 039799          340 DEHFTT  345 (346)
Q Consensus       340 ~~R~~~  345 (346)
                      ++||+.
T Consensus       233 ~~R~~~  238 (250)
T cd05123         233 TKRLGS  238 (250)
T ss_pred             hhCCCc
Confidence            999987

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=2.3e-35  Score=266.84  Aligned_cols=197  Identities=23%  Similarity=0.337  Sum_probs=161.7

Q ss_pred             Cccccc--CceEEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecCCC
Q 039799          109 PLIGKG--GFGSVYKAIIQ-DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPH  183 (346)
Q Consensus       109 ~~lg~G--~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  183 (346)
                      ..||+|  ++|+||++... +|+.||+|++....  ....+.+.+|+.+++.++||||+++++++...+..++|+||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            356666  99999999875 79999999987432  33457788899999999999999999999999999999999999


Q ss_pred             CChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccc-
Q 039799          184 GSLEKCLYLS-NYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT-  261 (346)
Q Consensus       184 gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~-  261 (346)
                      +++.+++... ...+++..+..++.|++.||+|||   +.+++||||||+||+++.++.++++||+.+........... 
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (328)
T cd08226          84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV  160 (328)
T ss_pred             CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence            9999988653 345888999999999999999999   99999999999999999999999999986543322111100 


Q ss_pred             ----cccccCCcccccCCCCCCC--CCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 039799          262 ----QTQTLATIGYMAPEYGREG--RVSTNGDVYSFGIMLMEIFTRTKPTDEI  308 (346)
Q Consensus       262 ----~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~s~G~il~elltg~~p~~~~  308 (346)
                          .....++..|+|||++.+.  .++.++||||||++++||++|+.||...
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~  213 (328)
T cd08226         161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM  213 (328)
T ss_pred             cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence                0112245679999998763  4789999999999999999999999653

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.5e-35  Score=266.47  Aligned_cols=234  Identities=21%  Similarity=0.229  Sum_probs=180.6

Q ss_pred             CCcccccCceEEEEEEEcCCCEEEEEEecCC--CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecCCCCC
Q 039799          108 PPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQ--YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGS  185 (346)
Q Consensus       108 ~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  185 (346)
                      .+.+|.|+++.||++.. +++.+|+|++...  .....+.+..|++.+++++|+||+++++++...+..+++|||+++++
T Consensus         7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~   85 (314)
T cd08216           7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS   85 (314)
T ss_pred             hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence            33444445544554444 6899999998754  33455788999999999999999999999999999999999999999


Q ss_pred             hhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccc-----
Q 039799          186 LEKCLYLS-NYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS-----  259 (346)
Q Consensus       186 L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~-----  259 (346)
                      |.+++... ...+++.....++.+++.||+|||   +.+|+||||||+||+++.++.++++|||.+..+......     
T Consensus        86 l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~  162 (314)
T cd08216          86 CEDLLKTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH  162 (314)
T ss_pred             HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence            99988753 346888889999999999999999   999999999999999999999999999998765432211     


Q ss_pred             cccccccCCcccccCCCCCC--CCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH------------------
Q 039799          260 LTQTQTLATIGYMAPEYGRE--GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV------------------  319 (346)
Q Consensus       260 ~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~------------------  319 (346)
                      .......++..|+|||.+..  ..++.++||||||++++||++|+.||........ ..+..                  
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  241 (314)
T cd08216         163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM-LLEKVRGTVPCLLDKSTYPLYED  241 (314)
T ss_pred             cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhccCccccccCchhhhcC
Confidence            11122346778999998765  3578899999999999999999999975321110 00000                  


Q ss_pred             ----------------------hhhcCCChhhhhchhccCCcccccccC
Q 039799          320 ----------------------NDLLPISVMEVVDANLLSQEDEHFTTK  346 (346)
Q Consensus       320 ----------------------~~~~~~~~~~~~d~~l~~~p~~R~~~k  346 (346)
                                            ...+...+.+++.+||..+|++||+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~  290 (314)
T cd08216         242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSAS  290 (314)
T ss_pred             CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHH
Confidence                                  001112467899999999999999863

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-36  Score=277.66  Aligned_cols=197  Identities=32%  Similarity=0.487  Sum_probs=169.7

Q ss_pred             CCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCC------ceeE
Q 039799          105 ANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDD------FKAL  176 (346)
Q Consensus       105 ~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~~~l  176 (346)
                      +...+.||+|+||.||+|+.+ +|+.||||.++... ....+...+|++++++++|+|||++++.-++..      ...+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            456678999999999999955 89999999997643 334577788999999999999999998765543      6679


Q ss_pred             EEecCCCCChhhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEEC--CCC--cEEEeeecCC
Q 039799          177 VLEYMPHGSLEKCLYLSN--YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD--DNM--VAHLSDFGMA  250 (346)
Q Consensus       177 v~e~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~--~~~--~~~l~Dfg~~  250 (346)
                      |||||.+|||...+....  ..++....+.++.++..|+.|||   ..+|+||||||.||++-  ++|  ..||+|||.|
T Consensus        95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            999999999999997543  57999999999999999999999   99999999999999994  333  6799999999


Q ss_pred             ccCCccccccccccccCCcccccCCCCCC-CCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 039799          251 KPLLEEDQSLTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMEIFTRTKPTDE  307 (346)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~  307 (346)
                      +.+.++.   ......||..|.+||.... +.|+..+|.|||||++||+.||..||..
T Consensus       172 rel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p  226 (732)
T KOG4250|consen  172 RELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP  226 (732)
T ss_pred             ccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence            9875543   3456789999999998884 7899999999999999999999999954

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2e-35  Score=268.20  Aligned_cols=237  Identities=24%  Similarity=0.267  Sum_probs=187.8

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC--CchhHHHHHHHHHHHHhcCCCCceeeEEEEecC-----Cc
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ--YEGAFKSFDIECDVMKRICHRNLIKIISSYSND-----DF  173 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~  173 (346)
                      ..+|.+.+.||+|++|+||+|... +++.||+|.+...  .......+.+|+.+++.++|+|++++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            457888999999999999999865 7899999998643  222345677899999999999999999987644     35


Q ss_pred             eeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccC
Q 039799          174 KALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  253 (346)
Q Consensus       174 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~  253 (346)
                      .++++||+. ++|.+++.. ...+++.....++.+++.||.|||   +.+++||||||+||+++.++.++|+|||++...
T Consensus        84 ~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~  158 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTT  158 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence            789999995 688887753 356889999999999999999999   999999999999999999999999999999865


Q ss_pred             CccccccccccccCCcccccCCCCCC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccC---------------------
Q 039799          254 LEEDQSLTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSG---------------------  311 (346)
Q Consensus       254 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~---------------------  311 (346)
                      ....  .......++..|+|||.+.. ..++.++||||||+++|+|++|+.||......                     
T Consensus       159 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
T cd07858         159 SEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFI  236 (337)
T ss_pred             CCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence            4321  11223457889999997754 46889999999999999999999998642100                     


Q ss_pred             -cccHHHHH--------------hhhcCCChhhhhchhccCCccccccc
Q 039799          312 -EMTLKRWV--------------NDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       312 -~~~~~~~~--------------~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                       ......++              ...++..+.+++.+||..+|.+||+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~  285 (337)
T cd07858         237 RNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITV  285 (337)
T ss_pred             CchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCH
Confidence             00001111              11234467899999999999999985

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-35  Score=261.44  Aligned_cols=235  Identities=23%  Similarity=0.315  Sum_probs=187.1

Q ss_pred             CCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCc-hhHHHHHHHHHHHHhcC-CCCceeeEEEEecCCceeEEEecC
Q 039799          105 ANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYE-GAFKSFDIECDVMKRIC-HRNLIKIISSYSNDDFKALVLEYM  181 (346)
Q Consensus       105 ~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~  181 (346)
                      |.+.+.||+|++|+||+|... +++.+++|.+..... .......+|+..+++++ |+|++++++++..++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            567789999999999999976 578999999865432 12234456899999999 999999999999999999999999


Q ss_pred             CCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccc
Q 039799          182 PHGSLEKCLYLSN-YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  260 (346)
Q Consensus       182 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~  260 (346)
                       +++|.+++.... ..+++..+..++.+++++|.|||   +.+++|+||+|+||++++++.++|+|||.+........  
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~--  154 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--  154 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence             889988876554 56899999999999999999999   99999999999999999999999999999986533211  


Q ss_pred             ccccccCCcccccCCCCC-CCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcc-----------cHHHH----------
Q 039799          261 TQTQTLATIGYMAPEYGR-EGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM-----------TLKRW----------  318 (346)
Q Consensus       261 ~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~-----------~~~~~----------  318 (346)
                       .....++..|+|||... ...++.++|+||||++++||++|+.||......+.           ....|          
T Consensus       155 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07830         155 -YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL  233 (283)
T ss_pred             -cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence             12345788999999774 44578999999999999999999999854211000           00000          


Q ss_pred             -----------Hhh---hcCCChhhhhchhccCCcccccccC
Q 039799          319 -----------VND---LLPISVMEVVDANLLSQEDEHFTTK  346 (346)
Q Consensus       319 -----------~~~---~~~~~~~~~~d~~l~~~p~~R~~~k  346 (346)
                                 ...   ..+..+.+++.+|+..+|++||+.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~  275 (283)
T cd07830         234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTAS  275 (283)
T ss_pred             cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHH
Confidence                       000   1134678999999999999999863

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.3e-35  Score=267.03  Aligned_cols=237  Identities=24%  Similarity=0.308  Sum_probs=192.0

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEecCC-----cee
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSNDD-----FKA  175 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~  175 (346)
                      +|.+.+.||+|++|.||+|... +++.+|+|++....  ....+.+..|+++++.++|+|++++.+++...+     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            3778899999999999999976 58999999987543  334567889999999999999999999987765     789


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCc
Q 039799          176 LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  255 (346)
Q Consensus       176 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~  255 (346)
                      ++|||++ ++|.+++... ..+++..+..++.+++.||+|||   +.+++||||||+||+++.++.++|+|||++.....
T Consensus        81 lv~e~~~-~~l~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~  155 (330)
T cd07834          81 IVTELME-TDLHKVIKSP-QPLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP  155 (330)
T ss_pred             EEecchh-hhHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence            9999997 4888887643 37899999999999999999999   99999999999999999999999999999997644


Q ss_pred             cccc-cccccccCCcccccCCCCCCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccCc---------------------
Q 039799          256 EDQS-LTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE---------------------  312 (346)
Q Consensus       256 ~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~---------------------  312 (346)
                      .... .......++..|+|||.+.+. .++.++|+||||+++++|++|+.||......+                     
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  235 (330)
T cd07834         156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFIT  235 (330)
T ss_pred             cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcc
Confidence            3210 112334578899999998877 78999999999999999999999996432100                     


Q ss_pred             -ccHHHHH--------------hhhcCCChhhhhchhccCCccccccc
Q 039799          313 -MTLKRWV--------------NDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       313 -~~~~~~~--------------~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                       .....++              ...++..+.+++.+||..+|++||+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~  283 (330)
T cd07834         236 SEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITA  283 (330)
T ss_pred             ccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCH
Confidence             0001111              11234467899999999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-35  Score=261.12  Aligned_cols=235  Identities=27%  Similarity=0.322  Sum_probs=191.2

Q ss_pred             CCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecC
Q 039799          105 ANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYM  181 (346)
Q Consensus       105 ~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  181 (346)
                      |...+.||+|++|.||+|+.. +++.+|+|++....  ....+.+..|++++++++|+|++++.+++...+..++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            456778999999999999976 58999999987642  333467788999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccc
Q 039799          182 PHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT  261 (346)
Q Consensus       182 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~  261 (346)
                      + ++|.+++......+++..+..++.+++.||+|||   +.+++||||+|+||++++++.++|+|||.+........  .
T Consensus        81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~  154 (282)
T cd07829          81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--T  154 (282)
T ss_pred             C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--c
Confidence            7 5899998766567999999999999999999999   89999999999999999999999999999986543221  1


Q ss_pred             cccccCCcccccCCCCCCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccCc---------------------------c
Q 039799          262 QTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE---------------------------M  313 (346)
Q Consensus       262 ~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~---------------------------~  313 (346)
                      .....++..|+|||...+. .++.++||||||++++|+++|+.||......+                           .
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
T cd07829         155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP  234 (282)
T ss_pred             cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence            2233457789999988766 78899999999999999999999985421100                           0


Q ss_pred             cHHHH-------HhhhcCCChhhhhchhccCCccccccc
Q 039799          314 TLKRW-------VNDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       314 ~~~~~-------~~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ....+       ....++..+.+++.+||..+|++||++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~  273 (282)
T cd07829         235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISA  273 (282)
T ss_pred             cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCH
Confidence            00000       001123478999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=8.8e-35  Score=263.81  Aligned_cols=239  Identities=21%  Similarity=0.265  Sum_probs=186.4

Q ss_pred             CCCCC-CCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchh--------------HHHHHHHHHHHHhcCCCCceeeE
Q 039799          102 PNDAN-MPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGA--------------FKSFDIECDVMKRICHRNLIKII  165 (346)
Q Consensus       102 ~~~~~-~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~niv~~~  165 (346)
                      .++|. +.+.||+|++|.||+|... +++.||+|++.......              ...+.+|++++++++|+|+++++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV   86 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence            34554 4578999999999999865 78999999986432111              12467899999999999999999


Q ss_pred             EEEecCCceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEe
Q 039799          166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLS  245 (346)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~  245 (346)
                      +++...+..++||||+. ++|.+++.. ...+++.....++.+++.||+|||   +.+++|+||+|+||+++.++.++|+
T Consensus        87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl~  161 (335)
T PTZ00024         87 DVYVEGDFINLVMDIMA-SDLKKVVDR-KIRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIA  161 (335)
T ss_pred             EEEecCCcEEEEEeccc-cCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEEC
Confidence            99999999999999996 688888753 445888999999999999999999   9999999999999999999999999


Q ss_pred             eecCCccCCccc------------cccccccccCCcccccCCCCCCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccCc
Q 039799          246 DFGMAKPLLEED------------QSLTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE  312 (346)
Q Consensus       246 Dfg~~~~~~~~~------------~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~  312 (346)
                      |||++.......            .........++..|+|||.+.+. .++.++||||+|+++|||+||+.||......+
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~  241 (335)
T PTZ00024        162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID  241 (335)
T ss_pred             CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            999998654110            01111223467889999988764 46889999999999999999999986432110


Q ss_pred             cc--------------HHH-------------------HHhhhcCCChhhhhchhccCCccccccc
Q 039799          313 MT--------------LKR-------------------WVNDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       313 ~~--------------~~~-------------------~~~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ..              ..+                   ......+..+.+++.+||..+|++||++
T Consensus       242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~  307 (335)
T PTZ00024        242 QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISA  307 (335)
T ss_pred             HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCH
Confidence            00              000                   0001123467899999999999999985

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-37  Score=279.07  Aligned_cols=236  Identities=24%  Similarity=0.357  Sum_probs=199.3

Q ss_pred             CCCCCCcccccCceEEEEEEEcC-CCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecCC
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMP  182 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  182 (346)
                      .|++..-||.|+||.||+|..++ +-..|-|++........+.+.-|+++|+.++||+||++++.|...+.++++.|||.
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~  112 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG  112 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence            46778889999999999998763 44567788888888888999999999999999999999998888889999999999


Q ss_pred             CCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccccc
Q 039799          183 HGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ  262 (346)
Q Consensus       183 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~  262 (346)
                      ||-+..++-.-+..+...++.-++.+++.||.|||   +..|+|||+|+.|||++-+|.++|+|||.+-....  .....
T Consensus       113 GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~qkR  187 (1187)
T KOG0579|consen  113 GGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TRQKR  187 (1187)
T ss_pred             CchHhHHHHHhccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccchh--HHhhh
Confidence            99999988777788999999999999999999999   99999999999999999999999999999875432  12234


Q ss_pred             ccccCCcccccCCCC-----CCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH---------hhhcCCChh
Q 039799          263 TQTLATIGYMAPEYG-----REGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV---------NDLLPISVM  328 (346)
Q Consensus       263 ~~~~~~~~y~aPE~~-----~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~---------~~~~~~~~~  328 (346)
                      ....||+.|||||+.     .+.+|+.++||||||+.|.||..+.+|..+..... .+....         ...|...+.
T Consensus       188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR-VllKiaKSePPTLlqPS~Ws~~F~  266 (1187)
T KOG0579|consen  188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-VLLKIAKSEPPTLLQPSHWSRSFS  266 (1187)
T ss_pred             ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH-HHHHHhhcCCCcccCcchhhhHHH
Confidence            567899999999964     46789999999999999999999999986532111 111111         233445889


Q ss_pred             hhhchhccCCccccccc
Q 039799          329 EVVDANLLSQEDEHFTT  345 (346)
Q Consensus       329 ~~~d~~l~~~p~~R~~~  345 (346)
                      |++.+||..+|..||++
T Consensus       267 DfLk~cL~Knp~~Rp~a  283 (1187)
T KOG0579|consen  267 DFLKRCLVKNPRNRPPA  283 (1187)
T ss_pred             HHHHHHHhcCCccCCCH
Confidence            99999999999999985

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=2.5e-36  Score=291.64  Aligned_cols=237  Identities=26%  Similarity=0.382  Sum_probs=180.7

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC-CchhHHHHHHHHHHHHhcCCCCceeeEEEEecC---------
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ-YEGAFKSFDIECDVMKRICHRNLIKIISSYSND---------  171 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~---------  171 (346)
                      .+|+...+||+|+||.||+++.+ ||+.||||++... .......+.+|++.++++.|||||+++..|.+.         
T Consensus       479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei  558 (1351)
T KOG1035|consen  479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI  558 (1351)
T ss_pred             hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence            34677789999999999999987 8999999998754 344566788899999999999999998555110         


Q ss_pred             --------------------------------------------------------------------------------
Q 039799          172 --------------------------------------------------------------------------------  171 (346)
Q Consensus       172 --------------------------------------------------------------------------------  171 (346)
                                                                                                      
T Consensus       559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~  638 (1351)
T KOG1035|consen  559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG  638 (1351)
T ss_pred             cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence                                                                                            


Q ss_pred             ------------------------------CceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 039799          172 ------------------------------DFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYS  221 (346)
Q Consensus       172 ------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~  221 (346)
                                                    ...|+-||||+..++.++++.....-.....++++++|++||+|+|   +
T Consensus       639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH---~  715 (1351)
T KOG1035|consen  639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH---D  715 (1351)
T ss_pred             ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH---h
Confidence                                          1246788999888888877644332245667899999999999999   9


Q ss_pred             CCeeecCCCCCceEECCCCcEEEeeecCCccCCc----------------cccccccccccCCcccccCCCCCCCC---C
Q 039799          222 APIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE----------------EDQSLTQTQTLATIGYMAPEYGREGR---V  282 (346)
Q Consensus       222 ~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~----------------~~~~~~~~~~~~~~~y~aPE~~~~~~---~  282 (346)
                      ++|+||||||.||++|++..+||+|||+|.....                .......+..+||.-|+|||++.+..   |
T Consensus       716 ~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Y  795 (1351)
T KOG1035|consen  716 QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKY  795 (1351)
T ss_pred             CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccc
Confidence            9999999999999999999999999999997320                01112345678999999999987654   9


Q ss_pred             CcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHhhhcCC----------ChhhhhchhccCCccccccc
Q 039799          283 STNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPI----------SVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       283 ~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~----------~~~~~~d~~l~~~p~~R~~~  345 (346)
                      +.|+|+||+|||++||+.-   |....+....+...-+..+|.          .-..+|..++..||.+|||+
T Consensus       796 n~KiDmYSLGIVlFEM~yP---F~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA  865 (1351)
T KOG1035|consen  796 NSKIDMYSLGIVLFEMLYP---FGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTA  865 (1351)
T ss_pred             cchhhhHHHHHHHHHHhcc---CCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCH
Confidence            9999999999999999853   443211111111111222221          33678999999999999996

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=3.2e-35  Score=253.64  Aligned_cols=218  Identities=20%  Similarity=0.180  Sum_probs=176.2

Q ss_pred             cCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecCCCCChhhhhhh
Q 039799          114 GGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYL  192 (346)
Q Consensus       114 G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~  192 (346)
                      |.+|.||++... +++.+|+|.+....     .+..|...+....|||++++++++...+..+++|||+++++|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            899999999865 78999999986542     223355555566799999999999999999999999999999998864


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccccccccCCcccc
Q 039799          193 SNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYM  272 (346)
Q Consensus       193 ~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~  272 (346)
                      . ..+++.....++.++++||+|||   +.+++||||||+||+++.++.++++|||.+......     .....++..|+
T Consensus        79 ~-~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y~  149 (237)
T cd05576          79 F-LNIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMYC  149 (237)
T ss_pred             h-cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCcccc
Confidence            3 35889999999999999999999   999999999999999999999999999987754321     12234567899


Q ss_pred             cCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccH-HHHHhhhcCCChhhhhchhccCCccccccc
Q 039799          273 APEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTL-KRWVNDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       273 aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      |||......++.++||||+|+++|||++|+.|++......... .......++..+.+++.+||..||++|+++
T Consensus       150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~  223 (237)
T cd05576         150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGA  223 (237)
T ss_pred             CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcccccccCCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence            9999988888999999999999999999998876432111100 001122345578899999999999999984

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-36  Score=274.17  Aligned_cols=233  Identities=24%  Similarity=0.387  Sum_probs=195.4

Q ss_pred             CCCCcccccCceEEEEEEEc--CCC--EEEEEEecCCCch-hHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEec
Q 039799          106 NMPPLIGKGGFGSVYKAIIQ--DGM--EVAVKVFDPQYEG-AFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEY  180 (346)
Q Consensus       106 ~~~~~lg~G~~g~vy~~~~~--~~~--~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  180 (346)
                      ...++||+|.||.|++|.|.  .|+  .||||++...... ....|.+|+.+|.+|+|+|+++++|...+ ....||+|.
T Consensus       113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL  191 (1039)
T KOG0199|consen  113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL  191 (1039)
T ss_pred             HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence            34467999999999999987  343  5899999866544 67899999999999999999999999887 677799999


Q ss_pred             CCCCChhhhhhh-cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccc
Q 039799          181 MPHGSLEKCLYL-SNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  259 (346)
Q Consensus       181 ~~~gsL~~~l~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~  259 (346)
                      ++.|||.+.|+. ....+-......++.|||.|++||.   ++.+||||+-..|+|+-....+||+|||+.+.+......
T Consensus       192 aplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~  268 (1039)
T KOG0199|consen  192 APLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM  268 (1039)
T ss_pred             cccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence            999999999987 4456888889999999999999999   999999999999999999999999999999988765544


Q ss_pred             cccc-cccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHh--------hhcCCChhh
Q 039799          260 LTQT-QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVN--------DLLPISVME  329 (346)
Q Consensus       260 ~~~~-~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~  329 (346)
                      +... ...-...|+|||.+....++.++|||+|||++|||+| |..||-....  ..+.+.+.        ...++++.+
T Consensus       269 Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g--~qIL~~iD~~erLpRPk~csedIY~  346 (1039)
T KOG0199|consen  269 YVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG--IQILKNIDAGERLPRPKYCSEDIYQ  346 (1039)
T ss_pred             eEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH--HHHHHhccccccCCCCCCChHHHHH
Confidence            4333 2335678999999999999999999999999999998 8889976321  11222221        223458999


Q ss_pred             hhchhccCCcccccc
Q 039799          330 VVDANLLSQEDEHFT  344 (346)
Q Consensus       330 ~~d~~l~~~p~~R~~  344 (346)
                      ++..||...|.+||+
T Consensus       347 imk~cWah~paDRpt  361 (1039)
T KOG0199|consen  347 IMKNCWAHNPADRPT  361 (1039)
T ss_pred             HHHHhccCCcccccc
Confidence            999999999999997

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-36  Score=272.57  Aligned_cols=235  Identities=26%  Similarity=0.358  Sum_probs=197.0

Q ss_pred             CCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecCCC
Q 039799          105 ANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPH  183 (346)
Q Consensus       105 ~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  183 (346)
                      ..+...||-|.||.||.|.|+ -.-.||||.++.. ....++|..|..+++.++|||+|+++|.|......|+|+|||..
T Consensus       269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~y  347 (1157)
T KOG4278|consen  269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCY  347 (1157)
T ss_pred             eeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccC
Confidence            445678999999999999988 4668999999754 45678999999999999999999999999999999999999999


Q ss_pred             CChhhhhhhcCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccccc
Q 039799          184 GSLEKCLYLSNY-ILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ  262 (346)
Q Consensus       184 gsL~~~l~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~  262 (346)
                      |+|.++|...+. ..+.-..+.|+.||++|++||.   .+.+||||+-..|.|+.++..+|++|||+++.+..+.... .
T Consensus       348 GNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTA-H  423 (1157)
T KOG4278|consen  348 GNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTA-H  423 (1157)
T ss_pred             ccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhhcCCceec-c
Confidence            999999987763 4666677899999999999999   9999999999999999999999999999999886543211 1


Q ss_pred             ccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCc------ccHHHHHhhhcCCChhhhhchhc
Q 039799          263 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGE------MTLKRWVNDLLPISVMEVVDANL  335 (346)
Q Consensus       263 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~~d~~l  335 (346)
                      ....-...|.|||-+....++.|+|||+|||+||||.| |..||..+....      ...+---.+..|+.+.+++..||
T Consensus       424 AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVYeLMraCW  503 (1157)
T KOG4278|consen  424 AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYELMRACW  503 (1157)
T ss_pred             cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHHHHHHHHHh
Confidence            11223677999999999999999999999999999998 999987642111      11112223445679999999999


Q ss_pred             cCCcccccc
Q 039799          336 LSQEDEHFT  344 (346)
Q Consensus       336 ~~~p~~R~~  344 (346)
                      .-.|.+||+
T Consensus       504 ~WsPsDRPs  512 (1157)
T KOG4278|consen  504 NWSPSDRPS  512 (1157)
T ss_pred             cCCcccCcc
Confidence            999999997

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.1e-35  Score=266.02  Aligned_cols=233  Identities=26%  Similarity=0.345  Sum_probs=184.0

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEecCC-----
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSNDD-----  172 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----  172 (346)
                      ...+|...+.||+|++|.||+|... +|+.||+|++....  ......+.+|++++++++||||+++++++....     
T Consensus        13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~   92 (342)
T cd07879          13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF   92 (342)
T ss_pred             cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence            3567889999999999999999865 78999999986432  223456788999999999999999999886543     


Q ss_pred             -ceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCc
Q 039799          173 -FKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAK  251 (346)
Q Consensus       173 -~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~  251 (346)
                       ..++|+||+.. +|.++.   ...+++..+..++.+++.|++|||   +.+++||||+|+||+++.++.++|+|||+++
T Consensus        93 ~~~~lv~e~~~~-~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~  165 (342)
T cd07879          93 QDFYLVMPYMQT-DLQKIM---GHPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR  165 (342)
T ss_pred             ceEEEEeccccc-CHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence             45899999964 676644   235788999999999999999999   9999999999999999999999999999988


Q ss_pred             cCCccccccccccccCCcccccCCCCCC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccCc------------------
Q 039799          252 PLLEEDQSLTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE------------------  312 (346)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~------------------  312 (346)
                      .....     .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.......                  
T Consensus       166 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  240 (342)
T cd07879         166 HADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQ  240 (342)
T ss_pred             CCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            54221     123457888999998766 468899999999999999999999996521100                  


Q ss_pred             ----ccHHHHHh--------------hhcCCChhhhhchhccCCccccccc
Q 039799          313 ----MTLKRWVN--------------DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       313 ----~~~~~~~~--------------~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                          .....++.              ...+..+.+++.+||..||++||+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~  291 (342)
T cd07879         241 KLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTA  291 (342)
T ss_pred             HhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCH
Confidence                00011110              0123357899999999999999985

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=4.7e-35  Score=266.27  Aligned_cols=238  Identities=21%  Similarity=0.251  Sum_probs=185.5

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecC---------
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSND---------  171 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~---------  171 (346)
                      ..+|.+.+.||.|++|.||+|... +|..||+|.+........+.+.+|++++++++|||++++++.+...         
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            467889999999999999999865 6899999998765555567788999999999999999998766543         


Q ss_pred             -----CceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEEC-CCCcEEEe
Q 039799          172 -----DFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD-DNMVAHLS  245 (346)
Q Consensus       172 -----~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~-~~~~~~l~  245 (346)
                           ...++|+||++ ++|.+.+..  ..+++.....++.|+++||.|||   +.+++||||||+||+++ +++.++++
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~kl~  157 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIG  157 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEEEC
Confidence                 35789999997 588877642  35788999999999999999999   99999999999999998 45678999


Q ss_pred             eecCCccCCcccccc-ccccccCCcccccCCCCCC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccCcc----------
Q 039799          246 DFGMAKPLLEEDQSL-TQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM----------  313 (346)
Q Consensus       246 Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~----------  313 (346)
                      |||.++......... ......++..|+|||.+.. ..++.++|||||||++|||++|+.||......+.          
T Consensus       158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~  237 (342)
T cd07854         158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV  237 (342)
T ss_pred             CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            999998653321111 1122357888999997644 5678899999999999999999999964211000          


Q ss_pred             -----------cHHH--------------HHhhhcCCChhhhhchhccCCccccccc
Q 039799          314 -----------TLKR--------------WVNDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       314 -----------~~~~--------------~~~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                                 ....              .....++..+.+++.+||..||++||++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  294 (342)
T cd07854         238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTA  294 (342)
T ss_pred             CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCH
Confidence                       0000              0011233466789999999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=3.2e-35  Score=269.60  Aligned_cols=206  Identities=26%  Similarity=0.354  Sum_probs=172.5

Q ss_pred             CCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcC-C-----CCceeeEEEEecCCceeEE
Q 039799          105 ANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRIC-H-----RNLIKIISSYSNDDFKALV  177 (346)
Q Consensus       105 ~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~~~~~~~~~~~~~lv  177 (346)
                      |.+.+.||+|+||.|-+|... +++.||||+++.. .....+...|+.+|..++ |     -|+|+++++|...++.+||
T Consensus       188 Y~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV  266 (586)
T KOG0667|consen  188 YEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV  266 (586)
T ss_pred             EEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence            567789999999999999855 7999999999765 344567778999999997 3     4899999999999999999


Q ss_pred             EecCCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC--CCcEEEeeecCCccCC
Q 039799          178 LEYMPHGSLEKCLYLSN-YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD--NMVAHLSDFGMAKPLL  254 (346)
Q Consensus       178 ~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~--~~~~~l~Dfg~~~~~~  254 (346)
                      +|.+ ..+|.++++... ..++......|+.||+.||.+||   +.+|||+||||+||||.+  ...+||+|||.+++..
T Consensus       267 fELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~  342 (586)
T KOG0667|consen  267 FELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFES  342 (586)
T ss_pred             ehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEecccccccC
Confidence            9999 559999997655 45889999999999999999999   999999999999999974  3489999999999753


Q ss_pred             ccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHhhh
Q 039799          255 EEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDL  322 (346)
Q Consensus       255 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~  322 (346)
                      ..-     ..-+-+..|.|||++.+.+|+.+.||||||||+.||++|.+-|..  +++.+....+-+.
T Consensus       343 q~v-----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG--~ne~DQl~~I~e~  403 (586)
T KOG0667|consen  343 QRV-----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG--DNEYDQLARIIEV  403 (586)
T ss_pred             Ccc-----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC--CCHHHHHHHHHHH
Confidence            321     234467889999999999999999999999999999999877754  3333444444333

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.7e-35  Score=264.57  Aligned_cols=234  Identities=24%  Similarity=0.308  Sum_probs=186.7

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEecCC-----
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSNDD-----  172 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----  172 (346)
                      ..++|.+.+.||+|++|.||++... ++..||+|++....  ....+.+.+|++++++++||||+++++.+....     
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            4567999999999999999999855 78999999986432  223456788999999999999999999886544     


Q ss_pred             -ceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCc
Q 039799          173 -FKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAK  251 (346)
Q Consensus       173 -~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~  251 (346)
                       ..++||||+ +++|.+++..  ..+++..+..++.|+++|++|||   +.+|+||||||+||+++.++.++++|||++.
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~  166 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR  166 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeccccc
Confidence             358999999 7799887753  45889999999999999999999   9999999999999999999999999999998


Q ss_pred             cCCccccccccccccCCcccccCCCCCC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccCcc-----------------
Q 039799          252 PLLEEDQSLTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM-----------------  313 (346)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~-----------------  313 (346)
                      .....     .....++..|+|||.+.+ ..++.++|+||+|++++++++|+.||........                 
T Consensus       167 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  241 (343)
T cd07880         167 QTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQ  241 (343)
T ss_pred             ccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            65321     123357889999998765 4578999999999999999999999964211000                 


Q ss_pred             -----cHHHH--------------HhhhcCCChhhhhchhccCCccccccc
Q 039799          314 -----TLKRW--------------VNDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       314 -----~~~~~--------------~~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                           ....+              ....++..+.+++.+||..||++||+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~  292 (343)
T cd07880         242 KLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITA  292 (343)
T ss_pred             hhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCH
Confidence                 00000              011233457899999999999999985

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.2e-34  Score=262.62  Aligned_cols=236  Identities=22%  Similarity=0.243  Sum_probs=183.2

Q ss_pred             CCCCCcccccCceEEEEEEEc-C--CCEEEEEEecCCC--chhHHHHHHHHHHHHhc-CCCCceeeEEEEecC----Cce
Q 039799          105 ANMPPLIGKGGFGSVYKAIIQ-D--GMEVAVKVFDPQY--EGAFKSFDIECDVMKRI-CHRNLIKIISSYSND----DFK  174 (346)
Q Consensus       105 ~~~~~~lg~G~~g~vy~~~~~-~--~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~----~~~  174 (346)
                      |.+.+.||+|+||.||++... .  +..+|+|++....  ....+.+.+|+++++++ .||||+++++.+...    ...
T Consensus         2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~   81 (332)
T cd07857           2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL   81 (332)
T ss_pred             ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence            667789999999999999966 4  7789999986432  22346678899999999 599999999875432    456


Q ss_pred             eEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCC
Q 039799          175 ALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  254 (346)
Q Consensus       175 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~  254 (346)
                      +++++++. ++|.+++. ....+++..+..++.|++.||+|||   +.+++||||||+||++++++.++|+|||+++.+.
T Consensus        82 ~~~~e~~~-~~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~  156 (332)
T cd07857          82 YLYEELME-ADLHQIIR-SGQPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFS  156 (332)
T ss_pred             EEEEeccc-CCHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence            78888885 68888775 3456889999999999999999999   9999999999999999999999999999998664


Q ss_pred             ccccc--cccccccCCcccccCCCCCC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccC--------------cccHH-
Q 039799          255 EEDQS--LTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSG--------------EMTLK-  316 (346)
Q Consensus       255 ~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~--------------~~~~~-  316 (346)
                      .....  .......++..|+|||...+ ..++.++|+||+|++++++++|+.||......              ..... 
T Consensus       157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (332)
T cd07857         157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR  236 (332)
T ss_pred             cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            32211  11223468899999997655 46889999999999999999999998642100              00000 


Q ss_pred             ---------------------HHHhhhcCCChhhhhchhccCCccccccc
Q 039799          317 ---------------------RWVNDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       317 ---------------------~~~~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                                           .+.....+..+.+++.+||..+|.+||+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~  286 (332)
T cd07857         237 IGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISV  286 (332)
T ss_pred             hhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCH
Confidence                                 01111123477899999999999999985

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-37  Score=297.17  Aligned_cols=237  Identities=27%  Similarity=0.351  Sum_probs=189.6

Q ss_pred             CCCCCcccccCceEEEEEE-EcCCCEEEEEEecCC--CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecC
Q 039799          105 ANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQ--YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYM  181 (346)
Q Consensus       105 ~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  181 (346)
                      +.-...||.|.||.||-|. ..+|.-.|+|-+.-.  .....+.+.+|..++..++|||+|+++|.-.+++..++-||||
T Consensus      1237 Wqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC 1316 (1509)
T KOG4645|consen 1237 WQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYC 1316 (1509)
T ss_pred             eccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHh
Confidence            4556789999999999998 557888999976533  2344567888999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccc--c
Q 039799          182 PHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ--S  259 (346)
Q Consensus       182 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~--~  259 (346)
                      ++|+|.+.+... ...++.....+..|++.|++|||   +.|||||||||.||+++.+|.+|++|||.|..+.....  .
T Consensus      1317 ~~GsLa~ll~~g-ri~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~ 1392 (1509)
T KOG4645|consen 1317 EGGSLASLLEHG-RIEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMP 1392 (1509)
T ss_pred             ccCcHHHHHHhc-chhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecCchhcCC
Confidence            999999988644 33455555568899999999999   99999999999999999999999999999998865421  1


Q ss_pred             cccccccCCcccccCCCCCCCC---CCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHH-------HHhhhcCCChhh
Q 039799          260 LTQTQTLATIGYMAPEYGREGR---VSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKR-------WVNDLLPISVME  329 (346)
Q Consensus       260 ~~~~~~~~~~~y~aPE~~~~~~---~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~-------~~~~~~~~~~~~  329 (346)
                      .......||+.|||||.+.+..   ...++||||+||+++||+||+.||.....+-.....       -+.+.+...-.+
T Consensus      1393 ~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~d 1472 (1509)
T KOG4645|consen 1393 GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRD 1472 (1509)
T ss_pred             HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHH
Confidence            2223467999999999987543   467889999999999999999999763221111111       111123335589


Q ss_pred             hhchhccCCccccccc
Q 039799          330 VVDANLLSQEDEHFTT  345 (346)
Q Consensus       330 ~~d~~l~~~p~~R~~~  345 (346)
                      +++.||..||++|+++
T Consensus      1473 Fle~Cl~~dP~~Rw~~ 1488 (1509)
T KOG4645|consen 1473 FLEHCLEQDPKMRWTA 1488 (1509)
T ss_pred             HHHHHHhcCchhhhHH
Confidence            9999999999999876

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-36  Score=278.69  Aligned_cols=237  Identities=27%  Similarity=0.362  Sum_probs=199.8

Q ss_pred             CCCCcccccCceEEEEEEEc-CC----CEEEEEEecCC-CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEe
Q 039799          106 NMPPLIGKGGFGSVYKAIIQ-DG----MEVAVKVFDPQ-YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLE  179 (346)
Q Consensus       106 ~~~~~lg~G~~g~vy~~~~~-~~----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  179 (346)
                      ...++||+|+||+||+|.|- .|    .+||+|++... ......++..|+-.|.+++|||+++++++|.... ..||++
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq  777 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ  777 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence            34568999999999999854 44    46899988644 3445688999999999999999999999998776 779999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccc
Q 039799          180 YMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  259 (346)
Q Consensus       180 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~  259 (346)
                      ||+.|+|.++++..+..+.....+.+..|||+|+.|||   .+.++||||-.+|||+.+-..+|+.|||+++.+..+...
T Consensus       778 ~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e  854 (1177)
T KOG1025|consen  778 LMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE  854 (1177)
T ss_pred             hcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence            99999999999988888888999999999999999999   999999999999999999999999999999988776665


Q ss_pred             cccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHhhhc------CCChhhhhc
Q 039799          260 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVNDLL------PISVMEVVD  332 (346)
Q Consensus       260 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~------~~~~~~~~d  332 (346)
                      .....-.-.+-|+|-|.+....++.++|||||||++||++| |..|++.+...+..-.-.....+      +.+++.++-
T Consensus       855 y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~mv  934 (1177)
T KOG1025|consen  855 YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVMV  934 (1177)
T ss_pred             ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHHHH
Confidence            55555556778999999999999999999999999999998 99999886544432111111122      237889999


Q ss_pred             hhccCCcccccccC
Q 039799          333 ANLLSQEDEHFTTK  346 (346)
Q Consensus       333 ~~l~~~p~~R~~~k  346 (346)
                      +||..|++.||+.|
T Consensus       935 kCwmid~~~rp~fk  948 (1177)
T KOG1025|consen  935 KCWMIDADSRPTFK  948 (1177)
T ss_pred             HHhccCcccCccHH
Confidence            99999999999754

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=2.3e-34  Score=260.14  Aligned_cols=234  Identities=23%  Similarity=0.274  Sum_probs=186.5

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEec-CCceeE
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSN-DDFKAL  176 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~l  176 (346)
                      ..++|.+.+.||+|+||.||++... +++.+|+|++....  ....+.+..|++++++++|||++++.+++.. ....++
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l   87 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF   87 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence            4567999999999999999999865 78999999875422  2334677789999999999999999998865 567889


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcc
Q 039799          177 VLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  256 (346)
Q Consensus       177 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~  256 (346)
                      ++||+ +++|.+++..  ..+++.....++.++++||+|||   +.+++||||+|+||++++++.++|+|||.+......
T Consensus        88 v~e~~-~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~  161 (328)
T cd07856          88 VTELL-GTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ  161 (328)
T ss_pred             Eeehh-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCccccccccCCC
Confidence            99998 5688887753  34677888889999999999999   999999999999999999999999999998854221


Q ss_pred             ccccccccccCCcccccCCCCCC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccCc----------ccHHHHH------
Q 039799          257 DQSLTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE----------MTLKRWV------  319 (346)
Q Consensus       257 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~----------~~~~~~~------  319 (346)
                           .....++..|+|||.+.+ ..++.++||||||++++||+||+.||.......          ....++.      
T Consensus       162 -----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (328)
T cd07856         162 -----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSE  236 (328)
T ss_pred             -----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccch
Confidence                 122346788999998765 568999999999999999999999986422100          0000000      


Q ss_pred             -----------------h---hhcCCChhhhhchhccCCccccccc
Q 039799          320 -----------------N---DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       320 -----------------~---~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                                       .   ..++..+.+++.+||..+|++||++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~  282 (328)
T cd07856         237 NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISA  282 (328)
T ss_pred             hhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCH
Confidence                             0   1234578899999999999999985

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=2e-35  Score=244.03  Aligned_cols=236  Identities=24%  Similarity=0.295  Sum_probs=187.8

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC-CchhHHHHHHHHHHHHhcC-CCCceeeEEEEecCCceeEEEe
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ-YEGAFKSFDIECDVMKRIC-HRNLIKIISSYSNDDFKALVLE  179 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e  179 (346)
                      ++..+...||.|+.|.|+++..+ .|...|||.+... .....+++...++++.... .|.||+.+|+|..+....+-||
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe  171 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME  171 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence            44566678999999999999977 6889999998654 3455677778888777664 8999999999999998889999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccc
Q 039799          180 YMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  259 (346)
Q Consensus       180 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~  259 (346)
                      .|. ..++..+..-...+++...-++...+.+||.||.+  +.+|+|||+||+|||+|+.|.+|++|||.+..+.+..  
T Consensus       172 lMs-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk--  246 (391)
T KOG0983|consen  172 LMS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK--  246 (391)
T ss_pred             HHH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccc--
Confidence            883 35566665555667887788899999999999985  6799999999999999999999999999999875432  


Q ss_pred             cccccccCCcccccCCCCCC---CCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh---------hhcCCCh
Q 039799          260 LTQTQTLATIGYMAPEYGRE---GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN---------DLLPISV  327 (346)
Q Consensus       260 ~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~---------~~~~~~~  327 (346)
                       ..+...|-+.|||||.+.-   ..|+.++||||||+.++|+.||+.||.....+-..+....+         ..++..+
T Consensus       247 -AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F  325 (391)
T KOG0983|consen  247 -AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDF  325 (391)
T ss_pred             -ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHH
Confidence             2234458899999998753   36889999999999999999999999763222122222221         1134478


Q ss_pred             hhhhchhccCCcccccc
Q 039799          328 MEVVDANLLSQEDEHFT  344 (346)
Q Consensus       328 ~~~~d~~l~~~p~~R~~  344 (346)
                      .++++.||..|+.+||.
T Consensus       326 ~~fv~~CL~kd~r~RP~  342 (391)
T KOG0983|consen  326 QSFVKDCLTKDHRKRPK  342 (391)
T ss_pred             HHHHHHHhhcCcccCcc
Confidence            89999999999999995

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.7e-34  Score=262.90  Aligned_cols=234  Identities=24%  Similarity=0.328  Sum_probs=184.4

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEecC------
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSND------  171 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------  171 (346)
                      ..++|.+.+.||+|+||.||+|... +++.||+|++....  ....+.+.+|++++++++||||+++.+++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (345)
T cd07877          15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   94 (345)
T ss_pred             ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence            4577999999999999999999854 78999999986532  22345677899999999999999999987532      


Q ss_pred             CceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCc
Q 039799          172 DFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAK  251 (346)
Q Consensus       172 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~  251 (346)
                      ...+++++++ +++|.+++..  ..+++..+..++.|+++|++|||   +.+++||||||+||++++++.++|+|||++.
T Consensus        95 ~~~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~  168 (345)
T cd07877          95 NDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR  168 (345)
T ss_pred             ccEEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCEEEecccccc
Confidence            3467788876 7899887653  35889999999999999999999   9999999999999999999999999999988


Q ss_pred             cCCccccccccccccCCcccccCCCCCC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccCcc-----------------
Q 039799          252 PLLEEDQSLTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM-----------------  313 (346)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~-----------------  313 (346)
                      .....     .....++..|+|||...+ ..++.++||||||++++||++|+.||........                 
T Consensus       169 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (345)
T cd07877         169 HTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK  243 (345)
T ss_pred             ccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHh
Confidence            54221     223457889999998765 4678899999999999999999999854211000                 


Q ss_pred             -----cHHHHHhh--------------hcCCChhhhhchhccCCccccccc
Q 039799          314 -----TLKRWVND--------------LLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       314 -----~~~~~~~~--------------~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                           ....+...              ..+..+.+++.+||..||++||+.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~  294 (345)
T cd07877         244 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA  294 (345)
T ss_pred             hcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCH
Confidence                 00000000              123356799999999999999985

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-36  Score=248.91  Aligned_cols=238  Identities=23%  Similarity=0.287  Sum_probs=190.6

Q ss_pred             cCCCCCCCCCCC-CcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhc-CCCCceeeEEEEec---
Q 039799           97 RGKPLPNDANMP-PLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRI-CHRNLIKIISSYSN---  170 (346)
Q Consensus        97 ~~~~~~~~~~~~-~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~---  170 (346)
                      +.....++|.+. ++||-|-.|.|-.+..+ +|+.+|+|++...     ....+|+++--.. .|||||.+++.|.+   
T Consensus        55 k~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~  129 (400)
T KOG0604|consen   55 KEYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQ  129 (400)
T ss_pred             hcccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhcc
Confidence            445566778765 57999999999998866 7999999997532     3344577655444 69999999998754   


Q ss_pred             -CCceeEEEecCCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEEC---CCCcEEEe
Q 039799          171 -DDFKALVLEYMPHGSLEKCLYLSN-YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD---DNMVAHLS  245 (346)
Q Consensus       171 -~~~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~---~~~~~~l~  245 (346)
                       ...+.+|||.|+||.|.+.++.++ ..+++...-.|..+|..|+.|||   +.+|.||||||+|+|..   .+..+||+
T Consensus       130 ~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLt  206 (400)
T KOG0604|consen  130 GRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLT  206 (400)
T ss_pred             CceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEec
Confidence             457889999999999999887654 56899999999999999999999   99999999999999996   45689999


Q ss_pred             eecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCc-------------
Q 039799          246 DFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE-------------  312 (346)
Q Consensus       246 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~-------------  312 (346)
                      |||+|+.-..   .....+.+-|+.|.|||++...+|+..+|+||+||++|-|++|.+||.....-.             
T Consensus       207 DfGFAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gq  283 (400)
T KOG0604|consen  207 DFGFAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQ  283 (400)
T ss_pred             ccccccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccC
Confidence            9999996432   233456678999999999999999999999999999999999999997643211             


Q ss_pred             ccHHHHHhhhcCCChhhhhchhccCCccccccc
Q 039799          313 MTLKRWVNDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ..+..--...+++...|+|.+.|+.+|.+|.|.
T Consensus       284 y~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI  316 (400)
T KOG0604|consen  284 YEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTI  316 (400)
T ss_pred             ccCCChhHhHHHHHHHHHHHHHhcCCchhheeH
Confidence            111111122344577899999999999999875

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=8.5e-35  Score=254.41  Aligned_cols=235  Identities=21%  Similarity=0.290  Sum_probs=186.5

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC-----CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEE
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ-----YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALV  177 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  177 (346)
                      +|.+.+.||+|++|.||++... .+..+++|+++..     .......+..|+.++++++|||++++++++.+.+..++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            3778899999999999999865 3455666665431     122334566789999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCC
Q 039799          178 LEYMPHGSLEKCLYL---SNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  254 (346)
Q Consensus       178 ~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~  254 (346)
                      +||+++++|.+++..   ....+++..++.++.++++|+.|||   +.+++|+||+|+||++++ +.++|+|||.+....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecC
Confidence            999999999988753   3356899999999999999999999   999999999999999975 569999999988764


Q ss_pred             ccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH-------hhhcCCCh
Q 039799          255 EEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV-------NDLLPISV  327 (346)
Q Consensus       255 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~-------~~~~~~~~  327 (346)
                      ....  ......++..|+|||...+..++.++|+||||++++++++|..||+..... .......       ....+..+
T Consensus       157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  233 (260)
T cd08222         157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL-SVVLRIVEGPTPSLPETYSRQL  233 (260)
T ss_pred             CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHcCCCCCCcchhcHHH
Confidence            3221  122345788999999988888899999999999999999999998642111 1111111       11234477


Q ss_pred             hhhhchhccCCccccccc
Q 039799          328 MEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       328 ~~~~d~~l~~~p~~R~~~  345 (346)
                      .+++.+|+..+|++||+.
T Consensus       234 ~~li~~~l~~~p~~Rp~~  251 (260)
T cd08222         234 NSIMQSMLNKDPSLRPSA  251 (260)
T ss_pred             HHHHHHHhcCChhhCcCH
Confidence            899999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.7e-35  Score=248.43  Aligned_cols=199  Identities=26%  Similarity=0.367  Sum_probs=165.6

Q ss_pred             CCCCCCCcccccCceEEEEEEEc---C--CCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEec-CCce
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ---D--GMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSN-DDFK  174 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~---~--~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~  174 (346)
                      ..|+....||+|+||.||+|.-.   +  ...+|+|.++.+.  .+......+|+.+++.++|||++.+...+.. +...
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            46899999999999999999633   2  2379999997553  2344667789999999999999999998876 7789


Q ss_pred             eEEEecCCCCChhhhhhhc----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCC----CcEEEee
Q 039799          175 ALVLEYMPHGSLEKCLYLS----NYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDN----MVAHLSD  246 (346)
Q Consensus       175 ~lv~e~~~~gsL~~~l~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~----~~~~l~D  246 (346)
                      +|++||.+. +|.++++..    ...++......|+.||+.|+.|||   +.=|+|||+||.|||+..+    |.+||+|
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeEeec
Confidence            999999977 787777532    257888889999999999999999   7779999999999999877    8999999


Q ss_pred             ecCCccCCccccc-cccccccCCcccccCCCCCCC-CCCcchhHHHHHHHHHHHHcCCCCC
Q 039799          247 FGMAKPLLEEDQS-LTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMEIFTRTKPT  305 (346)
Q Consensus       247 fg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~  305 (346)
                      +|+++.+...-.. ......+-|.+|.|||.+.+. .|+.+.||||.|||+.||+|-.+-|
T Consensus       180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF  240 (438)
T KOG0666|consen  180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLF  240 (438)
T ss_pred             ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccc
Confidence            9999987543222 233456689999999998876 5889999999999999999987765

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-34  Score=262.52  Aligned_cols=233  Identities=25%  Similarity=0.381  Sum_probs=195.4

Q ss_pred             CCCcccccCceEEEEEEEc---CCC--EEEEEEecCC-CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEec
Q 039799          107 MPPLIGKGGFGSVYKAIIQ---DGM--EVAVKVFDPQ-YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEY  180 (346)
Q Consensus       107 ~~~~lg~G~~g~vy~~~~~---~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  180 (346)
                      ..++||+|-||.||+|...   .|+  .||||..+.. .....+.|.+|..++++++||||++++|.|.+. ..++|||.
T Consensus       393 l~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~WivmEL  471 (974)
T KOG4257|consen  393 LKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVMEL  471 (974)
T ss_pred             HHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEEec
Confidence            3467999999999999843   233  5889988764 344578899999999999999999999999876 46799999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccc
Q 039799          181 MPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  260 (346)
Q Consensus       181 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~  260 (346)
                      ++-|-|..+++.....++......++.||..+|+|||   +..++||||-.+|||+....-+||+|||+++.+.+... .
T Consensus       472 ~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~y-Y  547 (974)
T KOG4257|consen  472 APLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAY-Y  547 (974)
T ss_pred             ccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhccccch-h
Confidence            9999999999988889999999999999999999999   99999999999999999999999999999998755432 3


Q ss_pred             ccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccH------HHHHhhhcCCChhhhhch
Q 039799          261 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTL------KRWVNDLLPISVMEVVDA  333 (346)
Q Consensus       261 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~------~~~~~~~~~~~~~~~~d~  333 (346)
                      ..+...-...|+|||...-..++.++|||.|||.+||+++ |..||......+...      +--.....|..+..++.+
T Consensus       548 kaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LYslmsk  627 (974)
T KOG4257|consen  548 KASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALYSLMSK  627 (974)
T ss_pred             hccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHHHHHHH
Confidence            3333345677999999988899999999999999999986 999997644333211      122234456688999999


Q ss_pred             hccCCcccccc
Q 039799          334 NLLSQEDEHFT  344 (346)
Q Consensus       334 ~l~~~p~~R~~  344 (346)
                      |+..+|.+||.
T Consensus       628 cWayeP~kRPr  638 (974)
T KOG4257|consen  628 CWAYEPSKRPR  638 (974)
T ss_pred             HhccCcccCCc
Confidence            99999999996

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-34  Score=264.00  Aligned_cols=234  Identities=25%  Similarity=0.326  Sum_probs=188.2

Q ss_pred             CCCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCc---
Q 039799          100 PLPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDF---  173 (346)
Q Consensus       100 ~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---  173 (346)
                      ...++|.+...||+|++|.||+|... +++.||+|++....  ....+.+.+|+.++++++|||++++.+++...+.   
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            45678999999999999999999976 68899999986432  2234567789999999999999999987765554   


Q ss_pred             ---eeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCC
Q 039799          174 ---KALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMA  250 (346)
Q Consensus       174 ---~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~  250 (346)
                         .++|+||+ +++|.+++..  ..+++..+..++.++++|++|||   +.+++||||+|+||++++++.++|+|||++
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~~  165 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLA  165 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEcccccc
Confidence               88999998 6799888754  45899999999999999999999   999999999999999999999999999999


Q ss_pred             ccCCccccccccccccCCcccccCCCCCC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHH-------------
Q 039799          251 KPLLEEDQSLTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLK-------------  316 (346)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~-------------  316 (346)
                      ......     .....++..|+|||...+ ..++.++||||||+++||++||+.||......+ .+.             
T Consensus       166 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~-~~~~i~~~~~~~~~~~  239 (343)
T cd07851         166 RHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID-QLKRIMNLVGTPDEEL  239 (343)
T ss_pred             cccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHhcCCCCHHH
Confidence            865322     223357888999998754 367899999999999999999999986421100 000             


Q ss_pred             ----------HH--------------HhhhcCCChhhhhchhccCCccccccc
Q 039799          317 ----------RW--------------VNDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       317 ----------~~--------------~~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                                .+              .....+..+.+++.+||..+|++|||+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~  292 (343)
T cd07851         240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITA  292 (343)
T ss_pred             HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCH
Confidence                      00              001134477899999999999999985

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-35  Score=261.19  Aligned_cols=227  Identities=25%  Similarity=0.388  Sum_probs=187.8

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecCCCC
Q 039799          108 PPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHG  184 (346)
Q Consensus       108 ~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  184 (346)
                      .+.||+|-||+||-|+++ +|+.||||++++..  .....++.+|+.+|.+++||.||.+...|+..+..+.|||-+.|.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            357999999999999976 89999999997542  233467888999999999999999999999999999999999766


Q ss_pred             ChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCC---CcEEEeeecCCccCCccccccc
Q 039799          185 SLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDN---MVAHLSDFGMAKPLLEEDQSLT  261 (346)
Q Consensus       185 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~---~~~~l~Dfg~~~~~~~~~~~~~  261 (346)
                      -|+-++......++...-.-++.||+.||.|||   -++|+|+|+||+|||+.+.   -.+||+|||+|+.+.+..   .
T Consensus       649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks---F  722 (888)
T KOG4236|consen  649 MLEMILSSEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS---F  722 (888)
T ss_pred             HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecchhh---h
Confidence            666667666678888888889999999999999   9999999999999999643   379999999999885433   3


Q ss_pred             cccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHhh-----------hcCCChhhh
Q 039799          262 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVND-----------LLPISVMEV  330 (346)
Q Consensus       262 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~-----------~~~~~~~~~  330 (346)
                      ....+||+.|.|||++....|+..-|+||.|||+|--++|..||.+..    ++.+.+..           .+.....|+
T Consensus       723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE----dIndQIQNAaFMyPp~PW~eis~~Aidl  798 (888)
T KOG4236|consen  723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE----DINDQIQNAAFMYPPNPWSEISPEAIDL  798 (888)
T ss_pred             hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc----chhHHhhccccccCCCchhhcCHHHHHH
Confidence            456789999999999999999999999999999999999999997622    22222211           122355778


Q ss_pred             hchhccCCcccccc
Q 039799          331 VDANLLSQEDEHFT  344 (346)
Q Consensus       331 ~d~~l~~~p~~R~~  344 (346)
                      |...|+..=.+|.|
T Consensus       799 In~LLqVkm~kRys  812 (888)
T KOG4236|consen  799 INNLLQVKMRKRYS  812 (888)
T ss_pred             HHHHHHHHHHHhcc
Confidence            88888777777765

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-34  Score=262.49  Aligned_cols=231  Identities=21%  Similarity=0.295  Sum_probs=188.9

Q ss_pred             CCCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhc-CCCCceeeEEEEecCCceeEE
Q 039799          100 PLPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRI-CHRNLIKIISSYSNDDFKALV  177 (346)
Q Consensus       100 ~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  177 (346)
                      ....+|.+...+|.|+|+.|-.+... +++..++|++....    .+..+|+.++... .|||++++.+.+.+..+.++|
T Consensus       319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v  394 (612)
T KOG0603|consen  319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLV  394 (612)
T ss_pred             CcchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeee
Confidence            35677888888999999999998855 78899999997652    2233466555554 799999999999999999999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEE-CCCCcEEEeeecCCccCCcc
Q 039799          178 LEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL-DDNMVAHLSDFGMAKPLLEE  256 (346)
Q Consensus       178 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll-~~~~~~~l~Dfg~~~~~~~~  256 (346)
                      ||.+.++-+.+.+.... ... ..+..|+.+|+.++.|||   +++++|||+||+|||+ ++.++++|+|||.++.....
T Consensus       395 ~e~l~g~ell~ri~~~~-~~~-~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~  469 (612)
T KOG0603|consen  395 MELLDGGELLRRIRSKP-EFC-SEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS  469 (612)
T ss_pred             ehhccccHHHHHHHhcc-hhH-HHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence            99999988877664332 222 566679999999999999   9999999999999999 58899999999999976443


Q ss_pred             ccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh-----hhcCCChhhhh
Q 039799          257 DQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN-----DLLPISVMEVV  331 (346)
Q Consensus       257 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~  331 (346)
                           ....+-|..|.|||......|++.+|+||||++||+|++|+.||..-..+ .++...+.     ..+++..++++
T Consensus       470 -----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~ei~~~i~~~~~s~~vS~~AKdLl  543 (612)
T KOG0603|consen  470 -----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-IEIHTRIQMPKFSECVSDEAKDLL  543 (612)
T ss_pred             -----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-HHHHHhhcCCccccccCHHHHHHH
Confidence                 23345788999999999999999999999999999999999999874444 33333332     23456889999


Q ss_pred             chhccCCccccccc
Q 039799          332 DANLLSQEDEHFTT  345 (346)
Q Consensus       332 d~~l~~~p~~R~~~  345 (346)
                      ..+|..||.+|+++
T Consensus       544 ~~LL~~dP~~Rl~~  557 (612)
T KOG0603|consen  544 QQLLQVDPALRLGA  557 (612)
T ss_pred             HHhccCChhhCcCh
Confidence            99999999999986

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-35  Score=253.73  Aligned_cols=234  Identities=24%  Similarity=0.299  Sum_probs=188.9

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhc-CCCCceeeEEEEecCCceeEEE
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRI-CHRNLIKIISSYSNDDFKALVL  178 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  178 (346)
                      +|++..+||+|+||.|-+|.-+ +.+.+|||++++..   ....+--+.|-++|+.- +-|.++++..+|..-+.+|.||
T Consensus       350 DFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVM  429 (683)
T KOG0696|consen  350 DFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVM  429 (683)
T ss_pred             ccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEE
Confidence            5888899999999999999866 56789999987642   22233344567777665 5788889999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccc
Q 039799          179 EYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  258 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~  258 (346)
                      ||+.||+|-.+++. -..+.++.+.-+|..||-||-|||   +++|+.||+|.+|||+|.+|++||+|||+++.-.-  .
T Consensus       430 EyvnGGDLMyhiQQ-~GkFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~--~  503 (683)
T KOG0696|consen  430 EYVNGGDLMYHIQQ-VGKFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF--D  503 (683)
T ss_pred             EEecCchhhhHHHH-hcccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeeccccccccc--C
Confidence            99999999877753 345666778889999999999999   99999999999999999999999999999985322  2


Q ss_pred             ccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH-hhh--cCC----Chhhhh
Q 039799          259 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV-NDL--LPI----SVMEVV  331 (346)
Q Consensus       259 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~-~~~--~~~----~~~~~~  331 (346)
                      ..+..+.+||+-|+|||.+..++|+..+|-|||||+||||+.|++||+.  +++..+-+-+ ...  +|.    +..++.
T Consensus       504 ~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdG--eDE~elF~aI~ehnvsyPKslSkEAv~ic  581 (683)
T KOG0696|consen  504 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG--EDEDELFQAIMEHNVSYPKSLSKEAVAIC  581 (683)
T ss_pred             CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCC--CCHHHHHHHHHHccCcCcccccHHHHHHH
Confidence            2344567899999999999999999999999999999999999999987  2333333332 222  233    556788


Q ss_pred             chhccCCccccccc
Q 039799          332 DANLLSQEDEHFTT  345 (346)
Q Consensus       332 d~~l~~~p~~R~~~  345 (346)
                      ...|...|.+|..+
T Consensus       582 kg~ltK~P~kRLGc  595 (683)
T KOG0696|consen  582 KGLLTKHPGKRLGC  595 (683)
T ss_pred             HHHhhcCCccccCC
Confidence            88889999999753

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.8e-33  Score=275.37  Aligned_cols=145  Identities=28%  Similarity=0.401  Sum_probs=130.2

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEE
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVL  178 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  178 (346)
                      ++|.+.+.||+|+||.||+|... +++.||+|++....   ......+..|+.+++.++||||+++++.+...+..++||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            56888999999999999999976 78999999986432   233467888999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCc
Q 039799          179 EYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAK  251 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~  251 (346)
                      ||+++++|.+++... ..+++...+.++.+++.||+|||   ..+|+||||||+|||++.++.++|+|||+++
T Consensus        84 Ey~~g~~L~~li~~~-~~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999999988643 35788889999999999999999   8999999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=4e-33  Score=240.37  Aligned_cols=223  Identities=30%  Similarity=0.390  Sum_probs=187.1

Q ss_pred             CceEEEEEEEc-CCCEEEEEEecCCCchh-HHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecCCCCChhhhhhh
Q 039799          115 GFGSVYKAIIQ-DGMEVAVKVFDPQYEGA-FKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYL  192 (346)
Q Consensus       115 ~~g~vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~  192 (346)
                      ++|.||+|... +++.+++|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            57999999987 58999999997654433 67889999999999999999999999999999999999999999998865


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccccccccCCcccc
Q 039799          193 SNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYM  272 (346)
Q Consensus       193 ~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~  272 (346)
                      ... +++..++.++.+++.++.|||   +.+++|+||+|+||++++++.++++|||.+.......   ......++..|+
T Consensus        81 ~~~-~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~  153 (244)
T smart00220       81 RGR-LSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYM  153 (244)
T ss_pred             ccC-CCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCC
Confidence            433 889999999999999999999   8999999999999999999999999999998764432   223345788999


Q ss_pred             cCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHhhh----------cCCChhhhhchhccCCcccc
Q 039799          273 APEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDL----------LPISVMEVVDANLLSQEDEH  342 (346)
Q Consensus       273 aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~----------~~~~~~~~~d~~l~~~p~~R  342 (346)
                      +||......++.++||||||++++++++|..||+..... ....++....          ++..+.+++.+|+..+|++|
T Consensus       154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R  232 (244)
T smart00220      154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL-LELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKR  232 (244)
T ss_pred             CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhc
Confidence            999998888899999999999999999999999653211 1122222111          44577899999999999999


Q ss_pred             ccc
Q 039799          343 FTT  345 (346)
Q Consensus       343 ~~~  345 (346)
                      |+.
T Consensus       233 p~~  235 (244)
T smart00220      233 LTA  235 (244)
T ss_pred             cCH
Confidence            985

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-34  Score=277.92  Aligned_cols=204  Identities=25%  Similarity=0.359  Sum_probs=178.1

Q ss_pred             CCCCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC---CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCce
Q 039799           99 KPLPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ---YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFK  174 (346)
Q Consensus        99 ~~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  174 (346)
                      +..+++|.+.++||+|+||.|..++++ +++.||+|++++-   ......-|..|-++|..-..+=|+.+.-.|.+..++
T Consensus        71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~L  150 (1317)
T KOG0612|consen   71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYL  150 (1317)
T ss_pred             hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccce
Confidence            345678999999999999999999976 7889999998752   223345678899999988889999999999999999


Q ss_pred             eEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCC
Q 039799          175 ALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  254 (346)
Q Consensus       175 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~  254 (346)
                      |+|||||+||+|-..+.... .++...+..++..+.-||.-+|   +.|+|||||||+|||+|..|++||+|||.|-.+.
T Consensus       151 YlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~  226 (1317)
T KOG0612|consen  151 YLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMD  226 (1317)
T ss_pred             EEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhHHhcC
Confidence            99999999999999887666 6777777789999999999999   9999999999999999999999999999999886


Q ss_pred             ccccccccccccCCcccccCCCCC----C-CCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 039799          255 EEDQSLTQTQTLATIGYMAPEYGR----E-GRVSTNGDVYSFGIMLMEIFTRTKPTDE  307 (346)
Q Consensus       255 ~~~~~~~~~~~~~~~~y~aPE~~~----~-~~~~~~~Dv~s~G~il~elltg~~p~~~  307 (346)
                      .++. ......+|||-|++||++.    + +.|+..+|.||+||++|||+.|..||..
T Consensus       227 ~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa  283 (1317)
T KOG0612|consen  227 ADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA  283 (1317)
T ss_pred             CCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence            5443 3345678999999999765    2 5789999999999999999999999964

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-33  Score=267.73  Aligned_cols=235  Identities=28%  Similarity=0.435  Sum_probs=192.7

Q ss_pred             CCCCcccccCceEEEEEEEc----C----CCEEEEEEecCCC-chhHHHHHHHHHHHHhc-CCCCceeeEEEEecCCcee
Q 039799          106 NMPPLIGKGGFGSVYKAIIQ----D----GMEVAVKVFDPQY-EGAFKSFDIECDVMKRI-CHRNLIKIISSYSNDDFKA  175 (346)
Q Consensus       106 ~~~~~lg~G~~g~vy~~~~~----~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  175 (346)
                      .+.+.+|+|.||.|++|...    .    ...||||.+.... ....+.+..|++++..+ +|+|++.++|.|..++..+
T Consensus       299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~  378 (609)
T KOG0200|consen  299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLY  378 (609)
T ss_pred             cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceE
Confidence            45568999999999999833    1    4579999987543 34567889999999998 5999999999999999999


Q ss_pred             EEEecCCCCChhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCC
Q 039799          176 LVLEYMPHGSLEKCLYLSN---------------YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM  240 (346)
Q Consensus       176 lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~  240 (346)
                      +|+||+..|+|.+++....               ..++....+.++.|||.|++||+   +.+++|||+-.+|||+.++.
T Consensus       379 ~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRNVLi~~~~  455 (609)
T KOG0200|consen  379 VIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARNVLITKNK  455 (609)
T ss_pred             EEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhhEEecCCC
Confidence            9999999999999997666               34888999999999999999999   99999999999999999999


Q ss_pred             cEEEeeecCCccCCcccccccc-ccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHH
Q 039799          241 VAHLSDFGMAKPLLEEDQSLTQ-TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRW  318 (346)
Q Consensus       241 ~~~l~Dfg~~~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~  318 (346)
                      .+||+|||+|+........... +...-...|+|||.+....++.|+|||||||+||||+| |..||..... ..++.++
T Consensus       456 ~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~-~~~l~~~  534 (609)
T KOG0200|consen  456 VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP-TEELLEF  534 (609)
T ss_pred             EEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc-HHHHHHH
Confidence            9999999999965443322211 11013556999999999999999999999999999998 8889976321 2233445


Q ss_pred             Hhhhc--------CCChhhhhchhccCCcccccc
Q 039799          319 VNDLL--------PISVMEVVDANLLSQEDEHFT  344 (346)
Q Consensus       319 ~~~~~--------~~~~~~~~d~~l~~~p~~R~~  344 (346)
                      ++...        ++++.+++..|+..+|++||+
T Consensus       535 l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~  568 (609)
T KOG0200|consen  535 LKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPT  568 (609)
T ss_pred             HhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCC
Confidence            54432        337789999999999999997

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-33  Score=220.04  Aligned_cols=196  Identities=27%  Similarity=0.331  Sum_probs=169.3

Q ss_pred             CCCCCCcccccCceEEEEEEE-cCCCEEEEEEec--CCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEec
Q 039799          104 DANMPPLIGKGGFGSVYKAII-QDGMEVAVKVFD--PQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEY  180 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  180 (346)
                      +|+-.+.||+|+||+||+|+. .+++.||+|...  ...++......+|+-+++.++|.|||++++....+...-+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            455667899999999999984 478899999875  34456667888999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccc
Q 039799          181 MPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  260 (346)
Q Consensus       181 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~  260 (346)
                      + ..+|..+....+..++.+....++.|+++|+.|+|   +..+.|||+||.|.|++.+|+.|++|||+++.+.-+-  .
T Consensus        83 c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgipv--r  156 (292)
T KOG0662|consen   83 C-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV--R  156 (292)
T ss_pred             h-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCce--E
Confidence            9 45899998888889999999999999999999999   9999999999999999999999999999999763322  2


Q ss_pred             ccccccCCcccccCCCCCCCC-CCcchhHHHHHHHHHHHHc-CCCCC
Q 039799          261 TQTQTLATIGYMAPEYGREGR-VSTNGDVYSFGIMLMEIFT-RTKPT  305 (346)
Q Consensus       261 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~s~G~il~ellt-g~~p~  305 (346)
                      ..+..+-|.+|.+|..+.+.+ |+...|+||.|||+.|+.. |++-|
T Consensus       157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplf  203 (292)
T KOG0662|consen  157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF  203 (292)
T ss_pred             eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCC
Confidence            234456799999999888765 7888999999999999986 55544

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.8e-32  Score=256.37  Aligned_cols=242  Identities=19%  Similarity=0.250  Sum_probs=174.4

Q ss_pred             CCCCCCCCCCcccccCceEEEEEEE-----------------cCCCEEEEEEecCCCchhHHH--------------HHH
Q 039799          100 PLPNDANMPPLIGKGGFGSVYKAII-----------------QDGMEVAVKVFDPQYEGAFKS--------------FDI  148 (346)
Q Consensus       100 ~~~~~~~~~~~lg~G~~g~vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~  148 (346)
                      ...++|.+.+.||+|+||.||+|..                 .+++.||||++........++              ...
T Consensus       142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v  221 (507)
T PLN03224        142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV  221 (507)
T ss_pred             ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence            3467899999999999999999964                 235689999986543322222              334


Q ss_pred             HHHHHHhcCCCCc-----eeeEEEEec--------CCceeEEEecCCCCChhhhhhhcC---------------------
Q 039799          149 ECDVMKRICHRNL-----IKIISSYSN--------DDFKALVLEYMPHGSLEKCLYLSN---------------------  194 (346)
Q Consensus       149 e~~~l~~l~h~ni-----v~~~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~---------------------  194 (346)
                      |+.++.+++|.++     ++++++|..        ++..+|||||+++++|.++++...                     
T Consensus       222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~  301 (507)
T PLN03224        222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM  301 (507)
T ss_pred             HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence            7777778876654     567777643        356789999999999999886421                     


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccccccccCCcccc
Q 039799          195 --YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYM  272 (346)
Q Consensus       195 --~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~  272 (346)
                        ..+++..+..++.+++++|.|||   +.+|+||||||+||+++.++.++|+|||++..+..... .......+++.|+
T Consensus       302 ~~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~  377 (507)
T PLN03224        302 PQDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYS  377 (507)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCccee
Confidence              13467778899999999999999   99999999999999999999999999999976532211 1111223578999


Q ss_pred             cCCCCCCCCC----------------------CcchhHHHHHHHHHHHHcCCC-CCCccc--c-----CcccHHHHHh--
Q 039799          273 APEYGREGRV----------------------STNGDVYSFGIMLMEIFTRTK-PTDEIF--S-----GEMTLKRWVN--  320 (346)
Q Consensus       273 aPE~~~~~~~----------------------~~~~Dv~s~G~il~elltg~~-p~~~~~--~-----~~~~~~~~~~--  320 (346)
                      |||.+.....                      ..+.||||+||+++||++|.. |+....  .     ...+...|..  
T Consensus       378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~  457 (507)
T PLN03224        378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYK  457 (507)
T ss_pred             ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhc
Confidence            9998753321                      134699999999999999986 665321  1     1112222321  


Q ss_pred             ---------hhcCCChhhhhchhccCCc---cccccc
Q 039799          321 ---------DLLPISVMEVVDANLLSQE---DEHFTT  345 (346)
Q Consensus       321 ---------~~~~~~~~~~~d~~l~~~p---~~R~~~  345 (346)
                               ...++..++++.++|..+|   .+|+|+
T Consensus       458 ~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa  494 (507)
T PLN03224        458 GQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSV  494 (507)
T ss_pred             ccCCCcccccccChHHHHHHHHHhccCCCCcccCCCH
Confidence                     1123367899999999766   689986

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1.3e-32  Score=263.35  Aligned_cols=238  Identities=21%  Similarity=0.269  Sum_probs=163.7

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEc-C----CCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEE------Ee
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQ-D----GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISS------YS  169 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~------~~  169 (346)
                      ..++|.+.+.||+|+||.||+|.+. +    +..||+|++......  +....|  .+....+.++..+...      ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            4467899999999999999999976 4    689999987643221  111111  1122222222222211      24


Q ss_pred             cCCceeEEEecCCCCChhhhhhhcCCC-------------------CCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCC
Q 039799          170 NDDFKALVLEYMPHGSLEKCLYLSNYI-------------------LDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLK  230 (346)
Q Consensus       170 ~~~~~~lv~e~~~~gsL~~~l~~~~~~-------------------l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik  230 (346)
                      .....++|+||+.+++|.+++......                   .....+..++.|++.||+|||   +.+|+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCC
Confidence            566889999999999999988644311                   112334578999999999999   9999999999


Q ss_pred             CCceEECC-CCcEEEeeecCCccCCccccccccccccCCcccccCCCCCCC----------------------CCCcchh
Q 039799          231 PSNVLLDD-NMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREG----------------------RVSTNGD  287 (346)
Q Consensus       231 ~~NIll~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~D  287 (346)
                      |+|||+++ ++.+||+|||+++.+.... ........+++.|+|||.+...                      .++.++|
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            99999985 5799999999998653321 1223345689999999954321                      2345679


Q ss_pred             HHHHHHHHHHHHcCCCCCCcc--------ccCcccHHHHHhhhcCC-----------------ChhhhhchhccCCcccc
Q 039799          288 VYSFGIMLMEIFTRTKPTDEI--------FSGEMTLKRWVNDLLPI-----------------SVMEVVDANLLSQEDEH  342 (346)
Q Consensus       288 v~s~G~il~elltg~~p~~~~--------~~~~~~~~~~~~~~~~~-----------------~~~~~~d~~l~~~p~~R  342 (346)
                      ||||||++|||+++..|++..        ...+.+...|.....+.                 ..++++++||..||.+|
T Consensus       362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR  441 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQR  441 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccC
Confidence            999999999999988876542        11122333443221111                 23489999999999999


Q ss_pred             cccC
Q 039799          343 FTTK  346 (346)
Q Consensus       343 ~~~k  346 (346)
                      ||++
T Consensus       442 ~ta~  445 (566)
T PLN03225        442 ISAK  445 (566)
T ss_pred             CCHH
Confidence            9863

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.9e-35  Score=239.70  Aligned_cols=199  Identities=25%  Similarity=0.369  Sum_probs=165.7

Q ss_pred             CCCCCcccccCceEEEEEEEc-CCCEEEEEEe--cCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEec--------CCc
Q 039799          105 ANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVF--DPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSN--------DDF  173 (346)
Q Consensus       105 ~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~--~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------~~~  173 (346)
                      |.-...||+|.||.||+|+.+ .|+.||+|+.  ..+.++......+|+++|..++|+|++.+++.|..        ...
T Consensus        19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t   98 (376)
T KOG0669|consen   19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT   98 (376)
T ss_pred             HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence            555678999999999999866 6778888764  23334444566789999999999999999987743        235


Q ss_pred             eeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccC
Q 039799          174 KALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  253 (346)
Q Consensus       174 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~  253 (346)
                      .|+||++++. +|.-.+......++...+.+++.++..||.|+|   ...|+|||+|+.|+|++.++.++|+|||+++.+
T Consensus        99 ~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGlar~f  174 (376)
T KOG0669|consen   99 FYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGLARAF  174 (376)
T ss_pred             eeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeeccccccce
Confidence            8899999976 777777666678999999999999999999999   999999999999999999999999999999876


Q ss_pred             Ccc--ccccccccccCCcccccCCCCCC-CCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 039799          254 LEE--DQSLTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMEIFTRTKPTDE  307 (346)
Q Consensus       254 ~~~--~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~  307 (346)
                      ...  ......+..+-|.+|.+||.+.+ ..++++.|||+.|||+.||+||.+-+..
T Consensus       175 s~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqg  231 (376)
T KOG0669|consen  175 STSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQG  231 (376)
T ss_pred             ecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccC
Confidence            432  23344566778999999998765 4689999999999999999999987754

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-33  Score=234.59  Aligned_cols=238  Identities=23%  Similarity=0.326  Sum_probs=194.5

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhc-CCCCceeeEEEEecCCceeEE
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRI-CHRNLIKIISSYSNDDFKALV  177 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  177 (346)
                      ++|+...+||+|+|+.|-.+.+. +.+.+|+|+++++.   ....+..+.|-.+..+. +||.+|-+..+|......++|
T Consensus       250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv  329 (593)
T KOG0695|consen  250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV  329 (593)
T ss_pred             ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence            57899999999999999999865 67889999987542   23344555676666665 699999999999999999999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccc
Q 039799          178 LEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  257 (346)
Q Consensus       178 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~  257 (346)
                      .||++||+|--+++ ++..++...+.-+...|.-||.|||   ++||+.||+|.+|+|+|.+|++|++|||+++.-..+ 
T Consensus       330 ieyv~ggdlmfhmq-rqrklpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~l~~-  404 (593)
T KOG0695|consen  330 IEYVNGGDLMFHMQ-RQRKLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP-  404 (593)
T ss_pred             EEEecCcceeeehh-hhhcCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcCCCC-
Confidence            99999999976665 3456778888889999999999999   999999999999999999999999999999964332 


Q ss_pred             cccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCcc--ccCcccHHHHHhhh-----------cC
Q 039799          258 QSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEI--FSGEMTLKRWVNDL-----------LP  324 (346)
Q Consensus       258 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~--~~~~~~~~~~~~~~-----------~~  324 (346)
                       ....++.+||+.|+|||.+.+..|+...|-|++||+++||+.|+.||+-.  ...+++..++.-+.           ++
T Consensus       405 -gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprsls  483 (593)
T KOG0695|consen  405 -GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSLS  483 (593)
T ss_pred             -CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccceee
Confidence             23445678999999999999999999999999999999999999999742  23333333333221           22


Q ss_pred             CChhhhhchhccCCcccccccC
Q 039799          325 ISVMEVVDANLLSQEDEHFTTK  346 (346)
Q Consensus       325 ~~~~~~~d~~l~~~p~~R~~~k  346 (346)
                      -+...++..-|..||++|...|
T Consensus       484 vkas~vlkgflnkdp~erlgc~  505 (593)
T KOG0695|consen  484 VKASHVLKGFLNKDPKERLGCR  505 (593)
T ss_pred             hhhHHHHHHhhcCCcHHhcCCC
Confidence            2667899999999999998654

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-33  Score=246.50  Aligned_cols=240  Identities=26%  Similarity=0.408  Sum_probs=187.5

Q ss_pred             CCCCCCCcccccCceEEEEEE-EcCCCEEEEEEecCC--C-----chhHHHHHHHHHHHHhcCCCCceeeEEEEe-cCCc
Q 039799          103 NDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQ--Y-----EGAFKSFDIECDVMKRICHRNLIKIISSYS-NDDF  173 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~--~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~  173 (346)
                      ++|-+..+||+|+|+.||+|. +...+-||||+-..+  .     +.-.+...+|.++-+.|.||.||++++++. +.+.
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds  542 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS  542 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence            346667789999999999997 456888999986432  1     122345668999999999999999999986 4567


Q ss_pred             eeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEEC---CCCcEEEeeecCC
Q 039799          174 KALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFGMA  250 (346)
Q Consensus       174 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~---~~~~~~l~Dfg~~  250 (346)
                      .+-|+||++|.+|.-+|+ ....++......|+.||..||.||. +.+++|+|-|+||.|||+-   ..|.+||+|||++
T Consensus       543 FCTVLEYceGNDLDFYLK-QhklmSEKEARSIiMQiVnAL~YLN-EikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS  620 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFYLK-QHKLMSEKEARSIIMQIVNALKYLN-EIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS  620 (775)
T ss_pred             ceeeeeecCCCchhHHHH-hhhhhhHHHHHHHHHHHHHHHHHHh-ccCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence            778999999999998886 4456888889999999999999998 4588999999999999994   5689999999999


Q ss_pred             ccCCccccc-----cccccccCCcccccCCCCCCC----CCCcchhHHHHHHHHHHHHcCCCCCCccccCcc-----cHH
Q 039799          251 KPLLEEDQS-----LTQTQTLATIGYMAPEYGREG----RVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM-----TLK  316 (346)
Q Consensus       251 ~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~----~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~-----~~~  316 (346)
                      +.+.++...     .......||.+|.+||++.-+    +.+.|+||||.|||+|+++-|+.||.-......     .+.
T Consensus       621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIl  700 (775)
T KOG1151|consen  621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTIL  700 (775)
T ss_pred             hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchh
Confidence            988654322     223456799999999987654    367899999999999999999999964221110     000


Q ss_pred             HH------HhhhcCCChhhhhchhccCCcccccc
Q 039799          317 RW------VNDLLPISVMEVVDANLLSQEDEHFT  344 (346)
Q Consensus       317 ~~------~~~~~~~~~~~~~d~~l~~~p~~R~~  344 (346)
                      .-      .+..+.....++|.+||....++|+.
T Consensus       701 kAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~D  734 (775)
T KOG1151|consen  701 KATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRID  734 (775)
T ss_pred             cceeccCCCCCccCHHHHHHHHHHHHhhhhhhhh
Confidence            00      12223347789999999998888864

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.98  E-value=5.1e-34  Score=234.73  Aligned_cols=232  Identities=28%  Similarity=0.337  Sum_probs=180.5

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHHhc-CCCCceeeEEEEecCCceeEEEecCCCC
Q 039799          108 PPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRI-CHRNLIKIISSYSNDDFKALVLEYMPHG  184 (346)
Q Consensus       108 ~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g  184 (346)
                      ...||.|+||+|++-.++ .|+..|||++.... +...+++..|.+...+- ..||||+++|.+...+..++-||.| ..
T Consensus        69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~  147 (361)
T KOG1006|consen   69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-DI  147 (361)
T ss_pred             HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hh
Confidence            457999999999999876 79999999987543 35567888888765554 7999999999988888889999999 44


Q ss_pred             Chhhhh---h-hcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccc
Q 039799          185 SLEKCL---Y-LSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  260 (346)
Q Consensus       185 sL~~~l---~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~  260 (346)
                      |+..+-   + .+...+++...-.|......||.||..  ...|+|||+||+|||+|..|.+||+|||.+..+..   +.
T Consensus       148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~---Si  222 (361)
T KOG1006|consen  148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD---SI  222 (361)
T ss_pred             hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHH---HH
Confidence            664432   2 233567777777788888999999975  67899999999999999999999999999987632   33


Q ss_pred             ccccccCCcccccCCCCCC--CCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHhhh------------cCCC
Q 039799          261 TQTQTLATIGYMAPEYGRE--GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDL------------LPIS  326 (346)
Q Consensus       261 ~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~------------~~~~  326 (346)
                      ..+...|-..|+|||.+..  ..|+.++||||+|++|+|+.||+.|+..=.+--..+.+.+...            +...
T Consensus       223 AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~  302 (361)
T KOG1006|consen  223 AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFS  302 (361)
T ss_pred             HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCHH
Confidence            3445568888999998753  3489999999999999999999999865211112223333222            2236


Q ss_pred             hhhhhchhccCCccccccc
Q 039799          327 VMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       327 ~~~~~d~~l~~~p~~R~~~  345 (346)
                      +..++.-|+..|...||..
T Consensus       303 ~~~fintCl~Kd~~~Rpky  321 (361)
T KOG1006|consen  303 MVRFINTCLIKDRSDRPKY  321 (361)
T ss_pred             HHHHHHHHhhcccccCcch
Confidence            7889999999999999963

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=1.7e-33  Score=250.01  Aligned_cols=233  Identities=21%  Similarity=0.283  Sum_probs=191.5

Q ss_pred             CCCCCCcccccCceEEEEEEEcCCC-EEEEEEecCCC---chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEe
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQDGM-EVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLE  179 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~~~~-~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  179 (346)
                      +.+....||-|+||.|-++...... .+|+|++++..   ....+....|-.+|..++.|.||+++-.|.+..+.|+.||
T Consensus       421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE  500 (732)
T KOG0614|consen  421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME  500 (732)
T ss_pred             hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence            3455667999999999999876433 48888886542   2334567779999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccc
Q 039799          180 YMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  259 (346)
Q Consensus       180 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~  259 (346)
                      -|-||.++..+..+ ..++..+..-++..+.+|++|||   +.+|+.||+||+|.++|.+|-+||.|||+|+++....  
T Consensus       501 aClGGElWTiLrdR-g~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~--  574 (732)
T KOG0614|consen  501 ACLGGELWTILRDR-GSFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR--  574 (732)
T ss_pred             hhcCchhhhhhhhc-CCcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhccCC--
Confidence            99999999998754 44666677778999999999999   9999999999999999999999999999999875432  


Q ss_pred             cccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCc--------ccHHHHHhhhcCCChhhhh
Q 039799          260 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE--------MTLKRWVNDLLPISVMEVV  331 (346)
Q Consensus       260 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~--------~~~~~~~~~~~~~~~~~~~  331 (346)
                       ..-+.+||+.|.|||.+.....+..+|.||+|+++||++||.+||.......        .+...| ...++....+++
T Consensus       575 -KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~-Pr~I~k~a~~Li  652 (732)
T KOG0614|consen  575 -KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEF-PRRITKTATDLI  652 (732)
T ss_pred             -ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhc-ccccchhHHHHH
Confidence             2345789999999999999999999999999999999999999997632111        111111 133445778999


Q ss_pred             chhccCCcccccc
Q 039799          332 DANLLSQEDEHFT  344 (346)
Q Consensus       332 d~~l~~~p~~R~~  344 (346)
                      .+....+|.+|.-
T Consensus       653 k~LCr~~P~ERLG  665 (732)
T KOG0614|consen  653 KKLCRDNPTERLG  665 (732)
T ss_pred             HHHHhcCcHhhhc
Confidence            9999999999975

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=4.8e-32  Score=246.41  Aligned_cols=208  Identities=22%  Similarity=0.312  Sum_probs=171.2

Q ss_pred             CCCCCCCCCcccccCceEEEEEE-EcCCCEEEEEEecCCC---chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeE
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKAL  176 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  176 (346)
                      ..+-|-..+.||-|+||+|.++. .++...||.|.+.+..   .........|-++|+....+=||+++-.|.+++.+|+
T Consensus       627 dKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYF  706 (1034)
T KOG0608|consen  627 DKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYF  706 (1034)
T ss_pred             cccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEE
Confidence            34456677889999999999997 4567789999886542   2334456679999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcc
Q 039799          177 VLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  256 (346)
Q Consensus       177 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~  256 (346)
                      ||+|++||++-.+|- +-..+.+.....++..+..|+++.|   +.|+|||||||+|||+|.+|++||+|||+|.-+...
T Consensus       707 VMdYIPGGDmMSLLI-rmgIFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT  782 (1034)
T KOG0608|consen  707 VMDYIPGGDMMSLLI-RMGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  782 (1034)
T ss_pred             EEeccCCccHHHHHH-HhccCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccceec
Confidence            999999999988764 3345666666778889999999999   999999999999999999999999999999743211


Q ss_pred             c---------cc-------------------------------cccccccCCcccccCCCCCCCCCCcchhHHHHHHHHH
Q 039799          257 D---------QS-------------------------------LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLM  296 (346)
Q Consensus       257 ~---------~~-------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~  296 (346)
                      +         ..                               ......+||+.|+|||++....++.-+|.||.|||||
T Consensus       783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~  862 (1034)
T KOG0608|consen  783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY  862 (1034)
T ss_pred             cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence            0         00                               0111346899999999999999999999999999999


Q ss_pred             HHHcCCCCCCccccCc
Q 039799          297 EIFTRTKPTDEIFSGE  312 (346)
Q Consensus       297 elltg~~p~~~~~~~~  312 (346)
                      ||+.|++||-+....+
T Consensus       863 em~~g~~pf~~~tp~~  878 (1034)
T KOG0608|consen  863 EMLVGQPPFLADTPGE  878 (1034)
T ss_pred             HHhhCCCCccCCCCCc
Confidence            9999999997655444

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=2.3e-32  Score=220.55  Aligned_cols=232  Identities=22%  Similarity=0.366  Sum_probs=183.5

Q ss_pred             CCCCCCCCcccccCceEEEEEE-EcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcC-CCCceeeEEEEec--CCceeEE
Q 039799          102 PNDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRIC-HRNLIKIISSYSN--DDFKALV  177 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~--~~~~~lv  177 (346)
                      .++|.+.+.+|+|.++.||.|. ..+.+.++||++++..   .+.+.+|+++|..++ ||||+++++...+  ...+.||
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            3568888999999999999997 5578999999998643   467888999999997 9999999998765  4467899


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC-CCcEEEeeecCCccCCcc
Q 039799          178 LEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD-NMVAHLSDFGMAKPLLEE  256 (346)
Q Consensus       178 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~-~~~~~l~Dfg~~~~~~~~  256 (346)
                      +||+.+.+.....    ..++...+...+.+++.||.|+|   +.||.|||+||.|+++|. .-.++|+|+|+|.++.+.
T Consensus       114 FE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~  186 (338)
T KOG0668|consen  114 FEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  186 (338)
T ss_pred             hhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence            9999998876543    23555667789999999999999   999999999999999995 558999999999998654


Q ss_pred             ccccccccccCCcccccCCCCCCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccCcc----------------------
Q 039799          257 DQSLTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM----------------------  313 (346)
Q Consensus       257 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~----------------------  313 (346)
                      ..   .+..+.+..|..||.+.+- .|+..-|+|||||++.+|+..+.||--..++..                      
T Consensus       187 ~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~  263 (338)
T KOG0668|consen  187 KE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQ  263 (338)
T ss_pred             ce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHc
Confidence            32   3445677889999987654 578888999999999999999999832111110                      


Q ss_pred             -----------------cHHHHHhh---h-cCCChhhhhchhccCCcccccccC
Q 039799          314 -----------------TLKRWVND---L-LPISVMEVVDANLLSQEDEHFTTK  346 (346)
Q Consensus       314 -----------------~~~~~~~~---~-~~~~~~~~~d~~l~~~p~~R~~~k  346 (346)
                                       ....++..   . +.++..|++|+.|.-|-.+|+|+|
T Consensus       264 i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTak  317 (338)
T KOG0668|consen  264 IDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAK  317 (338)
T ss_pred             cCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchH
Confidence                             01111111   0 124678999999999999999986

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=6.9e-33  Score=259.09  Aligned_cols=231  Identities=26%  Similarity=0.379  Sum_probs=182.6

Q ss_pred             CCCcccccCce-EEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhc-CCCCceeeEEEEecCCceeEEEecCCCC
Q 039799          107 MPPLIGKGGFG-SVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRI-CHRNLIKIISSYSNDDFKALVLEYMPHG  184 (346)
Q Consensus       107 ~~~~lg~G~~g-~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g  184 (346)
                      ..+++|.|+.| .||+|..+ |+.||||++-..   ..+...+|+..++.- .||||+++++.-.++...|+..|.| ..
T Consensus       513 ~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~  587 (903)
T KOG1027|consen  513 PKEILGYGSNGTVVFRGVYE-GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-AC  587 (903)
T ss_pred             cHHHcccCCCCcEEEEEeeC-CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hh
Confidence            34568899887 57999988 789999998543   345667899999887 6999999999999999999999999 66


Q ss_pred             ChhhhhhhcCC---CCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC-----CCcEEEeeecCCccCCcc
Q 039799          185 SLEKCLYLSNY---ILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD-----NMVAHLSDFGMAKPLLEE  256 (346)
Q Consensus       185 sL~~~l~~~~~---~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~-----~~~~~l~Dfg~~~~~~~~  256 (346)
                      +|.++++....   .......+.+..|+++|+++||   +.+|+|||+||.|||++.     ...++|+|||+++.+...
T Consensus       588 sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~  664 (903)
T KOG1027|consen  588 SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG  664 (903)
T ss_pred             hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence            99999976311   1111345678999999999999   999999999999999975     258999999999998655


Q ss_pred             cccc-ccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcC-CCCCCccccCcccHHHHHhhh--c--CC--Chh
Q 039799          257 DQSL-TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTR-TKPTDEIFSGEMTLKRWVNDL--L--PI--SVM  328 (346)
Q Consensus       257 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg-~~p~~~~~~~~~~~~~~~~~~--~--~~--~~~  328 (346)
                      ..+. ......||.||+|||++.....+..+||+|+||++|+++|| ..||.+....+.++..=....  +  ..  ...
T Consensus       665 ~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L~~L~~~~d~eA~  744 (903)
T KOG1027|consen  665 KSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTLVHLEPLPDCEAK  744 (903)
T ss_pred             cchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccceeeeccCchHHHH
Confidence            4332 24456799999999999988888899999999999999986 999987544332221111100  0  11  568


Q ss_pred             hhhchhccCCccccccc
Q 039799          329 EVVDANLLSQEDEHFTT  345 (346)
Q Consensus       329 ~~~d~~l~~~p~~R~~~  345 (346)
                      ++|.+|+..+|..||++
T Consensus       745 dLI~~ml~~dP~~RPsa  761 (903)
T KOG1027|consen  745 DLISRMLNPDPQLRPSA  761 (903)
T ss_pred             HHHHHhcCCCcccCCCH
Confidence            99999999999999986

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=2e-31  Score=250.44  Aligned_cols=237  Identities=24%  Similarity=0.332  Sum_probs=194.1

Q ss_pred             CCCCCCCcccccCceEEEEEEE-cCCCEEEEEEecCCCchhHHHHHHHHHHHHhc-CCCCceeeEEEEe-----cCCcee
Q 039799          103 NDANMPPLIGKGGFGSVYKAII-QDGMEVAVKVFDPQYEGAFKSFDIECDVMKRI-CHRNLIKIISSYS-----NDDFKA  175 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~-----~~~~~~  175 (346)
                      +.|.+...||.|.+|.||+++. ++++..|+|+...... ..++++.|.++++.. .|||++.++|++.     .++.++
T Consensus        19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLW   97 (953)
T KOG0587|consen   19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLW   97 (953)
T ss_pred             CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEE
Confidence            4588899999999999999984 4789999999876543 346778899999887 6999999999884     467899


Q ss_pred             EEEecCCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCC
Q 039799          176 LVLEYMPHGSLEKCLYLS-NYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  254 (346)
Q Consensus       176 lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~  254 (346)
                      ||||||.+||..+.++.- +..+.|..+..|+..++.|+.+||   ...++|||||-.|||+++++.+|+.|||.+..+.
T Consensus        98 LVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQld  174 (953)
T KOG0587|consen   98 LVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD  174 (953)
T ss_pred             EEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEEeeeeeeeeee
Confidence            999999999999988642 567999999999999999999999   9999999999999999999999999999998764


Q ss_pred             ccccccccccccCCcccccCCCCCC-----CCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccH--------HHHHhh
Q 039799          255 EEDQSLTQTQTLATIGYMAPEYGRE-----GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTL--------KRWVND  321 (346)
Q Consensus       255 ~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~--------~~~~~~  321 (346)
                      ..  -....+..||+.|||||++.-     ..|+.++|+||+|++..||--|.+|+-++......+        .-.-..
T Consensus       175 sT--~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~  252 (953)
T KOG0587|consen  175 ST--VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPK  252 (953)
T ss_pred             cc--cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccchh
Confidence            32  223445679999999997653     346788999999999999999999987654322100        000122


Q ss_pred             hcCCChhhhhchhccCCccccccc
Q 039799          322 LLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       322 ~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      .+..++.++|+.||..|-..||++
T Consensus       253 kWs~~FndFIs~cL~Kd~e~RP~~  276 (953)
T KOG0587|consen  253 KWSKKFNDFISTCLVKDYEQRPST  276 (953)
T ss_pred             hHHHHHHHHHHHHHhhccccCcch
Confidence            234478999999999999999975

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=3e-30  Score=220.12  Aligned_cols=199  Identities=30%  Similarity=0.412  Sum_probs=172.9

Q ss_pred             CCCCCcccccCceEEEEEEEcC-CCEEEEEEecCCCch-hHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecCC
Q 039799          105 ANMPPLIGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEG-AFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMP  182 (346)
Q Consensus       105 ~~~~~~lg~G~~g~vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  182 (346)
                      |.+.+.||+|++|.||++...+ ++.+++|.+...... ..+.+.+|++.+++++|+|++++++++...+..++++|+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            4567889999999999999874 899999999865544 56788899999999999999999999999999999999999


Q ss_pred             CCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccccc
Q 039799          183 HGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ  262 (346)
Q Consensus       183 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~  262 (346)
                      +++|.+++......+++.....++.+++.++.+||   +.+++|+|++|+||+++.++.++|+|||.+......... ..
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-~~  156 (225)
T smart00221       81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-LL  156 (225)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-cc
Confidence            99999988755443889999999999999999999   889999999999999999999999999999876443211 12


Q ss_pred             ccccCCcccccCCCC-CCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 039799          263 TQTLATIGYMAPEYG-REGRVSTNGDVYSFGIMLMEIFTRTKPTDE  307 (346)
Q Consensus       263 ~~~~~~~~y~aPE~~-~~~~~~~~~Dv~s~G~il~elltg~~p~~~  307 (346)
                      ....++..|++||.. ....++.++|+|+||++++||++|+.||+.
T Consensus       157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            234577889999988 666778899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=3.6e-31  Score=210.48  Aligned_cols=211  Identities=26%  Similarity=0.322  Sum_probs=168.6

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHHhc-CCCCceeeEEEEecCCceeEEEecCCCC
Q 039799          108 PPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRI-CHRNLIKIISSYSNDDFKALVLEYMPHG  184 (346)
Q Consensus       108 ~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g  184 (346)
                      ...||+|++|.|-+-++. +|...|+|.+.... .+..++..+|+++..+. ..|.+|.++|.+......++-||.|+ .
T Consensus        51 i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~-t  129 (282)
T KOG0984|consen   51 IEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD-T  129 (282)
T ss_pred             hhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh-h
Confidence            456899999999888754 89999999986432 34456777788776654 79999999998888888999999994 4


Q ss_pred             Chhhhh---hhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccc
Q 039799          185 SLEKCL---YLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT  261 (346)
Q Consensus       185 sL~~~l---~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~  261 (346)
                      ||..+-   ...+..+++...-+|+..+.+||.|||.  +..++|||+||+|||++.+|.+|++|||.+..+.+.   ..
T Consensus       130 Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS---iA  204 (282)
T KOG0984|consen  130 SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDS---IA  204 (282)
T ss_pred             hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhh---hH
Confidence            665543   2345678888889999999999999995  678999999999999999999999999999876432   22


Q ss_pred             cccccCCcccccCCCCCC----CCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHhhhcC
Q 039799          262 QTQTLATIGYMAPEYGRE----GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLP  324 (346)
Q Consensus       262 ~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  324 (346)
                      .+...|--.|+|||....    ..|+.|+||||+|+.+.||.+++.||+.-...-+.+.+.|.+.-|
T Consensus       205 kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P  271 (282)
T KOG0984|consen  205 KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSP  271 (282)
T ss_pred             HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCC
Confidence            233457778999997643    368999999999999999999999998765555556666655444

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.97  E-value=9.4e-32  Score=231.75  Aligned_cols=199  Identities=24%  Similarity=0.295  Sum_probs=165.9

Q ss_pred             CCCCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCC--C----CceeeEEEEecC
Q 039799           99 KPLPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICH--R----NLIKIISSYSND  171 (346)
Q Consensus        99 ~~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~----niv~~~~~~~~~  171 (346)
                      ..+.++|.+...+|+|+||.|-.+... .+..||+|+++.-. ...+....|++++.++.+  |    -++.+.++|.-.
T Consensus        85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr  163 (415)
T KOG0671|consen   85 DILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR  163 (415)
T ss_pred             cccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence            345677999999999999999999865 57899999986542 234556679999999932  2    266777889999


Q ss_pred             CceeEEEecCCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC------------
Q 039799          172 DFKALVLEYMPHGSLEKCLYLSN-YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD------------  238 (346)
Q Consensus       172 ~~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~------------  238 (346)
                      ++.++|+|.+ |-|+.+++...+ ..++...+..|+.|++++++|||   +.+++|-|+||+|||+-+            
T Consensus       164 ghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k~~  239 (415)
T KOG0671|consen  164 GHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPKKK  239 (415)
T ss_pred             CceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccCCc
Confidence            9999999998 779999997655 46889999999999999999999   999999999999999921            


Q ss_pred             --------CCcEEEeeecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 039799          239 --------NMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDE  307 (346)
Q Consensus       239 --------~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~  307 (346)
                              +..++++|||.|.+-.+..     +..+.|.-|.|||++.+-.++..+||||+||||.|++||..-|..
T Consensus       240 ~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqt  311 (415)
T KOG0671|consen  240 VCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQT  311 (415)
T ss_pred             cceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceeccc
Confidence                    3468999999999754332     345678899999999999999999999999999999999987754

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=1.5e-29  Score=213.04  Aligned_cols=204  Identities=32%  Similarity=0.531  Sum_probs=178.7

Q ss_pred             ccccCceEEEEEEEc-CCCEEEEEEecCCCch-hHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecCCCCChhh
Q 039799          111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEG-AFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEK  188 (346)
Q Consensus       111 lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~  188 (346)
                      ||+|.+|.||++... +++.+++|++...... ..+.+.+|++.++.++|++++++++++......++++|++++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            689999999999976 4899999999765432 35678899999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC-CCcEEEeeecCCccCCccccccccccccC
Q 039799          189 CLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD-NMVAHLSDFGMAKPLLEEDQSLTQTQTLA  267 (346)
Q Consensus       189 ~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~  267 (346)
                      ++......+++..+..++.++++++++||   +.+++|+||+|.||+++. ++.++|+|||.+........  ......+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~  155 (215)
T cd00180          81 LLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVG  155 (215)
T ss_pred             HHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccC
Confidence            88755456899999999999999999999   899999999999999999 89999999999986543221  1223457


Q ss_pred             CcccccCCCCCCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHhhhcCCChhhhhchhccCCccccccc
Q 039799          268 TIGYMAPEYGREG-RVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       268 ~~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ...|.+||..... ..+.+.|+|++|++++++                          ..+.+++.+|+..+|++||+.
T Consensus       156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------~~~~~~l~~~l~~~p~~R~~~  208 (215)
T cd00180         156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------PELKDLIRKMLQKDPEKRPSA  208 (215)
T ss_pred             CCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------HHHHHHHHHHhhCCcccCcCH
Confidence            8889999988776 788999999999999999                          578999999999999999985

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.97  E-value=3.4e-31  Score=238.69  Aligned_cols=197  Identities=24%  Similarity=0.358  Sum_probs=167.7

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCc--------hhHHHHHHHHHHHHhcC---CCCceeeEEEEec
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYE--------GAFKSFDIECDVMKRIC---HRNLIKIISSYSN  170 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~  170 (346)
                      .+|...+.+|+|+||.|+.|.++ +...|+||.+.++.-        ......-.|+.+|+.++   |+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            35888899999999999999977 567899998865421        11223446999999997   9999999999999


Q ss_pred             CCceeEEEecC-CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecC
Q 039799          171 DDFKALVLEYM-PHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGM  249 (346)
Q Consensus       171 ~~~~~lv~e~~-~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~  249 (346)
                      ++++||+||-. ++.+|.+++.. .+.+++.....|++|++.|+++||   +++|+|||||-+|+.++.+|-+||+|||.
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~-kp~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klidfgs  716 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEF-KPRMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLIDFGS  716 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhc-cCccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEeeccc
Confidence            99999999986 56788998864 456888889999999999999999   99999999999999999999999999999


Q ss_pred             CccCCccccccccccccCCcccccCCCCCCCCC-CcchhHHHHHHHHHHHHcCCCCCCc
Q 039799          250 AKPLLEEDQSLTQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMEIFTRTKPTDE  307 (346)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~s~G~il~elltg~~p~~~  307 (346)
                      +......    .....+||..|.|||.+.+.+| +..-|||++|++||.++....||..
T Consensus       717 aa~~ksg----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  717 AAYTKSG----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             hhhhcCC----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            9865432    2345679999999999998887 5667999999999999999999853

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=6.3e-31  Score=227.14  Aligned_cols=237  Identities=22%  Similarity=0.305  Sum_probs=196.1

Q ss_pred             CCCCCCcccccCceEEEEEEEcC------CCEEEEEEecCC-CchhHHHHHHHHHHHHhcCCCCceeeEEEEec-CCcee
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQD------GMEVAVKVFDPQ-YEGAFKSFDIECDVMKRICHRNLIKIISSYSN-DDFKA  175 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~  175 (346)
                      ++....++.+|+||.||.|.|++      .+.+.+|.++.. ++-....+..|.-++..+.|||+.++.+.+.+ .+..+
T Consensus       285 Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~  364 (563)
T KOG1024|consen  285 RVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPF  364 (563)
T ss_pred             heechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcce
Confidence            36667789999999999997763      334566666533 33445677788889999999999999998754 56888


Q ss_pred             EEEecCCCCChhhhhhhcC-------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeec
Q 039799          176 LVLEYMPHGSLEKCLYLSN-------YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFG  248 (346)
Q Consensus       176 lv~e~~~~gsL~~~l~~~~-------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg  248 (346)
                      .+|.++.-|+|..++....       ..++-.+...++.|++.|++|||   +.+++|.||..+|.++|+...+||+|=.
T Consensus       365 V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~LqVkltDsa  441 (563)
T KOG1024|consen  365 VLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQLQVKLTDSA  441 (563)
T ss_pred             EEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhheeEEeccch
Confidence            9999999999999987322       45667778889999999999999   9999999999999999999999999999


Q ss_pred             CCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHH--------
Q 039799          249 MAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWV--------  319 (346)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~--------  319 (346)
                      +++.+.+.+...-.........||+||.+....++..+|||||||+||||+| |+.|+.++...++  ..+.        
T Consensus       442 LSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm--~~ylkdGyRlaQ  519 (563)
T KOG1024|consen  442 LSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM--EHYLKDGYRLAQ  519 (563)
T ss_pred             hccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH--HHHHhccceecC
Confidence            9999888776666666678899999999999999999999999999999998 9999987544332  2222        


Q ss_pred             hhhcCCChhhhhchhccCCccccccc
Q 039799          320 NDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       320 ~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      .-..|+++..++.=||...|++||+-
T Consensus       520 P~NCPDeLf~vMacCWallpeeRPsf  545 (563)
T KOG1024|consen  520 PFNCPDELFTVMACCWALLPEERPSF  545 (563)
T ss_pred             CCCCcHHHHHHHHHHHhcCcccCCCH
Confidence            23357799999999999999999973

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=3.4e-30  Score=212.82  Aligned_cols=231  Identities=21%  Similarity=0.334  Sum_probs=178.3

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhc-CCCCceeeEE-EEecCCceeEE
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRI-CHRNLIKIIS-SYSNDDFKALV  177 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~-~~~~~~~~~lv  177 (346)
                      +.+.|++.+.+|+|.||.+-++.++ ....+++|-+.... ...++|.+|..---.| .|.||+.-++ .|...+.++++
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~  100 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV  100 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence            4577999999999999999999987 57789999886553 3457888887655555 4899998776 56777888899


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEEC--CCCcEEEeeecCCccCCc
Q 039799          178 LEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD--DNMVAHLSDFGMAKPLLE  255 (346)
Q Consensus       178 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~--~~~~~~l~Dfg~~~~~~~  255 (346)
                      +||++.|+|.+-+..  ..+.+....+++.|+++||.|+|   +.+++|||||.+|||+-  +..++||+|||..+....
T Consensus       101 qE~aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~  175 (378)
T KOG1345|consen  101 QEFAPRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT  175 (378)
T ss_pred             eccCccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence            999999999886543  34667777889999999999999   99999999999999994  334899999999885421


Q ss_pred             cccccccccccCCcccccCCCCCCC-----CCCcchhHHHHHHHHHHHHcCCCCCCccccCcccH---HHHHhhh---cC
Q 039799          256 EDQSLTQTQTLATIGYMAPEYGREG-----RVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTL---KRWVNDL---LP  324 (346)
Q Consensus       256 ~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~---~~~~~~~---~~  324 (346)
                           +......+..|.+||.....     ...+.+|+|.||++++.++||+.||...-..+...   .+|....   +|
T Consensus       176 -----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P  250 (378)
T KOG1345|consen  176 -----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALP  250 (378)
T ss_pred             -----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCc
Confidence                 12223356678999865432     35678899999999999999999997543344433   4444322   22


Q ss_pred             -------CChhhhhchhccCCcccc
Q 039799          325 -------ISVMEVVDANLLSQEDEH  342 (346)
Q Consensus       325 -------~~~~~~~d~~l~~~p~~R  342 (346)
                             +++..++.+.|..++++|
T Consensus       251 ~~F~~fs~~a~r~Fkk~lt~~~~dr  275 (378)
T KOG1345|consen  251 KKFNPFSEKALRLFKKSLTPRFKDR  275 (378)
T ss_pred             hhhcccCHHHHHHHHHhcCCccccc
Confidence                   366778889999999888

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.4e-30  Score=215.50  Aligned_cols=199  Identities=26%  Similarity=0.383  Sum_probs=163.2

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEecCC-----ce
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSNDD-----FK  174 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~  174 (346)
                      .+..-.+.||-|+||.||..+.. +|+.||.|++....  -...+++.+|++++...+|.|++..++......     +.
T Consensus        53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi  132 (449)
T KOG0664|consen   53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL  132 (449)
T ss_pred             ccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence            35566789999999999999865 89999999886432  234578889999999999999999988765433     55


Q ss_pred             eEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCC
Q 039799          175 ALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  254 (346)
Q Consensus       175 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~  254 (346)
                      |.++|.| ..+|..++- +...++.....-+..||++||.|||   +.+|.||||||.|.|++.+..+||+|||+++...
T Consensus       133 YV~TELm-QSDLHKIIV-SPQ~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee  207 (449)
T KOG0664|consen  133 YVLTELM-QSDLHKIIV-SPQALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWD  207 (449)
T ss_pred             HHHHHHH-Hhhhhheec-cCCCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccc
Confidence            6788888 447777664 4455666677778999999999999   9999999999999999999999999999999653


Q ss_pred             ccccccccccccCCcccccCCCCCCC-CCCcchhHHHHHHHHHHHHcCCCCCCc
Q 039799          255 EEDQSLTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMEIFTRTKPTDE  307 (346)
Q Consensus       255 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~  307 (346)
                      . +.....+..+-|..|.|||.+++. .|+...||||.|||+.|++.++.-|..
T Consensus       208 ~-d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQA  260 (449)
T KOG0664|consen  208 Q-RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQA  260 (449)
T ss_pred             h-hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhc
Confidence            3 334445666778999999998875 589999999999999999988877653

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.96  E-value=2.5e-30  Score=236.52  Aligned_cols=240  Identities=25%  Similarity=0.326  Sum_probs=200.0

Q ss_pred             CCCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEE
Q 039799          100 PLPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVL  178 (346)
Q Consensus       100 ~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  178 (346)
                      ...++|...+.+|.|+||.||+++.. .++..|+|+++-........+++|+-+++.++||||+.+++.+...+..++.|
T Consensus        12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM   91 (829)
T KOG0576|consen   12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM   91 (829)
T ss_pred             CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence            56688999999999999999999855 78999999998776777788889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccc
Q 039799          179 EYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  258 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~  258 (346)
                      ||+.+|+|++.-+ ....++..++-.+.+...+|++|||   +.+-+|||||-.||++++.+.+|++|||.+-.+...  
T Consensus        92 EycgggslQdiy~-~TgplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqitat--  165 (829)
T KOG0576|consen   92 EYCGGGSLQDIYH-VTGPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT--  165 (829)
T ss_pred             EecCCCcccceee-ecccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhhh--
Confidence            9999999998544 4566888888889999999999999   999999999999999999999999999998876432  


Q ss_pred             ccccccccCCcccccCCCC---CCCCCCcchhHHHHHHHHHHHHcCCCCCCccc----------cCcccHHHHHhhhcCC
Q 039799          259 SLTQTQTLATIGYMAPEYG---REGRVSTNGDVYSFGIMLMEIFTRTKPTDEIF----------SGEMTLKRWVNDLLPI  325 (346)
Q Consensus       259 ~~~~~~~~~~~~y~aPE~~---~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~----------~~~~~~~~~~~~~~~~  325 (346)
                      -.......||+.|+|||+.   ..+.|..++|||+.|+...|+---++|.-+..          ++-.......+..+.+
T Consensus       166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~  245 (829)
T KOG0576|consen  166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSE  245 (829)
T ss_pred             hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchH
Confidence            1223356799999999965   35678999999999999999988888754321          1111112222333445


Q ss_pred             ChhhhhchhccCCccccccc
Q 039799          326 SVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       326 ~~~~~~d~~l~~~p~~R~~~  345 (346)
                      .+.+++.-++-.+|++||++
T Consensus       246 ~fh~fvK~altknpKkRpta  265 (829)
T KOG0576|consen  246 FFHNFVKGALTKNPKKRPTA  265 (829)
T ss_pred             HHHHHHHHHhcCCCccCCCh
Confidence            77899999999999999986

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.95  E-value=8.1e-29  Score=209.10  Aligned_cols=193  Identities=28%  Similarity=0.317  Sum_probs=159.7

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC--CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCC------c
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ--YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDD------F  173 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~  173 (346)
                      .+|--...+|.|+. .|..+... .+++||+|.....  .....++..+|...+..+.|+|+++++.++.-..      .
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            45666678888888 66666544 6889999987543  2344678889999999999999999999986443      6


Q ss_pred             eeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccC
Q 039799          174 KALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  253 (346)
Q Consensus       174 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~  253 (346)
                      .|+|||+| ..+|.+.+.   ..++-.+...++.|+..|++|||   +.+|+|||+||+||++..++.+||.|||+|+.-
T Consensus        96 ~y~v~e~m-~~nl~~vi~---~elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e  168 (369)
T KOG0665|consen   96 VYLVMELM-DANLCQVIL---MELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLARTE  168 (369)
T ss_pred             HHHHHHhh-hhHHHHHHH---HhcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhccc
Confidence            78999999 558877765   34677788899999999999999   999999999999999999999999999999954


Q ss_pred             CccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCC
Q 039799          254 LEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTD  306 (346)
Q Consensus       254 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~  306 (346)
                      ...   -..+..+.|..|.|||...+..+.+.+||||.||++.||++|+.-|.
T Consensus       169 ~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~  218 (369)
T KOG0665|consen  169 DTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP  218 (369)
T ss_pred             Ccc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec
Confidence            222   23444567889999999988889999999999999999999998764

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.95  E-value=2.9e-29  Score=223.79  Aligned_cols=197  Identities=25%  Similarity=0.306  Sum_probs=165.6

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcC------CCCceeeEEEEecCCce
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRIC------HRNLIKIISSYSNDDFK  174 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~~~~~~~~~~~~  174 (346)
                      -..|.+....|+|-|++|.+|..+ .|..||||++..+ +...+.=..|+++|++|.      --++++++..|...+++
T Consensus       431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHL  509 (752)
T KOG0670|consen  431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHL  509 (752)
T ss_pred             cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhccee
Confidence            345778888999999999999866 5889999999765 333455567999999995      34788999999999999


Q ss_pred             eEEEecCCCCChhhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCC-CcEEEeeecCCc
Q 039799          175 ALVLEYMPHGSLEKCLYLSN--YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDN-MVAHLSDFGMAK  251 (346)
Q Consensus       175 ~lv~e~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~-~~~~l~Dfg~~~  251 (346)
                      +||+|-+ ..+|.++|...+  ..+....+..++.|+.-||..|-   .++|+|.||||+|||+++. ..+||+|||.|.
T Consensus       510 ClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~  585 (752)
T KOG0670|consen  510 CLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILKLCDFGSAS  585 (752)
T ss_pred             EEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceeeeccCcccc
Confidence            9999998 568999987654  45777888899999999999999   9999999999999999964 578999999999


Q ss_pred             cCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 039799          252 PLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDE  307 (346)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~  307 (346)
                      ...+...    +...-+..|.|||++.+-.|+...|+||.||+|||++||+..|..
T Consensus       586 ~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG  637 (752)
T KOG0670|consen  586 FASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPG  637 (752)
T ss_pred             ccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCC
Confidence            7754332    112245679999999999999999999999999999999987754

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=4.7e-26  Score=202.00  Aligned_cols=134  Identities=25%  Similarity=0.344  Sum_probs=111.5

Q ss_pred             CCCC-CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcC-----C---CCceeeEEEE
Q 039799           99 KPLP-NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRIC-----H---RNLIKIISSY  168 (346)
Q Consensus        99 ~~~~-~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~~~~~~  168 (346)
                      ..+. .+|-+.+.||.|.|++||++... +.+.||+|+.+... .-.+....|+++|++++     |   .+||++++.|
T Consensus        73 D~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~F  151 (590)
T KOG1290|consen   73 DVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHF  151 (590)
T ss_pred             ccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccc
Confidence            3344 57888999999999999999854 77889999987542 33456677999999984     2   4699999998


Q ss_pred             ec----CCceeEEEecCCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEE
Q 039799          169 SN----DDFKALVLEYMPHGSLEKCLYLSN-YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL  236 (346)
Q Consensus       169 ~~----~~~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll  236 (346)
                      ..    ..+.+||+|++ |.+|..++...+ ..++...+..|+.|++.||.|||.  .++|+|-||||+|||+
T Consensus       152 khsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  152 KHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLL  221 (590)
T ss_pred             eecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeee
Confidence            64    45889999999 778888887665 468999999999999999999996  5699999999999999

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.94  E-value=1e-26  Score=191.29  Aligned_cols=144  Identities=22%  Similarity=0.200  Sum_probs=117.5

Q ss_pred             CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccccc
Q 039799          184 GSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT  263 (346)
Q Consensus       184 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~~  263 (346)
                      |+|.+++......+++..++.++.|+++||+|||   +.+      ||+|||++.++.+++  ||+++.....       
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-------   62 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPE-------   62 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeeccc-------
Confidence            6899998766677999999999999999999999   665      999999999999999  9998865332       


Q ss_pred             cccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHhhhc-------------CC--Chh
Q 039799          264 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLL-------------PI--SVM  328 (346)
Q Consensus       264 ~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~-------------~~--~~~  328 (346)
                      ...|++.|+|||++.+..++.++|||||||++|||+||+.||............+.....             ..  .+.
T Consensus        63 ~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  142 (176)
T smart00750       63 QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFA  142 (176)
T ss_pred             cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHH
Confidence            125889999999999999999999999999999999999999754332222222222111             11  488


Q ss_pred             hhhchhccCCccccccc
Q 039799          329 EVVDANLLSQEDEHFTT  345 (346)
Q Consensus       329 ~~~d~~l~~~p~~R~~~  345 (346)
                      +++.+||..+|++||++
T Consensus       143 ~~i~~cl~~~p~~Rp~~  159 (176)
T smart00750      143 DFMRVCASRLPQRREAA  159 (176)
T ss_pred             HHHHHHHhcccccccCH
Confidence            99999999999999985

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.94  E-value=1.7e-27  Score=238.46  Aligned_cols=184  Identities=18%  Similarity=0.246  Sum_probs=133.1

Q ss_pred             hcCC-CCceeeEEEE-------ecCCceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeee
Q 039799          155 RICH-RNLIKIISSY-------SNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIH  226 (346)
Q Consensus       155 ~l~h-~niv~~~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H  226 (346)
                      .++| +||.++++++       .+.+..+.++|++ +++|.+++......+++..+..++.||++||+|||   +++|+|
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~gIvH  103 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAH---SQGIVV  103 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHH---hCCeee
Confidence            3445 5777777776       2334667788987 66999999765667999999999999999999999   999999


Q ss_pred             cCCCCCceEECCCC-------------------cEEEeeecCCccCCcccc--------------ccccccccCCccccc
Q 039799          227 CDLKPSNVLLDDNM-------------------VAHLSDFGMAKPLLEEDQ--------------SLTQTQTLATIGYMA  273 (346)
Q Consensus       227 ~dik~~NIll~~~~-------------------~~~l~Dfg~~~~~~~~~~--------------~~~~~~~~~~~~y~a  273 (346)
                      |||||+|||++..+                   .+|++|||+++.......              ........||+.|+|
T Consensus       104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A  183 (793)
T PLN00181        104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS  183 (793)
T ss_pred             ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence            99999999996544                   455556665553211000              000112357888999


Q ss_pred             CCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHhhhcC-------CChhhhhchhccCCccccccc
Q 039799          274 PEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLP-------ISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       274 PE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~-------~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ||++.+..++.++|||||||+||||++|..|+.....   .........++       ....+++.+||..+|.+||++
T Consensus       184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~  259 (793)
T PLN00181        184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR---TMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSM  259 (793)
T ss_pred             hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH---HHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcCh
Confidence            9999999999999999999999999999998764211   11111111111       144577888999999999986

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=1.4e-25  Score=201.73  Aligned_cols=167  Identities=19%  Similarity=0.136  Sum_probs=129.9

Q ss_pred             CCCCCCCCCCcccccCceEEEEEEEc--CCCEEEEEEecCC-----CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCC
Q 039799          100 PLPNDANMPPLIGKGGFGSVYKAIIQ--DGMEVAVKVFDPQ-----YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDD  172 (346)
Q Consensus       100 ~~~~~~~~~~~lg~G~~g~vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  172 (346)
                      .+...|.+.+.||+|+||+||+|.+.  +++.+|||+....     .......+.+|++++++++|+|+++.+..+   +
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~   91 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---G   91 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---C
Confidence            34577999999999999999999865  5778899986533     122356788999999999999998533322   4


Q ss_pred             ceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCC-CCCceEECCCCcEEEeeecCCc
Q 039799          173 FKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL-KPSNVLLDDNMVAHLSDFGMAK  251 (346)
Q Consensus       173 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~di-k~~NIll~~~~~~~l~Dfg~~~  251 (346)
                      ..++||||+++++|... .  .  ..   ...++.+++++|+|||   +.+|+|||| ||+|||++.++.++|+|||+++
T Consensus        92 ~~~LVmE~~~G~~L~~~-~--~--~~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~  160 (365)
T PRK09188         92 KDGLVRGWTEGVPLHLA-R--P--HG---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQLAS  160 (365)
T ss_pred             CcEEEEEccCCCCHHHh-C--c--cc---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECccce
Confidence            57899999999999632 1  1  11   1457889999999999   999999999 9999999999999999999999


Q ss_pred             cCCccccccc------cccccCCcccccCCCCCCC
Q 039799          252 PLLEEDQSLT------QTQTLATIGYMAPEYGREG  280 (346)
Q Consensus       252 ~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~  280 (346)
                      .+........      .+...+++.|+|||.+...
T Consensus       161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             ecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            7754332111      1345678889999987643

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.93  E-value=2e-26  Score=201.41  Aligned_cols=198  Identities=28%  Similarity=0.378  Sum_probs=163.2

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEc----CCCEEEEEEecCCCchhHHHHHHHHHHHHhc-CCCCceeeEEEEecCCcee
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQ----DGMEVAVKVFDPQYEGAFKSFDIECDVMKRI-CHRNLIKIISSYSNDDFKA  175 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  175 (346)
                      ..+.|...+.||+|.|++||++...    ..+.||+|.+...+.  ..++.+|+++|..+ .+.||+++.+++...+...
T Consensus        34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~  111 (418)
T KOG1167|consen   34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA  111 (418)
T ss_pred             hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence            3466888999999999999999854    367899999875443  36788999999999 5999999999999999999


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEEC-CCCcEEEeeecCCccCC
Q 039799          176 LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLL  254 (346)
Q Consensus       176 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~-~~~~~~l~Dfg~~~~~~  254 (346)
                      +|+||+++....++..    .++......++..+..||+++|   ..||+||||||+|+|.+ ..+.-.|.|||+|....
T Consensus       112 ivlp~~~H~~f~~l~~----~l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d  184 (418)
T KOG1167|consen  112 IVLPYFEHDRFRDLYR----SLSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYD  184 (418)
T ss_pred             EEecccCccCHHHHHh----cCCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhHHHHH
Confidence            9999999999888764    3567788889999999999999   99999999999999998 56788999999998221


Q ss_pred             ccc------c------c------------------------------cccccccCCcccccCCCCCCC-CCCcchhHHHH
Q 039799          255 EED------Q------S------------------------------LTQTQTLATIGYMAPEYGREG-RVSTNGDVYSF  291 (346)
Q Consensus       255 ~~~------~------~------------------------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~  291 (346)
                      ...      .      .                              .......||+||.|||++... ..++++||||.
T Consensus       185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~  264 (418)
T KOG1167|consen  185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSA  264 (418)
T ss_pred             hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeec
Confidence            000      0      0                              001123589999999987654 46889999999


Q ss_pred             HHHHHHHHcCCCCCCc
Q 039799          292 GIMLMEIFTRTKPTDE  307 (346)
Q Consensus       292 G~il~elltg~~p~~~  307 (346)
                      |||++.+++++.||-.
T Consensus       265 GVI~Lslls~~~PFf~  280 (418)
T KOG1167|consen  265 GVILLSLLSRRYPFFK  280 (418)
T ss_pred             cceeehhhcccccccc
Confidence            9999999999999843

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=1.5e-24  Score=184.40  Aligned_cols=199  Identities=22%  Similarity=0.310  Sum_probs=172.5

Q ss_pred             CCCCCCcccccCceEEEEEE-EcCCCEEEEEEecCCCchhHHHHHHHHHHHHhc-CCCCceeeEEEEecCCceeEEEecC
Q 039799          104 DANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRI-CHRNLIKIISSYSNDDFKALVLEYM  181 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~  181 (346)
                      .|.+++.||+|+||.++.|+ +-+++.||||.-...  ....++..|.+..+.| ..++|..++-+..+..+..||+|.+
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL  106 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL  106 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence            58999999999999999998 558999999974433  3345677788888887 4789999988888888999999999


Q ss_pred             CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEEC-----CCCcEEEeeecCCccCCcc
Q 039799          182 PHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD-----DNMVAHLSDFGMAKPLLEE  256 (346)
Q Consensus       182 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~-----~~~~~~l~Dfg~~~~~~~~  256 (346)
                       |-||++.+.-++..++..+..-+|.|+..-++|+|   +..+|.|||||+|+|+.     +...+.++|||+|+.+.++
T Consensus       107 -GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp  182 (449)
T KOG1165|consen  107 -GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP  182 (449)
T ss_pred             -CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence             88999999999999999999999999999999999   99999999999999995     3457899999999998765


Q ss_pred             ccccc-----cccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 039799          257 DQSLT-----QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEI  308 (346)
Q Consensus       257 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~  308 (346)
                      .....     .....||.+||+-....+.+.+.+.|+-|+|.++.+.+-|..||...
T Consensus       183 ~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGL  239 (449)
T KOG1165|consen  183 KTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL  239 (449)
T ss_pred             cccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccc
Confidence            43211     22346999999999999999999999999999999999999999763

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=4.3e-25  Score=179.86  Aligned_cols=201  Identities=24%  Similarity=0.313  Sum_probs=170.7

Q ss_pred             CCCCCCCcccccCceEEEEEE-EcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCC-CCceeeEEEEecCCceeEEEec
Q 039799          103 NDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICH-RNLIKIISSYSNDDFKALVLEY  180 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~  180 (346)
                      ..|...+.||+|+||.+|.|. ..+|++||||+-.....  ..++..|.++.+.+++ ..|..+..+..+..+..+||+.
T Consensus        15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdL   92 (341)
T KOG1163|consen   15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDL   92 (341)
T ss_pred             cceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeeec
Confidence            568888999999999999998 66899999998654322  2456678888888864 5777788888899999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEEC---CCCcEEEeeecCCccCCccc
Q 039799          181 MPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFGMAKPLLEED  257 (346)
Q Consensus       181 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~---~~~~~~l~Dfg~~~~~~~~~  257 (346)
                      + |-||++.+.-+...++..+.+-++-|++.-++|+|   .++++||||||+|+|+.   ....+.++|||+++.+.+..
T Consensus        93 L-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~  168 (341)
T KOG1163|consen   93 L-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIR  168 (341)
T ss_pred             c-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhhcccc
Confidence            9 88999999888889999999999999999999999   99999999999999996   34579999999999886533


Q ss_pred             cc-----cccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccc
Q 039799          258 QS-----LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIF  309 (346)
Q Consensus       258 ~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~  309 (346)
                      ..     .......||.+|.+-....+.+.+.+.|+-|+|.+|.+.--|..||....
T Consensus       169 t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglk  225 (341)
T KOG1163|consen  169 TRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLK  225 (341)
T ss_pred             ccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccc
Confidence            21     12234569999999888888888999999999999999999999998754

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=5.1e-24  Score=191.71  Aligned_cols=201  Identities=25%  Similarity=0.326  Sum_probs=165.7

Q ss_pred             CCCCCCcccccCceEEEEEEEcCC--CEEEEEEecCCCchhHHHHHHHHHHHHhcCC----CCceeeEEEE-ecCCceeE
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQDG--MEVAVKVFDPQYEGAFKSFDIECDVMKRICH----RNLIKIISSY-SNDDFKAL  176 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~~~~~~-~~~~~~~l  176 (346)
                      .|.+.+.||+|+||.||.+.....  ..+|+|.-..........+..|+.++..+..    +++..+++.. ......++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            789999999999999999996643  4788888665432222267778888888863    6888999888 57788999


Q ss_pred             EEecCCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCC-----CcEEEeeecCC
Q 039799          177 VLEYMPHGSLEKCLYLSN-YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDN-----MVAHLSDFGMA  250 (346)
Q Consensus       177 v~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~-----~~~~l~Dfg~~  250 (346)
                      ||+.+ |.+|.++..... ..++..+.+.++.|++.+|+++|   +.|++||||||.|+++...     ..+.+.|||++
T Consensus        99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            99988 889999875444 78999999999999999999999   9999999999999999754     47999999999


Q ss_pred             c--cCCccccc----c-c-cccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 039799          251 K--PLLEEDQS----L-T-QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEI  308 (346)
Q Consensus       251 ~--~~~~~~~~----~-~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~  308 (346)
                      +  .+......    . . .....||.+|++++...+.+.+.+.|+||++.++.|+..|..||...
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~  240 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEAL  240 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccc
Confidence            9  43322211    1 1 12355999999999999999999999999999999999999999653

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.91  E-value=7.6e-23  Score=183.83  Aligned_cols=236  Identities=31%  Similarity=0.458  Sum_probs=188.2

Q ss_pred             CCCCCcccccCceEEEEEEEcCCCEEEEEEecCCCch---hHHHHHHHHHHHHhcCCC-CceeeEEEEecCCceeEEEec
Q 039799          105 ANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRICHR-NLIKIISSYSNDDFKALVLEY  180 (346)
Q Consensus       105 ~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e~  180 (346)
                      |.+.+.||.|+|+.||++...  ..+++|.+......   ....+.+|...++.+.|+ +++++.+.+......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            566778999999999999977  78899998754322   467888999999999988 799999999777778999999


Q ss_pred             CCCCChhhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCC-cEEEeeecCCccCCccc
Q 039799          181 MPHGSLEKCLYLSN--YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM-VAHLSDFGMAKPLLEED  257 (346)
Q Consensus       181 ~~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~-~~~l~Dfg~~~~~~~~~  257 (346)
                      +.++++.+.+....  ..++......++.+++.++.|+|   ..+++|||+||+||+++... .++++|||.++......
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            99999996665443  26888889999999999999999   99999999999999999888 79999999998654332


Q ss_pred             ccc----ccccccCCcccccCCCCCC---CCCCcchhHHHHHHHHHHHHcCCCCCCccccC--cccHHHHHhhhc-C---
Q 039799          258 QSL----TQTQTLATIGYMAPEYGRE---GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSG--EMTLKRWVNDLL-P---  324 (346)
Q Consensus       258 ~~~----~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~--~~~~~~~~~~~~-~---  324 (346)
                      ...    ......++..|+|||....   ..++...|+||+|++++++++|..|+......  .......+.... +   
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA  236 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccc
Confidence            221    2355679999999999887   57889999999999999999999997654321  111222221111 1   


Q ss_pred             ------------CChhhhhchhccCCccccccc
Q 039799          325 ------------ISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       325 ------------~~~~~~~d~~l~~~p~~R~~~  345 (346)
                                  ..+.+++.+++..+|..|.+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~  269 (384)
T COG0515         237 SPLSPSNPELISKAASDLLKKLLAKDPKNRLSS  269 (384)
T ss_pred             cccCccccchhhHHHHHHHHHHHhcCchhcCCH
Confidence                        136789999999999998764

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.90  E-value=6.6e-25  Score=181.89  Aligned_cols=230  Identities=19%  Similarity=0.311  Sum_probs=175.5

Q ss_pred             CCCCcccccCceEEEEEEEcCCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecCCC
Q 039799          106 NMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPH  183 (346)
Q Consensus       106 ~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  183 (346)
                      +....|.+...|+.|+|+|+ |..+++|+++...  ......|..|.-.++-..||||+++++.|.......++..||+.
T Consensus       193 nl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~  271 (448)
T KOG0195|consen  193 NLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF  271 (448)
T ss_pred             hhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence            34456888999999999999 5667778876432  22235788899999999999999999999999999999999999


Q ss_pred             CChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccccc
Q 039799          184 GSLEKCLYLSN-YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ  262 (346)
Q Consensus       184 gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~  262 (346)
                      |||...++... ...+-.+..+++.++|+|++|||.- ++-|.---+.+..+++|++.+++|+-- -+++      +...
T Consensus       272 gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarisma-d~kf------sfqe  343 (448)
T KOG0195|consen  272 GSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMA-DTKF------SFQE  343 (448)
T ss_pred             hHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecc-ccee------eeec
Confidence            99999998765 3567788999999999999999942 233444568899999999998887521 1111      1112


Q ss_pred             ccccCCcccccCCCCCCCCC---CcchhHHHHHHHHHHHHcCCCCCCccccCccc-------HHHHHhhhcCCChhhhhc
Q 039799          263 TQTLATIGYMAPEYGREGRV---STNGDVYSFGIMLMEIFTRTKPTDEIFSGEMT-------LKRWVNDLLPISVMEVVD  332 (346)
Q Consensus       263 ~~~~~~~~y~aPE~~~~~~~---~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~-------~~~~~~~~~~~~~~~~~d  332 (346)
                      ......+.|++||.++..+-   -..+|+|||++++||+-|+..||.+....+..       ++.-+..........++.
T Consensus       344 ~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~klm~  423 (448)
T KOG0195|consen  344 VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKLMN  423 (448)
T ss_pred             cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHHHHH
Confidence            23446788999998876653   34689999999999999999999875544321       122222333336678999


Q ss_pred             hhccCCcccccc
Q 039799          333 ANLLSQEDEHFT  344 (346)
Q Consensus       333 ~~l~~~p~~R~~  344 (346)
                      -|+..||.+||.
T Consensus       424 icmnedpgkrpk  435 (448)
T KOG0195|consen  424 ICMNEDPGKRPK  435 (448)
T ss_pred             HHhcCCCCcCCC
Confidence            999999999985

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.89  E-value=1.1e-23  Score=176.55  Aligned_cols=171  Identities=15%  Similarity=0.157  Sum_probs=132.3

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEcCCCEEEEEEecCCCchhH---HH------HHHHHHHHHhcCCCCceeeEEEEecC
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAF---KS------FDIECDVMKRICHRNLIKIISSYSND  171 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~---~~------~~~e~~~l~~l~h~niv~~~~~~~~~  171 (346)
                      +..+|...+++|.|+||.||+... ++..+|+|++.+......   ..      +.+|++.+.++.|+++..+..++...
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            356789999999999999999766 577899999976543222   22      57899999999999999998886533


Q ss_pred             --------CceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEE
Q 039799          172 --------DFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAH  243 (346)
Q Consensus       172 --------~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~  243 (346)
                              ...+++|||++|.+|.++..     .+.    ....+++.++..+|   ..+++|||++|+||+++.++ ++
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g-i~  174 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG-LR  174 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC-EE
Confidence                    35789999999999988632     222    34669999999999   99999999999999999888 99


Q ss_pred             EeeecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHH
Q 039799          244 LSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIF  299 (346)
Q Consensus       244 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ell  299 (346)
                      ++|||............              .+.....+..++|+||||+.+....
T Consensus       175 liDfg~~~~~~e~~a~d--------------~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        175 IIDLSGKRCTAQRKAKD--------------RIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEECCCcccccchhhHH--------------HHHHHhHhcccccccceeEeehHHH
Confidence            99999987553211100              0233345667899999999887653

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.89  E-value=1.4e-22  Score=167.98  Aligned_cols=139  Identities=17%  Similarity=0.195  Sum_probs=108.7

Q ss_pred             CCcccccCceEEEEEEEcCCCEEEEEEecCCCch--h------------------------HHHHHHHHHHHHhcCCCCc
Q 039799          108 PPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEG--A------------------------FKSFDIECDVMKRICHRNL  161 (346)
Q Consensus       108 ~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~e~~~l~~l~h~ni  161 (346)
                      ...||+|++|.||+|...+|+.||+|++......  .                        ......|++.+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4679999999999999888999999998654211  0                        1122359999999988776


Q ss_pred             eeeEEEEecCCceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCeeecCCCCCceEECCCC
Q 039799          162 IKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYL-HFGYSAPIIHCDLKPSNVLLDDNM  240 (346)
Q Consensus       162 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~i~H~dik~~NIll~~~~  240 (346)
                      .....+...  ..++||||++++++..... ....++......++.+++.+|.++ |   +.+|+||||||+||+++ ++
T Consensus        82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli~-~~  154 (190)
T cd05147          82 PCPEPILLK--SHVLVMEFIGDDGWAAPRL-KDAPLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLYH-DG  154 (190)
T ss_pred             CCCcEEEec--CCEEEEEEeCCCCCcchhh-hcCCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEE-CC
Confidence            543333222  2379999999887765432 235688888999999999999999 7   88999999999999998 47


Q ss_pred             cEEEeeecCCccC
Q 039799          241 VAHLSDFGMAKPL  253 (346)
Q Consensus       241 ~~~l~Dfg~~~~~  253 (346)
                      .++|+|||++...
T Consensus       155 ~v~LiDFG~a~~~  167 (190)
T cd05147         155 KLYIIDVSQSVEH  167 (190)
T ss_pred             cEEEEEccccccC
Confidence            8999999999854

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.88  E-value=1.2e-21  Score=162.82  Aligned_cols=140  Identities=21%  Similarity=0.232  Sum_probs=110.9

Q ss_pred             CCcccccCceEEEEEEEcCCCEEEEEEecCCCch--------------------------hHHHHHHHHHHHHhcCCCCc
Q 039799          108 PPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEG--------------------------AFKSFDIECDVMKRICHRNL  161 (346)
Q Consensus       108 ~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~e~~~l~~l~h~ni  161 (346)
                      ...||+|++|.||+|...+|+.||||++......                          ....+..|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            5689999999999999878999999998754211                          01233578999999999987


Q ss_pred             eeeEEEEecCCceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeeecCCCCCceEECCCC
Q 039799          162 IKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYS-APIIHCDLKPSNVLLDDNM  240 (346)
Q Consensus       162 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~i~H~dik~~NIll~~~~  240 (346)
                      .....+....  .++||||++++++..... ....++......++.+++.++.++|   + .+|+||||||+||+++ ++
T Consensus        82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l-~~~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIll~-~~  154 (190)
T cd05145          82 PVPEPILLKK--NVLVMEFIGDDGSPAPRL-KDVPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNILYH-DG  154 (190)
T ss_pred             CCceEEEecC--CEEEEEEecCCCchhhhh-hhccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEEEE-CC
Confidence            5544443332  479999999886543221 2345677888999999999999999   8 9999999999999999 78


Q ss_pred             cEEEeeecCCccCC
Q 039799          241 VAHLSDFGMAKPLL  254 (346)
Q Consensus       241 ~~~l~Dfg~~~~~~  254 (346)
                      .++|+|||++....
T Consensus       155 ~~~liDFG~a~~~~  168 (190)
T cd05145         155 KPYIIDVSQAVELD  168 (190)
T ss_pred             CEEEEEcccceecC
Confidence            99999999998653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.86  E-value=8.4e-23  Score=195.44  Aligned_cols=235  Identities=22%  Similarity=0.234  Sum_probs=179.5

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEEEEec----C-CCch-hHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEE
Q 039799          106 NMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFD----P-QYEG-AFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVL  178 (346)
Q Consensus       106 ~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~----~-~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  178 (346)
                      ....++|.|++|.|+..... .....+.|.+.    + .... ....+..|+.+-..+.|+|++..+..+.+.....-.|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            45678999999988777633 34444444332    1 1111 1222556777778889999988877776666555669


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccc
Q 039799          179 EYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  258 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~  258 (346)
                      ||+++ +|...+... ..+....+..++.|+..|+.|+|   +.|+.|||+|++|++++.++.+||+|||.+....-+..
T Consensus       401 E~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e  475 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE  475 (601)
T ss_pred             hcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence            99999 998877533 45777788889999999999999   99999999999999999999999999999987643333


Q ss_pred             c--cccccccCCcccccCCCCCCCCCCcc-hhHHHHHHHHHHHHcCCCCCCccccCcc--------------cHHHHHhh
Q 039799          259 S--LTQTQTLATIGYMAPEYGREGRVSTN-GDVYSFGIMLMEIFTRTKPTDEIFSGEM--------------TLKRWVND  321 (346)
Q Consensus       259 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~s~G~il~elltg~~p~~~~~~~~~--------------~~~~~~~~  321 (346)
                      .  ......+|+..|+|||.+...+|.+. .||||.|+++..|.+|+.||......+.              .-...+..
T Consensus       476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~  555 (601)
T KOG0590|consen  476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLS  555 (601)
T ss_pred             hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHH
Confidence            3  45566789999999999999988765 6999999999999999999965322211              12333444


Q ss_pred             hcCCChhhhhchhccCCccccccc
Q 039799          322 LLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       322 ~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      .+|..-..++-++|..+|.+|.+.
T Consensus       556 ~lp~~~~~~~~~~l~~~P~~R~ti  579 (601)
T KOG0590|consen  556 LLPRETRIIIYRMLQLDPTKRITI  579 (601)
T ss_pred             hchhhHHHHHHHHccCChhheecH
Confidence            566677899999999999999875

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.86  E-value=1.3e-22  Score=195.52  Aligned_cols=235  Identities=21%  Similarity=0.229  Sum_probs=175.9

Q ss_pred             CCCCCCcccccCceEEEEEEEcCCCEEEEEEecCCC-chhHH---HHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEe
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQY-EGAFK---SFDIECDVMKRICHRNLIKIISSYSNDDFKALVLE  179 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~-~~~~~---~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  179 (346)
                      ++...+.||++.|=+|.+|++++|. |+||++-+.. .-...   +...|++ ....+|||.+++.-....+...|||-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            6778889999999999999999887 8999986553 22233   3334444 555689999998777667777788888


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCC-cccc
Q 039799          180 YMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL-EEDQ  258 (346)
Q Consensus       180 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~-~~~~  258 (346)
                      |..+ +|.|.+..+ +.+.......|+.|++.|+..+|   ..+|+|||||.+|||++.-..+.|+||..-+... +.+.
T Consensus       102 yvkh-nLyDRlSTR-PFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN  176 (1431)
T KOG1240|consen  102 YVKH-NLYDRLSTR-PFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN  176 (1431)
T ss_pred             HHhh-hhhhhhccc-hHHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence            8854 888877644 34566667789999999999999   9999999999999999999999999998877532 2111


Q ss_pred             c----cccccccCCcccccCCCCCCC----------C-CCcchhHHHHHHHHHHHHc-CCCCCCccc-----cCcccHHH
Q 039799          259 S----LTQTQTLATIGYMAPEYGREG----------R-VSTNGDVYSFGIMLMEIFT-RTKPTDEIF-----SGEMTLKR  317 (346)
Q Consensus       259 ~----~~~~~~~~~~~y~aPE~~~~~----------~-~~~~~Dv~s~G~il~ellt-g~~p~~~~~-----~~~~~~~~  317 (346)
                      .    ....+...-..|+|||.+...          . .+++-||||+||++.|+++ |++||.-..     .++....+
T Consensus       177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e  256 (1431)
T KOG1240|consen  177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPE  256 (1431)
T ss_pred             cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHH
Confidence            1    112223345679999976431          1 4677899999999999987 799986421     22233344


Q ss_pred             HHhhhcCC-ChhhhhchhccCCccccccc
Q 039799          318 WVNDLLPI-SVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       318 ~~~~~~~~-~~~~~~d~~l~~~p~~R~~~  345 (346)
                      .+-+..++ .++.++-.|+..||.+|.++
T Consensus       257 ~~Le~Ied~~~Rnlil~Mi~rdPs~RlSA  285 (1431)
T KOG1240|consen  257 QLLEKIEDVSLRNLILSMIQRDPSKRLSA  285 (1431)
T ss_pred             HHHHhCcCccHHHHHHHHHccCchhccCH
Confidence            44444444 99999999999999999985

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.85  E-value=1.7e-21  Score=169.50  Aligned_cols=183  Identities=20%  Similarity=0.255  Sum_probs=134.8

Q ss_pred             CCCCceeeEEEEec---------------------------CCceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHH
Q 039799          157 CHRNLIKIISSYSN---------------------------DDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDV  209 (346)
Q Consensus       157 ~h~niv~~~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i  209 (346)
                      +|||||++.++|.+                           ....|+||... ..+|.+++..+  ..+...+.-|+.|+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~--~~s~r~~~~~laQl  350 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTR--HRSYRTGRVILAQL  350 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcC--CCchHHHHHHHHHH
Confidence            59999999876622                           33678898877 45888887533  34555666799999


Q ss_pred             HHHHHHHhcCCCCCeeecCCCCCceEEC--CCC--cEEEeeecCCccCCccc----cccccccccCCcccccCCCCCCCC
Q 039799          210 ASALEYLHFGYSAPIIHCDLKPSNVLLD--DNM--VAHLSDFGMAKPLLEED----QSLTQTQTLATIGYMAPEYGREGR  281 (346)
Q Consensus       210 ~~~l~~LH~~~~~~i~H~dik~~NIll~--~~~--~~~l~Dfg~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~  281 (346)
                      ++|+.|||   ..+|.|||+|++|||+.  +|.  .+.++|||+|-.-....    ........-|....+|||+....+
T Consensus       351 LEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P  427 (598)
T KOG4158|consen  351 LEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP  427 (598)
T ss_pred             HHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence            99999999   99999999999999993  333  68999999986321100    001111233677789999875432


Q ss_pred             ------CCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHhhhc-------CCChhhhhchhccCCccccccc
Q 039799          282 ------VSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLL-------PISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       282 ------~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~-------~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                            ...|+|.|+.|.+.||+++...||....+...+...+.+..+       |..+.+++-..|+.||.+|++.
T Consensus       428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp  504 (598)
T KOG4158|consen  428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSP  504 (598)
T ss_pred             CCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCc
Confidence                  246899999999999999999999874333344445555444       3477999999999999999985

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.85  E-value=1.9e-21  Score=178.32  Aligned_cols=190  Identities=30%  Similarity=0.426  Sum_probs=152.9

Q ss_pred             HHhcCCCCceeeEEEEecCCceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe-eecCCCC
Q 039799          153 MKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPI-IHCDLKP  231 (346)
Q Consensus       153 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i-~H~dik~  231 (346)
                      |+.+.|.|+.+++|.+.+....+.|.+|+..|+|.+.+......++|.....+.++++.|++|+|   ..+| .|+.+++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh---~s~i~~hg~l~s   77 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLH---NSPIGYHGALKS   77 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHh---cCcceeeeeecc
Confidence            35688999999999999999999999999999999999988889999999999999999999999   6665 9999999


Q ss_pred             CceEECCCCcEEEeeecCCccCCccccccccccccCCcccccCCCCCCCC-------CCcchhHHHHHHHHHHHHcCCCC
Q 039799          232 SNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGR-------VSTNGDVYSFGIMLMEIFTRTKP  304 (346)
Q Consensus       232 ~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Dv~s~G~il~elltg~~p  304 (346)
                      +|.++|..+.+|++|||+.....+..............-|.|||.+....       .+.++||||||++++|+++.+.|
T Consensus        78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~  157 (484)
T KOG1023|consen   78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP  157 (484)
T ss_pred             ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence            99999999999999999998764311111112222456699999877531       46779999999999999999999


Q ss_pred             CCccccCcc--cHHHHHhh--------------hcCCChhhhhchhccCCccccccc
Q 039799          305 TDEIFSGEM--TLKRWVND--------------LLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       305 ~~~~~~~~~--~~~~~~~~--------------~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      |+.....+.  ++..+++.              ..++.+..++..|+..+|.+||+.
T Consensus       158 ~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~  214 (484)
T KOG1023|consen  158 FDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSI  214 (484)
T ss_pred             cccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccH
Confidence            987433222  23333222              223357789999999999999985

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.85  E-value=2.2e-20  Score=153.47  Aligned_cols=187  Identities=15%  Similarity=0.092  Sum_probs=136.8

Q ss_pred             CCCCCcccccCceEEEEEEEcCCCEEEEEEecCCCch----hHHHHHHHHHHHHhcC-CCCceeeEEEEecCCceeEEEe
Q 039799          105 ANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEG----AFKSFDIECDVMKRIC-HRNLIKIISSYSNDDFKALVLE  179 (346)
Q Consensus       105 ~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e  179 (346)
                      +.....|++|+||+||.+.- .+.+++.+.+......    ....+.+|+++++++. |+++++++++    +..+++||
T Consensus         4 ~~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme   78 (218)
T PRK12274          4 PAVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS   78 (218)
T ss_pred             cccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence            34567899999999997765 5788887777644321    1225788999999995 5789999886    34689999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCC-CCCceEECCCCcEEEeeecCCccCCcccc
Q 039799          180 YMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL-KPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  258 (346)
Q Consensus       180 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~di-k~~NIll~~~~~~~l~Dfg~~~~~~~~~~  258 (346)
                      |++|.+|.+....        ....++.++++++.++|   +.||+|||| ||+|||++.++.++|+|||++........
T Consensus        79 yI~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~  147 (218)
T PRK12274         79 YLAGAAMYQRPPR--------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR  147 (218)
T ss_pred             eecCccHHhhhhh--------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence            9999998754321        12357789999999999   999999999 79999999999999999999985443221


Q ss_pred             c----cc-------cccccCCcccccCCCCCCC-CCC-cchhHHHHHHHHHHHHcCCCCCCc
Q 039799          259 S----LT-------QTQTLATIGYMAPEYGREG-RVS-TNGDVYSFGIMLMEIFTRTKPTDE  307 (346)
Q Consensus       259 ~----~~-------~~~~~~~~~y~aPE~~~~~-~~~-~~~Dv~s~G~il~elltg~~p~~~  307 (346)
                      .    ..       ..-...++.|.+|+...-. ..+ ...+-++-|.-+|.++||..|.-.
T Consensus       148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence            0    00       0011246667777633211 223 456788899999999999998644

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.84  E-value=5e-21  Score=165.37  Aligned_cols=225  Identities=21%  Similarity=0.285  Sum_probs=144.9

Q ss_pred             CCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhcC----------CCCceeeEEEEe---
Q 039799          107 MPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRIC----------HRNLIKIISSYS---  169 (346)
Q Consensus       107 ~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~----------h~niv~~~~~~~---  169 (346)
                      ....||.|+++.||.+++. +++++|+|++....   ....+++.+|.-....+.          |-.++-.++...   
T Consensus        16 ~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~   95 (288)
T PF14531_consen   16 RGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPG   95 (288)
T ss_dssp             EEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETT
T ss_pred             EccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcC
Confidence            4568999999999999987 68999999975322   234566666654444432          212222222211   


Q ss_pred             ------cC---C-----ceeEEEecCCCCChhhhhhh---cCC---CCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCC
Q 039799          170 ------ND---D-----FKALVLEYMPHGSLEKCLYL---SNY---ILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL  229 (346)
Q Consensus       170 ------~~---~-----~~~lv~e~~~~gsL~~~l~~---~~~---~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~di  229 (346)
                            ..   .     ..+++|+-+ .++|.+.+..   ...   .+....++.+..|+.+.+++||   ..|++|+||
T Consensus        96 ~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVHgdi  171 (288)
T PF14531_consen   96 KPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVHGDI  171 (288)
T ss_dssp             S-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEEST-
T ss_pred             CCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEeccc
Confidence                  11   1     235677777 5688776532   222   2445666778899999999999   999999999


Q ss_pred             CCCceEECCCCcEEEeeecCCccCCccccccccccccCCcccccCCCCCC--------CCCCcchhHHHHHHHHHHHHcC
Q 039799          230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE--------GRVSTNGDVYSFGIMLMEIFTR  301 (346)
Q Consensus       230 k~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~s~G~il~elltg  301 (346)
                      +|+|++++.+|.+.|+||+.........    .. ...+..|.+||....        ..++.+.|.|++|+++|.|++|
T Consensus       172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~----~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~  246 (288)
T PF14531_consen  172 KPENFLLDQDGGVFLGDFSSLVRAGTRY----RC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG  246 (288)
T ss_dssp             SGGGEEE-TTS-EEE--GGGEEETTEEE----EG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred             ceeeEEEcCCCCEEEcChHHHeecCcee----ec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence            9999999999999999998877543211    11 234577899985532        2468889999999999999999


Q ss_pred             CCCCCccccCcc---cHHHHHhhhcCCChhhhhchhccCCcccc
Q 039799          302 TKPTDEIFSGEM---TLKRWVNDLLPISVMEVVDANLLSQEDEH  342 (346)
Q Consensus       302 ~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~d~~l~~~p~~R  342 (346)
                      ..||+.......   ++....  ..|+.+.++|..+|..+|.+|
T Consensus       247 ~lPf~~~~~~~~~~~~f~~C~--~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  247 RLPFGLSSPEADPEWDFSRCR--DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             S-STCCCGGGSTSGGGGTTSS-----HHHHHHHHHHT-SSGGGS
T ss_pred             cCCCCCCCccccccccchhcC--CcCHHHHHHHHHHccCCcccC
Confidence            999986533222   222222  567789999999999999988

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.83  E-value=1.2e-20  Score=184.62  Aligned_cols=225  Identities=24%  Similarity=0.230  Sum_probs=171.0

Q ss_pred             CCCCCCcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcC---CCCceeeEEEEecCCceeEEEec
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRIC---HRNLIKIISSYSNDDFKALVLEY  180 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~  180 (346)
                      .|.+.+.+|+|+||+||+|...+|+.+|+|+=++.....   |..-.+++.+|+   -+.|..+...+.-.+..+||+||
T Consensus       699 ~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey  775 (974)
T KOG1166|consen  699 KFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEY  775 (974)
T ss_pred             eEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeec
Confidence            478888999999999999998889999999977654321   112223444444   23455555566667778899999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEEC-------CCCcEEEeeecCCccC
Q 039799          181 MPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD-------DNMVAHLSDFGMAKPL  253 (346)
Q Consensus       181 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~-------~~~~~~l~Dfg~~~~~  253 (346)
                      .+-|||.+++. ....++|...+.++.++++.++.||   ..+||||||||+|.||.       +...++|+|||.+..+
T Consensus       776 ~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm  851 (974)
T KOG1166|consen  776 SPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDM  851 (974)
T ss_pred             cccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEEecccceee
Confidence            99999999987 6677999999999999999999999   99999999999999994       3457899999999877


Q ss_pred             CccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHhhhcCC-Chhhhhc
Q 039799          254 LEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPI-SVMEVVD  332 (346)
Q Consensus       254 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~d  332 (346)
                      ..-.........++|-++..+|...+..++...|.|.++.+++-|+.|+.-- ..-.......+-+++.+.. -+.++++
T Consensus       852 ~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-~~~g~~~~~~~~~~Ry~~~~~W~~~F~  930 (974)
T KOG1166|consen  852 KLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-VKNGSSWMVKTNFPRYWKRDMWNKFFD  930 (974)
T ss_pred             eEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-hcCCcceeccccchhhhhHHHHHHHHH
Confidence            5433334455677899999999999999999999999999999999998643 1111111111113334433 3456777


Q ss_pred             hhcc
Q 039799          333 ANLL  336 (346)
Q Consensus       333 ~~l~  336 (346)
                      ..|.
T Consensus       931 ~lLN  934 (974)
T KOG1166|consen  931 LLLN  934 (974)
T ss_pred             HHhC
Confidence            7777

>PRK10345 hypothetical protein; Provisional

Probab=99.82  E-value=1.9e-19  Score=150.57  Aligned_cols=138  Identities=14%  Similarity=0.214  Sum_probs=106.7

Q ss_pred             CCCCCcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhc-----CCCCceeeEEEEecCC---cee-
Q 039799          105 ANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRI-----CHRNLIKIISSYSNDD---FKA-  175 (346)
Q Consensus       105 ~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~~~~~~~~~~---~~~-  175 (346)
                      .+-..+||+|++|.||.  +......+||+.........+.+.+|+++++++     .||||+++++++.++.   ..+ 
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~   81 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD   81 (210)
T ss_pred             cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence            34567899999999996  443333479988765444567889999999999     5799999999998764   333 


Q ss_pred             EEEec--CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHH-HHHhcCCCCCeeecCCCCCceEECC----CCcEEEeeec
Q 039799          176 LVLEY--MPHGSLEKCLYLSNYILDIFQRLDIMIDVASAL-EYLHFGYSAPIIHCDLKPSNVLLDD----NMVAHLSDFG  248 (346)
Q Consensus       176 lv~e~--~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l-~~LH~~~~~~i~H~dik~~NIll~~----~~~~~l~Dfg  248 (346)
                      +|+||  .++++|.+++...  .++..  ..++.+++.++ +|||   +.+|+||||||+|||++.    ++.++|+||+
T Consensus        82 ~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             EEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence            78999  5579999999643  34444  34577888777 9999   999999999999999973    3489999944


Q ss_pred             CCc
Q 039799          249 MAK  251 (346)
Q Consensus       249 ~~~  251 (346)
                      -+.
T Consensus       155 G~~  157 (210)
T PRK10345        155 GES  157 (210)
T ss_pred             CCc
Confidence            444

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.82  E-value=2.5e-21  Score=177.87  Aligned_cols=219  Identities=24%  Similarity=0.309  Sum_probs=170.0

Q ss_pred             cccccCceEEEEEE----EcCCCEEEEEEecCCCch--hHHHHHHHHHHHHhcC-CCCceeeEEEEecCCceeEEEecCC
Q 039799          110 LIGKGGFGSVYKAI----IQDGMEVAVKVFDPQYEG--AFKSFDIECDVMKRIC-HRNLIKIISSYSNDDFKALVLEYMP  182 (346)
Q Consensus       110 ~lg~G~~g~vy~~~----~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~  182 (346)
                      .+|+|++|.|+++.    .+.|.-+|.|+..+....  .......|..++..++ ||.++++...+..+...+++.++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            37899999999865    335777888887644211  1124445777888887 9999999999999999999999999


Q ss_pred             CCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccccc
Q 039799          183 HGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ  262 (346)
Q Consensus       183 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~  262 (346)
                      +|.+...+.... .++..........++-+++++|   +.+++|||+|++||+++.+|++++.|||+++...+...    
T Consensus        81 gg~lft~l~~~~-~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~----  152 (612)
T KOG0603|consen   81 GGDLFTRLSKEV-MFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI----  152 (612)
T ss_pred             cchhhhccccCC-chHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhh----
Confidence            999988775443 3445555567778899999999   99999999999999999999999999999997643321    


Q ss_pred             ccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh------hhcCCChhhhhchhcc
Q 039799          263 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN------DLLPISVMEVVDANLL  336 (346)
Q Consensus       263 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~------~~~~~~~~~~~d~~l~  336 (346)
                        .+||..|+|||...  .....+|-||||++++||+||..||..     .......+      +.+.....++++.++.
T Consensus       153 --~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-----~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~  223 (612)
T KOG0603|consen  153 --ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-----DTMKRILKAELEMPRELSAEARSLFRQLFK  223 (612)
T ss_pred             --cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-----HHHHHHhhhccCCchhhhHHHHHHHHHHHh
Confidence              27999999999987  567789999999999999999999976     11112222      1122256788888888


Q ss_pred             CCccccccc
Q 039799          337 SQEDEHFTT  345 (346)
Q Consensus       337 ~~p~~R~~~  345 (346)
                      .+|..|...
T Consensus       224 r~p~nrLg~  232 (612)
T KOG0603|consen  224 RNPENRLGA  232 (612)
T ss_pred             hCHHHHhcc
Confidence            898888653

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.81  E-value=4.8e-19  Score=149.90  Aligned_cols=134  Identities=24%  Similarity=0.310  Sum_probs=113.4

Q ss_pred             CcccccCceEEEEEEEcCCCEEEEEEecCCCc--------hhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEec
Q 039799          109 PLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYE--------GAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEY  180 (346)
Q Consensus       109 ~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  180 (346)
                      +.||+|++|.||+|.+ .|..+++|+......        .....+.+|++++..+.|+++.....++...+..+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5789999999999987 577899998654321        1124577899999999999998877777777788999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCcc
Q 039799          181 MPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  252 (346)
Q Consensus       181 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~  252 (346)
                      ++|++|.+++....    + .+..++.+++.++.++|   +.+++|+|++|.||+++ ++.++++|||.+..
T Consensus        81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999875432    2 77889999999999999   99999999999999999 78999999999885

>smart00090 RIO RIO-like kinase

Probab=99.80  E-value=4.8e-19  Score=151.69  Aligned_cols=141  Identities=19%  Similarity=0.210  Sum_probs=109.9

Q ss_pred             CCCCCCcccccCceEEEEEE--EcCCCEEEEEEecCCCch------------------------hHHHHHHHHHHHHhcC
Q 039799          104 DANMPPLIGKGGFGSVYKAI--IQDGMEVAVKVFDPQYEG------------------------AFKSFDIECDVMKRIC  157 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l~  157 (346)
                      .|.+.+.||+|++|.||+|.  ..+|+.||+|++......                        ....+..|++.+.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            36788999999999999998  558999999998643210                        1123567999999997


Q ss_pred             CCC--ceeeEEEEecCCceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-eeecCCCCCce
Q 039799          158 HRN--LIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP-IIHCDLKPSNV  234 (346)
Q Consensus       158 h~n--iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-i~H~dik~~NI  234 (346)
                      +..  +.++++.    ...++||||+++.++..... ............++.+++.++++||   +.+ ++||||||+||
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp~NI  180 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL-KDVEPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSEYNI  180 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCccccccc-ccCCcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCChhhE
Confidence            633  3444443    23479999999988876542 2233555566789999999999999   999 99999999999


Q ss_pred             EECCCCcEEEeeecCCccC
Q 039799          235 LLDDNMVAHLSDFGMAKPL  253 (346)
Q Consensus       235 ll~~~~~~~l~Dfg~~~~~  253 (346)
                      +++ ++.++|+|||.+...
T Consensus       181 li~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      181 LVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             EEE-CCCEEEEEChhhhcc
Confidence            999 889999999998854

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.79  E-value=1.1e-18  Score=146.45  Aligned_cols=131  Identities=24%  Similarity=0.324  Sum_probs=107.2

Q ss_pred             cccccCceEEEEEEEcCCCEEEEEEecCCC---c-----hhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecC
Q 039799          110 LIGKGGFGSVYKAIIQDGMEVAVKVFDPQY---E-----GAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYM  181 (346)
Q Consensus       110 ~lg~G~~g~vy~~~~~~~~~vavK~~~~~~---~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  181 (346)
                      +||+|++|.||+|.+. +..+++|......   .     ....++.+|++++..++|+++.....++...+..++||||+
T Consensus         1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            4899999999999864 7889999865321   1     11356778999999999887666555566666778999999


Q ss_pred             CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccC
Q 039799          182 PHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  253 (346)
Q Consensus       182 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~  253 (346)
                      +|++|.+.+.....        .++.+++.+|.+||   +.+++|+|++|.||+++ ++.++++|||++...
T Consensus        80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        80 EGKPLKDVIEEGND--------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CCccHHHHHhhcHH--------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            99999987643211        78999999999999   99999999999999999 789999999998853

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.79  E-value=1.5e-18  Score=145.31  Aligned_cols=135  Identities=23%  Similarity=0.242  Sum_probs=107.7

Q ss_pred             CCCCCcccccCceEEEEEEEcCCCEEEEEEecCCCch----------------------hHHHHHHHHHHHHhcCCCC--
Q 039799          105 ANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEG----------------------AFKSFDIECDVMKRICHRN--  160 (346)
Q Consensus       105 ~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~e~~~l~~l~h~n--  160 (346)
                      |.+.+.||+|++|.||++...+|+.+|||++......                      .......|...+.++.|++  
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   96 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP   96 (198)
T ss_pred             hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence            7778999999999999999888999999987543210                      1123567888899888774  


Q ss_pred             ceeeEEEEecCCceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCC
Q 039799          161 LIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM  240 (346)
Q Consensus       161 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~  240 (346)
                      +.+.++    ....++||||+++++|......       .....++.+++.++.++|   +.+++||||+|+||++++++
T Consensus        97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p~Nill~~~~  162 (198)
T cd05144          97 VPKPID----WNRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAY---KHGIIHGDLSEFNILVDDDE  162 (198)
T ss_pred             CCceee----cCCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHH---HCCCCcCCCCcccEEEcCCC
Confidence            444443    2345899999999999765321       234568899999999999   89999999999999999999


Q ss_pred             cEEEeeecCCccC
Q 039799          241 VAHLSDFGMAKPL  253 (346)
Q Consensus       241 ~~~l~Dfg~~~~~  253 (346)
                      .++|+|||.+...
T Consensus       163 ~~~liDfg~~~~~  175 (198)
T cd05144         163 KIYIIDWPQMVST  175 (198)
T ss_pred             cEEEEECCccccC
Confidence            9999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.78  E-value=3.4e-18  Score=164.07  Aligned_cols=134  Identities=23%  Similarity=0.285  Sum_probs=109.6

Q ss_pred             CCCCcccccCceEEEEEEEcCCCEEEEEEecCC-C-------chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEE
Q 039799          106 NMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQ-Y-------EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALV  177 (346)
Q Consensus       106 ~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~-~-------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  177 (346)
                      ...+.||+|+||+||+|.+... .+++|+.... .       ....+++.+|+++++.++|++++....++......++|
T Consensus       336 ~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv  414 (535)
T PRK09605        336 IPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIV  414 (535)
T ss_pred             CccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEE
Confidence            4467899999999999987644 3444432211 1       11235678899999999999999888888777788999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccC
Q 039799          178 LEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  253 (346)
Q Consensus       178 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~  253 (346)
                      |||+++++|.+++.         ....++.++++++.+||   +.+++|||+||+||++ +++.++|+|||+++..
T Consensus       415 ~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        415 MEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             EEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            99999999998774         35678999999999999   9999999999999999 6779999999999853

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.75  E-value=7.7e-19  Score=169.48  Aligned_cols=208  Identities=26%  Similarity=0.345  Sum_probs=146.8

Q ss_pred             cCCCCCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCcee
Q 039799           97 RGKPLPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKA  175 (346)
Q Consensus        97 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  175 (346)
                      ++.+..++|+..++|..|+||.||..+++ ..+.+|.|+ +++.-     +.+-  ++.....|.+|             
T Consensus        77 ~~~p~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l-----ilRn--ilt~a~npfvv-------------  135 (1205)
T KOG0606|consen   77 RRAPSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL-----ILRN--ILTFAGNPFVV-------------  135 (1205)
T ss_pred             ccCCCccccceeEeeccCCCCceeeeeccccccchhhcc-cccch-----hhhc--cccccCCccee-------------
Confidence            55677889999999999999999999877 466788854 22211     0000  33333444433             


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCc
Q 039799          176 LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  255 (346)
Q Consensus       176 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~  255 (346)
                              |+=...+..- ..++.        +++.+++|||   +.+|+|||+||+|.+++.-|++|+.|||+.+....
T Consensus       136 --------gDc~tllk~~-g~lPv--------dmvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLm  195 (1205)
T KOG0606|consen  136 --------GDCATLLKNI-GPLPV--------DMVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLM  195 (1205)
T ss_pred             --------chhhhhcccC-CCCcc--------hhhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhh
Confidence                    1111111111 11221        2267899999   99999999999999999999999999999886422


Q ss_pred             c-------------ccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcc------cHH
Q 039799          256 E-------------DQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM------TLK  316 (346)
Q Consensus       256 ~-------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~------~~~  316 (346)
                      .             .......+.+||+.|+|||+...+.|+..+|.|++|+|+||.+-|..||...+.++.      +..
T Consensus       196 s~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i  275 (1205)
T KOG0606|consen  196 SLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI  275 (1205)
T ss_pred             hccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhc
Confidence            1             011122356799999999999999999999999999999999999999977532221      112


Q ss_pred             HHHh--hhcCCChhhhhchhccCCccccccc
Q 039799          317 RWVN--DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       317 ~~~~--~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      .|-.  ..++.+..++++..|..+|-+|.-+
T Consensus       276 ~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt  306 (1205)
T KOG0606|consen  276 EWPEEDEALPPEAQDLIEQLLRQNPLCRLGT  306 (1205)
T ss_pred             cccccCcCCCHHHHHHHHHHHHhChHhhccc
Confidence            2222  2345588999999999999998644

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.74  E-value=2e-19  Score=162.43  Aligned_cols=163  Identities=26%  Similarity=0.413  Sum_probs=128.9

Q ss_pred             ceeEEEecCCCCChhhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCC
Q 039799          173 FKALVLEYMPHGSLEKCLYLSN--YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMA  250 (346)
Q Consensus       173 ~~~lv~e~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~  250 (346)
                      +.|+.|++++-.+|.+++..+.  ...++.....++.+++.++.|      ++.+|+|+||.||+...+..++|.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence            6789999999999999996443  567888899999999999998      68999999999999999999999999999


Q ss_pred             ccCCccc----cccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHhhhcC-
Q 039799          251 KPLLEED----QSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVNDLLP-  324 (346)
Q Consensus       251 ~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~-  324 (346)
                      .......    .....+...||..|++||++.++.|+.|+||||+|++|+|++. =..+++...    .....-...+| 
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~----t~~d~r~g~ip~  479 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA----TLTDIRDGIIPP  479 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH----hhhhhhcCCCCh
Confidence            8765433    2234556779999999999999999999999999999999997 333333211    11111111222 


Q ss_pred             ----C--ChhhhhchhccCCccccccc
Q 039799          325 ----I--SVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       325 ----~--~~~~~~d~~l~~~p~~R~~~  345 (346)
                          +  .-..++..++...|.+||++
T Consensus       480 ~~~~d~p~e~~ll~~lls~~p~~RP~~  506 (516)
T KOG1033|consen  480 EFLQDYPEEYTLLQQLLSPSPEERPSA  506 (516)
T ss_pred             HHhhcCcHHHHHHHHhcCCCcccCchH
Confidence                2  33589999999999999954

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.72  E-value=5.2e-17  Score=134.74  Aligned_cols=136  Identities=24%  Similarity=0.249  Sum_probs=97.5

Q ss_pred             CCcccccCceEEEEEEEcCCCEEEEEEecCCCchh--HHH----------------------HHHHHHHHHhcCCCC--c
Q 039799          108 PPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGA--FKS----------------------FDIECDVMKRICHRN--L  161 (346)
Q Consensus       108 ~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~--~~~----------------------~~~e~~~l~~l~h~n--i  161 (346)
                      .+.||+|++|.||+|...+++.||||++.......  ...                      ...|.+.+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            56799999999999998889999999986532111  111                      134555566654433  3


Q ss_pred             eeeEEEEecCCceeEEEecCCCCChhhh-hhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeeecCCCCCceEECCC
Q 039799          162 IKIISSYSNDDFKALVLEYMPHGSLEKC-LYLSNYILDIFQRLDIMIDVASALEYLHFGYS-APIIHCDLKPSNVLLDDN  239 (346)
Q Consensus       162 v~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~i~H~dik~~NIll~~~  239 (346)
                      .+.++.    ...++||||++++++... +....  .. .....++.+++.++.++|   . .+++|+||+|+||+++ +
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili~-~  150 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLY---REAGLVHGDLSEYNILVD-D  150 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEEE-C
Confidence            344433    245899999998543221 11110  11 456789999999999999   7 9999999999999999 8


Q ss_pred             CcEEEeeecCCccCC
Q 039799          240 MVAHLSDFGMAKPLL  254 (346)
Q Consensus       240 ~~~~l~Dfg~~~~~~  254 (346)
                      +.++++|||.+....
T Consensus       151 ~~~~liDfg~a~~~~  165 (187)
T cd05119         151 GKVYIIDVPQAVEID  165 (187)
T ss_pred             CcEEEEECccccccc
Confidence            999999999998653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.71  E-value=1.9e-16  Score=126.22  Aligned_cols=135  Identities=21%  Similarity=0.269  Sum_probs=114.0

Q ss_pred             CCCcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCC--CCceeeEEEEecCCceeEEEecCCCC
Q 039799          107 MPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICH--RNLIKIISSYSNDDFKALVLEYMPHG  184 (346)
Q Consensus       107 ~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~g  184 (346)
                      +.+.||+|.++.||++...+ ..+++|.......  ...+..|+..++.++|  ..+.+++.+....+..++++||++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            34679999999999999864 7899999865433  4678889999999977  58889999888888899999999988


Q ss_pred             ChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCcc
Q 039799          185 SLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  252 (346)
Q Consensus       185 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~  252 (346)
                      ++...        +......++.+++++++++|.....+++|+|++|+||++++.+.++++|||.+..
T Consensus        79 ~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            77653        5566778899999999999944336799999999999999989999999999874

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.68  E-value=6.5e-18  Score=161.96  Aligned_cols=243  Identities=23%  Similarity=0.284  Sum_probs=191.8

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc--CCCEEEEEEecCCC--chhHHHHHHHHHHHHhcC-CCCceeeEEEEecCCceeE
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ--DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRIC-HRNLIKIISSYSNDDFKAL  176 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~l  176 (346)
                      ...|...+.||+|+++.|-.....  ....+|+|.+....  .....+...|..+-..+. |+|++.+++.....+..++
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            456888888999999999887753  34456666655332  333444555777777776 9999999999999999999


Q ss_pred             EEecCCCCChhhhh-hhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCC-cEEEeeecCCccCC
Q 039799          177 VLEYMPHGSLEKCL-YLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM-VAHLSDFGMAKPLL  254 (346)
Q Consensus       177 v~e~~~~gsL~~~l-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~-~~~l~Dfg~~~~~~  254 (346)
                      .+++..++++.+-+ +......+....-..+.++..++.|+|.  ..++.|+|++|+|.+++..+ ..+++|||+|..+.
T Consensus        99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~  176 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR  176 (601)
T ss_pred             ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence            99999999998877 4333255666677799999999999995  67899999999999999999 99999999999886


Q ss_pred             c-cccccccccccC-CcccccCCCCCCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHhhh---------
Q 039799          255 E-EDQSLTQTQTLA-TIGYMAPEYGREG-RVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDL---------  322 (346)
Q Consensus       255 ~-~~~~~~~~~~~~-~~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~---------  322 (346)
                      . .+........+| ++.|.|||...+. ...+..|+||.|+++.-+++|..|++...........|....         
T Consensus       177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (601)
T KOG0590|consen  177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWN  256 (601)
T ss_pred             ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccc
Confidence            6 444455556678 9999999988874 557888999999999999999999988665555555555442         


Q ss_pred             -cCCChhhhhchhccCCcccccccC
Q 039799          323 -LPISVMEVVDANLLSQEDEHFTTK  346 (346)
Q Consensus       323 -~~~~~~~~~d~~l~~~p~~R~~~k  346 (346)
                       ......+++.+++..+|..|.+.+
T Consensus       257 ~~~~~~~~~l~k~l~~~~~~r~s~~  281 (601)
T KOG0590|consen  257 SISDQAHDLLHKILKENPSNRLSIE  281 (601)
T ss_pred             cCChhhhhcccccccCCchhccccc
Confidence             233778899999999999998753

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.67  E-value=1e-15  Score=131.46  Aligned_cols=136  Identities=17%  Similarity=0.185  Sum_probs=105.2

Q ss_pred             CCccc-ccCceEEEEEEEcCCCEEEEEEecCCC-------------chhHHHHHHHHHHHHhcCCCCc--eeeEEEEecC
Q 039799          108 PPLIG-KGGFGSVYKAIIQDGMEVAVKVFDPQY-------------EGAFKSFDIECDVMKRICHRNL--IKIISSYSND  171 (346)
Q Consensus       108 ~~~lg-~G~~g~vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~~  171 (346)
                      ...|| .|+.|+||++... +..+++|.+....             .....++.+|++++.++.|+++  +..+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            45687 8999999999876 7789999885311             1223567889999999998885  6677664432


Q ss_pred             C----ceeEEEecCCC-CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEee
Q 039799          172 D----FKALVLEYMPH-GSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSD  246 (346)
Q Consensus       172 ~----~~~lv~e~~~~-gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~D  246 (346)
                      .    ..++|+|++++ .+|.+++...  .++..    .+.+++.++.+||   +.||+||||||.|||++.++.++|+|
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~LID  185 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEA--PLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWLID  185 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcC--CCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEEEE
Confidence            2    23599999997 6898877532  33332    3678999999999   99999999999999999988999999


Q ss_pred             ecCCccC
Q 039799          247 FGMAKPL  253 (346)
Q Consensus       247 fg~~~~~  253 (346)
                      ||.+...
T Consensus       186 fg~~~~~  192 (239)
T PRK01723        186 FDRGELR  192 (239)
T ss_pred             CCCcccC
Confidence            9998864

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.62  E-value=3.7e-15  Score=138.72  Aligned_cols=142  Identities=23%  Similarity=0.278  Sum_probs=101.1

Q ss_pred             CCcccccCceEEEEEEEcCCCEEEEEEecCCCchhHH----------------------------------------HHH
Q 039799          108 PPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFK----------------------------------------SFD  147 (346)
Q Consensus       108 ~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~----------------------------------------~~~  147 (346)
                      .+.||+|++|.||+|++++|+.||||+..+.......                                        .+.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            4689999999999999999999999998765311100                                        133


Q ss_pred             HHHHHHHhc----C-CCCceeeEEEEecCCceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHH-HHHHHhcCCC
Q 039799          148 IECDVMKRI----C-HRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVAS-ALEYLHFGYS  221 (346)
Q Consensus       148 ~e~~~l~~l----~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~-~l~~LH~~~~  221 (346)
                      +|.+.+.++    + ++++.-.--++......++||||++|++|.+.........+   +..++..++. .+..+|   .
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~---~  275 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVL---R  275 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHH---h
Confidence            344444444    2 33333222233334567899999999999887643322222   3456666666 467888   8


Q ss_pred             CCeeecCCCCCceEECCCCcEEEeeecCCccCCc
Q 039799          222 APIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  255 (346)
Q Consensus       222 ~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~  255 (346)
                      .|++|+|++|.||++++++.++++|||++..+.+
T Consensus       276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            9999999999999999999999999999987754

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.57  E-value=5.8e-15  Score=126.23  Aligned_cols=194  Identities=21%  Similarity=0.274  Sum_probs=138.0

Q ss_pred             HHHHhcCCCCceeeEEEEecCC-----ceeEEEecCCCCChhhhhhhc---CCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 039799          151 DVMKRICHRNLIKIISSYSNDD-----FKALVLEYMPHGSLEKCLYLS---NYILDIFQRLDIMIDVASALEYLHFGYSA  222 (346)
Q Consensus       151 ~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~  222 (346)
                      .-+-++.|.|++++..||.+..     ...++.|||+.|++.++|+.-   ...+......+++.||..||.||| .|++
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLh-s~~P  197 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLH-SCDP  197 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhh-ccCC
Confidence            3445667999999999986544     567899999999999998643   345667777889999999999999 5689


Q ss_pred             CeeecCCCCCceEECCCCcEEEeeecCCccCCcc--ccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc
Q 039799          223 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE--DQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT  300 (346)
Q Consensus       223 ~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt  300 (346)
                      +|+|+++..+-|++..++-+|+.----...-...  ..........+.++|.+||+-.....+..+|||+||+..+||..
T Consensus       198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai  277 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI  277 (458)
T ss_pred             ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence            9999999999999998888887431111100000  00011122346889999999888888889999999999999988


Q ss_pred             CCCCCCcccc---CcccHHHHHhhhcCC-ChhhhhchhccCCcccccccC
Q 039799          301 RTKPTDEIFS---GEMTLKRWVNDLLPI-SVMEVVDANLLSQEDEHFTTK  346 (346)
Q Consensus       301 g~~p~~~~~~---~~~~~~~~~~~~~~~-~~~~~~d~~l~~~p~~R~~~k  346 (346)
                      +..-.....+   .+..... +...+.. .=++.+.+|+...|..||+++
T Consensus       278 lEiq~tnseS~~~~ee~ia~-~i~~len~lqr~~i~kcl~~eP~~rp~ar  326 (458)
T KOG1266|consen  278 LEIQSTNSESKVEVEENIAN-VIIGLENGLQRGSITKCLEGEPNGRPDAR  326 (458)
T ss_pred             heeccCCCcceeehhhhhhh-heeeccCccccCcCcccccCCCCCCcchh
Confidence            7764222111   1111111 1122233 347899999999999999874

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.47  E-value=3.3e-13  Score=109.97  Aligned_cols=127  Identities=21%  Similarity=0.220  Sum_probs=95.4

Q ss_pred             CcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCce-eeEEEEecCCceeEEEecCCCCChh
Q 039799          109 PLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLI-KIISSYSNDDFKALVLEYMPHGSLE  187 (346)
Q Consensus       109 ~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~gsL~  187 (346)
                      +.++.|..+.||+++.. +..+++|+...... ....+..|++.++.+.+.+++ +++...  ....++||||+++.++.
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~   79 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL   79 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence            56789999999999876 78899999765432 123456789999988765554 444443  23457999999998886


Q ss_pred             hhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-----eeecCCCCCceEECCCCcEEEeeecCCcc
Q 039799          188 KCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP-----IIHCDLKPSNVLLDDNMVAHLSDFGMAKP  252 (346)
Q Consensus       188 ~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-----i~H~dik~~NIll~~~~~~~l~Dfg~~~~  252 (346)
                      +.     . .   .....+.+++++++.||   ..+     ++|+|++|.||+++ ++.++++||+.+..
T Consensus        80 ~~-----~-~---~~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          80 TE-----D-F---SDPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cc-----c-c---cCHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            42     0 1   11235678999999999   665     59999999999999 66899999998874

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.47  E-value=9e-13  Score=123.02  Aligned_cols=169  Identities=15%  Similarity=0.172  Sum_probs=126.1

Q ss_pred             EcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecCCCCChhhhhhhcCCCCCHHHHH
Q 039799          124 IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL  203 (346)
Q Consensus       124 ~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~  203 (346)
                      ..++.+|.|..++...........+.++.++.+|||||+++++.+...+..|+|+|.+.  .|..++....    .....
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~----~~~v~  107 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG----KEEVC  107 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH----HHHHH
Confidence            34788999999876655455667778899999999999999999999999999999974  4444454322    34455


Q ss_pred             HHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccccccccCCcccccCCCCCCCCCC
Q 039799          204 DIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVS  283 (346)
Q Consensus       204 ~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  283 (346)
                      .-+.||+.||.|||+  +.+++|++|.-+.|++++.|+.||++|.++........  ......---.|..|+......  
T Consensus       108 ~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~--  181 (690)
T KOG1243|consen  108 LGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE--  181 (690)
T ss_pred             HHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--
Confidence            678899999999985  67899999999999999999999999999875432211  011111223355665433222  


Q ss_pred             cchhHHHHHHHHHHHHcCCCC
Q 039799          284 TNGDVYSFGIMLMEIFTRTKP  304 (346)
Q Consensus       284 ~~~Dv~s~G~il~elltg~~p  304 (346)
                      -..|.|-||++++|++.|..+
T Consensus       182 ~s~D~~~Lg~li~el~ng~~~  202 (690)
T KOG1243|consen  182 WSIDSWGLGCLIEELFNGSLL  202 (690)
T ss_pred             cchhhhhHHHHHHHHhCcccC
Confidence            346999999999999999443

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.43  E-value=1.7e-12  Score=122.54  Aligned_cols=145  Identities=19%  Similarity=0.219  Sum_probs=94.5

Q ss_pred             CCCCCCcccccCceEEEEEEEcC-CCEEEEEEecCCCchh----------------------------------HHH---
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGA----------------------------------FKS---  145 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~~-~~~vavK~~~~~~~~~----------------------------------~~~---  145 (346)
                      +|+. +.||+|++|.||+|++++ |+.||||+..+.....                                  .+.   
T Consensus       121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~  199 (537)
T PRK04750        121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD  199 (537)
T ss_pred             hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence            4665 789999999999999987 9999999997652110                                  111   


Q ss_pred             ---HHHHHHHHHhcC----CCCceeeEEEE-ecCCceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHH-HHHH
Q 039799          146 ---FDIECDVMKRIC----HRNLIKIISSY-SNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASA-LEYL  216 (346)
Q Consensus       146 ---~~~e~~~l~~l~----h~niv~~~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~-l~~L  216 (346)
                         +.+|..-+.+++    +.+.+.+-..+ .-....+|||||++|+++.+.-.......+.   ..++...+.. +.-+
T Consensus       200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~---~~la~~~v~~~~~Qi  276 (537)
T PRK04750        200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDM---KLLAERGVEVFFTQV  276 (537)
T ss_pred             hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCH---HHHHHHHHHHHHHHH
Confidence               223333333332    33334333333 2355678999999999998743222111221   1222222222 2233


Q ss_pred             hcCCCCCeeecCCCCCceEECCCC----cEEEeeecCCccCCc
Q 039799          217 HFGYSAPIIHCDLKPSNVLLDDNM----VAHLSDFGMAKPLLE  255 (346)
Q Consensus       217 H~~~~~~i~H~dik~~NIll~~~~----~~~l~Dfg~~~~~~~  255 (346)
                      .   ..|++|+|+||.||+++.++    .++++|||++..+.+
T Consensus       277 f---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        277 F---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             H---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            4   67999999999999999888    999999999998754

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.42  E-value=6.9e-12  Score=103.25  Aligned_cols=137  Identities=20%  Similarity=0.188  Sum_probs=98.1

Q ss_pred             CCcccccCceEEEEEEEcC-------CCEEEEEEecCCC----------------------chhHHHH----HHHHHHHH
Q 039799          108 PPLIGKGGFGSVYKAIIQD-------GMEVAVKVFDPQY----------------------EGAFKSF----DIECDVMK  154 (346)
Q Consensus       108 ~~~lg~G~~g~vy~~~~~~-------~~~vavK~~~~~~----------------------~~~~~~~----~~e~~~l~  154 (346)
                      ...||.|.-+.||.|...+       +..+|||++....                      ....+.+    .+|++.|.
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4578999999999997543       4799999974321                      0112222    37999999


Q ss_pred             hcCC--CCceeeEEEEecCCceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCeeecCCCC
Q 039799          155 RICH--RNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYL-HFGYSAPIIHCDLKP  231 (346)
Q Consensus       155 ~l~h--~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~i~H~dik~  231 (346)
                      ++..  -++..++++    ...++||||+.+..+.... .....++......+..+++.++..| |   ..+++|||+++
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~-Lkd~~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDLs~  153 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPK-LKDAKLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADLSE  153 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchh-hhccccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCCCH
Confidence            8854  455566654    4567999999765432211 1122344445667789999999998 8   88999999999


Q ss_pred             CceEECCCCcEEEeeecCCccC
Q 039799          232 SNVLLDDNMVAHLSDFGMAKPL  253 (346)
Q Consensus       232 ~NIll~~~~~~~l~Dfg~~~~~  253 (346)
                      .||++++ +.+.++|||.+...
T Consensus       154 ~NIL~~~-~~v~iIDF~qav~~  174 (197)
T cd05146         154 YNMLWHD-GKVWFIDVSQSVEP  174 (197)
T ss_pred             HHEEEEC-CcEEEEECCCceeC
Confidence            9999974 68999999998865

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.42  E-value=4.1e-12  Score=101.18  Aligned_cols=131  Identities=24%  Similarity=0.308  Sum_probs=104.5

Q ss_pred             CcccccCceEEEEEEEcCCCEEEEEEecCCC--------chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEec
Q 039799          109 PLIGKGGFGSVYKAIIQDGMEVAVKVFDPQY--------EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEY  180 (346)
Q Consensus       109 ~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  180 (346)
                      .++++|+-+.+|.+.+. |.++++|.=.++.        .-...+..+|.+++++++--.+....-+..+.+...++|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            46789999999999876 4557777533221        11234667899999999877777767777788888899999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCcc
Q 039799          181 MPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  252 (346)
Q Consensus       181 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~  252 (346)
                      ++|-.|.+.+...        +..++..+-.-+.-||   ..+|+|+|+.++||.+..+. +.++|||++..
T Consensus        81 I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA--------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc--------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999999888644        3567788888899999   99999999999999998765 99999999884

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.40  E-value=3.7e-13  Score=124.22  Aligned_cols=237  Identities=22%  Similarity=0.205  Sum_probs=172.2

Q ss_pred             CCCCCCcccc--cCceEEEEEEE--c-CCCEEEEEEecCCCc--hhHHHHHHHHHHHHhc-CCCCceeeEEEEecCCcee
Q 039799          104 DANMPPLIGK--GGFGSVYKAII--Q-DGMEVAVKVFDPQYE--GAFKSFDIECDVMKRI-CHRNLIKIISSYSNDDFKA  175 (346)
Q Consensus       104 ~~~~~~~lg~--G~~g~vy~~~~--~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  175 (346)
                      .+.+...+|.  |.+|.+|.+..  . ++..+|+|.-+....  ....+=.+|+...+++ .|+|.++....+...+..+
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            3667788999  99999999986  3 688899987432211  2223334466666666 4999999889999999999


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHH----HHHHHhcCCCCCeeecCCCCCceEECCC-CcEEEeeecCC
Q 039799          176 LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVAS----ALEYLHFGYSAPIIHCDLKPSNVLLDDN-MVAHLSDFGMA  250 (346)
Q Consensus       176 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~----~l~~LH~~~~~~i~H~dik~~NIll~~~-~~~~l~Dfg~~  250 (346)
                      +-+|.+ +.+|.++.+.....++....+....+..+    |+.++|   +.+++|-|+||.||+...+ ...+++|||+.
T Consensus       195 iqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df~~v  270 (524)
T KOG0601|consen  195 IQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDFGLV  270 (524)
T ss_pred             eeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCCccee
Confidence            999998 47888877766666777888888888888    999999   9999999999999999999 89999999999


Q ss_pred             ccCCcccccccc---ccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccc-cCcccHHHHH--hhhc-
Q 039799          251 KPLLEEDQSLTQ---TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIF-SGEMTLKRWV--NDLL-  323 (346)
Q Consensus       251 ~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~-~~~~~~~~~~--~~~~-  323 (346)
                      ..+.+.+.....   ....+...|++||... +-++..+|+|++|.+..+..++..+..... ..=..+.++.  .+.+ 
T Consensus       271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~  349 (524)
T KOG0601|consen  271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCE  349 (524)
T ss_pred             EEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhc
Confidence            988665422111   1225788899999774 557889999999999999999887654321 1111111111  1111 


Q ss_pred             --CCChhhhhchhccCCccccccc
Q 039799          324 --PISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       324 --~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                        ..++...+..++..+|..|++.
T Consensus       350 ~~s~~l~~~~~~~~d~~~~~~~~~  373 (524)
T KOG0601|consen  350 GGSSSLRSVTSQMLDEDPRLRLTA  373 (524)
T ss_pred             CcchhhhhHHHHhcCcchhhhhHH
Confidence              1244456667777777777654

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.40  E-value=5.8e-12  Score=99.94  Aligned_cols=142  Identities=18%  Similarity=0.186  Sum_probs=107.6

Q ss_pred             CCCcccccCceEEEEEEEcCCCEEEEEEec-CCC-------chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEE
Q 039799          107 MPPLIGKGGFGSVYKAIIQDGMEVAVKVFD-PQY-------EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVL  178 (346)
Q Consensus       107 ~~~~lg~G~~g~vy~~~~~~~~~vavK~~~-~~~-------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  178 (346)
                      ...++.+|+-+.|+++.+. |+.+.||.-. +..       .-..++..+|++.+.+++--.|.-..-++.+.....++|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            5678899999999999988 7888887532 221       122467778999999997666666666666777777999


Q ss_pred             ecCCC-CChhhhhhhcCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCC---cEEEeeecCCcc
Q 039799          179 EYMPH-GSLEKCLYLSNY-ILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM---VAHLSDFGMAKP  252 (346)
Q Consensus       179 e~~~~-gsL~~~l~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~---~~~l~Dfg~~~~  252 (346)
                      ||+++ .++.+++..... .........++..+-+.+.-||   ..+|+|+|+..+||++..++   .+.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            99977 467777654332 2222333678999999999999   99999999999999996544   568999999874

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.33  E-value=2.4e-11  Score=103.41  Aligned_cols=142  Identities=18%  Similarity=0.173  Sum_probs=108.5

Q ss_pred             CcccccCceEEEEEEEcCCCEEEEEEecCCCc-hhHHHHHHHHHHHHhcCCC--CceeeEEEEecCC---ceeEEEecCC
Q 039799          109 PLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYE-GAFKSFDIECDVMKRICHR--NLIKIISSYSNDD---FKALVLEYMP  182 (346)
Q Consensus       109 ~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~--niv~~~~~~~~~~---~~~lv~e~~~  182 (346)
                      +.++.|..+.+|++...+|+.+++|....... .....+..|.++++.+++.  .+.+++.+.....   ..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            46899999999999987778999999764322 1345678899999999764  4566777766543   5689999999


Q ss_pred             CCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcC-------------------------------------------
Q 039799          183 HGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFG-------------------------------------------  219 (346)
Q Consensus       183 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-------------------------------------------  219 (346)
                      |.++.+.+..  ..++...+..++.++++++..||..                                           
T Consensus        84 G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (223)
T cd05154          84 GRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL  161 (223)
T ss_pred             CEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence            9988775421  2456667777888888888888831                                           


Q ss_pred             ----------CCCCeeecCCCCCceEECC--CCcEEEeeecCCcc
Q 039799          220 ----------YSAPIIHCDLKPSNVLLDD--NMVAHLSDFGMAKP  252 (346)
Q Consensus       220 ----------~~~~i~H~dik~~NIll~~--~~~~~l~Dfg~~~~  252 (346)
                                ....++|+|+++.||+++.  ++.+.++||+.+..
T Consensus       162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                      1245799999999999998  66789999998774

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PLN03150 hypothetical protein; Provisional

Probab=99.18  E-value=2.1e-11  Score=118.81  Aligned_cols=75  Identities=37%  Similarity=0.628  Sum_probs=44.1

Q ss_pred             CccCcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCC-C-CCcccccccccCCcchhhcc
Q 039799            2 GSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-G-PFRNLSVKSFEGNELLCEIV   76 (346)
Q Consensus         2 g~ip~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~-~-~~~~l~~l~~~~n~~~~~~~   76 (346)
                      |.+|.++++|++|+.|||++|+|+|.+|+++++|++|+.|+|++|+|+|.+|.. + .+.++..+++.+|..+|..|
T Consensus       456 g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p  532 (623)
T PLN03150        456 GNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP  532 (623)
T ss_pred             CcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEecCCccccCCC
Confidence            455666666666666666666666666666666666666666666666666553 1 12234455666676666643

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.18  E-value=3.1e-10  Score=93.08  Aligned_cols=125  Identities=28%  Similarity=0.326  Sum_probs=82.4

Q ss_pred             EEEEEEEcCCCEEEEEEecCCC--------------------------chhHHHHHHHHHHHHhcCCC--CceeeEEEEe
Q 039799          118 SVYKAIIQDGMEVAVKVFDPQY--------------------------EGAFKSFDIECDVMKRICHR--NLIKIISSYS  169 (346)
Q Consensus       118 ~vy~~~~~~~~~vavK~~~~~~--------------------------~~~~~~~~~e~~~l~~l~h~--niv~~~~~~~  169 (346)
                      .||.|...+|..+|+|+.....                          ........+|.+.|.++..-  ++.+++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            4899998889999999974321                          01123566799999999766  455666542 


Q ss_pred             cCCceeEEEecCC--CCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHH-HhcCCCCCeeecCCCCCceEECCCCcEEEee
Q 039799          170 NDDFKALVLEYMP--HGSLEKCLYLSNYILDIFQRLDIMIDVASALEY-LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSD  246 (346)
Q Consensus       170 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~-LH~~~~~~i~H~dik~~NIll~~~~~~~l~D  246 (346)
                         ...+||||++  |..+..+....   ++......++.+++..+.. +|   ..+++|+|+++.||+++++ .+.++|
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~iID  149 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYIID  149 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE--
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEEEe
Confidence               3469999998  55554433211   1122345577777775554 58   9999999999999999987 999999


Q ss_pred             ecCCccC
Q 039799          247 FGMAKPL  253 (346)
Q Consensus       247 fg~~~~~  253 (346)
                      ||.+...
T Consensus       150 f~qav~~  156 (188)
T PF01163_consen  150 FGQAVDS  156 (188)
T ss_dssp             GTTEEET
T ss_pred             cCcceec
Confidence            9988754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.18  E-value=4.8e-10  Score=102.11  Aligned_cols=168  Identities=20%  Similarity=0.265  Sum_probs=127.5

Q ss_pred             CceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEe----cCCceeEEEecCCC-CChhh
Q 039799          115 GFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYS----NDDFKALVLEYMPH-GSLEK  188 (346)
Q Consensus       115 ~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~----~~~~~~lv~e~~~~-gsL~~  188 (346)
                      .-.+.|++... +|..|++|+++............-+++++++.|+|+|++.+.+.    .+....+||+|.++ ++|.+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            34578999855 89999999995443333333445678999999999999998775    35578899999985 46665


Q ss_pred             hhhh--------------cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCC
Q 039799          189 CLYL--------------SNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  254 (346)
Q Consensus       189 ~l~~--------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~  254 (346)
                      ....              .+...++...|.++.|+..||.++|   +.|+..+-+.+++|+++.+.+++|+..|....+.
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence            4321              1245678889999999999999999   9999999999999999999899999888766553


Q ss_pred             ccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCC
Q 039799          255 EEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKP  304 (346)
Q Consensus       255 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p  304 (346)
                      .+..                |-+   +--.+-|.-.||.+++.+.||..-
T Consensus       445 ~d~~----------------~~l---e~~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  445 EDPT----------------EPL---ESQQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCCC----------------cch---hHHhhhhHHHHHHHHHHHhhcccc
Confidence            3220                001   112356999999999999999654

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.16  E-value=9.5e-10  Score=95.62  Aligned_cols=140  Identities=17%  Similarity=0.071  Sum_probs=100.7

Q ss_pred             CcccccCceEEEEEEEcCCCEEEEEEecCCCch-hHH----------HHHHHHHHHHhcCCCCce--eeEEEEec-----
Q 039799          109 PLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEG-AFK----------SFDIECDVMKRICHRNLI--KIISSYSN-----  170 (346)
Q Consensus       109 ~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~-~~~----------~~~~e~~~l~~l~h~niv--~~~~~~~~-----  170 (346)
                      +.+-......|++..+. |+.+.||........ ..+          .+.+|.+.+.++...+|.  .++++...     
T Consensus        28 e~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            33444444556776664 788999987543211 111          377899999888544444  44556543     


Q ss_pred             CCceeEEEecCCCC-Chhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC-------CCc
Q 039799          171 DDFKALVLEYMPHG-SLEKCLYLS-NYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD-------NMV  241 (346)
Q Consensus       171 ~~~~~lv~e~~~~g-sL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~-------~~~  241 (346)
                      ....++|+|++++. +|.+++... ....+...+..++.+++..+.-||   ..||+|+|++++|||++.       +..
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~  183 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLK  183 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCce
Confidence            23577999999886 898887432 233455667789999999999999   999999999999999975       468


Q ss_pred             EEEeeecCCcc
Q 039799          242 AHLSDFGMAKP  252 (346)
Q Consensus       242 ~~l~Dfg~~~~  252 (346)
                      +.++||+.+..
T Consensus       184 ~~LIDl~r~~~  194 (268)
T PRK15123        184 LSVIDLHRAQI  194 (268)
T ss_pred             EEEEECCcccc
Confidence            99999998864

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.15  E-value=2.5e-11  Score=112.29  Aligned_cols=192  Identities=23%  Similarity=0.235  Sum_probs=145.3

Q ss_pred             CCCCCCcccccCceEEEEEEEc--CCCEEEEEEecCCCchhHHHH--HHHHHHHHhc-CCCCceeeEEEEecCCceeEEE
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQ--DGMEVAVKVFDPQYEGAFKSF--DIECDVMKRI-CHRNLIKIISSYSNDDFKALVL  178 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~--~~~~vavK~~~~~~~~~~~~~--~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  178 (346)
                      +|.....||.|.|+.|+....+  ++..|++|...........+.  ..|+.+...+ .|.+++.....|......++--
T Consensus       266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~  345 (524)
T KOG0601|consen  266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPL  345 (524)
T ss_pred             CcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCch
Confidence            4677778999999999998754  678899998765433322222  2355555555 5888999888898888888999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCC-CcEEEeeecCCccCCccc
Q 039799          179 EYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDN-MVAHLSDFGMAKPLLEED  257 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~-~~~~l~Dfg~~~~~~~~~  257 (346)
                      ||++++++.... .....++...++++..+++.++.++|   ++.++|+|++|+||++..+ +..+++|||.+..+.-..
T Consensus       346 e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~  421 (524)
T KOG0601|consen  346 EFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS  421 (524)
T ss_pred             hhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhccccccccccceec
Confidence            999999887655 22345677778899999999999999   9999999999999999875 888999999987421111


Q ss_pred             cccccccccCCcccc--cCCCCCCCCCCcchhHHHHHHHHHHHHcCCCC
Q 039799          258 QSLTQTQTLATIGYM--APEYGREGRVSTNGDVYSFGIMLMEIFTRTKP  304 (346)
Q Consensus       258 ~~~~~~~~~~~~~y~--aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p  304 (346)
                           .......++.  +++......+..+.|++|||.-+.|.+++.+-
T Consensus       422 -----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l  465 (524)
T KOG0601|consen  422 -----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL  465 (524)
T ss_pred             -----ccccccccccccchhhccccccccccccccccccccccccCccc
Confidence                 1111233344  55556666788999999999999999998864

>PLN03150 hypothetical protein; Provisional

Probab=99.07  E-value=1.1e-10  Score=113.92  Aligned_cols=78  Identities=35%  Similarity=0.643  Sum_probs=72.4

Q ss_pred             CCccCcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCC-CCCcccccccccCCcchhhcccc
Q 039799            1 QGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSVKSFEGNELLCEIVLP   78 (346)
Q Consensus         1 ~g~ip~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~~~~~~~~~   78 (346)
                      +|.+|.+|++|++|+.|+|++|+|+|.+|.+++.|++|+.|||++|+|+|.+|.. +.+++|+.+++++|.+.+.+|..
T Consensus       431 ~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~  509 (623)
T PLN03150        431 RGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAA  509 (623)
T ss_pred             cccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChH
Confidence            4789999999999999999999999999999999999999999999999999875 78999999999999988776643

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.04  E-value=3e-09  Score=90.05  Aligned_cols=136  Identities=24%  Similarity=0.272  Sum_probs=100.0

Q ss_pred             CCCCCcccccCceEEEEEEEcCCCEEEEEEecCCC----------------------chhHHHHHHHHHHHHhcCCC--C
Q 039799          105 ANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQY----------------------EGAFKSFDIECDVMKRICHR--N  160 (346)
Q Consensus       105 ~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~----------------------~~~~~~~~~e~~~l~~l~h~--n  160 (346)
                      ..++..||.|.-+.||.|..++|.++|||.-....                      .-......+|.++|.++...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            46778999999999999999999999999642210                      01133566799999998654  5


Q ss_pred             ceeeEEEEecCCceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCC
Q 039799          161 LIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM  240 (346)
Q Consensus       161 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~  240 (346)
                      +.+.++.    +...+|||+++|-.|...-      ++....-.++..|++-+.-.-   ..|++|+|+++-||+++++|
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~~dg  239 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVTEDG  239 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEecCC
Confidence            6665543    4667999999987665421      122333445556666665555   78899999999999999999


Q ss_pred             cEEEeeecCCccC
Q 039799          241 VAHLSDFGMAKPL  253 (346)
Q Consensus       241 ~~~l~Dfg~~~~~  253 (346)
                      .+.++||-.+...
T Consensus       240 ~~~vIDwPQ~v~~  252 (304)
T COG0478         240 DIVVIDWPQAVPI  252 (304)
T ss_pred             CEEEEeCcccccC
Confidence            9999999877643

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.02  E-value=7.6e-11  Score=115.07  Aligned_cols=239  Identities=20%  Similarity=0.241  Sum_probs=155.7

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEe
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLE  179 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  179 (346)
                      .+.+.+.+.+|.++.++.+.-. .|...+.|+.....   ....+....+-.++-..++|-++...-.+.-....+|+++
T Consensus       805 ~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~  884 (1205)
T KOG0606|consen  805 GFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGH  884 (1205)
T ss_pred             cceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhH
Confidence            3555667888888888877633 33333333322110   1111111122222222345666655545555677889999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcc---
Q 039799          180 YMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE---  256 (346)
Q Consensus       180 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~---  256 (346)
                      |..+++|...++.....-....|. ....+..+.+|||   ...+.|+|++|.|++...++..+++|||........   
T Consensus       885 ~~~~~~~~Skl~~~~~~saepaRs-~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~  960 (1205)
T KOG0606|consen  885 YLNGGDLPSKLHNSGCLSAEPARS-PILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPT  960 (1205)
T ss_pred             HhccCCchhhhhcCCCcccccccc-hhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCccccccccccccCc
Confidence            999999999887665333333333 4556778899999   888999999999999999999999999854432100   


Q ss_pred             ----------------------c----cccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCcccc
Q 039799          257 ----------------------D----QSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFS  310 (346)
Q Consensus       257 ----------------------~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~  310 (346)
                                            .    .........+|+.|.+||...+......+|.|++|++++|.++|.+||...+.
T Consensus       961 ~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tp 1040 (1205)
T KOG0606|consen  961 TDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETP 1040 (1205)
T ss_pred             CCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcch
Confidence                                  0    00112234589999999999999999999999999999999999999976432


Q ss_pred             Ccc--c----HHHHHhhh--cCCChhhhhchhccCCcccccccC
Q 039799          311 GEM--T----LKRWVNDL--LPISVMEVVDANLLSQEDEHFTTK  346 (346)
Q Consensus       311 ~~~--~----~~~~~~~~--~~~~~~~~~d~~l~~~p~~R~~~k  346 (346)
                      ...  +    ...|-...  .+....+++.+.+..+|.+|..++
T Consensus      1041 q~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1041 QQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             hhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            211  0    01111111  123667788888888888887653

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.94  E-value=2e-08  Score=89.69  Aligned_cols=192  Identities=14%  Similarity=0.124  Sum_probs=128.4

Q ss_pred             CCCCcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhc-CCCCceeeEE-----EE--ecCCceeEE
Q 039799          106 NMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRI-CHRNLIKIIS-----SY--SNDDFKALV  177 (346)
Q Consensus       106 ~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~-----~~--~~~~~~~lv  177 (346)
                      ..+..||+|+-+.+|-.--  -...+-|++.........+   .+..|... .||-+-.-+.     .+  .+.....+.
T Consensus        14 ~~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl   88 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL   88 (637)
T ss_pred             CCCccccCCccceeeecch--hhchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence            4567899999999996421  1234568886544332222   23334333 4553322011     01  112235567


Q ss_pred             EecCCCCChhhhhhh------cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCc
Q 039799          178 LEYMPHGSLEKCLYL------SNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAK  251 (346)
Q Consensus       178 ~e~~~~gsL~~~l~~------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~  251 (346)
                      |..+.+.---..++.      +-...+|...++.++.+|.+.+-||   ..|.+-+|+.++|+|+.+++.++|.|-....
T Consensus        89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq  165 (637)
T COG4248          89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ  165 (637)
T ss_pred             cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEccccee
Confidence            777765422222221      1146889999999999999999999   9999999999999999999999999865433


Q ss_pred             cCCccccccccccccCCcccccCCCCC-----CCCCCcchhHHHHHHHHHHHHcC-CCCCCcc
Q 039799          252 PLLEEDQSLTQTQTLATIGYMAPEYGR-----EGRVSTNGDVYSFGIMLMEIFTR-TKPTDEI  308 (346)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~s~G~il~elltg-~~p~~~~  308 (346)
                      .-   .........+|...|.+||...     +-.-+...|-|.+|+++++++.| +.||..+
T Consensus       166 i~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI  225 (637)
T COG4248         166 IN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI  225 (637)
T ss_pred             ec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence            21   1223334567899999999754     33456789999999999999986 9999764

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.93  E-value=1.1e-08  Score=96.22  Aligned_cols=141  Identities=22%  Similarity=0.270  Sum_probs=97.6

Q ss_pred             CcccccCceEEEEEEEcCCCEEEEEEecCCCchh------------------------------H----H------HHHH
Q 039799          109 PLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGA------------------------------F----K------SFDI  148 (346)
Q Consensus       109 ~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~------------------------------~----~------~~~~  148 (346)
                      ..|+.++-|.||+|++++|+.||||+..+.....                              .    +      .+.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            6799999999999999999999999987652110                              0    1      1222


Q ss_pred             HHHHHHhc-----CCCCceeeEEEEecCCceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHH-HHHHhcCCCC
Q 039799          149 ECDVMKRI-----CHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASA-LEYLHFGYSA  222 (346)
Q Consensus       149 e~~~l~~l-----~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~-l~~LH~~~~~  222 (346)
                      |..-+.++     ..+++.-.--|++-.....|+|||++|..+.+.........+.   ..++..++++ +..+-   .-
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~---k~ia~~~~~~f~~q~~---~d  284 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDR---KELAELLVRAFLRQLL---RD  284 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCH---HHHHHHHHHHHHHHHH---hc
Confidence            33333333     2444443444555567788999999999998875444444442   2344444443 22222   56


Q ss_pred             CeeecCCCCCceEECCCCcEEEeeecCCccCCc
Q 039799          223 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  255 (346)
Q Consensus       223 ~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~  255 (346)
                      |++|.|.+|.||+++.++++.+.|||+...+.+
T Consensus       285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         285 GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            899999999999999999999999999998754

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.88  E-value=1.9e-08  Score=84.49  Aligned_cols=106  Identities=25%  Similarity=0.251  Sum_probs=83.3

Q ss_pred             HHHHHHHHHHHhcCCCC--ceeeEEEEecCC----ceeEEEecCCCC-ChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHH
Q 039799          144 KSFDIECDVMKRICHRN--LIKIISSYSNDD----FKALVLEYMPHG-SLEKCLYLSNYILDIFQRLDIMIDVASALEYL  216 (346)
Q Consensus       144 ~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~----~~~lv~e~~~~g-sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L  216 (346)
                      .+..+|.+.+..+....  ..+++++.....    ..++|+|++++. +|.+++..... .+......++.+++..++-|
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~l  134 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKL  134 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHH
Confidence            46777888888775443  445666665532    457999999884 78888764222 55667788999999999999


Q ss_pred             hcCCCCCeeecCCCCCceEECCCC---cEEEeeecCCccC
Q 039799          217 HFGYSAPIIHCDLKPSNVLLDDNM---VAHLSDFGMAKPL  253 (346)
Q Consensus       217 H~~~~~~i~H~dik~~NIll~~~~---~~~l~Dfg~~~~~  253 (346)
                      |   ..+|+|+|++++|||++.+.   .+.++||+-++..
T Consensus       135 H---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  135 H---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             H---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            9   99999999999999999876   8999999988753

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.84  E-value=1.2e-07  Score=78.43  Aligned_cols=138  Identities=17%  Similarity=0.067  Sum_probs=102.3

Q ss_pred             ccccCceEEEEEEEcCCCEEEEEEecCCC------chhHHHHHHHHHHHHhcCCCC--ceeeEEEEe-c----CCceeEE
Q 039799          111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQY------EGAFKSFDIECDVMKRICHRN--LIKIISSYS-N----DDFKALV  177 (346)
Q Consensus       111 lg~G~~g~vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~-~----~~~~~lv  177 (346)
                      -|.|+.+.|++-..+ |..+-+|.-....      +.....|.+|+..+.++...+  +.++. ++. .    .-..+||
T Consensus        26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            467888899998776 4468888764221      223567889999999885433  44444 332 2    1246799


Q ss_pred             EecCCC-CChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCc--EEEeeecCCccC
Q 039799          178 LEYMPH-GSLEKCLYLSN-YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV--AHLSDFGMAKPL  253 (346)
Q Consensus       178 ~e~~~~-gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~--~~l~Dfg~~~~~  253 (346)
                      +|-+++ -+|.+++.... ...+...+..+..+++..++-||   +.++.|+|+.+.||+++.++.  +.++||.-++..
T Consensus       104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~~  180 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRRR  180 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhccchh
Confidence            998864 48888775433 34567778899999999999999   999999999999999986666  999999987753

>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B

Probab=98.78  E-value=3.3e-09  Score=64.95  Aligned_cols=39  Identities=36%  Similarity=0.559  Sum_probs=34.7

Q ss_pred             CCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCC
Q 039799           12 INLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGE   51 (346)
Q Consensus        12 ~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~   51 (346)
                      ++|++|+|++|+++ .||+++++|++|+.|++++|+++..
T Consensus         1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~~i   39 (44)
T PF12799_consen    1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPISDI   39 (44)
T ss_dssp             TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCSBE
T ss_pred             CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCCCC
Confidence            58999999999999 9999999999999999999999853

...

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.72  E-value=6.7e-09  Score=69.01  Aligned_cols=59  Identities=37%  Similarity=0.512  Sum_probs=52.5

Q ss_pred             CCCCEEEeecCcccccCC-ccccCcCCCCeEECcCCcCcCCCCCC-CCCcccccccccCCcc
Q 039799           12 INLKSLNLSNNNLSGTIP-ISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSVKSFEGNEL   71 (346)
Q Consensus        12 ~~L~~l~l~~N~l~g~~p-~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~~   71 (346)
                      ++|+.|+|++|+++ .|| ..+..+++|+.|++++|+++..+|.. ..+++++.+++++|++
T Consensus         1 p~L~~L~l~~n~l~-~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLT-EIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTES-EECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCC-ccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            57999999999999 777 57899999999999999999888765 7788999999999964

...

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=98.72  E-value=8.1e-09  Score=106.79  Aligned_cols=73  Identities=38%  Similarity=0.671  Sum_probs=36.9

Q ss_pred             CccCcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCCCCCcccccccccCCcchhh
Q 039799            2 GSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNELLCE   74 (346)
Q Consensus         2 g~ip~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~l~~l~~~~n~~~~~   74 (346)
                      |.+|..++++++|+.|||++|+++|.+|..+.++++|+.|++++|+++|.+|..+.+..+....+.+|+..|+
T Consensus       537 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~  609 (968)
T PLN00113        537 GQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCG  609 (968)
T ss_pred             ccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccC
Confidence            3444444444455555555555554455444445555555555555555555444444444455556655554

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.70  E-value=4.8e-07  Score=77.08  Aligned_cols=138  Identities=14%  Similarity=0.198  Sum_probs=85.7

Q ss_pred             CcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCc--eeeEEEEecCCceeEEEecCCCCC-
Q 039799          109 PLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNL--IKIISSYSNDDFKALVLEYMPHGS-  185 (346)
Q Consensus       109 ~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~~~~~~lv~e~~~~gs-  185 (346)
                      ..||+|..+.||+.   .+..+++|......  ......+|.++++.+..-.+  .+++++....+...+|||+++|.+ 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            57899999999984   25568889886543  23456789999998864444  567777777777789999999863 


Q ss_pred             hhhhh---------------------hhcC-CCCCHHHHHH-HHH----------HHHH-HHHHHhc-CCCCCeeecCCC
Q 039799          186 LEKCL---------------------YLSN-YILDIFQRLD-IMI----------DVAS-ALEYLHF-GYSAPIIHCDLK  230 (346)
Q Consensus       186 L~~~l---------------------~~~~-~~l~~~~~~~-i~~----------~i~~-~l~~LH~-~~~~~i~H~dik  230 (346)
                      +...+                     +.-. ...+...... +..          .+.+ ...+|.. .....++|+|+.
T Consensus        82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~  161 (226)
T TIGR02172        82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ  161 (226)
T ss_pred             hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence            21111                     1000 0111111110 000          0111 1222221 123457899999


Q ss_pred             CCceEECCCCcEEEeeecCCcc
Q 039799          231 PSNVLLDDNMVAHLSDFGMAKP  252 (346)
Q Consensus       231 ~~NIll~~~~~~~l~Dfg~~~~  252 (346)
                      |.||++++++ +.++||+.+..
T Consensus       162 ~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       162 IGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CCcEEEcCCC-cEEEechhcCc
Confidence            9999999888 99999998763

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.67  E-value=6e-09  Score=98.22  Aligned_cols=135  Identities=20%  Similarity=0.248  Sum_probs=98.3

Q ss_pred             HHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccccc-------ccccCCcccccCCCCCCC
Q 039799          208 DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ-------TQTLATIGYMAPEYGREG  280 (346)
Q Consensus       208 ~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~-------~~~~~~~~y~aPE~~~~~  280 (346)
                      +++.|+.|+|.  +.+++|++|.|++|.++..+..||..|+.+............       ........|.|||++...
T Consensus       107 ~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~  184 (700)
T KOG2137|consen  107 NVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT  184 (700)
T ss_pred             cccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence            44589999995  789999999999999999999999999998865542221111       111246779999999988


Q ss_pred             CCCcchhHHHHHHHHHHHHc-CCCCCCccc-----cCcc----cHHHHHhhhcCCChhhhhchhccCCcccccc
Q 039799          281 RVSTNGDVYSFGIMLMEIFT-RTKPTDEIF-----SGEM----TLKRWVNDLLPISVMEVVDANLLSQEDEHFT  344 (346)
Q Consensus       281 ~~~~~~Dv~s~G~il~ellt-g~~p~~~~~-----~~~~----~~~~~~~~~~~~~~~~~~d~~l~~~p~~R~~  344 (346)
                      ..+.++|+||+|+++|-+.. |+.-+....     ..+.    ....-....+|.++.+-+.+.+..++..||+
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~  258 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPT  258 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcc
Confidence            88999999999999999994 444333210     0000    0111122456778999999999999999984

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.65  E-value=4.7e-07  Score=75.25  Aligned_cols=136  Identities=17%  Similarity=0.156  Sum_probs=86.9

Q ss_pred             CCCCCCCCcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHH---------HHHHHHHHhcC---CCCceeeEEEE-
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSF---------DIECDVMKRIC---HRNLIKIISSY-  168 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~---------~~e~~~l~~l~---h~niv~~~~~~-  168 (346)
                      ..+|...+++.......|.+-..+ |..+++|...+...-..+.|         .+.+..+.+++   -.....++... 
T Consensus        30 ~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e  108 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE  108 (229)
T ss_pred             hCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence            345666666766666666665555 78899998765432221211         12233333332   22222322222 


Q ss_pred             ----ecCCceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEE
Q 039799          169 ----SNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHL  244 (346)
Q Consensus       169 ----~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l  244 (346)
                          ......+++|||++|..|.++..     ++.    .++..+.+++.-+|   +.|+.|+|.+|.|++++++ .+++
T Consensus       109 kk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~~-~i~i  175 (229)
T PF06176_consen  109 KKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSNN-GIRI  175 (229)
T ss_pred             eeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEEEECC-cEEE
Confidence                22345568999999998876432     221    25566778899999   9999999999999999865 4899


Q ss_pred             eeecCCc
Q 039799          245 SDFGMAK  251 (346)
Q Consensus       245 ~Dfg~~~  251 (346)
                      +||+..+
T Consensus       176 ID~~~k~  182 (229)
T PF06176_consen  176 IDTQGKR  182 (229)
T ss_pred             EECcccc
Confidence            9998765

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.63  E-value=3.4e-07  Score=86.16  Aligned_cols=143  Identities=21%  Similarity=0.260  Sum_probs=94.6

Q ss_pred             CCcccccCceEEEEEEEcCCCEEEEEEecCCCch-------------------------------hHHH------HHHHH
Q 039799          108 PPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEG-------------------------------AFKS------FDIEC  150 (346)
Q Consensus       108 ~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~-------------------------------~~~~------~~~e~  150 (346)
                      .+.|+..+.|.||+|++++|+.||||+-++..+.                               ..+.      |.+|.
T Consensus       166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            4679999999999999999999999997654211                               0111      22222


Q ss_pred             HHH----HhcCCCCc---eeeEE-EEecCCceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 039799          151 DVM----KRICHRNL---IKIIS-SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSA  222 (346)
Q Consensus       151 ~~l----~~l~h~ni---v~~~~-~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~  222 (346)
                      +-.    +.++|-+.   |.+=. |+.-.....|+||||+|..+.+.-......++...   ++..+.++...+=.  ..
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~---i~~~l~~~~~~qIf--~~  320 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHD---ILNKLVEAYLEQIF--KT  320 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcCCCHHH---HHHHHHHHHHHHHH--hc
Confidence            222    22235551   11222 33445577899999999998887655555565553   44444444332211  45


Q ss_pred             CeeecCCCCCceEECC----CCcEEEeeecCCccCCc
Q 039799          223 PIIHCDLKPSNVLLDD----NMVAHLSDFGMAKPLLE  255 (346)
Q Consensus       223 ~i~H~dik~~NIll~~----~~~~~l~Dfg~~~~~~~  255 (346)
                      |++|+|-+|.||+++.    ++.+.+-|||+...+..
T Consensus       321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            7999999999999983    67999999999987643

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.63  E-value=5.9e-07  Score=75.52  Aligned_cols=137  Identities=24%  Similarity=0.251  Sum_probs=91.0

Q ss_pred             CcccccCceEEEEEEEcCCCEEEEEEecCCCch------------------------hHHHHHHHHHHHHhcC--CCCce
Q 039799          109 PLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEG------------------------AFKSFDIECDVMKRIC--HRNLI  162 (346)
Q Consensus       109 ~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l~--h~niv  162 (346)
                      ..|++|.-+.||+|...++..+|+|++......                        .......|..-|.++.  +=.+.
T Consensus        54 g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP  133 (268)
T COG1718          54 GCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP  133 (268)
T ss_pred             eeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence            367888899999999888999999998643210                        0112234666666653  33344


Q ss_pred             eeEEEEecCCceeEEEecCCCCChhh-hhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCc
Q 039799          163 KIISSYSNDDFKALVLEYMPHGSLEK-CLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV  241 (346)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~  241 (346)
                      +.+++.    ...|||||+....... .|  ....+.......+..++.+.+.-|-.  ..+++|+|++.=|||+. ++.
T Consensus       134 ~Pi~~~----~nVLvMEfIg~~g~pAP~L--kDv~~e~~e~~~~~~~~v~~~~~l~~--~a~LVHgDLSEyNiL~~-~~~  204 (268)
T COG1718         134 EPIAFR----NNVLVMEFIGDDGLPAPRL--KDVPLELEEAEGLYEDVVEYMRRLYK--EAGLVHGDLSEYNILVH-DGE  204 (268)
T ss_pred             Cceeec----CCeEEEEeccCCCCCCCCc--ccCCcCchhHHHHHHHHHHHHHHHHH--hcCcccccchhhheEEE-CCe
Confidence            445443    3359999996542110 11  11122222455667777788877761  48999999999999999 889


Q ss_pred             EEEeeecCCccCC
Q 039799          242 AHLSDFGMAKPLL  254 (346)
Q Consensus       242 ~~l~Dfg~~~~~~  254 (346)
                      +.++|+|.+....
T Consensus       205 p~iID~~QaV~~~  217 (268)
T COG1718         205 PYIIDVSQAVTID  217 (268)
T ss_pred             EEEEECccccccC
Confidence            9999999988653

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=98.62  E-value=1.5e-08  Score=79.56  Aligned_cols=70  Identities=36%  Similarity=0.475  Sum_probs=53.9

Q ss_pred             ccCcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCCCCCcccccccccCCcchh
Q 039799            3 SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNELLC   73 (346)
Q Consensus         3 ~ip~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~l~~l~~~~n~~~~   73 (346)
                      .+|+.|..|.+|+.|+++||+++ .+|.+++.|+.|+.|+++-|+|.-.|-..++++.++.+++..|.+.-
T Consensus        47 ~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~~lprgfgs~p~levldltynnl~e  116 (264)
T KOG0617|consen   47 VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLNILPRGFGSFPALEVLDLTYNNLNE  116 (264)
T ss_pred             ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhhcCccccCCCchhhhhhcccccccc
Confidence            46777888888888888888888 78888888888888888888887766666777777777777776543

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.52  E-value=2.5e-06  Score=73.71  Aligned_cols=138  Identities=14%  Similarity=0.115  Sum_probs=84.5

Q ss_pred             ccccCc-eEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcC-CCCceeeEEEEecCCceeEEEecCCCCChhh
Q 039799          111 IGKGGF-GSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRIC-HRNLIKIISSYSNDDFKALVLEYMPHGSLEK  188 (346)
Q Consensus       111 lg~G~~-g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~  188 (346)
                      |..|.. ..||+.... +..+.+|+.....   .....+|+++++.+. +--+.+++++....+..++|||+++|.++..
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~   81 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA   81 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence            334444 788998765 4788899876442   245667888888874 3445577777776677889999999987764


Q ss_pred             hhh-------------------hcC---CCCC--HHHHHHHHH--------------------HHHHHHHHHhc----CC
Q 039799          189 CLY-------------------LSN---YILD--IFQRLDIMI--------------------DVASALEYLHF----GY  220 (346)
Q Consensus       189 ~l~-------------------~~~---~~l~--~~~~~~i~~--------------------~i~~~l~~LH~----~~  220 (346)
                      ...                   .-.   ....  ......-..                    .+...+..|-.    ..
T Consensus        82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  161 (244)
T cd05150          82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE  161 (244)
T ss_pred             hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence            321                   000   0000  000000000                    01111222210    12


Q ss_pred             CCCeeecCCCCCceEECCCCcEEEeeecCCcc
Q 039799          221 SAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  252 (346)
Q Consensus       221 ~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~  252 (346)
                      ...++|+|+.|.||+++++....|+||+.+..
T Consensus       162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             ceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            45689999999999999987788999998763

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=98.51  E-value=3.8e-08  Score=87.06  Aligned_cols=68  Identities=26%  Similarity=0.345  Sum_probs=64.0

Q ss_pred             ccCcchh-CCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCCCCCcccccccccCCcch
Q 039799            3 SIPDSIG-DLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNELL   72 (346)
Q Consensus         3 ~ip~~~~-~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~l~~l~~~~n~~~   72 (346)
                      .+|++++ +|++|.+|||..|++. ++|++++-|.+|+.||||+|.+++.+++.+.+ .+..+.+.||++.
T Consensus       242 ~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~Lp~sLgnl-hL~~L~leGNPlr  310 (565)
T KOG0472|consen  242 MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISSLPYSLGNL-HLKFLALEGNPLR  310 (565)
T ss_pred             hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccccCCcccccc-eeeehhhcCCchH
Confidence            4788887 9999999999999999 99999999999999999999999999999998 8999999999874

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.45  E-value=1.6e-06  Score=74.20  Aligned_cols=140  Identities=21%  Similarity=0.339  Sum_probs=84.0

Q ss_pred             CcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCC--ceeeEEEEec---CCceeEEEecCCC
Q 039799          109 PLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRN--LIKIISSYSN---DDFKALVLEYMPH  183 (346)
Q Consensus       109 ~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~---~~~~~lv~e~~~~  183 (346)
                      +.++.|..+.||+....+ ..+++|.....  .....+..|..+++.+....  +.+++.+...   ....+++|+++++
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g   79 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG   79 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence            467889999999999887 69999997654  34567778888888885433  4566664422   3356899999999


Q ss_pred             CChhh----------------hh---hhc---CCCCCHHHH---------HHH------------HHHHHH-HHHHHh--
Q 039799          184 GSLEK----------------CL---YLS---NYILDIFQR---------LDI------------MIDVAS-ALEYLH--  217 (346)
Q Consensus       184 gsL~~----------------~l---~~~---~~~l~~~~~---------~~i------------~~~i~~-~l~~LH--  217 (346)
                      .++..                .+   +..   .....+...         ...            ...+.+ .++.++  
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (239)
T PF01636_consen   80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL  159 (239)
T ss_dssp             EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence            88777                11   111   011111110         000            111222 233333  


Q ss_pred             --cCCCCCeeecCCCCCceEEC-CCCcEEEeeecCCc
Q 039799          218 --FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFGMAK  251 (346)
Q Consensus       218 --~~~~~~i~H~dik~~NIll~-~~~~~~l~Dfg~~~  251 (346)
                        ......++|+|+.++||+++ +++.+.|+||+.+.
T Consensus       160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             hccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence              12357799999999999999 66666899998876

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.39  E-value=3.8e-06  Score=66.98  Aligned_cols=130  Identities=21%  Similarity=0.220  Sum_probs=89.4

Q ss_pred             CCCCcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecCCCCC
Q 039799          106 NMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGS  185 (346)
Q Consensus       106 ~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  185 (346)
                      ...+.|++|++|.||+|.|. |..+|+|+-...+  ....+..|++++..+.--++.+=+-.+.+.   ++.|||+.|-.
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg~~---~i~me~i~G~~   98 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYGED---FIRMEYIDGRP   98 (201)
T ss_pred             hhhhhhhcccccEEEEeecc-CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEechh---hhhhhhhcCcc
Confidence            44578999999999999998 5688999865443  357788899999998877666443333322   24599999988


Q ss_pred             hhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCC-CceEECCCCcEEEeeecCCcc
Q 039799          186 LEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKP-SNVLLDDNMVAHLSDFGMAKP  252 (346)
Q Consensus       186 L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~-~NIll~~~~~~~l~Dfg~~~~  252 (346)
                      |.+.-...    +.    +....+++.-.-|-   ..||-|+.|+- ...++-.+..+.|+||..|+.
T Consensus        99 L~~~~~~~----~r----k~l~~vlE~a~~LD---~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          99 LGKLEIGG----DR----KHLLRVLEKAYKLD---RLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hhhhhhcc----cH----HHHHHHHHHHHHHH---HhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            87643211    12    23344455544455   77888888864 444444445999999999884

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=98.31  E-value=5.4e-08  Score=76.49  Aligned_cols=71  Identities=23%  Similarity=0.384  Sum_probs=52.1

Q ss_pred             ccCcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcC-CCCCC-CCCcccccccccCCcchhh
Q 039799            3 SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEG-EIPRE-GPFRNLSVKSFEGNELLCE   74 (346)
Q Consensus         3 ~ip~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~-~~p~~-~~~~~l~~l~~~~n~~~~~   74 (346)
                      .+|.+|++|+.|+.|+++-|+|. .+|..|+.++.|+.|||++|+|+. .+|.. --+.-+..+.+++|.+...
T Consensus        70 ~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe~l  142 (264)
T KOG0617|consen   70 ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFEIL  142 (264)
T ss_pred             hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcccC
Confidence            47888888888888888888888 888888888888888888888865 34432 2233455566666665443

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.29  E-value=4.3e-07  Score=60.24  Aligned_cols=46  Identities=43%  Similarity=0.659  Sum_probs=39.8

Q ss_pred             ccC-cchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcC
Q 039799            3 SIP-DSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKL   48 (346)
Q Consensus         3 ~ip-~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l   48 (346)
                      .|| ..+.++++|++|++++|+++.--|..|..|++|+.|++++|+|
T Consensus        15 ~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen   15 EIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             EECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             ccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            456 4678999999999999999954456889999999999999986

...

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.26  E-value=5.1e-06  Score=68.52  Aligned_cols=102  Identities=23%  Similarity=0.195  Sum_probs=81.5

Q ss_pred             HHHHHHHhcCC-CCceeeEEEEecCCceeEEEecCCCCChhhhhh--hcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 039799          148 IECDVMKRICH-RNLIKIISSYSNDDFKALVLEYMPHGSLEKCLY--LSNYILDIFQRLDIMIDVASALEYLHFGYSAPI  224 (346)
Q Consensus       148 ~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i  224 (346)
                      .|.-++..+.+ +++.+++|+|..    +++.||...+++...-.  ..-...+|..|.+||.++++.+.++++.....+
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~   83 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF   83 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence            47777888866 589999999943    57899998776642100  011347899999999999999999997655568


Q ss_pred             eecCCCCCceEECCCCcEEEeeecCCccC
Q 039799          225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPL  253 (346)
Q Consensus       225 ~H~dik~~NIll~~~~~~~l~Dfg~~~~~  253 (346)
                      .-.|++++|+-+++++++|++|...+...
T Consensus        84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   84 YLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEeecchHHeEEeCCCcEEEEechhcchh
Confidence            88999999999999999999999987754

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.26  E-value=2.5e-07  Score=86.79  Aligned_cols=182  Identities=18%  Similarity=0.212  Sum_probs=129.4

Q ss_pred             CcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCC-ceeeEEEEecCCceeEEEecCCCC-Ch
Q 039799          109 PLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRN-LIKIISSYSNDDFKALVLEYMPHG-SL  186 (346)
Q Consensus       109 ~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~~~~g-sL  186 (346)
                      +-.++++++.++|.+-...+....+.+...     ....-++++|.+++||| .+..++.+..+++..++++++.++ +.
T Consensus       248 h~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~  322 (829)
T KOG0576|consen  248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSS  322 (829)
T ss_pred             HHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccc
Confidence            457889999999876443333334444322     33445889999999999 677777777788888999999876 33


Q ss_pred             hhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccccccccc
Q 039799          187 EKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL  266 (346)
Q Consensus       187 ~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~  266 (346)
                      ..-.......+...+...+.+.-.++++++|   +..=+|+|    ||+..+ ...+..||+....+.+..   ......
T Consensus       323 ~~~~~~se~~~~~~~~~~~~r~et~~l~~l~---~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t~~  391 (829)
T KOG0576|consen  323 ALEMTVSEIALEQYQFAYPLRKETRPLAELH---SSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRTAI  391 (829)
T ss_pred             cccCChhhHhhhhhhhhhhhhhhcccccccc---cccccCcc----cccccc-cccccccccCCcccCccc---ccccCC
Confidence            2212112223334444556667778999999   66567888    777655 678999999988764432   344566


Q ss_pred             CCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCC
Q 039799          267 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTD  306 (346)
Q Consensus       267 ~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~  306 (346)
                      +++.++|||......+..+.|+|+.|+--.++--|-+|-.
T Consensus       392 ~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  392 GTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             CCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence            8999999999999999999999999987777777777653

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.24  E-value=4.8e-05  Score=63.06  Aligned_cols=136  Identities=21%  Similarity=0.286  Sum_probs=94.3

Q ss_pred             CCCCcccccCceEEEEEEEcCCCEEEEEEecCCC----------------chhHHHHHHHHHHHHhcC------CCCcee
Q 039799          106 NMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQY----------------EGAFKSFDIECDVMKRIC------HRNLIK  163 (346)
Q Consensus       106 ~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~e~~~l~~l~------h~niv~  163 (346)
                      +-..+||+|+.-.||.  +++.....||+..+..                ....++..+|+.-...+.      +..|.+
T Consensus         4 ~~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r   81 (199)
T PF10707_consen    4 SESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR   81 (199)
T ss_pred             CCCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence            3456899999999985  4455667889887654                223456667777666665      888999


Q ss_pred             eEEEEecCCceeEEEecCCC--C----ChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEEC
Q 039799          164 IISSYSNDDFKALVLEYMPH--G----SLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD  237 (346)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~--g----sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~  237 (346)
                      ++|....+....+|+|.+.+  |    +|.+++...  .++. .....   +-+-..||-   +..|+.+|++|+||++.
T Consensus        82 ~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~--~~~~-~~~~~---L~~f~~~l~---~~~Iv~~dl~~~NIv~~  152 (199)
T PF10707_consen   82 FYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG--GLTE-ELRQA---LDEFKRYLL---DHHIVIRDLNPHNIVVQ  152 (199)
T ss_pred             EeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC--CccH-HHHHH---HHHHHHHHH---HcCCeecCCCcccEEEE
Confidence            99999999999999998753  2    577776433  3443 33333   334445555   66799999999999995


Q ss_pred             C--CC--cEEEee-ecCCcc
Q 039799          238 D--NM--VAHLSD-FGMAKP  252 (346)
Q Consensus       238 ~--~~--~~~l~D-fg~~~~  252 (346)
                      .  ++  .+.|+| ||-...
T Consensus       153 ~~~~~~~~lvlIDG~G~~~~  172 (199)
T PF10707_consen  153 RRDSGEFRLVLIDGLGEKEL  172 (199)
T ss_pred             ecCCCceEEEEEeCCCCccc
Confidence            3  22  577887 665543

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PLN02876 acyl-CoA dehydrogenase

Probab=98.23  E-value=3.3e-05  Score=78.34  Aligned_cols=79  Identities=13%  Similarity=0.241  Sum_probs=57.4

Q ss_pred             CCcccccCceEEEEEEEcCC---CEEEEEEecCCC-chhHHHHHHHHHHHHhcC-CCCc--eeeEEEEecC---CceeEE
Q 039799          108 PPLIGKGGFGSVYKAIIQDG---MEVAVKVFDPQY-EGAFKSFDIECDVMKRIC-HRNL--IKIISSYSND---DFKALV  177 (346)
Q Consensus       108 ~~~lg~G~~g~vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~ni--v~~~~~~~~~---~~~~lv  177 (346)
                      ...++.|.+..+|+....++   ..+++|+..... ......+.+|.++++.+. |+++  .+++.+|.+.   +..++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            45678999999999887654   467888764432 122356788999999995 6665  6777877654   467899


Q ss_pred             EecCCCCCh
Q 039799          178 LEYMPHGSL  186 (346)
Q Consensus       178 ~e~~~~gsL  186 (346)
                      |||++|..+
T Consensus       123 ME~v~G~~~  131 (822)
T PLN02876        123 MEYLEGRIF  131 (822)
T ss_pred             EEecCCccc
Confidence            999988653

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.18  E-value=2.4e-05  Score=67.17  Aligned_cols=73  Identities=10%  Similarity=0.138  Sum_probs=45.5

Q ss_pred             CcccccCce-EEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCC---CceeeEEEEecC---CceeEEEecC
Q 039799          109 PLIGKGGFG-SVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHR---NLIKIISSYSND---DFKALVLEYM  181 (346)
Q Consensus       109 ~~lg~G~~g-~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~~~---~~~~lv~e~~  181 (346)
                      +.++.|+.. .||+.    +..+++|......  ....+..|.+.++.+...   -+.++++.....   ...+++|+++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~~--~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i   76 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSAAG--YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL   76 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCccc--hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence            346666665 58875    3467888765422  245788899999887532   233444433322   2457899999


Q ss_pred             CCCChh
Q 039799          182 PHGSLE  187 (346)
Q Consensus       182 ~~gsL~  187 (346)
                      +|.++.
T Consensus        77 ~G~~l~   82 (235)
T cd05155          77 EGETAT   82 (235)
T ss_pred             cCCCCC
Confidence            987764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=98.16  E-value=7e-07  Score=83.57  Aligned_cols=50  Identities=34%  Similarity=0.456  Sum_probs=36.6

Q ss_pred             CccCcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCC
Q 039799            2 GSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEI   52 (346)
Q Consensus         2 g~ip~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~   52 (346)
                      ..||.+|..|..|+.||||+|+|+ +.|..+.+-+++-.||||+|+++..|
T Consensus        93 sGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIP  142 (1255)
T KOG0444|consen   93 SGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIP  142 (1255)
T ss_pred             CCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCC
Confidence            458888888888888888888888 88887776666666666666655433

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=98.15  E-value=6.5e-07  Score=79.45  Aligned_cols=69  Identities=30%  Similarity=0.542  Sum_probs=38.8

Q ss_pred             ccCcchhCCCCCCEEEeecCcccccCCc-----------------------c-ccCcCCCCeEECcCCcCcCCCCCCCCC
Q 039799            3 SIPDSIGDLINLKSLNLSNNNLSGTIPI-----------------------S-LEKLLDLKDINVSFNKLEGEIPREGPF   58 (346)
Q Consensus         3 ~ip~~~~~l~~L~~l~l~~N~l~g~~p~-----------------------~-~~~l~~l~~l~l~~N~l~~~~p~~~~~   58 (346)
                      .+|.+++.+..|+.||||+|+|. .+|.                       + +.+|.+|..|||.+|.+...||..+.+
T Consensus       449 ~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq~IPp~Lgnm  527 (565)
T KOG0472|consen  449 DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQQIPPILGNM  527 (565)
T ss_pred             hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchhhCChhhccc
Confidence            35555555555555555555554 4443                       1 334555555555555555555555666


Q ss_pred             cccccccccCCcch
Q 039799           59 RNLSVKSFEGNELL   72 (346)
Q Consensus        59 ~~l~~l~~~~n~~~   72 (346)
                      .++..+.+.||++.
T Consensus       528 tnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  528 TNLRHLELDGNPFR  541 (565)
T ss_pred             cceeEEEecCCccC
Confidence            66666666666654

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=98.14  E-value=3.7e-07  Score=85.39  Aligned_cols=70  Identities=34%  Similarity=0.348  Sum_probs=64.1

Q ss_pred             ccCcchhCCCCCCEEEeecCcccccCCccc-cCcCCCCeEECcCCcCcCCCCCCCCCcccccccccCCcchh
Q 039799            3 SIPDSIGDLINLKSLNLSNNNLSGTIPISL-EKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNELLC   73 (346)
Q Consensus         3 ~ip~~~~~l~~L~~l~l~~N~l~g~~p~~~-~~l~~l~~l~l~~N~l~~~~p~~~~~~~l~~l~~~~n~~~~   73 (346)
                      ..|.++..-+++.+||||+|++. +||..+ .+|+.|-+||||+|+|+..||..-.+..|+.+.+++|++.-
T Consensus       117 EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe~LPPQ~RRL~~LqtL~Ls~NPL~h  187 (1255)
T KOG0444|consen  117 EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLEMLPPQIRRLSMLQTLKLSNNPLNH  187 (1255)
T ss_pred             hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhhhcCHHHHHHhhhhhhhcCCChhhH
Confidence            46888999999999999999999 999765 79999999999999999999999889999999999998653

>PRK10593 hypothetical protein; Provisional

Probab=98.12  E-value=0.00011  Score=65.30  Aligned_cols=78  Identities=9%  Similarity=0.035  Sum_probs=56.6

Q ss_pred             CCCCcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCC---CCceeeEEEEec---CCceeEEEe
Q 039799          106 NMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICH---RNLIKIISSYSN---DDFKALVLE  179 (346)
Q Consensus       106 ~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~~~~~~~~---~~~~~lv~e  179 (346)
                      ...+.||.|..+.||+....++ .+++|..+...  ....+..|.+.++.+..   -.+.++++.+..   .+..++|||
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE   93 (297)
T PRK10593         17 SRVECISEQPYAALWALYDSQG-NPMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE   93 (297)
T ss_pred             heeeecCCccceeEEEEEcCCC-CEEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence            3356799999999999877655 46677754311  23577789999988853   357788887754   366899999


Q ss_pred             cCCCCCh
Q 039799          180 YMPHGSL  186 (346)
Q Consensus       180 ~~~~gsL  186 (346)
                      ++++.++
T Consensus        94 ~i~G~~~  100 (297)
T PRK10593         94 RLRGVSV  100 (297)
T ss_pred             ccCCEec
Confidence            9998765

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.11  E-value=4.4e-05  Score=62.89  Aligned_cols=125  Identities=25%  Similarity=0.395  Sum_probs=90.2

Q ss_pred             CCCCCCCcccccCc-eEEEEEEEcCCCEEEEEEecC---CC--------c----------hhHHHHHHHHHHHHhcC---
Q 039799          103 NDANMPPLIGKGGF-GSVYKAIIQDGMEVAVKVFDP---QY--------E----------GAFKSFDIECDVMKRIC---  157 (346)
Q Consensus       103 ~~~~~~~~lg~G~~-g~vy~~~~~~~~~vavK~~~~---~~--------~----------~~~~~~~~e~~~l~~l~---  157 (346)
                      .+++..+.||.|.. |.||++++. |+.+|+|++..   ..        .          ....-|..|++...+++   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            56788899999999 999999988 77999999321   10        0          12345778999888885   


Q ss_pred             CCCc--eeeEEEEecC------------------CceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHh
Q 039799          158 HRNL--IKIISSYSND------------------DFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLH  217 (346)
Q Consensus       158 h~ni--v~~~~~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH  217 (346)
                      +.++  ++++|+..-.                  ....+|.||++...              ....+-+.++.+-+..+|
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------------~~~~~~~~~~~~dl~~~~  181 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------------PLQIRDIPQMLRDLKILH  181 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------------ccchhHHHHHHHHHHHHH
Confidence            3455  8888887321                  12346777765533              112334567778888999


Q ss_pred             cCCCCCeeecCCCCCceEECCCCcEEEeeecCC
Q 039799          218 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMA  250 (346)
Q Consensus       218 ~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~  250 (346)
                         ..+|+-+|+++.|..     .-+|+|||.+
T Consensus       182 ---k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  182 ---KLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             ---HCCeeeccCcccccc-----CCEEEecccC
Confidence               999999999999987     4478899864

>TIGR02721 ycfN_thiK thiamine kinase

Probab=98.11  E-value=2.5e-05  Score=68.01  Aligned_cols=136  Identities=14%  Similarity=0.161  Sum_probs=78.6

Q ss_pred             ccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCce-eeEEEEecCCceeEEEecCCCCChhhh
Q 039799          111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLI-KIISSYSNDDFKALVLEYMPHGSLEKC  189 (346)
Q Consensus       111 lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~gsL~~~  189 (346)
                      +..|-...+|+... ++..+++|..........-...+|.++++.+....+. +++....    ..+|+||++|.++...
T Consensus         4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~   78 (256)
T TIGR02721         4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD   78 (256)
T ss_pred             CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence            45677889998874 4678899986543222112346788888888644343 4444332    3689999998765421


Q ss_pred             -----------------hhhcC---CCCCHHHHH-HHHH---------HHHHHHHHHhc-----CCCCCeeecCCCCCce
Q 039799          190 -----------------LYLSN---YILDIFQRL-DIMI---------DVASALEYLHF-----GYSAPIIHCDLKPSNV  234 (346)
Q Consensus       190 -----------------l~~~~---~~l~~~~~~-~i~~---------~i~~~l~~LH~-----~~~~~i~H~dik~~NI  234 (346)
                                       ++...   ..++....+ ....         .+...+..+-.     .....++|+|+.|.||
T Consensus        79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni  158 (256)
T TIGR02721        79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL  158 (256)
T ss_pred             cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence                             11111   112221111 1110         11111221211     1134589999999999


Q ss_pred             EECCCCcEEEeeecCCcc
Q 039799          235 LLDDNMVAHLSDFGMAKP  252 (346)
Q Consensus       235 ll~~~~~~~l~Dfg~~~~  252 (346)
                      ++++++ +.++||+.+..
T Consensus       159 l~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       159 VVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             EEeCCC-CEEEeccccCc
Confidence            999877 78999998874

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.09  E-value=5.2e-05  Score=65.03  Aligned_cols=139  Identities=16%  Similarity=0.178  Sum_probs=81.4

Q ss_pred             CcccccCceEEEEEEEcC--CCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCce-eeEEEEecCCceeEEEecCCCCC
Q 039799          109 PLIGKGGFGSVYKAIIQD--GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLI-KIISSYSNDDFKALVLEYMPHGS  185 (346)
Q Consensus       109 ~~lg~G~~g~vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~gs  185 (346)
                      +.|..|-...+|+....+  +..+++|+....... .-...+|+.+++.+...+++ ++++...    ..++|||++|.+
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~   78 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT   78 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence            356778888999998764  678999987654222 12334688888888544443 4444332    247999999876


Q ss_pred             hhhh-------h----------hhcCCC----------CC-HHHHHHHHH----------------------HHHHHHHH
Q 039799          186 LEKC-------L----------YLSNYI----------LD-IFQRLDIMI----------------------DVASALEY  215 (346)
Q Consensus       186 L~~~-------l----------~~~~~~----------l~-~~~~~~i~~----------------------~i~~~l~~  215 (346)
                      +...       .          +.....          .. +.....+..                      .+...+..
T Consensus        79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  158 (235)
T cd05157          79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW  158 (235)
T ss_pred             CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence            6321       0          111111          11 111111110                      11111111


Q ss_pred             ----Hhc-CCCCCeeecCCCCCceEECC-CCcEEEeeecCCcc
Q 039799          216 ----LHF-GYSAPIIHCDLKPSNVLLDD-NMVAHLSDFGMAKP  252 (346)
Q Consensus       216 ----LH~-~~~~~i~H~dik~~NIll~~-~~~~~l~Dfg~~~~  252 (346)
                          +.. .....++|+|+.+.||++++ ++.+.++||..|..
T Consensus       159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~  201 (235)
T cd05157         159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY  201 (235)
T ss_pred             HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence                111 12456999999999999997 57899999988763

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=98.08  E-value=1.7e-06  Score=70.03  Aligned_cols=38  Identities=34%  Similarity=0.525  Sum_probs=9.3

Q ss_pred             CCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcC
Q 039799           11 LINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEG   50 (346)
Q Consensus        11 l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~   50 (346)
                      |.+|+.||||+|.++ .|+ .+..|++|+.|++++|+++.
T Consensus        41 l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~~   78 (175)
T PF14580_consen   41 LDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRISS   78 (175)
T ss_dssp             -TT--EEE-TTS--S---T-T----TT--EEE--SS---S
T ss_pred             hcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCCc
Confidence            444555555555555 443 24444555555555555543

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.91  E-value=8.6e-05  Score=66.08  Aligned_cols=141  Identities=18%  Similarity=0.200  Sum_probs=85.8

Q ss_pred             CCcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCC--ceeeEEE------EecCCceeEEEe
Q 039799          108 PPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRN--LIKIISS------YSNDDFKALVLE  179 (346)
Q Consensus       108 ~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~------~~~~~~~~lv~e  179 (346)
                      .+.+..|....+|+....+ ..+++|++...   .......|++++..+.+.+  +.+++..      ....+..+.+++
T Consensus        19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTTDS-GRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEeCC-CcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            4567778888999987654 47889987642   2345666888888775433  3444331      123456689999


Q ss_pred             cCCCCChhh----h----------hhhc--C--------CCCCHHHHH----------HHHHHHHHHHHHHhc----CCC
Q 039799          180 YMPHGSLEK----C----------LYLS--N--------YILDIFQRL----------DIMIDVASALEYLHF----GYS  221 (346)
Q Consensus       180 ~~~~gsL~~----~----------l~~~--~--------~~l~~~~~~----------~i~~~i~~~l~~LH~----~~~  221 (346)
                      |++|.++..    .          ++..  .        ....|....          .....+..++.++..    ...
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            999876532    0          0100  0        011222111          011112334444441    224


Q ss_pred             CCeeecCCCCCceEECCCCcEEEeeecCCcc
Q 039799          222 APIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  252 (346)
Q Consensus       222 ~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~  252 (346)
                      .+++|+|+.|.||+++++....|+||+.+..
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            5799999999999999987788999998874

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.89  E-value=0.00056  Score=62.92  Aligned_cols=76  Identities=20%  Similarity=0.284  Sum_probs=54.2

Q ss_pred             CCcccccCceEEEEEEEcCC-CEEEEEEecCC-------CchhHHHHHHHHHHHHhcC---CCCceeeEEEEecCCceeE
Q 039799          108 PPLIGKGGFGSVYKAIIQDG-MEVAVKVFDPQ-------YEGAFKSFDIECDVMKRIC---HRNLIKIISSYSNDDFKAL  176 (346)
Q Consensus       108 ~~~lg~G~~g~vy~~~~~~~-~~vavK~~~~~-------~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~l  176 (346)
                      .+.||.|.+..||++...+| +.++||.-.+.       .+-..++...|.+.|..+.   ...+.+++.+  +.+..++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            46789999999999998877 48999984321       1223466777888888763   3456667766  3355789


Q ss_pred             EEecCCCCC
Q 039799          177 VLEYMPHGS  185 (346)
Q Consensus       177 v~e~~~~gs  185 (346)
                      |||++++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999998744

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=97.86  E-value=9.4e-07  Score=67.02  Aligned_cols=63  Identities=16%  Similarity=0.170  Sum_probs=36.3

Q ss_pred             CCCCCCEEEeecCcccccCCccccCc-CCCCeEECcCCcCcCCCCCCCCCcccccccccCCcchh
Q 039799           10 DLINLKSLNLSNNNLSGTIPISLEKL-LDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNELLC   73 (346)
Q Consensus        10 ~l~~L~~l~l~~N~l~g~~p~~~~~l-~~l~~l~l~~N~l~~~~p~~~~~~~l~~l~~~~n~~~~   73 (346)
                      ....|+..+||+|.|. .+|..|... +.+++|||++|.++..|-+...++.|+.+++..|++..
T Consensus        51 ~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neisdvPeE~Aam~aLr~lNl~~N~l~~  114 (177)
T KOG4579|consen   51 KGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEISDVPEELAAMPALRSLNLRFNPLNA  114 (177)
T ss_pred             CCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhhhchHHHhhhHHhhhcccccCcccc
Confidence            3344555566666666 666655443 25666666666666555555555666666666665543

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=97.83  E-value=4.6e-06  Score=67.54  Aligned_cols=64  Identities=34%  Similarity=0.455  Sum_probs=23.1

Q ss_pred             hhCCCCCCEEEeecCcccccCCccc-cCcCCCCeEECcCCcCcCCC--CCCCCCcccccccccCCcch
Q 039799            8 IGDLINLKSLNLSNNNLSGTIPISL-EKLLDLKDINVSFNKLEGEI--PREGPFRNLSVKSFEGNELL   72 (346)
Q Consensus         8 ~~~l~~L~~l~l~~N~l~g~~p~~~-~~l~~l~~l~l~~N~l~~~~--p~~~~~~~l~~l~~~~n~~~   72 (346)
                      +..|++|+.|+|++|+++ .+++.+ ..+++|+.|++++|++...-  -....+++|..+++.+|+.+
T Consensus        60 l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~  126 (175)
T PF14580_consen   60 LPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC  126 (175)
T ss_dssp             ----TT--EEE--SS----S-CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred             ccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence            455667777777777777 665544 24677777777777776431  12244566666677777654

>PRK05231 homoserine kinase; Provisional

Probab=97.82  E-value=0.00077  Score=60.70  Aligned_cols=141  Identities=18%  Similarity=0.211  Sum_probs=78.3

Q ss_pred             CCcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCC--ceeeEE------EEecCCceeEEEe
Q 039799          108 PPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRN--LIKIIS------SYSNDDFKALVLE  179 (346)
Q Consensus       108 ~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~------~~~~~~~~~lv~e  179 (346)
                      .+.++.|....+|+....+| .+++|++....   .+....|..++..+...+  +.+++.      +....+..+++++
T Consensus        27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~  102 (319)
T PRK05231         27 LKGIAEGIENSNFFLTTTQG-EYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT  102 (319)
T ss_pred             cchhccccccceEEEEeCCC-cEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence            34567788889999887655 68899886211   233344555555553222  233332      1123456789999


Q ss_pred             cCCCCChhh-----h---------hhhcCC----------CCCH-HHHHHH------------H-HHHHHHHHHHhc---
Q 039799          180 YMPHGSLEK-----C---------LYLSNY----------ILDI-FQRLDI------------M-IDVASALEYLHF---  218 (346)
Q Consensus       180 ~~~~gsL~~-----~---------l~~~~~----------~l~~-~~~~~i------------~-~~i~~~l~~LH~---  218 (346)
                      |++|..+..     +         ++....          .+.| .....-            . ..+...+..+..   
T Consensus       103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  182 (319)
T PRK05231        103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW  182 (319)
T ss_pred             ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence            999875421     1         111000          1112 111110            1 111112222221   


Q ss_pred             -CCCCCeeecCCCCCceEECCCCcEEEeeecCCcc
Q 039799          219 -GYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  252 (346)
Q Consensus       219 -~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~  252 (346)
                       ....++||+|+.+.||+++++...-|+||+.+..
T Consensus       183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             ccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence             1356899999999999999766668999999874

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.79  E-value=0.00014  Score=73.31  Aligned_cols=191  Identities=19%  Similarity=0.243  Sum_probs=126.2

Q ss_pred             HHHHHHHHHHHhcCCCCceeeEEEEecCCcee----EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 039799          144 KSFDIECDVMKRICHRNLIKIISSYSNDDFKA----LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFG  219 (346)
Q Consensus       144 ~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~----lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~  219 (346)
                      .....|.+.+.++.|+|++.++.|-.+.....    +..+++...++.+.++.- ...+..+...+..++.+|++|+|  
T Consensus       227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v-~~i~~~~~r~~~~~~~~GL~~~h--  303 (1351)
T KOG1035|consen  227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV-GSIPLETLRILHQKLLEGLAYLH--  303 (1351)
T ss_pred             HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc-cccCHHHHHHHHHHHhhhHHHHH--
Confidence            34445778888999999999999877654333    345677777777766533 44667777788999999999999  


Q ss_pred             CCCCeeecCCCCC---ceEECCCCcEEEe--eecCCccCCccccccccccccCCcccccCCCCCCCCCC--cchhHHHHH
Q 039799          220 YSAPIIHCDLKPS---NVLLDDNMVAHLS--DFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVS--TNGDVYSFG  292 (346)
Q Consensus       220 ~~~~i~H~dik~~---NIll~~~~~~~l~--Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~--~~~Dv~s~G  292 (346)
                       +....|.-+..+   +--.+.++...++  ||+..+.+......   .....+..+.++|........  ...|+|.+|
T Consensus       304 -~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg  379 (1351)
T KOG1035|consen  304 -SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCLG  379 (1351)
T ss_pred             -HhccceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHHHH
Confidence             665555555444   4445566677776  88888876543322   122345567788876555443  346999999


Q ss_pred             HHHHHHHcCCCCCCccccCcccHHHHHhhhcCCChhhhhchhccCCccccccc
Q 039799          293 IMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       293 ~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      .....+..|..+-..    .................+...+|+..++++|+++
T Consensus       380 ll~~~~~~~~~i~~~----~~~~~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~  428 (1351)
T KOG1035|consen  380 LLLLQLSQGEDISEK----SAVPVSLLDVLSTSELLDALPKCLDEDSEERLSA  428 (1351)
T ss_pred             HHHhhhhhcCccccc----ccchhhhhccccchhhhhhhhhhcchhhhhccch
Confidence            999999988775322    1111122222222246677888888888888764

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.79  E-value=0.00023  Score=63.57  Aligned_cols=138  Identities=26%  Similarity=0.277  Sum_probs=82.6

Q ss_pred             cccccCceEEEEEEEcC-------CCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCce-eeEEEEecCCceeEEEecC
Q 039799          110 LIGKGGFGSVYKAIIQD-------GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLI-KIISSYSNDDFKALVLEYM  181 (346)
Q Consensus       110 ~lg~G~~g~vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~  181 (346)
                      .+..|-...+|+....+       ++.+++|+...... ......+|.+++..+....+. ++++++..    ..|+||+
T Consensus         5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i   79 (302)
T cd05156           5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFI   79 (302)
T ss_pred             EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhee
Confidence            45567777899988664       57899999765432 223456788888887543333 45555432    3689999


Q ss_pred             CCCChhhh-----------------hhhcCCC--------CC--HHHHHH--------------------------HHHH
Q 039799          182 PHGSLEKC-----------------LYLSNYI--------LD--IFQRLD--------------------------IMID  208 (346)
Q Consensus       182 ~~gsL~~~-----------------l~~~~~~--------l~--~~~~~~--------------------------i~~~  208 (346)
                      +|.++...                 +|.....        .+  |.....                          +...
T Consensus        80 ~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (302)
T cd05156          80 PSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLED  159 (302)
T ss_pred             CCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHH
Confidence            88766431                 0111010        00  101000                          0111


Q ss_pred             HHHHHHHHhc------CCCCCeeecCCCCCceEECCC----CcEEEeeecCCcc
Q 039799          209 VASALEYLHF------GYSAPIIHCDLKPSNVLLDDN----MVAHLSDFGMAKP  252 (346)
Q Consensus       209 i~~~l~~LH~------~~~~~i~H~dik~~NIll~~~----~~~~l~Dfg~~~~  252 (346)
                      +...+.++-.      .....++|+|+.+.||+++++    +.+.++||..|..
T Consensus       160 ~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~  213 (302)
T cd05156         160 EAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY  213 (302)
T ss_pred             HHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence            2222333321      245678999999999999975    8899999998874

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PF00560 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []

Probab=97.76  E-value=8.8e-06  Score=41.61  Aligned_cols=22  Identities=55%  Similarity=0.810  Sum_probs=18.6

Q ss_pred             CCCEEEeecCcccccCCccccCc
Q 039799           13 NLKSLNLSNNNLSGTIPISLEKL   35 (346)
Q Consensus        13 ~L~~l~l~~N~l~g~~p~~~~~l   35 (346)
                      +|++||||+|+|+ .||++|++|
T Consensus         1 ~L~~Ldls~n~l~-~ip~~~~~l   22 (22)
T PF00560_consen    1 NLEYLDLSGNNLT-SIPSSFSNL   22 (22)
T ss_dssp             TESEEEETSSEES-EEGTTTTT-
T ss_pred             CccEEECCCCcCE-eCChhhcCC
Confidence            5899999999999 999987764

LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. ; GO: 0005515 protein binding; PDB: 4ECO_B 2A0Z_A 3ULU_A 1ZIW_A 3ULV_A 1DCE_C 1LTX_A 3J0A_B 3A79_B 4FCG_A ....

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.68  E-value=0.001  Score=59.59  Aligned_cols=143  Identities=20%  Similarity=0.271  Sum_probs=84.6

Q ss_pred             CCCcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCC--ceeeEEE------EecCCceeEEE
Q 039799          107 MPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRN--LIKIISS------YSNDDFKALVL  178 (346)
Q Consensus       107 ~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~------~~~~~~~~lv~  178 (346)
                      ..+.++.|....+|+....+| .+++|+......  ......|.+++..+....  +.+++..      ....+..++++
T Consensus        26 ~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~  102 (307)
T TIGR00938        26 SLKGIAEGVENSNYLLTTDVG-RYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV  102 (307)
T ss_pred             eccccCCccccceEEEEeCCC-cEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence            356678888889999876655 678898765321  234455677777774322  3344331      12245678999


Q ss_pred             ecCCCCChhh-----h---------hhhcCC-----------CCCHHHHH------------HHHHHHHHHHHHHhc---
Q 039799          179 EYMPHGSLEK-----C---------LYLSNY-----------ILDIFQRL------------DIMIDVASALEYLHF---  218 (346)
Q Consensus       179 e~~~~gsL~~-----~---------l~~~~~-----------~l~~~~~~------------~i~~~i~~~l~~LH~---  218 (346)
                      +|++|.++..     +         ++....           ...|....            .....+.+.++++..   
T Consensus       103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~  182 (307)
T TIGR00938       103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP  182 (307)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence            9998865421     0         111000           01111110            011123334555532   


Q ss_pred             -CCCCCeeecCCCCCceEECCCCcEEEeeecCCcc
Q 039799          219 -GYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  252 (346)
Q Consensus       219 -~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~  252 (346)
                       ....+++|+|+.+.||++++++...|+||+.+..
T Consensus       183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             hcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence             2357899999999999999887778999999864

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.65  E-value=0.00058  Score=61.02  Aligned_cols=142  Identities=18%  Similarity=0.207  Sum_probs=94.3

Q ss_pred             CCCCcccccCceEEEEEEEcCCCEEEEEEecCCC--------------------------chhHHHHHHHHHHHHhcCCC
Q 039799          106 NMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQY--------------------------EGAFKSFDIECDVMKRICHR  159 (346)
Q Consensus       106 ~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~--------------------------~~~~~~~~~e~~~l~~l~h~  159 (346)
                      ++...|..|.-+.||.+.-.+|..+|||+++...                          .........|++-|.++...
T Consensus       147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            5667789999999999999999999999985320                          11122345677888887655


Q ss_pred             CceeeEEEEecCCceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCC
Q 039799          160 NLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDN  239 (346)
Q Consensus       160 niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~  239 (346)
                      .|...--...  ....|||+|+..... -.=......++...+..+-.+++.-+.-|.+  .+.+||.||+-=|+|+.+ 
T Consensus       227 GIP~PePIlL--k~hVLVM~FlGrdgw-~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~--~c~LVHADLSEfN~Lyhd-  300 (520)
T KOG2270|consen  227 GIPCPEPILL--KNHVLVMEFLGRDGW-AAPKLKDASLSTSKARELYQQCVRIMRRLYQ--KCRLVHADLSEFNLLYHD-  300 (520)
T ss_pred             CCCCCCceee--ecceEeeeeccCCCC-cCcccccccCChHHHHHHHHHHHHHHHHHHH--HhceeccchhhhhheEEC-
Confidence            5432211111  134699999953322 1111123345544555566667777776653  678999999999999865 


Q ss_pred             CcEEEeeecCCccC
Q 039799          240 MVAHLSDFGMAKPL  253 (346)
Q Consensus       240 ~~~~l~Dfg~~~~~  253 (346)
                      |.+.++|-+.+...
T Consensus       301 G~lyiIDVSQSVE~  314 (520)
T KOG2270|consen  301 GKLYIIDVSQSVEH  314 (520)
T ss_pred             CEEEEEEccccccC
Confidence            68999999988754

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.62  E-value=0.00083  Score=59.08  Aligned_cols=31  Identities=32%  Similarity=0.586  Sum_probs=26.0

Q ss_pred             CCeeecCCCCCceEECCCCc-EEEeeecCCcc
Q 039799          222 APIIHCDLKPSNVLLDDNMV-AHLSDFGMAKP  252 (346)
Q Consensus       222 ~~i~H~dik~~NIll~~~~~-~~l~Dfg~~~~  252 (346)
                      ..++|+|+++.||++++++. .-|+||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            45899999999999997555 46999998874

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02236 choline kinase

Probab=97.56  E-value=0.0013  Score=59.90  Aligned_cols=139  Identities=14%  Similarity=0.179  Sum_probs=82.2

Q ss_pred             cccccCceEEEEEEEcC-----CCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCce-eeEEEEecCCceeEEEecCCC
Q 039799          110 LIGKGGFGSVYKAIIQD-----GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLI-KIISSYSNDDFKALVLEYMPH  183 (346)
Q Consensus       110 ~lg~G~~g~vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~  183 (346)
                      .+..|-...+|+..+.+     ++.+++|+.......... ..+|..+++.+...++. ++++.+...    .|++|+++
T Consensus        43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g  117 (344)
T PLN02236         43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA  117 (344)
T ss_pred             EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence            45557888999987642     368999998765433222 36688888888654444 555655332    58999987


Q ss_pred             CChhhh-----------------hhhcC----CCCC-HHHHHHHHHH-----------------HHHHHHHH----hc-C
Q 039799          184 GSLEKC-----------------LYLSN----YILD-IFQRLDIMID-----------------VASALEYL----HF-G  219 (346)
Q Consensus       184 gsL~~~-----------------l~~~~----~~l~-~~~~~~i~~~-----------------i~~~l~~L----H~-~  219 (346)
                      .++...                 +|...    ...+ +....++..+                 +...+..|    .. .
T Consensus       118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~  197 (344)
T PLN02236        118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD  197 (344)
T ss_pred             CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence            666321                 11111    0011 2222122111                 11112222    21 2


Q ss_pred             CCCCeeecCCCCCceEECC-CCcEEEeeecCCccC
Q 039799          220 YSAPIIHCDLKPSNVLLDD-NMVAHLSDFGMAKPL  253 (346)
Q Consensus       220 ~~~~i~H~dik~~NIll~~-~~~~~l~Dfg~~~~~  253 (346)
                      ....++|+|+++.||++++ ++.+.++||..+..-
T Consensus       198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~  232 (344)
T PLN02236        198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYN  232 (344)
T ss_pred             CCceEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence            2456899999999999986 468999999998753

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.51  E-value=0.00014  Score=63.75  Aligned_cols=135  Identities=19%  Similarity=0.226  Sum_probs=93.6

Q ss_pred             CCCCCcccccCceEEEEEEEcCCCEEEEEEecCC-----------------Cch-----hHHHHHHHHHHHHhcCCC--C
Q 039799          105 ANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQ-----------------YEG-----AFKSFDIECDVMKRICHR--N  160 (346)
Q Consensus       105 ~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~-----------------~~~-----~~~~~~~e~~~l~~l~h~--n  160 (346)
                      +.+++.||-|.-+.||.+...+|.+.++|.-.-.                 ...     ..-...+|...++.+...  -
T Consensus        94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp  173 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP  173 (465)
T ss_pred             hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence            5788999999999999999999999998853111                 000     012344677777777432  2


Q ss_pred             ceeeEEEEecCCceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCC
Q 039799          161 LIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM  240 (346)
Q Consensus       161 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~  240 (346)
                      +.+.++    .+..++|||++.+..|.+.-+..    +.++   +...+...+--|.   ..|+||+|..-=||++++++
T Consensus       174 VPkpiD----~~RH~Vvmelv~g~Pl~~v~~v~----d~~~---ly~~lm~~Iv~la---~~GlIHgDFNEFNimv~dd~  239 (465)
T KOG2268|consen  174 VPKPID----HNRHCVVMELVDGYPLRQVRHVE----DPPT---LYDDLMGLIVRLA---NHGLIHGDFNEFNIMVKDDD  239 (465)
T ss_pred             CCCccc----ccceeeHHHhhcccceeeeeecC----ChHH---HHHHHHHHHHHHH---HcCceecccchheeEEecCC
Confidence            333333    34567899999998887644322    2222   3334444455566   88999999999999999999


Q ss_pred             cEEEeeecCCccC
Q 039799          241 VAHLSDFGMAKPL  253 (346)
Q Consensus       241 ~~~l~Dfg~~~~~  253 (346)
                      .++++||-.+...
T Consensus       240 ~i~vIDFPQmvS~  252 (465)
T KOG2268|consen  240 KIVVIDFPQMVST  252 (465)
T ss_pred             CEEEeechHhhcc
Confidence            9999999876644

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=97.45  E-value=3.4e-05  Score=66.32  Aligned_cols=62  Identities=23%  Similarity=0.283  Sum_probs=31.3

Q ss_pred             hhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCCCCCcccccccccCCcc
Q 039799            8 IGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNEL   71 (346)
Q Consensus         8 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~l~~l~~~~n~~   71 (346)
                      +-..+.|+.||||+|.++ .|-+++--++.++.|+||+|.+... -....+.++..+++++|.+
T Consensus       280 ~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v-~nLa~L~~L~~LDLS~N~L  341 (490)
T KOG1259|consen  280 ADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV-QNLAELPQLQLLDLSGNLL  341 (490)
T ss_pred             cchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee-hhhhhcccceEeecccchh
Confidence            333445555555555555 5555555555555555555555422 1133344555555555543

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=97.40  E-value=3.3e-05  Score=72.06  Aligned_cols=65  Identities=20%  Similarity=0.167  Sum_probs=47.3

Q ss_pred             chhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCC-CCCcccccccccCCcc
Q 039799            7 SIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSVKSFEGNEL   71 (346)
Q Consensus         7 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~~   71 (346)
                      .+.+|++|+.||||+|.+.-.=++++.-+++|+.|+||+|+++...+.. ..+++|+.|.+++|.+
T Consensus       288 ~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi  353 (873)
T KOG4194|consen  288 WLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSI  353 (873)
T ss_pred             cccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccch
Confidence            3567888888888888888555677888888888888888888877654 3345555555555543

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=97.38  E-value=2.2e-05  Score=72.96  Aligned_cols=69  Identities=32%  Similarity=0.430  Sum_probs=49.3

Q ss_pred             ccCcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCCCCCcccccccccCCcchh
Q 039799            3 SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNELLC   73 (346)
Q Consensus         3 ~ip~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~l~~l~~~~n~~~~   73 (346)
                      ++|+.+++|.+|+.|++..|++. .+|++++.| .|..||+|+|+++..|-..-.++.|..+.+.+|++..
T Consensus       180 slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis~iPv~fr~m~~Lq~l~LenNPLqS  248 (722)
T KOG0532|consen  180 SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKISYLPVDFRKMRHLQVLQLENNPLQS  248 (722)
T ss_pred             hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCceeecchhhhhhhhheeeeeccCCCCC
Confidence            45666666777777777777777 677777643 5777788888887666566677788888888888764

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	346
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-28
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		9e-28
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-27
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		5e-27
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		5e-25
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		9e-25
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-24
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		5e-24
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		6e-24
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-22
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-21
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		3e-20
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		3e-20
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		4e-20
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		4e-20
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		6e-20
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		6e-20
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		7e-20
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		8e-20
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		8e-20
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		9e-20
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-19
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-19
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-19
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-19
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-19
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-19
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-19
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-19
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-19
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-19
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-19
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-19
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		3e-19
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		4e-19
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		4e-19
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		7e-19
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		9e-19
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-18
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-18
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-18
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		3e-18
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-18
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		3e-18
4h58_A	275	Braf In Complex With Compound 3 Length = 275		3e-18
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		4e-18
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		4e-18
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		4e-18
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		4e-18
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		4e-18
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		5e-18
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		5e-18
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		5e-18
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		5e-18
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		6e-18
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		7e-18
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		8e-18
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-18
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		8e-18
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		9e-18
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-17
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-17
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-17
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-17
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-17
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-17
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-17
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-17
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-17
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-17
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-17
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-17
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-17
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-17
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-17
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-17
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-17
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-17
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-17
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-17
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-17
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-17
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-17
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-17
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-17
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-17
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-17
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-17
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-17
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		3e-17
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		3e-17
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		5e-17
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		5e-17
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		6e-17
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		6e-17
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-17
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		7e-17
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		8e-17
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		8e-17
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-16
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-16
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-16
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-16
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-16
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-16
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-16
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-16
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-16
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-16
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-16
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-16
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-16
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-16
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-16
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-16
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		3e-16
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		3e-16
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		3e-16
3a4o_X	286	Lyn Kinase Domain Length = 286		3e-16
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-16
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		4e-16
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		4e-16
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		6e-16
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		6e-16
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		6e-16
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		6e-16
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		7e-16
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		7e-16
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		7e-16
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		7e-16
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		7e-16
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-16
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		7e-16
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-16
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		7e-16
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		7e-16
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		8e-16
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		8e-16
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		8e-16
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		8e-16
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-16
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		8e-16
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		8e-16
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		8e-16
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		8e-16
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		8e-16
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-16
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-16
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		9e-16
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		9e-16
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		9e-16
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-15
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-15
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-15
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-15
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-15
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-15
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-15
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-15
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-15
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-15
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-15
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-15
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-15
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-15
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-15
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		3e-15
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		3e-15
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		4e-15
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-15
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		6e-15
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		6e-15
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		7e-15
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		9e-15
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-14
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-14
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-14
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-14
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-14
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-14
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-14
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-14
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-14
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-14
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-14
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-14
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-14
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-14
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-14
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-14
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-14
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-14
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-14
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-14
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-14
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-14
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		3e-14
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		3e-14
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		3e-14
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		3e-14
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-14
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-14
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-14
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		3e-14
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		3e-14
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-14
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-14
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		3e-14
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		3e-14
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		4e-14
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		4e-14
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		4e-14
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		4e-14
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		4e-14
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		4e-14
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		5e-14
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		5e-14
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		5e-14
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-14
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-14
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		5e-14
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-14
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		5e-14
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		5e-14
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		6e-14
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		6e-14
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-14
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		6e-14
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		6e-14
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		6e-14
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		6e-14
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		6e-14
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-14
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		8e-14
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		8e-14
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		8e-14
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		9e-14
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		9e-14
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		9e-14
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		9e-14
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		9e-14
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		9e-14
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		9e-14
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-13
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-13
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-13
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-13
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-13
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-13
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-13
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-13
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-13
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-13
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-13
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-13
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-13
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-13
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-13
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-13
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-13
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-13
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-13
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-13
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-13
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-13
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-13
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		3e-13
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		3e-13
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-13
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-13
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-13
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		3e-13
3b2t_A	311	Structure Of Phosphotransferase Length = 311		3e-13
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		3e-13
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-13
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		3e-13
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		3e-13
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		4e-13
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		4e-13
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		4e-13
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		5e-13
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		5e-13
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-13
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-13
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		6e-13
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		6e-13
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		7e-13
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		8e-13
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		8e-13
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		9e-13
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		9e-13
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		9e-13
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-13
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		9e-13
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		9e-13
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-12
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-12
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-12
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-12
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-12
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-12
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-12
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-12
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-12
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-12
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-12
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-12
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-12
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-12
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-12
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-12
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-12
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-12
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-12
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-12
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-12
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-12
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-12
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		3e-12
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		3e-12
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-12
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-12
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-12
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		3e-12
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		3e-12
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		3e-12
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-12
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		3e-12
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-12
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		3e-12
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		3e-12
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		4e-12
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		4e-12
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		4e-12
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		4e-12
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		4e-12
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		4e-12
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		4e-12
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		4e-12
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		4e-12
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		4e-12
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		5e-12
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-12
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-12
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		5e-12
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		5e-12
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		5e-12
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		5e-12
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		5e-12
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		5e-12
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		6e-12
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		6e-12
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		6e-12
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-12
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		7e-12
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		7e-12
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		7e-12
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		7e-12
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		7e-12
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		8e-12
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		9e-12
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		9e-12
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		9e-12
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		9e-12
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-11
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-11
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-11
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-11
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-11
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-11
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-11
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-11
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-11
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-11
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-11
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-11
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-11
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-11
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-11
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-11
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		1e-11
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-11
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-11
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-11
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-11
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-11
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		1e-11
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-11
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-11
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-11
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-11
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-11
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-11
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-11
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-11
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-11
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-11
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-11
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-11
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-11
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-11
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-11
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-11
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-11
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-11
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-11
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-11
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-11
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-11
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-11
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-11
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-11
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-11
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-11
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-11
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-11
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-11
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-11
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-11
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-11
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-11
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-11
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-11
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		3e-11
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-11
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-11
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-11
3kk9_A	282	Camkii Substrate Complex B Length = 282		3e-11
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-11
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		3e-11
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-11
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		3e-11
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-11
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-11
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		4e-11
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-11
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		4e-11
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-11
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-11
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		5e-11
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		5e-11
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		5e-11
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		5e-11
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		5e-11
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		6e-11
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-11
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		6e-11
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		6e-11
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		6e-11
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		6e-11
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		6e-11
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		6e-11
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		7e-11
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		7e-11
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		7e-11
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		7e-11
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		7e-11
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		8e-11
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		8e-11
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		9e-11
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		9e-11
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		9e-11
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		9e-11
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-10
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-10
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-10
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-10
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-10
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-10
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-10
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-10
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-10
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-10
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-10
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-10
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-10
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-10
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-10
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-10
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-10
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-10
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-10
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-10
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-10
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-10
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-10
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-10
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-10
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-10
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-10
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-10
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-10
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-10
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-10
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-10
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-10
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-10
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-10
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-10
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-10
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-10
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-10
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-10
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-10
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		3e-10
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		3e-10
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		3e-10
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-10
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		3e-10
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		3e-10
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		3e-10
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-10
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		3e-10
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		3e-10
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-10
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		3e-10
4fl3_A	635	Structural And Biophysical Characterization Of The		4e-10
4fl2_A	636	Structural And Biophysical Characterization Of The		4e-10
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		4e-10
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		4e-10
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		4e-10
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-10
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		5e-10
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		5e-10
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		5e-10
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		5e-10
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		5e-10
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		5e-10
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		6e-10
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		6e-10
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		6e-10
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		6e-10
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		6e-10
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		6e-10
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		6e-10
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		6e-10
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		6e-10
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		6e-10
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		6e-10
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		6e-10
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-10
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-10
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		6e-10
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		6e-10
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		6e-10
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		6e-10
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		7e-10
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		7e-10
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		7e-10
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		7e-10
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		7e-10
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		7e-10
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		7e-10
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		7e-10
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		7e-10
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		7e-10
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		7e-10
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		8e-10
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		8e-10
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		8e-10
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		8e-10
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		8e-10
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		8e-10
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		8e-10
3hec_A	348	P38 In Complex With Imatinib Length = 348		8e-10
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		8e-10
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		9e-10
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		9e-10
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		9e-10
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		9e-10
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		9e-10
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		9e-10
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		9e-10
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		9e-10
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		9e-10
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		9e-10
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		9e-10
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		9e-10
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-09
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-09
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-09
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-09
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-09
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-09
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-09
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-09
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-09
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-09
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-09
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-09
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-09
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-09
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-09
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-09
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-09
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-09
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-09
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-09
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-09
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-09
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-09
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-09
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-09
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-09
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-09
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-09
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-09
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-09
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-09
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-09
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-09
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-09
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-09
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-09
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-09
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-09
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-09
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-09
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-09
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-09
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-09
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		3e-09
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-09
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-09
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		3e-09
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-09
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-09
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		3e-09
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-09
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		3e-09
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		4e-09
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-09
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		4e-09
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		4e-09
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		4e-09
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-09
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-09
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		4e-09
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		4e-09
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		4e-09
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		4e-09
4fie_A	423	Full-Length Human Pak4 Length = 423		4e-09
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		5e-09
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-09
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-09
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-09
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		5e-09
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		5e-09
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		5e-09
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		5e-09
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-09
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		6e-09
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-09
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		6e-09
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		7e-09
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		7e-09
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		7e-09
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		7e-09
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		7e-09
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		7e-09
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		7e-09
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		7e-09
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		7e-09
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		7e-09
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		8e-09
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-09
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		8e-09
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		8e-09
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		8e-09
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		8e-09
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		8e-09
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		8e-09
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		8e-09
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		8e-09
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		8e-09
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-09
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		8e-09
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		8e-09
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		8e-09
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		8e-09
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		9e-09
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-08
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-08
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-08
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-08
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-08
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-08
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-08
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-08
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-08
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-08
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-08
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-08
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-08
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-08
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		1e-08
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-08
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-08
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-08
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-08
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-08
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-08
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-08
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-08
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-08
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-08
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-08
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-08
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-08
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-08
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-08
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-08
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-08
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-08
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-08
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-08
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-08
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-08
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-08
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-08
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-08
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-08
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-08
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-08
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-08
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-08
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-08
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-08
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		3e-08
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		3e-08
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-08
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-08
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-08
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		3e-08
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		3e-08
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		3e-08
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-08
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-08
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-08
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-08
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		3e-08
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		3e-08
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-08
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		3e-08
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		4e-08
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-08
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		4e-08
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-08
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		4e-08
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		4e-08
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		4e-08
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		4e-08
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		4e-08
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		4e-08
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		4e-08
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		5e-08
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		5e-08
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-08
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		5e-08
4ae6_A	343	Structure And Function Of The Human Sperm-specific		5e-08
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		5e-08
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		6e-08
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		6e-08
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		6e-08
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		6e-08
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		6e-08
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-08
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		6e-08
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-08
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		6e-08
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		6e-08
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		7e-08
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		7e-08
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		7e-08
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		7e-08
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		7e-08
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		7e-08
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		8e-08
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		8e-08
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		8e-08
4exu_A	371	Mapk13, Inactive Form Length = 371		8e-08
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		8e-08
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		9e-08
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		9e-08
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		9e-08
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		1e-07
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-07
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-07
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-07
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-07
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-07
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-07
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-07
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-07
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-07
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-07
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-07
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-07
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-07
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-07
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-07
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-07
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-07
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-07
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-07
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-07
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-07
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-07
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-07
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-07
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-07
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-07
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-07
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		2e-07
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-07
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-07
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-07
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-07
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-07
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-07
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-07
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-07
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-07
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-07
3soa_A	444	Full-Length Human Camkii Length = 444		3e-07
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		3e-07
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		3e-07
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		3e-07
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		3e-07
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-07
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		4e-07
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		4e-07
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		4e-07
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		4e-07
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-07
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		4e-07
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-07
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		4e-07
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		4e-07
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		4e-07
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		4e-07
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		4e-07
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		4e-07
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		5e-07
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		5e-07
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		5e-07
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		5e-07
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		5e-07
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		5e-07
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		5e-07
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		6e-07
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		6e-07
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		6e-07
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		6e-07
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		6e-07
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		6e-07
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		6e-07
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		6e-07
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		6e-07
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		6e-07
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-07
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		6e-07
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		6e-07
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		6e-07
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-07
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		6e-07
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-07
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		6e-07
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		6e-07
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		6e-07
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		6e-07
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		6e-07
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-07
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		7e-07
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		7e-07
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		7e-07
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		7e-07
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		7e-07
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		7e-07
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		7e-07
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		7e-07
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		7e-07
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		8e-07
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		8e-07
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		8e-07
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		8e-07
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		8e-07
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		8e-07
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		8e-07
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		8e-07
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		8e-07
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		8e-07
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		8e-07
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		9e-07
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		9e-07
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		9e-07
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		9e-07
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		9e-07
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		9e-07
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		9e-07
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		9e-07
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		9e-07
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-06
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-06
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-06
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-06
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-06
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		1e-06
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-06
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-06
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-06
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		1e-06
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		1e-06
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-06
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-06
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		1e-06
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-06
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-06
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-06
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-06
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-06
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-06
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-06
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-06
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-06
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-06
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-06
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-06
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-06
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		1e-06
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		2e-06
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-06
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-06
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		2e-06
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-06
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-06
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-06
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-06
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-06
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-06
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-06
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-06
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		2e-06
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-06
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-06
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-06
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-06
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-06
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-06
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-06
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		3e-06
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		3e-06
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		3e-06
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		3e-06
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-06
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-06
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		3e-06
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		3e-06
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-06
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-06
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		4e-06
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		4e-06
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		5e-06
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		5e-06
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		6e-06
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		6e-06
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		6e-06
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-06
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		7e-06
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		8e-06
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		9e-06
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		9e-06
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		9e-06
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		1e-05
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-05
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		1e-05
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-05
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-05
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-05
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		2e-05
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-05
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-05
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-05
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-05
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-05
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-05
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-05
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-05
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-05
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-05
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-05
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		3e-05
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		3e-05
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		3e-05
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		3e-05
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		3e-05
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		3e-05
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		3e-05

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 82/238 (34%), Positives = 127/238 (53%), Gaps = 8/238 (3%)
Query: 103 NDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLI 162
           N+ +   LIG G FG VYK +++DG +VA+K   P+     + F+ E + +    H +L+
Sbjct: 39  NNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLV 98
Query: 163 KIISSYSNDDFKALVLEYMPHGSLEKCLY---LSNYILDIFQRLDIMIDVASALEYLHFG 219
            +I      +   L+ +YM +G+L++ LY   L    +   QRL+I I  A  L YLH  
Sbjct: 99  SLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH-- 156
Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
            +  IIH D+K  N+LLD+N V  ++DFG++K   E DQ+        T+GY+ PEY  +
Sbjct: 157 -TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYIDPEYFIK 215
Query: 280 GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM-TLKRWVNDLLPISVME-VVDANL 335
           GR++   DVYSFG++L E+        +    EM  L  W  +      +E +VD NL
Sbjct: 216 GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNL 273

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  120 bits (302), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 81/238 (34%), Positives = 126/238 (52%), Gaps = 8/238 (3%)
Query: 103 NDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLI 162
           N+ +   LIG G FG VYK +++DG +VA+K   P+     + F+ E + +    H +L+
Sbjct: 39  NNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLV 98
Query: 163 KIISSYSNDDFKALVLEYMPHGSLEKCLY---LSNYILDIFQRLDIMIDVASALEYLHFG 219
            +I      +   L+ +YM +G+L++ LY   L    +   QRL+I I  A  L YLH  
Sbjct: 99  SLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH-- 156
Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
            +  IIH D+K  N+LLD+N V  ++DFG++K   E  Q+        T+GY+ PEY  +
Sbjct: 157 -TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYIDPEYFIK 215
Query: 280 GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM-TLKRWVNDLLPISVME-VVDANL 335
           GR++   DVYSFG++L E+        +    EM  L  W  +      +E +VD NL
Sbjct: 216 GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNL 273

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 81/234 (34%), Positives = 121/234 (51%), Gaps = 9/234 (3%)
Query: 110 LIGKGGFGSVYKAIIQDGMEVAVKVF-DPQYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
           ++G+GGFG VYK  + DG  VAVK   + + +G    F  E +++    HRNL+++    
Sbjct: 45  ILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTEVEMISMAVHRNLLRLRGFC 104
Query: 169 SNDDFKALVLEYMPHGSLEKCLYL---SNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
                + LV  YM +GS+  CL     S   LD  +R  I +  A  L YLH      II
Sbjct: 105 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKII 164
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
           H D+K +N+LLD+   A + DFG+AK L++            TIG++APEY   G+ S  
Sbjct: 165 HRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDXHVXXAVRGTIGHIAPEYLSTGKSSEK 223
Query: 286 GDVYSFGIMLMEIFTRTKPTDEIF---SGEMTLKRWVNDLLPISVME-VVDANL 335
            DV+ +G+ML+E+ T  +  D        ++ L  WV  LL    +E +VD +L
Sbjct: 224 TDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDL 277

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  118 bits (296), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 80/234 (34%), Positives = 121/234 (51%), Gaps = 9/234 (3%)
Query: 110 LIGKGGFGSVYKAIIQDGMEVAVKVF-DPQYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
           ++G+GGFG VYK  + DG  VAVK   + + +G    F  E +++    HRNL+++    
Sbjct: 37  ILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96
Query: 169 SNDDFKALVLEYMPHGSLEKCLYL---SNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
                + LV  YM +GS+  CL     S   LD  +R  I +  A  L YLH      II
Sbjct: 97  MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKII 156
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
           H D+K +N+LLD+   A + DFG+AK +  +D  +        IG++APEY   G+ S  
Sbjct: 157 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXA-VRGXIGHIAPEYLSTGKSSEK 215
Query: 286 GDVYSFGIMLMEIFTRTKPTDEIF---SGEMTLKRWVNDLLPISVME-VVDANL 335
            DV+ +G+ML+E+ T  +  D        ++ L  WV  LL    +E +VD +L
Sbjct: 216 TDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDL 269

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  111 bits (278), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 73/203 (35%), Positives = 110/203 (54%), Gaps = 11/203 (5%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVK----VFDPQYEGAFKSFDIECDVMKRICHRNLIKIIS 166
           +G+GGFG VYK  + +   VAVK    + D   E   + FD E  VM +  H NL++++ 
Sbjct: 39  MGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 97
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLYLSNYI--LDIFQRLDIMIDVASALEYLHFGYSAPI 224
             S+ D   LV  YMP+GSL   L   +    L    R  I    A+ + +LH  +    
Sbjct: 98  FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH--- 154
Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVST 284
           IH D+K +N+LLD+   A +SDFG+A+   +  Q++  ++ + T  YMAPE  R G ++ 
Sbjct: 155 IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEALR-GEITP 213
Query: 285 NGDVYSFGIMLMEIFTRTKPTDE 307
             D+YSFG++L+EI T     DE
Sbjct: 214 KSDIYSFGVVLLEIITGLPAVDE 236

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  110 bits (276), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 73/203 (35%), Positives = 109/203 (53%), Gaps = 11/203 (5%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVK----VFDPQYEGAFKSFDIECDVMKRICHRNLIKIIS 166
           +G+GGFG VYK  + +   VAVK    + D   E   + FD E  VM +  H NL++++ 
Sbjct: 39  MGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 97
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLYLSNYI--LDIFQRLDIMIDVASALEYLHFGYSAPI 224
             S+ D   LV  YMP+GSL   L   +    L    R  I    A+ + +LH  +    
Sbjct: 98  FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH--- 154
Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVST 284
           IH D+K +N+LLD+   A +SDFG+A+   +  Q++   + + T  YMAPE  R G ++ 
Sbjct: 155 IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEALR-GEITP 213
Query: 285 NGDVYSFGIMLMEIFTRTKPTDE 307
             D+YSFG++L+EI T     DE
Sbjct: 214 KSDIYSFGVVLLEIITGLPAVDE 236

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 73/203 (35%), Positives = 108/203 (53%), Gaps = 11/203 (5%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVK----VFDPQYEGAFKSFDIECDVMKRICHRNLIKIIS 166
           +G+GGFG VYK  + +   VAVK    + D   E   + FD E  VM +  H NL++++ 
Sbjct: 33  MGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 91
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLYLSNYI--LDIFQRLDIMIDVASALEYLHFGYSAPI 224
             S+ D   LV  YMP+GSL   L   +    L    R  I    A+ + +LH  +    
Sbjct: 92  FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH--- 148
Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVST 284
           IH D+K +N+LLD+   A +SDFG+A+   +  Q +   + + T  YMAPE  R G ++ 
Sbjct: 149 IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEALR-GEITP 207
Query: 285 NGDVYSFGIMLMEIFTRTKPTDE 307
             D+YSFG++L+EI T     DE
Sbjct: 208 KSDIYSFGVVLLEIITGLPAVDE 230

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 70/205 (34%), Positives = 108/205 (52%), Gaps = 8/205 (3%)
Query: 104 DANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQ--YEGAFKSFDIECDVMKRICHRNL 161
           D N+   IG G FG+V++A    G +VAVK+   Q  +      F  E  +MKR+ H N+
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 162 IKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYI--LDIFQRLDIMIDVASALEYLHFG 219
           +  + + +     ++V EY+  GSL + L+ S     LD  +RL +  DVA  + YLH  
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-N 155
Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
            + PI+H DLK  N+L+D      + DFG+++  L+    L       T  +MAPE  R+
Sbjct: 156 RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR--LKASXFLXSKXAAGTPEWMAPEVLRD 213
Query: 280 GRVSTNGDVYSFGIMLMEIFTRTKP 304
              +   DVYSFG++L E+ T  +P
Sbjct: 214 EPSNEKSDVYSFGVILWELATLQQP 238

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 69/205 (33%), Positives = 109/205 (53%), Gaps = 8/205 (3%)
Query: 104 DANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQ--YEGAFKSFDIECDVMKRICHRNL 161
           D N+   IG G FG+V++A    G +VAVK+   Q  +      F  E  +MKR+ H N+
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 162 IKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYI--LDIFQRLDIMIDVASALEYLHFG 219
           +  + + +     ++V EY+  GSL + L+ S     LD  +RL +  DVA  + YLH  
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-N 155
Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
            + PI+H +LK  N+L+D      + DFG+++  L+    L+      T  +MAPE  R+
Sbjct: 156 RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR--LKASTFLSSKSAAGTPEWMAPEVLRD 213
Query: 280 GRVSTNGDVYSFGIMLMEIFTRTKP 304
              +   DVYSFG++L E+ T  +P
Sbjct: 214 EPSNEKSDVYSFGVILWELATLQQP 238

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 70/202 (34%), Positives = 105/202 (51%), Gaps = 11/202 (5%)
Query: 112 GKGGFGSVYKAIIQDGMEVAVK----VFDPQYEGAFKSFDIECDVMKRICHRNLIKIISS 167
           G+GGFG VYK  + +   VAVK    + D   E   + FD E  V  +  H NL++++  
Sbjct: 31  GEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVELLGF 89
Query: 168 YSNDDFKALVLEYMPHGSLEKCLYLSNYI--LDIFQRLDIMIDVASALEYLHFGYSAPII 225
            S+ D   LV  Y P+GSL   L   +    L    R  I    A+ + +LH  +    I
Sbjct: 90  SSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHENHH---I 146
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
           H D+K +N+LLD+   A +SDFG+A+   +  Q +  ++ + T  Y APE  R G ++  
Sbjct: 147 HRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEALR-GEITPK 205
Query: 286 GDVYSFGIMLMEIFTRTKPTDE 307
            D+YSFG++L+EI T     DE
Sbjct: 206 SDIYSFGVVLLEIITGLPAVDE 227

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 100/202 (49%), Gaps = 9/202 (4%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAV-KVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYS 169
           IG G FG+VYK      + V + KV DP  E  F++F  E  V+++  H N++ +   Y 
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKILKVVDPTPE-QFQAFRNEVAVLRKTRHVNIL-LFMGYM 101
Query: 170 NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
             D  A+V ++    SL K L++      +FQ +DI    A  ++YLH   +  IIH D+
Sbjct: 102 TKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDM 158
Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGR---EGRVSTNG 286
           K +N+ L + +   + DFG+A        S    Q   ++ +MAPE  R       S   
Sbjct: 159 KSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQS 218
Query: 287 DVYSFGIMLMEIFTRTKPTDEI 308
           DVYS+GI+L E+ T   P   I
Sbjct: 219 DVYSYGIVLYELMTGELPYSHI 240

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 105/195 (53%), Gaps = 9/195 (4%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSN 170
           +G+G FG V+         VA+K   P      ++F  E  VMK++ H  L+++ +  S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 171 DDFKALVLEYMPHGSLEKCLY--LSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCD 228
           +    +V+EYM  GSL   L   +  Y L + Q +D+   +AS + Y+        +H D
Sbjct: 85  EPI-YIVIEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 229 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDV 288
           L+ +N+L+ +N+V  ++DFG+A+ L+E+++   +      I + APE    GR +   DV
Sbjct: 140 LRAANILVGENLVCKVADFGLAR-LIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 289 YSFGIMLMEIFTRTK 303
           +SFGI+L E+ T+ +
Sbjct: 199 WSFGILLTELTTKGR 213

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 103/194 (53%), Gaps = 7/194 (3%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSN 170
           +G+G FG V+         VA+K   P      ++F  E  VMK++ H  L+++ +  S 
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 74
Query: 171 DDFKALVLEYMPHGSLEKCLY-LSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
           +    +V EYM  GSL   L   +   L + Q +D+   +AS + Y+        +H DL
Sbjct: 75  EPI-XIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 130
Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 289
           + +N+L+ +N+V  ++DFG+A+ L+E+++   +      I + APE    GR +   DV+
Sbjct: 131 RAANILVGENLVCKVADFGLAR-LIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVW 189
Query: 290 SFGIMLMEIFTRTK 303
           SFGI+L E+ T+ +
Sbjct: 190 SFGILLTELTTKGR 203

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 61/195 (31%), Positives = 104/195 (53%), Gaps = 9/195 (4%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSN 170
           +G+G FG V+         VA+K   P      ++F  E  VMK+I H  L+++ +  S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKIRHEKLVQLYAVVSE 84
Query: 171 DDFKALVLEYMPHGSLEKCLY--LSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCD 228
           +    +V EYM  GSL   L   +  Y L + Q +D+   +AS + Y+        +H D
Sbjct: 85  EPI-YIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 229 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDV 288
           L+ +N+L+ +N+V  ++DFG+A+ L+E+++   +      I + APE    GR +   DV
Sbjct: 140 LRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 289 YSFGIMLMEIFTRTK 303
           +SFGI+L E+ T+ +
Sbjct: 199 WSFGILLTELTTKGR 213

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 105/195 (53%), Gaps = 9/195 (4%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSN 170
           +G+G FG V+         VA+K   P      ++F  E  VMK++ H  L+++ +  S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 171 DDFKALVLEYMPHGSLEKCLY--LSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCD 228
           +    +V+EYM  GSL   L   +  Y L + Q +D+   +AS + Y+        +H D
Sbjct: 85  EPI-YIVIEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 229 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDV 288
           L+ +N+L+ +N+V  ++DFG+A+ L+E+++   +      I + APE    GR +   DV
Sbjct: 140 LRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 289 YSFGIMLMEIFTRTK 303
           +SFGI+L E+ T+ +
Sbjct: 199 WSFGILLTELTTKGR 213

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 104/195 (53%), Gaps = 9/195 (4%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSN 170
           +G+G FG V+         VA+K   P      ++F  E  VMK++ H  L+++ +  S 
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 73
Query: 171 DDFKALVLEYMPHGSLEKCLY--LSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCD 228
           +    +V EYM  GSL   L   +  Y L + Q +D+   +AS + Y+        +H D
Sbjct: 74  EPI-YIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHRD 128
Query: 229 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDV 288
           L+ +N+L+ +N+V  ++DFG+A+ L+E+++   +      I + APE    GR +   DV
Sbjct: 129 LRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 187
Query: 289 YSFGIMLMEIFTRTK 303
           +SFGI+L E+ T+ +
Sbjct: 188 WSFGILLTELTTKGR 202

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 103/194 (53%), Gaps = 7/194 (3%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSN 170
           +G+G FG V+         VA+K   P      ++F  E  VMK++ H  L+++ +  S 
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 77
Query: 171 DDFKALVLEYMPHGSLEKCLY-LSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
           +    +V EYM  GSL   L   +   L + Q +D+   +AS + Y+        +H DL
Sbjct: 78  EPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 133
Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 289
           + +N+L+ +N+V  ++DFG+A+ L+E+++   +      I + APE    GR +   DV+
Sbjct: 134 RAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 192
Query: 290 SFGIMLMEIFTRTK 303
           SFGI+L E+ T+ +
Sbjct: 193 SFGILLTELTTKGR 206

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 104/195 (53%), Gaps = 9/195 (4%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSN 170
           +G+G FG V+         VA+K   P      ++F  E  VMK++ H  L+++ +  S 
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 75
Query: 171 DDFKALVLEYMPHGSLEKCLY--LSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCD 228
           +    +V EYM  GSL   L   +  Y L + Q +D+   +AS + Y+        +H D
Sbjct: 76  EPI-YIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHRD 130
Query: 229 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDV 288
           L+ +N+L+ +N+V  ++DFG+A+ L+E+++   +      I + APE    GR +   DV
Sbjct: 131 LRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 189
Query: 289 YSFGIMLMEIFTRTK 303
           +SFGI+L E+ T+ +
Sbjct: 190 WSFGILLTELTTKGR 204

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 94.4 bits (233), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 104/195 (53%), Gaps = 9/195 (4%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSN 170
           +G+G FG V+         VA+K   P      ++F  E  VMK++ H  L+++ +  S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 171 DDFKALVLEYMPHGSLEKCLY--LSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCD 228
           +    +V EYM  GSL   L   +  Y L + Q +D+   +AS + Y+        +H D
Sbjct: 85  EPI-YIVCEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 229 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDV 288
           L+ +N+L+ +N+V  ++DFG+A+ L+E+++   +      I + APE    GR +   DV
Sbjct: 140 LRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 289 YSFGIMLMEIFTRTK 303
           +SFGI+L E+ T+ +
Sbjct: 199 WSFGILLTELTTKGR 213

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 94.4 bits (233), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 104/195 (53%), Gaps = 9/195 (4%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSN 170
           +G+G FG V+         VA+K   P      ++F  E  VMK++ H  L+++ +  S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 171 DDFKALVLEYMPHGSLEKCLY--LSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCD 228
           +    +V EYM  GSL   L   +  Y L + Q +D+   +AS + Y+        +H D
Sbjct: 85  EPI-YIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 229 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDV 288
           L+ +N+L+ +N+V  ++DFG+A+ L+E+++   +      I + APE    GR +   DV
Sbjct: 140 LRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 289 YSFGIMLMEIFTRTK 303
           +SFGI+L E+ T+ +
Sbjct: 199 WSFGILLTELTTKGR 213

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 103/194 (53%), Gaps = 7/194 (3%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSN 170
           +G+G FG V+         VA+K   P      ++F  E  VMK++ H  L+++ +  S 
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 81
Query: 171 DDFKALVLEYMPHGSLEKCLY-LSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
           +    +V EYM  GSL   L   +   L + Q +D+   +AS + Y+        +H DL
Sbjct: 82  EPI-YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYVHRDL 137
Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 289
           + +N+L+ +N+V  ++DFG+A+ L+E+++   +      I + APE    GR +   DV+
Sbjct: 138 RAANILVGENLVCKVADFGLAR-LIEDNEWTARQGAKFPIKWTAPEAALYGRFTIKSDVW 196
Query: 290 SFGIMLMEIFTRTK 303
           SFGI+L E+ T+ +
Sbjct: 197 SFGILLTELTTKGR 210

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 103/194 (53%), Gaps = 7/194 (3%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSN 170
           +G+G FG V+         VA+K   P      ++F  E  VMK++ H  L+++ +  S 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 171 DDFKALVLEYMPHGSLEKCLY-LSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
           +    +V EYM  GSL   L   +   L + Q +D+   +AS + Y+        +H DL
Sbjct: 251 EPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 306
Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 289
           + +N+L+ +N+V  ++DFG+A+ L+E+++   +      I + APE    GR +   DV+
Sbjct: 307 RAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 365
Query: 290 SFGIMLMEIFTRTK 303
           SFGI+L E+ T+ +
Sbjct: 366 SFGILLTELTTKGR 379

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 103/194 (53%), Gaps = 7/194 (3%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSN 170
           +G+G FG V+         VA+K   P      ++F  E  VMK++ H  L+++ +  S 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 171 DDFKALVLEYMPHGSLEKCLY-LSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
           +    +V EYM  GSL   L   +   L + Q +D+   +AS + Y+        +H DL
Sbjct: 251 EPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 306
Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 289
           + +N+L+ +N+V  ++DFG+A+ L+E+++   +      I + APE    GR +   DV+
Sbjct: 307 RAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 365
Query: 290 SFGIMLMEIFTRTK 303
           SFGI+L E+ T+ +
Sbjct: 366 SFGILLTELTTKGR 379

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 103/194 (53%), Gaps = 7/194 (3%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSN 170
           +G+G FG V+         VA+K   P      ++F  E  VMK++ H  L+++ +  S 
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 81
Query: 171 DDFKALVLEYMPHGSLEKCLY-LSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
           +    +V EYM  GSL   L   +   L + Q +D+   +AS + Y+        +H DL
Sbjct: 82  EPI-YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYVHRDL 137
Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 289
           + +N+L+ +N+V  ++DFG+A+ L+E+++   +      I + APE    GR +   DV+
Sbjct: 138 RAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 196
Query: 290 SFGIMLMEIFTRTK 303
           SFGI+L E+ T+ +
Sbjct: 197 SFGILLTELTTKGR 210

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 104/195 (53%), Gaps = 9/195 (4%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSN 170
           +G+G FG V+         VA+K   P      ++F  E  VMK++ H  L+++ +  S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 171 DDFKALVLEYMPHGSLEKCLY--LSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCD 228
           +    +V+EYM  G L   L   +  Y L + Q +D+   +AS + Y+        +H D
Sbjct: 85  EPI-YIVMEYMSKGCLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 229 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDV 288
           L+ +N+L+ +N+V  ++DFG+A+ L+E+++   +      I + APE    GR +   DV
Sbjct: 140 LRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 289 YSFGIMLMEIFTRTK 303
           +SFGI+L E+ T+ +
Sbjct: 199 WSFGILLTELTTKGR 213

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 98/204 (48%), Gaps = 9/204 (4%)
Query: 102 PNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDI--ECDVMKRICHR 159
           P++      IG G FG V+     +  +VA+K      EGA    D   E +VM ++ H 
Sbjct: 6   PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHP 62
Query: 160 NLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFG 219
            L+++           LV E+M HG L   L     +      L + +DV   + YL   
Sbjct: 63  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE-- 120
Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
             A +IH DL   N L+ +N V  +SDFGM + +L+ DQ  + T T   + + +PE    
Sbjct: 121 -EASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSF 178
Query: 280 GRVSTNGDVYSFGIMLMEIFTRTK 303
            R S+  DV+SFG+++ E+F+  K
Sbjct: 179 SRYSSKSDVWSFGVLMWEVFSEGK 202

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 103/194 (53%), Gaps = 7/194 (3%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSN 170
           +G+G FG V+         VA+K   P      ++F  E  VMK++ H  L+++ +  S 
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 333
Query: 171 DDFKALVLEYMPHGSLEKCLY-LSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
           +    +V EYM  GSL   L   +   L + Q +D+   +AS + Y+        +H DL
Sbjct: 334 EPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 389
Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 289
           + +N+L+ +N+V  ++DFG+A+ L+E+++   +      I + APE    GR +   DV+
Sbjct: 390 RAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 448
Query: 290 SFGIMLMEIFTRTK 303
           SFGI+L E+ T+ +
Sbjct: 449 SFGILLTELTTKGR 462

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 98/204 (48%), Gaps = 9/204 (4%)
Query: 102 PNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDI--ECDVMKRICHR 159
           P++      IG G FG V+     +  +VA+K      EGA    D   E +VM ++ H 
Sbjct: 9   PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHP 65
Query: 160 NLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFG 219
            L+++           LV E+M HG L   L     +      L + +DV   + YL   
Sbjct: 66  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE-- 123
Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
             A +IH DL   N L+ +N V  +SDFGM + +L+ DQ  + T T   + + +PE    
Sbjct: 124 -EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSF 181
Query: 280 GRVSTNGDVYSFGIMLMEIFTRTK 303
            R S+  DV+SFG+++ E+F+  K
Sbjct: 182 SRYSSKSDVWSFGVLMWEVFSEGK 205

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 98/204 (48%), Gaps = 9/204 (4%)
Query: 102 PNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDI--ECDVMKRICHR 159
           P++      IG G FG V+     +  +VA+K      EGA    D   E +VM ++ H 
Sbjct: 4   PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHP 60
Query: 160 NLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFG 219
            L+++           LV E+M HG L   L     +      L + +DV   + YL   
Sbjct: 61  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE-- 118
Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
             A +IH DL   N L+ +N V  +SDFGM + +L+ DQ  + T T   + + +PE    
Sbjct: 119 -EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSF 176
Query: 280 GRVSTNGDVYSFGIMLMEIFTRTK 303
            R S+  DV+SFG+++ E+F+  K
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGK 200

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 98/204 (48%), Gaps = 9/204 (4%)
Query: 102 PNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDI--ECDVMKRICHR 159
           P++      IG G FG V+     +  +VA+K      EGA    D   E +VM ++ H 
Sbjct: 6   PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHP 62
Query: 160 NLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFG 219
            L+++           LV E+M HG L   L     +      L + +DV   + YL   
Sbjct: 63  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE-- 120
Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
             A +IH DL   N L+ +N V  +SDFGM + +L+ DQ  + T T   + + +PE    
Sbjct: 121 -EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSF 178
Query: 280 GRVSTNGDVYSFGIMLMEIFTRTK 303
            R S+  DV+SFG+++ E+F+  K
Sbjct: 179 SRYSSKSDVWSFGVLMWEVFSEGK 202

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 103/195 (52%), Gaps = 9/195 (4%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSN 170
           +G+G FG V+         VA+K   P      ++F  E  VMK++ H  L+++ +  S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 171 DDFKALVLEYMPHGSLEKCLY--LSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCD 228
           +    +V EYM  GSL   L   +  Y L + Q +D+   +AS + Y+        +H D
Sbjct: 85  EPI-YIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 229 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDV 288
           L  +N+L+ +N+V  ++DFG+A+ L+E+++   +      I + APE    GR +   DV
Sbjct: 140 LAAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 289 YSFGIMLMEIFTRTK 303
           +SFGI+L E+ T+ +
Sbjct: 199 WSFGILLTELTTKGR 213

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 103/194 (53%), Gaps = 7/194 (3%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSN 170
           +G+G FG V+         VA+K   P      ++F  E  VMK++ H  L+++ +  S 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 171 DDFKALVLEYMPHGSLEKCLY-LSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
           +    +V EYM  GSL   L   +   L + Q +D+   +AS + Y+        +H DL
Sbjct: 251 EPI-YIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 306
Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 289
           + +N+L+ +N+V  ++DFG+A+ L+E+++   +      I + APE    GR +   DV+
Sbjct: 307 RAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 365
Query: 290 SFGIMLMEIFTRTK 303
           SFGI+L E+ T+ +
Sbjct: 366 SFGILLTELTTKGR 379

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 98/204 (48%), Gaps = 9/204 (4%)
Query: 102 PNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDI--ECDVMKRICHR 159
           P++      IG G FG V+     +  +VA+K      EGA    D   E +VM ++ H 
Sbjct: 7   PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHP 63
Query: 160 NLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFG 219
            L+++           LV E+M HG L   L     +      L + +DV   + YL   
Sbjct: 64  KLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE-- 121
Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
             A +IH DL   N L+ +N V  +SDFGM + +L+ DQ  + T T   + + +PE    
Sbjct: 122 -EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSF 179
Query: 280 GRVSTNGDVYSFGIMLMEIFTRTK 303
            R S+  DV+SFG+++ E+F+  K
Sbjct: 180 SRYSSKSDVWSFGVLMWEVFSEGK 203

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 103/195 (52%), Gaps = 9/195 (4%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSN 170
           +G+G FG V+         VA+K   P      ++F  E  VMK++ H  L+++ +  S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 171 DDFKALVLEYMPHGSLEKCLY--LSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCD 228
           +    +V EYM  G L   L   +  Y L + Q +D+   +AS + Y+        +H D
Sbjct: 85  EPI-YIVTEYMSKGCLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 229 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDV 288
           L+ +N+L+ +N+V  ++DFG+A+ L+E+++   +      I + APE    GR +   DV
Sbjct: 140 LRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 289 YSFGIMLMEIFTRTK 303
           +SFGI+L E+ T+ +
Sbjct: 199 WSFGILLTELTTKGR 213

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 9/204 (4%)
Query: 102 PNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDI--ECDVMKRICHR 159
           P++      IG G FG V+     +  +VA+K      EG+    D   E +VM ++ H 
Sbjct: 26  PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIK---EGSMSEDDFIEEAEVMMKLSHP 82
Query: 160 NLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFG 219
            L+++           LV E+M HG L   L     +      L + +DV   + YL   
Sbjct: 83  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE-- 140
Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
             A +IH DL   N L+ +N V  +SDFGM + +L+ DQ  + T T   + + +PE    
Sbjct: 141 -EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSF 198
Query: 280 GRVSTNGDVYSFGIMLMEIFTRTK 303
            R S+  DV+SFG+++ E+F+  K
Sbjct: 199 SRYSSKSDVWSFGVLMWEVFSEGK 222

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 104/195 (53%), Gaps = 9/195 (4%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSN 170
           +G+G FG V+         VA+K   P    + ++F  E  VMK++ H  L+++ +  S 
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLKPG-NMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 251
Query: 171 DDFKALVLEYMPHGSLEKCLY--LSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCD 228
           +    +V EYM  GSL   L   +  Y L + Q +D+   +AS + Y+        +H D
Sbjct: 252 EPI-YIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHRD 306
Query: 229 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDV 288
           L+ +N+L+ +N+V  ++DFG+ + L+E+++   +      I + APE    GR +   DV
Sbjct: 307 LRAANILVGENLVCKVADFGLGR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 365
Query: 289 YSFGIMLMEIFTRTK 303
           +SFGI+L E+ T+ +
Sbjct: 366 WSFGILLTELTTKGR 380

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 97/214 (45%), Gaps = 24/214 (11%)
Query: 111 IGKGGFGSVYKA------IIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKI 164
           +G+G FG V+ A        +D M VAVK        A K F  E +++  + H +++K 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 165 ISSYSNDDFKALVLEYMPHGSLEKCLYL---------------SNYILDIFQRLDIMIDV 209
                + D   +V EYM HG L K L                 +   L + Q L I   +
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 210 ASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATI 269
           AS + YL    S   +H DL   N L+  N++  + DFGM++ +   D       T+  I
Sbjct: 143 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 270 GYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTK 303
            +M PE     + +T  DV+SFG++L EIFT  K
Sbjct: 200 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK 233

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 107/207 (51%), Gaps = 12/207 (5%)
Query: 102 PNDANMPPLIGKGGFGSVYKAIIQDG-----MEVAVKVFDPQY-EGAFKSFDIECDVMKR 155
           P+      +IG G FG VYK +++       + VA+K     Y E     F  E  +M +
Sbjct: 43  PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQ 102
Query: 156 ICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEY 215
             H N+I++    S      ++ EYM +G+L+K L   +    + Q + ++  +A+ ++Y
Sbjct: 103 FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKY 162
Query: 216 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMA 273
           L    +   +H DL   N+L++ N+V  +SDFG+++ +LE+D   T T +     I + A
Sbjct: 163 LA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSR-VLEDDPEATYTTSGGKIPIRWTA 218
Query: 274 PEYGREGRVSTNGDVYSFGIMLMEIFT 300
           PE     + ++  DV+SFGI++ E+ T
Sbjct: 219 PEAISYRKFTSASDVWSFGIVMWEVMT 245

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 100/194 (51%), Gaps = 7/194 (3%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSN 170
           +G G FG V+        +VA+K   P      +SF  E  +MK++ H  L+++ +  S 
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSP-ESFLEEAQIMKKLKHDKLVQLYAVVSE 75
Query: 171 DDFKALVLEYMPHGSLEKCLY-LSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
           +    +V EYM  GSL   L       L +   +D+   VA+ + Y+        IH DL
Sbjct: 76  EPI-YIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDL 131
Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 289
           + +N+L+ + ++  ++DFG+A+ L+E+++   +      I + APE    GR +   DV+
Sbjct: 132 RSANILVGNGLICKIADFGLAR-LIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVW 190
Query: 290 SFGIMLMEIFTRTK 303
           SFGI+L E+ T+ +
Sbjct: 191 SFGILLTELVTKGR 204

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 98/202 (48%), Gaps = 13/202 (6%)
Query: 110 LIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYS 169
           ++G+G FG V KA  +   +VA+K  + + E   K+F +E   + R+ H N++K+  +  
Sbjct: 16  VVGRGAFGVVCKAKWR-AKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACL 72
Query: 170 NDDFKALVLEYMPHGSLEKCLYLSNYI--LDIFQRLDIMIDVASALEYLHFGYSAPIIHC 227
           N     LV+EY   GSL   L+ +  +        +   +  +  + YLH      +IH 
Sbjct: 73  NP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHR 130
Query: 228 DLKPSNVLL-DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNG 286
           DLKP N+LL     V  + DFG A      D     T    +  +MAPE       S   
Sbjct: 131 DLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSEKC 185
Query: 287 DVYSFGIMLMEIFTRTKPTDEI 308
           DV+S+GI+L E+ TR KP DEI
Sbjct: 186 DVFSWGIILWEVITRRKPFDEI 207

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 102/206 (49%), Gaps = 17/206 (8%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFD-----PQYEGAFKSFDIECDVMKRICHRNLIKII 165
           IG G FG+VYK       +VAVK+ +     PQ   AFK+   E  V+++  H N++ + 
Sbjct: 16  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKN---EVGVLRKTRHVNIL-LF 69
Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
             YS     A+V ++    SL   L++     ++ + +DI    A  ++YLH   +  II
Sbjct: 70  MGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSII 126
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGR---EGRV 282
           H DLK +N+ L +++   + DFG+A        S    Q   +I +MAPE  R   +   
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 186
Query: 283 STNGDVYSFGIMLMEIFTRTKPTDEI 308
           S   DVY+FGI+L E+ T   P   I
Sbjct: 187 SFQSDVYAFGIVLYELMTGQLPYSNI 212

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 98/202 (48%), Gaps = 13/202 (6%)
Query: 110 LIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYS 169
           ++G+G FG V KA  +   +VA+K  + + E   K+F +E   + R+ H N++K+  +  
Sbjct: 15  VVGRGAFGVVCKAKWR-AKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACL 71
Query: 170 NDDFKALVLEYMPHGSLEKCLYLSNYI--LDIFQRLDIMIDVASALEYLHFGYSAPIIHC 227
           N     LV+EY   GSL   L+ +  +        +   +  +  + YLH      +IH 
Sbjct: 72  NP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHR 129
Query: 228 DLKPSNVLL-DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNG 286
           DLKP N+LL     V  + DFG A      D     T    +  +MAPE       S   
Sbjct: 130 DLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSEKC 184
Query: 287 DVYSFGIMLMEIFTRTKPTDEI 308
           DV+S+GI+L E+ TR KP DEI
Sbjct: 185 DVFSWGIILWEVITRRKPFDEI 206

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 102/206 (49%), Gaps = 17/206 (8%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFD-----PQYEGAFKSFDIECDVMKRICHRNLIKII 165
           IG G FG+VYK       +VAVK+ +     PQ   AFK+   E  V+++  H N++ + 
Sbjct: 36  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKN---EVGVLRKTRHVNIL-LF 89
Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
             YS     A+V ++    SL   L++     ++ + +DI    A  ++YLH   +  II
Sbjct: 90  MGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSII 146
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGR---EGRV 282
           H DLK +N+ L +++   + DFG+A        S    Q   +I +MAPE  R   +   
Sbjct: 147 HRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 206
Query: 283 STNGDVYSFGIMLMEIFTRTKPTDEI 308
           S   DVY+FGI+L E+ T   P   I
Sbjct: 207 SFQSDVYAFGIVLYELMTGQLPYSNI 232

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 102/206 (49%), Gaps = 17/206 (8%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFD-----PQYEGAFKSFDIECDVMKRICHRNLIKII 165
           IG G FG+VYK       +VAVK+ +     PQ   AFK+   E  V+++  H N++ + 
Sbjct: 44  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKN---EVGVLRKTRHVNIL-LF 97
Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
             YS     A+V ++    SL   L++     ++ + +DI    A  ++YLH   +  II
Sbjct: 98  MGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSII 154
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGR---EGRV 282
           H DLK +N+ L +++   + DFG+A        S    Q   +I +MAPE  R   +   
Sbjct: 155 HRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 214
Query: 283 STNGDVYSFGIMLMEIFTRTKPTDEI 308
           S   DVY+FGI+L E+ T   P   I
Sbjct: 215 SFQSDVYAFGIVLYELMTGQLPYSNI 240

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 102/206 (49%), Gaps = 17/206 (8%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFD-----PQYEGAFKSFDIECDVMKRICHRNLIKII 165
           IG G FG+VYK       +VAVK+ +     PQ   AFK+   E  V+++  H N++ + 
Sbjct: 16  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKN---EVGVLRKTRHVNIL-LF 69
Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
             YS     A+V ++    SL   L++     ++ + +DI    A  ++YLH   +  II
Sbjct: 70  MGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSII 126
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGR---EGRV 282
           H DLK +N+ L +++   + DFG+A        S    Q   +I +MAPE  R   +   
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 186
Query: 283 STNGDVYSFGIMLMEIFTRTKPTDEI 308
           S   DVY+FGI+L E+ T   P   I
Sbjct: 187 SFQSDVYAFGIVLYELMTGQLPYSNI 212

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 102/206 (49%), Gaps = 17/206 (8%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFD-----PQYEGAFKSFDIECDVMKRICHRNLIKII 165
           IG G FG+VYK       +VAVK+ +     PQ   AFK+   E  V+++  H N++ + 
Sbjct: 21  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKN---EVGVLRKTRHVNIL-LF 74
Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
             YS     A+V ++    SL   L++     ++ + +DI    A  ++YLH   +  II
Sbjct: 75  MGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSII 131
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGR---EGRV 282
           H DLK +N+ L +++   + DFG+A        S    Q   +I +MAPE  R   +   
Sbjct: 132 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 191
Query: 283 STNGDVYSFGIMLMEIFTRTKPTDEI 308
           S   DVY+FGI+L E+ T   P   I
Sbjct: 192 SFQSDVYAFGIVLYELMTGQLPYSNI 217

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 102/206 (49%), Gaps = 17/206 (8%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFD-----PQYEGAFKSFDIECDVMKRICHRNLIKII 165
           IG G FG+VYK       +VAVK+ +     PQ   AFK+   E  V+++  H N++ + 
Sbjct: 18  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKN---EVGVLRKTRHVNIL-LF 71
Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
             YS     A+V ++    SL   L++     ++ + +DI    A  ++YLH   +  II
Sbjct: 72  MGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSII 128
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGR---EGRV 282
           H DLK +N+ L +++   + DFG+A        S    Q   +I +MAPE  R   +   
Sbjct: 129 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 188
Query: 283 STNGDVYSFGIMLMEIFTRTKPTDEI 308
           S   DVY+FGI+L E+ T   P   I
Sbjct: 189 SFQSDVYAFGIVLYELMTGQLPYSNI 214

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 102/206 (49%), Gaps = 17/206 (8%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFD-----PQYEGAFKSFDIECDVMKRICHRNLIKII 165
           IG G FG+VYK       +VAVK+ +     PQ   AFK+   E  V+++  H N++ + 
Sbjct: 21  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKN---EVGVLRKTRHVNIL-LF 74
Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
             YS     A+V ++    SL   L++     ++ + +DI    A  ++YLH   +  II
Sbjct: 75  MGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSII 131
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGR---EGRV 282
           H DLK +N+ L +++   + DFG+A        S    Q   +I +MAPE  R   +   
Sbjct: 132 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 191
Query: 283 STNGDVYSFGIMLMEIFTRTKPTDEI 308
           S   DVY+FGI+L E+ T   P   I
Sbjct: 192 SFQSDVYAFGIVLYELMTGQLPYSNI 217

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 102/206 (49%), Gaps = 17/206 (8%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFD-----PQYEGAFKSFDIECDVMKRICHRNLIKII 165
           IG G FG+VYK       +VAVK+ +     PQ   AFK+   E  V+++  H N++ + 
Sbjct: 44  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKN---EVGVLRKTRHVNIL-LF 97
Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
             YS     A+V ++    SL   L++     ++ + +DI    A  ++YLH   +  II
Sbjct: 98  MGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSII 154
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGR---EGRV 282
           H DLK +N+ L +++   + DFG+A        S    Q   +I +MAPE  R   +   
Sbjct: 155 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 214
Query: 283 STNGDVYSFGIMLMEIFTRTKPTDEI 308
           S   DVY+FGI+L E+ T   P   I
Sbjct: 215 SFQSDVYAFGIVLYELMTGQLPYSNI 240

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 102/206 (49%), Gaps = 17/206 (8%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFD-----PQYEGAFKSFDIECDVMKRICHRNLIKII 165
           IG G FG+VYK       +VAVK+ +     PQ   AFK+   E  V+++  H N++ + 
Sbjct: 43  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKN---EVGVLRKTRHVNIL-LF 96
Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
             YS     A+V ++    SL   L++     ++ + +DI    A  ++YLH   +  II
Sbjct: 97  MGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSII 153
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGR---EGRV 282
           H DLK +N+ L +++   + DFG+A        S    Q   +I +MAPE  R   +   
Sbjct: 154 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 213
Query: 283 STNGDVYSFGIMLMEIFTRTKPTDEI 308
           S   DVY+FGI+L E+ T   P   I
Sbjct: 214 SFQSDVYAFGIVLYELMTGQLPYSNI 239

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 102/206 (49%), Gaps = 17/206 (8%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFD-----PQYEGAFKSFDIECDVMKRICHRNLIKII 165
           IG G FG+VYK       +VAVK+ +     PQ   AFK+   E  V+++  H N++ + 
Sbjct: 16  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKN---EVGVLRKTRHVNIL-LF 69
Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
             YS     A+V ++    SL   L++     ++ + +DI    A  ++YLH   +  II
Sbjct: 70  MGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSII 126
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGR---EGRV 282
           H DLK +N+ L +++   + DFG+A        S    Q   +I +MAPE  R   +   
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 186
Query: 283 STNGDVYSFGIMLMEIFTRTKPTDEI 308
           S   DVY+FGI+L E+ T   P   I
Sbjct: 187 SFQSDVYAFGIVLYELMTGQLPYSNI 212

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 95/211 (45%), Gaps = 21/211 (9%)
Query: 111 IGKGGFGSVYKAII------QDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKI 164
           +G+G FG V+ A        QD + VAVK      + A K F  E +++  + H +++K 
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 165 ISSYSNDDFKALVLEYMPHGSLEKCLYLSN------------YILDIFQRLDIMIDVASA 212
                  D   +V EYM HG L K L                  L   Q L I   +A+ 
Sbjct: 81  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAG 140
Query: 213 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYM 272
           + YL    S   +H DL   N L+ +N++  + DFGM++ +   D       T+  I +M
Sbjct: 141 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 197
Query: 273 APEYGREGRVSTNGDVYSFGIMLMEIFTRTK 303
            PE     + +T  DV+S G++L EIFT  K
Sbjct: 198 PPESIMYRKFTTESDVWSLGVVLWEIFTYGK 228

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 100/216 (46%), Gaps = 29/216 (13%)
Query: 111 IGKGGFGSVYKAII------QDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKI 164
           +G+G FG V+ A        QD M VAVK      E A + F  E +++  + H+++++ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 165 ISSYSNDDFKALVLEYMPHGSLEKCLY--------------LSNYILDIFQRLDIMIDVA 210
               +      +V EYM HG L + L               ++   L + Q L +   VA
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 211 SALEYL---HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA 267
           + + YL   HF      +H DL   N L+   +V  + DFGM++ +   D      +T+ 
Sbjct: 169 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222
Query: 268 TIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTK 303
            I +M PE     + +T  DV+SFG++L EIFT  K
Sbjct: 223 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGK 258

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 100/216 (46%), Gaps = 29/216 (13%)
Query: 111 IGKGGFGSVYKAII------QDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKI 164
           +G+G FG V+ A        QD M VAVK      E A + F  E +++  + H+++++ 
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 165 ISSYSNDDFKALVLEYMPHGSLEKCLY--------------LSNYILDIFQRLDIMIDVA 210
               +      +V EYM HG L + L               ++   L + Q L +   VA
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 211 SALEYL---HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA 267
           + + YL   HF      +H DL   N L+   +V  + DFGM++ +   D      +T+ 
Sbjct: 146 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 199
Query: 268 TIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTK 303
            I +M PE     + +T  DV+SFG++L EIFT  K
Sbjct: 200 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGK 235

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 100/216 (46%), Gaps = 29/216 (13%)
Query: 111 IGKGGFGSVYKAII------QDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKI 164
           +G+G FG V+ A        QD M VAVK      E A + F  E +++  + H+++++ 
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 165 ISSYSNDDFKALVLEYMPHGSLEKCLY--------------LSNYILDIFQRLDIMIDVA 210
               +      +V EYM HG L + L               ++   L + Q L +   VA
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 211 SALEYL---HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA 267
           + + YL   HF      +H DL   N L+   +V  + DFGM++ +   D      +T+ 
Sbjct: 140 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 193
Query: 268 TIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTK 303
            I +M PE     + +T  DV+SFG++L EIFT  K
Sbjct: 194 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGK 229

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 72/236 (30%), Positives = 113/236 (47%), Gaps = 46/236 (19%)
Query: 111 IGKGGFGSVYKAIIQD---GMEVAVK-VFDP--QYEGAFKSFDIECDVMKRICHRNLIKI 164
           +G GG  +VY A  +D    ++VA+K +F P  + E   K F+ E     ++ H+N++ +
Sbjct: 19  LGGGGMSTVYLA--EDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 165 ISSYSNDDFKALVLEYM----------PHG--SLEKCLYLSNYILDIFQRLDIMIDVASA 212
           I     DD   LV+EY+           HG  S++  +  +N ILD              
Sbjct: 77  IDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILD-------------G 123
Query: 213 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT-QTLATIGY 271
           +++ H      I+H D+KP N+L+D N    + DFG+AK L E   SLTQT   L T+ Y
Sbjct: 124 IKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE--TSLTQTNHVLGTVQY 178
Query: 272 MAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLK---RWVNDLLP 324
            +PE  +        D+YS GI+L E+     P    F+GE  +    + + D +P
Sbjct: 179 FSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP----FNGETAVSIAIKHIQDSVP 230

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 67/192 (34%), Positives = 98/192 (51%), Gaps = 13/192 (6%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSN 170
           IGKG FG V     + G +VAVK    + +   ++F  E  VM ++ H NL++++     
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 171 DDFKA-LVLEYMPHGSLEKCLY-LSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCD 228
           +     +V EYM  GSL   L      +L     L   +DV  A+EYL        +H D
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRD 127
Query: 229 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDV 288
           L   NVL+ ++ VA +SDFG+ K     + S TQ      + + APE  RE + ST  DV
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSDV 182
Query: 289 YSFGIMLMEIFT 300
           +SFGI+L EI++
Sbjct: 183 WSFGILLWEIYS 194

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 100/206 (48%), Gaps = 17/206 (8%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFD-----PQYEGAFKSFDIECDVMKRICHRNLIKII 165
           IG G FG+VYK       +VAVK+ +     PQ   AFK+   E  V+++  H N++ + 
Sbjct: 32  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKN---EVGVLRKTRHVNIL-LF 85
Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
             YS     A+V ++    SL   L+ S    ++ + +DI    A  ++YLH   +  II
Sbjct: 86  MGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSII 142
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGR---EGRV 282
           H DLK +N+ L ++    + DFG+A        S    Q   +I +MAPE  R       
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 283 STNGDVYSFGIMLMEIFTRTKPTDEI 308
           S   DVY+FGI+L E+ T   P   I
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLPYSNI 228

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 67/192 (34%), Positives = 98/192 (51%), Gaps = 13/192 (6%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSN 170
           IGKG FG V     + G +VAVK    + +   ++F  E  VM ++ H NL++++     
Sbjct: 29  IGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 171 DDFKA-LVLEYMPHGSLEKCLY-LSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCD 228
           +     +V EYM  GSL   L      +L     L   +DV  A+EYL        +H D
Sbjct: 86  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRD 142
Query: 229 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDV 288
           L   NVL+ ++ VA +SDFG+ K     + S TQ      + + APE  RE + ST  DV
Sbjct: 143 LAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSDV 197
Query: 289 YSFGIMLMEIFT 300
           +SFGI+L EI++
Sbjct: 198 WSFGILLWEIYS 209

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 102/200 (51%), Gaps = 15/200 (7%)
Query: 111 IGKGGFGSVYKAI---IQD--GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIK-- 163
           +GKG FGSV       +QD  G  VAVK      E   + F+ E +++K + H N++K  
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 164 -IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSA 222
            +  S    + K L++EY+P+GSL   L      +D  + L     +   +EYL    + 
Sbjct: 82  GVCYSAGRRNLK-LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TK 137
Query: 223 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT--LATIGYMAPEYGREG 280
             IH DL   N+L+++     + DFG+ K +L +D+   + +    + I + APE   E 
Sbjct: 138 RYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPESLTES 196
Query: 281 RVSTNGDVYSFGIMLMEIFT 300
           + S   DV+SFG++L E+FT
Sbjct: 197 KFSVASDVWSFGVVLYELFT 216

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 102/200 (51%), Gaps = 15/200 (7%)
Query: 111 IGKGGFGSVYKAI---IQD--GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIK-- 163
           +GKG FGSV       +QD  G  VAVK      E   + F+ E +++K + H N++K  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 164 -IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSA 222
            +  S    + K L++EY+P+GSL   L      +D  + L     +   +EYL    + 
Sbjct: 81  GVCYSAGRRNLK-LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TK 136
Query: 223 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT--LATIGYMAPEYGREG 280
             IH DL   N+L+++     + DFG+ K +L +D+   + +    + I + APE   E 
Sbjct: 137 RYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPESLTES 195
Query: 281 RVSTNGDVYSFGIMLMEIFT 300
           + S   DV+SFG++L E+FT
Sbjct: 196 KFSVASDVWSFGVVLYELFT 215

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 100/206 (48%), Gaps = 17/206 (8%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFD-----PQYEGAFKSFDIECDVMKRICHRNLIKII 165
           IG G FG+VYK       +VAVK+ +     PQ   AFK+   E  V+++  H N++ + 
Sbjct: 32  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKN---EVGVLRKTRHVNIL-LF 85
Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
             YS     A+V ++    SL   L+ S    ++ + +DI    A  ++YLH   +  II
Sbjct: 86  MGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSII 142
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGR---EGRV 282
           H DLK +N+ L ++    + DFG+A        S    Q   +I +MAPE  R       
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 283 STNGDVYSFGIMLMEIFTRTKPTDEI 308
           S   DVY+FGI+L E+ T   P   I
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLPYSNI 228

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 102/200 (51%), Gaps = 15/200 (7%)
Query: 111 IGKGGFGSVYKAI---IQD--GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIK-- 163
           +GKG FGSV       +QD  G  VAVK      E   + F+ E +++K + H N++K  
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 164 -IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSA 222
            +  S    + K L++EY+P+GSL   L      +D  + L     +   +EYL    + 
Sbjct: 96  GVCYSAGRRNLK-LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TK 151
Query: 223 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT--LATIGYMAPEYGREG 280
             IH DL   N+L+++     + DFG+ K +L +D+   + +    + I + APE   E 
Sbjct: 152 RYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPESLTES 210
Query: 281 RVSTNGDVYSFGIMLMEIFT 300
           + S   DV+SFG++L E+FT
Sbjct: 211 KFSVASDVWSFGVVLYELFT 230

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/192 (34%), Positives = 98/192 (51%), Gaps = 13/192 (6%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSN 170
           IGKG FG V     + G +VAVK    + +   ++F  E  VM ++ H NL++++     
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 171 DDFK-ALVLEYMPHGSLEKCLY-LSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCD 228
           +     +V EYM  GSL   L      +L     L   +DV  A+EYL        +H D
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRD 314
Query: 229 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDV 288
           L   NVL+ ++ VA +SDFG+ K     + S TQ      + + APE  RE + ST  DV
Sbjct: 315 LAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSDV 369
Query: 289 YSFGIMLMEIFT 300
           +SFGI+L EI++
Sbjct: 370 WSFGILLWEIYS 381

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 102/200 (51%), Gaps = 15/200 (7%)
Query: 111 IGKGGFGSVYKAI---IQD--GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIK-- 163
           +GKG FGSV       +QD  G  VAVK      E   + F+ E +++K + H N++K  
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 164 -IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSA 222
            +  S    + K L++EY+P+GSL   L      +D  + L     +   +EYL    + 
Sbjct: 83  GVCYSAGRRNLK-LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TK 138
Query: 223 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT--LATIGYMAPEYGREG 280
             IH DL   N+L+++     + DFG+ K +L +D+   + +    + I + APE   E 
Sbjct: 139 RYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPESLTES 197
Query: 281 RVSTNGDVYSFGIMLMEIFT 300
           + S   DV+SFG++L E+FT
Sbjct: 198 KFSVASDVWSFGVVLYELFT 217

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 102/200 (51%), Gaps = 15/200 (7%)
Query: 111 IGKGGFGSVYKAI---IQD--GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIK-- 163
           +GKG FGSV       +QD  G  VAVK      E   + F+ E +++K + H N++K  
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 164 -IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSA 222
            +  S    + K L++EY+P+GSL   L      +D  + L     +   +EYL    + 
Sbjct: 77  GVCYSAGRRNLK-LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TK 132
Query: 223 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT--LATIGYMAPEYGREG 280
             IH DL   N+L+++     + DFG+ K +L +D+   + +    + I + APE   E 
Sbjct: 133 RYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPESLTES 191
Query: 281 RVSTNGDVYSFGIMLMEIFT 300
           + S   DV+SFG++L E+FT
Sbjct: 192 KFSVASDVWSFGVVLYELFT 211

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 102/200 (51%), Gaps = 15/200 (7%)
Query: 111 IGKGGFGSVYKAI---IQD--GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIK-- 163
           +GKG FGSV       +QD  G  VAVK      E   + F+ E +++K + H N++K  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 164 -IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSA 222
            +  S    + K L++EY+P+GSL   L      +D  + L     +   +EYL    + 
Sbjct: 78  GVCYSAGRRNLK-LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TK 133
Query: 223 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT--LATIGYMAPEYGREG 280
             IH DL   N+L+++     + DFG+ K +L +D+   + +    + I + APE   E 
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEFFKVKEPGESPIFWYAPESLTES 192
Query: 281 RVSTNGDVYSFGIMLMEIFT 300
           + S   DV+SFG++L E+FT
Sbjct: 193 KFSVASDVWSFGVVLYELFT 212

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 102/200 (51%), Gaps = 15/200 (7%)
Query: 111 IGKGGFGSVYKAI---IQD--GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIK-- 163
           +GKG FGSV       +QD  G  VAVK      E   + F+ E +++K + H N++K  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 164 -IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSA 222
            +  S    + K L++EY+P+GSL   L      +D  + L     +   +EYL    + 
Sbjct: 78  GVCYSAGRRNLK-LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TK 133
Query: 223 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT--LATIGYMAPEYGREG 280
             IH DL   N+L+++     + DFG+ K +L +D+   + +    + I + APE   E 
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPESLTES 192
Query: 281 RVSTNGDVYSFGIMLMEIFT 300
           + S   DV+SFG++L E+FT
Sbjct: 193 KFSVASDVWSFGVVLYELFT 212

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 102/200 (51%), Gaps = 15/200 (7%)
Query: 111 IGKGGFGSVYKAI---IQD--GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIK-- 163
           +GKG FGSV       +QD  G  VAVK      E   + F+ E +++K + H N++K  
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 164 -IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSA 222
            +  S    + K L++EY+P+GSL   L      +D  + L     +   +EYL    + 
Sbjct: 76  GVCYSAGRRNLK-LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TK 131
Query: 223 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT--LATIGYMAPEYGREG 280
             IH DL   N+L+++     + DFG+ K +L +D+   + +    + I + APE   E 
Sbjct: 132 RYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPESLTES 190
Query: 281 RVSTNGDVYSFGIMLMEIFT 300
           + S   DV+SFG++L E+FT
Sbjct: 191 KFSVASDVWSFGVVLYELFT 210

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/192 (34%), Positives = 97/192 (50%), Gaps = 13/192 (6%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSN 170
           IGKG FG V     + G +VAVK    + +   ++F  E  VM ++ H NL++++     
Sbjct: 20  IGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 76
Query: 171 DDFKA-LVLEYMPHGSLEKCLY-LSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCD 228
           +     +V EYM  GSL   L      +L     L   +DV  A+EYL        +H D
Sbjct: 77  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRD 133
Query: 229 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDV 288
           L   NVL+ ++ VA +SDFG+ K     + S TQ      + + APE  RE   ST  DV
Sbjct: 134 LAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREAAFSTKSDV 188
Query: 289 YSFGIMLMEIFT 300
           +SFGI+L EI++
Sbjct: 189 WSFGILLWEIYS 200

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 102/200 (51%), Gaps = 15/200 (7%)
Query: 111 IGKGGFGSVYKAI---IQD--GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIK-- 163
           +GKG FGSV       +QD  G  VAVK      E   + F+ E +++K + H N++K  
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 164 -IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSA 222
            +  S    + K L++EY+P+GSL   L      +D  + L     +   +EYL    + 
Sbjct: 84  GVCYSAGRRNLK-LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TK 139
Query: 223 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT--LATIGYMAPEYGREG 280
             IH DL   N+L+++     + DFG+ K +L +D+   + +    + I + APE   E 
Sbjct: 140 RYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPESLTES 198
Query: 281 RVSTNGDVYSFGIMLMEIFT 300
           + S   DV+SFG++L E+FT
Sbjct: 199 KFSVASDVWSFGVVLYELFT 218

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 102/200 (51%), Gaps = 15/200 (7%)
Query: 111 IGKGGFGSVYKAI---IQD--GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIK-- 163
           +GKG FGSV       +QD  G  VAVK      E   + F+ E +++K + H N++K  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 164 -IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSA 222
            +  S    + K L++EY+P+GSL   L      +D  + L     +   +EYL    + 
Sbjct: 78  GVCYSAGRRNLK-LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TK 133
Query: 223 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT--LATIGYMAPEYGREG 280
             IH DL   N+L+++     + DFG+ K +L +D+   + +    + I + APE   E 
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPESLTES 192
Query: 281 RVSTNGDVYSFGIMLMEIFT 300
           + S   DV+SFG++L E+FT
Sbjct: 193 KFSVASDVWSFGVVLYELFT 212

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 102/200 (51%), Gaps = 15/200 (7%)
Query: 111 IGKGGFGSVYKAI---IQD--GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIK-- 163
           +GKG FGSV       +QD  G  VAVK      E   + F+ E +++K + H N++K  
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 164 -IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSA 222
            +  S    + K L++EY+P+GSL   L      +D  + L     +   +EYL    + 
Sbjct: 109 GVCYSAGRRNLK-LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TK 164
Query: 223 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT--LATIGYMAPEYGREG 280
             IH DL   N+L+++     + DFG+ K +L +D+   + +    + I + APE   E 
Sbjct: 165 RYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPESLTES 223
Query: 281 RVSTNGDVYSFGIMLMEIFT 300
           + S   DV+SFG++L E+FT
Sbjct: 224 KFSVASDVWSFGVVLYELFT 243

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 102/200 (51%), Gaps = 15/200 (7%)
Query: 111 IGKGGFGSVYKAI---IQD--GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIK-- 163
           +GKG FGSV       +QD  G  VAVK      E   + F+ E +++K + H N++K  
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 164 -IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSA 222
            +  S    + K L++EY+P+GSL   L      +D  + L     +   +EYL    + 
Sbjct: 96  GVCYSAGRRNLK-LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TK 151
Query: 223 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT--LATIGYMAPEYGREG 280
             IH DL   N+L+++     + DFG+ K +L +D+   + +    + I + APE   E 
Sbjct: 152 RYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPESLTES 210
Query: 281 RVSTNGDVYSFGIMLMEIFT 300
           + S   DV+SFG++L E+FT
Sbjct: 211 KFSVASDVWSFGVVLYELFT 230

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 102/200 (51%), Gaps = 15/200 (7%)
Query: 111 IGKGGFGSVYKAI---IQD--GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIK-- 163
           +GKG FGSV       +QD  G  VAVK      E   + F+ E +++K + H N++K  
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 164 -IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSA 222
            +  S    + K L++EY+P+GSL   L      +D  + L     +   +EYL    + 
Sbjct: 85  GVCYSAGRRNLK-LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TK 140
Query: 223 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT--LATIGYMAPEYGREG 280
             IH DL   N+L+++     + DFG+ K +L +D+   + +    + I + APE   E 
Sbjct: 141 RYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPESLTES 199
Query: 281 RVSTNGDVYSFGIMLMEIFT 300
           + S   DV+SFG++L E+FT
Sbjct: 200 KFSVASDVWSFGVVLYELFT 219

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 100/206 (48%), Gaps = 17/206 (8%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFD-----PQYEGAFKSFDIECDVMKRICHRNLIKII 165
           IG G FG+VYK       +VAVK+ +     PQ   AFK+   E  V+++  H N++ + 
Sbjct: 20  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKN---EVGVLRKTRHVNIL-LF 73
Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
             YS     A+V ++    SL   L+ S    ++ + +DI    A  ++YLH   +  II
Sbjct: 74  MGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSII 130
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGR---EGRV 282
           H DLK +N+ L ++    + DFG+A        S    Q   +I +MAPE  R       
Sbjct: 131 HRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 190
Query: 283 STNGDVYSFGIMLMEIFTRTKPTDEI 308
           S   DVY+FGI+L E+ T   P   I
Sbjct: 191 SFQSDVYAFGIVLYELMTGQLPYSNI 216

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 102/200 (51%), Gaps = 15/200 (7%)
Query: 111 IGKGGFGSVYKAI---IQD--GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIK-- 163
           +GKG FGSV       +QD  G  VAVK      E   + F+ E +++K + H N++K  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 164 -IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSA 222
            +  S    + K L++EY+P+GSL   L      +D  + L     +   +EYL    + 
Sbjct: 81  GVCYSAGRRNLK-LIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLG---TK 136
Query: 223 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT--LATIGYMAPEYGREG 280
             IH DL   N+L+++     + DFG+ K +L +D+   + +    + I + APE   E 
Sbjct: 137 RYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPESLTES 195
Query: 281 RVSTNGDVYSFGIMLMEIFT 300
           + S   DV+SFG++L E+FT
Sbjct: 196 KFSVASDVWSFGVVLYELFT 215

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 102/194 (52%), Gaps = 7/194 (3%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSN 170
           +G G FG V+        +VAVK    Q   +  +F  E ++MK++ H+ L+++ +  + 
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 88
Query: 171 DDFKALVLEYMPHGSLEKCLYLSNYI-LDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
           +    ++ EYM +GSL   L   + I L I + LD+   +A  + ++        IH DL
Sbjct: 89  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 144
Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 289
           + +N+L+ D +   ++DFG+A+ L+E+++   +      I + APE    G  +   DV+
Sbjct: 145 RAANILVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 203
Query: 290 SFGIMLMEIFTRTK 303
           SFGI+L EI T  +
Sbjct: 204 SFGILLTEIVTHGR 217

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 102/194 (52%), Gaps = 7/194 (3%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSN 170
           +G G FG V+        +VAVK    Q   +  +F  E ++MK++ H+ L+++ +  + 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 171 DDFKALVLEYMPHGSLEKCLYLSNYI-LDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
           +    ++ EYM +GSL   L   + I L I + LD+   +A  + ++        IH DL
Sbjct: 80  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 135
Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 289
           + +N+L+ D +   ++DFG+A+ L+E+++   +      I + APE    G  +   DV+
Sbjct: 136 RAANILVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 194
Query: 290 SFGIMLMEIFTRTK 303
           SFGI+L EI T  +
Sbjct: 195 SFGILLTEIVTHGR 208

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 102/194 (52%), Gaps = 7/194 (3%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSN 170
           +G G FG V+        +VAVK    Q   +  +F  E ++MK++ H+ L+++ +  + 
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 87
Query: 171 DDFKALVLEYMPHGSLEKCLYLSNYI-LDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
           +    ++ EYM +GSL   L   + I L I + LD+   +A  + ++        IH DL
Sbjct: 88  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 143
Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 289
           + +N+L+ D +   ++DFG+A+ L+E+++   +      I + APE    G  +   DV+
Sbjct: 144 RAANILVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 202
Query: 290 SFGIMLMEIFTRTK 303
           SFGI+L EI T  +
Sbjct: 203 SFGILLTEIVTHGR 216

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 102/194 (52%), Gaps = 7/194 (3%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSN 170
           +G G FG V+        +VAVK    Q   +  +F  E ++MK++ H+ L+++ +  + 
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 85
Query: 171 DDFKALVLEYMPHGSLEKCLYLSNYI-LDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
           +    ++ EYM +GSL   L   + I L I + LD+   +A  + ++        IH DL
Sbjct: 86  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 141
Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 289
           + +N+L+ D +   ++DFG+A+ L+E+++   +      I + APE    G  +   DV+
Sbjct: 142 RAANILVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 200
Query: 290 SFGIMLMEIFTRTK 303
           SFGI+L EI T  +
Sbjct: 201 SFGILLTEIVTHGR 214

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 102/194 (52%), Gaps = 7/194 (3%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSN 170
           +G G FG V+        +VAVK    Q   +  +F  E ++MK++ H+ L+++ +  + 
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 81
Query: 171 DDFKALVLEYMPHGSLEKCLYLSNYI-LDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
           +    ++ EYM +GSL   L   + I L I + LD+   +A  + ++        IH DL
Sbjct: 82  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 137
Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 289
           + +N+L+ D +   ++DFG+A+ L+E+++   +      I + APE    G  +   DV+
Sbjct: 138 RAANILVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 196
Query: 290 SFGIMLMEIFTRTK 303
           SFGI+L EI T  +
Sbjct: 197 SFGILLTEIVTHGR 210

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 102/194 (52%), Gaps = 7/194 (3%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSN 170
           +G G FG V+        +VAVK    Q   +  +F  E ++MK++ H+ L+++ +  + 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 171 DDFKALVLEYMPHGSLEKCLYLSNYI-LDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
           +    ++ EYM +GSL   L   + I L I + LD+   +A  + ++        IH DL
Sbjct: 80  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 135
Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 289
           + +N+L+ D +   ++DFG+A+ L+E+++   +      I + APE    G  +   DV+
Sbjct: 136 RAANILVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 194
Query: 290 SFGIMLMEIFTRTK 303
           SFGI+L EI T  +
Sbjct: 195 SFGILLTEIVTHGR 208

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 103/200 (51%), Gaps = 15/200 (7%)
Query: 111 IGKGGFGSVYKAI---IQD--GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIK-- 163
           +GKG FGSV       +QD  G  VAVK      E   + F+ E +++K + H N++K  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 164 -IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSA 222
            +  S    + K L++E++P+GSL + L      +D  + L     +   +EYL    + 
Sbjct: 81  GVCYSAGRRNLK-LIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYLG---TK 136
Query: 223 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT--LATIGYMAPEYGREG 280
             IH DL   N+L+++     + DFG+ K +L +D+   + +    + I + APE   E 
Sbjct: 137 RYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPESLTES 195
Query: 281 RVSTNGDVYSFGIMLMEIFT 300
           + S   DV+SFG++L E+FT
Sbjct: 196 KFSVASDVWSFGVVLYELFT 215

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 102/194 (52%), Gaps = 7/194 (3%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSN 170
           +G G FG V+        +VAVK    Q   +  +F  E ++MK++ H+ L+++ +  + 
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 80
Query: 171 DDFKALVLEYMPHGSLEKCLYLSNYI-LDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
           +    ++ EYM +GSL   L   + I L I + LD+   +A  + ++        IH DL
Sbjct: 81  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 136
Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 289
           + +N+L+ D +   ++DFG+A+ L+E+++   +      I + APE    G  +   DV+
Sbjct: 137 RAANILVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 195
Query: 290 SFGIMLMEIFTRTK 303
           SFGI+L EI T  +
Sbjct: 196 SFGILLTEIVTHGR 209

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 108/218 (49%), Gaps = 15/218 (6%)
Query: 95  QKRGKPLPNDANMPPL--------IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSF 146
           QK  KP   D    P         +G G FG V+        +VAVK    Q   +  +F
Sbjct: 2   QKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAF 60
Query: 147 DIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYI-LDIFQRLDI 205
             E ++MK++ H+ L+++ +  + +    ++ EYM +GSL   L   + I L I + LD+
Sbjct: 61  LAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDM 119
Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              +A  + ++        IH DL+ +N+L+ D +   ++DFG+A+ L+E+++   +   
Sbjct: 120 AAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGA 175
Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTK 303
              I + APE    G  +   DV+SFGI+L EI T  +
Sbjct: 176 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 213

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 108/218 (49%), Gaps = 15/218 (6%)
Query: 95  QKRGKPLPNDANMPPL--------IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSF 146
           QK  KP   D    P         +G G FG V+        +VAVK    Q   +  +F
Sbjct: 3   QKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAF 61
Query: 147 DIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYI-LDIFQRLDI 205
             E ++MK++ H+ L+++ +  + +    ++ EYM +GSL   L   + I L I + LD+
Sbjct: 62  LAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDM 120
Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              +A  + ++        IH DL+ +N+L+ D +   ++DFG+A+ L+E+++   +   
Sbjct: 121 AAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGA 176
Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTK 303
              I + APE    G  +   DV+SFGI+L EI T  +
Sbjct: 177 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 214

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 94/207 (45%), Gaps = 19/207 (9%)
Query: 110 LIGKGGFGSVYKAIIQDGMEVAVKVF----DPQYEGAFKSFDIECDVMKRICHRNLIKII 165
           +IG GGFG VY+A    G EVAVK      D       ++   E  +   + H N+I + 
Sbjct: 14  IIGIGGFGKVYRAF-WIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
                +    LV+E+   G L + L       DI   ++  + +A  + YLH     PII
Sbjct: 73  GVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDIL--VNWAVQIARGMNYLHDEAIVPII 130
Query: 226 HCDLKPSNVLLDD--------NMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYG 277
           H DLK SN+L+          N +  ++DFG+A+    E    T+        +MAPE  
Sbjct: 131 HRDLKSSNILILQKVENGDLSNKILKITDFGLAR----EWHRTTKMSAAGAYAWMAPEVI 186
Query: 278 REGRVSTNGDVYSFGIMLMEIFTRTKP 304
           R    S   DV+S+G++L E+ T   P
Sbjct: 187 RASMFSKGSDVWSYGVLLWELLTGEVP 213

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 110/221 (49%), Gaps = 15/221 (6%)
Query: 92  LRYQKRGKPLPNDANMPPL--------IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAF 143
           ++ QK  KP   D    P         +G G FG V+        +VAVK    Q   + 
Sbjct: 4   MQTQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSP 62
Query: 144 KSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYI-LDIFQR 202
            +F  E ++MK++ H+ L+++ +  + +    ++ EYM +GSL   L   + I L I + 
Sbjct: 63  DAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKL 121
Query: 203 LDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ 262
           LD+   +A  + ++        IH DL+ +N+L+ D +   ++DFG+A+ L+E+++   +
Sbjct: 122 LDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLAR-LIEDNEYTAR 177
Query: 263 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTK 303
                 I + APE    G  +   DV+SFGI+L EI T  +
Sbjct: 178 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 218

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 102/194 (52%), Gaps = 7/194 (3%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSN 170
           +G G FG V+        +VAVK    Q   +  +F  E ++MK++ H+ L+++ +  + 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 171 DDFKALVLEYMPHGSLEKCLYLSNYI-LDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
           +    ++ EYM +GSL   L   + I L I + LD+   +A  + ++        IH DL
Sbjct: 80  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 135
Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 289
           + +N+L+ D +   ++DFG+A+ L+E+++   +      I + APE    G  +   DV+
Sbjct: 136 RAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 194
Query: 290 SFGIMLMEIFTRTK 303
           SFGI+L EI T  +
Sbjct: 195 SFGILLTEIVTHGR 208

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 102/194 (52%), Gaps = 7/194 (3%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSN 170
           +G G FG V+        +VAVK    Q   +  +F  E ++MK++ H+ L+++ +  + 
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 74
Query: 171 DDFKALVLEYMPHGSLEKCLYLSNYI-LDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
           +    ++ EYM +GSL   L   + I L I + LD+   +A  + ++        IH DL
Sbjct: 75  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 130
Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 289
           + +N+L+ D +   ++DFG+A+ L+E+++   +      I + APE    G  +   DV+
Sbjct: 131 RAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 189
Query: 290 SFGIMLMEIFTRTK 303
           SFGI+L EI T  +
Sbjct: 190 SFGILLTEIVTHGR 203

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 102/200 (51%), Gaps = 15/200 (7%)
Query: 111 IGKGGFGSVYKAI---IQD--GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIK-- 163
           +GKG FGSV       +QD  G  VAVK      E   + F+ E +++K + H N++K  
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 78
Query: 164 -IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSA 222
            +  S    + K L++EY+P+GSL   L      +D  + L     +   +EYL    + 
Sbjct: 79  GVCYSAGRRNLK-LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TK 134
Query: 223 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT--LATIGYMAPEYGREG 280
             IH +L   N+L+++     + DFG+ K +L +D+   + +    + I + APE   E 
Sbjct: 135 RYIHRNLATRNILVENENRVKIGDFGLTK-VLPQDKEYYKVKEPGESPIFWYAPESLTES 193
Query: 281 RVSTNGDVYSFGIMLMEIFT 300
           + S   DV+SFG++L E+FT
Sbjct: 194 KFSVASDVWSFGVVLYELFT 213

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 8/210 (3%)
Query: 99  KPLPNDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQY---EGAFKSFDIECDVMK 154
           K  P D     ++G+G F +V  A  +    E A+K+ + ++   E        E DVM 
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 155 RICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALE 214
           R+ H   +K+  ++ +D+     L Y  +G L K +       +   R     ++ SALE
Sbjct: 64  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALE 122
Query: 215 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 274
           YLH      IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++P
Sbjct: 123 YLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 179
Query: 275 EYGREGRVSTNGDVYSFGIMLMEIFTRTKP 304
           E   E     + D+++ G ++ ++     P
Sbjct: 180 ELLTEKSACKSSDLWALGCIIYQLVAGLPP 209

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 98/204 (48%), Gaps = 8/204 (3%)
Query: 99  KPLPNDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQY---EGAFKSFDIECDVMK 154
           K  P D     ++G+G F +V  A  +    E A+K+ + ++   E        E DVM 
Sbjct: 3   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 62
Query: 155 RICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALE 214
           R+ H   +K+  ++ +D+     L Y  +G L K +       +   R     ++ SALE
Sbjct: 63  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALE 121
Query: 215 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 274
           YLH      IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++P
Sbjct: 122 YLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 178
Query: 275 EYGREGRVSTNGDVYSFGIMLMEI 298
           E   E     + D+++ G ++ ++
Sbjct: 179 ELLTEKSACKSSDLWALGCIIYQL 202

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 8/210 (3%)
Query: 99  KPLPNDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQY---EGAFKSFDIECDVMK 154
           K  P D     ++G+G F +V  A  +    E A+K+ + ++   E        E DVM 
Sbjct: 6   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 65
Query: 155 RICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALE 214
           R+ H   +K+  ++ +D+     L Y  +G L K +       +   R     ++ SALE
Sbjct: 66  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALE 124
Query: 215 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 274
           YLH      IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++P
Sbjct: 125 YLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 181
Query: 275 EYGREGRVSTNGDVYSFGIMLMEIFTRTKP 304
           E   E     + D+++ G ++ ++     P
Sbjct: 182 ELLTEKSACKSSDLWALGCIIYQLVAGLPP 211

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 8/210 (3%)
Query: 99  KPLPNDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQY---EGAFKSFDIECDVMK 154
           K  P D     ++G+G F +V  A  +    E A+K+ + ++   E        E DVM 
Sbjct: 5   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 64
Query: 155 RICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALE 214
           R+ H   +K+  ++ +D+     L Y  +G L K +       +   R     ++ SALE
Sbjct: 65  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALE 123
Query: 215 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 274
           YLH      IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++P
Sbjct: 124 YLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 180
Query: 275 EYGREGRVSTNGDVYSFGIMLMEIFTRTKP 304
           E   E     + D+++ G ++ ++     P
Sbjct: 181 ELLTEKSACKSSDLWALGCIIYQLVAGLPP 210

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 108/209 (51%), Gaps = 8/209 (3%)
Query: 94  YQKRGKPLPNDA-NMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDV 152
           ++K    +P ++  +   +G G FG V+ A      +VAVK   P    + ++F  E +V
Sbjct: 5   WEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANV 63
Query: 153 MKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASA 212
           MK + H  L+K+ +  + +    ++ E+M  GSL   L          Q L  +ID ++ 
Sbjct: 64  MKTLQHDKLVKLHAVVTKEPI-YIITEFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQ 119
Query: 213 L-EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGY 271
           + E + F      IH DL+ +N+L+  ++V  ++DFG+A+ ++E+++   +      I +
Sbjct: 120 IAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLAR-VIEDNEYTAREGAKFPIKW 178
Query: 272 MAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
            APE    G  +   DV+SFGI+LMEI T
Sbjct: 179 TAPEAINFGSFTIKSDVWSFGILLMEIVT 207

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 108/220 (49%), Gaps = 23/220 (10%)
Query: 111 IGKGGFGSVYKA-IIQDGMEVAVKVF---DPQYEG----AFKSFDIECDVMKRICHRNLI 162
           IGKGGFG V+K  +++D   VA+K     D + E      F+ F  E  +M  + H N++
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 163 KIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSA 222
           K+     N     +V+E++P G L   L    + +    +L +M+D+A  +EY+    + 
Sbjct: 87  KLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ-NQNP 143
Query: 223 PIIHCDLKPSNVLL---DDN--MVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEY- 276
           PI+H DL+  N+ L   D+N  + A ++DFG+++  +     L     L    +MAPE  
Sbjct: 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGL-----LGNFQWMAPETI 198
Query: 277 -GREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTL 315
              E   +   D YSF ++L  I T   P DE   G++  
Sbjct: 199 GAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF 238

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 102/194 (52%), Gaps = 7/194 (3%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSN 170
           +G G FG V+        +VAVK    Q   +  +F  E ++MK++ H+ L+++ +  + 
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 75
Query: 171 DDFKALVLEYMPHGSLEKCLYLSNYI-LDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
           +    ++ EYM +GSL   L   + I L I + LD+   +A  + ++        IH +L
Sbjct: 76  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRNL 131
Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 289
           + +N+L+ D +   ++DFG+A+ L+E+++   +      I + APE    G  +   DV+
Sbjct: 132 RAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 190
Query: 290 SFGIMLMEIFTRTK 303
           SFGI+L EI T  +
Sbjct: 191 SFGILLTEIVTHGR 204

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 98/203 (48%), Gaps = 11/203 (5%)
Query: 110 LIGKGGFGSVYKAIIQDG----MEVAVKVFDPQYE-GAFKSFDIECDVMKRICHRNLIKI 164
           +IG+G FG VY   + D     +  AVK  +   + G    F  E  +MK   H N++ +
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 165 IS-SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
           +     ++    +VL YM HG L   +    +   +   +   + VA  ++YL    S  
Sbjct: 96  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---ASKK 152
Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAPEYGREGR 281
            +H DL   N +LD+     ++DFG+A+ + +++      +T A   + +MA E  +  +
Sbjct: 153 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQTQK 212
Query: 282 VSTNGDVYSFGIMLMEIFTRTKP 304
            +T  DV+SFG++L E+ TR  P
Sbjct: 213 FTTKSDVWSFGVLLWELMTRGAP 235

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 97/198 (48%), Gaps = 11/198 (5%)
Query: 110 LIGKGGFGSVYKAII----QDGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKI 164
           +IG G  G V    +    Q  + VA+K     Y E   + F  E  +M +  H N+I++
Sbjct: 56  IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115
Query: 165 ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLH-FGYSAP 223
               +      +V EYM +GSL+  L   +    I Q + ++  V + + YL   GY   
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY--- 172
Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE-DQSLTQTQTLATIGYMAPEYGREGRV 282
            +H DL   NVL+D N+V  +SDFG+++ L ++ D + T T     I + APE       
Sbjct: 173 -VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRTF 231
Query: 283 STNGDVYSFGIMLMEIFT 300
           S+  DV+SFG+++ E+  
Sbjct: 232 SSASDVWSFGVVMWEVLA 249

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 97/198 (48%), Gaps = 11/198 (5%)
Query: 110 LIGKGGFGSVYKAII----QDGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKI 164
           +IG G  G V    +    Q  + VA+K     Y E   + F  E  +M +  H N+I++
Sbjct: 56  IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115
Query: 165 ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLH-FGYSAP 223
               +      +V EYM +GSL+  L   +    I Q + ++  V + + YL   GY   
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY--- 172
Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE-DQSLTQTQTLATIGYMAPEYGREGRV 282
            +H DL   NVL+D N+V  +SDFG+++ L ++ D + T T     I + APE       
Sbjct: 173 -VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTF 231
Query: 283 STNGDVYSFGIMLMEIFT 300
           S+  DV+SFG+++ E+  
Sbjct: 232 SSASDVWSFGVVMWEVLA 249

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 108/209 (51%), Gaps = 8/209 (3%)
Query: 94  YQKRGKPLPNDA-NMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDV 152
           ++K    +P ++  +   +G G FG V+ A      +VAVK   P    + ++F  E +V
Sbjct: 178 WEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANV 236
Query: 153 MKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASA 212
           MK + H  L+K+ +  + +    ++ E+M  GSL   L          Q L  +ID ++ 
Sbjct: 237 MKTLQHDKLVKLHAVVTKEPI-YIITEFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQ 292
Query: 213 L-EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGY 271
           + E + F      IH DL+ +N+L+  ++V  ++DFG+A+ ++E+++   +      I +
Sbjct: 293 IAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLAR-VIEDNEYTAREGAKFPIKW 351
Query: 272 MAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
            APE    G  +   DV+SFGI+LMEI T
Sbjct: 352 TAPEAINFGSFTIKSDVWSFGILLMEIVT 380

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 107/220 (48%), Gaps = 23/220 (10%)
Query: 111 IGKGGFGSVYKA-IIQDGMEVAVKVF---DPQYEG----AFKSFDIECDVMKRICHRNLI 162
           IGKGGFG V+K  +++D   VA+K     D + E      F+ F  E  +M  + H N++
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 163 KIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSA 222
           K+     N     +V+E++P G L   L    + +    +L +M+D+A  +EY+    + 
Sbjct: 87  KLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ-NQNP 143
Query: 223 PIIHCDLKPSNVLL---DDN--MVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEY- 276
           PI+H DL+  N+ L   D+N  + A ++DFG ++  +     L     L    +MAPE  
Sbjct: 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVHSVSGL-----LGNFQWMAPETI 198
Query: 277 -GREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTL 315
              E   +   D YSF ++L  I T   P DE   G++  
Sbjct: 199 GAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF 238

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 103/213 (48%), Gaps = 23/213 (10%)
Query: 107 MPPLIGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKS-FDIECDVMKRICHRNLIKI 164
           M   +G GGFG V + I QD G +VA+K    +     +  + +E  +MK++ H N++  
Sbjct: 18  MKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSA 77
Query: 165 ------ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYI----LDIFQRLDIMIDVASALE 214
                 +   + +D   L +EY   G L K  YL+ +     L       ++ D++SAL 
Sbjct: 78  REVPDGLQKLAPNDLPLLAMEYCEGGDLRK--YLNQFENCCGLKEGPIRTLLSDISSALR 135
Query: 215 YLHFGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGY 271
           YLH      IIH DLKP N++L      ++  + D G AK L   DQ    T+ + T+ Y
Sbjct: 136 YLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL---DQGELCTEFVGTLQY 189
Query: 272 MAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKP 304
           +APE   + + +   D +SFG +  E  T  +P
Sbjct: 190 LAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 222

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 103/213 (48%), Gaps = 23/213 (10%)
Query: 107 MPPLIGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKS-FDIECDVMKRICHRNLIKI 164
           M   +G GGFG V + I QD G +VA+K    +     +  + +E  +MK++ H N++  
Sbjct: 19  MKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSA 78
Query: 165 ------ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYI----LDIFQRLDIMIDVASALE 214
                 +   + +D   L +EY   G L K  YL+ +     L       ++ D++SAL 
Sbjct: 79  REVPDGLQKLAPNDLPLLAMEYCEGGDLRK--YLNQFENCCGLKEGPIRTLLSDISSALR 136
Query: 215 YLHFGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGY 271
           YLH      IIH DLKP N++L      ++  + D G AK L   DQ    T+ + T+ Y
Sbjct: 137 YLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL---DQGELCTEFVGTLQY 190
Query: 272 MAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKP 304
           +APE   + + +   D +SFG +  E  T  +P
Sbjct: 191 LAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 223

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 99/203 (48%), Gaps = 11/203 (5%)
Query: 110 LIGKGGFGSVYKAIIQDG----MEVAVKVFDPQYE-GAFKSFDIECDVMKRICHRNLIKI 164
           +IG+G FG VY   + D     +  AVK  +   + G    F  E  +MK   H N++ +
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 165 IS-SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
           +     ++    +VL YM HG L   +    +   +   +   + VA  +++L    S  
Sbjct: 98  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---ASKK 154
Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAPEYGREGR 281
            +H DL   N +LD+     ++DFG+A+ +L+++      +T A   + +MA E  +  +
Sbjct: 155 FVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQTQK 214
Query: 282 VSTNGDVYSFGIMLMEIFTRTKP 304
            +T  DV+SFG++L E+ TR  P
Sbjct: 215 FTTKSDVWSFGVLLWELMTRGAP 237

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 102/209 (48%), Gaps = 10/209 (4%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKS--FDIECDVMKRICHRNLIKIISSY 168
           +G G FG V     +   +VAVK+     EG+     F  E   M ++ H  L+K     
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIK---EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCD 228
           S +    +V EY+ +G L   L      L+  Q L++  DV   + +L    S   IH D
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRD 129
Query: 229 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDV 288
           L   N L+D ++   +SDFGM + +L+ DQ ++   T   + + APE     + S+  DV
Sbjct: 130 LAARNCLVDRDLCVKVSDFGMTRYVLD-DQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDV 188
Query: 289 YSFGIMLMEIFTRTK-PTDEIFSGEMTLK 316
           ++FGI++ E+F+  K P D   + E+ LK
Sbjct: 189 WAFGILMWEVFSLGKMPYDLYTNSEVVLK 217

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 98/203 (48%), Gaps = 11/203 (5%)
Query: 110 LIGKGGFGSVYKAIIQDG----MEVAVKVFDPQYE-GAFKSFDIECDVMKRICHRNLIKI 164
           +IG+G FG VY   + D     +  AVK  +   + G    F  E  +MK   H N++ +
Sbjct: 56  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 115
Query: 165 IS-SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
           +     ++    +VL YM HG L   +    +   +   +   + VA  ++YL    S  
Sbjct: 116 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---ASKK 172
Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAPEYGREGR 281
            +H DL   N +LD+     ++DFG+A+ + +++      +T A   + +MA E  +  +
Sbjct: 173 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK 232
Query: 282 VSTNGDVYSFGIMLMEIFTRTKP 304
            +T  DV+SFG++L E+ TR  P
Sbjct: 233 FTTKSDVWSFGVLLWELMTRGAP 255

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 8/206 (3%)
Query: 103 NDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICH 158
            D     ++G+G F +V  A  +    E A+K+ + ++   E        E DVM R+ H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 159 RNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHF 218
              +K+  ++ +D+     L Y  +G L K +       +   R     ++ SALEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 149
Query: 219 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGR 278
                IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++PE   
Sbjct: 150 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 207
Query: 279 EGRVSTNGDVYSFGIMLMEIFTRTKP 304
           E   S + D+++ G ++ ++     P
Sbjct: 208 EKSASKSSDLWALGCIIYQLVAGLPP 233

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 98/203 (48%), Gaps = 11/203 (5%)
Query: 110 LIGKGGFGSVYKAIIQDG----MEVAVKVFDPQYE-GAFKSFDIECDVMKRICHRNLIKI 164
           +IG+G FG VY   + D     +  AVK  +   + G    F  E  +MK   H N++ +
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 165 IS-SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
           +     ++    +VL YM HG L   +    +   +   +   + VA  ++YL    S  
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---ASKK 153
Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAPEYGREGR 281
            +H DL   N +LD+     ++DFG+A+ + +++      +T A   + +MA E  +  +
Sbjct: 154 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK 213
Query: 282 VSTNGDVYSFGIMLMEIFTRTKP 304
            +T  DV+SFG++L E+ TR  P
Sbjct: 214 FTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 98/203 (48%), Gaps = 11/203 (5%)
Query: 110 LIGKGGFGSVYKAIIQDG----MEVAVKVFDPQYE-GAFKSFDIECDVMKRICHRNLIKI 164
           +IG+G FG VY   + D     +  AVK  +   + G    F  E  +MK   H N++ +
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 165 IS-SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
           +     ++    +VL YM HG L   +    +   +   +   + VA  ++YL    S  
Sbjct: 95  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---ASKK 151
Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAPEYGREGR 281
            +H DL   N +LD+     ++DFG+A+ + +++      +T A   + +MA E  +  +
Sbjct: 152 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK 211
Query: 282 VSTNGDVYSFGIMLMEIFTRTKP 304
            +T  DV+SFG++L E+ TR  P
Sbjct: 212 FTTKSDVWSFGVLLWELMTRGAP 234

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 98/203 (48%), Gaps = 11/203 (5%)
Query: 110 LIGKGGFGSVYKAIIQDG----MEVAVKVFDPQYE-GAFKSFDIECDVMKRICHRNLIKI 164
           +IG+G FG VY   + D     +  AVK  +   + G    F  E  +MK   H N++ +
Sbjct: 55  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 114
Query: 165 IS-SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
           +     ++    +VL YM HG L   +    +   +   +   + VA  ++YL    S  
Sbjct: 115 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---ASKK 171
Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAPEYGREGR 281
            +H DL   N +LD+     ++DFG+A+ + +++      +T A   + +MA E  +  +
Sbjct: 172 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK 231
Query: 282 VSTNGDVYSFGIMLMEIFTRTKP 304
            +T  DV+SFG++L E+ TR  P
Sbjct: 232 FTTKSDVWSFGVLLWELMTRGAP 254

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 98/203 (48%), Gaps = 11/203 (5%)
Query: 110 LIGKGGFGSVYKAIIQDG----MEVAVKVFDPQYE-GAFKSFDIECDVMKRICHRNLIKI 164
           +IG+G FG VY   + D     +  AVK  +   + G    F  E  +MK   H N++ +
Sbjct: 29  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 88
Query: 165 IS-SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
           +     ++    +VL YM HG L   +    +   +   +   + VA  ++YL    S  
Sbjct: 89  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---ASKK 145
Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAPEYGREGR 281
            +H DL   N +LD+     ++DFG+A+ + +++      +T A   + +MA E  +  +
Sbjct: 146 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK 205
Query: 282 VSTNGDVYSFGIMLMEIFTRTKP 304
            +T  DV+SFG++L E+ TR  P
Sbjct: 206 FTTKSDVWSFGVLLWELMTRGAP 228

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 98/203 (48%), Gaps = 11/203 (5%)
Query: 110 LIGKGGFGSVYKAIIQDG----MEVAVKVFDPQYE-GAFKSFDIECDVMKRICHRNLIKI 164
           +IG+G FG VY   + D     +  AVK  +   + G    F  E  +MK   H N++ +
Sbjct: 34  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 165 IS-SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
           +     ++    +VL YM HG L   +    +   +   +   + VA  ++YL    S  
Sbjct: 94  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---ASKK 150
Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAPEYGREGR 281
            +H DL   N +LD+     ++DFG+A+ + +++      +T A   + +MA E  +  +
Sbjct: 151 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK 210
Query: 282 VSTNGDVYSFGIMLMEIFTRTKP 304
            +T  DV+SFG++L E+ TR  P
Sbjct: 211 FTTKSDVWSFGVLLWELMTRGAP 233

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 98/203 (48%), Gaps = 11/203 (5%)
Query: 110 LIGKGGFGSVYKAIIQDG----MEVAVKVFDPQYE-GAFKSFDIECDVMKRICHRNLIKI 164
           +IG+G FG VY   + D     +  AVK  +   + G    F  E  +MK   H N++ +
Sbjct: 32  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 165 IS-SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
           +     ++    +VL YM HG L   +    +   +   +   + VA  ++YL    S  
Sbjct: 92  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---ASKK 148
Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAPEYGREGR 281
            +H DL   N +LD+     ++DFG+A+ + +++      +T A   + +MA E  +  +
Sbjct: 149 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK 208
Query: 282 VSTNGDVYSFGIMLMEIFTRTKP 304
            +T  DV+SFG++L E+ TR  P
Sbjct: 209 FTTKSDVWSFGVLLWELMTRGAP 231

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 98/203 (48%), Gaps = 11/203 (5%)
Query: 110 LIGKGGFGSVYKAIIQDG----MEVAVKVFDPQYE-GAFKSFDIECDVMKRICHRNLIKI 164
           +IG+G FG VY   + D     +  AVK  +   + G    F  E  +MK   H N++ +
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 165 IS-SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
           +     ++    +VL YM HG L   +    +   +   +   + VA  ++YL    S  
Sbjct: 96  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---ASKK 152
Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAPEYGREGR 281
            +H DL   N +LD+     ++DFG+A+ + +++      +T A   + +MA E  +  +
Sbjct: 153 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK 212
Query: 282 VSTNGDVYSFGIMLMEIFTRTKP 304
            +T  DV+SFG++L E+ TR  P
Sbjct: 213 FTTKSDVWSFGVLLWELMTRGAP 235

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 98/203 (48%), Gaps = 11/203 (5%)
Query: 110 LIGKGGFGSVYKAIIQDG----MEVAVKVFDPQYE-GAFKSFDIECDVMKRICHRNLIKI 164
           +IG+G FG VY   + D     +  AVK  +   + G    F  E  +MK   H N++ +
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 165 IS-SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
           +     ++    +VL YM HG L   +    +   +   +   + VA  ++YL    S  
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---ASKK 153
Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAPEYGREGR 281
            +H DL   N +LD+     ++DFG+A+ + +++      +T A   + +MA E  +  +
Sbjct: 154 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK 213
Query: 282 VSTNGDVYSFGIMLMEIFTRTKP 304
            +T  DV+SFG++L E+ TR  P
Sbjct: 214 FTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 105/214 (49%), Gaps = 14/214 (6%)
Query: 99  KPLPNDANMPPL--------IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIEC 150
           KP   DA   P         +G G FG V+     +  +VAVK   P    + ++F  E 
Sbjct: 1   KPWDKDAWEIPRESIKLVKRLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEA 59
Query: 151 DVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL-DIMIDV 209
           ++MK + H  L+++ +  + ++   ++ EYM  GSL   L        +  +L D    +
Sbjct: 60  NLMKTLQHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQI 119
Query: 210 ASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATI 269
           A  + Y+        IH DL+ +NVL+ ++++  ++DFG+A+ ++E+++   +      I
Sbjct: 120 AEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLAR-VIEDNEYTAREGAKFPI 175
Query: 270 GYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTK 303
            + APE    G  +   DV+SFGI+L EI T  K
Sbjct: 176 KWTAPEAINFGCFTIKSDVWSFGILLYEIVTYGK 209

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 100/194 (51%), Gaps = 7/194 (3%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSN 170
           +G G  G V+        +VAVK    Q   +  +F  E ++MK++ H+ L+++ +  + 
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 171 DDFKALVLEYMPHGSLEKCLYLSNYI-LDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
           +    ++ EYM +GSL   L   + I L I + LD+   +A  + ++        IH DL
Sbjct: 80  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 135
Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 289
           + +N+L+ D +   ++DFG+A+ L+E+ +   +      I + APE    G  +   DV+
Sbjct: 136 RAANILVSDTLSCKIADFGLAR-LIEDAEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 194
Query: 290 SFGIMLMEIFTRTK 303
           SFGI+L EI T  +
Sbjct: 195 SFGILLTEIVTHGR 208

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 107/220 (48%), Gaps = 23/220 (10%)
Query: 111 IGKGGFGSVYKA-IIQDGMEVAVKVF---DPQYEG----AFKSFDIECDVMKRICHRNLI 162
           IGKGGFG V+K  +++D   VA+K     D + E      F+ F  E  +M  + H N++
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 163 KIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSA 222
           K+     N     +V+E++P G L   L    + +    +L +M+D+A  +EY+    + 
Sbjct: 87  KLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ-NQNP 143
Query: 223 PIIHCDLKPSNVLL---DDN--MVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEY- 276
           PI+H DL+  N+ L   D+N  + A ++DF +++  +     L     L    +MAPE  
Sbjct: 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVHSVSGL-----LGNFQWMAPETI 198
Query: 277 -GREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTL 315
              E   +   D YSF ++L  I T   P DE   G++  
Sbjct: 199 GAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF 238

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 102/199 (51%), Gaps = 11/199 (5%)
Query: 110 LIGKGGFGSVYKAIIQDGME----VAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKI 164
           +IG G FG V +  ++   +    VA+K     Y E   + F  E  +M +  H N+I++
Sbjct: 23  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRL 82
Query: 165 ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPI 224
               +N     ++ E+M +G+L+  L L++    + Q + ++  +AS + YL        
Sbjct: 83  EGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLA---EMSY 139
Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA---TIGYMAPEYGREGR 281
           +H DL   N+L++ N+V  +SDFG+++ L E     T+T +L     I + APE     +
Sbjct: 140 VHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFRK 199
Query: 282 VSTNGDVYSFGIMLMEIFT 300
            ++  D +S+GI++ E+ +
Sbjct: 200 FTSASDAWSYGIVMWEVMS 218

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 101/215 (46%), Gaps = 9/215 (4%)
Query: 102 PNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKS--FDIECDVMKRICHR 159
           P D      +G G FG V     +   +VA+K+     EG+     F  E  VM  + H 
Sbjct: 23  PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHE 79
Query: 160 NLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFG 219
            L+++    +      ++ EYM +G L   L    +     Q L++  DV  A+EYL   
Sbjct: 80  KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE-- 137
Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
            S   +H DL   N L++D  V  +SDFG+++ +L +D+  +   +   + +  PE    
Sbjct: 138 -SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEETSSVGSKFPVRWSPPEVLMY 195
Query: 280 GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMT 314
            + S+  D+++FG+++ EI++  K   E F+   T
Sbjct: 196 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET 230

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 8/206 (3%)
Query: 103 NDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICH 158
            D     ++G+G F +V  A  +    E A+K+ + ++   E        E DVM R+ H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 159 RNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHF 218
              +K+  ++ +D+     L Y  +G L K +       +   R     ++ SALEYLH 
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 150
Query: 219 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGR 278
                IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++PE   
Sbjct: 151 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 208
Query: 279 EGRVSTNGDVYSFGIMLMEIFTRTKP 304
           E     + D+++ G ++ ++     P
Sbjct: 209 EKSACKSSDLWALGCIIYQLVAGLPP 234

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 8/206 (3%)
Query: 103 NDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICH 158
            D     ++G+G F +V  A  +    E A+K+ + ++   E        E DVM R+ H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 159 RNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHF 218
              +K+  ++ +D+     L Y  +G L K +       +   R     ++ SALEYLH 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 147
Query: 219 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGR 278
                IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++PE   
Sbjct: 148 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLT 205
Query: 279 EGRVSTNGDVYSFGIMLMEIFTRTKP 304
           E     + D+++ G ++ ++     P
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 97/199 (48%), Gaps = 8/199 (4%)
Query: 111 IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYS 169
           +G+G +GSVYKAI ++ G  VA+K      E   +    E  +M++    +++K   SY 
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVP--VESDLQEIIKEISIMQQCDSPHVVKYYGSYF 94
Query: 170 NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
            +    +V+EY   GS+   + L N  L   +   I+      LEYLHF      IH D+
Sbjct: 95  KNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK---IHRDI 151
Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 289
           K  N+LL+    A L+DFG+A  L   D    +   + T  +MAPE  +E   +   D++
Sbjct: 152 KAGNILLNTEGHAKLADFGVAGQLT--DXMAKRNXVIGTPFWMAPEVIQEIGYNCVADIW 209
Query: 290 SFGIMLMEIFTRTKPTDEI 308
           S GI  +E+     P  +I
Sbjct: 210 SLGITAIEMAEGKPPYADI 228

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 98/203 (48%), Gaps = 11/203 (5%)
Query: 110 LIGKGGFGSVYKAIIQDG----MEVAVKVFDPQYE-GAFKSFDIECDVMKRICHRNLIKI 164
           +IG+G FG VY   + D     +  AVK  +   + G    F  E  +MK   H N++ +
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 165 IS-SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
           +     ++    +VL YM HG L   +    +   +   +   + VA  +++L    S  
Sbjct: 98  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---ASKK 154
Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAPEYGREGR 281
            +H DL   N +LD+     ++DFG+A+ + +++      +T A   + +MA E  +  +
Sbjct: 155 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK 214
Query: 282 VSTNGDVYSFGIMLMEIFTRTKP 304
            +T  DV+SFG++L E+ TR  P
Sbjct: 215 FTTKSDVWSFGVLLWELMTRGAP 237

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 8/205 (3%)
Query: 104 DANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHR 159
           D     ++G+G F +V  A  +    E A+K+ + ++   E        E DVM R+ H 
Sbjct: 30  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 89
Query: 160 NLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFG 219
             +K+  ++ +D+     L Y  +G L K +       +   R     ++ SALEYLH  
Sbjct: 90  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH-- 146
Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
               IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++PE   E
Sbjct: 147 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 205
Query: 280 GRVSTNGDVYSFGIMLMEIFTRTKP 304
                + D+++ G ++ ++     P
Sbjct: 206 KSACKSSDLWALGCIIYQLVAGLPP 230

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 8/206 (3%)
Query: 103 NDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICH 158
            D     ++G+G F +V  A  +    E A+K+ + ++   E        E DVM R+ H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 159 RNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHF 218
              +K+  ++ +D+     L Y  +G L K +       +   R     ++ SALEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 149
Query: 219 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGR 278
                IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++PE   
Sbjct: 150 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 279 EGRVSTNGDVYSFGIMLMEIFTRTKP 304
           E     + D+++ G ++ ++     P
Sbjct: 208 EKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 8/205 (3%)
Query: 104 DANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHR 159
           D     ++G+G F +V  A  +    E A+K+ + ++   E        E DVM R+ H 
Sbjct: 30  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 89
Query: 160 NLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFG 219
             +K+  ++ +D+     L Y  +G L K +       +   R     ++ SALEYLH  
Sbjct: 90  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH-- 146
Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
               IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++PE   E
Sbjct: 147 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 205
Query: 280 GRVSTNGDVYSFGIMLMEIFTRTKP 304
                + D+++ G ++ ++     P
Sbjct: 206 KSACKSSDLWALGCIIYQLVAGLPP 230

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 8/206 (3%)
Query: 103 NDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICH 158
            D     ++G+G F +V  A  +    E A+K+ + ++   E        E DVM R+ H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 159 RNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHF 218
              +K+  ++ +D+     L Y  +G L K +       +   R     ++ SALEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 149
Query: 219 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGR 278
                IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++PE   
Sbjct: 150 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 279 EGRVSTNGDVYSFGIMLMEIFTRTKP 304
           E     + D+++ G ++ ++     P
Sbjct: 208 EKSAXKSSDLWALGCIIYQLVAGLPP 233

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 98/203 (48%), Gaps = 11/203 (5%)
Query: 110 LIGKGGFGSVYKAIIQDG----MEVAVKVFDPQYE-GAFKSFDIECDVMKRICHRNLIKI 164
           +IG+G FG VY   + D     +  AVK  +   + G    F  E  +MK   H N++ +
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 165 IS-SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
           +     ++    +VL YM HG L   +    +   +   +   + VA  +++L    S  
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---ASKK 153
Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAPEYGREGR 281
            +H DL   N +LD+     ++DFG+A+ + +++      +T A   + +MA E  +  +
Sbjct: 154 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK 213
Query: 282 VSTNGDVYSFGIMLMEIFTRTKP 304
            +T  DV+SFG++L E+ TR  P
Sbjct: 214 FTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 8/206 (3%)
Query: 103 NDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICH 158
            D     ++G+G F +V  A  +    E A+K+ + ++   E        E DVM R+ H
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 159 RNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHF 218
              +K+  ++ +D+     L Y  +G L K +       +   R     ++ SALEYLH 
Sbjct: 74  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 131
Query: 219 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGR 278
                IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++PE   
Sbjct: 132 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 189
Query: 279 EGRVSTNGDVYSFGIMLMEIFTRTKP 304
           E     + D+++ G ++ ++     P
Sbjct: 190 EKSACKSSDLWALGCIIYQLVAGLPP 215

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 8/206 (3%)
Query: 103 NDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICH 158
            D     ++G+G F +V  A  +    E A+K+ + ++   E        E DVM R+ H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 159 RNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHF 218
              +K+  ++ +D+     L Y  +G L K +       +   R     ++ SALEYLH 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 147
Query: 219 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGR 278
                IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++PE   
Sbjct: 148 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 279 EGRVSTNGDVYSFGIMLMEIFTRTKP 304
           E     + D+++ G ++ ++     P
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 8/206 (3%)
Query: 103 NDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICH 158
            D     ++G+G F +V  A  +    E A+K+ + ++   E        E DVM R+ H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 159 RNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHF 218
              +K+  ++ +D+     L Y  +G L K +       +   R     ++ SALEYLH 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 147
Query: 219 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGR 278
                IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++PE   
Sbjct: 148 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 279 EGRVSTNGDVYSFGIMLMEIFTRTKP 304
           E     + D+++ G ++ ++     P
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 98/203 (48%), Gaps = 11/203 (5%)
Query: 110 LIGKGGFGSVYKAIIQDG----MEVAVKVFDPQYE-GAFKSFDIECDVMKRICHRNLIKI 164
           +IG+G FG VY   + D     +  AVK  +   + G    F  E  +MK   H N++ +
Sbjct: 42  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 101
Query: 165 IS-SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
           +     ++    +VL YM HG L   +    +   +   +   + VA  +++L    S  
Sbjct: 102 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---ASKK 158
Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAPEYGREGR 281
            +H DL   N +LD+     ++DFG+A+ + +++      +T A   + +MA E  +  +
Sbjct: 159 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK 218
Query: 282 VSTNGDVYSFGIMLMEIFTRTKP 304
            +T  DV+SFG++L E+ TR  P
Sbjct: 219 FTTKSDVWSFGVLLWELMTRGAP 241

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 8/206 (3%)
Query: 103 NDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICH 158
            D     ++G+G F +V  A  +    E A+K+ + ++   E        E DVM R+ H
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 159 RNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHF 218
              +K+  ++ +D+     L Y  +G L K +       +   R     ++ SALEYLH 
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 152
Query: 219 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGR 278
                IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++PE   
Sbjct: 153 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 210
Query: 279 EGRVSTNGDVYSFGIMLMEIFTRTKP 304
           E     + D+++ G ++ ++     P
Sbjct: 211 EKSACKSSDLWALGCIIYQLVAGLPP 236

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 102/215 (47%), Gaps = 9/215 (4%)
Query: 102 PNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKS--FDIECDVMKRICHR 159
           P D      +G G FG V     +   +VA+K+     EG+     F  E  VM  + H 
Sbjct: 8   PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHE 64
Query: 160 NLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFG 219
            L+++    +      ++ EYM +G L   L    +     Q L++  DV  A+EYL   
Sbjct: 65  KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE-- 122
Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
            S   +H DL   N L++D  V  +SDFG+++ +L+++ + ++      + +  PE    
Sbjct: 123 -SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFP-VRWSPPEVLMY 180
Query: 280 GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMT 314
            + S+  D+++FG+++ EI++  K   E F+   T
Sbjct: 181 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET 215

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 8/206 (3%)
Query: 103 NDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICH 158
            D     ++G+G F +V  A  +    E A+K+ + ++   E        E DVM R+ H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 159 RNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHF 218
              +K+  ++ +D+     L Y  +G L K +       +   R     ++ SALEYLH 
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 150
Query: 219 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGR 278
                IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++PE   
Sbjct: 151 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 208
Query: 279 EGRVSTNGDVYSFGIMLMEIFTRTKP 304
           E     + D+++ G ++ ++     P
Sbjct: 209 EKSACKSSDLWALGCIIYQLVAGLPP 234

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 101/215 (46%), Gaps = 9/215 (4%)
Query: 102 PNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKS--FDIECDVMKRICHR 159
           P D      +G G FG V     +   +VA+K+     EG+     F  E  VM  + H 
Sbjct: 8   PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHE 64
Query: 160 NLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFG 219
            L+++    +      ++ EYM +G L   L    +     Q L++  DV  A+EYL   
Sbjct: 65  KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE-- 122
Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
            S   +H DL   N L++D  V  +SDFG+++ +L +D+  +   +   + +  PE    
Sbjct: 123 -SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMY 180
Query: 280 GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMT 314
            + S+  D+++FG+++ EI++  K   E F+   T
Sbjct: 181 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET 215

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 98/203 (48%), Gaps = 11/203 (5%)
Query: 110 LIGKGGFGSVYKAIIQDG----MEVAVKVFDPQYE-GAFKSFDIECDVMKRICHRNLIKI 164
           +IG+G FG VY   + D     +  AVK  +   + G    F  E  +MK   H N++ +
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 165 IS-SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
           +     ++    +VL YM HG L   +    +   +   +   + VA  +++L    S  
Sbjct: 95  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---ASKK 151
Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAPEYGREGR 281
            +H DL   N +LD+     ++DFG+A+ + +++      +T A   + +MA E  +  +
Sbjct: 152 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK 211
Query: 282 VSTNGDVYSFGIMLMEIFTRTKP 304
            +T  DV+SFG++L E+ TR  P
Sbjct: 212 FTTKSDVWSFGVLLWELMTRGAP 234

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 8/206 (3%)
Query: 103 NDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICH 158
            D     ++G+G F +V  A  +    E A+K+ + ++   E        E DVM R+ H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 159 RNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHF 218
              +K+  ++ +D+     L Y  +G L K +       +   R     ++ SALEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 149
Query: 219 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGR 278
                IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++PE   
Sbjct: 150 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 279 EGRVSTNGDVYSFGIMLMEIFTRTKP 304
           E     + D+++ G ++ ++     P
Sbjct: 208 EKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 8/206 (3%)
Query: 103 NDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICH 158
            D     ++G+G F +V  A  +    E A+K+ + ++   E        E DVM R+ H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 159 RNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHF 218
              +K+  ++ +D+     L Y  +G L K +       +   R     ++ SALEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 149
Query: 219 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGR 278
                IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++PE   
Sbjct: 150 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 279 EGRVSTNGDVYSFGIMLMEIFTRTKP 304
           E     + D+++ G ++ ++     P
Sbjct: 208 EKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 8/206 (3%)
Query: 103 NDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICH 158
            D     ++G+G F +V  A  +    E A+K+ + ++   E        E DVM R+ H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 159 RNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHF 218
              +K+  ++ +D+     L Y  +G L K +       +   R     ++ SALEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 149
Query: 219 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGR 278
                IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++PE   
Sbjct: 150 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 279 EGRVSTNGDVYSFGIMLMEIFTRTKP 304
           E     + D+++ G ++ ++     P
Sbjct: 208 EKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 92/192 (47%), Gaps = 5/192 (2%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKS-FDIECDVMKRICHRNLIKIISSY 168
           IG+G FG V+   ++ D   VAVK          K+ F  E  ++K+  H N++++I   
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCD 228
           +      +V+E +  G     L      L +   L ++ D A+ +EYL    S   IH D
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRD 238
Query: 229 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDV 288
           L   N L+ +  V  +SDFGM++   +   + +       + + APE    GR S+  DV
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYSSESDV 298
Query: 289 YSFGIMLMEIFT 300
           +SFGI+L E F+
Sbjct: 299 WSFGILLWETFS 310

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 98/203 (48%), Gaps = 11/203 (5%)
Query: 110 LIGKGGFGSVYKAIIQDG----MEVAVKVFDPQYE-GAFKSFDIECDVMKRICHRNLIKI 164
           +IG+G FG VY   + D     +  AVK  +   + G    F  E  +MK   H N++ +
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 165 IS-SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
           +     ++    +VL YM HG L   +    +   +   +   + VA  +++L    S  
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---ASKK 153
Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAPEYGREGR 281
            +H DL   N +LD+     ++DFG+A+ + +++      +T A   + +MA E  +  +
Sbjct: 154 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK 213
Query: 282 VSTNGDVYSFGIMLMEIFTRTKP 304
            +T  DV+SFG++L E+ TR  P
Sbjct: 214 FTTKSDVWSFGVLLWELMTRGAP 236

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 101/199 (50%), Gaps = 13/199 (6%)
Query: 110 LIGKGGFGSVYKAIIQ----DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKI 164
           ++G G FG V    ++      + VA+K     Y E   + F  E  +M +  H N+I++
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 165 ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLH-FGYSAP 223
               +      +V EYM +GSL+  L   +    + Q + ++  +AS ++YL   GY   
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY--- 168
Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAPEYGREGR 281
            +H DL   N+L++ N+V  +SDFG+A+ +LE+D     T       I + +PE     +
Sbjct: 169 -VHRDLAARNILINSNLVCKVSDFGLAR-VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 282 VSTNGDVYSFGIMLMEIFT 300
            ++  DV+S+GI+L E+ +
Sbjct: 227 FTSASDVWSYGIVLWEVMS 245

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 98/203 (48%), Gaps = 11/203 (5%)
Query: 110 LIGKGGFGSVYKAIIQDG----MEVAVKVFDPQYE-GAFKSFDIECDVMKRICHRNLIKI 164
           +IG+G FG VY   + D     +  AVK  +   + G    F  E  +MK   H N++ +
Sbjct: 96  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155
Query: 165 IS-SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
           +     ++    +VL YM HG L   +    +   +   +   + VA  +++L    S  
Sbjct: 156 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---ASKK 212
Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAPEYGREGR 281
            +H DL   N +LD+     ++DFG+A+ + +++      +T A   + +MA E  +  +
Sbjct: 213 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK 272
Query: 282 VSTNGDVYSFGIMLMEIFTRTKP 304
            +T  DV+SFG++L E+ TR  P
Sbjct: 273 FTTKSDVWSFGVLLWELMTRGAP 295

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 101/215 (46%), Gaps = 9/215 (4%)
Query: 102 PNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKS--FDIECDVMKRICHR 159
           P D      +G G FG V     +   +VA+K+     EG+     F  E  VM  + H 
Sbjct: 3   PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHE 59
Query: 160 NLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFG 219
            L+++    +      ++ EYM +G L   L    +     Q L++  DV  A+EYL   
Sbjct: 60  KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE-- 117
Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
            S   +H DL   N L++D  V  +SDFG+++ +L +D+  +   +   + +  PE    
Sbjct: 118 -SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMY 175
Query: 280 GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMT 314
            + S+  D+++FG+++ EI++  K   E F+   T
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET 210

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 101/215 (46%), Gaps = 9/215 (4%)
Query: 102 PNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKS--FDIECDVMKRICHR 159
           P D      +G G FG V     +   +VA+K+     EG+     F  E  VM  + H 
Sbjct: 23  PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHE 79
Query: 160 NLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFG 219
            L+++    +      ++ EYM +G L   L    +     Q L++  DV  A+EYL   
Sbjct: 80  KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE-- 137
Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
            S   +H DL   N L++D  V  +SDFG+++ +L +D+  +   +   + +  PE    
Sbjct: 138 -SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMY 195
Query: 280 GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMT 314
            + S+  D+++FG+++ EI++  K   E F+   T
Sbjct: 196 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET 230

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 101/215 (46%), Gaps = 9/215 (4%)
Query: 102 PNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKS--FDIECDVMKRICHR 159
           P D      +G G FG V     +   +VA+K+     EG+     F  E  VM  + H 
Sbjct: 14  PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHE 70
Query: 160 NLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFG 219
            L+++    +      ++ EYM +G L   L    +     Q L++  DV  A+EYL   
Sbjct: 71  KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE-- 128
Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
            S   +H DL   N L++D  V  +SDFG+++ +L +D+  +   +   + +  PE    
Sbjct: 129 -SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMY 186
Query: 280 GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMT 314
            + S+  D+++FG+++ EI++  K   E F+   T
Sbjct: 187 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET 221

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 107/219 (48%), Gaps = 28/219 (12%)
Query: 103 NDANMPPLIGKGGFGSVYKA-IIQDG--MEVAVKVFDPQYEGA--FKSFDIECDVMKRIC 157
           ND     +IG+G FG V KA I +DG  M+ A+K    +Y      + F  E +V+ ++ 
Sbjct: 15  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAGELEVLCKLG 73
Query: 158 HR-NLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYI---------------LDIFQ 201
           H  N+I ++ +  +  +  L +EY PHG+L   L  S  +               L   Q
Sbjct: 74  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 133
Query: 202 RLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT 261
            L    DVA  ++YL        IH DL   N+L+ +N VA ++DFG+++    ++  + 
Sbjct: 134 LLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRG---QEVYVK 187
Query: 262 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
           +T     + +MA E       +TN DV+S+G++L EI +
Sbjct: 188 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 107/219 (48%), Gaps = 28/219 (12%)
Query: 103 NDANMPPLIGKGGFGSVYKA-IIQDG--MEVAVKVFDPQYEGA--FKSFDIECDVMKRIC 157
           ND     +IG+G FG V KA I +DG  M+ A+K    +Y      + F  E +V+ ++ 
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAGELEVLCKLG 83
Query: 158 HR-NLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYI---------------LDIFQ 201
           H  N+I ++ +  +  +  L +EY PHG+L   L  S  +               L   Q
Sbjct: 84  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 143
Query: 202 RLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT 261
            L    DVA  ++YL        IH DL   N+L+ +N VA ++DFG+++    ++  + 
Sbjct: 144 LLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRG---QEVYVK 197
Query: 262 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
           +T     + +MA E       +TN DV+S+G++L EI +
Sbjct: 198 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 101/215 (46%), Gaps = 9/215 (4%)
Query: 102 PNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKS--FDIECDVMKRICHR 159
           P D      +G G FG V     +   +VA+K+     EG+     F  E  VM  + H 
Sbjct: 7   PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHE 63
Query: 160 NLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFG 219
            L+++    +      ++ EYM +G L   L    +     Q L++  DV  A+EYL   
Sbjct: 64  KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE-- 121
Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
            S   +H DL   N L++D  V  +SDFG+++ +L +D+  +   +   + +  PE    
Sbjct: 122 -SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMY 179
Query: 280 GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMT 314
            + S+  D+++FG+++ EI++  K   E F+   T
Sbjct: 180 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET 214

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 101/199 (50%), Gaps = 11/199 (5%)
Query: 110 LIGKGGFGSVYKAIIQDGME----VAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKI 164
           +IG G FG V +  ++   +    VA+K     Y E   + F  E  +M +  H N+I++
Sbjct: 21  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRL 80
Query: 165 ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPI 224
               +N     ++ E+M +G+L+  L L++    + Q + ++  +AS + YL        
Sbjct: 81  EGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLA---EMSY 137
Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA---TIGYMAPEYGREGR 281
           +H DL   N+L++ N+V  +SDFG+++ L E     T T +L     I + APE     +
Sbjct: 138 VHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAFRK 197
Query: 282 VSTNGDVYSFGIMLMEIFT 300
            ++  D +S+GI++ E+ +
Sbjct: 198 FTSASDAWSYGIVMWEVMS 216

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 92/192 (47%), Gaps = 5/192 (2%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKS-FDIECDVMKRICHRNLIKIISSY 168
           IG+G FG V+   ++ D   VAVK          K+ F  E  ++K+  H N++++I   
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCD 228
           +      +V+E +  G     L      L +   L ++ D A+ +EYL    S   IH D
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRD 238
Query: 229 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDV 288
           L   N L+ +  V  +SDFGM++   +   + +       + + APE    GR S+  DV
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDV 298
Query: 289 YSFGIMLMEIFT 300
           +SFGI+L E F+
Sbjct: 299 WSFGILLWETFS 310

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 8/206 (3%)
Query: 103 NDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICH 158
            D     ++G+G F +V  A  +    E A+K+ + ++   E        E DVM R+ H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 159 RNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHF 218
              +K+   + +D+     L Y  +G L K +       +   R     ++ SALEYLH 
Sbjct: 97  PFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 154
Query: 219 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGR 278
                IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++PE   
Sbjct: 155 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 212
Query: 279 EGRVSTNGDVYSFGIMLMEIFTRTKP 304
           E     + D+++ G ++ ++     P
Sbjct: 213 EKSACKSSDLWALGCIIYQLVAGLPP 238

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 101/199 (50%), Gaps = 13/199 (6%)
Query: 110 LIGKGGFGSVYKAIIQ----DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKI 164
           ++G G FG V    ++      + VA+K     Y E   + F  E  +M +  H N+I++
Sbjct: 23  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 82
Query: 165 ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLH-FGYSAP 223
               +      +V EYM +GSL+  L   +    + Q + ++  +AS ++YL   GY   
Sbjct: 83  EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY--- 139
Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAPEYGREGR 281
            +H DL   N+L++ N+V  +SDFG+++ +LE+D     T       I + +PE     +
Sbjct: 140 -VHRDLAARNILINSNLVCKVSDFGLSR-VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 197
Query: 282 VSTNGDVYSFGIMLMEIFT 300
            ++  DV+S+GI+L E+ +
Sbjct: 198 FTSASDVWSYGIVLWEVMS 216

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 101/199 (50%), Gaps = 13/199 (6%)
Query: 110 LIGKGGFGSVYKAIIQ----DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKI 164
           ++G G FG V    ++      + VA+K     Y E   + F  E  +M +  H N+I++
Sbjct: 40  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 99
Query: 165 ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLH-FGYSAP 223
               +      +V EYM +GSL+  L   +    + Q + ++  +AS ++YL   GY   
Sbjct: 100 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY--- 156
Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAPEYGREGR 281
            +H DL   N+L++ N+V  +SDFG+++ +LE+D     T       I + +PE     +
Sbjct: 157 -VHRDLAARNILINSNLVCKVSDFGLSR-VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 214
Query: 282 VSTNGDVYSFGIMLMEIFT 300
            ++  DV+S+GI+L E+ +
Sbjct: 215 FTSASDVWSYGIVLWEVMS 233

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 101/199 (50%), Gaps = 13/199 (6%)
Query: 110 LIGKGGFGSVYKAIIQ----DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKI 164
           ++G G FG V    ++      + VA+K     Y E   + F  E  +M +  H N+I++
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 165 ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLH-FGYSAP 223
               +      +V EYM +GSL+  L   +    + Q + ++  +AS ++YL   GY   
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY--- 168
Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAPEYGREGR 281
            +H DL   N+L++ N+V  +SDFG+++ +LE+D     T       I + +PE     +
Sbjct: 169 -VHRDLAARNILINSNLVCKVSDFGLSR-VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 282 VSTNGDVYSFGIMLMEIFT 300
            ++  DV+S+GI+L E+ +
Sbjct: 227 FTSASDVWSYGIVLWEVMS 245

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 101/199 (50%), Gaps = 13/199 (6%)
Query: 110 LIGKGGFGSVYKAIIQ----DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKI 164
           ++G G FG V    ++      + VA+K     Y E   + F  E  +M +  H N+I++
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 165 ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLH-FGYSAP 223
               +      +V EYM +GSL+  L   +    + Q + ++  +AS ++YL   GY   
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY--- 168
Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAPEYGREGR 281
            +H DL   N+L++ N+V  +SDFG+++ +LE+D     T       I + +PE     +
Sbjct: 169 -VHRDLAARNILINSNLVCKVSDFGLSR-VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 282 VSTNGDVYSFGIMLMEIFT 300
            ++  DV+S+GI+L E+ +
Sbjct: 227 FTSASDVWSYGIVLWEVMS 245

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 101/199 (50%), Gaps = 13/199 (6%)
Query: 110 LIGKGGFGSVYKAIIQ----DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKI 164
           ++G G FG V    ++      + VA+K     Y E   + F  E  +M +  H N+I++
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 165 ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLH-FGYSAP 223
               +      +V EYM +GSL+  L   +    + Q + ++  +AS ++YL   GY   
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY--- 168
Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAPEYGREGR 281
            +H DL   N+L++ N+V  +SDFG+++ +LE+D     T       I + +PE     +
Sbjct: 169 -VHRDLAARNILINSNLVCKVSDFGLSR-VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 282 VSTNGDVYSFGIMLMEIFT 300
            ++  DV+S+GI+L E+ +
Sbjct: 227 FTSASDVWSYGIVLWEVMS 245

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 101/199 (50%), Gaps = 13/199 (6%)
Query: 110 LIGKGGFGSVYKAIIQ----DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKI 164
           ++G G FG V    ++      + VA+K     Y E   + F  E  +M +  H N+I++
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 165 ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLH-FGYSAP 223
               +      +V EYM +GSL+  L   +    + Q + ++  +AS ++YL   GY   
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY--- 168
Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAPEYGREGR 281
            +H DL   N+L++ N+V  +SDFG+++ +LE+D     T       I + +PE     +
Sbjct: 169 -VHRDLAARNILINSNLVCKVSDFGLSR-VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 282 VSTNGDVYSFGIMLMEIFT 300
            ++  DV+S+GI+L E+ +
Sbjct: 227 FTSASDVWSYGIVLWEVMS 245

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 96/206 (46%), Gaps = 8/206 (3%)
Query: 103 NDANMPPLIGKGGFGS-VYKAIIQDGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICH 158
            D     ++G+G F + V    +    E A+K+ + ++   E        E DVM R+ H
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 159 RNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHF 218
              +K+  ++ +D+     L Y  +G L K +       +   R     ++ SALEYLH 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 147
Query: 219 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGR 278
                IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++PE   
Sbjct: 148 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 279 EGRVSTNGDVYSFGIMLMEIFTRTKP 304
           E     + D+++ G ++ ++     P
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 100/199 (50%), Gaps = 13/199 (6%)
Query: 110 LIGKGGFGSVYKAIIQ----DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKI 164
           ++G G FG V    ++      + VA+K     Y E   + F  E  +M +  H N+I++
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 165 ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLH-FGYSAP 223
               +      +V EYM +GSL+  L   +    + Q + ++  +AS ++YL   GY   
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY--- 168
Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAPEYGREGR 281
            +H DL   N+L++ N+V  +SDFG+ + +LE+D     T       I + +PE     +
Sbjct: 169 -VHRDLAARNILINSNLVCKVSDFGLGR-VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 282 VSTNGDVYSFGIMLMEIFT 300
            ++  DV+S+GI+L E+ +
Sbjct: 227 FTSASDVWSYGIVLWEVMS 245

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 101/199 (50%), Gaps = 13/199 (6%)
Query: 110 LIGKGGFGSVYKAIIQ----DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKI 164
           ++G G FG V    ++      + VA+K     Y E   + F  E  +M +  H N+I++
Sbjct: 50  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 109
Query: 165 ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLH-FGYSAP 223
               +      +V EYM +GSL+  L   +    + Q + ++  +AS ++YL   GY   
Sbjct: 110 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY--- 166
Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAPEYGREGR 281
            +H DL   N+L++ N+V  +SDFG+++ +LE+D     T       I + +PE     +
Sbjct: 167 -VHRDLAARNILINSNLVCKVSDFGLSR-VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 224
Query: 282 VSTNGDVYSFGIMLMEIFT 300
            ++  DV+S+GI+L E+ +
Sbjct: 225 FTSASDVWSYGIVLWEVMS 243

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 107/219 (48%), Gaps = 28/219 (12%)
Query: 103 NDANMPPLIGKGGFGSVYKA-IIQDG--MEVAVKVFDPQYEGA--FKSFDIECDVMKRIC 157
           ND     +IG+G FG V KA I +DG  M+ A+K    +Y      + F  E +V+ ++ 
Sbjct: 22  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLG 80
Query: 158 HR-NLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYI---------------LDIFQ 201
           H  N+I ++ +  +  +  L +EY PHG+L   L  S  +               L   Q
Sbjct: 81  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 140
Query: 202 RLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT 261
            L    DVA  ++YL        IH +L   N+L+ +N VA ++DFG+++    ++  + 
Sbjct: 141 LLHFAADVARGMDYLS---QKQFIHRNLAARNILVGENYVAKIADFGLSRG---QEVYVK 194
Query: 262 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
           +T     + +MA E       +TN DV+S+G++L EI +
Sbjct: 195 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 100/194 (51%), Gaps = 6/194 (3%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSN 170
           +G G FG V+     +  +VAVK   P    + ++F  E ++MK + H  L+++ +  + 
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 78
Query: 171 DDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL-DIMIDVASALEYLHFGYSAPIIHCDL 229
           ++   ++ E+M  GSL   L        +  +L D    +A  + Y+        IH DL
Sbjct: 79  EEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDL 135
Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 289
           + +NVL+ ++++  ++DFG+A+ ++E+++   +      I + APE    G  +   +V+
Sbjct: 136 RAANVLVSESLMCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSNVW 194
Query: 290 SFGIMLMEIFTRTK 303
           SFGI+L EI T  K
Sbjct: 195 SFGILLYEIVTYGK 208

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 101/220 (45%), Gaps = 28/220 (12%)
Query: 102 PNDANMPPLIGKGGFGSVYKAIIQDGMEVAVK----VFDPQYEGAFKSFDIECDVMKRIC 157
           P+D     ++GKG FG   K   ++  EV V      FD + +   ++F  E  VM+ + 
Sbjct: 9   PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQ---RTFLKEVKVMRCLE 65
Query: 158 HRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLH 217
           H N++K I     D     + EY+  G+L   +   +      QR+    D+AS + YLH
Sbjct: 66  HPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH 125
Query: 218 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG------- 270
              S  IIH DL   N L+ +N    ++DFG+A+ +++E    TQ + L ++        
Sbjct: 126 ---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK---TQPEGLRSLKKPDRKKR 179
Query: 271 --------YMAPEYGREGRVSTNGDVYSFGIMLMEIFTRT 302
                   +MAPE           DV+SFGI+L EI  R 
Sbjct: 180 YTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRV 219

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 101/199 (50%), Gaps = 13/199 (6%)
Query: 110 LIGKGGFGSVYKAIIQ----DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKI 164
           ++G G FG V    ++      + VA+K     Y E   + F  E  +M +  H N+I++
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 165 ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLH-FGYSAP 223
               +      +V EYM +GSL+  L   +    + Q + ++  +AS ++YL   G+   
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGF--- 168
Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAPEYGREGR 281
            +H DL   N+L++ N+V  +SDFG+++ +LE+D     T       I + +PE     +
Sbjct: 169 -VHRDLAARNILINSNLVCKVSDFGLSR-VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 282 VSTNGDVYSFGIMLMEIFT 300
            ++  DV+S+GI+L E+ +
Sbjct: 227 FTSASDVWSYGIVLWEVMS 245

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 99/212 (46%), Gaps = 25/212 (11%)
Query: 111 IGKGGFGSVYKAII------QDGMEVAVKVFDPQYEGAFKS-FDIECDVMKRICHRNLIK 163
           +G+  FG VYK  +      +    VA+K    + EG  +  F  E  +  R+ H N++ 
Sbjct: 34  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 93
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLD---------------IMID 208
           ++   + D   +++  Y  HG L + L + +   D+    D               ++  
Sbjct: 94  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 153
Query: 209 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 268
           +A+ +EYL    S  ++H DL   NVL+ D +   +SD G+ + +   D       +L  
Sbjct: 154 IAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 210
Query: 269 IGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
           I +MAPE    G+ S + D++S+G++L E+F+
Sbjct: 211 IRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 108/229 (47%), Gaps = 30/229 (13%)
Query: 111 IGKGGFGSVYKAIIQ-----DGMEVAVKVFD----PQYEGAFKSFDIECDVMKRICHRNL 161
           +G+G FG V            G  VAVK       PQ+   +K    E D+++ + H ++
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQ---EIDILRTLYHEHI 78
Query: 162 IKIISSYSNDDFKAL--VLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFG 219
           IK      +   K+L  V+EY+P GSL    YL  + + + Q L     +   + YLH  
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSLRD--YLPRHSIGLAQLLLFAQQICEGMAYLH-- 134
Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE-EDQSLTQTQTLATIGYMAPEYGR 278
            S   IH +L   NVLLD++ +  + DFG+AK + E  +    +    + + + APE  +
Sbjct: 135 -SQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK 193
Query: 279 EGRVSTNGDVYSFGIMLMEIFT-----RTKPTD-----EIFSGEMTLKR 317
           E +     DV+SFG+ L E+ T     ++ PT       I  G+MT+ R
Sbjct: 194 EYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR 242

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 99/212 (46%), Gaps = 25/212 (11%)
Query: 111 IGKGGFGSVYKAII------QDGMEVAVKVFDPQYEGAFKS-FDIECDVMKRICHRNLIK 163
           +G+  FG VYK  +      +    VA+K    + EG  +  F  E  +  R+ H N++ 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLD---------------IMID 208
           ++   + D   +++  Y  HG L + L + +   D+    D               ++  
Sbjct: 77  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 209 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 268
           +A+ +EYL    S  ++H DL   NVL+ D +   +SD G+ + +   D       +L  
Sbjct: 137 IAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 193
Query: 269 IGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
           I +MAPE    G+ S + D++S+G++L E+F+
Sbjct: 194 IRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 97/200 (48%), Gaps = 7/200 (3%)
Query: 103 NDANMPPLIGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNL 161
            D  M   +G G +G VY+ + +   + VAVK          + F  E  VMK I H NL
Sbjct: 14  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNL 72
Query: 162 IKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYI-LDIFQRLDIMIDVASALEYLHFGY 220
           ++++   + +    +++E+M +G+L   L   N   ++    L +   ++SA+EYL    
Sbjct: 73  VQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--- 129
Query: 221 SAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREG 280
               IH DL   N L+ +N +  ++DFG+++ L+  D           I + APE     
Sbjct: 130 KKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTXTAHAGAKFPIKWTAPESLAYN 188
Query: 281 RVSTNGDVYSFGIMLMEIFT 300
           + S   DV++FG++L EI T
Sbjct: 189 KFSIKSDVWAFGVLLWEIAT 208

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 94/200 (47%), Gaps = 7/200 (3%)
Query: 103 NDANMPPLIGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNL 161
            D  M   +G G +G VY  + +   + VAVK          + F  E  VMK I H NL
Sbjct: 32  TDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNL 90
Query: 162 IKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNY-ILDIFQRLDIMIDVASALEYLHFGY 220
           ++++   + +    +V EYMP+G+L   L   N   +     L +   ++SA+EYL    
Sbjct: 91  VQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLE--- 147
Query: 221 SAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREG 280
               IH DL   N L+ +N V  ++DFG+++ L+  D           I + APE     
Sbjct: 148 KKNFIHRDLAARNCLVGENHVVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYN 206
Query: 281 RVSTNGDVYSFGIMLMEIFT 300
             S   DV++FG++L EI T
Sbjct: 207 TFSIKSDVWAFGVLLWEIAT 226

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 95/200 (47%), Gaps = 7/200 (3%)
Query: 103 NDANMPPLIGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNL 161
            D  M   +G G FG VY+ + +   + VAVK          + F  E  VMK I H NL
Sbjct: 11  TDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNL 69
Query: 162 IKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYI-LDIFQRLDIMIDVASALEYLHFGY 220
           ++++   + +    ++ E+M +G+L   L   N   +     L +   ++SA+EYL    
Sbjct: 70  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--- 126
Query: 221 SAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREG 280
               IH DL   N L+ +N +  ++DFG+++ L+  D           I + APE     
Sbjct: 127 KKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTXTAHAGAKFPIKWTAPESLAYN 185
Query: 281 RVSTNGDVYSFGIMLMEIFT 300
           + S   DV++FG++L EI T
Sbjct: 186 KFSIKSDVWAFGVLLWEIAT 205

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 97/200 (48%), Gaps = 7/200 (3%)
Query: 103 NDANMPPLIGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNL 161
            D  M   +G G +G VY+ + +   + VAVK          + F  E  VMK I H NL
Sbjct: 18  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNL 76
Query: 162 IKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYI-LDIFQRLDIMIDVASALEYLHFGY 220
           ++++   + +    +++E+M +G+L   L   N   ++    L +   ++SA+EYL    
Sbjct: 77  VQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--- 133
Query: 221 SAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREG 280
               IH DL   N L+ +N +  ++DFG+++ L+  D           I + APE     
Sbjct: 134 KKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYN 192
Query: 281 RVSTNGDVYSFGIMLMEIFT 300
           + S   DV++FG++L EI T
Sbjct: 193 KFSIKSDVWAFGVLLWEIAT 212

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 7/200 (3%)
Query: 103 NDANMPPLIGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNL 161
            D  M   +G G +G VY+ + +   + VAVK          + F  E  VMK I H NL
Sbjct: 11  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNL 69
Query: 162 IKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYI-LDIFQRLDIMIDVASALEYLHFGY 220
           ++++   + +    +++E+M +G+L   L   N   +     L +   ++SA+EYL    
Sbjct: 70  VQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--- 126
Query: 221 SAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREG 280
               IH DL   N L+ +N +  ++DFG+++ L+  D           I + APE     
Sbjct: 127 KKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTXTAHAGAKFPIKWTAPESLAYN 185
Query: 281 RVSTNGDVYSFGIMLMEIFT 300
           + S   DV++FG++L EI T
Sbjct: 186 KFSIKSDVWAFGVLLWEIAT 205

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 108/229 (47%), Gaps = 30/229 (13%)
Query: 111 IGKGGFGSVYKAIIQ-----DGMEVAVKVFD----PQYEGAFKSFDIECDVMKRICHRNL 161
           +G+G FG V            G  VAVK       PQ+   +K    E D+++ + H ++
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQ---EIDILRTLYHEHI 78
Query: 162 IKIISSYSNDDFKAL--VLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFG 219
           IK      +   K+L  V+EY+P GSL    YL  + + + Q L     +   + YLH  
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSLRD--YLPRHSIGLAQLLLFAQQICEGMAYLH-- 134
Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE-EDQSLTQTQTLATIGYMAPEYGR 278
            +   IH +L   NVLLD++ +  + DFG+AK + E  +    +    + + + APE  +
Sbjct: 135 -AQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK 193
Query: 279 EGRVSTNGDVYSFGIMLMEIFT-----RTKPTD-----EIFSGEMTLKR 317
           E +     DV+SFG+ L E+ T     ++ PT       I  G+MT+ R
Sbjct: 194 EYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR 242

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/245 (27%), Positives = 112/245 (45%), Gaps = 21/245 (8%)
Query: 72  LCEIVLPLSTIFMIVMILLILRYQKRGKPL-----PN---------DANMPPLIGKGGFG 117
           L E+V   ST+   ++  L     KR KP      PN         D  M   +G G +G
Sbjct: 214 LAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYG 273
Query: 118 SVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKAL 176
            VY+ + +   + VAVK          + F  E  VMK I H NL++++   + +    +
Sbjct: 274 EVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 332
Query: 177 VLEYMPHGSLEKCLYLSNYI-LDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVL 235
           + E+M +G+L   L   N   ++    L +   ++SA+EYL        IH +L   N L
Sbjct: 333 ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCL 389
Query: 236 LDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIML 295
           + +N +  ++DFG+++ L+  D           I + APE     + S   DV++FG++L
Sbjct: 390 VGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLL 448
Query: 296 MEIFT 300
            EI T
Sbjct: 449 WEIAT 453

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 107/229 (46%), Gaps = 30/229 (13%)
Query: 111 IGKGGFGSVYKAIIQ-----DGMEVAVKVFD----PQYEGAFKSFDIECDVMKRICHRNL 161
           +G+G FG V            G  VAVK       PQ+   +K    E D+++ + H ++
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQ---EIDILRTLYHEHI 95
Query: 162 IKIISSYSNDDFKAL--VLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFG 219
           IK      +    +L  V+EY+P GSL    YL  + + + Q L     +   + YLH  
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSLRD--YLPRHSIGLAQLLLFAQQICEGMAYLH-- 151
Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE-EDQSLTQTQTLATIGYMAPEYGR 278
            +   IH DL   NVLLD++ +  + DFG+AK + E  +    +    + + + APE  +
Sbjct: 152 -AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLK 210
Query: 279 EGRVSTNGDVYSFGIMLMEIFT-----RTKPTD-----EIFSGEMTLKR 317
           E +     DV+SFG+ L E+ T     ++ PT       I  G+MT+ R
Sbjct: 211 EYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR 259

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 100/199 (50%), Gaps = 13/199 (6%)
Query: 110 LIGKGGFGSVYKAIIQ----DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKI 164
           ++G G FG V    ++      + VA+K     Y E   + F  E  +M +  H N+I++
Sbjct: 23  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 82
Query: 165 ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLH-FGYSAP 223
               +      +V E M +GSL+  L   +    + Q + ++  +AS ++YL   GY   
Sbjct: 83  EGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY--- 139
Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAPEYGREGR 281
            +H DL   N+L++ N+V  +SDFG+++ +LE+D     T       I + +PE     +
Sbjct: 140 -VHRDLAARNILINSNLVCKVSDFGLSR-VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 197
Query: 282 VSTNGDVYSFGIMLMEIFT 300
            ++  DV+S+GI+L E+ +
Sbjct: 198 FTSASDVWSYGIVLWEVMS 216

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 95/195 (48%), Gaps = 8/195 (4%)
Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYS 169
           IG+G  G+VY A+ +  G EVA++  + Q +   +    E  VM+   + N++  + SY 
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 170 NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
             D   +V+EY+  GSL   +  +   +D  Q   +  +   ALE+LH   S  +IH D+
Sbjct: 88  VGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 142
Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 289
           K  N+LL  +    L+DFG    +  E     +++ + T  +MAPE           D++
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSEMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 290 SFGIMLMEIFTRTKP 304
           S GIM +E+     P
Sbjct: 201 SLGIMAIEMIEGEPP 215

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 98/201 (48%), Gaps = 12/201 (5%)
Query: 111 IGKGGFGSVYKA-IIQDGMEVAVK---VFDPQYEGAFKSFDIECDVMKRICHRNLIKIIS 166
           IG+G F  VY+A  + DG+ VA+K   +FD     A      E D++K++ H N+IK  +
Sbjct: 40  IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 99
Query: 167 SYSNDDFKALVLEYMPHGSLEKCL-YLSNYILDIFQR--LDIMIDVASALEYLHFGYSAP 223
           S+  D+   +VLE    G L + + +       I +R      + + SALE++H   S  
Sbjct: 100 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRR 156
Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVS 283
           ++H D+KP+NV +    V  L D G+ +      ++      + T  YM+PE   E   +
Sbjct: 157 VMHRDIKPANVFITATGVVKLGDLGLGR--FFSSKTTAAHSLVGTPYYMSPERIHENGYN 214
Query: 284 TNGDVYSFGIMLMEIFTRTKP 304
              D++S G +L E+     P
Sbjct: 215 FKSDIWSLGCLLYEMAALQSP 235

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 100/199 (50%), Gaps = 13/199 (6%)
Query: 110 LIGKGGFGSVYKAIIQ----DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKI 164
           ++G G FG V    ++      + VA+K     Y E   + F  E  +M +  H N+I++
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 165 ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLH-FGYSAP 223
               +      +V E M +GSL+  L   +    + Q + ++  +AS ++YL   GY   
Sbjct: 112 EGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY--- 168
Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAPEYGREGR 281
            +H DL   N+L++ N+V  +SDFG+++ +LE+D     T       I + +PE     +
Sbjct: 169 -VHRDLAARNILINSNLVCKVSDFGLSR-VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 282 VSTNGDVYSFGIMLMEIFT 300
            ++  DV+S+GI+L E+ +
Sbjct: 227 FTSASDVWSYGIVLWEVMS 245

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 7/200 (3%)
Query: 103 NDANMPPLIGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNL 161
            D  M   +G G +G VY+ + +   + VAVK          + F  E  VMK I H NL
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNL 71
Query: 162 IKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYI-LDIFQRLDIMIDVASALEYLHFGY 220
           ++++   + +    +++E+M +G+L   L   N   +     L +   ++SA+EYL    
Sbjct: 72  VQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--- 128
Query: 221 SAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREG 280
               IH DL   N L+ +N +  ++DFG+++ L+  D           I + APE     
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYN 187
Query: 281 RVSTNGDVYSFGIMLMEIFT 300
           + S   DV++FG++L EI T
Sbjct: 188 KFSIKSDVWAFGVLLWEIAT 207

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 102/199 (51%), Gaps = 13/199 (6%)
Query: 110 LIGKGGFGSVYKAIIQ----DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKI 164
           +IG G FG V    ++      + VA+K     Y E   + F  E  +M +  H N++ +
Sbjct: 50  VIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHL 109
Query: 165 ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLH-FGYSAP 223
               +      +V+E+M +G+L+  L   +    + Q + ++  +A+ + YL   GY   
Sbjct: 110 EGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLADMGY--- 166
Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATI--GYMAPEYGREGR 281
            +H DL   N+L++ N+V  +SDFG+++ ++E+D     T T   I   + APE  +  +
Sbjct: 167 -VHRDLAARNILVNSNLVCKVSDFGLSR-VIEDDPEAVYTTTGGKIPVRWTAPEAIQYRK 224
Query: 282 VSTNGDVYSFGIMLMEIFT 300
            ++  DV+S+GI++ E+ +
Sbjct: 225 FTSASDVWSYGIVMWEVMS 243

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 7/200 (3%)
Query: 103 NDANMPPLIGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNL 161
            D  M   +G G +G VY+ + +   + VAVK          + F  E  VMK I H NL
Sbjct: 18  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNL 76
Query: 162 IKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYI-LDIFQRLDIMIDVASALEYLHFGY 220
           ++++   + +    ++ E+M +G+L   L   N   ++    L +   ++SA+EYL    
Sbjct: 77  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--- 133
Query: 221 SAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREG 280
               IH DL   N L+ +N +  ++DFG+++ L+  D           I + APE     
Sbjct: 134 KKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTXTAHAGAKFPIKWTAPESLAYN 192
Query: 281 RVSTNGDVYSFGIMLMEIFT 300
           + S   DV++FG++L EI T
Sbjct: 193 KFSIKSDVWAFGVLLWEIAT 212

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 7/200 (3%)
Query: 103 NDANMPPLIGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNL 161
            D  M   +G G +G VY+ + +   + VAVK          + F  E  VMK I H NL
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNL 71
Query: 162 IKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYI-LDIFQRLDIMIDVASALEYLHFGY 220
           ++++   + +    +++E+M +G+L   L   N   +     L +   ++SA+EYL    
Sbjct: 72  VQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--- 128
Query: 221 SAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREG 280
               IH DL   N L+ +N +  ++DFG+++ L+  D           I + APE     
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYN 187
Query: 281 RVSTNGDVYSFGIMLMEIFT 300
           + S   DV++FG++L EI T
Sbjct: 188 KFSIKSDVWAFGVLLWEIAT 207

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/245 (27%), Positives = 111/245 (45%), Gaps = 21/245 (8%)
Query: 72  LCEIVLPLSTIFMIVMILLILRYQKRGKPL-----PN---------DANMPPLIGKGGFG 117
           L E+V   ST+   ++  L     KR KP      PN         D  M   +G G +G
Sbjct: 175 LAELVHHHSTVADGLITTLHYPAPKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYG 234
Query: 118 SVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKAL 176
            VY+ + +   + VAVK          + F  E  VMK I H NL++++   + +    +
Sbjct: 235 EVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 293
Query: 177 VLEYMPHGSLEKCLYLSNYI-LDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVL 235
           + E+M +G+L   L   N   +     L +   ++SA+EYL        IH +L   N L
Sbjct: 294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCL 350
Query: 236 LDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIML 295
           + +N +  ++DFG+++ L+  D           I + APE     + S   DV++FG++L
Sbjct: 351 VGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLL 409
Query: 296 MEIFT 300
            EI T
Sbjct: 410 WEIAT 414

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 7/200 (3%)
Query: 103 NDANMPPLIGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNL 161
            D  M   +G G +G VY+ + +   + VAVK          + F  E  VMK I H NL
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNL 71
Query: 162 IKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYI-LDIFQRLDIMIDVASALEYLHFGY 220
           ++++   + +    ++ E+M +G+L   L   N   ++    L +   ++SA+EYL    
Sbjct: 72  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--- 128
Query: 221 SAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREG 280
               IH DL   N L+ +N +  ++DFG+++ L+  D           I + APE     
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYN 187
Query: 281 RVSTNGDVYSFGIMLMEIFT 300
           + S   DV++FG++L EI T
Sbjct: 188 KFSIKSDVWAFGVLLWEIAT 207

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 23/224 (10%)
Query: 111 IGKGGFGSVYKA----IIQDGMEVAVKVFDPQYEGAFKS---FDIECDVMKRICHRNLIK 163
           +G+G FG VY+     II+   E  V V       + +    F  E  VMK     ++++
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILD-----------IFQRLDIMIDVASA 212
           ++   S      +V+E M HG L+   YL +   +           + + + +  ++A  
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKS--YLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 139
Query: 213 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYM 272
           + YL+   +   +H DL   N ++  +    + DFGM + + E D      + L  + +M
Sbjct: 140 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 196
Query: 273 APEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLK 316
           APE  ++G  +T+ D++SFG++L EI +  +   +  S E  LK
Sbjct: 197 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 240

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 23/224 (10%)
Query: 111 IGKGGFGSVYKA----IIQDGMEVAVKVFDPQYEGAFKS---FDIECDVMKRICHRNLIK 163
           +G+G FG VY+     II+   E  V V       + +    F  E  VMK     ++++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILD-----------IFQRLDIMIDVASA 212
           ++   S      +V+E M HG L+   YL +   +           + + + +  ++A  
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKS--YLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 213 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYM 272
           + YL+   +   +H DL   N ++  +    + DFGM + + E D      + L  + +M
Sbjct: 143 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 199
Query: 273 APEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLK 316
           APE  ++G  +T+ D++SFG++L EI +  +   +  S E  LK
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 243

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 23/224 (10%)
Query: 111 IGKGGFGSVYKA----IIQDGMEVAVKVFDPQYEGAFKS---FDIECDVMKRICHRNLIK 163
           +G+G FG VY+     II+   E  V V       + +    F  E  VMK     ++++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILD-----------IFQRLDIMIDVASA 212
           ++   S      +V+E M HG L+   YL +   +           + + + +  ++A  
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKS--YLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 213 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYM 272
           + YL+   +   +H DL   N ++  +    + DFGM + + E D      + L  + +M
Sbjct: 143 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 199
Query: 273 APEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLK 316
           APE  ++G  +T+ D++SFG++L EI +  +   +  S E  LK
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 243

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 7/200 (3%)
Query: 103 NDANMPPLIGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNL 161
            D  M   +G G +G VY+ + +   + VAVK          + F  E  VMK I H NL
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNL 71
Query: 162 IKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYI-LDIFQRLDIMIDVASALEYLHFGY 220
           ++++   + +    ++ E+M +G+L   L   N   ++    L +   ++SA+EYL    
Sbjct: 72  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--- 128
Query: 221 SAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREG 280
               IH DL   N L+ +N +  ++DFG+++ L+  D           I + APE     
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYN 187
Query: 281 RVSTNGDVYSFGIMLMEIFT 300
           + S   DV++FG++L EI T
Sbjct: 188 KFSIKSDVWAFGVLLWEIAT 207

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 7/200 (3%)
Query: 103 NDANMPPLIGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNL 161
            D  M   +G G +G VY+ + +   + VAVK          + F  E  VMK I H NL
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNL 75
Query: 162 IKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYI-LDIFQRLDIMIDVASALEYLHFGY 220
           ++++   + +    ++ E+M +G+L   L   N   ++    L +   ++SA+EYL    
Sbjct: 76  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--- 132
Query: 221 SAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREG 280
               IH DL   N L+ +N +  ++DFG+++ L+  D           I + APE     
Sbjct: 133 KKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYN 191
Query: 281 RVSTNGDVYSFGIMLMEIFT 300
           + S   DV++FG++L EI T
Sbjct: 192 KFSIKSDVWAFGVLLWEIAT 211

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 7/200 (3%)
Query: 103 NDANMPPLIGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNL 161
            D  M   +G G +G VY+ + +   + VAVK          + F  E  VMK I H NL
Sbjct: 18  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNL 76
Query: 162 IKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYI-LDIFQRLDIMIDVASALEYLHFGY 220
           ++++   + +    ++ E+M +G+L   L   N   ++    L +   ++SA+EYL    
Sbjct: 77  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--- 133
Query: 221 SAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREG 280
               IH DL   N L+ +N +  ++DFG+++ L+  D           I + APE     
Sbjct: 134 KKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYN 192
Query: 281 RVSTNGDVYSFGIMLMEIFT 300
           + S   DV++FG++L EI T
Sbjct: 193 KFSIKSDVWAFGVLLWEIAT 212

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 7/200 (3%)
Query: 103 NDANMPPLIGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNL 161
            D  M   +G G +G VY+ + +   + VAVK          + F  E  VMK I H NL
Sbjct: 18  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNL 76
Query: 162 IKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYI-LDIFQRLDIMIDVASALEYLHFGY 220
           ++++   + +    ++ E+M +G+L   L   N   ++    L +   ++SA+EYL    
Sbjct: 77  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--- 133
Query: 221 SAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREG 280
               IH DL   N L+ +N +  ++DFG+++ L+  D           I + APE     
Sbjct: 134 KKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYN 192
Query: 281 RVSTNGDVYSFGIMLMEIFT 300
           + S   DV++FG++L EI T
Sbjct: 193 KFSIKSDVWAFGVLLWEIAT 212

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 18/209 (8%)
Query: 94  YQKRGKPLPNDA-NMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDV 152
           ++K    +P ++  +   +G G FG V+ A      +VAVK   P    + ++F  E +V
Sbjct: 172 WEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANV 230
Query: 153 MKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASA 212
           MK + H  L+K+ +  + +    ++ E+M  GSL   L          Q L  +ID ++ 
Sbjct: 231 MKTLQHDKLVKLHAVVTKEPI-YIITEFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQ 286
Query: 213 L-EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGY 271
           + E + F      IH DL+ +N+L+  ++V  ++DFG+A+                 I +
Sbjct: 287 IAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLAR-----------VGAKFPIKW 335
Query: 272 MAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
            APE    G  +   DV+SFGI+LMEI T
Sbjct: 336 TAPEAINFGSFTIKSDVWSFGILLMEIVT 364

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 7/200 (3%)
Query: 103 NDANMPPLIGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNL 161
            D  M   +G G +G VY+ + +   + VAVK          + F  E  VMK I H NL
Sbjct: 26  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNL 84
Query: 162 IKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYI-LDIFQRLDIMIDVASALEYLHFGY 220
           ++++   + +    ++ E+M +G+L   L   N   ++    L +   ++SA+EYL    
Sbjct: 85  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--- 141
Query: 221 SAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREG 280
               IH DL   N L+ +N +  ++DFG+++ L+  D           I + APE     
Sbjct: 142 KKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYN 200
Query: 281 RVSTNGDVYSFGIMLMEIFT 300
           + S   DV++FG++L EI T
Sbjct: 201 KFSIKSDVWAFGVLLWEIAT 220

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 7/200 (3%)
Query: 103 NDANMPPLIGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNL 161
            D  M   +G G +G VY+ + +   + VAVK          + F  E  VMK I H NL
Sbjct: 15  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNL 73
Query: 162 IKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYI-LDIFQRLDIMIDVASALEYLHFGY 220
           ++++   + +    ++ E+M +G+L   L   N   ++    L +   ++SA+EYL    
Sbjct: 74  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--- 130
Query: 221 SAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREG 280
               IH DL   N L+ +N +  ++DFG+++ L+  D           I + APE     
Sbjct: 131 KKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYN 189
Query: 281 RVSTNGDVYSFGIMLMEIFT 300
           + S   DV++FG++L EI T
Sbjct: 190 KFSIKSDVWAFGVLLWEIAT 209

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 7/200 (3%)
Query: 103 NDANMPPLIGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNL 161
            D  M   +G G +G VY+ + +   + VAVK          + F  E  VMK I H NL
Sbjct: 15  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNL 73
Query: 162 IKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYI-LDIFQRLDIMIDVASALEYLHFGY 220
           ++++   + +    ++ E+M +G+L   L   N   ++    L +   ++SA+EYL    
Sbjct: 74  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--- 130
Query: 221 SAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREG 280
               IH DL   N L+ +N +  ++DFG+++ L+  D           I + APE     
Sbjct: 131 KKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYN 189
Query: 281 RVSTNGDVYSFGIMLMEIFT 300
           + S   DV++FG++L EI T
Sbjct: 190 KFSIKSDVWAFGVLLWEIAT 209

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 100/210 (47%), Gaps = 15/210 (7%)
Query: 104 DANMPPLIGKGGFGSVYKA-IIQDGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHR 159
           D  +  L+GKG F  VY+A  I  G+EVA+K+ D +     G  +    E  +  ++ H 
Sbjct: 12  DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHP 71
Query: 160 NLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQR--LDIMIDVASALEYLH 217
           +++++ + + + ++  LVLE   +G + +  YL N +    +      M  + + + YLH
Sbjct: 72  SILELYNYFEDSNYVYLVLEMCHNGEMNR--YLKNRVKPFSENEARHFMHQIITGMLYLH 129
Query: 218 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LEEDQSLTQTQTLATIGYMAPEY 276
              S  I+H DL  SN+LL  NM   ++DFG+A  L +  ++  T      T  Y++PE 
Sbjct: 130 ---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT---LCGTPNYISPEI 183
Query: 277 GREGRVSTNGDVYSFGIMLMEIFTRTKPTD 306
                     DV+S G M   +     P D
Sbjct: 184 ATRSAHGLESDVWSLGCMFYTLLIGRPPFD 213

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 101/199 (50%), Gaps = 13/199 (6%)
Query: 110 LIGKGGFGSVYKAIIQ----DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKI 164
           +IG G FG V    ++      + VA+K     Y E   + F  E  +M +  H N+I +
Sbjct: 29  VIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHL 88
Query: 165 ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLH-FGYSAP 223
               +      +V EYM +GSL+  L  ++    + Q + ++  +++ ++YL   GY   
Sbjct: 89  EGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSDMGY--- 145
Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAPEYGREGR 281
            +H DL   N+L++ N+V  +SDFG+++ +LE+D     T       I + APE     +
Sbjct: 146 -VHRDLAARNILINSNLVCKVSDFGLSR-VLEDDPEAAYTTRGGKIPIRWTAPEAIAFRK 203
Query: 282 VSTNGDVYSFGIMLMEIFT 300
            ++  DV+S+GI++ E+ +
Sbjct: 204 FTSASDVWSYGIVMWEVVS 222

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 94/195 (48%), Gaps = 8/195 (4%)
Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYS 169
           IG+G  G+VY A+ +  G EVA++  + Q +   +    E  VM+   + N++  + SY 
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 170 NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
             D   +V+EY+  GSL   +  +   +D  Q   +  +   ALE+LH   S  +IH D+
Sbjct: 89  VGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 143
Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 289
           K  N+LL  +    L+DFG    +  E     ++  + T  +MAPE           D++
Sbjct: 144 KSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSXMVGTPYWMAPEVVTRKAYGPKVDIW 201
Query: 290 SFGIMLMEIFTRTKP 304
           S GIM +E+     P
Sbjct: 202 SLGIMAIEMIEGEPP 216

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 94/195 (48%), Gaps = 8/195 (4%)
Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYS 169
           IG+G  G+VY A+ +  G EVA++  + Q +   +    E  VM+   + N++  + SY 
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 170 NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
             D   +V+EY+  GSL   +  +   +D  Q   +  +   ALE+LH   S  +IH D+
Sbjct: 88  VGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 142
Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 289
           K  N+LL  +    L+DFG    +  E     ++  + T  +MAPE           D++
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSXMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 290 SFGIMLMEIFTRTKP 304
           S GIM +E+     P
Sbjct: 201 SLGIMAIEMIEGEPP 215

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 94/195 (48%), Gaps = 8/195 (4%)
Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYS 169
           IG+G  G+VY A+ +  G EVA++  + Q +   +    E  VM+   + N++  + SY 
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 170 NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
             D   +V+EY+  GSL   +  +   +D  Q   +  +   ALE+LH   S  +IH D+
Sbjct: 88  VGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 142
Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 289
           K  N+LL  +    L+DFG    +  E     ++  + T  +MAPE           D++
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 290 SFGIMLMEIFTRTKP 304
           S GIM +E+     P
Sbjct: 201 SLGIMAIEMIEGEPP 215

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 104/222 (46%), Gaps = 19/222 (8%)
Query: 111 IGKGGFGSVY----KAIIQDGMEVAVKVFDPQYEGAFKS---FDIECDVMKRICHRNLIK 163
           +G+G FG VY    K +++D  E  V +       + +    F  E  VMK     ++++
Sbjct: 18  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 77
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYL------SNYIL---DIFQRLDIMIDVASALE 214
           ++   S      +++E M  G L+  L        +N +L    + + + +  ++A  + 
Sbjct: 78  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 137
Query: 215 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 274
           YL+   +   +H DL   N ++ ++    + DFGM + + E D      + L  + +M+P
Sbjct: 138 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSP 194
Query: 275 EYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLK 316
           E  ++G  +T  DV+SFG++L EI T  +   +  S E  L+
Sbjct: 195 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 236

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 7/200 (3%)
Query: 103 NDANMPPLIGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNL 161
            D  M   +G G +G VY+ + +   + VAVK          + F  E  VMK I H NL
Sbjct: 18  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNL 76
Query: 162 IKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYI-LDIFQRLDIMIDVASALEYLHFGY 220
           ++++   + +    ++ E+M +G+L   L   N   +     L +   ++SA+EYL    
Sbjct: 77  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--- 133
Query: 221 SAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREG 280
               IH DL   N L+ +N +  ++DFG+++ L+  D           I + APE     
Sbjct: 134 KKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYN 192
Query: 281 RVSTNGDVYSFGIMLMEIFT 300
           + S   DV++FG++L EI T
Sbjct: 193 KFSIKSDVWAFGVLLWEIAT 212

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 7/200 (3%)
Query: 103 NDANMPPLIGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNL 161
            D  M   +G G +G VY+ + +   + VAVK          + F  E  VMK I H NL
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNL 71
Query: 162 IKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYI-LDIFQRLDIMIDVASALEYLHFGY 220
           ++++   + +    ++ E+M +G+L   L   N   +     L +   ++SA+EYL    
Sbjct: 72  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--- 128
Query: 221 SAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREG 280
               IH DL   N L+ +N +  ++DFG+++ L+  D           I + APE     
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYN 187
Query: 281 RVSTNGDVYSFGIMLMEIFT 300
           + S   DV++FG++L EI T
Sbjct: 188 KFSIKSDVWAFGVLLWEIAT 207

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 7/200 (3%)
Query: 103 NDANMPPLIGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNL 161
            D  M   +G G +G VY+ + +   + VAVK          + F  E  VMK I H NL
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNL 71
Query: 162 IKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYI-LDIFQRLDIMIDVASALEYLHFGY 220
           ++++   + +    ++ E+M +G+L   L   N   +     L +   ++SA+EYL    
Sbjct: 72  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--- 128
Query: 221 SAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREG 280
               IH DL   N L+ +N +  ++DFG+++ L+  D           I + APE     
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYN 187
Query: 281 RVSTNGDVYSFGIMLMEIFT 300
           + S   DV++FG++L EI T
Sbjct: 188 KFSIKSDVWAFGVLLWEIAT 207

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 104/222 (46%), Gaps = 19/222 (8%)
Query: 111 IGKGGFGSVY----KAIIQDGMEVAVKVFDPQYEGAFKS---FDIECDVMKRICHRNLIK 163
           +G+G FG VY    K +++D  E  V +       + +    F  E  VMK     ++++
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYL------SNYIL---DIFQRLDIMIDVASALE 214
           ++   S      +++E M  G L+  L        +N +L    + + + +  ++A  + 
Sbjct: 87  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 146
Query: 215 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 274
           YL+   +   +H DL   N ++ ++    + DFGM + + E D      + L  + +M+P
Sbjct: 147 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSP 203
Query: 275 EYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLK 316
           E  ++G  +T  DV+SFG++L EI T  +   +  S E  L+
Sbjct: 204 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 245

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 31/213 (14%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGA-FKSFDIECDVMKRICHRNLIKIISSYS 169
           IGKG FG V++   + G EVAVK+F  + E + F+  +I   VM R  H N++  I++ +
Sbjct: 50  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLR--HENILGFIAADN 106
Query: 170 NDDFKA----LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHF------G 219
            D+       LV +Y  HGSL    YL+ Y + +   + + +  AS L +LH       G
Sbjct: 107 KDNGTWTQLWLVSDYHEHGSLFD--YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQG 164
Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS-----LTQTQTLATIGYMAP 274
             A I H DLK  N+L+  N    ++D G+A   +  D +     +     + T  YMAP
Sbjct: 165 KPA-IAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPNHRVGTKRYMAP 220
Query: 275 EY------GREGRVSTNGDVYSFGIMLMEIFTR 301
           E        +        D+Y+ G++  EI  R
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 100/199 (50%), Gaps = 11/199 (5%)
Query: 110 LIGKGGFGSVYKAIIQ----DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKI 164
           +IG G FG V    ++      + VA+K     Y E   + F  E  +M +  H N+I +
Sbjct: 40  VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHL 99
Query: 165 ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPI 224
               +      ++ E+M +GSL+  L  ++    + Q + ++  +A+ ++YL        
Sbjct: 100 EGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMNY 156
Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA---TIGYMAPEYGREGR 281
           +H DL   N+L++ N+V  +SDFG+++ L ++    T T  L     I + APE  +  +
Sbjct: 157 VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRK 216
Query: 282 VSTNGDVYSFGIMLMEIFT 300
            ++  DV+S+GI++ E+ +
Sbjct: 217 FTSASDVWSYGIVMWEVMS 235

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 7/200 (3%)
Query: 103 NDANMPPLIGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNL 161
            D  M   +G G +G VY+ + +   + VAVK          + F  E  VMK I H NL
Sbjct: 14  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNL 72
Query: 162 IKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYI-LDIFQRLDIMIDVASALEYLHFGY 220
           ++++   + +    ++ E+M +G+L   L   N   ++    L +   ++SA+EYL    
Sbjct: 73  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--- 129
Query: 221 SAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREG 280
               IH DL   N L+ +N +  ++DFG+++ L+  D           I + APE     
Sbjct: 130 KKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAPAGAKFPIKWTAPESLAYN 188
Query: 281 RVSTNGDVYSFGIMLMEIFT 300
           + S   DV++FG++L EI T
Sbjct: 189 KFSIKSDVWAFGVLLWEIAT 208

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 105/231 (45%), Gaps = 22/231 (9%)
Query: 111 IGKGGFGSVYKAII-----QDGMEVAVKVFDPQYEG-AFKSFDIECDVMKRICHRNLIKI 164
           +G+G FG V            G +VAVK   P+  G        E ++++ + H N++K 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 165 ISSYSNDDFKA--LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSA 222
               + D      L++E++P GSL++ L  +   +++ Q+L   + +   ++YL    S 
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SR 145
Query: 223 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT-QTQTLATIGYMAPEYGREGR 281
             +H DL   NVL++      + DFG+ K +  + +  T +    + + + APE   + +
Sbjct: 146 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSK 205
Query: 282 VSTNGDVYSFGIMLMEIFTRTKPTDEIFS----------GEMTLKRWVNDL 322
                DV+SFG+ L E+ T         +          G+MT+ R VN L
Sbjct: 206 FYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL 256

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 104/212 (49%), Gaps = 11/212 (5%)
Query: 111 IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYS 169
           +G G FG VYKA  ++ G   A KV + + E   + + +E +++    H  ++K++ +Y 
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 170 NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
           +D    +++E+ P G+++  +   +  L   Q   I +     LE L+F +S  IIH DL
Sbjct: 79  HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ---IQVVCRQMLEALNFLHSKRIIHRDL 135
Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEY-----GREGRVST 284
           K  NVL+       L+DFG++   L+  Q   +   + T  +MAPE       ++     
Sbjct: 136 KAGNVLMTLEGDIRLADFGVSAKNLKTLQK--RDSFIGTPYWMAPEVVMCETMKDTPYDY 193
Query: 285 NGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLK 316
             D++S GI L+E+     P  E+    + LK
Sbjct: 194 KADIWSLGITLIEMAQIEPPHHELNPMRVLLK 225

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 7/200 (3%)
Query: 103 NDANMPPLIGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNL 161
            D  M   +G G +G VY+ + +   + VAVK          + F  E  VMK I H NL
Sbjct: 11  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNL 69
Query: 162 IKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYI-LDIFQRLDIMIDVASALEYLHFGY 220
           ++++   + +    ++ E+M +G+L   L   N   +     L +   ++SA+EYL    
Sbjct: 70  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--- 126
Query: 221 SAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREG 280
               IH DL   N L+ +N +  ++DFG+++ L+  D           I + APE     
Sbjct: 127 KKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTFTAHAGAKFPIKWTAPESLAYN 185
Query: 281 RVSTNGDVYSFGIMLMEIFT 300
           + S   DV++FG++L EI T
Sbjct: 186 KFSIKSDVWAFGVLLWEIAT 205

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 7/200 (3%)
Query: 103 NDANMPPLIGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNL 161
            D  M   +G G +G VY+ + +   + VAVK          + F  E  VMK I H NL
Sbjct: 15  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNL 73
Query: 162 IKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYI-LDIFQRLDIMIDVASALEYLHFGY 220
           ++++   + +    ++ E+M +G+L   L   N   ++    L +   ++SA+EYL    
Sbjct: 74  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--- 130
Query: 221 SAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREG 280
               IH DL   N L+ +N +  ++DFG+++ L+  D           I + APE     
Sbjct: 131 KKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAPAGAKFPIKWTAPESLAYN 189
Query: 281 RVSTNGDVYSFGIMLMEIFT 300
           + S   DV++FG++L EI T
Sbjct: 190 KFSIKSDVWAFGVLLWEIAT 209

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 23/224 (10%)
Query: 111 IGKGGFGSVYKA----IIQDGMEVAVKVFDPQYEGAFKS---FDIECDVMKRICHRNLIK 163
           +G+G FG VY+     II+   E  V V       + +    F  E  VMK     ++++
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILD-----------IFQRLDIMIDVASA 212
           ++   S      +V+E M HG L+   YL +   +           + + + +  ++A  
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKS--YLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 141
Query: 213 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYM 272
           + YL+   +   +H DL   N ++  +    + DFGM + + E D      + L  + +M
Sbjct: 142 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 198
Query: 273 APEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLK 316
           APE  ++G  +T+ D++SFG++L EI +  +   +  S E  LK
Sbjct: 199 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 242

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 31/213 (14%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGA-FKSFDIECDVMKRICHRNLIKIISSYS 169
           IGKG FG V++   + G EVAVK+F  + E + F+  +I   VM R  H N++  I++ +
Sbjct: 37  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLR--HENILGFIAADN 93
Query: 170 NDDFKA----LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHF------G 219
            D+       LV +Y  HGSL    YL+ Y + +   + + +  AS L +LH       G
Sbjct: 94  KDNGTWTQLWLVSDYHEHGSLFD--YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQG 151
Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS-----LTQTQTLATIGYMAP 274
             A I H DLK  N+L+  N    ++D G+A   +  D +     +     + T  YMAP
Sbjct: 152 KPA-IAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPNHRVGTKRYMAP 207
Query: 275 EY------GREGRVSTNGDVYSFGIMLMEIFTR 301
           E        +        D+Y+ G++  EI  R
Sbjct: 208 EVLDDSINMKHFESFKRADIYAMGLVFWEIARR 240

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 105/231 (45%), Gaps = 22/231 (9%)
Query: 111 IGKGGFGSVYKAII-----QDGMEVAVKVFDPQYEG-AFKSFDIECDVMKRICHRNLIKI 164
           +G+G FG V            G +VAVK   P+  G        E ++++ + H N++K 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 165 ISSYSNDDFKA--LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSA 222
               + D      L++E++P GSL++ L  +   +++ Q+L   + +   ++YL    S 
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SR 133
Query: 223 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT-QTQTLATIGYMAPEYGREGR 281
             +H DL   NVL++      + DFG+ K +  + +  T +    + + + APE   + +
Sbjct: 134 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSK 193
Query: 282 VSTNGDVYSFGIMLMEIFTRTKPTDEIFS----------GEMTLKRWVNDL 322
                DV+SFG+ L E+ T         +          G+MT+ R VN L
Sbjct: 194 FYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL 244

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 97/203 (47%), Gaps = 11/203 (5%)
Query: 110 LIGKGGFGSVYKA----IIQDGMEVAVKVFDPQYE-GAFKSFDIECDVMKRICHRNLIKI 164
           +IGKG FG VY        Q+ ++ A+K      E    ++F  E  +M+ + H N++ +
Sbjct: 28  VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87
Query: 165 IS-SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
           I      +    ++L YM HG L + +        +   +   + VA  +EYL       
Sbjct: 88  IGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL---AEQK 144
Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAPEYGREGR 281
            +H DL   N +LD++    ++DFG+A+ +L+ +    Q    A   + + A E  +  R
Sbjct: 145 FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYR 204
Query: 282 VSTNGDVYSFGIMLMEIFTRTKP 304
            +T  DV+SFG++L E+ TR  P
Sbjct: 205 FTTKSDVWSFGVLLWELLTRGAP 227

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 31/213 (14%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGA-FKSFDIECDVMKRICHRNLIKIISSYS 169
           IGKG FG V++   + G EVAVK+F  + E + F+  +I   VM R  H N++  I++ +
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLR--HENILGFIAADN 67
Query: 170 NDDFKA----LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHF------G 219
            D+       LV +Y  HGSL    YL+ Y + +   + + +  AS L +LH       G
Sbjct: 68  KDNGTWTQLWLVSDYHEHGSLFD--YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQG 125
Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS-----LTQTQTLATIGYMAP 274
             A I H DLK  N+L+  N    ++D G+A   +  D +     +     + T  YMAP
Sbjct: 126 KPA-IAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 275 EY------GREGRVSTNGDVYSFGIMLMEIFTR 301
           E        +        D+Y+ G++  EI  R
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARR 214

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 104/212 (49%), Gaps = 11/212 (5%)
Query: 111 IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYS 169
           +G G FG VYKA  ++ G   A KV + + E   + + +E +++    H  ++K++ +Y 
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 170 NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
           +D    +++E+ P G+++  +   +  L   Q   I +     LE L+F +S  IIH DL
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ---IQVVCRQMLEALNFLHSKRIIHRDL 143
Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEY-----GREGRVST 284
           K  NVL+       L+DFG++   L+  Q   +   + T  +MAPE       ++     
Sbjct: 144 KAGNVLMTLEGDIRLADFGVSAKNLKTLQK--RDSFIGTPYWMAPEVVMCETMKDTPYDY 201
Query: 285 NGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLK 316
             D++S GI L+E+     P  E+    + LK
Sbjct: 202 KADIWSLGITLIEMAQIEPPHHELNPMRVLLK 233

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 23/224 (10%)
Query: 111 IGKGGFGSVYKA----IIQDGMEVAVKVFDPQYEGAFKS---FDIECDVMKRICHRNLIK 163
           +G+G FG VY+     II+   E  V V       + +    F  E  VMK     ++++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILD-----------IFQRLDIMIDVASA 212
           ++   S      +V+E M HG L+   YL +   +           + + + +  ++A  
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKS--YLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 213 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYM 272
           + YL+   +   +H DL   N ++  +    + DFGM + + E D      + L  + +M
Sbjct: 143 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 199
Query: 273 APEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLK 316
           APE  ++G  +T+ D++SFG++L EI +  +   +  S E  LK
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 243

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 31/213 (14%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGA-FKSFDIECDVMKRICHRNLIKIISSYS 169
           IGKG FG V++   + G EVAVK+F  + E + F+  +I   VM R  H N++  I++ +
Sbjct: 14  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLR--HENILGFIAADN 70
Query: 170 NDDFKA----LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHF------G 219
            D+       LV +Y  HGSL    YL+ Y + +   + + +  AS L +LH       G
Sbjct: 71  KDNGTWTQLWLVSDYHEHGSLFD--YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQG 128
Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS-----LTQTQTLATIGYMAP 274
             A I H DLK  N+L+  N    ++D G+A   +  D +     +     + T  YMAP
Sbjct: 129 KPA-IAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPNHRVGTKRYMAP 184
Query: 275 EY------GREGRVSTNGDVYSFGIMLMEIFTR 301
           E        +        D+Y+ G++  EI  R
Sbjct: 185 EVLDDSINMKHFESFKRADIYAMGLVFWEIARR 217

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 31/213 (14%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGA-FKSFDIECDVMKRICHRNLIKIISSYS 169
           IGKG FG V++   + G EVAVK+F  + E + F+  +I   VM R  H N++  I++ +
Sbjct: 12  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLR--HENILGFIAADN 68
Query: 170 NDDFKA----LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHF------G 219
            D+       LV +Y  HGSL    YL+ Y + +   + + +  AS L +LH       G
Sbjct: 69  KDNGTWTQLWLVSDYHEHGSLFD--YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQG 126
Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS-----LTQTQTLATIGYMAP 274
             A I H DLK  N+L+  N    ++D G+A   +  D +     +     + T  YMAP
Sbjct: 127 KPA-IAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPNHRVGTKRYMAP 182
Query: 275 EY------GREGRVSTNGDVYSFGIMLMEIFTR 301
           E        +        D+Y+ G++  EI  R
Sbjct: 183 EVLDDSINMKHFESFKRADIYAMGLVFWEIARR 215

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 31/213 (14%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGA-FKSFDIECDVMKRICHRNLIKIISSYS 169
           IGKG FG V++   + G EVAVK+F  + E + F+  +I   VM R  H N++  I++ +
Sbjct: 17  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLR--HENILGFIAADN 73
Query: 170 NDDFKA----LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHF------G 219
            D+       LV +Y  HGSL    YL+ Y + +   + + +  AS L +LH       G
Sbjct: 74  KDNGTWTQLWLVSDYHEHGSLFD--YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQG 131
Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS-----LTQTQTLATIGYMAP 274
             A I H DLK  N+L+  N    ++D G+A   +  D +     +     + T  YMAP
Sbjct: 132 KPA-IAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPNHRVGTKRYMAP 187
Query: 275 EY------GREGRVSTNGDVYSFGIMLMEIFTR 301
           E        +        D+Y+ G++  EI  R
Sbjct: 188 EVLDDSINMKHFESFKRADIYAMGLVFWEIARR 220

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 104/222 (46%), Gaps = 19/222 (8%)
Query: 111 IGKGGFGSVY----KAIIQDGMEVAVKVFDPQYEGAFKS---FDIECDVMKRICHRNLIK 163
           +G+G FG VY    K +++D  E  V +       + +    F  E  VMK     ++++
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLY------LSNYIL---DIFQRLDIMIDVASALE 214
           ++   S      +++E M  G L+  L        +N +L    + + + +  ++A  + 
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 215 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 274
           YL+   +   +H DL   N ++ ++    + DFGM + + E D      + L  + +M+P
Sbjct: 153 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 209
Query: 275 EYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLK 316
           E  ++G  +T  DV+SFG++L EI T  +   +  S E  L+
Sbjct: 210 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 251

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 104/222 (46%), Gaps = 19/222 (8%)
Query: 111 IGKGGFGSVY----KAIIQDGMEVAVKVFDPQYEGAFKS---FDIECDVMKRICHRNLIK 163
           +G+G FG VY    K +++D  E  V +       + +    F  E  VMK     ++++
Sbjct: 23  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 82
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLY------LSNYIL---DIFQRLDIMIDVASALE 214
           ++   S      +++E M  G L+  L        +N +L    + + + +  ++A  + 
Sbjct: 83  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 142
Query: 215 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 274
           YL+   +   +H DL   N ++ ++    + DFGM + + E D      + L  + +M+P
Sbjct: 143 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 199
Query: 275 EYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLK 316
           E  ++G  +T  DV+SFG++L EI T  +   +  S E  L+
Sbjct: 200 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 241

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 110 LIGKGGFGSVYKAIIQ----DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKI 164
           ++G G FG V    ++      + VA+K     Y E   + F  E  +M +  H N+I++
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 165 ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPI 224
               +      +V E M +GSL+  L   +    + Q + ++  +AS ++YL        
Sbjct: 112 EGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGA 168
Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAPEYGREGRV 282
           +H DL   N+L++ N+V  +SDFG+++ +LE+D     T       I + +PE     + 
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLSR-VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 227
Query: 283 STNGDVYSFGIMLMEIFT 300
           ++  DV+S+GI+L E+ +
Sbjct: 228 TSASDVWSYGIVLWEVMS 245

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 104/222 (46%), Gaps = 19/222 (8%)
Query: 111 IGKGGFGSVY----KAIIQDGMEVAVKVFDPQYEGAFKS---FDIECDVMKRICHRNLIK 163
           +G+G FG VY    K +++D  E  V +       + +    F  E  VMK     ++++
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYL------SNYIL---DIFQRLDIMIDVASALE 214
           ++   S      +++E M  G L+  L        +N +L    + + + +  ++A  + 
Sbjct: 86  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 145
Query: 215 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 274
           YL+   +   +H DL   N ++ ++    + DFGM + + E D      + L  + +M+P
Sbjct: 146 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 202
Query: 275 EYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLK 316
           E  ++G  +T  DV+SFG++L EI T  +   +  S E  L+
Sbjct: 203 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 244

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 104/222 (46%), Gaps = 19/222 (8%)
Query: 111 IGKGGFGSVY----KAIIQDGMEVAVKVFDPQYEGAFKS---FDIECDVMKRICHRNLIK 163
           +G+G FG VY    K +++D  E  V +       + +    F  E  VMK     ++++
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYL------SNYIL---DIFQRLDIMIDVASALE 214
           ++   S      +++E M  G L+  L        +N +L    + + + +  ++A  + 
Sbjct: 80  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 139
Query: 215 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 274
           YL+   +   +H DL   N ++ ++    + DFGM + + E D      + L  + +M+P
Sbjct: 140 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 196
Query: 275 EYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLK 316
           E  ++G  +T  DV+SFG++L EI T  +   +  S E  L+
Sbjct: 197 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 238

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 104/222 (46%), Gaps = 19/222 (8%)
Query: 111 IGKGGFGSVY----KAIIQDGMEVAVKVFDPQYEGAFKS---FDIECDVMKRICHRNLIK 163
           +G+G FG VY    K +++D  E  V +       + +    F  E  VMK     ++++
Sbjct: 55  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 114
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYL------SNYIL---DIFQRLDIMIDVASALE 214
           ++   S      +++E M  G L+  L        +N +L    + + + +  ++A  + 
Sbjct: 115 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 174
Query: 215 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 274
           YL+   +   +H DL   N ++ ++    + DFGM + + E D      + L  + +M+P
Sbjct: 175 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 231
Query: 275 EYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLK 316
           E  ++G  +T  DV+SFG++L EI T  +   +  S E  L+
Sbjct: 232 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 273

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 104/222 (46%), Gaps = 19/222 (8%)
Query: 111 IGKGGFGSVY----KAIIQDGMEVAVKVFDPQYEGAFKS---FDIECDVMKRICHRNLIK 163
           +G+G FG VY    K +++D  E  V +       + +    F  E  VMK     ++++
Sbjct: 24  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 83
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYL------SNYIL---DIFQRLDIMIDVASALE 214
           ++   S      +++E M  G L+  L        +N +L    + + + +  ++A  + 
Sbjct: 84  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 143
Query: 215 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 274
           YL+   +   +H DL   N ++ ++    + DFGM + + E D      + L  + +M+P
Sbjct: 144 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 200
Query: 275 EYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLK 316
           E  ++G  +T  DV+SFG++L EI T  +   +  S E  L+
Sbjct: 201 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 242

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 104/222 (46%), Gaps = 19/222 (8%)
Query: 111 IGKGGFGSVY----KAIIQDGMEVAVKVFDPQYEGAFKS---FDIECDVMKRICHRNLIK 163
           +G+G FG VY    K +++D  E  V +       + +    F  E  VMK     ++++
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYL------SNYIL---DIFQRLDIMIDVASALE 214
           ++   S      +++E M  G L+  L        +N +L    + + + +  ++A  + 
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 215 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 274
           YL+   +   +H DL   N ++ ++    + DFGM + + E D      + L  + +M+P
Sbjct: 153 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 209
Query: 275 EYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLK 316
           E  ++G  +T  DV+SFG++L EI T  +   +  S E  L+
Sbjct: 210 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 251

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 28/215 (13%)
Query: 111 IGKGGFGSVYKAII--------QDGMEVAVKVF-DPQYEGAFKSFDIECDVMKRIC-HRN 160
           +G+G FG V  A          ++ + VAVK+  D   E        E ++MK I  H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 161 LIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSN-----YILDI---------FQRL-DI 205
           +I ++ + + D    +++EY   G+L + L         Y  DI         F+ L   
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
              + +MAPE   +   +   DV+SFG+++ EIFT
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 94/195 (48%), Gaps = 8/195 (4%)
Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYS 169
           IG+G  G+VY A+ +  G EVA++  + Q +   +    E  VM+   + N++  + SY 
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 170 NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
             D   +V+EY+  GSL   +  +   +D  Q   +  +   ALE+LH   S  +IH ++
Sbjct: 89  VGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQVIHRNI 143
Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 289
           K  N+LL  +    L+DFG    +  E     ++  + T  +MAPE           D++
Sbjct: 144 KSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIW 201
Query: 290 SFGIMLMEIFTRTKP 304
           S GIM +E+     P
Sbjct: 202 SLGIMAIEMIEGEPP 216

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 104/222 (46%), Gaps = 19/222 (8%)
Query: 111 IGKGGFGSVY----KAIIQDGMEVAVKVFDPQYEGAFKS---FDIECDVMKRICHRNLIK 163
           +G+G FG VY    K +++D  E  V +       + +    F  E  VMK     ++++
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYL------SNYIL---DIFQRLDIMIDVASALE 214
           ++   S      +++E M  G L+  L        +N +L    + + + +  ++A  + 
Sbjct: 86  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 145
Query: 215 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 274
           YL+   +   +H DL   N ++ ++    + DFGM + + E D      + L  + +M+P
Sbjct: 146 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 202
Query: 275 EYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLK 316
           E  ++G  +T  DV+SFG++L EI T  +   +  S E  L+
Sbjct: 203 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 244

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 105/228 (46%), Gaps = 37/228 (16%)
Query: 99  KPLPNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGA-FKSFDIECDVMKRIC 157
           + +  D  +   +GKG +G V++   Q G  VAVK+F  + E + F+  ++   VM R  
Sbjct: 4   RTVARDITLLECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVMLR-- 60
Query: 158 HRNLIKIISSYSNDDFKA----LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASAL 213
           H N++  I+S       +    L+  Y   GSL   L L+   LD    L I++ +AS L
Sbjct: 61  HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGL 118
Query: 214 EYLH---FGYSA--PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT--- 265
            +LH   FG      I H DLK  N+L+  N    ++D G+A   +   QS  Q      
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA---VMHSQSTNQLDVGNN 175
Query: 266 --LATIGYMAPE----------YGREGRVSTNGDVYSFGIMLMEIFTR 301
             + T  YMAPE          +    RV    D+++FG++L E+  R
Sbjct: 176 PRVGTKRYMAPEVLDETIQVDCFDSYKRV----DIWAFGLVLWEVARR 219

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 96/200 (48%), Gaps = 9/200 (4%)
Query: 111 IGKGGFGSVYKAIIQDGMEV-AVKVFD-PQYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
           IGKG FG V+K I     +V A+K+ D  + E   +    E  V+ +     + K   SY
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCD 228
             D    +++EY+  GS    L      LD  Q   I+ ++   L+YLH   S   IH D
Sbjct: 75  LKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH---SEKKIHRD 129
Query: 229 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDV 288
           +K +NVLL ++    L+DFG+A  L   D  + +   + T  +MAPE  ++    +  D+
Sbjct: 130 IKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNXFVGTPFWMAPEVIKQSAYDSKADI 187
Query: 289 YSFGIMLMEIFTRTKPTDEI 308
           +S GI  +E+     P  E+
Sbjct: 188 WSLGITAIELARGEPPHSEL 207

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 96/200 (48%), Gaps = 9/200 (4%)
Query: 111 IGKGGFGSVYKAIIQDGMEV-AVKVFD-PQYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
           IGKG FG V+K I     +V A+K+ D  + E   +    E  V+ +     + K   SY
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCD 228
             D    +++EY+  GS    L      LD  Q   I+ ++   L+YLH   S   IH D
Sbjct: 90  LKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH---SEKKIHRD 144
Query: 229 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDV 288
           +K +NVLL ++    L+DFG+A  L   D  + +   + T  +MAPE  ++    +  D+
Sbjct: 145 IKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNXFVGTPFWMAPEVIKQSAYDSKADI 202
Query: 289 YSFGIMLMEIFTRTKPTDEI 308
           +S GI  +E+     P  E+
Sbjct: 203 WSLGITAIELARGEPPHSEL 222

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 96/200 (48%), Gaps = 9/200 (4%)
Query: 111 IGKGGFGSVYKAIIQDGMEV-AVKVFD-PQYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
           IGKG FG V+K I     +V A+K+ D  + E   +    E  V+ +     + K   SY
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCD 228
             D    +++EY+  GS    L      LD  Q   I+ ++   L+YLH   S   IH D
Sbjct: 75  LKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH---SEKKIHRD 129
Query: 229 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDV 288
           +K +NVLL ++    L+DFG+A  L   D  + +   + T  +MAPE  ++    +  D+
Sbjct: 130 IKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVIKQSAYDSKADI 187
Query: 289 YSFGIMLMEIFTRTKPTDEI 308
           +S GI  +E+     P  E+
Sbjct: 188 WSLGITAIELARGEPPHSEL 207

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 96/200 (48%), Gaps = 9/200 (4%)
Query: 111 IGKGGFGSVYKAIIQDGMEV-AVKVFD-PQYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
           IGKG FG V+K I     +V A+K+ D  + E   +    E  V+ +     + K   SY
Sbjct: 35  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 94
Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCD 228
             D    +++EY+  GS    L      LD  Q   I+ ++   L+YLH   S   IH D
Sbjct: 95  LKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH---SEKKIHRD 149
Query: 229 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDV 288
           +K +NVLL ++    L+DFG+A  L   D  + +   + T  +MAPE  ++    +  D+
Sbjct: 150 IKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVIKQSAYDSKADI 207
Query: 289 YSFGIMLMEIFTRTKPTDEI 308
           +S GI  +E+     P  E+
Sbjct: 208 WSLGITAIELARGEPPHSEL 227

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 104/222 (46%), Gaps = 19/222 (8%)
Query: 111 IGKGGFGSVY----KAIIQDGMEVAVKVFDPQYEGAFKS---FDIECDVMKRICHRNLIK 163
           +G+G FG VY    K +++D  E  V +       + +    F  E  VMK     ++++
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYL------SNYIL---DIFQRLDIMIDVASALE 214
           ++   S      +++E M  G L+  L        +N +L    + + + +  ++A  + 
Sbjct: 87  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 146
Query: 215 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 274
           YL+   +   +H DL   N ++ ++    + DFGM + + E D      + L  + +M+P
Sbjct: 147 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 203
Query: 275 EYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLK 316
           E  ++G  +T  DV+SFG++L EI T  +   +  S E  L+
Sbjct: 204 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 245

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 28/215 (13%)
Query: 111 IGKGGFGSVYKAII--------QDGMEVAVKVF-DPQYEGAFKSFDIECDVMKRIC-HRN 160
           +G+G FG V  A          ++ + VAVK+  D   E        E ++MK I  H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 161 LIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSN-----YILDI---------FQRL-DI 205
           +I ++ + + D    +++EY   G+L + L         Y  DI         F+ L   
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNG 219
Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
              + +MAPE   +   +   DV+SFG+++ EIFT
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 28/215 (13%)
Query: 111 IGKGGFGSVYKAII--------QDGMEVAVKVF-DPQYEGAFKSFDIECDVMKRIC-HRN 160
           +G+G FG V  A          ++ + VAVK+  D   E        E ++MK I  H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 161 LIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSN-----YILDI---------FQRL-DI 205
           +I ++ + + D    +++EY   G+L + L         Y  DI         F+ L   
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNG 219
Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
              + +MAPE   +   +   DV+SFG+++ EIFT
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 101/211 (47%), Gaps = 20/211 (9%)
Query: 110 LIGKGGFGSVYKAII--QDG--MEVAVKVF--DPQYEGAFKSFDIECDVMKRICHRNLIK 163
           ++GKG FGSV +A +  +DG  ++VAVK+   D       + F  E   MK   H ++ K
Sbjct: 30  MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89
Query: 164 IISSYSNDDFKA------LVLEYMPHGSLEKCLYLSN-----YILDIFQRLDIMIDVASA 212
           ++        K       ++L +M HG L   L  S      + L +   +  M+D+A  
Sbjct: 90  LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149
Query: 213 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYM 272
           +EYL    S   IH DL   N +L ++M   ++DFG+++ +   D       +   + ++
Sbjct: 150 MEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWL 206
Query: 273 APEYGREGRVSTNGDVYSFGIMLMEIFTRTK 303
           A E   +   + + DV++FG+ + EI TR +
Sbjct: 207 ALESLADNLYTVHSDVWAFGVTMWEIMTRGQ 237

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 110 LIGKGGFGSVYKAIIQ----DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKI 164
           +IG G FG V    ++      + VA+K     Y +   + F  E  +M +  H N+I +
Sbjct: 36  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHL 95
Query: 165 ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPI 224
               +      ++ EYM +GSL+  L  ++    + Q + ++  + S ++YL        
Sbjct: 96  EGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLS---DMSA 152
Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAPEYGREGRV 282
           +H DL   N+L++ N+V  +SDFGM++ +LE+D     T       I + APE     + 
Sbjct: 153 VHRDLAARNILVNSNLVCKVSDFGMSR-VLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 211
Query: 283 STNGDVYSFGIMLMEIFT 300
           ++  DV+S+GI++ E+ +
Sbjct: 212 TSASDVWSYGIVMWEVMS 229

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 102/215 (47%), Gaps = 23/215 (10%)
Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVF------DPQYEGAFKSFDIECDVMKRICHRNLI 162
           ++G GG   V+ A  ++D  +VAVKV       DP +   +  F  E      + H  ++
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSF---YLRFRREAQNAAALNHPAIV 75
Query: 163 KIISSYSNDD----FKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHF 218
            +  +   +        +V+EY+   +L   ++       +  +  I + +A A + L+F
Sbjct: 76  AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEV-IADACQALNF 131
Query: 219 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT-LATIGYMAPEYG 277
            +   IIH D+KP+N+++       + DFG+A+ + +   S+TQT   + T  Y++PE  
Sbjct: 132 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 278 REGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE 312
           R   V    DVYS G +L E+ T   P    F+G+
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPP----FTGD 222

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 102/215 (47%), Gaps = 23/215 (10%)
Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVF------DPQYEGAFKSFDIECDVMKRICHRNLI 162
           ++G GG   V+ A  ++D  +VAVKV       DP +   +  F  E      + H  ++
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSF---YLRFRREAQNAAALNHPAIV 75
Query: 163 KIISSYSNDD----FKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHF 218
            +  +   +        +V+EY+   +L   ++       +  +  I + +A A + L+F
Sbjct: 76  AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEV-IADACQALNF 131
Query: 219 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT-LATIGYMAPEYG 277
            +   IIH D+KP+N+++       + DFG+A+ + +   S+TQT   + T  Y++PE  
Sbjct: 132 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 278 REGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE 312
           R   V    DVYS G +L E+ T   P    F+G+
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPP----FTGD 222

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 103/224 (45%), Gaps = 23/224 (10%)
Query: 111 IGKGGFGSVYKA----IIQDGMEVAVKVFDPQYEGAFKS---FDIECDVMKRICHRNLIK 163
           +G+G FG VY+     II+   E  V V       + +    F  E  VMK     ++++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILD-----------IFQRLDIMIDVASA 212
           ++   S      +V+E M HG L+   YL +   +           + + + +  ++A  
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKS--YLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 213 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYM 272
           + YL+   +   +H +L   N ++  +    + DFGM + + E D      + L  + +M
Sbjct: 143 MAYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 199
Query: 273 APEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLK 316
           APE  ++G  +T+ D++SFG++L EI +  +   +  S E  LK
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 243

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 103/224 (45%), Gaps = 23/224 (10%)
Query: 111 IGKGGFGSVYKA----IIQDGMEVAVKVFDPQYEGAFKS---FDIECDVMKRICHRNLIK 163
           +G+G FG VY+     II+   E  V V       + +    F  E  VMK     ++++
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILD-----------IFQRLDIMIDVASA 212
           ++   S      +V+E M HG L+   YL +   +           + + + +  ++A  
Sbjct: 86  LLGVVSKGQPTLVVMELMAHGDLKS--YLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 143
Query: 213 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYM 272
           + YL+   +   +H +L   N ++  +    + DFGM + + E D      + L  + +M
Sbjct: 144 MAYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 200
Query: 273 APEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLK 316
           APE  ++G  +T+ D++SFG++L EI +  +   +  S E  LK
Sbjct: 201 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 244

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 73/235 (31%), Positives = 112/235 (47%), Gaps = 47/235 (20%)
Query: 110 LIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMK--RICHRNLIKIISS 167
           LIG+G +G+VYK  + D   VAVKVF        ++F  E ++ +   + H N+ + I  
Sbjct: 20  LIGRGRYGAVYKGSL-DERPVAVKVFSF---ANRQNFINEKNIYRVPLMEHDNIARFI-- 73
Query: 168 YSNDDFKA-------LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHF-- 218
             ++   A       LV+EY P+GSL K  YLS +  D      +   V   L YLH   
Sbjct: 74  VGDERVTADGRMEYLLVMEYYPNGSLXK--YLSLHTSDWVSSCRLAHSVTRGLAYLHTEL 131
Query: 219 ----GYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMA---------KPLLEEDQSLTQTQT 265
                Y   I H DL   NVL+ ++    +SDFG++         +P  E++ ++++   
Sbjct: 132 PRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISE--- 188
Query: 266 LATIGYMAPEYGREGRVSTNG--------DVYSFGIMLMEIFTRTKPTDEIFSGE 312
           + TI YMAPE   EG V+           D+Y+ G++  EIF R     ++F GE
Sbjct: 189 VGTIRYMAPEV-LEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT---DLFPGE 239

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 28/215 (13%)
Query: 111 IGKGGFGSVYKAII--------QDGMEVAVKVF-DPQYEGAFKSFDIECDVMKRIC-HRN 160
           +G+G FG V  A          ++ + VAVK+  D   E        E ++MK I  H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 161 LIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSN-----YILDI---------FQRL-DI 205
           +I ++ + + D    +++EY   G+L + L         Y  DI         F+ L   
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
              + +MAPE   +   +   DV+SFG+++ EIFT
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 103/222 (46%), Gaps = 19/222 (8%)
Query: 111 IGKGGFGSVY----KAIIQDGMEVAVKVFDPQYEGAFKS---FDIECDVMKRICHRNLIK 163
           +G+G FG VY    K +++D  E  V +       + +    F  E  VMK     ++++
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYL------SNYIL---DIFQRLDIMIDVASALE 214
           ++   S      +++E M  G L+  L        +N +L    + + + +  ++A  + 
Sbjct: 80  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 139
Query: 215 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 274
           YL+   +   +H DL   N  + ++    + DFGM + + E D      + L  + +M+P
Sbjct: 140 YLN---ANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 196
Query: 275 EYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLK 316
           E  ++G  +T  DV+SFG++L EI T  +   +  S E  L+
Sbjct: 197 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 238

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 95/200 (47%), Gaps = 9/200 (4%)
Query: 111 IGKGGFGSVYKAIIQDGMEV-AVKVFD-PQYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
           IGKG FG V+K I     +V A+K+ D  + E   +    E  V+ +     + K   SY
Sbjct: 31  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYYGSY 90
Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCD 228
                  +++EY+  GS    L    +  D FQ   ++ ++   L+YLH   S   IH D
Sbjct: 91  LKGSKLWIIMEYLGGGSALDLLRAGPF--DEFQIATMLKEILKGLDYLH---SEKKIHRD 145
Query: 229 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDV 288
           +K +NVLL +     L+DFG+A  L   D  + +   + T  +MAPE  ++    +  D+
Sbjct: 146 IKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVIQQSAYDSKADI 203
Query: 289 YSFGIMLMEIFTRTKPTDEI 308
           +S GI  +E+     P  ++
Sbjct: 204 WSLGITAIELAKGEPPNSDM 223

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 28/215 (13%)
Query: 111 IGKGGFGSVYKAII--------QDGMEVAVKVF-DPQYEGAFKSFDIECDVMKRIC-HRN 160
           +G+G FG V  A          ++ + VAVK+  D   E        E ++MK I  H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 161 LIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSN-----YILDI---------FQRL-DI 205
           +I ++ + + D    +++EY   G+L + L         Y  DI         F+ L   
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
              + +MAPE   +   +   DV+SFG+++ EIFT
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 103/199 (51%), Gaps = 13/199 (6%)
Query: 110 LIGKGGFGSVYKAIIQDGME-VAVKVFDPQY-----EGAFKSFDIECDVMKRICHRNLIK 163
            +G+G F +VYKA  ++  + VA+K     +     +G  ++   E  +++ + H N+I 
Sbjct: 17  FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 76
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
           ++ ++ +    +LV ++M    LE  +  ++ +L        M+     LEYLH  +   
Sbjct: 77  LLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--- 132
Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVS 283
           I+H DLKP+N+LLD+N V  L+DFG+AK     +++      + T  Y APE     R+ 
Sbjct: 133 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--XHQVVTRWYRAPELLFGARMY 190
Query: 284 TNG-DVYSFGIMLMEIFTR 301
             G D+++ G +L E+  R
Sbjct: 191 GVGVDMWAVGCILAELLLR 209

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 110 LIGKGGFGSVYKAIIQ----DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKI 164
           +IG G FG V    ++      + VA+K     Y +   + F  E  +M +  H N+I +
Sbjct: 15  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHL 74
Query: 165 ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPI 224
               +      ++ EYM +GSL+  L  ++    + Q + ++  + S ++YL        
Sbjct: 75  EGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLS---DMSY 131
Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAPEYGREGRV 282
           +H DL   N+L++ N+V  +SDFGM++ +LE+D     T       I + APE     + 
Sbjct: 132 VHRDLAARNILVNSNLVCKVSDFGMSR-VLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 190
Query: 283 STNGDVYSFGIMLMEIFT 300
           ++  DV+S+GI++ E+ +
Sbjct: 191 TSASDVWSYGIVMWEVMS 208

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 110 LIGKGGFGSVYKAIIQ----DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKI 164
           +IG G FG V    ++      + VA+K     Y +   + F  E  +M +  H N+I +
Sbjct: 21  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHL 80
Query: 165 ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPI 224
               +      ++ EYM +GSL+  L  ++    + Q + ++  + S ++YL        
Sbjct: 81  EGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLS---DMSY 137
Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAPEYGREGRV 282
           +H DL   N+L++ N+V  +SDFGM++ +LE+D     T       I + APE     + 
Sbjct: 138 VHRDLAARNILVNSNLVCKVSDFGMSR-VLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 196
Query: 283 STNGDVYSFGIMLMEIFT 300
           ++  DV+S+GI++ E+ +
Sbjct: 197 TSASDVWSYGIVMWEVMS 214

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 28/215 (13%)
Query: 111 IGKGGFGSVYKAII--------QDGMEVAVKVF-DPQYEGAFKSFDIECDVMKRIC-HRN 160
           +G+G FG V  A          ++ + VAVK+  D   E        E ++MK I  H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 161 LIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSN-----YILDI---------FQRL-DI 205
           +I ++ + + D    +++EY   G+L + L         Y  DI         F+ L   
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
              + +MAPE   +   +   DV+SFG+++ EIFT
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 110/215 (51%), Gaps = 24/215 (11%)
Query: 102 PNDANMPPLIGKGGFGSVY---KAIIQDGMEV-AVKVFDPQYEGAFKSFD-----IECDV 152
           P+   +  ++G+G FG V+   K    D  ++ A+KV     +   K  D     +E D+
Sbjct: 23  PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLK---KATLKVRDRVRTKMERDI 79
Query: 153 MKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDI---MIDV 209
           +  + H  ++K+  ++  +    L+L+++  G L     LS  ++  F   D+   + ++
Sbjct: 80  LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDL--FTRLSKEVM--FTEEDVKFYLAEL 135
Query: 210 ASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATI 269
           A AL++LH   S  II+ DLKP N+LLD+     L+DFG++K  ++ ++         T+
Sbjct: 136 ALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCGTV 190
Query: 270 GYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKP 304
            YMAPE       + + D +SFG+++ E+ T T P
Sbjct: 191 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 110/215 (51%), Gaps = 24/215 (11%)
Query: 102 PNDANMPPLIGKGGFGSVY---KAIIQDGMEV-AVKVFDPQYEGAFKSFD-----IECDV 152
           P+   +  ++G+G FG V+   K    D  ++ A+KV     +   K  D     +E D+
Sbjct: 24  PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLK---KATLKVRDRVRTKMERDI 80
Query: 153 MKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDI---MIDV 209
           +  + H  ++K+  ++  +    L+L+++  G L     LS  ++  F   D+   + ++
Sbjct: 81  LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDL--FTRLSKEVM--FTEEDVKFYLAEL 136
Query: 210 ASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATI 269
           A AL++LH   S  II+ DLKP N+LLD+     L+DFG++K  ++ ++         T+
Sbjct: 137 ALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCGTV 191
Query: 270 GYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKP 304
            YMAPE       + + D +SFG+++ E+ T T P
Sbjct: 192 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 226

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 28/215 (13%)
Query: 111 IGKGGFGSVYKAII--------QDGMEVAVKVF-DPQYEGAFKSFDIECDVMKRIC-HRN 160
           +G+G FG V  A          ++ + VAVK+  D   E        E ++MK I  H+N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 161 LIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSN-----YILDI---------FQRL-DI 205
           +I ++ + + D    +++EY   G+L + L         Y  DI         F+ L   
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T  
Sbjct: 209 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265
Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
              + +MAPE   +   +   DV+SFG+++ EIFT
Sbjct: 266 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 103/227 (45%), Gaps = 18/227 (7%)
Query: 92  LRYQKRGKPLPNDANMPPLIGKGGFGSVYKAII-----QDG-MEVAVKVFDPQYEGAFK- 144
           L Y ++ +   N+      +G G FG V +A       +D  ++VAVK+         K 
Sbjct: 35  LPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKE 94
Query: 145 SFDIECDVMKRIC-HRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL 203
           +   E  +M  +  H N++ ++ + ++     ++ EY  +G L   L   + +L+     
Sbjct: 95  ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAF 154
Query: 204 DIMIDVASALEYLHFG----------YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL 253
            I    AS  + LHF            S   IH D+   NVLL +  VA + DFG+A+ +
Sbjct: 155 AIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI 214
Query: 254 LEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
           + +   + +      + +MAPE   +   +   DV+S+GI+L EIF+
Sbjct: 215 MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 110/215 (51%), Gaps = 24/215 (11%)
Query: 102 PNDANMPPLIGKGGFGSVY---KAIIQDGMEV-AVKVFDPQYEGAFKSFD-----IECDV 152
           P+   +  ++G+G FG V+   K    D  ++ A+KV     +   K  D     +E D+
Sbjct: 23  PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLK---KATLKVRDRVRTKMERDI 79
Query: 153 MKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDI---MIDV 209
           +  + H  ++K+  ++  +    L+L+++  G L     LS  ++  F   D+   + ++
Sbjct: 80  LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDL--FTRLSKEVM--FTEEDVKFYLAEL 135
Query: 210 ASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATI 269
           A AL++LH   S  II+ DLKP N+LLD+     L+DFG++K  ++ ++         T+
Sbjct: 136 ALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCGTV 190
Query: 270 GYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKP 304
            YMAPE       + + D +SFG+++ E+ T T P
Sbjct: 191 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 101/215 (46%), Gaps = 28/215 (13%)
Query: 111 IGKGGFGSVYKAII--------QDGMEVAVKVF-DPQYEGAFKSFDIECDVMKRIC-HRN 160
           +G+G FG V  A          ++ + VAVK+  D   E        E ++MK I  H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 161 LIKIISSYSNDDFKALVLEYMPHGSLEKCL-----------YLSNYILD---IFQRL-DI 205
           +I ++ + + D    +++EY   G+L + L           Y  N + +    F+ L   
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
              + +MAPE   +   +   DV+SFG+++ EIFT
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 99/199 (49%), Gaps = 11/199 (5%)
Query: 110 LIGKGGFGSVYKAIIQ----DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKI 164
           +IG G FG V    ++      + VA+K     Y E   + F  E  +M +  H N+I +
Sbjct: 14  VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHL 73
Query: 165 ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPI 224
               +      ++ E+M +GSL+  L  ++    + Q + ++  +A+ ++YL        
Sbjct: 74  EGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMNY 130
Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA---TIGYMAPEYGREGR 281
           +H  L   N+L++ N+V  +SDFG+++ L ++    T T  L     I + APE  +  +
Sbjct: 131 VHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRK 190
Query: 282 VSTNGDVYSFGIMLMEIFT 300
            ++  DV+S+GI++ E+ +
Sbjct: 191 FTSASDVWSYGIVMWEVMS 209

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 94/199 (47%), Gaps = 13/199 (6%)
Query: 111 IGKGGFGSV----YKAIIQD-GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLI--- 162
           +GKG FGSV    Y  +  + G  VAVK          + F  E  ++K + H + I   
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-HSDFIVKY 73
Query: 163 KIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSA 222
           + +S         LV+EY+P G L   L      LD  + L     +   +EYL    S 
Sbjct: 74  RGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SR 130
Query: 223 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LEEDQSLTQTQTLATIGYMAPEYGREGR 281
             +H DL   N+L++      ++DFG+AK L L++D  + +    + I + APE   +  
Sbjct: 131 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNI 190
Query: 282 VSTNGDVYSFGIMLMEIFT 300
            S   DV+SFG++L E+FT
Sbjct: 191 FSRQSDVWSFGVVLYELFT 209

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 28/215 (13%)
Query: 111 IGKGGFGSVYKAII--------QDGMEVAVKVF-DPQYEGAFKSFDIECDVMKRIC-HRN 160
           +G+G FG V  A          ++ + VAVK+  D   E        E ++MK I  H+N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 161 LIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSN-----YILDI---------FQRL-DI 205
           +I ++ + + D    +++EY   G+L + L         Y  DI         F+ L   
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T  
Sbjct: 150 TYQLARGMEYLA---SQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 206
Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
              + +MAPE   +   +   DV+SFG+++ EIFT
Sbjct: 207 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 101/216 (46%), Gaps = 37/216 (17%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGA-FKSFDIECDVMKRICHRNLIKIISSYS 169
           +GKG +G V++   Q G  VAVK+F  + E + F+  ++   VM R  H N++  I+S  
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVMLR--HENILGFIASDM 72
Query: 170 NDDFKA----LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLH---FGYSA 222
                +    L+  Y   GSL   L L+   LD    L I++ +AS L +LH   FG   
Sbjct: 73  TSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEIFGTQG 130
Query: 223 --PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT-----LATIGYMAPE 275
              I H DLK  N+L+  N    ++D G+A   +   QS  Q        + T  YMAPE
Sbjct: 131 KPAIAHRDLKSKNILVKKNGQCCIADLGLA---VMHSQSTNQLDVGNNPRVGTKRYMAPE 187
Query: 276 ----------YGREGRVSTNGDVYSFGIMLMEIFTR 301
                     +    RV    D+++FG++L E+  R
Sbjct: 188 VLDETIQVDCFDSYKRV----DIWAFGLVLWEVARR 219

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 23/215 (10%)
Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVF------DPQYEGAFKSFDIECDVMKRICHRNLI 162
           ++G GG   V+ A  ++D  +VAVKV       DP +   +  F  E      + H  ++
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSF---YLRFRREAQNAAALNHPAIV 75
Query: 163 KIISSYSNDD----FKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHF 218
            +  +   +        +V+EY+   +L   ++       +  +  I + +A A + L+F
Sbjct: 76  AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEV-IADACQALNF 131
Query: 219 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT-LATIGYMAPEYG 277
            +   IIH D+KP+N+L+       + DFG+A+ + +   S+ QT   + T  Y++PE  
Sbjct: 132 SHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQA 191
Query: 278 REGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE 312
           R   V    DVYS G +L E+ T   P    F+G+
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPP----FTGD 222

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 101/216 (46%), Gaps = 37/216 (17%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGA-FKSFDIECDVMKRICHRNLIKIISSYS 169
           +GKG +G V++   Q G  VAVK+F  + E + F+  ++   VM R  H N++  I+S  
Sbjct: 45  VGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVMLR--HENILGFIASDM 101
Query: 170 NDDFKA----LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLH---FGYSA 222
                +    L+  Y   GSL   L L+   LD    L I++ +AS L +LH   FG   
Sbjct: 102 TSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEIFGTQG 159
Query: 223 --PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT-----LATIGYMAPE 275
              I H DLK  N+L+  N    ++D G+A   +   QS  Q        + T  YMAPE
Sbjct: 160 KPAIAHRDLKSKNILVKKNGQCCIADLGLA---VMHSQSTNQLDVGNNPRVGTKRYMAPE 216
Query: 276 ----------YGREGRVSTNGDVYSFGIMLMEIFTR 301
                     +    RV    D+++FG++L E+  R
Sbjct: 217 VLDETIQVDCFDSYKRV----DIWAFGLVLWEVARR 248

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 28/215 (13%)
Query: 111 IGKGGFGSVYKAII--------QDGMEVAVKVF-DPQYEGAFKSFDIECDVMKRIC-HRN 160
           +G+G FG V  A          ++ + VAVK+  D   E        E ++MK I  H+N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 161 LIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSN-----YILDI---------FQRL-DI 205
           +I ++ + + D    +++EY   G+L + L         Y  DI         F+ L   
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T  
Sbjct: 152 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 208
Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
              + +MAPE   +   +   DV+SFG+++ EIFT
Sbjct: 209 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 28/215 (13%)
Query: 111 IGKGGFGSVYKAII--------QDGMEVAVKVF-DPQYEGAFKSFDIECDVMKRIC-HRN 160
           +G+G FG V  A          ++ + VAVK+  D   E        E ++MK I  H+N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 161 LIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSN-----YILDI---------FQRL-DI 205
           +I ++ + + D    +++EY   G+L + L         Y  DI         F+ L   
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T  
Sbjct: 155 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 211
Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
              + +MAPE   +   +   DV+SFG+++ EIFT
Sbjct: 212 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 102/224 (45%), Gaps = 23/224 (10%)
Query: 111 IGKGGFGSVYKA----IIQDGMEVAVKVFDPQYEGAFKS---FDIECDVMKRICHRNLIK 163
           +G+G FG VY+     II+   E  V V       + +    F  E  VMK     ++++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILD-----------IFQRLDIMIDVASA 212
           ++   S      +V+E M HG L+   YL +   +           + + + +  ++A  
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKS--YLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 213 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYM 272
           + YL+   +   +H DL   N ++  +    + DFGM + + E        + L  + +M
Sbjct: 143 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWM 199
Query: 273 APEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLK 316
           APE  ++G  +T+ D++SFG++L EI +  +   +  S E  LK
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 243

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 104/213 (48%), Gaps = 17/213 (7%)
Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKV-FDPQYE--GAFKSFDIECDVMKRICHRNLIKIIS 166
           +GKG FG+VY A   Q    +A+KV F  Q E  G       E ++   + H N++++  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLY-LSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
            + +     L+LEY P G + K L  LS +  D  +    + ++A+AL Y H   S  +I
Sbjct: 81  YFHDATRVYLILEYAPRGEVYKELQKLSKF--DEQRTATYITELANALSYCH---SKRVI 135
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
           H D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE   EGR+   
Sbjct: 136 HRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPPEMI-EGRMHDE 190
Query: 286 G-DVYSFGIMLMEIFTRTKPTDEIFSGEMTLKR 317
             D++S G++  E F   KP  E  + + T KR
Sbjct: 191 KVDLWSLGVLCYE-FLVGKPPFEANTYQETYKR 222

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 105/218 (48%), Gaps = 37/218 (16%)
Query: 110 LIGKGGFGSVYKAIIQ-DGMEVAVKVFD--------PQYEGAFKSFDIECDVMKRIC-HR 159
           +IG+G    V + + +  G E AVK+ +         Q E   ++   E  +++++  H 
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 160 NLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYI-LDIFQRLDIMIDVASALEYLHF 218
           ++I +I SY +  F  LV + M  G L    YL+  + L   +   IM  +  A+ +LH 
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGELFD--YLTEKVALSEKETRSIMRSLLEAVSFLH- 217
Query: 219 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE--- 275
             +  I+H DLKP N+LLDDNM   LSDFG +   LE  + L   +   T GY+APE   
Sbjct: 218 --ANNIVHRDLKPENILLDDNMQIRLSDFGFS-CHLEPGEKL--RELCGTPGYLAPEILK 272
Query: 276 ---------YGREGRVSTNGDVYSFGIMLMEIFTRTKP 304
                    YG+E       D+++ G++L  +   + P
Sbjct: 273 CSMDETHPGYGKE------VDLWACGVILFTLLAGSPP 304

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 106/213 (49%), Gaps = 17/213 (7%)
Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKV-FDPQYE--GAFKSFDIECDVMKRICHRNLIKIIS 166
           +GKG FG+VY A   Q    +A+KV F  Q E  G       E ++   + H N++++  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLY-LSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
            + +     L+LEY P G++ + L  LS +  D  +    + ++A+AL Y H   S  +I
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKF--DEQRTATYITELANALSYCH---SKRVI 130
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
           H D+KP N+LL       ++DFG +        S  +T+   T+ Y+ PE   EGR+   
Sbjct: 131 HRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTELCGTLDYLPPEMI-EGRMHDE 185
Query: 286 G-DVYSFGIMLMEIFTRTKPTDEIFSGEMTLKR 317
             D++S G++  E F   KP  E  + + T KR
Sbjct: 186 KVDLWSLGVLCYE-FLVGKPPFEANTYQETYKR 217

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 101/220 (45%), Gaps = 33/220 (15%)
Query: 111 IGKGGFGSVYKAII-----QDG-MEVAVKVFDPQYEGA-FKSFDIECDVMKRICHRNLIK 163
           +G+G FG V KA       + G   VAVK+       +  +    E +V+K++ H ++IK
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYI-----------------------LDIF 200
           +  + S D    L++EY  +GSL   L  S  +                       L + 
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 201 QRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL 260
             +     ++  ++YL       ++H DL   N+L+ +     +SDFG+++ + EED  +
Sbjct: 151 DLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXV 207
Query: 261 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
            ++Q    + +MA E   +   +T  DV+SFG++L EI T
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 101/220 (45%), Gaps = 33/220 (15%)
Query: 111 IGKGGFGSVYKAII-----QDG-MEVAVKVFDPQYEGA-FKSFDIECDVMKRICHRNLIK 163
           +G+G FG V KA       + G   VAVK+       +  +    E +V+K++ H ++IK
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYI-----------------------LDIF 200
           +  + S D    L++EY  +GSL   L  S  +                       L + 
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 201 QRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL 260
             +     ++  ++YL       ++H DL   N+L+ +     +SDFG+++ + EED  +
Sbjct: 151 DLISFAWQISQGMQYLA---EMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXV 207
Query: 261 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
            ++Q    + +MA E   +   +T  DV+SFG++L EI T
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 94/199 (47%), Gaps = 13/199 (6%)
Query: 111 IGKGGFGSV----YKAIIQD-GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLI--- 162
           +GKG FGSV    Y  +  + G  VAVK          + F  E  ++K + H + I   
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-HSDFIVKY 77
Query: 163 KIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSA 222
           + +S         LV+EY+P G L   L      LD  + L     +   +EYL    S 
Sbjct: 78  RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SR 134
Query: 223 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LEEDQSLTQTQTLATIGYMAPEYGREGR 281
             +H DL   N+L++      ++DFG+AK L L++D  + +    + I + APE   +  
Sbjct: 135 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI 194
Query: 282 VSTNGDVYSFGIMLMEIFT 300
            S   DV+SFG++L E+FT
Sbjct: 195 FSRQSDVWSFGVVLYELFT 213

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 94/199 (47%), Gaps = 13/199 (6%)
Query: 111 IGKGGFGSV----YKAIIQD-GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLI--- 162
           +GKG FGSV    Y  +  + G  VAVK          + F  E  ++K + H + I   
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-HSDFIVKY 76
Query: 163 KIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSA 222
           + +S         LV+EY+P G L   L      LD  + L     +   +EYL    S 
Sbjct: 77  RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SR 133
Query: 223 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LEEDQSLTQTQTLATIGYMAPEYGREGR 281
             +H DL   N+L++      ++DFG+AK L L++D  + +    + I + APE   +  
Sbjct: 134 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI 193
Query: 282 VSTNGDVYSFGIMLMEIFT 300
            S   DV+SFG++L E+FT
Sbjct: 194 FSRQSDVWSFGVVLYELFT 212

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 94/199 (47%), Gaps = 13/199 (6%)
Query: 111 IGKGGFGSV----YKAIIQD-GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLI--- 162
           +GKG FGSV    Y  +  + G  VAVK          + F  E  ++K + H + I   
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-HSDFIVKY 89
Query: 163 KIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSA 222
           + +S         LV+EY+P G L   L      LD  + L     +   +EYL    S 
Sbjct: 90  RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SR 146
Query: 223 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LEEDQSLTQTQTLATIGYMAPEYGREGR 281
             +H DL   N+L++      ++DFG+AK L L++D  + +    + I + APE   +  
Sbjct: 147 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI 206
Query: 282 VSTNGDVYSFGIMLMEIFT 300
            S   DV+SFG++L E+FT
Sbjct: 207 FSRQSDVWSFGVVLYELFT 225

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 101/220 (45%), Gaps = 33/220 (15%)
Query: 111 IGKGGFGSVYKAII-----QDG-MEVAVKVFDPQYEGA-FKSFDIECDVMKRICHRNLIK 163
           +G+G FG V KA       + G   VAVK+       +  +    E +V+K++ H ++IK
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYI-----------------------LDIF 200
           +  + S D    L++EY  +GSL   L  S  +                       L + 
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 201 QRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL 260
             +     ++  ++YL       ++H DL   N+L+ +     +SDFG+++ + EED  +
Sbjct: 151 DLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207
Query: 261 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
            ++Q    + +MA E   +   +T  DV+SFG++L EI T
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 105/213 (49%), Gaps = 17/213 (7%)
Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKV-FDPQYE--GAFKSFDIECDVMKRICHRNLIKIIS 166
           +GKG FG+VY A   Q    +A+KV F  Q E  G       E ++   + H N++++  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLY-LSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
            + +     L+LEY P G++ + L  LS +  D  +    + ++A+AL Y H   S  +I
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKF--DEQRTATYITELANALSYCH---SKRVI 130
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
           H D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE   EGR+   
Sbjct: 131 HRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTXLCGTLDYLPPEMI-EGRMHDE 185
Query: 286 G-DVYSFGIMLMEIFTRTKPTDEIFSGEMTLKR 317
             D++S G++  E F   KP  E  + + T KR
Sbjct: 186 KVDLWSLGVLCYE-FLVGKPPFEANTYQETYKR 217

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 106/229 (46%), Gaps = 30/229 (13%)
Query: 111 IGKGGFGSVYKAIIQ-----DGMEVAVKVFD----PQYEGAFKSFDIECDVMKRICHRNL 161
           +G+G FG V            G  VAVK       PQ    ++    E ++++ + H ++
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQR---EIEILRTLYHEHI 72
Query: 162 IKIISSYSNDDFKA--LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFG 219
           +K      +   K+  LV+EY+P GSL    YL  + + + Q L     +   + YLH  
Sbjct: 73  VKYKGCCEDQGEKSVQLVMEYVPLGSLRD--YLPRHCVGLAQLLLFAQQICEGMAYLH-- 128
Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE-EDQSLTQTQTLATIGYMAPEYGR 278
            +   IH  L   NVLLD++ +  + DFG+AK + E  +    +    + + + APE  +
Sbjct: 129 -AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK 187
Query: 279 EGRVSTNGDVYSFGIMLMEIFT--------RTKPTDEI--FSGEMTLKR 317
           E +     DV+SFG+ L E+ T         TK T+ I    G+MT+ R
Sbjct: 188 ECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLR 236

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 106/229 (46%), Gaps = 30/229 (13%)
Query: 111 IGKGGFGSVYKAIIQ-----DGMEVAVKVFD----PQYEGAFKSFDIECDVMKRICHRNL 161
           +G+G FG V            G  VAVK       PQ    ++    E ++++ + H ++
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQR---EIEILRTLYHEHI 73
Query: 162 IKIISSYSNDDFKA--LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFG 219
           +K      +   K+  LV+EY+P GSL    YL  + + + Q L     +   + YLH  
Sbjct: 74  VKYKGCCEDQGEKSVQLVMEYVPLGSLRD--YLPRHCVGLAQLLLFAQQICEGMAYLH-- 129
Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE-EDQSLTQTQTLATIGYMAPEYGR 278
            +   IH  L   NVLLD++ +  + DFG+AK + E  +    +    + + + APE  +
Sbjct: 130 -AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK 188
Query: 279 EGRVSTNGDVYSFGIMLMEIFT--------RTKPTDEI--FSGEMTLKR 317
           E +     DV+SFG+ L E+ T         TK T+ I    G+MT+ R
Sbjct: 189 ECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLR 237

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 105/213 (49%), Gaps = 17/213 (7%)
Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKV-FDPQYE--GAFKSFDIECDVMKRICHRNLIKIIS 166
           +GKG FG+VY A   Q    +A+KV F  Q E  G       E ++   + H N++++  
Sbjct: 15  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 74
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLY-LSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
            + +     L+LEY P G++ + L  LS +  D  +    + ++A+AL Y H   S  +I
Sbjct: 75  YFHDATRVYLILEYAPLGTVYRELQKLSKF--DEQRTATYITELANALSYCH---SKRVI 129
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
           H D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE   EGR+   
Sbjct: 130 HRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPPEMI-EGRMHDE 184
Query: 286 G-DVYSFGIMLMEIFTRTKPTDEIFSGEMTLKR 317
             D++S G++  E F   KP  E  + + T KR
Sbjct: 185 KVDLWSLGVLCYE-FLVGKPPFEANTYQETYKR 216

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 28/215 (13%)
Query: 111 IGKGGFGSVYKAII--------QDGMEVAVKVF-DPQYEGAFKSFDIECDVMKRIC-HRN 160
           +G+G FG V  A          ++ + VAVK+  D   E        E ++MK I  H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 161 LIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSN-----YILDI---------FQRL-DI 205
           +I ++ + + D    +++ Y   G+L + L         Y  DI         F+ L   
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
              + +MAPE   +   +   DV+SFG+++ EIFT
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 105/213 (49%), Gaps = 17/213 (7%)
Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKV-FDPQYE--GAFKSFDIECDVMKRICHRNLIKIIS 166
           +GKG FG+VY A   Q    +A+KV F  Q E  G       E ++   + H N++++  
Sbjct: 20  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLY-LSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
            + +     L+LEY P G++ + L  LS +  D  +    + ++A+AL Y H   S  +I
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKLSKF--DEQRTATYITELANALSYCH---SKRVI 134
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
           H D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE   EGR+   
Sbjct: 135 HRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPPEMI-EGRMHDE 189
Query: 286 G-DVYSFGIMLMEIFTRTKPTDEIFSGEMTLKR 317
             D++S G++  E F   KP  E  + + T KR
Sbjct: 190 KVDLWSLGVLCYE-FLVGKPPFEANTYQETYKR 221

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 105/213 (49%), Gaps = 17/213 (7%)
Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKV-FDPQYE--GAFKSFDIECDVMKRICHRNLIKIIS 166
           +GKG FG+VY A   Q    +A+KV F  Q E  G       E ++   + H N++++  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLY-LSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
            + +     L+LEY P G++ + L  LS +  D  +    + ++A+AL Y H   S  +I
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKF--DEQRTATYITELANALSYCH---SKRVI 133
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
           H D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE   EGR+   
Sbjct: 134 HRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPPEMI-EGRMHDE 188
Query: 286 G-DVYSFGIMLMEIFTRTKPTDEIFSGEMTLKR 317
             D++S G++  E F   KP  E  + + T KR
Sbjct: 189 KVDLWSLGVLCYE-FLVGKPPFEANTYQETYKR 220

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 105/213 (49%), Gaps = 17/213 (7%)
Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKV-FDPQYE--GAFKSFDIECDVMKRICHRNLIKIIS 166
           +GKG FG+VY A   Q    +A+KV F  Q E  G       E ++   + H N++++  
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLY-LSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
            + +     L+LEY P G++ + L  LS +  D  +    + ++A+AL Y H   S  +I
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKLSRF--DEQRTATYITELANALSYCH---SKRVI 134
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
           H D+KP N+LL  N    ++DFG +        S  +T    T+ Y+ PE   EGR+   
Sbjct: 135 HRDIKPENLLLGSNGELKIADFGWSV----HAPSSRRTTLCGTLDYLPPEMI-EGRMHDE 189
Query: 286 G-DVYSFGIMLMEIFTRTKPTDEIFSGEMTLKR 317
             D++S G++  E F    P  E  + + T +R
Sbjct: 190 KVDLWSLGVLCYE-FLVGMPPFEAHTYQETYRR 221

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 105/213 (49%), Gaps = 17/213 (7%)
Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKV-FDPQYE--GAFKSFDIECDVMKRICHRNLIKIIS 166
           +GKG FG+VY A   Q    +A+KV F  Q E  G       E ++   + H N++++  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLY-LSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
            + +     L+LEY P G++ + L  LS +  D  +    + ++A+AL Y H   S  +I
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKF--DEQRTATYITELANALSYCH---SKRVI 130
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
           H D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE   EGR+   
Sbjct: 131 HRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPPEMI-EGRMHDE 185
Query: 286 G-DVYSFGIMLMEIFTRTKPTDEIFSGEMTLKR 317
             D++S G++  E F   KP  E  + + T KR
Sbjct: 186 KVDLWSLGVLCYE-FLVGKPPFEANTYQETYKR 217

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 105/213 (49%), Gaps = 17/213 (7%)
Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKV-FDPQYE--GAFKSFDIECDVMKRICHRNLIKIIS 166
           +GKG FG+VY A   Q    +A+KV F  Q E  G       E ++   + H N++++  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLY-LSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
            + +     L+LEY P G++ + L  LS +  D  +    + ++A+AL Y H   S  +I
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKF--DEQRTATYITELANALSYCH---SKRVI 130
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
           H D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE   EGR+   
Sbjct: 131 HRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTDLCGTLDYLPPEMI-EGRMHDE 185
Query: 286 G-DVYSFGIMLMEIFTRTKPTDEIFSGEMTLKR 317
             D++S G++  E F   KP  E  + + T KR
Sbjct: 186 KVDLWSLGVLCYE-FLVGKPPFEANTYQETYKR 217

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 105/213 (49%), Gaps = 17/213 (7%)
Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKV-FDPQYE--GAFKSFDIECDVMKRICHRNLIKIIS 166
           +GKG FG+VY A   Q    +A+KV F  Q E  G       E ++   + H N++++  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLY-LSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
            + +     L+LEY P G++ + L  LS +  D  +    + ++A+AL Y H   S  +I
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKF--DEQRTATYITELANALSYCH---SKRVI 130
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
           H D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE   EGR+   
Sbjct: 131 HRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTDLCGTLDYLPPEMI-EGRMHDE 185
Query: 286 G-DVYSFGIMLMEIFTRTKPTDEIFSGEMTLKR 317
             D++S G++  E F   KP  E  + + T KR
Sbjct: 186 KVDLWSLGVLCYE-FLVGKPPFEANTYQETYKR 217

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 105/213 (49%), Gaps = 17/213 (7%)
Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKV-FDPQYE--GAFKSFDIECDVMKRICHRNLIKIIS 166
           +GKG FG+VY A   Q    +A+KV F  Q E  G       E ++   + H N++++  
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLY-LSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
            + +     L+LEY P G++ + L  LS +  D  +    + ++A+AL Y H   S  +I
Sbjct: 102 YFHDATRVYLILEYAPLGTVYRELQKLSKF--DEQRTATYITELANALSYCH---SKRVI 156
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
           H D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE   EGR+   
Sbjct: 157 HRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPPEMI-EGRMHDE 211
Query: 286 G-DVYSFGIMLMEIFTRTKPTDEIFSGEMTLKR 317
             D++S G++  E F   KP  E  + + T KR
Sbjct: 212 KVDLWSLGVLCYE-FLVGKPPFEANTYQETYKR 243

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 105/213 (49%), Gaps = 17/213 (7%)
Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKV-FDPQYE--GAFKSFDIECDVMKRICHRNLIKIIS 166
           +GKG FG+VY A   Q    +A+KV F  Q E  G       E ++   + H N++++  
Sbjct: 13  LGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 72
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLY-LSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
            + +     L+LEY P G++ + L  LS +  D  +    + ++A+AL Y H   S  +I
Sbjct: 73  YFHDATRVYLILEYAPLGTVYRELQKLSKF--DEQRTATYITELANALSYCH---SKRVI 127
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
           H D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE   EGR+   
Sbjct: 128 HRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPPEMI-EGRMHDE 182
Query: 286 G-DVYSFGIMLMEIFTRTKPTDEIFSGEMTLKR 317
             D++S G++  E F   KP  E  + + T KR
Sbjct: 183 KVDLWSLGVLCYE-FLVGKPPFEANTYQETYKR 214

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 28/215 (13%)
Query: 111 IGKGGFGSVYKAII--------QDGMEVAVKVF-DPQYEGAFKSFDIECDVMKRIC-HRN 160
           +G+G FG V  A          ++ + VAVK+  D   E        E ++MK I  H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 161 LIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSN-----YILDI---------FQRL-DI 205
           +I ++ + + D    +++ Y   G+L + L         Y  DI         F+ L   
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
              + +MAPE   +   +   DV+SFG+++ EIFT
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 105/213 (49%), Gaps = 17/213 (7%)
Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKV-FDPQYE--GAFKSFDIECDVMKRICHRNLIKIIS 166
           +GKG FG+VY A   Q    +A+KV F  Q E  G       E ++   + H N++++  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLY-LSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
            + +     L+LEY P G++ + L  LS +  D  +    + ++A+AL Y H   S  +I
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKF--DEQRTATYITELANALSYCH---SKRVI 133
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
           H D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE   EGR+   
Sbjct: 134 HRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPPEMI-EGRMHDE 188
Query: 286 G-DVYSFGIMLMEIFTRTKPTDEIFSGEMTLKR 317
             D++S G++  E F   KP  E  + + T KR
Sbjct: 189 KVDLWSLGVLCYE-FLVGKPPFEANTYQETYKR 220

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 105/213 (49%), Gaps = 17/213 (7%)
Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKV-FDPQYE--GAFKSFDIECDVMKRICHRNLIKIIS 166
           +GKG FG+VY A   Q    +A+KV F  Q E  G       E ++   + H N++++  
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLY-LSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
            + +     L+LEY P G++ + L  LS +  D  +    + ++A+AL Y H   S  +I
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLSKF--DEQRTATYITELANALSYCH---SKRVI 131
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
           H D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE   EGR+   
Sbjct: 132 HRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTDLCGTLDYLPPEMI-EGRMHDE 186
Query: 286 G-DVYSFGIMLMEIFTRTKPTDEIFSGEMTLKR 317
             D++S G++  E F   KP  E  + + T KR
Sbjct: 187 KVDLWSLGVLCYE-FLVGKPPFEANTYQETYKR 218

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 105/213 (49%), Gaps = 17/213 (7%)
Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKV-FDPQYE--GAFKSFDIECDVMKRICHRNLIKIIS 166
           +GKG FG+VY A   Q    +A+KV F  Q E  G       E ++   + H N++++  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLY-LSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
            + +     L+LEY P G++ + L  LS +  D  +    + ++A+AL Y H   S  +I
Sbjct: 81  YFHDATRVYLILEYAPLGTVYRELQKLSKF--DEQRTATYITELANALSYCH---SKRVI 135
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
           H D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE   EGR+   
Sbjct: 136 HRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTDLCGTLDYLPPEMI-EGRMHDE 190
Query: 286 G-DVYSFGIMLMEIFTRTKPTDEIFSGEMTLKR 317
             D++S G++  E F   KP  E  + + T KR
Sbjct: 191 KVDLWSLGVLCYE-FLVGKPPFEANTYQETYKR 222

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 102/227 (44%), Gaps = 18/227 (7%)
Query: 92  LRYQKRGKPLPNDANMPPLIGKGGFGSVYKAII-----QDG-MEVAVKVFDPQYEGAFK- 144
           L Y ++ +   N+      +G G FG V +A       +D  ++VAVK+         K 
Sbjct: 35  LPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKE 94
Query: 145 SFDIECDVMKRIC-HRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL 203
           +   E  +M  +  H N++ ++ + ++     ++ EY  +G L   L   + +L+     
Sbjct: 95  ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAF 154
Query: 204 DIMIDVASALEYLHFG----------YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL 253
            I     S  + LHF            S   IH D+   NVLL +  VA + DFG+A+ +
Sbjct: 155 AIANSTLSTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI 214
Query: 254 LEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
           + +   + +      + +MAPE   +   +   DV+S+GI+L EIF+
Sbjct: 215 MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 105/213 (49%), Gaps = 17/213 (7%)
Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKV-FDPQYE--GAFKSFDIECDVMKRICHRNLIKIIS 166
           +GKG FG+VY A   Q    +A+KV F  Q E  G       E ++   + H N++++  
Sbjct: 33  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 92
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLY-LSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
            + +     L+LEY P G++ + L  LS +  D  +    + ++A+AL Y H   S  +I
Sbjct: 93  YFHDATRVYLILEYAPLGTVYRELQKLSKF--DEQRTATYITELANALSYCH---SKRVI 147
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
           H D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE   EGR+   
Sbjct: 148 HRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPPEMI-EGRMHDE 202
Query: 286 G-DVYSFGIMLMEIFTRTKPTDEIFSGEMTLKR 317
             D++S G++  E F   KP  E  + + T KR
Sbjct: 203 KVDLWSLGVLCYE-FLVGKPPFEANTYQETYKR 234

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 102/215 (47%), Gaps = 23/215 (10%)
Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVF------DPQYEGAFKSFDIECDVMKRICHRNLI 162
           ++G GG   V+ A  ++   +VAVKV       DP +   +  F  E      + H  ++
Sbjct: 19  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSF---YLRFRREAQNAAALNHPAIV 75
Query: 163 KIISSYSNDD----FKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHF 218
            + ++   +        +V+EY+   +L   ++       +  +  I + +A A + L+F
Sbjct: 76  AVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEV-IADACQALNF 131
Query: 219 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT-LATIGYMAPEYG 277
            +   IIH D+KP+N+++       + DFG+A+ + +   S+TQT   + T  Y++PE  
Sbjct: 132 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 278 REGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE 312
           R   V    DVYS G +L E+ T   P    F+G+
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPP----FTGD 222

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 105/213 (49%), Gaps = 17/213 (7%)
Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKV-FDPQYE--GAFKSFDIECDVMKRICHRNLIKIIS 166
           +GKG FG+VY A   Q    +A+KV F  Q E  G       E ++   + H N++++  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLY-LSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
            + +     L+LEY P G++ + L  LS +  D  +    + ++A+AL Y H   S  +I
Sbjct: 81  YFHDATRVYLILEYAPLGTVYRELQKLSKF--DEQRTATYITELANALSYCH---SKRVI 135
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
           H D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE   EGR+   
Sbjct: 136 HRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPPEMI-EGRMHDE 190
Query: 286 G-DVYSFGIMLMEIFTRTKPTDEIFSGEMTLKR 317
             D++S G++  E F   KP  E  + + T KR
Sbjct: 191 KVDLWSLGVLCYE-FLVGKPPFEANTYQETYKR 222

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 103/213 (48%), Gaps = 17/213 (7%)
Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKV-FDPQYE--GAFKSFDIECDVMKRICHRNLIKIIS 166
           +GKG FG+VY A   Q    +A+KV F  Q E  G       E ++   + H N++++  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLY-LSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
            + +     L+LEY P G + K L  LS +  D  +    + ++A+AL Y H   S  +I
Sbjct: 81  YFHDATRVYLILEYAPRGEVYKELQKLSKF--DEQRTATYITELANALSYCH---SKRVI 135
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
           H D+KP N+LL       ++DFG +        S  +     T+ Y+ PE   EGR+   
Sbjct: 136 HRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRXXLXGTLDYLPPEMI-EGRMHDE 190
Query: 286 G-DVYSFGIMLMEIFTRTKPTDEIFSGEMTLKR 317
             D++S G++  E F   KP  E  + + T KR
Sbjct: 191 KVDLWSLGVLCYE-FLVGKPPFEANTYQETYKR 222

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 92/194 (47%), Gaps = 10/194 (5%)
Query: 111 IGKGGFGSVYKAIIQD----GMEVAVKVF-DPQYEGAFKSFDIECDVMKRICHRNLIKII 165
           IG+G FG V++ I        M VA+K   +   +   + F  E   M++  H +++K+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
              + +    +++E    G L   L +  Y LD+   +     +++AL YL    S   +
Sbjct: 78  GVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 133
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
           H D+   NVL+  N    L DFG+++  +E+      ++    I +MAPE     R ++ 
Sbjct: 134 HRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 192
Query: 286 GDVYSFGIMLMEIF 299
            DV+ FG+ + EI 
Sbjct: 193 SDVWMFGVCMWEIL 206

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 58/105 (55%), Gaps = 5/105 (4%)
Query: 209 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT-LA 267
           +A A + L+F +   IIH D+KP+N+++       + DFG+A+ + +   S+TQT   + 
Sbjct: 139 IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 198
Query: 268 TIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE 312
           T  Y++PE  R   V    DVYS G +L E+ T   P    F+G+
Sbjct: 199 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGD 239

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 104/213 (48%), Gaps = 17/213 (7%)
Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKV-FDPQYE--GAFKSFDIECDVMKRICHRNLIKIIS 166
           +GKG FG+VY A   Q    +A+KV F  Q E  G       E ++   + H N++++  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLY-LSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
            + +     L+LEY P G++ + L  LS +  D  +    + ++A+AL Y H   S  +I
Sbjct: 81  YFHDATRVYLILEYAPLGTVYRELQKLSKF--DEQRTATYITELANALSYCH---SKRVI 135
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
           H D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE   EGR    
Sbjct: 136 HRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPPEXI-EGRXHDE 190
Query: 286 G-DVYSFGIMLMEIFTRTKPTDEIFSGEMTLKR 317
             D++S G++  E F   KP  E  + + T KR
Sbjct: 191 KVDLWSLGVLCYE-FLVGKPPFEANTYQETYKR 222

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 58/105 (55%), Gaps = 5/105 (4%)
Query: 209 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT-LA 267
           +A A + L+F +   IIH D+KP+N+++       + DFG+A+ + +   S+TQT   + 
Sbjct: 122 IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 181
Query: 268 TIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE 312
           T  Y++PE  R   V    DVYS G +L E+ T   P    F+G+
Sbjct: 182 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGD 222

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 102/213 (47%), Gaps = 29/213 (13%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGA-FKSFDIECDVMKRICHRNLIKII---- 165
           +GKG +G V++ +   G  VAVK+F  + E + F+  +I   V+ R  H N++  I    
Sbjct: 16  VGKGRYGEVWRGLWH-GESVAVKIFSSRDEQSWFRETEIYNTVLLR--HDNILGFIASDM 72
Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLH---FGYSA 222
           +S ++     L+  Y  HGSL    +L    L+    L + +  A  L +LH   FG   
Sbjct: 73  TSRNSSTQLWLITHYHEHGSLYD--FLQRQTLEPHLALRLAVSAACGLAHLHVEIFGTQG 130
Query: 223 --PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS----LTQTQTLATIGYMAPEY 276
              I H D K  NVL+  N+   ++D G+A  ++    S    +     + T  YMAPE 
Sbjct: 131 KPAIAHRDFKSRNVLVKSNLQCCIADLGLA--VMHSQGSDYLDIGNNPRVGTKRYMAPEV 188
Query: 277 GREGRVSTN-------GDVYSFGIMLMEIFTRT 302
             E ++ T+        D+++FG++L EI  RT
Sbjct: 189 LDE-QIRTDCFESYKWTDIWAFGLVLWEIARRT 220

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 105/213 (49%), Gaps = 17/213 (7%)
Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKV-FDPQYE--GAFKSFDIECDVMKRICHRNLIKIIS 166
           +GKG FG+VY A   Q    +A+KV F  Q E  G       E ++   + H N++++  
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLY-LSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
            + +     L+LEY P G++ + L  LS +  D  +    + ++A+AL Y H   S  +I
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLSKF--DEQRTATYITELANALSYCH---SKRVI 131
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
           H D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE   EGR+   
Sbjct: 132 HRDIKPENLLLGSAGELKIADFGWSC----HAPSSRRTTLSGTLDYLPPEMI-EGRMHDE 186
Query: 286 G-DVYSFGIMLMEIFTRTKPTDEIFSGEMTLKR 317
             D++S G++  E F   KP  E  + + T KR
Sbjct: 187 KVDLWSLGVLCYE-FLVGKPPFEANTYQETYKR 218

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 111/216 (51%), Gaps = 26/216 (12%)
Query: 102 PNDANMPPLIGKGGFGSVY---KAIIQD-GMEVAVKVFDPQYEGAFKSFD-----IECDV 152
           P+   +  ++G+G FG V+   K    D G   A+KV     +   K  D     +E D+
Sbjct: 27  PSHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLK---KATLKVRDRVRTKMERDI 83
Query: 153 MKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDI---MIDV 209
           +  + H  ++K+  ++  +    L+L+++  G L     LS  ++  F   D+   + ++
Sbjct: 84  LADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDL--FTRLSKEVM--FTEEDVKFYLAEL 139
Query: 210 ASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATI 269
           A  L++LH   S  II+ DLKP N+LLD+     L+DFG++K  ++ ++         T+
Sbjct: 140 ALGLDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKK--AYSFCGTV 194
Query: 270 GYMAPE-YGREGRVSTNGDVYSFGIMLMEIFTRTKP 304
            YMAPE   R+G  S + D +S+G+++ E+ T + P
Sbjct: 195 EYMAPEVVNRQGH-SHSADWWSYGVLMFEMLTGSLP 229

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 100/198 (50%), Gaps = 15/198 (7%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVK--VFDPQYEGAFKSFDIECDVMKRICHRNLIKIISS 167
           IG+G +G VYKA  +  G  VA+K    D + EG   +   E  ++K + H N++K++  
Sbjct: 18  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 77
Query: 168 YSNDDFKALVLEYMPHGSLEKCL---YLSNYILDIFQRLDIMIDVASALEYLHFGYSAPI 224
              ++   LV E++ H  L+K +    L+   L + +     +     L+ L F +S  +
Sbjct: 78  IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL-----LQGLAFCHSHRV 131
Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGR-VS 283
           +H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y APE     +  S
Sbjct: 132 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGXKYYS 189
Query: 284 TNGDVYSFGIMLMEIFTR 301
           T  D++S G +  E+ TR
Sbjct: 190 TAVDIWSLGCIFAEMVTR 207

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 92/194 (47%), Gaps = 10/194 (5%)
Query: 111 IGKGGFGSVYKAIIQD----GMEVAVKVF-DPQYEGAFKSFDIECDVMKRICHRNLIKII 165
           IG+G FG V++ I        M VA+K   +   +   + F  E   M++  H +++K+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
              + +    +++E    G L   L +  + LD+   +     +++AL YL    S   +
Sbjct: 78  GVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFV 133
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
           H D+   NVL+  N    L DFG+++  +E+      ++    I +MAPE     R ++ 
Sbjct: 134 HRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTXXKASKGKLPIKWMAPESINFRRFTSA 192
Query: 286 GDVYSFGIMLMEIF 299
            DV+ FG+ + EI 
Sbjct: 193 SDVWMFGVCMWEIL 206

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 100/198 (50%), Gaps = 15/198 (7%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVK--VFDPQYEGAFKSFDIECDVMKRICHRNLIKIISS 167
           IG+G +G VYKA  +  G  VA+K    D + EG   +   E  ++K + H N++K++  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 168 YSNDDFKALVLEYMPHGSLEKCL---YLSNYILDIFQRLDIMIDVASALEYLHFGYSAPI 224
              ++   LV E++ H  L+K +    L+   L + +     +     L+ L F +S  +
Sbjct: 71  IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL-----LQGLAFCHSHRV 124
Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGR-VS 283
           +H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y APE     +  S
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGXKYYS 182
Query: 284 TNGDVYSFGIMLMEIFTR 301
           T  D++S G +  E+ TR
Sbjct: 183 TAVDIWSLGCIFAEMVTR 200

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 105/213 (49%), Gaps = 17/213 (7%)
Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKV-FDPQYE--GAFKSFDIECDVMKRICHRNLIKIIS 166
           +GKG FG+VY A   Q    +A+KV F  Q E  G       E ++   + H N++++  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLY-LSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
            + +     L+LEY P G++ + L  LS +  D  +    + ++A+AL Y H   S  +I
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKF--DEQRTATYITELANALSYCH---SKRVI 133
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
           H D+KP N+LL       +++FG +        S  +T    T+ Y+ PE   EGR+   
Sbjct: 134 HRDIKPENLLLGSAGELKIANFGWSV----HAPSSRRTTLCGTLDYLPPEMI-EGRMHDE 188
Query: 286 G-DVYSFGIMLMEIFTRTKPTDEIFSGEMTLKR 317
             D++S G++  E F   KP  E  + + T KR
Sbjct: 189 KVDLWSLGVLCYE-FLVGKPPFEANTYQETYKR 220

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 100/198 (50%), Gaps = 15/198 (7%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVK--VFDPQYEGAFKSFDIECDVMKRICHRNLIKIISS 167
           IG+G +G VYKA  +  G  VA+K    D + EG   +   E  ++K + H N++K++  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 168 YSNDDFKALVLEYMPHGSLEKCL---YLSNYILDIFQRLDIMIDVASALEYLHFGYSAPI 224
              ++   LV E++ H  L+K +    L+   L + +     +     L+ L F +S  +
Sbjct: 71  IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL-----LQGLSFCHSHRV 124
Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGR-VS 283
           +H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y APE     +  S
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYS 182
Query: 284 TNGDVYSFGIMLMEIFTR 301
           T  D++S G +  E+ TR
Sbjct: 183 TAVDIWSLGCIFAEMVTR 200

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 100/198 (50%), Gaps = 15/198 (7%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVK--VFDPQYEGAFKSFDIECDVMKRICHRNLIKIISS 167
           IG+G +G VYKA  +  G  VA+K    D + EG   +   E  ++K + H N++K++  
Sbjct: 18  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 77
Query: 168 YSNDDFKALVLEYMPHGSLEKCL---YLSNYILDIFQRLDIMIDVASALEYLHFGYSAPI 224
              ++   LV E++ H  L+K +    L+   L + +     +     L+ L F +S  +
Sbjct: 78  IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL-----LQGLAFCHSHRV 131
Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGR-VS 283
           +H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y APE     +  S
Sbjct: 132 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYS 189
Query: 284 TNGDVYSFGIMLMEIFTR 301
           T  D++S G +  E+ TR
Sbjct: 190 TAVDIWSLGCIFAEMVTR 207

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 100/198 (50%), Gaps = 15/198 (7%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVK--VFDPQYEGAFKSFDIECDVMKRICHRNLIKIISS 167
           IG+G +G VYKA  +  G  VA+K    D + EG   +   E  ++K + H N++K++  
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 74
Query: 168 YSNDDFKALVLEYMPHGSLEKCL---YLSNYILDIFQRLDIMIDVASALEYLHFGYSAPI 224
              ++   LV E++ H  L+K +    L+   L + +     +     L+ L F +S  +
Sbjct: 75  IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL-----LQGLAFCHSHRV 128
Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGR-VS 283
           +H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y APE     +  S
Sbjct: 129 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYS 186
Query: 284 TNGDVYSFGIMLMEIFTR 301
           T  D++S G +  E+ TR
Sbjct: 187 TAVDIWSLGCIFAEMVTR 204

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 100/198 (50%), Gaps = 15/198 (7%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVK--VFDPQYEGAFKSFDIECDVMKRICHRNLIKIISS 167
           IG+G +G VYKA  +  G  VA+K    D + EG   +   E  ++K + H N++K++  
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 168 YSNDDFKALVLEYMPHGSLEKCL---YLSNYILDIFQRLDIMIDVASALEYLHFGYSAPI 224
              ++   LV E++ H  L+K +    L+   L + +     +     L+ L F +S  +
Sbjct: 70  IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL-----LQGLAFCHSHRV 123
Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGR-VS 283
           +H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y APE     +  S
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYS 181
Query: 284 TNGDVYSFGIMLMEIFTR 301
           T  D++S G +  E+ TR
Sbjct: 182 TAVDIWSLGCIFAEMVTR 199

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 100/198 (50%), Gaps = 15/198 (7%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVK--VFDPQYEGAFKSFDIECDVMKRICHRNLIKIISS 167
           IG+G +G VYKA  +  G  VA+K    D + EG   +   E  ++K + H N++K++  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 168 YSNDDFKALVLEYMPHGSLEKCL---YLSNYILDIFQRLDIMIDVASALEYLHFGYSAPI 224
              ++   LV E++ H  L+K +    L+   L + +     +     L+ L F +S  +
Sbjct: 71  IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL-----LQGLAFCHSHRV 124
Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGR-VS 283
           +H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y APE     +  S
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYS 182
Query: 284 TNGDVYSFGIMLMEIFTR 301
           T  D++S G +  E+ TR
Sbjct: 183 TAVDIWSLGCIFAEMVTR 200

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 17/213 (7%)
Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKV-FDPQYE--GAFKSFDIECDVMKRICHRNLIKIIS 166
           +GKG FG+VY A   Q    +A+KV F  Q E  G       E ++   + H N++++  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLY-LSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
            + +     L+LEY P G++ + L  LS +  D  +    + ++A+AL Y H   S  +I
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKF--DEQRTATYITELANALSYCH---SKRVI 130
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
           H D+KP N+LL       ++DFG +        S  +     T+ Y+ PE   EGR+   
Sbjct: 131 HRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRAALCGTLDYLPPEMI-EGRMHDE 185
Query: 286 G-DVYSFGIMLMEIFTRTKPTDEIFSGEMTLKR 317
             D++S G++  E F   KP  E  + + T KR
Sbjct: 186 KVDLWSLGVLCYE-FLVGKPPFEANTYQETYKR 217

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 100/198 (50%), Gaps = 15/198 (7%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVK--VFDPQYEGAFKSFDIECDVMKRICHRNLIKIISS 167
           IG+G +G VYKA  +  G  VA+K    D + EG   +   E  ++K + H N++K++  
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 168 YSNDDFKALVLEYMPHGSLEKCL---YLSNYILDIFQRLDIMIDVASALEYLHFGYSAPI 224
              ++   LV E++ H  L+K +    L+   L + +     +     L+ L F +S  +
Sbjct: 70  IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL-----LQGLAFCHSHRV 123
Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGR-VS 283
           +H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y APE     +  S
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYS 181
Query: 284 TNGDVYSFGIMLMEIFTR 301
           T  D++S G +  E+ TR
Sbjct: 182 TAVDIWSLGCIFAEMVTR 199

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 100/198 (50%), Gaps = 15/198 (7%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVK--VFDPQYEGAFKSFDIECDVMKRICHRNLIKIISS 167
           IG+G +G VYKA  +  G  VA+K    D + EG   +   E  ++K + H N++K++  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 168 YSNDDFKALVLEYMPHGSLEKCL---YLSNYILDIFQRLDIMIDVASALEYLHFGYSAPI 224
              ++   LV E++ H  L+K +    L+   L + +     +     L+ L F +S  +
Sbjct: 71  IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL-----LQGLAFCHSHRV 124
Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGR-VS 283
           +H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y APE     +  S
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYS 182
Query: 284 TNGDVYSFGIMLMEIFTR 301
           T  D++S G +  E+ TR
Sbjct: 183 TAVDIWSLGCIFAEMVTR 200

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 100/198 (50%), Gaps = 15/198 (7%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVK--VFDPQYEGAFKSFDIECDVMKRICHRNLIKIISS 167
           IG+G +G VYKA  +  G  VA+K    D + EG   +   E  ++K + H N++K++  
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 168 YSNDDFKALVLEYMPHGSLEKCL---YLSNYILDIFQRLDIMIDVASALEYLHFGYSAPI 224
              ++   LV E++ H  L+K +    L+   L + +     +     L+ L F +S  +
Sbjct: 72  IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL-----LQGLAFCHSHRV 125
Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGR-VS 283
           +H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y APE     +  S
Sbjct: 126 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYS 183
Query: 284 TNGDVYSFGIMLMEIFTR 301
           T  D++S G +  E+ TR
Sbjct: 184 TAVDIWSLGCIFAEMVTR 201

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 17/213 (7%)
Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKV-FDPQYE--GAFKSFDIECDVMKRICHRNLIKIIS 166
           +GKG FG+VY A   Q    +A+KV F  Q E  G       E ++   + H N++++  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLY-LSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
            + +     L+LEY P G++ + L  LS +  D  +    + ++A+AL Y H   S  +I
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKF--DEQRTATYITELANALSYCH---SKRVI 130
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
           H D+KP N+LL       ++DFG +        S  +     T+ Y+ PE   EGR+   
Sbjct: 131 HRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRXXLCGTLDYLPPEMI-EGRMHDE 185
Query: 286 G-DVYSFGIMLMEIFTRTKPTDEIFSGEMTLKR 317
             D++S G++  E F   KP  E  + + T KR
Sbjct: 186 KVDLWSLGVLCYE-FLVGKPPFEANTYQETYKR 217

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 105/213 (49%), Gaps = 17/213 (7%)
Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKV-FDPQYE--GAFKSFDIECDVMKRICHRNLIKIIS 166
           +GKG FG+VY A   Q    +A+KV F  Q E  G       E ++   + H N++++  
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLY-LSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
            + +     L+LEY P G++ + L  LS +  D  +    + ++A+AL Y H   S  +I
Sbjct: 78  YFHDATRVYLILEYAPLGTVYRELQKLSKF--DEQRTATYITELANALSYCH---SKRVI 132
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
           H D+KP N+LL       +++FG +        S  +T    T+ Y+ PE   EGR+   
Sbjct: 133 HRDIKPENLLLGSAGELKIANFGWSV----HAPSSRRTTLCGTLDYLPPEMI-EGRMHDE 187
Query: 286 G-DVYSFGIMLMEIFTRTKPTDEIFSGEMTLKR 317
             D++S G++  E F   KP  E  + + T KR
Sbjct: 188 KVDLWSLGVLCYE-FLVGKPPFEANTYQETYKR 219

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 17/213 (7%)
Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKV-FDPQYE--GAFKSFDIECDVMKRICHRNLIKIIS 166
           +GKG FG+VY A   Q    +A+KV F  Q E  G       E ++   + H N++++  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLY-LSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
            + +     L+LEY P G++ + L  LS +  D  +    + ++A+AL Y H   S  +I
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKF--DEQRTATYITELANALSYCH---SKRVI 133
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
           H D+KP N+LL       ++DFG +        S  +     T+ Y+ PE   EGR+   
Sbjct: 134 HRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRXXLCGTLDYLPPEMI-EGRMHDE 188
Query: 286 G-DVYSFGIMLMEIFTRTKPTDEIFSGEMTLKR 317
             D++S G++  E F   KP  E  + + T KR
Sbjct: 189 KVDLWSLGVLCYE-FLVGKPPFEANTYQETYKR 220

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 17/213 (7%)
Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKV-FDPQYE--GAFKSFDIECDVMKRICHRNLIKIIS 166
           +GKG FG+VY A   Q    +A+KV F  Q E  G       E ++   + H N++++  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLY-LSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
            + +     L+LEY P G++ + L  LS +  D  +    + ++A+AL Y H   S  +I
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKF--DEQRTATYITELANALSYCH---SKRVI 133
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
           H D+KP N+LL       ++DFG +        S  +     T+ Y+ PE   EGR+   
Sbjct: 134 HRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRAALCGTLDYLPPEMI-EGRMHDE 188
Query: 286 G-DVYSFGIMLMEIFTRTKPTDEIFSGEMTLKR 317
             D++S G++  E F   KP  E  + + T KR
Sbjct: 189 KVDLWSLGVLCYE-FLVGKPPFEANTYQETYKR 220

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 91/206 (44%), Gaps = 19/206 (9%)
Query: 111 IGKGGFGSVYKAIIQ------DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIK 163
           +G G FG VY+  +         ++VAVK     Y E     F +E  ++ +  H+N+++
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSN------YILDIFQRLDIMIDVASALEYLH 217
            I        + ++LE M  G L+  L  +         L +   L +  D+A   +YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 218 FGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 274
             +    IH D+   N LL       VA + DFGMA+ +            +  + +M P
Sbjct: 173 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 275 EYGREGRVSTNGDVYSFGIMLMEIFT 300
           E   EG  ++  D +SFG++L EIF+
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 92/194 (47%), Gaps = 10/194 (5%)
Query: 111 IGKGGFGSVYKAIIQD----GMEVAVKVF-DPQYEGAFKSFDIECDVMKRICHRNLIKII 165
           IG+G FG V++ I        + VA+K   +   +   + F  E   M++  H +++K+I
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
              + +    +++E    G L   L +  Y LD+   +     +++AL YL    S   +
Sbjct: 75  GVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 130
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
           H D+   NVL+  N    L DFG+++  +E+      ++    I +MAPE     R ++ 
Sbjct: 131 HRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 189
Query: 286 GDVYSFGIMLMEIF 299
            DV+ FG+ + EI 
Sbjct: 190 SDVWMFGVCMWEIL 203

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 92/194 (47%), Gaps = 10/194 (5%)
Query: 111 IGKGGFGSVYKAIIQD----GMEVAVKVF-DPQYEGAFKSFDIECDVMKRICHRNLIKII 165
           IG+G FG V++ I        + VA+K   +   +   + F  E   M++  H +++K+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
              + +    +++E    G L   L +  Y LD+   +     +++AL YL    S   +
Sbjct: 78  GVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 133
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
           H D+   NVL+  N    L DFG+++  +E+      ++    I +MAPE     R ++ 
Sbjct: 134 HRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 192
Query: 286 GDVYSFGIMLMEIF 299
            DV+ FG+ + EI 
Sbjct: 193 SDVWMFGVCMWEIL 206

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 105/213 (49%), Gaps = 17/213 (7%)
Query: 111 IGKGGFGSVYKAIIQDGMEV-AVKV-FDPQYE--GAFKSFDIECDVMKRICHRNLIKIIS 166
           +GKG FG+VY A  ++   + A+KV F  Q E  G       E ++   + H N++++  
Sbjct: 16  LGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLY-LSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
            + +     L+LEY P G++ + L  LS +  D  +    + ++A+AL Y H   S  +I
Sbjct: 76  YFHDSTRVYLILEYAPLGTVYRELQKLSKF--DEQRTATYITELANALSYCH---SKKVI 130
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
           H D+KP N+LL       ++DFG +        S  +     T+ Y+ PE   EGR+   
Sbjct: 131 HRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRAALCGTLDYLPPEMI-EGRMHDE 185
Query: 286 G-DVYSFGIMLMEIFTRTKPTDEIFSGEMTLKR 317
             D++S G++  E F   KP  E  + + T KR
Sbjct: 186 KVDLWSLGVLCYE-FLVGKPPFEANTYQDTYKR 217

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 92/194 (47%), Gaps = 10/194 (5%)
Query: 111 IGKGGFGSVYKAIIQD----GMEVAVKVF-DPQYEGAFKSFDIECDVMKRICHRNLIKII 165
           IG+G FG V++ I        + VA+K   +   +   + F  E   M++  H +++K+I
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
              + +    +++E    G L   L +  Y LD+   +     +++AL YL    S   +
Sbjct: 106 GVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 161
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
           H D+   NVL+  N    L DFG+++  +E+      ++    I +MAPE     R ++ 
Sbjct: 162 HRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 220
Query: 286 GDVYSFGIMLMEIF 299
            DV+ FG+ + EI 
Sbjct: 221 SDVWMFGVCMWEIL 234

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 98/212 (46%), Gaps = 11/212 (5%)
Query: 111 IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYS 169
           +G G FG VYKA  ++  +  A KV D + E   + + +E D++    H N++K++ ++ 
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 170 NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
            ++   +++E+   G+++  +      L   Q   +      AL YLH      IIH DL
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDL 161
Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEY-----GREGRVST 284
           K  N+L   +    L+DFG++       Q   +   + T  +MAPE       ++     
Sbjct: 162 KAGNILFTLDGDIKLADFGVSAKNTRXIQR--RDSFIGTPYWMAPEVVMCETSKDRPYDY 219
Query: 285 NGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLK 316
             DV+S GI L+E+     P  E+    + LK
Sbjct: 220 KADVWSLGITLIEMAEIEPPHHELNPMRVLLK 251

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 92/194 (47%), Gaps = 10/194 (5%)
Query: 111 IGKGGFGSVYKAIIQD----GMEVAVKVF-DPQYEGAFKSFDIECDVMKRICHRNLIKII 165
           IG+G FG V++ I        + VA+K   +   +   + F  E   M++  H +++K+I
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
              + +    +++E    G L   L +  Y LD+   +     +++AL YL    S   +
Sbjct: 83  GVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 138
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
           H D+   NVL+  N    L DFG+++  +E+      ++    I +MAPE     R ++ 
Sbjct: 139 HRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 197
Query: 286 GDVYSFGIMLMEIF 299
            DV+ FG+ + EI 
Sbjct: 198 SDVWMFGVCMWEIL 211

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 98/212 (46%), Gaps = 11/212 (5%)
Query: 111 IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYS 169
           +G G FG VYKA  ++  +  A KV D + E   + + +E D++    H N++K++ ++ 
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 170 NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
            ++   +++E+   G+++  +      L   Q   +      AL YLH      IIH DL
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDL 161
Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEY-----GREGRVST 284
           K  N+L   +    L+DFG++       Q   +   + T  +MAPE       ++     
Sbjct: 162 KAGNILFTLDGDIKLADFGVSAKNTRTIQR--RDSFIGTPYWMAPEVVMCETSKDRPYDY 219
Query: 285 NGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLK 316
             DV+S GI L+E+     P  E+    + LK
Sbjct: 220 KADVWSLGITLIEMAEIEPPHHELNPMRVLLK 251

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 92/194 (47%), Gaps = 10/194 (5%)
Query: 111 IGKGGFGSVYKAIIQD----GMEVAVKVF-DPQYEGAFKSFDIECDVMKRICHRNLIKII 165
           IG+G FG V++ I        + VA+K   +   +   + F  E   M++  H +++K+I
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
              + +    +++E    G L   L +  Y LD+   +     +++AL YL    S   +
Sbjct: 81  GVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 136
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
           H D+   NVL+  N    L DFG+++  +E+      ++    I +MAPE     R ++ 
Sbjct: 137 HRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 195
Query: 286 GDVYSFGIMLMEIF 299
            DV+ FG+ + EI 
Sbjct: 196 SDVWMFGVCMWEIL 209

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 17/213 (7%)
Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKV-FDPQYE--GAFKSFDIECDVMKRICHRNLIKIIS 166
           +GKG FG+VY A   Q    +A+KV F  Q E  G       E ++   + H N++++  
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLY-LSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
            + +     L+LEY P G++ + L  LS +  D  +    + ++A+AL Y H   S  +I
Sbjct: 78  YFHDATRVYLILEYAPLGTVYRELQKLSKF--DEQRTATYITELANALSYCH---SKRVI 132
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
           H D+KP N+LL       ++DFG +        S  +     T+ Y+ PE   EGR+   
Sbjct: 133 HRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRXXLCGTLDYLPPEMI-EGRMHDE 187
Query: 286 G-DVYSFGIMLMEIFTRTKPTDEIFSGEMTLKR 317
             D++S G++  E F   KP  E  + + T KR
Sbjct: 188 KVDLWSLGVLCYE-FLVGKPPFEANTYQETYKR 219

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 17/213 (7%)
Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKV-FDPQYE--GAFKSFDIECDVMKRICHRNLIKIIS 166
           +GKG FG+VY A   Q    +A+KV F  Q E  G       E ++   + H N++++  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLY-LSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
            + +     L+LEY P G++ + L  LS +  D  +    + ++A+AL Y H   S  +I
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKF--DEQRTATYITELANALSYCH---SKRVI 133
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
           H D+KP N+LL       ++DFG +        S  +     T+ Y+ PE   EGR+   
Sbjct: 134 HRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRDDLCGTLDYLPPEMI-EGRMHDE 188
Query: 286 G-DVYSFGIMLMEIFTRTKPTDEIFSGEMTLKR 317
             D++S G++  E F   KP  E  + + T KR
Sbjct: 189 KVDLWSLGVLCYE-FLVGKPPFEANTYQETYKR 220

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 92/194 (47%), Gaps = 10/194 (5%)
Query: 111 IGKGGFGSVYKAIIQD----GMEVAVKVF-DPQYEGAFKSFDIECDVMKRICHRNLIKII 165
           IG+G FG V++ I        + VA+K   +   +   + F  E   M++  H +++K+I
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
              + +    +++E    G L   L +  Y LD+   +     +++AL YL    S   +
Sbjct: 80  GVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 135
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
           H D+   NVL+  N    L DFG+++  +E+      ++    I +MAPE     R ++ 
Sbjct: 136 HRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 194
Query: 286 GDVYSFGIMLMEIF 299
            DV+ FG+ + EI 
Sbjct: 195 SDVWMFGVCMWEIL 208

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 28/215 (13%)
Query: 111 IGKGGFGSVY--KAIIQDG------MEVAVKVFDPQY-EGAFKSFDIECDVMKRIC-HRN 160
           +G+G FG V   +AI  D        +VAVK+      E        E ++MK I  H+N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 161 LIKIISSYSNDDFKALVLEYMPHGSL------------EKCLYLSNYILDIFQRLDIM-- 206
           +I ++ + + D    +++EY   G+L            E C   S+   +     D++  
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 207 -IDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ +   D     T  
Sbjct: 141 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
              + +MAPE   +   +   DV+SFG++L EIFT
Sbjct: 198 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 98/212 (46%), Gaps = 11/212 (5%)
Query: 111 IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYS 169
           +G G FG VYKA  ++  +  A KV D + E   + + +E D++    H N++K++ ++ 
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 170 NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
            ++   +++E+   G+++  +      L   Q   +      AL YLH      IIH DL
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDL 161
Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEY-----GREGRVST 284
           K  N+L   +    L+DFG++       Q   +   + T  +MAPE       ++     
Sbjct: 162 KAGNILFTLDGDIKLADFGVSAKNTRXIQR--RDXFIGTPYWMAPEVVMCETSKDRPYDY 219
Query: 285 NGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLK 316
             DV+S GI L+E+     P  E+    + LK
Sbjct: 220 KADVWSLGITLIEMAEIEPPHHELNPMRVLLK 251

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 70/224 (31%), Positives = 105/224 (46%), Gaps = 17/224 (7%)
Query: 111 IGKGGFGSVYKAIIQDG-MEVAVKV-FDPQ--YEGAFKSFDIECDVMKRICHRNLIKIIS 166
           +GKG FG+VY A  +     VA+KV F  Q   EG       E ++   + H N++++ +
Sbjct: 31  LGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYN 90
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIH 226
            + +     L+LEY P G L K L  S    D  +   IM ++A AL Y H      +IH
Sbjct: 91  YFYDRRRIYLILEYAPRGELYKELQKSC-TFDEQRTATIMEELADALMYCH---GKKVIH 146
Query: 227 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNG 286
            D+KP N+LL       ++DFG +        SL +     T+ Y+ PE   EGR+    
Sbjct: 147 RDIKPENLLLGLKGELKIADFGWSV----HAPSLRRKTMCGTLDYLPPEMI-EGRMHNEK 201
Query: 287 -DVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN-DL-LPISV 327
            D++  G++  E+     P +     E T +R V  DL  P SV
Sbjct: 202 VDLWCIGVLCYELLVGNPPFESASHNE-TYRRIVKVDLKFPASV 244

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 96/220 (43%), Gaps = 33/220 (15%)
Query: 111 IGKGGFGSVYKAIIQDGME------VAVKVFDPQYEGAFKS-FDIECDVMKRICHRNLIK 163
           IG+G FG V++A     +       VAVK+   +     ++ F  E  +M    + N++K
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLY--------------LSNYI---------LDIF 200
           ++   +      L+ EYM +G L + L               LS            L   
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 201 QRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL 260
           ++L I   VA+ + YL        +H DL   N L+ +NMV  ++DFG+++ +   D   
Sbjct: 175 EQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 261 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
                   I +M PE     R +T  DV+++G++L EIF+
Sbjct: 232 ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 104/213 (48%), Gaps = 17/213 (7%)
Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKV-FDPQYE--GAFKSFDIECDVMKRICHRNLIKIIS 166
           +GKG FG+VY A   Q    +A+KV F  Q E  G       E ++   + H N++++  
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLY-LSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
            + +     L+LEY P G++ + L  LS +  D  +    + ++A+AL Y H   S  +I
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKLSRF--DEQRTATYITELANALSYCH---SKRVI 134
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
           H D+KP N+LL  N    ++DFG +        S  +     T+ Y+ PE   EGR+   
Sbjct: 135 HRDIKPENLLLGSNGELKIADFGWSV----HAPSSRRDTLCGTLDYLPPEMI-EGRMHDE 189
Query: 286 G-DVYSFGIMLMEIFTRTKPTDEIFSGEMTLKR 317
             D++S G++  E F    P  E  + + T +R
Sbjct: 190 KVDLWSLGVLCYE-FLVGMPPFEAHTYQETYRR 221

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 86/200 (43%), Gaps = 16/200 (8%)
Query: 111 IGKGGFGSV----YKAIIQDGMEVAVKVFDP---QYEGAFKSFDIECDVMKRICHRNLIK 163
           +G G FG V    + A     + VAVK   P       A   F  E + M  + HRNLI+
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCL--YLSNYILDIFQRLDIMIDVASALEYLHFGYS 221
           +         K +V E  P GSL   L  +  +++L    R    + VA  + YL    S
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLE---S 129
Query: 222 APIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE-EDQSLTQTQTLATIGYMAPEYGREG 280
              IH DL   N+LL    +  + DFG+ + L + +D  + Q        + APE  +  
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTR 189
Query: 281 RVSTNGDVYSFGIMLMEIFT 300
             S   D + FG+ L E+FT
Sbjct: 190 TFSHASDTWMFGVTLWEMFT 209

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 28/215 (13%)
Query: 111 IGKGGFGSVY--KAIIQDG------MEVAVKVFDPQY-EGAFKSFDIECDVMKRIC-HRN 160
           +G+G FG V   +AI  D        +VAVK+      E        E ++MK I  H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 161 LIKIISSYSNDDFKALVLEYMPHGSL------------EKCLYLSNYILDIFQRLDIM-- 206
           +I ++ + + D    +++EY   G+L            E C   S+   +     D++  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 207 -IDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ +   D     T  
Sbjct: 156 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
              + +MAPE   +   +   DV+SFG++L EIFT
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 86/200 (43%), Gaps = 16/200 (8%)
Query: 111 IGKGGFGSV----YKAIIQDGMEVAVKVFDP---QYEGAFKSFDIECDVMKRICHRNLIK 163
           +G G FG V    + A     + VAVK   P       A   F  E + M  + HRNLI+
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCL--YLSNYILDIFQRLDIMIDVASALEYLHFGYS 221
           +         K +V E  P GSL   L  +  +++L    R    + VA  + YL    S
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLE---S 139
Query: 222 APIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE-EDQSLTQTQTLATIGYMAPEYGREG 280
              IH DL   N+LL    +  + DFG+ + L + +D  + Q        + APE  +  
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTR 199
Query: 281 RVSTNGDVYSFGIMLMEIFT 300
             S   D + FG+ L E+FT
Sbjct: 200 TFSHASDTWMFGVTLWEMFT 219

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 92/194 (47%), Gaps = 10/194 (5%)
Query: 111 IGKGGFGSVYKAIIQD----GMEVAVKVF-DPQYEGAFKSFDIECDVMKRICHRNLIKII 165
           IG+G FG V++ I        M VA+K   +   +   + F  E   M++  H +++K+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
              + +    +++E    G L   L +  + LD+   +     +++AL YL    S   +
Sbjct: 458 GVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFV 513
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
           H D+   NVL+  N    L DFG+++  +E+      ++    I +MAPE     R ++ 
Sbjct: 514 HRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 572
Query: 286 GDVYSFGIMLMEIF 299
            DV+ FG+ + EI 
Sbjct: 573 SDVWMFGVCMWEIL 586

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 17/213 (7%)
Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKV-FDPQYE--GAFKSFDIECDVMKRICHRNLIKIIS 166
           +GKG FG+VY A   Q    +A+KV F  Q E  G       E ++   + H N++++  
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLY-LSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
            + +     L+LEY P G++ + L  LS +  D  +    + ++A+AL Y H   S  +I
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLSKF--DEQRTATYITELANALSYCH---SKRVI 131
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
           H D+KP N+LL       ++DFG +        S  +     T+ Y+ PE   EGR+   
Sbjct: 132 HRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRDTLCGTLDYLPPEMI-EGRMHDE 186
Query: 286 G-DVYSFGIMLMEIFTRTKPTDEIFSGEMTLKR 317
             D++S G++  E F   KP  E  + + T KR
Sbjct: 187 KVDLWSLGVLCYE-FLVGKPPFEANTYQETYKR 218

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 17/213 (7%)
Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKV-FDPQYE--GAFKSFDIECDVMKRICHRNLIKIIS 166
           +GKG FG+VY A   Q    +A+KV F  Q E  G       E ++   + H N++++  
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLY-LSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
            + +     L+LEY P G++ + L  LS +  D  +    + ++A+AL Y H   S  +I
Sbjct: 102 YFHDATRVYLILEYAPLGTVYRELQKLSKF--DEQRTATYITELANALSYCH---SKRVI 156
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
           H D+KP N+LL       ++DFG +        S  +     T+ Y+ PE   EGR+   
Sbjct: 157 HRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRDDLCGTLDYLPPEMI-EGRMHDE 211
Query: 286 G-DVYSFGIMLMEIFTRTKPTDEIFSGEMTLKR 317
             D++S G++  E F   KP  E  + + T KR
Sbjct: 212 KVDLWSLGVLCYE-FLVGKPPFEANTYQETYKR 243

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 97/194 (50%), Gaps = 11/194 (5%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKV--FDPQYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
           +G+G +G VYKA    G  VA+K    D + EG   +   E  ++K + H N++ +I   
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCD 228
            ++    LV E+M    L+K L  +   L   Q   I I +   L  +   +   I+H D
Sbjct: 89  HSERCLTLVFEFM-EKDLKKVLDENKTGL---QDSQIKIYLYQLLRGVAHCHQHRILHRD 144
Query: 229 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEY--GREGRVSTNG 286
           LKP N+L++ +    L+DFG+A+      +S   T  + T+ Y AP+   G + + ST+ 
Sbjct: 145 LKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVTLWYRAPDVLMGSK-KYSTSV 201
Query: 287 DVYSFGIMLMEIFT 300
           D++S G +  E+ T
Sbjct: 202 DIWSIGCIFAEMIT 215

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 95/193 (49%), Gaps = 9/193 (4%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKV--FDPQYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
           +G+G +G VYKA    G  VA+K    D + EG   +   E  ++K + H N++ +I   
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCD 228
            ++    LV E+M    L+K L  +   L   Q   I I +   L  +   +   I+H D
Sbjct: 89  HSERCLTLVFEFM-EKDLKKVLDENKTGL---QDSQIKIYLYQLLRGVAHCHQHRILHRD 144
Query: 229 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEY-GREGRVSTNGD 287
           LKP N+L++ +    L+DFG+A+      +S   T  + T+ Y AP+      + ST+ D
Sbjct: 145 LKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVTLWYRAPDVLMGSKKYSTSVD 202
Query: 288 VYSFGIMLMEIFT 300
           ++S G +  E+ T
Sbjct: 203 IWSIGCIFAEMIT 215

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 92/207 (44%), Gaps = 21/207 (10%)
Query: 111 IGKGGFGSVYKAIIQ------DGMEVAVKVFDPQYEGAFKSFD--IECDVMKRICHRNLI 162
           +G G FG VY+  +         ++VAVK   P+        D  +E  ++ ++ H+N++
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKLNHQNIV 97
Query: 163 KIISSYSNDDFKALVLEYMPHGSLEKCLYLSN------YILDIFQRLDIMIDVASALEYL 216
           + I        + ++LE M  G L+  L  +         L +   L +  D+A   +YL
Sbjct: 98  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 157
Query: 217 HFGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
              +    IH D+   N LL       VA + DFGMA+ +            +  + +M 
Sbjct: 158 EENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 214
Query: 274 PEYGREGRVSTNGDVYSFGIMLMEIFT 300
           PE   EG  ++  D +SFG++L EIF+
Sbjct: 215 PEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 93/204 (45%), Gaps = 17/204 (8%)
Query: 111 IGKGGFGSVYKAIIQDGMEV-AVKVFD-PQYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
           IGKG FG VYK I     EV A+K+ D  + E   +    E  V+ +     + +   SY
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGSY 86
Query: 169 SNDDFKALVLEYMPHGS----LEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPI 224
                  +++EY+  GS    L+       YI  I +      ++   L+YLH   S   
Sbjct: 87  LKSTKLWIIMEYLGGGSALDLLKPGPLEETYIATILR------EILKGLDYLH---SERK 137
Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVST 284
           IH D+K +NVLL +     L+DFG+A  L   D  + +   + T  +MAPE  ++     
Sbjct: 138 IHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNXFVGTPFWMAPEVIKQSAYDF 195
Query: 285 NGDVYSFGIMLMEIFTRTKPTDEI 308
             D++S GI  +E+     P  ++
Sbjct: 196 KADIWSLGITAIELAKGEPPNSDL 219

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 99/198 (50%), Gaps = 15/198 (7%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAV--KV-FDPQYEGAFKSFDIECDVMKRICHRNLIKIISS 167
           IG+G +G VYKA  +   EV    K+  D + EG   +   E  ++K + H N++K++  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 168 YSNDDFKALVLEYMPHGSLEKCL---YLSNYILDIFQRLDIMIDVASALEYLHFGYSAPI 224
              ++   LV E++ H  L+K +    L+   L + +     +     L+ L F +S  +
Sbjct: 71  IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL-----LQGLAFCHSHRV 124
Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGR-VS 283
           +H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y APE     +  S
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYS 182
Query: 284 TNGDVYSFGIMLMEIFTR 301
           T  D++S G +  E+ TR
Sbjct: 183 TAVDIWSLGCIFAEMVTR 200

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 99/198 (50%), Gaps = 15/198 (7%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAV--KV-FDPQYEGAFKSFDIECDVMKRICHRNLIKIISS 167
           IG+G +G VYKA  +   EV    K+  D + EG   +   E  ++K + H N++K++  
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 168 YSNDDFKALVLEYMPHGSLEKCL---YLSNYILDIFQRLDIMIDVASALEYLHFGYSAPI 224
              ++   LV E++ H  L+K +    L+   L + +     +     L+ L F +S  +
Sbjct: 70  IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL-----LQGLAFCHSHRV 123
Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGR-VS 283
           +H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y APE     +  S
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYS 181
Query: 284 TNGDVYSFGIMLMEIFTR 301
           T  D++S G +  E+ TR
Sbjct: 182 TAVDIWSLGCIFAEMVTR 199

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 86/200 (43%), Gaps = 16/200 (8%)
Query: 111 IGKGGFGSV----YKAIIQDGMEVAVKVFDP---QYEGAFKSFDIECDVMKRICHRNLIK 163
           +G G FG V    + A     + VAVK   P       A   F  E + M  + HRNLI+
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCL--YLSNYILDIFQRLDIMIDVASALEYLHFGYS 221
           +         K +V E  P GSL   L  +  +++L    R    + VA  + YL    S
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLE---S 129
Query: 222 APIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE-EDQSLTQTQTLATIGYMAPEYGREG 280
              IH DL   N+LL    +  + DFG+ + L + +D  + Q        + APE  +  
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189
Query: 281 RVSTNGDVYSFGIMLMEIFT 300
             S   D + FG+ L E+FT
Sbjct: 190 TFSHASDTWMFGVTLWEMFT 209

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 86/200 (43%), Gaps = 16/200 (8%)
Query: 111 IGKGGFGSV----YKAIIQDGMEVAVKVFDP---QYEGAFKSFDIECDVMKRICHRNLIK 163
           +G G FG V    + A     + VAVK   P       A   F  E + M  + HRNLI+
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCL--YLSNYILDIFQRLDIMIDVASALEYLHFGYS 221
           +         K +V E  P GSL   L  +  +++L    R    + VA  + YL    S
Sbjct: 80  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLE---S 133
Query: 222 APIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE-EDQSLTQTQTLATIGYMAPEYGREG 280
              IH DL   N+LL    +  + DFG+ + L + +D  + Q        + APE  +  
Sbjct: 134 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 193
Query: 281 RVSTNGDVYSFGIMLMEIFT 300
             S   D + FG+ L E+FT
Sbjct: 194 TFSHASDTWMFGVTLWEMFT 213

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 86/200 (43%), Gaps = 16/200 (8%)
Query: 111 IGKGGFGSV----YKAIIQDGMEVAVKVFDP---QYEGAFKSFDIECDVMKRICHRNLIK 163
           +G G FG V    + A     + VAVK   P       A   F  E + M  + HRNLI+
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCL--YLSNYILDIFQRLDIMIDVASALEYLHFGYS 221
           +         K +V E  P GSL   L  +  +++L    R    + VA  + YL    S
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLE---S 139
Query: 222 APIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE-EDQSLTQTQTLATIGYMAPEYGREG 280
              IH DL   N+LL    +  + DFG+ + L + +D  + Q        + APE  +  
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 199
Query: 281 RVSTNGDVYSFGIMLMEIFT 300
             S   D + FG+ L E+FT
Sbjct: 200 TFSHASDTWMFGVTLWEMFT 219

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 86/200 (43%), Gaps = 16/200 (8%)
Query: 111 IGKGGFGSV----YKAIIQDGMEVAVKVFDP---QYEGAFKSFDIECDVMKRICHRNLIK 163
           +G G FG V    + A     + VAVK   P       A   F  E + M  + HRNLI+
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCL--YLSNYILDIFQRLDIMIDVASALEYLHFGYS 221
           +         K +V E  P GSL   L  +  +++L    R    + VA  + YL    S
Sbjct: 80  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLE---S 133
Query: 222 APIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE-EDQSLTQTQTLATIGYMAPEYGREG 280
              IH DL   N+LL    +  + DFG+ + L + +D  + Q        + APE  +  
Sbjct: 134 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 193
Query: 281 RVSTNGDVYSFGIMLMEIFT 300
             S   D + FG+ L E+FT
Sbjct: 194 TFSHASDTWMFGVTLWEMFT 213

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 92/207 (44%), Gaps = 21/207 (10%)
Query: 111 IGKGGFGSVYKAIIQ------DGMEVAVKVFDPQYEGAFKSFD--IECDVMKRICHRNLI 162
           +G G FG VY+  +         ++VAVK   P+        D  +E  ++ ++ H+N++
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKLNHQNIV 111
Query: 163 KIISSYSNDDFKALVLEYMPHGSLEKCLYLSN------YILDIFQRLDIMIDVASALEYL 216
           + I        + ++LE M  G L+  L  +         L +   L +  D+A   +YL
Sbjct: 112 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 171
Query: 217 HFGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
              +    IH D+   N LL       VA + DFGMA+ +            +  + +M 
Sbjct: 172 EENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 228
Query: 274 PEYGREGRVSTNGDVYSFGIMLMEIFT 300
           PE   EG  ++  D +SFG++L EIF+
Sbjct: 229 PEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 86/200 (43%), Gaps = 16/200 (8%)
Query: 111 IGKGGFGSV----YKAIIQDGMEVAVKVFDP---QYEGAFKSFDIECDVMKRICHRNLIK 163
           +G G FG V    + A     + VAVK   P       A   F  E + M  + HRNLI+
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCL--YLSNYILDIFQRLDIMIDVASALEYLHFGYS 221
           +         K +V E  P GSL   L  +  +++L    R    + VA  + YL    S
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLE---S 129
Query: 222 APIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE-EDQSLTQTQTLATIGYMAPEYGREG 280
              IH DL   N+LL    +  + DFG+ + L + +D  + Q        + APE  +  
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189
Query: 281 RVSTNGDVYSFGIMLMEIFT 300
             S   D + FG+ L E+FT
Sbjct: 190 TFSHASDTWMFGVTLWEMFT 209

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 28/215 (13%)
Query: 111 IGKGGFGSVY--KAIIQDG------MEVAVKVFDPQY-EGAFKSFDIECDVMKRIC-HRN 160
           +G+G FG V   +AI  D        +VAVK+      E        E ++MK I  H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 161 LIKIISSYSNDDFKALVLEYMPHGSLEKCLYL------------SNYILDIFQRLDIM-- 206
           +I ++ + + D    +++EY   G+L + L              S+   +     D++  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 207 -IDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ +   D     T  
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
              + +MAPE   +   +   DV+SFG++L EIFT
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 19/208 (9%)
Query: 110 LIGKGGFGSVYKAII--QDG--MEVAVKV--FDPQYEGAFKSFDIECDVMKRICHRNLIK 163
           ++G+G FGSV +  +  +DG  ++VAVK    D   +   + F  E   MK   H N+I+
Sbjct: 41  ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100
Query: 164 IIS-----SYSNDDFKALVLEYMPHGSLEKCLYLSNY-----ILDIFQRLDIMIDVASAL 213
           ++      S        ++L +M +G L   L  S        + +   L  M+D+A  +
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160
Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
           EYL    +   +H DL   N +L D+M   ++DFG++K +   D           + ++A
Sbjct: 161 EYLS---NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 217
Query: 274 PEYGREGRVSTNGDVYSFGIMLMEIFTR 301
            E   +   ++  DV++FG+ + EI TR
Sbjct: 218 IESLADRVYTSKSDVWAFGVTMWEIATR 245

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 99/198 (50%), Gaps = 15/198 (7%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVK--VFDPQYEGAFKSFDIECDVMKRICHRNLIKIISS 167
           IG+G +G VYKA  +  G  VA+K    D + EG   +   E  ++K + H N++K++  
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 168 YSNDDFKALVLEYMPHGSLEKCL---YLSNYILDIFQRLDIMIDVASALEYLHFGYSAPI 224
              ++   LV E++ H  L+K +    L+   L + +     +     L+ L F +S  +
Sbjct: 74  IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL-----LQGLAFCHSHRV 127
Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGR-VS 283
           +H DLKP N+L++      L+DFG+A+      +  T    + T+ Y APE     +  S
Sbjct: 128 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCKYYS 185
Query: 284 TNGDVYSFGIMLMEIFTR 301
           T  D++S G +  E+ TR
Sbjct: 186 TAVDIWSLGCIFAEMVTR 203

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 99/198 (50%), Gaps = 15/198 (7%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVK--VFDPQYEGAFKSFDIECDVMKRICHRNLIKIISS 167
           IG+G +G VYKA  +  G  VA+K    D + EG   +   E  ++K + H N++K++  
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 168 YSNDDFKALVLEYMPHGSLEKCL---YLSNYILDIFQRLDIMIDVASALEYLHFGYSAPI 224
              ++   LV E++ H  L+K +    L+   L + +     +     L+ L F +S  +
Sbjct: 73  IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL-----LQGLAFCHSHRV 126
Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGR-VS 283
           +H DLKP N+L++      L+DFG+A+      +  T    + T+ Y APE     +  S
Sbjct: 127 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCKYYS 184
Query: 284 TNGDVYSFGIMLMEIFTR 301
           T  D++S G +  E+ TR
Sbjct: 185 TAVDIWSLGCIFAEMVTR 202

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 28/215 (13%)
Query: 111 IGKGGFGSVY--KAIIQDG------MEVAVKVFDP-QYEGAFKSFDIECDVMKRIC-HRN 160
           +G+G FG V   +AI  D        +VAVK+      E        E ++MK I  H+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 161 LIKIISSYSNDDFKALVLEYMPHGSLEKCL---------YLSNYILDIFQRLD------I 205
           +I ++ + + D    +++EY   G+L + L         Y  N   +  ++L        
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ +   D     T  
Sbjct: 197 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
              + +MAPE   +   +   DV+SFG++L EIFT
Sbjct: 254 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 99/198 (50%), Gaps = 15/198 (7%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVK--VFDPQYEGAFKSFDIECDVMKRICHRNLIKIISS 167
           IG+G +G VYKA  +  G  VA+K    D + EG   +   E  ++K + H N++K++  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 168 YSNDDFKALVLEYMPHGSLEKCL---YLSNYILDIFQRLDIMIDVASALEYLHFGYSAPI 224
              ++   LV E++ H  L+K +    L+   L + +     +     L+ L F +S  +
Sbjct: 71  IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL-----LQGLAFCHSHRV 124
Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGR-VS 283
           +H DLKP N+L++      L+DFG+A+      +  T    + T+ Y APE     +  S
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCKYYS 182
Query: 284 TNGDVYSFGIMLMEIFTR 301
           T  D++S G +  E+ TR
Sbjct: 183 TAVDIWSLGCIFAEMVTR 200

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 91/207 (43%), Gaps = 21/207 (10%)
Query: 111 IGKGGFGSVYKAIIQ------DGMEVAVKVFDPQYEGAFKSFD--IECDVMKRICHRNLI 162
           +G G FG VY+  +         ++VAVK   P+        D  +E  ++ +  H+N++
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQNIV 97
Query: 163 KIISSYSNDDFKALVLEYMPHGSLEKCLYLSN------YILDIFQRLDIMIDVASALEYL 216
           + I        + ++LE M  G L+  L  +         L +   L +  D+A   +YL
Sbjct: 98  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 157
Query: 217 HFGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
              +    IH D+   N LL       VA + DFGMA+ +            +  + +M 
Sbjct: 158 EENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 214
Query: 274 PEYGREGRVSTNGDVYSFGIMLMEIFT 300
           PE   EG  ++  D +SFG++L EIF+
Sbjct: 215 PEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 99/198 (50%), Gaps = 15/198 (7%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVK--VFDPQYEGAFKSFDIECDVMKRICHRNLIKIISS 167
           IG+G +G VYKA  +  G  VA+K    D + EG   +   E  ++K + H N++K++  
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 168 YSNDDFKALVLEYMPHGSLEKCL---YLSNYILDIFQRLDIMIDVASALEYLHFGYSAPI 224
              ++   LV E++ H  L+K +    L+   L + +     +     L+ L F +S  +
Sbjct: 73  IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL-----LQGLAFCHSHRV 126
Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGR-VS 283
           +H DLKP N+L++      L+DFG+A+      +  T    + T+ Y APE     +  S
Sbjct: 127 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCKYYS 184
Query: 284 TNGDVYSFGIMLMEIFTR 301
           T  D++S G +  E+ TR
Sbjct: 185 TAVDIWSLGCIFAEMVTR 202

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 99/198 (50%), Gaps = 15/198 (7%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVK--VFDPQYEGAFKSFDIECDVMKRICHRNLIKIISS 167
           IG+G +G VYKA  +  G  VA+K    D + EG   +   E  ++K + H N++K++  
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 168 YSNDDFKALVLEYMPHGSLEKCL---YLSNYILDIFQRLDIMIDVASALEYLHFGYSAPI 224
              ++   LV E++ H  L+K +    L+   L + +     +     L+ L F +S  +
Sbjct: 74  IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL-----LQGLAFCHSHRV 127
Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGR-VS 283
           +H DLKP N+L++      L+DFG+A+      +  T    + T+ Y APE     +  S
Sbjct: 128 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCKYYS 185
Query: 284 TNGDVYSFGIMLMEIFTR 301
           T  D++S G +  E+ TR
Sbjct: 186 TAVDIWSLGCIFAEMVTR 203

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 28/215 (13%)
Query: 111 IGKGGFGSVY--KAIIQDG------MEVAVKVFDPQY-EGAFKSFDIECDVMKRIC-HRN 160
           +G+G FG V   +AI  D        +VAVK+      E        E ++MK I  H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 161 LIKIISSYSNDDFKALVLEYMPHGSLEKCL---------YLSNYILDIFQRLD------I 205
           +I ++ + + D    +++EY   G+L + L         Y  N   +  ++L        
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ +   D     T  
Sbjct: 156 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
              + +MAPE   +   +   DV+SFG++L EIFT
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 91/207 (43%), Gaps = 21/207 (10%)
Query: 111 IGKGGFGSVYKAIIQ------DGMEVAVKVFDPQYEGAFKSFD--IECDVMKRICHRNLI 162
           +G G FG VY+  +         ++VAVK   P+        D  +E  ++ +  H+N++
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQNIV 96
Query: 163 KIISSYSNDDFKALVLEYMPHGSLEKCLYLSN------YILDIFQRLDIMIDVASALEYL 216
           + I        + ++LE M  G L+  L  +         L +   L +  D+A   +YL
Sbjct: 97  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 217 HFGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
              +    IH D+   N LL       VA + DFGMA+ +            +  + +M 
Sbjct: 157 EENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 213
Query: 274 PEYGREGRVSTNGDVYSFGIMLMEIFT 300
           PE   EG  ++  D +SFG++L EIF+
Sbjct: 214 PEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 99/198 (50%), Gaps = 15/198 (7%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVK--VFDPQYEGAFKSFDIECDVMKRICHRNLIKIISS 167
           IG+G +G VYKA  +  G  VA+K    D + EG   +   E  ++K + H N++K++  
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 168 YSNDDFKALVLEYMPHGSLEKCL---YLSNYILDIFQRLDIMIDVASALEYLHFGYSAPI 224
              ++   LV E++ H  L+K +    L+   L + +     +     L+ L F +S  +
Sbjct: 70  IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL-----LQGLAFCHSHRV 123
Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGR-VS 283
           +H DLKP N+L++      L+DFG+A+      +  T    + T+ Y APE     +  S
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCKYYS 181
Query: 284 TNGDVYSFGIMLMEIFTR 301
           T  D++S G +  E+ TR
Sbjct: 182 TAVDIWSLGCIFAEMVTR 199

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 28/215 (13%)
Query: 111 IGKGGFGSVY--KAIIQDG------MEVAVKVFDPQY-EGAFKSFDIECDVMKRIC-HRN 160
           +G+G FG V   +AI  D        +VAVK+      E        E ++MK I  H+N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 161 LIKIISSYSNDDFKALVLEYMPHGSLEKCL---------YLSNYILDIFQRLD------I 205
           +I ++ + + D    +++EY   G+L + L         Y  N   +  ++L        
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ +   D     T  
Sbjct: 145 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 201
Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
              + +MAPE   +   +   DV+SFG++L EIFT
Sbjct: 202 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 99/198 (50%), Gaps = 15/198 (7%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVK--VFDPQYEGAFKSFDIECDVMKRICHRNLIKIISS 167
           IG+G +G VYKA  +  G  VA+K    D + EG   +   E  ++K + H N++K++  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 168 YSNDDFKALVLEYMPHGSLEKCL---YLSNYILDIFQRLDIMIDVASALEYLHFGYSAPI 224
              ++   LV E++ H  L+K +    L+   L + +     +     L+ L F +S  +
Sbjct: 71  IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL-----LQGLAFCHSHRV 124
Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGR-VS 283
           +H DLKP N+L++      L+DFG+A+      +  T    + T+ Y APE     +  S
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCKYYS 182
Query: 284 TNGDVYSFGIMLMEIFTR 301
           T  D++S G +  E+ TR
Sbjct: 183 TAVDIWSLGCIFAEMVTR 200

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 28/215 (13%)
Query: 111 IGKGGFGSVY--KAIIQDG------MEVAVKVFDPQY-EGAFKSFDIECDVMKRIC-HRN 160
           +G+G FG V   +AI  D        +VAVK+      E        E ++MK I  H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 161 LIKIISSYSNDDFKALVLEYMPHGSLEKCL---------YLSNYILDIFQRLD------I 205
           +I ++ + + D    +++EY   G+L + L         Y  N   +  ++L        
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ +   D     T  
Sbjct: 156 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
              + +MAPE   +   +   DV+SFG++L EIFT
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 99/198 (50%), Gaps = 15/198 (7%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVK--VFDPQYEGAFKSFDIECDVMKRICHRNLIKIISS 167
           IG+G +G VYKA  +  G  VA+K    D + EG   +   E  ++K + H N++K++  
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 168 YSNDDFKALVLEYMPHGSLEKCL---YLSNYILDIFQRLDIMIDVASALEYLHFGYSAPI 224
              ++   LV E++ H  L+K +    L+   L + +     +     L+ L F +S  +
Sbjct: 72  IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL-----LQGLAFCHSHRV 125
Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGR-VS 283
           +H DLKP N+L++      L+DFG+A+      +  T    + T+ Y APE     +  S
Sbjct: 126 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCKYYS 183
Query: 284 TNGDVYSFGIMLMEIFTR 301
           T  D++S G +  E+ TR
Sbjct: 184 TAVDIWSLGCIFAEMVTR 201

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 91/207 (43%), Gaps = 21/207 (10%)
Query: 111 IGKGGFGSVYKAIIQ------DGMEVAVKVFDPQYEGAFKSFD--IECDVMKRICHRNLI 162
           +G G FG VY+  +         ++VAVK   P+        D  +E  ++ +  H+N++
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQNIV 113
Query: 163 KIISSYSNDDFKALVLEYMPHGSLEKCLYLSN------YILDIFQRLDIMIDVASALEYL 216
           + I        + ++LE M  G L+  L  +         L +   L +  D+A   +YL
Sbjct: 114 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 173
Query: 217 HFGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
              +    IH D+   N LL       VA + DFGMA+ +            +  + +M 
Sbjct: 174 EENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 230
Query: 274 PEYGREGRVSTNGDVYSFGIMLMEIFT 300
           PE   EG  ++  D +SFG++L EIF+
Sbjct: 231 PEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 99/198 (50%), Gaps = 15/198 (7%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVK--VFDPQYEGAFKSFDIECDVMKRICHRNLIKIISS 167
           IG+G +G VYKA  +  G  VA+K    D + EG   +   E  ++K + H N++K++  
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 168 YSNDDFKALVLEYMPHGSLEKCL---YLSNYILDIFQRLDIMIDVASALEYLHFGYSAPI 224
              ++   LV E++ H  L+K +    L+   L + +     +     L+ L F +S  +
Sbjct: 70  IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL-----LQGLAFCHSHRV 123
Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGR-VS 283
           +H DLKP N+L++      L+DFG+A+      +  T    + T+ Y APE     +  S
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCKYYS 181
Query: 284 TNGDVYSFGIMLMEIFTR 301
           T  D++S G +  E+ TR
Sbjct: 182 TAVDIWSLGCIFAEMVTR 199

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 99/198 (50%), Gaps = 15/198 (7%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVK--VFDPQYEGAFKSFDIECDVMKRICHRNLIKIISS 167
           IG+G +G VYKA  +  G  VA+K    D + EG   +   E  ++K + H N++K++  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 168 YSNDDFKALVLEYMPHGSLEKCL---YLSNYILDIFQRLDIMIDVASALEYLHFGYSAPI 224
              ++   LV E++ H  L+K +    L+   L + +     +     L+ L F +S  +
Sbjct: 71  IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL-----LQGLAFCHSHRV 124
Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGR-VS 283
           +H DLKP N+L++      L+DFG+A+      +  T    + T+ Y APE     +  S
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCKYYS 182
Query: 284 TNGDVYSFGIMLMEIFTR 301
           T  D++S G +  E+ TR
Sbjct: 183 TAVDIWSLGCIFAEMVTR 200

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 28/215 (13%)
Query: 111 IGKGGFGSVY--KAIIQDG------MEVAVKVFDPQY-EGAFKSFDIECDVMKRIC-HRN 160
           +G+G FG V   +AI  D        +VAVK+      E        E ++MK I  H+N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 161 LIKIISSYSNDDFKALVLEYMPHGSLEKCL---------YLSNYILDIFQRLD------I 205
           +I ++ + + D    +++EY   G+L + L         Y  N   +  ++L        
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ +   D     T  
Sbjct: 148 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 204
Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
              + +MAPE   +   +   DV+SFG++L EIFT
Sbjct: 205 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 99/198 (50%), Gaps = 15/198 (7%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVK--VFDPQYEGAFKSFDIECDVMKRICHRNLIKIISS 167
           IG+G +G VYKA  +  G  VA+K    D + EG   +   E  ++K + H N++K++  
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 168 YSNDDFKALVLEYMPHGSLEKCL---YLSNYILDIFQRLDIMIDVASALEYLHFGYSAPI 224
              ++   LV E++ H  L+K +    L+   L + +     +     L+ L F +S  +
Sbjct: 73  IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL-----LQGLAFCHSHRV 126
Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGR-VS 283
           +H DLKP N+L++      L+DFG+A+      +  T    + T+ Y APE     +  S
Sbjct: 127 LHRDLKPENLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCKYYS 184
Query: 284 TNGDVYSFGIMLMEIFTR 301
           T  D++S G +  E+ TR
Sbjct: 185 TAVDIWSLGCIFAEMVTR 202

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 91/207 (43%), Gaps = 21/207 (10%)
Query: 111 IGKGGFGSVYKAIIQ------DGMEVAVKVFDPQYEGAFKSFD--IECDVMKRICHRNLI 162
           +G G FG VY+  +         ++VAVK   P+        D  +E  ++ +  H+N++
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQNIV 103
Query: 163 KIISSYSNDDFKALVLEYMPHGSLEKCLYLSN------YILDIFQRLDIMIDVASALEYL 216
           + I        + ++LE M  G L+  L  +         L +   L +  D+A   +YL
Sbjct: 104 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 163
Query: 217 HFGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
              +    IH D+   N LL       VA + DFGMA+ +            +  + +M 
Sbjct: 164 EENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 220
Query: 274 PEYGREGRVSTNGDVYSFGIMLMEIFT 300
           PE   EG  ++  D +SFG++L EIF+
Sbjct: 221 PEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 91/207 (43%), Gaps = 21/207 (10%)
Query: 111 IGKGGFGSVYKAIIQ------DGMEVAVKVFDPQYEGAFKSFD--IECDVMKRICHRNLI 162
           +G G FG VY+  +         ++VAVK   P+        D  +E  ++ +  H+N++
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQNIV 123
Query: 163 KIISSYSNDDFKALVLEYMPHGSLEKCLYLSN------YILDIFQRLDIMIDVASALEYL 216
           + I        + ++LE M  G L+  L  +         L +   L +  D+A   +YL
Sbjct: 124 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 183
Query: 217 HFGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
              +    IH D+   N LL       VA + DFGMA+ +            +  + +M 
Sbjct: 184 EENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 240
Query: 274 PEYGREGRVSTNGDVYSFGIMLMEIFT 300
           PE   EG  ++  D +SFG++L EIF+
Sbjct: 241 PEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 99/198 (50%), Gaps = 15/198 (7%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVK--VFDPQYEGAFKSFDIECDVMKRICHRNLIKIISS 167
           IG+G +G VYKA  +  G  VA+K    D + EG   +   E  ++K + H N++K++  
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 168 YSNDDFKALVLEYMPHGSLEKCL---YLSNYILDIFQRLDIMIDVASALEYLHFGYSAPI 224
              ++   LV E++ H  L+K +    L+   L + +     +     L+ L F +S  +
Sbjct: 72  IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL-----LQGLAFCHSHRV 125
Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGR-VS 283
           +H DLKP N+L++      L+DFG+A+      +  T    + T+ Y APE     +  S
Sbjct: 126 LHRDLKPENLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCKYYS 183
Query: 284 TNGDVYSFGIMLMEIFTR 301
           T  D++S G +  E+ TR
Sbjct: 184 TAVDIWSLGCIFAEMVTR 201

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 99/198 (50%), Gaps = 15/198 (7%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVK--VFDPQYEGAFKSFDIECDVMKRICHRNLIKIISS 167
           IG+G +G VYKA  +  G  VA+K    D + EG   +   E  ++K + H N++K++  
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 74
Query: 168 YSNDDFKALVLEYMPHGSLEKCL---YLSNYILDIFQRLDIMIDVASALEYLHFGYSAPI 224
              ++   LV E++ H  L+K +    L+   L + +     +     L+ L F +S  +
Sbjct: 75  IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL-----LQGLAFCHSHRV 128
Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGR-VS 283
           +H DLKP N+L++      L+DFG+A+      +  T    + T+ Y APE     +  S
Sbjct: 129 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCKYYS 186
Query: 284 TNGDVYSFGIMLMEIFTR 301
           T  D++S G +  E+ TR
Sbjct: 187 TAVDIWSLGCIFAEMVTR 204

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 28/215 (13%)
Query: 111 IGKGGFGSVY--KAIIQDG------MEVAVKVFDPQY-EGAFKSFDIECDVMKRIC-HRN 160
           +G+G FG V   +AI  D        +VAVK+      E        E ++MK I  H+N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 161 LIKIISSYSNDDFKALVLEYMPHGSLEKCL---------YLSNYILDIFQRLD------I 205
           +I ++ + + D    +++EY   G+L + L         Y  N   +  ++L        
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ +   D     T  
Sbjct: 149 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 205
Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
              + +MAPE   +   +   DV+SFG++L EIFT
Sbjct: 206 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 91/207 (43%), Gaps = 21/207 (10%)
Query: 111 IGKGGFGSVYKAIIQ------DGMEVAVKVFDPQYEGAFKSFD--IECDVMKRICHRNLI 162
           +G G FG VY+  +         ++VAVK   P+        D  +E  ++ +  H+N++
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQNIV 88
Query: 163 KIISSYSNDDFKALVLEYMPHGSLEKCLYLSN------YILDIFQRLDIMIDVASALEYL 216
           + I        + ++LE M  G L+  L  +         L +   L +  D+A   +YL
Sbjct: 89  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 148
Query: 217 HFGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
              +    IH D+   N LL       VA + DFGMA+ +            +  + +M 
Sbjct: 149 EENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 205
Query: 274 PEYGREGRVSTNGDVYSFGIMLMEIFT 300
           PE   EG  ++  D +SFG++L EIF+
Sbjct: 206 PEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 96/225 (42%), Gaps = 35/225 (15%)
Query: 100 PLPNDANMPPLIGKGGFGSVYKAIIQDGME-VAVKVFDPQYEGAFKSFDIECDVMKRIC- 157
           P   D ++   +G+G +G V  A+ +   E VAVK+ D +     ++ D   ++ K IC 
Sbjct: 3   PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEICI 57
Query: 158 -----HRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL--DIMIDVA 210
                H N++K        + + L LEY   G L             F R+  DI +   
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEP 104
Query: 211 SALEYLH-------FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 263
            A  + H       + +   I H D+KP N+LLD+     +SDFG+A      ++     
Sbjct: 105 DAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 164
Query: 264 QTLATIGYMAPEYGREGRVSTNG-DVYSFGIMLMEIFTRTKPTDE 307
           +   T+ Y+APE  +         DV+S GI+L  +     P D+
Sbjct: 165 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 96/225 (42%), Gaps = 35/225 (15%)
Query: 100 PLPNDANMPPLIGKGGFGSVYKAIIQDGME-VAVKVFDPQYEGAFKSFDIECDVMKRIC- 157
           P   D ++   +G+G +G V  A+ +   E VAVK+ D +     ++ D   ++ K IC 
Sbjct: 3   PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEICI 57
Query: 158 -----HRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL--DIMIDVA 210
                H N++K        + + L LEY   G L             F R+  DI +   
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEP 104
Query: 211 SALEYLH-------FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 263
            A  + H       + +   I H D+KP N+LLD+     +SDFG+A      ++     
Sbjct: 105 DAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 164
Query: 264 QTLATIGYMAPEYGREGRVSTNG-DVYSFGIMLMEIFTRTKPTDE 307
           +   T+ Y+APE  +         DV+S GI+L  +     P D+
Sbjct: 165 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 96/225 (42%), Gaps = 35/225 (15%)
Query: 100 PLPNDANMPPLIGKGGFGSVYKAIIQDGME-VAVKVFDPQYEGAFKSFDIECDVMKRIC- 157
           P   D ++   +G+G +G V  A+ +   E VAVK+ D +     ++ D   ++ K IC 
Sbjct: 4   PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEICI 58
Query: 158 -----HRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL--DIMIDVA 210
                H N++K        + + L LEY   G L             F R+  DI +   
Sbjct: 59  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEP 105
Query: 211 SALEYLH-------FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 263
            A  + H       + +   I H D+KP N+LLD+     +SDFG+A      ++     
Sbjct: 106 DAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 165
Query: 264 QTLATIGYMAPEYGREGRVSTNG-DVYSFGIMLMEIFTRTKPTDE 307
           +   T+ Y+APE  +         DV+S GI+L  +     P D+
Sbjct: 166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 99/198 (50%), Gaps = 15/198 (7%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVK--VFDPQYEGAFKSFDIECDVMKRICHRNLIKIISS 167
           IG+G +G VYKA  +  G  VA+K    D + EG   +   E  ++K + H N++K++  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 168 YSNDDFKALVLEYMPHGSLEKCL---YLSNYILDIFQRLDIMIDVASALEYLHFGYSAPI 224
              ++   LV E++ H  L+K +    L+   L + +     +     L+ L F +S  +
Sbjct: 71  IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL-----LQGLAFCHSHRV 124
Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGR-VS 283
           +H DLKP N+L++      L+DFG+A+      +  T    + T+ Y APE     +  S
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCKYYS 182
Query: 284 TNGDVYSFGIMLMEIFTR 301
           T  D++S G +  E+ TR
Sbjct: 183 TAVDIWSLGCIFAEMVTR 200

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 99/198 (50%), Gaps = 15/198 (7%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVK--VFDPQYEGAFKSFDIECDVMKRICHRNLIKIISS 167
           IG+G +G VYKA  +  G  VA+K    D + EG   +   E  ++K + H N++K++  
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 168 YSNDDFKALVLEYMPHGSLEKCL---YLSNYILDIFQRLDIMIDVASALEYLHFGYSAPI 224
              ++   LV E++ H  L+K +    L+   L + +     +     L+ L F +S  +
Sbjct: 72  IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL-----LQGLAFCHSHRV 125
Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGR-VS 283
           +H DLKP N+L++      L+DFG+A+      +  T    + T+ Y APE     +  S
Sbjct: 126 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCKYYS 183
Query: 284 TNGDVYSFGIMLMEIFTR 301
           T  D++S G +  E+ TR
Sbjct: 184 TAVDIWSLGCIFAEMVTR 201

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 96/225 (42%), Gaps = 35/225 (15%)
Query: 100 PLPNDANMPPLIGKGGFGSVYKAIIQDGME-VAVKVFDPQYEGAFKSFDIECDVMKRIC- 157
           P   D ++   +G+G +G V  A+ +   E VAVK+ D +     ++ D   ++ K IC 
Sbjct: 3   PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEICI 57
Query: 158 -----HRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL--DIMIDVA 210
                H N++K        + + L LEY   G L             F R+  DI +   
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEP 104
Query: 211 SALEYLH-------FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 263
            A  + H       + +   I H D+KP N+LLD+     +SDFG+A      ++     
Sbjct: 105 DAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 164
Query: 264 QTLATIGYMAPEYGREGRVSTNG-DVYSFGIMLMEIFTRTKPTDE 307
           +   T+ Y+APE  +         DV+S GI+L  +     P D+
Sbjct: 165 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 91/207 (43%), Gaps = 21/207 (10%)
Query: 111 IGKGGFGSVYKAIIQ------DGMEVAVKVFDPQYEGAFKSFD--IECDVMKRICHRNLI 162
           +G G FG VY+  +         ++VAVK   P+        D  +E  ++ +  H+N++
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQNIV 97
Query: 163 KIISSYSNDDFKALVLEYMPHGSLEKCLYLSN------YILDIFQRLDIMIDVASALEYL 216
           + I        + ++LE M  G L+  L  +         L +   L +  D+A   +YL
Sbjct: 98  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 157
Query: 217 HFGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
              +    IH D+   N LL       VA + DFGMA+ +            +  + +M 
Sbjct: 158 EENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMP 214
Query: 274 PEYGREGRVSTNGDVYSFGIMLMEIFT 300
           PE   EG  ++  D +SFG++L EIF+
Sbjct: 215 PEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 40/214 (18%)
Query: 110 LIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
           LIG GGFG V+KA  + DG    +K      E A    + E   + ++ H N++     +
Sbjct: 18  LIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKA----EREVKALAKLDHVNIVHYNGCW 73
Query: 169 SNDDFKALVLEYMPHGSLEKCLY----------LSNYI-------LDIFQRLDIMIDVAS 211
              D+           S  KCL+          L  +I       LD    L++   +  
Sbjct: 74  DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITK 133
Query: 212 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGY 271
            ++Y+H   S  +I+ DLKPSN+ L D     + DFG+   L  + +   + ++  T+ Y
Sbjct: 134 GVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK---RXRSKGTLRY 187
Query: 272 MAPE------YGREGRVSTNGDVYSFGIMLMEIF 299
           M+PE      YG+E       D+Y+ G++L E+ 
Sbjct: 188 MSPEQISSQDYGKE------VDLYALGLILAELL 215

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 96/225 (42%), Gaps = 35/225 (15%)
Query: 100 PLPNDANMPPLIGKGGFGSVYKAIIQDGME-VAVKVFDPQYEGAFKSFDIECDVMKRIC- 157
           P   D ++   +G+G +G V  A+ +   E VAVK+ D +     ++ D   ++ K IC 
Sbjct: 3   PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEICI 57
Query: 158 -----HRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL--DIMIDVA 210
                H N++K        + + L LEY   G L             F R+  DI +   
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEP 104
Query: 211 SALEYLH-------FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 263
            A  + H       + +   I H D+KP N+LLD+     +SDFG+A      ++     
Sbjct: 105 DAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 164
Query: 264 QTLATIGYMAPEYGREGRVSTNG-DVYSFGIMLMEIFTRTKPTDE 307
           +   T+ Y+APE  +         DV+S GI+L  +     P D+
Sbjct: 165 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 96/225 (42%), Gaps = 35/225 (15%)
Query: 100 PLPNDANMPPLIGKGGFGSVYKAIIQDGME-VAVKVFDPQYEGAFKSFDIECDVMKRIC- 157
           P   D ++   +G+G +G V  A+ +   E VAVK+ D +     ++ D   ++ K IC 
Sbjct: 4   PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEICI 58
Query: 158 -----HRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL--DIMIDVA 210
                H N++K        + + L LEY   G L             F R+  DI +   
Sbjct: 59  NAMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEP 105
Query: 211 SALEYLH-------FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 263
            A  + H       + +   I H D+KP N+LLD+     +SDFG+A      ++     
Sbjct: 106 DAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 165
Query: 264 QTLATIGYMAPEYGREGRVSTNG-DVYSFGIMLMEIFTRTKPTDE 307
           +   T+ Y+APE  +         DV+S GI+L  +     P D+
Sbjct: 166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 96/225 (42%), Gaps = 35/225 (15%)
Query: 100 PLPNDANMPPLIGKGGFGSVYKAIIQDGME-VAVKVFDPQYEGAFKSFDIECDVMKRIC- 157
           P   D ++   +G+G +G V  A+ +   E VAVK+ D +     ++ D   ++ K IC 
Sbjct: 4   PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEICI 58
Query: 158 -----HRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL--DIMIDVA 210
                H N++K        + + L LEY   G L             F R+  DI +   
Sbjct: 59  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEP 105
Query: 211 SALEYLH-------FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 263
            A  + H       + +   I H D+KP N+LLD+     +SDFG+A      ++     
Sbjct: 106 DAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 165
Query: 264 QTLATIGYMAPEYGREGRVSTNG-DVYSFGIMLMEIFTRTKPTDE 307
           +   T+ Y+APE  +         DV+S GI+L  +     P D+
Sbjct: 166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 91/207 (43%), Gaps = 21/207 (10%)
Query: 111 IGKGGFGSVYKAIIQ------DGMEVAVKVFDPQYEGAFKSFD--IECDVMKRICHRNLI 162
           +G G FG VY+  +         ++VAVK   P+        D  +E  ++ +  H+N++
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQNIV 114
Query: 163 KIISSYSNDDFKALVLEYMPHGSLEKCLYLSN------YILDIFQRLDIMIDVASALEYL 216
           + I        + ++LE M  G L+  L  +         L +   L +  D+A   +YL
Sbjct: 115 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 174
Query: 217 HFGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
              +    IH D+   N LL       VA + DFGMA+ +            +  + +M 
Sbjct: 175 EENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMP 231
Query: 274 PEYGREGRVSTNGDVYSFGIMLMEIFT 300
           PE   EG  ++  D +SFG++L EIF+
Sbjct: 232 PEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 96/225 (42%), Gaps = 35/225 (15%)
Query: 100 PLPNDANMPPLIGKGGFGSVYKAIIQDGME-VAVKVFDPQYEGAFKSFDIECDVMKRIC- 157
           P   D ++   +G+G +G V  A+ +   E VAVK+ D +     ++ D   ++ K IC 
Sbjct: 3   PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEICI 57
Query: 158 -----HRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL--DIMIDVA 210
                H N++K        + + L LEY   G L             F R+  DI +   
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEP 104
Query: 211 SALEYLH-------FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 263
            A  + H       + +   I H D+KP N+LLD+     +SDFG+A      ++     
Sbjct: 105 DAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 164
Query: 264 QTLATIGYMAPEYGREGRVSTNG-DVYSFGIMLMEIFTRTKPTDE 307
           +   T+ Y+APE  +         DV+S GI+L  +     P D+
Sbjct: 165 KMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 91/207 (43%), Gaps = 21/207 (10%)
Query: 111 IGKGGFGSVYKAIIQ------DGMEVAVKVFDPQYEGAFKSFD--IECDVMKRICHRNLI 162
           +G G FG VY+  +         ++VAVK   P+        D  +E  ++ +  H+N++
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQNIV 137
Query: 163 KIISSYSNDDFKALVLEYMPHGSLEKCLYLSN------YILDIFQRLDIMIDVASALEYL 216
           + I        + ++LE M  G L+  L  +         L +   L +  D+A   +YL
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197
Query: 217 HFGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
              +    IH D+   N LL       VA + DFGMA+ +            +  + +M 
Sbjct: 198 EENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMP 254
Query: 274 PEYGREGRVSTNGDVYSFGIMLMEIFT 300
           PE   EG  ++  D +SFG++L EIF+
Sbjct: 255 PEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 93/191 (48%), Gaps = 13/191 (6%)
Query: 111 IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGA--FKSFDIECDVMKRICHRNLIKIISS 167
           +GKG F  V + + +  G+E A K+ + +   A  F+  + E  + +++ H N++++  S
Sbjct: 37  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 168 YSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHC 227
              + F  LV + +  G L + +    +    +   D    +   LE + + +S  I+H 
Sbjct: 97  IQEESFHYLVFDLVTGGELFEDIVAREF----YSEADASHCIQQILESIAYCHSNGIVHR 152
Query: 228 DLKPSNVLLDDN---MVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVST 284
           +LKP N+LL          L+DFG+A   +E + S        T GY++PE  ++   S 
Sbjct: 153 NLKPENLLLASKAKGAAVKLADFGLA---IEVNDSEAWHGFAGTPGYLSPEVLKKDPYSK 209
Query: 285 NGDVYSFGIML 295
             D+++ G++L
Sbjct: 210 PVDIWACGVIL 220

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/255 (24%), Positives = 105/255 (41%), Gaps = 35/255 (13%)
Query: 100 PLPNDANMPPLIGKGGFGSVYKAIIQDGME-VAVKVFDPQYEGAFKSFDIECDVMKRIC- 157
           P   D ++   +G+G +G V  A+ +   E VAVK+ D +     ++ D   ++ K IC 
Sbjct: 3   PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEICI 57
Query: 158 -----HRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL--DIMIDVA 210
                H N++K        + + L LEY   G L             F R+  DI +   
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEP 104
Query: 211 SALEYLH-------FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 263
            A  + H       + +   I H D+KP N+LLD+     +SDFG+A      ++     
Sbjct: 105 DAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 164
Query: 264 QTLATIGYMAPEYGREGRVSTNG-DVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDL 322
           +   T+ Y+APE  +         DV+S GI+L  +     P D+          W    
Sbjct: 165 KMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSXQEYSDWKEKK 224
Query: 323 LPISVMEVVDANLLS 337
             ++  + +D+  L+
Sbjct: 225 TYLNPWKKIDSAPLA 239

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 96/225 (42%), Gaps = 35/225 (15%)
Query: 100 PLPNDANMPPLIGKGGFGSVYKAIIQDGME-VAVKVFDPQYEGAFKSFDIECDVMKRIC- 157
           P   D ++   +G+G +G V  A+ +   E VAVK+ D +     ++ D   ++ K IC 
Sbjct: 2   PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEICI 56
Query: 158 -----HRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL--DIMIDVA 210
                H N++K        + + L LEY   G L             F R+  DI +   
Sbjct: 57  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEP 103
Query: 211 SALEYLH-------FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 263
            A  + H       + +   I H D+KP N+LLD+     +SDFG+A      ++     
Sbjct: 104 DAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 163
Query: 264 QTLATIGYMAPEYGREGRVSTNG-DVYSFGIMLMEIFTRTKPTDE 307
           +   T+ Y+APE  +         DV+S GI+L  +     P D+
Sbjct: 164 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 208

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 96/225 (42%), Gaps = 35/225 (15%)
Query: 100 PLPNDANMPPLIGKGGFGSVYKAIIQDGME-VAVKVFDPQYEGAFKSFDIECDVMKRIC- 157
           P   D ++   +G+G +G V  A+ +   E VAVK+ D +     ++ D   ++ K IC 
Sbjct: 3   PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEICI 57
Query: 158 -----HRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL--DIMIDVA 210
                H N++K        + + L LEY   G L             F R+  DI +   
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEP 104
Query: 211 SALEYLH-------FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 263
            A  + H       + +   I H D+KP N+LLD+     +SDFG+A      ++     
Sbjct: 105 DAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 164
Query: 264 QTLATIGYMAPEYGREGRVSTNG-DVYSFGIMLMEIFTRTKPTDE 307
           +   T+ Y+APE  +         DV+S GI+L  +     P D+
Sbjct: 165 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 93/191 (48%), Gaps = 13/191 (6%)
Query: 111 IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGA--FKSFDIECDVMKRICHRNLIKIISS 167
           +GKG F  V + + +  G+E A K+ + +   A  F+  + E  + +++ H N++++  S
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 168 YSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHC 227
              + F  LV + +  G L + +    +    +   D    +   LE + + +S  I+H 
Sbjct: 74  IQEESFHYLVFDLVTGGELFEDIVAREF----YSEADASHCIQQILESIAYCHSNGIVHR 129
Query: 228 DLKPSNVLLDDN---MVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVST 284
           +LKP N+LL          L+DFG+A   +E + S        T GY++PE  ++   S 
Sbjct: 130 NLKPENLLLASKAKGAAVKLADFGLA---IEVNDSEAWHGFAGTPGYLSPEVLKKDPYSK 186
Query: 285 NGDVYSFGIML 295
             D+++ G++L
Sbjct: 187 PVDIWACGVIL 197

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 96/225 (42%), Gaps = 35/225 (15%)
Query: 100 PLPNDANMPPLIGKGGFGSVYKAIIQDGME-VAVKVFDPQYEGAFKSFDIECDVMKRIC- 157
           P   D ++   +G+G +G V  A+ +   E VAVK+ D +     ++ D   ++ K IC 
Sbjct: 4   PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEICI 58
Query: 158 -----HRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL--DIMIDVA 210
                H N++K        + + L LEY   G L             F R+  DI +   
Sbjct: 59  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEP 105
Query: 211 SALEYLH-------FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 263
            A  + H       + +   I H D+KP N+LLD+     +SDFG+A      ++     
Sbjct: 106 DAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 165
Query: 264 QTLATIGYMAPEYGREGRVSTNG-DVYSFGIMLMEIFTRTKPTDE 307
           +   T+ Y+APE  +         DV+S GI+L  +     P D+
Sbjct: 166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 96/225 (42%), Gaps = 35/225 (15%)
Query: 100 PLPNDANMPPLIGKGGFGSVYKAIIQDGME-VAVKVFDPQYEGAFKSFDIECDVMKRIC- 157
           P   D ++   +G+G +G V  A+ +   E VAVK+ D +     ++ D   ++ K IC 
Sbjct: 4   PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEICI 58
Query: 158 -----HRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL--DIMIDVA 210
                H N++K        + + L LEY   G L             F R+  DI +   
Sbjct: 59  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEP 105
Query: 211 SALEYLH-------FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 263
            A  + H       + +   I H D+KP N+LLD+     +SDFG+A      ++     
Sbjct: 106 DAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 165
Query: 264 QTLATIGYMAPEYGREGRVSTNG-DVYSFGIMLMEIFTRTKPTDE 307
           +   T+ Y+APE  +         DV+S GI+L  +     P D+
Sbjct: 166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 96/225 (42%), Gaps = 35/225 (15%)
Query: 100 PLPNDANMPPLIGKGGFGSVYKAIIQDGME-VAVKVFDPQYEGAFKSFDIECDVMKRIC- 157
           P   D ++   +G+G +G V  A+ +   E VAVK+ D +     ++ D   ++ K IC 
Sbjct: 4   PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEICI 58
Query: 158 -----HRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL--DIMIDVA 210
                H N++K        + + L LEY   G L             F R+  DI +   
Sbjct: 59  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEP 105
Query: 211 SALEYLH-------FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 263
            A  + H       + +   I H D+KP N+LLD+     +SDFG+A      ++     
Sbjct: 106 DAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 165
Query: 264 QTLATIGYMAPEYGREGRVSTNG-DVYSFGIMLMEIFTRTKPTDE 307
           +   T+ Y+APE  +         DV+S GI+L  +     P D+
Sbjct: 166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 96/225 (42%), Gaps = 35/225 (15%)
Query: 100 PLPNDANMPPLIGKGGFGSVYKAIIQDGME-VAVKVFDPQYEGAFKSFDIECDVMKRIC- 157
           P   D ++   +G+G +G V  A+ +   E VAVK+ D +     ++ D   ++ K IC 
Sbjct: 3   PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEICI 57
Query: 158 -----HRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL--DIMIDVA 210
                H N++K        + + L LEY   G L             F R+  DI +   
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEP 104
Query: 211 SALEYLH-------FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 263
            A  + H       + +   I H D+KP N+LLD+     +SDFG+A      ++     
Sbjct: 105 DAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 164
Query: 264 QTLATIGYMAPEYGREGRVSTNG-DVYSFGIMLMEIFTRTKPTDE 307
           +   T+ Y+APE  +         DV+S GI+L  +     P D+
Sbjct: 165 KMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 93/191 (48%), Gaps = 13/191 (6%)
Query: 111 IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGA--FKSFDIECDVMKRICHRNLIKIISS 167
           +GKG F  V + + +  G+E A K+ + +   A  F+  + E  + +++ H N++++  S
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 168 YSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHC 227
              + F  LV + +  G L + +    +    +   D    +   LE + + +S  I+H 
Sbjct: 74  IQEESFHYLVFDLVTGGELFEDIVAREF----YSEADASHCIQQILESIAYCHSNGIVHR 129
Query: 228 DLKPSNVLLDDN---MVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVST 284
           +LKP N+LL          L+DFG+A   +E + S        T GY++PE  ++   S 
Sbjct: 130 NLKPENLLLASKAKGAAVKLADFGLA---IEVNDSEAWHGFAGTPGYLSPEVLKKDPYSK 186
Query: 285 NGDVYSFGIML 295
             D+++ G++L
Sbjct: 187 PVDIWACGVIL 197

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 106/217 (48%), Gaps = 19/217 (8%)
Query: 117 GSVYKAIIQDGMEVAVKVFDPQYEGAFKS--FDIECDVMKRICHRNLIKIISSYSNDD-- 172
           G ++K   Q G ++ VKV   +     KS  F+ EC  ++   H N++ ++ +  +    
Sbjct: 24  GELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82
Query: 173 FKALVLEYMPHGSLEKCLYL-SNYILDIFQRLDIMIDVASALEYLHFGYSAPII-HCDLK 230
              L+  +MP+GSL   L+  +N+++D  Q +   +D+A  + +LH     P+I    L 
Sbjct: 83  HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH--TLEPLIPRHALN 140
Query: 231 PSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN---GD 287
             +V++D++M A +S       + +   S      +    ++APE  ++    TN    D
Sbjct: 141 SRSVMIDEDMTARIS-------MADVKFSFQSPGRMYAPAWVAPEALQKKPEDTNRRSAD 193
Query: 288 VYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLP 324
           ++SF ++L E+ TR  P  ++ + E+ +K  +  L P
Sbjct: 194 MWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP 230

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 113/225 (50%), Gaps = 34/225 (15%)
Query: 110 LIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIIS-SY 168
           +IG G FG V++A + +  EVA+K      +  FK+ +++  +M+ + H N++ + +  Y
Sbjct: 47  VIGNGSFGVVFQAKLVESDEVAIKKV--LQDKRFKNRELQ--IMRIVKHPNVVDLKAFFY 102
Query: 169 SNDD-----FKALVLEYMPHGSLEKCLYLSNYILDIFQRLDI------MIDVASALEYLH 217
           SN D     F  LVLEY+P    E     S +   + Q + +      M  +  +L Y+H
Sbjct: 103 SNGDKKDEVFLNLVLEYVP----ETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH 158
Query: 218 FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE- 275
              S  I H D+KP N+LLD  + V  L DFG AK L+  + +++    + +  Y APE 
Sbjct: 159 ---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVS---XICSRYYRAPEL 212
Query: 276 -YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV 319
            +G     +TN D++S G ++ E+         +F GE  + + V
Sbjct: 213 IFGATN-YTTNIDIWSTGCVMAELMQ----GQPLFPGESGIDQLV 252

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 23/213 (10%)
Query: 112 GKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSY--- 168
            +G FG V+KA + +   VAVK+F  Q + +++S + E      + H NL++ I++    
Sbjct: 24  ARGRFGCVWKAQLMNDF-VAVKIFPLQDKQSWQS-EREIFSTPGMKHENLLQFIAAEKRG 81
Query: 169 SNDDFK-ALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHF--------G 219
           SN + +  L+  +   GSL    YL   I+   +   +   ++  L YLH         G
Sbjct: 82  SNLEVELWLITAFHDKGSLTD--YLKGNIITWNELCHVAETMSRGLSYLHEDVPWCRGEG 139
Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
           +   I H D K  NVLL  ++ A L+DFG+A               + T  YMAPE   E
Sbjct: 140 HKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEV-LE 198
Query: 280 GRVSTNG------DVYSFGIMLMEIFTRTKPTD 306
           G ++         D+Y+ G++L E+ +R K  D
Sbjct: 199 GAINFQRDAFLRIDMYAMGLVLWELVSRCKAAD 231

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 91/207 (43%), Gaps = 21/207 (10%)
Query: 111 IGKGGFGSVYKAIIQ------DGMEVAVKVFDPQYEGAFKSFD--IECDVMKRICHRNLI 162
           +G G FG VY+  +         ++VAVK   P+        D  +E  ++ +  H+N++
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQNIV 96
Query: 163 KIISSYSNDDFKALVLEYMPHGSLEKCLYLSN------YILDIFQRLDIMIDVASALEYL 216
           + I        + +++E M  G L+  L  +         L +   L +  D+A   +YL
Sbjct: 97  RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 217 HFGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
              +    IH D+   N LL       VA + DFGMA+ +            +  + +M 
Sbjct: 157 EENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 213
Query: 274 PEYGREGRVSTNGDVYSFGIMLMEIFT 300
           PE   EG  ++  D +SFG++L EIF+
Sbjct: 214 PEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 13/214 (6%)
Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKV-FDPQYE--GAFKSFDIECDVMKRICHRNLIKIIS 166
           +GKG FG+VY A   Q+   +A+KV F  Q E  G       E ++   + H N++++ +
Sbjct: 23  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 82
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIH 226
            + +     L+LE+ P G L K L   +   D  +    M ++A AL Y H      +IH
Sbjct: 83  YFHDRKRIYLMLEFAPRGELYKELQ-KHGRFDEQRSATFMEELADALHYCH---ERKVIH 138
Query: 227 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNG 286
            D+KP N+L+       ++DFG +        SL +     T+ Y+ PE           
Sbjct: 139 RDIKPENLLMGYKGELKIADFGWSV----HAPSLRRRXMCGTLDYLPPEMIEGKTHDEKV 194
Query: 287 DVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN 320
           D++  G++  E      P D     E T +R VN
Sbjct: 195 DLWCAGVLCYEFLVGMPPFDSPSHTE-THRRIVN 227

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 99/198 (50%), Gaps = 15/198 (7%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVK--VFDPQYEGAFKSFDIECDVMKRICHRNLIKIISS 167
           IG+G +G VYKA  +  G  VA+K    D + EG   +   E  ++K + H N++K++  
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 168 YSNDDFKALVLEYMPHGSLEKCL---YLSNYILDIFQRLDIMIDVASALEYLHFGYSAPI 224
              ++   LV E++ H  L+  +    L+   L + +     +     L+ L F +S  +
Sbjct: 70  IHTENKLYLVFEHV-HQDLKTFMDASALTGIPLPLIKSYLFQL-----LQGLAFCHSHRV 123
Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGR-VS 283
           +H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y APE     +  S
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYS 181
Query: 284 TNGDVYSFGIMLMEIFTR 301
           T  D++S G +  E+ TR
Sbjct: 182 TAVDIWSLGCIFAEMVTR 199

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 93/191 (48%), Gaps = 13/191 (6%)
Query: 111 IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGA--FKSFDIECDVMKRICHRNLIKIISS 167
           +GKG F  V + + +  G+E A K+ + +   A  F+  + E  + +++ H N++++  S
Sbjct: 13  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 72
Query: 168 YSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHC 227
              + F  LV + +  G L + +    +    +   D    +   LE + + +S  I+H 
Sbjct: 73  IQEESFHYLVFDLVTGGELFEDIVAREF----YSEADASHCIQQILESIAYCHSNGIVHR 128
Query: 228 DLKPSNVLLDDN---MVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVST 284
           +LKP N+LL          L+DFG+A   +E + S        T GY++PE  ++   S 
Sbjct: 129 NLKPENLLLASKAKGAAVKLADFGLA---IEVNDSEAWHGFAGTPGYLSPEVLKKDPYSK 185
Query: 285 NGDVYSFGIML 295
             D+++ G++L
Sbjct: 186 PVDIWACGVIL 196

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 13/214 (6%)
Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKV-FDPQYE--GAFKSFDIECDVMKRICHRNLIKIIS 166
           +GKG FG+VY A   Q+   +A+KV F  Q E  G       E ++   + H N++++ +
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIH 226
            + +     L+LE+ P G L K L   +   D  +    M ++A AL Y H      +IH
Sbjct: 82  YFHDRKRIYLMLEFAPRGELYKELQ-KHGRFDEQRSATFMEELADALHYCH---ERKVIH 137
Query: 227 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNG 286
            D+KP N+L+       ++DFG +        SL +     T+ Y+ PE           
Sbjct: 138 RDIKPENLLMGYKGELKIADFGWS----VHAPSLRRRXMCGTLDYLPPEMIEGKTHDEKV 193
Query: 287 DVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN 320
           D++  G++  E      P D     E T +R VN
Sbjct: 194 DLWCAGVLCYEFLVGMPPFDSPSHTE-THRRIVN 226

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 91/194 (46%), Gaps = 10/194 (5%)
Query: 111 IGKGGFGSVYKAIIQD----GMEVAVKVF-DPQYEGAFKSFDIECDVMKRICHRNLIKII 165
           IG+G FG V++ I        M VA+K   +   +   + F  E   M++  H +++K+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
              + +    +++E    G L   L +  + LD+   +     +++AL YL    S   +
Sbjct: 78  GVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFV 133
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
           H D+   NVL+       L DFG+++  +E+      ++    I +MAPE     R ++ 
Sbjct: 134 HRDIAARNVLVSATDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 192
Query: 286 GDVYSFGIMLMEIF 299
            DV+ FG+ + EI 
Sbjct: 193 SDVWMFGVCMWEIL 206

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 96/225 (42%), Gaps = 35/225 (15%)
Query: 100 PLPNDANMPPLIGKGGFGSVYKAIIQDGME-VAVKVFDPQYEGAFKSFDIECDVMKRIC- 157
           P   D ++   +G+G +G V  A+ +   E VAVK+ D +     ++ D   ++ K IC 
Sbjct: 3   PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEICI 57
Query: 158 -----HRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL--DIMIDVA 210
                H N++K        + + L LEY   G L             F R+  DI +   
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEP 104
Query: 211 SALEYLH-------FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 263
            A  + H       + +   I H D+KP N+LLD+     +SDFG+A      ++     
Sbjct: 105 DAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 164
Query: 264 QTLATIGYMAPEYGREGRVSTNG-DVYSFGIMLMEIFTRTKPTDE 307
           +   T+ Y+APE  +         DV+S GI+L  +     P D+
Sbjct: 165 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 96/225 (42%), Gaps = 35/225 (15%)
Query: 100 PLPNDANMPPLIGKGGFGSVYKAIIQDGME-VAVKVFDPQYEGAFKSFDIECDVMKRIC- 157
           P   D ++   +G+G +G V  A+ +   E VAVK+ D +     ++ D   ++ K IC 
Sbjct: 4   PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEICI 58
Query: 158 -----HRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL--DIMIDVA 210
                H N++K        + + L LEY   G L             F R+  DI +   
Sbjct: 59  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEP 105
Query: 211 SALEYLH-------FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 263
            A  + H       + +   I H D+KP N+LLD+     +SDFG+A      ++     
Sbjct: 106 DAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 165
Query: 264 QTLATIGYMAPEYGREGRVSTNG-DVYSFGIMLMEIFTRTKPTDE 307
           +   T+ Y+APE  +         DV+S GI+L  +     P D+
Sbjct: 166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 91/207 (43%), Gaps = 21/207 (10%)
Query: 111 IGKGGFGSVYKAIIQ------DGMEVAVKVFDPQYEGAFKSFD--IECDVMKRICHRNLI 162
           +G G FG VY+  +         ++VAVK   P+        D  +E  ++ +  H+N++
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQNIV 111
Query: 163 KIISSYSNDDFKALVLEYMPHGSLEKCLYLSN------YILDIFQRLDIMIDVASALEYL 216
           + I        + +++E M  G L+  L  +         L +   L +  D+A   +YL
Sbjct: 112 RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 171
Query: 217 HFGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
              +    IH D+   N LL       VA + DFGMA+ +            +  + +M 
Sbjct: 172 EENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 228
Query: 274 PEYGREGRVSTNGDVYSFGIMLMEIFT 300
           PE   EG  ++  D +SFG++L EIF+
Sbjct: 229 PEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 103/213 (48%), Gaps = 24/213 (11%)
Query: 112 GKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISS---- 167
            +G FG V+KA + +   VAVK+F  Q + ++++ + E   +  + H N+++ I +    
Sbjct: 33  ARGRFGCVWKAQLLNEY-VAVKIFPIQDKQSWQN-EYEVYSLPGMKHENILQFIGAEKRG 90
Query: 168 YSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHF-------GY 220
            S D    L+  +   GSL    +L   ++   +   I   +A  L YLH        G+
Sbjct: 91  TSVDVDLWLITAFHEKGSLSD--FLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGH 148
Query: 221 SAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ-TLATIGYMAPEYGRE 279
              I H D+K  NVLL +N+ A ++DFG+A    E  +S   T   + T  YMAPE   E
Sbjct: 149 KPAISHRDIKSKNVLLKNNLTACIADFGLALK-FEAGKSAGDTHGQVGTRRYMAPEV-LE 206
Query: 280 GRVSTNG------DVYSFGIMLMEIFTRTKPTD 306
           G ++         D+Y+ G++L E+ +R    D
Sbjct: 207 GAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 110/231 (47%), Gaps = 34/231 (14%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDP-QYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
           IG+G +G V  A    + + VA+K   P +++   +    E  ++ R  H N+I I    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 90
Query: 169 SNDDFKALVLEYMPH------------GSLEKCLYLSNYILDIFQRLDIMIDVASALEYL 216
            ND  +A  +E M                L KC +LSN  +  F     +  +   L+Y+
Sbjct: 91  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYF-----LYQILRGLKYI 144
Query: 217 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LEEDQSLTQTQTLATIGYMAPE 275
           H   SA ++H DLKPSN+LL+      + DFG+A+    + D +   T+ +AT  Y APE
Sbjct: 145 H---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201
Query: 276 YGREGRVSTNG-DVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPI 325
                +  T   D++S G +L E+ +  +P   IF G+  L + +N +L I
Sbjct: 202 IMLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQ-LNHILGI 247

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 91/194 (46%), Gaps = 10/194 (5%)
Query: 111 IGKGGFGSVYKAIIQD----GMEVAVKVF-DPQYEGAFKSFDIECDVMKRICHRNLIKII 165
           IG+G FG V++ I        M VA+K   +   +   + F  E   M++  H +++K+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
              + +    +++E    G L   L +  + LD+   +     +++AL YL    S   +
Sbjct: 458 GVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFV 513
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
           H D+   NVL+       L DFG+++  +E+      ++    I +MAPE     R ++ 
Sbjct: 514 HRDIAARNVLVSATDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 572
Query: 286 GDVYSFGIMLMEIF 299
            DV+ FG+ + EI 
Sbjct: 573 SDVWMFGVCMWEIL 586

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 69/214 (32%), Positives = 110/214 (51%), Gaps = 47/214 (21%)
Query: 110 LIGKGGFGSVYKAIIQDGME-VAVKVFDPQYEG-AFKSFDIECDVMKRICHRNLIKI--- 164
           +IG G FG VY+A + D  E VA+K      +G AFK+ +++  +M+++ H N++++   
Sbjct: 27  VIGNGSFGVVYQAKLCDSGELVAIKKV---LQGKAFKNRELQ--IMRKLDHCNIVRLRYF 81
Query: 165 -ISSYSNDD--FKALVLEYMP--------HGSLEK----CLYLSNYILDIFQRLDIMIDV 209
             SS    D  +  LVL+Y+P        H S  K     +Y+  Y+  +F+        
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFR-------- 133
Query: 210 ASALEYLH-FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQTLA 267
             +L Y+H FG    I H D+KP N+LLD D  V  L DFG AK L+  + +++    + 
Sbjct: 134 --SLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XIC 184
Query: 268 TIGYMAPE--YGREGRVSTNGDVYSFGIMLMEIF 299
           +  Y APE  +G     S+  DV+S G +L E+ 
Sbjct: 185 SRYYRAPELIFGATDYTSSI-DVWSAGCVLAELL 217

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 98/218 (44%), Gaps = 13/218 (5%)
Query: 102 PNDANMPPLIGKGGFGSVYKAIIQDGMEV--AVKVFDPQY---EGAFKSFDIECDVM-KR 155
           P+D +   +IGKG FG V  A      EV  AVKV   +    +   K    E +V+ K 
Sbjct: 37  PSDFHFLKVIGKGSFGKVLLAR-HKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKN 95
Query: 156 ICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEY 215
           + H  L+ +  S+   D    VL+Y+  G L   L      L+   R     ++ASAL Y
Sbjct: 96  VKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGY 154
Query: 216 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE 275
           LH   S  I++ DLKP N+LLD      L+DFG+ K  +E +   T +    T  Y+APE
Sbjct: 155 LH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS--TTSTFCGTPEYLAPE 209
Query: 276 YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM 313
              +       D +  G +L E+     P     + EM
Sbjct: 210 VLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM 247

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 103/206 (50%), Gaps = 13/206 (6%)
Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
           ++GKG +G VY    + + + +A+K    +     +    E  + K + H+N+++ + S+
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 74
Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNY--ILDIFQRLDIMI-DVASALEYLHFGYSAPII 225
           S + F  + +E +P GSL   L  S +  + D  Q +      +   L+YLH      I+
Sbjct: 75  SENGFIKIFMEQVPGGSLS-ALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIV 130
Query: 226 HCDLKPSNVLLDD-NMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREG--RV 282
           H D+K  NVL++  + V  +SDFG +K L   +   T+T T  T+ YMAPE   +G    
Sbjct: 131 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-PCTETFT-GTLQYMAPEIIDKGPRGY 188
Query: 283 STNGDVYSFGIMLMEIFTRTKPTDEI 308
               D++S G  ++E+ T   P  E+
Sbjct: 189 GKAADIWSLGCTIIEMATGKPPFYEL 214

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 103/206 (50%), Gaps = 13/206 (6%)
Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
           ++GKG +G VY    + + + +A+K    +     +    E  + K + H+N+++ + S+
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNY--ILDIFQRLDIMI-DVASALEYLHFGYSAPII 225
           S + F  + +E +P GSL   L  S +  + D  Q +      +   L+YLH      I+
Sbjct: 89  SENGFIKIFMEQVPGGSLS-ALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIV 144
Query: 226 HCDLKPSNVLLDD-NMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREG--RV 282
           H D+K  NVL++  + V  +SDFG +K L   +   T+T T  T+ YMAPE   +G    
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-PCTETFT-GTLQYMAPEIIDKGPRGY 202
Query: 283 STNGDVYSFGIMLMEIFTRTKPTDEI 308
               D++S G  ++E+ T   P  E+
Sbjct: 203 GKAADIWSLGCTIIEMATGKPPFYEL 228

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 103/221 (46%), Gaps = 33/221 (14%)
Query: 110 LIGKGGFGSVYKA----IIQDG--MEVAVKVFDPQYEGAFK-SFDIECDVMKRI-CHRNL 161
           ++G G FG V  A    I + G  ++VAVK+   + + + + +   E  +M ++  H N+
Sbjct: 52  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 111
Query: 162 IKIISSYSNDDFKALVLEYMPHGSLEKCL-------------YLSNYILDIFQRLDIMI- 207
           + ++ + +      L+ EY  +G L   L             Y +   L+  + L+++  
Sbjct: 112 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171
Query: 208 --------DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS 259
                    VA  +E+L F      +H DL   NVL+    V  + DFG+A+ ++ +   
Sbjct: 172 EDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 228
Query: 260 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
           + +      + +MAPE   EG  +   DV+S+GI+L EIF+
Sbjct: 229 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 98/227 (43%), Gaps = 53/227 (23%)
Query: 110 LIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
           LIG GGFG V+KA  + DG    ++      E A    + E   + ++ H N++     +
Sbjct: 19  LIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKA----EREVKALAKLDHVNIVHYNGCW 74
Query: 169 SNDDFKALVLE-------YMPHGSLE------KCLY----------LSNYI-------LD 198
              D+     +       Y P  S        KCL+          L  +I       LD
Sbjct: 75  DGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLD 134
Query: 199 IFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ 258
               L++   +   ++Y+H   S  +IH DLKPSN+ L D     + DFG+   L  + +
Sbjct: 135 KVLALELFEQITKGVDYIH---SKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK 191
Query: 259 SLTQTQTLATIGYMAPE------YGREGRVSTNGDVYSFGIMLMEIF 299
              +T++  T+ YM+PE      YG+E       D+Y+ G++L E+ 
Sbjct: 192 ---RTRSKGTLRYMSPEQISSQDYGKE------VDLYALGLILAELL 229

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 105/213 (49%), Gaps = 15/213 (7%)
Query: 110 LIGKGGFGSVYKAI-IQDG----MEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIK 163
           ++G G FG+VYK I + +G    + VA+K+ +      A   F  E  +M  + H +L++
Sbjct: 45  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 104
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL--DIMIDVASALEYLHFGYS 221
           ++    +   + LV + MPHG L +  Y+  +  +I  +L  +  + +A  + YL     
Sbjct: 105 LLGVCLSPTIQ-LVTQLMPHGCLLE--YVHEHKDNIGSQLLLNWCVQIAKGMMYLE---E 158
Query: 222 APIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGR 281
             ++H DL   NVL+       ++DFG+A+ L  +++          I +MA E     +
Sbjct: 159 RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRK 218
Query: 282 VSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEM 313
            +   DV+S+G+ + E+ T   KP D I + E+
Sbjct: 219 FTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI 251

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 96/195 (49%), Gaps = 9/195 (4%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVK--VFDPQYEGAFKSFDIECDVMKRICHRNLIKIISS 167
           IG+G +G VYKA  +  G  VA+K    D + EG   +   E  ++K + H N++K++  
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 168 YSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHC 227
              ++   LV E++   S++   ++    L       I   +   L+ L F +S  ++H 
Sbjct: 74  IHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 130
Query: 228 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGR-VSTNG 286
           DLKP N+L++      L+DFG+A+      +  T    + T+ Y APE     +  ST  
Sbjct: 131 DLKPENLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCKYYSTAV 188
Query: 287 DVYSFGIMLMEIFTR 301
           D++S G +  E+ TR
Sbjct: 189 DIWSLGCIFAEMVTR 203

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 16/212 (7%)
Query: 103 NDANMPPLIGKGGFGSVYKAIIQDGME-VAVKVFDPQYEGAFKSFDI-ECDVMKRICHRN 160
           +D  +  L+G+G +G V  A  +   E VA+K  +P  +  F    + E  ++K   H N
Sbjct: 11  SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHEN 70
Query: 161 LIKIISSYSNDDFKALVLEYMPHGSLEKCLY--LSNYILDIFQRLDIMIDVASALEYLHF 218
           +I I +    D F+     Y+    ++  L+  +S  +L        +     A++ LH 
Sbjct: 71  IITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLH- 129
Query: 219 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE--------DQSLTQTQTLATIG 270
              + +IH DLKPSN+L++ N    + DFG+A+ + E          Q    T+ +AT  
Sbjct: 130 --GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRW 187
Query: 271 YMAPEYG-REGRVSTNGDVYSFGIMLMEIFTR 301
           Y APE      + S   DV+S G +L E+F R
Sbjct: 188 YRAPEVMLTSAKYSRAMDVWSCGCILAELFLR 219

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 98/198 (49%), Gaps = 15/198 (7%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVK--VFDPQYEGAFKSFDIECDVMKRICHRNLIKIISS 167
           IG+G +G VYKA  +  G  VA+K    D + EG   +   E  ++K + H N++K++  
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 168 YSNDDFKALVLEYMPHGSLEKCL---YLSNYILDIFQRLDIMIDVASALEYLHFGYSAPI 224
              ++   LV E++ H  L+  +    L+   L + +     +     L+ L F +S  +
Sbjct: 74  IHTENKLYLVFEFL-HQDLKTFMDASALTGIPLPLIKSYLFQL-----LQGLAFCHSHRV 127
Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGR-VS 283
           +H DLKP N+L++      L+DFG+A+      +  T    + T+ Y APE     +  S
Sbjct: 128 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCKYYS 185
Query: 284 TNGDVYSFGIMLMEIFTR 301
           T  D++S G +  E+ TR
Sbjct: 186 TAVDIWSLGCIFAEMVTR 203

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 102/226 (45%), Gaps = 20/226 (8%)
Query: 93  RYQK-----RGKPL-PNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKS- 145
           RY+K     RG  +   D ++  +IG+G FG V     +   +V       ++E   +S 
Sbjct: 59  RYEKIVKKIRGLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSD 118
Query: 146 ---FDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQR 202
              F  E D+M       ++++  ++ +D +  +V+EYMP G L   +  SNY +     
Sbjct: 119 SAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM--SNYDVPEKWA 176
Query: 203 LDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ 262
                +V  AL+ +H   S  +IH D+KP N+LLD +    L+DFG    + E       
Sbjct: 177 KFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCD 233
Query: 263 TQTLATIGYMAPE----YGREGRVSTNGDVYSFGIMLMEIFTRTKP 304
           T  + T  Y++PE     G +G      D +S G+ L E+     P
Sbjct: 234 T-AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 278

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 69/214 (32%), Positives = 110/214 (51%), Gaps = 47/214 (21%)
Query: 110 LIGKGGFGSVYKAIIQDGME-VAVKVFDPQYEG-AFKSFDIECDVMKRICHRNLIKI--- 164
           +IG G FG VY+A + D  E VA+K      +G AFK+ +++  +M+++ H N++++   
Sbjct: 27  VIGNGSFGVVYQAKLCDSGELVAIKKV---LQGKAFKNRELQ--IMRKLDHCNIVRLRYF 81
Query: 165 -ISSYSNDD--FKALVLEYMP--------HGSLEK----CLYLSNYILDIFQRLDIMIDV 209
             SS    D  +  LVL+Y+P        H S  K     +Y+  Y+  +F+        
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR-------- 133
Query: 210 ASALEYLH-FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQTLA 267
             +L Y+H FG    I H D+KP N+LLD D  V  L DFG AK L+  + +++    + 
Sbjct: 134 --SLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---IC 184
Query: 268 TIGYMAPE--YGREGRVSTNGDVYSFGIMLMEIF 299
           +  Y APE  +G     S+  DV+S G +L E+ 
Sbjct: 185 SRYYRAPELIFGATDYTSSI-DVWSAGCVLAELL 217

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 69/214 (32%), Positives = 110/214 (51%), Gaps = 47/214 (21%)
Query: 110 LIGKGGFGSVYKAIIQDGME-VAVKVFDPQYEG-AFKSFDIECDVMKRICHRNLIKI--- 164
           +IG G FG VY+A + D  E VA+K      +G AFK+ +++  +M+++ H N++++   
Sbjct: 27  VIGNGSFGVVYQAKLCDSGELVAIKKV---LQGKAFKNRELQ--IMRKLDHCNIVRLRYF 81
Query: 165 -ISSYSNDD--FKALVLEYMP--------HGSLEK----CLYLSNYILDIFQRLDIMIDV 209
             SS    D  +  LVL+Y+P        H S  K     +Y+  Y+  +F+        
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR-------- 133
Query: 210 ASALEYLH-FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQTLA 267
             +L Y+H FG    I H D+KP N+LLD D  V  L DFG AK L+  + +++    + 
Sbjct: 134 --SLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---IC 184
Query: 268 TIGYMAPE--YGREGRVSTNGDVYSFGIMLMEIF 299
           +  Y APE  +G     S+  DV+S G +L E+ 
Sbjct: 185 SRYYRAPELIFGATDYTSSI-DVWSAGCVLAELL 217

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 91/204 (44%), Gaps = 19/204 (9%)
Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISS 167
           IGKG F  V  A  I  G EVAVK+ D       + +    E  +MK + H N++K+   
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 74
Query: 168 YSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHC 227
              +    LV+EY   G +   L    ++ +   R      + SA++Y H  +   I+H 
Sbjct: 75  IETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFR-QIVSAVQYCHQKF---IVHR 130
Query: 228 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG----YMAPEYGREGRV- 282
           DLK  N+LLD +M   ++DFG +          T    L T      Y APE  +  +  
Sbjct: 131 DLKAENLLLDADMNIKIADFGFS-------NEFTFGNKLDTFCGSPPYAAPELFQGKKYD 183
Query: 283 STNGDVYSFGIMLMEIFTRTKPTD 306
               DV+S G++L  + + + P D
Sbjct: 184 GPEVDVWSLGVILYTLVSGSLPFD 207

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 96/195 (49%), Gaps = 9/195 (4%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVK--VFDPQYEGAFKSFDIECDVMKRICHRNLIKIISS 167
           IG+G +G VYKA  +  G  VA+K    D + EG   +   E  ++K + H N++K++  
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 168 YSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHC 227
              ++   LV E++   S++   ++    L       I   +   L+ L F +S  ++H 
Sbjct: 72  IHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 128
Query: 228 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGR-VSTNG 286
           DLKP N+L++      L+DFG+A+      +  T    + T+ Y APE     +  ST  
Sbjct: 129 DLKPENLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCKYYSTAV 186
Query: 287 DVYSFGIMLMEIFTR 301
           D++S G +  E+ TR
Sbjct: 187 DIWSLGCIFAEMVTR 201

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 96/199 (48%), Gaps = 14/199 (7%)
Query: 110 LIGKGGFGSVYKAI-IQDG----MEVAVKVFDPQYEGAFKSFDIECDVMKRIC---HRNL 161
           ++G G FG+V+K + I +G    + V +KV + +     +SF    D M  I    H ++
Sbjct: 38  VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK--SGRQSFQAVTDHMLAIGSLDHAHI 95
Query: 162 IKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYS 221
           ++++        + LV +Y+P GSL   +      L     L+  + +A  + YL     
Sbjct: 96  VRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---E 151
Query: 222 APIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGR 281
             ++H +L   NVLL       ++DFG+A  L  +D+ L  ++    I +MA E    G+
Sbjct: 152 HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGK 211
Query: 282 VSTNGDVYSFGIMLMEIFT 300
            +   DV+S+G+ + E+ T
Sbjct: 212 YTHQSDVWSYGVTVWELMT 230

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 96/199 (48%), Gaps = 14/199 (7%)
Query: 110 LIGKGGFGSVYKAI-IQDG----MEVAVKVFDPQYEGAFKSFDIECDVMKRIC---HRNL 161
           ++G G FG+V+K + I +G    + V +KV + +     +SF    D M  I    H ++
Sbjct: 20  VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK--SGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 162 IKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYS 221
           ++++        + LV +Y+P GSL   +      L     L+  + +A  + YL     
Sbjct: 78  VRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---E 133
Query: 222 APIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGR 281
             ++H +L   NVLL       ++DFG+A  L  +D+ L  ++    I +MA E    G+
Sbjct: 134 HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGK 193
Query: 282 VSTNGDVYSFGIMLMEIFT 300
            +   DV+S+G+ + E+ T
Sbjct: 194 YTHQSDVWSYGVTVWELMT 212

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 108/213 (50%), Gaps = 45/213 (21%)
Query: 110 LIGKGGFGSVYKAIIQDGME-VAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKI---- 164
           +IG G FG VY+A + D  E VA+K      +  FK+ +++  +M+++ H N++++    
Sbjct: 61  VIGNGSFGVVYQAKLCDSGELVAIKKV--LQDKRFKNRELQ--IMRKLDHCNIVRLRYFF 116
Query: 165 ISSYSNDD--FKALVLEYMP--------HGSLEK----CLYLSNYILDIFQRLDIMIDVA 210
            SS    D  +  LVL+Y+P        H S  K     +Y+  Y+  +F+         
Sbjct: 117 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR--------- 167
Query: 211 SALEYLH-FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 268
            +L Y+H FG    I H D+KP N+LLD D  V  L DFG AK L+  + +++    + +
Sbjct: 168 -SLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICS 219
Query: 269 IGYMAPE--YGREGRVSTNGDVYSFGIMLMEIF 299
             Y APE  +G     S+  DV+S G +L E+ 
Sbjct: 220 RYYRAPELIFGATDYTSSI-DVWSAGCVLAELL 251

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 16/212 (7%)
Query: 103 NDANMPPLIGKGGFGSVYKAIIQDGME-VAVKVFDPQYEGAFKSFDI-ECDVMKRICHRN 160
           +D  +  L+G+G +G V  A  +   E VA+K  +P  +  F    + E  ++K   H N
Sbjct: 11  SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHEN 70
Query: 161 LIKIISSYSNDDFKALVLEYMPHGSLEKCLY--LSNYILDIFQRLDIMIDVASALEYLHF 218
           +I I +    D F+     Y+    ++  L+  +S  +L        +     A++ LH 
Sbjct: 71  IITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLH- 129
Query: 219 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE--------DQSLTQTQTLATIG 270
              + +IH DLKPSN+L++ N    + DFG+A+ + E          Q    T+ +AT  
Sbjct: 130 --GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRW 187
Query: 271 YMAPEYG-REGRVSTNGDVYSFGIMLMEIFTR 301
           Y APE      + S   DV+S G +L E+F R
Sbjct: 188 YRAPEVMLTSAKYSRAMDVWSCGCILAELFLR 219

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 98/198 (49%), Gaps = 15/198 (7%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVK--VFDPQYEGAFKSFDIECDVMKRICHRNLIKIISS 167
           IG+G +G VYKA  +  G  VA+K    D + EG   +   E  ++K + H N++K++  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 168 YSNDDFKALVLEYMPHGSLEKCL---YLSNYILDIFQRLDIMIDVASALEYLHFGYSAPI 224
              ++   LV E++ H  L+  +    L+   L + +     +     L+ L F +S  +
Sbjct: 71  IHTENKLYLVFEFL-HQDLKDFMDASALTGIPLPLIKSYLFQL-----LQGLAFCHSHRV 124
Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGR-VS 283
           +H DLKP N+L++      L+DFG+A+      +  T    + T+ Y APE     +  S
Sbjct: 125 LHRDLKPENLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCKYYS 182
Query: 284 TNGDVYSFGIMLMEIFTR 301
           T  D++S G +  E+ TR
Sbjct: 183 TAVDIWSLGCIFAEMVTR 200

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 95/195 (48%), Gaps = 8/195 (4%)
Query: 111 IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYS 169
           IG+G  G V  A  +  G +VAVK  D + +   +    E  +M+   H N++ + SSY 
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYL 112
Query: 170 NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
             D   +V+E++  G+L     +++  ++  Q   + + V  AL YLH   +  +IH D+
Sbjct: 113 VGDELWVVMEFLEGGALTDI--VTHTRMNEEQIATVCLSVLRALSYLH---NQGVIHRDI 167
Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 289
           K  ++LL  +    LSDFG    + +E     +   + T  +MAPE        T  D++
Sbjct: 168 KSDSILLTSDGRIKLSDFGFCAQVSKEVPK--RKXLVGTPYWMAPEVISRLPYGTEVDIW 225
Query: 290 SFGIMLMEIFTRTKP 304
           S GIM++E+     P
Sbjct: 226 SLGIMVIEMIDGEPP 240

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 105/213 (49%), Gaps = 15/213 (7%)
Query: 110 LIGKGGFGSVYKAI-IQDG----MEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIK 163
           ++G G FG+VYK I + +G    + VA+K+ +      A   F  E  +M  + H +L++
Sbjct: 22  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 81
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL--DIMIDVASALEYLHFGYS 221
           ++    +   + LV + MPHG L +  Y+  +  +I  +L  +  + +A  + YL     
Sbjct: 82  LLGVCLSPTIQ-LVTQLMPHGCLLE--YVHEHKDNIGSQLLLNWCVQIAKGMMYLE---E 135
Query: 222 APIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGR 281
             ++H DL   NVL+       ++DFG+A+ L  +++          I +MA E     +
Sbjct: 136 RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRK 195
Query: 282 VSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEM 313
            +   DV+S+G+ + E+ T   KP D I + E+
Sbjct: 196 FTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI 228

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 95/225 (42%), Gaps = 35/225 (15%)
Query: 100 PLPNDANMPPLIGKGGFGSVYKAIIQDGME-VAVKVFDPQYEGAFKSFDIECDVMKRIC- 157
           P   D ++   +G+G  G V  A+ +   E VAVK+ D +     ++ D   ++ K IC 
Sbjct: 3   PFVEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEICI 57
Query: 158 -----HRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL--DIMIDVA 210
                H N++K        + + L LEY   G L             F R+  DI +   
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEP 104
Query: 211 SALEYLH-------FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 263
            A  + H       + +   I H D+KP N+LLD+     +SDFG+A      ++     
Sbjct: 105 DAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 164
Query: 264 QTLATIGYMAPEYGREGRVSTNG-DVYSFGIMLMEIFTRTKPTDE 307
           +   T+ Y+APE  +         DV+S GI+L  +     P D+
Sbjct: 165 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 96/195 (49%), Gaps = 9/195 (4%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVK--VFDPQYEGAFKSFDIECDVMKRICHRNLIKIISS 167
           IG+G +G VYKA  +  G  VA+K    D + EG   +   E  ++K + H N++K++  
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 168 YSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHC 227
              ++   LV E++   S++   ++    L       I   +   L+ L F +S  ++H 
Sbjct: 74  IHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 130
Query: 228 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGR-VSTNG 286
           DLKP N+L++      L+DFG+A+      +  T    + T+ Y APE     +  ST  
Sbjct: 131 DLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCKYYSTAV 188
Query: 287 DVYSFGIMLMEIFTR 301
           D++S G +  E+ TR
Sbjct: 189 DIWSLGCIFAEMVTR 203

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 108/213 (50%), Gaps = 45/213 (21%)
Query: 110 LIGKGGFGSVYKAIIQDGME-VAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKI---- 164
           +IG G FG VY+A + D  E VA+K      +  FK+ +++  +M+++ H N++++    
Sbjct: 39  VIGNGSFGVVYQAKLCDSGELVAIKKV--LQDKRFKNRELQ--IMRKLDHCNIVRLRYFF 94
Query: 165 ISSYSNDD--FKALVLEYMP--------HGSLEK----CLYLSNYILDIFQRLDIMIDVA 210
            SS    D  +  LVL+Y+P        H S  K     +Y+  Y+  +F+         
Sbjct: 95  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR--------- 145
Query: 211 SALEYLH-FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 268
            +L Y+H FG    I H D+KP N+LLD D  V  L DFG AK L+  + +++    + +
Sbjct: 146 -SLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICS 197
Query: 269 IGYMAPE--YGREGRVSTNGDVYSFGIMLMEIF 299
             Y APE  +G     S+  DV+S G +L E+ 
Sbjct: 198 RYYRAPELIFGATDYTSSI-DVWSAGCVLAELL 229

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 108/213 (50%), Gaps = 45/213 (21%)
Query: 110 LIGKGGFGSVYKAIIQDGME-VAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKI---- 164
           +IG G FG VY+A + D  E VA+K      +  FK+ +++  +M+++ H N++++    
Sbjct: 46  VIGNGSFGVVYQAKLCDSGELVAIKKV--LQDKRFKNRELQ--IMRKLDHCNIVRLRYFF 101
Query: 165 ISSYSNDD--FKALVLEYMP--------HGSLEK----CLYLSNYILDIFQRLDIMIDVA 210
            SS    D  +  LVL+Y+P        H S  K     +Y+  Y+  +F+         
Sbjct: 102 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR--------- 152
Query: 211 SALEYLH-FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 268
            +L Y+H FG    I H D+KP N+LLD D  V  L DFG AK L+  + +++    + +
Sbjct: 153 -SLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICS 204
Query: 269 IGYMAPE--YGREGRVSTNGDVYSFGIMLMEIF 299
             Y APE  +G     S+  DV+S G +L E+ 
Sbjct: 205 RYYRAPELIFGATDYTSSI-DVWSAGCVLAELL 236

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 108/213 (50%), Gaps = 45/213 (21%)
Query: 110 LIGKGGFGSVYKAIIQDGME-VAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKI---- 164
           +IG G FG VY+A + D  E VA+K      +  FK+ +++  +M+++ H N++++    
Sbjct: 35  VIGNGSFGVVYQAKLCDSGELVAIKKV--LQDKRFKNRELQ--IMRKLDHCNIVRLRYFF 90
Query: 165 ISSYSNDD--FKALVLEYMP--------HGSLEK----CLYLSNYILDIFQRLDIMIDVA 210
            SS    D  +  LVL+Y+P        H S  K     +Y+  Y+  +F+         
Sbjct: 91  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR--------- 141
Query: 211 SALEYLH-FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 268
            +L Y+H FG    I H D+KP N+LLD D  V  L DFG AK L+  + +++    + +
Sbjct: 142 -SLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICS 193
Query: 269 IGYMAPE--YGREGRVSTNGDVYSFGIMLMEIF 299
             Y APE  +G     S+  DV+S G +L E+ 
Sbjct: 194 RYYRAPELIFGATDYTSSI-DVWSAGCVLAELL 225

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 25/205 (12%)
Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFD---PQYEGAFKSFDIECDVMKRICHRNLIKIIS 166
           IG G FG+VY A  +++   VA+K       Q    ++    E   ++++ H N I+   
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDI----FQRLDIMIDVASALEYLHFGYSA 222
            Y  +    LV+EY        CL  ++ +L++     Q ++I      AL+ L + +S 
Sbjct: 122 CYLREHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 173
Query: 223 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEY---GRE 279
            +IH D+K  N+LL +  +  L DFG A  +   +        + T  +MAPE      E
Sbjct: 174 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN------XFVGTPYWMAPEVILAMDE 227
Query: 280 GRVSTNGDVYSFGIMLMEIFTRTKP 304
           G+     DV+S GI  +E+  R  P
Sbjct: 228 GQYDGKVDVWSLGITCIELAERKPP 252

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 96/195 (49%), Gaps = 9/195 (4%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVK--VFDPQYEGAFKSFDIECDVMKRICHRNLIKIISS 167
           IG+G +G VYKA  +  G  VA+K    D + EG   +   E  ++K + H N++K++  
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 168 YSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHC 227
              ++   LV E++   S++   ++    L       I   +   L+ L F +S  ++H 
Sbjct: 73  IHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 129
Query: 228 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGR-VSTNG 286
           DLKP N+L++      L+DFG+A+      +  T    + T+ Y APE     +  ST  
Sbjct: 130 DLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCKYYSTAV 187
Query: 287 DVYSFGIMLMEIFTR 301
           D++S G +  E+ TR
Sbjct: 188 DIWSLGCIFAEMVTR 202

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 25/205 (12%)
Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFD---PQYEGAFKSFDIECDVMKRICHRNLIKIIS 166
           IG G FG+VY A  +++   VA+K       Q    ++    E   ++++ H N I+   
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDI----FQRLDIMIDVASALEYLHFGYSA 222
            Y  +    LV+EY        CL  ++ +L++     Q ++I      AL+ L + +S 
Sbjct: 83  CYLREHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 223 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEY---GRE 279
            +IH D+K  N+LL +  +  L DFG A  +   +        + T  +MAPE      E
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN------XFVGTPYWMAPEVILAMDE 188
Query: 280 GRVSTNGDVYSFGIMLMEIFTRTKP 304
           G+     DV+S GI  +E+  R  P
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPP 213

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 108/213 (50%), Gaps = 45/213 (21%)
Query: 110 LIGKGGFGSVYKAIIQDGME-VAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKI---- 164
           +IG G FG VY+A + D  E VA+K      +  FK+ +++  +M+++ H N++++    
Sbjct: 61  VIGNGSFGVVYQAKLCDSGELVAIKKV--LQDKRFKNRELQ--IMRKLDHCNIVRLRYFF 116
Query: 165 ISSYSNDD--FKALVLEYMP--------HGSLEK----CLYLSNYILDIFQRLDIMIDVA 210
            SS    D  +  LVL+Y+P        H S  K     +Y+  Y+  +F+         
Sbjct: 117 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR--------- 167
Query: 211 SALEYLH-FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 268
            +L Y+H FG    I H D+KP N+LLD D  V  L DFG AK L+  + +++    + +
Sbjct: 168 -SLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICS 219
Query: 269 IGYMAPE--YGREGRVSTNGDVYSFGIMLMEIF 299
             Y APE  +G     S+  DV+S G +L E+ 
Sbjct: 220 RYYRAPELIFGATDYTSSI-DVWSAGCVLAELL 251

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 108/213 (50%), Gaps = 45/213 (21%)
Query: 110 LIGKGGFGSVYKAIIQDGME-VAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKI---- 164
           +IG G FG VY+A + D  E VA+K      +  FK+ +++  +M+++ H N++++    
Sbjct: 27  VIGNGSFGVVYQAKLCDSGELVAIKKV--LQDKRFKNRELQ--IMRKLDHCNIVRLRYFF 82
Query: 165 ISSYSNDD--FKALVLEYMP--------HGSLEK----CLYLSNYILDIFQRLDIMIDVA 210
            SS    D  +  LVL+Y+P        H S  K     +Y+  Y+  +F+         
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR--------- 133
Query: 211 SALEYLH-FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 268
            +L Y+H FG    I H D+KP N+LLD D  V  L DFG AK L+  + +++    + +
Sbjct: 134 -SLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICS 185
Query: 269 IGYMAPE--YGREGRVSTNGDVYSFGIMLMEIF 299
             Y APE  +G     S+  DV+S G +L E+ 
Sbjct: 186 RYYRAPELIFGATDYTSSI-DVWSAGCVLAELL 217

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 16/210 (7%)
Query: 104 DANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKS----FDIECDVMKRICHR 159
           D  +  +IG+G FG V     +   +V       ++E   +S    F  E D+M      
Sbjct: 75  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 134
Query: 160 NLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNY-ILDIFQRLDIMIDVASALEYLHF 218
            ++++  ++ +D +  +V+EYMP G L   +  SNY + + + R     +V  AL+ +H 
Sbjct: 135 WVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARF-YTAEVVLALDAIH- 190
Query: 219 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE--- 275
             S   IH D+KP N+LLD +    L+DFG    + +E      T  + T  Y++PE   
Sbjct: 191 --SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISPEVLK 247
Query: 276 -YGREGRVSTNGDVYSFGIMLMEIFTRTKP 304
             G +G      D +S G+ L E+     P
Sbjct: 248 SQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 108/213 (50%), Gaps = 45/213 (21%)
Query: 110 LIGKGGFGSVYKAIIQDGME-VAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKI---- 164
           +IG G FG VY+A + D  E VA+K      +  FK+ +++  +M+++ H N++++    
Sbjct: 27  VIGNGSFGVVYQAKLCDSGELVAIKKV--LQDKRFKNRELQ--IMRKLDHCNIVRLRYFF 82
Query: 165 ISSYSNDD--FKALVLEYMP--------HGSLEK----CLYLSNYILDIFQRLDIMIDVA 210
            SS    D  +  LVL+Y+P        H S  K     +Y+  Y+  +F+         
Sbjct: 83  YSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR--------- 133
Query: 211 SALEYLH-FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 268
            +L Y+H FG    I H D+KP N+LLD D  V  L DFG AK L+  + +++    + +
Sbjct: 134 -SLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICS 185
Query: 269 IGYMAPE--YGREGRVSTNGDVYSFGIMLMEIF 299
             Y APE  +G     S+  DV+S G +L E+ 
Sbjct: 186 RYYRAPELIFGATDYTSSI-DVWSAGCVLAELL 217

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 108/213 (50%), Gaps = 45/213 (21%)
Query: 110 LIGKGGFGSVYKAIIQDGME-VAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKI---- 164
           +IG G FG VY+A + D  E VA+K      +  FK+ +++  +M+++ H N++++    
Sbjct: 28  VIGNGSFGVVYQAKLCDSGELVAIKKV--LQDKRFKNRELQ--IMRKLDHCNIVRLRYFF 83
Query: 165 ISSYSNDD--FKALVLEYMP--------HGSLEK----CLYLSNYILDIFQRLDIMIDVA 210
            SS    D  +  LVL+Y+P        H S  K     +Y+  Y+  +F+         
Sbjct: 84  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR--------- 134
Query: 211 SALEYLH-FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 268
            +L Y+H FG    I H D+KP N+LLD D  V  L DFG AK L+  + +++    + +
Sbjct: 135 -SLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICS 186
Query: 269 IGYMAPE--YGREGRVSTNGDVYSFGIMLMEIF 299
             Y APE  +G     S+  DV+S G +L E+ 
Sbjct: 187 RYYRAPELIFGATDYTSSI-DVWSAGCVLAELL 218

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 108/213 (50%), Gaps = 45/213 (21%)
Query: 110 LIGKGGFGSVYKAIIQDGME-VAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKI---- 164
           +IG G FG VY+A + D  E VA+K      +  FK+ +++  +M+++ H N++++    
Sbjct: 39  VIGNGSFGVVYQAKLCDSGELVAIKKV--LQDKRFKNRELQ--IMRKLDHCNIVRLRYFF 94
Query: 165 ISSYSNDD--FKALVLEYMP--------HGSLEK----CLYLSNYILDIFQRLDIMIDVA 210
            SS    D  +  LVL+Y+P        H S  K     +Y+  Y+  +F+         
Sbjct: 95  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR--------- 145
Query: 211 SALEYLH-FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 268
            +L Y+H FG    I H D+KP N+LLD D  V  L DFG AK L+  + +++    + +
Sbjct: 146 -SLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICS 197
Query: 269 IGYMAPE--YGREGRVSTNGDVYSFGIMLMEIF 299
             Y APE  +G     S+  DV+S G +L E+ 
Sbjct: 198 RYYRAPELIFGATDYTSSI-DVWSAGCVLAELL 229

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 108/213 (50%), Gaps = 45/213 (21%)
Query: 110 LIGKGGFGSVYKAIIQDGME-VAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKI---- 164
           +IG G FG VY+A + D  E VA+K      +  FK+ +++  +M+++ H N++++    
Sbjct: 63  VIGNGSFGVVYQAKLCDSGELVAIKKV--LQDKRFKNRELQ--IMRKLDHCNIVRLRYFF 118
Query: 165 ISSYSNDD--FKALVLEYMP--------HGSLEK----CLYLSNYILDIFQRLDIMIDVA 210
            SS    D  +  LVL+Y+P        H S  K     +Y+  Y+  +F+         
Sbjct: 119 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR--------- 169
Query: 211 SALEYLH-FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 268
            +L Y+H FG    I H D+KP N+LLD D  V  L DFG AK L+  + +++    + +
Sbjct: 170 -SLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICS 221
Query: 269 IGYMAPE--YGREGRVSTNGDVYSFGIMLMEIF 299
             Y APE  +G     S+  DV+S G +L E+ 
Sbjct: 222 RYYRAPELIFGATDYTSSI-DVWSAGCVLAELL 253

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 104/222 (46%), Gaps = 44/222 (19%)
Query: 110 LIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDI---------ECDVMKRIC-H 158
           ++G+G    V + I +    E AVK+ D    G+F + ++         E D+++++  H
Sbjct: 11  ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 70
Query: 159 RNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYIL----DIFQRLDIMIDVASALE 214
            N+I++  +Y  + F  LV + M  G L    YL+  +     +  + +  +++V  AL 
Sbjct: 71  PNIIQLKDTYETNTFFFLVFDLMKKGELFD--YLTEKVTLSEKETRKIMRALLEVICALH 128
Query: 215 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 274
            L+      I+H DLKP N+LLDD+M   L+DFG +  L   D      +   T  Y+AP
Sbjct: 129 KLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGEKLREVCGTPSYLAP 179
Query: 275 E------------YGREGRVSTNGDVYSFGIMLMEIFTRTKP 304
           E            YG+E       D++S G+++  +   + P
Sbjct: 180 EIIECSMNDNHPGYGKE------VDMWSTGVIMYTLLAGSPP 215

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 101/226 (44%), Gaps = 20/226 (8%)
Query: 92  LRYQKRGKPLPNDANMPPLIGKGGFGSVYKAII-----QDG-MEVAVKVFDPQYEGAFK- 144
           L Y ++ +   N+      +G G FG V +A       +D  ++VAVK+         K 
Sbjct: 27  LPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKE 86
Query: 145 SFDIECDVMKRIC-HRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYI------- 196
           +   E  +M  +  H N++ ++ + ++     ++ EY  +G L   L             
Sbjct: 87  ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDG 146
Query: 197 --LDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL 254
             L++   L     VA  + +L    S   IH D+   NVLL +  VA + DFG+A+ ++
Sbjct: 147 RPLELRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIM 203
Query: 255 EEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
            +   + +      + +MAPE   +   +   DV+S+GI+L EIF+
Sbjct: 204 NDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 108/213 (50%), Gaps = 45/213 (21%)
Query: 110 LIGKGGFGSVYKAIIQDGME-VAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKI---- 164
           +IG G FG VY+A + D  E VA+K      +  FK+ +++  +M+++ H N++++    
Sbjct: 27  VIGNGSFGVVYQAKLCDSGELVAIKKV--LQDKRFKNRELQ--IMRKLDHCNIVRLRYFF 82
Query: 165 ISSYSNDD--FKALVLEYMP--------HGSLEK----CLYLSNYILDIFQRLDIMIDVA 210
            SS    D  +  LVL+Y+P        H S  K     +Y+  Y+  +F+         
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR--------- 133
Query: 211 SALEYLH-FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 268
            +L Y+H FG    I H D+KP N+LLD D  V  L DFG AK L+  + +++    + +
Sbjct: 134 -SLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICS 185
Query: 269 IGYMAPE--YGREGRVSTNGDVYSFGIMLMEIF 299
             Y APE  +G     S+  DV+S G +L E+ 
Sbjct: 186 RYYRAPELIFGATDYTSSI-DVWSAGCVLAELL 217

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 108/213 (50%), Gaps = 45/213 (21%)
Query: 110 LIGKGGFGSVYKAIIQDGME-VAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKI---- 164
           +IG G FG VY+A + D  E VA+K      +  FK+ +++  +M+++ H N++++    
Sbjct: 65  VIGNGSFGVVYQAKLCDSGELVAIKKV--LQDKRFKNRELQ--IMRKLDHCNIVRLRYFF 120
Query: 165 ISSYSNDD--FKALVLEYMP--------HGSLEK----CLYLSNYILDIFQRLDIMIDVA 210
            SS    D  +  LVL+Y+P        H S  K     +Y+  Y+  +F+         
Sbjct: 121 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR--------- 171
Query: 211 SALEYLH-FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 268
            +L Y+H FG    I H D+KP N+LLD D  V  L DFG AK L+  + +++    + +
Sbjct: 172 -SLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICS 223
Query: 269 IGYMAPE--YGREGRVSTNGDVYSFGIMLMEIF 299
             Y APE  +G     S+  DV+S G +L E+ 
Sbjct: 224 RYYRAPELIFGATDYTSSI-DVWSAGCVLAELL 255

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 16/210 (7%)
Query: 104 DANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKS----FDIECDVMKRICHR 159
           D  +  +IG+G FG V     +   +V       ++E   +S    F  E D+M      
Sbjct: 75  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 134
Query: 160 NLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNY-ILDIFQRLDIMIDVASALEYLHF 218
            ++++  ++ +D +  +V+EYMP G L   +  SNY + + + R     +V  AL+ +H 
Sbjct: 135 WVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARF-YTAEVVLALDAIH- 190
Query: 219 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE--- 275
             S   IH D+KP N+LLD +    L+DFG    + +E      T  + T  Y++PE   
Sbjct: 191 --SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISPEVLK 247
Query: 276 -YGREGRVSTNGDVYSFGIMLMEIFTRTKP 304
             G +G      D +S G+ L E+     P
Sbjct: 248 SQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 16/210 (7%)
Query: 104 DANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKS----FDIECDVMKRICHR 159
           D  +  +IG+G FG V     +   +V       ++E   +S    F  E D+M      
Sbjct: 70  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 129
Query: 160 NLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNY-ILDIFQRLDIMIDVASALEYLHF 218
            ++++  ++ +D +  +V+EYMP G L   +  SNY + + + R     +V  AL+ +H 
Sbjct: 130 WVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARF-YTAEVVLALDAIH- 185
Query: 219 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE--- 275
             S   IH D+KP N+LLD +    L+DFG    + +E      T  + T  Y++PE   
Sbjct: 186 --SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISPEVLK 242
Query: 276 -YGREGRVSTNGDVYSFGIMLMEIFTRTKP 304
             G +G      D +S G+ L E+     P
Sbjct: 243 SQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 108/213 (50%), Gaps = 45/213 (21%)
Query: 110 LIGKGGFGSVYKAIIQDGME-VAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKI---- 164
           +IG G FG VY+A + D  E VA+K      +  FK+ +++  +M+++ H N++++    
Sbjct: 31  VIGNGSFGVVYQAKLCDSGELVAIKKV--LQDKRFKNRELQ--IMRKLDHCNIVRLRYFF 86
Query: 165 ISSYSNDD--FKALVLEYMP--------HGSLEK----CLYLSNYILDIFQRLDIMIDVA 210
            SS    D  +  LVL+Y+P        H S  K     +Y+  Y+  +F+         
Sbjct: 87  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR--------- 137
Query: 211 SALEYLH-FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 268
            +L Y+H FG    I H D+KP N+LLD D  V  L DFG AK L+  + +++    + +
Sbjct: 138 -SLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICS 189
Query: 269 IGYMAPE--YGREGRVSTNGDVYSFGIMLMEIF 299
             Y APE  +G     S+  DV+S G +L E+ 
Sbjct: 190 RYYRAPELIFGATDYTSSI-DVWSAGCVLAELL 221

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 108/213 (50%), Gaps = 45/213 (21%)
Query: 110 LIGKGGFGSVYKAIIQDGME-VAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKI---- 164
           +IG G FG VY+A + D  E VA+K      +  FK+ +++  +M+++ H N++++    
Sbjct: 55  VIGNGSFGVVYQAKLCDSGELVAIKKV--LQDKRFKNRELQ--IMRKLDHCNIVRLRYFF 110
Query: 165 ISSYSNDD--FKALVLEYMP--------HGSLEK----CLYLSNYILDIFQRLDIMIDVA 210
            SS    D  +  LVL+Y+P        H S  K     +Y+  Y+  +F+         
Sbjct: 111 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR--------- 161
Query: 211 SALEYLH-FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 268
            +L Y+H FG    I H D+KP N+LLD D  V  L DFG AK L+  + +++    + +
Sbjct: 162 -SLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICS 213
Query: 269 IGYMAPE--YGREGRVSTNGDVYSFGIMLMEIF 299
             Y APE  +G     S+  DV+S G +L E+ 
Sbjct: 214 RYYRAPELIFGATDYTSSI-DVWSAGCVLAELL 245

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 104/222 (46%), Gaps = 44/222 (19%)
Query: 110 LIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDI---------ECDVMKRIC-H 158
           ++G+G    V + I +    E AVK+ D    G+F + ++         E D+++++  H
Sbjct: 24  ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 159 RNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYIL----DIFQRLDIMIDVASALE 214
            N+I++  +Y  + F  LV + M  G L    YL+  +     +  + +  +++V  AL 
Sbjct: 84  PNIIQLKDTYETNTFFFLVFDLMKKGELFD--YLTEKVTLSEKETRKIMRALLEVICALH 141
Query: 215 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 274
            L+      I+H DLKP N+LLDD+M   L+DFG +  L   D      +   T  Y+AP
Sbjct: 142 KLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGEKLREVCGTPSYLAP 192
Query: 275 E------------YGREGRVSTNGDVYSFGIMLMEIFTRTKP 304
           E            YG+E       D++S G+++  +   + P
Sbjct: 193 EIIECSMNDNHPGYGKE------VDMWSTGVIMYTLLAGSPP 228

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 108/213 (50%), Gaps = 45/213 (21%)
Query: 110 LIGKGGFGSVYKAIIQDGME-VAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKI---- 164
           +IG G FG VY+A + D  E VA+K      +  FK+ +++  +M+++ H N++++    
Sbjct: 40  VIGNGSFGVVYQAKLCDSGELVAIKKV--LQDKRFKNRELQ--IMRKLDHCNIVRLRYFF 95
Query: 165 ISSYSNDD--FKALVLEYMP--------HGSLEK----CLYLSNYILDIFQRLDIMIDVA 210
            SS    D  +  LVL+Y+P        H S  K     +Y+  Y+  +F+         
Sbjct: 96  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR--------- 146
Query: 211 SALEYLH-FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 268
            +L Y+H FG    I H D+KP N+LLD D  V  L DFG AK L+  + +++    + +
Sbjct: 147 -SLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICS 198
Query: 269 IGYMAPE--YGREGRVSTNGDVYSFGIMLMEIF 299
             Y APE  +G     S+  DV+S G +L E+ 
Sbjct: 199 RYYRAPELIFGATDYTSSI-DVWSAGCVLAELL 230

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 108/213 (50%), Gaps = 45/213 (21%)
Query: 110 LIGKGGFGSVYKAIIQDGME-VAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKI---- 164
           +IG G FG VY+A + D  E VA+K      +  FK+ +++  +M+++ H N++++    
Sbjct: 32  VIGNGSFGVVYQAKLCDSGELVAIKKV--LQDKRFKNRELQ--IMRKLDHCNIVRLRYFF 87
Query: 165 ISSYSNDD--FKALVLEYMP--------HGSLEK----CLYLSNYILDIFQRLDIMIDVA 210
            SS    D  +  LVL+Y+P        H S  K     +Y+  Y+  +F+         
Sbjct: 88  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR--------- 138
Query: 211 SALEYLH-FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 268
            +L Y+H FG    I H D+KP N+LLD D  V  L DFG AK L+  + +++    + +
Sbjct: 139 -SLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICS 190
Query: 269 IGYMAPE--YGREGRVSTNGDVYSFGIMLMEIF 299
             Y APE  +G     S+  DV+S G +L E+ 
Sbjct: 191 RYYRAPELIFGATDYTSSI-DVWSAGCVLAELL 222

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 11/212 (5%)
Query: 99  KPLPNDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQY--EGAFKSFDIECDVMKR 155
           +P   +  +   IGKG F  V  A  +  G EVAVK+ D       + +    E  +MK 
Sbjct: 11  QPHIGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKI 70
Query: 156 ICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEY 215
           + H N++K+      +    LV+EY   G +   L     + +   R      + SA++Y
Sbjct: 71  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQY 129
Query: 216 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE 275
            H  Y   I+H DLK  N+LLD +M   ++DFG +      ++  T      +  Y APE
Sbjct: 130 CHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDT---FCGSPPYAAPE 183
Query: 276 YGREGRV-STNGDVYSFGIMLMEIFTRTKPTD 306
             +  +      DV+S G++L  + + + P D
Sbjct: 184 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 108/213 (50%), Gaps = 45/213 (21%)
Query: 110 LIGKGGFGSVYKAIIQDGME-VAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKI---- 164
           +IG G FG VY+A + D  E VA+K      +  FK+ +++  +M+++ H N++++    
Sbjct: 106 VIGNGSFGVVYQAKLCDSGELVAIKKV--LQDKRFKNRELQ--IMRKLDHCNIVRLRYFF 161
Query: 165 ISSYSNDD--FKALVLEYMP--------HGSLEK----CLYLSNYILDIFQRLDIMIDVA 210
            SS    D  +  LVL+Y+P        H S  K     +Y+  Y+  +F+         
Sbjct: 162 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR--------- 212
Query: 211 SALEYLH-FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 268
            +L Y+H FG    I H D+KP N+LLD D  V  L DFG AK L+  + +++    + +
Sbjct: 213 -SLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICS 264
Query: 269 IGYMAPE--YGREGRVSTNGDVYSFGIMLMEIF 299
             Y APE  +G     S+  DV+S G +L E+ 
Sbjct: 265 RYYRAPELIFGATDYTSSI-DVWSAGCVLAELL 296

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 94/201 (46%), Gaps = 13/201 (6%)
Query: 110 LIGKGGFGSVYKAIIQD-----GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKI 164
           ++GKGGFG V    ++        +   K    + +G   + + E  +++++  R ++ +
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALN-EKQILEKVNSRFVVSL 249
Query: 165 ISSYSNDDFKALVLEYMPHGSLEKCLY-LSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
             +Y   D   LVL  M  G L+  +Y +        + +    ++   LE LH      
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RER 306
Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVS 283
           I++ DLKP N+LLDD+    +SD G+A  + E     T    + T+GYMAPE  +  R +
Sbjct: 307 IVYRDLKPENILLDDHGHIRISDLGLAVHVPE---GQTIKGRVGTVGYMAPEVVKNERYT 363
Query: 284 TNGDVYSFGIMLMEIFTRTKP 304
            + D ++ G +L E+     P
Sbjct: 364 FSPDWWALGCLLYEMIAGQSP 384

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 94/201 (46%), Gaps = 13/201 (6%)
Query: 110 LIGKGGFGSVYKAIIQD-----GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKI 164
           ++GKGGFG V    ++        +   K    + +G   + + E  +++++  R ++ +
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALN-EKQILEKVNSRFVVSL 249
Query: 165 ISSYSNDDFKALVLEYMPHGSLEKCLY-LSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
             +Y   D   LVL  M  G L+  +Y +        + +    ++   LE LH      
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RER 306
Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVS 283
           I++ DLKP N+LLDD+    +SD G+A  + E     T    + T+GYMAPE  +  R +
Sbjct: 307 IVYRDLKPENILLDDHGHIRISDLGLAVHVPE---GQTIKGRVGTVGYMAPEVVKNERYT 363
Query: 284 TNGDVYSFGIMLMEIFTRTKP 304
            + D ++ G +L E+     P
Sbjct: 364 FSPDWWALGCLLYEMIAGQSP 384

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 101/226 (44%), Gaps = 20/226 (8%)
Query: 92  LRYQKRGKPLPNDANMPPLIGKGGFGSVYKAII-----QDG-MEVAVKVFDPQYEGAFK- 144
           L Y ++ +   N+      +G G FG V +A       +D  ++VAVK+         K 
Sbjct: 35  LPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKE 94
Query: 145 SFDIECDVMKRIC-HRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYI------- 196
           +   E  +M  +  H N++ ++ + ++     ++ EY  +G L   L             
Sbjct: 95  ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDG 154
Query: 197 --LDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL 254
             L++   L     VA  + +L    S   IH D+   NVLL +  VA + DFG+A+ ++
Sbjct: 155 RPLELRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIM 211
Query: 255 EEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
            +   + +      + +MAPE   +   +   DV+S+GI+L EIF+
Sbjct: 212 NDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 98/225 (43%), Gaps = 31/225 (13%)
Query: 99  KPLPNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGA-FKSFDIECDVMKRIC 157
           + +     M   IGKG +G V+    + G +VAVKVF    E + F+  +I   V+ R  
Sbjct: 33  RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRETEIYQTVLMR-- 89
Query: 158 HRNLIKIISSYSNDDFKA--------LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDV 209
           H N++  I++    D K         L+ +Y  +GSL    YL +  LD    L +    
Sbjct: 90  HENILGFIAA----DIKGTGSWTQLYLITDYHENGSLYD--YLKSTTLDAKSMLKLAYSS 143
Query: 210 ASALEYLH---FGYSA--PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS--LTQ 262
            S L +LH   F       I H DLK  N+L+  N    ++D G+A   + +     +  
Sbjct: 144 VSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPP 203
Query: 263 TQTLATIGYMAPEYGREGRVSTN------GDVYSFGIMLMEIFTR 301
              + T  YM PE   E     +       D+YSFG++L E+  R
Sbjct: 204 NTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR 248

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/232 (28%), Positives = 113/232 (48%), Gaps = 36/232 (15%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDP-QYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
           IG+G +G V  A    + + VA+K   P +++   +    E  ++ R  H N+I I    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 106
Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNYIL--DIFQRLD-----------IMIDVASALEY 215
            ND  +A  +E M      K +YL  +++  D+++ L             +  +   L+Y
Sbjct: 107 -NDIIRAPTIEQM------KDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKY 159
Query: 216 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LEEDQSLTQTQTLATIGYMAP 274
           +H   SA ++H DLKPSN+LL+      + DFG+A+    + D +   T+ +AT  Y AP
Sbjct: 160 IH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 216
Query: 275 EYGREGRVSTNG-DVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPI 325
           E     +  T   D++S G +L E+ +  +P   IF G+  L + +N +L I
Sbjct: 217 EIMLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQ-LNHILGI 263

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 108/213 (50%), Gaps = 45/213 (21%)
Query: 110 LIGKGGFGSVYKAIIQDGME-VAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKI---- 164
           +IG G FG VY+A + D  E VA+K      +  FK+ +++  +M+++ H N++++    
Sbjct: 27  VIGNGSFGVVYQAKLCDSGELVAIKKV--LQDKRFKNRELQ--IMRKLDHCNIVRLRYFF 82
Query: 165 ISSYSNDD--FKALVLEYMP--------HGSLEK----CLYLSNYILDIFQRLDIMIDVA 210
            SS    D  +  LVL+Y+P        H S  K     +Y+  Y+  +F+         
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR--------- 133
Query: 211 SALEYLH-FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 268
            +L Y+H FG    I H D+KP N+LLD D  V  L DFG AK L+  + +++    + +
Sbjct: 134 -SLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICS 185
Query: 269 IGYMAPE--YGREGRVSTNGDVYSFGIMLMEIF 299
             Y APE  +G     S+  DV+S G +L E+ 
Sbjct: 186 RYYRAPELIFGATDYTSSI-DVWSAGCVLAELL 217

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 94/220 (42%), Gaps = 25/220 (11%)
Query: 100 PLPNDANMPPLIGKGGFGSVYKAIIQDGME-VAVKVFDPQYE-GAFKSFDIECDVMKRIC 157
           P   D ++   +G+G +G V  A+ +   E VAVK+ D +      ++   E  + K + 
Sbjct: 3   PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLN 62
Query: 158 HRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL--DIMIDVASALEY 215
           H N++K        + + L LEY   G L             F R+  DI +    A  +
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRF 109
Query: 216 LH-------FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 268
            H       + +   I H D+KP N+LLD+     +SDFG+A      ++     +   T
Sbjct: 110 FHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169
Query: 269 IGYMAPEYGREGRVSTNG-DVYSFGIMLMEIFTRTKPTDE 307
           + Y+APE  +         DV+S GI+L  +     P D+
Sbjct: 170 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 94/220 (42%), Gaps = 25/220 (11%)
Query: 100 PLPNDANMPPLIGKGGFGSVYKAIIQDGME-VAVKVFDPQYE-GAFKSFDIECDVMKRIC 157
           P   D ++   +G+G +G V  A+ +   E VAVK+ D +      ++   E  + K + 
Sbjct: 3   PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLN 62
Query: 158 HRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL--DIMIDVASALEY 215
           H N++K        + + L LEY   G L             F R+  DI +    A  +
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRF 109
Query: 216 LH-------FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 268
            H       + +   I H D+KP N+LLD+     +SDFG+A      ++     +   T
Sbjct: 110 FHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGT 169
Query: 269 IGYMAPEYGREGRVSTNG-DVYSFGIMLMEIFTRTKPTDE 307
           + Y+APE  +         DV+S GI+L  +     P D+
Sbjct: 170 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 94/220 (42%), Gaps = 25/220 (11%)
Query: 100 PLPNDANMPPLIGKGGFGSVYKAIIQDGME-VAVKVFDPQYE-GAFKSFDIECDVMKRIC 157
           P   D ++   +G+G +G V  A+ +   E VAVK+ D +      ++   E  + K + 
Sbjct: 4   PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLN 63
Query: 158 HRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL--DIMIDVASALEY 215
           H N++K        + + L LEY   G L             F R+  DI +    A  +
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRF 110
Query: 216 LH-------FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 268
            H       + +   I H D+KP N+LLD+     +SDFG+A      ++     +   T
Sbjct: 111 FHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGT 170
Query: 269 IGYMAPEYGREGRVSTNG-DVYSFGIMLMEIFTRTKPTDE 307
           + Y+APE  +         DV+S GI+L  +     P D+
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 100/202 (49%), Gaps = 16/202 (7%)
Query: 111 IGKGGFGSVYKAIIQDGMEV-AVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKIIS 166
           IGKG FG V      D  ++ A+K  + Q        ++   E  +M+ + H  L+ +  
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIH 226
           S+ +++   +V++ +  G L   L  + +  +   +L  + ++  AL+YL    +  IIH
Sbjct: 83  SFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKL-FICELVMALDYLQ---NQRIIH 138
Query: 227 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA-TIGYMAPEY--GREGR-V 282
            D+KP N+LLD++   H++DF +A  L  E    TQ  T+A T  YMAPE    R+G   
Sbjct: 139 RDMKPDNILLDEHGHVHITDFNIAAMLPRE----TQITTMAGTKPYMAPEMFSSRKGAGY 194
Query: 283 STNGDVYSFGIMLMEIFTRTKP 304
           S   D +S G+   E+    +P
Sbjct: 195 SFAVDWWSLGVTAYELLRGRRP 216

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 103/222 (46%), Gaps = 44/222 (19%)
Query: 110 LIGKGGFGSVYKAIIQDGM-EVAVKVFDPQYEGAFKSFDI---------ECDVMKRIC-H 158
           ++G+G    V + I +    E AVK+ D    G+F + ++         E D+++++  H
Sbjct: 24  ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 159 RNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYIL----DIFQRLDIMIDVASALE 214
            N+I++  +Y  + F  LV + M  G L    YL+  +     +  + +  +++V  AL 
Sbjct: 84  PNIIQLKDTYETNTFFFLVFDLMKKGELFD--YLTEKVTLSEKETRKIMRALLEVICALH 141
Query: 215 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 274
            L+      I+H DLKP N+LLDD+M   L+DFG +  L   D          T  Y+AP
Sbjct: 142 KLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGEKLRSVCGTPSYLAP 192
Query: 275 E------------YGREGRVSTNGDVYSFGIMLMEIFTRTKP 304
           E            YG+E       D++S G+++  +   + P
Sbjct: 193 EIIECSMNDNHPGYGKE------VDMWSTGVIMYTLLAGSPP 228

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 91/198 (45%), Gaps = 13/198 (6%)
Query: 111 IGKGGFGSVYK-AIIQDGMEVAVKVFDPQYEGAFKSFDIECD---VMKRICHRNLIKIIS 166
           +G G FG V+      +G   A+KV   +     K  +   D   ++  + H  +I++  
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIH 226
           ++ +     ++++Y+  G L   L  S    +   +     +V  ALEYLH   S  II+
Sbjct: 74  TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF-YAAEVCLALEYLH---SKDIIY 129
Query: 227 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNG 286
            DLKP N+LLD N    ++DFG AK + +    L       T  Y+APE       + + 
Sbjct: 130 RDLKPENILLDKNGHIKITDFGFAKYVPDVTYXLC-----GTPDYIAPEVVSTKPYNKSI 184
Query: 287 DVYSFGIMLMEIFTRTKP 304
           D +SFGI++ E+     P
Sbjct: 185 DWWSFGILIYEMLAGYTP 202

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 98/216 (45%), Gaps = 14/216 (6%)
Query: 97  RGKP----LPNDANMPPLIGKGGFGSVYKAIIQD--GMEVAVKVFDPQYEGAF---KSFD 147
           RG P       D  +  ++G+G FG VY+ +  +  G ++ V V   + +      + F 
Sbjct: 14  RGSPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFM 73
Query: 148 IECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMI 207
            E  +MK + H +++K+I     +    +++E  P+G L   L  +   L +   +   +
Sbjct: 74  SEAVIMKNLDHPHIVKLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL 132
Query: 208 DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA 267
            +  A+ YL    S   +H D+   N+L+       L DFG+++ + +ED        L 
Sbjct: 133 QICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP 189
Query: 268 TIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTK 303
            I +M+PE     R +T  DV+ F + + EI +  K
Sbjct: 190 -IKWMSPESINFRRFTTASDVWMFAVCMWEILSFGK 224

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 102/214 (47%), Gaps = 18/214 (8%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAV--------KVFDPQYEGAFKSFDIECDVMKRICHRNLI 162
           +G G FG+V K   Q    V          +  DP  +    +   E +VM+++ +  ++
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA---EANVMQQLDNPYIV 75
Query: 163 KIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSA 222
           ++I     + +  LV+E    G L K L  + ++ D    ++++  V+  ++YL     +
Sbjct: 76  RMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQVSMGMKYLE---ES 130
Query: 223 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LEEDQSLTQTQTLATIGYMAPEYGREGR 281
             +H DL   NVLL     A +SDFG++K L  +E+    QT     + + APE     +
Sbjct: 131 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINYYK 190
Query: 282 VSTNGDVYSFGIMLMEIFTR-TKPTDEIFSGEMT 314
            S+  DV+SFG+++ E F+   KP   +   E+T
Sbjct: 191 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 224

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 91/200 (45%), Gaps = 11/200 (5%)
Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISS 167
           IGKG F  V  A  I  G EVAVK+ D       + +    E  +MK + H N++K+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 168 YSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHC 227
              +    LV+EY   G +   L     + +   R      + SA++Y H  +   I+H 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVHR 137
Query: 228 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRV-STNG 286
           DLK  N+LLD +M   ++DFG +      ++  T      +  Y APE  +  +      
Sbjct: 138 DLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPELFQGKKYDGPEV 194
Query: 287 DVYSFGIMLMEIFTRTKPTD 306
           DV+S G++L  + + + P D
Sbjct: 195 DVWSLGVILYTLVSGSLPFD 214

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 91/200 (45%), Gaps = 11/200 (5%)
Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISS 167
           IGKG F  V  A  I  G EVAVK+ D       + +    E  +MK + H N++K+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 168 YSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHC 227
              +    LV+EY   G +   L     + +   R      + SA++Y H  +   I+H 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVHR 137
Query: 228 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRV-STNG 286
           DLK  N+LLD +M   ++DFG +      ++  T      +  Y APE  +  +      
Sbjct: 138 DLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPELFQGKKYDGPEV 194
Query: 287 DVYSFGIMLMEIFTRTKPTD 306
           DV+S G++L  + + + P D
Sbjct: 195 DVWSLGVILYTLVSGSLPFD 214

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 99/206 (48%), Gaps = 20/206 (9%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDI------ECDVMKRICHRNLIK 163
           +G G FG V     Q  G +VAVK+ + Q     +S D+      E   +K   H ++IK
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQ---KIRSLDVVGKIKREIQNLKLFRHPHIIK 75
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
           +    S      +V+EY+  G L   +     + ++  R  +   + SA++Y H      
Sbjct: 76  LYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEAR-RLFQQILSAVDYCH---RHM 131
Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVS 283
           ++H DLKP NVLLD +M A ++DFG++   +  D    +T +  +  Y APE    GR+ 
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSN--MMSDGEFLRT-SCGSPNYAAPEV-ISGRLY 187
Query: 284 TNG--DVYSFGIMLMEIFTRTKPTDE 307
                D++S G++L  +   T P D+
Sbjct: 188 AGPEVDIWSCGVILYALLCGTLPFDD 213

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 95/205 (46%), Gaps = 10/205 (4%)
Query: 104 DANMPPLIGKGGFGSVYKAIIQD--GMEVAVKVFDPQYEGAF---KSFDIECDVMKRICH 158
           D  +  ++G+G FG VY+ +  +  G ++ V V   + +      + F  E  +MK + H
Sbjct: 13  DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDH 72
Query: 159 RNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHF 218
            +++K+I     +    +++E  P+G L   L  +   L +   +   + +  A+ YL  
Sbjct: 73  PHIVKLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE- 130
Query: 219 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGR 278
             S   +H D+   N+L+       L DFG+++ + +ED        L  I +M+PE   
Sbjct: 131 --SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP-IKWMSPESIN 187
Query: 279 EGRVSTNGDVYSFGIMLMEIFTRTK 303
             R +T  DV+ F + + EI +  K
Sbjct: 188 FRRFTTASDVWMFAVCMWEILSFGK 212

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 102/214 (47%), Gaps = 18/214 (8%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAV--------KVFDPQYEGAFKSFDIECDVMKRICHRNLI 162
           +G G FG+V K   Q    V          +  DP  +    +   E +VM+++ +  ++
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA---EANVMQQLDNPYIV 81
Query: 163 KIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSA 222
           ++I     + +  LV+E    G L K L  + ++ D    ++++  V+  ++YL     +
Sbjct: 82  RMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQVSMGMKYLE---ES 136
Query: 223 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LEEDQSLTQTQTLATIGYMAPEYGREGR 281
             +H DL   NVLL     A +SDFG++K L  +E+    QT     + + APE     +
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 196
Query: 282 VSTNGDVYSFGIMLMEIFTR-TKPTDEIFSGEMT 314
            S+  DV+SFG+++ E F+   KP   +   E+T
Sbjct: 197 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 230

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 98/198 (49%), Gaps = 15/198 (7%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVK--VFDPQYEGAFKSFDIECDVMKRICHRNLIKIISS 167
           IG+G +G VYKA  +  G  VA+K    D + EG   +   E  ++K + H N++K++  
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 168 YSNDDFKALVLEYMPHGSLEKCL---YLSNYILDIFQRLDIMIDVASALEYLHFGYSAPI 224
              ++   LV E++    L+K +    L+   L + +     +     L+ L F +S  +
Sbjct: 74  IHTENKLYLVFEHVDQ-DLKKFMDASALTGIPLPLIKSYLFQL-----LQGLAFCHSHRV 127
Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGR-VS 283
           +H DLKP N+L++      L+DFG+A+      +  T    + T+ Y APE     +  S
Sbjct: 128 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCKYYS 185
Query: 284 TNGDVYSFGIMLMEIFTR 301
           T  D++S G +  E+ TR
Sbjct: 186 TAVDIWSLGCIFAEMVTR 203

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 102/214 (47%), Gaps = 18/214 (8%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAV--------KVFDPQYEGAFKSFDIECDVMKRICHRNLI 162
           +G G FG+V K   Q    V          +  DP  +    +   E +VM+++ +  ++
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA---EANVMQQLDNPYIV 91
Query: 163 KIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSA 222
           ++I     + +  LV+E    G L K L  + ++ D    ++++  V+  ++YL     +
Sbjct: 92  RMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQVSMGMKYLE---ES 146
Query: 223 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LEEDQSLTQTQTLATIGYMAPEYGREGR 281
             +H DL   NVLL     A +SDFG++K L  +E+    QT     + + APE     +
Sbjct: 147 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 206
Query: 282 VSTNGDVYSFGIMLMEIFTR-TKPTDEIFSGEMT 314
            S+  DV+SFG+++ E F+   KP   +   E+T
Sbjct: 207 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 240

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 102/214 (47%), Gaps = 18/214 (8%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAV--------KVFDPQYEGAFKSFDIECDVMKRICHRNLI 162
           +G G FG+V K   Q    V          +  DP  +    +   E +VM+++ +  ++
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA---EANVMQQLDNPYIV 91
Query: 163 KIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSA 222
           ++I     + +  LV+E    G L K L  + ++ D    ++++  V+  ++YL     +
Sbjct: 92  RMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQVSMGMKYLE---ES 146
Query: 223 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LEEDQSLTQTQTLATIGYMAPEYGREGR 281
             +H DL   NVLL     A +SDFG++K L  +E+    QT     + + APE     +
Sbjct: 147 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 206
Query: 282 VSTNGDVYSFGIMLMEIFTR-TKPTDEIFSGEMT 314
            S+  DV+SFG+++ E F+   KP   +   E+T
Sbjct: 207 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 240

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 102/214 (47%), Gaps = 18/214 (8%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAV--------KVFDPQYEGAFKSFDIECDVMKRICHRNLI 162
           +G G FG+V K   Q    V          +  DP  +    +   E +VM+++ +  ++
Sbjct: 33  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA---EANVMQQLDNPYIV 89
Query: 163 KIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSA 222
           ++I     + +  LV+E    G L K L  + ++ D    ++++  V+  ++YL     +
Sbjct: 90  RMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQVSMGMKYLE---ES 144
Query: 223 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LEEDQSLTQTQTLATIGYMAPEYGREGR 281
             +H DL   NVLL     A +SDFG++K L  +E+    QT     + + APE     +
Sbjct: 145 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 204
Query: 282 VSTNGDVYSFGIMLMEIFTR-TKPTDEIFSGEMT 314
            S+  DV+SFG+++ E F+   KP   +   E+T
Sbjct: 205 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 238

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 95/205 (46%), Gaps = 10/205 (4%)
Query: 104 DANMPPLIGKGGFGSVYKAIIQD--GMEVAVKVFDPQYEGAF---KSFDIECDVMKRICH 158
           D  +  ++G+G FG VY+ +  +  G ++ V V   + +      + F  E  +MK + H
Sbjct: 9   DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDH 68
Query: 159 RNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHF 218
            +++K+I     +    +++E  P+G L   L  +   L +   +   + +  A+ YL  
Sbjct: 69  PHIVKLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE- 126
Query: 219 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGR 278
             S   +H D+   N+L+       L DFG+++ + +ED        L  I +M+PE   
Sbjct: 127 --SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP-IKWMSPESIN 183
Query: 279 EGRVSTNGDVYSFGIMLMEIFTRTK 303
             R +T  DV+ F + + EI +  K
Sbjct: 184 FRRFTTASDVWMFAVCMWEILSFGK 208

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 102/214 (47%), Gaps = 18/214 (8%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAV--------KVFDPQYEGAFKSFDIECDVMKRICHRNLI 162
           +G G FG+V K   Q    V          +  DP  +    +   E +VM+++ +  ++
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA---EANVMQQLDNPYIV 71
Query: 163 KIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSA 222
           ++I     + +  LV+E    G L K L  + ++ D    ++++  V+  ++YL     +
Sbjct: 72  RMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQVSMGMKYLE---ES 126
Query: 223 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LEEDQSLTQTQTLATIGYMAPEYGREGR 281
             +H DL   NVLL     A +SDFG++K L  +E+    QT     + + APE     +
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186
Query: 282 VSTNGDVYSFGIMLMEIFTR-TKPTDEIFSGEMT 314
            S+  DV+SFG+++ E F+   KP   +   E+T
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 220

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 102/214 (47%), Gaps = 18/214 (8%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAV--------KVFDPQYEGAFKSFDIECDVMKRICHRNLI 162
           +G G FG+V K   Q    V          +  DP  +    +   E +VM+++ +  ++
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA---EANVMQQLDNPYIV 69
Query: 163 KIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSA 222
           ++I     + +  LV+E    G L K L  + ++ D    ++++  V+  ++YL     +
Sbjct: 70  RMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQVSMGMKYLE---ES 124
Query: 223 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LEEDQSLTQTQTLATIGYMAPEYGREGR 281
             +H DL   NVLL     A +SDFG++K L  +E+    QT     + + APE     +
Sbjct: 125 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 184
Query: 282 VSTNGDVYSFGIMLMEIFTR-TKPTDEIFSGEMT 314
            S+  DV+SFG+++ E F+   KP   +   E+T
Sbjct: 185 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 218

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 102/214 (47%), Gaps = 18/214 (8%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAV--------KVFDPQYEGAFKSFDIECDVMKRICHRNLI 162
           +G G FG+V K   Q    V          +  DP  +    +   E +VM+++ +  ++
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA---EANVMQQLDNPYIV 75
Query: 163 KIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSA 222
           ++I     + +  LV+E    G L K L  + ++ D    ++++  V+  ++YL     +
Sbjct: 76  RMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQVSMGMKYLE---ES 130
Query: 223 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LEEDQSLTQTQTLATIGYMAPEYGREGR 281
             +H DL   NVLL     A +SDFG++K L  +E+    QT     + + APE     +
Sbjct: 131 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 190
Query: 282 VSTNGDVYSFGIMLMEIFTR-TKPTDEIFSGEMT 314
            S+  DV+SFG+++ E F+   KP   +   E+T
Sbjct: 191 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 224

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 16/212 (7%)
Query: 103 NDANMPPLIGKGGFGSVYKAIIQDGME-VAVKVFDPQYEGAFKSFDI-ECDVMKRICHRN 160
           +D  +  L+G+G +G V  A  +   E VA+K  +P  +  F    + E  ++K   H N
Sbjct: 11  SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHEN 70
Query: 161 LIKIISSYSNDDFKALVLEYMPHGSLEKCLY--LSNYILDIFQRLDIMIDVASALEYLHF 218
           +I I +    D F+     Y+    ++  L+  +S  +L        +     A++ LH 
Sbjct: 71  IITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLH- 129
Query: 219 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE--------DQSLTQTQTLATIG 270
              + +IH DLKPSN+L++ N    + DFG+A+ + E          Q     + +AT  
Sbjct: 130 --GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRW 187
Query: 271 YMAPEYG-REGRVSTNGDVYSFGIMLMEIFTR 301
           Y APE      + S   DV+S G +L E+F R
Sbjct: 188 YRAPEVMLTSAKYSRAMDVWSCGCILAELFLR 219

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 102/214 (47%), Gaps = 18/214 (8%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAV--------KVFDPQYEGAFKSFDIECDVMKRICHRNLI 162
           +G G FG+V K   Q    V          +  DP  +    +   E +VM+++ +  ++
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA---EANVMQQLDNPYIV 433
Query: 163 KIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSA 222
           ++I     + +  LV+E    G L K L  + ++ D    ++++  V+  ++YL     +
Sbjct: 434 RMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQVSMGMKYLE---ES 488
Query: 223 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LEEDQSLTQTQTLATIGYMAPEYGREGR 281
             +H DL   NVLL     A +SDFG++K L  +E+    QT     + + APE     +
Sbjct: 489 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 548
Query: 282 VSTNGDVYSFGIMLMEIFTR-TKPTDEIFSGEMT 314
            S+  DV+SFG+++ E F+   KP   +   E+T
Sbjct: 549 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 582

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 87/168 (51%), Gaps = 7/168 (4%)
Query: 149 ECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMID 208
           E +VM+++ +  ++++I     + +  LV+E    G L K L  + ++ D    ++++  
Sbjct: 421 EANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQ 478
Query: 209 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LEEDQSLTQTQTLA 267
           V+  ++YL     +  +H DL   NVLL     A +SDFG++K L  +E+    QT    
Sbjct: 479 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 535
Query: 268 TIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTR-TKPTDEIFSGEMT 314
            + + APE     + S+  DV+SFG+++ E F+   KP   +   E+T
Sbjct: 536 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 583

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 28/208 (13%)
Query: 106 NMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRICHRNL 161
           N+ P +G G +GSV  A   + G+ VAVK     ++    A +++  E  ++K + H N+
Sbjct: 33  NLSP-VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENV 90
Query: 162 IKIISSYS--------NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASAL 213
           I ++  ++        ND +    L      ++ KC  L++   D  Q L  +  +   L
Sbjct: 91  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQILRGL 145
Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
           +Y+H   SA IIH DLKPSN+ ++++    + DFG+A+   +E      T  +AT  Y A
Sbjct: 146 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRA 197
Query: 274 PEYGREG-RVSTNGDVYSFGIMLMEIFT 300
           PE        +   D++S G ++ E+ T
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLT 225

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 28/208 (13%)
Query: 106 NMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRICHRNL 161
           N+ P +G G +GSV  A   + G+ VAVK     ++    A +++  E  ++K + H N+
Sbjct: 33  NLSP-VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENV 90
Query: 162 IKIISSYS--------NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASAL 213
           I ++  ++        ND +    L      ++ KC  L++   D  Q L  +  +   L
Sbjct: 91  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQILRGL 145
Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
           +Y+H   SA IIH DLKPSN+ ++++    + DFG+A+   +E      T  +AT  Y A
Sbjct: 146 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRA 197
Query: 274 PEYGREG-RVSTNGDVYSFGIMLMEIFT 300
           PE        +   D++S G ++ E+ T
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLT 225

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 28/208 (13%)
Query: 106 NMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRICHRNL 161
           N+ P +G G +GSV  A   + G+ VAVK     ++    A +++  E  ++K + H N+
Sbjct: 33  NLSP-VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENV 90
Query: 162 IKIISSYS--------NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASAL 213
           I ++  ++        ND +    L      ++ KC  L++   D  Q L  +  +   L
Sbjct: 91  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQILRGL 145
Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
           +Y+H   SA IIH DLKPSN+ ++++    + DFG+A+   +E      T  +AT  Y A
Sbjct: 146 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRA 197
Query: 274 PEYGREG-RVSTNGDVYSFGIMLMEIFT 300
           PE        +   D++S G ++ E+ T
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLT 225

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 91/200 (45%), Gaps = 11/200 (5%)
Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISS 167
           IGKG F  V  A  I  G EVAV++ D       + +    E  +MK + H N++K+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 168 YSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHC 227
              +    LV+EY   G +   L     + +   R      + SA++Y H  +   I+H 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVHR 137
Query: 228 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRV-STNG 286
           DLK  N+LLD +M   ++DFG +      ++  T      +  Y APE  +  +      
Sbjct: 138 DLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPELFQGKKYDGPEV 194
Query: 287 DVYSFGIMLMEIFTRTKPTD 306
           DV+S G++L  + + + P D
Sbjct: 195 DVWSLGVILYTLVSGSLPFD 214

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 107/228 (46%), Gaps = 28/228 (12%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDP-QYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
           IG+G +G V  A        VA+K   P +++   +    E  ++ R  H N+I I    
Sbjct: 51  IGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDIL 110
Query: 169 SNDDFKALVLEYMPHGSLEKCLY-------LSNYILDIFQRLDIMIDVASALEYLHFGYS 221
                +A+   Y+    +E  LY       LSN  +  F     +  +   L+Y+H   S
Sbjct: 111 RASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYF-----LYQILRGLKYIH---S 162
Query: 222 APIIHCDLKPSNVLLDDNMVAHLSDFGMAK---PLLEEDQSLTQTQTLATIGYMAPEYGR 278
           A ++H DLKPSN+L++      + DFG+A+   P  E D +   T+ +AT  Y APE   
Sbjct: 163 ANVLHRDLKPSNLLINTTCDLKICDFGLARIADP--EHDHTGFLTEXVATRWYRAPEIML 220
Query: 279 EGRVSTNG-DVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPI 325
             +  T   D++S G +L E+ +  +P   IF G+  L + +N +L I
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQ-LNHILGI 263

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 111/231 (48%), Gaps = 34/231 (14%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDP-QYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
           IG+G +G V  A    + + VA+K   P +++   +    E  ++ R  H N+I I    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGI---- 90
Query: 169 SNDDFKALVLE-----YMPHGSLEKCLY-------LSNYILDIFQRLDIMIDVASALEYL 216
            ND  +A  +E     Y+    +E  LY       LSN  +  F     +  +   L+Y+
Sbjct: 91  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF-----LYQILRGLKYI 144
Query: 217 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LEEDQSLTQTQTLATIGYMAPE 275
           H   SA ++H DLKPSN+LL+      + DFG+A+    + D +   T+ +AT  Y APE
Sbjct: 145 H---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201
Query: 276 YGREGRVSTNG-DVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPI 325
                +  T   D++S G +L E+ +  +P   IF G+  L + +N +L I
Sbjct: 202 IMLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQ-LNHILGI 247

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 28/208 (13%)
Query: 106 NMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRICHRNL 161
           N+ P IG G +GSV  A   + G+ VAVK     ++    A +++  E  ++K + H N+
Sbjct: 31  NLSP-IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENV 88
Query: 162 IKIISSYS--------NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASAL 213
           I ++  ++        ND +    L      ++ KC  L++   D  Q L  +  +   L
Sbjct: 89  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQILRGL 143
Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
           +Y+H   SA IIH DLKPSN+ ++++    + DFG+A+   +E      T  +AT  Y A
Sbjct: 144 KYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRWYRA 195
Query: 274 PEYGREG-RVSTNGDVYSFGIMLMEIFT 300
           PE        +   D++S G ++ E+ T
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLT 223

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 97/211 (45%), Gaps = 18/211 (8%)
Query: 110 LIGKGGFGSVYKAIIQDG--------MEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNL 161
           ++GKGG+G V++     G        M+V  K    +          E ++++ + H  +
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 162 IKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYS 221
           + +I ++       L+LEY+  G L   L      ++       + +++ AL +LH    
Sbjct: 84  VDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACF-YLAEISMALGHLH---Q 139
Query: 222 APIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGR 281
             II+ DLKP N++L+      L+DFG+ K  +  D ++T T    TI YMAPE      
Sbjct: 140 KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI-HDGTVTHT-FCGTIEYMAPEILMRSG 197
Query: 282 VSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE 312
            +   D +S G ++ ++ T   P    F+GE
Sbjct: 198 HNRAVDWWSLGALMYDMLTGAPP----FTGE 224

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 104/240 (43%), Gaps = 45/240 (18%)
Query: 110 LIGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDIE--------CDVMKRICHRN 160
           +IGKG F  V + I ++ G + AVK+ D     +      E        C ++K   H +
Sbjct: 31  VIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK---HPH 87
Query: 161 LIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASA-------- 212
           +++++ +YS+D    +V E+M    L           +I +R D     + A        
Sbjct: 88  IVELLETYSSDGMLYMVFEFMDGADL---------CFEIVKRADAGFVYSEAVASHYMRQ 138
Query: 213 -LEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 268
            LE L + +   IIH D+KP NVLL   +++    L DFG+A  L E    L     + T
Sbjct: 139 ILEALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGE--SGLVAGGRVGT 196
Query: 269 IGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKP----TDEIFSG------EMTLKRW 318
             +MAPE  +        DV+  G++L  + +   P     + +F G      +M  ++W
Sbjct: 197 PHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQW 256

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 101/219 (46%), Gaps = 34/219 (15%)
Query: 103 NDANMPPLIGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNL 161
           ND ++  +IG+GGFG VY     D G   A+K  D       K   ++      +  R +
Sbjct: 188 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDK------KRIKMKQGETLALNERIM 241
Query: 162 IKIISS------------YSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDV 209
           + ++S+            +   D  + +L+ M  G L    +LS +   +F   D+    
Sbjct: 242 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH--YHLSQH--GVFSEADMRFYA 297
Query: 210 AS---ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL 266
           A     LE++H  +   +++ DLKP+N+LLD++    +SD G+A    ++        ++
Sbjct: 298 AEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SV 350
Query: 267 ATIGYMAPEYGREG-RVSTNGDVYSFGIMLMEIFTRTKP 304
            T GYMAPE  ++G    ++ D +S G ML ++     P
Sbjct: 351 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 389

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 101/219 (46%), Gaps = 34/219 (15%)
Query: 103 NDANMPPLIGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNL 161
           ND ++  +IG+GGFG VY     D G   A+K  D       K   ++      +  R +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDK------KRIKMKQGETLALNERIM 242
Query: 162 IKIISS------------YSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDV 209
           + ++S+            +   D  + +L+ M  G L    +LS +   +F   D+    
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH--YHLSQH--GVFSEADMRFYA 298
Query: 210 AS---ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL 266
           A     LE++H  +   +++ DLKP+N+LLD++    +SD G+A    ++        ++
Sbjct: 299 AEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH----ASV 351
Query: 267 ATIGYMAPEYGREG-RVSTNGDVYSFGIMLMEIFTRTKP 304
            T GYMAPE  ++G    ++ D +S G ML ++     P
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 101/219 (46%), Gaps = 34/219 (15%)
Query: 103 NDANMPPLIGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNL 161
           ND ++  +IG+GGFG VY     D G   A+K  D       K   ++      +  R +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDK------KRIKMKQGETLALNERIM 242
Query: 162 IKIISS------------YSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDV 209
           + ++S+            +   D  + +L+ M  G L    +LS +   +F   D+    
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH--YHLSQH--GVFSEADMRFYA 298
Query: 210 AS---ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL 266
           A     LE++H  +   +++ DLKP+N+LLD++    +SD G+A    ++        ++
Sbjct: 299 AEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH----ASV 351
Query: 267 ATIGYMAPEYGREG-RVSTNGDVYSFGIMLMEIFTRTKP 304
            T GYMAPE  ++G    ++ D +S G ML ++     P
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 101/219 (46%), Gaps = 34/219 (15%)
Query: 103 NDANMPPLIGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNL 161
           ND ++  +IG+GGFG VY     D G   A+K  D       K   ++      +  R +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDK------KRIKMKQGETLALNERIM 242
Query: 162 IKIISS------------YSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDV 209
           + ++S+            +   D  + +L+ M  G L    +LS +   +F   D+    
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH--YHLSQH--GVFSEADMRFYA 298
Query: 210 AS---ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL 266
           A     LE++H  +   +++ DLKP+N+LLD++    +SD G+A    ++        ++
Sbjct: 299 AEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH----ASV 351
Query: 267 ATIGYMAPEYGREG-RVSTNGDVYSFGIMLMEIFTRTKP 304
            T GYMAPE  ++G    ++ D +S G ML ++     P
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 111/231 (48%), Gaps = 34/231 (14%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDP-QYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
           IG+G +G V  A    + + VA+K   P +++   +    E  ++ R  H N+I I    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 90
Query: 169 SNDDFKALVLE-----YMPHGSLEKCLY-------LSNYILDIFQRLDIMIDVASALEYL 216
            ND  +A  +E     Y+    +E  LY       LSN  +  F     +  +   L+Y+
Sbjct: 91  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF-----LYQILRGLKYI 144
Query: 217 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LEEDQSLTQTQTLATIGYMAPE 275
           H   SA ++H DLKPSN+LL+      + DFG+A+    + D +   T+ +AT  Y APE
Sbjct: 145 H---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201
Query: 276 YGREGRVSTNG-DVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPI 325
                +  T   D++S G +L E+ +  +P   IF G+  L + +N +L I
Sbjct: 202 IMLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQ-LNHILGI 247

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 111/231 (48%), Gaps = 34/231 (14%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDP-QYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
           IG+G +G V  A    + + VA+K   P +++   +    E  ++ R  H N+I I    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 86
Query: 169 SNDDFKALVLE-----YMPHGSLEKCLY-------LSNYILDIFQRLDIMIDVASALEYL 216
            ND  +A  +E     Y+    +E  LY       LSN  +  F     +  +   L+Y+
Sbjct: 87  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF-----LYQILRGLKYI 140
Query: 217 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LEEDQSLTQTQTLATIGYMAPE 275
           H   SA ++H DLKPSN+LL+      + DFG+A+    + D +   T+ +AT  Y APE
Sbjct: 141 H---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 197
Query: 276 YGREGRVSTNG-DVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPI 325
                +  T   D++S G +L E+ +  +P   IF G+  L + +N +L I
Sbjct: 198 IMLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQ-LNHILGI 243

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 111/231 (48%), Gaps = 34/231 (14%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDP-QYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
           IG+G +G V  A    + + VA+K   P +++   +    E  ++ R  H N+I I    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 86
Query: 169 SNDDFKALVLE-----YMPHGSLEKCLY-------LSNYILDIFQRLDIMIDVASALEYL 216
            ND  +A  +E     Y+    +E  LY       LSN  +  F     +  +   L+Y+
Sbjct: 87  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF-----LYQILRGLKYI 140
Query: 217 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LEEDQSLTQTQTLATIGYMAPE 275
           H   SA ++H DLKPSN+LL+      + DFG+A+    + D +   T+ +AT  Y APE
Sbjct: 141 H---SANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPE 197
Query: 276 YGREGRVSTNG-DVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPI 325
                +  T   D++S G +L E+ +  +P   IF G+  L + +N +L I
Sbjct: 198 IMLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQ-LNHILGI 243

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 28/208 (13%)
Query: 106 NMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRICHRNL 161
           N+ P +G G +GSV  A   + G+ VAVK     ++    A +++  E  ++K + H N+
Sbjct: 26  NLSP-VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENV 83
Query: 162 IKIISSYS--------NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASAL 213
           I ++  ++        ND +    L      ++ KC  L++   D  Q L  +  +   L
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQILRGL 138
Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
           +Y+H   SA IIH DLKPSN+ ++++    + DFG+A+   +E      T  +AT  Y A
Sbjct: 139 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRA 190
Query: 274 PEYGREG-RVSTNGDVYSFGIMLMEIFT 300
           PE        +   D++S G ++ E+ T
Sbjct: 191 PEIMLNAMHYNQTVDIWSVGCIMAELLT 218

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 91/200 (45%), Gaps = 11/200 (5%)
Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISS 167
           IGKG F  V  A  I  G EVAV++ D       + +    E  +MK + H N++K+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 168 YSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHC 227
              +    LV+EY   G +   L     + +   R      + SA++Y H  +   I+H 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVHR 137
Query: 228 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRV-STNG 286
           DLK  N+LLD +M   ++DFG +      ++     +   +  Y APE  +  +      
Sbjct: 138 DLKAENLLLDADMNIKIADFGFSNEFTFGNK---LDEFCGSPPYAAPELFQGKKYDGPEV 194
Query: 287 DVYSFGIMLMEIFTRTKPTD 306
           DV+S G++L  + + + P D
Sbjct: 195 DVWSLGVILYTLVSGSLPFD 214

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/229 (23%), Positives = 102/229 (44%), Gaps = 20/229 (8%)
Query: 92  LRYQKRGKPLPNDANMPPLIGKGGFGSVYKAII-----QDG-MEVAVKVFDPQYEGAFK- 144
           L Y ++ +   N+      +G G FG V +A       +D  ++VAVK+         K 
Sbjct: 35  LPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKE 94
Query: 145 SFDIECDVMKRIC-HRNLIKIISSYSNDDFKALVLEYMPHG------------SLEKCLY 191
           +   E  +M  +  H N++ ++ + ++     ++ EY  +G             LE    
Sbjct: 95  ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYN 154
Query: 192 LSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAK 251
            S+   +     D++   +   + + F  S   IH D+   NVLL +  VA + DFG+A+
Sbjct: 155 PSHNPEEQLSSRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 214
Query: 252 PLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
            ++ +   + +      + +MAPE   +   +   DV+S+GI+L EIF+
Sbjct: 215 DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 100/206 (48%), Gaps = 20/206 (9%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDI------ECDVMKRICHRNLIK 163
           +G G FG V     Q  G +VAVK+ + Q     +S D+      E   +K   H ++IK
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQ---KIRSLDVVGKIKREIQNLKLFRHPHIIK 75
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
           +    S      +V+EY+  G L   +     + ++  R  +   + SA++Y H      
Sbjct: 76  LYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEAR-RLFQQILSAVDYCH---RHM 131
Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVS 283
           ++H DLKP NVLLD +M A ++DFG++  ++ + + L    +  +  Y APE    GR+ 
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSN-MMSDGEFL--RDSCGSPNYAAPEV-ISGRLY 187
Query: 284 TNG--DVYSFGIMLMEIFTRTKPTDE 307
                D++S G++L  +   T P D+
Sbjct: 188 AGPEVDIWSCGVILYALLCGTLPFDD 213

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 28/208 (13%)
Query: 106 NMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRICHRNL 161
           N+ P +G G +GSV  A   + G+ VAVK     ++    A +++  E  ++K + H N+
Sbjct: 26  NLSP-VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENV 83
Query: 162 IKIISSYS--------NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASAL 213
           I ++  ++        ND +    L      ++ KC  L++   D  Q L  +  +   L
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQILRGL 138
Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
           +Y+H   SA IIH DLKPSN+ ++++    + DFG+A+   +E      T  +AT  Y A
Sbjct: 139 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGXVATRWYRA 190
Query: 274 PEYGREG-RVSTNGDVYSFGIMLMEIFT 300
           PE        +   D++S G ++ E+ T
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 209 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 268
           VA  +E+L    S   IH DL   N+LL +N V  + DFG+A+ + +    + +  T   
Sbjct: 208 VARGMEFLS---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLP 264
Query: 269 IGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
           + +MAPE   +   ST  DV+S+G++L EIF+
Sbjct: 265 LKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 111/231 (48%), Gaps = 34/231 (14%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDP-QYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
           IG+G +G V  A    + + VA+K   P +++   +    E  ++ R  H N+I I    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 88
Query: 169 SNDDFKALVLE-----YMPHGSLEKCLY-------LSNYILDIFQRLDIMIDVASALEYL 216
            ND  +A  +E     Y+    +E  LY       LSN  +  F     +  +   L+Y+
Sbjct: 89  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF-----LYQILRGLKYI 142
Query: 217 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LEEDQSLTQTQTLATIGYMAPE 275
           H   SA ++H DLKPSN+LL+      + DFG+A+    + D +   T+ +AT  Y APE
Sbjct: 143 H---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 199
Query: 276 YGREGRVSTNG-DVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPI 325
                +  T   D++S G +L E+ +  +P   IF G+  L + +N +L I
Sbjct: 200 IMLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQ-LNHILGI 245

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISS 167
           IGKG F  V  A  I  G EVAVK+ D       + +    E  +MK + H N++K+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 168 YSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHC 227
              +    LV+EY   G +   L     + +   R      + SA++Y H  +   I+H 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVHR 137
Query: 228 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG---YMAPEYGREGRV-S 283
           DLK  N+LLD +M   ++DFG +      ++     +  A  G   Y APE  +  +   
Sbjct: 138 DLKAENLLLDADMNIKIADFGFS------NEFTFGNKLDAFCGAPPYAAPELFQGKKYDG 191
Query: 284 TNGDVYSFGIMLMEIFTRTKPTD 306
              DV+S G++L  + + + P D
Sbjct: 192 PEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 111/231 (48%), Gaps = 34/231 (14%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDP-QYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
           IG+G +G V  A    + + VA+K   P +++   +    E  ++ R  H N+I I    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 91
Query: 169 SNDDFKALVLE-----YMPHGSLEKCLY-------LSNYILDIFQRLDIMIDVASALEYL 216
            ND  +A  +E     Y+    +E  LY       LSN  +  F     +  +   L+Y+
Sbjct: 92  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF-----LYQILRGLKYI 145
Query: 217 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LEEDQSLTQTQTLATIGYMAPE 275
           H   SA ++H DLKPSN+LL+      + DFG+A+    + D +   T+ +AT  Y APE
Sbjct: 146 H---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 202
Query: 276 YGREGRVSTNG-DVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPI 325
                +  T   D++S G +L E+ +  +P   IF G+  L + +N +L I
Sbjct: 203 IMLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQ-LNHILGI 248

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 111/231 (48%), Gaps = 34/231 (14%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDP-QYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
           IG+G +G V  A    + + VA+K   P +++   +    E  ++ R  H N+I I    
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 92
Query: 169 SNDDFKALVLE-----YMPHGSLEKCLY-------LSNYILDIFQRLDIMIDVASALEYL 216
            ND  +A  +E     Y+    +E  LY       LSN  +  F     +  +   L+Y+
Sbjct: 93  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF-----LYQILRGLKYI 146
Query: 217 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LEEDQSLTQTQTLATIGYMAPE 275
           H   SA ++H DLKPSN+LL+      + DFG+A+    + D +   T+ +AT  Y APE
Sbjct: 147 H---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 203
Query: 276 YGREGRVSTNG-DVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPI 325
                +  T   D++S G +L E+ +  +P   IF G+  L + +N +L I
Sbjct: 204 IMLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQ-LNHILGI 249

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 111/231 (48%), Gaps = 34/231 (14%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDP-QYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
           IG+G +G V  A    + + VA+K   P +++   +    E  ++ R  H N+I I    
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 83
Query: 169 SNDDFKALVLE-----YMPHGSLEKCLY-------LSNYILDIFQRLDIMIDVASALEYL 216
            ND  +A  +E     Y+    +E  LY       LSN  +  F     +  +   L+Y+
Sbjct: 84  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF-----LYQILRGLKYI 137
Query: 217 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LEEDQSLTQTQTLATIGYMAPE 275
           H   SA ++H DLKPSN+LL+      + DFG+A+    + D +   T+ +AT  Y APE
Sbjct: 138 H---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 194
Query: 276 YGREGRVSTNG-DVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPI 325
                +  T   D++S G +L E+ +  +P   IF G+  L + +N +L I
Sbjct: 195 IMLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQ-LNHILGI 240

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 111/231 (48%), Gaps = 34/231 (14%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDP-QYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
           IG+G +G V  A    + + VA+K   P +++   +    E  ++ R  H N+I I    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 90
Query: 169 SNDDFKALVLE-----YMPHGSLEKCLY-------LSNYILDIFQRLDIMIDVASALEYL 216
            ND  +A  +E     Y+    +E  LY       LSN  +  F     +  +   L+Y+
Sbjct: 91  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF-----LYQILRGLKYI 144
Query: 217 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LEEDQSLTQTQTLATIGYMAPE 275
           H   SA ++H DLKPSN+LL+      + DFG+A+    + D +   T+ +AT  Y APE
Sbjct: 145 H---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201
Query: 276 YGREGRVSTNG-DVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPI 325
                +  T   D++S G +L E+ +  +P   IF G+  L + +N +L I
Sbjct: 202 IMLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQ-LNHILGI 247

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 111/231 (48%), Gaps = 34/231 (14%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDP-QYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
           IG+G +G V  A    + + VA+K   P +++   +    E  ++ R  H N+I I    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 86
Query: 169 SNDDFKALVLE-----YMPHGSLEKCLY-------LSNYILDIFQRLDIMIDVASALEYL 216
            ND  +A  +E     Y+    +E  LY       LSN  +  F     +  +   L+Y+
Sbjct: 87  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF-----LYQILRGLKYI 140
Query: 217 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LEEDQSLTQTQTLATIGYMAPE 275
           H   SA ++H DLKPSN+LL+      + DFG+A+    + D +   T+ +AT  Y APE
Sbjct: 141 H---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 197
Query: 276 YGREGRVSTNG-DVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPI 325
                +  T   D++S G +L E+ +  +P   IF G+  L + +N +L I
Sbjct: 198 IMLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQ-LNHILGI 243

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 111/231 (48%), Gaps = 34/231 (14%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDP-QYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
           IG+G +G V  A    + + VA+K   P +++   +    E  ++ R  H N+I I    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 86
Query: 169 SNDDFKALVLE-----YMPHGSLEKCLY-------LSNYILDIFQRLDIMIDVASALEYL 216
            ND  +A  +E     Y+    +E  LY       LSN  +  F     +  +   L+Y+
Sbjct: 87  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF-----LYQILRGLKYI 140
Query: 217 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LEEDQSLTQTQTLATIGYMAPE 275
           H   SA ++H DLKPSN+LL+      + DFG+A+    + D +   T+ +AT  Y APE
Sbjct: 141 H---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 197
Query: 276 YGREGRVSTNG-DVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPI 325
                +  T   D++S G +L E+ +  +P   IF G+  L + +N +L I
Sbjct: 198 IMLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQ-LNHILGI 243

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 28/208 (13%)
Query: 106 NMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRICHRNL 161
           N+ P +G G +GSV  A   + G+ VAVK     ++    A +++  E  ++K + H N+
Sbjct: 31  NLSP-VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENV 88
Query: 162 IKIISSYS--------NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASAL 213
           I ++  ++        ND +    L      ++ KC  L++   D  Q L  +  +   L
Sbjct: 89  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQILRGL 143
Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
           +Y+H   SA IIH DLKPSN+ ++++    + DFG+A+   +E      T  +AT  Y A
Sbjct: 144 KYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRWYRA 195
Query: 274 PEYGREG-RVSTNGDVYSFGIMLMEIFT 300
           PE        +   D++S G ++ E+ T
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLT 223

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 111/231 (48%), Gaps = 34/231 (14%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDP-QYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
           IG+G +G V  A    + + VA+K   P +++   +    E  ++ R  H N+I I    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 84
Query: 169 SNDDFKALVLE-----YMPHGSLEKCLY-------LSNYILDIFQRLDIMIDVASALEYL 216
            ND  +A  +E     Y+    +E  LY       LSN  +  F     +  +   L+Y+
Sbjct: 85  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF-----LYQILRGLKYI 138
Query: 217 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LEEDQSLTQTQTLATIGYMAPE 275
           H   SA ++H DLKPSN+LL+      + DFG+A+    + D +   T+ +AT  Y APE
Sbjct: 139 H---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 195
Query: 276 YGREGRVSTNG-DVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPI 325
                +  T   D++S G +L E+ +  +P   IF G+  L + +N +L I
Sbjct: 196 IMLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQ-LNHILGI 241

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 111/231 (48%), Gaps = 34/231 (14%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDP-QYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
           IG+G +G V  A    + + VA+K   P +++   +    E  ++ R  H N+I I    
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 94
Query: 169 SNDDFKALVLE-----YMPHGSLEKCLY-------LSNYILDIFQRLDIMIDVASALEYL 216
            ND  +A  +E     Y+    +E  LY       LSN  +  F     +  +   L+Y+
Sbjct: 95  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF-----LYQILRGLKYI 148
Query: 217 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LEEDQSLTQTQTLATIGYMAPE 275
           H   SA ++H DLKPSN+LL+      + DFG+A+    + D +   T+ +AT  Y APE
Sbjct: 149 H---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 205
Query: 276 YGREGRVSTNG-DVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPI 325
                +  T   D++S G +L E+ +  +P   IF G+  L + +N +L I
Sbjct: 206 IMLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQ-LNHILGI 251

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 111/231 (48%), Gaps = 34/231 (14%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDP-QYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
           IG+G +G V  A    + + VA+K   P +++   +    E  ++ R  H N+I I    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 86
Query: 169 SNDDFKALVLE-----YMPHGSLEKCLY-------LSNYILDIFQRLDIMIDVASALEYL 216
            ND  +A  +E     Y+    +E  LY       LSN  +  F     +  +   L+Y+
Sbjct: 87  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF-----LYQILRGLKYI 140
Query: 217 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LEEDQSLTQTQTLATIGYMAPE 275
           H   SA ++H DLKPSN+LL+      + DFG+A+    + D +   T+ +AT  Y APE
Sbjct: 141 H---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 197
Query: 276 YGREGRVSTNG-DVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPI 325
                +  T   D++S G +L E+ +  +P   IF G+  L + +N +L I
Sbjct: 198 IMLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQ-LNHILGI 243

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 111/231 (48%), Gaps = 34/231 (14%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDP-QYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
           IG+G +G V  A    + + VA+K   P +++   +    E  ++ R  H N+I I    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 84
Query: 169 SNDDFKALVLE-----YMPHGSLEKCLY-------LSNYILDIFQRLDIMIDVASALEYL 216
            ND  +A  +E     Y+    +E  LY       LSN  +  F     +  +   L+Y+
Sbjct: 85  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF-----LYQILRGLKYI 138
Query: 217 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LEEDQSLTQTQTLATIGYMAPE 275
           H   SA ++H DLKPSN+LL+      + DFG+A+    + D +   T+ +AT  Y APE
Sbjct: 139 H---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 195
Query: 276 YGREGRVSTNG-DVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPI 325
                +  T   D++S G +L E+ +  +P   IF G+  L + +N +L I
Sbjct: 196 IMLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQ-LNHILGI 241

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 28/208 (13%)
Query: 106 NMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRICHRNL 161
           N+ P +G G +GSV  A   + G+ VAVK     ++    A +++  E  ++K + H N+
Sbjct: 37  NLSP-VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENV 94
Query: 162 IKIISSYS--------NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASAL 213
           I ++  ++        ND +    L      ++ KC  L++   D  Q L  +  +   L
Sbjct: 95  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQILRGL 149
Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
           +Y+H   SA IIH DLKPSN+ ++++    + DFG+A+   +E      T  +AT  Y A
Sbjct: 150 KYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRWYRA 201
Query: 274 PEYGREG-RVSTNGDVYSFGIMLMEIFT 300
           PE        +   D++S G ++ E+ T
Sbjct: 202 PEIMLNWMHYNQTVDIWSVGCIMAELLT 229

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 111/231 (48%), Gaps = 34/231 (14%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDP-QYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
           IG+G +G V  A    + + VA+K   P +++   +    E  ++ R  H N+I I    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 106
Query: 169 SNDDFKALVLE-----YMPHGSLEKCLY-------LSNYILDIFQRLDIMIDVASALEYL 216
            ND  +A  +E     Y+    +E  LY       LSN  +  F     +  +   L+Y+
Sbjct: 107 -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF-----LYQILRGLKYI 160
Query: 217 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LEEDQSLTQTQTLATIGYMAPE 275
           H   SA ++H DLKPSN+LL+      + DFG+A+    + D +   T+ +AT  Y APE
Sbjct: 161 H---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 217
Query: 276 YGREGRVSTNG-DVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPI 325
                +  T   D++S G +L E+ +  +P   IF G+  L + +N +L I
Sbjct: 218 IMLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQ-LNHILGI 263

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 93/212 (43%), Gaps = 26/212 (12%)
Query: 110 LIGKGGFGSVYKAIIQDGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISS 167
           LIGKG FG VY        EVA+++ D +   E   K+F  E    ++  H N++  + +
Sbjct: 40  LIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97
Query: 168 YSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHC 227
             +    A++       +L   +  +  +LD+ +   I  ++   + YLH   +  I+H 
Sbjct: 98  CMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHK 154
Query: 228 DLKPSNVLLDDNMVAHLSDFGM------AKPLLEEDQSLTQTQTLATIGYMAPEYGREGR 281
           DLK  NV  D+  V  ++DFG+       +    ED+   Q   L    ++APE  R+  
Sbjct: 155 DLKSKNVFYDNGKVV-ITDFGLFSISGVLQAGRREDKLRIQNGWLC---HLAPEIIRQLS 210
Query: 282 ---------VSTNGDVYSFGIMLMEIFTRTKP 304
                     S + DV++ G +  E+  R  P
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 28/208 (13%)
Query: 106 NMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRICHRNL 161
           N+ P +G G +GSV  A   + G+ VAVK     ++    A +++  E  ++K + H N+
Sbjct: 38  NLSP-VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYR-ELRLLKHMKHENV 95
Query: 162 IKIISSYS--------NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASAL 213
           I ++  ++        ND +    L      ++ KC  L++   D  Q L  +  +   L
Sbjct: 96  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQILRGL 150
Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
           +Y+H   SA IIH DLKPSN+ ++++    + DFG+A+   +E      T  +AT  Y A
Sbjct: 151 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRA 202
Query: 274 PEYGREG-RVSTNGDVYSFGIMLMEIFT 300
           PE        +   D++S G ++ E+ T
Sbjct: 203 PEIMLNWMHYNQTVDIWSVGCIMAELLT 230

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 28/208 (13%)
Query: 106 NMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRICHRNL 161
           N+ P +G G +GSV  A   + G+ VAVK     ++    A +++  E  ++K + H N+
Sbjct: 26  NLSP-VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENV 83
Query: 162 IKIISSYS--------NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASAL 213
           I ++  ++        ND +    L      ++ KC  L++   D  Q L  +  +   L
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQILRGL 138
Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
           +Y+H   SA IIH DLKPSN+ ++++    + DFG+A+   +E      T  +AT  Y A
Sbjct: 139 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRA 190
Query: 274 PEYGREG-RVSTNGDVYSFGIMLMEIFT 300
           PE        +   D++S G ++ E+ T
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 28/208 (13%)
Query: 106 NMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRICHRNL 161
           N+ P +G G +GSV  A   + G+ VAVK     ++    A +++  E  ++K + H N+
Sbjct: 26  NLSP-VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENV 83
Query: 162 IKIISSYS--------NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASAL 213
           I ++  ++        ND +    L      ++ KC  L++   D  Q L  +  +   L
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQILRGL 138
Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
           +Y+H   SA IIH DLKPSN+ ++++    + DFG+A+   +E      T  +AT  Y A
Sbjct: 139 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRA 190
Query: 274 PEYGREG-RVSTNGDVYSFGIMLMEIFT 300
           PE        +   D++S G ++ E+ T
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 28/208 (13%)
Query: 106 NMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRICHRNL 161
           N+ P +G G +GSV  A   + G+ VAVK     ++    A +++  E  ++K + H N+
Sbjct: 26  NLSP-VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENV 83
Query: 162 IKIISSYS--------NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASAL 213
           I ++  ++        ND +    L      ++ KC  L++   D  Q L  +  +   L
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQILRGL 138
Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
           +Y+H   SA IIH DLKPSN+ ++++    + DFG+A+   +E      T  +AT  Y A
Sbjct: 139 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRA 190
Query: 274 PEYGREG-RVSTNGDVYSFGIMLMEIFT 300
           PE        +   D++S G ++ E+ T
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 28/208 (13%)
Query: 106 NMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRICHRNL 161
           N+ P +G G +GSV  A   + G+ VAVK     ++    A +++  E  ++K + H N+
Sbjct: 26  NLSP-VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENV 83
Query: 162 IKIISSYS--------NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASAL 213
           I ++  ++        ND +    L      ++ KC  L++   D  Q L  +  +   L
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQILRGL 138
Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
           +Y+H   SA IIH DLKPSN+ ++++    + DFG+A+   +E      T  +AT  Y A
Sbjct: 139 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRA 190
Query: 274 PEYGREG-RVSTNGDVYSFGIMLMEIFT 300
           PE        +   D++S G ++ E+ T
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 28/208 (13%)
Query: 106 NMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRICHRNL 161
           N+ P +G G +GSV  A   + G+ VAVK     ++    A +++  E  ++K + H N+
Sbjct: 33  NLSP-VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENV 90
Query: 162 IKIISSYS--------NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASAL 213
           I ++  ++        ND +    L      ++ KC  L++   D  Q L  +  +   L
Sbjct: 91  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQILRGL 145
Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
           +Y+H   SA IIH DLKPSN+ ++++    + DFG+A+   +E      T  +AT  Y A
Sbjct: 146 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRA 197
Query: 274 PEYGREG-RVSTNGDVYSFGIMLMEIFT 300
           PE        +   D++S G ++ E+ T
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLT 225

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 28/208 (13%)
Query: 106 NMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRICHRNL 161
           N+ P +G G +GSV  A   + G+ VAVK     ++    A +++  E  ++K + H N+
Sbjct: 23  NLSP-VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENV 80
Query: 162 IKIISSYS--------NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASAL 213
           I ++  ++        ND +    L      ++ KC  L++   D  Q L  +  +   L
Sbjct: 81  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQILRGL 135
Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
           +Y+H   SA IIH DLKPSN+ ++++    + DFG+A+   +E      T  +AT  Y A
Sbjct: 136 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRA 187
Query: 274 PEYGREG-RVSTNGDVYSFGIMLMEIFT 300
           PE        +   D++S G ++ E+ T
Sbjct: 188 PEIMLNWMHYNQTVDIWSVGCIMAELLT 215

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 28/208 (13%)
Query: 106 NMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRICHRNL 161
           N+ P +G G +GSV  A   + G+ VAVK     ++    A +++  E  ++K + H N+
Sbjct: 24  NLSP-VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENV 81
Query: 162 IKIISSYS--------NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASAL 213
           I ++  ++        ND +    L      ++ KC  L++   D  Q L  +  +   L
Sbjct: 82  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQILRGL 136
Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
           +Y+H   SA IIH DLKPSN+ ++++    + DFG+A+   +E      T  +AT  Y A
Sbjct: 137 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRA 188
Query: 274 PEYGREG-RVSTNGDVYSFGIMLMEIFT 300
           PE        +   D++S G ++ E+ T
Sbjct: 189 PEIMLNWMHYNQTVDIWSVGCIMAELLT 216

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 28/208 (13%)
Query: 106 NMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRICHRNL 161
           N+ P +G G +GSV  A   + G+ VAVK     ++    A +++  E  ++K + H N+
Sbjct: 22  NLSP-VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENV 79
Query: 162 IKIISSYS--------NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASAL 213
           I ++  ++        ND +    L      ++ KC  L++   D  Q L  +  +   L
Sbjct: 80  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQILRGL 134
Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
           +Y+H   SA IIH DLKPSN+ ++++    + DFG+A+   +E      T  +AT  Y A
Sbjct: 135 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRA 186
Query: 274 PEYGREG-RVSTNGDVYSFGIMLMEIFT 300
           PE        +   D++S G ++ E+ T
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLT 214

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 28/208 (13%)
Query: 106 NMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRICHRNL 161
           N+ P +G G +GSV  A   + G+ VAVK     ++    A +++  E  ++K + H N+
Sbjct: 26  NLSP-VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENV 83
Query: 162 IKIISSYS--------NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASAL 213
           I ++  ++        ND +    L      ++ KC  L++   D  Q L  +  +   L
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQILRGL 138
Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
           +Y+H   SA IIH DLKPSN+ ++++    + DFG+A+   +E      T  +AT  Y A
Sbjct: 139 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRA 190
Query: 274 PEYGREG-RVSTNGDVYSFGIMLMEIFT 300
           PE        +   D++S G ++ E+ T
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 28/208 (13%)
Query: 106 NMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRICHRNL 161
           N+ P +G G +GSV  A   + G+ VAVK     ++    A +++  E  ++K + H N+
Sbjct: 37  NLSP-VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENV 94
Query: 162 IKIISSYS--------NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASAL 213
           I ++  ++        ND +    L      ++ KC  L++   D  Q L  +  +   L
Sbjct: 95  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQILRGL 149
Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
           +Y+H   SA IIH DLKPSN+ ++++    + DFG+A+   +E      T  +AT  Y A
Sbjct: 150 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRA 201
Query: 274 PEYGREG-RVSTNGDVYSFGIMLMEIFT 300
           PE        +   D++S G ++ E+ T
Sbjct: 202 PEIMLNWMHYNQTVDIWSVGCIMAELLT 229

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 28/208 (13%)
Query: 106 NMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRICHRNL 161
           N+ P +G G +GSV  A   + G+ VAVK     ++    A +++  E  ++K + H N+
Sbjct: 23  NLSP-VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENV 80
Query: 162 IKIISSYS--------NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASAL 213
           I ++  ++        ND +    L      ++ KC  L++   D  Q L  +  +   L
Sbjct: 81  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQILRGL 135
Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
           +Y+H   SA IIH DLKPSN+ ++++    + DFG+A+   +E      T  +AT  Y A
Sbjct: 136 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRA 187
Query: 274 PEYGREG-RVSTNGDVYSFGIMLMEIFT 300
           PE        +   D++S G ++ E+ T
Sbjct: 188 PEIMLNWMHYNQTVDIWSVGCIMAELLT 215

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 28/208 (13%)
Query: 106 NMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRICHRNL 161
           N+ P +G G +GSV  A   + G+ VAVK     ++    A +++  E  ++K + H N+
Sbjct: 32  NLSP-VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENV 89
Query: 162 IKIISSYS--------NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASAL 213
           I ++  ++        ND +    L      ++ KC  L++   D  Q L  +  +   L
Sbjct: 90  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQILRGL 144
Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
           +Y+H   SA IIH DLKPSN+ ++++    + DFG+A+   +E      T  +AT  Y A
Sbjct: 145 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRA 196
Query: 274 PEYGREG-RVSTNGDVYSFGIMLMEIFT 300
           PE        +   D++S G ++ E+ T
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLT 224

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 28/208 (13%)
Query: 106 NMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRICHRNL 161
           N+ P +G G +GSV  A   + G+ VAVK     ++    A +++  E  ++K + H N+
Sbjct: 45  NLSP-VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENV 102
Query: 162 IKIISSYS--------NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASAL 213
           I ++  ++        ND +    L      ++ KC  L++   D  Q L  +  +   L
Sbjct: 103 IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQILRGL 157
Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
           +Y+H   SA IIH DLKPSN+ ++++    + DFG+A+   +E      T  +AT  Y A
Sbjct: 158 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRA 209
Query: 274 PEYGREG-RVSTNGDVYSFGIMLMEIFT 300
           PE        +   D++S G ++ E+ T
Sbjct: 210 PEIMLNWMHYNQTVDIWSVGCIMAELLT 237

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 28/208 (13%)
Query: 106 NMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRICHRNL 161
           N+ P +G G +GSV  A   + G+ VAVK     ++    A +++  E  ++K + H N+
Sbjct: 28  NLSP-VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENV 85
Query: 162 IKIISSYS--------NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASAL 213
           I ++  ++        ND +    L      ++ KC  L++   D  Q L  +  +   L
Sbjct: 86  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQILRGL 140
Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
           +Y+H   SA IIH DLKPSN+ ++++    + DFG+A+   +E      T  +AT  Y A
Sbjct: 141 KYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDE-----MTGYVATRWYRA 192
Query: 274 PEYGREG-RVSTNGDVYSFGIMLMEIFT 300
           PE        +   D++S G ++ E+ T
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLT 220

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 28/208 (13%)
Query: 106 NMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRICHRNL 161
           N+ P +G G +GSV  A   + G+ VAVK     ++    A +++  E  ++K + H N+
Sbjct: 28  NLSP-VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENV 85
Query: 162 IKIISSYS--------NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASAL 213
           I ++  ++        ND +    L      ++ KC  L++   D  Q L  +  +   L
Sbjct: 86  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQILRGL 140
Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
           +Y+H   SA IIH DLKPSN+ ++++    + DFG+A+   +E      T  +AT  Y A
Sbjct: 141 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRA 192
Query: 274 PEYGREG-RVSTNGDVYSFGIMLMEIFT 300
           PE        +   D++S G ++ E+ T
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLT 220

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 28/208 (13%)
Query: 106 NMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRICHRNL 161
           N+ P +G G +GSV  A   + G+ VAVK     ++    A +++  E  ++K + H N+
Sbjct: 26  NLSP-VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENV 83
Query: 162 IKIISSYS--------NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASAL 213
           I ++  ++        ND +    L      ++ KC  L++   D  Q L  +  +   L
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQILRGL 138
Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
           +Y+H   SA IIH DLKPSN+ ++++    + DFG+A+   +E      T  +AT  Y A
Sbjct: 139 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRA 190
Query: 274 PEYGREG-RVSTNGDVYSFGIMLMEIFT 300
           PE        +   D++S G ++ E+ T
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 28/208 (13%)
Query: 106 NMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRICHRNL 161
           N+ P +G G +GSV  A   + G+ VAVK     ++    A +++  E  ++K + H N+
Sbjct: 26  NLSP-VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENV 83
Query: 162 IKIISSYS--------NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASAL 213
           I ++  ++        ND +    L      ++ KC  L++   D  Q L  +  +   L
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQILRGL 138
Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
           +Y+H   SA IIH DLKPSN+ ++++    + DFG+A+   +E      T  +AT  Y A
Sbjct: 139 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRA 190
Query: 274 PEYGREG-RVSTNGDVYSFGIMLMEIFT 300
           PE        +   D++S G ++ E+ T
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 28/208 (13%)
Query: 106 NMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRICHRNL 161
           N+ P +G G +GSV  A   + G+ VAVK     ++    A +++  E  ++K + H N+
Sbjct: 46  NLSP-VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENV 103
Query: 162 IKIISSYS--------NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASAL 213
           I ++  ++        ND +    L      ++ KC  L++   D  Q L  +  +   L
Sbjct: 104 IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQILRGL 158
Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
           +Y+H   SA IIH DLKPSN+ ++++    + DFG+A+   +E      T  +AT  Y A
Sbjct: 159 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRA 210
Query: 274 PEYGREG-RVSTNGDVYSFGIMLMEIFT 300
           PE        +   D++S G ++ E+ T
Sbjct: 211 PEIMLNWMHYNQTVDIWSVGCIMAELLT 238

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 28/208 (13%)
Query: 106 NMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRICHRNL 161
           N+ P +G G +GSV  A   + G+ VAVK     ++    A +++  E  ++K + H N+
Sbjct: 31  NLSP-VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENV 88
Query: 162 IKIISSYS--------NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASAL 213
           I ++  ++        ND +    L      ++ KC  L++   D  Q L  +  +   L
Sbjct: 89  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQILRGL 143
Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
           +Y+H   SA IIH DLKPSN+ ++++    + DFG+A+   +E      T  +AT  Y A
Sbjct: 144 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRA 195
Query: 274 PEYGREG-RVSTNGDVYSFGIMLMEIFT 300
           PE        +   D++S G ++ E+ T
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLT 223

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 28/208 (13%)
Query: 106 NMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRICHRNL 161
           N+ P +G G +GSV  A   + G+ VAVK     ++    A +++  E  ++K + H N+
Sbjct: 25  NLSP-VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENV 82
Query: 162 IKIISSYS--------NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASAL 213
           I ++  ++        ND +    L      ++ KC  L++   D  Q L  +  +   L
Sbjct: 83  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQILRGL 137
Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
           +Y+H   SA IIH DLKPSN+ ++++    + DFG+A+   +E      T  +AT  Y A
Sbjct: 138 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRA 189
Query: 274 PEYGREG-RVSTNGDVYSFGIMLMEIFT 300
           PE        +   D++S G ++ E+ T
Sbjct: 190 PEIMLNWMHYNQTVDIWSVGCIMAELLT 217

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 28/208 (13%)
Query: 106 NMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRICHRNL 161
           N+ P +G G +GSV  A   + G+ VAVK     ++    A +++  E  ++K + H N+
Sbjct: 31  NLSP-VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENV 88
Query: 162 IKIISSYS--------NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASAL 213
           I ++  ++        ND +    L      ++ KC  L++   D  Q L  +  +   L
Sbjct: 89  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQILRGL 143
Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
           +Y+H   SA IIH DLKPSN+ ++++    + DFG+A+   +E      T  +AT  Y A
Sbjct: 144 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRA 195
Query: 274 PEYGREG-RVSTNGDVYSFGIMLMEIFT 300
           PE        +   D++S G ++ E+ T
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLT 223

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 28/208 (13%)
Query: 106 NMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRICHRNL 161
           N+ P +G G +GSV  A   + G+ VAVK     ++    A +++  E  ++K + H N+
Sbjct: 38  NLSP-VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENV 95
Query: 162 IKIISSYS--------NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASAL 213
           I ++  ++        ND +    L      ++ KC  L++   D  Q L  +  +   L
Sbjct: 96  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQILRGL 150
Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
           +Y+H   SA IIH DLKPSN+ ++++    + DFG+A+   +E      T  +AT  Y A
Sbjct: 151 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRA 202
Query: 274 PEYGREG-RVSTNGDVYSFGIMLMEIFT 300
           PE        +   D++S G ++ E+ T
Sbjct: 203 PEIMLNWMHYNQTVDIWSVGCIMAELLT 230

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 28/208 (13%)
Query: 106 NMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRICHRNL 161
           N+ P +G G +GSV  A   + G+ VAVK     ++    A +++  E  ++K + H N+
Sbjct: 38  NLSP-VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENV 95
Query: 162 IKIISSYS--------NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASAL 213
           I ++  ++        ND +    L      ++ KC  L++   D  Q L  +  +   L
Sbjct: 96  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQILRGL 150
Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
           +Y+H   SA IIH DLKPSN+ ++++    + DFG+A+   +E      T  +AT  Y A
Sbjct: 151 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRA 202
Query: 274 PEYGREG-RVSTNGDVYSFGIMLMEIFT 300
           PE        +   D++S G ++ E+ T
Sbjct: 203 PEIMLNWMHYNQTVDIWSVGCIMAELLT 230

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 28/208 (13%)
Query: 106 NMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRICHRNL 161
           N+ P +G G +GSV  A   + G+ VAVK     ++    A +++  E  ++K + H N+
Sbjct: 49  NLSP-VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENV 106
Query: 162 IKIISSYS--------NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASAL 213
           I ++  ++        ND +    L      ++ KC  L++   D  Q L  +  +   L
Sbjct: 107 IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQILRGL 161
Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
           +Y+H   SA IIH DLKPSN+ ++++    + DFG+A+   +E      T  +AT  Y A
Sbjct: 162 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRA 213
Query: 274 PEYGREG-RVSTNGDVYSFGIMLMEIFT 300
           PE        +   D++S G ++ E+ T
Sbjct: 214 PEIMLNWMHYNQTVDIWSVGCIMAELLT 241

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 28/208 (13%)
Query: 106 NMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRICHRNL 161
           N+ P +G G +GSV  A   + G+ VAVK     ++    A +++  E  ++K + H N+
Sbjct: 32  NLSP-VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENV 89
Query: 162 IKIISSYS--------NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASAL 213
           I ++  ++        ND +    L      ++ KC  L++   D  Q L  +  +   L
Sbjct: 90  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQILRGL 144
Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
           +Y+H   SA IIH DLKPSN+ ++++    + DFG+A+   +E      T  +AT  Y A
Sbjct: 145 KYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDE-----MTGYVATRWYRA 196
Query: 274 PEYGREG-RVSTNGDVYSFGIMLMEIFT 300
           PE        +   D++S G ++ E+ T
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLT 224

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 28/208 (13%)
Query: 106 NMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRICHRNL 161
           N+ P +G G +GSV  A   + G+ VAVK     ++    A +++  E  ++K + H N+
Sbjct: 28  NLSP-VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENV 85
Query: 162 IKIISSYS--------NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASAL 213
           I ++  ++        ND +    L      ++ KC  L++   D  Q L  +  +   L
Sbjct: 86  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQILRGL 140
Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
           +Y+H   SA IIH DLKPSN+ ++++    + DFG+A+   +E      T  +AT  Y A
Sbjct: 141 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRA 192
Query: 274 PEYGREG-RVSTNGDVYSFGIMLMEIFT 300
           PE        +   D++S G ++ E+ T
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLT 220

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 111/231 (48%), Gaps = 34/231 (14%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDP-QYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
           IG+G +G V  A    + + VA++   P +++   +    E  ++ R  H N+I I    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 90
Query: 169 SNDDFKALVLE-----YMPHGSLEKCLY-------LSNYILDIFQRLDIMIDVASALEYL 216
            ND  +A  +E     Y+    +E  LY       LSN  +  F     +  +   L+Y+
Sbjct: 91  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF-----LYQILRGLKYI 144
Query: 217 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LEEDQSLTQTQTLATIGYMAPE 275
           H   SA ++H DLKPSN+LL+      + DFG+A+    + D +   T+ +AT  Y APE
Sbjct: 145 H---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201
Query: 276 YGREGRVSTNG-DVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPI 325
                +  T   D++S G +L E+ +  +P   IF G+  L + +N +L I
Sbjct: 202 IMLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQ-LNHILGI 247

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 28/208 (13%)
Query: 106 NMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRICHRNL 161
           N+ P +G G +GSV  A   + G+ VAVK     ++    A +++  E  ++K + H N+
Sbjct: 28  NLSP-VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENV 85
Query: 162 IKIISSYS--------NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASAL 213
           I ++  ++        ND +    L      ++ KC  L++   D  Q L  +  +   L
Sbjct: 86  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQILRGL 140
Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
           +Y+H   SA IIH DLKPSN+ ++++    + DFG+A+   +E      T  +AT  Y A
Sbjct: 141 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRA 192
Query: 274 PEYGREG-RVSTNGDVYSFGIMLMEIFT 300
           PE        +   D++S G ++ E+ T
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLT 220

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 91/198 (45%), Gaps = 9/198 (4%)
Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
           ++G G FG V+K      G+++A K+   +     +    E  VM ++ H NLI++  ++
Sbjct: 96  ILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAF 155
Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCD 228
            + +   LV+EY+  G L   +   +Y L     +  M  +   + ++H  Y   I+H D
Sbjct: 156 ESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY---ILHLD 212
Query: 229 LKPSNVLLDDNMVAHLS--DFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNG 286
           LKP N+L  +     +   DFG+A+     ++         T  ++APE      VS   
Sbjct: 213 LKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV---NFGTPEFLAPEVVNYDFVSFPT 269
Query: 287 DVYSFGIMLMEIFTRTKP 304
           D++S G++   + +   P
Sbjct: 270 DMWSVGVIAYMLLSGLSP 287

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 28/208 (13%)
Query: 106 NMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRICHRNL 161
           N+ P +G G +GSV  A   + G+ VAVK     ++    A +++  E  ++K + H N+
Sbjct: 32  NLSP-VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENV 89
Query: 162 IKIISSYS--------NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASAL 213
           I ++  ++        ND +    L      ++ KC  L++   D  Q L  +  +   L
Sbjct: 90  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQILRGL 144
Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
           +Y+H   SA IIH DLKPSN+ ++++    + DFG+A+   +E      T  +AT  Y A
Sbjct: 145 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRA 196
Query: 274 PEYGREG-RVSTNGDVYSFGIMLMEIFT 300
           PE        +   D++S G ++ E+ T
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLT 224

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 20/206 (9%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDI------ECDVMKRICHRNLIK 163
           +G G FG V     +  G +VAVK+ + Q     +S D+      E   +K   H ++IK
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQ---KIRSLDVVGKIRREIQNLKLFRHPHIIK 80
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
           +    S      +V+EY+  G L   +   N  LD  +   +   + S ++Y H      
Sbjct: 81  LYQVISTPSDIFMVMEYVSGGELFDYI-CKNGRLDEKESRRLFQQILSGVDYCH---RHM 136
Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVS 283
           ++H DLKP NVLLD +M A ++DFG++  ++ + + L    +  +  Y APE    GR+ 
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLSN-MMSDGEFL--RXSCGSPNYAAPEVI-SGRLY 192
Query: 284 TNG--DVYSFGIMLMEIFTRTKPTDE 307
                D++S G++L  +   T P D+
Sbjct: 193 AGPEVDIWSSGVILYALLCGTLPFDD 218

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 94/195 (48%), Gaps = 8/195 (4%)
Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYS 169
           IG+G  G V  A     G +VAVK+ D + +   +    E  +M+   H N++++  SY 
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 170 NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
             +   +++E++  G+L     +S   L+  Q   +   V  AL YLH   +  +IH D+
Sbjct: 113 VGEELWVLMEFLQGGALTDI--VSQVRLNEEQIATVCEAVLQALAYLH---AQGVIHRDI 167
Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 289
           K  ++LL  +    LSDFG    + ++     +   + T  +MAPE       +T  D++
Sbjct: 168 KSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKXLVGTPYWMAPEVISRSLYATEVDIW 225
Query: 290 SFGIMLMEIFTRTKP 304
           S GIM++E+     P
Sbjct: 226 SLGIMVIEMVDGEPP 240

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 92/196 (46%), Gaps = 11/196 (5%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKV--FDPQYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
           IG+G +G VYKA    G   A+K    + + EG   +   E  ++K + H N++K+    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCD 228
                  LV E++    L+K L +    L+       ++ + + + Y H      ++H D
Sbjct: 70  HTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRD 125
Query: 229 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEY--GREGRVSTNG 286
           LKP N+L++      ++DFG+A+      +    T  + T+ Y AP+   G + + ST  
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRKY--THEIVTLWYRAPDVLMGSK-KYSTTI 182
Query: 287 DVYSFGIMLMEIFTRT 302
           D++S G +  E+   T
Sbjct: 183 DIWSVGCIFAEMVNGT 198

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 93/216 (43%), Gaps = 19/216 (8%)
Query: 99  KPLPNDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQY--EGAFKSFDIECDVMKR 155
           +P   +  +   IGKG F  V  A  I  G EVA+K+ D       + +    E  +MK 
Sbjct: 8   QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKI 67
Query: 156 ICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEY 215
           + H N++K+      +    L++EY   G +   L     + +   R      + SA++Y
Sbjct: 68  LNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR-QIVSAVQY 126
Query: 216 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG----Y 271
            H      I+H DLK  N+LLD +M   ++DFG +          T    L T      Y
Sbjct: 127 CH---QKRIVHRDLKAENLLLDADMNIKIADFGFS-------NEFTVGGKLDTFCGSPPY 176
Query: 272 MAPEYGREGRV-STNGDVYSFGIMLMEIFTRTKPTD 306
            APE  +  +      DV+S G++L  + + + P D
Sbjct: 177 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 212

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 102/228 (44%), Gaps = 24/228 (10%)
Query: 110 LIGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDIECDVM-KRIC-----HRNLI 162
           ++GKG FG V  A +++ G   AVKV   + +   +  D+EC +  KRI      H  L 
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVL--KKDVILQDDDVECTMTEKRILSLARNHPFLT 87
Query: 163 KIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSA 222
           ++   +   D    V+E++  G L   +  S    +   R     ++ SAL +LH     
Sbjct: 88  QLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAAEIISALMFLH---DK 143
Query: 223 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRV 282
            II+ DLK  NVLLD      L+DFGM K  +     +T      T  Y+APE  +E   
Sbjct: 144 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI--CNGVTTATFCGTPDYIAPEILQEMLY 201
Query: 283 STNGDVYSFGIMLMEIFTRTKP-----TDEIFSG----EMTLKRWVND 321
               D ++ G++L E+     P      D++F      E+    W+++
Sbjct: 202 GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHE 249

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 93/195 (47%), Gaps = 9/195 (4%)
Query: 111 IGKGGFGSVYKAIIQ---DGMEVAVKVFDPQYEGA-FKSFDIECDVMKRICHRNLIKIIS 166
           +G G FGSV + + +     ++VA+KV     E A  +    E  +M ++ +  ++++I 
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIH 226
               +    LV+E    G L K L      + +    +++  V+  ++YL        +H
Sbjct: 78  VCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVH 133
Query: 227 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT-QTQTLATIGYMAPEYGREGRVSTN 285
            DL   NVLL +   A +SDFG++K L  +D   T ++     + + APE     + S+ 
Sbjct: 134 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR 193
Query: 286 GDVYSFGIMLMEIFT 300
            DV+S+G+ + E  +
Sbjct: 194 SDVWSYGVTMWEALS 208

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 92/196 (46%), Gaps = 11/196 (5%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKV--FDPQYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
           IG+G +G VYKA    G   A+K    + + EG   +   E  ++K + H N++K+    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCD 228
                  LV E++    L+K L +    L+       ++ + + + Y H      ++H D
Sbjct: 70  HTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRD 125
Query: 229 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEY--GREGRVSTNG 286
           LKP N+L++      ++DFG+A+      +    T  + T+ Y AP+   G + + ST  
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRKY--THEVVTLWYRAPDVLMGSK-KYSTTI 182
Query: 287 DVYSFGIMLMEIFTRT 302
           D++S G +  E+   T
Sbjct: 183 DIWSVGCIFAEMVNGT 198

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 97/197 (49%), Gaps = 11/197 (5%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDI-ECDVMKRICHRNLIKIISSY 168
           +G G  G V+K   +  G+ +A K+   + + A ++  I E  V+       ++    ++
Sbjct: 17  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 76
Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNYILD-IFQRLDIMIDVASALEYLHFGYSAPIIHC 227
            +D   ++ +E+M  GSL++ L  +  I + I  ++ I   V   L YL   +   I+H 
Sbjct: 77  YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREKHK--IMHR 132
Query: 228 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGD 287
           D+KPSN+L++      L DFG++  L++E       + + T  YM+PE  +    S   D
Sbjct: 133 DVKPSNILVNSRGEIKLCDFGVSGQLIDE----MANEFVGTRSYMSPERLQGTHYSVQSD 188
Query: 288 VYSFGIMLMEIFTRTKP 304
           ++S G+ L+E+     P
Sbjct: 189 IWSMGLSLVEMAVGRYP 205

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 89/191 (46%), Gaps = 12/191 (6%)
Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGA--FKSFDIECDVMKRICHRNLIKIISS 167
           +GKG F  V + + I  G E A K+ + +   A   +  + E  + + + H N++++  S
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 168 YSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHC 227
            S + F  LV + +  G L + +    Y    +   D    +   LE ++  +   I+H 
Sbjct: 72  ISEEGFHYLVFDLVTGGELFEDIVAREY----YSEADASHCIQQILESVNHCHLNGIVHR 127
Query: 228 DLKPSNVLL---DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVST 284
           DLKP N+LL          L+DFG+A  +  + Q+        T GY++PE  R+     
Sbjct: 128 DLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFA--GTPGYLSPEVLRKDPYGK 185
Query: 285 NGDVYSFGIML 295
             D+++ G++L
Sbjct: 186 PVDMWACGVIL 196

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 96/213 (45%), Gaps = 34/213 (15%)
Query: 110 LIGKGGFGSVYKAIIQDGMEVAVKVF------------DPQYEGAFKSFDIECDVMKRIC 157
           ++G+GGFG V+       M+   K++               Y+GA     +E  ++ ++ 
Sbjct: 192 VLGRGGFGEVFAC----QMKATGKLYACKKLNKKRLKKRKGYQGAM----VEKKILAKVH 243
Query: 158 HRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMI---DVASALE 214
            R ++ +  ++       LV+  M  G +   +Y  +     FQ    +     + S LE
Sbjct: 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 215 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA-TIGYMA 273
           +LH      II+ DLKP NVLLDD+    +SD G+A   +E     T+T+  A T G+MA
Sbjct: 304 HLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLA---VELKAGQTKTKGYAGTPGFMA 357
Query: 274 PE--YGREGRVSTNGDVYSFGIMLMEIFTRTKP 304
           PE   G E   S   D ++ G+ L E+     P
Sbjct: 358 PELLLGEEYDFSV--DYFALGVTLYEMIAARGP 388

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 21/212 (9%)
Query: 93  RYQKRGKPLPNDANMPPLIGKGGFGSVYKAIIQD-GMEVAVKVF-DPQYEGAFKSFDI-E 149
           +Y+K GK           IG+G +G V+K   +D G  VA+K F + + +   K   + E
Sbjct: 4   KYEKIGK-----------IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALRE 52
Query: 150 CDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDV 209
             ++K++ H NL+ ++  +       LV EY  H  L +   L  Y   + + L   I  
Sbjct: 53  IRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHE---LDRYQRGVPEHLVKSI-T 108
Query: 210 ASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATI 269
              L+ ++F +    IH D+KP N+L+  + V  L DFG A+  L    S      +AT 
Sbjct: 109 WQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFAR--LLTGPSDYYDDEVATR 166
Query: 270 GYMAPE-YGREGRVSTNGDVYSFGIMLMEIFT 300
            Y +PE    + +     DV++ G +  E+ +
Sbjct: 167 WYRSPELLVGDTQYGPPVDVWAIGCVFAELLS 198

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 96/213 (45%), Gaps = 34/213 (15%)
Query: 110 LIGKGGFGSVYKAIIQDGMEVAVKVF------------DPQYEGAFKSFDIECDVMKRIC 157
           ++G+GGFG V+       M+   K++               Y+GA     +E  ++ ++ 
Sbjct: 192 VLGRGGFGEVFAC----QMKATGKLYACKKLNKKRLKKRKGYQGAM----VEKKILAKVH 243
Query: 158 HRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMI---DVASALE 214
            R ++ +  ++       LV+  M  G +   +Y  +     FQ    +     + S LE
Sbjct: 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 215 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA-TIGYMA 273
           +LH      II+ DLKP NVLLDD+    +SD G+A   +E     T+T+  A T G+MA
Sbjct: 304 HLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLA---VELKAGQTKTKGYAGTPGFMA 357
Query: 274 PE--YGREGRVSTNGDVYSFGIMLMEIFTRTKP 304
           PE   G E   S   D ++ G+ L E+     P
Sbjct: 358 PELLLGEEYDFSV--DYFALGVTLYEMIAARGP 388

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 89/191 (46%), Gaps = 12/191 (6%)
Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGA--FKSFDIECDVMKRICHRNLIKIISS 167
           +GKG F  V + + I  G E A K+ + +   A   +  + E  + + + H N++++  S
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 168 YSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHC 227
            S + F  LV + +  G L + +    Y    +   D    +   LE ++  +   I+H 
Sbjct: 72  ISEEGFHYLVFDLVTGGELFEDIVAREY----YSEADASHCIQQILESVNHCHLNGIVHR 127
Query: 228 DLKPSNVLL---DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVST 284
           DLKP N+LL          L+DFG+A  +  + Q+        T GY++PE  R+     
Sbjct: 128 DLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFA--GTPGYLSPEVLRKDPYGK 185
Query: 285 NGDVYSFGIML 295
             D+++ G++L
Sbjct: 186 PVDMWACGVIL 196

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 96/213 (45%), Gaps = 34/213 (15%)
Query: 110 LIGKGGFGSVYKAIIQDGMEVAVKVF------------DPQYEGAFKSFDIECDVMKRIC 157
           ++G+GGFG V+       M+   K++               Y+GA     +E  ++ ++ 
Sbjct: 192 VLGRGGFGEVFAC----QMKATGKLYACKKLNKKRLKKRKGYQGAM----VEKKILAKVH 243
Query: 158 HRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMI---DVASALE 214
            R ++ +  ++       LV+  M  G +   +Y  +     FQ    +     + S LE
Sbjct: 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 215 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA-TIGYMA 273
           +LH      II+ DLKP NVLLDD+    +SD G+A   +E     T+T+  A T G+MA
Sbjct: 304 HLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLA---VELKAGQTKTKGYAGTPGFMA 357
Query: 274 PE--YGREGRVSTNGDVYSFGIMLMEIFTRTKP 304
           PE   G E   S   D ++ G+ L E+     P
Sbjct: 358 PELLLGEEYDFSV--DYFALGVTLYEMIAARGP 388

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 102/208 (49%), Gaps = 28/208 (13%)
Query: 106 NMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRICHRNL 161
           N+ P +G G +GSV  A   + G+ VAVK     ++    A +++  E  ++K + H N+
Sbjct: 26  NLSP-VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENV 83
Query: 162 IKIISSYS--------NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASAL 213
           I ++  ++        ND +    L      ++ KC  L++   D  Q L  +  +   L
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQILRGL 138
Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
           +Y+H   SA IIH DLKPSN+ ++++    + D+G+A+   +E      T  +AT  Y A
Sbjct: 139 KYIH---SADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDE-----MTGYVATRWYRA 190
Query: 274 PEYGREG-RVSTNGDVYSFGIMLMEIFT 300
           PE        +   D++S G ++ E+ T
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 101/208 (48%), Gaps = 28/208 (13%)
Query: 106 NMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRICHRNL 161
           N+ P +G G +GSV  A   + G  VAVK     ++    A +++  E  ++K + H N+
Sbjct: 22  NLSP-VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENV 79
Query: 162 IKIISSYS--------NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASAL 213
           I ++  ++        ND +    L      ++ KC  L++   D  Q L  +  +   L
Sbjct: 80  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTD---DHVQFL--IYQILRGL 134
Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
           +Y+H   SA IIH DLKPSN+ ++++    + DFG+A+   +E      T  +AT  Y A
Sbjct: 135 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRA 186
Query: 274 PEYGREG-RVSTNGDVYSFGIMLMEIFT 300
           PE        +   D++S G ++ E+ T
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLT 214

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 101/208 (48%), Gaps = 28/208 (13%)
Query: 106 NMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRICHRNL 161
           N+ P +G G +GSV  A   + G  VAVK     ++    A +++  E  ++K + H N+
Sbjct: 36  NLAP-VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENV 93
Query: 162 IKIISSYS--------NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASAL 213
           I ++  ++        ND +    L      ++ KC  L++   D  Q L  +  +   L
Sbjct: 94  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQILRGL 148
Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
           +Y+H   SA IIH DLKPSN+ ++++    + DFG+A+   +E      T  +AT  Y A
Sbjct: 149 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRA 200
Query: 274 PEYGREG-RVSTNGDVYSFGIMLMEIFT 300
           PE        +   D++S G ++ E+ T
Sbjct: 201 PEIMLNWMHYNQTVDIWSVGCIMAELLT 228

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 110/231 (47%), Gaps = 34/231 (14%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDP-QYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
           IG+G +G V  A    + + VA+K   P +++   +    E  ++ R  H N+I I    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 90
Query: 169 SNDDFKALVLE-----YMPHGSLEKCLY-------LSNYILDIFQRLDIMIDVASALEYL 216
            ND  +A  +E     Y+    +E  LY       LSN  +  F     +  +   L+Y+
Sbjct: 91  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF-----LYQILRGLKYI 144
Query: 217 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LEEDQSLTQTQTLATIGYMAPE 275
           H   SA ++H DLKPSN+LL+      + DFG+A+    + D +    + +AT  Y APE
Sbjct: 145 H---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPE 201
Query: 276 YGREGRVSTNG-DVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPI 325
                +  T   D++S G +L E+ +  +P   IF G+  L + +N +L I
Sbjct: 202 IMLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQ-LNHILGI 247

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 110/231 (47%), Gaps = 34/231 (14%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDP-QYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
           IG+G +G V  A    + + VA+K   P +++   +    E  ++ R  H N+I I    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 91
Query: 169 SNDDFKALVLE-----YMPHGSLEKCLY-------LSNYILDIFQRLDIMIDVASALEYL 216
            ND  +A  +E     Y+    +E  LY       LSN  +  F     +  +   L+Y+
Sbjct: 92  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF-----LYQILRGLKYI 145
Query: 217 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LEEDQSLTQTQTLATIGYMAPE 275
           H   SA ++H DLKPSN+LL+      + DFG+A+    + D +    + +AT  Y APE
Sbjct: 146 H---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPE 202
Query: 276 YGREGRVSTNG-DVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPI 325
                +  T   D++S G +L E+ +  +P   IF G+  L + +N +L I
Sbjct: 203 IMLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQ-LNHILGI 248

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 101/208 (48%), Gaps = 28/208 (13%)
Query: 106 NMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRICHRNL 161
           N+ P +G G +GSV  A   + G  VAVK     ++    A +++  E  ++K + H N+
Sbjct: 26  NLSP-VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENV 83
Query: 162 IKIISSYS--------NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASAL 213
           I ++  ++        ND +    L      ++ KC  L++   D  Q L  +  +   L
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQILRGL 138
Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
           +Y+H   SA IIH DLKPSN+ ++++    + DFG+A+   +E      T  +AT  Y A
Sbjct: 139 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRA 190
Query: 274 PEYGREG-RVSTNGDVYSFGIMLMEIFT 300
           PE        +   D++S G ++ E+ T
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 101/208 (48%), Gaps = 28/208 (13%)
Query: 106 NMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRICHRNL 161
           N+ P +G G +GSV  A   + G  VAVK     ++    A +++  E  ++K + H N+
Sbjct: 45  NLSP-VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENV 102
Query: 162 IKIISSYS--------NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASAL 213
           I ++  ++        ND +    L      ++ KC  L++   D  Q L  +  +   L
Sbjct: 103 IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQILRGL 157
Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
           +Y+H   SA IIH DLKPSN+ ++++    + DFG+A+   +E      T  +AT  Y A
Sbjct: 158 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRA 209
Query: 274 PEYGREG-RVSTNGDVYSFGIMLMEIFT 300
           PE        +   D++S G ++ E+ T
Sbjct: 210 PEIMLNWMHYNQTVDIWSVGCIMAELLT 237

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 96/211 (45%), Gaps = 18/211 (8%)
Query: 110 LIGKGGFGSVYKAIIQDG--------MEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNL 161
           ++GKGG+G V++     G        M+V  K    +          E ++++ + H  +
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 162 IKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYS 221
           + +I ++       L+LEY+  G L   L      ++       + +++ AL +LH    
Sbjct: 84  VDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACF-YLAEISMALGHLH---Q 139
Query: 222 APIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGR 281
             II+ DLKP N++L+      L+DFG+ K  +  D ++T      TI YMAPE      
Sbjct: 140 KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI-HDGTVTHX-FCGTIEYMAPEILMRSG 197
Query: 282 VSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE 312
            +   D +S G ++ ++ T   P    F+GE
Sbjct: 198 HNRAVDWWSLGALMYDMLTGAPP----FTGE 224

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 88/191 (46%), Gaps = 12/191 (6%)
Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGA--FKSFDIECDVMKRICHRNLIKIISS 167
           IGKG F  V + + +  G E A K+ + +   A   +  + E  + + + H N++++  S
Sbjct: 12  IGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDS 71
Query: 168 YSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHC 227
            S + F  LV + +  G L + +    Y    +   D    +   LE +   +   ++H 
Sbjct: 72  ISEEGFHYLVFDLVTGGELFEDIVAREY----YSEADASHCIQQILEAVLHCHQMGVVHR 127
Query: 228 DLKPSNVLLDDN---MVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVST 284
           DLKP N+LL          L+DFG+A  +  + Q+        T GY++PE  R+     
Sbjct: 128 DLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFA--GTPGYLSPEVLRKEAYGK 185
Query: 285 NGDVYSFGIML 295
             D+++ G++L
Sbjct: 186 PVDIWACGVIL 196

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 26/204 (12%)
Query: 111 IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDI-ECDVMKRICHRNLIKIISSY 168
           +G G + +VYK + +  G+ VA+K      E    S  I E  +MK + H N++++    
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI 72
Query: 169 SNDDFKALVLEYMPH-----------GSLEKCLYLSNYILDIFQRLDIMIDVASALEYLH 217
             ++   LV E+M +           G+  + L L+  ++  FQ           L+ L 
Sbjct: 73  HTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELN--LVKYFQ--------WQLLQGLA 122
Query: 218 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYG 277
           F +   I+H DLKP N+L++      L DFG+A+       +   +  + T+ Y AP+  
Sbjct: 123 FCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF--SSEVVTLWYRAPDVL 180
Query: 278 REGRV-STNGDVYSFGIMLMEIFT 300
              R  ST+ D++S G +L E+ T
Sbjct: 181 MGSRTYSTSIDIWSCGCILAEMIT 204

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 101/208 (48%), Gaps = 28/208 (13%)
Query: 106 NMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRICHRNL 161
           N+ P +G G +GSV  A   + G  VAVK     ++    A +++  E  ++K + H N+
Sbjct: 22  NLSP-VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENV 79
Query: 162 IKIISSYS--------NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASAL 213
           I ++  ++        ND +    L      ++ KC  L++   D  Q L  +  +   L
Sbjct: 80  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQILRGL 134
Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
           +Y+H   SA IIH DLKPSN+ ++++    + DFG+A+   +E      T  +AT  Y A
Sbjct: 135 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRA 186
Query: 274 PEYGREG-RVSTNGDVYSFGIMLMEIFT 300
           PE        +   D++S G ++ E+ T
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLT 214

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 94/195 (48%), Gaps = 8/195 (4%)
Query: 111 IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYS 169
           IG+G  G V  A ++  G  VAVK  D + +   +    E  +M+   H N++++ +SY 
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 170 NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
             D   +V+E++  G+L     +++  ++  Q   + + V  AL  LH   +  +IH D+
Sbjct: 88  VGDELWVVMEFLEGGALTDI--VTHTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 142
Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 289
           K  ++LL  +    LSDFG    + +E     +   + T  +MAPE           D++
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKXLVGTPYWMAPELISRLPYGPEVDIW 200
Query: 290 SFGIMLMEIFTRTKP 304
           S GIM++E+     P
Sbjct: 201 SLGIMVIEMVDGEPP 215

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 94/195 (48%), Gaps = 8/195 (4%)
Query: 111 IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYS 169
           IG+G  G V  A ++  G  VAVK  D + +   +    E  +M+   H N++++ +SY 
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 98
Query: 170 NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
             D   +V+E++  G+L     +++  ++  Q   + + V  AL  LH   +  +IH D+
Sbjct: 99  VGDELWVVMEFLEGGALTDI--VTHTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 153
Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 289
           K  ++LL  +    LSDFG    + +E     +   + T  +MAPE           D++
Sbjct: 154 KSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKXLVGTPYWMAPELISRLPYGPEVDIW 211
Query: 290 SFGIMLMEIFTRTKP 304
           S GIM++E+     P
Sbjct: 212 SLGIMVIEMVDGEPP 226

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 94/195 (48%), Gaps = 8/195 (4%)
Query: 111 IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYS 169
           IG+G  G V  A ++  G  VAVK  D + +   +    E  +M+   H N++++ +SY 
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 91
Query: 170 NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
             D   +V+E++  G+L     +++  ++  Q   + + V  AL  LH   +  +IH D+
Sbjct: 92  VGDELWVVMEFLEGGALTDI--VTHTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 146
Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 289
           K  ++LL  +    LSDFG    + +E     +   + T  +MAPE           D++
Sbjct: 147 KSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKXLVGTPYWMAPELISRLPYGPEVDIW 204
Query: 290 SFGIMLMEIFTRTKP 304
           S GIM++E+     P
Sbjct: 205 SLGIMVIEMVDGEPP 219

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 101/208 (48%), Gaps = 28/208 (13%)
Query: 106 NMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRICHRNL 161
           N+ P +G G +GSV  A   + G  VAVK     ++    A +++  E  ++K + H N+
Sbjct: 46  NLSP-VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENV 103
Query: 162 IKIISSYS--------NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASAL 213
           I ++  ++        ND +    L      ++ KC  L++   D  Q L  +  +   L
Sbjct: 104 IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQILRGL 158
Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
           +Y+H   SA IIH DLKPSN+ ++++    + DFG+A+   +E      T  +AT  Y A
Sbjct: 159 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRA 210
Query: 274 PEYGREG-RVSTNGDVYSFGIMLMEIFT 300
           PE        +   D++S G ++ E+ T
Sbjct: 211 PEIMLNWMHYNQTVDIWSVGCIMAELLT 238

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 96/213 (45%), Gaps = 34/213 (15%)
Query: 110 LIGKGGFGSVYKAIIQDGMEVAVKVF------------DPQYEGAFKSFDIECDVMKRIC 157
           ++G+GGFG V+       M+   K++               Y+GA     +E  ++ ++ 
Sbjct: 192 VLGRGGFGEVFAC----QMKATGKLYACKKLNKKRLKKRKGYQGAM----VEKKILAKVH 243
Query: 158 HRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMI---DVASALE 214
            R ++ +  ++       LV+  M  G +   +Y  +     FQ    +     + S LE
Sbjct: 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 215 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA-TIGYMA 273
           +LH      II+ DLKP NVLLDD+    +SD G+A   +E     T+T+  A T G+MA
Sbjct: 304 HLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLA---VELKAGQTKTKGYAGTPGFMA 357
Query: 274 PE--YGREGRVSTNGDVYSFGIMLMEIFTRTKP 304
           PE   G E   S   D ++ G+ L E+     P
Sbjct: 358 PELLLGEEYDFSV--DYFALGVTLYEMIAARGP 388

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 96/208 (46%), Gaps = 15/208 (7%)
Query: 104 DANMPPLIGKGGFGSVYKAIIQDGMEV-AVKVFDPQYEGAFKSFDIECD-VMKRIC---- 157
           D  +  ++GKG FG V+ A  +   +  A+K    + +      D+EC  V KR+     
Sbjct: 19  DFELHKMLGKGSFGKVFLAEFKKTNQFFAIKAL--KKDVVLMDDDVECTMVEKRVLSLAW 76
Query: 158 -HRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYL 216
            H  L  +  ++   +    V+EY+  G L   +  S +  D+ +      ++   L++L
Sbjct: 77  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ-SCHKFDLSRATFYAAEIILGLQFL 135
Query: 217 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEY 276
           H   S  I++ DLK  N+LLD +    ++DFGM K  +  D      +   T  Y+APE 
Sbjct: 136 H---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNEFCGTPDYIAPEI 190
Query: 277 GREGRVSTNGDVYSFGIMLMEIFTRTKP 304
               + + + D +SFG++L E+     P
Sbjct: 191 LLGQKYNHSVDWWSFGVLLYEMLIGQSP 218

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 93/201 (46%), Gaps = 24/201 (11%)
Query: 110 LIGKGGFGSVYKAIIQD-GMEVAVKVF-DPQYEGAFKSFDI-ECDVMKRICHRNLIKIIS 166
           L+G+G +G V K   +D G  VA+K F +   +   K   + E  ++K++ H NL+ ++ 
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLE 91
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLYLSNYI-LDIFQRLDIMIDVASALEYLHFGYSAPII 225
                    LV E++ H  L+      N +   + Q+    I     +  + F +S  II
Sbjct: 92  VCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQI-----INGIGFCHSHNII 146
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE-------YGR 278
           H D+KP N+L+  + V  L DFG A+ L    +       +AT  Y APE       YG+
Sbjct: 147 HRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYDDEVATRWYRAPELLVGDVKYGK 204
Query: 279 EGRVSTNGDVYSFGIMLMEIF 299
                   DV++ G ++ E+F
Sbjct: 205 A------VDVWAIGCLVTEMF 219

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 94/195 (48%), Gaps = 8/195 (4%)
Query: 111 IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYS 169
           IG+G  G V  A ++  G  VAVK  D + +   +    E  +M+   H N++++ +SY 
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 96
Query: 170 NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
             D   +V+E++  G+L     +++  ++  Q   + + V  AL  LH   +  +IH D+
Sbjct: 97  VGDELWVVMEFLEGGALTDI--VTHTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 151
Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 289
           K  ++LL  +    LSDFG    + +E     +   + T  +MAPE           D++
Sbjct: 152 KSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKXLVGTPYWMAPELISRLPYGPEVDIW 209
Query: 290 SFGIMLMEIFTRTKP 304
           S GIM++E+     P
Sbjct: 210 SLGIMVIEMVDGEPP 224

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 101/208 (48%), Gaps = 28/208 (13%)
Query: 106 NMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRICHRNL 161
           N+ P +G G +GSV  A   + G  VAVK     ++    A +++  E  ++K + H N+
Sbjct: 32  NLSP-VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENV 89
Query: 162 IKIISSYS--------NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASAL 213
           I ++  ++        ND +    L      ++ KC  L++   D  Q L  +  +   L
Sbjct: 90  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQILRGL 144
Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
           +Y+H   SA IIH DLKPSN+ ++++    + DFG+A+   +E      T  +AT  Y A
Sbjct: 145 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRA 196
Query: 274 PEYGREG-RVSTNGDVYSFGIMLMEIFT 300
           PE        +   D++S G ++ E+ T
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLT 224

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 94/195 (48%), Gaps = 8/195 (4%)
Query: 111 IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYS 169
           IG+G  G V  A ++  G  VAVK  D + +   +    E  +M+   H N++++ +SY 
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 141
Query: 170 NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
             D   +V+E++  G+L     +++  ++  Q   + + V  AL  LH   +  +IH D+
Sbjct: 142 VGDELWVVMEFLEGGALTDI--VTHTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 196
Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 289
           K  ++LL  +    LSDFG    + +E     +   + T  +MAPE           D++
Sbjct: 197 KSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAPELISRLPYGPEVDIW 254
Query: 290 SFGIMLMEIFTRTKP 304
           S GIM++E+     P
Sbjct: 255 SLGIMVIEMVDGEPP 269

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 98/214 (45%), Gaps = 35/214 (16%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYS 169
           IG G +G V  A  +  G +VA+K           +FD+  +  + +     +KI+  + 
Sbjct: 63  IGNGAYGVVSSARRRLTGQQVAIKKIP-------NAFDVVTNAKRTL---RELKILKHFK 112
Query: 170 NDDF---KALVLEYMPHGSLEKCLYLSNYILDIFQR-LDIMIDVASALEYLHFGY----- 220
           +D+    K ++   +P+G   K +Y+   +LD+ +  L  +I  +  L   H  Y     
Sbjct: 113 HDNIIAIKDILRPTVPYGEF-KSVYV---VLDLMESDLHQIIHSSQPLTLEHVRYFLYQL 168
Query: 221 --------SAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE--DQSLTQTQTLATIG 270
                   SA +IH DLKPSN+L+++N    + DFGMA+ L     +     T+ +AT  
Sbjct: 169 LRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRW 228
Query: 271 YMAPEYGREGRVSTNG-DVYSFGIMLMEIFTRTK 303
           Y APE        T   D++S G +  E+  R +
Sbjct: 229 YRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 95/215 (44%), Gaps = 17/215 (7%)
Query: 99  KPLPNDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQY--EGAFKSFDIECDVMKR 155
           +P   +  +   IGKG F  V  A  I  G EVA+K+ D       + +    E  +MK 
Sbjct: 11  QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKI 70
Query: 156 ICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEY 215
           + H N++K+      +    L++EY   G +   L     + +   R      + SA++Y
Sbjct: 71  LNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR-QIVSAVQY 129
Query: 216 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG---YM 272
            H      I+H DLK  N+LLD +M   ++DFG +      ++     +  A  G   Y 
Sbjct: 130 CH---QKRIVHRDLKAENLLLDADMNIKIADFGFS------NEFTVGGKLDAFCGAPPYA 180
Query: 273 APEYGREGRV-STNGDVYSFGIMLMEIFTRTKPTD 306
           APE  +  +      DV+S G++L  + + + P D
Sbjct: 181 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 102/216 (47%), Gaps = 19/216 (8%)
Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVF-----DPQYEGAFKSFDIECDVMKRICHRNLIK 163
           ++G G FG+VYK + I +G +V + V      +     A K    E  VM  + + ++ +
Sbjct: 26  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 85
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCL--YLSNYILDIFQR--LDIMIDVASALEYLHFG 219
           ++        + L+++ MP G    CL  Y+  +  +I  +  L+  + +A  + YL   
Sbjct: 86  LLGICLTSTVQ-LIMQLMPFG----CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-- 138
Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
               ++H DL   NVL+       ++DFG+AK L  E++          I +MA E    
Sbjct: 139 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 197
Query: 280 GRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMT 314
              +   DV+S+G+ + E+ T  +KP D I + E++
Sbjct: 198 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 233

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 91/192 (47%), Gaps = 11/192 (5%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKV--FDPQYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
           IG+G +G VYKA    G   A+K    + + EG   +   E  ++K + H N++K+    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCD 228
                  LV E++    L+K L +    L+       ++ + + + Y H      ++H D
Sbjct: 70  HTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRD 125
Query: 229 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEY--GREGRVSTNG 286
           LKP N+L++      ++DFG+A+      +    T  + T+ Y AP+   G + + ST  
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRKY--THEVVTLWYRAPDVLMGSK-KYSTTI 182
Query: 287 DVYSFGIMLMEI 298
           D++S G +  E+
Sbjct: 183 DIWSVGCIFAEM 194

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 106 NMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRICHRNL 161
           N+ P +G G +GSV  A   + G+ VAVK     ++    A +++  E  ++K + H N+
Sbjct: 26  NLSP-VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENV 83
Query: 162 IKIISSY----SNDDFKALVL-EYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYL 216
           I ++  +    S ++F  + L  ++    L   +       D  Q L  +  +   L+Y+
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFL--IYQILRGLKYI 141
Query: 217 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEY 276
           H   SA IIH DLKPSN+ ++++    + DFG+A+   +E      T  +AT  Y APE 
Sbjct: 142 H---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRWYRAPEI 193
Query: 277 GREG-RVSTNGDVYSFGIMLMEIFT 300
                  +   D++S G ++ E+ T
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 98/214 (45%), Gaps = 35/214 (16%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYS 169
           IG G +G V  A  +  G +VA+K           +FD+  +  + +     +KI+  + 
Sbjct: 62  IGNGAYGVVSSARRRLTGQQVAIKKIP-------NAFDVVTNAKRTL---RELKILKHFK 111
Query: 170 NDDF---KALVLEYMPHGSLEKCLYLSNYILDIFQR-LDIMIDVASALEYLHFGY----- 220
           +D+    K ++   +P+G   K +Y+   +LD+ +  L  +I  +  L   H  Y     
Sbjct: 112 HDNIIAIKDILRPTVPYGEF-KSVYV---VLDLMESDLHQIIHSSQPLTLEHVRYFLYQL 167
Query: 221 --------SAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE--DQSLTQTQTLATIG 270
                   SA +IH DLKPSN+L+++N    + DFGMA+ L     +     T+ +AT  
Sbjct: 168 LRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRW 227
Query: 271 YMAPEYGREGRVSTNG-DVYSFGIMLMEIFTRTK 303
           Y APE        T   D++S G +  E+  R +
Sbjct: 228 YRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 80/163 (49%), Gaps = 12/163 (7%)
Query: 138 QYEGAFKSFDIECDVMKRICHRNLIKIISSYS--NDDFKALVLEYMPHGSLEKCLYLSNY 195
           Q  G  +    E  ++K++ H N++K++      N+D   +V E +  G + +   L   
Sbjct: 75  QPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPL 134
Query: 196 ILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE 255
             D  Q      D+   +EYLH+     IIH D+KPSN+L+ ++    ++DFG++     
Sbjct: 135 SED--QARFYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189
Query: 256 EDQSLTQTQTLATIGYMAPEYGREGRVSTNG---DVYSFGIML 295
            D  L  + T+ T  +MAPE   E R   +G   DV++ G+ L
Sbjct: 190 SDALL--SNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 102/216 (47%), Gaps = 19/216 (8%)
Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVF-----DPQYEGAFKSFDIECDVMKRICHRNLIK 163
           ++G G FG+VYK + I +G +V + V      +     A K    E  VM  + + ++ +
Sbjct: 25  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCL--YLSNYILDIFQR--LDIMIDVASALEYLHFG 219
           ++        + L+++ MP G    CL  Y+  +  +I  +  L+  + +A  + YL   
Sbjct: 85  LLGICLTSTVQ-LIMQLMPFG----CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-- 137
Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
               ++H DL   NVL+       ++DFG+AK L  E++          I +MA E    
Sbjct: 138 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 196
Query: 280 GRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMT 314
              +   DV+S+G+ + E+ T  +KP D I + E++
Sbjct: 197 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 232

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 102/216 (47%), Gaps = 19/216 (8%)
Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVF-----DPQYEGAFKSFDIECDVMKRICHRNLIK 163
           ++G G FG+VYK + I +G +V + V      +     A K    E  VM  + + ++ +
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCL--YLSNYILDIFQR--LDIMIDVASALEYLHFG 219
           ++        + L+++ MP G    CL  Y+  +  +I  +  L+  + +A  + YL   
Sbjct: 84  LLGICLTSTVQ-LIMQLMPFG----CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-- 136
Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
               ++H DL   NVL+       ++DFG+AK L  E++          I +MA E    
Sbjct: 137 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 195
Query: 280 GRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMT 314
              +   DV+S+G+ + E+ T  +KP D I + E++
Sbjct: 196 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 231

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 102/216 (47%), Gaps = 19/216 (8%)
Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVF-----DPQYEGAFKSFDIECDVMKRICHRNLIK 163
           ++G G FG+VYK + I +G +V + V      +     A K    E  VM  + + ++ +
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCL--YLSNYILDIFQR--LDIMIDVASALEYLHFG 219
           ++        + L+++ MP G    CL  Y+  +  +I  +  L+  + +A  + YL   
Sbjct: 82  LLGICLTSTVQ-LIMQLMPFG----CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-- 134
Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
               ++H DL   NVL+       ++DFG+AK L  E++          I +MA E    
Sbjct: 135 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 280 GRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMT 314
              +   DV+S+G+ + E+ T  +KP D I + E++
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 96/198 (48%), Gaps = 10/198 (5%)
Query: 111 IGKGGFGSVYKAIIQDGME-VAVKV--FDPQYEGAFKSFDIECDVMKRICHRNLIKIISS 167
           IG+G +G+V+KA  ++  E VA+K    D   EG   S   E  ++K + H+N++++   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 168 YSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHC 227
             +D    LV E+     L+K     N  LD       +  +   L + H   S  ++H 
Sbjct: 70  LHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHR 125
Query: 228 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRV-STNG 286
           DLKP N+L++ N    L+DFG+A+      +    +  + T+ Y  P+     ++ ST+ 
Sbjct: 126 DLKPQNLLINRNGELKLADFGLARAFGIPVRCY--SAEVVTLWYRPPDVLFGAKLYSTSI 183
Query: 287 DVYSFGIMLMEIFTRTKP 304
           D++S G +  E+    +P
Sbjct: 184 DMWSAGCIFAELANAARP 201

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/239 (23%), Positives = 101/239 (42%), Gaps = 33/239 (13%)
Query: 92  LRYQKRGKPLPNDANMPPLIGKGGFGSVYKAII-----QDG-MEVAVKVFDPQYEGAFK- 144
           L Y ++ +   N+      +G G FG V +A       +D  ++VAVK+         K 
Sbjct: 20  LPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKE 79
Query: 145 SFDIECDVMKRIC-HRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYI------- 196
           +   E  +M  +  H N++ ++ + ++     ++ EY  +G L   L             
Sbjct: 80  ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLA 139
Query: 197 ---------------LDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV 241
                          L++   L     VA  + +L    S   IH D+   NVLL +  V
Sbjct: 140 PGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHV 196
Query: 242 AHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
           A + DFG+A+ ++ +   + +      + +MAPE   +   +   DV+S+GI+L EIF+
Sbjct: 197 AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 97/204 (47%), Gaps = 19/204 (9%)
Query: 111 IGKGGFGSVYKAIIQD---GMEVAVKVFDP-QYEGAFKSFDIECDVMKRICHRNLIKIIS 166
           +G G FG V+  ++++   G+E  +K  +  + +   +  + E +V+K + H N+IKI  
Sbjct: 30  LGSGAFGDVH--LVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFE 87
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQR---LDIMIDVASALEYLHFGYSAP 223
            + +     +V+E    G L + +  +             ++M  + +AL Y H   S  
Sbjct: 88  VFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQH 144
Query: 224 IIHCDLKPSNVLLDD---NMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREG 280
           ++H DLKP N+L  D   +    + DFG+A+    ++ S   T    T  YMAPE  +  
Sbjct: 145 VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS---TNAAGTALYMAPEVFKRD 201
Query: 281 RVSTNGDVYSFGIMLMEIFTRTKP 304
            V+   D++S G+++  + T   P
Sbjct: 202 -VTFKCDIWSAGVVMYFLLTGCLP 224

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 102/216 (47%), Gaps = 19/216 (8%)
Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVF-----DPQYEGAFKSFDIECDVMKRICHRNLIK 163
           ++G G FG+VYK + I +G +V + V      +     A K    E  VM  + + ++ +
Sbjct: 23  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 82
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCL--YLSNYILDIFQR--LDIMIDVASALEYLHFG 219
           ++        + L+++ MP G    CL  Y+  +  +I  +  L+  + +A  + YL   
Sbjct: 83  LLGICLTSTVQ-LIMQLMPFG----CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-- 135
Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
               ++H DL   NVL+       ++DFG+AK L  E++          I +MA E    
Sbjct: 136 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 194
Query: 280 GRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMT 314
              +   DV+S+G+ + E+ T  +KP D I + E++
Sbjct: 195 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 230

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 106 NMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRICHRNL 161
           N+ P +G G +GSV  A   + G+ VAVK     ++    A +++  E  ++K + H N+
Sbjct: 26  NLSP-VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENV 83
Query: 162 IKIISSY----SNDDFKALVL-EYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYL 216
           I ++  +    S ++F  + L  ++    L   +       D  Q L  +  +   L+Y+
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFL--IYQILRGLKYI 141
Query: 217 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEY 276
           H   SA IIH DLKPSN+ ++++    + DFG+A+   +E      T  +AT  Y APE 
Sbjct: 142 H---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEI 193
Query: 277 GREG-RVSTNGDVYSFGIMLMEIFT 300
                  +   D++S G ++ E+ T
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 22/213 (10%)
Query: 111 IGKGGFGSVYKA--IIQDGMEVAVKVFDPQY--EGAFKSFDIECDVMKRIC---HRNLIK 163
           IG+G +G V+KA  +   G  VA+K    Q   EG   S   E  V++ +    H N+++
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 164 I--ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYI---LDIFQRLDIMIDVASALEYLHF 218
           +  + + S  D +  +     H   +   YL       +      D+M  +   L++LH 
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH- 137
Query: 219 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGR 278
             S  ++H DLKP N+L+  +    L+DFG+A+        +  T  + T+ Y APE   
Sbjct: 138 --SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWYRAPEVLL 192
Query: 279 EGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSG 311
           +   +T  D++S G +  E+F R KP   +F G
Sbjct: 193 QSSYATPVDLWSVGCIFAEMF-RRKP---LFRG 221

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 22/213 (10%)
Query: 111 IGKGGFGSVYKA--IIQDGMEVAVKVFDPQY--EGAFKSFDIECDVMKRIC---HRNLIK 163
           IG+G +G V+KA  +   G  VA+K    Q   EG   S   E  V++ +    H N+++
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 164 I--ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYI---LDIFQRLDIMIDVASALEYLHF 218
           +  + + S  D +  +     H   +   YL       +      D+M  +   L++LH 
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH- 137
Query: 219 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGR 278
             S  ++H DLKP N+L+  +    L+DFG+A+        +  T  + T+ Y APE   
Sbjct: 138 --SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWYRAPEVLL 192
Query: 279 EGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSG 311
           +   +T  D++S G +  E+F R KP   +F G
Sbjct: 193 QSSYATPVDLWSVGCIFAEMF-RRKP---LFRG 221

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 109/234 (46%), Gaps = 38/234 (16%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAV--KVFDP--QYEGAFKSFDIECDVMKRICHRNLIKIIS 166
           +GKG +G V+K+I +   EV    K+FD       A ++F     + +   H N++ +++
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 167 --SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPI 224
                ND    LV +YM    L   +  +  IL+   +  ++  +   ++YLH   S  +
Sbjct: 77  VLRADNDRDVYLVFDYM-ETDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLH---SGGL 130
Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAK------------PL--------LEEDQSLTQTQ 264
           +H D+KPSN+LL+      ++DFG+++            PL         ++DQ +  T 
Sbjct: 131 LHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPIL-TD 189
Query: 265 TLATIGYMAPEYGREGRVSTNG-DVYSFGIMLMEIFTRTKPTDEIFSGEMTLKR 317
            +AT  Y APE        T G D++S G +L EI    KP   IF G  T+ +
Sbjct: 190 YVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILC-GKP---IFPGSSTMNQ 239

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 101/208 (48%), Gaps = 28/208 (13%)
Query: 106 NMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRICHRNL 161
           N+ P +G G +GSV  A   + G+ VAVK     ++    A +++  E  ++K + H N+
Sbjct: 49  NLSP-VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENV 106
Query: 162 IKIISSYS--------NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASAL 213
           I ++  ++        ND +    L      ++ KC  L++   D  Q L  +  +   L
Sbjct: 107 IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQILRGL 161
Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
           +Y+H   SA IIH DLKPSN+ ++++    + DFG+A+   +E         +AT  Y A
Sbjct: 162 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MXGYVATRWYRA 213
Query: 274 PEYGREG-RVSTNGDVYSFGIMLMEIFT 300
           PE        +   D++S G ++ E+ T
Sbjct: 214 PEIMLNWMHYNQTVDIWSVGCIMAELLT 241

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 93/189 (49%), Gaps = 8/189 (4%)
Query: 111 IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYS 169
           IG+G  G V  A ++  G  VAVK  D + +   +    E  +M+   H N++++ +SY 
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 218
Query: 170 NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
             D   +V+E++  G+L     +++  ++  Q   + + V  AL  LH   +  +IH D+
Sbjct: 219 VGDELWVVMEFLEGGALTDI--VTHTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 273
Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 289
           K  ++LL  +    LSDFG    + +E     +   + T  +MAPE           D++
Sbjct: 274 KSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAPELISRLPYGPEVDIW 331
Query: 290 SFGIMLMEI 298
           S GIM++E+
Sbjct: 332 SLGIMVIEM 340

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 22/213 (10%)
Query: 111 IGKGGFGSVYKA--IIQDGMEVAVKVFDPQY--EGAFKSFDIECDVMKRIC---HRNLIK 163
           IG+G +G V+KA  +   G  VA+K    Q   EG   S   E  V++ +    H N+++
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 164 I--ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYI---LDIFQRLDIMIDVASALEYLHF 218
           +  + + S  D +  +     H   +   YL       +      D+M  +   L++LH 
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH- 137
Query: 219 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGR 278
             S  ++H DLKP N+L+  +    L+DFG+A+        +  T  + T+ Y APE   
Sbjct: 138 --SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWYRAPEVLL 192
Query: 279 EGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSG 311
           +   +T  D++S G +  E+F R KP   +F G
Sbjct: 193 QSSYATPVDLWSVGCIFAEMF-RRKP---LFRG 221

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 103/240 (42%), Gaps = 44/240 (18%)
Query: 92  LRYQKRGKPLPNDA-NMPPLIGKGGFGSVYKA------IIQDGMEVAVKVFDPQYEGA-- 142
           L Y       P D  N+   +G+G FG V +A             VAVK+     EGA  
Sbjct: 15  LPYDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLK---EGATH 71
Query: 143 --FKSFDIECDVMKRICHR-NLIKIISSYSNDDFKALVL------------------EYM 181
              ++   E  ++  I H  N++ ++ + +      +V+                  E++
Sbjct: 72  SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFV 131
Query: 182 PHGSLEK-CLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM 240
           P+  L K  L L + I   FQ       VA  +E+L    S   IH DL   N+LL +  
Sbjct: 132 PYKDLYKDFLTLEHLIXYSFQ-------VAKGMEFL---ASRKXIHRDLAARNILLSEKN 181
Query: 241 VAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
           V  + DFG+A+ + ++   + +      + +MAPE   +   +   DV+SFG++L EIF+
Sbjct: 182 VVKIXDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 101/214 (47%), Gaps = 15/214 (7%)
Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVF-----DPQYEGAFKSFDIECDVMKRICHRNLIK 163
           ++G G FG+VYK + I +G +V + V      +     A K    E  VM  + + ++ +
Sbjct: 23  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 82
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQR--LDIMIDVASALEYLHFGYS 221
           ++        + L+++ MP G L    Y+  +  +I  +  L+  + +A  + YL     
Sbjct: 83  LLGICLTSTVQ-LIMQLMPFGXLLD--YVREHKDNIGSQYLLNWCVQIAKGMNYLE---D 136
Query: 222 APIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGR 281
             ++H DL   NVL+       ++DFG+AK L  E++          I +MA E      
Sbjct: 137 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 196
Query: 282 VSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMT 314
            +   DV+S+G+ + E+ T  +KP D I + E++
Sbjct: 197 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 230

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 110/231 (47%), Gaps = 34/231 (14%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDP-QYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
           IG+G +G V  A    + + VA+K   P +++   +    E  ++    H N+I I    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGI---- 88
Query: 169 SNDDFKALVLE-----YMPHGSLEKCLY-------LSNYILDIFQRLDIMIDVASALEYL 216
            ND  +A  +E     Y+    +E  LY       LSN  +  F     +  +   L+Y+
Sbjct: 89  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF-----LYQILRGLKYI 142
Query: 217 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LEEDQSLTQTQTLATIGYMAPE 275
           H   SA ++H DLKPSN+LL+      + DFG+A+    + D +   T+ +AT  Y APE
Sbjct: 143 H---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 199
Query: 276 YGREGRVSTNG-DVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPI 325
                +  T   D++S G +L E+ +  +P   IF G+  L + +N +L I
Sbjct: 200 IMLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQ-LNHILGI 245

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 11/211 (5%)
Query: 110 LIGKGGFGSVYKAI-IQDG----MEVAVKVFDPQYE-GAFKSFDIECDVMKRICHRNLIK 163
           ++G G FG+VYK I I DG    + VA+KV        A K    E  VM  +    + +
Sbjct: 24  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSR 83
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
           ++        + LV + MP+G L   +  +   L     L+  + +A  + YL       
Sbjct: 84  LLGICLTSTVQ-LVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLE---DVR 139
Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVS 283
           ++H DL   NVL+       ++DFG+A+ L  ++           I +MA E     R +
Sbjct: 140 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRRFT 199
Query: 284 TNGDVYSFGIMLMEIFT-RTKPTDEIFSGEM 313
              DV+S+G+ + E+ T   KP D I + E+
Sbjct: 200 HQSDVWSYGVTVWELMTFGAKPYDGIPAREI 230

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 101/203 (49%), Gaps = 27/203 (13%)
Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRICHRNLIKIIS 166
           +G G +GSV  +  ++ G+++AVK     ++    A +++  E  ++K + H N+I ++ 
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 117
Query: 167 SYS--------NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHF 218
            ++        ND +    L      ++ KC  L++   D  Q L  +  +   L+Y+H 
Sbjct: 118 VFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQILRGLKYIH- 171
Query: 219 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGR 278
             SA IIH DLKPSN+ ++++    + DFG+A+   +E      T  +AT  Y APE   
Sbjct: 172 --SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML 224
Query: 279 EG-RVSTNGDVYSFGIMLMEIFT 300
                +   D++S G ++ E+ T
Sbjct: 225 NWMHYNMTVDIWSVGCIMAELLT 247

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 88/191 (46%), Gaps = 12/191 (6%)
Query: 111 IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGA--FKSFDIECDVMKRICHRNLIKIISS 167
           +GKG F  V + + +    E A K+ + +   A   +  + E  + + + H N++++  S
Sbjct: 39  LGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 98
Query: 168 YSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHC 227
            S + F  LV + +  G L + +    Y    +   D    +   LE ++  +   I+H 
Sbjct: 99  ISEEGFHYLVFDLVTGGELFEDIVAREY----YSEADASHCIHQILESVNHIHQHDIVHR 154
Query: 228 DLKPSNVLLDDN---MVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVST 284
           DLKP N+LL          L+DFG+A  +  E Q+        T GY++PE  R+     
Sbjct: 155 DLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFA--GTPGYLSPEVLRKDPYGK 212
Query: 285 NGDVYSFGIML 295
             D+++ G++L
Sbjct: 213 PVDIWACGVIL 223

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 104/242 (42%), Gaps = 44/242 (18%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVKVFD-PQYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
           +G+GGFG V++A  + D    A+K    P  E A +    E   + ++ H  +++    Y
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVR----Y 68
Query: 169 SNDDFKALVLEYMPHGSLEKCLYLS-------------NYILDIFQR-----LDIMIDVA 210
            N   +    E +   S +  LY+              N    I +R     L I + +A
Sbjct: 69  FNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIA 128
Query: 211 SALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT--------- 261
            A+E+LH   S  ++H DLKPSN+    + V  + DFG+   + ++++  T         
Sbjct: 129 EAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185
Query: 262 -QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN 320
             T  + T  YM+PE       S   D++S G++L E+          FS +M   R + 
Sbjct: 186 RHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY-------PFSTQMERVRTLT 238
Query: 321 DL 322
           D+
Sbjct: 239 DV 240

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 103/240 (42%), Gaps = 44/240 (18%)
Query: 92  LRYQKRGKPLPNDA-NMPPLIGKGGFGSVYKA------IIQDGMEVAVKVFDPQYEGA-- 142
           L Y       P D  N+   +G+G FG V +A             VAVK+     EGA  
Sbjct: 15  LPYDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLK---EGATH 71
Query: 143 --FKSFDIECDVMKRICHR-NLIKIISSYSNDDFKALVL------------------EYM 181
              ++   E  ++  I H  N++ ++ + +      +V+                  E++
Sbjct: 72  SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFV 131
Query: 182 PHGSLEK-CLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM 240
           P+  L K  L L + I   FQ       VA  +E+L    S   IH DL   N+LL +  
Sbjct: 132 PYKDLYKDFLTLEHLICYSFQ-------VAKGMEFL---ASRKXIHRDLAARNILLSEKN 181
Query: 241 VAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
           V  + DFG+A+ + ++   + +      + +MAPE   +   +   DV+SFG++L EIF+
Sbjct: 182 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 107/229 (46%), Gaps = 12/229 (5%)
Query: 90  LILRYQKRGKPLPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDI 148
            + + QK G+   +D      +G G  G V+K   +  G+ +A K+   + + A ++  I
Sbjct: 12  FLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII 71
Query: 149 -ECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL-DIM 206
            E  V+       ++    ++ +D   ++ +E+M  GSL++ L  +  I +  Q L  + 
Sbjct: 72  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE--QILGKVS 129
Query: 207 IDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL 266
           I V   L YL   +   I+H D+KPSN+L++      L DFG++  L++          +
Sbjct: 130 IAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFV 183
Query: 267 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTL 315
            T  YM+PE  +    S   D++S G+ L+E+     P     SG M +
Sbjct: 184 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIGS-GSGSMAI 231

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 110/231 (47%), Gaps = 34/231 (14%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDP-QYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
           IG+G +G V  A    + + VA+K   P +++   +    E  ++    H N+I I    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGI---- 88
Query: 169 SNDDFKALVLE-----YMPHGSLEKCLY-------LSNYILDIFQRLDIMIDVASALEYL 216
            ND  +A  +E     Y+    +E  LY       LSN  +  F     +  +   L+Y+
Sbjct: 89  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF-----LYQILRGLKYI 142
Query: 217 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LEEDQSLTQTQTLATIGYMAPE 275
           H   SA ++H DLKPSN+LL+      + DFG+A+    + D +   T+ +AT  Y APE
Sbjct: 143 H---SANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 199
Query: 276 YGREGRVSTNG-DVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPI 325
                +  T   D++S G +L E+ +  +P   IF G+  L + +N +L I
Sbjct: 200 IMLNSKGYTKSIDIWSVGCILAEMLS-NRP---IFPGKHYLDQ-LNHILGI 245

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 108/238 (45%), Gaps = 20/238 (8%)
Query: 111 IGKGGFGSVYKAII----QDGMEVAVKVFDPQYEGAFKSFDI--ECDVMKRICHRNLIKI 164
           IG+G FG   KAI+    +DG +  +K  +     + +  +   E  V+  + H N+++ 
Sbjct: 32  IGEGSFG---KAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQY 88
Query: 165 ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQR---LDIMIDVASALEYLHFGYS 221
             S+  +    +V++Y   G L K +     +L  FQ    LD  + +  AL+++H    
Sbjct: 89  RESFEENGSLYIVMDYCEGGDLFKRINAQKGVL--FQEDQILDWFVQICLALKHVH---D 143
Query: 222 APIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGR 281
             I+H D+K  N+ L  +    L DFG+A+ +L     L +   + T  Y++PE      
Sbjct: 144 RKILHRDIKSQNIFLTKDGTVQLGDFGIAR-VLNSTVELARA-CIGTPYYLSPEICENKP 201
Query: 282 VSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPISVMEVVD-ANLLSQ 338
            +   D+++ G +L E+ T     +      + LK       P+S+    D  +L+SQ
Sbjct: 202 YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQ 259

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 101/208 (48%), Gaps = 28/208 (13%)
Query: 106 NMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRICHRNL 161
           N+ P +G G +GSV  A   + G+ VAVK     ++    A +++  E  ++K + H N+
Sbjct: 26  NLSP-VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENV 83
Query: 162 IKIISSYS--------NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASAL 213
           I ++  ++        ND +    L      ++ KC  L++   D  Q L  +  +   L
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQILRGL 138
Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
           +Y+H   SA IIH DLKPSN+ ++++    +  FG+A+   +E      T  +AT  Y A
Sbjct: 139 KYIH---SADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDE-----MTGYVATRWYRA 190
Query: 274 PEYGREG-RVSTNGDVYSFGIMLMEIFT 300
           PE        +   D++S G ++ E+ T
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 101/230 (43%), Gaps = 41/230 (17%)
Query: 96  KRGKPLPNDANMPPLIGKGGFGSVYKA------IIQDGMEVAVKVFDPQYEGA----FKS 145
           K GKPL          G+G FG V +A             VAVK+     EGA     ++
Sbjct: 32  KLGKPL----------GRGAFGQVIEADAFGIDKTATXRTVAVKMLK---EGATHSEHRA 78
Query: 146 FDIECDVMKRICHR-NLIKIISSYSNDDFKALVL-EYMPHGSLEKCL---------YLSN 194
              E  ++  I H  N++ ++ + +      +V+ E+   G+L   L         Y   
Sbjct: 79  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPE 138
Query: 195 YILDIFQRLDIMI----DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMA 250
            +   F  L+ +I     VA  +E+L    S   IH DL   N+LL +  V  + DFG+A
Sbjct: 139 DLYKDFLTLEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLA 195
Query: 251 KPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
           + + ++   + +      + +MAPE   +   +   DV+SFG++L EIF+
Sbjct: 196 RDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 86/200 (43%), Gaps = 16/200 (8%)
Query: 111 IGKGGFGSVYKAIIQDG--MEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
           IG G + SV K  I     ME AVK+ D       +  +I   +++   H N+I +   Y
Sbjct: 30  IGVGSY-SVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEI---LLRYGQHPNIITLKDVY 85
Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCD 228
            +  +  +V E M  G L   + L        +   ++  +   +EYLH   +  ++H D
Sbjct: 86  DDGKYVYVVTELMKGGELLDKI-LRQKFFSEREASAVLFTITKTVEYLH---AQGVVHRD 141
Query: 229 LKPSNVLLDDNM----VAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVST 284
           LKPSN+L  D         + DFG AK L  E+  L       T  ++APE         
Sbjct: 142 LKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL--MTPCYTANFVAPEVLERQGYDA 199
Query: 285 NGDVYSFGIMLMEIFTRTKP 304
             D++S G++L  + T   P
Sbjct: 200 ACDIWSLGVLLYTMLTGYTP 219

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 101/216 (46%), Gaps = 19/216 (8%)
Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVF-----DPQYEGAFKSFDIECDVMKRICHRNLIK 163
           ++G G FG+VYK + I +G +V + V      +     A K    E  VM  + + ++ +
Sbjct: 56  VLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVCR 115
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCL--YLSNYILDIFQR--LDIMIDVASALEYLHFG 219
           ++        + L+ + MP G    CL  Y+  +  +I  +  L+  + +A  + YL   
Sbjct: 116 LLGICLTSTVQ-LITQLMPFG----CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-- 168
Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
               ++H DL   NVL+       ++DFG+AK L  E++          I +MA E    
Sbjct: 169 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 227
Query: 280 GRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMT 314
              +   DV+S+G+ + E+ T  +KP D I + E++
Sbjct: 228 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 263

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 93/195 (47%), Gaps = 9/195 (4%)
Query: 111 IGKGGFGSVYKAII---QDGMEVAVKVFDPQYEGA-FKSFDIECDVMKRICHRNLIKIIS 166
           +G G FGSV + +    +  ++VA+KV     E A  +    E  +M ++ +  ++++I 
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIH 226
               +    LV+E    G L K L      + +    +++  V+  ++YL        +H
Sbjct: 404 VCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVH 459
Query: 227 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT-QTQTLATIGYMAPEYGREGRVSTN 285
            +L   NVLL +   A +SDFG++K L  +D   T ++     + + APE     + S+ 
Sbjct: 460 RNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR 519
Query: 286 GDVYSFGIMLMEIFT 300
            DV+S+G+ + E  +
Sbjct: 520 SDVWSYGVTMWEALS 534

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 101/216 (46%), Gaps = 19/216 (8%)
Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVF-----DPQYEGAFKSFDIECDVMKRICHRNLIK 163
           ++G G FG+VYK + I +G +V + V      +     A K    E  VM  + + ++ +
Sbjct: 25  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCL--YLSNYILDIFQR--LDIMIDVASALEYLHFG 219
           ++        + L+ + MP G    CL  Y+  +  +I  +  L+  + +A  + YL   
Sbjct: 85  LLGICLTSTVQ-LITQLMPFG----CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-- 137
Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
               ++H DL   NVL+       ++DFG+AK L  E++          I +MA E    
Sbjct: 138 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 196
Query: 280 GRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMT 314
              +   DV+S+G+ + E+ T  +KP D I + E++
Sbjct: 197 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 232

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 101/216 (46%), Gaps = 19/216 (8%)
Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVF-----DPQYEGAFKSFDIECDVMKRICHRNLIK 163
           ++G G FG+VYK + I +G +V + V      +     A K    E  VM  + + ++ +
Sbjct: 25  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCL--YLSNYILDIFQR--LDIMIDVASALEYLHFG 219
           ++        + L+ + MP G    CL  Y+  +  +I  +  L+  + +A  + YL   
Sbjct: 85  LLGICLTSTVQ-LITQLMPFG----CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-- 137
Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
               ++H DL   NVL+       ++DFG+AK L  E++          I +MA E    
Sbjct: 138 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 196
Query: 280 GRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMT 314
              +   DV+S+G+ + E+ T  +KP D I + E++
Sbjct: 197 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 232

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 101/216 (46%), Gaps = 19/216 (8%)
Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVF-----DPQYEGAFKSFDIECDVMKRICHRNLIK 163
           ++G G FG+VYK + I +G +V + V      +     A K    E  VM  + + ++ +
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCL--YLSNYILDIFQR--LDIMIDVASALEYLHFG 219
           ++        + L+++ MP G    CL  Y+  +  +I  +  L+  + +A  + YL   
Sbjct: 84  LLGICLTSTVQ-LIMQLMPFG----CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-- 136
Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
               ++H DL   NVL+       ++DFG AK L  E++          I +MA E    
Sbjct: 137 -DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILH 195
Query: 280 GRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMT 314
              +   DV+S+G+ + E+ T  +KP D I + E++
Sbjct: 196 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 231

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 101/216 (46%), Gaps = 19/216 (8%)
Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVF-----DPQYEGAFKSFDIECDVMKRICHRNLIK 163
           ++G G FG+VYK + I +G +V + V      +     A K    E  VM  + + ++ +
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCL--YLSNYILDIFQR--LDIMIDVASALEYLHFG 219
           ++        + L+ + MP G    CL  Y+  +  +I  +  L+  + +A  + YL   
Sbjct: 82  LLGICLTSTVQ-LITQLMPFG----CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-- 134
Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
               ++H DL   NVL+       ++DFG+AK L  E++          I +MA E    
Sbjct: 135 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 280 GRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMT 314
              +   DV+S+G+ + E+ T  +KP D I + E++
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 98/223 (43%), Gaps = 28/223 (12%)
Query: 111 IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDIECDVMKRI--------CHRNL 161
           +G+G F  V + I +  G E A K    +  G     D   +++  I        C R +
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ----DCRAEILHEIAVLELAKSCPR-V 91
Query: 162 IKIISSYSNDDFKALVLEYMPHGSL-EKCLYLSNYILDIFQRLDIMIDVASALEYLHFGY 220
           I +   Y N     L+LEY   G +   CL     + ++    D++  +   LE +++ +
Sbjct: 92  INLHEVYENTSEIILILEYAAGGEIFSLCL---PELAEMVSENDVIRLIKQILEGVYYLH 148
Query: 221 SAPIIHCDLKPSNVLLDDNMV---AHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYG 277
              I+H DLKP N+LL          + DFGM++ +     +    + + T  Y+APE  
Sbjct: 149 QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI---GHACELREIMGTPEYLAPEIL 205
Query: 278 REGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN 320
               ++T  D+++ GI+   + T T P    F GE   + ++N
Sbjct: 206 NYDPITTATDMWNIGIIAYMLLTHTSP----FVGEDNQETYLN 244

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 100/204 (49%), Gaps = 31/204 (15%)
Query: 111 IGKGGFGSV---YKAIIQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRICHRNLIKI 164
           +G G +GSV   Y A ++   +VAVK     ++    A +++  E  ++K + H N+I +
Sbjct: 28  VGSGAYGSVCSAYDARLRQ--KVAVKKLSRPFQSLIHARRTYR-ELRLLKHLKHENVIGL 84
Query: 165 ISSY----SNDDFKALVLEYMPHGS----LEKCLYLSNYILDIFQRLDIMIDVASALEYL 216
           +  +    S +DF  + L     G+    + KC  LS+  +       ++  +   L+Y+
Sbjct: 85  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQF-----LVYQLLRGLKYI 139
Query: 217 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEY 276
           H   SA IIH DLKPSNV ++++    + DFG+A+   EE      T  +AT  Y APE 
Sbjct: 140 H---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADEE-----MTGYVATRWYRAPEI 191
Query: 277 GREG-RVSTNGDVYSFGIMLMEIF 299
                  +   D++S G ++ E+ 
Sbjct: 192 MLNWMHYNQTVDIWSVGCIMAELL 215

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 103/218 (47%), Gaps = 11/218 (5%)
Query: 90  LILRYQKRGKPLPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDI 148
            + + QK G+   +D      +G G  G V+K   +  G+ +A K+   + + A ++  I
Sbjct: 20  FLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII 79
Query: 149 -ECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILD-IFQRLDIM 206
            E  V+       ++    ++ +D   ++ +E+M  GSL++ L  +  I + I  ++ I 
Sbjct: 80  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA 139
Query: 207 IDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL 266
             V   L YL   +   I+H D+KPSN+L++      L DFG++  L++          +
Sbjct: 140 --VIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFV 191
Query: 267 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKP 304
            T  YM+PE  +    S   D++S G+ L+E+     P
Sbjct: 192 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 101/216 (46%), Gaps = 19/216 (8%)
Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVF-----DPQYEGAFKSFDIECDVMKRICHRNLIK 163
           ++G G FG+VYK + I +G +V + V      +     A K    E  VM  + + ++ +
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCL--YLSNYILDIFQR--LDIMIDVASALEYLHFG 219
           ++        + L+ + MP G    CL  Y+  +  +I  +  L+  + +A  + YL   
Sbjct: 82  LLGICLTSTVQ-LITQLMPFG----CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-- 134
Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
               ++H DL   NVL+       ++DFG+AK L  E++          I +MA E    
Sbjct: 135 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 280 GRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMT 314
              +   DV+S+G+ + E+ T  +KP D I + E++
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 101/216 (46%), Gaps = 19/216 (8%)
Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVF-----DPQYEGAFKSFDIECDVMKRICHRNLIK 163
           ++G G FG+VYK + I +G +V + V      +     A K    E  VM  + + ++ +
Sbjct: 29  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 88
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCL--YLSNYILDIFQR--LDIMIDVASALEYLHFG 219
           ++        + L+ + MP G    CL  Y+  +  +I  +  L+  + +A  + YL   
Sbjct: 89  LLGICLTSTVQ-LITQLMPFG----CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-- 141
Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
               ++H DL   NVL+       ++DFG+AK L  E++          I +MA E    
Sbjct: 142 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 200
Query: 280 GRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMT 314
              +   DV+S+G+ + E+ T  +KP D I + E++
Sbjct: 201 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 236

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 101/216 (46%), Gaps = 19/216 (8%)
Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVF-----DPQYEGAFKSFDIECDVMKRICHRNLIK 163
           ++G G FG+VYK + I +G +V + V      +     A K    E  VM  + + ++ +
Sbjct: 25  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCL--YLSNYILDIFQR--LDIMIDVASALEYLHFG 219
           ++        + L+ + MP G    CL  Y+  +  +I  +  L+  + +A  + YL   
Sbjct: 85  LLGICLTSTVQ-LITQLMPFG----CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-- 137
Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
               ++H DL   NVL+       ++DFG+AK L  E++          I +MA E    
Sbjct: 138 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 196
Query: 280 GRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMT 314
              +   DV+S+G+ + E+ T  +KP D I + E++
Sbjct: 197 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 232

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 101/216 (46%), Gaps = 19/216 (8%)
Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVF-----DPQYEGAFKSFDIECDVMKRICHRNLIK 163
           ++G G FG+VYK + I +G +V + V      +     A K    E  VM  + + ++ +
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCL--YLSNYILDIFQR--LDIMIDVASALEYLHFG 219
           ++        + L+++ MP G    CL  Y+  +  +I  +  L+  + +A  + YL   
Sbjct: 84  LLGICLTSTVQ-LIMQLMPFG----CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-- 136
Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
               ++H DL   NVL+       ++DFG AK L  E++          I +MA E    
Sbjct: 137 -DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILH 195
Query: 280 GRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMT 314
              +   DV+S+G+ + E+ T  +KP D I + E++
Sbjct: 196 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 231

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 101/216 (46%), Gaps = 19/216 (8%)
Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVF-----DPQYEGAFKSFDIECDVMKRICHRNLIK 163
           ++G G FG+VYK + I +G +V + V      +     A K    E  VM  + + ++ +
Sbjct: 32  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 91
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCL--YLSNYILDIFQR--LDIMIDVASALEYLHFG 219
           ++        + L+ + MP G    CL  Y+  +  +I  +  L+  + +A  + YL   
Sbjct: 92  LLGICLTSTVQ-LITQLMPFG----CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-- 144
Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
               ++H DL   NVL+       ++DFG+AK L  E++          I +MA E    
Sbjct: 145 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 203
Query: 280 GRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMT 314
              +   DV+S+G+ + E+ T  +KP D I + E++
Sbjct: 204 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 239

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 101/216 (46%), Gaps = 19/216 (8%)
Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVF-----DPQYEGAFKSFDIECDVMKRICHRNLIK 163
           ++G G FG+VYK + I +G +V + V      +     A K    E  VM  + + ++ +
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCL--YLSNYILDIFQR--LDIMIDVASALEYLHFG 219
           ++        + L+ + MP G    CL  Y+  +  +I  +  L+  + +A  + YL   
Sbjct: 84  LLGICLTSTVQ-LITQLMPFG----CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-- 136
Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
               ++H DL   NVL+       ++DFG+AK L  E++          I +MA E    
Sbjct: 137 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 195
Query: 280 GRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMT 314
              +   DV+S+G+ + E+ T  +KP D I + E++
Sbjct: 196 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 231

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 100/208 (48%), Gaps = 28/208 (13%)
Query: 106 NMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRICHRNL 161
           N+ P +G G +GSV  A   + G  VAVK     ++    A +++  E  ++K + H N+
Sbjct: 46  NLSP-VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENV 103
Query: 162 IKIISSYS--------NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASAL 213
           I ++  ++        ND +    L      ++ KC  L++   D  Q L  +  +   L
Sbjct: 104 IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQILRGL 158
Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
           +Y+H   SA IIH DLKPSN+ ++++    + DFG+A+   +E         +AT  Y A
Sbjct: 159 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MXGXVATRWYRA 210
Query: 274 PEYGREG-RVSTNGDVYSFGIMLMEIFT 300
           PE        +   D++S G ++ E+ T
Sbjct: 211 PEIMLNWMHYNQTVDIWSVGCIMAELLT 238

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 101/208 (48%), Gaps = 28/208 (13%)
Query: 106 NMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRICHRNL 161
           N+ P +G G +GSV  A   + G+ VAVK     ++    A +++  E  ++K + H N+
Sbjct: 26  NLSP-VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENV 83
Query: 162 IKIISSYS--------NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASAL 213
           I ++  ++        ND +    L      ++ KC  L++   D  Q L  +  +   L
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQILRGL 138
Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
           +Y+H   SA IIH DLKPSN+ ++++    + D G+A+   +E      T  +AT  Y A
Sbjct: 139 KYIH---SADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDE-----MTGYVATRWYRA 190
Query: 274 PEYGREG-RVSTNGDVYSFGIMLMEIFT 300
           PE        +   D++S G ++ E+ T
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 100/204 (49%), Gaps = 31/204 (15%)
Query: 111 IGKGGFGSV---YKAIIQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRICHRNLIKI 164
           +G G +GSV   Y A ++   +VAVK     ++    A +++  E  ++K + H N+I +
Sbjct: 36  VGSGAYGSVCSAYDARLRQ--KVAVKKLSRPFQSLIHARRTYR-ELRLLKHLKHENVIGL 92
Query: 165 ISSY----SNDDFKALVLEYMPHGS----LEKCLYLSNYILDIFQRLDIMIDVASALEYL 216
           +  +    S +DF  + L     G+    + KC  LS+  +       ++  +   L+Y+
Sbjct: 93  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQF-----LVYQLLRGLKYI 147
Query: 217 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEY 276
           H   SA IIH DLKPSNV ++++    + DFG+A+   EE      T  +AT  Y APE 
Sbjct: 148 H---SAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEE-----MTGYVATRWYRAPEI 199
Query: 277 GREG-RVSTNGDVYSFGIMLMEIF 299
                  +   D++S G ++ E+ 
Sbjct: 200 MLNWMHYNQTVDIWSVGCIMAELL 223

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 101/208 (48%), Gaps = 28/208 (13%)
Query: 106 NMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRICHRNL 161
           N+ P +G G +GSV  A   + G+ VAVK     ++    A +++  E  ++K + H N+
Sbjct: 26  NLSP-VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENV 83
Query: 162 IKIISSYS--------NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASAL 213
           I ++  ++        ND +    L      ++ KC  L++   D  Q L  +  +   L
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQILRGL 138
Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
           +Y+H   SA IIH DLKPSN+ ++++    + D G+A+   +E      T  +AT  Y A
Sbjct: 139 KYIH---SADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDE-----MTGYVATRWYRA 190
Query: 274 PEYGREG-RVSTNGDVYSFGIMLMEIFT 300
           PE        +   D++S G ++ E+ T
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 101/216 (46%), Gaps = 19/216 (8%)
Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVF-----DPQYEGAFKSFDIECDVMKRICHRNLIK 163
           ++G G FG+VYK + I +G +V + V      +     A K    E  VM  + + ++ +
Sbjct: 26  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 85
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCL--YLSNYILDIFQR--LDIMIDVASALEYLHFG 219
           ++        + L+++ MP G    CL  Y+  +  +I  +  L+  + +A  + YL   
Sbjct: 86  LLGICLTSTVQ-LIMQLMPFG----CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-- 138
Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
               ++H DL   NVL+       ++DFG AK L  E++          I +MA E    
Sbjct: 139 -DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILH 197
Query: 280 GRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMT 314
              +   DV+S+G+ + E+ T  +KP D I + E++
Sbjct: 198 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 233

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 100/208 (48%), Gaps = 28/208 (13%)
Query: 106 NMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRICHRNL 161
           N+ P +G G +GSV  A   + G  VAVK     ++    A +++  E  ++K + H N+
Sbjct: 26  NLSP-VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENV 83
Query: 162 IKIISSYS--------NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASAL 213
           I ++  ++        ND +    L      ++ KC  L++   D  Q L  +  +   L
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQILRGL 138
Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
           +Y+H   SA IIH DLKPSN+ ++++    + DFG+A+   +E         +AT  Y A
Sbjct: 139 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGF-----VATRWYRA 190
Query: 274 PEYGREG-RVSTNGDVYSFGIMLMEIFT 300
           PE        +   D++S G ++ E+ T
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 100/208 (48%), Gaps = 28/208 (13%)
Query: 106 NMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRICHRNL 161
           N+ P +G G +GSV  A   + G  VAVK     ++    A +++  E  ++K + H N+
Sbjct: 26  NLSP-VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENV 83
Query: 162 IKIISSYS--------NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASAL 213
           I ++  ++        ND +    L      ++ KC  L++   D  Q L  +  +   L
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQILRGL 138
Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
           +Y+H   SA IIH DLKPSN+ ++++    + DFG+A+   +E         +AT  Y A
Sbjct: 139 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGF-----VATRWYRA 190
Query: 274 PEYGREG-RVSTNGDVYSFGIMLMEIFT 300
           PE        +   D++S G ++ E+ T
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 100/208 (48%), Gaps = 28/208 (13%)
Query: 106 NMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRICHRNL 161
           N+ P +G G +GSV  A   + G  VAVK     ++    A +++  E  ++K + H N+
Sbjct: 22  NLSP-VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENV 79
Query: 162 IKIISSYS--------NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASAL 213
           I ++  ++        ND +    L      ++ KC  L++   D  Q L  +  +   L
Sbjct: 80  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQILRGL 134
Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
           +Y+H   SA IIH DLKPSN+ ++++    + DFG+A+   +E         +AT  Y A
Sbjct: 135 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGF-----VATRWYRA 186
Query: 274 PEYGREG-RVSTNGDVYSFGIMLMEIFT 300
           PE        +   D++S G ++ E+ T
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLT 214

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 101/216 (46%), Gaps = 19/216 (8%)
Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVF-----DPQYEGAFKSFDIECDVMKRICHRNLIK 163
           ++G G FG+VYK + I +G +V + V      +     A K    E  VM  + + ++ +
Sbjct: 47  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 106
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCL--YLSNYILDIFQR--LDIMIDVASALEYLHFG 219
           ++        + L+ + MP G    CL  Y+  +  +I  +  L+  + +A  + YL   
Sbjct: 107 LLGICLTSTVQ-LITQLMPFG----CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-- 159
Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
               ++H DL   NVL+       ++DFG+AK L  E++          I +MA E    
Sbjct: 160 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 218
Query: 280 GRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMT 314
              +   DV+S+G+ + E+ T  +KP D I + E++
Sbjct: 219 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 254

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 93/202 (46%), Gaps = 15/202 (7%)
Query: 110 LIGKGGFGSVYKAIIQDGMEV-AVKVFDPQYEGAFKSFDIECD-VMKRIC-----HRNLI 162
           ++GKG FG V+ A  +   +  A+K    + +      D+EC  V KR+      H  L 
Sbjct: 24  MLGKGSFGKVFLAEFKKTNQFFAIKAL--KKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 81
Query: 163 KIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSA 222
            +  ++   +    V+EY+  G L   +  S +  D+ +      ++   L++LH   S 
Sbjct: 82  HMFCTFQTKENLFFVMEYLNGGDLMYHIQ-SCHKFDLSRATFYAAEIILGLQFLH---SK 137
Query: 223 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRV 282
            I++ DLK  N+LLD +    ++DFGM K  +  D          T  Y+APE     + 
Sbjct: 138 GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNXFCGTPDYIAPEILLGQKY 195
Query: 283 STNGDVYSFGIMLMEIFTRTKP 304
           + + D +SFG++L E+     P
Sbjct: 196 NHSVDWWSFGVLLYEMLIGQSP 217

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 92/213 (43%), Gaps = 18/213 (8%)
Query: 95  QKRGKPLPNDANMPPL-----IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDI 148
           +K   P  N A++        IG G FG V     ++ G   A+K+ D Q     K  + 
Sbjct: 28  KKWENPAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEH 87
Query: 149 ---ECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDI 205
              E  +++ +    L+K+  S+ ++    +V+EYMP G +   L       +   R   
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARF-Y 146
Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              +    EYLH   S  +I+ DLKP N+L+D      ++DFG AK +      L     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC---- 199
Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEI 298
             T  Y+APE       +   D ++ G+++ E+
Sbjct: 200 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 100/214 (46%), Gaps = 15/214 (7%)
Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVF-----DPQYEGAFKSFDIECDVMKRICHRNLIK 163
           ++G G FG+VYK + I +G +V + V      +     A K    E  VM  + + ++ +
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQR--LDIMIDVASALEYLHFGYS 221
           ++        + L+ + MP G L    Y+  +  +I  +  L+  + +A  + YL     
Sbjct: 82  LLGICLTSTVQ-LITQLMPFGXLLD--YVREHKDNIGSQYLLNWCVQIAKGMNYLE---D 135
Query: 222 APIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGR 281
             ++H DL   NVL+       ++DFG+AK L  E++          I +MA E      
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 282 VSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMT 314
            +   DV+S+G+ + E+ T  +KP D I + E++
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 101/216 (46%), Gaps = 19/216 (8%)
Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVF-----DPQYEGAFKSFDIECDVMKRICHRNLIK 163
           ++G G FG+VYK + I +G +V + V      +     A K    E  VM  + + ++ +
Sbjct: 28  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 87
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCL--YLSNYILDIFQR--LDIMIDVASALEYLHFG 219
           ++        + L+ + MP G    CL  Y+  +  +I  +  L+  + +A  + YL   
Sbjct: 88  LLGICLTSTVQ-LITQLMPFG----CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-- 140
Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
               ++H DL   NVL+       ++DFG+AK L  E++          I +MA E    
Sbjct: 141 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 199
Query: 280 GRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMT 314
              +   DV+S+G+ + E+ T  +KP D I + E++
Sbjct: 200 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 235

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 101/216 (46%), Gaps = 19/216 (8%)
Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVF-----DPQYEGAFKSFDIECDVMKRICHRNLIK 163
           ++G G FG+VYK + I +G +V + V      +     A K    E  VM  + + ++ +
Sbjct: 19  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 78
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCL--YLSNYILDIFQR--LDIMIDVASALEYLHFG 219
           ++        + L+ + MP G    CL  Y+  +  +I  +  L+  + +A  + YL   
Sbjct: 79  LLGICLTSTVQ-LITQLMPFG----CLLDYVREHKDNIGSQYLLNWCVQIAEGMNYLE-- 131
Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
               ++H DL   NVL+       ++DFG+AK L  E++          I +MA E    
Sbjct: 132 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 190
Query: 280 GRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMT 314
              +   DV+S+G+ + E+ T  +KP D I + E++
Sbjct: 191 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 226

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 92/213 (43%), Gaps = 18/213 (8%)
Query: 95  QKRGKPLPNDANMPPL-----IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDI 148
           +K   P  N A++        IG G FG V     ++ G   A+K+ D Q     K  + 
Sbjct: 28  KKWENPAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEH 87
Query: 149 ---ECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDI 205
              E  +++ +    L+K+  S+ ++    +V+EYMP G +   L       +   R   
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARF-Y 146
Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              +    EYLH   S  +I+ DLKP N+L+D      ++DFG AK +      L     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC---- 199
Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEI 298
             T  Y+APE       +   D ++ G+++ E+
Sbjct: 200 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 101/216 (46%), Gaps = 19/216 (8%)
Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVF-----DPQYEGAFKSFDIECDVMKRICHRNLIK 163
           ++G G FG+VYK + I +G +V + V      +     A K    E  VM  + + ++ +
Sbjct: 16  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 75
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCL--YLSNYILDIFQR--LDIMIDVASALEYLHFG 219
           ++        + L+ + MP G    CL  Y+  +  +I  +  L+  + +A  + YL   
Sbjct: 76  LLGICLTSTVQ-LITQLMPFG----CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-- 128
Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
               ++H DL   NVL+       ++DFG+AK L  E++          I +MA E    
Sbjct: 129 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 187
Query: 280 GRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMT 314
              +   DV+S+G+ + E+ T  +KP D I + E++
Sbjct: 188 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 223

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 84/199 (42%), Gaps = 14/199 (7%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYS 169
           IG G +    + + +   ME AVKV D       +  +I   +++   H N+I +   Y 
Sbjct: 35  IGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEI---LLRYGQHPNIITLKDVYD 91
Query: 170 NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
           +     LV E M  G L   +    +  +      ++  +   +EYLH   S  ++H DL
Sbjct: 92  DGKHVYLVTELMRGGELLDKILRQKFFSEREASF-VLHTIGKTVEYLH---SQGVVHRDL 147
Query: 230 KPSNVLLDDNM----VAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
           KPSN+L  D         + DFG AK L  E+  L       T  ++APE  +       
Sbjct: 148 KPSNILYVDESGNPECLRICDFGFAKQLRAENGLL--MTPCYTANFVAPEVLKRQGYDEG 205
Query: 286 GDVYSFGIMLMEIFTRTKP 304
            D++S GI+L  +     P
Sbjct: 206 CDIWSLGILLYTMLAGYTP 224

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 95/197 (48%), Gaps = 11/197 (5%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDI-ECDVMKRICHRNLIKIISSY 168
           +G G  G V+K   +  G+ +A K+   + + A ++  I E  V+       ++    ++
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNYILD-IFQRLDIMIDVASALEYLHFGYSAPIIHC 227
            +D   ++ +E+M  GSL++ L  +  I + I  ++ I   V   L YL   +   I+H 
Sbjct: 74  YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREKHK--IMHR 129
Query: 228 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGD 287
           D+KPSN+L++      L DFG++  L++          + T  YM+PE  +    S   D
Sbjct: 130 DVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSD 185
Query: 288 VYSFGIMLMEIFTRTKP 304
           ++S G+ L+E+     P
Sbjct: 186 IWSMGLSLVEMAVGRYP 202

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 84/199 (42%), Gaps = 14/199 (7%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYS 169
           IG G +    + + +   ME AVKV D       +  +I   +++   H N+I +   Y 
Sbjct: 35  IGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEI---LLRYGQHPNIITLKDVYD 91
Query: 170 NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
           +     LV E M  G L   +    +  +      ++  +   +EYLH   S  ++H DL
Sbjct: 92  DGKHVYLVTELMRGGELLDKILRQKFFSEREASF-VLHTIGKTVEYLH---SQGVVHRDL 147
Query: 230 KPSNVLLDDNM----VAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
           KPSN+L  D         + DFG AK L  E+  L       T  ++APE  +       
Sbjct: 148 KPSNILYVDESGNPECLRICDFGFAKQLRAENGLL--MTPCYTANFVAPEVLKRQGYDEG 205
Query: 286 GDVYSFGIMLMEIFTRTKP 304
            D++S GI+L  +     P
Sbjct: 206 CDIWSLGILLYTMLAGYTP 224

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 100/204 (49%), Gaps = 20/204 (9%)
Query: 106 NMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRICHRNL 161
           N+ P +G G +GSV  A   + G+ VAVK     ++    A +++  E  ++K + H N+
Sbjct: 26  NLSP-VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENV 83
Query: 162 IKIISSY----SNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLH 217
           I ++  +    S ++F  + L     G+    +  S  + D   +  ++  +   L+Y+H
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQF-LIYQILRGLKYIH 142
Query: 218 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYG 277
              SA IIH DLKPSN+ ++++    + DFG+ +   +E      T  +AT  Y APE  
Sbjct: 143 ---SADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDE-----MTGYVATRWYRAPEIM 194
Query: 278 REG-RVSTNGDVYSFGIMLMEIFT 300
                 +   D++S G ++ E+ T
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 95/197 (48%), Gaps = 11/197 (5%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDI-ECDVMKRICHRNLIKIISSY 168
           +G G  G V+K   +  G+ +A K+   + + A ++  I E  V+       ++    ++
Sbjct: 76  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 135
Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNYILD-IFQRLDIMIDVASALEYLHFGYSAPIIHC 227
            +D   ++ +E+M  GSL++ L  +  I + I  ++ I   V   L YL   +   I+H 
Sbjct: 136 YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREKHK--IMHR 191
Query: 228 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGD 287
           D+KPSN+L++      L DFG++  L++          + T  YM+PE  +    S   D
Sbjct: 192 DVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSD 247
Query: 288 VYSFGIMLMEIFTRTKP 304
           ++S G+ L+E+     P
Sbjct: 248 IWSMGLSLVEMAVGRYP 264

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 101/208 (48%), Gaps = 28/208 (13%)
Query: 106 NMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRICHRNL 161
           N+ P +G G +GSV  A   + G+ VAVK     ++    A +++  E  ++K + H N+
Sbjct: 26  NLSP-VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENV 83
Query: 162 IKIISSYS--------NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASAL 213
           I ++  ++        ND +    L      ++ KC  L++   D  Q L  +  +   L
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQILRGL 138
Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
           +Y+H   SA IIH DLKPSN+ ++++    + D G+A+   +E      T  +AT  Y A
Sbjct: 139 KYIH---SADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDE-----MTGYVATRWYRA 190
Query: 274 PEYGREG-RVSTNGDVYSFGIMLMEIFT 300
           PE        +   D++S G ++ E+ T
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 91/196 (46%), Gaps = 24/196 (12%)
Query: 110 LIGKGGFGSVYKAIIQDGME-VAVKVFDPQ-YEGAFKSFDIECDVMKRICHRNLIKIISS 167
           ++G G F  V  A  +   + VA+K    +  EG   S + E  V+ +I H N++ +   
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDI 84
Query: 168 YSNDDFKALVLEYMPHGSL-----EKCLYLSNYILD-IFQRLDIMIDVASALEYLHFGYS 221
           Y +     L+++ +  G L     EK  Y        IFQ LD       A++YLH    
Sbjct: 85  YESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLD-------AVKYLH---D 134
Query: 222 APIIHCDLKPSNVL---LDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGR 278
             I+H DLKP N+L   LD++    +SDFG++K    ED     +    T GY+APE   
Sbjct: 135 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVLA 191
Query: 279 EGRVSTNGDVYSFGIM 294
           +   S   D +S G++
Sbjct: 192 QKPYSKAVDCWSIGVI 207

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 100/225 (44%), Gaps = 39/225 (17%)
Query: 105 ANMPPLIGKGGFGSVYKAIIQD-GMEVAVK------------VFDPQYEGAFKSFDIECD 151
           + M PL G G FG V+ A+ ++   EV VK            + DP+         +E  
Sbjct: 27  STMSPL-GSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPK----LGKVTLEIA 81
Query: 152 VMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLD------I 205
           ++ R+ H N+IK++  + N  F  LV+E   HGS    L L  +I D   RLD      I
Sbjct: 82  ILSRVEHANIIKVLDIFENQGFFQLVME--KHGS---GLDLFAFI-DRHPRLDEPLASYI 135
Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              + SA+ YL       IIH D+K  N+++ ++    L DFG A  L  E   L  T  
Sbjct: 136 FRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL--ERGKLFYT-F 189
Query: 266 LATIGYMAPEY--GREGRVSTNGDVYSFGIMLMEIFTRTKPTDEI 308
             TI Y APE   G   R     +++S G+ L  +     P  E+
Sbjct: 190 CGTIEYCAPEVLMGNPYR-GPELEMWSLGVTLYTLVFEENPFCEL 233

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 95/197 (48%), Gaps = 11/197 (5%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDI-ECDVMKRICHRNLIKIISSY 168
           +G G  G V+K   +  G+ +A K+   + + A ++  I E  V+       ++    ++
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNYILD-IFQRLDIMIDVASALEYLHFGYSAPIIHC 227
            +D   ++ +E+M  GSL++ L  +  I + I  ++ I   V   L YL   +   I+H 
Sbjct: 74  YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREKHK--IMHR 129
Query: 228 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGD 287
           D+KPSN+L++      L DFG++  L++          + T  YM+PE  +    S   D
Sbjct: 130 DVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSD 185
Query: 288 VYSFGIMLMEIFTRTKP 304
           ++S G+ L+E+     P
Sbjct: 186 IWSMGLSLVEMAVGRYP 202

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 95/197 (48%), Gaps = 11/197 (5%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDI-ECDVMKRICHRNLIKIISSY 168
           +G G  G V+K   +  G+ +A K+   + + A ++  I E  V+       ++    ++
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNYILD-IFQRLDIMIDVASALEYLHFGYSAPIIHC 227
            +D   ++ +E+M  GSL++ L  +  I + I  ++ I   V   L YL   +   I+H 
Sbjct: 74  YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREKHK--IMHR 129
Query: 228 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGD 287
           D+KPSN+L++      L DFG++  L++          + T  YM+PE  +    S   D
Sbjct: 130 DVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSD 185
Query: 288 VYSFGIMLMEIFTRTKP 304
           ++S G+ L+E+     P
Sbjct: 186 IWSMGLSLVEMAVGRYP 202

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 95/197 (48%), Gaps = 11/197 (5%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDI-ECDVMKRICHRNLIKIISSY 168
           +G G  G V+K   +  G+ +A K+   + + A ++  I E  V+       ++    ++
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNYILD-IFQRLDIMIDVASALEYLHFGYSAPIIHC 227
            +D   ++ +E+M  GSL++ L  +  I + I  ++ I   V   L YL   +   I+H 
Sbjct: 74  YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREKHK--IMHR 129
Query: 228 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGD 287
           D+KPSN+L++      L DFG++  L++          + T  YM+PE  +    S   D
Sbjct: 130 DVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSD 185
Query: 288 VYSFGIMLMEIFTRTKP 304
           ++S G+ L+E+     P
Sbjct: 186 IWSMGLSLVEMAVGRYP 202

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 95/197 (48%), Gaps = 11/197 (5%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDI-ECDVMKRICHRNLIKIISSY 168
           +G G  G V+K   +  G+ +A K+   + + A ++  I E  V+       ++    ++
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNYILD-IFQRLDIMIDVASALEYLHFGYSAPIIHC 227
            +D   ++ +E+M  GSL++ L  +  I + I  ++ I   V   L YL   +   I+H 
Sbjct: 74  YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREKHK--IMHR 129
Query: 228 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGD 287
           D+KPSN+L++      L DFG++  L++          + T  YM+PE  +    S   D
Sbjct: 130 DVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSD 185
Query: 288 VYSFGIMLMEIFTRTKP 304
           ++S G+ L+E+     P
Sbjct: 186 IWSMGLSLVEMAVGRYP 202

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 91/196 (46%), Gaps = 24/196 (12%)
Query: 110 LIGKGGFGSVYKAIIQDGME-VAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISS 167
           ++G G F  V  A  +   + VA+K    +  EG   S + E  V+ +I H N++ +   
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDI 84
Query: 168 YSNDDFKALVLEYMPHGSL-----EKCLYLSNYILD-IFQRLDIMIDVASALEYLHFGYS 221
           Y +     L+++ +  G L     EK  Y        IFQ LD       A++YLH    
Sbjct: 85  YESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLD-------AVKYLH---D 134
Query: 222 APIIHCDLKPSNVL---LDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGR 278
             I+H DLKP N+L   LD++    +SDFG++K    ED     +    T GY+APE   
Sbjct: 135 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVLA 191
Query: 279 EGRVSTNGDVYSFGIM 294
           +   S   D +S G++
Sbjct: 192 QKPYSKAVDCWSIGVI 207

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 94/196 (47%), Gaps = 24/196 (12%)
Query: 110 LIGKGGFGSVYKAIIQDGME-VAVK-VFDPQYEGAFKSFDIECDVMKRICHRNLIKIISS 167
           ++G G F  V  A  +   + VA+K +     EG   S + E  V+ +I H N++ +   
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI 84
Query: 168 YSNDDFKALVLEYMPHGSL-----EKCLYLSNYILD-IFQRLDIMIDVASALEYLHFGYS 221
           Y +     L+++ +  G L     EK  Y        IFQ LD       A++YLH    
Sbjct: 85  YESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLD-------AVKYLH---D 134
Query: 222 APIIHCDLKPSNVL---LDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGR 278
             I+H DLKP N+L   LD++    +SDFG++K  +E+  S+  T    T GY+APE   
Sbjct: 135 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK--MEDPGSVLST-ACGTPGYVAPEVLA 191
Query: 279 EGRVSTNGDVYSFGIM 294
           +   S   D +S G++
Sbjct: 192 QKPYSKAVDCWSIGVI 207

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 91/196 (46%), Gaps = 24/196 (12%)
Query: 110 LIGKGGFGSVYKAIIQDGME-VAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISS 167
           ++G G F  V  A  +   + VA+K    +  EG   S + E  V+ +I H N++ +   
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDI 84
Query: 168 YSNDDFKALVLEYMPHGSL-----EKCLYLSNYILD-IFQRLDIMIDVASALEYLHFGYS 221
           Y +     L+++ +  G L     EK  Y        IFQ LD       A++YLH    
Sbjct: 85  YESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLD-------AVKYLH---D 134
Query: 222 APIIHCDLKPSNVL---LDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGR 278
             I+H DLKP N+L   LD++    +SDFG++K    ED     +    T GY+APE   
Sbjct: 135 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVLA 191
Query: 279 EGRVSTNGDVYSFGIM 294
           +   S   D +S G++
Sbjct: 192 QKPYSKAVDCWSIGVI 207

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/253 (24%), Positives = 111/253 (43%), Gaps = 25/253 (9%)
Query: 111 IGKGGFGSVYKAI-IQDGMEVA-VKVFDPQ-YEGAFKSFDIECDVMKRICHRNLIKIISS 167
           IG+G F +VYK +  +  +EVA  ++ D +  +   + F  E + +K + H N+++   S
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYDS 93
Query: 168 YSN----DDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMI-DVASALEYLHFGYSA 222
           + +         LV E    G+L+   YL  + +   + L      +   L++LH   + 
Sbjct: 94  WESTVKGKKCIVLVTELXTSGTLK--TYLKRFKVXKIKVLRSWCRQILKGLQFLH-TRTP 150
Query: 223 PIIHCDLKPSNVLLDD-NMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGR 281
           PIIH DLK  N+ +        + D G+A       ++      + T  + APE   E +
Sbjct: 151 PIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEFXAPEXYEE-K 205
Query: 282 VSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPIS--------VMEVVDA 333
              + DVY+FG   +E  T   P  E  +     +R  + + P S        V E+++ 
Sbjct: 206 YDESVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEG 265
Query: 334 NLLSQEDEHFTTK 346
            +   +DE ++ K
Sbjct: 266 CIRQNKDERYSIK 278

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/191 (24%), Positives = 88/191 (46%), Gaps = 12/191 (6%)
Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGA--FKSFDIECDVMKRICHRNLIKIISS 167
           +GKG F  V + + +  G E A K+ + +   A   +  + E  + + + H N++++  S
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 89
Query: 168 YSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHC 227
            S +    L+ + +  G L + +    Y    +   D    +   LE +   +   ++H 
Sbjct: 90  ISEEGHHYLIFDLVTGGELFEDIVAREY----YSEADASHCIQQILEAVLHCHQMGVVHR 145
Query: 228 DLKPSNVLLDDNM---VAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVST 284
           DLKP N+LL   +      L+DFG+A  +  E Q+        T GY++PE  R+     
Sbjct: 146 DLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA--GTPGYLSPEVLRKDPYGK 203
Query: 285 NGDVYSFGIML 295
             D+++ G++L
Sbjct: 204 PVDLWACGVIL 214

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 100/216 (46%), Gaps = 19/216 (8%)
Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVF-----DPQYEGAFKSFDIECDVMKRICHRNLIK 163
           ++G G FG+VYK + I +G +V + V      +     A K    E  VM  + + ++ +
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCL--YLSNYILDIFQR--LDIMIDVASALEYLHFG 219
           ++        + L+ + MP G    CL  Y+  +  +I  +  L+  + +A  + YL   
Sbjct: 82  LLGICLTSTVQ-LITQLMPFG----CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-- 134
Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
               ++H DL   NVL+       ++DFG AK L  E++          I +MA E    
Sbjct: 135 -DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 280 GRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMT 314
              +   DV+S+G+ + E+ T  +KP D I + E++
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 100/216 (46%), Gaps = 19/216 (8%)
Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVF-----DPQYEGAFKSFDIECDVMKRICHRNLIK 163
           ++G G FG+VYK + I +G +V + V      +     A K    E  VM  + + ++ +
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCL--YLSNYILDIFQR--LDIMIDVASALEYLHFG 219
           ++        + L+ + MP G    CL  Y+  +  +I  +  L+  + +A  + YL   
Sbjct: 84  LLGICLTSTVQ-LITQLMPFG----CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-- 136
Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
               ++H DL   NVL+       ++DFG AK L  E++          I +MA E    
Sbjct: 137 -DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILH 195
Query: 280 GRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMT 314
              +   DV+S+G+ + E+ T  +KP D I + E++
Sbjct: 196 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 231

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 20/205 (9%)
Query: 111 IGKGGFGSVYKAI-IQDGMEVAVK-VFDPQYEGAFKSFDI----ECDVMKRIC---HRNL 161
           IG G +G+VYKA     G  VA+K V  P   G      I    E  +++R+    H N+
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 162 IKI--ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYI---LDIFQRLDIMIDVASALEYL 216
           +++  + + S  D +  V     H   +   YL       L      D+M      L++L
Sbjct: 77  VRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFL 136
Query: 217 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEY 276
           H      I+H DLKP N+L+       L+DFG+A+        +  T  + T+ Y APE 
Sbjct: 137 HANC---IVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALTPVVVTLWYRAPEV 190
Query: 277 GREGRVSTNGDVYSFGIMLMEIFTR 301
             +   +T  D++S G +  E+F R
Sbjct: 191 LLQSTYATPVDMWSVGCIFAEMFRR 215

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 100/216 (46%), Gaps = 19/216 (8%)
Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVF-----DPQYEGAFKSFDIECDVMKRICHRNLIK 163
           ++G G FG+VYK + I +G +V + V      +     A K    E  VM  + + ++ +
Sbjct: 29  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 88
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCL--YLSNYILDIFQR--LDIMIDVASALEYLHFG 219
           ++        + L+ + MP G    CL  Y+  +  +I  +  L+  + +A  + YL   
Sbjct: 89  LLGICLTSTVQ-LITQLMPFG----CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-- 141
Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
               ++H DL   NVL+       ++DFG AK L  E++          I +MA E    
Sbjct: 142 -DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILH 200
Query: 280 GRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMT 314
              +   DV+S+G+ + E+ T  +KP D I + E++
Sbjct: 201 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 236

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 33/212 (15%)
Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFK---SFDIECDVMKRICHRNLIKIIS 166
           +G+G FG V  A     G +VA+K+ + +           + E   ++ + H ++IK+  
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 71
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMID---------VASALEYLH 217
              + D   +V+EY             N + D   + D M +         + SA+EY H
Sbjct: 72  VIKSKDEIIMVIEYA-----------GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCH 120
Query: 218 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYG 277
                 I+H DLKP N+LLD+++   ++DFG++   +  D +  +T +  +  Y APE  
Sbjct: 121 ---RHKIVHRDLKPENLLLDEHLNVKIADFGLSN--IMTDGNFLKT-SCGSPNYAAPEV- 173
Query: 278 REGRVSTNG--DVYSFGIMLMEIFTRTKPTDE 307
             G++      DV+S G++L  +  R  P D+
Sbjct: 174 ISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 205

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 93/213 (43%), Gaps = 18/213 (8%)
Query: 95  QKRGKPLPNDANMPPL-----IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDI 148
           +K   P  N A++        +G G FG V     ++ G   A+K+ D Q     K  + 
Sbjct: 14  KKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEH 73
Query: 149 ---ECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDI 205
              E  +++ +    L+K+  S+ ++    +V+EY+P G +   L       +   R   
Sbjct: 74  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-Y 132
Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              +    EYLH   S  +I+ DLKP N+L+D      ++DFG AK +     +L     
Sbjct: 133 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC---- 185
Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEI 298
             T  Y+APE       +   D ++ G+++ E+
Sbjct: 186 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 217

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/243 (25%), Positives = 103/243 (42%), Gaps = 47/243 (19%)
Query: 92  LRYQKRGKPLPNDA-NMPPLIGKGGFGSVYKA------IIQDGMEVAVKVFDPQYEGA-- 142
           L Y       P D  N+   +G+G FG V +A             VAVK+     EGA  
Sbjct: 16  LPYDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATH 72
Query: 143 --FKSFDIECDVMKRICHR-NLIKIISSYSNDDFKALVL------------------EYM 181
              ++   E  ++  I H  N++ ++ + +      +V+                  E++
Sbjct: 73  SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFV 132
Query: 182 PHGSLEKC----LYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD 237
           P+ + E      L L + I   FQ       VA  +E+L    S   IH DL   N+LL 
Sbjct: 133 PYKTPEDLYKDFLTLEHLICYSFQ-------VAKGMEFL---ASRKCIHRDLAARNILLS 182
Query: 238 DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLME 297
           +  V  + DFG+A+ + ++   + +      + +MAPE   +   +   DV+SFG++L E
Sbjct: 183 EKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE 242
Query: 298 IFT 300
           IF+
Sbjct: 243 IFS 245

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 96/198 (48%), Gaps = 10/198 (5%)
Query: 111 IGKGGFGSVYKAIIQDGME-VAVKV--FDPQYEGAFKSFDIECDVMKRICHRNLIKIISS 167
           IG+G +G+V+KA  ++  E VA+K    D   EG   S   E  ++K + H+N++++   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 168 YSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHC 227
             +D    LV E+     L+K     N  LD       +  +   L + H   S  ++H 
Sbjct: 70  LHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHR 125
Query: 228 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRV-STNG 286
           DLKP N+L++ N    L++FG+A+      +    +  + T+ Y  P+     ++ ST+ 
Sbjct: 126 DLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVTLWYRPPDVLFGAKLYSTSI 183
Query: 287 DVYSFGIMLMEIFTRTKP 304
           D++S G +  E+    +P
Sbjct: 184 DMWSAGCIFAELANAGRP 201

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 33/212 (15%)
Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFK---SFDIECDVMKRICHRNLIKIIS 166
           +G+G FG V  A     G +VA+K+ + +           + E   ++ + H ++IK+  
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 81
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMID---------VASALEYLH 217
              + D   +V+EY             N + D   + D M +         + SA+EY H
Sbjct: 82  VIKSKDEIIMVIEYA-----------GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCH 130
Query: 218 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYG 277
                 I+H DLKP N+LLD+++   ++DFG++   +  D +  +T +  +  Y APE  
Sbjct: 131 ---RHKIVHRDLKPENLLLDEHLNVKIADFGLSN--IMTDGNFLKT-SCGSPNYAAPEV- 183
Query: 278 REGRVSTNG--DVYSFGIMLMEIFTRTKPTDE 307
             G++      DV+S G++L  +  R  P D+
Sbjct: 184 ISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 215

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 33/212 (15%)
Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFK---SFDIECDVMKRICHRNLIKIIS 166
           +G+G FG V  A     G +VA+K+ + +           + E   ++ + H ++IK+  
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 75
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMID---------VASALEYLH 217
              + D   +V+EY             N + D   + D M +         + SA+EY H
Sbjct: 76  VIKSKDEIIMVIEYA-----------GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCH 124
Query: 218 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYG 277
                 I+H DLKP N+LLD+++   ++DFG++   +  D +  +T +  +  Y APE  
Sbjct: 125 ---RHKIVHRDLKPENLLLDEHLNVKIADFGLSN--IMTDGNFLKT-SCGSPNYAAPEV- 177
Query: 278 REGRVSTNG--DVYSFGIMLMEIFTRTKPTDE 307
             G++      DV+S G++L  +  R  P D+
Sbjct: 178 ISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 209

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 94/197 (47%), Gaps = 11/197 (5%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDI-ECDVMKRICHRNLIKIISSY 168
           +G G  G V K   +  G+ +A K+   + + A ++  I E  V+       ++    ++
Sbjct: 24  LGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 83
Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNYILD-IFQRLDIMIDVASALEYLHFGYSAPIIHC 227
            +D   ++ +E+M  GSL++ L  +  I + I  ++ I   V   L YL   +   I+H 
Sbjct: 84  YSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA--VLRGLAYLREKHQ--IMHR 139
Query: 228 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGD 287
           D+KPSN+L++      L DFG++  L++          + T  YMAPE  +    S   D
Sbjct: 140 DVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMAPERLQGTHYSVQSD 195
Query: 288 VYSFGIMLMEIFTRTKP 304
           ++S G+ L+E+     P
Sbjct: 196 IWSMGLSLVELAVGRYP 212

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 101/216 (46%), Gaps = 19/216 (8%)
Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVF-----DPQYEGAFKSFDIECDVMKRICHRNLIK 163
           ++  G FG+VYK + I +G +V + V      +     A K    E  VM  + + ++ +
Sbjct: 29  VLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 88
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCL--YLSNYILDIFQR--LDIMIDVASALEYLHFG 219
           ++        + L+++ MP G    CL  Y+  +  +I  +  L+  + +A  + YL   
Sbjct: 89  LLGICLTSTVQ-LIMQLMPFG----CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-- 141
Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
               ++H DL   NVL+       ++DFG+AK L  E++          I +MA E    
Sbjct: 142 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 200
Query: 280 GRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMT 314
              +   DV+S+G+ + E+ T  +KP D I + E++
Sbjct: 201 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 236

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 33/212 (15%)
Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFK---SFDIECDVMKRICHRNLIKIIS 166
           +G+G FG V  A     G +VA+K+ + +           + E   ++ + H ++IK+  
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 80
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMID---------VASALEYLH 217
              + D   +V+EY             N + D   + D M +         + SA+EY H
Sbjct: 81  VIKSKDEIIMVIEYA-----------GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCH 129
Query: 218 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYG 277
                 I+H DLKP N+LLD+++   ++DFG++   +  D +  +T +  +  Y APE  
Sbjct: 130 ---RHKIVHRDLKPENLLLDEHLNVKIADFGLSN--IMTDGNFLKT-SCGSPNYAAPEV- 182
Query: 278 REGRVSTNG--DVYSFGIMLMEIFTRTKPTDE 307
             G++      DV+S G++L  +  R  P D+
Sbjct: 183 ISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 214

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 50/92 (54%), Gaps = 3/92 (3%)
Query: 209 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 268
           VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+ + ++   + +      
Sbjct: 148 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 204
Query: 269 IGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
           + +MAPE   +   +   DV+SFG++L EIF+
Sbjct: 205 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 93/213 (43%), Gaps = 18/213 (8%)
Query: 95  QKRGKPLPNDANMPPL-----IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDI 148
           +K   P  N A++        +G G FG V     ++ G   A+K+ D Q     K  + 
Sbjct: 29  KKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEH 88
Query: 149 ---ECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDI 205
              E  +++ +    L+K+  S+ ++    +V+EY+P G +   L       +   R   
Sbjct: 89  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-Y 147
Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              +    EYLH   S  +I+ DLKP N+L+D      ++DFG AK +     +L     
Sbjct: 148 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC---- 200
Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEI 298
             T  Y+APE       +   D ++ G+++ E+
Sbjct: 201 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 50/92 (54%), Gaps = 3/92 (3%)
Query: 209 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 268
           VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+ + ++   + +      
Sbjct: 148 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 204
Query: 269 IGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
           + +MAPE   +   +   DV+SFG++L EIF+
Sbjct: 205 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 88/199 (44%), Gaps = 14/199 (7%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVKVFD--PQYEGAFKSFDIECDVMKRICHRNLIKIISS 167
           IG G +G   K   + DG  +  K  D     E   +    E ++++ + H N+++    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 168 YSNDDFKAL--VLEYMPHGSLE----KCLYLSNYILDIFQRLDIMIDVASALEYLHFGYS 221
             +     L  V+EY   G L     K      Y+ + F  L +M  +  AL+  H    
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV-LRVMTQLTLALKECHRRSD 132
Query: 222 A--PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
               ++H DLKP+NV LD      L DFG+A+ +L  D S  +T  + T  YM+PE    
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR-ILNHDTSFAKT-FVGTPYYMSPEQMNR 190
Query: 280 GRVSTNGDVYSFGIMLMEI 298
              +   D++S G +L E+
Sbjct: 191 MSYNEKSDIWSLGCLLYEL 209

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 50/92 (54%), Gaps = 3/92 (3%)
Query: 209 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 268
           VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+ + ++   + +      
Sbjct: 157 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 213
Query: 269 IGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
           + +MAPE   +   +   DV+SFG++L EIF+
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 91/202 (45%), Gaps = 17/202 (8%)
Query: 111 IGKGGFGSVYKAI-IQDGMEVAVK-VFDPQ-YEGAFKSFDIECDVMKRIC---HRNLIKI 164
           IG G +G+VYKA     G  VA+K V  P   EG   S   E  +++R+    H N++++
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 165 --ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYI---LDIFQRLDIMIDVASALEYLHFG 219
             + + S  D +  V     H   +   YL       L      D+M      L++LH  
Sbjct: 72  MDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN 131
Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
               I+H DLKP N+L+       L+DFG+A+        +     + T+ Y APE   +
Sbjct: 132 C---IVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALAPVVVTLWYRAPEVLLQ 185
Query: 280 GRVSTNGDVYSFGIMLMEIFTR 301
              +T  D++S G +  E+F R
Sbjct: 186 STYATPVDMWSVGCIFAEMFRR 207

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 50/92 (54%), Gaps = 3/92 (3%)
Query: 209 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 268
           VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+ + ++   + +      
Sbjct: 157 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARLP 213
Query: 269 IGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
           + +MAPE   +   +   DV+SFG++L EIF+
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 100/208 (48%), Gaps = 28/208 (13%)
Query: 106 NMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRICHRNL 161
           N+ P +G G +GSV  A   + G  VAVK     ++    A +++  E  ++K + H N+
Sbjct: 26  NLSP-VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENV 83
Query: 162 IKIISSYS--------NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASAL 213
           I ++  ++        ND +    L      ++ KC  L++   D  Q L  +  +   L
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL--IYQILRGL 138
Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
           +Y+H   SA IIH DLKPSN+ ++++    + DF +A+   +E      T  +AT  Y A
Sbjct: 139 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDE-----MTGYVATRWYRA 190
Query: 274 PEYGREG-RVSTNGDVYSFGIMLMEIFT 300
           PE        +   D++S G ++ E+ T
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 95/214 (44%), Gaps = 35/214 (16%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSY 168
           IG+G +GSV K + +  G  +AVK       E   K   ++ DV+ R    +   I+  Y
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMR--SSDCPYIVQFY 87
Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL------DIM-------IDVASALEY 215
                 AL  E    G    C+ L +   D F +       D++       I +A+    
Sbjct: 88  G-----ALFRE----GDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKAL 138
Query: 216 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE 275
            H   +  IIH D+KPSN+LLD +    L DFG++  L++   S+ +T+      YMAPE
Sbjct: 139 NHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD---SIAKTRDAGCRPYMAPE 195
Query: 276 Y-----GREGRVSTNGDVYSFGIMLMEIFTRTKP 304
                  R+G      DV+S GI L E+ T   P
Sbjct: 196 RIDPSASRQG-YDVRSDVWSLGITLYELATGRFP 228

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 92/213 (43%), Gaps = 18/213 (8%)
Query: 95  QKRGKPLPNDANMPPL-----IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDI 148
           +K   P  N A++        +G G FG V     ++ G   A+K+ D Q     K  + 
Sbjct: 28  KKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEH 87
Query: 149 ---ECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDI 205
              E  +++ +    L+K+  S+ ++    +V+EY+P G +   L       +   R   
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-Y 146
Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              +    EYLH   S  +I+ DLKP N+L+D      ++DFG AK +      L     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEI 298
             T  Y+APE       +   D ++ G+++ E+
Sbjct: 200 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 92/213 (43%), Gaps = 18/213 (8%)
Query: 95  QKRGKPLPNDANMPPL-----IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDI 148
           +K   P  N A++        +G G FG V     ++ G   A+K+ D Q     K  + 
Sbjct: 29  KKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEH 88
Query: 149 ---ECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDI 205
              E  +++ +    L+K+  S+ ++    +V+EY+P G +   L       +   R   
Sbjct: 89  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-Y 147
Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              +    EYLH   S  +I+ DLKP N+L+D      ++DFG AK +      L     
Sbjct: 148 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 200
Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEI 298
             T  Y+APE       +   D ++ G+++ E+
Sbjct: 201 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 92/213 (43%), Gaps = 18/213 (8%)
Query: 95  QKRGKPLPNDANMPPL-----IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDI 148
           +K   P  N A++        +G G FG V     ++ G   A+K+ D Q     K  + 
Sbjct: 28  KKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEH 87
Query: 149 ---ECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDI 205
              E  +++ +    L+K+  S+ ++    +V+EY+P G +   L       +   R   
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-Y 146
Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              +    EYLH   S  +I+ DLKP N+L+D      ++DFG AK +      L     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEI 298
             T  Y+APE       +   D ++ G+++ E+
Sbjct: 200 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 104/230 (45%), Gaps = 33/230 (14%)
Query: 111 IGKGGFGSVYKAIIQDGMEV--AVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
           IG+G +G V K  +Q G  +  A K     +      F  E ++MK + H N+I++  ++
Sbjct: 17  IGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 169 SNDDFKALVLEYMPHGSL-EKCLYLSNYILDIFQRLD---IMIDVASALEYLHFGYSAPI 224
            ++    LV+E    G L E+ ++       +F+  D   IM DV SA+ Y H      +
Sbjct: 76  EDNTDIYLVMELCTGGELFERVVHKR-----VFRESDAARIMKDVLSAVAYCH---KLNV 127
Query: 225 IHCDLKPSNVL-LDDNMVAHLS--DFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGR 281
            H DLKP N L L D+  + L   DFG+A          T+   + T  Y++P+   EG 
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK---VGTPYYVSPQV-LEGL 183
Query: 282 VSTNGDVYSFGIMLMEIFTR----TKPTD-----EIFSGEMTL--KRWVN 320
                D +S G+M+  +       + PTD     +I  G  T   K W+N
Sbjct: 184 YGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLN 233

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/237 (24%), Positives = 107/237 (45%), Gaps = 31/237 (13%)
Query: 91  ILRYQKRGKPLPN----------DANMPPLIGKGGFGSVYKAIIQDGMEV-AVKVFDPQY 139
           IL Y +  KP  +          D  +  +IG+G FG V    +++  +V A+K+ + ++
Sbjct: 52  ILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILN-KW 110
Query: 140 E----GAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLY-LSN 194
           E         F  E DV+     + +  +  ++ +D+   LV++Y   G L   L    +
Sbjct: 111 EMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFED 170
Query: 195 YILDIFQR--LDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP 252
            + +   R  L  M+    ++  LH+      +H D+KP N+L+D N    L+DFG    
Sbjct: 171 RLPEEMARFYLAEMVIAIDSVHQLHY------VHRDIKPDNILMDMNGHIRLADFGSCLK 224
Query: 253 LLEEDQSLTQTQTLATIGYMAPEY-----GREGRVSTNGDVYSFGIMLMEIFTRTKP 304
           L+ ED ++  +  + T  Y++PE      G +GR     D +S G+ + E+     P
Sbjct: 225 LM-EDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 50/92 (54%), Gaps = 3/92 (3%)
Query: 209 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 268
           VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+ + ++   + +      
Sbjct: 200 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 269 IGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
           + +MAPE   +   +   DV+SFG++L EIF+
Sbjct: 257 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 50/92 (54%), Gaps = 3/92 (3%)
Query: 209 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 268
           VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+ + ++   + +      
Sbjct: 209 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 269 IGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
           + +MAPE   +   +   DV+SFG++L EIF+
Sbjct: 266 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 50/92 (54%), Gaps = 3/92 (3%)
Query: 209 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 268
           VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+ + ++   + +      
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 269 IGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
           + +MAPE   +   +   DV+SFG++L EIF+
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 92/213 (43%), Gaps = 18/213 (8%)
Query: 95  QKRGKPLPNDANMPPL-----IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDI 148
           +K   P  N A++        IG G FG V     ++ G   A+K+ D Q     K  + 
Sbjct: 28  KKWENPAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEH 87
Query: 149 ---ECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDI 205
              E  +++ +    L+K+  S+ ++    +V+EY+P G +   L       +   R   
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-Y 146
Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              +    EYLH   S  +I+ DLKP N+L+D      ++DFG AK +      L     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC---- 199
Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEI 298
             T  Y+APE       +   D ++ G+++ E+
Sbjct: 200 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 104/230 (45%), Gaps = 33/230 (14%)
Query: 111 IGKGGFGSVYKAIIQDGMEV--AVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
           IG+G +G V K  +Q G  +  A K     +      F  E ++MK + H N+I++  ++
Sbjct: 34  IGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 92
Query: 169 SNDDFKALVLEYMPHGSL-EKCLYLSNYILDIFQRLD---IMIDVASALEYLHFGYSAPI 224
            ++    LV+E    G L E+ ++       +F+  D   IM DV SA+ Y H      +
Sbjct: 93  EDNTDIYLVMELCTGGELFERVVHKR-----VFRESDAARIMKDVLSAVAYCH---KLNV 144
Query: 225 IHCDLKPSNVL-LDDNMVAHLS--DFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGR 281
            H DLKP N L L D+  + L   DFG+A          T+   + T  Y++P+   EG 
Sbjct: 145 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK---VGTPYYVSPQV-LEGL 200
Query: 282 VSTNGDVYSFGIMLMEIFTR----TKPTD-----EIFSGEMTL--KRWVN 320
                D +S G+M+  +       + PTD     +I  G  T   K W+N
Sbjct: 201 YGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLN 250

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 50/92 (54%), Gaps = 3/92 (3%)
Query: 209 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 268
           VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+ + ++   + +      
Sbjct: 207 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 269 IGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
           + +MAPE   +   +   DV+SFG++L EIF+
Sbjct: 264 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 89/194 (45%), Gaps = 22/194 (11%)
Query: 110 LIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
           ++G G F  V+    +  G   A+K           S + E  V+K+I H N++ +   Y
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 169 SNDDFKALVLEYMPHGS-----LEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
            +     LV++ +  G      LE+ +Y       + Q+      V SA++YLH      
Sbjct: 76  ESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQ------VLSAVKYLH---ENG 126
Query: 224 IIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREG 280
           I+H DLKP N+L    ++N    ++DFG++K     +Q+   +    T GY+APE   + 
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLSKM----EQNGIMSTACGTPGYVAPEVLAQK 182
Query: 281 RVSTNGDVYSFGIM 294
             S   D +S G++
Sbjct: 183 PYSKAVDCWSIGVI 196

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 50/92 (54%), Gaps = 3/92 (3%)
Query: 209 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 268
           VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+ + ++   + +      
Sbjct: 157 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 213
Query: 269 IGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
           + +MAPE   +   +   DV+SFG++L EIF+
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 50/94 (53%), Gaps = 3/94 (3%)
Query: 207 IDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL 266
             VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+ + ++   + +    
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 267 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
             + +MAPE   +   +   DV+SFG++L EIF+
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 92/213 (43%), Gaps = 18/213 (8%)
Query: 95  QKRGKPLPNDANMPPL-----IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDI 148
           +K   P  N A++        +G G FG V     ++ G   A+K+ D Q     K  + 
Sbjct: 21  KKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEH 80
Query: 149 ---ECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDI 205
              E  +++ +    L+K+  S+ ++    +V+EY+P G +   L       +   R   
Sbjct: 81  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-Y 139
Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              +    EYLH   S  +I+ DLKP N+L+D      ++DFG AK +      L     
Sbjct: 140 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 192
Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEI 298
             T  Y+APE       +   D ++ G+++ E+
Sbjct: 193 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 224

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 26/206 (12%)
Query: 111 IGKGGFGSVYKAIIQDGME-VAVKV--FDPQYEGAFKSFDIECDVMKRICHRNLIKIISS 167
           +G+G +G VYKAI     E VA+K    + + EG   +   E  ++K + HRN+I++ S 
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 168 YSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEY-----LHFGYSA 222
             ++    L+ EY     L+K  Y+        +  D+ + V  +  Y     ++F +S 
Sbjct: 102 IHHNHRLHLIFEYA-ENDLKK--YMD-------KNPDVSMRVIKSFLYQLINGVNFCHSR 151
Query: 223 PIIHCDLKPSNVLL-----DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYG 277
             +H DLKP N+LL      +  V  + DFG+A+      +    T  + T+ Y  PE  
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF--THEIITLWYRPPEIL 209
Query: 278 REGR-VSTNGDVYSFGIMLMEIFTRT 302
              R  ST+ D++S   +  E+  +T
Sbjct: 210 LGSRHYSTSVDIWSIACIWAEMLMKT 235

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 50/92 (54%), Gaps = 3/92 (3%)
Query: 209 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 268
           VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+ + ++   + +      
Sbjct: 194 VAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 250
Query: 269 IGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
           + +MAPE   +   +   DV+SFG++L EIF+
Sbjct: 251 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 50/94 (53%), Gaps = 3/94 (3%)
Query: 207 IDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL 266
             VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+ + ++   + +    
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 267 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
             + +MAPE   +   +   DV+SFG++L EIF+
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 63/127 (49%), Gaps = 15/127 (11%)
Query: 179 EYMPHGSLEKCLY-----LSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSN 233
           E++P+    + LY     L + I   FQ       VA  +E+L    S   IH DL   N
Sbjct: 131 EFVPYKEAPEDLYKDFLTLEHLICYSFQ-------VAKGMEFL---ASRKCIHRDLAARN 180
Query: 234 VLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGI 293
           +LL +  V  + DFG+A+ + ++   + +      + +MAPE   +   +   DV+SFG+
Sbjct: 181 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 240
Query: 294 MLMEIFT 300
           +L EIF+
Sbjct: 241 LLWEIFS 247

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 94/209 (44%), Gaps = 19/209 (9%)
Query: 117 GSVYKAIIQDGMEVAVKVFDPQYEGAFKS--FDIECDVMKRICHRNLIKIISSYSNDD-- 172
           G ++K   Q G ++ VKV   +     KS  F+ EC  ++   H N++ ++ +  +    
Sbjct: 24  GELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82
Query: 173 FKALVLEYMPHGSLEKCLYL-SNYILDIFQRLDIMIDVASALEYLHFGYSAPII-HCDLK 230
              L+  + P+GSL   L+  +N+++D  Q +   +D A    +LH     P+I    L 
Sbjct: 83  HPTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAFLH--TLEPLIPRHALN 140
Query: 231 PSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN---GD 287
             +V +D++  A +S   +         S           ++APE  ++    TN    D
Sbjct: 141 SRSVXIDEDXTARISXADVK-------FSFQSPGRXYAPAWVAPEALQKKPEDTNRRSAD 193
Query: 288 VYSFGIMLMEIFTRTKPTDEIFSGEMTLK 316
            +SF ++L E+ TR  P  ++ + E+  K
Sbjct: 194 XWSFAVLLWELVTREVPFADLSNXEIGXK 222

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 91/202 (45%), Gaps = 17/202 (8%)
Query: 111 IGKGGFGSVYKAI-IQDGMEVAVK-VFDPQ-YEGAFKSFDIECDVMKRIC---HRNLIKI 164
           IG G +G+VYKA     G  VA+K V  P   EG   S   E  +++R+    H N++++
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 165 --ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYI---LDIFQRLDIMIDVASALEYLHFG 219
             + + S  D +  V     H   +   YL       L      D+M      L++LH  
Sbjct: 72  MDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN 131
Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
               I+H DLKP N+L+       L+DFG+A+        +     + T+ Y APE   +
Sbjct: 132 C---IVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALDPVVVTLWYRAPEVLLQ 185
Query: 280 GRVSTNGDVYSFGIMLMEIFTR 301
              +T  D++S G +  E+F R
Sbjct: 186 STYATPVDMWSVGCIFAEMFRR 207

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 98/200 (49%), Gaps = 23/200 (11%)
Query: 111 IGKGGFGSV---YKAIIQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRICHRNLIKI 164
           +G G +GSV   Y A ++   +VAVK     ++    A +++  E  ++K + H N+I +
Sbjct: 36  VGSGAYGSVCSAYDARLRQ--KVAVKKLSRPFQSLIHARRTYR-ELRLLKHLKHENVIGL 92
Query: 165 ISSY----SNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGY 220
           +  +    S +DF  + L     G+    +  S  + D   +  ++  +   L+Y+H   
Sbjct: 93  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQF-LVYQLLRGLKYIH--- 148
Query: 221 SAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREG 280
           SA IIH DLKPSNV ++++    + DFG+A+   EE      T  +AT  Y APE     
Sbjct: 149 SAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEE-----MTGYVATRWYRAPEIMLNW 203
Query: 281 -RVSTNGDVYSFGIMLMEIF 299
              +   D++S G ++ E+ 
Sbjct: 204 MHYNQTVDIWSVGCIMAELL 223

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 92/213 (43%), Gaps = 18/213 (8%)
Query: 95  QKRGKPLPNDANMPPL-----IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDI 148
           +K   P  N A++        +G G FG V     ++ G   A+K+ D Q     K  + 
Sbjct: 29  KKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEH 88
Query: 149 ---ECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDI 205
              E  +++ +    L+K+  S+ ++    +V+EY+P G +   L       +   R   
Sbjct: 89  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-Y 147
Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              +    EYLH   S  +I+ DLKP N+L+D      ++DFG AK +      L     
Sbjct: 148 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 200
Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEI 298
             T  Y+APE       +   D ++ G+++ E+
Sbjct: 201 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 98/216 (45%), Gaps = 24/216 (11%)
Query: 96  KRGKPLPNDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAF--KSFDIECDV 152
           K    LP     P  +G G +GSV  AI  + G +VA+K     ++     K    E  +
Sbjct: 17  KTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLL 76
Query: 153 MKRICHRNLIKII------SSYSN-DDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDI 205
           +K + H N+I ++      SS  N  DF  LV+ +M    L+K + L       F    I
Sbjct: 77  LKHMQHENVIGLLDVFTPASSLRNFYDF-YLVMPFM-QTDLQKIMGLK------FSEEKI 128
Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              V   L+ L + +SA ++H DLKP N+ ++++    + DFG+A+    E      T  
Sbjct: 129 QYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGY 183
Query: 266 LATIGYMAPEYGREG-RVSTNGDVYSFGIMLMEIFT 300
           + T  Y APE        +   D++S G ++ E+ T
Sbjct: 184 VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLT 219

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 92/213 (43%), Gaps = 18/213 (8%)
Query: 95  QKRGKPLPNDANMPPL-----IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDI 148
           +K   P  N A++        +G G FG V     ++ G   A+K+ D Q     K  + 
Sbjct: 28  KKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEH 87
Query: 149 ---ECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDI 205
              E  +++ +    L+K+  S+ ++    +V+EY+P G +   L       +   R   
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-Y 146
Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              +    EYLH   S  +I+ DLKP N+L+D      ++DFG AK +      L     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEI 298
             T  Y+APE       +   D ++ G+++ E+
Sbjct: 200 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 92/213 (43%), Gaps = 18/213 (8%)
Query: 95  QKRGKPLPNDANMPPL-----IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDI 148
           +K   P  N A++        +G G FG V     ++ G   A+K+ D Q     K  + 
Sbjct: 28  KKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEH 87
Query: 149 ---ECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDI 205
              E  +++ +    L+K+  S+ ++    +V+EY+P G +   L       +   R   
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-Y 146
Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              +    EYLH   S  +I+ DLKP N+L+D      ++DFG AK +      L     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEI 298
             T  Y+APE       +   D ++ G+++ E+
Sbjct: 200 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 92/213 (43%), Gaps = 18/213 (8%)
Query: 95  QKRGKPLPNDANMPPL-----IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDI 148
           +K   P  N A++        +G G FG V     ++ G   A+K+ D Q     K  + 
Sbjct: 28  KKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEH 87
Query: 149 ---ECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDI 205
              E  +++ +    L+K+  S+ ++    +V+EY+P G +   L       +   R   
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-Y 146
Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              +    EYLH   S  +I+ DLKP N+L+D      ++DFG AK +      L     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEI 298
             T  Y+APE       +   D ++ G+++ E+
Sbjct: 200 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 100/216 (46%), Gaps = 19/216 (8%)
Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVF-----DPQYEGAFKSFDIECDVMKRICHRNLIK 163
           ++  G FG+VYK + I +G +V + V      +     A K    E  VM  + + ++ +
Sbjct: 29  VLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 88
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCL--YLSNYILDIFQR--LDIMIDVASALEYLHFG 219
           ++        + L+ + MP G    CL  Y+  +  +I  +  L+  + +A  + YL   
Sbjct: 89  LLGICLTSTVQ-LITQLMPFG----CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-- 141
Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
               ++H DL   NVL+       ++DFG+AK L  E++          I +MA E    
Sbjct: 142 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 200
Query: 280 GRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMT 314
              +   DV+S+G+ + E+ T  +KP D I + E++
Sbjct: 201 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 236

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 92/213 (43%), Gaps = 18/213 (8%)
Query: 95  QKRGKPLPNDANMPPL-----IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDI 148
           +K   P  N A++        +G G FG V     ++ G   A+K+ D Q     K  + 
Sbjct: 28  KKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEH 87
Query: 149 ---ECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDI 205
              E  +++ +    L+K+  S+ ++    +V+EY+P G +   L       +   R   
Sbjct: 88  TLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-Y 146
Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              +    EYLH   S  +I+ DLKP N+L+D      ++DFG AK +      L     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEI 298
             T  Y+APE       +   D ++ G+++ E+
Sbjct: 200 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 92/213 (43%), Gaps = 18/213 (8%)
Query: 95  QKRGKPLPNDANMPPL-----IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDI 148
           +K   P  N A++        +G G FG V     ++ G   A+K+ D Q     K  + 
Sbjct: 28  KKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEH 87
Query: 149 ---ECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDI 205
              E  +++ +    L+K+  S+ ++    +V+EY+P G +   L       +   R   
Sbjct: 88  TLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-Y 146
Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              +    EYLH   S  +I+ DLKP N+L+D      ++DFG AK +      L     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEI 298
             T  Y+APE       +   D ++ G+++ E+
Sbjct: 200 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 92/213 (43%), Gaps = 18/213 (8%)
Query: 95  QKRGKPLPNDANMPPL-----IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDI 148
           +K   P  N A++        +G G FG V     ++ G   A+K+ D Q     K  + 
Sbjct: 28  KKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEH 87
Query: 149 ---ECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDI 205
              E  +++ +    L+K+  S+ ++    +V+EY+P G +   L       +   R   
Sbjct: 88  TLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-Y 146
Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              +    EYLH   S  +I+ DLKP N+L+D      ++DFG AK +      L     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEI 298
             T  Y+APE       +   D ++ G+++ E+
Sbjct: 200 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 100/216 (46%), Gaps = 19/216 (8%)
Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVF-----DPQYEGAFKSFDIECDVMKRICHRNLIK 163
           ++  G FG+VYK + I +G +V + V      +     A K    E  VM  + + ++ +
Sbjct: 22  VLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCL--YLSNYILDIFQR--LDIMIDVASALEYLHFG 219
           ++        + L+ + MP G    CL  Y+  +  +I  +  L+  + +A  + YL   
Sbjct: 82  LLGICLTSTVQ-LITQLMPFG----CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-- 134
Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
               ++H DL   NVL+       ++DFG+AK L  E++          I +MA E    
Sbjct: 135 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 280 GRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMT 314
              +   DV+S+G+ + E+ T  +KP D I + E++
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 92/202 (45%), Gaps = 17/202 (8%)
Query: 111 IGKGGFGSVYKAI-IQDGMEVAVK-VFDPQ-YEGAFKSFDIECDVMKRIC---HRNLIKI 164
           IG G +G+VYKA     G  VA+K V  P   EG   S   E  +++R+    H N++++
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 165 --ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYI---LDIFQRLDIMIDVASALEYLHFG 219
             + + S  D +  V     H   +   YL       L      D+M      L++LH  
Sbjct: 72  MDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH-- 129
Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
            +  I+H DLKP N+L+       L+DFG+A+        +     + T+ Y APE   +
Sbjct: 130 -ANCIVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALFPVVVTLWYRAPEVLLQ 185
Query: 280 GRVSTNGDVYSFGIMLMEIFTR 301
              +T  D++S G +  E+F R
Sbjct: 186 STYATPVDMWSVGCIFAEMFRR 207

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/209 (22%), Positives = 93/209 (44%), Gaps = 13/209 (6%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYS 169
           +G G FG V++ + +  G     K  +  Y     +   E  +M ++ H  LI +  ++ 
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 170 NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
           +     L+LE++  G L   +   +Y +   + ++ M      L+++H      I+H D+
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDI 175
Query: 230 KPSNVLLDDNMVAHLS--DFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGD 287
           KP N++ +    + +   DFG+A  L  ++       T AT  + APE      V    D
Sbjct: 176 KPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTD 232
Query: 288 VYSFGIMLMEIFTRTKPTDEIFSGEMTLK 316
           +++ G++   + +   P    F+GE  L+
Sbjct: 233 MWAIGVLGYVLLSGLSP----FAGEDDLE 257

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 92/213 (43%), Gaps = 18/213 (8%)
Query: 95  QKRGKPLPNDANMPPL-----IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDI 148
           +K   P  N A++        +G G FG V     ++ G   A+K+ D Q     K  + 
Sbjct: 21  KKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEH 80
Query: 149 ---ECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDI 205
              E  +++ +    L+K+  S+ ++    +V+EY+P G +   L       +   R   
Sbjct: 81  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-Y 139
Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              +    EYLH   S  +I+ DLKP N+L+D      ++DFG AK +      L     
Sbjct: 140 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 192
Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEI 298
             T  Y+APE       +   D ++ G+++ E+
Sbjct: 193 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 224

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 103/215 (47%), Gaps = 28/215 (13%)
Query: 110 LIGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDI---ECDVMKRICHRNLIKI- 164
           ++G+G   +V++   +  G   A+KVF+       +  D+   E +V+K++ H+N++K+ 
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNI--SFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 165 -ISSYSNDDFKALVLEYMPHGSLEKCLY--LSNYILDIFQRLDIMIDVASALEYLHFGYS 221
            I   +    K L++E+ P GSL   L    + Y L   + L ++ DV   + +L     
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---E 130
Query: 222 APIIHCDLKPSNVLL----DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE-Y 276
             I+H ++KP N++     D   V  L+DFG A+ L +++Q ++      T  Y+ P+ Y
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS---LYGTEEYLHPDMY 187
Query: 277 GR-------EGRVSTNGDVYSFGIMLMEIFTRTKP 304
            R       + +     D++S G+      T + P
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 96/217 (44%), Gaps = 20/217 (9%)
Query: 103 NDANMPPLIGKGGFGSVYKAIIQDGME-VAVKVFD-PQYEGAFKSFDIECDVMKRICHRN 160
           +D  +  +IG G    V  A      E VA+K  +  + + +      E   M +  H N
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 161 LIKIISSYSNDDFKALVLEYMPHGSL--------EKCLYLSNYILDIFQRLDIMIDVASA 212
           ++   +S+   D   LV++ +  GS+         K  + S  +LD      I+ +V   
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSG-VLDESTIATILREVLEG 128
Query: 213 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT----LAT 268
           LEYLH       IH D+K  N+LL ++    ++DFG++   L     +T+ +     + T
Sbjct: 129 LEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVS-AFLATGGDITRNKVRKTFVGT 184
Query: 269 IGYMAPEYGREGR-VSTNGDVYSFGIMLMEIFTRTKP 304
             +MAPE   + R      D++SFGI  +E+ T   P
Sbjct: 185 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 221

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 96/217 (44%), Gaps = 20/217 (9%)
Query: 103 NDANMPPLIGKGGFGSVYKAIIQDGME-VAVKVFD-PQYEGAFKSFDIECDVMKRICHRN 160
           +D  +  +IG G    V  A      E VA+K  +  + + +      E   M +  H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 161 LIKIISSYSNDDFKALVLEYMPHGSL--------EKCLYLSNYILDIFQRLDIMIDVASA 212
           ++   +S+   D   LV++ +  GS+         K  + S  +LD      I+ +V   
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSG-VLDESTIATILREVLEG 133
Query: 213 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT----LAT 268
           LEYLH       IH D+K  N+LL ++    ++DFG++   L     +T+ +     + T
Sbjct: 134 LEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVS-AFLATGGDITRNKVRKTFVGT 189
Query: 269 IGYMAPEYGREGR-VSTNGDVYSFGIMLMEIFTRTKP 304
             +MAPE   + R      D++SFGI  +E+ T   P
Sbjct: 190 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 60/240 (25%), Positives = 102/240 (42%), Gaps = 45/240 (18%)
Query: 110 LIGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDIE--------CDVMKRICHRN 160
           +IGKG F  V + I ++ G + AVK+ D     +      E        C ++K   H +
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK---HPH 87
Query: 161 LIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASA-------- 212
           +++++ +YS+D    +V E+M    L           +I +R D     + A        
Sbjct: 88  IVELLETYSSDGMLYMVFEFMDGADL---------CFEIVKRADAGFVYSEAVASHYMRQ 138
Query: 213 -LEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 268
            LE L + +   IIH D+KP  VLL   +++    L  FG+A  L E    L     + T
Sbjct: 139 ILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE--SGLVAGGRVGT 196
Query: 269 IGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKP----TDEIFSG------EMTLKRW 318
             +MAPE  +        DV+  G++L  + +   P     + +F G      +M  ++W
Sbjct: 197 PHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQW 256

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 60/240 (25%), Positives = 102/240 (42%), Gaps = 45/240 (18%)
Query: 110 LIGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDIE--------CDVMKRICHRN 160
           +IGKG F  V + I ++ G + AVK+ D     +      E        C ++K   H +
Sbjct: 33  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK---HPH 89
Query: 161 LIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASA-------- 212
           +++++ +YS+D    +V E+M    L           +I +R D     + A        
Sbjct: 90  IVELLETYSSDGMLYMVFEFMDGADL---------CFEIVKRADAGFVYSEAVASHYMRQ 140
Query: 213 -LEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 268
            LE L + +   IIH D+KP  VLL   +++    L  FG+A  L E    L     + T
Sbjct: 141 ILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE--SGLVAGGRVGT 198
Query: 269 IGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKP----TDEIFSG------EMTLKRW 318
             +MAPE  +        DV+  G++L  + +   P     + +F G      +M  ++W
Sbjct: 199 PHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQW 258

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 99/238 (41%), Gaps = 19/238 (7%)
Query: 110 LIGKGGFGSVYKAIIQDGMEVAVKVFDPQ----YEGAFKSFDIECDVMKRICHRNLIKII 165
            +GKGGF   Y+    D  EV      P+         +    E  + K + + +++   
Sbjct: 49  FLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFH 108
Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
             + +DDF  +VLE     SL +       + +   R   M      ++YLH   +  +I
Sbjct: 109 GFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARY-FMRQTIQGVQYLH---NNRVI 164
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
           H DLK  N+ L+D+M   + DFG+A   +E D    +T    T  Y+APE   +   S  
Sbjct: 165 HRDLKLGNLFLNDDMDVKIGDFGLATK-IEFDGERKKT-LCGTPNYIAPEVLCKKGHSFE 222
Query: 286 GDVYSFGIMLMEIFTRTKPTD---------EIFSGEMTLKRWVNDLLPISVMEVVDAN 334
            D++S G +L  +     P +          I   E ++ R +N +    +  ++ A+
Sbjct: 223 VDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASALIRRMLHAD 280

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/238 (23%), Positives = 97/238 (40%), Gaps = 19/238 (7%)
Query: 110 LIGKGGFGSVYKAIIQDGMEVAVKVFDPQ----YEGAFKSFDIECDVMKRICHRNLIKII 165
            +GKGGF   Y+    D  EV      P+         +    E  + K + + +++   
Sbjct: 33  FLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFH 92
Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
             + +DDF  +VLE     SL +       + +   R   M      ++YLH   +  +I
Sbjct: 93  GFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARY-FMRQTIQGVQYLH---NNRVI 148
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
           H DLK  N+ L+D+M   + DFG+A  +  E     +     T  Y+APE   +   S  
Sbjct: 149 HRDLKLGNLFLNDDMDVKIGDFGLATKI--EFDGERKKDLCGTPNYIAPEVLCKKGHSFE 206
Query: 286 GDVYSFGIMLMEIFTRTKPTD---------EIFSGEMTLKRWVNDLLPISVMEVVDAN 334
            D++S G +L  +     P +          I   E ++ R +N +    +  ++ A+
Sbjct: 207 VDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASALIRRMLHAD 264

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 92/213 (43%), Gaps = 18/213 (8%)
Query: 95  QKRGKPLPNDANMPPL-----IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDI 148
           +K   P  N A++        +G G FG V     ++ G   A+K+ D Q     K  + 
Sbjct: 29  KKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEH 88
Query: 149 ---ECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDI 205
              E  +++ +    L+K+  S+ ++    +V+EY+P G +   L       +   R   
Sbjct: 89  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-Y 147
Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              +    EYLH   S  +I+ DLKP N+L+D      ++DFG AK +      L     
Sbjct: 148 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 200
Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEI 298
             T  Y+APE       +   D ++ G+++ E+
Sbjct: 201 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 17/203 (8%)
Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISS 167
           IGKG F  V  A  I  G EVAVK+ D       + +    E  + K + H N++K+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEV 81
Query: 168 YSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHC 227
              +    LV EY   G +   L       +   R      + SA++Y H  +   I+H 
Sbjct: 82  IETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFR-QIVSAVQYCHQKF---IVHR 137
Query: 228 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG---YMAPEYGREGRV-S 283
           DLK  N+LLD +    ++DFG +      ++     +  A  G   Y APE  +  +   
Sbjct: 138 DLKAENLLLDADXNIKIADFGFS------NEFTFGNKLDAFCGAPPYAAPELFQGKKYDG 191
Query: 284 TNGDVYSFGIMLMEIFTRTKPTD 306
              DV+S G++L  + + + P D
Sbjct: 192 PEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 92/213 (43%), Gaps = 18/213 (8%)
Query: 95  QKRGKPLPNDANMPPL-----IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDI 148
           +K   P  N A++        +G G FG V     ++ G   A+K+ D Q     K  + 
Sbjct: 29  KKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEH 88
Query: 149 ---ECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDI 205
              E  +++ +    L+K+  S+ ++    +V+EY+P G +   L       +   R   
Sbjct: 89  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-Y 147
Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              +    EYLH   S  +I+ DLKP N+L+D      ++DFG AK +      L     
Sbjct: 148 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 200
Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEI 298
             T  Y+APE       +   D ++ G+++ E+
Sbjct: 201 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 92/213 (43%), Gaps = 18/213 (8%)
Query: 95  QKRGKPLPNDANMPPL-----IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDI 148
           +K   P  N A++        +G G FG V     ++ G   A+K+ D Q     K  + 
Sbjct: 29  KKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEH 88
Query: 149 ---ECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDI 205
              E  +++ +    L+K+  S+ ++    +V+EY+P G +   L       +   R   
Sbjct: 89  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-Y 147
Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              +    EYLH   S  +I+ DLKP N+L+D      ++DFG AK +      L     
Sbjct: 148 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 200
Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEI 298
             T  Y+APE       +   D ++ G+++ E+
Sbjct: 201 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 92/213 (43%), Gaps = 18/213 (8%)
Query: 95  QKRGKPLPNDANMPPL-----IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDI 148
           +K   P  N A++        +G G FG V     ++ G   A+K+ D Q     K  + 
Sbjct: 49  KKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEH 108
Query: 149 ---ECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDI 205
              E  +++ +    L+K+  S+ ++    +V+EY+P G +   L       +   R   
Sbjct: 109 TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-Y 167
Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              +    EYLH   S  +I+ DLKP N+L+D      ++DFG AK +      L     
Sbjct: 168 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 220
Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEI 298
             T  Y+APE       +   D ++ G+++ E+
Sbjct: 221 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 252

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 93/209 (44%), Gaps = 16/209 (7%)
Query: 97  RGKPLPNDANMPPLIGKGGFGSVYKAIIQD---GMEVAVKVFDPQY---EGAFKSFDIEC 150
           R K   ND +   L+GKG FG V   ++++   G   A+K+   +    +        E 
Sbjct: 2   RAKVTMNDFDYLKLLGKGTFGKV--ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTES 59
Query: 151 DVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIM-IDV 209
            V++   H  L  +  ++   D    V+EY   G L    +LS   +   +R      ++
Sbjct: 60  RVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEI 117
Query: 210 ASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATI 269
            SALEYLH   S  +++ D+K  N++LD +    ++DFG+ K  + +    T      T 
Sbjct: 118 VSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTP 172
Query: 270 GYMAPEYGREGRVSTNGDVYSFGIMLMEI 298
            Y+APE   +       D +  G+++ E+
Sbjct: 173 EYLAPEVLEDNDYGRAVDWWGLGVVMYEM 201

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 65/133 (48%), Gaps = 10/133 (7%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRIC---HRNLIKIIS 166
           IG G FGSV+K + + DG   A+K       G+    +   +V        H ++++  S
Sbjct: 15  IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFS 74
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL---DIMIDVASALEYLHFGYSAP 223
           +++ DD   +  EY   GSL   +  +  I+  F+     D+++ V   L Y+H   S  
Sbjct: 75  AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMS 131
Query: 224 IIHCDLKPSNVLL 236
           ++H D+KPSN+ +
Sbjct: 132 LVHMDIKPSNIFI 144

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 65/133 (48%), Gaps = 10/133 (7%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRIC---HRNLIKIIS 166
           IG G FGSV+K + + DG   A+K       G+    +   +V        H ++++  S
Sbjct: 19  IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFS 78
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL---DIMIDVASALEYLHFGYSAP 223
           +++ DD   +  EY   GSL   +  +  I+  F+     D+++ V   L Y+H   S  
Sbjct: 79  AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMS 135
Query: 224 IIHCDLKPSNVLL 236
           ++H D+KPSN+ +
Sbjct: 136 LVHMDIKPSNIFI 148

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 110/244 (45%), Gaps = 31/244 (12%)
Query: 96  KRGKPLPNDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSF------DI 148
           K  +PL +   + PL+G GGFGSVY  I + D + VA+K  +      +          +
Sbjct: 1   KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 60
Query: 149 ECDVMKRICH--RNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIM 206
           E  ++K++      +I+++  +   D   L+LE M     E    L ++I    +R  + 
Sbjct: 61  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERM-----EPVQDLFDFIT---ERGALQ 112
Query: 207 IDVASA-----LEYLHFGYSAPIIHCDLKPSNVLLDDNMVA-HLSDFGMAKPLLEEDQSL 260
            ++A +     LE +   ++  ++H D+K  N+L+D N     L DFG    L    +  
Sbjct: 113 EELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDT 168
Query: 261 TQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMEIFTRTKP---TDEIFSGEMTLK 316
             T    T  Y  PE+ R  R    +  V+S GI+L ++     P    +EI  G++  +
Sbjct: 169 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 228
Query: 317 RWVN 320
           + V+
Sbjct: 229 QRVS 232

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 92/213 (43%), Gaps = 18/213 (8%)
Query: 95  QKRGKPLPNDANMPPL-----IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDI 148
           +K   P  N A++        +G G FG V     ++ G   A+K+ D Q     K  + 
Sbjct: 28  KKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEH 87
Query: 149 ---ECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDI 205
              E  +++ +    L+K+  S+ ++    +V+EY P G +   L       +   R   
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-Y 146
Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              +    EYLH   S  +I+ DLKP N+++D      ++DFG+AK +      L     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXLC---- 199
Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEI 298
             T  Y+APE       +   D ++ G+++ E+
Sbjct: 200 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 63/130 (48%), Gaps = 20/130 (15%)
Query: 203 LDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL--LEEDQSL 260
           L I I +A A+E+LH   S  ++H DLKPSN+    + V  + DFG+   +   EE+Q++
Sbjct: 167 LHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 261 --------TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE 312
                   T    + T  YM+PE       S   D++S G++L E+          FS +
Sbjct: 224 LTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS-------FSTQ 276
Query: 313 MTLKRWVNDL 322
           M   R + D+
Sbjct: 277 MERVRIITDV 286

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 65/133 (48%), Gaps = 10/133 (7%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRIC---HRNLIKIIS 166
           IG G FGSV+K + + DG   A+K       G+    +   +V        H ++++  S
Sbjct: 17  IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFS 76
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL---DIMIDVASALEYLHFGYSAP 223
           +++ DD   +  EY   GSL   +  +  I+  F+     D+++ V   L Y+H   S  
Sbjct: 77  AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMS 133
Query: 224 IIHCDLKPSNVLL 236
           ++H D+KPSN+ +
Sbjct: 134 LVHMDIKPSNIFI 146

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 65/133 (48%), Gaps = 10/133 (7%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRIC---HRNLIKIIS 166
           IG G FGSV+K + + DG   A+K       G+    +   +V        H ++++  S
Sbjct: 17  IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFS 76
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL---DIMIDVASALEYLHFGYSAP 223
           +++ DD   +  EY   GSL   +  +  I+  F+     D+++ V   L Y+H   S  
Sbjct: 77  AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMS 133
Query: 224 IIHCDLKPSNVLL 236
           ++H D+KPSN+ +
Sbjct: 134 LVHMDIKPSNIFI 146

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 22/215 (10%)
Query: 96  KRGKPLPNDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAF--KSFDIECDV 152
           K    LP     P  +G G +GSV  AI  + G +VA+K     ++     K    E  +
Sbjct: 35  KTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLL 94
Query: 153 MKRICHRNLIKII------SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIM 206
           +K + H N+I ++      SS  N     LV+ +M    L+K + +       F    I 
Sbjct: 95  LKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGME------FSEEKIQ 147
Query: 207 IDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL 266
             V   L+ L + +SA ++H DLKP N+ ++++    + DFG+A+    E      T  +
Sbjct: 148 YLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYV 202
Query: 267 ATIGYMAPEYGREG-RVSTNGDVYSFGIMLMEIFT 300
            T  Y APE        +   D++S G ++ E+ T
Sbjct: 203 VTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLT 237

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 87/199 (43%), Gaps = 14/199 (7%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVKVFD--PQYEGAFKSFDIECDVMKRICHRNLIKIISS 167
           IG G +G   K   + DG  +  K  D     E   +    E ++++ + H N+++    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 168 YSNDDFKAL--VLEYMPHGSLE----KCLYLSNYILDIFQRLDIMIDVASALEYLHFGYS 221
             +     L  V+EY   G L     K      Y+ + F  L +M  +  AL+  H    
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV-LRVMTQLTLALKECHRRSD 132
Query: 222 A--PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
               ++H DLKP+NV LD      L DFG+A+ +L  D S  +   + T  YM+PE    
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR-ILNHDTSFAKA-FVGTPYYMSPEQMNR 190
Query: 280 GRVSTNGDVYSFGIMLMEI 298
              +   D++S G +L E+
Sbjct: 191 MSYNEKSDIWSLGCLLYEL 209

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 55/238 (23%), Positives = 97/238 (40%), Gaps = 19/238 (7%)
Query: 110 LIGKGGFGSVYKAIIQDGMEVAVKVFDPQ----YEGAFKSFDIECDVMKRICHRNLIKII 165
            +GKGGF   Y+    D  EV      P+         +    E  + K + + +++   
Sbjct: 49  FLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFH 108
Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
             + +DDF  +VLE     SL +       + +   R   M      ++YLH   +  +I
Sbjct: 109 GFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARY-FMRQTIQGVQYLH---NNRVI 164
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
           H DLK  N+ L+D+M   + DFG+A  +  E     +     T  Y+APE   +   S  
Sbjct: 165 HRDLKLGNLFLNDDMDVKIGDFGLATKI--EFDGERKKXLCGTPNYIAPEVLCKKGHSFE 222
Query: 286 GDVYSFGIMLMEIFTRTKPTD---------EIFSGEMTLKRWVNDLLPISVMEVVDAN 334
            D++S G +L  +     P +          I   E ++ R +N +    +  ++ A+
Sbjct: 223 VDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASALIRRMLHAD 280

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 55/238 (23%), Positives = 97/238 (40%), Gaps = 19/238 (7%)
Query: 110 LIGKGGFGSVYKAIIQDGMEVAVKVFDPQ----YEGAFKSFDIECDVMKRICHRNLIKII 165
            +GKGGF   Y+    D  EV      P+         +    E  + K + + +++   
Sbjct: 49  FLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFH 108
Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
             + +DDF  +VLE     SL +       + +   R   M      ++YLH   +  +I
Sbjct: 109 GFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARY-FMRQTIQGVQYLH---NNRVI 164
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
           H DLK  N+ L+D+M   + DFG+A  +  E     +     T  Y+APE   +   S  
Sbjct: 165 HRDLKLGNLFLNDDMDVKIGDFGLATKI--EFDGERKKDLCGTPNYIAPEVLCKKGHSFE 222
Query: 286 GDVYSFGIMLMEIFTRTKPTD---------EIFSGEMTLKRWVNDLLPISVMEVVDAN 334
            D++S G +L  +     P +          I   E ++ R +N +    +  ++ A+
Sbjct: 223 VDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASALIRRMLHAD 280

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 88/199 (44%), Gaps = 14/199 (7%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVKVFD--PQYEGAFKSFDIECDVMKRICHRNLIKIISS 167
           IG G +G   K   + DG  +  K  D     E   +    E ++++ + H N+++    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 168 YSNDDFKAL--VLEYMPHGSLE----KCLYLSNYILDIFQRLDIMIDVASALEYLHFGYS 221
             +     L  V+EY   G L     K      Y+ + F  L +M  +  AL+  H    
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV-LRVMTQLTLALKECHRRSD 132
Query: 222 A--PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
               ++H DLKP+NV LD      L DFG+A+ +L  D+   + + + T  YM+PE    
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR-ILNHDEDFAK-EFVGTPYYMSPEQMNR 190
Query: 280 GRVSTNGDVYSFGIMLMEI 298
              +   D++S G +L E+
Sbjct: 191 MSYNEKSDIWSLGCLLYEL 209

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 102/215 (47%), Gaps = 28/215 (13%)
Query: 110 LIGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDI---ECDVMKRICHRNLIKI- 164
           ++G+G   +V++   +  G   A+KVF+       +  D+   E +V+K++ H+N++K+ 
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNI--SFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 165 -ISSYSNDDFKALVLEYMPHGSLEKCLY--LSNYILDIFQRLDIMIDVASALEYLHFGYS 221
            I   +    K L++E+ P GSL   L    + Y L   + L ++ DV   + +L     
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---E 130
Query: 222 APIIHCDLKPSNVLL----DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE-Y 276
             I+H ++KP N++     D   V  L+DFG A+ L +++Q +       T  Y+ P+ Y
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVX---LYGTEEYLHPDMY 187
Query: 277 GR-------EGRVSTNGDVYSFGIMLMEIFTRTKP 304
            R       + +     D++S G+      T + P
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 26/211 (12%)
Query: 106 NMPPLIGKGGFGSVYKA---IIQDGMEVAVKVFDPQYEGAFKSFDI-----ECDVMKRIC 157
           N+  ++GKG FG V K    I Q   E AVKV +   + + K+ D      E +++K++ 
Sbjct: 25  NIVCMLGKGSFGEVLKCKDRITQ--QEYAVKVIN---KASAKNKDTSTILREVELLKKLD 79
Query: 158 HRNLIKIISSYSNDDFKALVLEYMPHGSL-EKCLYLSNYILDIFQRLDIMIDVASALEYL 216
           H N++K+     +     +V E    G L ++ +    +      R  I+  V S + Y+
Sbjct: 80  HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR--IIKQVFSGITYM 137
Query: 217 HFGYSAPIIHCDLKPSNVLLDD---NMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
           H      I+H DLKP N+LL+    +    + DFG++       Q+      + T  Y+A
Sbjct: 138 H---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKDRIGTAYYIA 191
Query: 274 PEYGREGRVSTNGDVYSFGIMLMEIFTRTKP 304
           PE  R G      DV+S G++L  + + T P
Sbjct: 192 PEVLR-GTYDEKCDVWSAGVILYILLSGTPP 221

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 92/213 (43%), Gaps = 18/213 (8%)
Query: 95  QKRGKPLPNDANMPPL-----IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDI 148
           +K   P  N A++        +G G FG V     ++ G   A+K+ D Q     K  + 
Sbjct: 28  KKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEH 87
Query: 149 ---ECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDI 205
              E  +++ +    L+K+  S+ ++    +V+EY P G +   L       +   R   
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-Y 146
Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              +    EYLH   S  +I+ DLKP N+++D      ++DFG+AK +      L     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLC---- 199
Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEI 298
             T  Y+APE       +   D ++ G+++ E+
Sbjct: 200 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 91/213 (42%), Gaps = 18/213 (8%)
Query: 95  QKRGKPLPNDANMPPL-----IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDI 148
           +K   P  N A++        +G G FG V     ++ G   A+K+ D Q     K  + 
Sbjct: 28  KKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEH 87
Query: 149 ---ECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDI 205
              E  +++ +    L+K+  S+ ++    +V+EY P G +   L       +   R   
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARF-Y 146
Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              +    EYLH   S  +I+ DLKP N+++D      ++DFG AK +      L     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC---- 199
Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEI 298
             T  Y+APE       +   D ++ G+++ E+
Sbjct: 200 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 91/213 (42%), Gaps = 18/213 (8%)
Query: 95  QKRGKPLPNDANMPPL-----IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDI 148
           +K   P  N A++        +G G FG V     ++ G   A+K+ D Q     K  + 
Sbjct: 28  KKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEH 87
Query: 149 ---ECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDI 205
              E  +++ +    L+K+  S+ ++    +V+EY P G +   L       +   R   
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-Y 146
Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              +    EYLH   S  +I+ DLKP N+++D      ++DFG AK +      L     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEI 298
             T  Y+APE       +   D ++ G+++ E+
Sbjct: 200 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 125/280 (44%), Gaps = 47/280 (16%)
Query: 99  KPLPNDANMPPLIGKGGFGSVYKAIIQDGME-VAVKVFDPQ--YEGAFKSFD------IE 149
           K L ++  M   +G G  G V  A  +   + VA+K+   +    G+ +  D       E
Sbjct: 6   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 150 CDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSL------EKCLYLSNYILDIFQRL 203
            +++K++ H  +IKI + +  +D+  +VLE M  G L       K L  +   L  +Q L
Sbjct: 66  IEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 124
Query: 204 DIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLEEDQSL 260
                   A++YLH      IIH DLKP NVLL   +++ +  ++DFG +K L E   SL
Sbjct: 125 -------LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSL 172
Query: 261 TQTQTLATIGYMAPE----YGREGRVSTNGDVYSFGIMLM----------EIFTRTKPTD 306
            +T    T  Y+APE     G  G  +   D +S G++L           E  T+    D
Sbjct: 173 MRT-LCGTPTYLAPEVLVSVGTAG-YNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKD 230
Query: 307 EIFSGEMTLKRWVNDLLPISVMEVVDANLLSQEDEHFTTK 346
           +I SG+      V   +    +++V   L+      FTT+
Sbjct: 231 QITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTE 270

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 98/202 (48%), Gaps = 25/202 (12%)
Query: 111 IGKGGFGSVYKAIIQDGM-EVAVKV-----FDP-QYEGAFKSFDI-------ECDVMKRI 156
           +G G +G V     ++G  E A+KV     FD  +Y    K+ +        E  ++K +
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 157 CHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYL 216
            H N+IK+   + +  +  LV E+   G L + + ++ +  D     +IM  + S + YL
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI-INRHKFDECDAANIMKQILSGICYL 162
Query: 217 HFGYSAPIIHCDLKPSNVLLDDN---MVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
           H      I+H D+KP N+LL++    +   + DFG++     +D  L     L T  Y+A
Sbjct: 163 H---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLS-SFFSKDYKL--RDRLGTAYYIA 216
Query: 274 PEYGREGRVSTNGDVYSFGIML 295
           PE  ++ + +   DV+S G+++
Sbjct: 217 PEVLKK-KYNEKCDVWSCGVIM 237

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 125/280 (44%), Gaps = 47/280 (16%)
Query: 99  KPLPNDANMPPLIGKGGFGSVYKAIIQDGME-VAVKVFDPQ--YEGAFKSFD------IE 149
           K L ++  M   +G G  G V  A  +   + VA+K+   +    G+ +  D       E
Sbjct: 6   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 150 CDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSL------EKCLYLSNYILDIFQRL 203
            +++K++ H  +IKI + +  +D+  +VLE M  G L       K L  +   L  +Q L
Sbjct: 66  IEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 124
Query: 204 DIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLEEDQSL 260
                   A++YLH      IIH DLKP NVLL   +++ +  ++DFG +K L E   SL
Sbjct: 125 -------LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSL 172
Query: 261 TQTQTLATIGYMAPE----YGREGRVSTNGDVYSFGIMLM----------EIFTRTKPTD 306
            +T    T  Y+APE     G  G  +   D +S G++L           E  T+    D
Sbjct: 173 MRT-LCGTPTYLAPEVLVSVGTAG-YNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKD 230
Query: 307 EIFSGEMTLKRWVNDLLPISVMEVVDANLLSQEDEHFTTK 346
           +I SG+      V   +    +++V   L+      FTT+
Sbjct: 231 QITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTE 270

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/233 (23%), Positives = 100/233 (42%), Gaps = 10/233 (4%)
Query: 110 LIGKGGFGSVYKAIIQDGMEVAVKVFDPQ----YEGAFKSFDIECDVMKRICHRNLIKII 165
            +GKGGF   ++    D  EV      P+         +   +E  + + + H++++   
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 83
Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
             + ++DF  +VLE     SL + L+     L   +    +  +    +YLH      +I
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VI 139
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
           H DLK  N+ L++++   + DFG+A   +E D    +T    T  Y+APE   +   S  
Sbjct: 140 HRDLKLGNLFLNEDLEVKIGDFGLATK-VEYDGERKKT-LCGTPNYIAPEVLSKKGHSFE 197
Query: 286 GDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPISVMEVVDANLLSQ 338
            DV+S G ++  +     P +     E  L+   N+      +  V A+L+ +
Sbjct: 198 VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK 250

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 125/280 (44%), Gaps = 47/280 (16%)
Query: 99  KPLPNDANMPPLIGKGGFGSVYKAIIQDGME-VAVKVFDPQ--YEGAFKSFD------IE 149
           K L ++  M   +G G  G V  A  +   + VA+K+   +    G+ +  D       E
Sbjct: 5   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 64
Query: 150 CDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSL------EKCLYLSNYILDIFQRL 203
            +++K++ H  +IKI + +  +D+  +VLE M  G L       K L  +   L  +Q L
Sbjct: 65  IEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 123
Query: 204 DIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLEEDQSL 260
                   A++YLH      IIH DLKP NVLL   +++ +  ++DFG +K L E   SL
Sbjct: 124 -------LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSL 171
Query: 261 TQTQTLATIGYMAPE----YGREGRVSTNGDVYSFGIMLM----------EIFTRTKPTD 306
            +T    T  Y+APE     G  G  +   D +S G++L           E  T+    D
Sbjct: 172 MRT-LCGTPTYLAPEVLVSVGTAG-YNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKD 229
Query: 307 EIFSGEMTLKRWVNDLLPISVMEVVDANLLSQEDEHFTTK 346
           +I SG+      V   +    +++V   L+      FTT+
Sbjct: 230 QITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTE 269

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/233 (23%), Positives = 100/233 (42%), Gaps = 10/233 (4%)
Query: 110 LIGKGGFGSVYKAIIQDGMEVAVKVFDPQ----YEGAFKSFDIECDVMKRICHRNLIKII 165
            +GKGGF   ++    D  EV      P+         +   +E  + + + H++++   
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 83
Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
             + ++DF  +VLE     SL + L+     L   +    +  +    +YLH      +I
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VI 139
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
           H DLK  N+ L++++   + DFG+A   +E D    +T    T  Y+APE   +   S  
Sbjct: 140 HRDLKLGNLFLNEDLEVKIGDFGLATK-VEYDGERKKT-LCGTPNYIAPEVLSKKGHSFE 197
Query: 286 GDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPISVMEVVDANLLSQ 338
            DV+S G ++  +     P +     E  L+   N+      +  V A+L+ +
Sbjct: 198 VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK 250

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/233 (23%), Positives = 100/233 (42%), Gaps = 10/233 (4%)
Query: 110 LIGKGGFGSVYKAIIQDGMEVAVKVFDPQ----YEGAFKSFDIECDVMKRICHRNLIKII 165
            +GKGGF   ++    D  EV      P+         +   +E  + + + H++++   
Sbjct: 28  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 87
Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
             + ++DF  +VLE     SL + L+     L   +    +  +    +YLH      +I
Sbjct: 88  GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VI 143
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
           H DLK  N+ L++++   + DFG+A   +E D    +T    T  Y+APE   +   S  
Sbjct: 144 HRDLKLGNLFLNEDLEVKIGDFGLATK-VEYDGERKKT-LCGTPNYIAPEVLSKKGHSFE 201
Query: 286 GDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPISVMEVVDANLLSQ 338
            DV+S G ++  +     P +     E  L+   N+      +  V A+L+ +
Sbjct: 202 VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK 254

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 102/203 (50%), Gaps = 22/203 (10%)
Query: 106 NMPPLIGKGGFG---SVYKAIIQDGMEVAVKVFDP-QYEGAFKSFDIECDVMKRICHRNL 161
           N+ P IG G  G   + Y AI++  + +  K+  P Q +   K    E  +MK + H+N+
Sbjct: 28  NLKP-IGSGAQGIVVAAYDAILERNVAIK-KLSRPFQNQTHAKRAYRELVLMKVVNHKNI 85
Query: 162 IKIISSY----SNDDFK--ALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEY 215
           I +++ +    S ++F+   +V+E M   +L + + +    LD  +   ++  +   +++
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQME---LDHERMSYLLYQMLVGIKH 141
Query: 216 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE 275
           LH   SA IIH DLKPSN+++  +    + DFG+A+       S   T  + T  Y APE
Sbjct: 142 LH---SAGIIHRDLKPSNIVVKSDATLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPE 195
Query: 276 YGREGRVSTNGDVYSFGIMLMEI 298
                    N D++S G+++ E+
Sbjct: 196 VILGMGYKENVDIWSVGVIMGEM 218

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 125/280 (44%), Gaps = 47/280 (16%)
Query: 99  KPLPNDANMPPLIGKGGFGSVYKAIIQDGME-VAVKVFDPQ--YEGAFKSFD------IE 149
           K L ++  M   +G G  G V  A  +   + VA+K+   +    G+ +  D       E
Sbjct: 12  KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 71
Query: 150 CDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSL------EKCLYLSNYILDIFQRL 203
            +++K++ H  +IKI + +  +D+  +VLE M  G L       K L  +   L  +Q L
Sbjct: 72  IEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 130
Query: 204 DIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLEEDQSL 260
                   A++YLH      IIH DLKP NVLL   +++ +  ++DFG +K L E   SL
Sbjct: 131 -------LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSL 178
Query: 261 TQTQTLATIGYMAPE----YGREGRVSTNGDVYSFGIMLM----------EIFTRTKPTD 306
            +T    T  Y+APE     G  G  +   D +S G++L           E  T+    D
Sbjct: 179 MRT-LCGTPTYLAPEVLVSVGTAG-YNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKD 236
Query: 307 EIFSGEMTLKRWVNDLLPISVMEVVDANLLSQEDEHFTTK 346
           +I SG+      V   +    +++V   L+      FTT+
Sbjct: 237 QITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTE 276

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 85/189 (44%), Gaps = 15/189 (7%)
Query: 111 IGKGGFGSVYKAIIQDGME--VAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
           +G+G    VY+   Q G +   A+KV     +   K    E  V+ R+ H N+IK+   +
Sbjct: 61  LGRGATSIVYRCK-QKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPNIIKLKEIF 117
Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCD 228
                 +LVLE +  G L   +    Y    +   D    V   LE + + +   I+H D
Sbjct: 118 ETPTEISLVLELVTGGELFDRIVEKGY----YSERDAADAVKQILEAVAYLHENGIVHRD 173
Query: 229 LKPSNVLLDD---NMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
           LKP N+L      +    ++DFG++K  + E Q L +T    T GY APE  R       
Sbjct: 174 LKPENLLYATPAPDAPLKIADFGLSK--IVEHQVLMKT-VCGTPGYCAPEILRGCAYGPE 230
Query: 286 GDVYSFGIM 294
            D++S GI+
Sbjct: 231 VDMWSVGII 239

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 125/280 (44%), Gaps = 47/280 (16%)
Query: 99  KPLPNDANMPPLIGKGGFGSVYKAIIQDGME-VAVKVFDPQ--YEGAFKSFD------IE 149
           K L ++  M   +G G  G V  A  +   + VA+K+   +    G+ +  D       E
Sbjct: 6   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 150 CDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSL------EKCLYLSNYILDIFQRL 203
            +++K++ H  +IKI + +  +D+  +VLE M  G L       K L  +   L  +Q L
Sbjct: 66  IEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 124
Query: 204 DIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLEEDQSL 260
                   A++YLH      IIH DLKP NVLL   +++ +  ++DFG +K L E   SL
Sbjct: 125 -------LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSL 172
Query: 261 TQTQTLATIGYMAPE----YGREGRVSTNGDVYSFGIMLM----------EIFTRTKPTD 306
            +T    T  Y+APE     G  G  +   D +S G++L           E  T+    D
Sbjct: 173 MRT-LCGTPTYLAPEVLVSVGTAG-YNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKD 230
Query: 307 EIFSGEMTLKRWVNDLLPISVMEVVDANLLSQEDEHFTTK 346
           +I SG+      V   +    +++V   L+      FTT+
Sbjct: 231 QITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTE 270

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 91/213 (42%), Gaps = 18/213 (8%)
Query: 95  QKRGKPLPNDANMPPL-----IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDI 148
           +K   P  N A++        +G G FG V     ++ G   A+K+ D Q     K  + 
Sbjct: 28  KKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEH 87
Query: 149 ---ECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDI 205
              E  +++ +    L+K+  S+ ++    +V+EY P G +   L       +   R   
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-Y 146
Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              +    EYLH   S  +I+ DLKP N+++D      ++DFG AK +      L     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC---- 199
Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEI 298
             T  Y+APE       +   D ++ G+++ E+
Sbjct: 200 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 102/203 (50%), Gaps = 22/203 (10%)
Query: 106 NMPPLIGKGGFG---SVYKAIIQDGMEVAVKVFDP-QYEGAFKSFDIECDVMKRICHRNL 161
           N+ P IG G  G   + Y AI++  + +  K+  P Q +   K    E  +MK + H+N+
Sbjct: 28  NLKP-IGSGAQGIVCAAYDAILERNVAIK-KLSRPFQNQTHAKRAYRELVLMKVVNHKNI 85
Query: 162 IKIISSY----SNDDFK--ALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEY 215
           I +++ +    S ++F+   +V+E M   +L + + +    LD  +   ++  +   +++
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQME---LDHERMSYLLYQMLVGIKH 141
Query: 216 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE 275
           LH   SA IIH DLKPSN+++  +    + DFG+A+       S   T  + T  Y APE
Sbjct: 142 LH---SAGIIHRDLKPSNIVVKSDATLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPE 195
Query: 276 YGREGRVSTNGDVYSFGIMLMEI 298
                    N D++S G+++ E+
Sbjct: 196 VILGMGYKENVDIWSVGVIMGEM 218

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 22/209 (10%)
Query: 110 LIGKGGFGSVYKAIIQDG--------MEVAVKVFDPQYEGAFKSFDIECDVMKRICHRN- 160
           ++G G +G V+      G        M+V  K    Q     +    E  V++ I     
Sbjct: 61  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 161 LIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVAS---ALEYLH 217
           L+ +  ++  +    L+L+Y+  G L    +LS    + F   ++ I V     ALE+LH
Sbjct: 121 LVTLHYAFQTETKLHLILDYINGGEL--FTHLSQR--ERFTEHEVQIYVGEIVLALEHLH 176
Query: 218 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYG 277
                 II+ D+K  N+LLD N    L+DFG++K  +  D++        TI YMAP+  
Sbjct: 177 ---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV-ADETERAYDFCGTIEYMAPDIV 232
Query: 278 REGRVSTNG--DVYSFGIMLMEIFTRTKP 304
           R G    +   D +S G+++ E+ T   P
Sbjct: 233 RGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 90/213 (42%), Gaps = 18/213 (8%)
Query: 95  QKRGKPLPNDANMPPL-----IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDI 148
           +K   P  N A++        +G G FG V     ++ G   A+K+ D Q     K  + 
Sbjct: 29  KKWESPAQNTAHLDQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEH 88
Query: 149 ---ECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDI 205
              E  + + +    L+K+  S+ ++    +VLEY P G +   L       +   R   
Sbjct: 89  TLNEKRIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARF-Y 147
Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              +    EYLH   S  +I+ DLKP N+L+D      ++DFG AK +      L     
Sbjct: 148 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC---- 200
Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEI 298
             T  Y+APE       +   D ++ G+++ E+
Sbjct: 201 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 135/306 (44%), Gaps = 48/306 (15%)
Query: 74  EIVLPLSTIFMIVMILLILRYQK-RGKPLPNDANMPPLIGKGGFGSVYKAIIQDGME-VA 131
           EI L LS   + V   L +  Q    K L ++  M   +G G  G V  A  +   + VA
Sbjct: 105 EIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVA 164
Query: 132 VKVFDPQYE--GAFKSFD------IECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPH 183
           +++   +    G+ +  D       E +++K++ H  +IKI + +  +D+  +VLE M  
Sbjct: 165 IRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEG 223
Query: 184 GSL------EKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL- 236
           G L       K L  +   L  +Q L        A++YLH      IIH DLKP NVLL 
Sbjct: 224 GELFDKVVGNKRLKEATCKLYFYQML-------LAVQYLH---ENGIIHRDLKPENVLLS 273
Query: 237 --DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE----YGREGRVSTNGDVYS 290
             +++ +  ++DFG +K L E   SL +T    T  Y+APE     G  G  +   D +S
Sbjct: 274 SQEEDCLIKITDFGHSKILGE--TSLMRT-LCGTPTYLAPEVLVSVGTAG-YNRAVDCWS 329
Query: 291 FGIMLM----------EIFTRTKPTDEIFSGEMTLKRWVNDLLPISVMEVVDANLLSQED 340
            G++L           E  T+    D+I SG+      V   +    +++V   L+    
Sbjct: 330 LGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPK 389
Query: 341 EHFTTK 346
             FTT+
Sbjct: 390 ARFTTE 395

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 26/211 (12%)
Query: 106 NMPPLIGKGGFGSVYKA---IIQDGMEVAVKVFDPQYEGAFKSFDI-----ECDVMKRIC 157
           N+  ++GKG FG V K    I Q   E AVKV +   + + K+ D      E +++K++ 
Sbjct: 25  NIVCMLGKGSFGEVLKCKDRITQ--QEYAVKVIN---KASAKNKDTSTILREVELLKKLD 79
Query: 158 HRNLIKIISSYSNDDFKALVLEYMPHGSL-EKCLYLSNYILDIFQRLDIMIDVASALEYL 216
           H N++K+     +     +V E    G L ++ +    +      R  I+  V S + Y+
Sbjct: 80  HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR--IIKQVFSGITYM 137
Query: 217 HFGYSAPIIHCDLKPSNVLLDD---NMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
           H      I+H DLKP N+LL+    +    + DFG++       Q+      + T  Y+A
Sbjct: 138 H---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKDRIGTAYYIA 191
Query: 274 PEYGREGRVSTNGDVYSFGIMLMEIFTRTKP 304
           PE  R G      DV+S G++L  + + T P
Sbjct: 192 PEVLR-GTYDEKCDVWSAGVILYILLSGTPP 221

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/125 (32%), Positives = 64/125 (51%), Gaps = 11/125 (8%)
Query: 205 IMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ 264
           I + +  ALE+LH   S  +IH D+KPSNVL++      + DFG++  L++   S+ +T 
Sbjct: 158 IAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVD---SVAKTI 212
Query: 265 TLATIGYMAPEY-----GREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV 319
                 YMAPE       ++G  S   D++S GI ++E+     P D   +    LK+ V
Sbjct: 213 DAGCKPYMAPERINPELNQKG-YSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVV 271
Query: 320 NDLLP 324
            +  P
Sbjct: 272 EEPSP 276

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 92/209 (44%), Gaps = 20/209 (9%)
Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICH-RNLIKIISS 167
           L+G G +G VYK   ++ G   A+KV D   +   +    E +++K+  H RN+     +
Sbjct: 31  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRNIATYYGA 89
Query: 168 Y------SNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYS 221
           +        DD   LV+E+   GS+   +   N   +  +   I       L  L   + 
Sbjct: 90  FIKKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGNTLKEEWIAYICREILRGLSHLHQ 147
Query: 222 APIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT-LATIGYMAPEY---- 276
             +IH D+K  NVLL +N    L DFG++  L   D+++ +  T + T  +MAPE     
Sbjct: 148 HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGTPYWMAPEVIACD 204
Query: 277 -GREGRVSTNGDVYSFGIMLMEIFTRTKP 304
              +       D++S GI  +E+     P
Sbjct: 205 ENPDATYDFKSDLWSLGITAIEMAEGAPP 233

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 26/211 (12%)
Query: 106 NMPPLIGKGGFGSVYKA---IIQDGMEVAVKVFDPQYEGAFKSFDI-----ECDVMKRIC 157
           N+  ++GKG FG V K    I Q   E AVKV +   + + K+ D      E +++K++ 
Sbjct: 25  NIVCMLGKGSFGEVLKCKDRITQ--QEYAVKVIN---KASAKNKDTSTILREVELLKKLD 79
Query: 158 HRNLIKIISSYSNDDFKALVLEYMPHGSL-EKCLYLSNYILDIFQRLDIMIDVASALEYL 216
           H N++K+     +     +V E    G L ++ +    +      R  I+  V S + Y+
Sbjct: 80  HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR--IIKQVFSGITYM 137
Query: 217 HFGYSAPIIHCDLKPSNVLLDD---NMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
           H      I+H DLKP N+LL+    +    + DFG++       Q+      + T  Y+A
Sbjct: 138 H---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKDRIGTAYYIA 191
Query: 274 PEYGREGRVSTNGDVYSFGIMLMEIFTRTKP 304
           PE  R G      DV+S G++L  + + T P
Sbjct: 192 PEVLR-GTYDEKCDVWSAGVILYILLSGTPP 221

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 91/216 (42%), Gaps = 31/216 (14%)
Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICH---------- 158
           ++G+G FG V KA    D    A+K      E    +   E  ++  + H          
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVVRYYAAW 71
Query: 159 ---RNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEY 215
              RN +K +++        + +EY  +G+L   ++  N      +   +   +  AL Y
Sbjct: 72  LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSY 131
Query: 216 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE-------EDQSL-----TQT 263
           +H   S  IIH DLKP N+ +D++    + DFG+AK +         + Q+L       T
Sbjct: 132 IH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLT 188
Query: 264 QTLATIGYMAPEY-GREGRVSTNGDVYSFGIMLMEI 298
             + T  Y+A E     G  +   D+YS GI+  E+
Sbjct: 189 SAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM 224

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 135/306 (44%), Gaps = 48/306 (15%)
Query: 74  EIVLPLSTIFMIVMILLILRYQK-RGKPLPNDANMPPLIGKGGFGSVYKAIIQDGME-VA 131
           EI L LS   + V   L +  Q    K L ++  M   +G G  G V  A  +   + VA
Sbjct: 119 EIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVA 178
Query: 132 VKVFDPQYE--GAFKSFD------IECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPH 183
           +++   +    G+ +  D       E +++K++ H  +IKI + +  +D+  +VLE M  
Sbjct: 179 IRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEG 237
Query: 184 GSL------EKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL- 236
           G L       K L  +   L  +Q L        A++YLH      IIH DLKP NVLL 
Sbjct: 238 GELFDKVVGNKRLKEATCKLYFYQML-------LAVQYLH---ENGIIHRDLKPENVLLS 287
Query: 237 --DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE----YGREGRVSTNGDVYS 290
             +++ +  ++DFG +K L E   SL +T    T  Y+APE     G  G  +   D +S
Sbjct: 288 SQEEDCLIKITDFGHSKILGE--TSLMRT-LCGTPTYLAPEVLVSVGTAG-YNRAVDCWS 343
Query: 291 FGIMLM----------EIFTRTKPTDEIFSGEMTLKRWVNDLLPISVMEVVDANLLSQED 340
            G++L           E  T+    D+I SG+      V   +    +++V   L+    
Sbjct: 344 LGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPK 403
Query: 341 EHFTTK 346
             FTT+
Sbjct: 404 ARFTTE 409

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 98/200 (49%), Gaps = 21/200 (10%)
Query: 111 IGKGGFGSVYKAII-QDGMEVAVK-VFDP-QYEGAFKSFDIECDVMKRICHRNLIKIISS 167
           +G G +G+V  A+  + G +VA+K ++ P Q E   K    E  ++K + H N+I ++  
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 168 YSND----DFK--ALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYS 221
           ++ D    DF    LV+ +M    L K +       D  Q L  +  +   L Y+H   +
Sbjct: 93  FTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFL--VYQMLKGLRYIH---A 146
Query: 222 APIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREG- 280
           A IIH DLKP N+ ++++    + DFG+A+   + D  +     + T  Y APE      
Sbjct: 147 AGIIHRDLKPGNLAVNEDCELKILDFGLAR---QADSEM--XGXVVTRWYRAPEVILNWM 201
Query: 281 RVSTNGDVYSFGIMLMEIFT 300
           R +   D++S G ++ E+ T
Sbjct: 202 RYTQTVDIWSVGCIMAEMIT 221

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 108/223 (48%), Gaps = 26/223 (11%)
Query: 106 NMPPLIGKGGFG---SVYKAIIQDGMEVAVKVFDP-QYEGAFKSFDIECDVMKRICHRNL 161
           N+ P IG G  G   + Y A++   + +  K+  P Q +   K    E  +MK + H+N+
Sbjct: 28  NLKP-IGSGAQGIVCAAYDAVLDRNVAIK-KLSRPFQNQTHAKRAYRELVLMKXVNHKNI 85
Query: 162 IKIISSYSN----DDFK--ALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEY 215
           I +++ ++     ++F+   LV+E M   +L + + +    LD  +   ++  +   +++
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQME---LDHERMSYLLYQMLXGIKH 141
Query: 216 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE 275
           LH   SA IIH DLKPSN+++  +    + DFG+A+       S   T  + T  Y APE
Sbjct: 142 LH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPE 195
Query: 276 YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRW 318
                    N D++S G ++ E+  R K    +F G   + +W
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEM-VRHKI---LFPGRDYIDQW 234

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 91/203 (44%), Gaps = 16/203 (7%)
Query: 103 NDANMPPLIGKGGFGSVYKAIIQD---GMEVAVKVFDPQY---EGAFKSFDIECDVMKRI 156
           ND +   L+GKG FG V   ++++   G   A+K+   +    +        E  V++  
Sbjct: 5   NDFDYLKLLGKGTFGKV--ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 157 CHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIM-IDVASALEY 215
            H  L  +  ++   D    V+EY   G L    +LS   +   +R      ++ SALEY
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 216 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE 275
           LH   S  +++ D+K  N++LD +    ++DFG+ K  + +    T      T  Y+APE
Sbjct: 121 LH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKXFCGTPEYLAPE 175
Query: 276 YGREGRVSTNGDVYSFGIMLMEI 298
              +       D +  G+++ E+
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEM 198

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 108/223 (48%), Gaps = 26/223 (11%)
Query: 106 NMPPLIGKGGFG---SVYKAIIQDGMEVAVKVFDP-QYEGAFKSFDIECDVMKRICHRNL 161
           N+ P IG G  G   + Y A++   + +  K+  P Q +   K    E  +MK + H+N+
Sbjct: 28  NLKP-IGSGAQGIVCAAYDAVLDRNVAIK-KLSRPFQNQTHAKRAYRELVLMKXVNHKNI 85
Query: 162 IKIISSYSN----DDFK--ALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEY 215
           I +++ ++     ++F+   LV+E M   +L + + +    LD  +   ++  +   +++
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQME---LDHERMSYLLYQMLCGIKH 141
Query: 216 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE 275
           LH   SA IIH DLKPSN+++  +    + DFG+A+       S   T  + T  Y APE
Sbjct: 142 LH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPE 195
Query: 276 YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRW 318
                    N D++S G ++ E+  R K    +F G   + +W
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEM-VRHKI---LFPGRDYIDQW 234

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 83/200 (41%), Gaps = 16/200 (8%)
Query: 111 IGKGGFGSVYKAIIQDGM--EVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
           IG G + SV K  I      E AVK+ D       +  +I   +++   H N+I +   Y
Sbjct: 30  IGVGSY-SVCKRCIHKATNXEFAVKIIDKSKRDPTEEIEI---LLRYGQHPNIITLKDVY 85
Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCD 228
            +  +  +V E    G L   + L        +   ++  +   +EYLH   +  ++H D
Sbjct: 86  DDGKYVYVVTELXKGGELLDKI-LRQKFFSEREASAVLFTITKTVEYLH---AQGVVHRD 141
Query: 229 LKPSNVLLDDNM----VAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVST 284
           LKPSN+L  D         + DFG AK L  E+  L       T  ++APE         
Sbjct: 142 LKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL--XTPCYTANFVAPEVLERQGYDA 199
Query: 285 NGDVYSFGIMLMEIFTRTKP 304
             D++S G++L    T   P
Sbjct: 200 ACDIWSLGVLLYTXLTGYTP 219

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 91/203 (44%), Gaps = 16/203 (7%)
Query: 103 NDANMPPLIGKGGFGSVYKAIIQD---GMEVAVKVFDPQY---EGAFKSFDIECDVMKRI 156
           ND +   L+GKG FG V   ++++   G   A+K+   +    +        E  V++  
Sbjct: 5   NDFDYLKLLGKGTFGKV--ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 157 CHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIM-IDVASALEY 215
            H  L  +  ++   D    V+EY   G L    +LS   +   +R      ++ SALEY
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 216 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE 275
           LH   S  +++ D+K  N++LD +    ++DFG+ K  + +    T      T  Y+APE
Sbjct: 121 LH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKXFCGTPEYLAPE 175
Query: 276 YGREGRVSTNGDVYSFGIMLMEI 298
              +       D +  G+++ E+
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEM 198

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 91/203 (44%), Gaps = 16/203 (7%)
Query: 103 NDANMPPLIGKGGFGSVYKAIIQD---GMEVAVKVFDPQY---EGAFKSFDIECDVMKRI 156
           ND +   L+GKG FG V   ++++   G   A+K+   +    +        E  V++  
Sbjct: 5   NDFDYLKLLGKGTFGKV--ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 157 CHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIM-IDVASALEY 215
            H  L  +  ++   D    V+EY   G L    +LS   +   +R      ++ SALEY
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 216 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE 275
           LH   S  +++ D+K  N++LD +    ++DFG+ K  + +    T      T  Y+APE
Sbjct: 121 LH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPE 175
Query: 276 YGREGRVSTNGDVYSFGIMLMEI 298
              +       D +  G+++ E+
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEM 198

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 91/203 (44%), Gaps = 16/203 (7%)
Query: 103 NDANMPPLIGKGGFGSVYKAIIQD---GMEVAVKVFDPQY---EGAFKSFDIECDVMKRI 156
           ND +   L+GKG FG V   ++++   G   A+K+   +    +        E  V++  
Sbjct: 10  NDFDYLKLLGKGTFGKV--ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 67
Query: 157 CHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIM-IDVASALEY 215
            H  L  +  ++   D    V+EY   G L    +LS   +   +R      ++ SALEY
Sbjct: 68  RHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEY 125
Query: 216 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE 275
           LH   S  +++ D+K  N++LD +    ++DFG+ K  + +    T      T  Y+APE
Sbjct: 126 LH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKXFCGTPEYLAPE 180
Query: 276 YGREGRVSTNGDVYSFGIMLMEI 298
              +       D +  G+++ E+
Sbjct: 181 VLEDNDYGRAVDWWGLGVVMYEM 203

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 91/203 (44%), Gaps = 16/203 (7%)
Query: 103 NDANMPPLIGKGGFGSVYKAIIQD---GMEVAVKVFDPQY---EGAFKSFDIECDVMKRI 156
           ND +   L+GKG FG V   ++++   G   A+K+   +    +        E  V++  
Sbjct: 5   NDFDYLKLLGKGTFGKV--ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 157 CHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIM-IDVASALEY 215
            H  L  +  ++   D    V+EY   G L    +LS   +   +R      ++ SALEY
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 216 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE 275
           LH   S  +++ D+K  N++LD +    ++DFG+ K  + +    T      T  Y+APE
Sbjct: 121 LH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPE 175
Query: 276 YGREGRVSTNGDVYSFGIMLMEI 298
              +       D +  G+++ E+
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEM 198

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 90/213 (42%), Gaps = 18/213 (8%)
Query: 95  QKRGKPLPNDANMPPL-----IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDI 148
           +K   P  N A++        +G G FG V     ++ G   A+K+ D Q     K  + 
Sbjct: 29  KKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEH 88
Query: 149 ---ECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDI 205
              E  +++ +    L K+  S+ ++    +V+EY P G +   L       +   R   
Sbjct: 89  TLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARF-Y 147
Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              +    EYLH   S  +I+ DLKP N+++D      ++DFG AK +      L     
Sbjct: 148 AAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC---- 200
Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEI 298
             T  Y+APE       +   D ++ G+++ E+
Sbjct: 201 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 91/213 (42%), Gaps = 18/213 (8%)
Query: 95  QKRGKPLPNDANMPPL-----IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDI 148
           +K   P  N A++        +G G FG V     ++ G   A+K+ D Q     K  + 
Sbjct: 29  KKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEH 88
Query: 149 ---ECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDI 205
              E  +++ +    L+K+  S+ ++    +V+EY P G +   L       +   R   
Sbjct: 89  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-Y 147
Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              +    EYLH   S  +I+ DLKP N+++D      ++DFG AK +      L     
Sbjct: 148 AAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC---- 200
Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEI 298
             T  Y+APE       +   D ++ G+++ E+
Sbjct: 201 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 91/203 (44%), Gaps = 16/203 (7%)
Query: 103 NDANMPPLIGKGGFGSVYKAIIQD---GMEVAVKVFDPQY---EGAFKSFDIECDVMKRI 156
           ND +   L+GKG FG V   ++++   G   A+K+   +    +        E  V++  
Sbjct: 5   NDFDYLKLLGKGTFGKV--ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 157 CHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIM-IDVASALEY 215
            H  L  +  ++   D    V+EY   G L    +LS   +   +R      ++ SALEY
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 216 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE 275
           LH   S  +++ D+K  N++LD +    ++DFG+ K  + +    T      T  Y+APE
Sbjct: 121 LH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKXFCGTPEYLAPE 175
Query: 276 YGREGRVSTNGDVYSFGIMLMEI 298
              +       D +  G+++ E+
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEM 198

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/191 (23%), Positives = 87/191 (45%), Gaps = 12/191 (6%)
Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGA--FKSFDIECDVMKRICHRNLIKIISS 167
           +GKG F  V + + +  G E A  + + +   A   +  + E  + + + H N++++  S
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 168 YSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHC 227
            S +    L+ + +  G L + +    Y    +   D    +   LE +   +   ++H 
Sbjct: 79  ISEEGHHYLIFDLVTGGELFEDIVAREY----YSEADASHCIQQILEAVLHCHQMGVVHR 134
Query: 228 DLKPSNVLLDDNM---VAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVST 284
           +LKP N+LL   +      L+DFG+A  +  E Q+        T GY++PE  R+     
Sbjct: 135 NLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA--GTPGYLSPEVLRKDPYGK 192
Query: 285 NGDVYSFGIML 295
             D+++ G++L
Sbjct: 193 PVDLWACGVIL 203

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 97/205 (47%), Gaps = 26/205 (12%)
Query: 111 IGKGGFGSVYKAIIQD--------GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLI 162
           +G+G F  ++K + ++          EV +KV D  +    +SF     +M ++ H++L+
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 163 KIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSA 222
                    D   LV E++  GSL+  L  +   ++I  +L++   +A+A   +HF    
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAA---MHFLEEN 132
Query: 223 PIIHCDLKPSNVLL---DDNMVAH-----LSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 274
            +IH ++   N+LL   +D    +     LSD G++  +L +D  + Q +    I ++ P
Sbjct: 133 TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD--ILQER----IPWVPP 186
Query: 275 EYGREGR-VSTNGDVYSFGIMLMEI 298
           E     + ++   D +SFG  L EI
Sbjct: 187 ECIENPKNLNLATDKWSFGTTLWEI 211

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/233 (22%), Positives = 98/233 (42%), Gaps = 10/233 (4%)
Query: 110 LIGKGGFGSVYKAIIQDGMEVAVKVFDPQ----YEGAFKSFDIECDVMKRICHRNLIKII 165
            +GKGGF   ++    D  EV      P+         +   +E  + + + H++++   
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
             + ++DF  +VLE     SL + L+     L   +    +  +    +YLH      +I
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VI 163
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
           H DLK  N+ L++++   + DFG+A  +  E     +     T  Y+APE   +   S  
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKVLCGTPNYIAPEVLSKKGHSFE 221
Query: 286 GDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPISVMEVVDANLLSQ 338
            DV+S G ++  +     P +     E  L+   N+      +  V A+L+ +
Sbjct: 222 VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK 274

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 90/213 (42%), Gaps = 18/213 (8%)
Query: 95  QKRGKPLPNDANMPPL-----IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDI 148
           +K   P  N A++        +G G FG V     ++ G   A+K+ D Q     K  + 
Sbjct: 29  KKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEH 88
Query: 149 ---ECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDI 205
              E  +++ +    L K+  S+ ++    +V+EY P G +   L       +   R   
Sbjct: 89  TLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-Y 147
Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              +    EYLH   S  +I+ DLKP N+++D      ++DFG AK +      L     
Sbjct: 148 AAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC---- 200
Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEI 298
             T  Y+APE       +   D ++ G+++ E+
Sbjct: 201 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 90/213 (42%), Gaps = 18/213 (8%)
Query: 95  QKRGKPLPNDANMPPL-----IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDI 148
           +K   P  N A++        +G G FG V     ++ G   A+K+ D Q     K  + 
Sbjct: 29  KKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEH 88
Query: 149 ---ECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDI 205
              E  +++ +    L K+  S+ ++    +V+EY P G +   L       +   R   
Sbjct: 89  TLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-Y 147
Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              +    EYLH   S  +I+ DLKP N+++D      ++DFG AK +      L     
Sbjct: 148 AAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC---- 200
Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEI 298
             T  Y+APE       +   D ++ G+++ E+
Sbjct: 201 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 21/208 (10%)
Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRIC------HRNLIK 163
           +G+G FG V  A   +   +VA+K    Q     K  D+   V + I       H ++IK
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQ---LLKKSDMHMRVEREISYLKLLRHPHIIK 73
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
           +    +      +V+EY      +  +       D  +R      +  A+EY H      
Sbjct: 74  LYDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRF--FQQIICAIEYCH---RHK 128
Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVS 283
           I+H DLKP N+LLDDN+   ++DFG++  +   D +  +T +  +  Y APE    G++ 
Sbjct: 129 IVHRDLKPENLLLDDNLNVKIADFGLSNIMT--DGNFLKT-SCGSPNYAAPEVI-NGKLY 184
Query: 284 TNG--DVYSFGIMLMEIFTRTKPTDEIF 309
                DV+S GI+L  +     P D+ F
Sbjct: 185 AGPEVDVWSCGIVLYVMLVGRLPFDDEF 212

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 101/209 (48%), Gaps = 24/209 (11%)
Query: 111 IGKGGFGSVYKAIIQD-GMEVAVK--VFDPQYEGAFKSFDIECDVMKRICHRNLIKII-- 165
           IG+G FG V+KA  +  G +VA+K  + + + EG   +   E  +++ + H N++ +I  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 166 ---SSYSNDDFKA---LVLEYMPH---GSLEKCLYLSNYILDIFQRLDIMIDVASALEYL 216
               +   +  KA   LV ++  H   G L   L    + L   +R  +M  + + L Y+
Sbjct: 86  CRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLV--KFTLSEIKR--VMQMLLNGLYYI 141
Query: 217 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP--LLEEDQSLTQTQTLATIGYMAP 274
           H      I+H D+K +NVL+  + V  L+DFG+A+   L +  Q       + T+ Y  P
Sbjct: 142 H---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 198
Query: 275 EYGREGR-VSTNGDVYSFGIMLMEIFTRT 302
           E     R      D++  G ++ E++TR+
Sbjct: 199 ELLLGERDYGPPIDLWGAGCIMAEMWTRS 227

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/246 (24%), Positives = 110/246 (44%), Gaps = 31/246 (12%)
Query: 94  YQKRGKPLPNDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSF------ 146
           + K  +PL +   + PL+G GGFGSVY  I + D + VA+K  +      +         
Sbjct: 22  HMKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 81
Query: 147 DIECDVMKRICH--RNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLD 204
            +E  ++K++      +I+++  +   D   L+LE       E    L ++I    +R  
Sbjct: 82  PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-----RPEPVQDLFDFIT---ERGA 133
Query: 205 IMIDVASA-----LEYLHFGYSAPIIHCDLKPSNVLLDDNMVA-HLSDFGMAKPLLEEDQ 258
           +  ++A +     LE +   ++  ++H D+K  N+L+D N     L DFG    L    +
Sbjct: 134 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----K 189
Query: 259 SLTQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMEIFTRTKP---TDEIFSGEMT 314
               T    T  Y  PE+ R  R    +  V+S GI+L ++     P    +EI  G++ 
Sbjct: 190 DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF 249
Query: 315 LKRWVN 320
            ++ V+
Sbjct: 250 FRQRVS 255

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/233 (22%), Positives = 98/233 (42%), Gaps = 10/233 (4%)
Query: 110 LIGKGGFGSVYKAIIQDGMEVAVKVFDPQ----YEGAFKSFDIECDVMKRICHRNLIKII 165
            +GKGGF   ++    D  EV      P+         +   +E  + + + H++++   
Sbjct: 46  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 105
Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
             + ++DF  +VLE     SL + L+     L   +    +  +    +YLH      +I
Sbjct: 106 GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VI 161
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
           H DLK  N+ L++++   + DFG+A  +  E     +     T  Y+APE   +   S  
Sbjct: 162 HRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKVLCGTPNYIAPEVLSKKGHSFE 219
Query: 286 GDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPISVMEVVDANLLSQ 338
            DV+S G ++  +     P +     E  L+   N+      +  V A+L+ +
Sbjct: 220 VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK 272

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 91/213 (42%), Gaps = 18/213 (8%)
Query: 95  QKRGKPLPNDANMPPL-----IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDI 148
           +K   P  N A++        +G G FG V     ++ G   A+K+ D Q     K  + 
Sbjct: 28  KKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEH 87
Query: 149 ---ECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDI 205
              E  +++ +    L+K+  S+ ++    +V+EY+  G +   L       +   R   
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-Y 146
Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              +    EYLH   S  +I+ DLKP N+L+D      ++DFG AK +      L     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEI 298
             T  Y+APE       +   D ++ G+++ E+
Sbjct: 200 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 101/203 (49%), Gaps = 22/203 (10%)
Query: 106 NMPPLIGKGGFG---SVYKAIIQDGMEVAVKVFDP-QYEGAFKSFDIECDVMKRICHRNL 161
           N+ P IG G  G   + Y AI++  + +  K+  P Q +   K    E  +MK + H+N+
Sbjct: 28  NLKP-IGSGAQGIVCAAYDAILERNVAIK-KLSRPFQNQTHAKRAYRELVLMKVVNHKNI 85
Query: 162 IKIISSY----SNDDFK--ALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEY 215
           I +++ +    S ++F+   +V+E M   +L + + +    LD  +   ++  +   +++
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQME---LDHERMSYLLYQMLCGIKH 141
Query: 216 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE 275
           LH   SA IIH DLKPSN+++  +    + DFG+A+       S   T  + T  Y APE
Sbjct: 142 LH---SAGIIHRDLKPSNIVVKSDATLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPE 195
Query: 276 YGREGRVSTNGDVYSFGIMLMEI 298
                    N D++S G ++ E+
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEM 218

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 108/223 (48%), Gaps = 26/223 (11%)
Query: 106 NMPPLIGKGGFG---SVYKAIIQDGMEVAVKVFDP-QYEGAFKSFDIECDVMKRICHRNL 161
           N+ P IG G  G   + Y A++   + +  K+  P Q +   K    E  +MK + H+N+
Sbjct: 21  NLKP-IGSGAQGIVCAAYDAVLDRNVAIK-KLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 162 IKIISSYSN----DDFK--ALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEY 215
           I +++ ++     ++F+   LV+E M   +L + + +    LD  +   ++  +   +++
Sbjct: 79  ISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQME---LDHERMSYLLYQMLXGIKH 134
Query: 216 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE 275
           LH   SA IIH DLKPSN+++  +    + DFG+A+       S   T  + T  Y APE
Sbjct: 135 LH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPE 188
Query: 276 YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRW 318
                    N D++S G ++ E+  R K    +F G   + +W
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEM-VRHKI---LFPGRDYIDQW 227

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 93/211 (44%), Gaps = 22/211 (10%)
Query: 94  YQKRGKPLPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY-EGAFKSFDIECD 151
           ++K+ + +         +G G F  V  A  +  G   AVK    +  +G   S + E  
Sbjct: 13  WKKQAEDIKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIA 72
Query: 152 VMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSL-----EKCLYLSNYILDIFQRLDIM 206
           V+++I H N++ +   Y + +   LV++ +  G L     EK  Y       + ++    
Sbjct: 73  VLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQ---- 128
Query: 207 IDVASALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLEEDQSLTQT 263
             V  A+ YLH      I+H DLKP N+L    D+     +SDFG++K    E +    +
Sbjct: 129 --VLDAVYYLH---RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKM---EGKGDVMS 180
Query: 264 QTLATIGYMAPEYGREGRVSTNGDVYSFGIM 294
               T GY+APE   +   S   D +S G++
Sbjct: 181 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 211

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 108/223 (48%), Gaps = 26/223 (11%)
Query: 106 NMPPLIGKGGFG---SVYKAIIQDGMEVAVKVFDP-QYEGAFKSFDIECDVMKRICHRNL 161
           N+ P IG G  G   + Y A++   + +  K+  P Q +   K    E  +MK + H+N+
Sbjct: 28  NLKP-IGSGAQGIVCAAYDAVLDRNVAIK-KLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 162 IKIISSYSN----DDFK--ALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEY 215
           I +++ ++     ++F+   LV+E M   +L + + +    LD  +   ++  +   +++
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQME---LDHERMSYLLYQMLXGIKH 141
Query: 216 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE 275
           LH   SA IIH DLKPSN+++  +    + DFG+A+       S   T  + T  Y APE
Sbjct: 142 LH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPE 195
Query: 276 YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRW 318
                    N D++S G ++ E+  R K    +F G   + +W
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEM-VRHKI---LFPGRDYIDQW 234

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 84/192 (43%), Gaps = 13/192 (6%)
Query: 111 IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDI---ECDVMKRICHRNLIKIIS 166
           +G G FG V     ++ G   A+K+ D Q     K  +    E  +++ +    L+K+  
Sbjct: 44  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 103
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIH 226
           S+ ++    +V+EY+  G +   L       +   R      +    EYLH   S  +I+
Sbjct: 104 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH---SLDLIY 159
Query: 227 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNG 286
            DLKP N+L+D      ++DFG AK +      L       T  Y+APE       +   
Sbjct: 160 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKAV 214
Query: 287 DVYSFGIMLMEI 298
           D ++ G+++ E+
Sbjct: 215 DWWALGVLIYEM 226

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/233 (22%), Positives = 98/233 (42%), Gaps = 10/233 (4%)
Query: 110 LIGKGGFGSVYKAIIQDGMEVAVKVFDPQ----YEGAFKSFDIECDVMKRICHRNLIKII 165
            +GKGGF   ++    D  EV      P+         +   +E  + + + H++++   
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
             + ++DF  +VLE     SL + L+     L   +    +  +    +YLH      +I
Sbjct: 82  GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VI 137
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
           H DLK  N+ L++++   + DFG+A  +  E     +     T  Y+APE   +   S  
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKVLCGTPNYIAPEVLSKKGHSFE 195
Query: 286 GDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPISVMEVVDANLLSQ 338
            DV+S G ++  +     P +     E  L+   N+      +  V A+L+ +
Sbjct: 196 VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK 248

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 106/218 (48%), Gaps = 25/218 (11%)
Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRICHRNLIKIIS 166
           IG G  G V  A     G+ VAVK     ++    A +++  E  ++K + H+N+I +++
Sbjct: 32  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLN 90
Query: 167 SYSN----DDFK--ALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGY 220
            ++     ++F+   LV+E M   +L + +++    LD  +   ++  +   +++LH   
Sbjct: 91  VFTPQKTLEEFQDVYLVMELM-DANLCQVIHME---LDHERMSYLLYQMLCGIKHLH--- 143
Query: 221 SAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREG 280
           SA IIH DLKPSN+++  +    + DFG+A+       +   T  + T  Y APE     
Sbjct: 144 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC---TNFMMTPYVVTRYYRAPEVILGM 200
Query: 281 RVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRW 318
             + N D++S G ++ E+         IF G   + +W
Sbjct: 201 GYAANVDIWSVGCIMGELVKGCV----IFQGTDHIDQW 234

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 85/192 (44%), Gaps = 13/192 (6%)
Query: 111 IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDI---ECDVMKRICHRNLIKIIS 166
           +G G FG V     ++ G   A+K+ D Q     K  +    E  +++ +    L+K+  
Sbjct: 36  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 95
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIH 226
           S+ ++    +V+EY+  G +   L       +   R      +    EYLH   S  +I+
Sbjct: 96  SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIY 151
Query: 227 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNG 286
            DLKP N+L+D+     ++DFG AK +      L       T  Y+APE       +   
Sbjct: 152 RDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKAV 206
Query: 287 DVYSFGIMLMEI 298
           D ++ G+++ E+
Sbjct: 207 DWWALGVLIYEM 218

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 108/223 (48%), Gaps = 26/223 (11%)
Query: 106 NMPPLIGKGGFG---SVYKAIIQDGMEVAVKVFDP-QYEGAFKSFDIECDVMKRICHRNL 161
           N+ P IG G  G   + Y A++   + +  K+  P Q +   K    E  +MK + H+N+
Sbjct: 28  NLKP-IGSGAQGIVCAAYDAVLDRNVAIK-KLSRPFQNQTHAKRAYRELVLMKXVNHKNI 85
Query: 162 IKIISSYSN----DDFK--ALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEY 215
           I +++ ++     ++F+   LV+E M   +L + + +    LD  +   ++  +   +++
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME---LDHERMSYLLYQMLCGIKH 141
Query: 216 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE 275
           LH   SA IIH DLKPSN+++  +    + DFG+A+       S   T  + T  Y APE
Sbjct: 142 LH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPE 195
Query: 276 YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRW 318
                    N D++S G ++ E+  R K    +F G   + +W
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEM-VRHKI---LFPGRDYIDQW 234

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/205 (22%), Positives = 85/205 (41%), Gaps = 13/205 (6%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYS 169
           +G G FG V++   +  G   A K     +E   ++   E   M  + H  L+ +  ++ 
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224
Query: 170 NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
           +D+   ++ E+M  G L + +   +  +   + ++ M  V   L ++H       +H DL
Sbjct: 225 DDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDL 281
Query: 230 KPSNVLLDDNMVAHLS--DFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGD 287
           KP N++        L   DFG+   L   D   +   T  T  + APE      V    D
Sbjct: 282 KPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTD 338
Query: 288 VYSFGIMLMEIFTRTKPTDEIFSGE 312
           ++S G++   + +   P    F GE
Sbjct: 339 MWSVGVLSYILLSGLSP----FGGE 359

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 101/203 (49%), Gaps = 22/203 (10%)
Query: 106 NMPPLIGKGGFG---SVYKAIIQDGMEVAVKVFDP-QYEGAFKSFDIECDVMKRICHRNL 161
           N+ P IG G  G   + Y AI++  + +  K+  P Q +   K    E  +MK + H+N+
Sbjct: 28  NLKP-IGSGAQGIVCAAYDAILERNVAIK-KLSRPFQNQTHAKRAYRELVLMKVVNHKNI 85
Query: 162 IKIISSY----SNDDFK--ALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEY 215
           I +++ +    S ++F+   +V+E M   +L + + +    LD  +   ++  +   +++
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQME---LDHERMSYLLYQMLVGIKH 141
Query: 216 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE 275
           LH   SA IIH DLKPSN+++  +    + DFG+A+       S   T  + T  Y APE
Sbjct: 142 LH---SAGIIHRDLKPSNIVVKSDATLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPE 195
Query: 276 YGREGRVSTNGDVYSFGIMLMEI 298
                    N D++S G ++ E+
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEM 218

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 109/244 (44%), Gaps = 31/244 (12%)
Query: 96  KRGKPLPNDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSF------DI 148
           K  +PL +   + PL+G GGFGSVY  I + D + VA+K  +      +          +
Sbjct: 1   KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 60
Query: 149 ECDVMKRICH--RNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIM 206
           E  ++K++      +I+++  +   D   L+LE       E    L ++I    +R  + 
Sbjct: 61  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-----RPEPVQDLFDFIT---ERGALQ 112
Query: 207 IDVASA-----LEYLHFGYSAPIIHCDLKPSNVLLDDNMVA-HLSDFGMAKPLLEEDQSL 260
            ++A +     LE +   ++  ++H D+K  N+L+D N     L DFG    L    +  
Sbjct: 113 EELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDT 168
Query: 261 TQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMEIFTRTKP---TDEIFSGEMTLK 316
             T    T  Y  PE+ R  R    +  V+S GI+L ++     P    +EI  G++  +
Sbjct: 169 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 228
Query: 317 RWVN 320
           + V+
Sbjct: 229 QRVS 232

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/205 (22%), Positives = 85/205 (41%), Gaps = 13/205 (6%)
Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYS 169
           +G G FG V++   +  G   A K     +E   ++   E   M  + H  L+ +  ++ 
Sbjct: 59  LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 118
Query: 170 NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
           +D+   ++ E+M  G L + +   +  +   + ++ M  V   L ++H       +H DL
Sbjct: 119 DDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDL 175
Query: 230 KPSNVLLDDNMVAHLS--DFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGD 287
           KP N++        L   DFG+   L   D   +   T  T  + APE      V    D
Sbjct: 176 KPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTD 232
Query: 288 VYSFGIMLMEIFTRTKPTDEIFSGE 312
           ++S G++   + +   P    F GE
Sbjct: 233 MWSVGVLSYILLSGLSP----FGGE 253

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 101/203 (49%), Gaps = 22/203 (10%)
Query: 106 NMPPLIGKGGFG---SVYKAIIQDGMEVAVKVFDP-QYEGAFKSFDIECDVMKRICHRNL 161
           N+ P IG G  G   + Y AI++  + +  K+  P Q +   K    E  +MK + H+N+
Sbjct: 28  NLKP-IGSGAQGIVCAAYDAILERNVAIK-KLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 162 IKIISSY----SNDDFK--ALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEY 215
           I +++ +    S ++F+   +V+E M   +L + + +    LD  +   ++  +   +++
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQME---LDHERMSYLLYQMLCGIKH 141
Query: 216 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE 275
           LH   SA IIH DLKPSN+++  +    + DFG+A+       S   T  + T  Y APE
Sbjct: 142 LH---SAGIIHRDLKPSNIVVKSDATLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPE 195
Query: 276 YGREGRVSTNGDVYSFGIMLMEI 298
                    N D++S G ++ E+
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEM 218

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 109/244 (44%), Gaps = 31/244 (12%)
Query: 96  KRGKPLPNDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSF------DI 148
           K  +PL +   + PL+G GGFGSVY  I + D + VA+K  +      +          +
Sbjct: 2   KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 61
Query: 149 ECDVMKRICH--RNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIM 206
           E  ++K++      +I+++  +   D   L+LE       E    L ++I    +R  + 
Sbjct: 62  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-----RPEPVQDLFDFIT---ERGALQ 113
Query: 207 IDVASA-----LEYLHFGYSAPIIHCDLKPSNVLLDDNMVA-HLSDFGMAKPLLEEDQSL 260
            ++A +     LE +   ++  ++H D+K  N+L+D N     L DFG    L    +  
Sbjct: 114 EELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDT 169
Query: 261 TQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMEIFTRTKP---TDEIFSGEMTLK 316
             T    T  Y  PE+ R  R    +  V+S GI+L ++     P    +EI  G++  +
Sbjct: 170 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 229
Query: 317 RWVN 320
           + V+
Sbjct: 230 QRVS 233

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 100/209 (47%), Gaps = 24/209 (11%)
Query: 111 IGKGGFGSVYKAIIQD-GMEVAVK--VFDPQYEGAFKSFDIECDVMKRICHRNLIKII-- 165
           IG+G FG V+KA  +  G +VA+K  + + + EG   +   E  +++ + H N++ +I  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 166 -----SSYSNDDFKA-LVLEYMPH---GSLEKCLYLSNYILDIFQRLDIMIDVASALEYL 216
                S Y+       LV ++  H   G L   L    + L   +R  +M  + + L Y+
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV--KFTLSEIKR--VMQMLLNGLYYI 141
Query: 217 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP--LLEEDQSLTQTQTLATIGYMAP 274
           H      I+H D+K +NVL+  + V  L+DFG+A+   L +  Q       + T+ Y  P
Sbjct: 142 H---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 198
Query: 275 EYGREGR-VSTNGDVYSFGIMLMEIFTRT 302
           E     R      D++  G ++ E++TR+
Sbjct: 199 ELLLGERDYGPPIDLWGAGCIMAEMWTRS 227

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 84/192 (43%), Gaps = 13/192 (6%)
Query: 111 IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDI---ECDVMKRICHRNLIKIIS 166
           +G G FG V     ++ G   A+K+ D Q     K  +    E  +++ +    L+K+  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIH 226
           S+ ++    +V+EY+  G +   L       +   R      +    EYLH   S  +I+
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH---SLDLIY 164
Query: 227 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNG 286
            DLKP N+L+D      ++DFG AK +      L       T  Y+APE       +   
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKAV 219
Query: 287 DVYSFGIMLMEI 298
           D ++ G+++ E+
Sbjct: 220 DWWALGVLIYEM 231

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 84/192 (43%), Gaps = 13/192 (6%)
Query: 111 IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDI---ECDVMKRICHRNLIKIIS 166
           +G G FG V     ++ G   A+K+ D Q     K  +    E  +++ +    L+K+  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIH 226
           S+ ++    +V+EY+  G +   L       +   R      +    EYLH   S  +I+
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH---SLDLIY 164
Query: 227 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNG 286
            DLKP N+L+D      ++DFG AK +      L       T  Y+APE       +   
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKAV 219
Query: 287 DVYSFGIMLMEI 298
           D ++ G+++ E+
Sbjct: 220 DWWALGVLIYEM 231

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 84/192 (43%), Gaps = 13/192 (6%)
Query: 111 IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDI---ECDVMKRICHRNLIKIIS 166
           +G G FG V     ++ G   A+K+ D Q     K  +    E  +++ +    L+K+  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIH 226
           S+ ++    +V+EY+  G +   L       +   R      +    EYLH   S  +I+
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIY 164
Query: 227 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNG 286
            DLKP N+L+D      ++DFG AK +      L       T  Y+APE       +   
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLA-----GTPEYLAPEIILSKGYNKAV 219
Query: 287 DVYSFGIMLMEI 298
           D ++ G+++ E+
Sbjct: 220 DWWALGVLIYEM 231

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 84/192 (43%), Gaps = 13/192 (6%)
Query: 111 IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDI---ECDVMKRICHRNLIKIIS 166
           +G G FG V     ++ G   A+K+ D Q     K  +    E  +++ +    L+K+  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIH 226
           S+ ++    +V+EY+  G +   L       +   R      +    EYLH   S  +I+
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARF-YAAQIVLTFEYLH---SLDLIY 164
Query: 227 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNG 286
            DLKP N+L+D      ++DFG AK +      L       T  Y+APE       +   
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKAV 219
Query: 287 DVYSFGIMLMEI 298
           D ++ G+++ E+
Sbjct: 220 DWWALGVLIYEM 231

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 93/200 (46%), Gaps = 16/200 (8%)
Query: 111 IGKGGFGSVYKAIIQDGMEV-AVKVFDPQYEGAFKSFDIECDVMKRIC--HRNLIKIISS 167
           +G+G F    K + +   +  AVK+   + E   +    E   +K +C  H N++K+   
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALK-LCEGHPNIVKLHEV 74
Query: 168 YSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHC 227
           + +     LV+E +  G L + +    +  +  +   IM  + SA+ ++H      ++H 
Sbjct: 75  FHDQLHTFLVMELLNGGELFERIKKKKHFSET-EASYIMRKLVSAVSHMH---DVGVVHR 130
Query: 228 DLKPSNVLL---DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVST 284
           DLKP N+L    +DN+   + DFG A+    ++Q L       T+ Y APE   +     
Sbjct: 131 DLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL--KTPCFTLHYAAPELLNQNGYDE 188
Query: 285 NGDVYSFGIMLMEIFTRTKP 304
           + D++S G++L  + +   P
Sbjct: 189 SCDLWSLGVILYTMLSGQVP 208

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 92/204 (45%), Gaps = 19/204 (9%)
Query: 110 LIGKGGFGSVYKAIIQD---GMEVAVKVFDP---QYEGAFKSFDIECDVMKRICHRNLIK 163
           ++GKG FG V   + +D   G E AVKV      + +   +S   E  ++K++ H N++K
Sbjct: 39  VLGKGSFGEV--ILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMK 96
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
           +   + +  +  LV E    G L   + +S           I+  V S + Y+H      
Sbjct: 97  LYEFFEDKGYFYLVGEVYTGGELFDEI-ISRKRFSEVDAARIIRQVLSGITYMH---KNK 152
Query: 224 IIHCDLKPSNVLLDD---NMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREG 280
           I+H DLKP N+LL+    +    + DFG++      + S      + T  Y+APE    G
Sbjct: 153 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKMKDKIGTAYYIAPEV-LHG 208
Query: 281 RVSTNGDVYSFGIMLMEIFTRTKP 304
                 DV+S G++L  + +   P
Sbjct: 209 TYDEKCDVWSTGVILYILLSGCPP 232

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 100/209 (47%), Gaps = 24/209 (11%)
Query: 111 IGKGGFGSVYKAIIQD-GMEVAVK--VFDPQYEGAFKSFDIECDVMKRICHRNLIKII-- 165
           IG+G FG V+KA  +  G +VA+K  + + + EG   +   E  +++ + H N++ +I  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 166 -----SSYSNDDFKA-LVLEYMPH---GSLEKCLYLSNYILDIFQRLDIMIDVASALEYL 216
                S Y+       LV ++  H   G L   L    + L   +R  +M  + + L Y+
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV--KFTLSEIKR--VMQMLLNGLYYI 141
Query: 217 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP--LLEEDQSLTQTQTLATIGYMAP 274
           H      I+H D+K +NVL+  + V  L+DFG+A+   L +  Q       + T+ Y  P
Sbjct: 142 H---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 198
Query: 275 EYGREGR-VSTNGDVYSFGIMLMEIFTRT 302
           E     R      D++  G ++ E++TR+
Sbjct: 199 ELLLGERDYGPPIDLWGAGCIMAEMWTRS 227

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 109/244 (44%), Gaps = 31/244 (12%)
Query: 96  KRGKPLPNDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSF------DI 148
           K  +PL +   + PL+G GGFGSVY  I + D + VA+K  +      +          +
Sbjct: 44  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 103
Query: 149 ECDVMKRICH--RNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIM 206
           E  ++K++      +I+++  +   D   L+LE       E    L ++I    +R  + 
Sbjct: 104 EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-----RPEPVQDLFDFIT---ERGALQ 155
Query: 207 IDVASA-----LEYLHFGYSAPIIHCDLKPSNVLLDDNMVA-HLSDFGMAKPLLEEDQSL 260
            ++A +     LE +   ++  ++H D+K  N+L+D N     L DFG    L    +  
Sbjct: 156 EELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDT 211
Query: 261 TQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMEIFTRTKP---TDEIFSGEMTLK 316
             T    T  Y  PE+ R  R    +  V+S GI+L ++     P    +EI  G++  +
Sbjct: 212 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 271
Query: 317 RWVN 320
           + V+
Sbjct: 272 QRVS 275

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 109/244 (44%), Gaps = 31/244 (12%)
Query: 96  KRGKPLPNDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSF------DI 148
           K  +PL +   + PL+G GGFGSVY  I + D + VA+K  +      +          +
Sbjct: 29  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 88
Query: 149 ECDVMKRICH--RNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIM 206
           E  ++K++      +I+++  +   D   L+LE       E    L ++I    +R  + 
Sbjct: 89  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-----RPEPVQDLFDFIT---ERGALQ 140
Query: 207 IDVASA-----LEYLHFGYSAPIIHCDLKPSNVLLDDNMVA-HLSDFGMAKPLLEEDQSL 260
            ++A +     LE +   ++  ++H D+K  N+L+D N     L DFG    L    +  
Sbjct: 141 EELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDT 196
Query: 261 TQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMEIFTRTKP---TDEIFSGEMTLK 316
             T    T  Y  PE+ R  R    +  V+S GI+L ++     P    +EI  G++  +
Sbjct: 197 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR 256
Query: 317 RWVN 320
           + V+
Sbjct: 257 QRVS 260

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 84/192 (43%), Gaps = 13/192 (6%)
Query: 111 IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDI---ECDVMKRICHRNLIKIIS 166
           +G G FG V     ++ G   A+K+ D Q     K  +    E  +++ +    L+K+  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIH 226
           S+ ++    +V+EY+  G +   L       +   R      +    EYLH   S  +I+
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH---SLDLIY 164
Query: 227 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNG 286
            DLKP N+L+D      ++DFG AK +      L       T  Y+APE       +   
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKAV 219
Query: 287 DVYSFGIMLMEI 298
           D ++ G+++ E+
Sbjct: 220 DWWALGVLIYEM 231

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 109/244 (44%), Gaps = 31/244 (12%)
Query: 96  KRGKPLPNDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSF------DI 148
           K  +PL +   + PL+G GGFGSVY  I + D + VA+K  +      +          +
Sbjct: 30  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 89
Query: 149 ECDVMKRICH--RNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIM 206
           E  ++K++      +I+++  +   D   L+LE       E    L ++I    +R  + 
Sbjct: 90  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-----RPEPVQDLFDFIT---ERGALQ 141
Query: 207 IDVASA-----LEYLHFGYSAPIIHCDLKPSNVLLDDNMVA-HLSDFGMAKPLLEEDQSL 260
            ++A +     LE +   ++  ++H D+K  N+L+D N     L DFG    L    +  
Sbjct: 142 EELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDT 197
Query: 261 TQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMEIFTRTKP---TDEIFSGEMTLK 316
             T    T  Y  PE+ R  R    +  V+S GI+L ++     P    +EI  G++  +
Sbjct: 198 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR 257
Query: 317 RWVN 320
           + V+
Sbjct: 258 QRVS 261

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 109/244 (44%), Gaps = 31/244 (12%)
Query: 96  KRGKPLPNDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSF------DI 148
           K  +PL +   + PL+G GGFGSVY  I + D + VA+K  +      +          +
Sbjct: 29  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 88
Query: 149 ECDVMKRICH--RNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIM 206
           E  ++K++      +I+++  +   D   L+LE       E    L ++I    +R  + 
Sbjct: 89  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-----RPEPVQDLFDFIT---ERGALQ 140
Query: 207 IDVASA-----LEYLHFGYSAPIIHCDLKPSNVLLDDNMVA-HLSDFGMAKPLLEEDQSL 260
            ++A +     LE +   ++  ++H D+K  N+L+D N     L DFG    L    +  
Sbjct: 141 EELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDT 196
Query: 261 TQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMEIFTRTKP---TDEIFSGEMTLK 316
             T    T  Y  PE+ R  R    +  V+S GI+L ++     P    +EI  G++  +
Sbjct: 197 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR 256
Query: 317 RWVN 320
           + V+
Sbjct: 257 QRVS 260

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 100/209 (47%), Gaps = 24/209 (11%)
Query: 111 IGKGGFGSVYKAIIQD-GMEVAVK--VFDPQYEGAFKSFDIECDVMKRICHRNLIKII-- 165
           IG+G FG V+KA  +  G +VA+K  + + + EG   +   E  +++ + H N++ +I  
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 166 -----SSYSNDDFKA-LVLEYMPH---GSLEKCLYLSNYILDIFQRLDIMIDVASALEYL 216
                S Y+       LV ++  H   G L   L    + L   +R  +M  + + L Y+
Sbjct: 85  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV--KFTLSEIKR--VMQMLLNGLYYI 140
Query: 217 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP--LLEEDQSLTQTQTLATIGYMAP 274
           H      I+H D+K +NVL+  + V  L+DFG+A+   L +  Q       + T+ Y  P
Sbjct: 141 H---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 197
Query: 275 EYGREGR-VSTNGDVYSFGIMLMEIFTRT 302
           E     R      D++  G ++ E++TR+
Sbjct: 198 ELLLGERDYGPPIDLWGAGCIMAEMWTRS 226

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 109/244 (44%), Gaps = 31/244 (12%)
Query: 96  KRGKPLPNDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSF------DI 148
           K  +PL +   + PL+G GGFGSVY  I + D + VA+K  +      +          +
Sbjct: 2   KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 61
Query: 149 ECDVMKRICH--RNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIM 206
           E  ++K++      +I+++  +   D   L+LE       E    L ++I    +R  + 
Sbjct: 62  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-----RPEPVQDLFDFIT---ERGALQ 113
Query: 207 IDVASA-----LEYLHFGYSAPIIHCDLKPSNVLLDDNMVA-HLSDFGMAKPLLEEDQSL 260
            ++A +     LE +   ++  ++H D+K  N+L+D N     L DFG    L    +  
Sbjct: 114 EELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDT 169
Query: 261 TQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMEIFTRTKP---TDEIFSGEMTLK 316
             T    T  Y  PE+ R  R    +  V+S GI+L ++     P    +EI  G++  +
Sbjct: 170 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 229
Query: 317 RWVN 320
           + V+
Sbjct: 230 QRVS 233

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 109/244 (44%), Gaps = 31/244 (12%)
Query: 96  KRGKPLPNDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSF------DI 148
           K  +PL +   + PL+G GGFGSVY  I + D + VA+K  +      +          +
Sbjct: 30  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 89
Query: 149 ECDVMKRICH--RNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIM 206
           E  ++K++      +I+++  +   D   L+LE       E    L ++I    +R  + 
Sbjct: 90  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-----RPEPVQDLFDFIT---ERGALQ 141
Query: 207 IDVASA-----LEYLHFGYSAPIIHCDLKPSNVLLDDNMVA-HLSDFGMAKPLLEEDQSL 260
            ++A +     LE +   ++  ++H D+K  N+L+D N     L DFG    L    +  
Sbjct: 142 EELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDT 197
Query: 261 TQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMEIFTRTKP---TDEIFSGEMTLK 316
             T    T  Y  PE+ R  R    +  V+S GI+L ++     P    +EI  G++  +
Sbjct: 198 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR 257
Query: 317 RWVN 320
           + V+
Sbjct: 258 QRVS 261

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 109/244 (44%), Gaps = 31/244 (12%)
Query: 96  KRGKPLPNDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSF------DI 148
           K  +PL +   + PL+G GGFGSVY  I + D + VA+K  +      +          +
Sbjct: 29  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 88
Query: 149 ECDVMKRICH--RNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIM 206
           E  ++K++      +I+++  +   D   L+LE       E    L ++I    +R  + 
Sbjct: 89  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-----RPEPVQDLFDFIT---ERGALQ 140
Query: 207 IDVASA-----LEYLHFGYSAPIIHCDLKPSNVLLDDNMVA-HLSDFGMAKPLLEEDQSL 260
            ++A +     LE +   ++  ++H D+K  N+L+D N     L DFG    L    +  
Sbjct: 141 EELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDT 196
Query: 261 TQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMEIFTRTKP---TDEIFSGEMTLK 316
             T    T  Y  PE+ R  R    +  V+S GI+L ++     P    +EI  G++  +
Sbjct: 197 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR 256
Query: 317 RWVN 320
           + V+
Sbjct: 257 QRVS 260

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 109/244 (44%), Gaps = 31/244 (12%)
Query: 96  KRGKPLPNDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSF------DI 148
           K  +PL +   + PL+G GGFGSVY  I + D + VA+K  +      +          +
Sbjct: 30  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 89
Query: 149 ECDVMKRICH--RNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIM 206
           E  ++K++      +I+++  +   D   L+LE       E    L ++I    +R  + 
Sbjct: 90  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-----RPEPVQDLFDFIT---ERGALQ 141
Query: 207 IDVASA-----LEYLHFGYSAPIIHCDLKPSNVLLDDNMVA-HLSDFGMAKPLLEEDQSL 260
            ++A +     LE +   ++  ++H D+K  N+L+D N     L DFG    L    +  
Sbjct: 142 EELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDT 197
Query: 261 TQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMEIFTRTKP---TDEIFSGEMTLK 316
             T    T  Y  PE+ R  R    +  V+S GI+L ++     P    +EI  G++  +
Sbjct: 198 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR 257
Query: 317 RWVN 320
           + V+
Sbjct: 258 QRVS 261

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 101/203 (49%), Gaps = 22/203 (10%)
Query: 106 NMPPLIGKGGFG---SVYKAIIQDGMEVAVKVFDP-QYEGAFKSFDIECDVMKRICHRNL 161
           N+ P IG G  G   + Y AI++  + +  K+  P Q +   K    E  +MK + H+N+
Sbjct: 28  NLKP-IGSGAQGIVCAAYDAILERNVAIK-KLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 162 IKIISSY----SNDDFK--ALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEY 215
           I +++ +    S ++F+   +V+E M   +L + + +    LD  +   ++  +   +++
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQME---LDHERMSYLLYQMLCGIKH 141
Query: 216 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE 275
           LH   SA IIH DLKPSN+++  +    + DFG+A+       S   T  + T  Y APE
Sbjct: 142 LH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPE 195
Query: 276 YGREGRVSTNGDVYSFGIMLMEI 298
                    N D++S G ++ E+
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEM 218

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 85/192 (44%), Gaps = 13/192 (6%)
Query: 111 IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDI---ECDVMKRICHRNLIKIIS 166
           +G G FG V     ++ G   A+K+ D Q     K  +    E  +++ +    L+K+  
Sbjct: 70  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 129
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIH 226
           S+ ++    +V+EY+  G +   L       +   R      +    EYLH   S  +I+
Sbjct: 130 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIY 185
Query: 227 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNG 286
            DLKP N+L+D      ++DFG AK +     +L       T  Y+APE       +   
Sbjct: 186 RDLKPENLLIDQQGYIQVTDFGFAKRVKGATWTLC-----GTPEYLAPEIILSKGYNKAV 240
Query: 287 DVYSFGIMLMEI 298
           D ++ G+++ E+
Sbjct: 241 DWWALGVLIYEM 252

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 109/244 (44%), Gaps = 31/244 (12%)
Query: 96  KRGKPLPNDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSF------DI 148
           K  +PL +   + PL+G GGFGSVY  I + D + VA+K  +      +          +
Sbjct: 2   KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 61
Query: 149 ECDVMKRICH--RNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIM 206
           E  ++K++      +I+++  +   D   L+LE       E    L ++I    +R  + 
Sbjct: 62  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-----RPEPVQDLFDFIT---ERGALQ 113
Query: 207 IDVASA-----LEYLHFGYSAPIIHCDLKPSNVLLDDNMVA-HLSDFGMAKPLLEEDQSL 260
            ++A +     LE +   ++  ++H D+K  N+L+D N     L DFG    L    +  
Sbjct: 114 EELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDT 169
Query: 261 TQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMEIFTRTKP---TDEIFSGEMTLK 316
             T    T  Y  PE+ R  R    +  V+S GI+L ++     P    +EI  G++  +
Sbjct: 170 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 229
Query: 317 RWVN 320
           + V+
Sbjct: 230 QRVS 233

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 84/192 (43%), Gaps = 13/192 (6%)
Query: 111 IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDI---ECDVMKRICHRNLIKIIS 166
           +G G FG V     ++ G   A+K+ D Q     K  +    E  +++ +    L+K+  
Sbjct: 70  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 129
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIH 226
           S+ ++    +V+EY+  G +   L       +   R      +    EYLH   S  +I+
Sbjct: 130 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH---SLDLIY 185
Query: 227 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNG 286
            DLKP N+L+D      ++DFG AK +      L       T  Y+APE       +   
Sbjct: 186 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKAV 240
Query: 287 DVYSFGIMLMEI 298
           D ++ G+++ E+
Sbjct: 241 DWWALGVLIYEM 252

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 106/218 (48%), Gaps = 25/218 (11%)
Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEG---AFKSFDIECDVMKRICHRNLIKIIS 166
           IG G  G V  A     G+ VAVK     ++    A +++  E  ++K + H+N+I +++
Sbjct: 30  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLN 88
Query: 167 SYSN----DDFK--ALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGY 220
            ++     ++F+   LV+E M   +L + +++    LD  +   ++  +   +++LH   
Sbjct: 89  VFTPQKTLEEFQDVYLVMELM-DANLCQVIHME---LDHERMSYLLYQMLCGIKHLH--- 141
Query: 221 SAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREG 280
           SA IIH DLKPSN+++  +    + DFG+A+       +   T  + T  Y APE     
Sbjct: 142 SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TASTNFMMTPYVVTRYYRAPEVILGM 198
Query: 281 RVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRW 318
               N D++S G ++ E+   +     IF G   + +W
Sbjct: 199 GYKENVDIWSVGCIMGELVKGSV----IFQGTDHIDQW 232

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 109/244 (44%), Gaps = 31/244 (12%)
Query: 96  KRGKPLPNDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSF------DI 148
           K  +PL +   + PL+G GGFGSVY  I + D + VA+K  +      +          +
Sbjct: 30  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 89
Query: 149 ECDVMKRICH--RNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIM 206
           E  ++K++      +I+++  +   D   L+LE       E    L ++I    +R  + 
Sbjct: 90  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-----RPEPVQDLFDFIT---ERGALQ 141
Query: 207 IDVASA-----LEYLHFGYSAPIIHCDLKPSNVLLDDNMVA-HLSDFGMAKPLLEEDQSL 260
            ++A +     LE +   ++  ++H D+K  N+L+D N     L DFG    L    +  
Sbjct: 142 EELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDT 197
Query: 261 TQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMEIFTRTKP---TDEIFSGEMTLK 316
             T    T  Y  PE+ R  R    +  V+S GI+L ++     P    +EI  G++  +
Sbjct: 198 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR 257
Query: 317 RWVN 320
           + V+
Sbjct: 258 QRVS 261

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 109/244 (44%), Gaps = 31/244 (12%)
Query: 96  KRGKPLPNDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSF------DI 148
           K  +PL +   + PL+G GGFGSVY  I + D + VA+K  +      +          +
Sbjct: 17  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 76
Query: 149 ECDVMKRICH--RNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIM 206
           E  ++K++      +I+++  +   D   L+LE       E    L ++I    +R  + 
Sbjct: 77  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-----RPEPVQDLFDFIT---ERGALQ 128
Query: 207 IDVASA-----LEYLHFGYSAPIIHCDLKPSNVLLDDNMVA-HLSDFGMAKPLLEEDQSL 260
            ++A +     LE +   ++  ++H D+K  N+L+D N     L DFG    L    +  
Sbjct: 129 EELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDT 184
Query: 261 TQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMEIFTRTKP---TDEIFSGEMTLK 316
             T    T  Y  PE+ R  R    +  V+S GI+L ++     P    +EI  G++  +
Sbjct: 185 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 244
Query: 317 RWVN 320
           + V+
Sbjct: 245 QRVS 248

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 109/244 (44%), Gaps = 31/244 (12%)
Query: 96  KRGKPLPNDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSF------DI 148
           K  +PL +   + PL+G GGFGSVY  I + D + VA+K  +      +          +
Sbjct: 49  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 108
Query: 149 ECDVMKRICH--RNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIM 206
           E  ++K++      +I+++  +   D   L+LE       E    L ++I    +R  + 
Sbjct: 109 EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-----RPEPVQDLFDFIT---ERGALQ 160
Query: 207 IDVASA-----LEYLHFGYSAPIIHCDLKPSNVLLDDNMVA-HLSDFGMAKPLLEEDQSL 260
            ++A +     LE +   ++  ++H D+K  N+L+D N     L DFG    L    +  
Sbjct: 161 EELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDT 216
Query: 261 TQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMEIFTRTKP---TDEIFSGEMTLK 316
             T    T  Y  PE+ R  R    +  V+S GI+L ++     P    +EI  G++  +
Sbjct: 217 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 276
Query: 317 RWVN 320
           + V+
Sbjct: 277 QRVS 280

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 109/244 (44%), Gaps = 31/244 (12%)
Query: 96  KRGKPLPNDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSF------DI 148
           K  +PL +   + PL+G GGFGSVY  I + D + VA+K  +      +          +
Sbjct: 17  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 76
Query: 149 ECDVMKRICH--RNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIM 206
           E  ++K++      +I+++  +   D   L+LE       E    L ++I    +R  + 
Sbjct: 77  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-----RPEPVQDLFDFIT---ERGALQ 128
Query: 207 IDVASA-----LEYLHFGYSAPIIHCDLKPSNVLLDDNMVA-HLSDFGMAKPLLEEDQSL 260
            ++A +     LE +   ++  ++H D+K  N+L+D N     L DFG    L    +  
Sbjct: 129 EELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDT 184
Query: 261 TQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMEIFTRTKP---TDEIFSGEMTLK 316
             T    T  Y  PE+ R  R    +  V+S GI+L ++     P    +EI  G++  +
Sbjct: 185 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 244
Query: 317 RWVN 320
           + V+
Sbjct: 245 QRVS 248

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 109/244 (44%), Gaps = 31/244 (12%)
Query: 96  KRGKPLPNDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSF------DI 148
           K  +PL +   + PL+G GGFGSVY  I + D + VA+K  +      +          +
Sbjct: 16  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 75
Query: 149 ECDVMKRICH--RNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIM 206
           E  ++K++      +I+++  +   D   L+LE       E    L ++I    +R  + 
Sbjct: 76  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-----RPEPVQDLFDFIT---ERGALQ 127
Query: 207 IDVASA-----LEYLHFGYSAPIIHCDLKPSNVLLDDNMVA-HLSDFGMAKPLLEEDQSL 260
            ++A +     LE +   ++  ++H D+K  N+L+D N     L DFG    L    +  
Sbjct: 128 EELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDT 183
Query: 261 TQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMEIFTRTKP---TDEIFSGEMTLK 316
             T    T  Y  PE+ R  R    +  V+S GI+L ++     P    +EI  G++  +
Sbjct: 184 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 243
Query: 317 RWVN 320
           + V+
Sbjct: 244 QRVS 247

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 96/205 (46%), Gaps = 26/205 (12%)
Query: 111 IGKGGFGSVYKAIIQD--------GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLI 162
           +G+G F  ++K + ++          EV +KV D  +    +SF     +M ++ H++L+
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 163 KIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSA 222
                    D   LV E++  GSL+  L  +   ++I  +L++   +A A   +HF    
Sbjct: 76  LNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAWA---MHFLEEN 132
Query: 223 PIIHCDLKPSNVLL---DDNMVAH-----LSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 274
            +IH ++   N+LL   +D    +     LSD G++  +L +D  + Q +    I ++ P
Sbjct: 133 TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD--ILQER----IPWVPP 186
Query: 275 EYGREGR-VSTNGDVYSFGIMLMEI 298
           E     + ++   D +SFG  L EI
Sbjct: 187 ECIENPKNLNLATDKWSFGTTLWEI 211

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 109/244 (44%), Gaps = 31/244 (12%)
Query: 96  KRGKPLPNDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSF------DI 148
           K  +PL +   + PL+G GGFGSVY  I + D + VA+K  +      +          +
Sbjct: 44  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 103
Query: 149 ECDVMKRICH--RNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIM 206
           E  ++K++      +I+++  +   D   L+LE       E    L ++I    +R  + 
Sbjct: 104 EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-----RPEPVQDLFDFIT---ERGALQ 155
Query: 207 IDVASA-----LEYLHFGYSAPIIHCDLKPSNVLLDDNMVA-HLSDFGMAKPLLEEDQSL 260
            ++A +     LE +   ++  ++H D+K  N+L+D N     L DFG    L    +  
Sbjct: 156 EELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDT 211
Query: 261 TQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMEIFTRTKP---TDEIFSGEMTLK 316
             T    T  Y  PE+ R  R    +  V+S GI+L ++     P    +EI  G++  +
Sbjct: 212 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 271
Query: 317 RWVN 320
           + V+
Sbjct: 272 QRVS 275

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 109/244 (44%), Gaps = 31/244 (12%)
Query: 96  KRGKPLPNDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSF------DI 148
           K  +PL +   + PL+G GGFGSVY  I + D + VA+K  +      +          +
Sbjct: 29  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 88
Query: 149 ECDVMKRICH--RNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIM 206
           E  ++K++      +I+++  +   D   L+LE       E    L ++I    +R  + 
Sbjct: 89  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-----RPEPVQDLFDFIT---ERGALQ 140
Query: 207 IDVASA-----LEYLHFGYSAPIIHCDLKPSNVLLDDNMVA-HLSDFGMAKPLLEEDQSL 260
            ++A +     LE +   ++  ++H D+K  N+L+D N     L DFG    L    +  
Sbjct: 141 EELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDT 196
Query: 261 TQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMEIFTRTKP---TDEIFSGEMTLK 316
             T    T  Y  PE+ R  R    +  V+S GI+L ++     P    +EI  G++  +
Sbjct: 197 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 256
Query: 317 RWVN 320
           + V+
Sbjct: 257 QRVS 260

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 84/192 (43%), Gaps = 13/192 (6%)
Query: 111 IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDI---ECDVMKRICHRNLIKIIS 166
           +G G FG V     ++ G   A+K+ D Q     K  +    E  +++ +    L+K+  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIH 226
           S+ ++    +V+EY+  G +   L       +   R      +    EYLH   S  +I+
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIY 164
Query: 227 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNG 286
            DLKP N+L+D      ++DFG AK +      L       T  Y+APE       +   
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLX-----GTPEYLAPEIILSKGYNKAV 219
Query: 287 DVYSFGIMLMEI 298
           D ++ G+++ E+
Sbjct: 220 DWWALGVLIYEM 231

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 79/177 (44%), Gaps = 13/177 (7%)
Query: 149 ECDVMKRICHRNLIKIISSYSNDDFKAL--VLEYMPHGSLEKCLYLSNYILDIFQRLDIM 206
           E  +++R+ H+N+I+++    N++ + +  V+EY   G  E    +      + Q     
Sbjct: 56  EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYF 115
Query: 207 IDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL 266
             +   LEYLH   S  I+H D+KP N+LL       +S  G+A+ L       T   + 
Sbjct: 116 CQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ 172
Query: 267 ATIGYMAPEYGREGRVSTNG---DVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN 320
            +  +  PE    G  + +G   D++S G+ L  I T   P    F G+   K + N
Sbjct: 173 GSPAFQPPEIA-NGLDTFSGFKVDIWSAGVTLYNITTGLYP----FEGDNIYKLFEN 224

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 109/244 (44%), Gaps = 31/244 (12%)
Query: 96  KRGKPLPNDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSF------DI 148
           K  +PL +   + PL+G GGFGSVY  I + D + VA+K  +      +          +
Sbjct: 17  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 76
Query: 149 ECDVMKRICH--RNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIM 206
           E  ++K++      +I+++  +   D   L+LE       E    L ++I    +R  + 
Sbjct: 77  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-----RPEPVQDLFDFIT---ERGALQ 128
Query: 207 IDVASA-----LEYLHFGYSAPIIHCDLKPSNVLLDDNMVA-HLSDFGMAKPLLEEDQSL 260
            ++A +     LE +   ++  ++H D+K  N+L+D N     L DFG    L    +  
Sbjct: 129 EELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDT 184
Query: 261 TQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMEIFTRTKP---TDEIFSGEMTLK 316
             T    T  Y  PE+ R  R    +  V+S GI+L ++     P    +EI  G++  +
Sbjct: 185 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 244
Query: 317 RWVN 320
           + V+
Sbjct: 245 QRVS 248

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 101/210 (48%), Gaps = 26/210 (12%)
Query: 110 LIGKGGFGSVYKAIIQDGMEVAVK-VFDPQYEGAFKSFDIECDVMKRICHRNL--IKIIS 166
            I  G +G+V   +  +G+ VA+K VF+   +G  ++ +I  D    +C R L  I++++
Sbjct: 29  FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDG--RTVNILSDSF--LCKRVLREIRLLN 84
Query: 167 SYSNDDFKAL--VLEYMPHGSLEKCLYLSNYIL--DIFQRLDIMIDVAS--ALEY----- 215
            + + +   L  +  +    ++ K LYL   ++  D+ Q +     V S   ++Y     
Sbjct: 85  HFHHPNILGLRDIFVHFEEPAMHK-LYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHI 143
Query: 216 ---LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYM 272
              LH  + A ++H DL P N+LL DN    + DF +A+   E+     +T  +    Y 
Sbjct: 144 LLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR---EDTADANKTHYVTHRWYR 200
Query: 273 APEYGREGRVSTN-GDVYSFGIMLMEIFTR 301
           APE   + +  T   D++S G ++ E+F R
Sbjct: 201 APELVMQFKGFTKLVDMWSAGCVMAEMFNR 230

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 109/244 (44%), Gaps = 31/244 (12%)
Query: 96  KRGKPLPNDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSF------DI 148
           K  +PL +   + PL+G GGFGSVY  I + D + VA+K  +      +          +
Sbjct: 16  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 75
Query: 149 ECDVMKRICH--RNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIM 206
           E  ++K++      +I+++  +   D   L+LE       E    L ++I    +R  + 
Sbjct: 76  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-----RPEPVQDLFDFIT---ERGALQ 127
Query: 207 IDVASA-----LEYLHFGYSAPIIHCDLKPSNVLLDDNMVA-HLSDFGMAKPLLEEDQSL 260
            ++A +     LE +   ++  ++H D+K  N+L+D N     L DFG    L    +  
Sbjct: 128 EELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDT 183
Query: 261 TQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMEIFTRTKP---TDEIFSGEMTLK 316
             T    T  Y  PE+ R  R    +  V+S GI+L ++     P    +EI  G++  +
Sbjct: 184 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 243
Query: 317 RWVN 320
           + V+
Sbjct: 244 QRVS 247

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 84/192 (43%), Gaps = 13/192 (6%)
Query: 111 IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDI---ECDVMKRICHRNLIKIIS 166
           +G G FG V     ++ G   A+K+ D Q     K  +    E  +++ +    L+K+  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIH 226
           S+ ++    +V+EY+  G +   L       +   R      +    EYLH   S  +I+
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIY 164
Query: 227 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNG 286
            DLKP N+L+D      ++DFG AK +      L       T  Y+APE       +   
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKAV 219
Query: 287 DVYSFGIMLMEI 298
           D ++ G+++ E+
Sbjct: 220 DWWALGVLIYEM 231

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 109/244 (44%), Gaps = 31/244 (12%)
Query: 96  KRGKPLPNDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSF------DI 148
           K  +PL +   + PL+G GGFGSVY  I + D + VA+K  +      +          +
Sbjct: 36  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 95
Query: 149 ECDVMKRICH--RNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIM 206
           E  ++K++      +I+++  +   D   L+LE       E    L ++I    +R  + 
Sbjct: 96  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-----RPEPVQDLFDFIT---ERGALQ 147
Query: 207 IDVASA-----LEYLHFGYSAPIIHCDLKPSNVLLDDNMVA-HLSDFGMAKPLLEEDQSL 260
            ++A +     LE +   ++  ++H D+K  N+L+D N     L DFG    L    +  
Sbjct: 148 EELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDT 203
Query: 261 TQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMEIFTRTKP---TDEIFSGEMTLK 316
             T    T  Y  PE+ R  R    +  V+S GI+L ++     P    +EI  G++  +
Sbjct: 204 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 263
Query: 317 RWVN 320
           + V+
Sbjct: 264 QRVS 267

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 84/192 (43%), Gaps = 13/192 (6%)
Query: 111 IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDI---ECDVMKRICHRNLIKIIS 166
           +G G FG V     ++ G   A+K+ D Q     K  +    E  +++ +    L+K+  
Sbjct: 50  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIH 226
           S+ ++    +V+EY+  G +   L       +   R      +    EYLH   S  +I+
Sbjct: 110 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIY 165
Query: 227 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNG 286
            DLKP N+L+D      ++DFG AK +      L       T  Y+APE       +   
Sbjct: 166 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKAV 220
Query: 287 DVYSFGIMLMEI 298
           D ++ G+++ E+
Sbjct: 221 DWWALGVLIYEM 232

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 101/210 (48%), Gaps = 26/210 (12%)
Query: 110 LIGKGGFGSVYKAIIQDGMEVAVK-VFDPQYEGAFKSFDIECDVMKRICHRNL--IKIIS 166
            I  G +G+V   +  +G+ VA+K VF+   +G  ++ +I  D    +C R L  I++++
Sbjct: 29  FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDG--RTVNILSDSF--LCKRVLREIRLLN 84
Query: 167 SYSNDDFKAL--VLEYMPHGSLEKCLYLSNYIL--DIFQRLDIMIDVAS--ALEY----- 215
            + + +   L  +  +    ++ K LYL   ++  D+ Q +     V S   ++Y     
Sbjct: 85  HFHHPNILGLRDIFVHFEEPAMHK-LYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHI 143
Query: 216 ---LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYM 272
              LH  + A ++H DL P N+LL DN    + DF +A+   E+     +T  +    Y 
Sbjct: 144 LLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR---EDTADANKTHYVTHRWYR 200
Query: 273 APEYGREGRVSTN-GDVYSFGIMLMEIFTR 301
           APE   + +  T   D++S G ++ E+F R
Sbjct: 201 APELVMQFKGFTKLVDMWSAGCVMAEMFNR 230

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 89/195 (45%), Gaps = 19/195 (9%)
Query: 110 LIGKGGFGSVYKAIIQD---GMEVAVKVFDP---QYEGAFKSFDIECDVMKRICHRNLIK 163
           ++GKG FG V   + +D   G E AVKV      + +   +S   E  ++K++ H N++K
Sbjct: 33  VLGKGSFGEV--ILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMK 90
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
           +   + +  +  LV E    G L   + +S           I+  V S + Y+H      
Sbjct: 91  LYEFFEDKGYFYLVGEVYTGGELFDEI-ISRKRFSEVDAARIIRQVLSGITYMH---KNK 146
Query: 224 IIHCDLKPSNVLLDD---NMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREG 280
           I+H DLKP N+LL+    +    + DFG++      + S      + T  Y+APE    G
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKMKDKIGTAYYIAPEV-LHG 202
Query: 281 RVSTNGDVYSFGIML 295
                 DV+S G++L
Sbjct: 203 TYDEKCDVWSTGVIL 217

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 84/192 (43%), Gaps = 13/192 (6%)
Query: 111 IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDI---ECDVMKRICHRNLIKIIS 166
           +G G FG V     ++ G   A+K+ D Q     K  +    E  +++ +    L+K+  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIH 226
           S+ ++    +V+EY+  G +   L       +   R      +    EYLH   S  +I+
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIY 164
Query: 227 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNG 286
            DLKP N+L+D      ++DFG AK +      L       T  Y+APE       +   
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKAV 219
Query: 287 DVYSFGIMLMEI 298
           D ++ G+++ E+
Sbjct: 220 DWWALGVLIYEM 231

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 84/192 (43%), Gaps = 13/192 (6%)
Query: 111 IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDI---ECDVMKRICHRNLIKIIS 166
           +G G FG V     ++ G   A+K+ D Q     K  +    E  +++ +    L+K+  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIH 226
           S+ ++    +V+EY+  G +   L       +   R      +    EYLH   S  +I+
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIY 164
Query: 227 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNG 286
            DLKP N+L+D      ++DFG AK +      L       T  Y+APE       +   
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKAV 219
Query: 287 DVYSFGIMLMEI 298
           D ++ G+++ E+
Sbjct: 220 DWWALGVLIYEM 231

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 84/192 (43%), Gaps = 13/192 (6%)
Query: 111 IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDI---ECDVMKRICHRNLIKIIS 166
           +G G FG V     ++ G   A+K+ D Q     K  +    E  +++ +    L+K+  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIH 226
           S+ ++    +V+EY+  G +   L       +   R      +    EYLH   S  +I+
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIY 164
Query: 227 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNG 286
            DLKP N+L+D      ++DFG AK +      L       T  Y+APE       +   
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKAV 219
Query: 287 DVYSFGIMLMEI 298
           D ++ G+++ E+
Sbjct: 220 DWWALGVLIYEM 231

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 40/133 (30%), Positives = 68/133 (51%), Gaps = 14/133 (10%)
Query: 205 IMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ 264
           I+  V ++  Y+H      I H D+KPSN+L+D N    LSDFG ++ ++  D+ +  ++
Sbjct: 156 IIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV--DKKIKGSR 211
Query: 265 TLATIGYMAPEYGREGRVSTNG---DVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVND 321
              T  +M PE+      S NG   D++S GI L  +F    P    FS +++L    N+
Sbjct: 212 --GTYEFMPPEFF-SNESSYNGAKVDIWSLGICLYVMFYNVVP----FSLKISLVELFNN 264
Query: 322 LLPISVMEVVDAN 334
           +   ++   +D N
Sbjct: 265 IRTKNIEYPLDRN 277

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 84/192 (43%), Gaps = 13/192 (6%)
Query: 111 IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDI---ECDVMKRICHRNLIKIIS 166
           +G G FG V     ++ G   A+K+ D Q     K  +    E  +++ +    L+K+  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIH 226
           S+ ++    +V+EY+  G +   L       +   R      +    EYLH   S  +I+
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIY 164
Query: 227 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNG 286
            DLKP N+L+D      ++DFG AK +      L       T  Y+APE       +   
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKAV 219
Query: 287 DVYSFGIMLMEI 298
           D ++ G+++ E+
Sbjct: 220 DWWALGVLIYEM 231

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 108/223 (48%), Gaps = 26/223 (11%)
Query: 106 NMPPLIGKGGFG---SVYKAIIQDGMEVAVKVFDP-QYEGAFKSFDIECDVMKRICHRNL 161
           N+ P IG G  G   + Y A++   + +  K+  P Q +   K    E  +MK + H+N+
Sbjct: 21  NLKP-IGSGAQGIVCAAYDAVLDRNVAIK-KLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 162 IKIISSYSN----DDFK--ALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEY 215
           I +++ ++     ++F+   LV+E M   +L + + +    LD  +   ++  +   +++
Sbjct: 79  ISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME---LDHERMSYLLYQMLCGIKH 134
Query: 216 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE 275
           LH   SA IIH DLKPSN+++  +    + DFG+A+       S   T  + T  Y APE
Sbjct: 135 LH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPE 188
Query: 276 YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRW 318
                    N D++S G ++ E+  R K    +F G   + +W
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEM-VRHKI---LFPGRDYIDQW 227

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 88/215 (40%), Gaps = 28/215 (13%)
Query: 111 IGKGGFGSVYKAII------QDGMEVAVKVFDPQ-YEGAFKSFDIECDVMKRIC-HRNLI 162
           +G G FG V +A           M VAVK+  P  +    ++   E  V+  +  H N++
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 106
Query: 163 KIISSYSNDDFKALVLEYMPHGSLEK----------CLYLSNYILDIFQRL-------DI 205
            ++ + +      ++ EY  +G L            C   S  I++  +           
Sbjct: 107 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 166
Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              VA  + +L    S   IH DL   N+LL    +  + DFG+A+ +  +   + +   
Sbjct: 167 SYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 223
Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
              + +MAPE       +   DV+S+GI L E+F+
Sbjct: 224 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 258

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 108/223 (48%), Gaps = 26/223 (11%)
Query: 106 NMPPLIGKGGFG---SVYKAIIQDGMEVAVKVFDP-QYEGAFKSFDIECDVMKRICHRNL 161
           N+ P IG G  G   + Y A++   + +  K+  P Q +   K    E  +MK + H+N+
Sbjct: 27  NLKP-IGSGAQGIVCAAYDAVLDRNVAIK-KLSRPFQNQTHAKRAYRELVLMKCVNHKNI 84
Query: 162 IKIISSYSN----DDFK--ALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEY 215
           I +++ ++     ++F+   LV+E M   +L + + +    LD  +   ++  +   +++
Sbjct: 85  ISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME---LDHERMSYLLYQMLCGIKH 140
Query: 216 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE 275
           LH   SA IIH DLKPSN+++  +    + DFG+A+       S   T  + T  Y APE
Sbjct: 141 LH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPE 194
Query: 276 YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRW 318
                    N D++S G ++ E+  R K    +F G   + +W
Sbjct: 195 VILGMGYKENVDIWSVGCIMGEM-VRHKI---LFPGRDYIDQW 233

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 108/223 (48%), Gaps = 26/223 (11%)
Query: 106 NMPPLIGKGGFG---SVYKAIIQDGMEVAVKVFDP-QYEGAFKSFDIECDVMKRICHRNL 161
           N+ P IG G  G   + Y A++   + +  K+  P Q +   K    E  +MK + H+N+
Sbjct: 22  NLKP-IGSGAQGIVCAAYDAVLDRNVAIK-KLSRPFQNQTHAKRAYRELVLMKCVNHKNI 79
Query: 162 IKIISSYSN----DDFK--ALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEY 215
           I +++ ++     ++F+   LV+E M   +L + + +    LD  +   ++  +   +++
Sbjct: 80  ISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME---LDHERMSYLLYQMLCGIKH 135
Query: 216 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE 275
           LH   SA IIH DLKPSN+++  +    + DFG+A+       S   T  + T  Y APE
Sbjct: 136 LH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPE 189
Query: 276 YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRW 318
                    N D++S G ++ E+  R K    +F G   + +W
Sbjct: 190 VILGMGYKENVDIWSVGCIMGEM-VRHKI---LFPGRDYIDQW 228

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 94/211 (44%), Gaps = 15/211 (7%)
Query: 103 NDANMPPLIGKGGFGSVYKAIIQDGMEV-AVKVFDPQYEGAFKSFDIECD-VMKRICH-- 158
            D N   ++GKG FG V  A  +   E+ A+K+   + +   +  D+EC  V KR+    
Sbjct: 19  TDFNFLMVLGKGSFGKVMLADRKGTEELYAIKIL--KKDVVIQDDDVECTMVEKRVLALL 76
Query: 159 ---RNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEY 215
                L ++ S +   D    V+EY+  G L   +Y    +   F+    +   A     
Sbjct: 77  DKPPFLTQLHSCFQTVDRLYFVMEYVNGGDL---MYHIQQV-GKFKEPQAVFYAAEISIG 132
Query: 216 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE 275
           L F +   II+ DLK  NV+LD      ++DFGM K  + +   +T  +   T  Y+APE
Sbjct: 133 LFFLHKRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMD--GVTTREFCGTPDYIAPE 190
Query: 276 YGREGRVSTNGDVYSFGIMLMEIFTRTKPTD 306
                    + D +++G++L E+     P D
Sbjct: 191 IIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 221

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 101/203 (49%), Gaps = 22/203 (10%)
Query: 106 NMPPLIGKGGFG---SVYKAIIQDGMEVAVKVFDP-QYEGAFKSFDIECDVMKRICHRNL 161
           N+ P IG G  G   + Y AI++  + +  K+  P Q +   K    E  +MK + H+N+
Sbjct: 28  NLKP-IGSGAQGIVCAAYDAILERNVAIK-KLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 162 IKIISSY----SNDDFK--ALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEY 215
           I +++ +    S ++F+   +V+E M   +L + + +    LD  +   ++  +   +++
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME---LDHERMSYLLYQMLCGIKH 141
Query: 216 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE 275
           LH   SA IIH DLKPSN+++  +    + DFG+A+       S   T  + T  Y APE
Sbjct: 142 LH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPEVVTRYYRAPE 195
Query: 276 YGREGRVSTNGDVYSFGIMLMEI 298
                    N D++S G ++ E+
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEM 218

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 108/223 (48%), Gaps = 26/223 (11%)
Query: 106 NMPPLIGKGGFG---SVYKAIIQDGMEVAVKVFDP-QYEGAFKSFDIECDVMKRICHRNL 161
           N+ P IG G  G   + Y A++   + +  K+  P Q +   K    E  +MK + H+N+
Sbjct: 22  NLKP-IGSGAQGIVCAAYDAVLDRNVAIK-KLSRPFQNQTHAKRAYRELVLMKCVNHKNI 79
Query: 162 IKIISSYSN----DDFK--ALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEY 215
           I +++ ++     ++F+   LV+E M   +L + + +    LD  +   ++  +   +++
Sbjct: 80  ISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME---LDHERMSYLLYQMLCGIKH 135
Query: 216 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE 275
           LH   SA IIH DLKPSN+++  +    + DFG+A+       S   T  + T  Y APE
Sbjct: 136 LH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPE 189
Query: 276 YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRW 318
                    N D++S G ++ E+  R K    +F G   + +W
Sbjct: 190 VILGMGYKENVDIWSVGCIMGEM-VRHKI---LFPGRDYIDQW 228

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 83/173 (47%), Gaps = 14/173 (8%)
Query: 110 LIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRI-CHRNLIKIISSY 168
           ++G G  G++    + D  +VAVK   P+    F   D E  +++    H N+I+   + 
Sbjct: 31  VLGHGAEGTIVYRGMFDNRDVAVKRILPE---CFSFADREVQLLRESDEHPNVIRYFCTE 87
Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCD 228
            +  F+ + +E     +L++ +   ++     + + ++    S L +LH   S  I+H D
Sbjct: 88  KDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLNIVHRD 143
Query: 229 LKPSNVLLD-----DNMVAHLSDFGMAKPLLEEDQSLTQTQTL-ATIGYMAPE 275
           LKP N+L+        + A +SDFG+ K L     S ++   +  T G++APE
Sbjct: 144 LKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 108/223 (48%), Gaps = 26/223 (11%)
Query: 106 NMPPLIGKGGFG---SVYKAIIQDGMEVAVKVFDP-QYEGAFKSFDIECDVMKRICHRNL 161
           N+ P IG G  G   + Y A++   + +  K+  P Q +   K    E  +MK + H+N+
Sbjct: 29  NLKP-IGSGAQGIVCAAYDAVLDRNVAIK-KLSRPFQNQTHAKRAYRELVLMKCVNHKNI 86
Query: 162 IKIISSYSN----DDFK--ALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEY 215
           I +++ ++     ++F+   LV+E M   +L + + +    LD  +   ++  +   +++
Sbjct: 87  ISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME---LDHERMSYLLYQMLCGIKH 142
Query: 216 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE 275
           LH   SA IIH DLKPSN+++  +    + DFG+A+       S   T  + T  Y APE
Sbjct: 143 LH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPE 196
Query: 276 YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRW 318
                    N D++S G ++ E+  R K    +F G   + +W
Sbjct: 197 VILGMGYKENVDIWSVGCIMGEM-VRHKI---LFPGRDYIDQW 235

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 108/223 (48%), Gaps = 26/223 (11%)
Query: 106 NMPPLIGKGGFG---SVYKAIIQDGMEVAVKVFDP-QYEGAFKSFDIECDVMKRICHRNL 161
           N+ P IG G  G   + Y A++   + +  K+  P Q +   K    E  +MK + H+N+
Sbjct: 29  NLKP-IGSGAQGIVCAAYDAVLDRNVAIK-KLSRPFQNQTHAKRAYRELVLMKCVNHKNI 86
Query: 162 IKIISSYSN----DDFK--ALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEY 215
           I +++ ++     ++F+   LV+E M   +L + + +    LD  +   ++  +   +++
Sbjct: 87  ISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME---LDHERMSYLLYQMLCGIKH 142
Query: 216 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE 275
           LH   SA IIH DLKPSN+++  +    + DFG+A+       S   T  + T  Y APE
Sbjct: 143 LH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPE 196
Query: 276 YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRW 318
                    N D++S G ++ E+  R K    +F G   + +W
Sbjct: 197 VILGMGYKENVDIWSVGCIMGEM-VRHKI---LFPGRDYIDQW 235

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 106/223 (47%), Gaps = 26/223 (11%)
Query: 106 NMPPLIGKGGFG---SVYKAIIQDGMEVAVKVFDP-QYEGAFKSFDIECDVMKRICHRNL 161
           N+ P IG G  G   + Y A++   + +  K+  P Q +   K    E  +MK + H+N+
Sbjct: 28  NLKP-IGSGAQGIVCAAYDAVLDRNVAIK-KLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 162 IKIISSYSN----DDFK--ALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEY 215
           I +++ ++     ++F+   LV+E M   +L + + +    LD  +   ++  +   +++
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME---LDHERMSYLLYQMLCGIKH 141
Query: 216 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE 275
           LH   SA IIH DLKPSN+++  +    + DFG+A+       S   T  + T  Y APE
Sbjct: 142 LH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPE 195
Query: 276 YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRW 318
                    N D++S G ++ E+         +F G   + +W
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 234

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 108/223 (48%), Gaps = 26/223 (11%)
Query: 106 NMPPLIGKGGFG---SVYKAIIQDGMEVAVKVFDP-QYEGAFKSFDIECDVMKRICHRNL 161
           N+ P IG G  G   + Y A++   + +  K+  P Q +   K    E  +MK + H+N+
Sbjct: 28  NLKP-IGSGAQGIVCAAYDAVLDRNVAIK-KLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 162 IKIISSYSN----DDFK--ALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEY 215
           I +++ ++     ++F+   LV+E M   +L + + +    LD  +   ++  +   +++
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME---LDHERMSYLLYQMLCGIKH 141
Query: 216 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE 275
           LH   SA IIH DLKPSN+++  +    + DFG+A+       S   T  + T  Y APE
Sbjct: 142 LH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPE 195
Query: 276 YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRW 318
                    N D++S G ++ E+  R K    +F G   + +W
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEM-VRHKI---LFPGRDYIDQW 234

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 21/211 (9%)
Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRIC--HRNLIKIIS 166
           ++G+G    V   I +    E AVK+ + Q  G  +S       M   C  HRN++++I 
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQ-PGHIRSRVFREVEMLYQCQGHRNVLELIE 78
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIH 226
            +  +D   LV E M  GS+   ++   +  ++   + ++ DVASAL++LH   +  I H
Sbjct: 79  FFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV-VVQDVASALDFLH---NKGIAH 134
Query: 227 CDLKPSNVLLDD-NMVA--HLSDFGMAKPL-LEEDQSLTQTQTLAT----IGYMAPE--- 275
            DLKP N+L +  N V+   + DFG+   + L  D S   T  L T      YMAPE   
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVE 194
Query: 276 -YGREGRV-STNGDVYSFGIMLMEIFTRTKP 304
            +  E  +     D++S G++L  + +   P
Sbjct: 195 AFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 89/195 (45%), Gaps = 19/195 (9%)
Query: 110 LIGKGGFGSVYKAIIQD---GMEVAVKVFDP---QYEGAFKSFDIECDVMKRICHRNLIK 163
           ++GKG FG V   + +D   G E AVKV      + +   +S   E  ++K++ H N++K
Sbjct: 56  VLGKGSFGEVI--LCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMK 113
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
           +   + +  +  LV E    G L   + +S           I+  V S + Y+H      
Sbjct: 114 LYEFFEDKGYFYLVGEVYTGGELFDEI-ISRKRFSEVDAARIIRQVLSGITYMH---KNK 169
Query: 224 IIHCDLKPSNVLLDD---NMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREG 280
           I+H DLKP N+LL+    +    + DFG++      + S      + T  Y+APE    G
Sbjct: 170 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKMKDKIGTAYYIAPEV-LHG 225
Query: 281 RVSTNGDVYSFGIML 295
                 DV+S G++L
Sbjct: 226 TYDEKCDVWSTGVIL 240

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 89/195 (45%), Gaps = 19/195 (9%)
Query: 110 LIGKGGFGSVYKAIIQD---GMEVAVKVFDP---QYEGAFKSFDIECDVMKRICHRNLIK 163
           ++GKG FG V   + +D   G E AVKV      + +   +S   E  ++K++ H N++K
Sbjct: 57  VLGKGSFGEVI--LCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMK 114
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
           +   + +  +  LV E    G L   + +S           I+  V S + Y+H      
Sbjct: 115 LYEFFEDKGYFYLVGEVYTGGELFDEI-ISRKRFSEVDAARIIRQVLSGITYMH---KNK 170
Query: 224 IIHCDLKPSNVLLDD---NMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREG 280
           I+H DLKP N+LL+    +    + DFG++      + S      + T  Y+APE    G
Sbjct: 171 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKMKDKIGTAYYIAPEV-LHG 226
Query: 281 RVSTNGDVYSFGIML 295
                 DV+S G++L
Sbjct: 227 TYDEKCDVWSTGVIL 241

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 108/223 (48%), Gaps = 26/223 (11%)
Query: 106 NMPPLIGKGGFG---SVYKAIIQDGMEVAVKVFDP-QYEGAFKSFDIECDVMKRICHRNL 161
           N+ P IG G  G   + Y A++   + +  K+  P Q +   K    E  +MK + H+N+
Sbjct: 66  NLKP-IGSGAQGIVCAAYDAVLDRNVAIK-KLSRPFQNQTHAKRAYRELVLMKCVNHKNI 123
Query: 162 IKIISSYSN----DDFK--ALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEY 215
           I +++ ++     ++F+   LV+E M   +L + + +    LD  +   ++  +   +++
Sbjct: 124 ISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME---LDHERMSYLLYQMLCGIKH 179
Query: 216 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE 275
           LH   SA IIH DLKPSN+++  +    + DFG+A+       S   T  + T  Y APE
Sbjct: 180 LH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPE 233
Query: 276 YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRW 318
                    N D++S G ++ E+  R K    +F G   + +W
Sbjct: 234 VILGMGYKENVDIWSVGCIMGEM-VRHKI---LFPGRDYIDQW 272

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 108/241 (44%), Gaps = 31/241 (12%)
Query: 99  KPLPNDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSF------DIECD 151
           +PL +   + PL+G GGFGSVY  I + D + VA+K  +      +          +E  
Sbjct: 3   EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 62
Query: 152 VMKRICH--RNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDV 209
           ++K++      +I+++  +   D   L+LE       E    L ++I    +R  +  ++
Sbjct: 63  LLKKVSSGFSGVIRLLDWFERPDSFVLILE-----RPEPVQDLFDFIT---ERGALQEEL 114
Query: 210 ASA-----LEYLHFGYSAPIIHCDLKPSNVLLDDNMVA-HLSDFGMAKPLLEEDQSLTQT 263
           A +     LE +   ++  ++H D+K  N+L+D N     L DFG    L    +    T
Sbjct: 115 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYT 170
Query: 264 QTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMEIFTRTKP---TDEIFSGEMTLKRWV 319
               T  Y  PE+ R  R    +  V+S GI+L ++     P    +EI  G++  ++ V
Sbjct: 171 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV 230
Query: 320 N 320
           +
Sbjct: 231 S 231

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 29/80 (36%), Positives = 43/80 (53%), Gaps = 3/80 (3%)
Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ-TQTLATIGYMAPEYGREGRVST 284
           H D+KP N+L+  +  A+L DFG+A      D+ LTQ   T+ T+ Y APE   E   + 
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATT--DEKLTQLGNTVGTLYYXAPERFSESHATY 214
Query: 285 NGDVYSFGIMLMEIFTRTKP 304
             D+Y+   +L E  T + P
Sbjct: 215 RADIYALTCVLYECLTGSPP 234

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 88/215 (40%), Gaps = 28/215 (13%)
Query: 111 IGKGGFGSVYKAII------QDGMEVAVKVFDPQ-YEGAFKSFDIECDVMKRIC-HRNLI 162
           +G G FG V +A           M VAVK+  P  +    ++   E  V+  +  H N++
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 163 KIISSYSNDDFKALVLEYMPHGSLEK----------CLYLSNYILDIFQRL-------DI 205
            ++ + +      ++ EY  +G L            C   S  I++  +           
Sbjct: 91  NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              VA  + +L    S   IH DL   N+LL    +  + DFG+A+ +  +   + +   
Sbjct: 151 SYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207
Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
              + +MAPE       +   DV+S+GI L E+F+
Sbjct: 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 107/223 (47%), Gaps = 26/223 (11%)
Query: 106 NMPPLIGKGGFG---SVYKAIIQDGMEVAVKVFDP-QYEGAFKSFDIECDVMKRICHRNL 161
           N+ P IG G  G   + Y AI++  + +  K+  P Q +   K    E  +MK + H+N+
Sbjct: 22  NLKP-IGSGAQGIVCAAYDAILERNVAIK-KLSRPFQNQTHAKRAYRELVLMKCVNHKNI 79
Query: 162 IKIISSY----SNDDFK--ALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEY 215
           I +++ +    S ++F+   +V+E M   +L + + +    LD  +   ++  +   +++
Sbjct: 80  IGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME---LDHERMSYLLYQMLCGIKH 135
Query: 216 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE 275
           LH   SA IIH DLKPSN+++  +    + DFG+A+       S   T  + T  Y APE
Sbjct: 136 LH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPE 189
Query: 276 YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRW 318
                    N D++S G ++ E+         +F G   + +W
Sbjct: 190 VILGMGYKENVDLWSVGCIMGEMVCHKI----LFPGRDYIDQW 228

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/240 (25%), Positives = 107/240 (44%), Gaps = 31/240 (12%)
Query: 100 PLPNDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSF------DIECDV 152
           PL +   + PL+G GGFGSVY  I + D + VA+K  +      +          +E  +
Sbjct: 1   PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVL 60
Query: 153 MKRICH--RNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVA 210
           +K++      +I+++  +   D   L+LE       E    L ++I    +R  +  ++A
Sbjct: 61  LKKVSSGFSGVIRLLDWFERPDSFVLILE-----RPEPVQDLFDFIT---ERGALQEELA 112
Query: 211 SA-----LEYLHFGYSAPIIHCDLKPSNVLLDDNMVA-HLSDFGMAKPLLEEDQSLTQTQ 264
            +     LE +   ++  ++H D+K  N+L+D N     L DFG    L    +    T 
Sbjct: 113 RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTD 168
Query: 265 TLATIGYMAPEYGREGRV-STNGDVYSFGIMLMEIFTRTKP---TDEIFSGEMTLKRWVN 320
              T  Y  PE+ R  R    +  V+S GI+L ++     P    +EI  G++  ++ V+
Sbjct: 169 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVS 228

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 88/215 (40%), Gaps = 28/215 (13%)
Query: 111 IGKGGFGSVYKAII------QDGMEVAVKVFDPQ-YEGAFKSFDIECDVMKRIC-HRNLI 162
           +G G FG V +A           M VAVK+  P  +    ++   E  V+  +  H N++
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 163 KIISSYSNDDFKALVLEYMPHGSLEK----------CLYLSNYILDIFQRL-------DI 205
            ++ + +      ++ EY  +G L            C   S  I++  +           
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              VA  + +L    S   IH DL   N+LL    +  + DFG+A+ +  +   + +   
Sbjct: 174 SYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNA 230
Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
              + +MAPE       +   DV+S+GI L E+F+
Sbjct: 231 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 107/223 (47%), Gaps = 26/223 (11%)
Query: 106 NMPPLIGKGGFG---SVYKAIIQDGMEVAVKVFDP-QYEGAFKSFDIECDVMKRICHRNL 161
           N+ P IG G  G   + Y AI++  + +  K+  P Q +   K    E  +MK + H+N+
Sbjct: 33  NLKP-IGSGAQGIVCAAYDAILERNVAIK-KLSRPFQNQTHAKRAYRELVLMKCVNHKNI 90
Query: 162 IKIISSY----SNDDFK--ALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEY 215
           I +++ +    S ++F+   +V+E M   +L + + +    LD  +   ++  +   +++
Sbjct: 91  IGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME---LDHERMSYLLYQMLCGIKH 146
Query: 216 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE 275
           LH   SA IIH DLKPSN+++  +    + DFG+A+       S   T  + T  Y APE
Sbjct: 147 LH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPE 200
Query: 276 YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRW 318
                    N D++S G ++ E+         +F G   + +W
Sbjct: 201 VILGMGYKENVDLWSVGCIMGEMVCHKI----LFPGRDYIDQW 239

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 101/203 (49%), Gaps = 22/203 (10%)
Query: 106 NMPPLIGKGGFG---SVYKAIIQDGMEVAVKVFDP-QYEGAFKSFDIECDVMKRICHRNL 161
           N+ P IG G  G   + Y AI++  + +  K+  P Q +   K    E  +MK + H+N+
Sbjct: 28  NLKP-IGSGAQGIVCAAYDAILERNVAIK-KLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 162 IKIISSY----SNDDFK--ALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEY 215
           I +++ +    S ++F+   +V+E M   +L + + +    LD  +   ++  +   +++
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME---LDHERMSYLLYQMLCGIKH 141
Query: 216 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE 275
           LH   SA IIH DLKPSN+++  +    + DFG+A+       S   T  + T  Y APE
Sbjct: 142 LH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPE 195
Query: 276 YGREGRVSTNGDVYSFGIMLMEI 298
                    N D++S G ++ E+
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEM 218

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 89/215 (41%), Gaps = 28/215 (13%)
Query: 111 IGKGGFGSV-----YKAIIQDG-MEVAVKVFDPQ-YEGAFKSFDIECDVMKRIC-HRNLI 162
           +G G FG V     Y  I  D  M VAVK+  P  +    ++   E  V+  +  H N++
Sbjct: 49  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 108
Query: 163 KIISSYSNDDFKALVLEYMPHGSLEK----------CLYLSNYILDIFQRL-------DI 205
            ++ + +      ++ EY  +G L            C   S  I++  +           
Sbjct: 109 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 168
Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              VA  + +L    S   IH DL   N+LL    +  + DFG+A+ +  +   + +   
Sbjct: 169 SYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 225
Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
              + +MAPE       +   DV+S+GI L E+F+
Sbjct: 226 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 260

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 101/203 (49%), Gaps = 22/203 (10%)
Query: 106 NMPPLIGKGGFG---SVYKAIIQDGMEVAVKVFDP-QYEGAFKSFDIECDVMKRICHRNL 161
           N+ P IG G  G   + Y AI++  + +  K+  P Q +   K    E  +MK + H+N+
Sbjct: 29  NLKP-IGSGAQGIVCAAYDAILERNVAIK-KLSRPFQNQTHAKRAYRELVLMKCVNHKNI 86
Query: 162 IKIISSY----SNDDFK--ALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEY 215
           I +++ +    S ++F+   +V+E M   +L + + +    LD  +   ++  +   +++
Sbjct: 87  IGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME---LDHERMSYLLYQMLCGIKH 142
Query: 216 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE 275
           LH   SA IIH DLKPSN+++  +    + DFG+A+       S   T  + T  Y APE
Sbjct: 143 LH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPE 196
Query: 276 YGREGRVSTNGDVYSFGIMLMEI 298
                    N D++S G ++ E+
Sbjct: 197 VILGMGYKENVDIWSVGCIMGEM 219

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 108/223 (48%), Gaps = 26/223 (11%)
Query: 106 NMPPLIGKGGFG---SVYKAIIQDGMEVAVKVFDP-QYEGAFKSFDIECDVMKRICHRNL 161
           N+ P IG G  G   + Y A++   + +  K+  P Q +   K    E  +MK + H+N+
Sbjct: 66  NLKP-IGSGAQGIVCAAYDAVLDRNVAIK-KLSRPFQNQTHAKRAYRELVLMKCVNHKNI 123
Query: 162 IKIISSYSN----DDFK--ALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEY 215
           I +++ ++     ++F+   LV+E M   +L + + +    LD  +   ++  +   +++
Sbjct: 124 ISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME---LDHERMSYLLYQMLCGIKH 179
Query: 216 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE 275
           LH   SA IIH DLKPSN+++  +    + DFG+A+       S   T  + T  Y APE
Sbjct: 180 LH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPE 233
Query: 276 YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRW 318
                    N D++S G ++ E+  R K    +F G   + +W
Sbjct: 234 VILGMGYKENVDIWSVGCIMGEM-VRHKI---LFPGRDYIDQW 272

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 97/223 (43%), Gaps = 20/223 (8%)
Query: 103 NDANMPPLIGKGGFGSVYKAIIQDGMEV-AVKVFDPQYEGAFKSFDIECD-VMKRICHRN 160
            D N   ++GKG FG V  +  +   E+ AVK+   + +   +  D+EC  V KR+    
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKIL--KKDVVIQDDDVECTMVEKRVLALP 77
Query: 161 -----LIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEY 215
                L ++ S +   D    V+EY+  G L   +Y    +   F+    +   A     
Sbjct: 78  GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL---MYHIQQV-GRFKEPHAVFYAAEIAIG 133
Query: 216 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE 275
           L F  S  II+ DLK  NV+LD      ++DFGM K  + +   +T      T  Y+APE
Sbjct: 134 LFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD--GVTTKXFCGTPDYIAPE 191
Query: 276 YGREGRVSTNGDVYSFGIMLMEIFTRTKP-----TDEIFSGEM 313
                    + D ++FG++L E+     P      DE+F   M
Sbjct: 192 IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 234

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 90/216 (41%), Gaps = 31/216 (14%)
Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICH---------- 158
           ++G+G FG V KA    D    A+K      E    +   E  ++  + H          
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVVRYYAAW 71
Query: 159 ---RNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEY 215
              RN +K +++        + +EY  + +L   ++  N      +   +   +  AL Y
Sbjct: 72  LERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEALSY 131
Query: 216 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE-------EDQSL-----TQT 263
           +H   S  IIH DLKP N+ +D++    + DFG+AK +         + Q+L       T
Sbjct: 132 IH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLT 188
Query: 264 QTLATIGYMAPEY-GREGRVSTNGDVYSFGIMLMEI 298
             + T  Y+A E     G  +   D+YS GI+  E+
Sbjct: 189 SAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM 224

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 101/203 (49%), Gaps = 22/203 (10%)
Query: 106 NMPPLIGKGGFG---SVYKAIIQDGMEVAVKVFDP-QYEGAFKSFDIECDVMKRICHRNL 161
           N+ P IG G  G   + Y AI++  + +  K+  P Q +   K    E  +MK + H+N+
Sbjct: 28  NLKP-IGSGAQGIVCAAYDAILERNVAIK-KLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 162 IKIISSY----SNDDFK--ALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEY 215
           I +++ +    S ++F+   +V+E M   +L + + +    LD  +   ++  +   +++
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME---LDHERMSYLLYQMLCGIKH 141
Query: 216 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE 275
           LH   SA IIH DLKPSN+++  +    + DFG+A+       S   T  + T  Y APE
Sbjct: 142 LH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPE 195
Query: 276 YGREGRVSTNGDVYSFGIMLMEI 298
                    N D++S G ++ E+
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEM 218

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 88/205 (42%), Gaps = 18/205 (8%)
Query: 111 IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFK------SFDIECDVMKRICHRNLIK 163
           +G G F  V K   +  G+E A K    +   A +        + E  +++++ H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
           +   Y N     L+LE +  G L   L     + +  +    +  +   + YLH   +  
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE-EATSFIKQILDGVNYLH---TKK 135
Query: 224 IIHCDLKPSNV-LLDDNM-VAHLS--DFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
           I H DLKP N+ LLD N+ + H+   DFG+A  +   +  +       T  ++APE    
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPEFVAPEIVNY 192
Query: 280 GRVSTNGDVYSFGIMLMEIFTRTKP 304
             +    D++S G++   + +   P
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASP 217

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 88/215 (40%), Gaps = 28/215 (13%)
Query: 111 IGKGGFGSVYKAII------QDGMEVAVKVFDPQ-YEGAFKSFDIECDVMKRIC-HRNLI 162
           +G G FG V +A           M VAVK+  P  +    ++   E  V+  +  H N++
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 163 KIISSYSNDDFKALVLEYMPHGSLEK----------CLYLSNYILDIFQRL-------DI 205
            ++ + +      ++ EY  +G L            C   S  I++  +           
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              VA  + +L    S   IH DL   N+LL    +  + DFG+A+ +  +   + +   
Sbjct: 174 SYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 230
Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
              + +MAPE       +   DV+S+GI L E+F+
Sbjct: 231 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 88/205 (42%), Gaps = 18/205 (8%)
Query: 111 IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFK------SFDIECDVMKRICHRNLIK 163
           +G G F  V K   +  G+E A K    +   A +        + E  +++++ H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
           +   Y N     L+LE +  G L   L     + +  +    +  +   + YLH   +  
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE-EATSFIKQILDGVNYLH---TKK 135
Query: 224 IIHCDLKPSNV-LLDDNM-VAHLS--DFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
           I H DLKP N+ LLD N+ + H+   DFG+A  +   +  +       T  ++APE    
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPEFVAPEIVNY 192
Query: 280 GRVSTNGDVYSFGIMLMEIFTRTKP 304
             +    D++S G++   + +   P
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASP 217

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 88/205 (42%), Gaps = 18/205 (8%)
Query: 111 IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFK------SFDIECDVMKRICHRNLIK 163
           +G G F  V K   +  G+E A K    +   A +        + E  +++++ H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
           +   Y N     L+LE +  G L   L     + +  +    +  +   + YLH   +  
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE-EATSFIKQILDGVNYLH---TKK 135
Query: 224 IIHCDLKPSNV-LLDDNM-VAHLS--DFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
           I H DLKP N+ LLD N+ + H+   DFG+A  +   +  +       T  ++APE    
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPEFVAPEIVNY 192
Query: 280 GRVSTNGDVYSFGIMLMEIFTRTKP 304
             +    D++S G++   + +   P
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASP 217

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 95/214 (44%), Gaps = 19/214 (8%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSY 168
           IG GG   V++ + +     A+K  + +        S+  E   + ++  ++  KII  Y
Sbjct: 20  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKL-QQHSDKIIRLY 78
Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNY-ILDIFQRLDIMIDVASALEYLHFGYSAPIIHC 227
             +     +   M  G+++   +L     +D ++R        + LE +H  +   I+H 
Sbjct: 79  DYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYW---KNMLEAVHTIHQHGIVHS 135
Query: 228 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVST-NG 286
           DLKP+N L+ D M+  L DFG+A  +  +  S+ +   + T+ YM PE  ++   S  NG
Sbjct: 136 DLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENG 194
Query: 287 ----------DVYSFGIMLMEIFTRTKPTDEIFS 310
                     DV+S G +L  +     P  +I +
Sbjct: 195 KSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 228

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/240 (25%), Positives = 107/240 (44%), Gaps = 31/240 (12%)
Query: 100 PLPNDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSF------DIECDV 152
           PL +   + PL+G GGFGSVY  I + D + VA+K  +      +          +E  +
Sbjct: 1   PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVL 60
Query: 153 MKRICH--RNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVA 210
           +K++      +I+++  +   D   L+LE       E    L ++I    +R  +  ++A
Sbjct: 61  LKKVSSGFSGVIRLLDWFERPDSFVLILE-----RPEPVQDLFDFIT---ERGALQEELA 112
Query: 211 SA-----LEYLHFGYSAPIIHCDLKPSNVLLDDNMVA-HLSDFGMAKPLLEEDQSLTQTQ 264
            +     LE +   ++  ++H D+K  N+L+D N     L DFG    L    +    T 
Sbjct: 113 RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTD 168
Query: 265 TLATIGYMAPEYGREGRV-STNGDVYSFGIMLMEIFTRTKP---TDEIFSGEMTLKRWVN 320
              T  Y  PE+ R  R    +  V+S GI+L ++     P    +EI  G++  ++ V+
Sbjct: 169 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVS 228

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 88/205 (42%), Gaps = 18/205 (8%)
Query: 111 IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFK------SFDIECDVMKRICHRNLIK 163
           +G G F  V K   +  G+E A K    +   A +        + E  +++++ H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
           +   Y N     L+LE +  G L   L     + +  +    +  +   + YLH   +  
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE-EATSFIKQILDGVNYLH---TKK 135
Query: 224 IIHCDLKPSNV-LLDDNM-VAHLS--DFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
           I H DLKP N+ LLD N+ + H+   DFG+A  +   +  +       T  ++APE    
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPEFVAPEIVNY 192
Query: 280 GRVSTNGDVYSFGIMLMEIFTRTKP 304
             +    D++S G++   + +   P
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASP 217

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 95/214 (44%), Gaps = 19/214 (8%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSY 168
           IG GG   V++ + +     A+K  + +        S+  E   + ++  ++  KII  Y
Sbjct: 16  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKL-QQHSDKIIRLY 74
Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNY-ILDIFQRLDIMIDVASALEYLHFGYSAPIIHC 227
             +     +   M  G+++   +L     +D ++R        + LE +H  +   I+H 
Sbjct: 75  DYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYW---KNMLEAVHTIHQHGIVHS 131
Query: 228 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVST-NG 286
           DLKP+N L+ D M+  L DFG+A  +  +  S+ +   + T+ YM PE  ++   S  NG
Sbjct: 132 DLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENG 190
Query: 287 ----------DVYSFGIMLMEIFTRTKPTDEIFS 310
                     DV+S G +L  +     P  +I +
Sbjct: 191 KSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 224

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/240 (25%), Positives = 107/240 (44%), Gaps = 31/240 (12%)
Query: 100 PLPNDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSF------DIECDV 152
           PL +   + PL+G GGFGSVY  I + D + VA+K  +      +          +E  +
Sbjct: 1   PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVL 60
Query: 153 MKRICH--RNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVA 210
           +K++      +I+++  +   D   L+LE       E    L ++I    +R  +  ++A
Sbjct: 61  LKKVSSGFSGVIRLLDWFERPDSFVLILE-----RPEPVQDLFDFIT---ERGALQEELA 112
Query: 211 SA-----LEYLHFGYSAPIIHCDLKPSNVLLDDNMVA-HLSDFGMAKPLLEEDQSLTQTQ 264
            +     LE +   ++  ++H D+K  N+L+D N     L DFG    L    +    T 
Sbjct: 113 RSFFWQVLEAVRHCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTD 168
Query: 265 TLATIGYMAPEYGREGRV-STNGDVYSFGIMLMEIFTRTKP---TDEIFSGEMTLKRWVN 320
              T  Y  PE+ R  R    +  V+S GI+L ++     P    +EI  G++  ++ V+
Sbjct: 169 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVS 228

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 69/155 (44%), Gaps = 6/155 (3%)
Query: 158 HRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLH 217
           H  L+ + S +  +     V+EY+  G L   +     + +   R     +++ AL YLH
Sbjct: 69  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH 127
Query: 218 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYG 277
                 II+ DLK  NVLLD      L+D+GM K  L      T +    T  Y+APE  
Sbjct: 128 ---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSXFCGTPNYIAPEIL 182
Query: 278 REGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE 312
           R      + D ++ G+++ E+     P D + S +
Sbjct: 183 RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 217

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/192 (24%), Positives = 84/192 (43%), Gaps = 13/192 (6%)
Query: 111 IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDI---ECDVMKRICHRNLIKIIS 166
           +G G FG V     ++ G   A+K+ D Q     K  +    E  +++ +    L+K+  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIH 226
           S+ ++    +V+EY+  G +   L       +   R      +    EYLH   S  +I+
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIY 164
Query: 227 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNG 286
            DLKP N+L+D      ++DFG AK +      L       T  Y+APE       +   
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKAV 219
Query: 287 DVYSFGIMLMEI 298
           D ++ G+++ ++
Sbjct: 220 DWWALGVLIYQM 231

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 69/155 (44%), Gaps = 6/155 (3%)
Query: 158 HRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLH 217
           H  L+ + S +  +     V+EY+  G L   +     + +   R     +++ AL YLH
Sbjct: 65  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH 123
Query: 218 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYG 277
                 II+ DLK  NVLLD      L+D+GM K  L      T +    T  Y+APE  
Sbjct: 124 ---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSXFCGTPNYIAPEIL 178
Query: 278 REGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE 312
           R      + D ++ G+++ E+     P D + S +
Sbjct: 179 RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 213

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 88/205 (42%), Gaps = 18/205 (8%)
Query: 111 IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFK------SFDIECDVMKRICHRNLIK 163
           +G G F  V K   +  G+E A K    +   A +        + E  +++++ H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
           +   Y N     L+LE +  G L   L     + +  +    +  +   + YLH   +  
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE-EATSFIKQILDGVNYLH---TKK 135
Query: 224 IIHCDLKPSNV-LLDDNM-VAHLS--DFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
           I H DLKP N+ LLD N+ + H+   DFG+A  +   +  +       T  ++APE    
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPEFVAPEIVNY 192
Query: 280 GRVSTNGDVYSFGIMLMEIFTRTKP 304
             +    D++S G++   + +   P
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASP 217

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 90/220 (40%), Gaps = 28/220 (12%)
Query: 109 PLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVM-KRICHRNLIKIIS 166
           P +G+G FG V++    Q G + AVK          + F +E  V    +    ++ +  
Sbjct: 80  PRVGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPRIVPLYG 133
Query: 167 SYSNDDFKALVLEYMPHGSLEK------CLYLSNYILDIFQRLDIMIDVASALEYLHFGY 220
           +     +  + +E +  GSL +      CL     +  + Q L+        LEYLH   
Sbjct: 134 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALE-------GLEYLH--- 183
Query: 221 SAPIIHCDLKPSNVLL-DDNMVAHLSDFGMAKPLLEEDQS---LTQTQTLATIGYMAPEY 276
           +  I+H D+K  NVLL  D   A L DFG A  L  +      LT      T  +MAPE 
Sbjct: 184 TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV 243
Query: 277 GREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLK 316
                     D++S   M++ +     P  + F G + LK
Sbjct: 244 VMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK 283

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 106/230 (46%), Gaps = 38/230 (16%)
Query: 111 IGKGGFGSVYKAIIQD-GMEVAVK---VFDPQYEGAFKSFDIECDVMKRICHRNLIKII- 165
           +G GG G V+ A+  D    VA+K   + DPQ   + K    E  +++R+ H N++K+  
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQ---SVKHALREIKIIRRLDHDNIVKVFE 75
Query: 166 -----SSYSNDDFKAL--------VLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASA 212
                 S   DD  +L        V EYM    L   L     +L+   RL  M  +   
Sbjct: 76  ILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLE-QGPLLEEHARL-FMYQLLRG 132
Query: 213 LEYLHFGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFGMAK---PLLEEDQSLTQTQTLAT 268
           L+Y+H   SA ++H DLKP+N+ ++ +++V  + DFG+A+   P       L  ++ L T
Sbjct: 133 LKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHL--SEGLVT 187
Query: 269 IGYMAPEYGREGRVSTNG-DVYSFGIMLMEIFTRTKPTDEIFSGEMTLKR 317
             Y +P         T   D+++ G +  E+ T       +F+G   L++
Sbjct: 188 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLT----GKTLFAGAHELEQ 233

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 69/155 (44%), Gaps = 6/155 (3%)
Query: 158 HRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLH 217
           H  L+ + S +  +     V+EY+  G L   +     + +   R     +++ AL YLH
Sbjct: 80  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH 138
Query: 218 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYG 277
                 II+ DLK  NVLLD      L+D+GM K  L      T +    T  Y+APE  
Sbjct: 139 ---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSXFCGTPNYIAPEIL 193
Query: 278 REGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE 312
           R      + D ++ G+++ E+     P D + S +
Sbjct: 194 RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 228

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 69/155 (44%), Gaps = 6/155 (3%)
Query: 158 HRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLH 217
           H  L+ + S +  +     V+EY+  G L   +     + +   R     +++ AL YLH
Sbjct: 112 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH 170
Query: 218 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYG 277
                 II+ DLK  NVLLD      L+D+GM K  L      T +    T  Y+APE  
Sbjct: 171 ---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEIL 225
Query: 278 REGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE 312
           R      + D ++ G+++ E+     P D + S +
Sbjct: 226 RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 260

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 96/214 (44%), Gaps = 19/214 (8%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSY 168
           IG GG   V++ + +     A+K  + +        S+  E   + ++  ++  KII  Y
Sbjct: 17  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKL-QQHSDKIIRLY 75
Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNY-ILDIFQRLDIMIDVASALEYLHFGYSAPIIHC 227
             +     +   M  G+++   +L     +D ++R     ++   LE +H  +   I+H 
Sbjct: 76  DYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNM---LEAVHTIHQHGIVHS 132
Query: 228 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVST-NG 286
           DLKP+N L+ D M+  L DFG+A  +  +  S+ +   + T+ YM PE  ++   S  NG
Sbjct: 133 DLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENG 191
Query: 287 ----------DVYSFGIMLMEIFTRTKPTDEIFS 310
                     DV+S G +L  +     P  +I +
Sbjct: 192 KSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 225

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 95/214 (44%), Gaps = 19/214 (8%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSY 168
           IG GG   V++ + +     A+K  + +        S+  E   + ++  ++  KII  Y
Sbjct: 36  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKL-QQHSDKIIRLY 94
Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNY-ILDIFQRLDIMIDVASALEYLHFGYSAPIIHC 227
             +     +   M  G+++   +L     +D ++R        + LE +H  +   I+H 
Sbjct: 95  DYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYW---KNMLEAVHTIHQHGIVHS 151
Query: 228 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVST-NG 286
           DLKP+N L+ D M+  L DFG+A  +  +  S+ +   + T+ YM PE  ++   S  NG
Sbjct: 152 DLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENG 210
Query: 287 ----------DVYSFGIMLMEIFTRTKPTDEIFS 310
                     DV+S G +L  +     P  +I +
Sbjct: 211 KSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 244

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 90/220 (40%), Gaps = 28/220 (12%)
Query: 109 PLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVM-KRICHRNLIKIIS 166
           P +G+G FG V++    Q G + AVK          + F +E  V    +    ++ +  
Sbjct: 64  PRVGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPRIVPLYG 117
Query: 167 SYSNDDFKALVLEYMPHGSLEK------CLYLSNYILDIFQRLDIMIDVASALEYLHFGY 220
           +     +  + +E +  GSL +      CL     +  + Q L+        LEYLH   
Sbjct: 118 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALE-------GLEYLH--- 167
Query: 221 SAPIIHCDLKPSNVLL-DDNMVAHLSDFGMAKPLLEEDQS---LTQTQTLATIGYMAPEY 276
           +  I+H D+K  NVLL  D   A L DFG A  L  +      LT      T  +MAPE 
Sbjct: 168 TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV 227
Query: 277 GREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLK 316
                     D++S   M++ +     P  + F G + LK
Sbjct: 228 VMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK 267

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/125 (30%), Positives = 63/125 (50%), Gaps = 11/125 (8%)
Query: 205 IMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ 264
           I + +  ALE+LH   S  +IH D+KPSNVL++      + DFG++  L+++   + +  
Sbjct: 114 IAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDD---VAKDI 168
Query: 265 TLATIGYMAPEY-----GREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV 319
                 YMAPE       ++G  S   D++S GI ++E+     P D   +    LK+ V
Sbjct: 169 DAGCKPYMAPERINPELNQKG-YSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVV 227
Query: 320 NDLLP 324
            +  P
Sbjct: 228 EEPSP 232

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/192 (24%), Positives = 84/192 (43%), Gaps = 13/192 (6%)
Query: 111 IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDI---ECDVMKRICHRNLIKIIS 166
           +G G FG V     ++ G   A+K+ D Q     K  +    E  +++ +    L+K+  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIH 226
           S+ ++    +V+EY+  G +   L       +   R      +    EYLH   S  +I+
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIY 164
Query: 227 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNG 286
            DLKP N+++D      ++DFG AK +      L       T  Y+APE       +   
Sbjct: 165 RDLKPENLIIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIISKGYNKAV 219
Query: 287 DVYSFGIMLMEI 298
           D ++ G+++ E+
Sbjct: 220 DWWALGVLIYEM 231

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/105 (31%), Positives = 53/105 (50%), Gaps = 10/105 (9%)
Query: 205 IMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ 264
           + + +  AL YL   +   +IH D+KPSN+LLD+     L DFG++  L+++     + +
Sbjct: 129 MTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK---AKDR 183
Query: 265 TLATIGYMAPEY-----GREGRVSTNGDVYSFGIMLMEIFTRTKP 304
           +     YMAPE        +       DV+S GI L+E+ T   P
Sbjct: 184 SAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 96/214 (44%), Gaps = 19/214 (8%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSY 168
           IG GG   V++ + +     A+K  + +        S+  E   + ++  ++  KII  Y
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKL-QQHSDKIIRLY 122
Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNY-ILDIFQRLDIMIDVASALEYLHFGYSAPIIHC 227
             +     +   M  G+++   +L     +D ++R     ++   LE +H  +   I+H 
Sbjct: 123 DYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNM---LEAVHTIHQHGIVHS 179
Query: 228 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVST-NG 286
           DLKP+N L+ D M+  L DFG+A  +  +  S+ +   + T+ YM PE  ++   S  NG
Sbjct: 180 DLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENG 238
Query: 287 ----------DVYSFGIMLMEIFTRTKPTDEIFS 310
                     DV+S G +L  +     P  +I +
Sbjct: 239 KSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 272

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 94/201 (46%), Gaps = 19/201 (9%)
Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRI-CHRNLIKIISS 167
           L+G+G +  V  A+ +Q+G E AVK+ + Q   +      E + + +   ++N++++I  
Sbjct: 20  LLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEF 79
Query: 168 YSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHC 227
           + +D    LV E +  GS+   +    +  +  +   ++ DVA+AL++LH   +  I H 
Sbjct: 80  FEDDTRFYLVFEKLQGGSILAHIQKQKH-FNEREASRVVRDVAAALDFLH---TKGIAHR 135
Query: 228 DLKPSNVLLDD-NMVAHLS----DFGMAKPLLEEDQSLTQTQTLATIG---YMAPEY--- 276
           DLKP N+L +    V+ +     D G    L      +T  +     G   YMAPE    
Sbjct: 136 DLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEV 195
Query: 277 --GREGRVSTNGDVYSFGIML 295
              +        D++S G++L
Sbjct: 196 FTDQATFYDKRCDLWSLGVVL 216

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 88/211 (41%), Gaps = 14/211 (6%)
Query: 111 IGKGGFGSVYK-AIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYS 169
           +G+G FG V++    Q G + AVK    +    F++ ++       +    ++ +  +  
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKVRLE---VFRAEELM--ACAGLTSPRIVPLYGAVR 155
Query: 170 NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
              +  + +E +  GSL + L      L   + L  +      LEYLH   S  I+H D+
Sbjct: 156 EGPWVNIFMELLEGGSLGQ-LVKEQGCLPEDRALYYLGQALEGLEYLH---SRRILHGDV 211
Query: 230 KPSNVLL-DDNMVAHLSDFGMAKPLLEEDQS---LTQTQTLATIGYMAPEYGREGRVSTN 285
           K  NVLL  D   A L DFG A  L  +      LT      T  +MAPE          
Sbjct: 212 KADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSCDAK 271
Query: 286 GDVYSFGIMLMEIFTRTKPTDEIFSGEMTLK 316
            DV+S   M++ +     P  + F G + LK
Sbjct: 272 VDVWSSCCMMLHMLNGCHPWTQFFRGPLCLK 302

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 97/223 (43%), Gaps = 20/223 (8%)
Query: 103 NDANMPPLIGKGGFGSVYKAIIQDGMEV-AVKVFDPQYEGAFKSFDIECD-VMKRICHRN 160
            D N   ++GKG FG V  +  +   E+ AVK+   + +   +  D+EC  V KR+    
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKIL--KKDVVIQDDDVECTMVEKRVLALP 398
Query: 161 -----LIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEY 215
                L ++ S +   D    V+EY+  G L   +Y    +   F+    +   A     
Sbjct: 399 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL---MYHIQQV-GRFKEPHAVFYAAEIAIG 454
Query: 216 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE 275
           L F  S  II+ DLK  NV+LD      ++DFGM K  + +   +T      T  Y+APE
Sbjct: 455 LFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD--GVTTKXFCGTPDYIAPE 512
Query: 276 YGREGRVSTNGDVYSFGIMLMEIFTRTKP-----TDEIFSGEM 313
                    + D ++FG++L E+     P      DE+F   M
Sbjct: 513 IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 555

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 88/211 (41%), Gaps = 14/211 (6%)
Query: 111 IGKGGFGSVYK-AIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYS 169
           +G+G FG V++    Q G + AVK    +    F++ ++       +    ++ +  +  
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKVRLE---VFRAEELM--ACAGLTSPRIVPLYGAVR 136
Query: 170 NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
              +  + +E +  GSL + L      L   + L  +      LEYLH   S  I+H D+
Sbjct: 137 EGPWVNIFMELLEGGSLGQ-LVKEQGCLPEDRALYYLGQALEGLEYLH---SRRILHGDV 192
Query: 230 KPSNVLL-DDNMVAHLSDFGMAKPLLEEDQS---LTQTQTLATIGYMAPEYGREGRVSTN 285
           K  NVLL  D   A L DFG A  L  +      LT      T  +MAPE          
Sbjct: 193 KADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSCDAK 252
Query: 286 GDVYSFGIMLMEIFTRTKPTDEIFSGEMTLK 316
            DV+S   M++ +     P  + F G + LK
Sbjct: 253 VDVWSSCCMMLHMLNGCHPWTQFFRGPLCLK 283

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 91/198 (45%), Gaps = 20/198 (10%)
Query: 85  IVMILLILRYQKRGKPLPNDANMPPLIGKGGFGSVYKAII---QDGMEVAVKV---FDPQ 138
           IV+ L  +R Q+      +D  +  +IG+G F  V  A++   Q G   A+K+   +D  
Sbjct: 49  IVVRLKEVRLQR------DDFEILKVIGRGAFSEV--AVVKMKQTGQVYAMKIMNKWDML 100
Query: 139 YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILD 198
             G    F  E DV+     R + ++  ++ ++++  LV+EY   G L   L      + 
Sbjct: 101 KRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIP 160
Query: 199 IFQRLDIMIDVASALEYLH-FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED 257
                  + ++  A++ +H  GY    +H D+KP N+LLD      L+DFG     L  D
Sbjct: 161 AEMARFYLAEIVMAIDSVHRLGY----VHRDIKPDNILLDRCGHIRLADFGSCLK-LRAD 215
Query: 258 QSLTQTQTLATIGYMAPE 275
            ++     + T  Y++PE
Sbjct: 216 GTVRSLVAVGTPDYLSPE 233

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 89/197 (45%), Gaps = 25/197 (12%)
Query: 111 IGKGGFGSVYKAIIQD---GMEVAVKVFDPQY------EGAFKSFDIECDVMKRICHRNL 161
           +G G +G V   + +D   G E A+K+            GA      E  V+K++ H N+
Sbjct: 29  LGSGAYGEV--LLCKDKLTGAERAIKIIKKSSVTTTSNSGALLD---EVAVLKQLDHPNI 83
Query: 162 IKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYS 221
           +K+   + +     LV+E    G L   + L     ++   + IM  V S   YLH    
Sbjct: 84  MKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAV-IMKQVLSGTTYLH---K 139
Query: 222 APIIHCDLKPSNVLLDD---NMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGR 278
             I+H DLKP N+LL+    + +  + DFG++      +      + L T  Y+APE  R
Sbjct: 140 HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF---EVGGKMKERLGTAYYIAPEVLR 196
Query: 279 EGRVSTNGDVYSFGIML 295
           + +     DV+S G++L
Sbjct: 197 K-KYDEKCDVWSCGVIL 212

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 90/220 (40%), Gaps = 28/220 (12%)
Query: 109 PLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVM-KRICHRNLIKIIS 166
           P +G+G FG V++    Q G + AVK          + F +E  V    +    ++ +  
Sbjct: 78  PRLGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPRIVPLYG 131
Query: 167 SYSNDDFKALVLEYMPHGSLEK------CLYLSNYILDIFQRLDIMIDVASALEYLHFGY 220
           +     +  + +E +  GSL +      CL     +  + Q L+        LEYLH   
Sbjct: 132 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALE-------GLEYLH--- 181
Query: 221 SAPIIHCDLKPSNVLL-DDNMVAHLSDFGMAKPLLEEDQS---LTQTQTLATIGYMAPEY 276
           +  I+H D+K  NVLL  D   A L DFG A  L  +      LT      T  +MAPE 
Sbjct: 182 TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV 241
Query: 277 GREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLK 316
                     D++S   M++ +     P  + F G + LK
Sbjct: 242 VMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK 281

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 106/223 (47%), Gaps = 26/223 (11%)
Query: 106 NMPPLIGKGGFG---SVYKAIIQDGMEVAVKVFDP-QYEGAFKSFDIECDVMKRICHRNL 161
           N+ P IG G  G   + Y AI++  + +  K+  P Q +   K    E  +MK + H+N+
Sbjct: 28  NLKP-IGSGAQGIVCAAYDAILERNVAIK-KLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 162 IKIISSY----SNDDFK--ALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEY 215
           I +++ +    S ++F+   +V+E M   +L + + +    LD  +   ++  +   +++
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME---LDHERMSYLLYQMLCGIKH 141
Query: 216 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE 275
           LH   SA IIH DLKPSN+++  +    + DFG+A+       S      + T  Y APE
Sbjct: 142 LH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMEPEVVTRYYRAPE 195
Query: 276 YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRW 318
                    N D++S G ++ E+         +F G   + +W
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMVCHKI----LFPGRDYIDQW 234

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 96/214 (44%), Gaps = 19/214 (8%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSY 168
           IG GG   V++ + +     A+K  + +        S+  E   + ++  ++  KII  Y
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKL-QQHSDKIIRLY 122
Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNY-ILDIFQRLDIMIDVASALEYLHFGYSAPIIHC 227
             +     +   M  G+++   +L     +D ++R     ++   LE +H  +   I+H 
Sbjct: 123 DYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNM---LEAVHTIHQHGIVHS 179
Query: 228 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVST-NG 286
           DLKP+N L+ D M+  L DFG+A  +  +  S+ +   + T+ YM PE  ++   S  NG
Sbjct: 180 DLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENG 238
Query: 287 ----------DVYSFGIMLMEIFTRTKPTDEIFS 310
                     DV+S G +L  +     P  +I +
Sbjct: 239 KSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 272

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 89/197 (45%), Gaps = 25/197 (12%)
Query: 111 IGKGGFGSVYKAIIQD---GMEVAVKVFDPQY------EGAFKSFDIECDVMKRICHRNL 161
           +G G +G V   + +D   G E A+K+            GA      E  V+K++ H N+
Sbjct: 12  LGSGAYGEVL--LCKDKLTGAERAIKIIKKSSVTTTSNSGALLD---EVAVLKQLDHPNI 66
Query: 162 IKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYS 221
           +K+   + +     LV+E    G L   + L     ++   + IM  V S   YLH    
Sbjct: 67  MKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAV-IMKQVLSGTTYLH---K 122
Query: 222 APIIHCDLKPSNVLLDD---NMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGR 278
             I+H DLKP N+LL+    + +  + DFG++      +      + L T  Y+APE  R
Sbjct: 123 HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF---EVGGKMKERLGTAYYIAPEVLR 179
Query: 279 EGRVSTNGDVYSFGIML 295
           + +     DV+S G++L
Sbjct: 180 K-KYDEKCDVWSCGVIL 195

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 87/195 (44%), Gaps = 19/195 (9%)
Query: 110 LIGKGGFGSVYKAIIQD---GMEVAVKVFDP---QYEGAFKSFDIECDVMKRICHRNLIK 163
           ++GKG FG V   + +D   G E AVKV      + +   +S   E  ++K++ H N+ K
Sbjct: 33  VLGKGSFGEV--ILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXK 90
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
           +   + +  +  LV E    G L   + +S           I+  V S + Y H      
Sbjct: 91  LYEFFEDKGYFYLVGEVYTGGELFDEI-ISRKRFSEVDAARIIRQVLSGITYXH---KNK 146
Query: 224 IIHCDLKPSNVLLDD---NMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREG 280
           I+H DLKP N+LL+    +    + DFG++      + S      + T  Y+APE    G
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKXKDKIGTAYYIAPEV-LHG 202
Query: 281 RVSTNGDVYSFGIML 295
                 DV+S G++L
Sbjct: 203 TYDEKCDVWSTGVIL 217

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/192 (24%), Positives = 83/192 (43%), Gaps = 13/192 (6%)
Query: 111 IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDI---ECDVMKRICHRNLIKIIS 166
           +G G FG V     ++ G   A+K+ D Q     K  +    E  +++ +    L+K+  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIH 226
           S+ ++    +V+EY+  G +   L       +   R      +    EYLH   S  +I+
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIY 164
Query: 227 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNG 286
            DLKP N+L+D      ++DFG AK +      L       T  Y+AP        +   
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPAIILSKGYNKAV 219
Query: 287 DVYSFGIMLMEI 298
           D ++ G+++ E+
Sbjct: 220 DWWALGVLIYEM 231

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 88/205 (42%), Gaps = 18/205 (8%)
Query: 111 IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFK------SFDIECDVMKRICHRNLIK 163
           +G G F  V K   +  G+E A K    +   A +        + E  +++++ H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
           +   Y N     L+LE +  G L   L     + +  +    +  +   + YLH   +  
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE-EATSFIKQILDGVNYLH---TKK 135
Query: 224 IIHCDLKPSNV-LLDDNM-VAHLS--DFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
           I H DLKP N+ LLD N+ + H+   DFG+A  +   +  +       T  ++APE    
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPEFVAPEIVNY 192
Query: 280 GRVSTNGDVYSFGIMLMEIFTRTKP 304
             +    D++S G++   + +   P
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASP 217

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 104/224 (46%), Gaps = 39/224 (17%)
Query: 110 LIGKGGFGSVYKAIIQD-GMEVAVK--VFDPQYEGAFKSFDIECDVMKRIC---HRNLIK 163
           + G+G FG+V     +  GM VA+K  + DP++         E  +M+ +    H N+++
Sbjct: 30  MAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNR------ELQIMQDLAVLHHPNIVQ 83
Query: 164 IISSY-------SNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDV-----AS 211
           + S +         D +  +V+EY+P  +L +C    NY         I+I V       
Sbjct: 84  LQSYFYTLGERDRRDIYLNVVMEYVP-DTLHRCC--RNYYRRQVAPPPILIKVFLFQLIR 140
Query: 212 ALEYLHFGYSAPIIHCDLKPSNVLLDD-NMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG 270
           ++  LH   S  + H D+KP NVL+++ +    L DFG AK L   + ++     + +  
Sbjct: 141 SIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA---YICSRY 196
Query: 271 YMAPE--YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE 312
           Y APE  +G +   +T  D++S G +  E+       + IF G+
Sbjct: 197 YRAPELIFGNQ-HYTTAVDIWSVGCIFAEMML----GEPIFRGD 235

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 106/223 (47%), Gaps = 26/223 (11%)
Query: 106 NMPPLIGKGGFG---SVYKAIIQDGMEVAVKVFDP-QYEGAFKSFDIECDVMKRICHRNL 161
           N+ P IG G  G   + Y AI++  + +  K+  P Q +   K    E  +MK + H+N+
Sbjct: 28  NLKP-IGSGAQGIVCAAYDAILERNVAIK-KLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 162 IKIISSY----SNDDFK--ALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEY 215
           I +++ +    S ++F+   +V+E M   +L + + +    LD  +   ++  +   +++
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME---LDHERMSYLLYQMLCGIKH 141
Query: 216 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE 275
           LH   SA IIH DLKPSN+++  +    + DFG+A+       S      + T  Y APE
Sbjct: 142 LH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMEPEVVTRYYRAPE 195
Query: 276 YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRW 318
                    N D++S G ++ E+         +F G   + +W
Sbjct: 196 VILGMGYKENVDLWSVGCIMGEMVCHKI----LFPGRDYIDQW 234

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 106 NMPPLIGKGGFG---SVYKAIIQDGMEVAVKVFDP-QYEGAFKSFDIECDVMKRICHRNL 161
           N+ P IG G  G   + Y AI++  + +  K+  P Q +   K    E  +MK + H+N+
Sbjct: 30  NLKP-IGSGAQGIVCAAYDAILERNVAIK-KLSRPFQNQTHAKRAYRELVLMKCVNHKNI 87
Query: 162 IKIISSY----SNDDFK--ALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEY 215
           I +++ +    S ++F+   +V+E M   +L + + +    LD  +   ++  +   +++
Sbjct: 88  IGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME---LDHERMSYLLYQMLCGIKH 143
Query: 216 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE 275
           LH   SA IIH DLKPSN+++  +    + DFG+A+       S      + T  Y APE
Sbjct: 144 LH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMVPFVVTRYYRAPE 197
Query: 276 YGREGRVSTNGDVYSFGIMLMEI 298
                    N D++S G ++ E+
Sbjct: 198 VILGMGYKENVDIWSVGCIMGEM 220

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 46/194 (23%), Positives = 89/194 (45%), Gaps = 11/194 (5%)
Query: 111 IGKGGFGSVYK--AIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
           +G+G + +VYK  + + D +    ++     EGA  +   E  ++K + H N++ +    
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 69
Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCD 228
             +    LV EY+    L++ L     I+++      +  +   L Y H      ++H D
Sbjct: 70  HTEKSLTLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRD 125
Query: 229 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE--YGREGRVSTNG 286
           LKP N+L+++     L+DFG+A+   +   + T    + T+ Y  P+   G     ST  
Sbjct: 126 LKPQNLLINERGELKLADFGLARA--KSIPTKTYDNEVVTLWYRPPDILLGSTD-YSTQI 182
Query: 287 DVYSFGIMLMEIFT 300
           D++  G +  E+ T
Sbjct: 183 DMWGVGCIFYEMAT 196

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 94/214 (43%), Gaps = 19/214 (8%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSY 168
           IG GG   V++ + +     A+K  + +        S+  E   + ++  ++  KII  Y
Sbjct: 36  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKL-QQHSDKIIRLY 94
Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNY-ILDIFQRLDIMIDVASALEYLHFGYSAPIIHC 227
             +     +   M  G+++   +L     +D ++R        + LE +H  +   I+H 
Sbjct: 95  DYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYW---KNMLEAVHTIHQHGIVHS 151
Query: 228 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVST-NG 286
           DLKP+N L+ D M+  L DFG+A  +  +   + +   + T+ YM PE  ++   S  NG
Sbjct: 152 DLKPANFLIVDGMLK-LIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKDMSSSRENG 210
Query: 287 ----------DVYSFGIMLMEIFTRTKPTDEIFS 310
                     DV+S G +L  +     P  +I +
Sbjct: 211 KSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 244

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 86/215 (40%), Gaps = 31/215 (14%)
Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICH---------- 158
           ++G+G FG V KA    D    A+K      E    +   E  ++  + H          
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVXLLASLNHQYVVRYYAAW 71
Query: 159 ---RNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEY 215
              RN +K  ++        +  EY  + +L   ++  N      +   +   +  AL Y
Sbjct: 72  LERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEALSY 131
Query: 216 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE-------EDQSL-----TQT 263
           +H   S  IIH +LKP N+ +D++    + DFG+AK +         + Q+L       T
Sbjct: 132 IH---SQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLT 188
Query: 264 QTLATIGYMAPEY-GREGRVSTNGDVYSFGIMLME 297
             + T  Y+A E     G  +   D YS GI+  E
Sbjct: 189 SAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFE 223

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 24/56 (42%), Positives = 32/56 (57%)
Query: 26  GTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNELLCEIVLPLST 81
           GT+P  L +L  L  +NVSFN L GEIP+ G  +   V ++  N+ LC   LP  T
Sbjct: 258 GTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLPACT 313

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 47/192 (24%), Positives = 83/192 (43%), Gaps = 13/192 (6%)
Query: 111 IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDI---ECDVMKRICHRNLIKIIS 166
           +G G FG V     ++ G   A+K+ D Q     K  +    E  +++ +    L+K+  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIH 226
           S+ ++    +V+EY+  G +   L       +   R      +    EYLH   S  +I+
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIY 164
Query: 227 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNG 286
            DLKP N+L+D      ++DFG AK +      L  T        +APE       +   
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEA-----LAPEIILSKGYNKAV 219
Query: 287 DVYSFGIMLMEI 298
           D ++ G+++ E+
Sbjct: 220 DWWALGVLIYEM 231

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 21/211 (9%)
Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRIC--HRNLIKIIS 166
           ++G+G    V   I +    E AVK+ + Q  G  +S       M   C  HRN++++I 
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQ-PGHIRSRVFREVEMLYQCQGHRNVLELIE 78
Query: 167 SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIH 226
            +  +D   LV E M  GS+   ++   +  ++   + ++ DVASAL++LH   +  I H
Sbjct: 79  FFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV-VVQDVASALDFLH---NKGIAH 134
Query: 227 CDLKPSNVLLDD-NMVA--HLSDFGMAKPL-LEEDQSLTQTQTLAT----IGYMAPE--- 275
            DLKP N+L +  N V+   + DF +   + L  D S   T  L T      YMAPE   
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVE 194
Query: 276 -YGREGRV-STNGDVYSFGIMLMEIFTRTKP 304
            +  E  +     D++S G++L  + +   P
Sbjct: 195 AFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 53/95 (55%), Gaps = 10/95 (10%)
Query: 204 DIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLEEDQSL 260
           +IM D+ +A+++LH   S  I H D+KP N+L    + + V  L+DFG AK   E  Q+ 
Sbjct: 132 EIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK---ETTQNA 185
Query: 261 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIML 295
            QT    T  Y+APE     +   + D++S G+++
Sbjct: 186 LQTPCY-TPYYVAPEVLGPEKYDKSCDMWSLGVIM 219

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 53/95 (55%), Gaps = 10/95 (10%)
Query: 204 DIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLEEDQSL 260
           +IM D+ +A+++LH   S  I H D+KP N+L    + + V  L+DFG AK   E  Q+ 
Sbjct: 113 EIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK---ETTQNA 166
Query: 261 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIML 295
            QT    T  Y+APE     +   + D++S G+++
Sbjct: 167 LQTPCY-TPYYVAPEVLGPEKYDKSCDMWSLGVIM 200

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/248 (21%), Positives = 107/248 (43%), Gaps = 21/248 (8%)
Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSF-DIECDVMKRICHRNLIKIISSYS 169
           +G+G FG V++ +     +  +  F  + +G  +     E  ++    HRN++ +  S+ 
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKF-VKVKGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 170 NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
           + +   ++ E++    + + +  S + L+  + +  +  V  AL++LH   S  I H D+
Sbjct: 72  SMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDI 128
Query: 230 KPSNVLLDDNMVAHLS--DFGMAKPLLEEDQSLTQTQTLATI-GYMAPEYGREGRVSTNG 286
           +P N++      + +   +FG A+ L   D      + L T   Y APE  +   VST  
Sbjct: 129 RPENIIYQTRRSSTIKIIEFGQARQLKPGDN----FRLLFTAPEYYAPEVHQHDVVSTAT 184
Query: 287 DVYSFGIMLMEIFTRTKP---------TDEIFSGEMTLKRWVNDLLPISVMEVVDANLLS 337
           D++S G ++  + +   P          + I + E T        + I  M+ VD  L+ 
Sbjct: 185 DMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVK 244
Query: 338 QEDEHFTT 345
           +     T 
Sbjct: 245 ERKSRMTA 252

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 66/288 (22%), Positives = 125/288 (43%), Gaps = 38/288 (13%)
Query: 43  VSFNKLEGEIPREGPFRNLSVKSFEGNELLCEIVLPLSTIFMIVMIL---LILRYQKRGK 99
           V   KLE ++  +GP+RN S  S E    L ++++ L T      +     +  + +  K
Sbjct: 5   VRLKKLE-QLLLDGPWRNESALSVE---TLLDVLVCLYTECSHSALRRDKYVAEFLEWAK 60
Query: 100 PLPN----------DANMPPLIGKGGFGSVYKAIIQDGMEV-AVKVFDPQYE----GAFK 144
           P             D  +  +IG+G FG V    +++   + A+K+ + ++E        
Sbjct: 61  PFTQLVKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILN-KWEMLKRAETA 119
Query: 145 SFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLY-LSNYILDIFQRL 203
            F  E DV+     + +  +  ++ +++   LV++Y   G L   L    + + +   R 
Sbjct: 120 CFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARF 179
Query: 204 DI--MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT 261
            I  M+    ++  LH+      +H D+KP NVLLD N    L+DFG     + +D ++ 
Sbjct: 180 YIGEMVLAIDSIHQLHY------VHRDIKPDNVLLDVNGHIRLADFGSCLK-MNDDGTVQ 232
Query: 262 QTQTLATIGYMAPEYGRE-----GRVSTNGDVYSFGIMLMEIFTRTKP 304
            +  + T  Y++PE  +      G+     D +S G+ + E+     P
Sbjct: 233 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 280

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 53/109 (48%), Gaps = 12/109 (11%)
Query: 213 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYM 272
           LE +H  +   I+H DLKP+N L+ D M+  L DFG+A  +  +  S+ +   +  + YM
Sbjct: 165 LEAVHTIHQHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGAVNYM 223
Query: 273 APEYGREGRVST-NG----------DVYSFGIMLMEIFTRTKPTDEIFS 310
            PE  ++   S  NG          DV+S G +L  +     P  +I +
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 272

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 66/288 (22%), Positives = 125/288 (43%), Gaps = 38/288 (13%)
Query: 43  VSFNKLEGEIPREGPFRNLSVKSFEGNELLCEIVLPLSTIFMIVMIL---LILRYQKRGK 99
           V   KLE ++  +GP+RN S  S E    L ++++ L T      +     +  + +  K
Sbjct: 21  VRLKKLE-QLLLDGPWRNESALSVE---TLLDVLVCLYTECSHSALRRDKYVAEFLEWAK 76
Query: 100 PLPN----------DANMPPLIGKGGFGSVYKAIIQDGMEV-AVKVFDPQYE----GAFK 144
           P             D  +  +IG+G FG V    +++   + A+K+ + ++E        
Sbjct: 77  PFTQLVKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILN-KWEMLKRAETA 135
Query: 145 SFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLY-LSNYILDIFQRL 203
            F  E DV+     + +  +  ++ +++   LV++Y   G L   L    + + +   R 
Sbjct: 136 CFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARF 195
Query: 204 DI--MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT 261
            I  M+    ++  LH+      +H D+KP NVLLD N    L+DFG     + +D ++ 
Sbjct: 196 YIGEMVLAIDSIHQLHY------VHRDIKPDNVLLDVNGHIRLADFGSCLK-MNDDGTVQ 248
Query: 262 QTQTLATIGYMAPEYGRE-----GRVSTNGDVYSFGIMLMEIFTRTKP 304
            +  + T  Y++PE  +      G+     D +S G+ + E+     P
Sbjct: 249 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 296

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 89/203 (43%), Gaps = 15/203 (7%)
Query: 103 NDANMPPLIGKGGFGSVYKAIIQD---GMEVAVKVFDPQYEGAFKSFD---IECDVMKRI 156
           N+     L+GKG FG V   ++++   G   A+K+   +   A         E  V++  
Sbjct: 151 NEFEYLKLLGKGTFGKV--ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 208
Query: 157 CHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIM-IDVASALEY 215
            H  L  +  S+   D    V+EY   G L    +LS   +    R      ++ SAL+Y
Sbjct: 209 RHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALDY 266
Query: 216 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE 275
           LH      +++ DLK  N++LD +    ++DFG+ K  +++    T      T  Y+APE
Sbjct: 267 LH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMKTFCGTPEYLAPE 322
Query: 276 YGREGRVSTNGDVYSFGIMLMEI 298
              +       D +  G+++ E+
Sbjct: 323 VLEDNDYGRAVDWWGLGVVMYEM 345

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 89/203 (43%), Gaps = 15/203 (7%)
Query: 103 NDANMPPLIGKGGFGSVYKAIIQD---GMEVAVKVFDPQYEGAFKSFD---IECDVMKRI 156
           N+     L+GKG FG V   ++++   G   A+K+   +   A         E  V++  
Sbjct: 148 NEFEYLKLLGKGTFGKV--ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 205
Query: 157 CHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIM-IDVASALEY 215
            H  L  +  S+   D    V+EY   G L    +LS   +    R      ++ SAL+Y
Sbjct: 206 RHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALDY 263
Query: 216 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE 275
           LH      +++ DLK  N++LD +    ++DFG+ K  +++    T      T  Y+APE
Sbjct: 264 LH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMKTFCGTPEYLAPE 319
Query: 276 YGREGRVSTNGDVYSFGIMLMEI 298
              +       D +  G+++ E+
Sbjct: 320 VLEDNDYGRAVDWWGLGVVMYEM 342

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 49/95 (51%), Gaps = 9/95 (9%)
Query: 204 DIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD---NMVAHLSDFGMAKPLLEEDQSL 260
           +IM  +  A++YLH   S  I H D+KP N+L      N +  L+DFG AK   E     
Sbjct: 119 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHN 172
Query: 261 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIML 295
           + T+   T  Y+APE     +   + D++S G+++
Sbjct: 173 SLTEPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 207

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 85/205 (41%), Gaps = 18/205 (8%)
Query: 111 IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKS------FDIECDVMKRICHRNLIK 163
           +G G F  V K   +  G++ A K    +   + +        + E  ++K I H N+I 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
           +   Y N     L+LE +  G L   L     + +  +  + +  + + + YLH   S  
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYYLH---SLQ 134
Query: 224 IIHCDLKPSNVLLDDNMVA----HLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
           I H DLKP N++L D  V      + DFG+A  +   D          T  ++APE    
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPAFVAPEIVNY 191
Query: 280 GRVSTNGDVYSFGIMLMEIFTRTKP 304
             +    D++S G++   + +   P
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASP 216

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 85/205 (41%), Gaps = 18/205 (8%)
Query: 111 IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKS------FDIECDVMKRICHRNLIK 163
           +G G F  V K   +  G++ A K    +   + +        + E  ++K I H N+I 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
           +   Y N     L+LE +  G L   L     + +  +  + +  + + + YLH   S  
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYYLH---SLQ 134
Query: 224 IIHCDLKPSNVLLDDNMVA----HLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
           I H DLKP N++L D  V      + DFG+A  +   D          T  ++APE    
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEFVAPEIVNY 191
Query: 280 GRVSTNGDVYSFGIMLMEIFTRTKP 304
             +    D++S G++   + +   P
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASP 216

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 85/205 (41%), Gaps = 18/205 (8%)
Query: 111 IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKS------FDIECDVMKRICHRNLIK 163
           +G G F  V K   +  G++ A K    +   + +        + E  ++K I H N+I 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
           +   Y N     L+LE +  G L   L     + +  +  + +  + + + YLH   S  
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYYLH---SLQ 134
Query: 224 IIHCDLKPSNVLLDDNMVA----HLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
           I H DLKP N++L D  V      + DFG+A  +   D          T  ++APE    
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEFVAPEIVNY 191
Query: 280 GRVSTNGDVYSFGIMLMEIFTRTKP 304
             +    D++S G++   + +   P
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASP 216

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 77/154 (50%), Gaps = 19/154 (12%)
Query: 149 ECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSL-EKCLYLSNYILDIFQRLD--- 204
           E  V+K + H N++K+   + +     LV+E    G L ++ ++        F  +D   
Sbjct: 86  EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMK-----FNEVDAAV 140
Query: 205 IMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD---NMVAHLSDFGMAKPLLEEDQSLT 261
           I+  V S + YLH      I+H DLKP N+LL+    + +  + DFG++  + E  + + 
Sbjct: 141 IIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLS-AVFENQKKM- 195
Query: 262 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIML 295
             + L T  Y+APE  R+ +     DV+S G++L
Sbjct: 196 -KERLGTAYYIAPEVLRK-KYDEKCDVWSIGVIL 227

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 85/205 (41%), Gaps = 18/205 (8%)
Query: 111 IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKS------FDIECDVMKRICHRNLIK 163
           +G G F  V K   +  G++ A K    +   + +        + E  ++K I H N+I 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
           +   Y N     L+LE +  G L   L     + +  +  + +  + + + YLH   S  
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYYLH---SLQ 134
Query: 224 IIHCDLKPSNVLLDDNMVA----HLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
           I H DLKP N++L D  V      + DFG+A  +   D          T  ++APE    
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEFVAPEIVNY 191
Query: 280 GRVSTNGDVYSFGIMLMEIFTRTKP 304
             +    D++S G++   + +   P
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASP 216

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 85/205 (41%), Gaps = 18/205 (8%)
Query: 111 IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKS------FDIECDVMKRICHRNLIK 163
           +G G F  V K   +  G++ A K    +   + +        + E  ++K I H N+I 
Sbjct: 19  LGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
           +   Y N     L+LE +  G L   L     + +  +  + +  + + + YLH   S  
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYYLH---SLQ 134
Query: 224 IIHCDLKPSNVLLDDNMVA----HLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
           I H DLKP N++L D  V      + DFG+A  +   D          T  ++APE    
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEFVAPEIVNY 191
Query: 280 GRVSTNGDVYSFGIMLMEIFTRTKP 304
             +    D++S G++   + +   P
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASP 216

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 88/191 (46%), Gaps = 33/191 (17%)
Query: 158 HRNLIKIISSYSNDDFKALVLEY--MPHGSLEKCLYLSNYILDI---FQRLDIMIDVASA 212
           H N+I+   S + D F  + LE   +    L +   +S+  L +   +  + ++  +AS 
Sbjct: 68  HPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127
Query: 213 LEYLHFGYSAPIIHCDLKPSNVLLD-------------DNMVAHLSDFGMAKPLLEEDQS 259
           + +LH   S  IIH DLKP N+L+              +N+   +SDFG+ K  L+  QS
Sbjct: 128 VAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK-LDSGQS 183
Query: 260 LTQT---QTLATIGYMAPEYGREG-------RVSTNGDVYSFGIMLMEIFTRTK-PTDEI 308
             +T       T G+ APE   E        R++ + D++S G +   I ++ K P  + 
Sbjct: 184 SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243
Query: 309 FSGEMTLKRWV 319
           +S E  + R +
Sbjct: 244 YSRESNIIRGI 254

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 85/205 (41%), Gaps = 18/205 (8%)
Query: 111 IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKS------FDIECDVMKRICHRNLIK 163
           +G G F  V K   +  G++ A K    +   + +        + E  ++K I H N+I 
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
           +   Y N     L+LE +  G L   L     + +  +  + +  + + + YLH   S  
Sbjct: 78  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYYLH---SLQ 133
Query: 224 IIHCDLKPSNVLLDDNMVA----HLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
           I H DLKP N++L D  V      + DFG+A  +   D          T  ++APE    
Sbjct: 134 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEFVAPEIVNY 190
Query: 280 GRVSTNGDVYSFGIMLMEIFTRTKP 304
             +    D++S G++   + +   P
Sbjct: 191 EPLGLEADMWSIGVITYILLSGASP 215

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 87/202 (43%), Gaps = 13/202 (6%)
Query: 103 NDANMPPLIGKGGFGSVYKAIIQD---GMEVAVKVFDPQYEGAFKSFD---IECDVMKRI 156
           N+     L+GKG FG V   ++++   G   A+K+   +   A         E  V++  
Sbjct: 9   NEFEYLKLLGKGTFGKV--ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 66
Query: 157 CHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYL 216
            H  L  +  S+   D    V+EY   G L   L       +   R     ++ SAL+YL
Sbjct: 67  RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYL 125
Query: 217 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEY 276
           H      +++ DLK  N++LD +    ++DFG+ K  +++    T      T  Y+APE 
Sbjct: 126 H--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMKXFCGTPEYLAPEV 181
Query: 277 GREGRVSTNGDVYSFGIMLMEI 298
             +       D +  G+++ E+
Sbjct: 182 LEDNDYGRAVDWWGLGVVMYEM 203

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 85/205 (41%), Gaps = 18/205 (8%)
Query: 111 IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKS------FDIECDVMKRICHRNLIK 163
           +G G F  V K   +  G++ A K    +   + +        + E  ++K I H N+I 
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
           +   Y N     L+LE +  G L   L     + +  +  + +  + + + YLH   S  
Sbjct: 78  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYYLH---SLQ 133
Query: 224 IIHCDLKPSNVLLDDNMVA----HLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
           I H DLKP N++L D  V      + DFG+A  +   D          T  ++APE    
Sbjct: 134 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEFVAPEIVNY 190
Query: 280 GRVSTNGDVYSFGIMLMEIFTRTKP 304
             +    D++S G++   + +   P
Sbjct: 191 EPLGLEADMWSIGVITYILLSGASP 215

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 87/202 (43%), Gaps = 13/202 (6%)
Query: 103 NDANMPPLIGKGGFGSVYKAIIQD---GMEVAVKVFDPQYEGAFKSFD---IECDVMKRI 156
           N+     L+GKG FG V   ++++   G   A+K+   +   A         E  V++  
Sbjct: 8   NEFEYLKLLGKGTFGKV--ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 65
Query: 157 CHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYL 216
            H  L  +  S+   D    V+EY   G L   L       +   R     ++ SAL+YL
Sbjct: 66  RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYL 124
Query: 217 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEY 276
           H      +++ DLK  N++LD +    ++DFG+ K  +++    T      T  Y+APE 
Sbjct: 125 H--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMKXFCGTPEYLAPEV 180
Query: 277 GREGRVSTNGDVYSFGIMLMEI 298
             +       D +  G+++ E+
Sbjct: 181 LEDNDYGRAVDWWGLGVVMYEM 202

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 87/202 (43%), Gaps = 13/202 (6%)
Query: 103 NDANMPPLIGKGGFGSVYKAIIQD---GMEVAVKVFDPQYEGAFKSFD---IECDVMKRI 156
           N+     L+GKG FG V   ++++   G   A+K+   +   A         E  V++  
Sbjct: 10  NEFEYLKLLGKGTFGKV--ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 67
Query: 157 CHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYL 216
            H  L  +  S+   D    V+EY   G L   L       +   R     ++ SAL+YL
Sbjct: 68  RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYL 126
Query: 217 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEY 276
           H      +++ DLK  N++LD +    ++DFG+ K  +++    T      T  Y+APE 
Sbjct: 127 H--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMKXFCGTPEYLAPEV 182
Query: 277 GREGRVSTNGDVYSFGIMLMEI 298
             +       D +  G+++ E+
Sbjct: 183 LEDNDYGRAVDWWGLGVVMYEM 204

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 85/205 (41%), Gaps = 18/205 (8%)
Query: 111 IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKS------FDIECDVMKRICHRNLIK 163
           +G G F  V K   +  G++ A K    +   + +        + E  ++K I H N+I 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
           +   Y N     L+LE +  G L   L     + +  +  + +  + + + YLH   S  
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYYLH---SLQ 134
Query: 224 IIHCDLKPSNVLLDDNMVA----HLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
           I H DLKP N++L D  V      + DFG+A  +   D          T  ++APE    
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEFVAPEIVNY 191
Query: 280 GRVSTNGDVYSFGIMLMEIFTRTKP 304
             +    D++S G++   + +   P
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASP 216

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 85/205 (41%), Gaps = 18/205 (8%)
Query: 111 IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKS------FDIECDVMKRICHRNLIK 163
           +G G F  V K   +  G++ A K    +   + +        + E  ++K I H N+I 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
           +   Y N     L+LE +  G L   L     + +  +  + +  + + + YLH   S  
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYYLH---SLQ 134
Query: 224 IIHCDLKPSNVLLDDNMVA----HLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
           I H DLKP N++L D  V      + DFG+A  +   D          T  ++APE    
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEFVAPEIVNY 191
Query: 280 GRVSTNGDVYSFGIMLMEIFTRTKP 304
             +    D++S G++   + +   P
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASP 216

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 85/205 (41%), Gaps = 18/205 (8%)
Query: 111 IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKS------FDIECDVMKRICHRNLIK 163
           +G G F  V K   +  G++ A K    +   + +        + E  ++K I H N+I 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
           +   Y N     L+LE +  G L   L     + +  +  + +  + + + YLH   S  
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYYLH---SLQ 134
Query: 224 IIHCDLKPSNVLLDDNMVA----HLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
           I H DLKP N++L D  V      + DFG+A  +   D          T  ++APE    
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEFVAPEIVNY 191
Query: 280 GRVSTNGDVYSFGIMLMEIFTRTKP 304
             +    D++S G++   + +   P
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASP 216

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 85/205 (41%), Gaps = 18/205 (8%)
Query: 111 IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKS------FDIECDVMKRICHRNLIK 163
           +G G F  V K   +  G++ A K    +   + +        + E  ++K I H N+I 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
           +   Y N     L+LE +  G L   L     + +  +  + +  + + + YLH   S  
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYYLH---SLQ 134
Query: 224 IIHCDLKPSNVLLDDNMVA----HLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
           I H DLKP N++L D  V      + DFG+A  +   D          T  ++APE    
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEFVAPEIVNY 191
Query: 280 GRVSTNGDVYSFGIMLMEIFTRTKP 304
             +    D++S G++   + +   P
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASP 216

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 9/95 (9%)
Query: 204 DIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD---NMVAHLSDFGMAKPLLEEDQSL 260
           +IM  +  A++YLH   S  I H D+KP N+L      N +  L+DFG AK   E     
Sbjct: 125 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHN 178
Query: 261 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIML 295
           + T    T  Y+APE     +   + D++S G+++
Sbjct: 179 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 213

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 9/95 (9%)
Query: 204 DIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD---NMVAHLSDFGMAKPLLEEDQSL 260
           +IM  +  A++YLH   S  I H D+KP N+L      N +  L+DFG AK   E     
Sbjct: 126 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHN 179
Query: 261 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIML 295
           + T    T  Y+APE     +   + D++S G+++
Sbjct: 180 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 214
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	346
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	8e-68
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	7e-66
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-59
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-56
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-55
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-54
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-53
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-53
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-52
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	5e-52
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	6e-52
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-51
3q4u_A	301	Activin receptor type-1; structural genomics conso	8e-50
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	9e-50
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	8e-49
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-48
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-48
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	5e-47
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	6e-38
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-37
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-37
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	5e-37
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	6e-37
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	8e-37
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-36
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	3e-36
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	4e-36
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	6e-36
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	7e-36
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	7e-36
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	8e-36
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-35
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-35
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-35
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-35
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-35
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-35
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-35
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	5e-35
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	6e-35
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	6e-35
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	6e-35
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-34
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-34
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-34
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-34
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-34
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-34
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-33
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-33
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-33
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-33
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-33
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-33
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-33
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	4e-33
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	5e-33
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	5e-33
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	5e-33
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	6e-33
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	9e-33
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-32
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-32
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-32
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-32
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-32
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-32
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	4e-32
4aoj_A	329	High affinity nerve growth factor receptor; transf	5e-32
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	8e-32
2a19_B	284	Interferon-induced, double-stranded RNA-activated	8e-32
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-31
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-31
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-31
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	3e-31
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-31
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-31
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	5e-31
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	6e-31
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	7e-31
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	8e-31
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-30
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-30
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-30
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-30
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	6e-30
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	7e-30
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-29
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-29
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	4e-29
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	6e-29
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-28
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-28
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	3e-28
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	4e-28
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	4e-28
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	7e-28
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	8e-28
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-27
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-27
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	8e-17
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-15
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-14
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-13
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	6e-09
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-27
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-27
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	4e-27
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	6e-27
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-26
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-26
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-26
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	3e-26
3an0_A	340	Dual specificity mitogen-activated protein kinase;	3e-26
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	4e-26
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	6e-26
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-15
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-14
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-14
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-14
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-14
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-13
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-13
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	7e-13
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-12
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-12
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	6e-12
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	4e-11
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-11
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-11
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	6e-11
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-10
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	4e-07
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-05
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	4e-05
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	8e-26
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-25
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-25
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-25
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	4e-25
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	5e-25
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	6e-25
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	6e-25
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	7e-25
2dyl_A	318	Dual specificity mitogen-activated protein kinase	9e-25
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-24
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-24
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-24
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-24
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	4e-24
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	5e-24
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	5e-24
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	5e-24
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	5e-24
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	6e-24
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	7e-24
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-23
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-23
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-23
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-23
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	3e-23
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	6e-23
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	7e-23
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	7e-23
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-22
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-22
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-22
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-22
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	4e-22
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	4e-22
3bhy_A	283	Death-associated protein kinase 3; death associate	5e-22
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	5e-22
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	5e-22
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	7e-22
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-21
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-21
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-21
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-21
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-21
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-21
3uqc_A	286	Probable conserved transmembrane protein; structur	4e-21
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	9e-21
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	9e-21
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-20
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-20
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-20
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-20
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-20
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	4e-20
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	6e-20
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-19
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-19
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-19
3o0g_A	292	Cell division protein kinase 5; kinase activator c	3e-19
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-19
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	4e-19
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	6e-19
3niz_A	311	Rhodanese family protein; structural genomics, str	6e-19
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	8e-19
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-18
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-18
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-18
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-18
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-18
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-18
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-18
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-18
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	4e-18
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	5e-18
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	9e-18
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-07
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-17
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-17
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-17
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-17
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	4e-17
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	4e-17
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	4e-17
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	6e-17
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	6e-17
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	6e-17
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	8e-17
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-16
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-16
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-16
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	4e-16
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	5e-16
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-15
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-15
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-15
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-15
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-15
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-15
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-15
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-15
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	6e-15
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	7e-15
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	8e-15
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-14
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-14
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	3e-14
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-14
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	8e-14
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-13
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-13
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-13
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	5e-13
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	6e-13
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	7e-13
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	9e-13
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-12
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-12
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	3e-12
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	6e-12
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-11
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-09
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-09
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-09
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	7e-09
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-08
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-08
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	8e-08
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-07
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	5e-07
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	7e-07
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	7e-07
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	7e-07
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-05
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-05
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-05
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-04
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-11
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-11
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-08
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-08
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-08
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-08
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	6e-08
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-07
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-07
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-07
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-06
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-06
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-06
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-06
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-06
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-06
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-05
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-05
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-04
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-11
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	4e-11
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	9e-11
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-10
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-09
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	9e-09
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	9e-09
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-08
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	4e-08
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-07
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	5e-07
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	7e-07
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-05
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-04
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	9e-11
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-10
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-10
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-09
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	7e-09
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	5e-07
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	9e-10
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-09
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	4e-08
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	5e-08
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-07
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	4e-07
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	4e-07
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	7e-07
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-06
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-06
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-06
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-05
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-05
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-09
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-08
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-08
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-08
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-07
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-06
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-06
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-06
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-05
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-05
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-05
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-04
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-04
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-04
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	6e-04
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	6e-08
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	6e-07
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	7e-07
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-06
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-06
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	5e-06
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	5e-06
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	8e-06
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-05
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-05
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-05
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-05
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-04
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-04
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	6e-08
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-07
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-07
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-07
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-07
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	8e-07
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-06
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-06
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-05
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	8e-08
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-07
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-07
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-04
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	6e-04
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-07
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	6e-06
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-05
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-04
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-04
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	4e-04
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	4e-07
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	6e-06
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	4e-05
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	4e-04
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	5e-04
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	5e-04
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	9e-07
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-04
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	6e-04
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	6e-04
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-06
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-05
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-04
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	5e-06
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	5e-06
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-05
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-04
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-04
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-04
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-04
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-04
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	6e-06
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-05
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-05
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	4e-05
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	4e-05
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-04
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	5e-04
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	6e-04
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	7e-04
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-05
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-05
1o6v_A	466	Internalin A; bacterial infection, extracellular r	5e-05
1o6v_A	466	Internalin A; bacterial infection, extracellular r	5e-05
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-04
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-04
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-04
1o6v_A	466	Internalin A; bacterial infection, extracellular r	9e-04
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-05
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-04
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-04
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-04
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-04
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-05
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-05
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-04
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	3e-04
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-05
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	9e-05
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-04
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	6e-04
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-05
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-04
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-04
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	4e-04
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	7e-05
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	8e-05
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	3e-04
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	4e-04
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	4e-04
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	1e-04
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-04
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-04
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-04
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-04
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	6e-04
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-04
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	3e-04
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-04
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-04
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	5e-04
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	5e-04
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	4e-04
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	4e-04
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	7e-04
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-04

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  214 bits (548), Expect = 8e-68
 Identities = 79/234 (33%), Positives = 124/234 (52%), Gaps = 8/234 (3%)

Query: 110 LIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYS 169
           LIG G FG VYK +++DG +VA+K   P+     + F+ E + +    H +L+ +I    
Sbjct: 46  LIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCD 105

Query: 170 NDDFKALVLEYMPHGSLEKCLY---LSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIH 226
             +   L+ +YM +G+L++ LY   L    +   QRL+I I  A  L YLH      IIH
Sbjct: 106 ERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIH 162

Query: 227 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNG 286
            D+K  N+LLD+N V  ++DFG++K   E DQ+   T    T+GY+ PEY  +GR++   
Sbjct: 163 RDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKS 222

Query: 287 DVYSFGIMLMEIFTRTKPTDEIFS-GEMTLKRWVNDLLPIS-VMEVVDANLLSQ 338
           DVYSFG++L E+        +      + L  W  +      + ++VD NL  +
Sbjct: 223 DVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADK 276

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  210 bits (536), Expect = 7e-66
 Identities = 82/247 (33%), Positives = 124/247 (50%), Gaps = 12/247 (4%)

Query: 103 NDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQ-YEGAFKSFDIECDVMKRICHRNL 161
           ++ N   ++G+GGFG VYK  + DG  VAVK    +  +G    F  E +++    HRNL
Sbjct: 33  SNKN---ILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 89

Query: 162 IKIISSYSNDDFKALVLEYMPHGSLEKCLY---LSNYILDIFQRLDIMIDVASALEYLHF 218
           +++         + LV  YM +GS+  CL     S   LD  +R  I +  A  L YLH 
Sbjct: 90  LRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHD 149

Query: 219 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGR 278
                IIH D+K +N+LLD+   A + DFG+AK L++   +   T    TIG++APEY  
Sbjct: 150 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDTHVTTAVRGTIGHIAPEYLS 208

Query: 279 EGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE---MTLKRWVNDLLPI-SVMEVVDAN 334
            G+ S   DV+ +G+ML+E+ T  +  D         + L  WV  LL    +  +VD +
Sbjct: 209 TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVD 268

Query: 335 LLSQEDE 341
           L     +
Sbjct: 269 LQGNYKD 275

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  193 bits (493), Expect = 1e-59
 Identities = 73/234 (31%), Positives = 116/234 (49%), Gaps = 14/234 (5%)

Query: 110 LIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGA----FKSFDIECDVMKRICHRNLIKII 165
            +G+GGFG VYK  + +   VAVK      +       + FD E  VM +  H NL++++
Sbjct: 38  KMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL 96

Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNY--ILDIFQRLDIMIDVASALEYLHFGYSAP 223
              S+ D   LV  YMP+GSL   L   +    L    R  I    A+ + +LH      
Sbjct: 97  GFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENH 153

Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVS 283
            IH D+K +N+LLD+   A +SDFG+A+   +  Q++  ++ + T  YMAPE  R G ++
Sbjct: 154 HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALR-GEIT 212

Query: 284 TNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLL--PISVMEVVDANL 335
              D+YSFG++L+EI T     DE       L     ++     ++ + +D  +
Sbjct: 213 PKSDIYSFGVVLLEIITGLPAVDEH-REPQLLLDIKEEIEDEEKTIEDYIDKKM 265

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  184 bits (470), Expect = 3e-56
 Identities = 62/245 (25%), Positives = 102/245 (41%), Gaps = 22/245 (8%)

Query: 110 LIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKII---- 165
           +  +G FG V+KA +     VAVK+F  Q + +++  + E   +  + H N+++ I    
Sbjct: 31  VKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQ-NEYEVYSLPGMKHENILQFIGAEK 88

Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLH-------F 218
              S D    L+  +   GSL    +L   ++   +   I   +A  L YLH        
Sbjct: 89  RGTSVDVDLWLITAFHEKGSLSD--FLKANVVSWNELCHIAETMARGLAYLHEDIPGLKD 146

Query: 219 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGR 278
           G+   I H D+K  NVLL +N+ A ++DFG+A        +      + T  YMAPE   
Sbjct: 147 GHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLE 206

Query: 279 EGRVSTNG-----DVYSFGIMLMEIFTRTKPTDEIFSGEMT-LKRWVNDLLPISVM-EVV 331
                        D+Y+ G++L E+ +R    D      M   +  +     +  M EVV
Sbjct: 207 GAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVV 266

Query: 332 DANLL 336
                
Sbjct: 267 VHKKK 271

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  182 bits (464), Expect = 2e-55
 Identities = 69/211 (32%), Positives = 109/211 (51%), Gaps = 8/211 (3%)

Query: 102 PNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHR 159
             D N+   IG G FG+V++A    G +VAVK+   Q         F  E  +MKR+ H 
Sbjct: 36  WCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHP 94

Query: 160 NLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSN--YILDIFQRLDIMIDVASALEYLH 217
           N++  + + +     ++V EY+  GSL + L+ S     LD  +RL +  DVA  + YLH
Sbjct: 95  NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154

Query: 218 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYG 277
              + PI+H +LK  N+L+D      + DFG+++  L+    L+      T  +MAPE  
Sbjct: 155 -NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR--LKASTFLSSKSAAGTPEWMAPEVL 211

Query: 278 REGRVSTNGDVYSFGIMLMEIFTRTKPTDEI 308
           R+   +   DVYSFG++L E+ T  +P   +
Sbjct: 212 RDEPSNEKSDVYSFGVILWELATLQQPWGNL 242

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  178 bits (454), Expect = 3e-54
 Identities = 61/224 (27%), Positives = 102/224 (45%), Gaps = 23/224 (10%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQ-------YEGAFKSFDIECDVMKRICHRNLI 162
           IGKGGFG V+K   ++D   VA+K                F+ F  E  +M  + H N++
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86

Query: 163 KIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSA 222
           K+     N     +V+E++P G L   L    + +    +L +M+D+A  +EY+    + 
Sbjct: 87  KLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ-NQNP 143

Query: 223 PIIHCDLKPSNVLLD-----DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE-- 275
           PI+H DL+  N+ L        + A ++DFG+++         + +  L    +MAPE  
Sbjct: 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQWMAPETI 198

Query: 276 YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV 319
              E   +   D YSF ++L  I T   P DE   G++     +
Sbjct: 199 GAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI 242

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  177 bits (451), Expect = 1e-53
 Identities = 59/199 (29%), Positives = 94/199 (47%), Gaps = 11/199 (5%)

Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSY 168
           IG G FG+VYK       +VAVK+ +         ++F  E  V+++  H N++  +   
Sbjct: 32  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89

Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCD 228
           +     A+V ++    SL   L+ S    ++ + +DI    A  ++YLH   +  IIH D
Sbjct: 90  TAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRD 145

Query: 229 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE---YGREGRVSTN 285
           LK +N+ L ++    + DFG+A        S    Q   +I +MAPE          S  
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205

Query: 286 GDVYSFGIMLMEIFTRTKP 304
            DVY+FGI+L E+ T   P
Sbjct: 206 SDVYAFGIVLYELMTGQLP 224

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  176 bits (449), Expect = 3e-53
 Identities = 67/228 (29%), Positives = 98/228 (42%), Gaps = 25/228 (10%)

Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSN 170
           +G+G FG V KA      +VA+K  + + E   K+F +E   + R+ H N++K+  +  N
Sbjct: 16  VGRGAFGVVCKAK-WRAKDVAIKQIESESE--RKAFIVELRQLSRVNHPNIVKLYGACLN 72

Query: 171 DDFKALVLEYMPHGSLEKCLYLSN--YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCD 228
                LV+EY   GSL   L+ +           +   +  +  + YLH      +IH D
Sbjct: 73  P--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130

Query: 229 LKPSNVLLDDNM-VAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGD 287
           LKP N+LL     V  + DFG A      D     T    +  +MAPE       S   D
Sbjct: 131 LKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSEKCD 185

Query: 288 VYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPISVMEVVDANL 335
           V+S+GI+L E+ TR KP DEI                  +M  V    
Sbjct: 186 VFSWGIILWEVITRRKPFDEI------------GGPAFRIMWAVHNGT 221

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  173 bits (440), Expect = 2e-52
 Identities = 62/210 (29%), Positives = 95/210 (45%), Gaps = 19/210 (9%)

Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVF----DPQYEGAFKSFDIECDVMKRICHRNLIKIIS 166
           IG GGFG VY+A    G EVAVK      D       ++   E  +   + H N+I +  
Sbjct: 15  IGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73

Query: 167 SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIH 226
               +    LV+E+   G L +   LS   +     ++  + +A  + YLH     PIIH
Sbjct: 74  VCLKEPNLCLVMEFARGGPLNR--VLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIH 131

Query: 227 CDLKPSNVLLD--------DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGR 278
            DLK SN+L+          N +  ++DFG+A+   E  ++   +       +MAPE  R
Sbjct: 132 RDLKSSNILILQKVENGDLSNKILKITDFGLAR---EWHRTTKMSAA-GAYAWMAPEVIR 187

Query: 279 EGRVSTNGDVYSFGIMLMEIFTRTKPTDEI 308
               S   DV+S+G++L E+ T   P   I
Sbjct: 188 ASMFSKGSDVWSYGVLLWELLTGEVPFRGI 217

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  172 bits (438), Expect = 5e-52
 Identities = 48/215 (22%), Positives = 95/215 (44%), Gaps = 17/215 (7%)

Query: 102 PNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHR 159
               N    + +   G ++K   Q G ++ VKV   +       + F+ EC  ++   H 
Sbjct: 9   FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHP 67

Query: 160 NLIKII--SSYSNDDFKALVLEYMPHGSLEKCLY-LSNYILDIFQRLDIMIDVASALEYL 216
           N++ ++            L+  +MP+GSL   L+  +N+++D  Q +   +D+A  + +L
Sbjct: 68  NVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFL 127

Query: 217 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEY 276
           H      I    L   +V++D++M A +S   +         S      +    ++APE 
Sbjct: 128 H-TLEPLIPRHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWVAPEA 179

Query: 277 GREGRVSTNG---DVYSFGIMLMEIFTRTKPTDEI 308
            ++    TN    D++SF ++L E+ TR  P  ++
Sbjct: 180 LQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL 214

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  172 bits (437), Expect = 2e-51
 Identities = 51/217 (23%), Positives = 90/217 (41%), Gaps = 20/217 (9%)

Query: 102 PNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHR 159
                +  LIGKG FG VY        EVA+++ D +   E   K+F  E    ++  H 
Sbjct: 32  FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHE 89

Query: 160 NLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFG 219
           N++  + +  +    A++       +L   +  +  +LD+ +   I  ++   + YLH  
Sbjct: 90  NVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH-- 147

Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAK---PLLEEDQSLTQTQTLATIGYMAPEY 276
            +  I+H DLK  NV  D+  V  ++DFG+      L    +          + ++APE 
Sbjct: 148 -AKGILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI 205

Query: 277 GREGRVSTNG---------DVYSFGIMLMEIFTRTKP 304
            R+    T           DV++ G +  E+  R  P
Sbjct: 206 IRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  167 bits (425), Expect = 8e-50
 Identities = 60/223 (26%), Positives = 93/223 (41%), Gaps = 25/223 (11%)

Query: 110 LIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDV--MKRICHRNLIKIISS 167
            +GKG +G V++   Q G  VAVK+F  + E   KS+  E ++     + H N++  I+S
Sbjct: 15  CVGKGRYGEVWRGSWQ-GENVAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIAS 70

Query: 168 YSNDDFKA----LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLH-----F 218
                  +    L+  Y   GSL    YL    LD    L I++ +AS L +LH      
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSLYD--YLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGT 128

Query: 219 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA--TIGYMAPE- 275
                I H DLK  N+L+  N    ++D G+A    +    L         T  YMAPE 
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEV 188

Query: 276 -----YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM 313
                           D+++FG++L E+  R      +   + 
Sbjct: 189 LDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP 231

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  168 bits (427), Expect = 9e-50
 Identities = 68/231 (29%), Positives = 97/231 (41%), Gaps = 34/231 (14%)

Query: 110 LIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMK--RICHRNLIKII-- 165
           LIG+G +G+VYK  + D   VAVKVF        ++F  E ++ +   + H N+ + I  
Sbjct: 20  LIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVG 75

Query: 166 ---SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLH----- 217
               +        LV+EY P+GSL K  YLS +  D      +   V   L YLH     
Sbjct: 76  DERVTADGRMEYLLVMEYYPNGSLXK--YLSLHTSDWVSSCRLAHSVTRGLAYLHTELPR 133

Query: 218 -FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA------TIG 270
              Y   I H DL   NVL+ ++    +SDFG++  L          +  A      TI 
Sbjct: 134 GDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIR 193

Query: 271 YMAPEYGRE-------GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMT 314
           YMAPE                  D+Y+ G++  EIF R   TD      + 
Sbjct: 194 YMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC--TDLFPGESVP 242

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  164 bits (416), Expect = 2e-48
 Identities = 59/207 (28%), Positives = 91/207 (43%), Gaps = 16/207 (7%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYS 169
           +GKG FG   K    + G  + +K      E   ++F  E  VM+ + H N++K I    
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77

Query: 170 NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
            D     + EY+  G+L   +   +      QR+    D+AS + YLH   S  IIH DL
Sbjct: 78  KDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDL 134

Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA------------TIGYMAPEYG 277
              N L+ +N    ++DFG+A+ +++E       ++L                +MAPE  
Sbjct: 135 NSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMI 194

Query: 278 REGRVSTNGDVYSFGIMLMEIFTRTKP 304
                    DV+SFGI+L EI  R   
Sbjct: 195 NGRSYDEKVDVFSFGIVLCEIIGRVNA 221

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  164 bits (418), Expect = 3e-48
 Identities = 57/223 (25%), Positives = 91/223 (40%), Gaps = 25/223 (11%)

Query: 110 LIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDV--MKRICHRNLIKIISS 167
            IGKG +G V+    + G +VAVKVF    E    S+  E ++     + H N++  I++
Sbjct: 44  QIGKGRYGEVWMGKWR-GEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFIAA 99

Query: 168 YSNDDFK----ALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLH-----F 218
                       L+ +Y  +GSL    YL +  LD    L +     S L +LH      
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYD--YLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFST 157

Query: 219 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA--TIGYMAPE- 275
                I H DLK  N+L+  N    ++D G+A   + +   +         T  YM PE 
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEV 217

Query: 276 -----YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM 313
                     +     D+YSFG++L E+  R      +   ++
Sbjct: 218 LDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL 260

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  161 bits (409), Expect = 5e-47
 Identities = 59/218 (27%), Positives = 95/218 (43%), Gaps = 25/218 (11%)

Query: 110 LIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDV--MKRICHRNLIKIISS 167
            IGKG FG V++   + G EVAVK+F  + E   +S+  E ++     + H N++  I++
Sbjct: 49  SIGKGRFGEVWRGKWR-GEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAA 104

Query: 168 YSNDDFKA----LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLH-----F 218
            + D+       LV +Y  HGSL    YL+ Y + +   + + +  AS L +LH      
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFD--YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGT 162

Query: 219 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA--TIGYMAPE- 275
                I H DLK  N+L+  N    ++D G+A        ++         T  YMAPE 
Sbjct: 163 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 222

Query: 276 -----YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEI 308
                  +        D+Y+ G++  EI  R       
Sbjct: 223 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 260

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  138 bits (350), Expect = 6e-38
 Identities = 56/192 (29%), Positives = 90/192 (46%), Gaps = 5/192 (2%)

Query: 111 IGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSY 168
           IG+G FG V+   ++ D   VAVK             F  E  ++K+  H N++++I   
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181

Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCD 228
           +      +V+E +  G     L      L +   L ++ D A+ +EYL    S   IH D
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRD 238

Query: 229 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDV 288
           L   N L+ +  V  +SDFGM++   +   + +       + + APE    GR S+  DV
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDV 298

Query: 289 YSFGIMLMEIFT 300
           +SFGI+L E F+
Sbjct: 299 WSFGILLWETFS 310

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  134 bits (339), Expect = 3e-37
 Identities = 62/255 (24%), Positives = 106/255 (41%), Gaps = 33/255 (12%)

Query: 93  RYQKRGKPLPNDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFD--PQYEGAFKSFDIE 149
           R+ K              IG+G F +VYK +  +  +EVA          +   + F  E
Sbjct: 26  RFLKFDI----------EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEE 75

Query: 150 CDVMKRICHRNLIKIISSYSNDDFKA----LVLEYMPHGSLEKCLYLSNY-ILDIFQRLD 204
            +++K + H N+++   S+ +         LV E M  G+L+   YL  + ++ I     
Sbjct: 76  AEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKT--YLKRFKVMKIKVLRS 133

Query: 205 IMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQT 263
               +   L++LH   + PIIH DLK  N+ +        + D G+A            +
Sbjct: 134 WCRQILKGLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT-------LKRAS 185

Query: 264 QTLATIG---YMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN 320
              A IG   +MAPE   E     + DVY+FG+ ++E+ T   P  E  +     +R  +
Sbjct: 186 FAKAVIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS 244

Query: 321 DLLPISVMEVVDANL 335
            + P S  +V    +
Sbjct: 245 GVKPASFDKVAIPEV 259

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  139 bits (351), Expect = 3e-37
 Identities = 59/193 (30%), Positives = 101/193 (52%), Gaps = 11/193 (5%)

Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSN 170
           +G+G FG V+         VA+K   P      ++F  E  VMK++ H  L+++ +  S 
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 333

Query: 171 DDFKALVLEYMPHGSLEKCLYLSN---YILDIFQRLDIMIDVASALEYLHFGYSAPIIHC 227
           +    +V EYM  GSL    +L       L + Q +D+   +AS + Y+        +H 
Sbjct: 334 EPI-YIVTEYMSKGSLLD--FLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 387

Query: 228 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGD 287
           DL+ +N+L+ +N+V  ++DFG+A+ L+E+++   +      I + APE    GR +   D
Sbjct: 388 DLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 446

Query: 288 VYSFGIMLMEIFT 300
           V+SFGI+L E+ T
Sbjct: 447 VWSFGILLTELTT 459

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  137 bits (347), Expect = 5e-37
 Identities = 59/193 (30%), Positives = 101/193 (52%), Gaps = 11/193 (5%)

Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSN 170
           +G+G FG V+         VA+K   P      ++F  E  VMK++ H  L+++ +  S 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 250

Query: 171 DDFKALVLEYMPHGSLEKCLYLSN---YILDIFQRLDIMIDVASALEYLHFGYSAPIIHC 227
           +    +V EYM  GSL    +L       L + Q +D+   +AS + Y+        +H 
Sbjct: 251 EPI-YIVTEYMSKGSLLD--FLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 304

Query: 228 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGD 287
           DL+ +N+L+ +N+V  ++DFG+A+ L+E+++   +      I + APE    GR +   D
Sbjct: 305 DLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363

Query: 288 VYSFGIMLMEIFT 300
           V+SFGI+L E+ T
Sbjct: 364 VWSFGILLTELTT 376

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  133 bits (336), Expect = 6e-37
 Identities = 56/193 (29%), Positives = 90/193 (46%), Gaps = 11/193 (5%)

Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSN 170
           IG G FG V+     +  +VA+K        + + F  E +VM ++ H  L+++      
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74

Query: 171 DDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYL---HFGYSAPIIHC 227
                LV E+M HG L   L     +      L + +DV   + YL           IH 
Sbjct: 75  QAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV------IHR 128

Query: 228 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGD 287
           DL   N L+ +N V  +SDFGM +  + +DQ  + T T   + + +PE     R S+  D
Sbjct: 129 DLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 187

Query: 288 VYSFGIMLMEIFT 300
           V+SFG+++ E+F+
Sbjct: 188 VWSFGVLMWEVFS 200

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  133 bits (338), Expect = 8e-37
 Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 19/210 (9%)

Query: 110 LIGKGGFGSVYKAIIQD---GMEVAVKVFDPQYEG--AFKS-FDIECDVMKRICHRNLIK 163
           L+G+GG G VY+A  +D      VA+K+          F++    E     R+   +++ 
Sbjct: 41  LVGRGGMGDVYEA--EDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98

Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
           I      D    + +  +    L   L      L   + + I+  + SAL+  H   +A 
Sbjct: 99  IHDFGEIDGQLYVDMRLINGVDLAAML-RRQGPLAPPRAVAIVRQIGSALDAAH---AAG 154

Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT-LATIGYMAPEYGREGRV 282
             H D+KP N+L+  +  A+L DFG+A      D+ LTQ    + T+ YMAPE   E   
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASAT--TDEKLTQLGNTVGTLYYMAPERFSESHA 212

Query: 283 STNGDVYSFGIMLMEIFTRTKPTDEIFSGE 312
           +   D+Y+   +L E  T + P    + G+
Sbjct: 213 TYRADIYALTCVLYECLTGSPP----YQGD 238

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  136 bits (344), Expect = 1e-36
 Identities = 55/193 (28%), Positives = 98/193 (50%), Gaps = 11/193 (5%)

Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSN 170
           +G G FG V+ A      +VAVK   P      ++F  E +VMK + H  L+K+ +  + 
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLVKLHAVVTK 254

Query: 171 DDFKALVLEYMPHGSLEKCLYL---SNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHC 227
           +    ++ E+M  GSL    +L         + + +D    +A  + ++        IH 
Sbjct: 255 EPI-YIITEFMAKGSLLD--FLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHR 308

Query: 228 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGD 287
           DL+ +N+L+  ++V  ++DFG+A+ ++E+++   +      I + APE    G  +   D
Sbjct: 309 DLRAANILVSASLVCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 367

Query: 288 VYSFGIMLMEIFT 300
           V+SFGI+LMEI T
Sbjct: 368 VWSFGILLMEIVT 380

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  136 bits (343), Expect = 3e-36
 Identities = 54/194 (27%), Positives = 94/194 (48%), Gaps = 11/194 (5%)

Query: 111 IGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYS 169
           +G G +G VY+ + +   + VAVK          + F  E  VMK I H NL++++   +
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 286

Query: 170 NDDFKALVLEYMPHGSLEKCLYL---SNYILDIFQRLDIMIDVASALEYLHFGYSAPIIH 226
            +    ++ E+M +G+L    YL   +   +     L +   ++SA+EYL        IH
Sbjct: 287 REPPFYIITEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 341

Query: 227 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNG 286
            +L   N L+ +N +  ++DFG+++ L+  D           I + APE     + S   
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 400

Query: 287 DVYSFGIMLMEIFT 300
           DV++FG++L EI T
Sbjct: 401 DVWAFGVLLWEIAT 414

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  131 bits (331), Expect = 4e-36
 Identities = 49/193 (25%), Positives = 91/193 (47%), Gaps = 11/193 (5%)

Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSN 170
           +G G FG V     +   +VA+K+       +   F  E  VM  + H  L+++    + 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90

Query: 171 DDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYL---HFGYSAPIIHC 227
                ++ EYM +G L   L    +     Q L++  DV  A+EYL    F      +H 
Sbjct: 91  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF------LHR 144

Query: 228 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGD 287
           DL   N L++D  V  +SDFG+++  + +D+  +   +   + +  PE     + S+  D
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSD 203

Query: 288 VYSFGIMLMEIFT 300
           +++FG+++ EI++
Sbjct: 204 IWAFGVLMWEIYS 216

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  130 bits (329), Expect = 6e-36
 Identities = 55/193 (28%), Positives = 91/193 (47%), Gaps = 11/193 (5%)

Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSN 170
           +G G FG V     +   +VAVK+       +   F  E   M ++ H  L+K     S 
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74

Query: 171 DDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYL---HFGYSAPIIHC 227
           +    +V EY+ +G L   L      L+  Q L++  DV   + +L    F      IH 
Sbjct: 75  EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQF------IHR 128

Query: 228 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGD 287
           DL   N L+D ++   +SDFGM +  + +DQ ++   T   + + APE     + S+  D
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTR-YVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSD 187

Query: 288 VYSFGIMLMEIFT 300
           V++FGI++ E+F+
Sbjct: 188 VWAFGILMWEVFS 200

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  131 bits (332), Expect = 7e-36
 Identities = 54/213 (25%), Positives = 99/213 (46%), Gaps = 30/213 (14%)

Query: 111 IGKGGFGSVYKAIIQDG----MEVAVKVF--DPQYEGAFKSFDIECDVMKRICHRNLIKI 164
           +GKG FGSV +A ++      ++VAVK+   D       + F  E   MK   H ++ K+
Sbjct: 31  LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90

Query: 165 I------SSYSNDDFKALVLEYMPHGSLEKCLYL-------SNYILDIFQRLDIMIDVAS 211
           +       +        ++L +M HG L    +L       + + L +   +  M+D+A 
Sbjct: 91  VGVSLRSRAKGRLPIPMVILPFMKHGDLHA--FLLASRIGENPFNLPLQTLVRFMVDIAC 148

Query: 212 ALEYL---HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 268
            +EYL   +F      IH DL   N +L ++M   ++DFG+++ +   D       +   
Sbjct: 149 GMEYLSSRNF------IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLP 202

Query: 269 IGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTR 301
           + ++A E   +   + + DV++FG+ + EI TR
Sbjct: 203 VKWLALESLADNLYTVHSDVWAFGVTMWEIMTR 235

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  131 bits (331), Expect = 7e-36
 Identities = 55/212 (25%), Positives = 96/212 (45%), Gaps = 29/212 (13%)

Query: 111 IGKGGFGSVYKAIIQDG----MEVAVKV--FDPQYEGAFKSFDIECDVMKRICHRNLIKI 164
           +G+G FGSV +  ++      ++VAVK    D   +   + F  E   MK   H N+I++
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101

Query: 165 I-----SSYSNDDFKALVLEYMPHGSLEKCLYL-------SNYILDIFQRLDIMIDVASA 212
           +      S        ++L +M +G L    YL           + +   L  M+D+A  
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHT--YLLYSRLETGPKHIPLQTLLKFMVDIALG 159

Query: 213 LEYL---HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATI 269
           +EYL   +F      +H DL   N +L D+M   ++DFG++K +   D           +
Sbjct: 160 MEYLSNRNF------LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 213

Query: 270 GYMAPEYGREGRVSTNGDVYSFGIMLMEIFTR 301
            ++A E   +   ++  DV++FG+ + EI TR
Sbjct: 214 KWIAIESLADRVYTSKSDVWAFGVTMWEIATR 245

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  130 bits (330), Expect = 8e-36
 Identities = 55/202 (27%), Positives = 93/202 (46%), Gaps = 17/202 (8%)

Query: 111 IGKGGFGSVYKAIIQDG----MEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKII 165
           IG+G FG VY   + D     +  AVK  +     G    F  E  +MK   H N++ ++
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92

Query: 166 SSYSNDDFKAL-VLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYL---HFGYS 221
                 +   L VL YM HG L   +    +   +   +   + VA  ++YL    F   
Sbjct: 93  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKF--- 149

Query: 222 APIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED--QSLTQTQTLATIGYMAPEYGRE 279
              +H DL   N +LD+     ++DFG+A+ + +++      +T     + +MA E  + 
Sbjct: 150 ---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 206

Query: 280 GRVSTNGDVYSFGIMLMEIFTR 301
            + +T  DV+SFG++L E+ TR
Sbjct: 207 QKFTTKSDVWSFGVLLWELMTR 228

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  130 bits (329), Expect = 1e-35
 Identities = 63/210 (30%), Positives = 101/210 (48%), Gaps = 19/210 (9%)

Query: 110 LIGKGGFGSVYKAIIQD---GMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIK 163
            +G GG  +VY A  +D    ++VA+K         E   K F+ E     ++ H+N++ 
Sbjct: 18  KLGGGGMSTVYLA--EDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75

Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
           +I     DD   LV+EY+   +L      S+  L +   ++    +   +++ H      
Sbjct: 76  MIDVDEEDDCYYLVMEYIEGPTL-SEYIESHGPLSVDTAINFTNQILDGIKHAH---DMR 131

Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT-LATIGYMAPEYGREGRV 282
           I+H D+KP N+L+D N    + DFG+AK L   + SLTQT   L T+ Y +PE  +    
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKAL--SETSLTQTNHVLGTVQYFSPEQAKGEAT 189

Query: 283 STNGDVYSFGIMLMEIFTRTKPTDEIFSGE 312
               D+YS GI+L E+     P    F+GE
Sbjct: 190 DECTDIYSIGIVLYEMLVGEPP----FNGE 215

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  130 bits (328), Expect = 2e-35
 Identities = 53/202 (26%), Positives = 92/202 (45%), Gaps = 17/202 (8%)

Query: 111 IGKGGFGSVYKAIIQDG----MEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKII 165
           IGKG FG VY     D     ++ A+K           ++F  E  +M+ + H N++ +I
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88

Query: 166 S-SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYL---HFGYS 221
                 +    ++L YM HG L + +        +   +   + VA  +EYL    F   
Sbjct: 89  GIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKF--- 145

Query: 222 APIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED--QSLTQTQTLATIGYMAPEYGRE 279
              +H DL   N +LD++    ++DFG+A+ +L+ +             + + A E  + 
Sbjct: 146 ---VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQT 202

Query: 280 GRVSTNGDVYSFGIMLMEIFTR 301
            R +T  DV+SFG++L E+ TR
Sbjct: 203 YRFTTKSDVWSFGVLLWELLTR 224

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  129 bits (327), Expect = 2e-35
 Identities = 59/199 (29%), Positives = 96/199 (48%), Gaps = 13/199 (6%)

Query: 111 IGKGGFGSVYKAII-----QDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKI- 164
           +GKG FGSV            G  VAVK      E   + F+ E +++K + H N++K  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77

Query: 165 -ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
            +   +      L++EY+P+GSL   L      +D  + L     +   +EYL    +  
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 134

Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAPEYGREGR 281
            IH DL   N+L+++     + DFG+ K +L +D+   + +      I + APE   E +
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEFFKVKEPGESPIFWYAPESLTESK 193

Query: 282 VSTNGDVYSFGIMLMEIFT 300
            S   DV+SFG++L E+FT
Sbjct: 194 FSVASDVWSFGVVLYELFT 212

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  130 bits (329), Expect = 2e-35
 Identities = 59/199 (29%), Positives = 96/199 (48%), Gaps = 13/199 (6%)

Query: 111 IGKGGFGSVYKAII-----QDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKI- 164
           +GKG FGSV            G  VAVK      E   + F+ E +++K + H N++K  
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108

Query: 165 -ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
            +   +      L++EY+P+GSL   L      +D  + L     +   +EYL    +  
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 165

Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAPEYGREGR 281
            IH DL   N+L+++     + DFG+ K +L +D+   + +      I + APE   E +
Sbjct: 166 YIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEYYKVKEPGESPIFWYAPESLTESK 224

Query: 282 VSTNGDVYSFGIMLMEIFT 300
            S   DV+SFG++L E+FT
Sbjct: 225 FSVASDVWSFGVVLYELFT 243

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  132 bits (334), Expect = 2e-35
 Identities = 47/205 (22%), Positives = 93/205 (45%), Gaps = 17/205 (8%)

Query: 110 LIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRIC-HRNLIKIISSY 168
           ++G G  G++    + D  +VAVK   P+    F   D E  +++    H N+I+   + 
Sbjct: 31  VLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTE 87

Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCD 228
            +  F+ + +E     +L++ +   ++     + + ++    S L +LH   S  I+H D
Sbjct: 88  KDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLNIVHRD 143

Query: 229 LKPSNVLL-----DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA-TIGYMAPEY---GRE 279
           LKP N+L+        + A +SDFG+ K L     S ++   +  T G++APE      +
Sbjct: 144 LKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCK 203

Query: 280 GRVSTNGDVYSFGIMLMEIFTRTKP 304
              +   D++S G +   + +    
Sbjct: 204 ENPTYTVDIFSAGCVFYYVISEGSH 228

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  131 bits (331), Expect = 3e-35
 Identities = 55/202 (27%), Positives = 94/202 (46%), Gaps = 17/202 (8%)

Query: 111 IGKGGFGSVYKAIIQDG----MEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKII 165
           IG+G FG VY   + D     +  AVK  +     G    F  E  +MK   H N++ ++
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156

Query: 166 SSYSNDDFKAL-VLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYL---HFGYS 221
                 +   L VL YM HG L   +    +   +   +   + VA  +++L    F   
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF--- 213

Query: 222 APIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAPEYGRE 279
              +H DL   N +LD+     ++DFG+A+ + +++      +T A   + +MA E  + 
Sbjct: 214 ---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 270

Query: 280 GRVSTNGDVYSFGIMLMEIFTR 301
            + +T  DV+SFG++L E+ TR
Sbjct: 271 QKFTTKSDVWSFGVLLWELMTR 292

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  134 bits (340), Expect = 3e-35
 Identities = 45/212 (21%), Positives = 85/212 (40%), Gaps = 28/212 (13%)

Query: 110 LIGKGGFGSVYKA--IIQDGMEVAVKVFDPQYEGAFKS-FDIECDVMKRICHRNLIKIIS 166
            I  GG G +Y A     +G  V +K      +   ++    E   +  + H ++++I +
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146

Query: 167 SYSNDDFKA-----LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYS 221
              + D        +V+EY+   SL++        L + + +  ++++  AL YLH   S
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSK---GQKLPVAEAIAYLLEILPALSYLH---S 200

Query: 222 APIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT-LATIGYMAPEYGREG 280
             +++ DLKP N++L +  +  L D G           +        T G+ APE  R  
Sbjct: 201 IGLVYNDLKPENIMLTEEQLK-LIDLGAVS-------RINSFGYLYGTPGFQAPEIVR-T 251

Query: 281 RVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE 312
             +   D+Y+ G  L  +           +G 
Sbjct: 252 GPTVATDIYTVGRTLAALTLDLPT----RNGR 279

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  129 bits (326), Expect = 5e-35
 Identities = 48/200 (24%), Positives = 82/200 (41%), Gaps = 16/200 (8%)

Query: 111 IGKGGFGSVYKAIIQDGME-----VAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKI 164
           +G G FG+VYK +     E     VA+K         A K    E  VM  + + ++ ++
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82

Query: 165 ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYL---HFGYS 221
           +        + L+ + MP G L   +      +     L+  + +A  + YL        
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL--- 138

Query: 222 APIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGR 281
              +H DL   NVL+       ++DFG+AK L  E++          I +MA E      
Sbjct: 139 ---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195

Query: 282 VSTNGDVYSFGIMLMEIFTR 301
            +   DV+S+G+ + E+ T 
Sbjct: 196 YTHQSDVWSYGVTVWELMTF 215

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  128 bits (325), Expect = 6e-35
 Identities = 57/200 (28%), Positives = 91/200 (45%), Gaps = 16/200 (8%)

Query: 111 IGKGGFGSVYKAIIQD-----GMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKI 164
           +G+G FG V            G  VAVK             +  E D+++ + H ++IK 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98

Query: 165 ISSYSNDDFKA--LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSA 222
                +    +  LV+EY+P GSL    YL  + + + Q L     +   + YLH   + 
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRD--YLPRHSIGLAQLLLFAQQICEGMAYLH---AQ 153

Query: 223 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAPEYGREG 280
             IH DL   NVLLD++ +  + DFG+AK  + E     + +      + + APE  +E 
Sbjct: 154 HYIHRDLAARNVLLDNDRLVKIGDFGLAK-AVPEGHEYYRVREDGDSPVFWYAPECLKEY 212

Query: 281 RVSTNGDVYSFGIMLMEIFT 300
           +     DV+SFG+ L E+ T
Sbjct: 213 KFYYASDVWSFGVTLYELLT 232

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  128 bits (323), Expect = 6e-35
 Identities = 55/193 (28%), Positives = 98/193 (50%), Gaps = 11/193 (5%)

Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSN 170
           +G G FG V+        +VAVK           +F  E ++MK++ H+ L+++ +  + 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAVVTQ 79

Query: 171 DDFKALVLEYMPHGSLEKCLYLSN---YILDIFQRLDIMIDVASALEYLHFGYSAPIIHC 227
           +    ++ EYM +GSL    +L       L I + LD+   +A  + ++        IH 
Sbjct: 80  EPI-YIITEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHR 133

Query: 228 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGD 287
           DL+ +N+L+ D +   ++DFG+A+ L+E+++   +      I + APE    G  +   D
Sbjct: 134 DLRAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 192

Query: 288 VYSFGIMLMEIFT 300
           V+SFGI+L EI T
Sbjct: 193 VWSFGILLTEIVT 205

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  129 bits (326), Expect = 6e-35
 Identities = 59/198 (29%), Positives = 90/198 (45%), Gaps = 11/198 (5%)

Query: 111 IGKGGFGSVYKAII-----QDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKI- 164
           +GKG FGSV            G  VAVK          + F  E  ++K +    ++K  
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90

Query: 165 -ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
            +S         LV+EY+P G L   L      LD  + L     +   +EYL    S  
Sbjct: 91  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRR 147

Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LEEDQSLTQTQTLATIGYMAPEYGREGRV 282
            +H DL   N+L++      ++DFG+AK L L++D  + +    + I + APE   +   
Sbjct: 148 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIF 207

Query: 283 STNGDVYSFGIMLMEIFT 300
           S   DV+SFG++L E+FT
Sbjct: 208 SRQSDVWSFGVVLYELFT 225

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  127 bits (321), Expect = 1e-34
 Identities = 55/197 (27%), Positives = 92/197 (46%), Gaps = 15/197 (7%)

Query: 111 IGKGGFGSVYKAIIQDG-MEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISS 167
           +G G +G VY+ + +   + VAVK           F     E  VMK I H NL++++  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK---EAAVMKEIKHPNLVQLLGV 77

Query: 168 YSNDDFKALVLEYMPHGSLEKCLYLSN---YILDIFQRLDIMIDVASALEYLHFGYSAPI 224
            + +    ++ E+M +G+L    YL       +     L +   ++SA+EYL        
Sbjct: 78  CTREPPFYIITEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNF 132

Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVST 284
           IH DL   N L+ +N +  ++DFG+++ L+  D           I + APE     + S 
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191

Query: 285 NGDVYSFGIMLMEIFTR 301
             DV++FG++L EI T 
Sbjct: 192 KSDVWAFGVLLWEIATY 208

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  127 bits (321), Expect = 1e-34
 Identities = 55/202 (27%), Positives = 78/202 (38%), Gaps = 18/202 (8%)

Query: 111 IGKGGFGSVYKAI----IQDGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIK 163
           +G G FG V +          + VAVK   P       A   F  E + M  + HRNLI+
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85

Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYL---HFGY 220
           +         K +V E  P GSL   L        +       + VA  + YL    F  
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF-- 142

Query: 221 SAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ-TLATIGYMAPEYGRE 279
               IH DL   N+LL    +  + DFG+ + L + D      +       + APE  + 
Sbjct: 143 ----IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 198

Query: 280 GRVSTNGDVYSFGIMLMEIFTR 301
              S   D + FG+ L E+FT 
Sbjct: 199 RTFSHASDTWMFGVTLWEMFTY 220

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  127 bits (321), Expect = 1e-34
 Identities = 51/200 (25%), Positives = 94/200 (47%), Gaps = 14/200 (7%)

Query: 111 IGKGGFGSVYKAI-----IQDGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKI 164
           +G+G FG V            G +VAVK   P+           E ++++ + H N++K 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88

Query: 165 --ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSA 222
             I +    +   L++E++P GSL++ L  +   +++ Q+L   + +   ++YL    S 
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SR 145

Query: 223 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAPEYGREG 280
             +H DL   NVL++      + DFG+ K  +E D+     +      + + APE   + 
Sbjct: 146 QYVHRDLAARNVLVESEHQVKIGDFGLTK-AIETDKEYYTVKDDRDSPVFWYAPECLMQS 204

Query: 281 RVSTNGDVYSFGIMLMEIFT 300
           +     DV+SFG+ L E+ T
Sbjct: 205 KFYIASDVWSFGVTLHELLT 224

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  127 bits (321), Expect = 2e-34
 Identities = 54/214 (25%), Positives = 98/214 (45%), Gaps = 21/214 (9%)

Query: 110 LIGKGGFGSVYKAIIQD---GMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIK 163
           ++G GG   V+ A  +D     +VAVKV           +  F  E      + H  ++ 
Sbjct: 19  ILGFGGMSEVHLA--RDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76

Query: 164 IISSYSNDDFKA----LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFG 219
           +  +   +        +V+EY+   +L + +  +   +   + ++++ D   AL + H  
Sbjct: 77  VYDTGEAETPAGPLPYIVMEYVDGVTL-RDIVHTEGPMTPKRAIEVIADACQALNFSH-- 133

Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT-LATIGYMAPEYGR 278
               IIH D+KP+N+++       + DFG+A+ + +   S+TQT   + T  Y++PE  R
Sbjct: 134 -QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192

Query: 279 EGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE 312
              V    DVYS G +L E+ T   P    F+G+
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPP----FTGD 222

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  126 bits (320), Expect = 2e-34
 Identities = 57/204 (27%), Positives = 99/204 (48%), Gaps = 25/204 (12%)

Query: 111 IGKGGFGSVYKAIIQDG---MEVAVKV-----FDPQYEGAFKSFDIECDVMKRICHRNLI 162
           +G G FG+V K   Q       VAVK+      DP  +    +   E +VM+++ +  ++
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA---EANVMQQLDNPYIV 81

Query: 163 KIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYL---HFG 219
           ++I     + +  LV+E    G L K L   N  +     ++++  V+  ++YL   +F 
Sbjct: 82  RMIGICEAESWM-LVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLEESNF- 138

Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAPEYG 277
                +H DL   NVLL     A +SDFG++K  L  D++  + QT     + + APE  
Sbjct: 139 -----VHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECI 192

Query: 278 REGRVSTNGDVYSFGIMLMEIFTR 301
              + S+  DV+SFG+++ E F+ 
Sbjct: 193 NYYKFSSKSDVWSFGVLMWEAFSY 216

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  126 bits (318), Expect = 3e-34
 Identities = 49/199 (24%), Positives = 92/199 (46%), Gaps = 15/199 (7%)

Query: 111 IGKGGFGSVYKAIIQDG---MEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIIS 166
           +G G FGSV + + +     ++VA+KV      +   +    E  +M ++ +  ++++I 
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77

Query: 167 SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYL---HFGYSAP 223
               +    LV+E    G L K L      + +    +++  V+  ++YL   +F     
Sbjct: 78  VCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF----- 131

Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ-TLATIGYMAPEYGREGRV 282
            +H DL   NVLL +   A +SDFG++K L  +D   T        + + APE     + 
Sbjct: 132 -VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 190

Query: 283 STNGDVYSFGIMLMEIFTR 301
           S+  DV+S+G+ + E  + 
Sbjct: 191 SSRSDVWSYGVTMWEALSY 209

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  130 bits (327), Expect = 1e-33
 Identities = 48/199 (24%), Positives = 92/199 (46%), Gaps = 15/199 (7%)

Query: 111 IGKGGFGSVYKAIIQDG---MEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIIS 166
           +G G FGSV + + +     ++VA+KV      +   +    E  +M ++ +  ++++I 
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403

Query: 167 SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYL---HFGYSAP 223
               +    LV+E    G L K L      + +    +++  V+  ++YL   +F     
Sbjct: 404 VCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF----- 457

Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ-TLATIGYMAPEYGREGRV 282
            +H +L   NVLL +   A +SDFG++K L  +D   T        + + APE     + 
Sbjct: 458 -VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 516

Query: 283 STNGDVYSFGIMLMEIFTR 301
           S+  DV+S+G+ + E  + 
Sbjct: 517 SSRSDVWSYGVTMWEALSY 535

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  128 bits (323), Expect = 1e-33
 Identities = 68/195 (34%), Positives = 97/195 (49%), Gaps = 19/195 (9%)

Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKII--SSY 168
           IGKG FG V     + G +VAVK          ++F  E  VM ++ H NL++++     
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 257

Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSN---YILDIFQRLDIMIDVASALEYLHFGYSAPII 225
                  +V EYM  GSL    YL +    +L     L   +DV  A+EYL        +
Sbjct: 258 EKGGL-YIVTEYMAKGSLVD--YLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFV 311

Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
           H DL   NVL+ ++ VA +SDFG+ K     + S TQ      + + APE  RE + ST 
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTK 366

Query: 286 GDVYSFGIMLMEIFT 300
            DV+SFGI+L EI++
Sbjct: 367 SDVWSFGILLWEIYS 381

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  125 bits (316), Expect = 2e-33
 Identities = 57/199 (28%), Positives = 94/199 (47%), Gaps = 15/199 (7%)

Query: 111 IGKGGFGSVYKAIIQDG----MEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKII 165
           IG G  G V    ++      + VA+K     Y E   + F  E  +M +  H N+I++ 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116

Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYL---HFGYSA 222
              +      +V EYM +GSL+  L   +    I Q + ++  V + + YL    +    
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY---- 172

Query: 223 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL-EEDQSLTQTQTLATIGYMAPEYGREGR 281
             +H DL   NVL+D N+V  +SDFG+++ L  + D + T T     I + APE      
Sbjct: 173 --VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT 230

Query: 282 VSTNGDVYSFGIMLMEIFT 300
            S+  DV+SFG+++ E+  
Sbjct: 231 FSSASDVWSFGVVMWEVLA 249

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  125 bits (315), Expect = 2e-33
 Identities = 48/197 (24%), Positives = 92/197 (46%), Gaps = 10/197 (5%)

Query: 111 IGKGGFGSVYKAIIQDGME-----VAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKI 164
           +G G FG+V+K +     E     V +KV + +    +F++       +  + H +++++
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80

Query: 165 ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPI 224
           +        + LV +Y+P GSL   +      L     L+  + +A  + YL       +
Sbjct: 81  LGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EHGM 136

Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVST 284
           +H +L   NVLL       ++DFG+A  L  +D+ L  ++    I +MA E    G+ + 
Sbjct: 137 VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTH 196

Query: 285 NGDVYSFGIMLMEIFTR 301
             DV+S+G+ + E+ T 
Sbjct: 197 QSDVWSYGVTVWELMTF 213

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  123 bits (311), Expect = 3e-33
 Identities = 47/199 (23%), Positives = 90/199 (45%), Gaps = 16/199 (8%)

Query: 111 IGKGGFGSVYKAIIQDG----MEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKII 165
           +G+G FG VY+ +  +     + VAVK           + F  E  +MK + H +++K+I
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79

Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYL---HFGYSA 222
                +    +++E  P+G L   L  +   L +   +   + +  A+ YL   +     
Sbjct: 80  GIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINC---- 134

Query: 223 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRV 282
             +H D+   N+L+       L DFG+++  +E++     + T   I +M+PE     R 
Sbjct: 135 --VHRDIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSPESINFRRF 191

Query: 283 STNGDVYSFGIMLMEIFTR 301
           +T  DV+ F + + EI + 
Sbjct: 192 TTASDVWMFAVCMWEILSF 210

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  123 bits (311), Expect = 3e-33
 Identities = 68/194 (35%), Positives = 97/194 (50%), Gaps = 17/194 (8%)

Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSN 170
           IGKG FG V     + G +VAVK          ++F  E  VM ++ H NL++++     
Sbjct: 29  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 85

Query: 171 DDFKA-LVLEYMPHGSLEKCLYL---SNYILDIFQRLDIMIDVASALEYLHFGYSAPIIH 226
           +     +V EYM  GSL    YL      +L     L   +DV  A+EYL        +H
Sbjct: 86  EKGGLYIVTEYMAKGSLVD--YLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 140

Query: 227 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNG 286
            DL   NVL+ ++ VA +SDFG+ K     + S TQ      + + APE  RE + ST  
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKS 195

Query: 287 DVYSFGIMLMEIFT 300
           DV+SFGI+L EI++
Sbjct: 196 DVWSFGILLWEIYS 209

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  124 bits (314), Expect = 3e-33
 Identities = 46/201 (22%), Positives = 77/201 (38%), Gaps = 16/201 (7%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
            +G+G FG V++    Q G + AVK    +          E      +    ++ +  + 
Sbjct: 65  RVGRGSFGEVHRMKDKQTGFQCAVKKVRLE-----VFRVEELVACAGLSSPRIVPLYGAV 119

Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNY-ILDIFQRLDIMIDVASALEYLHFGYSAPIIHC 227
               +  + +E +  GSL +   +     L   + L  +      LEYLH   +  I+H 
Sbjct: 120 REGPWVNIFMELLEGGSLGQL--IKQMGCLPEDRALYYLGQALEGLEYLH---TRRILHG 174

Query: 228 DLKPSNVLLDDN-MVAHLSDFGMAKPLLEEDQSLTQTQTLATIG---YMAPEYGREGRVS 283
           D+K  NVLL  +   A L DFG A  L  +    +        G   +MAPE        
Sbjct: 175 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 234

Query: 284 TNGDVYSFGIMLMEIFTRTKP 304
              D++S   M++ +     P
Sbjct: 235 AKVDIWSSCCMMLHMLNGCHP 255

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  125 bits (316), Expect = 4e-33
 Identities = 52/199 (26%), Positives = 97/199 (48%), Gaps = 15/199 (7%)

Query: 111 IGKGGFGSVYKAIIQ----DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKII 165
           +G G FG V    ++      + VA+K     Y E   + F  E  +M +  H N+I++ 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112

Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYL---HFGYSA 222
              +      +V EYM +GSL+  L   +    + Q + ++  +AS ++YL    +    
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY---- 168

Query: 223 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL-EEDQSLTQTQTLATIGYMAPEYGREGR 281
             +H DL   N+L++ N+V  +SDFG+ + L  + + + T       I + +PE     +
Sbjct: 169 --VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226

Query: 282 VSTNGDVYSFGIMLMEIFT 300
            ++  DV+S+GI+L E+ +
Sbjct: 227 FTSASDVWSYGIVLWEVMS 245

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  123 bits (312), Expect = 5e-33
 Identities = 48/200 (24%), Positives = 82/200 (41%), Gaps = 16/200 (8%)

Query: 111 IGKGGFGSVYKAIIQDGME-----VAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKI 164
           +G G FG+VYK +     E     VA+K         A K    E  VM  + + ++ ++
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82

Query: 165 ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYL---HFGYS 221
           +        + L+ + MP G L   +      +     L+  + +A  + YL        
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL--- 138

Query: 222 APIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGR 281
              +H DL   NVL+       ++DFG+AK L  E++          I +MA E      
Sbjct: 139 ---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195

Query: 282 VSTNGDVYSFGIMLMEIFTR 301
            +   DV+S+G+ + E+ T 
Sbjct: 196 YTHQSDVWSYGVTVWELMTF 215

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  122 bits (309), Expect = 5e-33
 Identities = 51/198 (25%), Positives = 91/198 (45%), Gaps = 16/198 (8%)

Query: 111 IGKGGFGSVYKAIIQDG----MEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKII 165
           IG+G FG V++ I        + VA+K       +   + F  E   M++  H +++K+I
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82

Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYL---HFGYSA 222
              + +    +++E    G L   L +  Y LD+   +     +++AL YL    F    
Sbjct: 83  GVITENPVW-IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF---- 137

Query: 223 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRV 282
             +H D+   NVL+  N    L DFG+++  +E+      ++    I +MAPE     R 
Sbjct: 138 --VHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRF 194

Query: 283 STNGDVYSFGIMLMEIFT 300
           ++  DV+ FG+ + EI  
Sbjct: 195 TSASDVWMFGVCMWEILM 212

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  123 bits (310), Expect = 5e-33
 Identities = 63/214 (29%), Positives = 96/214 (44%), Gaps = 30/214 (14%)

Query: 111 IGKGGFGSVYKAII------QDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKI 164
           +G+G FG V+ A        +D M VAVK        A K F  E +++  + H +++K 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82

Query: 165 ISSYSNDDFKALVLEYMPHGSL---------------EKCLYLSNYILDIFQRLDIMIDV 209
                + D   +V EYM HG L               +     +   L + Q L I   +
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142

Query: 210 ASALEYL---HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL 266
           AS + YL   HF      +H DL   N L+  N++  + DFGM++ +   D       T+
Sbjct: 143 ASGMVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196

Query: 267 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
             I +M PE     + +T  DV+SFG++L EIFT
Sbjct: 197 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  122 bits (309), Expect = 6e-33
 Identities = 48/210 (22%), Positives = 91/210 (43%), Gaps = 32/210 (15%)

Query: 111 IGKGGFGSVYKAIIQD--------GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLI 162
           +G+G F  ++K + ++          EV +KV D  +    +SF     +M ++ H++L+
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75

Query: 163 KIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYL---HFG 219
                    D   LV E++  GSL+  L  +   ++I  +L++   +A+A+ +L      
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTL- 134

Query: 220 YSAPIIHCDLKPSNVLLD--------DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGY 271
                IH ++   N+LL         +     LSD G++  +L +D           I +
Sbjct: 135 -----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD------ILQERIPW 183

Query: 272 MAPEYGREGRV-STNGDVYSFGIMLMEIFT 300
           + PE     +  +   D +SFG  L EI +
Sbjct: 184 VPPECIENPKNLNLATDKWSFGTTLWEICS 213

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  123 bits (310), Expect = 9e-33
 Identities = 47/207 (22%), Positives = 90/207 (43%), Gaps = 19/207 (9%)

Query: 111 IGKGGFGSVYKAIIQDG------MEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIK 163
           +G+G FG VY+ + +          VA+K  +          F  E  VMK     ++++
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92

Query: 164 IISSYSNDDFKALVLEYMPHGSL---------EKCLYLSNYILDIFQRLDIMIDVASALE 214
           ++   S      +++E M  G L                     + + + +  ++A  + 
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152

Query: 215 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 274
           YL+   +   +H DL   N ++ ++    + DFGM + + E D      + L  + +M+P
Sbjct: 153 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 209

Query: 275 EYGREGRVSTNGDVYSFGIMLMEIFTR 301
           E  ++G  +T  DV+SFG++L EI T 
Sbjct: 210 ESLKDGVFTTYSDVWSFGVVLWEIATL 236

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  123 bits (311), Expect = 1e-32
 Identities = 56/200 (28%), Positives = 103/200 (51%), Gaps = 16/200 (8%)

Query: 111 IGKGGFGSVYKAIIQDG-----MEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKI 164
           IG G FG VYK +++       + VA+K     Y E     F  E  +M +  H N+I++
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111

Query: 165 ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYL---HFGYS 221
               S      ++ EYM +G+L+K L   +    + Q + ++  +A+ ++YL   ++   
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNY--- 168

Query: 222 APIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ-TLATIGYMAPEYGREG 280
              +H DL   N+L++ N+V  +SDFG+++ L ++ ++   T      I + APE     
Sbjct: 169 ---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR 225

Query: 281 RVSTNGDVYSFGIMLMEIFT 300
           + ++  DV+SFGI++ E+ T
Sbjct: 226 KFTSASDVWSFGIVMWEVMT 245

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  123 bits (310), Expect = 1e-32
 Identities = 51/244 (20%), Positives = 101/244 (41%), Gaps = 23/244 (9%)

Query: 110 LIGKGGFGSVYKAIIQDGMEVAVKV--FDPQYEGAFKSFDIECDVMKRICHRNL--IKII 165
            IG GG   V++ + +     A+K    +        S+  E   + ++   +   I++ 
Sbjct: 16  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75

Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNY-ILDIFQRLDIMIDVASALEYLHFGYSAPI 224
                D +  +V+E   +  L    +L     +D ++R     ++  A+  +H      I
Sbjct: 76  DYEITDQYIYMVMEC-GNIDLNS--WLKKKKSIDPWERKSYWKNMLEAVHTIH---QHGI 129

Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE--------- 275
           +H DLKP+N L+ D M+  L DFG+A  +  +  S+ +   + T+ YM PE         
Sbjct: 130 VHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 188

Query: 276 --YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPISVMEVVDA 333
                + ++S   DV+S G +L  +     P  +I +    L   ++    I   ++ + 
Sbjct: 189 ENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEK 248

Query: 334 NLLS 337
           +L  
Sbjct: 249 DLQD 252

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  122 bits (308), Expect = 1e-32
 Identities = 51/244 (20%), Positives = 101/244 (41%), Gaps = 23/244 (9%)

Query: 110 LIGKGGFGSVYKAIIQDGMEVAVKV--FDPQYEGAFKSFDIECDVMKRICHRNL--IKII 165
            IG GG   V++ + +     A+K    +        S+  E   + ++   +   I++ 
Sbjct: 35  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94

Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNY-ILDIFQRLDIMIDVASALEYLHFGYSAPI 224
                D +  +V+E   +  L    +L     +D ++R     ++  A+  +H      I
Sbjct: 95  DYEITDQYIYMVMECG-NIDLNS--WLKKKKSIDPWERKSYWKNMLEAVHTIH---QHGI 148

Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE--------- 275
           +H DLKP+N L+ D M+  L DFG+A  +  +  S+ +   + T+ YM PE         
Sbjct: 149 VHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 207

Query: 276 --YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPISVMEVVDA 333
                + ++S   DV+S G +L  +     P  +I +    L   ++    I   ++ + 
Sbjct: 208 ENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEK 267

Query: 334 NLLS 337
           +L  
Sbjct: 268 DLQD 271

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  124 bits (312), Expect = 1e-32
 Identities = 50/243 (20%), Positives = 99/243 (40%), Gaps = 21/243 (8%)

Query: 110 LIGKGGFGSVYKAIIQDGMEVAVKV--FDPQYEGAFKSFDIECDVMKRICHRNL--IKII 165
            IG GG   V++ + +     A+K    +        S+  E   + ++   +   I++ 
Sbjct: 63  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122

Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
                D +  +V+E   +  L   L      +D ++R     ++  A+  +H      I+
Sbjct: 123 DYEITDQYIYMVMEC-GNIDLNSWLK-KKKSIDPWERKSYWKNMLEAVHTIH---QHGIV 177

Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE---------- 275
           H DLKP+N L+ D M+  L DFG+A  +  +  S+ +   +  + YM PE          
Sbjct: 178 HSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRE 236

Query: 276 -YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPISVMEVVDAN 334
               + ++S   DV+S G +L  +     P  +I +    L   ++    I   ++ + +
Sbjct: 237 NGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKD 296

Query: 335 LLS 337
           L  
Sbjct: 297 LQD 299

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  121 bits (305), Expect = 3e-32
 Identities = 57/213 (26%), Positives = 97/213 (45%), Gaps = 35/213 (16%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
           ++GKG +G VY    + + + +A+K    +     +    E  + K + H+N+++ + S+
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88

Query: 169 SNDDFKALVLEYMPHGSLEKCL------------YLSNYILDIFQRLDIMIDVASALEYL 216
           S + F  + +E +P GSL   L             +  Y   I +           L+YL
Sbjct: 89  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILE----------GLKYL 138

Query: 217 HFGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQTLA-TIGYMAP 274
           H      I+H D+K  NVL++  + V  +SDFG +K L   +     T+T   T+ YMAP
Sbjct: 139 H---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN---PCTETFTGTLQYMAP 192

Query: 275 E---YGREGRVSTNGDVYSFGIMLMEIFTRTKP 304
           E    G  G      D++S G  ++E+ T   P
Sbjct: 193 EIIDKGPRGY-GKAADIWSLGCTIIEMATGKPP 224

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  122 bits (307), Expect = 3e-32
 Identities = 55/211 (26%), Positives = 91/211 (43%), Gaps = 29/211 (13%)

Query: 111 IGKGGFGSVYKAIIQDG------MEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIK 163
           +G G FG VY+  +         ++VAVK       E     F +E  ++ +  H+N+++
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97

Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYL--------SNYILDIFQRLDIMIDVASALEY 215
            I        + +++E M  G L+   +L            L +   L +  D+A   +Y
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKS--FLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155

Query: 216 L---HFGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATI 269
           L   HF      IH D+   N LL       VA + DFGMA+ +            +  +
Sbjct: 156 LEENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 209

Query: 270 GYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
            +M PE   EG  ++  D +SFG++L EIF+
Sbjct: 210 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  121 bits (305), Expect = 4e-32
 Identities = 48/199 (24%), Positives = 78/199 (39%), Gaps = 12/199 (6%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDI--ECDVMKRIC-HRNLIKII 165
            +G G +G V+K    +DG   AVK     + G         E    +++  H   +++ 
Sbjct: 64  RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123

Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
            ++       L  E     SL++        L   Q    + D   AL +LH   S  ++
Sbjct: 124 QAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH---SQGLV 179

Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
           H D+KP+N+ L       L DFG+   L        Q        YMAPE  +     T 
Sbjct: 180 HLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE---GDPRYMAPELLQGSY-GTA 235

Query: 286 GDVYSFGIMLMEIFTRTKP 304
            DV+S G+ ++E+    + 
Sbjct: 236 ADVFSLGLTILEVACNMEL 254

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  121 bits (305), Expect = 5e-32
 Identities = 59/213 (27%), Positives = 96/213 (45%), Gaps = 29/213 (13%)

Query: 111 IGKGGFGSVYKAIIQDG------MEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKI 164
           +G+G FG V+ A   +       M VAVK      E A + F  E +++  + H+++++ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108

Query: 165 ISSYSNDDFKALVLEYMPHGSL--------------EKCLYLSNYILDIFQRLDIMIDVA 210
               +      +V EYM HG L                   ++   L + Q L +   VA
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168

Query: 211 SALEYL---HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA 267
           + + YL   HF      +H DL   N L+   +V  + DFGM++ +   D      +T+ 
Sbjct: 169 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222

Query: 268 TIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
            I +M PE     + +T  DV+SFG++L EIFT
Sbjct: 223 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  124 bits (314), Expect = 8e-32
 Identities = 51/198 (25%), Positives = 91/198 (45%), Gaps = 16/198 (8%)

Query: 111 IGKGGFGSVYKAIIQDG----MEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKII 165
           IG+G FG V++ I        M VA+K       +   + F  E   M++  H +++K+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457

Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYL---HFGYSA 222
              + +    +++E    G L   L +  + LD+   +     +++AL YL    F    
Sbjct: 458 GVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRF---- 512

Query: 223 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRV 282
             +H D+   NVL+  N    L DFG+++  +E+      ++    I +MAPE     R 
Sbjct: 513 --VHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRF 569

Query: 283 STNGDVYSFGIMLMEIFT 300
           ++  DV+ FG+ + EI  
Sbjct: 570 TSASDVWMFGVCMWEILM 587

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  119 bits (301), Expect = 8e-32
 Identities = 53/213 (24%), Positives = 90/213 (42%), Gaps = 28/213 (13%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
           LIG GGFG V+KA    DG    +K      E A +    E   + ++ H N++     +
Sbjct: 18  LIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDHVNIVHYNGCW 73

Query: 169 SNDDFKA----------------LVLEYMPHGSLEKCL-YLSNYILDIFQRLDIMIDVAS 211
              D+                  + +E+   G+LE+ +       LD    L++   +  
Sbjct: 74  DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITK 133

Query: 212 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGY 271
            ++Y+H   S  +I+ DLKPSN+ L D     + DFG+   L        +T++  T+ Y
Sbjct: 134 GVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL---KNDGKRTRSKGTLRY 187

Query: 272 MAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKP 304
           M+PE           D+Y+ G++L E+      
Sbjct: 188 MSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  120 bits (303), Expect = 1e-31
 Identities = 52/227 (22%), Positives = 87/227 (38%), Gaps = 23/227 (10%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
            +G+GGF  V     + DG   A+K      +   +    E D+ +   H N++++++  
Sbjct: 36  KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95

Query: 169 SNDDFKA----LVLEYMPHGSLEKCLY---LSNYILDIFQRLDIMIDVASALEYLHFGYS 221
             +        L+L +   G+L   +         L   Q L +++ +   LE +H   +
Sbjct: 96  LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---A 152

Query: 222 APIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA-------TIGYMAP 274
               H DLKP+N+LL D     L D G         +   Q  TL        TI Y AP
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212

Query: 275 E----YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKR 317
           E          +    DV+S G +L  +     P D +F    ++  
Sbjct: 213 ELFSVQSHCV-IDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL 258

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  120 bits (302), Expect = 1e-31
 Identities = 50/215 (23%), Positives = 86/215 (40%), Gaps = 28/215 (13%)

Query: 111 IGKGGFGSVYKAII------QDGMEVAVKVFDPQY-EGAFKSFDIECDVMKRI-CHRNLI 162
           +G G FG V +A           M VAVK+  P       ++   E  V+  +  H N++
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90

Query: 163 KIISSYSNDDFKALVLEYMPHGSL-----------------EKCLYLSNYILDIFQRLDI 205
            ++ + +      ++ EY  +G L                    +      LD+   L  
Sbjct: 91  NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150

Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              VA  + +L    S   IH DL   N+LL    +  + DFG+A+ +  +   + +   
Sbjct: 151 SYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207

Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
              + +MAPE       +   DV+S+GI L E+F+
Sbjct: 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  120 bits (303), Expect = 2e-31
 Identities = 56/211 (26%), Positives = 91/211 (43%), Gaps = 29/211 (13%)

Query: 111 IGKGGFGSVYKAIIQDG------MEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIK 163
           +G G FG VY+  +         ++VAVK       E     F +E  ++ +  H+N+++
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138

Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYL--------SNYILDIFQRLDIMIDVASALEY 215
            I        + ++LE M  G L+   +L            L +   L +  D+A   +Y
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKS--FLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196

Query: 216 L---HFGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATI 269
           L   HF      IH D+   N LL       VA + DFGMA+ +            +  +
Sbjct: 197 LEENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPV 250

Query: 270 GYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
            +M PE   EG  ++  D +SFG++L EIF+
Sbjct: 251 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  118 bits (299), Expect = 3e-31
 Identities = 54/223 (24%), Positives = 95/223 (42%), Gaps = 39/223 (17%)

Query: 111 IGKGGFGSVYKAIIQDG------MEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIK 163
           +G+G FG V KA             VAVK+          +    E +V+K++ H ++IK
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90

Query: 164 IISSYSNDDFKALVLEYMPHGSL-----------------------EKCLYLSNYILDIF 200
           +  + S D    L++EY  +GSL                           +     L + 
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150

Query: 201 QRLDIMIDVASALEYL---HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED 257
             +     ++  ++YL           +H DL   N+L+ +     +SDFG+++ + EED
Sbjct: 151 DLISFAWQISQGMQYLAEMKL------VHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204

Query: 258 QSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
             + ++Q    + +MA E   +   +T  DV+SFG++L EI T
Sbjct: 205 SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  119 bits (301), Expect = 3e-31
 Identities = 47/205 (22%), Positives = 86/205 (41%), Gaps = 21/205 (10%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKV--FDPQYEGAFKSFDIECDVMKRICHRNLIKIIS 166
            IG+G FG        +DG +  +K            +    E  V+  + H N+++   
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90

Query: 167 SYSNDDFKALVLEYMPHGSL------EKCLYLS-NYILDIFQRLDIMIDVASALEYLHFG 219
           S+  +    +V++Y   G L      +K +    + ILD F      + +  AL+++H  
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWF------VQICLALKHVH-- 142

Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
               I+H D+K  N+ L  +    L DFG+A+ +L     L +     T  Y++PE    
Sbjct: 143 -DRKILHRDIKSQNIFLTKDGTVQLGDFGIAR-VLNSTVELARACI-GTPYYLSPEICEN 199

Query: 280 GRVSTNGDVYSFGIMLMEIFTRTKP 304
              +   D+++ G +L E+ T    
Sbjct: 200 KPYNNKSDIWALGCVLYELCTLKHA 224

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  118 bits (298), Expect = 3e-31
 Identities = 50/215 (23%), Positives = 91/215 (42%), Gaps = 31/215 (14%)

Query: 111 IGKGGFGSVYKAIIQDG------MEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIK 163
           +G+  FG VYK  +           VA+K    +      + F  E  +  R+ H N++ 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76

Query: 164 IISSYSNDDFKALVLEYMPHGSL---------------EKCLYLSNYILDIFQRLDIMID 208
           ++   + D   +++  Y  HG L                         L+    + ++  
Sbjct: 77  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136

Query: 209 VASALEYL---HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
           +A+ +EYL   H       +H DL   NVL+ D +   +SD G+ + +   D       +
Sbjct: 137 IAAGMEYLSSHHV------VHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNS 190

Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
           L  I +MAPE    G+ S + D++S+G++L E+F+
Sbjct: 191 LLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  118 bits (297), Expect = 5e-31
 Identities = 49/214 (22%), Positives = 91/214 (42%), Gaps = 27/214 (12%)

Query: 111 IGKGGFGSVYKAIIQD------GMEVAVK-VFDPQYEGAFKSFDIECDVMKRI-CHRNLI 162
           +G+G FG V +A             VAVK + +       ++   E  ++  I  H N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94

Query: 163 KIISSYSNDDFKA-LVLEYMPHGSL---------------EKCLYLSNYILDIFQRLDIM 206
            ++ + +       +++E+   G+L                    L    L +   +   
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154

Query: 207 IDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL 266
             VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+ + ++   + +    
Sbjct: 155 FQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211

Query: 267 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
             + +MAPE   +   +   DV+SFG++L EIF+
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  118 bits (298), Expect = 6e-31
 Identities = 57/215 (26%), Positives = 93/215 (43%), Gaps = 28/215 (13%)

Query: 111 IGKGGFGSVYKAIIQD--------GMEVAVK-VFDPQYEGAFKSFDIECDVMKRI-CHRN 160
           +G+G FG V  A             + VAVK + D   E        E ++MK I  H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102

Query: 161 LIKIISSYSNDDFKALVLEYMPHGSL---------------EKCLYLSNYILDIFQRLDI 205
           +I ++ + + D    +++EY   G+L                    +    +     +  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162

Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219

Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
              + +MAPE   +   +   DV+SFG+++ EIFT
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  118 bits (298), Expect = 7e-31
 Identities = 50/211 (23%), Positives = 92/211 (43%), Gaps = 24/211 (11%)

Query: 111 IGKGGFGSVYKAIIQD------GMEVAVKVFDPQY-EGAFKSFDIECDVMKRI-CHRNLI 162
           +G G FG V +A           ++VAVK+          ++   E  +M  +  H N++
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113

Query: 163 KIISSYSNDDFKALVLEYMPHGSL-------------EKCLYLSNYILDIFQRLDIMIDV 209
            ++ + ++     ++ EY  +G L             +    ++N        L     V
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173

Query: 210 ASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATI 269
           A  + +L    S   IH D+   NVLL +  VA + DFG+A+ ++ +   + +      +
Sbjct: 174 AQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 230

Query: 270 GYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
            +MAPE   +   +   DV+S+GI+L EIF+
Sbjct: 231 KWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  117 bits (296), Expect = 8e-31
 Identities = 57/202 (28%), Positives = 94/202 (46%), Gaps = 12/202 (5%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVK---VFDPQYEGAFKSFDIECDVMKRICHRNLIKII 165
            IG+G F  VY+A  + DG+ VA+K   +FD     A      E D++K++ H N+IK  
Sbjct: 39  KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98

Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIF---QRLDIMIDVASALEYLHFGYSA 222
           +S+  D+   +VLE    G L + +        +          + + SALE++H   S 
Sbjct: 99  ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SR 155

Query: 223 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRV 282
            ++H D+KP+NV +    V  L D G+ +       +   +    T  YM+PE   E   
Sbjct: 156 RVMHRDIKPANVFITATGVVKLGDLGLGR-FFSSKTTAAHSLV-GTPYYMSPERIHENGY 213

Query: 283 STNGDVYSFGIMLMEIFTRTKP 304
           +   D++S G +L E+     P
Sbjct: 214 NFKSDIWSLGCLLYEMAALQSP 235

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  117 bits (296), Expect = 1e-30
 Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 26/211 (12%)

Query: 110 LIGKGGFGSVYKAIIQDG---MEVAVKVFDPQY-EGAFKSFDIECDVMKRI-CHRNLIKI 164
           +IG+G FG V KA I+     M+ A+K       +   + F  E +V+ ++  H N+I +
Sbjct: 32  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91

Query: 165 ISSYSNDDFKALVLEYMPHGSL---------------EKCLYLSNYILDIFQRLDIMIDV 209
           + +  +  +  L +EY PHG+L                     +   L   Q L    DV
Sbjct: 92  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 151

Query: 210 ASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATI 269
           A  ++YL        IH DL   N+L+ +N VA ++DFG+++    ++  + +T     +
Sbjct: 152 ARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPV 205

Query: 270 GYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
            +MA E       +TN DV+S+G++L EI +
Sbjct: 206 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  118 bits (298), Expect = 1e-30
 Identities = 58/215 (26%), Positives = 92/215 (42%), Gaps = 28/215 (13%)

Query: 111 IGKGGFGSVYKAIIQD--------GMEVAVK-VFDPQYEGAFKSFDIECDVMKRI-CHRN 160
           +G+G FG V  A              +VAVK +     E        E ++MK I  H+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136

Query: 161 LIKIISSYSNDDFKALVLEYMPHGSL---------------EKCLYLSNYILDIFQRLDI 205
           +I ++ + + D    +++EY   G+L                   +     L     +  
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196

Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ +   D     T  
Sbjct: 197 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253

Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
              + +MAPE   +   +   DV+SFG++L EIFT
Sbjct: 254 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  118 bits (297), Expect = 1e-30
 Identities = 56/215 (26%), Positives = 92/215 (42%), Gaps = 28/215 (13%)

Query: 111 IGKGGFGSVYKAIIQD--------GMEVAVKVFDPQY-EGAFKSFDIECDVMKRI-CHRN 160
           +G+G FG V  A             + VAVK+      E        E ++MK I  H+N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148

Query: 161 LIKIISSYSNDDFKALVLEYMPHGSL---------------EKCLYLSNYILDIFQRLDI 205
           +I ++ + + D    +++EY   G+L                    +    +     +  
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208

Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T  
Sbjct: 209 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265

Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
              + +MAPE   +   +   DV+SFG+++ EIFT
Sbjct: 266 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  117 bits (294), Expect = 2e-30
 Identities = 55/223 (24%), Positives = 91/223 (40%), Gaps = 39/223 (17%)

Query: 111 IGKGGFGSVYKAIIQDG------MEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIK 163
           IG+G FG V++A             VAVK+   +        F  E  +M    + N++K
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114

Query: 164 IISSYSNDDFKALVLEYMPHGSL-----------------------EKCLYLSNYILDIF 200
           ++   +      L+ EYM +G L                        +        L   
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174

Query: 201 QRLDIMIDVASALEYL---HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED 257
           ++L I   VA+ + YL    F      +H DL   N L+ +NMV  ++DFG+++ +   D
Sbjct: 175 EQLCIARQVAAGMAYLSERKF------VHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228

Query: 258 QSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
                      I +M PE     R +T  DV+++G++L EIF+
Sbjct: 229 YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  114 bits (288), Expect = 6e-30
 Identities = 52/205 (25%), Positives = 84/205 (40%), Gaps = 12/205 (5%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKV--FDPQYEGAFKSFDIECDVMKRICHRNLIKIIS 166
            IG G +G   K     DG  +  K   +    E   +    E ++++ + H N+++   
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72

Query: 167 SYSNDDFKAL--VLEYMPHGSLEKCLYLSNYILDIF---QRLDIMIDVASALEYLH--FG 219
              +     L  V+EY   G L   +               L +M  +  AL+  H    
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132

Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
               ++H DLKP+NV LD      L DFG+A+ +L  D S  +T  + T  YM+PE    
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR-ILNHDTSFAKTF-VGTPYYMSPEQMNR 190

Query: 280 GRVSTNGDVYSFGIMLMEIFTRTKP 304
              +   D++S G +L E+     P
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMPP 215

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  116 bits (292), Expect = 7e-30
 Identities = 40/230 (17%), Positives = 76/230 (33%), Gaps = 26/230 (11%)

Query: 110 LIGKGGFGSVYKAI------IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIK 163
           L+G+G F  VY+A        ++  +  +KV  P     F       + +K       +K
Sbjct: 72  LLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMK 131

Query: 164 IISSYSNDDFKALVLEYMPHGSL----EKCLYLSNYILDIFQRLDIMIDVASALEYLHFG 219
             S++   +   LV E   +G+L             ++     +   + +   +E +H  
Sbjct: 132 FYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH-- 189

Query: 220 YSAPIIHCDLKPSNVLLDDNMVAH-----------LSDFGMAKPLLEEDQSLTQTQTLAT 268
               IIH D+KP N +L +  +             L D G +  +    +    T    T
Sbjct: 190 -DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCET 248

Query: 269 IGYMAPEYGREGRVSTNG-DVYSFGIMLMEIFTRTKPTDEIFSGEMTLKR 317
            G+   E     +      D +     +  +   T    +   GE   + 
Sbjct: 249 SGFQCVEM-LSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEG 297

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  115 bits (289), Expect = 1e-29
 Identities = 51/220 (23%), Positives = 89/220 (40%), Gaps = 33/220 (15%)

Query: 111 IGKGGFGSVYKAIIQDG------MEVAVK-VFDPQYEGAFKSFDIECDVMKRI-CHRNLI 162
           +G G FG V  A           ++VAVK + +       ++   E  +M ++  H N++
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112

Query: 163 KIISSYSNDDFKALVLEYMPHGSL----------------------EKCLYLSNYILDIF 200
            ++ + +      L+ EY  +G L                               +L   
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172

Query: 201 QRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL 260
             L     VA  +E+L        +H DL   NVL+    V  + DFG+A+ ++ +   +
Sbjct: 173 DLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 229

Query: 261 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
            +      + +MAPE   EG  +   DV+S+GI+L EIF+
Sbjct: 230 VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  115 bits (290), Expect = 3e-29
 Identities = 54/244 (22%), Positives = 89/244 (36%), Gaps = 44/244 (18%)

Query: 110 LIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRIC-HRNLIKIISSY 168
           ++G G  G+V       G  VAVK     +        +E  ++     H N+I+   S 
Sbjct: 22  ILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSE 78

Query: 169 SNDDFKALVLEYMPHGSLE------KCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSA 222
           + D F  + LE     +L+           +  +   +  + ++  +AS + +LH   S 
Sbjct: 79  TTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SL 134

Query: 223 PIIHCDLKPSNVLLD-------------DNMVAHLSDFGMAKPLLEEDQSLTQTQTLA-- 267
            IIH DLKP N+L+              +N+   +SDFG+ K L     S          
Sbjct: 135 KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSG 194

Query: 268 TIGYMAPEYGREGRVSTNG-------DVYSFGIMLMEIFT--------RTKPTDEIFSGE 312
           T G+ APE   E              D++S G +   I +        +      I  G 
Sbjct: 195 TSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGI 254

Query: 313 MTLK 316
            +L 
Sbjct: 255 FSLD 258

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  115 bits (288), Expect = 4e-29
 Identities = 33/250 (13%), Positives = 73/250 (29%), Gaps = 59/250 (23%)

Query: 109 PLIGKGGFGSVYKAI-IQDGMEVAVKVF----------------------------DPQY 139
            ++G+    +  +A   + G    V V                             + + 
Sbjct: 84  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143

Query: 140 EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYM-PHGSLEKCL-YLSNYI- 196
                 F    D++K    + +I++     +    +    Y     +L+     L ++  
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203

Query: 197 ----LDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP 252
               L    RL + + V   L  LH      ++H  L+P +++LD      L+ F     
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260

Query: 253 LLEEDQSLTQTQTLATIGYMAPEY----------GREGRVSTNGDVYSFGIMLMEIFTRT 302
                       +    G+  PE                ++   D ++ G+ +  I+   
Sbjct: 261 DGAS------AVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314

Query: 303 KPTDEIFSGE 312
            P     + +
Sbjct: 315 LP----NTDD 320

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  113 bits (285), Expect = 6e-29
 Identities = 40/273 (14%), Positives = 84/273 (30%), Gaps = 65/273 (23%)

Query: 107 MPPLIGKGGFGSVYKAI-IQDGMEVAVKVFD----------------------------P 137
              ++G+    +  +A   + G    V V                               
Sbjct: 77  RGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQ 136

Query: 138 QYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYM-PHGSLEKCL-YLSNY 195
           +       F    D++K    + +I++     +    +    Y     +L+     L ++
Sbjct: 137 KQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSH 196

Query: 196 I-----LDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMA 250
                 L    RL + + V   L  LH      ++H  L+P +++LD      L+ F   
Sbjct: 197 SSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 253

Query: 251 KPLLEEDQSLTQTQTLATIGYMAPEY-----------GREGRVSTNGDVYSFGIMLMEIF 299
                 D +   +    + G+  PE             R   ++ + D ++ G+++  I+
Sbjct: 254 VR----DGARVVSSV--SRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307

Query: 300 TRTKPTDE---------IFSGEMTLKRWVNDLL 323
               P  +         IF     + + V  LL
Sbjct: 308 CADLPITKDAALGGSEWIFRSCKNIPQPVRALL 340

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  112 bits (281), Expect = 1e-28
 Identities = 58/253 (22%), Positives = 107/253 (42%), Gaps = 32/253 (12%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFD-PQYEGAFKSFDIECDVMKRICHRNLIKIISS 167
           ++G+G   +V++    + G   A+KVF+   +         E +V+K++ H+N++K+ + 
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 168 YSNDDFKA--LVLEYMPHGSLEKCLYL----SNYILDIFQRLDIMIDVASALEYLHFGYS 221
                 +   L++E+ P GSL     L    + Y L   + L ++ DV   + +L     
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYT--VLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---E 130

Query: 222 APIIHCDLKPSNVLL----DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE-Y 276
             I+H ++KP N++     D   V  L+DFG A+ L  ED     +    T  Y+ P+ Y
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL--EDDEQFVSL-YGTEEYLHPDMY 187

Query: 277 GREGRVSTNG-------DVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPISVME 329
            R      +        D++S G+      T + P    F      +R    +  I   +
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP----FRPFEGPRRNKEVMYKIITGK 243

Query: 330 VVDANLLSQEDEH 342
              A    Q+ E+
Sbjct: 244 PSGAISGVQKAEN 256

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  111 bits (280), Expect = 1e-28
 Identities = 54/252 (21%), Positives = 98/252 (38%), Gaps = 50/252 (19%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
           ++G+G FG V KA    D    A+K      E    +   E  ++  + H+ +++  +++
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQYVVRYYAAW 71

Query: 169 SNDDFKA-------------LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEY 215
                               + +EY  +G+L   ++  N      +   +   +  AL Y
Sbjct: 72  LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSY 131

Query: 216 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL--------LEEDQSLTQTQTLA 267
           +H   S  IIH DLKP N+ +D++    + DFG+AK +        L+       +  L 
Sbjct: 132 IH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLT 188

Query: 268 T-IG---YMAPE-------YGREGRVSTNGDVYSFGIMLMEI-------FTRTKPTDEIF 309
           + IG   Y+A E       Y  +       D+YS GI+  E+         R     ++ 
Sbjct: 189 SAIGTAMYVATEVLDGTGHYNEK------IDMYSLGIIFFEMIYPFSTGMERVNILKKLR 242

Query: 310 SGEMTLKRWVND 321
           S  +      +D
Sbjct: 243 SVSIEFPPDFDD 254

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  111 bits (279), Expect = 3e-28
 Identities = 58/232 (25%), Positives = 90/232 (38%), Gaps = 31/232 (13%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRIC-HRNLIKIISS 167
           ++ +GGF  VY+A  +  G E A+K      E   ++   E   MK++  H N+++  S+
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 168 YS-------NDDFKALVLEYMPHGSLEKCL--YLSNYILDIFQRLDIMIDVASALEYLHF 218
            S           + L+L  +  G L + L    S   L     L I      A++++H 
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH- 153

Query: 219 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA----------T 268
               PIIH DLK  N+LL +     L DFG A  +          Q  A          T
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213

Query: 269 IGYMAPE----YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLK 316
             Y  PE    Y     +    D+++ G +L  +  R  P    F     L+
Sbjct: 214 PMYRTPEIIDLYSNFP-IGEKQDIWALGCILYLLCFRQHP----FEDGAKLR 260

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  111 bits (280), Expect = 4e-28
 Identities = 52/209 (24%), Positives = 95/209 (45%), Gaps = 24/209 (11%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFD-PQYEGAFKSFDIECDVMKRICHRNLIKIISS 167
           ++G+G   +V++    + G   A+KVF+   +         E +V+K++ H+N++K+ + 
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 168 Y--SNDDFKALVLEYMPHGSLEKCLYL--SNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
              +    K L++E+ P GSL   L    + Y L   + L ++ DV   + +L       
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENG 132

Query: 224 IIHCDLKPSNVLL----DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE-YGR 278
           I+H ++KP N++     D   V  L+DFG A+ L  ED     +    T  Y+ P+ Y R
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL--EDDEQFVSL-YGTEEYLHPDMYER 189

Query: 279 EGRVSTNG-------DVYSFGIMLMEIFT 300
                 +        D++S G+      T
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAAT 218

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  110 bits (276), Expect = 4e-28
 Identities = 56/189 (29%), Positives = 92/189 (48%), Gaps = 10/189 (5%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYS 169
           IG+G  G+VY A+ +  G EVA++  + Q +   +    E  VM+   + N++  + SY 
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87

Query: 170 NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
             D   +V+EY+  GSL     ++   +D  Q   +  +   ALE+LH   S  +IH D+
Sbjct: 88  VGDELWVVMEYLAGGSLTDV--VTETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 142

Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA-TIGYMAPEYGREGRVSTNGDV 288
           K  N+LL  +    L+DFG    +       ++  T+  T  +MAPE           D+
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 199

Query: 289 YSFGIMLME 297
           +S GIM +E
Sbjct: 200 WSLGIMAIE 208

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  109 bits (275), Expect = 7e-28
 Identities = 54/196 (27%), Positives = 96/196 (48%), Gaps = 17/196 (8%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYS 169
           +G G FG VYKA   + G   A KV + + E   + + +E +++    H  ++K++ +Y 
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86

Query: 170 NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
           +D    +++E+ P G+++  +   +  L   Q   +   +  AL +LH   S  IIH DL
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDL 143

Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG---YMAPE-----YGREGR 281
           K  NVL+       L+DFG++       ++L +  +   IG   +MAPE       ++  
Sbjct: 144 KAGNVLMTLEGDIRLADFGVSAKN---LKTLQKRDSF--IGTPYWMAPEVVMCETMKDTP 198

Query: 282 VSTNGDVYSFGIMLME 297
                D++S GI L+E
Sbjct: 199 YDYKADIWSLGITLIE 214

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  109 bits (275), Expect = 8e-28
 Identities = 54/191 (28%), Positives = 95/191 (49%), Gaps = 14/191 (7%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYS 169
           IG+G  G V  A     G +VAVK+ D + +   +    E  +M+   H N++++  SY 
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112

Query: 170 NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
             +   +++E++  G+L   +  S   L+  Q   +   V  AL YLH   +  +IH D+
Sbjct: 113 VGEELWVLMEFLQGGALTDIV--SQVRLNEEQIATVCEAVLQALAYLH---AQGVIHRDI 167

Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG---YMAPEYGREGRVSTNG 286
           K  ++LL  +    LSDFG    +    + + + ++L  +G   +MAPE       +T  
Sbjct: 168 KSDSILLTLDGRVKLSDFGFCAQI---SKDVPKRKSL--VGTPYWMAPEVISRSLYATEV 222

Query: 287 DVYSFGIMLME 297
           D++S GIM++E
Sbjct: 223 DIWSLGIMVIE 233

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  112 bits (282), Expect = 1e-27
 Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 23/209 (11%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQ-YEGAFKSFDIECDVMKRICHRNLIKII--- 165
           +G GGFG V + I    G +VA+K    +      + + +E  +MK++ H N++      
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81

Query: 166 ---SSYSNDDFKALVLEYMPHGSLEKCLYL----SNYILDIFQRLDIMIDVASALEYLHF 218
                 + +D   L +EY   G L K  YL    +   L       ++ D++SAL YLH 
Sbjct: 82  DGLQKLAPNDLPLLAMEYCEGGDLRK--YLNQFENCCGLKEGPIRTLLSDISSALRYLH- 138

Query: 219 GYSAPIIHCDLKPSNVLLD---DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE 275
                IIH DLKP N++L      ++  + D G AK L  +   L     + T+ Y+APE
Sbjct: 139 --ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEF-VGTLQYLAPE 193

Query: 276 YGREGRVSTNGDVYSFGIMLMEIFTRTKP 304
              + + +   D +SFG +  E  T  +P
Sbjct: 194 LLEQKKYTVTVDYWSFGTLAFECITGFRP 222

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  108 bits (273), Expect = 2e-27
 Identities = 30/78 (38%), Positives = 42/78 (53%), Gaps = 1/78 (1%)

Query: 1   QGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRN 60
              +   +G   NL  L+L NN + GT+P  L +L  L  +NVSFN L GEIP+ G  + 
Sbjct: 234 AFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQR 292

Query: 61  LSVKSFEGNELLCEIVLP 78
             V ++  N+ LC   LP
Sbjct: 293 FDVSAYANNKCLCGSPLP 310

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 78.7 bits (195), Expect = 8e-17
 Identities = 24/71 (33%), Positives = 38/71 (53%), Gaps = 1/71 (1%)

Query: 2   GSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRN 60
           G IP +I  L  L  L +++ N+SG IP  L ++  L  ++ S+N L G +P       N
Sbjct: 91  GPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPN 150

Query: 61  LSVKSFEGNEL 71
           L   +F+GN +
Sbjct: 151 LVGITFDGNRI 161

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 74.9 bits (185), Expect = 2e-15
 Identities = 24/63 (38%), Positives = 34/63 (53%), Gaps = 1/63 (1%)

Query: 2   GSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRN 60
           G+IPD +  +  L +L+ S N LSGT+P S+  L +L  I    N++ G IP   G F  
Sbjct: 115 GAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSK 174

Query: 61  LSV 63
           L  
Sbjct: 175 LFT 177

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 72.6 bits (179), Expect = 1e-14
 Identities = 23/63 (36%), Positives = 32/63 (50%), Gaps = 3/63 (4%)

Query: 1   QGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDL-KDINVSFNKLEGEIPREGPFR 59
            G++P SI  L NL  +    N +SG IP S      L   + +S N+L G+IP    F 
Sbjct: 138 SGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPT--FA 195

Query: 60  NLS 62
           NL+
Sbjct: 196 NLN 198

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 69.9 bits (172), Expect = 1e-13
 Identities = 22/73 (30%), Positives = 32/73 (43%), Gaps = 2/73 (2%)

Query: 1   QGSIPDSIGDLINLKSLNLSN-NNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPF 58
              IP S+ +L  L  L +   NNL G IP ++ KL  L  + ++   + G IP      
Sbjct: 65  PYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQI 124

Query: 59  RNLSVKSFEGNEL 71
           + L    F  N L
Sbjct: 125 KTLVTLDFSYNAL 137

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 55.6 bits (135), Expect = 6e-09
 Identities = 19/74 (25%), Positives = 27/74 (36%), Gaps = 4/74 (5%)

Query: 2   GSIPDSIGDLINLKSLNLSNNNLSGTIPI--SLEKLLDLKDINVS-FNKLEGEIPRE-GP 57
           G + D+      + +L+LS  NL    PI  SL  L  L  + +   N L G IP     
Sbjct: 40  GVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAK 99

Query: 58  FRNLSVKSFEGNEL 71
              L         +
Sbjct: 100 LTQLHYLYITHTNV 113

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  108 bits (273), Expect = 2e-27
 Identities = 60/191 (31%), Positives = 94/191 (49%), Gaps = 14/191 (7%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYS 169
           +G+G +GSVYKAI  + G  VA+K      E   +    E  +M++    +++K   SY 
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVP--VESDLQEIIKEISIMQQCDSPHVVKYYGSYF 94

Query: 170 NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
            +    +V+EY   GS+   + L N  L   +   I+      LEYLH       IH D+
Sbjct: 95  KNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDI 151

Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG---YMAPEYGREGRVSTNG 286
           K  N+LL+    A L+DFG+A  L     ++ +  T+  IG   +MAPE  +E   +   
Sbjct: 152 KAGNILLNTEGHAKLADFGVAGQL---TDTMAKRNTV--IGTPFWMAPEVIQEIGYNCVA 206

Query: 287 DVYSFGIMLME 297
           D++S GI  +E
Sbjct: 207 DIWSLGITAIE 217

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  109 bits (273), Expect = 3e-27
 Identities = 23/232 (9%), Positives = 57/232 (24%), Gaps = 45/232 (19%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVF---------------------------DPQYEG 141
            +  G    V+    ++   + A+KVF                            P+   
Sbjct: 69  PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128

Query: 142 AFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYM-PHGSLEKCLYLSNYI---- 196
             +   +  D +         ++     +      +L        LE      +++    
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188

Query: 197 --LDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL 254
               I     +   +      L    S  ++H    P N+ +  +    L D        
Sbjct: 189 GDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWK-- 243

Query: 255 EEDQSLTQTQTLATIGYMAPEY--GREGRVSTNGDVYSFGIMLMEIFTRTKP 304
                   +     + Y   E+        +   + +  G+ +  ++    P
Sbjct: 244 -VGTRGPASSV--PVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  107 bits (269), Expect = 4e-27
 Identities = 47/218 (21%), Positives = 91/218 (41%), Gaps = 31/218 (14%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFD-PQYEGAFKSFDIECDVMKRICHRNLIKIISS 167
            +G+GGFG V++A    D    A+K    P  E A +    E   + ++ H  +++  ++
Sbjct: 12  CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71

Query: 168 YSNDDFKA------------LVLEYMPHGSLEKCL--YLSNYILDIFQRLDIMIDVASAL 213
           +   +               + ++     +L+  +    +    +    L I + +A A+
Sbjct: 72  WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAV 131

Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG--- 270
           E+LH   S  ++H DLKPSN+    + V  + DFG+    +++D+      T        
Sbjct: 132 EFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVT-AMDQDEEEQTVLTPMPAYARH 187

Query: 271 --------YMAPEYGREGRVSTNGDVYSFGIMLMEIFT 300
                   YM+PE       S   D++S G++L E+  
Sbjct: 188 TGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  106 bits (267), Expect = 6e-27
 Identities = 44/219 (20%), Positives = 85/219 (38%), Gaps = 38/219 (17%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDI--ECDVMKRIC-HRNLIKII 165
            IG G FGSV+K +   DG   A+K       G+    +   E      +  H ++++  
Sbjct: 18  KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYF 77

Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIF---QRLDIMIDVASALEYLHFGYSA 222
           S+++ DD   +  EY   GSL   +  +  I+  F   +  D+++ V   L Y+H   S 
Sbjct: 78  SAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SM 134

Query: 223 PIIHCDLKPSNVLLDDN-------------------MVAHLSDFGMAKPLLEEDQSLTQT 263
            ++H D+KPSN+ +                      ++  + D G           ++  
Sbjct: 135 SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT-------RISSP 187

Query: 264 QTLA-TIGYMAPEYGREGRVSTN-GDVYSFGIMLMEIFT 300
           Q       ++A E  +E        D+++  + ++    
Sbjct: 188 QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAG 226

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  106 bits (266), Expect = 1e-26
 Identities = 58/220 (26%), Positives = 94/220 (42%), Gaps = 60/220 (27%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDI---------ECDVMKRIC-HR 159
           +G+G    V + I      E AVK+ D    G+F + ++         E D+++++  H 
Sbjct: 25  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84

Query: 160 NLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL------------DIMI 207
           N+I++  +Y  + F  LV + M  G L             F  L             IM 
Sbjct: 85  NIIQLKDTYETNTFFFLVFDLMKKGEL-------------FDYLTEKVTLSEKETRKIMR 131

Query: 208 DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA 267
            +   +  LH      I+H DLKP N+LLDD+M   L+DFG +   L+  + L   +   
Sbjct: 132 ALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSC-QLDPGEKL--REVCG 185

Query: 268 TIGYMAPE------------YGREGRVSTNGDVYSFGIML 295
           T  Y+APE            YG+E       D++S G+++
Sbjct: 186 TPSYLAPEIIECSMNDNHPGYGKE------VDMWSTGVIM 219

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  105 bits (264), Expect = 2e-26
 Identities = 52/209 (24%), Positives = 89/209 (42%), Gaps = 50/209 (23%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
           ++G G F  V+       G   A+K           S + E  V+K+I H N++ +   Y
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75

Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL------------DIMIDVASALEYL 216
            +     LV++ +  G L             F R+             ++  V SA++YL
Sbjct: 76  ESTTHYYLVMQLVSGGEL-------------FDRILERGVYTEKDASLVIQQVLSAVKYL 122

Query: 217 HFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA-TIGYM 272
           H      I+H DLKP N+L    ++N    ++DFG++K  +E++  ++   T   T GY+
Sbjct: 123 H---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK--MEQNGIMS---TACGTPGYV 174

Query: 273 APE------YGREGRVSTNGDVYSFGIML 295
           APE      Y +        D +S G++ 
Sbjct: 175 APEVLAQKPYSKA------VDCWSIGVIT 197

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  105 bits (265), Expect = 2e-26
 Identities = 54/201 (26%), Positives = 83/201 (41%), Gaps = 21/201 (10%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQY-EGAFKSFDIECDVMKRIC-HRNLIKIISS 167
           IG+G +GSV K +    G  +AVK       E   K   ++ DV+ R      +++   +
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89

Query: 168 YSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLD------IMIDVASALEYLHFGYS 221
              +    + +E M   S +K          +   +       I +    AL +L     
Sbjct: 90  LFREGDCWICMELMS-TSFDKFY--KYVYSVLDDVIPEEILGKITLATVKALNHLKENLK 146

Query: 222 APIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE----YG 277
             IIH D+KPSN+LLD +    L DFG++  L     S+ +T+      YMAPE      
Sbjct: 147 --IIHRDIKPSNILLDRSGNIKLCDFGISGQL---VDSIAKTRDAGCRPYMAPERIDPSA 201

Query: 278 REGRVSTNGDVYSFGIMLMEI 298
                    DV+S GI L E+
Sbjct: 202 SRQGYDVRSDVWSLGITLYEL 222

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  106 bits (266), Expect = 3e-26
 Identities = 47/194 (24%), Positives = 90/194 (46%), Gaps = 13/194 (6%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDI--ECDVMKRICHRNLIKIISS 167
           +G G  G V+K      G+ +A K+   + + A ++  I  E  V+       ++    +
Sbjct: 41  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN-QIIRELQVLHECNSPYIVGFYGA 99

Query: 168 YSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHC 227
           + +D   ++ +E+M  GSL++ +      +       + I V   L YL   +   I+H 
Sbjct: 100 FYSDGEISICMEHMDGGSLDQ-VLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHR 156

Query: 228 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA-TIGYMAPEYGREGRVSTNG 286
           D+KPSN+L++      L DFG++  L++     +   +   T  YM+PE  +    S   
Sbjct: 157 DVKPSNILVNSRGEIKLCDFGVSGQLID-----SMANSFVGTRSYMSPERLQGTHYSVQS 211

Query: 287 DVYSFGIMLMEIFT 300
           D++S G+ L+E+  
Sbjct: 212 DIWSMGLSLVEMAV 225

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  105 bits (263), Expect = 4e-26
 Identities = 60/207 (28%), Positives = 96/207 (46%), Gaps = 31/207 (14%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFD-PQYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
           IGKG FG V+K I  +    VA+K+ D  + E   +    E  V+ +     + K   SY
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89

Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQ--RLD------IMIDVASALEYLHFGY 220
             D    +++EY+  GS           LD+ +   LD      I+ ++   L+YLH   
Sbjct: 90  LKDTKLWIIMEYLGGGSA----------LDLLEPGPLDETQIATILREILKGLDYLH--- 136

Query: 221 SAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG---YMAPEYG 277
           S   IH D+K +NVLL ++    L+DFG+A  L     +  +  T   +G   +MAPE  
Sbjct: 137 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQL---TDTQIKRNTF--VGTPFWMAPEVI 191

Query: 278 REGRVSTNGDVYSFGIMLMEIFTRTKP 304
           ++    +  D++S GI  +E+     P
Sbjct: 192 KQSAYDSKADIWSLGITAIELARGEPP 218

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  108 bits (271), Expect = 6e-26
 Identities = 34/78 (43%), Positives = 42/78 (53%)

Query: 1   QGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRN 60
            GSIPD +GDL  L  L+LS+N L G IP ++  L  L +I++S N L G IP  G F  
Sbjct: 669 SGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFET 728

Query: 61  LSVKSFEGNELLCEIVLP 78
                F  N  LC   LP
Sbjct: 729 FPPAKFLNNPGLCGYPLP 746

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 76.1 bits (188), Expect = 2e-15
 Identities = 31/71 (43%), Positives = 42/71 (59%), Gaps = 1/71 (1%)

Query: 2   GSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRN 60
           G IP ++ +   L SL+LS N LSGTIP SL  L  L+D+ +  N LEGEIP+E    + 
Sbjct: 408 GKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKT 467

Query: 61  LSVKSFEGNEL 71
           L     + N+L
Sbjct: 468 LETLILDFNDL 478

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 74.2 bits (183), Expect = 1e-14
 Identities = 25/72 (34%), Positives = 39/72 (54%), Gaps = 1/72 (1%)

Query: 1   QGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFR 59
           +G IP  +  +  L++L L  N+L+G IP  L    +L  I++S N+L GEIP+  G   
Sbjct: 455 EGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLE 514

Query: 60  NLSVKSFEGNEL 71
           NL++     N  
Sbjct: 515 NLAILKLSNNSF 526

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 72.6 bits (179), Expect = 3e-14
 Identities = 28/71 (39%), Positives = 36/71 (50%), Gaps = 1/71 (1%)

Query: 2   GSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRN 60
           G+IP S+G L  L+ L L  N L G IP  L  +  L+ + + FN L GEIP       N
Sbjct: 432 GTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTN 491

Query: 61  LSVKSFEGNEL 71
           L+  S   N L
Sbjct: 492 LNWISLSNNRL 502

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 72.6 bits (179), Expect = 3e-14
 Identities = 25/72 (34%), Positives = 36/72 (50%), Gaps = 1/72 (1%)

Query: 1   QGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFR 59
            G IP  + +  NL  ++LSNN L+G IP  + +L +L  + +S N   G IP E G  R
Sbjct: 479 TGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCR 538

Query: 60  NLSVKSFEGNEL 71
           +L       N  
Sbjct: 539 SLIWLDLNTNLF 550

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 72.2 bits (178), Expect = 5e-14
 Identities = 26/65 (40%), Positives = 39/65 (60%), Gaps = 3/65 (4%)

Query: 1   QGSIPDSIGDLINLKSLNLSNNNLSGTIPI-SLEKLLDLKDINVSFNKLEGEIPREGPFR 59
            G++P   G    L+SL LS+NN SG +P+ +L K+  LK +++SFN+  GE+P      
Sbjct: 307 YGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPES--LT 364

Query: 60  NLSVK 64
           NLS  
Sbjct: 365 NLSAS 369

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 71.1 bits (175), Expect = 1e-13
 Identities = 23/71 (32%), Positives = 36/71 (50%), Gaps = 2/71 (2%)

Query: 1   QGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRN 60
              IP  +GD   L+ L++S N LSG    ++    +LK +N+S N+  G IP   P ++
Sbjct: 213 STGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL-PLKS 270

Query: 61  LSVKSFEGNEL 71
           L   S   N+ 
Sbjct: 271 LQYLSLAENKF 281

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 69.2 bits (170), Expect = 5e-13
 Identities = 26/103 (25%), Positives = 36/103 (34%), Gaps = 3/103 (2%)

Query: 2   GSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNL 61
           G IP  IG L NL  L LSNN+ SG IP  L     L  ++++ N   G IP        
Sbjct: 504 GEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAA--MFKQ 561

Query: 62  SVKSFEGNELLCEIVLPLSTIFMIVMILLILRYQKRGKPLPND 104
           S      N +  +  + +    M           +        
Sbjct: 562 S-GKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQ 603

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 68.8 bits (169), Expect = 7e-13
 Identities = 23/73 (31%), Positives = 32/73 (43%), Gaps = 3/73 (4%)

Query: 2   GSIPDSIGD--LINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPF 58
           G I  ++       L+ L L NN  +G IP +L    +L  +++SFN L G IP   G  
Sbjct: 382 GPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSL 441

Query: 59  RNLSVKSFEGNEL 71
             L       N L
Sbjct: 442 SKLRDLKLWLNML 454

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 67.6 bits (166), Expect = 1e-12
 Identities = 23/73 (31%), Positives = 32/73 (43%), Gaps = 3/73 (4%)

Query: 2   GSIPDSI-GDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE--GPF 58
           G IPD + G    L  L+LS N+  G +P        L+ + +S N   GE+P +     
Sbjct: 283 GEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKM 342

Query: 59  RNLSVKSFEGNEL 71
           R L V     NE 
Sbjct: 343 RGLKVLDLSFNEF 355

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 66.1 bits (162), Expect = 5e-12
 Identities = 11/54 (20%), Positives = 24/54 (44%)

Query: 2   GSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE 55
           G   + +  L      N+++    G    + +    +  +++S+N L G IP+E
Sbjct: 598 GIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKE 651

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 65.7 bits (161), Expect = 6e-12
 Identities = 20/72 (27%), Positives = 35/72 (48%), Gaps = 4/72 (5%)

Query: 1   QGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFR 59
            G +   +   +NL+ L++S+NN S  IP  L     L+ +++S NKL G+  R      
Sbjct: 191 SGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCT 247

Query: 60  NLSVKSFEGNEL 71
            L + +   N+ 
Sbjct: 248 ELKLLNISSNQF 259

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 63.4 bits (155), Expect = 4e-11
 Identities = 24/85 (28%), Positives = 37/85 (43%), Gaps = 6/85 (7%)

Query: 1   QGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLD-LKDINVSFNKLEGEIPRE-GPF 58
            G IP     L +L+ L+L+ N  +G IP  L    D L  +++S N   G +P   G  
Sbjct: 260 VGPIPPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSC 317

Query: 59  RNLSVKSFEGNELLCEIVLPLSTIF 83
             L   +   N    E+  P+ T+ 
Sbjct: 318 SLLESLALSSNNFSGEL--PMDTLL 340

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 63.0 bits (154), Expect = 5e-11
 Identities = 15/61 (24%), Positives = 31/61 (50%), Gaps = 1/61 (1%)

Query: 2   GSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNL 61
            ++  S+  L  L+SL LSN++++G++    +    L  +++S N L G +       + 
Sbjct: 67  SAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSGPVTTLTSLGSC 125

Query: 62  S 62
           S
Sbjct: 126 S 126

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 62.6 bits (153), Expect = 5e-11
 Identities = 20/73 (27%), Positives = 32/73 (43%), Gaps = 5/73 (6%)

Query: 2   GSIPDSI---GDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPF 58
           G+             LK L +S N +SG + +S  + ++L+ ++VS N     IP  G  
Sbjct: 165 GANVVGWVLSDGCGELKHLAISGNKISGDVDVS--RCVNLEFLDVSSNNFSTGIPFLGDC 222

Query: 59  RNLSVKSFEGNEL 71
             L      GN+L
Sbjct: 223 SALQHLDISGNKL 235

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 62.6 bits (153), Expect = 6e-11
 Identities = 22/75 (29%), Positives = 37/75 (49%), Gaps = 4/75 (5%)

Query: 1   QGSIPDSIGDL-INLKSLNLSNNNLSGTIPISLEK--LLDLKDINVSFNKLEGEIPRE-G 56
            G +P+S+ +L  +L +L+LS+NN SG I  +L +     L+++ +  N   G+IP    
Sbjct: 356 SGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLS 415

Query: 57  PFRNLSVKSFEGNEL 71
               L       N L
Sbjct: 416 NCSELVSLHLSFNYL 430

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 61.5 bits (150), Expect = 1e-10
 Identities = 20/78 (25%), Positives = 33/78 (42%), Gaps = 7/78 (8%)

Query: 1   QGSIPD--SIGDLINLKSLNLSNNNLSGTIPISLE-KLLDLKDINVSFNKLEGEIPRE-- 55
            G +    S+G    LK LN+S+N L     +S   KL  L+ +++S N + G       
Sbjct: 113 SGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWV 172

Query: 56  --GPFRNLSVKSFEGNEL 71
                  L   +  GN++
Sbjct: 173 LSDGCGELKHLAISGNKI 190

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 50.7 bits (122), Expect = 4e-07
 Identities = 12/77 (15%), Positives = 20/77 (25%), Gaps = 3/77 (3%)

Query: 2   GSIPDSIGDLINLKSLNLSNN--NLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPF 58
           G     I +    K  + + N     G     L +L      N++     G         
Sbjct: 572 GKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNN 631

Query: 59  RNLSVKSFEGNELLCEI 75
            ++       N L   I
Sbjct: 632 GSMMFLDMSYNMLSGYI 648

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 46.4 bits (111), Expect = 1e-05
 Identities = 9/92 (9%), Positives = 31/92 (33%), Gaps = 7/92 (7%)

Query: 2   GSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFN--KLEGEIPRE-GPF 58
           G+IP ++       S  ++ N ++G   + ++     K+ + + N  + +G    +    
Sbjct: 552 GTIPAAMFKQ----SGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRL 607

Query: 59  RNLSVKSFEGNELLCEIVLPLSTIFMIVMILL 90
              +  +                   ++ + +
Sbjct: 608 STRNPCNITSRVYGGHTSPTFDNNGSMMFLDM 639

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 44.5 bits (106), Expect = 4e-05
 Identities = 13/62 (20%), Positives = 27/62 (43%), Gaps = 3/62 (4%)

Query: 13  NLKSLNLSNNNLS---GTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGN 69
            + S++LS+  L+     +  SL  L  L+ + +S + + G +       +L+      N
Sbjct: 51  KVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRN 110

Query: 70  EL 71
            L
Sbjct: 111 SL 112

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  104 bits (262), Expect = 8e-26
 Identities = 52/216 (24%), Positives = 83/216 (38%), Gaps = 55/216 (25%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKV-----FDPQYEGAFKSFDIECDVMKRICHRNLIKI 164
           IGKG F  V + I  + G + AVK+     F      + +    E  +   + H +++++
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91

Query: 165 ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL----------------DIMID 208
           + +YS+D    +V E+M    L                +                  M  
Sbjct: 92  LETYSSDGMLYMVFEFMDGADL-------------CFEIVKRADAGFVYSEAVASHYMRQ 138

Query: 209 VASALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
           +  AL Y H      IIH D+KP  VLL   +++    L  FG+A  L E          
Sbjct: 139 ILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVA--GGR 193

Query: 266 LATIGYMAPE------YGREGRVSTNGDVYSFGIML 295
           + T  +MAPE      YG+        DV+  G++L
Sbjct: 194 VGTPHFMAPEVVKREPYGKP------VDVWGCGVIL 223

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  103 bits (258), Expect = 1e-25
 Identities = 50/201 (24%), Positives = 85/201 (42%), Gaps = 22/201 (10%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGA-FKSFDIECDVMKRIC-HRNLIKIISS 167
           +G+G +G V K   +  G  +AVK           K   ++ D+  R       +    +
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74

Query: 168 YSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLD------IMIDVASALEYLHFGYS 221
              +    + +E M   SL+K       ++D  Q +       I + +  ALE+LH   S
Sbjct: 75  LFREGDVWICMELMD-TSLDK---FYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS 130

Query: 222 APIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE----YG 277
             +IH D+KPSNVL++      + DFG++  L      + +        YMAPE      
Sbjct: 131 --VIHRDVKPSNVLINALGQVKMCDFGISGYL---VDDVAKDIDAGCKPYMAPERINPEL 185

Query: 278 REGRVSTNGDVYSFGIMLMEI 298
            +   S   D++S GI ++E+
Sbjct: 186 NQKGYSVKSDIWSLGITMIEL 206

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  104 bits (261), Expect = 2e-25
 Identities = 43/209 (20%), Positives = 83/209 (39%), Gaps = 20/209 (9%)

Query: 111 IGKG--GFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDI--ECDVMKRICHRNLIKII 165
           IGKG     +V  A     G  V V+  + +         +  E  V K   H N++   
Sbjct: 33  IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYR 92

Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMI---DVASALEYLHFGYSA 222
           +++  D+   +V  +M +GS +  +    + +D    L I      V  AL+Y+H     
Sbjct: 93  ATFIADNELWVVTSFMAYGSAKDLI--CTHFMDGMNELAIAYILQGVLKALDYIH---HM 147

Query: 223 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED--QSLTQTQTLATIG---YMAPEYG 277
             +H  +K S++L+  +   +LS       ++     Q +       ++    +++PE  
Sbjct: 148 GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVL 207

Query: 278 REGRVSTNG--DVYSFGIMLMEIFTRTKP 304
           ++     +   D+YS GI   E+     P
Sbjct: 208 QQNLQGYDAKSDIYSVGITACELANGHVP 236

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  103 bits (259), Expect = 3e-25
 Identities = 64/220 (29%), Positives = 96/220 (43%), Gaps = 61/220 (27%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFD--------PQYEGAFKSFDIECDVMKRIC-HRN 160
           IG+G    V + +    G E AVK+ +         Q E   ++   E  +++++  H +
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161

Query: 161 LIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL------------DIMID 208
           +I +I SY +  F  LV + M  G L             F  L             IM  
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGEL-------------FDYLTEKVALSEKETRSIMRS 208

Query: 209 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA- 267
           +  A+ +LH   +  I+H DLKP N+LLDDNM   LSDFG +   LE  + L     L  
Sbjct: 209 LLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSC-HLEPGEKLR---ELCG 261

Query: 268 TIGYMAPE------------YGREGRVSTNGDVYSFGIML 295
           T GY+APE            YG+E       D+++ G++L
Sbjct: 262 TPGYLAPEILKCSMDETHPGYGKE------VDLWACGVIL 295

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  102 bits (256), Expect = 4e-25
 Identities = 50/201 (24%), Positives = 84/201 (41%), Gaps = 16/201 (7%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFD-PQYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
           IG G    V  A       +VA+K  +  + + +      E   M +  H N++   +S+
Sbjct: 23  IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82

Query: 169 SNDDFKALVLEYMPHGSL-------EKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYS 221
              D   LV++ +  GS+              + +LD      I+ +V   LEYLH    
Sbjct: 83  VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---K 139

Query: 222 APIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG---YMAPEYGR 278
              IH D+K  N+LL ++    ++DFG++  L               +G   +MAPE   
Sbjct: 140 NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVME 199

Query: 279 EGRV-STNGDVYSFGIMLMEI 298
           + R      D++SFGI  +E+
Sbjct: 200 QVRGYDFKADIWSFGITAIEL 220

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  102 bits (256), Expect = 5e-25
 Identities = 51/210 (24%), Positives = 82/210 (39%), Gaps = 54/210 (25%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRIC-HRNLIKIISSY 168
           IG G +    + I     ME AVK+ D       +    E +++ R   H N+I +   Y
Sbjct: 30  IGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE----EIEILLRYGQHPNIITLKDVY 85

Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL------------DIMIDVASALEYL 216
            +  +  +V E M  G L               ++             ++  +   +EYL
Sbjct: 86  DDGKYVYVVTELMKGGEL-------------LDKILRQKFFSEREASAVLFTITKTVEYL 132

Query: 217 HFGYSAPIIHCDLKPSNVLL----DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA-TIGY 271
           H   +  ++H DLKPSN+L      +     + DFG AK L  E+  L    T   T  +
Sbjct: 133 H---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLM---TPCYTANF 186

Query: 272 MAPE------YGREGRVSTNGDVYSFGIML 295
           +APE      Y          D++S G++L
Sbjct: 187 VAPEVLERQGYDAA--C----DIWSLGVLL 210

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  101 bits (253), Expect = 6e-25
 Identities = 58/237 (24%), Positives = 103/237 (43%), Gaps = 42/237 (17%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFDP---QYEGAFKSFDIECDVMKRICHRNLIKII 165
           L+GKG F  VY+A  I  G+EVA+K+ D       G  +    E  +  ++ H +++++ 
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77

Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLD------IMIDVASALEYLHFG 219
           + + + ++  LVLE   +G + +      Y+ +  +          M  + + + YLH  
Sbjct: 78  NYFEDSNYVYLVLEMCHNGEMNR------YLKNRVKPFSENEARHFMHQIITGMLYLH-- 129

Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE---- 275
            S  I+H DL  SN+LL  NM   ++DFG+A   L+       T    T  Y++PE    
Sbjct: 130 -SHGILHRDLTLSNLLLTRNMNIKIADFGLAT-QLKMPHEKHYT-LCGTPNYISPEIATR 186

Query: 276 --YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDE---------IFSGEMTLKRWVND 321
             +G E       DV+S G M   +     P D          +   +  +  +++ 
Sbjct: 187 SAHGLE------SDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSI 237

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  102 bits (256), Expect = 6e-25
 Identities = 55/198 (27%), Positives = 85/198 (42%), Gaps = 23/198 (11%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFD---PQYEGAFKSFDIECDVMKRICHRNLIKIIS 166
           IG G FG+VY A  +++   VA+K       Q    ++    E   ++++ H N I+   
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121

Query: 167 SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIH 226
            Y  +    LV+EY   GS    L +    L   +   +       L YLH   S  +IH
Sbjct: 122 CYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIH 177

Query: 227 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG---YMAPE---YGREG 280
            D+K  N+LL +  +  L DFG A         +    +   +G   +MAPE      EG
Sbjct: 178 RDVKAGNILLSEPGLVKLGDFGSA-------SIMAPANSF--VGTPYWMAPEVILAMDEG 228

Query: 281 RVSTNGDVYSFGIMLMEI 298
           +     DV+S GI  +E+
Sbjct: 229 QYDGKVDVWSLGITCIEL 246

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  101 bits (254), Expect = 7e-25
 Identities = 50/208 (24%), Positives = 85/208 (40%), Gaps = 50/208 (24%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRIC-HRNLIKIISSY 168
           +G+G F    K +  +     AVK+   + E   +    E   +K    H N++K+   +
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHEVF 75

Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL------------DIMIDVASALEYL 216
            +     LV+E +  G L             F+R+             IM  + SA+ ++
Sbjct: 76  HDQLHTFLVMELLNGGEL-------------FERIKKKKHFSETEASYIMRKLVSAVSHM 122

Query: 217 HFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
           H      ++H DLKP N+L    +DN+   + DFG A+    ++Q L       T+ Y A
Sbjct: 123 H---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL--KTPCFTLHYAA 177

Query: 274 PE------YGREGRVSTNGDVYSFGIML 295
           PE      Y          D++S G++L
Sbjct: 178 PELLNQNGYDES------CDLWSLGVIL 199

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  101 bits (253), Expect = 9e-25
 Identities = 47/196 (23%), Positives = 82/196 (41%), Gaps = 14/196 (7%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQY-EGAFKSFDIECDVMKRIC-HRNLIKIISS 167
           +G G  G V+K    + G  +AVK       +   K   ++ DV+ +      +++   +
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92

Query: 168 YSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHC 227
           +  +    + +E M     EK        +       + + +  AL YL   +   +IH 
Sbjct: 93  FITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG--VIHR 149

Query: 228 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE-----YGREGRV 282
           D+KPSN+LLD+     L DFG++  L        + ++     YMAPE        +   
Sbjct: 150 DVKPSNILLDERGQIKLCDFGISGRL---VDDKAKDRSAGCAAYMAPERIDPPDPTKPDY 206

Query: 283 STNGDVYSFGIMLMEI 298
               DV+S GI L+E+
Sbjct: 207 DIRADVWSLGISLVEL 222

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  101 bits (254), Expect = 1e-24
 Identities = 53/252 (21%), Positives = 89/252 (35%), Gaps = 35/252 (13%)

Query: 93  RYQKRGKPLPNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFD---------------- 136
           +Y K      ND  +   + +G F  +     +D    A+K ++                
Sbjct: 21  KYVKEKDKYINDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNND 79

Query: 137 -PQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNY 195
               +  +  F  E  ++  I +   +      +N D   ++ EYM + S+ K      +
Sbjct: 80  KISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFD-EYFF 138

Query: 196 ILDIFQRLDIMIDVA--------SALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDF 247
           +LD      I I V         ++  Y+H      I H D+KPSN+L+D N    LSDF
Sbjct: 139 VLDKNYTCFIPIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDF 196

Query: 248 GMAKPLLEEDQSLTQTQTLATIGYMAPE--YGREGRVSTNGDVYSFGIMLMEIFTRTKPT 305
           G ++          +  +  T  +M PE             D++S GI L  +F    P 
Sbjct: 197 GESE---YMVDKKIKG-SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF 252

Query: 306 DEIFSGEMTLKR 317
               S       
Sbjct: 253 SLKISLVELFNN 264

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  100 bits (251), Expect = 2e-24
 Identities = 53/205 (25%), Positives = 88/205 (42%), Gaps = 26/205 (12%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRIC-HRNLIKIISSY 168
           +G G +G VYK   ++ G   A+KV D       +    E +++K+   HRN+     ++
Sbjct: 32  VGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAF 90

Query: 169 SNDDFKA------LVLEYMPHGSLEKCL-YLSNYILDIFQRLDIMIDVASALEYLHFGYS 221
              +         LV+E+   GS+   +       L       I  ++   L +LH    
Sbjct: 91  IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---Q 147

Query: 222 APIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG---YMAPEYGR 278
             +IH D+K  NVLL +N    L DFG++  L   D+++ +  T   IG   +MAPE   
Sbjct: 148 HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTF--IGTPYWMAPEVIA 202

Query: 279 EGRVSTNG-----DVYSFGIMLMEI 298
                        D++S GI  +E+
Sbjct: 203 CDENPDATYDFKSDLWSLGITAIEM 227

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  101 bits (253), Expect = 2e-24
 Identities = 45/209 (21%), Positives = 87/209 (41%), Gaps = 49/209 (23%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFD--PQYEGAFKSFDIECDVMKRICHRNLIKIISS 167
           +GKG F  V + +    G+E A K+ +        F+  + E  + +++ H N++++  S
Sbjct: 37  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96

Query: 168 YSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL------------DIMIDVASALEY 215
              + F  LV + +  G L             F+ +              +  +  ++ Y
Sbjct: 97  IQEESFHYLVFDLVTGGEL-------------FEDIVAREFYSEADASHCIQQILESIAY 143

Query: 216 LHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYM 272
            H   S  I+H +LKP N+LL          L+DFG+A   + + ++        T GY+
Sbjct: 144 CH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI-EVNDSEAW--HGFAGTPGYL 197

Query: 273 APE------YGREGRVSTNGDVYSFGIML 295
           +PE      Y +        D+++ G++L
Sbjct: 198 SPEVLKKDPYSKP------VDIWACGVIL 220

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  100 bits (251), Expect = 2e-24
 Identities = 48/242 (19%), Positives = 89/242 (36%), Gaps = 53/242 (21%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFD------PQYEGAFKSFDIECDVMKRICHRNLI 162
            +GKGGF   ++          A K+        P           E  + + + H++++
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM---EISIHRSLAHQHVV 104

Query: 163 KIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLD------IMIDVASALEYL 216
                + ++DF  +VLE     SL +            + L        +  +    +YL
Sbjct: 105 GFHGFFEDNDFVFVVLELCRRRSLLE--LHKRR-----KALTEPEARYYLRQIVLGCQYL 157

Query: 217 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ--TLATIGYMAP 274
           H      +IH DLK  N+ L++++   + DFG+A   +E D    +    T     Y+AP
Sbjct: 158 H---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLAT-KVEYDGERKKVLCGTPN---YIAP 210

Query: 275 E------YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDE---------IFSGEMTLKRWV 319
           E      +  E       DV+S G ++  +     P +          I   E ++ + +
Sbjct: 211 EVLSKKGHSFE------VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHI 264

Query: 320 ND 321
           N 
Sbjct: 265 NP 266

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 99.7 bits (249), Expect = 4e-24
 Identities = 54/213 (25%), Positives = 87/213 (40%), Gaps = 43/213 (20%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRIC-HRNLIKIISS 167
           ++G+G    V   I +    E AVK+ + Q          E +++ +   HRN++++I  
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79

Query: 168 YSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL------------DIMIDVASALEY 215
           +  +D   LV E M  GS+                +             ++ DVASAL++
Sbjct: 80  FEEEDRFYLVFEKMRGGSI-------------LSHIHKRRHFNELEASVVVQDVASALDF 126

Query: 216 LHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPL-LEEDQSLTQTQTLATI-- 269
           LH   +  I H DLKP N+L    +      + DF +   + L  D S   T  L T   
Sbjct: 127 LH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCG 183

Query: 270 --GYMAPEYGREGRVSTNG-----DVYSFGIML 295
              YMAPE         +      D++S G++L
Sbjct: 184 SAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  101 bits (253), Expect = 5e-24
 Identities = 44/210 (20%), Positives = 85/210 (40%), Gaps = 50/210 (23%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFD--PQYEGAFKSFDIECDVMKRICHRNLIKIISS 167
           +GKG F  V + + +  G E A  + +         +  + E  + + + H N++++  S
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78

Query: 168 YSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL------------DIMIDVASALEY 215
            S +    L+ + +  G L             F+ +              +  +  A+ +
Sbjct: 79  ISEEGHHYLIFDLVTGGEL-------------FEDIVAREYYSEADASHCIQQILEAVLH 125

Query: 216 LHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA-TIGY 271
            H      ++H +LKP N+LL          L+DFG+A  +  E Q+       A T GY
Sbjct: 126 CH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF---GFAGTPGY 179

Query: 272 MAPE------YGREGRVSTNGDVYSFGIML 295
           ++PE      YG+        D+++ G++L
Sbjct: 180 LSPEVLRKDPYGKP------VDLWACGVIL 203

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 98.8 bits (247), Expect = 5e-24
 Identities = 45/209 (21%), Positives = 87/209 (41%), Gaps = 49/209 (23%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFD--PQYEGAFKSFDIECDVMKRICHRNLIKIISS 167
           +GKG F  V + +    G+E A K+ +        F+  + E  + +++ H N++++  S
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73

Query: 168 YSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL------------DIMIDVASALEY 215
              + F  LV + +  G L             F+ +              +  +  ++ Y
Sbjct: 74  IQEESFHYLVFDLVTGGEL-------------FEDIVAREFYSEADASHCIQQILESIAY 120

Query: 216 LHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYM 272
            H   S  I+H +LKP N+LL          L+DFG+A   + + ++        T GY+
Sbjct: 121 CH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI-EVNDSEAW--HGFAGTPGYL 174

Query: 273 APE------YGREGRVSTNGDVYSFGIML 295
           +PE      Y +        D+++ G++L
Sbjct: 175 SPEVLKKDPYSKP------VDIWACGVIL 197

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 99.6 bits (248), Expect = 5e-24
 Identities = 53/269 (19%), Positives = 96/269 (35%), Gaps = 74/269 (27%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFD-PQYEGAFKSFDIECDVMKRICHRNLIKIISS 167
            +G+GGFG V++A    D    A+K    P  E A +    E   + ++ H  +++  ++
Sbjct: 13  CMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 72

Query: 168 YSNDDFKALVLE-----------------------------------------YMPHGSL 186
           +     +    E                                          +   S 
Sbjct: 73  WLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSP 132

Query: 187 EKCLY----------LSNYI--------LDIFQRLDIMIDVASALEYLHFGYSAPIIHCD 228
           +  LY          L +++         +    L I I +A A+E+LH   S  ++H D
Sbjct: 133 KVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH---SKGLMHRD 189

Query: 229 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA----------TIGYMAPEYGR 278
           LKPSN+    + V  + DFG+   + ++++  T    +           T  YM+PE   
Sbjct: 190 LKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIH 249

Query: 279 EGRVSTNGDVYSFGIMLMEIFTRTKPTDE 307
               S   D++S G++L E+        E
Sbjct: 250 GNNYSHKVDIFSLGLILFELLYSFSTQME 278

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  100 bits (252), Expect = 5e-24
 Identities = 55/218 (25%), Positives = 94/218 (43%), Gaps = 59/218 (27%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFD--------PQYEGAFKSFDIECDVMKRICHRNL 161
           +G G  G V  A   +   +VA+++           +      + + E +++K++ H  +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202

Query: 162 IKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL------------DIMIDV 209
           IKI + +  +D+  +VLE M  G L             F ++                 +
Sbjct: 203 IKIKNFFDAEDY-YIVLELMEGGEL-------------FDKVVGNKRLKEATCKLYFYQM 248

Query: 210 ASALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLEEDQSLTQTQTL 266
             A++YLH      IIH DLKP NVLL   +++ +  ++DFG +K  +  + SL +T   
Sbjct: 249 LLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGETSLMRT-LC 302

Query: 267 ATIGYMAPE---------YGREGRVSTNGDVYSFGIML 295
            T  Y+APE         Y R   V    D +S G++L
Sbjct: 303 GTPTYLAPEVLVSVGTAGYNRA--V----DCWSLGVIL 334

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 98.4 bits (246), Expect = 6e-24
 Identities = 57/249 (22%), Positives = 98/249 (39%), Gaps = 45/249 (18%)

Query: 96  KRGKPLPNDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQY---EGAFKSFDIECD 151
           K+ +    D  +   +GKG FG+VY A   Q    +A+KV         G       E +
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61

Query: 152 VMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLD------I 205
           +   + H N++++   + +     L+LEY P G++ +   L         + D       
Sbjct: 62  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYR--ELQKL-----SKFDEQRTATY 114

Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
           + ++A+AL Y H   S  +IH D+KP N+LL       ++DFG +        S      
Sbjct: 115 ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHA---PSSRRTD-L 167

Query: 266 LATIGYMAPE------YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDE---------IFS 310
             T+ Y+ PE      +  +       D++S G++  E      P +          I  
Sbjct: 168 CGTLDYLPPEMIEGRMHDEK------VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR 221

Query: 311 GEMTLKRWV 319
            E T   +V
Sbjct: 222 VEFTFPDFV 230

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 98.4 bits (246), Expect = 7e-24
 Identities = 44/207 (21%), Positives = 79/207 (38%), Gaps = 44/207 (21%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFD------PQYEGAFKSFDIECDVMKRICHRNLI 162
            +GKGGF   ++          A K+        P           E  + + + H++++
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM---EISIHRSLAHQHVV 78

Query: 163 KIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLD------IMIDVASALEYL 216
                + ++DF  +VLE     SL +            + L        +  +    +YL
Sbjct: 79  GFHGFFEDNDFVFVVLELCRRRSLLE--LHKRR-----KALTEPEARYYLRQIVLGCQYL 131

Query: 217 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ--TLATIGYMAP 274
           H      +IH DLK  N+ L++++   + DFG+A   +E D    +    T     Y+AP
Sbjct: 132 H---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLAT-KVEYDGERKKVLCGTPN---YIAP 184

Query: 275 E------YGREGRVSTNGDVYSFGIML 295
           E      +  E       DV+S G ++
Sbjct: 185 EVLSKKGHSFE------VDVWSIGCIM 205

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 98.5 bits (246), Expect = 1e-23
 Identities = 57/219 (26%), Positives = 94/219 (42%), Gaps = 61/219 (27%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFD--------PQYEGAFKSFDIECDVMKRICHRNL 161
           +G G  G V  A   +   +VA+K+           +      + + E +++K++ H  +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77

Query: 162 IKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL------------DIMIDV 209
           IKI + +  +D+  +VLE M  G L             F ++                 +
Sbjct: 78  IKIKNFFDAEDY-YIVLELMEGGEL-------------FDKVVGNKRLKEATCKLYFYQM 123

Query: 210 ASALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLEEDQSLTQTQTL 266
             A++YLH      IIH DLKP NVLL   +++ +  ++DFG +K +L E   +    TL
Sbjct: 124 LLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK-ILGETSLMR---TL 176

Query: 267 A-TIGYMAPE---------YGREGRVSTNGDVYSFGIML 295
             T  Y+APE         Y R   V    D +S G++L
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRA--V----DCWSLGVIL 209

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 99.0 bits (247), Expect = 2e-23
 Identities = 43/201 (21%), Positives = 82/201 (40%), Gaps = 35/201 (17%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYS 169
           +G G FG V++ +    G     K  +  Y     +   E  +M ++ H  LI +  ++ 
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118

Query: 170 NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL-------------DIMIDVASALEYL 216
           +     L+LE++  G             ++F R+             + M      L+++
Sbjct: 119 DKYEMVLILEFLSGG-------------ELFDRIAAEDYKMSEAEVINYMRQACEGLKHM 165

Query: 217 HFGYSAPIIHCDLKPSNVLLDDNMVAHL--SDFGMAKPLLEEDQSLTQTQTLATIGYMAP 274
           H      I+H D+KP N++ +    + +   DFG+A   L  D+ +    T AT  + AP
Sbjct: 166 H---EHSIVHLDIKPENIMCETKKASSVKIIDFGLAT-KLNPDEIV--KVTTATAEFAAP 219

Query: 275 EYGREGRVSTNGDVYSFGIML 295
           E      V    D+++ G++ 
Sbjct: 220 EIVDREPVGFYTDMWAIGVLG 240

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 96.9 bits (242), Expect = 2e-23
 Identities = 50/208 (24%), Positives = 85/208 (40%), Gaps = 48/208 (23%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFD-PQYEGA-FKSFDIECDVMKRICHRNLIKIISS 167
           +GKG FG V K        E AVKV +    +     +   E +++K++ H N++K+   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89

Query: 168 YSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL------------DIMIDVASALEY 215
             +     +V E    G L             F  +             I+  V S + Y
Sbjct: 90  LEDSSSFYIVGELYTGGEL-------------FDEIIKRKRFSEHDAARIIKQVFSGITY 136

Query: 216 LHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYM 272
           +H      I+H DLKP N+LL   + +    + DFG++    +++  +     + T  Y+
Sbjct: 137 MH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLST-CFQQNTKM--KDRIGTAYYI 190

Query: 273 APE-----YGREGRVSTNGDVYSFGIML 295
           APE     Y  +       DV+S G++L
Sbjct: 191 APEVLRGTYDEK------CDVWSAGVIL 212

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 99.8 bits (249), Expect = 2e-23
 Identities = 53/227 (23%), Positives = 89/227 (39%), Gaps = 53/227 (23%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDI--ECDVMKRICHRNLIKIISS 167
           +G G +G V         +E A+K+          +  +  E  V+K + H N++K+   
Sbjct: 45  LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104

Query: 168 YSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL------------DIMIDVASALEY 215
           + +     LV+E    G L             F  +             I+  V S + Y
Sbjct: 105 FEDKRNYYLVMECYKGGEL-------------FDEIIHRMKFNEVDAAVIIKQVLSGVTY 151

Query: 216 LHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYM 272
           LH      I+H DLKP N+LL   + + +  + DFG++  + E  + +   + L T  Y+
Sbjct: 152 LH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSA-VFENQKKM--KERLGTAYYI 205

Query: 273 APE-----YGREGRVSTNGDVYSFGIMLMEIFTRTKP-----TDEIF 309
           APE     Y  +       DV+S G++L  +     P       EI 
Sbjct: 206 APEVLRKKYDEK------CDVWSIGVILFILLAGYPPFGGQTDQEIL 246

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 97.8 bits (244), Expect = 3e-23
 Identities = 56/214 (26%), Positives = 86/214 (40%), Gaps = 61/214 (28%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDI-----ECDVMKRICHRNLIK 163
            +G+G    VY+          A+KV         K+ D      E  V+ R+ H N+IK
Sbjct: 60  ELGRGATSIVYRCKQKGTQKPYALKVLK-------KTVDKKIVRTEIGVLLRLSHPNIIK 112

Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL------------DIMIDVAS 211
           +   +      +LVLE +  G L             F R+            D +  +  
Sbjct: 113 LKEIFETPTEISLVLELVTGGEL-------------FDRIVEKGYYSERDAADAVKQILE 159

Query: 212 ALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA- 267
           A+ YLH      I+H DLKP N+L      +    ++DFG++K ++E    +    T+  
Sbjct: 160 AVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSK-IVEHQVLMK---TVCG 212

Query: 268 TIGYMAPE------YGREGRVSTNGDVYSFGIML 295
           T GY APE      YG E       D++S GI+ 
Sbjct: 213 TPGYCAPEILRGCAYGPE------VDMWSVGIIT 240

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 96.8 bits (241), Expect = 6e-23
 Identities = 52/236 (22%), Positives = 83/236 (35%), Gaps = 54/236 (22%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDI-----ECDVMKRICHRNLIKI 164
           IG+G +G V  AI  Q     A+K+ +          D+     E  +MK++ H N+ ++
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93

Query: 165 ISSYSNDDFKALVLEYMPHGSL-----EKCLYLSNYILDIFQRL---------------- 203
              Y ++ +  LV+E    G L           +        +                 
Sbjct: 94  YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153

Query: 204 ------------------DIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHL- 244
                             +IM  + SAL YLH   +  I H D+KP N L   N    + 
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIK 210

Query: 245 -SDFGMAK--PLLEEDQSLTQTQTLATIGYMAPE--YGREGRVSTNGDVYSFGIML 295
             DFG++K    L   +    T    T  ++APE             D +S G++L
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 98.2 bits (245), Expect = 7e-23
 Identities = 51/208 (24%), Positives = 85/208 (40%), Gaps = 48/208 (23%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDI--ECDVMKRICHRNLIKIISS 167
           +GKG FG V K        E AVKV +        +  I  E +++K++ H N++K+   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89

Query: 168 YSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL------------DIMIDVASALEY 215
             +     +V E    G L             F  +             I+  V S + Y
Sbjct: 90  LEDSSSFYIVGELYTGGEL-------------FDEIIKRKRFSEHDAARIIKQVFSGITY 136

Query: 216 LHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYM 272
           +H      I+H DLKP N+LL   + +    + DFG++    +++  +     + T  Y+
Sbjct: 137 MH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLST-CFQQNTKM--KDRIGTAYYI 190

Query: 273 APE-----YGREGRVSTNGDVYSFGIML 295
           APE     Y  +       DV+S G++L
Sbjct: 191 APEVLRGTYDEK------CDVWSAGVIL 212

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 98.2 bits (245), Expect = 7e-23
 Identities = 53/209 (25%), Positives = 85/209 (40%), Gaps = 49/209 (23%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFD---PQYEGAFKSFDIECDVMKRICHRNLIKIIS 166
           +GKG FG V        G E AVKV      + +   +S   E  ++K++ H N++K+  
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93

Query: 167 SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL------------DIMIDVASALE 214
            + +  +  LV E    G L             F  +             I+  V S + 
Sbjct: 94  FFEDKGYFYLVGEVYTGGEL-------------FDEIISRKRFSEVDAARIIRQVLSGIT 140

Query: 215 YLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGY 271
           Y+H      I+H DLKP N+LL     +    + DFG++    E  + +     + T  Y
Sbjct: 141 YMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLST-HFEASKKM--KDKIGTAYY 194

Query: 272 MAPE-----YGREGRVSTNGDVYSFGIML 295
           +APE     Y  +       DV+S G++L
Sbjct: 195 IAPEVLHGTYDEK------CDVWSTGVIL 217

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 95.0 bits (237), Expect = 1e-22
 Identities = 56/243 (23%), Positives = 99/243 (40%), Gaps = 49/243 (20%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKII 165
            +GKG FG+VY A   Q+   +A+KV        EG       E ++   + H N++++ 
Sbjct: 21  PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80

Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLD------IMIDVASALEYLHFG 219
           + + +     L+LE+ P G L K   L  +      R D       M ++A AL Y H  
Sbjct: 81  NYFHDRKRIYLMLEFAPRGELYK--ELQKH-----GRFDEQRSATFMEELADALHYCH-- 131

Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE---- 275
               +IH D+KP N+L+       ++DFG +           +T    T+ Y+ PE    
Sbjct: 132 -ERKVIHRDIKPENLLMGYKGELKIADFGWSV---HAPSLRRRT-MCGTLDYLPPEMIEG 186

Query: 276 --YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDE---------IFSGEMTLKRWVN---- 320
             +  +       D++  G++  E      P D          I + ++    +++    
Sbjct: 187 KTHDEK------VDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSK 240

Query: 321 DLL 323
           DL+
Sbjct: 241 DLI 243

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 97.5 bits (243), Expect = 1e-22
 Identities = 51/219 (23%), Positives = 86/219 (39%), Gaps = 59/219 (26%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKV-------------FDPQYEGAFKSFDIECDVMKRI 156
           +G G +G V          E A+KV              +   E   +    E  ++K +
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103

Query: 157 CHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL------------D 204
            H N+IK+   + +  +  LV E+   G L             F+++            +
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGEL-------------FEQIINRHKFDECDAAN 150

Query: 205 IMIDVASALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLEEDQSLT 261
           IM  + S + YLH      I+H D+KP N+LL   +  +   + DFG++     +D  L 
Sbjct: 151 IMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSS-FFSKDYKL- 205

Query: 262 QTQTLATIGYMAPE-----YGREGRVSTNGDVYSFGIML 295
               L T  Y+APE     Y  +       DV+S G+++
Sbjct: 206 -RDRLGTAYYIAPEVLKKKYNEK------CDVWSCGVIM 237

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 94.6 bits (236), Expect = 1e-22
 Identities = 52/206 (25%), Positives = 84/206 (40%), Gaps = 46/206 (22%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYS 169
           IG+G +G V  A+     +  A K     +      F  E ++MK + H N+I++  ++ 
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76

Query: 170 NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL------------DIMIDVASALEYLH 217
           ++    LV+E    G L             F+R+             IM DV SA+ Y H
Sbjct: 77  DNTDIYLVMELCTGGEL-------------FERVVHKRVFRESDAARIMKDVLSAVAYCH 123

Query: 218 FGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 274
                 + H DLKP N L      +    L DFG+A    +  + +     + T  Y++P
Sbjct: 124 ---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA-RFKPGKMM--RTKVGTPYYVSP 177

Query: 275 E-----YGREGRVSTNGDVYSFGIML 295
           +     YG E       D +S G+M+
Sbjct: 178 QVLEGLYGPE------CDEWSAGVMM 197

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 94.6 bits (236), Expect = 3e-22
 Identities = 47/208 (22%), Positives = 76/208 (36%), Gaps = 42/208 (20%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFD-PQYEGAFKSFDI-----ECDVMKRICHRNLIK 163
           +G G F  V K      G+E A K     Q   + +         E  +++++ H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79

Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL------------DIMIDVAS 211
           +   Y N     L+LE +  G L             F  L              +  +  
Sbjct: 80  LHDVYENRTDVVLILELVSGGEL-------------FDFLAQKESLSEEEATSFIKQILD 126

Query: 212 ALEYLHFGYSAPIIHCDLKPSNVLL----DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA 267
            + YLH   +  I H DLKP N++L           L DFG+A   +E+           
Sbjct: 127 GVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVEF--KNIFG 180

Query: 268 TIGYMAPEYGREGRVSTNGDVYSFGIML 295
           T  ++APE      +    D++S G++ 
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 94.7 bits (236), Expect = 4e-22
 Identities = 47/208 (22%), Positives = 76/208 (36%), Gaps = 42/208 (20%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFD-PQYEGAFKSFDI-----ECDVMKRICHRNLIK 163
           +G G F  V K      G+E A K     Q   + +         E  +++++ H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79

Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL------------DIMIDVAS 211
           +   Y N     L+LE +  G L             F  L              +  +  
Sbjct: 80  LHDVYENRTDVVLILELVSGGEL-------------FDFLAQKESLSEEEATSFIKQILD 126

Query: 212 ALEYLHFGYSAPIIHCDLKPSNVLL----DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA 267
            + YLH   +  I H DLKP N++L           L DFG+A   +E+           
Sbjct: 127 GVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVEF--KNIFG 180

Query: 268 TIGYMAPEYGREGRVSTNGDVYSFGIML 295
           T  ++APE      +    D++S G++ 
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 93.5 bits (233), Expect = 4e-22
 Identities = 57/224 (25%), Positives = 93/224 (41%), Gaps = 51/224 (22%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFD--------------------PQYEGAFKSFDI 148
            IGKG +G V  A    D    A+KV                      P   G  +    
Sbjct: 20  EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79

Query: 149 ------ECDVMKRICHRNLIKIIS--SYSNDDFKALVLEYMPHGSLEKCLYLSNYILD-- 198
                 E  ++K++ H N++K++      N+D   +V E +  G + +    +   L   
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME--VPTLKPLSED 137

Query: 199 ----IFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL 254
                FQ      D+   +EYLH      IIH D+KPSN+L+ ++    ++DFG++    
Sbjct: 138 QARFYFQ------DLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSN-EF 187

Query: 255 EEDQSLTQTQTLATIGYMAPEYGREGRVSTNG---DVYSFGIML 295
           +   +L    T+ T  +MAPE   E R   +G   DV++ G+ L
Sbjct: 188 KGSDALLSN-TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 93.4 bits (233), Expect = 5e-22
 Identities = 49/208 (23%), Positives = 77/208 (37%), Gaps = 42/208 (20%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFD-PQYEGAFKSFDI-----ECDVMKRICHRNLIK 163
           +G G F  V K      G E A K     +   + +         E ++++ I H N+I 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72

Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL------------DIMIDVAS 211
           +   + N     L+LE +  G L             F  L              +  +  
Sbjct: 73  LHDIFENKTDVVLILELVSGGEL-------------FDFLAEKESLTEDEATQFLKQILD 119

Query: 212 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAH----LSDFGMAKPLLEEDQSLTQTQTLA 267
            + YLH   S  I H DLKP N++L D  V +    L DFG+A   +E            
Sbjct: 120 GVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH-KIEAGNEF--KNIFG 173

Query: 268 TIGYMAPEYGREGRVSTNGDVYSFGIML 295
           T  ++APE      +    D++S G++ 
Sbjct: 174 TPEFVAPEIVNYEPLGLEADMWSIGVIT 201

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 93.5 bits (233), Expect = 5e-22
 Identities = 54/258 (20%), Positives = 94/258 (36%), Gaps = 53/258 (20%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFD----PQYEGAFKSFDIECDVMKRICHRNLIK- 163
           L+G+G +G V + +  +     AVK+       +      +   E  +++R+ H+N+I+ 
Sbjct: 12  LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71

Query: 164 --IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILD----------IFQRLDIMIDVAS 211
             ++ +        +V+EY   G  E    + + + +           F +L        
Sbjct: 72  VDVLYNEEKQKM-YMVMEYCVCGMQE----MLDSVPEKRFPVCQAHGYFCQL------ID 120

Query: 212 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATI-- 269
            LEYLH   S  I+H D+KP N+LL       +S  G+A    E         T  T   
Sbjct: 121 GLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVA----EALHPFAADDTCRTSQG 173

Query: 270 --GYMAPE--YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDE---------IFSGEMTLK 316
              +  PE   G +       D++S G+ L  I T   P +          I  G   + 
Sbjct: 174 SPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIP 233

Query: 317 RWVNDLLP--ISVMEVVD 332
                 L   +  M   +
Sbjct: 234 GDCGPPLSDLLKGMLEYE 251

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 93.9 bits (234), Expect = 5e-22
 Identities = 48/199 (24%), Positives = 83/199 (41%), Gaps = 26/199 (13%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDI--ECDVMKRICHR-NLIKIIS 166
           +G+G F  V + I    G E A K    +  G     +I  E  V++       +I +  
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96

Query: 167 SYSNDDFKALVLEYMPHGSL-EKCLYLSNYILDIFQRL------DIMIDVASALEYLHFG 219
            Y N     L+LEY   G +   C      + ++ + +       ++  +   + YLH  
Sbjct: 97  VYENTSEIILILEYAAGGEIFSLC------LPELAEMVSENDVIRLIKQILEGVYYLHQN 150

Query: 220 YSAPIIHCDLKPSNVLLDDNMVAH---LSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEY 276
               I+H DLKP N+LL          + DFGM++  +     L   + + T  Y+APE 
Sbjct: 151 N---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSR-KIGHACEL--REIMGTPEYLAPEI 204

Query: 277 GREGRVSTNGDVYSFGIML 295
                ++T  D+++ GI+ 
Sbjct: 205 LNYDPITTATDMWNIGIIA 223

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 93.6 bits (233), Expect = 7e-22
 Identities = 61/248 (24%), Positives = 96/248 (38%), Gaps = 43/248 (17%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFD--------PQYEGAFKSFDIECDVMKRICHRNL 161
           +G G FG V+ A+  +   EV VK              +       +E  ++ R+ H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 162 IKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILD-----------IFQRLDIMIDVA 210
           IK++  + N  F  LV+E    G L+    L  +I             IF++L       
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSG-LD----LFAFIDRHPRLDEPLASYIFRQL------V 140

Query: 211 SALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG 270
           SA+ YL       IIH D+K  N+++ ++    L DFG A  L  E   L  T    TI 
Sbjct: 141 SAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL--ERGKLFYT-FCGTIE 194

Query: 271 YMAPE-YGREGRVSTNGDVYSFGIMLMEIFTRTKP---TDEIFSGEMTLKRWVNDLLP-- 324
           Y APE            +++S G+ L  +     P    +E     +     V+  L   
Sbjct: 195 YCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSKELMSL 254

Query: 325 ISVMEVVD 332
           +S +    
Sbjct: 255 VSGLLQPV 262

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 93.6 bits (233), Expect = 1e-21
 Identities = 49/189 (25%), Positives = 90/189 (47%), Gaps = 11/189 (5%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYS 169
           +G G FG V+K      G+++A K+   +     +    E  VM ++ H NLI++  ++ 
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE 156

Query: 170 NDDFKALVLEYMPHGSL-EKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCD 228
           + +   LV+EY+  G L ++ +   +Y L     +  M  +   + ++H  Y   I+H D
Sbjct: 157 SKNDIVLVMEYVDGGELFDRIID-ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLD 212

Query: 229 LKPSNVLLDDNMVAHL--SDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNG 286
           LKP N+L  +     +   DFG+A+   +  + L       T  ++APE      VS   
Sbjct: 213 LKPENILCVNRDAKQIKIIDFGLAR-RYKPREKL--KVNFGTPEFLAPEVVNYDFVSFPT 269

Query: 287 DVYSFGIML 295
           D++S G++ 
Sbjct: 270 DMWSVGVIA 278

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 92.3 bits (230), Expect = 1e-21
 Identities = 52/204 (25%), Positives = 89/204 (43%), Gaps = 37/204 (18%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFD-PQYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
           +G G FG V+       G+E  +K  +  + +   +  + E +V+K + H N+IKI   +
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89

Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL---------DIMIDVASALEYLHFG 219
            +     +V+E    G  E    L   I+    R          ++M  + +AL Y H  
Sbjct: 90  EDYHNMYIVMETCEGG--E----LLERIVSAQARGKALSEGYVAELMKQMMNALAYFH-- 141

Query: 220 YSAPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE- 275
            S  ++H DLKP N+L      +    + DFG+A+ L + D+    T    T  YMAPE 
Sbjct: 142 -SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE-LFKSDEHS--TNAAGTALYMAPEV 197

Query: 276 ----YGREGRVSTNGDVYSFGIML 295
                  +       D++S G+++
Sbjct: 198 FKRDVTFK------CDIWSAGVVM 215

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 94.9 bits (236), Expect = 1e-21
 Identities = 45/201 (22%), Positives = 78/201 (38%), Gaps = 35/201 (17%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYS 169
           +G G FG V++      G   A K     +E   ++   E   M  + H  L+ +  ++ 
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224

Query: 170 NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL-------------DIMIDVASALEYL 216
           +D+   ++ E+M  G L             F+++             + M  V   L ++
Sbjct: 225 DDNEMVMIYEFMSGGEL-------------FEKVADEHNKMSEDEAVEYMRQVCKGLCHM 271

Query: 217 HFGYSAPIIHCDLKPSNVLLDDNMVAHL--SDFGMAKPLLEEDQSLTQTQTLATIGYMAP 274
           H       +H DLKP N++        L   DFG+    L+  QS+    T  T  + AP
Sbjct: 272 H---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA-HLDPKQSV--KVTTGTAEFAAP 325

Query: 275 EYGREGRVSTNGDVYSFGIML 295
           E      V    D++S G++ 
Sbjct: 326 EVAEGKPVGYYTDMWSVGVLS 346

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 92.7 bits (231), Expect = 1e-21
 Identities = 46/208 (22%), Positives = 77/208 (37%), Gaps = 42/208 (20%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFD-PQYEGAFKSFDI-----ECDVMKRICHRNLIK 163
           +G G F  V K      G++ A K     + + + +         E  ++K I H N+I 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78

Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL------------DIMIDVAS 211
           +   Y N     L+LE +  G L             F  L            + +  + +
Sbjct: 79  LHEVYENKTDVILILELVAGGEL-------------FDFLAEKESLTEEEATEFLKQILN 125

Query: 212 ALEYLHFGYSAPIIHCDLKPSNVLL----DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA 267
            + YLH   S  I H DLKP N++L           + DFG+A   ++            
Sbjct: 126 GVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGNEF--KNIFG 179

Query: 268 TIGYMAPEYGREGRVSTNGDVYSFGIML 295
           T  ++APE      +    D++S G++ 
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVIT 207

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 92.8 bits (231), Expect = 1e-21
 Identities = 50/217 (23%), Positives = 85/217 (39%), Gaps = 64/217 (29%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDI--ECDVMKRIC-HRNLIKII 165
           ++G G  G V +    + G + A+K+          S     E D   +     +++ I+
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLLY-------DSPKARQEVDHHWQASGGPHIVCIL 88

Query: 166 SSYSNDDFKA----LVLEYMPHGSLEKCLYLSNYILDIFQRL--------------DIMI 207
             Y N         +++E M  G L             F R+              +IM 
Sbjct: 89  DVYENMHHGKRCLLIIMECMEGGEL-------------FSRIQERGDQAFTEREAAEIMR 135

Query: 208 DVASALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLEEDQSLTQTQ 264
           D+ +A+++LH   S  I H D+KP N+L    + + V  L+DFG AK       +L    
Sbjct: 136 DIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET--TQNAL--QT 188

Query: 265 TLATIGYMAPE------YGREGRVSTNGDVYSFGIML 295
              T  Y+APE      Y +        D++S G+++
Sbjct: 189 PCYTPYYVAPEVLGPEKYDKS------CDMWSLGVIM 219

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 91.9 bits (229), Expect = 2e-21
 Identities = 57/214 (26%), Positives = 98/214 (45%), Gaps = 22/214 (10%)

Query: 95  QKRGKPLPNDANMPPLIGKGGFGSVYKA-IIQDGMEVAVKVFDPQYEGAFKSFD---IEC 150
            +  K  P D     ++G+G F +V  A  +    E A+K+ + ++            E 
Sbjct: 22  PQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRER 81

Query: 151 DVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDI----- 205
           DVM R+ H   +K+  ++ +D+     L Y  +G L K  Y+           D      
Sbjct: 82  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLK--YIRKI-----GSFDETCTRF 134

Query: 206 -MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ 264
              ++ SALEYLH      IIH DLKP N+LL+++M   ++DFG AK +L  +    +  
Sbjct: 135 YTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQARAN 190

Query: 265 TL-ATIGYMAPEYGREGRVSTNGDVYSFGIMLME 297
           +   T  Y++PE   E     + D+++ G ++ +
Sbjct: 191 SFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQ 224

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 90.6 bits (225), Expect = 4e-21
 Identities = 32/204 (15%), Positives = 62/204 (30%), Gaps = 43/204 (21%)

Query: 110 LIGKGGFGSVYKAIIQD---GMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIK 163
             G       ++A   D     +VA+   DPQ    +   +        + RI    + +
Sbjct: 38  FHGGVPPLQFWQA--LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
           ++          +V E++  GSL++   +++        +  M  +A+A +  H    A 
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSLQE---VADTSPSPVGAIRAMQSLAAAADAAH---RAG 149

Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVS 283
           +      PS V +  +        G                 LA    M     ++    
Sbjct: 150 VALSIDHPSRVRVSID--------GDVV--------------LAYPATMPDANPQD---- 183

Query: 284 TNGDVYSFGIMLMEIFTRTKPTDE 307
              D+   G  L  +     P  E
Sbjct: 184 ---DIRGIGASLYALLVNRWPLPE 204

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 91.2 bits (227), Expect = 9e-21
 Identities = 63/221 (28%), Positives = 103/221 (46%), Gaps = 42/221 (19%)

Query: 111 IGKGGFGSVYKAIIQDGMEVAVK--VFDPQYEGAFKSFDIECDVMKRICHRNLIK----I 164
           IG G FG V++A + +  EVA+K  + D +++        E  +M+ + H N++      
Sbjct: 48  IGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKN------RELQIMRIVKHPNVVDLKAFF 101

Query: 165 ISSYSNDDFKA--LVLEYMP---HGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFG 219
            S+    D     LVLEY+P   + +      L   +  +  +L  M  +  +L Y+H  
Sbjct: 102 YSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKL-YMYQLLRSLAYIH-- 158

Query: 220 YSAPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE--- 275
            S  I H D+KP N+LLD  + V  L DFG AK L+  + +      + +  Y APE   
Sbjct: 159 -SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN---VSYICSRYYRAPELIF 214

Query: 276 ----YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE 312
               Y      +TN D++S G ++ E+    +P   +F GE
Sbjct: 215 GATNY------TTNIDIWSTGCVMAELMQG-QP---LFPGE 245

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 90.4 bits (225), Expect = 9e-21
 Identities = 42/206 (20%), Positives = 79/206 (38%), Gaps = 46/206 (22%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDI-----ECDVMKRICHRNLIKI 164
           +G+G FG V++ +          K          K  D      E  ++    HRN++ +
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKV------KGTDQVLVKKEISILNIARHRNILHL 66

Query: 165 ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL-------------DIMIDVAS 211
             S+ + +   ++ E++                DIF+R+               +  V  
Sbjct: 67  HESFESMEELVMIFEFISGL-------------DIFERINTSAFELNEREIVSYVHQVCE 113

Query: 212 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHL--SDFGMAKPLLEEDQSLTQTQTLATI 269
           AL++LH      I H D++P N++      + +   +FG A+  L+   +          
Sbjct: 114 ALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQAR-QLKPGDNF--RLLFTAP 167

Query: 270 GYMAPEYGREGRVSTNGDVYSFGIML 295
            Y APE  +   VST  D++S G ++
Sbjct: 168 EYYAPEVHQHDVVSTATDMWSLGTLV 193

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 89.7 bits (223), Expect = 1e-20
 Identities = 56/241 (23%), Positives = 96/241 (39%), Gaps = 53/241 (21%)

Query: 109 PLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDI------ECDVMKRICHR-- 159
           PL+G GGFGSVY  I + D + VA+K  +      +           E  ++K++     
Sbjct: 49  PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 108

Query: 160 NLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLD------IMIDVASAL 213
            +I+++  +   D   L+LE  P    +    L ++I +    L           V  A+
Sbjct: 109 GVIRLLDWFERPDSFVLILER-PEPVQD----LFDFITE-RGALQEELARSFFWQVLEAV 162

Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDN-MVAHLSDFGMAKPLLEEDQSLTQTQTLAT---- 268
            + H   +  ++H D+K  N+L+D N     L DFG          +L +          
Sbjct: 163 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSG--------ALLKDTVYTDFDGT 211

Query: 269 IGYMAPEY-------GREGRVSTNGDVYSFGIMLMEIFTRTKP---TDEIFSGEMTLKRW 318
             Y  PE+       GR         V+S GI+L ++     P    +EI  G++  ++ 
Sbjct: 212 RVYSPPEWIRYHRYHGRS------AAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 265

Query: 319 V 319
           V
Sbjct: 266 V 266

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 90.6 bits (225), Expect = 2e-20
 Identities = 50/213 (23%), Positives = 81/213 (38%), Gaps = 57/213 (26%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDI--ECDVMKRIC-HRNLIKIIS 166
           +G G  G V +    +   + A+K+                E ++  R     ++++I+ 
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVD 122

Query: 167 SY----SNDDFKALVLEYMPHGSLEKCLYLSNYILD-IFQRLD----------IMIDVAS 211
            Y    +      +V+E +  G L             I  R D          IM  +  
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGEL----------FSRIQDRGDQAFTEREASEIMKSIGE 172

Query: 212 ALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 268
           A++YLH   S  I H D+KP N+L      N +  L+DFG AK       SL  T    T
Sbjct: 173 AIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-ETTSHNSL--TTPCYT 226

Query: 269 IGYMAPE------YGREGRVSTNGDVYSFGIML 295
             Y+APE      Y +        D++S G+++
Sbjct: 227 PYYVAPEVLGPEKYDKS------CDMWSLGVIM 253

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 90.5 bits (225), Expect = 2e-20
 Identities = 64/222 (28%), Positives = 105/222 (47%), Gaps = 43/222 (19%)

Query: 111 IGKGGFGSVYKAIIQD-GMEVAVK-VF-DPQYEGAFKSFDIECDVMKRICHRNLIKII-- 165
           IG G FG VY+A + D G  VA+K V  D +++        E  +M+++ H N++++   
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNIVRLRYF 115

Query: 166 ----SSYSNDDFKALVLEYMP---HGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHF 218
                   ++ +  LVL+Y+P   +            +  I+ +L  M  +  +L Y+H 
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYIH- 173

Query: 219 GYSAPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE-- 275
             S  I H D+KP N+LLD D  V  L DFG AK L+  + +      + +  Y APE  
Sbjct: 174 --SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSYICSRYYRAPELI 228

Query: 276 -----YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE 312
                Y      +++ DV+S G +L E+    +P   IF G+
Sbjct: 229 FGATDY------TSSIDVWSAGCVLAELLLG-QP---IFPGD 260

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 90.1 bits (224), Expect = 2e-20
 Identities = 50/224 (22%), Positives = 86/224 (38%), Gaps = 40/224 (17%)

Query: 111 IGKGGFGSVYKAIIQDGMEVAVK-VFDPQYEGAFKS-FDIECD---------VMKRICHR 159
           I  G +G+V   +  +G+ VA+K VF+   +G   +                ++    H 
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89

Query: 160 NLIK---IISSYSNDDFKA--LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALE 214
           N++    I   +         LV E M    L + ++    ++        M  +   L 
Sbjct: 90  NILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLH 148

Query: 215 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 274
            LH    A ++H DL P N+LL DN    + DF +A+    +      T  +    Y AP
Sbjct: 149 VLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANK---THYVTHRWYRAP 202

Query: 275 E-------YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSG 311
           E       +      +   D++S G ++ E+F R K    +F G
Sbjct: 203 ELVMQFKGF------TKLVDMWSAGCVMAEMFNR-KA---LFRG 236

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 91.4 bits (227), Expect = 2e-20
 Identities = 52/207 (25%), Positives = 91/207 (43%), Gaps = 20/207 (9%)

Query: 102 PNDANMPPLIGKGGFGSVYKAIIQDGMEV-AVKVFDPQYEGAFKSFDIEC-----DVMKR 155
            +      ++G+GGFG V+   ++   ++ A K  + +     K    +       ++ +
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKR--LKKRKGYQGAMVEKKILAK 241

Query: 156 ICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMI----DVAS 211
           +  R ++ +  ++       LV+  M  G +   +Y  +     F +    I     + S
Sbjct: 242 VHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGF-QEPRAIFYTAQIVS 300

Query: 212 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA-TIG 270
            LE+LH      II+ DLKP NVLLDD+    +SD G+A  L       T+T+  A T G
Sbjct: 301 GLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ---TKTKGYAGTPG 354

Query: 271 YMAPEYGREGRVSTNGDVYSFGIMLME 297
           +MAPE         + D ++ G+ L E
Sbjct: 355 FMAPELLLGEEYDFSVDYFALGVTLYE 381

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 90.6 bits (225), Expect = 4e-20
 Identities = 53/215 (24%), Positives = 95/215 (44%), Gaps = 21/215 (9%)

Query: 93  RYQKRGKPLPNDANMPPLIGKGGFGSVYKAIIQDGMEV-AVKVFDPQYEGAFKSFDIEC- 150
           ++ +R     N      ++GKGGFG V    ++   ++ A K  + +     K       
Sbjct: 174 KWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKR--IKKRKGEAMA 231

Query: 151 ----DVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIM 206
                +++++  R ++ +  +Y   D   LVL  M  G L+   ++ +     F     +
Sbjct: 232 LNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLK--FHIYHMGQAGFPEARAV 289

Query: 207 I---DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 263
               ++   LE LH      I++ DLKP N+LLDD+    +SD G+A  + E        
Sbjct: 290 FYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ----TI 342

Query: 264 QTLA-TIGYMAPEYGREGRVSTNGDVYSFGIMLME 297
           +    T+GYMAPE  +  R + + D ++ G +L E
Sbjct: 343 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYE 377

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 87.7 bits (218), Expect = 6e-20
 Identities = 57/239 (23%), Positives = 94/239 (39%), Gaps = 47/239 (19%)

Query: 109 PLIGKGGFGSVYKAI-IQDGMEVAVKVFD------PQYEGAFKSFDIECDVMKRI----C 157
           PL+GKGGFG+V+    + D ++VA+KV                +  +E  ++ ++     
Sbjct: 37  PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96

Query: 158 HRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLD------IMIDVAS 211
           H  +I+++  +   +   LVLE            L +YI +    L           V +
Sbjct: 97  HPGVIRLLDWFETQEGFMLVLERP-----LPAQDLFDYITE-KGPLGEGPSRCFFGQVVA 150

Query: 212 ALEYLHFGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG 270
           A+++ H   S  ++H D+K  N+L+D     A L DFG     L  D+  T      T  
Sbjct: 151 AIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGA--LLHDEPYTDFD--GTRV 203

Query: 271 YMAPEY-------GREGRVSTNGDVYSFGIMLMEIFTRTKP---TDEIFSGEMTLKRWV 319
           Y  PE+                  V+S GI+L ++     P     EI   E+     V
Sbjct: 204 YSPPEWISRHQYHALP------ATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHV 256

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 86.1 bits (214), Expect = 2e-19
 Identities = 57/226 (25%), Positives = 88/226 (38%), Gaps = 31/226 (13%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFD-PQYEGAFKSFDIECDVMKRICHRNLIKIISS 167
            +G+G +G V  A+       VAVK+ D  +     ++   E  + K + H N++K    
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73

Query: 168 YSNDDFKALVLEYMPHGSLEKCLYLSNYILD-----------IFQRLDIMIDVASALEYL 216
               + + L LEY   G  E    L + I              F +L       + + YL
Sbjct: 74  RREGNIQYLFLEYCSGG--E----LFDRIEPDIGMPEPDAQRFFHQL------MAGVVYL 121

Query: 217 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGM-AKPLLEEDQSLTQTQTLATIGYMAPE 275
           H      I H D+KP N+LLD+     +SDFG+         + L       T+ Y+APE
Sbjct: 122 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAPE 177

Query: 276 -YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN 320
              R    +   DV+S GI+L  +     P D+          W  
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE 223

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 85.7 bits (213), Expect = 2e-19
 Identities = 67/255 (26%), Positives = 107/255 (41%), Gaps = 55/255 (21%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDI------ECDVMKRICHRNLI 162
            +G G FG V        G +VAVK+ + Q     +S D+      E   +K   H ++I
Sbjct: 18  TLGVGTFGKVKIGEHQLTGHKVAVKILNRQ---KIRSLDVVGKIKREIQNLKLFRHPHII 74

Query: 163 KIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILD-----------IFQRLDIMIDVAS 211
           K+    S      +V+EY+  G L       +YI             +FQ++       S
Sbjct: 75  KLYQVISTPTDFFMVMEYVSGGEL------FDYICKHGRVEEMEARRLFQQI------LS 122

Query: 212 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGY 271
           A++Y H      ++H DLKP NVLLD +M A ++DFG++   +  D    +T +  +  Y
Sbjct: 123 AVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSN--MMSDGEFLRT-SCGSPNY 176

Query: 272 MAPE-YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDE---------IFSGEMTLKRWVN- 320
            APE            D++S G++L  +   T P D+         I  G   +  ++N 
Sbjct: 177 AAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNR 236

Query: 321 ---DLLPISVMEVVD 332
               L  +  M  VD
Sbjct: 237 SVATL--LMHMLQVD 249

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 87.1 bits (216), Expect = 3e-19
 Identities = 56/229 (24%), Positives = 94/229 (41%), Gaps = 46/229 (20%)

Query: 96  KRGKPLPNDANMPPLIGKGGFGSVYKAIIQDGMEV-AVKVFDPQYEGAFKSFDIEC---- 150
           +  +    D  +  +IG+G FG V     +   +V A+K+         K  D       
Sbjct: 62  RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFE--MIKRSDSAFFWEE 119

Query: 151 -DVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDV 209
            D+M       ++++  ++ +D +  +V+EYMP G L          +++    D+    
Sbjct: 120 RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL----------VNLMSNYDVPEKW 169

Query: 210 A--------SALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT 261
           A         AL+ +H   S   IH D+KP N+LLD +    L+DFG    + +E     
Sbjct: 170 ARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC 226

Query: 262 QTQTLATIGYMAPE----------YGREGRVSTNGDVYSFGIMLMEIFT 300
            T  + T  Y++PE          YGRE       D +S G+ L E+  
Sbjct: 227 DT-AVGTPDYISPEVLKSQGGDGYYGRE--C----DWWSVGVFLYEMLV 268

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 85.6 bits (213), Expect = 3e-19
 Identities = 57/229 (24%), Positives = 102/229 (44%), Gaps = 34/229 (14%)

Query: 93  RYQKRGKPLPNDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKV--FDPQYEGAFKSFDI- 148
           +Y+K  K           IG+G +G+V+KA   +    VA+K    D   EG        
Sbjct: 3   KYEKLEK-----------IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG----VPSS 47

Query: 149 ---ECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDI 205
              E  ++K + H+N++++     +D    LV E+     L+K     N  LD       
Sbjct: 48  ALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSF 106

Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
           +  +   L + H   S  ++H DLKP N+L++ N    L++FG+A+      +    +  
Sbjct: 107 LFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAE 161

Query: 266 LATIGYMAPE--YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE 312
           + T+ Y  P+  +G +   ST+ D++S G +  E+    +P   +F G 
Sbjct: 162 VVTLWYRPPDVLFGAK-LYSTSIDMWSAGCIFAELANAGRP---LFPGN 206

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 87.1 bits (216), Expect = 3e-19
 Identities = 48/228 (21%), Positives = 94/228 (41%), Gaps = 41/228 (17%)

Query: 96  KRGKPLPNDANMPPLIGKGGFGSVYKAIIQDGMEV-AVKVFDPQYEGAFKSFDIEC---- 150
           K+ +    D  +  +IG+G FG V    +++  +V A+K+ +       K  +  C    
Sbjct: 67  KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWE--MLKRAETACFREE 124

Query: 151 -DVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMID- 208
            DV+     + +  +  ++ +D+   LV++Y   G L   L L         + +  +  
Sbjct: 125 RDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDL---LTL-------LSKFEDRLPE 174

Query: 209 ---------VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAH--LSDFGMAKPLLEED 257
                    +  A++ +H       +H D+KP N+L+D N   H  L+DFG    L+E+ 
Sbjct: 175 EMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMN--GHIRLADFGSCLKLMEDG 229

Query: 258 QSLTQTQTLATIGYMAPEYGREGRVSTNG-----DVYSFGIMLMEIFT 300
              +    + T  Y++PE  +             D +S G+ + E+  
Sbjct: 230 TVQSSV-AVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLY 276

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 86.2 bits (214), Expect = 4e-19
 Identities = 55/226 (24%), Positives = 94/226 (41%), Gaps = 45/226 (19%)

Query: 111 IGKGGFGSVYKAIIQD-GMEVAVK-VF-DPQYEGAFKSFDIECDVMKRIC---HRNLIK- 163
            G+G FG+V     +  GM VA+K V  DP++    +   I    M+ +    H N+++ 
Sbjct: 31  AGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF--RNRELQI----MQDLAVLHHPNIVQL 84

Query: 164 --IISSYSNDDFK----ALVLEYMP---HGSLEKCLYLSNYILDIFQRLDIMIDVASALE 214
                +    D +     +V+EY+P   H               I  ++  +  +  ++ 
Sbjct: 85  QSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKV-FLFQLIRSIG 143

Query: 215 YLHFGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
            LH   S  + H D+KP NVL++  +    L DFG AK L   + +      + +  Y A
Sbjct: 144 CLH-LPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN---VAYICSRYYRA 199

Query: 274 PE-------YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE 312
           PE       Y      +T  D++S G +  E+    +P   IF G+
Sbjct: 200 PELIFGNQHY------TTAVDIWSVGCIFAEMMLG-EP---IFRGD 235

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 85.9 bits (213), Expect = 6e-19
 Identities = 57/225 (25%), Positives = 94/225 (41%), Gaps = 39/225 (17%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVK-VFDPQYEGAFKSFDI------ECDVMKRICHRNLI 162
           IG G  G V  A        VA+K +  P     F++         E  +MK + H+N+I
Sbjct: 33  IGSGAQGIVCAAYDAILERNVAIKKLSRP-----FQNQTHAKRAYRELVLMKCVNHKNII 87

Query: 163 KI----ISSYSNDDFKA--LVLEYMP---HGSLEKCLYLSNYILDIFQRLDIMIDVASAL 213
            +        S ++F+   +V+E M       ++  L        ++Q L         +
Sbjct: 88  GLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQML-------CGI 140

Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
           ++LH   SA IIH DLKPSN+++  +    + DFG+A+       S   T  + T  Y A
Sbjct: 141 KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRA 194

Query: 274 PEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRW 318
           PE         N D++S G ++ E+         +F G   + +W
Sbjct: 195 PEVILGMGYKENVDIWSVGCIMGEMIKG-GV---LFPGTDHIDQW 235

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 84.9 bits (211), Expect = 6e-19
 Identities = 64/228 (28%), Positives = 105/228 (46%), Gaps = 34/228 (14%)

Query: 93  RYQKRGKPLPNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKV--FDPQYEGAFKSFDI-- 148
           +YQK  K           +G+G +G VYKA    G  VA+K    D + EG         
Sbjct: 22  KYQKLEK-----------VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEG----IPSTA 66

Query: 149 --ECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIM 206
             E  ++K + H N++ +I    ++    LV E+M    L+K L  +   L   Q    +
Sbjct: 67  IREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYL 125

Query: 207 IDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL 266
             +   + + H      I+H DLKP N+L++ +    L+DFG+A+      +S   T  +
Sbjct: 126 YQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEV 180

Query: 267 ATIGYMAPE--YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE 312
            T+ Y AP+   G + + ST+ D++S G +  E+ T  KP   +F G 
Sbjct: 181 VTLWYRAPDVLMGSK-KYSTSVDIWSIGCIFAEMITG-KP---LFPGV 223

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 84.7 bits (210), Expect = 8e-19
 Identities = 58/229 (25%), Positives = 88/229 (38%), Gaps = 37/229 (16%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFD-PQYEGAFKSFDIECDVMKRICHRNLIKIISS 167
            +G+G +G V  A+       VAVK+ D  +     ++   E  + K + H N++K    
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73

Query: 168 YSNDDFKALVLEYMPHGSLEKCLYLSNYILD-----------IFQRLDIMIDVASALEYL 216
               + + L LEY   G  E    L + I              F +L       + + YL
Sbjct: 74  RREGNIQYLFLEYCSGG--E----LFDRIEPDIGMPEPDAQRFFHQL------MAGVVYL 121

Query: 217 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGM-AKPLLEEDQSLTQTQTLATIGYMAPE 275
           H      I H D+KP N+LLD+     +SDFG+         + L       T+ Y+APE
Sbjct: 122 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAPE 177

Query: 276 --YGRE--GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN 320
               RE         DV+S GI+L  +     P D+          W  
Sbjct: 178 LLKRREFHAEPV---DVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE 223

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 84.8 bits (210), Expect = 2e-18
 Identities = 48/230 (20%), Positives = 90/230 (39%), Gaps = 43/230 (18%)

Query: 96  KRGKPLPNDANMPPLIGKGGFGSVYKAIIQDGMEV-AVKVFDPQYEGAFKSFDIEC---- 150
           K  +   +D  +  +IG+G F  V    ++   +V A+K+ +       K  ++ C    
Sbjct: 54  KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWD--MLKRGEVSCFREE 111

Query: 151 -DVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMID- 208
            DV+     R + ++  ++ ++++  LV+EY   G L   L L         +    I  
Sbjct: 112 RDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDL---LTL-------LSKFGERIPA 161

Query: 209 ---------VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAH--LSDFGMAKPLLEED 257
                    +  A++ +H       +H D+KP N+LLD     H  L+DFG    L  + 
Sbjct: 162 EMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRC--GHIRLADFGSCLKLRADG 216

Query: 258 QSLTQTQTLATIGYMAPEYGREGRVSTNGDVY-------SFGIMLMEIFT 300
              +    + T  Y++PE  +          Y       + G+   E+F 
Sbjct: 217 TVRSLV-AVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFY 265

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 83.8 bits (208), Expect = 2e-18
 Identities = 62/232 (26%), Positives = 104/232 (44%), Gaps = 38/232 (16%)

Query: 93  RYQKRGKPLPNDANMPPLIGKGGFGSVYKAI-IQDGMEVAVK-----VFDPQYEGAFKSF 146
           RY+K              +G+G F +VYKA        VA+K           +G     
Sbjct: 11  RYEKLDF-----------LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDG----I 55

Query: 147 DI----ECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQR 202
           +     E  +++ + H N+I ++ ++ +    +LV ++M    LE  +  ++ +L     
Sbjct: 56  NRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHI 114

Query: 203 LDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ 262
              M+     LEYLH      I+H DLKP+N+LLD+N V  L+DFG+AK     +++   
Sbjct: 115 KAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY-- 169

Query: 263 TQTLATIGYMAPE--YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE 312
           T  + T  Y APE  +G         D+++ G +L E+  R  P      G+
Sbjct: 170 THQVVTRWYRAPELLFGAR-MYGVGVDMWAVGCILAELLLR-VP---FLPGD 216

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 83.8 bits (208), Expect = 2e-18
 Identities = 62/236 (26%), Positives = 106/236 (44%), Gaps = 37/236 (15%)

Query: 93  RYQKRGKPLPNDANMPPLIGKGGFGSVYKAI-IQDGMEVAVK--VFDPQYEGAFKSFDI- 148
           +Y+K  K           IG+G FG V+KA   + G +VA+K  + + + EG F    + 
Sbjct: 18  KYEKLAK-----------IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG-FPITALR 65

Query: 149 ECDVMKRICHRN---LIKIISSYSNDDFKA-----LVLEYMPHGSLEKCLYLSNYILDIF 200
           E  +++ + H N   LI+I  + ++   +      LV ++  H  L   L        + 
Sbjct: 66  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLS 124

Query: 201 QRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL 260
           +   +M  + + L Y+H      I+H D+K +NVL+  + V  L+DFG+A+       S 
Sbjct: 125 EIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 181

Query: 261 TQ--TQTLATIGYMAPE--YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE 312
               T  + T+ Y  PE   G E       D++  G ++ E++TR  P   I  G 
Sbjct: 182 PNRYTNRVVTLWYRPPELLLG-ERDYGPPIDLWGAGCIMAEMWTR-SP---IMQGN 232

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 83.4 bits (207), Expect = 2e-18
 Identities = 56/231 (24%), Positives = 91/231 (39%), Gaps = 39/231 (16%)

Query: 93  RYQKRGKPLPNDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVF--DPQYEGAFKSFDI- 148
           +Y+K GK           IG+G +G V+K      G  VA+K F          K   + 
Sbjct: 4   KYEKIGK-----------IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPV-IKKIALR 51

Query: 149 ECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMID 208
           E  ++K++ H NL+ ++  +       LV EY  H ++   L      +       I   
Sbjct: 52  EIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQ 110

Query: 209 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 268
              A+ + H       IH D+KP N+L+  + V  L DFG A+ L            +AT
Sbjct: 111 TLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY--DDEVAT 165

Query: 269 IGYMAPE-------YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE 312
             Y +PE       Y          DV++ G +  E+ +   P   ++ G+
Sbjct: 166 RWYRSPELLVGDTQY------GPPVDVWAIGCVFAELLSG-VP---LWPGK 206

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 83.9 bits (208), Expect = 3e-18
 Identities = 56/227 (24%), Positives = 98/227 (43%), Gaps = 46/227 (20%)

Query: 94  YQKRGKPLPNDANMPPLIGKGGFGSVYKAIIQDGMEV-AVKVFDPQY---EGAFKSFDIE 149
           + +      +   +   IGKG FG V      D  ++ A+K  + Q        ++   E
Sbjct: 6   FDENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKE 65

Query: 150 CDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSL----EKCLYLSN-----YILDIF 200
             +M+ + H  L+ +  S+ +++   +V++ +  G L    ++ ++        +I ++ 
Sbjct: 66  LQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICEL- 124

Query: 201 QRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL 260
                      AL+YL    +  IIH D+KP N+LLD++   H++DF +A  L  E    
Sbjct: 125 ---------VMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE---- 168

Query: 261 TQTQTLA-TIGYMAPE---------YGREGRVSTNGDVYSFGIMLME 297
           TQ  T+A T  YMAPE         Y     V    D +S G+   E
Sbjct: 169 TQITTMAGTKPYMAPEMFSSRKGAGYSFA--V----DWWSLGVTAYE 209

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 83.1 bits (206), Expect = 3e-18
 Identities = 59/257 (22%), Positives = 103/257 (40%), Gaps = 62/257 (24%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDI-----ECDVMKRICHRNLIKI 164
           IGKG F  V  A  I  G EVA+K+ D           +     E  +MK + H N++K+
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKT---QLNPTSLQKLFREVRIMKILNHPNIVKL 79

Query: 165 ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILD-----------IFQRLDIMIDVASAL 213
                 +    L++EY   G +       +Y++             F+++       SA+
Sbjct: 80  FEVIETEKTLYLIMEYASGGEV------FDYLVAHGRMKEKEARSKFRQI------VSAV 127

Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATI---- 269
           +Y H      I+H DLK  N+LLD +M   ++DFG +          T    L       
Sbjct: 128 QYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFS-------NEFTVGGKLDAFCGAP 177

Query: 270 GYMAPE-YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDE---------IFSGEMTLKRWV 319
            Y APE +  +       DV+S G++L  + + + P D          +  G+  +  ++
Sbjct: 178 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYM 237

Query: 320 N----DLLPISVMEVVD 332
           +    +L  +    V++
Sbjct: 238 STDCENL--LKRFLVLN 252

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 84.9 bits (210), Expect = 3e-18
 Identities = 55/240 (22%), Positives = 100/240 (41%), Gaps = 40/240 (16%)

Query: 94  YQKRGKPLPNDANMPPLIGKGGFGSVYKAIIQDGMEV-AVKVFD-------PQYEGAFKS 145
            +       ND ++  +IG+GGFG VY     D  ++ A+K  D            A   
Sbjct: 180 VELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLAL-- 237

Query: 146 FDIECDVMKRI---CHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQR 202
              E  ++  +       ++ +  ++   D  + +L+ M  G L   L        +F  
Sbjct: 238 --NERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH----GVFSE 291

Query: 203 LDIMI---DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS 259
            D+     ++   LE++H   +  +++ DLKP+N+LLD++    +SD G+A    ++   
Sbjct: 292 ADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--- 345

Query: 260 LTQTQTLA-TIGYMAPE-YGREGRVSTNGDVYSFGIMLMEIFT--------RTKPTDEIF 309
             +      T GYMAPE   +     ++ D +S G ML ++          +TK   EI 
Sbjct: 346 --KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 403

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 82.6 bits (205), Expect = 3e-18
 Identities = 55/228 (24%), Positives = 97/228 (42%), Gaps = 34/228 (14%)

Query: 93  RYQKRGKPLPNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKV--FDPQYEGAFKSFDI-- 148
           +Y    K           IG+G +G VYKA    G   A+K    + + EG         
Sbjct: 3   KYHGLEK-----------IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEG----IPSTT 47

Query: 149 --ECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIM 206
             E  ++K + H N++K+           LV E++    L+K L +    L+       +
Sbjct: 48  IREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFL 106

Query: 207 IDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL 266
           + + + + Y H      ++H DLKP N+L++      ++DFG+A+      +    T  +
Sbjct: 107 LQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--THEI 161

Query: 267 ATIGYMAPE--YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE 312
            T+ Y AP+   G + + ST  D++S G +  E+     P   +F G 
Sbjct: 162 VTLWYRAPDVLMGSK-KYSTTIDIWSVGCIFAEMVNG-TP---LFPGV 204

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 84.1 bits (208), Expect = 4e-18
 Identities = 66/255 (25%), Positives = 106/255 (41%), Gaps = 55/255 (21%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDI------ECDVMKRICHRNLI 162
            +G G FG V        G +VAVK+ + Q     +S D+      E   +K   H ++I
Sbjct: 23  TLGVGTFGKVKVGKHELTGHKVAVKILNRQ---KIRSLDVVGKIRREIQNLKLFRHPHII 79

Query: 163 KIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILD-----------IFQRLDIMIDVAS 211
           K+    S      +V+EY+  G L       +YI             +FQ++       S
Sbjct: 80  KLYQVISTPSDIFMVMEYVSGGEL------FDYICKNGRLDEKESRRLFQQI------LS 127

Query: 212 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGY 271
            ++Y H      ++H DLKP NVLLD +M A ++DFG++   +  D    +T +  +  Y
Sbjct: 128 GVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSN--MMSDGEFLRT-SCGSPNY 181

Query: 272 MAPE-YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDE---------IFSGEMTLKRWVN- 320
            APE            D++S G++L  +   T P D+         I  G     +++N 
Sbjct: 182 AAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNP 241

Query: 321 ---DLLPISVMEVVD 332
               L  +  M  VD
Sbjct: 242 SVISL--LKHMLQVD 254

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 82.8 bits (205), Expect = 5e-18
 Identities = 54/210 (25%), Positives = 79/210 (37%), Gaps = 52/210 (24%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDI------ECDVMKRICHRNLI 162
            IG G FG             VAVK  +       +   I      E    + + H N++
Sbjct: 27  DIGSGNFGVARLMRDKLTKELVAVKYIE-------RGAAIDENVQREIINHRSLRHPNIV 79

Query: 163 KIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILD-----------IFQRLDIMIDVAS 211
           +           A+++EY   G L         I +            FQ+L       S
Sbjct: 80  RFKEVILTPTHLAIIMEYASGGEL------YERICNAGRFSEDEARFFFQQL------LS 127

Query: 212 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHL--SDFGMAKPLLEEDQSLTQTQTLATI 269
            + Y H   S  I H DLK  N LLD +    L   DFG +K       S  ++ T+ T 
Sbjct: 128 GVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKS-TVGTP 181

Query: 270 GYMAPE--YGRE--GRVSTNGDVYSFGIML 295
            Y+APE    +E  G+++   DV+S G+ L
Sbjct: 182 AYIAPEVLLRQEYDGKIA---DVWSCGVTL 208

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 82.3 bits (203), Expect = 9e-18
 Identities = 33/121 (27%), Positives = 55/121 (45%), Gaps = 3/121 (2%)

Query: 180 YMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDN 239
                  E    L    L +   +     VA  +E+L    S   IH DL   N+LL + 
Sbjct: 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEK 229

Query: 240 MVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIF 299
            V  + DFG+A+ + ++   + +      + +MAPE   +   +   DV+SFG++L EIF
Sbjct: 230 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 289

Query: 300 T 300
           +
Sbjct: 290 S 290

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 51.1 bits (122), Expect = 2e-07
 Identities = 29/152 (19%), Positives = 55/152 (36%), Gaps = 17/152 (11%)

Query: 111 IGKGGFGSVYKAII------QDGMEVAVK-VFDPQYEGAFKSFDIECDVMKRI-CHRNLI 162
           +G+G FG V +A             VAVK + +       ++   E  ++  I  H N++
Sbjct: 30  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89

Query: 163 KIISSYSNDDFKALV-LEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYS 221
            ++ + +      +V +E+   G+L    YL +   +               +Y+     
Sbjct: 90  NLLGACTKPGGPLMVIVEFCKFGNLST--YLRSKRNEFVPYKTKGARFRQGKDYVG---- 143

Query: 222 APIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL 253
              I  DLK     +  +  +  S F   K L
Sbjct: 144 --AIPVDLKRRLDSITSSQSSASSGFVEEKSL 173

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 81.6 bits (202), Expect = 2e-17
 Identities = 59/224 (26%), Positives = 101/224 (45%), Gaps = 47/224 (20%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECD---------VMKRICHRN 160
           IG+G +G V  A    + + VA+K   P        F+ +           ++ R  H N
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLREIKILLRFRHEN 86

Query: 161 LIK---IISSYSNDDFKA--LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEY 215
           +I    II + + +  K   +V + M    L K L  + ++ +       +  +   L+Y
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLK-TQHLSNDHICY-FLYQILRGLKY 143

Query: 216 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LEEDQSLTQTQTLATIGYMAP 274
           +H   SA ++H DLKPSN+LL+      + DFG+A+    + D +   T+ +AT  Y AP
Sbjct: 144 IH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200

Query: 275 E-------YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSG 311
           E       Y      + + D++S G +L E+ +  +P   IF G
Sbjct: 201 EIMLNSKGY------TKSIDIWSVGCILAEMLSN-RP---IFPG 234

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 81.8 bits (202), Expect = 2e-17
 Identities = 58/225 (25%), Positives = 96/225 (42%), Gaps = 39/225 (17%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVK-VFDPQYEGAFKSFDI------ECDVMKRICHRNLI 162
           IG G  G V  A        VA+K +  P     F++         E  +MK + H+N+I
Sbjct: 70  IGSGAQGIVCAAYDAVLDRNVAIKKLSRP-----FQNQTHAKRAYRELVLMKCVNHKNII 124

Query: 163 KII----SSYSNDDFKA--LVLEYMP---HGSLEKCLYLSNYILDIFQRLDIMIDVASAL 213
            ++       + ++F+   LV+E M       ++  L        ++Q L         +
Sbjct: 125 SLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQML-------CGI 177

Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
           ++LH   SA IIH DLKPSN+++  +    + DFG+A+       S   T  + T  Y A
Sbjct: 178 KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRA 231

Query: 274 PEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRW 318
           PE         N D++S G ++ E+    K    +F G   + +W
Sbjct: 232 PEVILGMGYKENVDIWSVGCIMGEMVRH-KI---LFPGRDYIDQW 272

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 80.0 bits (198), Expect = 3e-17
 Identities = 38/171 (22%), Positives = 64/171 (37%), Gaps = 48/171 (28%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDI--ECDVMKRIC-HRNLIKIIS 166
           +G G  G V +    +   + A+K+                E ++  R     ++++I+ 
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVD 78

Query: 167 SY----SNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRL--------------DIMID 208
            Y    +      +V+E +  G L             F R+              +IM  
Sbjct: 79  VYENLYAGRKCLLIVMECLDGGEL-------------FSRIQDRGDQAFTEREASEIMKS 125

Query: 209 VASALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLEE 256
           +  A++YLH   S  I H D+KP N+L      N +  L+DFG AK    E
Sbjct: 126 IGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGE 173

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 80.0 bits (198), Expect = 4e-17
 Identities = 58/226 (25%), Positives = 99/226 (43%), Gaps = 29/226 (12%)

Query: 93  RYQKRGKPLPNDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVF--DPQYEGAFKSFDI- 148
           +Y+  G            +G+G +G V K      G  VA+K F      +   K   + 
Sbjct: 26  KYENLGL-----------VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKM-VKKIAMR 73

Query: 149 ECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMID 208
           E  ++K++ H NL+ ++          LV E++ H ++   L L    LD       +  
Sbjct: 74  EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQ 132

Query: 209 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 268
           + + + + H   S  IIH D+KP N+L+  + V  L DFG A+ L    +       +AT
Sbjct: 133 IINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY--DDEVAT 187

Query: 269 IGYMAPE--YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE 312
             Y APE   G + +     DV++ G ++ E+F   +P   +F G+
Sbjct: 188 RWYRAPELLVG-DVKYGKAVDVWAIGCLVTEMFMG-EP---LFPGD 228

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 80.0 bits (198), Expect = 4e-17
 Identities = 52/224 (23%), Positives = 94/224 (41%), Gaps = 26/224 (11%)

Query: 93  RYQKRGKPLPNDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDI-EC 150
            Y K  K           +G+G + +VYK         VA+K    ++E       I E 
Sbjct: 3   TYIKLDK-----------LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREV 51

Query: 151 DVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVA 210
            ++K + H N++ +      +    LV EY+    L++ L     I+++      +  + 
Sbjct: 52  SLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLL 110

Query: 211 SALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG 270
             L Y H      ++H DLKP N+L+++     L+DFG+A+      ++      + T+ 
Sbjct: 111 RGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY--DNEVVTLW 165

Query: 271 YMAPE--YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE 312
           Y  P+   G     ST  D++  G +  E+ T  +P   +F G 
Sbjct: 166 YRPPDILLGST-DYSTQIDMWGVGCIFYEMATG-RP---LFPGS 204

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 80.0 bits (198), Expect = 4e-17
 Identities = 56/219 (25%), Positives = 95/219 (43%), Gaps = 42/219 (19%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVK-VFDPQYEGAFKSFDI------ECDVMKRICHRNLI 162
           +G G +GSV  AI  + G +VA+K +  P     F+S         E  ++K + H N+I
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRP-----FQSEIFAKRAYRELLLLKHMQHENVI 86

Query: 163 KI----ISSYSNDDFKA--LVLEYMP---HGSLEKCLYLSNYILDIFQRLDIMIDVASAL 213
            +      + S  +F    LV+ +M       +            ++Q L         L
Sbjct: 87  GLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQML-------KGL 139

Query: 214 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 273
           +Y+H   SA ++H DLKP N+ ++++    + DFG+A+    E      T  + T  Y A
Sbjct: 140 KYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRA 191

Query: 274 PE-YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSG 311
           PE        +   D++S G ++ E+ T  K    +F G
Sbjct: 192 PEVILSWMHYNQTVDIWSVGCIMAEMLTG-KT---LFKG 226

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 79.6 bits (197), Expect = 6e-17
 Identities = 62/256 (24%), Positives = 104/256 (40%), Gaps = 58/256 (22%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDI------ECDVMKRICHRNLI 162
            +G+G FG V  A   +   +VA+K    Q     K  D+      E   +K + H ++I
Sbjct: 16  TLGEGSFGKVKLATHYKTQQKVALKFISRQ---LLKKSDMHMRVEREISYLKLLRHPHII 72

Query: 163 KIISSYSNDDFKALVLEY---------MPHGSL---EKCLYLSNYILDIFQRLDIMIDVA 210
           K+    +      +V+EY         +    +   E   +        FQ++       
Sbjct: 73  KLYDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRF--------FQQI------I 118

Query: 211 SALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG 270
            A+EY H      I+H DLKP N+LLDDN+   ++DFG++   +  D +  +T +  +  
Sbjct: 119 CAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSN--IMTDGNFLKT-SCGSPN 172

Query: 271 YMAPE-YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDE---------IFSGEMTLKRWVN 320
           Y APE    +       DV+S GI+L  +     P D+         + S    +  +++
Sbjct: 173 YAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLS 232

Query: 321 ----DLLPISVMEVVD 332
                L  I  M V D
Sbjct: 233 PGAQSL--IRRMIVAD 246

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 80.2 bits (198), Expect = 6e-17
 Identities = 49/230 (21%), Positives = 90/230 (39%), Gaps = 47/230 (20%)

Query: 111 IGKGGFGSVYKAI---IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRN---LIKI 164
           +G+G +G VYKA     +D  + A+K    +  G   S   E  +++ + H N   L K+
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQI--EGTGISMSACREIALLRELKHPNVISLQKV 86

Query: 165 ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVA----------SALE 214
             S+++     L+ +Y  H  L     +  +      +  + +               + 
Sbjct: 87  FLSHADRKV-WLLFDYAEH-DLWH--IIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 142

Query: 215 YLHFGYSAPIIHCDLKPSNVLLDDNMVAH----LSDFGMAKPLLEEDQSLTQ-TQTLATI 269
           YLH   +  ++H DLKP+N+L+           ++D G A+      + L      + T 
Sbjct: 143 YLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 199

Query: 270 GYMAPE-------YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE 312
            Y APE       Y      +   D+++ G +  E+ T  +P   IF   
Sbjct: 200 WYRAPELLLGARHY------TKAIDIWAIGCIFAELLTS-EP---IFHCR 239

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 79.2 bits (196), Expect = 8e-17
 Identities = 66/239 (27%), Positives = 101/239 (42%), Gaps = 68/239 (28%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECD---------VMKRICHRN 160
           +G+G +G V  A     G  VA+K  +P        FD             ++K   H N
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLREIKILKHFKHEN 70

Query: 161 LIK---IISSYSNDDFKA--LVLEYMPHGSLEKCL---YLSN----YILDIFQRLDIMID 208
           +I    I    S ++F    ++ E M    L + +    LS+    Y   I+Q L     
Sbjct: 71  IITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVISTQMLSDDHIQYF--IYQTL----- 122

Query: 209 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ------ 262
              A++ LH    + +IH DLKPSN+L++ N    + DFG+A+ + E     ++      
Sbjct: 123 --RAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177

Query: 263 --TQTLATIGYMAPE-------YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE 312
              + +AT  Y APE       Y      S   DV+S G +L E+F R +P   IF G 
Sbjct: 178 GMVEFVATRWYRAPEVMLTSAKY------SRAMDVWSCGCILAELFLR-RP---IFPGR 226

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 79.1 bits (195), Expect = 2e-16
 Identities = 41/198 (20%), Positives = 75/198 (37%), Gaps = 43/198 (21%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVK-VFDPQYEGAFKSFDIECD---------VMKRICHR 159
           IG G +G V +A    +   VA+K +           F+   D         ++ R+ H 
Sbjct: 61  IGTGSYGHVCEAYDKLEKRVVAIKKILRV--------FEDLIDCKRILREIAILNRLNHD 112

Query: 160 NLIK---IISSYSNDDFKA--LVLEYMP---HGSLEKCLYLSN----YILDIFQRLDIMI 207
           +++K   I+     + F    +VLE             +YL+      +L  +  L    
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLL--YNLL---- 166

Query: 208 DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA 267
                ++Y+H   SA I+H DLKP+N L++ +    + DFG+A+ +   +   +Q     
Sbjct: 167 ---VGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISP 220

Query: 268 TIGYMAPEYGREGRVSTN 285
               M        +    
Sbjct: 221 REDDMNLVTFPHTKNLKR 238

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 78.1 bits (193), Expect = 2e-16
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 35/216 (16%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVK-VFDPQYEGAFKSFDI------ECDVMKRICHRNLI 162
           +G G +GSV  A   + G+ VAVK +  P     F+S         E  ++K + H N+I
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-----FQSIIHAKRTYRELRLLKHMKHENVI 91

Query: 163 KI----ISSYSNDDFKA--LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYL 216
            +      + S ++F    LV   M    L   +     + D   +  ++  +   L+Y+
Sbjct: 92  GLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVK-CQKLTDDHVQF-LIYQILRGLKYI 148

Query: 217 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE- 275
           H   SA IIH DLKPSN+ ++++    + DFG+A+   +E      T  +AT  Y APE 
Sbjct: 149 H---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAPEI 200

Query: 276 YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSG 311
                  +   D++S G ++ E+ T  +    +F G
Sbjct: 201 MLNWMHYNQTVDIWSVGCIMAELLTG-RT---LFPG 232

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 77.3 bits (191), Expect = 3e-16
 Identities = 56/233 (24%), Positives = 100/233 (42%), Gaps = 48/233 (20%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVK--VFDPQYEG--AFKSFDIECDVMKRICHRNLIKII 165
           +G GG G V+ A+       VA+K  V         A +    E  +++R+ H N++K+ 
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR----EIKIIRRLDHDNIVKVF 74

Query: 166 ------------SSYSNDDFKA--LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVAS 211
                          S  +  +  +V EYM    L   L     +L+   RL  M  +  
Sbjct: 75  EILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLE-QGPLLEEHARL-FMYQLLR 131

Query: 212 ALEYLHFGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQ-TQTLATI 269
            L+Y+H   SA ++H DLKP+N+ ++ +++V  + DFG+A+ +          ++ L T 
Sbjct: 132 GLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188

Query: 270 GYMAPE-------YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTL 315
            Y +P        Y      +   D+++ G +  E+ T  K    +F+G   L
Sbjct: 189 WYRSPRLLLSPNNY------TKAIDMWAAGCIFAEMLTG-KT---LFAGAHEL 231

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 77.5 bits (191), Expect = 4e-16
 Identities = 57/254 (22%), Positives = 98/254 (38%), Gaps = 75/254 (29%)

Query: 111 IGKGGFGSVYKAIIQD-GMEVAVK-VFDPQYEGAFKSFDI-ECDVMKRICHRNLIKII-- 165
           +G G FG V +    + G   A+K V           +   E D+MK + H N+IK++  
Sbjct: 15  LGTGSFGIVCEVFDIESGKRFALKKVLQ------DPRYKNRELDIMKVLDHVNIIKLVDY 68

Query: 166 ------------------------------------SSYSNDDFKALVLEYMP---HGSL 186
                                                + S + +  +++EY+P   H  L
Sbjct: 69  FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVL 128

Query: 187 EKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD-DNMVAHLS 245
           +  +     I      +  +  +  A+ ++H   S  I H D+KP N+L++  +    L 
Sbjct: 129 KSFIRSGRSIPMNLISI-YIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNTLKLC 184

Query: 246 DFGMAKPLLEEDQSLTQTQTLATIGYMAPE-------YGREGRVSTNGDVYSFGIMLMEI 298
           DFG AK L+  + S      + +  Y APE       Y      + + D++S G +  E+
Sbjct: 185 DFGSAKKLIPSEPS---VAYICSRFYRAPELMLGATEY------TPSIDLWSIGCVFGEL 235

Query: 299 FTRTKPTDEIFSGE 312
               KP   +FSGE
Sbjct: 236 ILG-KP---LFSGE 245

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 76.8 bits (190), Expect = 5e-16
 Identities = 63/240 (26%), Positives = 96/240 (40%), Gaps = 47/240 (19%)

Query: 93  RYQKRGKPLPNDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKV--FDPQYEGAFKSFDI- 148
           RY+   +           IG G +G+VYKA     G  VA+K         G      I 
Sbjct: 10  RYEPVAE-----------IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGG-GGLPIS 57

Query: 149 ---ECDVMKRI---CHRN---LIKIISSYSNDDFKA--LVLEYMPHGSLEKCLYLSNYIL 197
              E  +++R+    H N   L+ + ++   D      LV E++    L    YL     
Sbjct: 58  TVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRT--YLDKAPP 114

Query: 198 DIFQRLDI---MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL 254
                  I   M      L++LH   +  I+H DLKP N+L+       L+DFG+A+   
Sbjct: 115 PGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIY- 170

Query: 255 EEDQSLTQTQTLATIGYMAPE--YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE 312
                +  T  + T+ Y APE         +T  D++S G +  E+F R KP   +F G 
Sbjct: 171 --SYQMALTPVVVTLWYRAPEVLLQS--TYATPVDMWSVGCIFAEMFRR-KP---LFCGN 222

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 76.2 bits (188), Expect = 1e-15
 Identities = 61/223 (27%), Positives = 102/223 (45%), Gaps = 47/223 (21%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVK-VFDPQYEGAFKSFDI------ECDVMKRICHRNLI 162
           +G G +G+V  A+  + G +VA+K ++ P     F+S         E  ++K + H N+I
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRP-----FQSELFAKRAYRELRLLKHMRHENVI 87

Query: 163 KII----SSYSNDDFKA--LVLEYMPH--GSLEKCLYLSN----YILDIFQRLDIMIDVA 210
            ++       + DDF    LV+ +M    G L K   L      ++  ++Q L       
Sbjct: 88  GLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFL--VYQML------- 138

Query: 211 SALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG 270
             L Y+H   +A IIH DLKP N+ ++++    + DFG+A+    E      T  + T  
Sbjct: 139 KGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRW 190

Query: 271 YMAPEY-GREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE 312
           Y APE      R +   D++S G ++ E+ T  K    +F G 
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITG-KT---LFKGS 229

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 76.7 bits (189), Expect = 1e-15
 Identities = 50/244 (20%), Positives = 89/244 (36%), Gaps = 62/244 (25%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVK-VFDPQYEGAFKSFDIECD---------VMKRICHR 159
           IG+G +G VY A        VA+K V           F+   D         ++ R+   
Sbjct: 34  IGRGSYGYVYLAYDKNTEKNVAIKKVNRM--------FEDLIDCKRILREITILNRLKSD 85

Query: 160 NLIK---IISSYSNDDFKA--LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALE 214
            +I+   +I       F    +VLE      L+K      ++ +   +  I+ ++     
Sbjct: 86  YIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKT-ILYNLLLGEN 143

Query: 215 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ------------ 262
           ++H    + IIH DLKP+N LL+ +    + DFG+A+ +  E  +               
Sbjct: 144 FIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPH 200

Query: 263 --------TQTLATIGYMAPE-------YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDE 307
                   T  + T  Y APE       Y      + + D++S G +  E+    +    
Sbjct: 201 NKNLKKQLTSHVVTRWYRAPELILLQENY------TKSIDIWSTGCIFAELLNMLQSHIN 254

Query: 308 IFSG 311
             + 
Sbjct: 255 DPTN 258

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 76.2 bits (188), Expect = 1e-15
 Identities = 52/229 (22%), Positives = 89/229 (38%), Gaps = 43/229 (18%)

Query: 88  ILLILRYQKRGKPLPNDANMPPLIGKGGFGSVYKAIIQDGMEV-AVKVFDPQYEGAFKSF 146
            L       +     +  +    +G G FG V     ++     A+K+ D Q     K  
Sbjct: 26  FLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK--VVKLK 83

Query: 147 DIEC-----DVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQ 201
            IE       +++ +    L+K+  S+ ++    +V+EY+  G +          L    
Sbjct: 84  QIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM-------FSHLRRIG 136

Query: 202 RLDIMI------DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE 255
           R            +    EYLH   S  +I+ DLKP N+L+D      ++DFG AK    
Sbjct: 137 RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK---- 189

Query: 256 EDQSLTQTQTL-ATIGYMAPE------YGREGRVSTNGDVYSFGIMLME 297
             +   +T TL  T   +APE      Y +   V    D ++ G+++ E
Sbjct: 190 --RVKGRTWTLCGTPEALAPEIILSKGYNKA--V----DWWALGVLIYE 230

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 75.3 bits (186), Expect = 2e-15
 Identities = 59/231 (25%), Positives = 102/231 (44%), Gaps = 35/231 (15%)

Query: 93  RYQKRGKPLPNDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDI-EC 150
           ++++  K           +G G + +VYK +    G+ VA+K      E    S  I E 
Sbjct: 6   QFKQLEK-----------LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREI 54

Query: 151 DVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVA 210
            +MK + H N++++      ++   LV E+M +  L+K  Y+ +  +    R   +  V 
Sbjct: 55  SLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKK--YMDSRTVGNTPRGLELNLVK 111

Query: 211 S-------ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 263
                    L + H      I+H DLKP N+L++      L DFG+A+       +   +
Sbjct: 112 YFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF--S 166

Query: 264 QTLATIGYMAPE--YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE 312
             + T+ Y AP+   G     ST+ D++S G +L E+ T  KP   +F G 
Sbjct: 167 SEVVTLWYRAPDVLMGSR-TYSTSIDIWSCGCILAEMITG-KP---LFPGT 212

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 75.9 bits (187), Expect = 2e-15
 Identities = 54/246 (21%), Positives = 98/246 (39%), Gaps = 58/246 (23%)

Query: 95  QKRGKPLPNDANMPPLIGKGGFGSVYKAIIQDGMEV-AVKVFDPQYEGAFKSFDIEC--- 150
           + + +   N+     L+GKG FG V     +      A+K+   + E      ++     
Sbjct: 140 KPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKIL--KKEVIVAKDEVAHTLT 197

Query: 151 --DVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSL-----------EK--CLYLSNY 195
              V++   H  L  +  S+   D    V+EY   G L           E     Y +  
Sbjct: 198 ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA-- 255

Query: 196 ILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE 255
                       ++ SAL+YLH   +  +++ DLK  N++LD +    ++DFG+ K  ++
Sbjct: 256 ------------EIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301

Query: 256 EDQSLTQTQTL-ATIGYMAPE------YGREGRVSTNGDVYSFGIMLMEIFTRTKP---- 304
           +  +    +T   T  Y+APE      YGR   V    D +  G+++ E+     P    
Sbjct: 302 DGAT---MKTFCGTPEYLAPEVLEDNDYGRA--V----DWWGLGVVMYEMMCGRLPFYNQ 352

Query: 305 -TDEIF 309
             +++F
Sbjct: 353 DHEKLF 358

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 75.9 bits (187), Expect = 2e-15
 Identities = 62/249 (24%), Positives = 101/249 (40%), Gaps = 80/249 (32%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVK-VFDPQYEGAFKSFDIECDVMKRI-----------C 157
           +GKG +G V+K+I  + G  VAVK +FD         F    D  +R             
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDA--------FQNSTDA-QRTFREIMILTELSG 67

Query: 158 HRNLIKIISSYSNDDFKA--LVLEYMPHGSLEKCLY---LSN----YILDIFQRLDIMID 208
           H N++ +++    D+ +   LV +YM    L   +    L      Y+  ++Q +     
Sbjct: 68  HENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRANILEPVHKQYV--VYQLI----- 119

Query: 209 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ------ 262
               ++YLH   S  ++H D+KPSN+LL+      ++DFG+++  +   +          
Sbjct: 120 --KVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSIN 174

Query: 263 -------------TQTLATIGYMAPE-------YGREGRVSTNGDVYSFGIMLMEIFTRT 302
                        T  +AT  Y APE       Y      +   D++S G +L EI    
Sbjct: 175 ENTENFDDDQPILTDYVATRWYRAPEILLGSTKY------TKGIDMWSLGCILGEILCG- 227

Query: 303 KPTDEIFSG 311
           KP   IF G
Sbjct: 228 KP---IFPG 233

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 74.6 bits (184), Expect = 2e-15
 Identities = 57/235 (24%), Positives = 102/235 (43%), Gaps = 43/235 (18%)

Query: 93  RYQKRGKPLPNDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKV--FDPQYEGAFKSFDI- 148
           RY++  K           +G+G +G VYKAI       VA+K    + + EG        
Sbjct: 35  RYRRITK-----------LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEG----VPGT 79

Query: 149 ---ECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYI-LDIFQRLD 204
              E  ++K + HRN+I++ S   ++    L+ EY  +  L+K  Y+     + +     
Sbjct: 80  AIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKK--YMDKNPDVSMRVIKS 136

Query: 205 IMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAH-----LSDFGMAKPLLEEDQS 259
            +  + + + + H   S   +H DLKP N+LL  +  +      + DFG+A+      + 
Sbjct: 137 FLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQ 193

Query: 260 LTQTQTLATIGYMAPE--YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE 312
              T  + T+ Y  PE   G     ST+ D++S   +  E+  +  P   +F G+
Sbjct: 194 F--THEIITLWYRPPEILLGSR-HYSTSVDIWSIACIWAEMLMK-TP---LFPGD 241

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 74.5 bits (184), Expect = 3e-15
 Identities = 56/218 (25%), Positives = 90/218 (41%), Gaps = 49/218 (22%)

Query: 102 PNDANMPPLIGKGGFGSVYKAIIQDGMEV-AVKVFDPQYEGAFKSFDIEC-----DVMKR 155
             D  +   +G G FG V+    +      A+KV   +     +   +E       ++  
Sbjct: 5   LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEI--VVRLKQVEHTNDERLMLSI 62

Query: 156 ICHRNLIKIISSYSNDDFKALVLEYMPHGS----LEKCLYLSN-----YILDIFQRLDIM 206
           + H  +I++  ++ +     ++++Y+  G     L K     N     Y  ++       
Sbjct: 63  VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV------- 115

Query: 207 IDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL 266
                ALEYLH   S  II+ DLKP N+LLD N    ++DFG AK           T TL
Sbjct: 116 ---CLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAK------YVPDVTYTL 163

Query: 267 -ATIGYMAPE------YGREGRVSTNGDVYSFGIMLME 297
             T  Y+APE      Y +   +    D +SFGI++ E
Sbjct: 164 CGTPDYIAPEVVSTKPYNKS--I----DWWSFGILIYE 195

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 73.8 bits (182), Expect = 6e-15
 Identities = 60/239 (25%), Positives = 99/239 (41%), Gaps = 47/239 (19%)

Query: 93  RYQKRGKPLPNDANMPPLIGKGGFGSVYKA--IIQDGMEVAVKV--FDPQYEGAFKSFDI 148
           +Y+   +           IG+G +G V+KA  +   G  VA+K        EG      +
Sbjct: 12  QYECVAE-----------IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG----MPL 56

Query: 149 ----ECDVMKRI---CHRN---LIKIISSYSNDDFKA--LVLEYMPHGSLEKCL-YLSNY 195
               E  V++ +    H N   L  + +    D      LV E++    L   L  +   
Sbjct: 57  STIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEP 115

Query: 196 ILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE 255
            +      D+M  +   L++LH   S  ++H DLKP N+L+  +    L+DFG+A+    
Sbjct: 116 GVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY-- 170

Query: 256 EDQSLTQTQTLATIGYMAPE--YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE 312
               +  T  + T+ Y APE         +T  D++S G +  E+F R KP   +F G 
Sbjct: 171 -SFQMALTSVVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRR-KP---LFRGS 222

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 73.4 bits (181), Expect = 7e-15
 Identities = 59/248 (23%), Positives = 108/248 (43%), Gaps = 75/248 (30%)

Query: 102 PNDANMPPLIGKGGFGSVY---KAIIQDGMEV-AVKVFDPQYEGAFKSF-----DIEC-- 150
           P+   +  ++G+G FG V+   K    D  ++ A+KV         K+       +    
Sbjct: 23  PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLK-------KATLKVRDRVRTKM 75

Query: 151 --DVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSL-----------EK--CLYLSNY 195
             D++  + H  ++K+  ++  +    L+L+++  G L           E+    YL+  
Sbjct: 76  ERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-- 133

Query: 196 ILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAH--LSDFGMAKPL 253
                       ++A AL++LH   S  II+ DLKP N+LLD+    H  L+DFG++K  
Sbjct: 134 ------------ELALALDHLH---SLGIIYRDLKPENILLDEE--GHIKLTDFGLSKES 176

Query: 254 LEEDQSLTQTQTL-ATIGYMAPE------YGREGRVSTNGDVYSFGIMLMEIFTRTKP-- 304
           ++ ++      +   T+ YMAPE      + +        D +SFG+++ E+ T T P  
Sbjct: 177 IDHEKK---AYSFCGTVEYMAPEVVNRRGHTQS--A----DWWSFGVLMFEMLTGTLPFQ 227

Query: 305 ---TDEIF 309
                E  
Sbjct: 228 GKDRKETM 235

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 73.4 bits (181), Expect = 8e-15
 Identities = 55/244 (22%), Positives = 94/244 (38%), Gaps = 69/244 (28%)

Query: 102 PNDANMPPLIGKGGFGSVYKAIIQDGMEV-AVKVFDPQYEGAFKSF-----DIEC----- 150
            ND +   L+GKG FG V     +      A+K+         K       ++       
Sbjct: 4   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILR-------KEVIIAKDEVAHTVTES 56

Query: 151 DVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSL-----------EK--CLYLSNYIL 197
            V++   H  L  +  ++   D    V+EY   G L           E+    Y +    
Sbjct: 57  RVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA---- 112

Query: 198 DIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED 257
                     ++ SALEYLH   S  +++ D+K  N++LD +    ++DFG+ K  + + 
Sbjct: 113 ----------EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159

Query: 258 QSLTQTQTL-ATIGYMAPE------YGREGRVSTNGDVYSFGIMLMEIFTRTKP-----T 305
            +    +T   T  Y+APE      YGR   V    D +  G+++ E+     P      
Sbjct: 160 AT---MKTFCGTPEYLAPEVLEDNDYGRA--V----DWWGLGVVMYEMMCGRLPFYNQDH 210

Query: 306 DEIF 309
           + +F
Sbjct: 211 ERLF 214

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 72.6 bits (179), Expect = 1e-14
 Identities = 59/251 (23%), Positives = 102/251 (40%), Gaps = 65/251 (25%)

Query: 95  QKRGKPLPNDANMPPLIGKGGFGSVY---KAIIQDGMEV-AVKVFDPQYEGAFKSFDIEC 150
           +   K  P    +  ++GKGG+G V+   K    +  ++ A+KV          + D   
Sbjct: 9   RGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVR-NAKDTAH 67

Query: 151 -----DVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSL-----------EK--CLYL 192
                ++++ + H  ++ +I ++       L+LEY+  G L           E   C YL
Sbjct: 68  TKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYL 127

Query: 193 SNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAH--LSDFGMA 250
           +              +++ AL +LH      II+ DLKP N++L+     H  L+DFG+ 
Sbjct: 128 A--------------EISMALGHLH---QKGIIYRDLKPENIMLNHQ--GHVKLTDFGLC 168

Query: 251 KPLLEEDQSLTQTQTLA-TIGYMAPE------YGREGRVSTNGDVYSFGIMLMEIFTRTK 303
           K  + +      T T   TI YMAPE      + R   V    D +S G ++ ++ T   
Sbjct: 169 KESIHDGTV---THTFCGTIEYMAPEILMRSGHNRA--V----DWWSLGALMYDMLTGAP 219

Query: 304 P-----TDEIF 309
           P       +  
Sbjct: 220 PFTGENRKKTI 230

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 73.5 bits (180), Expect = 1e-14
 Identities = 65/243 (26%), Positives = 103/243 (42%), Gaps = 52/243 (21%)

Query: 95  QKRGKPLPNDANMPPLIGKGGFGSVYKAIIQDGMEV-AVKVFDPQYEGAFKSFDIECDVM 153
             R +    D N   ++GKG FG V  +  +   E+ AVK+   + +   +  D+EC ++
Sbjct: 333 GNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKIL--KKDVVIQDDDVECTMV 390

Query: 154 -KRI-----CHRNLIKIISSYSNDDFKALVLEYMPHGSL----EKCLYLSN-----YILD 198
            KR+         L ++ S +   D    V+EY+  G L    ++           Y  +
Sbjct: 391 EKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAE 450

Query: 199 IFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ 258
           I          A  L +L    S  II+ DLK  NV+LD      ++DFGM K  + +  
Sbjct: 451 I----------AIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV 497

Query: 259 SLTQTQTLA-TIGYMAPE------YGREGRVSTNGDVYSFGIMLMEIFTRTKP-----TD 306
               T+T   T  Y+APE      YG+   V    D ++FG++L E+     P      D
Sbjct: 498 ---TTKTFCGTPDYIAPEIIAYQPYGKS--V----DWWAFGVLLYEMLAGQAPFEGEDED 548

Query: 307 EIF 309
           E+F
Sbjct: 549 ELF 551

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 71.9 bits (177), Expect = 3e-14
 Identities = 54/232 (23%), Positives = 94/232 (40%), Gaps = 52/232 (22%)

Query: 95  QKRGKPLPNDANMPPLIGKGGFGSVY---KAIIQDGMEV-AVKVFDPQYEGAFKSF---- 146
               K    +  +  ++G G +G V+   K    D  ++ A+KV         K+     
Sbjct: 46  GHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLK-------KATIVQK 98

Query: 147 --DIEC-----DVMKRICHRN-LIKIISSYSNDDFKALVLEYMPHGSL----EKCLYLSN 194
               E       V++ I     L+ +  ++  +    L+L+Y+  G L     +    + 
Sbjct: 99  AKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTE 158

Query: 195 -----YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAH--LSDF 247
                Y+ +I            ALE+LH      II+ D+K  N+LLD N   H  L+DF
Sbjct: 159 HEVQIYVGEI----------VLALEHLH---KLGIIYRDIKLENILLDSN--GHVVLTDF 203

Query: 248 GMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDV--YSFGIMLME 297
           G++K  + ++          TI YMAP+  R G    +  V  +S G+++ E
Sbjct: 204 GLSKEFVADETERAYD-FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYE 254

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 71.3 bits (175), Expect = 3e-14
 Identities = 39/150 (26%), Positives = 66/150 (44%), Gaps = 17/150 (11%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLI-KIISSY 168
           IG G FG +     +     VA+K+     +       +E    K++   + I ++    
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIKL--EPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFG 74

Query: 169 SNDDFKALVLEYMPHG-SLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHC 227
               + A+VLE +  G SLE    L +    +   L I I + S +EY+H   S  +I+ 
Sbjct: 75  PCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYR 129

Query: 228 DLKPSNVLL------DDNMVAHLSDFGMAK 251
           D+KP N L+         ++ H+ DF +AK
Sbjct: 130 DVKPENFLIGRPGNKTQQVI-HIIDFALAK 158

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 70.5 bits (173), Expect = 8e-14
 Identities = 47/239 (19%), Positives = 90/239 (37%), Gaps = 44/239 (18%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVF--DPQYEGAFKSFDIECDVMKRI--------CH 158
            +G G F +V+ A  + +   VA+K+   D  Y    ++ + E  +++R+          
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY---TEAAEDEIKLLQRVNDADNTKEDS 82

Query: 159 RNLIKIISSYSNDDFKA-------LVLEYMPHGSLEKCLYLSNYI---LDIFQRLDIMID 208
                I+    + + K        +V E +   +L   +    +    L   ++  I   
Sbjct: 83  MGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQ--ISKQ 139

Query: 209 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAH------LSDFGMAKPLLEEDQSLTQ 262
           +   L+Y+H      IIH D+KP NVL++            ++D G A    E   +  Q
Sbjct: 140 LLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 197

Query: 263 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVND 321
           T+      Y +PE           D++S   ++ E+ T     D +F  +       +D
Sbjct: 198 TRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITG----DFLFEPDEGHSYTKDD 247

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 69.3 bits (170), Expect = 1e-13
 Identities = 31/149 (20%), Positives = 59/149 (39%), Gaps = 15/149 (10%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLI-KIISSY 168
           IG+G FG +++   + +  +VA+K               E    K +     I  +    
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIK--FEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFG 75

Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCD 228
                  LV++ +   SLE  L L      +         + + ++ +H      +++ D
Sbjct: 76  QEGLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRD 131

Query: 229 LKPSNVLL------DDNMVAHLSDFGMAK 251
           +KP N L+      + NM+ ++ DFGM K
Sbjct: 132 IKPDNFLIGRPNSKNANMI-YVVDFGMVK 159

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 69.2 bits (170), Expect = 2e-13
 Identities = 52/219 (23%), Positives = 94/219 (42%), Gaps = 44/219 (20%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRIC-HRNLIKII--- 165
           +G+G +  V++AI I +  +V VK+  P  +   K    E  +++ +    N+I +    
Sbjct: 44  LGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPNIITLADIV 100

Query: 166 -SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDI---MIDVASALEYLHFGYS 221
               S     ALV E++ +   ++       +       DI   M ++  AL+Y H   S
Sbjct: 101 KDPVSRTP--ALVFEHVNNTDFKQ-------LYQTLTDYDIRFYMYEILKALDYCH---S 148

Query: 222 APIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE----- 275
             I+H D+KP NV++D ++    L D+G+A+      +       +A+  +  PE     
Sbjct: 149 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPELLVDY 205

Query: 276 --YGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE 312
             Y        + D++S G ML  +  R +P    F G 
Sbjct: 206 QMY------DYSLDMWSLGCMLASMIFRKEP---FFHGH 235

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 68.8 bits (169), Expect = 3e-13
 Identities = 61/235 (25%), Positives = 92/235 (39%), Gaps = 65/235 (27%)

Query: 95  QKRGKPLPNDANMPPLIGKGGFGSVYKAIIQDGMEV-AVKVFDPQYEGAFKSF-----DI 148
             R +    D N   ++GKG FG V  +  +   E+ AVK+         K       D+
Sbjct: 12  GNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILK-------KDVVIQDDDV 64

Query: 149 EC-----DVMKRIC-HRNLIKIISSYSNDDFKALVLEYMPHGSL-----------EK--C 189
           EC      V+        L ++ S +   D    V+EY+  G L           E    
Sbjct: 65  ECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAV 124

Query: 190 LYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGM 249
            Y +              ++A  L +L    S  II+ DLK  NV+LD      ++DFGM
Sbjct: 125 FYAA--------------EIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGM 167

Query: 250 AKPLLEEDQSLTQTQTL-ATIGYMAPE------YGREGRVSTNGDVYSFGIMLME 297
            K  + +      T+T   T  Y+APE      YG+   V    D ++FG++L E
Sbjct: 168 CKENIWDGV---TTKTFCGTPDYIAPEIIAYQPYGKS--V----DWWAFGVLLYE 213

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 68.4 bits (168), Expect = 5e-13
 Identities = 67/254 (26%), Positives = 99/254 (38%), Gaps = 74/254 (29%)

Query: 95  QKRGKPLPNDANMPPLIGKGGFGSVYKAIIQDGMEV-AVKVFDPQYEGAFKSF-----DI 148
                  P+D +   +IGKG FG V  A  +      AVKV         K       + 
Sbjct: 30  SSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQ-------KKAILKKKEE 82

Query: 149 ECDVM-KRICHRN-----LIKIISSYSNDDFKALVLEYMPHGSL-----------EK--C 189
           +  +  + +  +N     L+ +  S+   D    VL+Y+  G L           E    
Sbjct: 83  KHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRAR 142

Query: 190 LYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAH--LSDF 247
            Y +              ++ASAL YLH   S  I++ DLKP N+LLD     H  L+DF
Sbjct: 143 FYAA--------------EIASALGYLH---SLNIVYRDLKPENILLDSQ--GHIVLTDF 183

Query: 248 GMAKPLLEEDQSLTQTQTL-ATIGYMAPE------YGREGRVSTNGDVYSFGIMLMEIFT 300
           G+ K  +E + +   T T   T  Y+APE      Y R   V    D +  G +L E+  
Sbjct: 184 GLCKENIEHNST---TSTFCGTPEYLAPEVLHKQPYDRT--V----DWWCLGAVLYEMLY 234

Query: 301 RTKP-----TDEIF 309
              P     T E++
Sbjct: 235 GLPPFYSRNTAEMY 248

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 68.2 bits (167), Expect = 6e-13
 Identities = 51/205 (24%), Positives = 89/205 (43%), Gaps = 28/205 (13%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVF--DPQYEGAFKSFDIECDVMKRICHR---NLIK 163
           +IGKG FG V KA   +    VA+K+   + ++    +    E  +++ +  +   N + 
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRF---HRQAAEEIRILEHLRKQDKDNTMN 160

Query: 164 IISSYSNDDFKA---LVLEYMPHGSLEKCLYLSNYI---LDIFQRLDIMIDVASALEYLH 217
           +I    N  F+    +  E +   +L + +  + +    L + ++      +   L+ LH
Sbjct: 161 VIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRK--FAHSILQCLDALH 217

Query: 218 FGYSAPIIHCDLKPSNVLLDDNMVAH--LSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE 275
                 IIHCDLKP N+LL     +   + DFG +    E  +  T  Q+     Y APE
Sbjct: 218 ---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC--YEHQRVYTYIQSRF---YRAPE 269

Query: 276 YGREGRVSTNGDVYSFGIMLMEIFT 300
                R     D++S G +L E+ T
Sbjct: 270 VILGARYGMPIDMWSLGCILAELLT 294

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 67.0 bits (164), Expect = 7e-13
 Identities = 41/146 (28%), Positives = 63/146 (43%), Gaps = 11/146 (7%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLI-KIISSY 168
           IG G FG +Y    I  G EVA+K      +       IE  + K +     I  I    
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIK--LECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCG 74

Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCD 228
           +  D+  +V+E +   SLE      +    +   L +   + S +EY+H   S   IH D
Sbjct: 75  AEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRD 130

Query: 229 LKPSNVLL---DDNMVAHLSDFGMAK 251
           +KP N L+       + ++ DFG+AK
Sbjct: 131 VKPDNFLMGLGKKGNLVYIIDFGLAK 156

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 67.2 bits (165), Expect = 9e-13
 Identities = 61/240 (25%), Positives = 100/240 (41%), Gaps = 42/240 (17%)

Query: 93  RYQKRGKPLPNDANMPPLIGKGGFGSVYKAIIQDGMEV-AVKVFDPQYEGAFKSFDIECD 151
           R   + K    D  +  ++GKG FG V+ A  +   +  A+K    + +      D+EC 
Sbjct: 7   RPSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKAL--KKDVVLMDDDVEC- 63

Query: 152 VM--KRICHRN-----LIKIISSYSNDDFKALVLEYMPHGSL----EKCLYLSN-----Y 195
            M  KR+         L  +  ++   +    V+EY+  G L    + C          Y
Sbjct: 64  TMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFY 123

Query: 196 ILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE 255
             +I             L++LH   S  I++ DLK  N+LLD +    ++DFGM K  + 
Sbjct: 124 AAEI----------ILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML 170

Query: 256 EDQSLTQTQTL-ATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKP-----TDEIF 309
            D     T T   T  Y+APE     + + + D +SFG++L E+     P      +E+F
Sbjct: 171 GDAK---TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF 227

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 66.9 bits (164), Expect = 1e-12
 Identities = 59/235 (25%), Positives = 91/235 (38%), Gaps = 65/235 (27%)

Query: 95  QKRGKPLPNDANMPPLIGKGGFGSVYKAIIQDGMEV-AVKVFDPQYEGAFKSF-----DI 148
               +   ++     ++GKG FG V  A +++  ++ AVKV         K       D+
Sbjct: 15  NSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLK-------KDVILQDDDV 67

Query: 149 EC-----DVMKRIC-HRNLIKIISSYSNDDFKALVLEYMPHGSL-----------EK--C 189
           EC      ++     H  L ++   +   D    V+E++  G L           E    
Sbjct: 68  ECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARAR 127

Query: 190 LYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGM 249
            Y +              ++ SAL +LH      II+ DLK  NVLLD      L+DFGM
Sbjct: 128 FYAA--------------EIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGM 170

Query: 250 AKPLLEEDQSLTQTQTL-ATIGYMAPE------YGREGRVSTNGDVYSFGIMLME 297
            K  +    +   T T   T  Y+APE      YG    V    D ++ G++L E
Sbjct: 171 CKEGICNGVT---TATFCGTPDYIAPEILQEMLYGPA--V----DWWAMGVLLYE 216

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 67.0 bits (163), Expect = 2e-12
 Identities = 37/147 (25%), Positives = 62/147 (42%), Gaps = 11/147 (7%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLI-KIISSY 168
           IG G FG +Y    IQ   EVA+K      +        E  + + +     I  +    
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLLYESKIYRILQGGTGIPNVRWFG 72

Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCD 228
              D+  LV++ +   SLE      +  L +   L +   + + +E++H   S   +H D
Sbjct: 73  VEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRD 128

Query: 229 LKPSNVLLDDNMVAH---LSDFGMAKP 252
           +KP N L+     A+   + DFG+AK 
Sbjct: 129 IKPDNFLMGLGRRANQVYIIDFGLAKK 155

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 65.7 bits (161), Expect = 3e-12
 Identities = 57/219 (26%), Positives = 89/219 (40%), Gaps = 47/219 (21%)

Query: 102 PNDANMPPLIGKGGFGSVYKAIIQDGMEV-AVKVFDPQYEGAFKSFDIEC-----DVMKR 155
             D ++  +IG+G +  V    ++    + A+KV   + E      DI+       V ++
Sbjct: 8   LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVV--KKELVNDDEDIDWVQTEKHVFEQ 65

Query: 156 IC-HRNLIKIISSYSNDDFKALVLEYMPHGSL----EKCLYLSN-----YILDIFQRLDI 205
              H  L+ + S +  +     V+EY+  G L    ++   L       Y  +I      
Sbjct: 66  ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEI------ 119

Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
               + AL YLH      II+ DLK  NVLLD      L+D+GM K  L        T T
Sbjct: 120 ----SLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTST 169

Query: 266 L-ATIGYMAPE------YGREGRVSTNGDVYSFGIMLME 297
              T  Y+APE      YG    V    D ++ G+++ E
Sbjct: 170 FCGTPNYIAPEILRGEDYGFS--V----DWWALGVLMFE 202

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 65.1 bits (159), Expect = 6e-12
 Identities = 56/226 (24%), Positives = 90/226 (39%), Gaps = 47/226 (20%)

Query: 95  QKRGKPLPNDANMPPLIGKGGFGSVYKAIIQDGMEV-AVKVFDPQYEGAFKSFDIEC--- 150
           +        D ++  +IG+G +  V    ++    + A++V   + E      DI+    
Sbjct: 44  KASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVV--KKELVNDDEDIDWVQT 101

Query: 151 --DVMKRIC-HRNLIKIISSYSNDDFKALVLEYMPHGSL----EKCLYLSN-----YILD 198
              V ++   H  L+ + S +  +     V+EY+  G L    ++   L       Y  +
Sbjct: 102 EKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAE 161

Query: 199 IFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ 258
           I          + AL YLH      II+ DLK  NVLLD      L+D+GM K  L    
Sbjct: 162 I----------SLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 208

Query: 259 SLTQTQTL-ATIGYMAPE------YGREGRVSTNGDVYSFGIMLME 297
               T T   T  Y+APE      YG    V    D ++ G+++ E
Sbjct: 209 ---TTSTFCGTPNYIAPEILRGEDYGFS--V----DWWALGVLMFE 245

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 64.3 bits (157), Expect = 1e-11
 Identities = 15/77 (19%), Positives = 32/77 (41%), Gaps = 2/77 (2%)

Query: 1   QGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPR--EGPF 58
           +   P +   L +L+ LN+S+NN         + L  L+ ++ S N +     +  +   
Sbjct: 483 EQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFP 542

Query: 59  RNLSVKSFEGNELLCEI 75
            +L+  +   N+  C  
Sbjct: 543 SSLAFLNLTQNDFACTC 559

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 58.1 bits (141), Expect = 2e-09
 Identities = 12/62 (19%), Positives = 23/62 (37%), Gaps = 2/62 (3%)

Query: 1   QGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRN 60
           +     S      L+ L+LS   +      + + L  L  + ++ N ++      G F  
Sbjct: 41  RHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLAL--GAFSG 98

Query: 61  LS 62
           LS
Sbjct: 99  LS 100

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 57.3 bits (139), Expect = 3e-09
 Identities = 11/62 (17%), Positives = 20/62 (32%), Gaps = 2/62 (3%)

Query: 1   QGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRN 60
           Q     +   L +L +L L+ N +      +   L  L+ +      L        P  +
Sbjct: 65  QTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLEN--FPIGH 122

Query: 61  LS 62
           L 
Sbjct: 123 LK 124

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 57.0 bits (138), Expect = 4e-09
 Identities = 15/62 (24%), Positives = 26/62 (41%), Gaps = 1/62 (1%)

Query: 1   QGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRN 60
           Q     +   L +L+ L     NL+      +  L  LK++NV+ N ++        F N
Sbjct: 89  QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS-FKLPEYFSN 147

Query: 61  LS 62
           L+
Sbjct: 148 LT 149

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 56.2 bits (136), Expect = 7e-09
 Identities = 17/59 (28%), Positives = 27/59 (45%), Gaps = 2/59 (3%)

Query: 4   IPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLS 62
           +PD   +L NL  L+LS   L    P +   L  L+ +N+S N          P++ L+
Sbjct: 462 LPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDT--FPYKCLN 518

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 54.3 bits (131), Expect = 3e-08
 Identities = 14/63 (22%), Positives = 28/63 (44%), Gaps = 3/63 (4%)

Query: 1   QGSIPDSIGDLINLKSLNLSNNNLSGTI-PISLEKLLDLKDINVSFNKLEGEIPREGPFR 59
           + +       L +L+ L ++ N+      P    +L +L  +++S  +LE   P    F 
Sbjct: 434 RVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTA--FN 491

Query: 60  NLS 62
           +LS
Sbjct: 492 SLS 494

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 53.9 bits (130), Expect = 4e-08
 Identities = 14/62 (22%), Positives = 26/62 (41%), Gaps = 2/62 (3%)

Query: 1   QGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRN 60
           +G    S     +LK L+LS N +  T+  +   L  L+ ++   + L+        F +
Sbjct: 362 KGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSE-FSVFLS 419

Query: 61  LS 62
           L 
Sbjct: 420 LR 421

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 52.7 bits (127), Expect = 8e-08
 Identities = 15/71 (21%), Positives = 32/71 (45%), Gaps = 2/71 (2%)

Query: 1   QGSIPDSIGDLINLKSLNLSNNNL-SGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPF 58
                  IG L  LK LN+++N + S  +P     L +L+ +++S NK++     +    
Sbjct: 113 ASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVL 172

Query: 59  RNLSVKSFEGN 69
             + + +   +
Sbjct: 173 HQMPLLNLSLD 183

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 51.2 bits (123), Expect = 3e-07
 Identities = 16/68 (23%), Positives = 30/68 (44%), Gaps = 6/68 (8%)

Query: 2   GSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKL----LDLKDINVSFNKLEGEIPREGP 57
             +P+   +L NL+ L+LS+N +       L  L    L    +++S N +    P  G 
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQP--GA 196

Query: 58  FRNLSVKS 65
           F+ + +  
Sbjct: 197 FKEIRLHK 204

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 50.4 bits (121), Expect = 5e-07
 Identities = 14/60 (23%), Positives = 30/60 (50%), Gaps = 4/60 (6%)

Query: 3  SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLS 62
           IPD++    + K+L+LS N L      S     +L+ +++S  +++        +++LS
Sbjct: 21 KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGA--YQSLS 76

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 50.0 bits (120), Expect = 7e-07
 Identities = 12/61 (19%), Positives = 23/61 (37%), Gaps = 3/61 (4%)

Query: 3   SIPDSIGDLINLKSLNLSNNNLSGTIPIS-LEKLLDLKDINVSFNKLEGEIPREGPFRNL 61
           ++  +   L  L+ L+  ++NL      S    L +L  +++S             F  L
Sbjct: 387 TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGI--FNGL 444

Query: 62  S 62
           S
Sbjct: 445 S 445

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 49.6 bits (119), Expect = 7e-07
 Identities = 13/74 (17%), Positives = 27/74 (36%), Gaps = 3/74 (4%)

Query: 1   QGSIPDSI-GDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE--GP 57
           +     S+   L NL  L++S+ +           L  L+ + ++ N  +     +    
Sbjct: 409 KQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 468

Query: 58  FRNLSVKSFEGNEL 71
            RNL+       +L
Sbjct: 469 LRNLTFLDLSQCQL 482

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 49.6 bits (119), Expect = 7e-07
 Identities = 21/73 (28%), Positives = 31/73 (42%), Gaps = 2/73 (2%)

Query: 1   QGSIPDSIGDLINLKSLNLSNNNLS--GTIPISLEKLLDLKDINVSFNKLEGEIPREGPF 58
           +G    S  DL +L+ L+LS N LS  G    S      LK +++SFN +          
Sbjct: 336 KGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGL 395

Query: 59  RNLSVKSFEGNEL 71
             L    F+ + L
Sbjct: 396 EQLEHLDFQHSNL 408

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 45.8 bits (109), Expect = 1e-05
 Identities = 15/78 (19%), Positives = 31/78 (39%), Gaps = 8/78 (10%)

Query: 1   QGSIPDSIGDLI-NLKSLNLSNNNLSGTIPIS--LEKLLDLKDINVSFNKLEGEIPREGP 57
             S    +     +L  LNL+ N+ + T      L+ + D + + V   ++E   P    
Sbjct: 531 MTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATP--SD 588

Query: 58  FRNLSVKSFEGNELLCEI 75
            + + V S     + C++
Sbjct: 589 KQGMPVLSL---NITCQM 603

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 45.0 bits (107), Expect = 2e-05
 Identities = 14/78 (17%), Positives = 26/78 (33%), Gaps = 3/78 (3%)

Query: 2   GSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRN 60
             I D    L N+ S +L +  +      S       + + +   K       +    + 
Sbjct: 272 DDIIDLFNCLTNVSSFSLVSVTIERVKDFSY--NFGWQHLELVNCKFGQFPTLKLKSLKR 329

Query: 61  LSVKSFEGNELLCEIVLP 78
           L+  S +G     E+ LP
Sbjct: 330 LTFTSNKGGNAFSEVDLP 347

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 44.6 bits (106), Expect = 3e-05
 Identities = 14/78 (17%), Positives = 25/78 (32%), Gaps = 7/78 (8%)

Query: 1   QGSIPDSIGDLINLK----SLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE- 55
           Q      +  L  +     SL+LS N ++   P +  K + L  + +  N     + +  
Sbjct: 162 QSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF-KEIRLHKLTLRNNFDSLNVMKTC 220

Query: 56  -GPFRNLSVKSFEGNELL 72
                 L V      E  
Sbjct: 221 IQGLAGLEVHRLVLGEFR 238

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 41.2 bits (97), Expect = 4e-04
 Identities = 14/74 (18%), Positives = 22/74 (29%), Gaps = 5/74 (6%)

Query: 3   SIPDSIGDLINLKSLNLSNNNLSGTIP-ISLEKLLDLKDINVSFNKLEGEI----PREGP 57
            I       I L  L L NN  S  +    ++ L  L+   +   +   E       +  
Sbjct: 191 FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250

Query: 58  FRNLSVKSFEGNEL 71
              L   + E   L
Sbjct: 251 LEGLCNLTIEEFRL 264

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 63.2 bits (154), Expect = 2e-11
 Identities = 34/168 (20%), Positives = 66/168 (39%), Gaps = 31/168 (18%)

Query: 109 PLIGKGGFGSVYKAI------IQDGMEVAVKVF---DPQ--YEGAFKSFDIECDVMKRIC 157
             IG+GGFG +Y A       +       VKV    +     E  F     + + +++  
Sbjct: 41  LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWI 100

Query: 158 HRNLIKII----------SSYSNDDFKALVLEYMPHG-SLEKCLYLSNYILDIFQRLDIM 206
               +K +             +   ++ ++++    G  L+K    +         L + 
Sbjct: 101 RTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTVLQLS 158

Query: 207 IDVASALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFGMAK 251
           + +   LEY+H       +H D+K SN+LL   + + V +L D+G+A 
Sbjct: 159 LRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQV-YLVDYGLAY 202

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 63.5 bits (155), Expect = 3e-11
 Identities = 18/77 (23%), Positives = 28/77 (36%), Gaps = 2/77 (2%)

Query: 1   QGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPR--EGPF 58
                +   DL  LK ++L  NNL+          + LK +N+  N +     +     F
Sbjct: 549 DEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAF 608

Query: 59  RNLSVKSFEGNELLCEI 75
           RNL+      N   C  
Sbjct: 609 RNLTELDMRFNPFDCTC 625

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 54.6 bits (132), Expect = 2e-08
 Identities = 17/62 (27%), Positives = 30/62 (48%)

Query: 1   QGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRN 60
           Q    +      NL +L+LS+N LS T   +  +L +L+++ +S NK++     E     
Sbjct: 110 QKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFA 169

Query: 61  LS 62
            S
Sbjct: 170 NS 171

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 54.6 bits (132), Expect = 2e-08
 Identities = 14/62 (22%), Positives = 24/62 (38%), Gaps = 2/62 (3%)

Query: 1   QGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRN 60
               P+    L  LK LNL +N LS     +     +L ++++  N ++       PF  
Sbjct: 62  SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKN--NPFVK 119

Query: 61  LS 62
             
Sbjct: 120 QK 121

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 54.6 bits (132), Expect = 2e-08
 Identities = 14/62 (22%), Positives = 24/62 (38%), Gaps = 2/62 (3%)

Query: 1  QGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRN 60
          +     +      L SL++  N +S   P   +KL  LK +N+  N+L         F  
Sbjct: 38 RRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSD--KTFAF 95

Query: 61 LS 62
           +
Sbjct: 96 CT 97

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 53.9 bits (130), Expect = 4e-08
 Identities = 12/62 (19%), Positives = 21/62 (33%), Gaps = 2/62 (3%)

Query: 1   QGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRN 60
                 +     NL  L+L +N++         K  +L  +++S N L       G    
Sbjct: 86  SQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKL--GTQVQ 143

Query: 61  LS 62
           L 
Sbjct: 144 LE 145

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 53.1 bits (128), Expect = 6e-08
 Identities = 11/58 (18%), Positives = 19/58 (32%)

Query: 5   PDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLS 62
                 L N+  + LS N        S   +  L+ + +    L+       PF+ L 
Sbjct: 423 GQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLR 480

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 51.2 bits (123), Expect = 3e-07
 Identities = 15/61 (24%), Positives = 22/61 (36%), Gaps = 2/61 (3%)

Query: 2   GSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNL 61
           G     +  L +L  LNL +N          + L +LK I++  N L         F N 
Sbjct: 526 GGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPA--SVFNNQ 583

Query: 62  S 62
            
Sbjct: 584 V 584

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 50.4 bits (121), Expect = 5e-07
 Identities = 13/65 (20%), Positives = 26/65 (40%)

Query: 1   QGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRN 60
                 S   L  L+ LN+ +N++ G        L++LK +++S +           F +
Sbjct: 318 PKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVS 377

Query: 61  LSVKS 65
           L+   
Sbjct: 378 LAHSP 382

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 50.4 bits (121), Expect = 5e-07
 Identities = 14/60 (23%), Positives = 25/60 (41%), Gaps = 4/60 (6%)

Query: 3  SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLS 62
           +PD +    N+  LNL++N L      +  +   L  ++V FN +    P     + L 
Sbjct: 18 QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPEL--CQKLP 73

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 49.2 bits (118), Expect = 1e-06
 Identities = 12/50 (24%), Positives = 23/50 (46%), Gaps = 1/50 (2%)

Query: 13  NLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLS 62
            L  LNL+ N +S     +   L  L+ +++  N++  E+     +R L 
Sbjct: 382 PLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTG-QEWRGLE 430

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 48.8 bits (117), Expect = 1e-06
 Identities = 13/73 (17%), Positives = 25/73 (34%), Gaps = 2/73 (2%)

Query: 1   QGSIPDSIGDLINLKSLNLSNNNLSGTIPIS-LEKLLDLKDINVSFNKLEGEIPRE-GPF 58
                D+   L +L+ L+L  N +   +       L ++ +I +S+NK            
Sbjct: 394 SKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALV 453

Query: 59  RNLSVKSFEGNEL 71
            +L         L
Sbjct: 454 PSLQRLMLRRVAL 466

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 48.8 bits (117), Expect = 1e-06
 Identities = 14/64 (21%), Positives = 23/64 (35%), Gaps = 4/64 (6%)

Query: 1   QGSIPDSIGDL--INLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPF 58
             +   +   L   NL  L+LS NNL+     S   L  L+   + +N ++         
Sbjct: 235 STTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHS--L 292

Query: 59  RNLS 62
             L 
Sbjct: 293 HGLF 296

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 48.8 bits (117), Expect = 1e-06
 Identities = 11/70 (15%), Positives = 25/70 (35%), Gaps = 5/70 (7%)

Query: 1   QGSIPDSIGDLINLKSLNLSNNNLSGTIPISL---EKLLDLKDINVSFNKLEGEIPREGP 57
           +   P     +  L  L L+N  L  ++   L        ++++++S ++L         
Sbjct: 184 KEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSN--TT 241

Query: 58  FRNLSVKSFE 67
           F  L   +  
Sbjct: 242 FLGLKWTNLT 251

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 47.7 bits (114), Expect = 4e-06
 Identities = 20/76 (26%), Positives = 32/76 (42%), Gaps = 2/76 (2%)

Query: 2   GSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNL 61
            S P     L NL  L+LSNNN++      LE L  L+ +++  N L   + +       
Sbjct: 470 DSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLA-RLWKHA-NPGG 527

Query: 62  SVKSFEGNELLCEIVL 77
            +   +G   L  + L
Sbjct: 528 PIYFLKGLSHLHILNL 543

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 47.3 bits (113), Expect = 5e-06
 Identities = 14/69 (20%), Positives = 25/69 (36%), Gaps = 7/69 (10%)

Query: 1   QGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPR------ 54
                DS   L  L+   L  NN+      SL  L +++ +N+  +  +  I        
Sbjct: 261 NVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKI 320

Query: 55  -EGPFRNLS 62
            +  F+ L 
Sbjct: 321 DDFSFQWLK 329

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 46.1 bits (110), Expect = 1e-05
 Identities = 13/74 (17%), Positives = 26/74 (35%), Gaps = 3/74 (4%)

Query: 1   QGSIPDSIGDLINLKSLNLSNNNLSG--TIPISLEKLLDLKDINVSFNKLEGEIPRE-GP 57
                +S   + +L+ L L    L    + P   + L +L  +++S N +          
Sbjct: 443 LQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEG 502

Query: 58  FRNLSVKSFEGNEL 71
              L +   + N L
Sbjct: 503 LEKLEILDLQHNNL 516

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 46.1 bits (110), Expect = 1e-05
 Identities = 13/61 (21%), Positives = 23/61 (37%), Gaps = 1/61 (1%)

Query: 7   SIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSF 66
            I    +LK L LS+N +    P     +  L  + ++  +L   +  E     L+  S 
Sbjct: 166 DIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLT-EKLCLELANTSI 224

Query: 67  E 67
            
Sbjct: 225 R 225

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 41.9 bits (99), Expect = 2e-04
 Identities = 16/71 (22%), Positives = 26/71 (36%), Gaps = 11/71 (15%)

Query: 1   QGSIPDSIGDLINLKSLN---------LSNNNLSGTIPISLEKLLDLKDINVSFNKLEGE 51
           Q     S+  L N++ LN         +S  +L      S + L  L+ +N+  N + G 
Sbjct: 285 QHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGI 344

Query: 52  IPREGPFRNLS 62
                 F  L 
Sbjct: 345 KS--NMFTGLI 353

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 62.8 bits (153), Expect = 3e-11
 Identities = 38/168 (22%), Positives = 69/168 (41%), Gaps = 36/168 (21%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKV--FDPQYEGAFKSFDIECDVMKRICHRNLIKI-- 164
            IG GGFG +Y A       + A  V   + Q  G       E    +R+  ++ IK   
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENG---PLFSELKFYQRVAKKDCIKKWI 100

Query: 165 -----------------ISSYSNDDFKALVLEYMPHG-SLEKCLYLSNYILDIFQRLDIM 206
                            ++ +    ++ +V+E +  G  L+K +   N        L + 
Sbjct: 101 ERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQK-ISGQNGTFKKSTVLQLG 157

Query: 207 IDVASALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFGMAK 251
           I +   LEY+H       +H D+K +N+LL   + + V +L+D+G++ 
Sbjct: 158 IRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQV-YLADYGLSY 201

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 63.1 bits (154), Expect = 4e-11
 Identities = 24/115 (20%), Positives = 42/115 (36%), Gaps = 6/115 (5%)

Query: 2   GSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE--GPFR 59
             +  S+  +  L  L    N L G +P +    + L  +N+++N++   IP    G   
Sbjct: 320 FPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITE-IPANFCGFTE 377

Query: 60  NLSVKSFEGNELLCEIVLPLSTIFMIVMILLILRY-QKRGKPLPNDANMPPLIGK 113
            +   SF  N+ L  I        + VM  +   Y +       N   + P   K
Sbjct: 378 QVENLSFAHNK-LKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFK 431

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 62.0 bits (151), Expect = 9e-11
 Identities = 19/101 (18%), Positives = 33/101 (32%), Gaps = 12/101 (11%)

Query: 3   SIPDSIGDLINLKSLNLSN------NNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREG 56
             P    +   LK   + N      N      P  +     L  + +  N +   +  E 
Sbjct: 527 KFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VN-EK 584

Query: 57  PFRNLSVKSFEGNELLCEIVLPLSTIF-MIVMILLILRYQK 96
              N+SV   + N  +    + LS +   I   + +L Y K
Sbjct: 585 ITPNISVLDIKDNPNIS---IDLSYVCPYIEAGMYMLFYDK 622

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 60.4 bits (147), Expect = 2e-10
 Identities = 14/82 (17%), Positives = 25/82 (30%), Gaps = 7/82 (8%)

Query: 1   QGSIPDSIGDLINLKSLNLSNNNLSG----TIPISLEKLLDLKDINVSFNKLEGEIPREG 56
            G +PD+IG L  L+ L L ++          P  +   +  +         +       
Sbjct: 94  SGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYD 153

Query: 57  P---FRNLSVKSFEGNELLCEI 75
           P   F +L       +     I
Sbjct: 154 PREDFSDLIKDCINSDPQQKSI 175

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 57.7 bits (140), Expect = 2e-09
 Identities = 11/61 (18%), Positives = 27/61 (44%)

Query: 2   GSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNL 61
            +      +L +L  + + N      +P  L+ L +++ INV+ N+       +  ++ L
Sbjct: 239 KTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQAL 298

Query: 62  S 62
           +
Sbjct: 299 A 299

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 55.8 bits (135), Expect = 9e-09
 Identities = 7/71 (9%), Positives = 24/71 (33%), Gaps = 4/71 (5%)

Query: 2   GSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRN 60
              P+ I    +L  L + +N++   +   +    ++  +++  N           P+  
Sbjct: 556 REWPEGITLCPSLTQLQIGSNDIR-KVNEKI--TPNISVLDIKDNPNISIDLSYVCPYIE 612

Query: 61  LSVKSFEGNEL 71
             +     ++ 
Sbjct: 613 AGMYMLFYDKT 623

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 55.8 bits (135), Expect = 9e-09
 Identities = 5/74 (6%), Positives = 21/74 (28%), Gaps = 6/74 (8%)

Query: 3   SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNL 61
            +  ++  L  L+   + N+           +  +       + +       +    ++L
Sbjct: 197 FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENS-----EYAQQYKTEDLKWDNLKDL 251

Query: 62  SVKSFEGNELLCEI 75
           +         L ++
Sbjct: 252 TDVEVYNCPNLTKL 265

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 55.8 bits (135), Expect = 1e-08
 Identities = 16/54 (29%), Positives = 23/54 (42%), Gaps = 1/54 (1%)

Query: 2   GSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE 55
             +  +    IN+ S+NLSNN +S            L  IN+  N L   IP+ 
Sbjct: 423 DPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTE-IPKN 475

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 53.9 bits (130), Expect = 4e-08
 Identities = 12/54 (22%), Positives = 25/54 (46%), Gaps = 1/54 (1%)

Query: 1   QGSIPDSIGDLINLKSLNLSNNNL-SGTIPISLEKLLDLKDINVSFNKLEGEIP 53
                        ++ + +  NNL +  +  SL+K+  L  +   +N+LEG++P
Sbjct: 294 DWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP 347

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 51.6 bits (124), Expect = 2e-07
 Identities = 12/73 (16%), Positives = 22/73 (30%), Gaps = 3/73 (4%)

Query: 2   GSIPDSIGDLINLKSLNLSNNNLSGTIP-ISLEKLLDLKDINVSFNKLEGEIPRE-GPFR 59
               ++  +   L S++L  N L+          L  L  I++S+N      P +     
Sbjct: 478 KDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSS 536

Query: 60  NLSVKSFEGNELL 72
            L           
Sbjct: 537 TLKGFGIRNQRDA 549

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 50.0 bits (120), Expect = 5e-07
 Identities = 11/69 (15%), Positives = 26/69 (37%), Gaps = 11/69 (15%)

Query: 3   SIPD--SIGDLINLKSLNLSNNNLSG-------TIPISLEKLLDLKDINVSFNKLEGEIP 53
            IP+      +  + +++ S N +          +  +  K +++  IN+S N++     
Sbjct: 391 YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPK 450

Query: 54  REGPFRNLS 62
               F   S
Sbjct: 451 EL--FSTGS 457

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 49.7 bits (119), Expect = 7e-07
 Identities = 10/51 (19%), Positives = 23/51 (45%)

Query: 7   SIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGP 57
           S+     +  L+L     SG +P ++ +L +L+ + +  +  +      GP
Sbjct: 76  SLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGP 126

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 7/60 (11%), Positives = 23/60 (38%), Gaps = 4/60 (6%)

Query: 3   SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLS 62
            + + I    N+  L++ +N         +   ++     + ++K + +I R     ++ 
Sbjct: 580 KVNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ-DI-RGCDALDIK 635

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 42.7 bits (101), Expect = 1e-04
 Identities = 13/106 (12%), Positives = 28/106 (26%), Gaps = 11/106 (10%)

Query: 1   QGSIPDSIG--DLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GP 57
           Q +  D     D  +L    ++++    +I  S    L    I    N +   + +    
Sbjct: 146 QKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMR 204

Query: 58  FRNLSVKSFEGNELLCEIVLPLSTIFMIVMILLILRYQKRGKPLPN 103
              L       +  + E +                 Y ++ K    
Sbjct: 205 LTKLRQFYMGNSPFVAENICEAWE-------NENSEYAQQYKTEDL 243

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 61.4 bits (148), Expect = 9e-11
 Identities = 38/240 (15%), Positives = 69/240 (28%), Gaps = 64/240 (26%)

Query: 111 IGKGGFGSVYKAIIQDGMEVAVKV--------FDPQYEGAFKSFDIECDVMKRIC----- 157
           IG+G FG V++ I  D   VA+K+         +  ++  F+    E  + K +      
Sbjct: 28  IGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGE 86

Query: 158 ----HRNLIKIISSY------------------------------SNDDFKALVLEYMPH 183
                   I + S +                                DD   +VLE+   
Sbjct: 87  VCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFG 146

Query: 184 GSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAH 243
           G       +   +  +     I+  + ++L            H DL   NVLL    +  
Sbjct: 147 GID--LEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGNVLLKKTSLKK 202

Query: 244 LSDFGMAKPL---------LEEDQSLTQTQTLATIGYMAPEYGRE---GRVSTNGDVYSF 291
           L      K              D +L++ +    + +       +   G      D+Y  
Sbjct: 203 LHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGDYQFDIYRL 262

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 60.5 bits (147), Expect = 1e-10
 Identities = 29/171 (16%), Positives = 58/171 (33%), Gaps = 41/171 (23%)

Query: 111 IGKGGFGSVYKAI---------IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNL 161
             +   G +Y+A               + ++K+     +        E +  +R      
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKL-----DAKDGRLFNEQNFFQRAAKPLQ 104

Query: 162 IKIISSYSN----------------DDFKALVLEYMPHG-SLEKCLYLSNY-ILDIFQRL 203
           +       +                D ++ LVL  +  G SL+  L +S   +L     L
Sbjct: 105 VNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVL 162

Query: 204 DIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFGMAK 251
            +   +  ALE+LH       +H ++   N+ +   D + V  L+ +G A 
Sbjct: 163 QVACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQV-TLAGYGFAF 209

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 59.1 bits (143), Expect = 9e-10
 Identities = 13/70 (18%), Positives = 29/70 (41%)

Query: 2   GSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNL 61
            +   S  +L +L  + L N      +P  L  L +L+ +N++ N+       +  +  L
Sbjct: 481 ENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRL 540

Query: 62  SVKSFEGNEL 71
           +     G ++
Sbjct: 541 ADDEDTGPKI 550

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 57.6 bits (139), Expect = 3e-09
 Identities = 14/70 (20%), Positives = 27/70 (38%), Gaps = 10/70 (14%)

Query: 2   GSIPDSIGDLINLKSLNLSNNNLSG---------TIPISLEKLLDLKDINVSFNKLEGEI 52
             +PD + DL  L+SLN++ N              +    +    ++   + +N LE E 
Sbjct: 505 TQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EF 563

Query: 53  PREGPFRNLS 62
           P     + + 
Sbjct: 564 PASASLQKMV 573

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 53.7 bits (129), Expect = 4e-08
 Identities = 13/99 (13%), Positives = 32/99 (32%), Gaps = 12/99 (12%)

Query: 3   SIPDSIGDLINLKSLNL------SNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREG 56
           S P    +   LK+  +        N +    P  +     L  + +  N +  ++  + 
Sbjct: 767 SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL 825

Query: 57  PFRNLSVKSFEGNELLCEIVLPLST-IFMIVMILLILRY 94
               L +     N  +    + +++    I   + +L Y
Sbjct: 826 -TPQLYILDIADNPNI---SIDVTSVCPYIEAGMYVLLY 860

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 53.7 bits (129), Expect = 5e-08
 Identities = 9/71 (12%), Positives = 25/71 (35%), Gaps = 4/71 (5%)

Query: 2   GSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKL-EGEIPREGPFRN 60
              P  I    +L  L + +N++   +   L     L  ++++ N     ++    P+  
Sbjct: 796 RQWPTGITTCPSLIQLQIGSNDIR-KVDEKL--TPQLYILDIADNPNISIDVTSVCPYIE 852

Query: 61  LSVKSFEGNEL 71
             +     ++ 
Sbjct: 853 AGMYVLLYDKT 863

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 51.8 bits (124), Expect = 2e-07
 Identities = 11/74 (14%), Positives = 31/74 (41%), Gaps = 2/74 (2%)

Query: 1   QGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE--GPF 58
           +G +PD+IG L  LK L+   ++ + +  +  ++ L         +++     +      
Sbjct: 336 KGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYD 395

Query: 59  RNLSVKSFEGNELL 72
           + L++     + + 
Sbjct: 396 QRLNLSDLLQDAIN 409

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 50.6 bits (121), Expect = 4e-07
 Identities = 12/69 (17%), Positives = 24/69 (34%), Gaps = 8/69 (11%)

Query: 1   QGSIPDSIGDLINLKSLNLSNNNLS-------GTIPISLEKLLDLKDINVSFNKLEGEIP 53
           Q    +       + ++ LSNN ++            + +    L  I++ FNKL   + 
Sbjct: 686 QKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLS 744

Query: 54  REGPFRNLS 62
            +     L 
Sbjct: 745 DDFRATTLP 753

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 50.6 bits (121), Expect = 4e-07
 Identities = 14/72 (19%), Positives = 29/72 (40%), Gaps = 4/72 (5%)

Query: 2   GSIPDSIGDLINLKSLNLSNNNLSGTIPIS--LEKLLDLKDINVSFNKLEGEIPREGPFR 59
             + D       ++   +  NNL    P S  L+K++ L  ++   NK+   +   G   
Sbjct: 538 TRLADDEDTGPKIQIFYMGYNNLEE-FPASASLQKMVKLGLLDCVHNKVR-HLEAFGTNV 595

Query: 60  NLSVKSFEGNEL 71
            L+    + N++
Sbjct: 596 KLTDLKLDYNQI 607

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 50.3 bits (120), Expect = 7e-07
 Identities = 13/61 (21%), Positives = 24/61 (39%), Gaps = 3/61 (4%)

Query: 3   SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLL-DLKDINVSFNKLEGEIPREGPFRNL 61
              ++ G  + L  L L  N +   IP         ++ +  S NKL+  IP     +++
Sbjct: 586 RHLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSV 643

Query: 62  S 62
            
Sbjct: 644 Y 644

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 49.1 bits (117), Expect = 1e-06
 Identities = 12/68 (17%), Positives = 22/68 (32%), Gaps = 11/68 (16%)

Query: 3   SIPDSI--GDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSF------NKLEGEIPR 54
           S+ D      L  L ++++S N  S + P        LK   +        N++  + P 
Sbjct: 742 SLSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPT 800

Query: 55  EGPFRNLS 62
                   
Sbjct: 801 G--ITTCP 806

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 49.1 bits (117), Expect = 1e-06
 Identities = 12/80 (15%), Positives = 24/80 (30%), Gaps = 21/80 (26%)

Query: 2   GSIPDSIGDLINLKSLNLSNNNLSG-------------------TIPISLEKLLDLKDIN 42
             I  +I  L  L+ +  +N+  +                       +S   L DL D+ 
Sbjct: 438 TFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVE 497

Query: 43  VSFNKLEGEIPREGPFRNLS 62
           +       ++P      +L 
Sbjct: 498 LYNCPNMTQLPDF--LYDLP 515

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 47.9 bits (114), Expect = 3e-06
 Identities = 11/82 (13%), Positives = 28/82 (34%), Gaps = 3/82 (3%)

Query: 2   GSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNL 61
                 + +   +  L+L+     G +P ++ +L +LK ++   +           F + 
Sbjct: 313 DQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGR---LFGDE 369

Query: 62  SVKSFEGNELLCEIVLPLSTIF 83
            +      E    I +    +F
Sbjct: 370 ELTPDMSEERKHRIRMHYKKMF 391

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 44.9 bits (106), Expect = 3e-05
 Identities = 11/53 (20%), Positives = 17/53 (32%), Gaps = 1/53 (1%)

Query: 3   SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE 55
           S        IN  ++ LS N +             +  I +S N +   IP  
Sbjct: 664 SCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPEN 715

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 44.5 bits (105), Expect = 3e-05
 Identities = 10/67 (14%), Positives = 27/67 (40%), Gaps = 9/67 (13%)

Query: 3   SIPD--SIGDLINLKSLNLSNNNLSG-----TIPISLEKLLDLKDINVSFNKLEGEIPRE 55
            IP+  +   +  + S++ S N +       +  +   K ++   + +S+N+++      
Sbjct: 633 YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTEL 692

Query: 56  GPFRNLS 62
             F   S
Sbjct: 693 --FATGS 697

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 57.8 bits (140), Expect = 1e-09
 Identities = 51/203 (25%), Positives = 85/203 (41%), Gaps = 22/203 (10%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVF--DPQYEGAFKSFDIECDVMKRICHR---NLIK 163
           LIGKG FG V KA    +   VA+K+      +        IE  +++ +          
Sbjct: 61  LIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAF---LNQAQIEVRLLELMNKHDTEMKYY 117

Query: 164 IISSYSNDDFKA---LVLEYMPHGSLEKCLYLSNYI-LDIFQRLDIMIDVASALEYLHFG 219
           I+    +  F+    LV E +   +L   L  +N+  + +         + +AL +L   
Sbjct: 118 IVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA-T 175

Query: 220 YSAPIIHCDLKPSNVLLDDNMVAH--LSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYG 277
               IIHCDLKP N+LL +   +   + DFG +  L +      Q++      Y +PE  
Sbjct: 176 PELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF-----YRSPEVL 230

Query: 278 REGRVSTNGDVYSFGIMLMEIFT 300
                    D++S G +L+E+ T
Sbjct: 231 LGMPYDLAIDMWSLGCILVEMHT 253

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 54.6 bits (132), Expect = 1e-08
 Identities = 42/226 (18%), Positives = 81/226 (35%), Gaps = 52/226 (23%)

Query: 110 LIGKGGFGSVYKAI--IQDGMEVAVKVF--DPQYEGAFKSFDIECDVMKRICHR---NLI 162
            +G+G FG V + +   +   +VA+K+     +Y    ++  +E +V+K+I  +   N  
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKY---REAARLEINVLKKIKEKDKENKF 82

Query: 163 KIISSYSNDDFKA---LVLEYMPHGSLEKCLY----LSNYI-LDIFQRLDIMIDVASALE 214
             +      +F     +  E      L K  +     +N+    +     +   +  AL 
Sbjct: 83  LCVLMSDWFNFHGHMCIAFE-----LLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALR 137

Query: 215 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL----------TQTQ 264
           +LH      + H DLKP N+L  ++    L +   +        +              +
Sbjct: 138 FLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE 194

Query: 265 TLATI----GYMAPE------YGREGRVSTNGDVYSFGIMLMEIFT 300
              TI     Y  PE      +      +   DV+S G +L E + 
Sbjct: 195 HHTTIVATRHYRPPEVILELGW------AQPCDVWSIGCILFEYYR 234

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 54.6 bits (132), Expect = 2e-08
 Identities = 54/235 (22%), Positives = 87/235 (37%), Gaps = 66/235 (28%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVF--DPQYEGAFKSFDIECDVMKRICHR-----NL 161
            +G G FG V     I +    AVKV     +Y    +S  IE D++K+I +      N+
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKY---TRSAKIEADILKKIQNDDINNNNI 98

Query: 162 IKIISSYSNDDFKA---LVLEYMPHGSLEKCLY----LSNYI---LDIFQRLDIMIDVAS 211
           +K    +    +     L+ E      L   LY     +NY    ++  +     I++  
Sbjct: 99  VKYHGKF---MYYDHMCLIFE-----PLGPSLYEIITRNNYNGFHIEDIKL--YCIEILK 148

Query: 212 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT---------- 261
           AL YL       + H DLKP N+LLDD                ++ Q             
Sbjct: 149 ALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLID 205

Query: 262 ------QTQTLATI----GYMAPE------YGREGRVSTNGDVYSFGIMLMEIFT 300
                 ++    +I     Y APE      +        + D++SFG +L E++T
Sbjct: 206 FGCATFKSDYHGSIINTRQYRAPEVILNLGW------DVSSDMWSFGCVLAELYT 254

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 53.9 bits (130), Expect = 4e-08
 Identities = 16/62 (25%), Positives = 27/62 (43%), Gaps = 1/62 (1%)

Query: 1   QGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRN 60
           Q   P S   L +L++L      L+      + +L+ LK +NV+ N +         F N
Sbjct: 93  QSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHS-CKLPAYFSN 151

Query: 61  LS 62
           L+
Sbjct: 152 LT 153

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 52.0 bits (125), Expect = 1e-07
 Identities = 17/71 (23%), Positives = 30/71 (42%), Gaps = 1/71 (1%)

Query: 4   IPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGP-FRNLS 62
                  L  L+ LN+S+NNL         +L  L  ++ SFN++E          ++L+
Sbjct: 489 SWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLA 548

Query: 63  VKSFEGNELLC 73
             +   N + C
Sbjct: 549 FFNLTNNSVAC 559

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 49.3 bits (118), Expect = 1e-06
 Identities = 13/62 (20%), Positives = 22/62 (35%), Gaps = 2/62 (3%)

Query: 1   QGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRN 60
           +     +   L +L +L L+ N +    P S   L  L+++     KL        P   
Sbjct: 69  ETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLES--FPIGQ 126

Query: 61  LS 62
           L 
Sbjct: 127 LI 128

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 47.3 bits (113), Expect = 4e-06
 Identities = 12/59 (20%), Positives = 24/59 (40%), Gaps = 2/59 (3%)

Query: 4   IPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLS 62
              S  +   L+ L+LS   +      +   L  L ++ ++ N ++   P  G F  L+
Sbjct: 48  KSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSP--GSFSGLT 104

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 46.9 bits (112), Expect = 5e-06
 Identities = 13/61 (21%), Positives = 23/61 (37%), Gaps = 2/61 (3%)

Query: 2   GSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNL 61
            ++ +   +  NL  L+LS   L        + L  L+ +N+S N L         +  L
Sbjct: 463 NTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDS--SHYNQL 520

Query: 62  S 62
            
Sbjct: 521 Y 521

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 11/61 (18%), Positives = 24/61 (39%), Gaps = 3/61 (4%)

Query: 3   SIPDSIGDLINLKSLNLSNNNLSGTIPIS-LEKLLDLKDINVSFNKLEGEIPREGPFRNL 61
            +  +   L  L+ L+  ++ L      S    L  L  +++S+   + +    G F  L
Sbjct: 390 IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFD--GIFLGL 447

Query: 62  S 62
           +
Sbjct: 448 T 448

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 10/58 (17%), Positives = 18/58 (31%), Gaps = 1/58 (1%)

Query: 5   PDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLS 62
             +   L  L  L++S  N           L  L  + ++ N  +        F N +
Sbjct: 417 FSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTL-SNVFANTT 473

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 44.6 bits (106), Expect = 3e-05
 Identities = 13/60 (21%), Positives = 26/60 (43%), Gaps = 4/60 (6%)

Query: 3  SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLS 62
           +PD I    + K+++LS N L      S     +L+ +++S  ++E        +  L 
Sbjct: 25 KVPDDIPS--STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIED--KAWHGLH 80

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 11/63 (17%), Positives = 23/63 (36%), Gaps = 3/63 (4%)

Query: 1   QGSIPDSIGDLINLKSLNLSNNNLSGTIPIS-LEKLLDLKDINVSFNKLEGEIPREGPFR 59
           +         L +L +L ++ N+       +      +L  +++S  +LE      G F 
Sbjct: 437 KIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISW--GVFD 494

Query: 60  NLS 62
            L 
Sbjct: 495 TLH 497

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 41.9 bits (99), Expect = 2e-04
 Identities = 19/73 (26%), Positives = 29/73 (39%), Gaps = 2/73 (2%)

Query: 1   QGSIPDSIGDLINLKSLNLSNNNLSGTIPISLE--KLLDLKDINVSFNKLEGEIPREGPF 58
           +GSI      L +L  L+LS N LS +   S        L+ +++SFN            
Sbjct: 339 KGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGL 398

Query: 59  RNLSVKSFEGNEL 71
             L    F+ + L
Sbjct: 399 EELQHLDFQHSTL 411

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 41.6 bits (98), Expect = 3e-04
 Identities = 10/52 (19%), Positives = 23/52 (44%), Gaps = 2/52 (3%)

Query: 11  LINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLS 62
             +L+ L+LS N     +  +   L +L+ ++   + L+  +     F +L 
Sbjct: 375 TNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKR-VTEFSAFLSLE 424

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 40.8 bits (96), Expect = 6e-04
 Identities = 16/79 (20%), Positives = 32/79 (40%), Gaps = 8/79 (10%)

Query: 3   SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKD----INVSFNKLEGEIPREGPF 58
            +P    +L NL  ++LS N +       L+ L +       +++S N ++  I  +  F
Sbjct: 144 KLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQ-DQAF 201

Query: 59  RNLSVKS--FEGNELLCEI 75
           + + +      GN     I
Sbjct: 202 QGIKLHELTLRGNFNSSNI 220

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 53.1 bits (128), Expect = 6e-08
 Identities = 16/60 (26%), Positives = 22/60 (36%), Gaps = 1/60 (1%)

Query: 3   SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLS 62
            +P  +  L  LK L LS N       IS      L  +++  N    E+   G   NL 
Sbjct: 292 ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELG-TGCLENLE 350

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 50.0 bits (120), Expect = 6e-07
 Identities = 8/62 (12%), Positives = 15/62 (24%), Gaps = 2/62 (3%)

Query: 1   QGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRN 60
                 ++     LK L      +S    I L     L+ + +  N +            
Sbjct: 94  IFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKL--PKGFP 151

Query: 61  LS 62
             
Sbjct: 152 TE 153

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 50.0 bits (120), Expect = 7e-07
 Identities = 15/61 (24%), Positives = 31/61 (50%), Gaps = 1/61 (1%)

Query: 2   GSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNL 61
                 + +L +L+SLNLS N        + ++   L+ ++++F +L+     + PF+NL
Sbjct: 366 DCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKV-KDAQSPFQNL 424

Query: 62  S 62
            
Sbjct: 425 H 425

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 49.2 bits (118), Expect = 1e-06
 Identities = 9/59 (15%), Positives = 18/59 (30%), Gaps = 2/59 (3%)

Query: 4   IPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLS 62
              +   LINL  L+L+   +      + +    L  + ++ N L              
Sbjct: 49  QNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAE--TALSGPK 105

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 47.3 bits (113), Expect = 4e-06
 Identities = 11/59 (18%), Positives = 17/59 (28%), Gaps = 2/59 (3%)

Query: 4   IPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLS 62
             D+      L +L L+ N L      +L     LK +      +        P  N  
Sbjct: 73  HEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDF--IPLHNQK 129

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 47.3 bits (113), Expect = 5e-06
 Identities = 14/107 (13%), Positives = 31/107 (28%), Gaps = 6/107 (5%)

Query: 1   QGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFR 59
                  + +   L+SL L +N++S            LK ++   N +      +    +
Sbjct: 118 SSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQ 177

Query: 60  NLSVKS--FEGNELLCEIVLPLSTIFMIVMILLILRYQKRGKPLPND 104
             +  S    GN++     +        V   L     +    +   
Sbjct: 178 QATNLSLNLNGNDIAG---IEPGAFDSAVFQSLNFGGTQNLLVIFKG 221

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 47.3 bits (113), Expect = 5e-06
 Identities = 13/71 (18%), Positives = 28/71 (39%), Gaps = 2/71 (2%)

Query: 4   IPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLS 62
              +   L  +  ++LS+N L+ +   +L  L  +  +N++ N +   +P          
Sbjct: 492 DQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQR 550

Query: 63  VKSFEGNELLC 73
             +   N L C
Sbjct: 551 TINLRQNPLDC 561

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 46.5 bits (111), Expect = 8e-06
 Identities = 13/58 (22%), Positives = 24/58 (41%), Gaps = 2/58 (3%)

Query: 5   PDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLS 62
            +S+  L  L+ L LS  +LS     +   L  +  +++S N+L           +L 
Sbjct: 469 TNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSI--EALSHLK 524

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 46.2 bits (110), Expect = 1e-05
 Identities = 14/60 (23%), Positives = 27/60 (45%), Gaps = 1/60 (1%)

Query: 4   IPDSIGDLINLKSLNLSNNNLSGTI-PISLEKLLDLKDINVSFNKLEGEIPREGPFRNLS 62
              S  +  +L  L++  N     +    LE L +L+++++S + +E         RNLS
Sbjct: 317 CQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLS 376

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 45.8 bits (109), Expect = 1e-05
 Identities = 20/77 (25%), Positives = 33/77 (42%), Gaps = 2/77 (2%)

Query: 1   QGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFR 59
                ++      L+ L+L+  +LS  +P  L  L  LK + +S NK E         F 
Sbjct: 267 FNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFP 325

Query: 60  NLSVKSFEGNELLCEIV 76
           +L+  S +GN    E+ 
Sbjct: 326 SLTHLSIKGNTKRLELG 342

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 44.6 bits (106), Expect = 3e-05
 Identities = 13/59 (22%), Positives = 24/59 (40%), Gaps = 1/59 (1%)

Query: 5   PDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLS 62
                +L  LK LNLS++ L  +     + L  L+ +N+  N       ++    + L 
Sbjct: 418 QSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLG 476

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 44.6 bits (106), Expect = 3e-05
 Identities = 9/60 (15%), Positives = 25/60 (41%), Gaps = 4/60 (6%)

Query: 3  SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLS 62
           IP ++    + + L  S N L      +  +L++L  ++++  ++         F++  
Sbjct: 26 EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHE--DTFQSQH 81

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 14/61 (22%), Positives = 29/61 (47%), Gaps = 4/61 (6%)

Query: 4   IPDSIGDLINLKSLNLSNNNL--SGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNL 61
               + +L NL+ L+LS++++  S    + L  L  L+ +N+S+N+          F+  
Sbjct: 342 GTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKT--EAFKEC 399

Query: 62  S 62
            
Sbjct: 400 P 400

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 41.2 bits (97), Expect = 4e-04
 Identities = 9/52 (17%), Positives = 23/52 (44%), Gaps = 3/52 (5%)

Query: 11  LINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLS 62
            ++++S+NL  +        +      L++++++   L  E+P       LS
Sbjct: 253 EMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSG--LVGLS 301

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 52.6 bits (127), Expect = 6e-08
 Identities = 14/74 (18%), Positives = 29/74 (39%), Gaps = 3/74 (4%)

Query: 3   SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNL 61
             PD    L +L+ + +    L   +P ++++   L+ + ++ N L   +P        L
Sbjct: 95  QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRL 152

Query: 62  SVKSFEGNELLCEI 75
              S      L E+
Sbjct: 153 RELSIRACPELTEL 166

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 51.9 bits (125), Expect = 1e-07
 Identities = 13/72 (18%), Positives = 23/72 (31%), Gaps = 3/72 (4%)

Query: 3   SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVS-FNKLEGEIPRE-GPFRN 60
           ++  +I  L  L+ L+L         P        LK + +   + L   +P +      
Sbjct: 220 ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQ 278

Query: 61  LSVKSFEGNELL 72
           L      G   L
Sbjct: 279 LEKLDLRGCVNL 290

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 51.5 bits (124), Expect = 1e-07
 Identities = 14/54 (25%), Positives = 29/54 (53%), Gaps = 3/54 (5%)

Query: 3   SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVS-FNKLEGEIPRE 55
            +PD++     L++L L+ N L   +P S+  L  L+++++    +L  E+P  
Sbjct: 118 ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELT-ELPEP 169

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 50.7 bits (122), Expect = 2e-07
 Identities = 12/60 (20%), Positives = 24/60 (40%), Gaps = 2/60 (3%)

Query: 3   SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLS 62
           + P   G    LK L L + +   T+P+ + +L  L+ +++        +P       L 
Sbjct: 244 NYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSL--IAQLP 301

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 50.3 bits (121), Expect = 3e-07
 Identities = 12/56 (21%), Positives = 24/56 (42%), Gaps = 1/56 (1%)

Query: 3   SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPF 58
           ++P  I  L  L+ L+L        +P  + +L     I V  + L+ ++ +  P 
Sbjct: 268 TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPH-LQAQLDQHRPV 322

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 49.2 bits (118), Expect = 8e-07
 Identities = 17/54 (31%), Positives = 29/54 (53%), Gaps = 3/54 (5%)

Query: 3   SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVS-FNKLEGEIPRE 55
           S+P SI +L NLKSL + N+ LS  +  ++  L  L+++++     L    P  
Sbjct: 197 SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALR-NYPPI 248

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 48.8 bits (117), Expect = 1e-06
 Identities = 15/88 (17%), Positives = 33/88 (37%), Gaps = 14/88 (15%)

Query: 3   SIPDSIGDLINLKSLNLSNNNLSGTIPISL---------EKLLDLKDINVSFNKLEGEIP 53
           ++P SI  L  L+ L++        +P  L         + L++L+ + + +  +   +P
Sbjct: 141 ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLP 199

Query: 54  RE-GPFRNLSVKSFEGNELLCEIVLPLS 80
                 +NL       + L     L  +
Sbjct: 200 ASIANLQNLKSLKIRNSPL---SALGPA 224

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 48.0 bits (115), Expect = 2e-06
 Identities = 15/72 (20%), Positives = 25/72 (34%), Gaps = 5/72 (6%)

Query: 3   SIPDSIGDL--INLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFR 59
           +  D + D       +L L +  L    P    +L  L+ + +    L  E+P     F 
Sbjct: 70  ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFA 127

Query: 60  NLSVKSFEGNEL 71
            L   +   N L
Sbjct: 128 GLETLTLARNPL 139

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 44.6 bits (106), Expect = 3e-05
 Identities = 15/76 (19%), Positives = 26/76 (34%), Gaps = 3/76 (3%)

Query: 1   QGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFR 59
                     L+NL+SL L    +  ++P S+  L +LK + +  + L   +        
Sbjct: 172 STDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLP 229

Query: 60  NLSVKSFEGNELLCEI 75
            L      G   L   
Sbjct: 230 KLEELDLRGCTALRNY 245

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 52.3 bits (126), Expect = 8e-08
 Identities = 42/228 (18%), Positives = 81/228 (35%), Gaps = 56/228 (24%)

Query: 110 LIGKGGFGSVYKAI--IQDGMEVAVKVF--DPQYEGAFKSFDIECDVMKRICHR---NLI 162
            +G+G FG V + I     G  VAVK+     +Y    ++   E  V++ +      +  
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRY---CEAARSEIQVLEHLNTTDPNSTF 77

Query: 163 KIISSYSNDDFKA---LVLEYMPHGSLEKCLY----LSNYI---LDIFQRLDIMIDVASA 212
           + +      +      +V E      L    Y     + ++   LD  ++  +   +  +
Sbjct: 78  RCVQMLEWFEHHGHICIVFE-----LLGLSTYDFIKENGFLPFRLDHIRK--MAYQICKS 130

Query: 213 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL----------TQ 262
           + +LH   S  + H DLKP N+L   +      +  + +                     
Sbjct: 131 VNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYD 187

Query: 263 TQTLATI----GYMAPE------YGREGRVSTNGDVYSFGIMLMEIFT 300
            +  +T+     Y APE      +      S   DV+S G +L+E + 
Sbjct: 188 DEHHSTLVSTRHYRAPEVILALGW------SQPCDVWSIGCILIEYYL 229

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 52.2 bits (125), Expect = 1e-07
 Identities = 55/259 (21%), Positives = 86/259 (33%), Gaps = 84/259 (32%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVF--DPQYEGAFKSFDIECDVMKRIC-----HRNLI 162
           +G G F +V+ +  IQ    VA+KV      Y         E  ++K +        N  
Sbjct: 45  LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETAL---DEIRLLKSVRNSDPNDPNRE 101

Query: 163 KIISSYSNDDFK---------ALVLEYMPHGSLEKCLYLSNYI---LDIFQRLDIMIDVA 210
            ++     DDFK          +V E + H  L K +  SNY    L   ++  I+  V 
Sbjct: 102 MVVQLL--DDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKK--IIQQVL 156

Query: 211 SALEYLHFGYSAPIIHCDLKPSNVLL---------------------------------- 236
             L+YLH      IIH D+KP N+LL                                  
Sbjct: 157 QGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAP 214

Query: 237 ---------------DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGR 281
                           + +   ++D G A  + +      QT+      Y + E      
Sbjct: 215 ATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSG 269

Query: 282 VSTNGDVYSFGIMLMEIFT 300
            +T  D++S   M  E+ T
Sbjct: 270 YNTPADIWSTACMAFELAT 288

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 50.8 bits (122), Expect = 2e-07
 Identities = 12/71 (16%), Positives = 29/71 (40%), Gaps = 3/71 (4%)

Query: 3   SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLS 62
           ++      +  LK L+LS+N+L   +  +  +   L+++ +  N +   +        L 
Sbjct: 286 ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK-LSTHHTLK 342

Query: 63  VKSFEGNELLC 73
             +   N+  C
Sbjct: 343 NLTLSHNDWDC 353

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 41.6 bits (98), Expect = 2e-04
 Identities = 15/68 (22%), Positives = 28/68 (41%), Gaps = 3/68 (4%)

Query: 5   PDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSV 63
                 +  L+ L +SNN L   + +  + +  LK +++S N L   + R    F  L  
Sbjct: 265 YHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLEN 322

Query: 64  KSFEGNEL 71
              + N +
Sbjct: 323 LYLDHNSI 330

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 40.4 bits (95), Expect = 6e-04
 Identities = 9/61 (14%), Positives = 26/61 (42%), Gaps = 3/61 (4%)

Query: 3   SIPDSI-GDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNL 61
            +P ++      ++ LNL++  +      +      ++ + + FN +   +P    F+N+
Sbjct: 59  KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLP-PHVFQNV 116

Query: 62  S 62
            
Sbjct: 117 P 117

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 50.4 bits (121), Expect = 3e-07
 Identities = 11/69 (15%), Positives = 25/69 (36%), Gaps = 1/69 (1%)

Query: 3   SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLS 62
            +         +  ++L NN L   I  +L    +L+  ++  N       R+   +N  
Sbjct: 205 FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQR 263

Query: 63  VKSFEGNEL 71
           V++     +
Sbjct: 264 VQTVAKQTV 272

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 46.1 bits (110), Expect = 6e-06
 Identities = 8/60 (13%), Positives = 26/60 (43%), Gaps = 2/60 (3%)

Query: 3  SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLS 62
          +I +   +    K   +++++L   +    +   ++K++++S N L  +I         +
Sbjct: 1  AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QIS-AADLAPFT 58

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 44.2 bits (105), Expect = 3e-05
 Identities = 17/59 (28%), Positives = 24/59 (40%), Gaps = 4/59 (6%)

Query: 4  IPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLS 62
          +        N+K L+LS N LS      L     L+ +N+S N L  E        +LS
Sbjct: 26 LASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETL---DLESLS 80

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 41.9 bits (99), Expect = 2e-04
 Identities = 15/70 (21%), Positives = 27/70 (38%), Gaps = 4/70 (5%)

Query: 3   SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNL 61
           +  +       L+ LNL  N +   +         LK +++S NKL   +  E      +
Sbjct: 160 NFAELAASSDTLEHLNLQYNFIY-DVK-GQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGV 216

Query: 62  SVKSFEGNEL 71
           +  S   N+L
Sbjct: 217 TWISLRNNKL 226

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 41.5 bits (98), Expect = 2e-04
 Identities = 10/69 (14%), Positives = 26/69 (37%), Gaps = 8/69 (11%)

Query: 3   SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLS 62
              D +  L  L++L+L+NN +       L     ++ ++ + N +   +      +   
Sbjct: 72  ETLD-LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSR-GQGKK 123

Query: 63  VKSFEGNEL 71
                 N++
Sbjct: 124 NIYLANNKI 132

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 40.7 bits (96), Expect = 4e-04
 Identities = 6/60 (10%), Positives = 23/60 (38%), Gaps = 3/60 (5%)

Query: 3   SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLS 62
            +  S       K++ L+NN ++    +       ++ +++  N+++  +       +  
Sbjct: 113 RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNFAELAASSD 169

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 50.6 bits (121), Expect = 4e-07
 Identities = 11/69 (15%), Positives = 25/69 (36%), Gaps = 1/69 (1%)

Query: 3   SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLS 62
            +         +  ++L NN L   I  +L    +L+  ++  N       R+   +N  
Sbjct: 205 FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQR 263

Query: 63  VKSFEGNEL 71
           V++     +
Sbjct: 264 VQTVAKQTV 272

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 46.8 bits (111), Expect = 6e-06
 Identities = 7/60 (11%), Positives = 25/60 (41%), Gaps = 2/60 (3%)

Query: 3  SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLS 62
          +I +   +    K   +++++L   +    +   ++K++++S N L      +      +
Sbjct: 1  AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAAD--LAPFT 58

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 44.5 bits (105), Expect = 4e-05
 Identities = 17/59 (28%), Positives = 24/59 (40%), Gaps = 4/59 (6%)

Query: 4  IPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLS 62
          +        N+K L+LS N LS      L     L+ +N+S N L  E        +LS
Sbjct: 26 LASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETL---DLESLS 80

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 41.4 bits (97), Expect = 4e-04
 Identities = 6/60 (10%), Positives = 23/60 (38%), Gaps = 3/60 (5%)

Query: 3   SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLS 62
            +  S       K++ L+NN ++    +       ++ +++  N+++  +       +  
Sbjct: 113 RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNFAELAASSD 169

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 40.6 bits (95), Expect = 5e-04
 Identities = 10/69 (14%), Positives = 26/69 (37%), Gaps = 8/69 (11%)

Query: 3   SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLS 62
              D +  L  L++L+L+NN +       L     ++ ++ + N +   +      +   
Sbjct: 72  ETLD-LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVS-CSRGQGKK 123

Query: 63  VKSFEGNEL 71
                 N++
Sbjct: 124 NIYLANNKI 132

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 40.6 bits (95), Expect = 5e-04
 Identities = 15/70 (21%), Positives = 28/70 (40%), Gaps = 4/70 (5%)

Query: 3   SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNL 61
           +  +       L+ LNL  N +   +   +     LK +++S NKL   +  E      +
Sbjct: 160 NFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGV 216

Query: 62  SVKSFEGNEL 71
           +  S   N+L
Sbjct: 217 TWISLRNNKL 226

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 49.5 bits (118), Expect = 9e-07
 Identities = 12/71 (16%), Positives = 29/71 (40%), Gaps = 3/71 (4%)

Query: 3   SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLS 62
           ++      +  LK L+LS+N+L   +  +  +   L+++ +  N +   +        L 
Sbjct: 292 ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK-LSTHHTLK 348

Query: 63  VKSFEGNELLC 73
             +   N+  C
Sbjct: 349 NLTLSHNDWDC 359

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 41.5 bits (97), Expect = 3e-04
 Identities = 15/68 (22%), Positives = 28/68 (41%), Gaps = 3/68 (4%)

Query: 5   PDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSV 63
                 +  L+ L +SNN L   + +  + +  LK +++S N L   + R    F  L  
Sbjct: 271 YHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLEN 328

Query: 64  KSFEGNEL 71
              + N +
Sbjct: 329 LYLDHNSI 336

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 40.7 bits (95), Expect = 6e-04
 Identities = 9/61 (14%), Positives = 26/61 (42%), Gaps = 3/61 (4%)

Query: 3   SIPDSI-GDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNL 61
            +P ++      ++ LNL++  +      +      ++ + + FN +   +P    F+N+
Sbjct: 65  KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLP-PHVFQNV 122

Query: 62  S 62
            
Sbjct: 123 P 123

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 40.7 bits (95), Expect = 6e-04
 Identities = 17/70 (24%), Positives = 32/70 (45%), Gaps = 3/70 (4%)

Query: 3   SIPDSI-GDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNL 61
           S+P  I  +   L +L++SNNNL      + +    L+++ +S N+L   +       +L
Sbjct: 137 SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDL-SLIPSL 194

Query: 62  SVKSFEGNEL 71
              +   N L
Sbjct: 195 FHANVSYNLL 204

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 49.4 bits (117), Expect = 1e-06
 Identities = 16/71 (22%), Positives = 33/71 (46%), Gaps = 4/71 (5%)

Query: 3   SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEG--EIPREGPFRN 60
           ++P ++  L  L+ L  S+N L   +   +  L  L+++ +  N+L+    I        
Sbjct: 477 ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPR 534

Query: 61  LSVKSFEGNEL 71
           L + + +GN L
Sbjct: 535 LVLLNLQGNSL 545

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 46.3 bits (109), Expect = 1e-05
 Identities = 17/66 (25%), Positives = 27/66 (40%), Gaps = 2/66 (3%)

Query: 6   DSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKS 65
             +  L+ +  L+LS+N L   +P +L  L  L+ +  S N LE  +        L    
Sbjct: 457 CHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDGVANLPRLQELL 514

Query: 66  FEGNEL 71
              N L
Sbjct: 515 LCNNRL 520

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 47.9 bits (113), Expect = 3e-06
 Identities = 47/360 (13%), Positives = 98/360 (27%), Gaps = 119/360 (33%)

Query: 38  LKDINVSFNKLEGEIPREGPFRNLSVKSFEGNELLCEIVLPLSTIFMIVMILLILRYQKR 97
           L + N  F K    + R  P+  L        + L E+                      
Sbjct: 119 LYNDNQVFAKYN--VSRLQPYLKL-------RQALLEL---------------------- 147

Query: 98  GKPLPNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDI------ECD 151
            +P  N      + G  G G   K  +             + +     F I       C+
Sbjct: 148 -RPAKNVL----IDGVLGSG---KTWV-----ALDVCLSYKVQCKM-DFKIFWLNLKNCN 193

Query: 152 -------VMKRICHR---NLIKIISSYSN-----DDFKALVLEYMPHGSLEKCLYLSNYI 196
                  +++++ ++   N        SN        +A +   +     E CL L   +
Sbjct: 194 SPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCL-L---V 249

Query: 197 LDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPL 253
           L          +V +A  +  F      + C      +LL      +   LS        
Sbjct: 250 LL---------NVQNAKAWNAFN-----LSC-----KILLTTRFKQVTDFLSAATTTHIS 290

Query: 254 LEE-DQSLTQTQT---LATIGYMAPEYGREGRVSTNGDVYS-FGIMLMEIFTRTKPTDEI 308
           L+    +LT  +    L       P+      ++TN    S     + +          +
Sbjct: 291 LDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHV 350

Query: 309 FSGEM--TLKRWVNDL--------------------LPISVMEVVDANLLSQEDEHFTTK 346
              ++   ++  +N L                    +P  ++ ++  +++  +      K
Sbjct: 351 NCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNK 410

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 43.3 bits (101), Expect = 1e-04
 Identities = 51/301 (16%), Positives = 85/301 (28%), Gaps = 125/301 (41%)

Query: 17  LNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNELLCEIV 76
           LNL N N   T+   L+KLL   D N +      +       R  S+++ E   LL    
Sbjct: 187 LNLKNCNSPETVLEMLQKLLYQIDPNWT---SRSDHSSNIKLRIHSIQA-ELRRLLKSKP 242

Query: 77  LPLSTIFMIVMILLILRYQKRGKPLPNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFD 136
                       LL+L                                 +       V +
Sbjct: 243 YENC--------LLVLL--------------------------------N-------VQN 255

Query: 137 PQYEGAFKSFDIECDVM--------------KRICHRNLIKIISSYSNDDFKALVLEY-- 180
            +   A+ +F++ C ++                  H +L     + + D+ K+L+L+Y  
Sbjct: 256 AK---AWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLD 312

Query: 181 MPHGSL--EKC----LYLS--------------NYILDIFQRLDIMIDVASALEYLH--- 217
                L  E        LS              N+      +L  +I+  S+L  L    
Sbjct: 313 CRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIE--SSLNVLEPAE 370

Query: 218 ----------FGYSAPIIHCDLKPSNVL----------LDDNMVAHLSDFGMAKPLLEED 257
                     F  SA I      P+ +L              +V  L        L+E+ 
Sbjct: 371 YRKMFDRLSVFPPSAHI------PTILLSLIWFDVIKSDVMVVVNKLHK----YSLVEKQ 420

Query: 258 Q 258
            
Sbjct: 421 P 421

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 47.0 bits (112), Expect = 5e-06
 Identities = 14/62 (22%), Positives = 28/62 (45%), Gaps = 2/62 (3%)

Query: 1   QGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRN 60
           +G    S     +LK L+LS N +  T+  +   L  L+ ++   + L+ ++     F +
Sbjct: 362 KGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLS 419

Query: 61  LS 62
           L 
Sbjct: 420 LR 421

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 47.0 bits (112), Expect = 5e-06
 Identities = 14/58 (24%), Positives = 25/58 (43%), Gaps = 1/58 (1%)

Query: 5   PDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLS 62
             +   L +L+ L     NL+      +  L  LK++NV+ N ++        F NL+
Sbjct: 93  LGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSNLT 149

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 44.3 bits (105), Expect = 4e-05
 Identities = 10/58 (17%), Positives = 19/58 (32%), Gaps = 2/58 (3%)

Query: 5   PDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLS 62
             +   L +L +L L+ N +      +   L  L+ +      L        P  +L 
Sbjct: 69  DGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLEN--FPIGHLK 124

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 42.4 bits (100), Expect = 1e-04
 Identities = 19/58 (32%), Positives = 31/58 (53%), Gaps = 2/58 (3%)

Query: 5   PDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLS 62
           PD   +L NL  L+LS   L    P +   L  L+ +N++ N+L+  +P +G F  L+
Sbjct: 463 PDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK-SVP-DGIFDRLT 518

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 41.6 bits (98), Expect = 3e-04
 Identities = 12/58 (20%), Positives = 23/58 (39%), Gaps = 2/58 (3%)

Query: 5   PDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLS 62
             S      L+ L+LS   +      + + L  L  + ++ N ++  +   G F  LS
Sbjct: 45  SYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ-SLA-LGAFSGLS 100

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 41.6 bits (98), Expect = 3e-04
 Identities = 13/59 (22%), Positives = 27/59 (45%), Gaps = 3/59 (5%)

Query: 5   PDSIGDLINLKSLNLSNNNLSGTI-PISLEKLLDLKDINVSFNKLEGEIPREGPFRNLS 62
                 L +L+ L ++ N+      P    +L +L  +++S  +LE ++     F +LS
Sbjct: 438 NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLS-PTAFNSLS 494

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 41.2 bits (97), Expect = 3e-04
 Identities = 19/68 (27%), Positives = 31/68 (45%), Gaps = 3/68 (4%)

Query: 5   PDSIGDLINLKSLNLSNNNL-SGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSV 63
              IG L  LK LN+++N + S  +P     L +L+ +++S NK++  I      R L  
Sbjct: 117 NFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTD-LRVLHQ 174

Query: 64  KSFEGNEL 71
                  L
Sbjct: 175 MPLLNLSL 182

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 41.2 bits (97), Expect = 3e-04
 Identities = 10/52 (19%), Positives = 19/52 (36%), Gaps = 1/52 (1%)

Query: 11  LINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLS 62
           L NL  L++S+ +           L  L+ + ++ N  +        F  L 
Sbjct: 420 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLP-DIFTELR 470

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 46.4 bits (111), Expect = 6e-06
 Identities = 18/70 (25%), Positives = 32/70 (45%), Gaps = 3/70 (4%)

Query: 3   SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNL 61
           S  +++ DL  LK LN+ +N +S    ++   L  L  + ++ N+L  E     G   NL
Sbjct: 256 SDINAVKDLTKLKMLNVGSNQISDISVLN--NLSQLNSLFLNNNQLGNEDMEVIGGLTNL 313

Query: 62  SVKSFEGNEL 71
           +      N +
Sbjct: 314 TTLFLSQNHI 323

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 45.6 bits (109), Expect = 1e-05
 Identities = 12/69 (17%), Positives = 32/69 (46%), Gaps = 2/69 (2%)

Query: 3   SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLS 62
           +   ++ +L NL+ L L+ +N+S   P++   L  +  +N+  N    ++        L+
Sbjct: 101 TDISALQNLTNLRELYLNEDNISDISPLA--NLTKMYSLNLGANHNLSDLSPLSNMTGLN 158

Query: 63  VKSFEGNEL 71
             +   +++
Sbjct: 159 YLTVTESKV 167

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 44.5 bits (106), Expect = 2e-05
 Identities = 15/69 (21%), Positives = 25/69 (36%), Gaps = 1/69 (1%)

Query: 3   SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLS 62
           S    + +L  L SL L+NN L       +  L +L  + +S N +    P       + 
Sbjct: 278 SDISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLAS-LSKMD 336

Query: 63  VKSFEGNEL 71
              F    +
Sbjct: 337 SADFANQVI 345

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 44.1 bits (105), Expect = 4e-05
 Identities = 11/51 (21%), Positives = 26/51 (50%), Gaps = 2/51 (3%)

Query: 3   SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIP 53
           S    + ++  L  L ++ + +    PI+   L DL  +++++N++E   P
Sbjct: 146 SDLSPLSNMTGLNYLTVTESKVKDVTPIA--NLTDLYSLSLNYNQIEDISP 194

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 44.1 bits (105), Expect = 4e-05
 Identities = 11/48 (22%), Positives = 23/48 (47%), Gaps = 2/48 (4%)

Query: 2   GSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLE 49
               + IG L NL +L LS N+++   P++   L  +   + +   ++
Sbjct: 301 NEDMEVIGGLTNLTTLFLSQNHITDIRPLA--SLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 41.8 bits (99), Expect = 2e-04
 Identities = 13/66 (19%), Positives = 27/66 (40%), Gaps = 3/66 (4%)

Query: 6   DSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKS 65
             + ++  L SL + NN ++   P  L  L  L  + +  N++   I        L + +
Sbjct: 215 TPVANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD-INAVKDLTKLKMLN 271

Query: 66  FEGNEL 71
              N++
Sbjct: 272 VGSNQI 277

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 40.6 bits (96), Expect = 5e-04
 Identities = 13/57 (22%), Positives = 26/57 (45%), Gaps = 5/57 (8%)

Query: 6   DSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLS 62
             + +L  + SLNL  N+   +    L  +  L  + V+ +K++  +    P  NL+
Sbjct: 126 SPLANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKD-VT---PIANLT 177

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 40.2 bits (95), Expect = 6e-04
 Identities = 9/66 (13%), Positives = 23/66 (34%), Gaps = 3/66 (4%)

Query: 6   DSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKS 65
             +  L +L       N ++   P++   +  L  + +  NK+   +        L+   
Sbjct: 193 SPLASLTSLHYFTAYVNQITDITPVA--NMTRLNSLKIGNNKITD-LSPLANLSQLTWLE 249

Query: 66  FEGNEL 71
              N++
Sbjct: 250 IGTNQI 255

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 39.8 bits (94), Expect = 7e-04
 Identities = 19/69 (27%), Positives = 32/69 (46%), Gaps = 4/69 (5%)

Query: 3   SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLS 62
           SI   I  L NL+ LNL+ N ++   P+S   L+ L ++ +  NK+  +I       NL 
Sbjct: 58  SIQG-IEYLTNLEYLNLNGNQITDISPLS--NLVKLTNLYIGTNKIT-DISALQNLTNLR 113

Query: 63  VKSFEGNEL 71
                 + +
Sbjct: 114 ELYLNEDNI 122

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 46.1 bits (110), Expect = 1e-05
 Identities = 19/71 (26%), Positives = 31/71 (43%), Gaps = 3/71 (4%)

Query: 1   QGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRN 60
                D +  L NL  +N SNN L+   P+    L  L DI ++ N++    P      N
Sbjct: 57  GIKSIDGVEYLNNLTQINFSNNQLTDITPLK--NLTKLVDILMNNNQIADITPLAN-LTN 113

Query: 61  LSVKSFEGNEL 71
           L+  +   N++
Sbjct: 114 LTGLTLFNNQI 124

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 45.7 bits (109), Expect = 1e-05
 Identities = 18/66 (27%), Positives = 29/66 (43%), Gaps = 3/66 (4%)

Query: 6   DSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKS 65
             I +L NL  L L  NN+S   P+S   L  L+ +    NK+   +       N++  S
Sbjct: 303 SPISNLKNLTYLTLYFNNISDISPVS--SLTKLQRLFFYNNKVSD-VSSLANLTNINWLS 359

Query: 66  FEGNEL 71
              N++
Sbjct: 360 AGHNQI 365

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 43.8 bits (104), Expect = 5e-05
 Identities = 17/67 (25%), Positives = 30/67 (44%), Gaps = 3/67 (4%)

Query: 5   PDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVK 64
             ++  L NL  L+L+NN +S   P+S   L  L ++ +  N++   I        L+  
Sbjct: 236 IGTLASLTNLTDLDLANNQISNLAPLS--GLTKLTELKLGANQISN-ISPLAGLTALTNL 292

Query: 65  SFEGNEL 71
               N+L
Sbjct: 293 ELNENQL 299

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 43.8 bits (104), Expect = 5e-05
 Identities = 12/67 (17%), Positives = 27/67 (40%), Gaps = 4/67 (5%)

Query: 3   SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLS 62
           S   S+ +L N+  L+  +N +S   P++   L  +  + ++               N+S
Sbjct: 344 SDVSSLANLTNINWLSAGHNQISDLTPLA--NLTRITQLGLNDQAWTNAPVNY--KANVS 399

Query: 63  VKSFEGN 69
           + +   N
Sbjct: 400 IPNTVKN 406

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 18/67 (26%), Positives = 32/67 (47%), Gaps = 3/67 (4%)

Query: 5   PDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVK 64
              + +L  L+ L++S+N +S      L KL +L+ +  + N++    P      NL   
Sbjct: 170 LKPLANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITPLGI-LTNLDEL 226

Query: 65  SFEGNEL 71
           S  GN+L
Sbjct: 227 SLNGNQL 233

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 18/69 (26%), Positives = 35/69 (50%), Gaps = 3/69 (4%)

Query: 3   SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLS 62
           S    +  L NL+SL  +NN +S   P+    L +L +++++ N+L+ +I       NL+
Sbjct: 190 SDISVLAKLTNLESLIATNNQISDITPLG--ILTNLDELSLNGNQLK-DIGTLASLTNLT 246

Query: 63  VKSFEGNEL 71
                 N++
Sbjct: 247 DLDLANNQI 255

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 41.9 bits (99), Expect = 2e-04
 Identities = 14/48 (29%), Positives = 21/48 (43%), Gaps = 2/48 (4%)

Query: 6   DSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIP 53
             +  L  L +L L+ N L    PIS   L +L  + + FN +    P
Sbjct: 281 SPLAGLTALTNLELNENQLEDISPIS--NLKNLTYLTLYFNNISDISP 326

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 39.9 bits (94), Expect = 9e-04
 Identities = 12/48 (25%), Positives = 22/48 (45%), Gaps = 2/48 (4%)

Query: 3   SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEG 50
           +    + +L NL  L L NN ++   P+    L +L  + +S N +  
Sbjct: 103 ADITPLANLTNLTGLTLFNNQITDIDPLK--NLTNLNRLELSSNTISD 148

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 46.3 bits (110), Expect = 1e-05
 Identities = 17/58 (29%), Positives = 28/58 (48%), Gaps = 1/58 (1%)

Query: 5   PDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLS 62
            D+   L +L+ L+LS+N+LS         L  LK +N+  N  +  +     F NL+
Sbjct: 67  GDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQ-TLGVTSLFPNLT 123

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 42.4 bits (100), Expect = 1e-04
 Identities = 15/69 (21%), Positives = 28/69 (40%), Gaps = 3/69 (4%)

Query: 3   SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLS 62
              + +  L NL SL++S N     +P S +    ++ +N+S   +   +      + L 
Sbjct: 378 KTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKT-CIPQTLE 434

Query: 63  VKSFEGNEL 71
           V     N L
Sbjct: 435 VLDVSNNNL 443

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 42.0 bits (99), Expect = 2e-04
 Identities = 12/74 (16%), Positives = 25/74 (33%), Gaps = 4/74 (5%)

Query: 3   SIPDSIGDLINLKSLNLSNNNLSGTIP-ISLEKLLDLKDINVSFNKLEGEIPRE--GPFR 59
            +     +L NL++L + N      I  I    L  L ++ +    L      +     R
Sbjct: 114 GVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR-NYQSQSLKSIR 172

Query: 60  NLSVKSFEGNELLC 73
           ++   +   +E   
Sbjct: 173 DIHHLTLHLSESAF 186

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 41.6 bits (98), Expect = 3e-04
 Identities = 12/58 (20%), Positives = 24/58 (41%), Gaps = 2/58 (3%)

Query: 5  PDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLS 62
             +    NL+ L L ++ ++     +   L  L+ +++S N L   +     F  LS
Sbjct: 43 HGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLS-SLS-SSWFGPLS 98

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 41.2 bits (97), Expect = 4e-04
 Identities = 23/86 (26%), Positives = 36/86 (41%), Gaps = 18/86 (20%)

Query: 3   SIPDSIGDLINLKSLNLSNNNLS---GTIPISLEKLL--------------DLKDINVSF 45
            +PDS      ++ LNLS+  +      IP +LE L                L+++ +S 
Sbjct: 401 PMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISR 460

Query: 46  NKLEGEIPREGPFRNLSVKSFEGNEL 71
           NKL+  +P    F  L V     N+L
Sbjct: 461 NKLK-TLPDASLFPVLLVMKISRNQL 485

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 46.0 bits (109), Expect = 1e-05
 Identities = 12/51 (23%), Positives = 22/51 (43%), Gaps = 4/51 (7%)

Query: 3   SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIP 53
           S+P        L++L +S N L+ ++P+    LL+L   +     L     
Sbjct: 75  SLPALPP---ELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPS 121

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 44.9 bits (106), Expect = 2e-05
 Identities = 16/70 (22%), Positives = 28/70 (40%), Gaps = 6/70 (8%)

Query: 3   SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLS 62
           S+P        L SL++  N L+  +P SL  L     +N+  N L  E   +   R ++
Sbjct: 255 SLPMLPS---GLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS-ERTLQ-ALREIT 308

Query: 63  VKSFEGNELL 72
                   ++
Sbjct: 309 SAPGYSGPII 318

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 42.6 bits (100), Expect = 1e-04
 Identities = 20/70 (28%), Positives = 32/70 (45%), Gaps = 9/70 (12%)

Query: 3   SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNL 61
           S+P        LK L +S N L+ ++P+    LL L   +V  N+L   +P       + 
Sbjct: 235 SLPVLPS---ELKELMVSGNRLT-SLPMLPSGLLSL---SVYRNQLT-RLPESLIHLSSE 286

Query: 62  SVKSFEGNEL 71
           +  + EGN L
Sbjct: 287 TTVNLEGNPL 296

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 41.4 bits (97), Expect = 3e-04
 Identities = 16/69 (23%), Positives = 25/69 (36%), Gaps = 10/69 (14%)

Query: 3   SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLS 62
           S+P     L+ L   +    +L   +P  L KL       +  N+L   +P       L 
Sbjct: 95  SLPVLPPGLLELSIFSNPLTHLP-ALPSGLCKL------WIFGNQLT-SLPVL--PPGLQ 144

Query: 63  VKSFEGNEL 71
             S   N+L
Sbjct: 145 ELSVSDNQL 153

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 46.0 bits (109), Expect = 1e-05
 Identities = 15/58 (25%), Positives = 31/58 (53%)

Query: 5   PDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLS 62
            ++  +L NL+ L+L ++ +    P + + L  L ++ + F  L   + ++G FRNL 
Sbjct: 66  KEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLK 123

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 43.3 bits (102), Expect = 9e-05
 Identities = 16/67 (23%), Positives = 30/67 (44%), Gaps = 1/67 (1%)

Query: 5   PDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVK 64
            D    L +L+ L L++N L+   P     L  L+ ++++ N+L   +       NL + 
Sbjct: 473 WDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHNDLPANLEIL 531

Query: 65  SFEGNEL 71
               N+L
Sbjct: 532 DISRNQL 538

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 42.5 bits (100), Expect = 2e-04
 Identities = 14/60 (23%), Positives = 21/60 (35%), Gaps = 4/60 (6%)

Query: 3  SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLS 62
           +P     L   + L LS N +      S   L  L+ + +        I +   FRNL 
Sbjct: 18 QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDK-EAFRNLP 73

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 40.6 bits (95), Expect = 6e-04
 Identities = 15/69 (21%), Positives = 30/69 (43%), Gaps = 3/69 (4%)

Query: 5   PDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE--GPFRNLS 62
                 L +LK LNL+ N ++     +   L +L+ +N+S+N L  E+          ++
Sbjct: 283 SRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLG-ELYSSNFYGLPKVA 341

Query: 63  VKSFEGNEL 71
               + N +
Sbjct: 342 YIDLQKNHI 350

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 44.6 bits (106), Expect = 3e-05
 Identities = 16/69 (23%), Positives = 30/69 (43%), Gaps = 6/69 (8%)

Query: 3   SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLS 62
            +P+ + +   LK +++ NN+L   +P     L  +       N+LE E+P       L+
Sbjct: 145 KLPE-LQNSSFLKIIDVDNNSLK-KLPDLPPSLEFI---AAGNNQLE-ELPELQNLPFLT 198

Query: 63  VKSFEGNEL 71
               + N L
Sbjct: 199 AIYADNNSL 207

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 19/69 (27%), Positives = 29/69 (42%), Gaps = 8/69 (11%)

Query: 3   SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLS 62
            +P+    L +L   N +   LS  +P  LE L       VS N+LE ++P       L 
Sbjct: 105 ELPELPQSLKSLLVDNNNLKALSD-LPPLLEYL------GVSNNQLE-KLPELQNSSFLK 156

Query: 63  VKSFEGNEL 71
           +   + N L
Sbjct: 157 IIDVDNNSL 165

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 41.9 bits (99), Expect = 2e-04
 Identities = 14/51 (27%), Positives = 23/51 (45%), Gaps = 4/51 (7%)

Query: 3   SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIP 53
           S+P+      +L+SL  S N+L+  +P   + L  L   N +   L    P
Sbjct: 85  SLPELPP---HLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPP 131

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 41.1 bits (97), Expect = 4e-04
 Identities = 16/69 (23%), Positives = 28/69 (40%), Gaps = 6/69 (8%)

Query: 3   SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLS 62
            +P+ + +L  L ++   NN+L   +P     L  +       N LE E+P       L+
Sbjct: 187 ELPE-LQNLPFLTAIYADNNSLK-KLPDLPLSLESI---VAGNNILE-ELPELQNLPFLT 240

Query: 63  VKSFEGNEL 71
               + N L
Sbjct: 241 TIYADNNLL 249

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 43.3 bits (102), Expect = 7e-05
 Identities = 16/61 (26%), Positives = 31/61 (50%), Gaps = 5/61 (8%)

Query: 3   SIPDSIGD-LINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNL 61
           S+   +     +L+ L++S+N L     IS   +  L+ +++SFN  +  +P    F NL
Sbjct: 90  SLDFHVFLFNQDLEYLDVSHNRLQN---ISCCPMASLRHLDLSFNDFD-VLPVCKEFGNL 145

Query: 62  S 62
           +
Sbjct: 146 T 146

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 43.4 bits (102), Expect = 8e-05
 Identities = 11/85 (12%), Positives = 22/85 (25%), Gaps = 5/85 (5%)

Query: 3   SIPDSIGDLINLKS----LNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPF 58
           S+P       + +          N ++  IP ++  L     I +  N L   I      
Sbjct: 194 SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQ 252

Query: 59  RNLSVKSFEGNELLCEIVLPLSTIF 83
           +                    +T+ 
Sbjct: 253 QTAQPDYHGPRIYFSMSDGQQNTLH 277

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 41.5 bits (97), Expect = 3e-04
 Identities = 12/59 (20%), Positives = 21/59 (35%)

Query: 3   SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNL 61
            IP++I  L    ++ L +N LS  I  SL +     D +           ++      
Sbjct: 221 HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRP 279

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 41.1 bits (96), Expect = 4e-04
 Identities = 18/69 (26%), Positives = 31/69 (44%), Gaps = 10/69 (14%)

Query: 3   SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLS 62
           S+P+      +L+ L+  +N LS T+P     L  L   +V  N+L   +P       L 
Sbjct: 94  SLPELPA---SLEYLDACDNRLS-TLPELPASLKHL---DVDNNQLT-MLPEL--PALLE 143

Query: 63  VKSFEGNEL 71
             + + N+L
Sbjct: 144 YINADNNQL 152

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 41.1 bits (96), Expect = 4e-04
 Identities = 15/96 (15%), Positives = 31/96 (32%), Gaps = 18/96 (18%)

Query: 2   GSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKD----INVSFNKLEGEIPRE-G 56
             +P+      +L++L++S N L  ++P    +    ++         N++   IP    
Sbjct: 173 TFLPELPE---SLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENIL 227

Query: 57  PFRNLSVKSFEGNELLCEIVLPLSTIFMIVMILLIL 92
                     E N        PLS+     +     
Sbjct: 228 SLDPTCTIILEDN--------PLSSRIRESLSQQTA 255

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 42.7 bits (101), Expect = 1e-04
 Identities = 12/52 (23%), Positives = 25/52 (48%), Gaps = 2/52 (3%)

Query: 11  LINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLS 62
             +LK L+LS N +  T+  +   L  L+ ++   + L+ ++     F +L 
Sbjct: 77  TTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLR 126

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 42.8 bits (100), Expect = 1e-04
 Identities = 9/61 (14%), Positives = 19/61 (31%), Gaps = 3/61 (4%)

Query: 3  SIPDSIGDLINLKSLNLSNNNLSGTIP-ISLEKLLDLKDINVSFNKLEGEIPREGPFRNL 61
               +    NL  L + N      +    L  L +L+++ +  + L   +     F   
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVA-PDAFHFT 79

Query: 62 S 62
           
Sbjct: 80 P 80

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 41.6 bits (97), Expect = 2e-04
 Identities = 18/71 (25%), Positives = 30/71 (42%), Gaps = 4/71 (5%)

Query: 5   PDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVK 64
              +  L  L++L +  + L    P +      L  +N+SFN LE  +      + LS++
Sbjct: 49  LRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLS-WKTVQGLSLQ 106

Query: 65  S--FEGNELLC 73
                GN L C
Sbjct: 107 ELVLSGNPLHC 117

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 42.8 bits (101), Expect = 1e-04
 Identities = 11/59 (18%), Positives = 24/59 (40%), Gaps = 2/59 (3%)

Query: 5   PDSIGDLINLKSLNLSNNNLSGTIPIS-LEKLLDLKDINVSFNKLEGEIPREGPFRNLS 62
            ++   L +L  L L  N     +       L +L+ + ++   L+G +     F+ L+
Sbjct: 72  NNTFRGLSSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLT 129

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 41.5 bits (98), Expect = 1e-04
 Identities = 11/57 (19%), Positives = 23/57 (40%), Gaps = 2/57 (3%)

Query: 6   DSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLS 62
           + I  L NL+ L +   +++     +L  L  L  +++S +  +  I        L 
Sbjct: 82  NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILT--KINTLP 136

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 39.2 bits (92), Expect = 6e-04
 Identities = 9/46 (19%), Positives = 22/46 (47%)

Query: 3   SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKL 48
               ++  L +L  L++S++    +I   +  L  +  I++S+N  
Sbjct: 103 DKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGA 148

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 42.2 bits (99), Expect = 1e-04
 Identities = 18/64 (28%), Positives = 30/64 (46%), Gaps = 3/64 (4%)

Query: 1   QGSIPDSIGDLINLKSLNLSNNNLSGTIP-ISLEKLLDLKDINVSFNKLEGEIPREGPFR 59
            G         + L+ L+LS+N+L       S +    L  +N+SF  L+ ++P+ G   
Sbjct: 217 SGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPK-GLPA 274

Query: 60  NLSV 63
            LSV
Sbjct: 275 KLSV 278

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 41.7 bits (98), Expect = 3e-04
 Identities = 20/58 (34%), Positives = 29/58 (50%), Gaps = 4/58 (6%)

Query: 5   PDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLS 62
             +   L NLK LNL   N+   +P +L  L+ L+++ +S N    EI   G F  LS
Sbjct: 189 EGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFP-EIR-PGSFHGLS 242

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 41.7 bits (98), Expect = 3e-04
 Identities = 20/58 (34%), Positives = 30/58 (51%), Gaps = 4/58 (6%)

Query: 5   PDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLS 62
             +   L NL+ LNL+  NL   IP +L  L+ L ++++S N L   I   G F+ L 
Sbjct: 178 EGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLS-AIR-PGSFQGLM 231

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 41.2 bits (97), Expect = 3e-04
 Identities = 10/66 (15%), Positives = 23/66 (34%), Gaps = 4/66 (6%)

Query: 7   SIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSF 66
            +     L  L L+N  L+  + +S      LK ++     ++ +    G    L+    
Sbjct: 313 DLSQNPKLVYLYLNNTELT-ELDVS--HNTKLKSLSCVNAHIQ-DFSSVGKIPALNNNFE 368

Query: 67  EGNELL 72
              + +
Sbjct: 369 AEGQTI 374

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 40.8 bits (96), Expect = 5e-04
 Identities = 16/66 (24%), Positives = 30/66 (45%), Gaps = 5/66 (7%)

Query: 6   DSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKS 65
             I  L  L  L  ++NN++ T+ +S  +  +L  +    NKL   +    P   L+  +
Sbjct: 58  TGIEKLTGLTKLICTSNNIT-TLDLS--QNTNLTYLACDSNKLT-NLDV-TPLTKLTYLN 112

Query: 66  FEGNEL 71
            + N+L
Sbjct: 113 CDTNKL 118

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 40.8 bits (96), Expect = 5e-04
 Identities = 15/65 (23%), Positives = 25/65 (38%), Gaps = 5/65 (7%)

Query: 7   SIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSF 66
            +   I L  L+ S+N L+  I ++   L  L   + S N L  E+        L+    
Sbjct: 207 DLNQNIQLTFLDCSSNKLT-EIDVT--PLTQLTYFDCSVNPLT-ELD-VSTLSKLTTLHC 261

Query: 67  EGNEL 71
              +L
Sbjct: 262 IQTDL 266

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 40.8 bits (96), Expect = 4e-04
 Identities = 20/67 (29%), Positives = 33/67 (49%), Gaps = 2/67 (2%)

Query: 5   PDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVK 64
                +L NL +L L NN +S   P +   L+ L+ + +S N+L+ E+P E   + L   
Sbjct: 69  DGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELP-EKMPKTLQEL 126

Query: 65  SFEGNEL 71
               NE+
Sbjct: 127 RVHENEI 133

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 40.9 bits (96), Expect = 4e-04
 Identities = 13/60 (21%), Positives = 31/60 (51%), Gaps = 2/60 (3%)

Query: 3   SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLS 62
           ++  +    +NL SL++++ NL+    +++  L+ L+ +N+S+N +   I        L 
Sbjct: 215 TMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPIS-TIE-GSMLHELL 272

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 40.1 bits (94), Expect = 7e-04
 Identities = 13/58 (22%), Positives = 24/58 (41%), Gaps = 2/58 (3%)

Query: 5   PDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLS 62
             S   L  LK L +S+     T+  +    L+L  ++++   L   +P     R+L 
Sbjct: 193 DYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVP-YLAVRHLV 248

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 39.3 bits (92), Expect = 4e-04
 Identities = 20/63 (31%), Positives = 30/63 (47%), Gaps = 2/63 (3%)

Query: 11  LINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLE--GEIPREGPFRNLSVKSFEG 68
           L  LK L LS+N +SG + +  EK  +L  +N+S NK++    I       NL       
Sbjct: 63  LNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFN 122

Query: 69  NEL 71
            E+
Sbjct: 123 CEV 125

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	346
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.91
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.83
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.73
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.41
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.35
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	99.29
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.19
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	99.18
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.16
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.09
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.08
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.08
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.06
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.03
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	98.96
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	98.96
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	98.94
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	98.92
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	98.92
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	98.9
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	98.9
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	98.85
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	98.85
3e6j_A	229	Variable lymphocyte receptor diversity region; var	98.84
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	98.83
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	98.82
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	98.81
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.8
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	98.8
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	98.79
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	98.77
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	98.77
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	98.77
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	98.75
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	98.73
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.73
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	98.73
3m19_A	251	Variable lymphocyte receptor A diversity region; a	98.73
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	98.72
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	98.71
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	98.71
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	98.71
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	98.7
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	98.7
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	98.69
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	98.69
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	98.68
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	98.68
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	98.67
3e6j_A	229	Variable lymphocyte receptor diversity region; var	98.67
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	98.66
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.65
3m19_A	251	Variable lymphocyte receptor A diversity region; a	98.64
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.63
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	98.61
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	98.61
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	98.61
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	98.59
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	98.57
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	98.57
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	98.57
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	98.56
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	98.56
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	98.56
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	98.55
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	98.55
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	98.54
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	98.54
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	98.54
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	98.51
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.51
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.49
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.48
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	98.48
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	98.46
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	98.45
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	98.45
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	98.44
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	98.44
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	98.44
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	98.43
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	98.43
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	98.42
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	98.42
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	98.42
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	98.42
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	98.41
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	98.41
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	98.41
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	98.4
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	98.39
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	98.38
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	98.37
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	98.37
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	98.36
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	98.36
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	98.36
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	98.35
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	98.35
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	98.34
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	98.34
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	98.34
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	98.34
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	98.33
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	98.33
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	98.32
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	98.32
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	98.31
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	98.31
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	98.3
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	98.3
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	98.29
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	98.27
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	98.27
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	98.24
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.24
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	98.24
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	98.23
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	98.22
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	98.21
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.2
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	98.18
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	98.17
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	98.17
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	98.16
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	98.15
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	98.13
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	98.13
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	98.11
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	98.08
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	98.07
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	98.07
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.06
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	98.02
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	98.01
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	98.01
1o6v_A	466	Internalin A; bacterial infection, extracellular r	97.95
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	97.94
1o6v_A	466	Internalin A; bacterial infection, extracellular r	97.92
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	97.92
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	97.89
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.89
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	97.89
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	97.84
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.83
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	97.82
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	97.79
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	97.79
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	97.76
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	97.76
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	97.76
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.73
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	97.7
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.63
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.62
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.62
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	97.61
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	97.56
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.55
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.39
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.38
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.36
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.32
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	97.13
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.0
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.99
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.93
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.93
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	96.83
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	96.83
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	96.74
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.35
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	96.15
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	96.1
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	96.02
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	95.86
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	95.7
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	95.54
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.29
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	95.11
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	94.81
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	94.35
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	93.95
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	93.43
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	91.68
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	91.07
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	89.9
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	86.38
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	85.68
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	84.64

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=7.8e-57  Score=397.98  Aligned_cols=239  Identities=27%  Similarity=0.417  Sum_probs=203.4

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc------CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCcee
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ------DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKA  175 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  175 (346)
                      .++|.+.+.||+|+||+||+|++.      ++..||||+++.......++|.+|++++++++|||||+++++|.+.+..+
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~   91 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   91 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence            356778889999999999999864      47789999998777777788999999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhhhc------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEE
Q 039799          176 LVLEYMPHGSLEKCLYLS------------NYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAH  243 (346)
Q Consensus       176 lv~e~~~~gsL~~~l~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~  243 (346)
                      +||||+++|+|.++++..            ...++|..++.++.|+++||+|||   +++|+||||||+|||+++++.+|
T Consensus        92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~K  168 (299)
T 4asz_A           92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVK  168 (299)
T ss_dssp             EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEE
Confidence            999999999999999753            246999999999999999999999   99999999999999999999999


Q ss_pred             EeeecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHh--
Q 039799          244 LSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVN--  320 (346)
Q Consensus       244 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~--  320 (346)
                      |+|||+|+...............||+.|+|||++.+..++.++|||||||++|||+| |+.||......  .+...+.  
T Consensus       169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~--~~~~~i~~~  246 (299)
T 4asz_A          169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--EVIECITQG  246 (299)
T ss_dssp             ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHHHHHHHT
T ss_pred             ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHcC
Confidence            999999987654433333344568999999999999999999999999999999999 89999764322  2222222  


Q ss_pred             ------hhcCCChhhhhchhccCCccccccc
Q 039799          321 ------DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       321 ------~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                            ..+++.+.+++.+||..||++|||.
T Consensus       247 ~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~  277 (299)
T 4asz_A          247 RVLQRPRTCPQEVYELMLGCWQREPHMRKNI  277 (299)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCCCCCccchHHHHHHHHHHcCCChhHCcCH
Confidence                  2234478999999999999999985

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.2e-55  Score=390.51  Aligned_cols=237  Identities=28%  Similarity=0.438  Sum_probs=192.8

Q ss_pred             CCCCCCCCcccccCceEEEEEEEcCCCEEEEEEecCC--CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEe
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQ--YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLE  179 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  179 (346)
                      .+++.+.+.||+|+||+||+|+++.  .||||+++..  .....+.|.+|++++++++|||||++++++.+ +..++|||
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE  111 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ  111 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence            4567788899999999999998763  6999998643  34456789999999999999999999998865 56889999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccc
Q 039799          180 YMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  259 (346)
Q Consensus       180 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~  259 (346)
                      |+++|+|.++++.....+++..++.++.|+|+||+|||   +++|+||||||+|||+++++.+||+|||+|+........
T Consensus       112 y~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~  188 (307)
T 3omv_A          112 WCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS  188 (307)
T ss_dssp             CCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence            99999999999877778999999999999999999999   999999999999999999999999999999876544333


Q ss_pred             cccccccCCcccccCCCCCC---CCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh------------hhcC
Q 039799          260 LTQTQTLATIGYMAPEYGRE---GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN------------DLLP  324 (346)
Q Consensus       260 ~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~------------~~~~  324 (346)
                      ......+||+.|+|||++.+   ..++.++|||||||++|||+||+.||....... .+...+.            ..++
T Consensus       189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~-~~~~~~~~~~~~p~~~~~~~~~~  267 (307)
T 3omv_A          189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD-QIIFMVGRGYASPDLSKLYKNCP  267 (307)
T ss_dssp             -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-HHHHHHHTTCCCCCSTTSCTTSC
T ss_pred             eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH-HHHHHHhcCCCCCCcccccccch
Confidence            34455679999999998753   468999999999999999999999997633211 1222221            1233


Q ss_pred             CChhhhhchhccCCccccccc
Q 039799          325 ISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       325 ~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ..+.+++.+||..||++|||.
T Consensus       268 ~~l~~li~~cl~~dP~~RPs~  288 (307)
T 3omv_A          268 KAMKRLVADCVKKVKEERPLF  288 (307)
T ss_dssp             HHHHHHHHHHTCSSSTTSCCH
T ss_pred             HHHHHHHHHHcCCCHhHCcCH
Confidence            467899999999999999985

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=6.9e-56  Score=397.08  Aligned_cols=238  Identities=26%  Similarity=0.422  Sum_probs=195.7

Q ss_pred             CCCCCCCcccccCceEEEEEEEc------CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeE
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ------DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKAL  176 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  176 (346)
                      +++.+.+.||+|+||+||+|+++      +++.||||+++.......++|.+|++++++++|||||+++++|.+.+..++
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            45667788999999999999864      478899999987777777899999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhcC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcE
Q 039799          177 VLEYMPHGSLEKCLYLSN--------------YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVA  242 (346)
Q Consensus       177 v~e~~~~gsL~~~l~~~~--------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~  242 (346)
                      ||||+++|+|.++++...              ..++|..++.++.|+|+||+|||   +++|+||||||+|||+++++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCcE
Confidence            999999999999986532              35899999999999999999999   9999999999999999999999


Q ss_pred             EEeeecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHh-
Q 039799          243 HLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVN-  320 (346)
Q Consensus       243 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~-  320 (346)
                      ||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||+| |+.||......  .....+. 
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~--~~~~~i~~  275 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT--EAIDCITQ  275 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH--HHHHHHHH
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH--HHHHHHHc
Confidence            9999999997654443334445679999999999999999999999999999999999 89999764321  2222222 


Q ss_pred             -------hhcCCChhhhhchhccCCccccccc
Q 039799          321 -------DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       321 -------~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                             ..+++.+.+++.+||..||++|||.
T Consensus       276 g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~  307 (329)
T 4aoj_A          276 GRELERPRACPPEVYAIMRGCWQREPQQRHSI  307 (329)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCH
T ss_pred             CCCCCCcccccHHHHHHHHHHcCcChhHCcCH
Confidence                   2234478999999999999999985

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.3e-55  Score=389.66  Aligned_cols=241  Identities=25%  Similarity=0.390  Sum_probs=205.8

Q ss_pred             CCCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC---CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCcee
Q 039799          100 PLPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ---YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKA  175 (346)
Q Consensus       100 ~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  175 (346)
                      ..+++|++.+.||+|+||+||+|+.. +|+.||||++++.   .....+.+.+|++++++++|||||++++++.+.+..|
T Consensus        29 ~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~y  108 (311)
T 4aw0_A           29 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY  108 (311)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             CCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence            34567999999999999999999976 7999999999643   1234577889999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCc
Q 039799          176 LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  255 (346)
Q Consensus       176 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~  255 (346)
                      +||||++||+|.+++... ..+++.....++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.+..
T Consensus       109 ivmEy~~gG~L~~~i~~~-~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~  184 (311)
T 4aw0_A          109 FGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  184 (311)
T ss_dssp             EEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence            999999999999998643 46899999999999999999999   99999999999999999999999999999998755


Q ss_pred             cccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh------hhcCCChhh
Q 039799          256 EDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN------DLLPISVME  329 (346)
Q Consensus       256 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~------~~~~~~~~~  329 (346)
                      ..........+||+.|+|||++.+..|+.++||||+||++|||+||+.||...... .......+      ..+++.+.+
T Consensus       185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-~~~~~i~~~~~~~p~~~s~~~~d  263 (311)
T 4aw0_A          185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG-LIFAKIIKLEYDFPEKFFPKARD  263 (311)
T ss_dssp             TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTCCCCCTTCCHHHHH
T ss_pred             CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHcCCCCCCcccCHHHHH
Confidence            44444445678999999999999999999999999999999999999999753211 11111121      223447789


Q ss_pred             hhchhccCCccccccc
Q 039799          330 VVDANLLSQEDEHFTT  345 (346)
Q Consensus       330 ~~d~~l~~~p~~R~~~  345 (346)
                      ++.+||..||++|||+
T Consensus       264 li~~lL~~dp~~R~t~  279 (311)
T 4aw0_A          264 LVEKLLVLDATKRLGC  279 (311)
T ss_dssp             HHHHHSCSSGGGSTTS
T ss_pred             HHHHHccCCHhHCcCh
Confidence            9999999999999986

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1e-55  Score=392.48  Aligned_cols=238  Identities=23%  Similarity=0.364  Sum_probs=201.0

Q ss_pred             CCCCCCCcccccCceEEEEEEEc------CCCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCcee
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ------DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKA  175 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  175 (346)
                      +++++.+.||+|+||+||+|.+.      +++.||||+++... ....++|.+|+.++++++|||||+++|+|.+.+..+
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            34566778999999999999863      46789999997543 334578999999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCC
Q 039799          176 LVLEYMPHGSLEKCLYLSN---------------YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM  240 (346)
Q Consensus       176 lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~  240 (346)
                      +||||+++|+|.+++....               ..++|..++.++.|+|+||+|||   +.+|+||||||+|||+++++
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECCCC
Confidence            9999999999999996432               45899999999999999999999   99999999999999999999


Q ss_pred             cEEEeeecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHH
Q 039799          241 VAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWV  319 (346)
Q Consensus       241 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~  319 (346)
                      .+||+|||+++.+...+.........||++|+|||++.++.++.++|||||||++|||+| |+.||.....  ..+...+
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~--~~~~~~i  260 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--QDVVEMI  260 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH--HHHHHHH
T ss_pred             CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH--HHHHHHH
Confidence            999999999997755444444455679999999999999999999999999999999999 8999976432  2233333


Q ss_pred             hh--------hcCCChhhhhchhccCCccccccc
Q 039799          320 ND--------LLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       320 ~~--------~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ..        ..+..+.+++.+||..||++|||.
T Consensus       261 ~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~  294 (308)
T 4gt4_A          261 RNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRF  294 (308)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HcCCCCCCcccchHHHHHHHHHHcCCChhHCcCH
Confidence            22        233478999999999999999985

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=9.3e-55  Score=389.66  Aligned_cols=234  Identities=25%  Similarity=0.308  Sum_probs=202.1

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecC
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYM  181 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  181 (346)
                      ..|++.+.||+|+||+||+|... +|+.||||+++.......+.+.+|++++++++|||||++++++.+.+..|+||||+
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            45888899999999999999976 79999999997554445567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccc
Q 039799          182 PHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT  261 (346)
Q Consensus       182 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~  261 (346)
                      ++|+|.+++..  ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.+....  ..
T Consensus       154 ~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--~~  226 (346)
T 4fih_A          154 EGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PR  226 (346)
T ss_dssp             TTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--CC
T ss_pred             CCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC--Cc
Confidence            99999998864  45899999999999999999999   9999999999999999999999999999999764332  22


Q ss_pred             cccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHhh----------hcCCChhhhh
Q 039799          262 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVND----------LLPISVMEVV  331 (346)
Q Consensus       262 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~----------~~~~~~~~~~  331 (346)
                      ....+||+.|+|||++.+..|+.++||||+||++|||+||+.||....  .......+..          .+++.+.+++
T Consensus       227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--~~~~~~~i~~~~~~~~~~~~~~s~~~~dli  304 (346)
T 4fih_A          227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP--PLKAMKMIRDNLPPRLKNLHKVSPSLKGFL  304 (346)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHSSCCCCSCGGGSCHHHHHHH
T ss_pred             ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--HHHHHHHHHcCCCCCCCccccCCHHHHHHH
Confidence            345679999999999999999999999999999999999999997532  1122222222          2344778999


Q ss_pred             chhccCCccccccc
Q 039799          332 DANLLSQEDEHFTT  345 (346)
Q Consensus       332 d~~l~~~p~~R~~~  345 (346)
                      .+||..||++|||+
T Consensus       305 ~~~L~~dP~~R~ta  318 (346)
T 4fih_A          305 DRLLVRDPAQRATA  318 (346)
T ss_dssp             HHHSCSSTTTSCCH
T ss_pred             HHHcCCChhHCcCH
Confidence            99999999999986

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=6.9e-55  Score=391.09  Aligned_cols=237  Identities=19%  Similarity=0.290  Sum_probs=196.2

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEe
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLE  179 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  179 (346)
                      ++|.+.+.||+|+||+||+|+.. +|+.||||++....  ....+.+.+|++++++++|||||++++++.+.+..|+|||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            57889999999999999999976 79999999997542  3446788999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccc
Q 039799          180 YMPHGSLEKCLYLSN-YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  258 (346)
Q Consensus       180 ~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~  258 (346)
                      |++||+|.+++.... ..+++.....++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.+.... 
T Consensus       104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-  179 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV-  179 (350)
T ss_dssp             CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-
T ss_pred             CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc-
Confidence            999999999997544 45789999999999999999999   9999999999999999999999999999999764321 


Q ss_pred             ccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHhh-------hcCCChhhhh
Q 039799          259 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVND-------LLPISVMEVV  331 (346)
Q Consensus       259 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~-------~~~~~~~~~~  331 (346)
                       ......+||+.|+|||++.+..|+.++||||+||++|||+||+.||......+ .+......       .++..+.+++
T Consensus       180 -~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~-~~~~i~~~~~~~~~~~~s~~~~~li  257 (350)
T 4b9d_A          180 -ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN-LVLKIISGSFPPVSLHYSYDLRSLV  257 (350)
T ss_dssp             -HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHTCCCCCCTTSCHHHHHHH
T ss_pred             -ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-HHHHHHcCCCCCCCccCCHHHHHHH
Confidence             12234579999999999999999999999999999999999999997532111 11222222       2344789999


Q ss_pred             chhccCCccccccc
Q 039799          332 DANLLSQEDEHFTT  345 (346)
Q Consensus       332 d~~l~~~p~~R~~~  345 (346)
                      .+||..||++|||+
T Consensus       258 ~~~L~~dP~~R~s~  271 (350)
T 4b9d_A          258 SQLFKRNPRDRPSV  271 (350)
T ss_dssp             HHHTCSSGGGSCCH
T ss_pred             HHHccCChhHCcCH
Confidence            99999999999985

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=6.1e-54  Score=383.26  Aligned_cols=233  Identities=21%  Similarity=0.251  Sum_probs=194.1

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecC
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYM  181 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  181 (346)
                      +.|.+.+.||+|+||+||+|+++ +|+.||||+++....     ..+|++++++++|||||++++++.+.+..++||||+
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  132 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL  132 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence            34666778999999999999976 799999999975432     235999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCC-cEEEeeecCCccCCcccccc
Q 039799          182 PHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM-VAHLSDFGMAKPLLEEDQSL  260 (346)
Q Consensus       182 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~-~~~l~Dfg~~~~~~~~~~~~  260 (346)
                      +||+|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++ .+||+|||+|+.+.......
T Consensus       133 ~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~  208 (336)
T 4g3f_A          133 EGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK  208 (336)
T ss_dssp             TTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred             CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence            999999999744 46899999999999999999999   99999999999999999887 69999999999775433221


Q ss_pred             ---ccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH---------hhhcCCChh
Q 039799          261 ---TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV---------NDLLPISVM  328 (346)
Q Consensus       261 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~---------~~~~~~~~~  328 (346)
                         .....+||+.|+|||++.+..++.++|||||||++|||+||+.||......+. .....         ...+++.+.
T Consensus       209 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~~s~~~~  287 (336)
T 4g3f_A          209 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL-CLKIASEPPPIREIPPSCAPLTA  287 (336)
T ss_dssp             -----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC-HHHHHHSCCGGGGSCTTSCHHHH
T ss_pred             ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH-HHHHHcCCCCchhcCccCCHHHH
Confidence               22345799999999999999999999999999999999999999976443332 11111         223444788


Q ss_pred             hhhchhccCCccccccc
Q 039799          329 EVVDANLLSQEDEHFTT  345 (346)
Q Consensus       329 ~~~d~~l~~~p~~R~~~  345 (346)
                      +++.+||..||++|||+
T Consensus       288 ~li~~~L~~dP~~R~sa  304 (336)
T 4g3f_A          288 QAIQEGLRKEPVHRASA  304 (336)
T ss_dssp             HHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHccCCHhHCcCH
Confidence            99999999999999985

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.5e-53  Score=390.91  Aligned_cols=234  Identities=25%  Similarity=0.308  Sum_probs=202.6

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecC
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYM  181 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  181 (346)
                      ..|++.+.||+|+||.||+|... +|+.||||++........+.+.+|++++++++|||||++++++...+..|+||||+
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            45888999999999999999976 79999999998665555677889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccc
Q 039799          182 PHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT  261 (346)
Q Consensus       182 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~  261 (346)
                      +||+|.+++..  ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.+....  ..
T Consensus       231 ~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~--~~  303 (423)
T 4fie_A          231 EGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PR  303 (423)
T ss_dssp             TTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC--CC
T ss_pred             CCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC--cc
Confidence            99999998864  35899999999999999999999   9999999999999999999999999999999764332  22


Q ss_pred             cccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHhh----------hcCCChhhhh
Q 039799          262 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVND----------LLPISVMEVV  331 (346)
Q Consensus       262 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~----------~~~~~~~~~~  331 (346)
                      ....+||+.|+|||++.+..|+.++|||||||++|||++|+.||....  .......+..          .++..+.+++
T Consensus       304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--~~~~~~~i~~~~~~~~~~~~~~s~~~~dli  381 (423)
T 4fie_A          304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP--PLKAMKMIRDNLPPRLKNLHKVSPSLKGFL  381 (423)
T ss_dssp             BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHSCCCCCSCTTSSCHHHHHHH
T ss_pred             ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--HHHHHHHHHcCCCCCCcccccCCHHHHHHH
Confidence            345679999999999999999999999999999999999999996522  1222222222          2334678999


Q ss_pred             chhccCCccccccc
Q 039799          332 DANLLSQEDEHFTT  345 (346)
Q Consensus       332 d~~l~~~p~~R~~~  345 (346)
                      .+||..||++|||+
T Consensus       382 ~~~L~~dP~~R~ta  395 (423)
T 4fie_A          382 DRLLVRDPAQRATA  395 (423)
T ss_dssp             HHHSCSSTTTSCCH
T ss_pred             HHHcCCChhHCcCH
Confidence            99999999999986

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.8e-53  Score=372.80  Aligned_cols=230  Identities=25%  Similarity=0.403  Sum_probs=190.0

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEEEEecCC--CchhHHHHHHHHHHHHhcCCCCceeeEEEEec----CCceeEEE
Q 039799          106 NMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ--YEGAFKSFDIECDVMKRICHRNLIKIISSYSN----DDFKALVL  178 (346)
Q Consensus       106 ~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~  178 (346)
                      .+.+.||+|+||+||+|.+. +++.||+|++...  .....+.+.+|++++++++|||||+++++|..    .+..++||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            55667999999999999976 6899999998643  33446789999999999999999999999864    34689999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeecCCCCCceEEC-CCCcEEEeeecCCccCCc
Q 039799          179 EYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP--IIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLE  255 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~dik~~NIll~-~~~~~~l~Dfg~~~~~~~  255 (346)
                      ||+++|+|.+++.. ...+++..+..++.|++.||+|||   +.+  |+||||||+|||++ .++.+||+|||+|+....
T Consensus       109 Ey~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~  184 (290)
T 3fpq_A          109 ELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             ECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence            99999999999974 456899999999999999999999   777  99999999999998 479999999999985322


Q ss_pred             cccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH---------hhhcCCC
Q 039799          256 EDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV---------NDLLPIS  326 (346)
Q Consensus       256 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~---------~~~~~~~  326 (346)
                          ......+||+.|+|||++.+ .++.++|||||||++|||+||+.||....... .+...+         ....++.
T Consensus       185 ----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~-~~~~~i~~~~~~~~~~~~~~~~  258 (290)
T 3fpq_A          185 ----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-QIYRRVTSGVKPASFDKVAIPE  258 (290)
T ss_dssp             ----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-HHHHHHTTTCCCGGGGGCCCHH
T ss_pred             ----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH-HHHHHHHcCCCCCCCCccCCHH
Confidence                22345679999999998864 69999999999999999999999996532211 121222         1222346


Q ss_pred             hhhhhchhccCCccccccc
Q 039799          327 VMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       327 ~~~~~d~~l~~~p~~R~~~  345 (346)
                      +.+++.+||..||++|||+
T Consensus       259 ~~~li~~~L~~dP~~R~s~  277 (290)
T 3fpq_A          259 VKEIIEGCIRQNKDERYSI  277 (290)
T ss_dssp             HHHHHHHHSCSSGGGSCCH
T ss_pred             HHHHHHHHccCChhHCcCH
Confidence            7899999999999999986

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=8.8e-54  Score=377.78  Aligned_cols=238  Identities=24%  Similarity=0.345  Sum_probs=193.2

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEc----CCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCce
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQ----DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFK  174 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  174 (346)
                      .+++|++.+.||+|+||+||+|+..    +++.||+|+++...  .....++.+|++++++++|||||++++++.+.+..
T Consensus        22 ~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  101 (304)
T 3ubd_A           22 DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKL  101 (304)
T ss_dssp             CGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEE
T ss_pred             CccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence            3467999999999999999999853    47899999986532  12234677899999999999999999999999999


Q ss_pred             eEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCC
Q 039799          175 ALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  254 (346)
Q Consensus       175 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~  254 (346)
                      ++||||++||+|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+|+...
T Consensus       102 ~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  177 (304)
T 3ubd_A          102 YLILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI  177 (304)
T ss_dssp             EEEECCCTTCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred             EEEEEcCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence            9999999999999998743 46899999999999999999999   9999999999999999999999999999998653


Q ss_pred             ccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh------hhcCCChh
Q 039799          255 EEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN------DLLPISVM  328 (346)
Q Consensus       255 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~------~~~~~~~~  328 (346)
                      ...  ......+||+.|+|||++.+..++.++||||+||++|||+||+.||......+ ......+      ..+++.+.
T Consensus       178 ~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~-~~~~i~~~~~~~p~~~s~~~~  254 (304)
T 3ubd_A          178 DHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE-TMTMILKAKLGMPQFLSPEAQ  254 (304)
T ss_dssp             -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCCCCCTTSCHHHH
T ss_pred             CCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH-HHHHHHcCCCCCCCcCCHHHH
Confidence            322  22345679999999999999999999999999999999999999997532111 1111111      22344789


Q ss_pred             hhhchhccCCccccccc
Q 039799          329 EVVDANLLSQEDEHFTT  345 (346)
Q Consensus       329 ~~~d~~l~~~p~~R~~~  345 (346)
                      +++.+||..||++|||+
T Consensus       255 ~li~~~L~~dP~~R~ta  271 (304)
T 3ubd_A          255 SLLRMLFKRNPANRLGA  271 (304)
T ss_dssp             HHHHHHTCSSGGGSTTC
T ss_pred             HHHHHHcccCHHHCCCC
Confidence            99999999999999985

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.5e-52  Score=365.12  Aligned_cols=233  Identities=22%  Similarity=0.356  Sum_probs=184.9

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEE
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVL  178 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  178 (346)
                      .+|.+.+.||+|+||+||+|... +|+.||+|+++...   ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            57999999999999999999965 79999999997542   233567889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccc
Q 039799          179 EYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  258 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~  258 (346)
                      ||+ +|+|.+++.. ...+++.....++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+|+...... 
T Consensus        93 Ey~-~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-  166 (275)
T 3hyh_A           93 EYA-GNELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-  166 (275)
T ss_dssp             ECC-CEEHHHHHHH-SCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred             eCC-CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC-
Confidence            999 6799998864 456999999999999999999999   9999999999999999999999999999998754322 


Q ss_pred             ccccccccCCcccccCCCCCCCCC-CcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh-------hhcCCChhhh
Q 039799          259 SLTQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN-------DLLPISVMEV  330 (346)
Q Consensus       259 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~-------~~~~~~~~~~  330 (346)
                        .....+||+.|+|||++.+..+ +.++||||+||++|||+||+.||....  ...+.+.+.       ..+++.+.++
T Consensus       167 --~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~--~~~~~~~i~~~~~~~p~~~s~~~~~l  242 (275)
T 3hyh_A          167 --FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES--IPVLFKNISNGVYTLPKFLSPGAAGL  242 (275)
T ss_dssp             ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHTCCCCCTTSCHHHHHH
T ss_pred             --ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC--HHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence              2334679999999999988775 579999999999999999999997532  111111111       2234478999


Q ss_pred             hchhccCCccccccc
Q 039799          331 VDANLLSQEDEHFTT  345 (346)
Q Consensus       331 ~d~~l~~~p~~R~~~  345 (346)
                      +.+||..||++|||+
T Consensus       243 i~~~L~~dP~~R~s~  257 (275)
T 3hyh_A          243 IKRMLIVNPLNRISI  257 (275)
T ss_dssp             HHHHSCSSGGGSCCH
T ss_pred             HHHHccCChhHCcCH
Confidence            999999999999986

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.7e-52  Score=378.01  Aligned_cols=240  Identities=22%  Similarity=0.358  Sum_probs=200.6

Q ss_pred             CCCCCCCCcccccCceEEEEEEEcC------CCEEEEEEecCCC-chhHHHHHHHHHHHHhcCC-CCceeeEEEEecC-C
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQD------GMEVAVKVFDPQY-EGAFKSFDIECDVMKRICH-RNLIKIISSYSND-D  172 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~-~  172 (346)
                      .++|.+.+.||+|+||+||+|.+..      ++.||||++.... ....+.+.+|++++.+++| ||||+++++|.+. +
T Consensus        63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~  142 (353)
T 4ase_A           63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG  142 (353)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred             HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCC
Confidence            3568888999999999999998652      3579999997653 3445779999999999976 8999999999764 5


Q ss_pred             ceeEEEecCCCCChhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEEC
Q 039799          173 FKALVLEYMPHGSLEKCLYLSN---------------YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD  237 (346)
Q Consensus       173 ~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~  237 (346)
                      ..++|||||++|+|.++++...               ..+++..++.++.|+|+||+|||   +++|+||||||+|||++
T Consensus       143 ~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRDLK~~NILl~  219 (353)
T 4ase_A          143 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLS  219 (353)
T ss_dssp             CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEC
T ss_pred             EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCccCccceeeC
Confidence            6899999999999999996532               34899999999999999999999   99999999999999999


Q ss_pred             CCCcEEEeeecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHH
Q 039799          238 DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLK  316 (346)
Q Consensus       238 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~  316 (346)
                      +++.+||+|||+|+.+.............||+.|+|||++.+..++.++|||||||++|||+| |+.||......+ .+.
T Consensus       220 ~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~-~~~  298 (353)
T 4ase_A          220 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EFC  298 (353)
T ss_dssp             GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-HHH
T ss_pred             CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH-HHH
Confidence            999999999999997755443334445678999999999999999999999999999999998 999997643222 233


Q ss_pred             HHHhh--------hcCCChhhhhchhccCCccccccc
Q 039799          317 RWVND--------LLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       317 ~~~~~--------~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ..+..        ..++.+.+++.+||..||++|||.
T Consensus       299 ~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~  335 (353)
T 4ase_A          299 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTF  335 (353)
T ss_dssp             HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCH
Confidence            33322        223478999999999999999985

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=7e-52  Score=366.78  Aligned_cols=236  Identities=23%  Similarity=0.336  Sum_probs=182.0

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCC---------
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDD---------  172 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---------  172 (346)
                      +|++.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||+++++|.+.+         
T Consensus         6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~   85 (299)
T 4g31_A            6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS   85 (299)
T ss_dssp             HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred             hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence            5778899999999999999976 79999999986443 344578899999999999999999999986544         


Q ss_pred             ---ceeEEEecCCCCChhhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeee
Q 039799          173 ---FKALVLEYMPHGSLEKCLYLSN--YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDF  247 (346)
Q Consensus       173 ---~~~lv~e~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Df  247 (346)
                         ..++||||+++|+|.+++....  ...++...+.++.|+++||+|||   +.+|+||||||+|||++.++.+||+||
T Consensus        86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl~DF  162 (299)
T 4g31_A           86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDF  162 (299)
T ss_dssp             -CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred             CCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEEccC
Confidence               3689999999999999997544  34567778899999999999999   999999999999999999999999999


Q ss_pred             cCCccCCccccc----------cccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHH
Q 039799          248 GMAKPLLEEDQS----------LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKR  317 (346)
Q Consensus       248 g~~~~~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~  317 (346)
                      |+|+.+......          ...+..+||+.|+|||++.+..|+.++|||||||++|||++   ||.........+..
T Consensus       163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~  239 (299)
T 4g31_A          163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTD  239 (299)
T ss_dssp             CCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHH
T ss_pred             ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHH
Confidence            999977543221          11234579999999999999999999999999999999997   77542111111111


Q ss_pred             HHhhhc-------CCChhhhhchhccCCccccccc
Q 039799          318 WVNDLL-------PISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       318 ~~~~~~-------~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      .....+       .+...+++.+||..||++|||+
T Consensus       240 ~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~  274 (299)
T 4g31_A          240 VRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEA  274 (299)
T ss_dssp             HHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCH
Confidence            111111       2245789999999999999986

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1e-51  Score=367.16  Aligned_cols=238  Identities=24%  Similarity=0.346  Sum_probs=182.5

Q ss_pred             CCCCCCcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCC----ceeEEEe
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDD----FKALVLE  179 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~lv~e  179 (346)
                      +|.+.+.||+|+||+||+|+++ |+.||||+++.... ....+..|+..+.+++|||||++++++.+.+    ..++|||
T Consensus         4 ~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E   81 (303)
T 3hmm_A            4 TIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD   81 (303)
T ss_dssp             GEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence            4566788999999999999985 89999999975422 2223345666777899999999999997654    5789999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCeeecCCCCCceEECCCCcEEEeeecCCccCC
Q 039799          180 YMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFG-----YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  254 (346)
Q Consensus       180 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~  254 (346)
                      |+++|+|.++++..  .++|..+.+++.|+++||+|||..     ..++|+||||||+|||+++++++||+|||+++...
T Consensus        82 y~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~  159 (303)
T 3hmm_A           82 YHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD  159 (303)
T ss_dssp             CCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred             CCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcccc
Confidence            99999999999643  589999999999999999999932     13499999999999999999999999999998764


Q ss_pred             ccccc--cccccccCCcccccCCCCCCC------CCCcchhHHHHHHHHHHHHcCCCCCCcccc----------CcccHH
Q 039799          255 EEDQS--LTQTQTLATIGYMAPEYGREG------RVSTNGDVYSFGIMLMEIFTRTKPTDEIFS----------GEMTLK  316 (346)
Q Consensus       255 ~~~~~--~~~~~~~~~~~y~aPE~~~~~------~~~~~~Dv~s~G~il~elltg~~p~~~~~~----------~~~~~~  316 (346)
                      .....  ......+||++|+|||++.+.      .++.++|||||||++|||+||++|+.....          ......
T Consensus       160 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~  239 (303)
T 3hmm_A          160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE  239 (303)
T ss_dssp             TTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred             CCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHH
Confidence            33221  122345799999999988654      467899999999999999999887643211          111111


Q ss_pred             HHHh----h----hcCC---------ChhhhhchhccCCccccccc
Q 039799          317 RWVN----D----LLPI---------SVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       317 ~~~~----~----~~~~---------~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ....    .    .+|.         .+.+++.+||..||++|||+
T Consensus       240 ~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~  285 (303)
T 3hmm_A          240 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA  285 (303)
T ss_dssp             HHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCH
T ss_pred             HHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCH
Confidence            1111    1    1111         35789999999999999985

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-48  Score=358.02  Aligned_cols=240  Identities=24%  Similarity=0.301  Sum_probs=193.6

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEec------C
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSN------D  171 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~  171 (346)
                      ..++|.+.+.||+|+||+||+|... +|+.||||++....  ....+.+.+|+++|++++|||||++++++..      .
T Consensus        52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~  131 (398)
T 4b99_A           52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEF  131 (398)
T ss_dssp             CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTC
T ss_pred             CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccC
Confidence            3467899999999999999999976 79999999997543  3345678899999999999999999998753      3


Q ss_pred             CceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCc
Q 039799          172 DFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAK  251 (346)
Q Consensus       172 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~  251 (346)
                      +..|+||||++ |+|.+++.. ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+|+
T Consensus       132 ~~~~ivmE~~~-g~L~~~i~~-~~~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~  206 (398)
T 4b99_A          132 KSVYVVLDLME-SDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMAR  206 (398)
T ss_dssp             CCEEEEEECCS-EEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             CEEEEEEeCCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecceee
Confidence            57899999996 679888864 457999999999999999999999   9999999999999999999999999999999


Q ss_pred             cCCccc--cccccccccCCcccccCCCCCCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccCcc---------------
Q 039799          252 PLLEED--QSLTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM---------------  313 (346)
Q Consensus       252 ~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~---------------  313 (346)
                      .+....  ........+||+.|+|||++.+. .++.++||||+||++|||++|+.||......+.               
T Consensus       207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~  286 (398)
T 4b99_A          207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAV  286 (398)
T ss_dssp             CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred             ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence            764322  12233456899999999987765 568999999999999999999999965211000               


Q ss_pred             -------cHHHH--------------HhhhcCCChhhhhchhccCCccccccc
Q 039799          314 -------TLKRW--------------VNDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       314 -------~~~~~--------------~~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                             .....              +...++..+.+++.+||..||++|||+
T Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta  339 (398)
T 4b99_A          287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISA  339 (398)
T ss_dssp             TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCH
T ss_pred             hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCH
Confidence                   00000              011223467899999999999999986

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=8.7e-49  Score=355.91  Aligned_cols=198  Identities=25%  Similarity=0.363  Sum_probs=169.1

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEc----CCCEEEEEEecCCCchhHHHHHHHHHHHHhc-CCCCceeeEEEEecCCcee
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQ----DGMEVAVKVFDPQYEGAFKSFDIECDVMKRI-CHRNLIKIISSYSNDDFKA  175 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  175 (346)
                      +.+.|.+.+.||+|+||+||+|+.+    +++.||+|++.....  ..++.+|+++++.+ +||||+++++++.+.++.+
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~   96 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV   96 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence            4467999999999999999999853    467899999875433  35678899999998 6999999999999999999


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCC-CcEEEeeecCCccCC
Q 039799          176 LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDN-MVAHLSDFGMAKPLL  254 (346)
Q Consensus       176 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~-~~~~l~Dfg~~~~~~  254 (346)
                      +||||+++|+|.+++.    .+++..+..++.|++.||+|||   +.+|+||||||+|||++.+ +.+||+|||+|+...
T Consensus        97 lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~  169 (361)
T 4f9c_A           97 IAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTH  169 (361)
T ss_dssp             EEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEECT
T ss_pred             EEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccC
Confidence            9999999999999884    4888999999999999999999   9999999999999999876 799999999998654


Q ss_pred             ccccc--------------------------cccccccCCcccccCCCCCCC-CCCcchhHHHHHHHHHHHHcCCCCCCc
Q 039799          255 EEDQS--------------------------LTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMEIFTRTKPTDE  307 (346)
Q Consensus       255 ~~~~~--------------------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~  307 (346)
                      +....                          ......+||+.|+|||++.+. .++.++||||+||++|||+||+.||..
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~  249 (361)
T 4f9c_A          170 DTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK  249 (361)
T ss_dssp             TCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred             CccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence            32110                          112335799999999988765 489999999999999999999999953

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=3.5e-48  Score=372.06  Aligned_cols=237  Identities=20%  Similarity=0.297  Sum_probs=203.4

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecC
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYM  181 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  181 (346)
                      ++|.+.+.||+|+||.||+|..+ +|+.||+|++........+.+.+|+++|+.++||||+++++++.+.+..++||||+
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~  236 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  236 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence            46888999999999999999976 79999999998766666778889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCC--CcEEEeeecCCccCCccccc
Q 039799          182 PHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDN--MVAHLSDFGMAKPLLEEDQS  259 (346)
Q Consensus       182 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~--~~~~l~Dfg~~~~~~~~~~~  259 (346)
                      +||+|.+++......+++..+..++.||+.||+|||   +.+|+||||||+|||++.+  +.+||+|||+|+.+....  
T Consensus       237 ~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~--  311 (573)
T 3uto_A          237 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--  311 (573)
T ss_dssp             CCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS--
T ss_pred             CCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC--
Confidence            999999998766677999999999999999999999   9999999999999999854  899999999999875432  


Q ss_pred             cccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcc---------cHHHHHhhhcCCChhhh
Q 039799          260 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM---------TLKRWVNDLLPISVMEV  330 (346)
Q Consensus       260 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~---------~~~~~~~~~~~~~~~~~  330 (346)
                       .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||......+.         .........++..+.++
T Consensus       312 -~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dl  390 (573)
T 3uto_A          312 -SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDF  390 (573)
T ss_dssp             -EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHH
T ss_pred             -ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence             23345799999999999999999999999999999999999999975321110         00111112234477899


Q ss_pred             hchhccCCccccccc
Q 039799          331 VDANLLSQEDEHFTT  345 (346)
Q Consensus       331 ~d~~l~~~p~~R~~~  345 (346)
                      +.+||..||++||++
T Consensus       391 i~~~L~~dp~~R~t~  405 (573)
T 3uto_A          391 IRKLLLADPNTRMTI  405 (573)
T ss_dssp             HHTTSCSSGGGSCCH
T ss_pred             HHHHccCChhHCcCH
Confidence            999999999999985

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.9e-47  Score=365.83  Aligned_cols=238  Identities=22%  Similarity=0.317  Sum_probs=195.3

Q ss_pred             CCCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC------chhHHHHHHHHHHHHhcCCCCceeeEEEEecCC
Q 039799          100 PLPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY------EGAFKSFDIECDVMKRICHRNLIKIISSYSNDD  172 (346)
Q Consensus       100 ~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  172 (346)
                      ..-++|.+.+.||+|+||+||+|+.. +|+.||+|++.+..      .........++.+++.++|||||++++++.+.+
T Consensus       186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~  265 (689)
T 3v5w_A          186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD  265 (689)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred             CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC
Confidence            34478999999999999999999976 79999999986321      111222233466777889999999999999999


Q ss_pred             ceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCcc
Q 039799          173 FKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  252 (346)
Q Consensus       173 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~  252 (346)
                      ..|+||||++||+|.+++... ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.+|.+||+|||+|+.
T Consensus       266 ~lylVmEy~~GGdL~~~l~~~-~~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~  341 (689)
T 3v5w_A          266 KLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACD  341 (689)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeee
Confidence            999999999999999999744 56899999999999999999999   99999999999999999999999999999987


Q ss_pred             CCccccccccccccCCcccccCCCCCC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccCcc-cHHHHHh-------hhc
Q 039799          253 LLEEDQSLTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM-TLKRWVN-------DLL  323 (346)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~-~~~~~~~-------~~~  323 (346)
                      +...    .....+||+.|+|||++.. ..|+.++|+||+||++|||++|+.||........ .+.+.+.       ..+
T Consensus       342 ~~~~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~  417 (689)
T 3v5w_A          342 FSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF  417 (689)
T ss_dssp             CSSC----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTS
T ss_pred             cCCC----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccC
Confidence            6432    2345679999999999864 5799999999999999999999999975332221 1111111       223


Q ss_pred             CCChhhhhchhccCCccccccc
Q 039799          324 PISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       324 ~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      +..+.+++.++|..||.+|++.
T Consensus       418 S~~a~dLI~~lL~~dP~~Rl~~  439 (689)
T 3v5w_A          418 SPELRSLLEGLLQRDVNRRLGC  439 (689)
T ss_dssp             CHHHHHHHHHHTCSCGGGCTTC
T ss_pred             CHHHHHHHHHHccCCHhHCCCC
Confidence            4478999999999999999973

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.9e-45  Score=328.88  Aligned_cols=241  Identities=26%  Similarity=0.375  Sum_probs=206.5

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEec
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEY  180 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  180 (346)
                      .++|.+.+.||+|+||+||+|... +++.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            356888899999999999999976 6899999998776667778899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccc
Q 039799          181 MPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  260 (346)
Q Consensus       181 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~  260 (346)
                      +++++|.+++......+++..++.++.++++||+|||   +.+|+||||||+||+++.++.++|+|||+++.........
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  165 (310)
T 3s95_A           89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP  165 (310)
T ss_dssp             CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred             cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence            9999999999877778999999999999999999999   9999999999999999999999999999998764322111


Q ss_pred             ------------ccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCc----ccHHHHH----h
Q 039799          261 ------------TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE----MTLKRWV----N  320 (346)
Q Consensus       261 ------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~----~~~~~~~----~  320 (346)
                                  ......||+.|+|||.+.+..++.++||||||+++|||++|..|+.......    .......    .
T Consensus       166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (310)
T 3s95_A          166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCP  245 (310)
T ss_dssp             --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHTCC
T ss_pred             cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccccCC
Confidence                        1114569999999999999999999999999999999999999987533222    2223333    2


Q ss_pred             hhcCCChhhhhchhccCCccccccc
Q 039799          321 DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       321 ~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ..++..+.+++.+||..||++||+.
T Consensus       246 ~~~~~~l~~li~~~l~~dP~~Rps~  270 (310)
T 3s95_A          246 PNCPPSFFPITVRCCDLDPEKRPSF  270 (310)
T ss_dssp             TTCCTTHHHHHHHHTCSSGGGSCCH
T ss_pred             CCCCHHHHHHHHHHccCChhhCcCH
Confidence            3456689999999999999999985

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.8e-45  Score=330.66  Aligned_cols=243  Identities=32%  Similarity=0.533  Sum_probs=206.1

Q ss_pred             CCCCCCCCCCcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEe
Q 039799          100 PLPNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLE  179 (346)
Q Consensus       100 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  179 (346)
                      ...++|.+.+.||+|+||.||+|.+++++.||+|++........+.+.+|++++++++||||+++++++...+..++|||
T Consensus        36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  115 (321)
T 2qkw_B           36 EATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYK  115 (321)
T ss_dssp             CCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEE
T ss_pred             HHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEE
Confidence            34578999999999999999999988899999999987766667889999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcc
Q 039799          180 YMPHGSLEKCLYLSN---YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  256 (346)
Q Consensus       180 ~~~~gsL~~~l~~~~---~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~  256 (346)
                      |+++++|.+++....   ..+++..++.++.+++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  192 (321)
T 2qkw_B          116 YMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTEL  192 (321)
T ss_dssp             CCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSS
T ss_pred             cCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            999999999886543   35899999999999999999999   899999999999999999999999999999865433


Q ss_pred             ccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCc-ccHHHHHhh--------------
Q 039799          257 DQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE-MTLKRWVND--------------  321 (346)
Q Consensus       257 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~-~~~~~~~~~--------------  321 (346)
                      ..........||+.|+|||.+.+..++.++||||||+++|||+||+.||......+ .....|...              
T Consensus       193 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (321)
T 2qkw_B          193 DQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPN  272 (321)
T ss_dssp             SCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSS
T ss_pred             cccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChh
Confidence            33333344568999999999888889999999999999999999999997643322 233333211              


Q ss_pred             -------hcCCChhhhhchhccCCccccccc
Q 039799          322 -------LLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       322 -------~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                             ..+..+.+++.+||..||++||++
T Consensus       273 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~  303 (321)
T 2qkw_B          273 LADKIRPESLRKFGDTAVKCLALSSEDRPSM  303 (321)
T ss_dssp             CTTCSCHHHHHHHHHHHHHHTCSSGGGSCCH
T ss_pred             hccccCHHHHHHHHHHHHHHcCCCcccCcCH
Confidence                   111246788999999999999986

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=3.4e-45  Score=325.24  Aligned_cols=238  Identities=25%  Similarity=0.312  Sum_probs=201.9

Q ss_pred             CCCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEE
Q 039799          100 PLPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVL  178 (346)
Q Consensus       100 ~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  178 (346)
                      ....+|.+.+.||+|+||+||+|... +++.||+|++........+.+.+|+.++++++||||+++++++...+..++||
T Consensus        17 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   96 (297)
T 3fxz_A           17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (297)
T ss_dssp             CGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEE
Confidence            34567999999999999999999864 78999999987655555677889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccc
Q 039799          179 EYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  258 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~  258 (346)
                      ||+++++|.+++...  .+++..+..++.+++.||+|||   +.+|+||||||+|||++.++.++|+|||++........
T Consensus        97 e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  171 (297)
T 3fxz_A           97 EYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (297)
T ss_dssp             ECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             ECCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence            999999999988643  5889999999999999999999   99999999999999999999999999999987643322


Q ss_pred             ccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH---------hhhcCCChhh
Q 039799          259 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV---------NDLLPISVME  329 (346)
Q Consensus       259 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~---------~~~~~~~~~~  329 (346)
                        ......||+.|+|||.+.+..++.++||||||+++|||+||+.||........ .....         ...++..+.+
T Consensus       172 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  248 (297)
T 3fxz_A          172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIATNGTPELQNPEKLSAIFRD  248 (297)
T ss_dssp             --CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHHCSCCCSCGGGSCHHHHH
T ss_pred             --ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhCCCCCCCCccccCHHHHH
Confidence              23345699999999999888999999999999999999999999965321111 11111         1223446789


Q ss_pred             hhchhccCCccccccc
Q 039799          330 VVDANLLSQEDEHFTT  345 (346)
Q Consensus       330 ~~d~~l~~~p~~R~~~  345 (346)
                      ++.+||..||++|||+
T Consensus       249 li~~~l~~dp~~Rps~  264 (297)
T 3fxz_A          249 FLNRCLEMDVEKRGSA  264 (297)
T ss_dssp             HHHHHSCSSTTTSCCH
T ss_pred             HHHHHccCChhHCcCH
Confidence            9999999999999985

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.2e-45  Score=326.24  Aligned_cols=239  Identities=21%  Similarity=0.323  Sum_probs=203.0

Q ss_pred             CCCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEE
Q 039799          100 PLPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVL  178 (346)
Q Consensus       100 ~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  178 (346)
                      ...++|.+.+.||+|+||.||+|... +++.+|+|++... ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus         2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   80 (321)
T 1tki_A            2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF   80 (321)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred             chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEE
Confidence            35578999999999999999999976 6889999998754 334567889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC--CCcEEEeeecCCccCCcc
Q 039799          179 EYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD--NMVAHLSDFGMAKPLLEE  256 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~--~~~~~l~Dfg~~~~~~~~  256 (346)
                      ||+++++|.+++......+++..+..++.|++.||+|||   +.+|+||||||+|||++.  ++.++|+|||+++.+...
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~  157 (321)
T 1tki_A           81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             EeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence            999999999999766667999999999999999999999   999999999999999987  789999999999876433


Q ss_pred             ccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcc---------cHHHHHhhhcCCCh
Q 039799          257 DQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM---------TLKRWVNDLLPISV  327 (346)
Q Consensus       257 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~---------~~~~~~~~~~~~~~  327 (346)
                      .   ......+|+.|+|||.+.+..++.++||||||+++|||++|..||......+.         .........++..+
T Consensus       158 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  234 (321)
T 1tki_A          158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA  234 (321)
T ss_dssp             C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred             C---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHH
Confidence            2   22345689999999999888899999999999999999999999975321110         01111112345578


Q ss_pred             hhhhchhccCCccccccc
Q 039799          328 MEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       328 ~~~~d~~l~~~p~~R~~~  345 (346)
                      .+++.+||..||++|||+
T Consensus       235 ~~li~~~L~~dp~~Rpt~  252 (321)
T 1tki_A          235 MDFVDRLLVKERKSRMTA  252 (321)
T ss_dssp             HHHHHTTSCSSGGGSCCH
T ss_pred             HHHHHHHcCCChhHCcCH
Confidence            999999999999999986

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=5.1e-45  Score=327.87  Aligned_cols=242  Identities=23%  Similarity=0.353  Sum_probs=202.3

Q ss_pred             CCCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEE
Q 039799          100 PLPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALV  177 (346)
Q Consensus       100 ~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  177 (346)
                      +..++|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         4 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv   83 (323)
T 3tki_A            4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   83 (323)
T ss_dssp             TTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            34578999999999999999999977 78999999986443 22346678899999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccc
Q 039799          178 LEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  257 (346)
Q Consensus       178 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~  257 (346)
                      |||+++++|.+++.. ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.++|+|||+++.+....
T Consensus        84 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  159 (323)
T 3tki_A           84 LEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (323)
T ss_dssp             EECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             EEcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence            999999999998863 345899999999999999999999   9999999999999999999999999999998764433


Q ss_pred             cccccccccCCcccccCCCCCCCCC-CcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHhh--------hcCCChh
Q 039799          258 QSLTQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVND--------LLPISVM  328 (346)
Q Consensus       258 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~~~~  328 (346)
                      .........||+.|+|||.+.+..+ +.++||||||+++|||++|+.||+...........+...        .++..+.
T Consensus       160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (323)
T 3tki_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL  239 (323)
T ss_dssp             EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHH
T ss_pred             cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHH
Confidence            3333445679999999999877665 778999999999999999999998654443444444432        2344778


Q ss_pred             hhhchhccCCccccccc
Q 039799          329 EVVDANLLSQEDEHFTT  345 (346)
Q Consensus       329 ~~~d~~l~~~p~~R~~~  345 (346)
                      +++.+||..||++|||+
T Consensus       240 ~li~~~L~~dP~~R~t~  256 (323)
T 3tki_A          240 ALLHKILVENPSARITI  256 (323)
T ss_dssp             HHHHHHSCSSTTTSCCH
T ss_pred             HHHHHHccCChhhCcCH
Confidence            99999999999999986

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.3e-44  Score=321.13  Aligned_cols=242  Identities=25%  Similarity=0.384  Sum_probs=199.2

Q ss_pred             CCCCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC---CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCce
Q 039799           99 KPLPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ---YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFK  174 (346)
Q Consensus        99 ~~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  174 (346)
                      +...++|.+.+.||+|+||.||+|... +++.||+|++...   .....+.+.+|++++++++||||+++++++...+..
T Consensus         7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~   86 (294)
T 4eqm_A            7 KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCY   86 (294)
T ss_dssp             SCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEE
T ss_pred             hHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeE
Confidence            345577999999999999999999966 7899999998543   234457888999999999999999999999999999


Q ss_pred             eEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCC
Q 039799          175 ALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  254 (346)
Q Consensus       175 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~  254 (346)
                      ++||||+++++|.+++... ..+++..++.++.+++.||+|||   +.+|+||||||+||+++.++.++|+|||+++...
T Consensus        87 ~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  162 (294)
T 4eqm_A           87 YLVMEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS  162 (294)
T ss_dssp             EEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred             EEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence            9999999999999998644 46899999999999999999999   9999999999999999999999999999998764


Q ss_pred             ccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCc----------ccHHHHHhhhcC
Q 039799          255 EEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE----------MTLKRWVNDLLP  324 (346)
Q Consensus       255 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~----------~~~~~~~~~~~~  324 (346)
                      .... .......||+.|+|||.+.+..++.++||||+|+++|||+||+.||.......          ..........++
T Consensus       163 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (294)
T 4eqm_A          163 ETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIP  241 (294)
T ss_dssp             -------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSC
T ss_pred             cccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCC
Confidence            3221 22234568999999999988889999999999999999999999997632211          112223334456


Q ss_pred             CChhhhhchhccCCccccccc
Q 039799          325 ISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       325 ~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ..+.+++.+||..||.+||++
T Consensus       242 ~~l~~li~~~l~~dp~~R~~~  262 (294)
T 4eqm_A          242 QSLSNVILRATEKDKANRYKT  262 (294)
T ss_dssp             HHHHHHHHHHSCSSGGGSCSS
T ss_pred             HHHHHHHHHHhcCCHhHcccc
Confidence            688999999999999999954

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.1e-44  Score=326.00  Aligned_cols=236  Identities=24%  Similarity=0.317  Sum_probs=199.6

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC--CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEE
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ--YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALV  177 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  177 (346)
                      ...+|.+.+.||+|+||.||+|... +|+.||+|++...  .....+.+.+|+++++.++||||+++++++...+..++|
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   92 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI   92 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence            3467999999999999999999974 8999999998653  234567788999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccc
Q 039799          178 LEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  257 (346)
Q Consensus       178 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~  257 (346)
                      |||+++++|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++.......
T Consensus        93 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  168 (328)
T 3fe3_A           93 MEYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG  168 (328)
T ss_dssp             ECCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred             EECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence            9999999999988644 45889999999999999999999   9999999999999999999999999999998654322


Q ss_pred             cccccccccCCcccccCCCCCCCCCC-cchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh-------hhcCCChhh
Q 039799          258 QSLTQTQTLATIGYMAPEYGREGRVS-TNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN-------DLLPISVME  329 (346)
Q Consensus       258 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~-------~~~~~~~~~  329 (346)
                         ......||+.|+|||.+.+..+. .++||||+|+++|||+||+.||+....  ......+.       ..++..+.+
T Consensus       169 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~~i~~~~~~~p~~~s~~~~~  243 (328)
T 3fe3_A          169 ---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL--KELRERVLRGKYRIPFYMSTDCEN  243 (328)
T ss_dssp             ---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred             ---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH--HHHHHHHHhCCCCCCCCCCHHHHH
Confidence               23445799999999998877764 799999999999999999999976321  11222221       123447889


Q ss_pred             hhchhccCCccccccc
Q 039799          330 VVDANLLSQEDEHFTT  345 (346)
Q Consensus       330 ~~d~~l~~~p~~R~~~  345 (346)
                      ++.+||..||.+|||+
T Consensus       244 li~~~L~~dP~~R~t~  259 (328)
T 3fe3_A          244 LLKRFLVLNPIKRGTL  259 (328)
T ss_dssp             HHHHHCCSSTTTSCCH
T ss_pred             HHHHHCCCChhHCcCH
Confidence            9999999999999985

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=3e-44  Score=327.18  Aligned_cols=240  Identities=21%  Similarity=0.310  Sum_probs=201.7

Q ss_pred             CCCCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCch------hHHHHHHHHHHHHhcCCCCceeeEEEEecC
Q 039799           99 KPLPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEG------AFKSFDIECDVMKRICHRNLIKIISSYSND  171 (346)
Q Consensus        99 ~~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  171 (346)
                      ....+.|.+.+.||+|+||.||+|... +|+.||+|++......      ..+.+.+|+.++++++||||+++++++...
T Consensus         8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~   87 (361)
T 2yab_A            8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENR   87 (361)
T ss_dssp             SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeC
Confidence            345567999999999999999999976 7899999998754321      346788999999999999999999999999


Q ss_pred             CceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCC----cEEEeee
Q 039799          172 DFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM----VAHLSDF  247 (346)
Q Consensus       172 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~----~~~l~Df  247 (346)
                      +..++||||+++|+|.+++.. ...+++..+..++.+++.||+|||   +.+|+||||||+|||++.++    .++|+||
T Consensus        88 ~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DF  163 (361)
T 2yab_A           88 TDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (361)
T ss_dssp             SEEEEEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             CEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence            999999999999999999864 456899999999999999999999   99999999999999998776    7999999


Q ss_pred             cCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCc---------ccHHHH
Q 039799          248 GMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE---------MTLKRW  318 (346)
Q Consensus       248 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~---------~~~~~~  318 (346)
                      |+++.+....   ......||+.|+|||.+.+..++.++||||+|+++|||++|..||......+         ......
T Consensus       164 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~  240 (361)
T 2yab_A          164 GLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEE  240 (361)
T ss_dssp             SSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHH
T ss_pred             CCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCch
Confidence            9998764322   2234569999999999988899999999999999999999999996532111         011111


Q ss_pred             HhhhcCCChhhhhchhccCCccccccc
Q 039799          319 VNDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       319 ~~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ....++..+.+++.+||..||++|||+
T Consensus       241 ~~~~~s~~~~~li~~~L~~dP~~R~t~  267 (361)
T 2yab_A          241 FFSQTSELAKDFIRKLLVKETRKRLTI  267 (361)
T ss_dssp             HHTTSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred             hccCCCHHHHHHHHHHCCCChhHCcCH
Confidence            223345578999999999999999985

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2.7e-44  Score=329.03  Aligned_cols=238  Identities=26%  Similarity=0.372  Sum_probs=199.3

Q ss_pred             CCCCCCCcccccCceEEEEEEEc--------CCCEEEEEEecCCC-chhHHHHHHHHHHHHhc-CCCCceeeEEEEecCC
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ--------DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRI-CHRNLIKIISSYSNDD  172 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  172 (346)
                      ++|.+.+.||+|+||.||+|.+.        ++..||+|++.... ....+.+.+|+++++++ +||||+++++++...+
T Consensus        81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  160 (370)
T 2psq_A           81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG  160 (370)
T ss_dssp             GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred             HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence            46788889999999999999853        34579999997653 33457789999999999 8999999999999999


Q ss_pred             ceeEEEecCCCCChhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEEC
Q 039799          173 FKALVLEYMPHGSLEKCLYLSN---------------YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD  237 (346)
Q Consensus       173 ~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~  237 (346)
                      ..++||||+++|+|.+++....               ..+++..++.++.|++.||+|||   +.+|+||||||+|||++
T Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~  237 (370)
T 2psq_A          161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVT  237 (370)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEC
T ss_pred             CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEEEC
Confidence            9999999999999999987543               35889999999999999999999   99999999999999999


Q ss_pred             CCCcEEEeeecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHH
Q 039799          238 DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLK  316 (346)
Q Consensus       238 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~  316 (346)
                      .++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|||+| |+.||.....  ....
T Consensus       238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~--~~~~  315 (370)
T 2psq_A          238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--EELF  315 (370)
T ss_dssp             TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG--GGHH
T ss_pred             CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH--HHHH
Confidence            999999999999987654333233334457889999999988899999999999999999999 9999976322  2222


Q ss_pred             HHHhh--------hcCCChhhhhchhccCCccccccc
Q 039799          317 RWVND--------LLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       317 ~~~~~--------~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ..+..        .++..+.+++.+||..+|++||++
T Consensus       316 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~  352 (370)
T 2psq_A          316 KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF  352 (370)
T ss_dssp             HHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCH
Confidence            22222        223378899999999999999985

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.3e-44  Score=324.96  Aligned_cols=233  Identities=23%  Similarity=0.297  Sum_probs=197.2

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC---CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEE
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ---YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVL  178 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  178 (346)
                      ++|.+.+.||+|+||.||+|... +|+.||+|++...   .......+.+|+++++.++||||+++++++...+..++||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            56888899999999999999976 7999999998643   1233567888999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccc
Q 039799          179 EYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  258 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~  258 (346)
                      ||+++|+|.+++.. ...+++..+..++.+++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...... 
T Consensus        85 E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-  159 (337)
T 1o6l_A           85 EYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-  159 (337)
T ss_dssp             ECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-
T ss_pred             eCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC-
Confidence            99999999998864 346889999999999999999999   9999999999999999999999999999998643222 


Q ss_pred             ccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH-------hhhcCCChhhhh
Q 039799          259 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV-------NDLLPISVMEVV  331 (346)
Q Consensus       259 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~  331 (346)
                       ......+||+.|+|||.+.+..++.++||||||+++|||++|+.||.....  ....+.+       ...++..+.+++
T Consensus       160 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~~~i~~~~~~~p~~~s~~~~~li  236 (337)
T 1o6l_A          160 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--ERLFELILMEEIRFPRTLSPEAKSLL  236 (337)
T ss_dssp             -CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred             -CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH--HHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence             223445799999999999999999999999999999999999999965321  1111111       122345789999


Q ss_pred             chhccCCccccc
Q 039799          332 DANLLSQEDEHF  343 (346)
Q Consensus       332 d~~l~~~p~~R~  343 (346)
                      .+||..||++||
T Consensus       237 ~~lL~~dP~~R~  248 (337)
T 1o6l_A          237 AGLLKKDPKQRL  248 (337)
T ss_dssp             HHHTCSSTTTST
T ss_pred             HHHhhcCHHHhc
Confidence            999999999999

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=3.7e-44  Score=320.65  Aligned_cols=240  Identities=24%  Similarity=0.323  Sum_probs=197.5

Q ss_pred             CCCCCCCCCCCcccccCceEEEEEEEcCCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeE
Q 039799           99 KPLPNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKAL  176 (346)
Q Consensus        99 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  176 (346)
                      +.+.++|.+.+.||+|+||+||+|...+|+.||+|++....  ......+.+|++++++++||||+++++++...+..++
T Consensus        17 q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   96 (311)
T 3niz_A           17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL   96 (311)
T ss_dssp             ECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred             cchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence            34567899999999999999999999889999999986442  2335678899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcc
Q 039799          177 VLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  256 (346)
Q Consensus       177 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~  256 (346)
                      ||||+++ +|.+.+......+++..+..++.+++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        97 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  172 (311)
T 3niz_A           97 VFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP  172 (311)
T ss_dssp             EEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred             EEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence            9999975 888888766677999999999999999999999   999999999999999999999999999999876432


Q ss_pred             ccccccccccCCcccccCCCCCC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHH------------------
Q 039799          257 DQSLTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKR------------------  317 (346)
Q Consensus       257 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~------------------  317 (346)
                      .  .......+|+.|+|||.+.+ ..++.++||||+|+++|||++|+.||......+. ...                  
T Consensus       173 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~  249 (311)
T 3niz_A          173 V--RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ-LPKIFSILGTPNPREWPQVQE  249 (311)
T ss_dssp             C--C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH-HHHHHHHHCCCCTTTSGGGTT
T ss_pred             c--ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHHCCCChHHhhhhhc
Confidence            2  22334568999999998765 5689999999999999999999999976432221 111                  


Q ss_pred             ---HH---------------hhhcCCChhhhhchhccCCccccccc
Q 039799          318 ---WV---------------NDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       318 ---~~---------------~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                         |.               ...++..+.+++.+||..||++|||+
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  295 (311)
T 3niz_A          250 LPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISA  295 (311)
T ss_dssp             SHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCH
T ss_pred             cchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCH
Confidence               11               11123356789999999999999986

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.2e-44  Score=323.43  Aligned_cols=236  Identities=30%  Similarity=0.427  Sum_probs=190.6

Q ss_pred             CCCCCCCCcccccCceEEEEEEEcCCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEe
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLE  179 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  179 (346)
                      ..+|.+.+.||+|+||+||+|.+. |+.||+|++....  ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus        36 ~~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  114 (309)
T 3p86_A           36 WCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE  114 (309)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred             hhHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence            356888899999999999999874 8899999987543  3345678899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeecCCCCCceEECCCCcEEEeeecCCccCCc
Q 039799          180 YMPHGSLEKCLYLSN--YILDIFQRLDIMIDVASALEYLHFGYSAP--IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  255 (346)
Q Consensus       180 ~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~  255 (346)
                      |+++++|.+++....  ..+++..++.++.+++.||+|||   +.+  |+||||||+||+++.++.+||+|||+++....
T Consensus       115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~  191 (309)
T 3p86_A          115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS  191 (309)
T ss_dssp             CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred             cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence            999999999987543  24899999999999999999999   888  99999999999999999999999999985432


Q ss_pred             cccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH---------hhhcCCC
Q 039799          256 EDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV---------NDLLPIS  326 (346)
Q Consensus       256 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~---------~~~~~~~  326 (346)
                      ..  .......||+.|+|||.+.+..++.++||||||+++|||+||+.||......+  ....+         ...++..
T Consensus       192 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  267 (309)
T 3p86_A          192 TF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ--VVAAVGFKCKRLEIPRNLNPQ  267 (309)
T ss_dssp             ------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH--HHHHHHHSCCCCCCCTTSCHH
T ss_pred             cc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhcCCCCCCCccCCHH
Confidence            21  22234568999999999999999999999999999999999999997632211  11111         1223447


Q ss_pred             hhhhhchhccCCccccccc
Q 039799          327 VMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       327 ~~~~~d~~l~~~p~~R~~~  345 (346)
                      +.+++.+||..+|++||++
T Consensus       268 l~~li~~~l~~dP~~Rps~  286 (309)
T 3p86_A          268 VAAIIEGCWTNEPWKRPSF  286 (309)
T ss_dssp             HHHHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHHHccCChhhCcCH
Confidence            8999999999999999985

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=6.4e-44  Score=327.81  Aligned_cols=236  Identities=19%  Similarity=0.328  Sum_probs=202.0

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEec
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEY  180 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  180 (346)
                      .+.|.+.+.||+|+||.||+|... +|+.+|+|++..........+.+|++++++++||||+++++++...+..++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            356888999999999999999976 7899999999876655567888999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC--CCcEEEeeecCCccCCcccc
Q 039799          181 MPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD--NMVAHLSDFGMAKPLLEEDQ  258 (346)
Q Consensus       181 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~--~~~~~l~Dfg~~~~~~~~~~  258 (346)
                      +++++|.+++......+++..+..++.+++.||+|||   +.+|+||||||+|||++.  ++.+||+|||+++...... 
T Consensus       130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~-  205 (387)
T 1kob_A          130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-  205 (387)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred             CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecCCCc-
Confidence            9999999998766667999999999999999999999   999999999999999974  5789999999998764332 


Q ss_pred             ccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh-----------hhcCCCh
Q 039799          259 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN-----------DLLPISV  327 (346)
Q Consensus       259 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~-----------~~~~~~~  327 (346)
                        ......||+.|+|||++.+..++.++|||||||++|||+||+.||.....  ......+.           ..++..+
T Consensus       206 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~s~~~  281 (387)
T 1kob_A          206 --IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--LETLQNVKRCDWEFDEDAFSSVSPEA  281 (387)
T ss_dssp             --CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--HHHHHHHHHCCCCCCSSTTTTSCHHH
T ss_pred             --ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH--HHHHHHHHhCCCCCCccccccCCHHH
Confidence              12334689999999999988999999999999999999999999975321  11111111           1234578


Q ss_pred             hhhhchhccCCccccccc
Q 039799          328 MEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       328 ~~~~d~~l~~~p~~R~~~  345 (346)
                      .+++.+||..||++||++
T Consensus       282 ~~li~~~L~~dP~~Rpt~  299 (387)
T 1kob_A          282 KDFIKNLLQKEPRKRLTV  299 (387)
T ss_dssp             HHHHHTTSCSSGGGSCCH
T ss_pred             HHHHHHHcCCChhHCcCH
Confidence            999999999999999986

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.5e-44  Score=328.29  Aligned_cols=237  Identities=24%  Similarity=0.315  Sum_probs=194.5

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhc-CCCCceeeEEEEecCCceeE
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRI-CHRNLIKIISSYSNDDFKAL  176 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  176 (346)
                      .++|.+.+.||+|+||.||+|+.. +++.||+|++....   ....+.+..|.++++.+ +||||+++++++...+..++
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            367999999999999999999976 68999999986431   22345677899999988 69999999999999999999


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcc
Q 039799          177 VLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  256 (346)
Q Consensus       177 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~  256 (346)
                      ||||+++|+|.+++... ..+++..+..++.+++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus       102 v~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~  177 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN  177 (353)
T ss_dssp             EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred             EEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence            99999999999988644 46899999999999999999999   999999999999999999999999999999864322


Q ss_pred             ccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh------hhcCCChhhh
Q 039799          257 DQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN------DLLPISVMEV  330 (346)
Q Consensus       257 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~------~~~~~~~~~~  330 (346)
                        .......+||+.|+|||++.+..++.++||||+||++|||++|+.||......+ .......      ..++..+.++
T Consensus       178 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-~~~~i~~~~~~~p~~~~~~~~~l  254 (353)
T 3txo_A          178 --GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD-LFEAILNDEVVYPTWLHEDATGI  254 (353)
T ss_dssp             ----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCCCCCTTSCHHHHHH
T ss_pred             --CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH-HHHHHHcCCCCCCCCCCHHHHHH
Confidence              122345679999999999988889999999999999999999999997532211 1111111      1234478899


Q ss_pred             hchhccCCccccccc
Q 039799          331 VDANLLSQEDEHFTT  345 (346)
Q Consensus       331 ~d~~l~~~p~~R~~~  345 (346)
                      +.+||..||.+||++
T Consensus       255 i~~lL~~dP~~R~~~  269 (353)
T 3txo_A          255 LKSFMTKNPTMRLGS  269 (353)
T ss_dssp             HHHHTCSSGGGSTTS
T ss_pred             HHHHhhhCHHHccCC
Confidence            999999999999986

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.6e-44  Score=324.98  Aligned_cols=240  Identities=24%  Similarity=0.380  Sum_probs=199.2

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEc----CCCEEEEEEecCC-CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCcee
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQ----DGMEVAVKVFDPQ-YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKA  175 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  175 (346)
                      ...+|.+.+.||+|+||.||+|.+.    .+..||||++... .....+.+.+|++++++++||||+++++++...+..+
T Consensus        47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  126 (325)
T 3kul_A           47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM  126 (325)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred             ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence            3456888999999999999999975    3456999999765 3344578899999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCc
Q 039799          176 LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  255 (346)
Q Consensus       176 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~  255 (346)
                      +||||+++++|.+++......+++..++.++.+++.||+|||   +.+|+||||||+|||++.++.++|+|||+++....
T Consensus       127 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  203 (325)
T 3kul_A          127 IVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED  203 (325)
T ss_dssp             EEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred             EEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence            999999999999999777678999999999999999999999   99999999999999999999999999999997654


Q ss_pred             ccc-ccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHhh--------hcCC
Q 039799          256 EDQ-SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVND--------LLPI  325 (346)
Q Consensus       256 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~--------~~~~  325 (346)
                      ... ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......  .....+..        .++.
T Consensus       204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~  281 (325)
T 3kul_A          204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR--DVISSVEEGYRLPAPMGCPH  281 (325)
T ss_dssp             ---CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--HHHHHHHTTCCCCCCTTCCH
T ss_pred             CccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH--HHHHHHHcCCCCCCCCCcCH
Confidence            322 122233446788999999988889999999999999999999 99999763221  12222221        2344


Q ss_pred             ChhhhhchhccCCccccccc
Q 039799          326 SVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       326 ~~~~~~d~~l~~~p~~R~~~  345 (346)
                      .+.+++.+||..||++||++
T Consensus       282 ~l~~li~~~l~~dp~~Rps~  301 (325)
T 3kul_A          282 ALHQLMLDCWHKDRAQRPRF  301 (325)
T ss_dssp             HHHHHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHHHHccCChhhCcCH
Confidence            78899999999999999985

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.7e-44  Score=324.42  Aligned_cols=236  Identities=24%  Similarity=0.331  Sum_probs=191.2

Q ss_pred             CCCCCCCcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCC----ceeEEE
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDD----FKALVL  178 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~lv~  178 (346)
                      ++|.+.+.||+|+||+||+|++. ++.||||++.... ........|+.++++++||||+++++++....    ..++||
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~  101 (322)
T 3soc_A           24 MPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT  101 (322)
T ss_dssp             EEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             hhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence            45888899999999999999887 7899999996543 33445667899999999999999999998754    368999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCC----------CeeecCCCCCceEECCCCcEEEeeec
Q 039799          179 EYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSA----------PIIHCDLKPSNVLLDDNMVAHLSDFG  248 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~----------~i~H~dik~~NIll~~~~~~~l~Dfg  248 (346)
                      ||+++|+|.+++...  .+++..++.++.+++.||+|||   +.          +|+||||||+|||++.++.+||+|||
T Consensus       102 e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg  176 (322)
T 3soc_A          102 AFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG  176 (322)
T ss_dssp             ECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             ecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence            999999999998653  4899999999999999999999   77          99999999999999999999999999


Q ss_pred             CCccCCccccccccccccCCcccccCCCCCCC-----CCCcchhHHHHHHHHHHHHcCCCCCCccccCcc----------
Q 039799          249 MAKPLLEEDQSLTQTQTLATIGYMAPEYGREG-----RVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM----------  313 (346)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~----------  313 (346)
                      +++.+.............||+.|+|||++.+.     .++.++||||||+++|||+||+.||........          
T Consensus       177 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~  256 (322)
T 3soc_A          177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQH  256 (322)
T ss_dssp             TCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSS
T ss_pred             cccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccC
Confidence            99876544333333446799999999988763     456788999999999999999999975332111          


Q ss_pred             -cHHHHHhhhc--------C---------CChhhhhchhccCCccccccc
Q 039799          314 -TLKRWVNDLL--------P---------ISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       314 -~~~~~~~~~~--------~---------~~~~~~~d~~l~~~p~~R~~~  345 (346)
                       ....+.....        +         ..+.+++.+||..||++|||+
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~  306 (322)
T 3soc_A          257 PSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA  306 (322)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCH
Confidence             1111111110        0         127899999999999999986

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=4.6e-44  Score=323.94  Aligned_cols=237  Identities=22%  Similarity=0.317  Sum_probs=198.5

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhc-CCCCceeeEEEEecCCcee
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRI-CHRNLIKIISSYSNDDFKA  175 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  175 (346)
                      ..++|.+.+.||+|+||.||+|+.+ +|+.||+|++....   ....+.+..|.+++..+ +||||+++++++...+..+
T Consensus        15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~   94 (345)
T 1xjd_A           15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF   94 (345)
T ss_dssp             -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence            3467999999999999999999976 68999999986431   22345677899999877 9999999999999999999


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCc
Q 039799          176 LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  255 (346)
Q Consensus       176 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~  255 (346)
                      +||||+++|+|.+++... ..+++..+..++.+++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        95 lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  170 (345)
T 1xjd_A           95 FVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML  170 (345)
T ss_dssp             EEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence            999999999999988643 46899999999999999999999   99999999999999999999999999999986432


Q ss_pred             cccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh-------hhcCCChh
Q 039799          256 EDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN-------DLLPISVM  328 (346)
Q Consensus       256 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~-------~~~~~~~~  328 (346)
                      ..  ......+||+.|+|||.+.+..++.++||||+|+++|||++|+.||.....  ....+.+.       ..++..+.
T Consensus       171 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~~~i~~~~~~~p~~~s~~~~  246 (345)
T 1xjd_A          171 GD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--EELFHSIRMDNPFYPRWLEKEAK  246 (345)
T ss_dssp             TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCCCCCCTTSCHHHH
T ss_pred             CC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHHhCCCCCCcccCHHHH
Confidence            21  123456799999999999988999999999999999999999999975321  11111111       12345788


Q ss_pred             hhhchhccCCccccccc
Q 039799          329 EVVDANLLSQEDEHFTT  345 (346)
Q Consensus       329 ~~~d~~l~~~p~~R~~~  345 (346)
                      +++.+||..||++||++
T Consensus       247 ~li~~lL~~dp~~R~~~  263 (345)
T 1xjd_A          247 DLLVKLFVREPEKRLGV  263 (345)
T ss_dssp             HHHHHHSCSSGGGSBTT
T ss_pred             HHHHHHhcCCHhHcCCC
Confidence            99999999999999986

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.5e-43  Score=318.17  Aligned_cols=232  Identities=24%  Similarity=0.311  Sum_probs=198.5

Q ss_pred             CCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecCCC
Q 039799          105 ANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPH  183 (346)
Q Consensus       105 ~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  183 (346)
                      |+..+.||+|+||.||+|... +|+.||||++........+.+.+|+.++++++||||+++++++...+..++||||+++
T Consensus        47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  126 (321)
T 2c30_A           47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG  126 (321)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred             hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence            555678999999999999977 7999999999876666677889999999999999999999999999999999999999


Q ss_pred             CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccccc
Q 039799          184 GSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT  263 (346)
Q Consensus       184 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~~  263 (346)
                      ++|.+++..  ..+++..+..++.+++.||+|||   +.+|+||||||+||+++.++.++|+|||++........  ...
T Consensus       127 ~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~  199 (321)
T 2c30_A          127 GALTDIVSQ--VRLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRK  199 (321)
T ss_dssp             CBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--CBC
T ss_pred             CCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc--ccc
Confidence            999998753  46899999999999999999999   89999999999999999999999999999987643221  223


Q ss_pred             cccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh----------hhcCCChhhhhch
Q 039799          264 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN----------DLLPISVMEVVDA  333 (346)
Q Consensus       264 ~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~----------~~~~~~~~~~~d~  333 (346)
                      ...||+.|+|||.+.+..++.++||||||+++|||++|+.||.....  ......+.          ..++..+.+++.+
T Consensus       200 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  277 (321)
T 2c30_A          200 SLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP--VQAMKRLRDSPPPKLKNSHKVSPVLRDFLER  277 (321)
T ss_dssp             CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHSSCCCCTTGGGSCHHHHHHHHH
T ss_pred             cccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHhcCCCCCcCccccCCHHHHHHHHH
Confidence            45699999999999988999999999999999999999999965321  11111111          1234467899999


Q ss_pred             hccCCccccccc
Q 039799          334 NLLSQEDEHFTT  345 (346)
Q Consensus       334 ~l~~~p~~R~~~  345 (346)
                      ||..||++||++
T Consensus       278 ~l~~dp~~Rps~  289 (321)
T 2c30_A          278 MLVRDPQERATA  289 (321)
T ss_dssp             HSCSSTTTSCCH
T ss_pred             HccCChhhCcCH
Confidence            999999999986

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.9e-44  Score=315.74  Aligned_cols=237  Identities=25%  Similarity=0.401  Sum_probs=201.9

Q ss_pred             CCCCCCCCcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecC
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYM  181 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  181 (346)
                      .++|.+.+.||+|+||.||+|.+.+++.||+|++..... ..+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   87 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence            456888899999999999999998889999999976543 3467889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccc
Q 039799          182 PHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT  261 (346)
Q Consensus       182 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~  261 (346)
                      ++++|.+++......+++..++.++.+++.||+|||   +.+++||||||+||+++.++.++|+|||+++...... ...
T Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~  163 (269)
T 4hcu_A           88 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTS  163 (269)
T ss_dssp             TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHS
T ss_pred             CCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEeccccccccccccc-ccc
Confidence            999999999877778999999999999999999999   9999999999999999999999999999998664322 122


Q ss_pred             cccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHhh--------hcCCChhhhhc
Q 039799          262 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVND--------LLPISVMEVVD  332 (346)
Q Consensus       262 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~d  332 (346)
                      .....+++.|+|||...+..++.++||||+|++++||++ |+.||......  .....+..        ..+..+.+++.
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~  241 (269)
T 4hcu_A          164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--EVVEDISTGFRLYKPRLASTHVYQIMN  241 (269)
T ss_dssp             TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTTCCCCCCTTSCHHHHHHHH
T ss_pred             ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH--HHHHHHhcCccCCCCCcCCHHHHHHHH
Confidence            233456788999999988889999999999999999999 99999763221  12222221        12347789999


Q ss_pred             hhccCCccccccc
Q 039799          333 ANLLSQEDEHFTT  345 (346)
Q Consensus       333 ~~l~~~p~~R~~~  345 (346)
                      +||..+|.+||++
T Consensus       242 ~~l~~~p~~Rps~  254 (269)
T 4hcu_A          242 HCWRERPEDRPAF  254 (269)
T ss_dssp             HHTCSSGGGSCCH
T ss_pred             HHccCCcccCcCH
Confidence            9999999999986

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=3.5e-44  Score=329.78  Aligned_cols=237  Identities=24%  Similarity=0.315  Sum_probs=195.9

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhc-CCCCceeeEEEEecCCceeEE
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRI-CHRNLIKIISSYSNDDFKALV  177 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  177 (346)
                      ++|.+.+.||+|+||.||+|+.+ +++.||+|++....   ....+.+..|..++.++ +||||+++++++...+..++|
T Consensus        52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV  131 (396)
T 4dc2_A           52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV  131 (396)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence            56888999999999999999977 67899999987532   22334577899999887 899999999999999999999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccc
Q 039799          178 LEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  257 (346)
Q Consensus       178 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~  257 (346)
                      |||+++|+|.+++... ..+++..+..++.+++.||+|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus       132 ~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~  207 (396)
T 4dc2_A          132 IEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG  207 (396)
T ss_dssp             EECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EEcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeecccCC
Confidence            9999999999988643 56899999999999999999999   9999999999999999999999999999998643222


Q ss_pred             cccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCc---c----cHHHHHh-------hhc
Q 039799          258 QSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE---M----TLKRWVN-------DLL  323 (346)
Q Consensus       258 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~---~----~~~~~~~-------~~~  323 (346)
                        ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+   .    ...+.+.       ..+
T Consensus       208 --~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~  285 (396)
T 4dc2_A          208 --DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL  285 (396)
T ss_dssp             --CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTTS
T ss_pred             --CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCcC
Confidence              22345679999999999999999999999999999999999999996432111   0    1111111       123


Q ss_pred             CCChhhhhchhccCCccccccc
Q 039799          324 PISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       324 ~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      +..+.+++.+||..||++||++
T Consensus       286 s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          286 SVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             CHHHHHHHHHHTCSCTTTSTTC
T ss_pred             CHHHHHHHHHHhcCCHhHcCCC
Confidence            3467899999999999999985

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=8.9e-45  Score=333.19  Aligned_cols=237  Identities=26%  Similarity=0.401  Sum_probs=198.4

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecC
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYM  181 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  181 (346)
                      +|.+.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|++++++++||||+++++++...+..++||||+
T Consensus       115 ~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  194 (377)
T 3cbl_A          115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELV  194 (377)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             HeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcC
Confidence            4667789999999999999987 78999999987543 233457888999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccc
Q 039799          182 PHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT  261 (346)
Q Consensus       182 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~  261 (346)
                      ++|+|.+++......+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++..........
T Consensus       195 ~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~  271 (377)
T 3cbl_A          195 QGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAAS  271 (377)
T ss_dssp             TTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECC
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeec
Confidence            999999999876677999999999999999999999   99999999999999999999999999999986533221111


Q ss_pred             cccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHhh--------hcCCChhhhhc
Q 039799          262 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVND--------LLPISVMEVVD  332 (346)
Q Consensus       262 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~d  332 (346)
                      .....++..|+|||.+.+..++.++||||||+++|||+| |..||.....  ......+..        ..+..+.+++.
T Consensus       272 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~  349 (377)
T 3cbl_A          272 GGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN--QQTREFVEKGGRLPCPELCPDAVFRLME  349 (377)
T ss_dssp             SSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH--HHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             CCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence            122235778999999988889999999999999999998 9999976322  122233322        23447889999


Q ss_pred             hhccCCccccccc
Q 039799          333 ANLLSQEDEHFTT  345 (346)
Q Consensus       333 ~~l~~~p~~R~~~  345 (346)
                      +||..||++|||.
T Consensus       350 ~cl~~dP~~Rps~  362 (377)
T 3cbl_A          350 QCWAYEPGQRPSF  362 (377)
T ss_dssp             HHTCSSGGGSCCH
T ss_pred             HHcCCCchhCcCH
Confidence            9999999999985

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1e-43  Score=325.34  Aligned_cols=231  Identities=23%  Similarity=0.355  Sum_probs=193.1

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecCCCCCh
Q 039799          108 PPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGSL  186 (346)
Q Consensus       108 ~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  186 (346)
                      .+.||+|+||.||+|... +|+.||+|++........+.+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L  173 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL  173 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence            457999999999999875 7899999999876656678899999999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEE--CCCCcEEEeeecCCccCCcccccccccc
Q 039799          187 EKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL--DDNMVAHLSDFGMAKPLLEEDQSLTQTQ  264 (346)
Q Consensus       187 ~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll--~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  264 (346)
                      .+++......+++..+..++.|++.||+|||   +.+|+||||||+|||+  +.++.+||+|||+++.+.....   ...
T Consensus       174 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---~~~  247 (373)
T 2x4f_A          174 FDRIIDESYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---LKV  247 (373)
T ss_dssp             HHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---CCC
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---ccc
Confidence            9988766677999999999999999999999   9999999999999999  5778999999999987643322   233


Q ss_pred             ccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh----------hhcCCChhhhhchh
Q 039799          265 TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN----------DLLPISVMEVVDAN  334 (346)
Q Consensus       265 ~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~----------~~~~~~~~~~~d~~  334 (346)
                      ..||+.|+|||++.+..++.++||||||+++|||++|+.||...... ..+.....          ..++..+.+++.+|
T Consensus       248 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~  326 (373)
T 2x4f_A          248 NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA-ETLNNILACRWDLEDEEFQDISEEAKEFISKL  326 (373)
T ss_dssp             CCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTT
T ss_pred             ccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccCCCChhhhccCCHHHHHHHHHH
Confidence            46999999999998888999999999999999999999999753211 11122221          22445789999999


Q ss_pred             ccCCccccccc
Q 039799          335 LLSQEDEHFTT  345 (346)
Q Consensus       335 l~~~p~~R~~~  345 (346)
                      |..||.+||++
T Consensus       327 L~~dp~~Rps~  337 (373)
T 2x4f_A          327 LIKEKSWRISA  337 (373)
T ss_dssp             SCSSGGGSCCH
T ss_pred             cCCChhhCCCH
Confidence            99999999986

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=2.5e-44  Score=328.83  Aligned_cols=237  Identities=20%  Similarity=0.209  Sum_probs=195.2

Q ss_pred             CCCCCCCcccccCceEEEEEE------EcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcC---CCCceeeEEEEecCCc
Q 039799          103 NDANMPPLIGKGGFGSVYKAI------IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRIC---HRNLIKIISSYSNDDF  173 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~  173 (346)
                      ++|.+.+.||+|+||+||+|.      ..+++.||+|++....   ...+..|+++++.++   |+|++++++++...+.
T Consensus        65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~  141 (365)
T 3e7e_A           65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNG  141 (365)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSC
T ss_pred             EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCC
Confidence            457888899999999999994      4468899999997653   346677788887776   9999999999999999


Q ss_pred             eeEEEecCCCCChhhhhhh----cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC-----------
Q 039799          174 KALVLEYMPHGSLEKCLYL----SNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD-----------  238 (346)
Q Consensus       174 ~~lv~e~~~~gsL~~~l~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~-----------  238 (346)
                      .++||||+++|+|.+++..    ....+++..++.++.|++.||+|||   +.+|+||||||+|||++.           
T Consensus       142 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~~~~~  218 (365)
T 3e7e_A          142 SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDL  218 (365)
T ss_dssp             EEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC------
T ss_pred             cEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCccccccc
Confidence            9999999999999999875    3456999999999999999999999   999999999999999998           


Q ss_pred             CCcEEEeeecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHH
Q 039799          239 NMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRW  318 (346)
Q Consensus       239 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~  318 (346)
                      ++.+||+|||+++.+.............||++|+|||++.+..++.++|||||||++|||+||+.||.....+.......
T Consensus       219 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~  298 (365)
T 3e7e_A          219 SAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGL  298 (365)
T ss_dssp             CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEEECSC
T ss_pred             cCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCceeechh
Confidence            89999999999986543333334455679999999999999999999999999999999999999996543332221111


Q ss_pred             Hhhh-cCCChhhhhchhccCCccccccc
Q 039799          319 VNDL-LPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       319 ~~~~-~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      .... .++.+.++++.+|..+|.+|+++
T Consensus       299 ~~~~~~~~~~~~~~~~~l~~~p~~r~~~  326 (365)
T 3e7e_A          299 FRRLPHLDMWNEFFHVMLNIPDCHHLPS  326 (365)
T ss_dssp             CTTCSSHHHHHHHHHHHHCCCCTTCCCC
T ss_pred             ccccCcHHHHHHHHHHHcCCCCCCcchH
Confidence            1111 12367889999999999999753

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=6.1e-44  Score=321.25  Aligned_cols=244  Identities=33%  Similarity=0.499  Sum_probs=201.2

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEcCCCEEEEEEecCCCc-hhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEe
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYE-GAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLE  179 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  179 (346)
                      ..++|.+.+.||+|+||.||+|...+++.||+|++..... .....+.+|++++++++||||+++++++...+..++|||
T Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  107 (326)
T 3uim_A           28 ASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP  107 (326)
T ss_dssp             TTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEE
T ss_pred             HhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEE
Confidence            3467999999999999999999988899999999875432 223368889999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcc
Q 039799          180 YMPHGSLEKCLYLSN---YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  256 (346)
Q Consensus       180 ~~~~gsL~~~l~~~~---~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~  256 (346)
                      |+++++|.+++....   ..+++..+..++.+++.||+|||..+..+|+||||||+|||++.++.++|+|||+++.....
T Consensus       108 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  187 (326)
T 3uim_A          108 YMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK  187 (326)
T ss_dssp             CCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSS
T ss_pred             eccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCcc
Confidence            999999999987543   34899999999999999999999333339999999999999999999999999999876432


Q ss_pred             ccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCcc---ccCcccHHHHHhhhcC---------
Q 039799          257 DQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEI---FSGEMTLKRWVNDLLP---------  324 (346)
Q Consensus       257 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~---~~~~~~~~~~~~~~~~---------  324 (346)
                      .. .......||+.|+|||.+.+..++.++||||||+++|||+||+.||+..   .........|+.....         
T Consensus       188 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (326)
T 3uim_A          188 DT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVD  266 (326)
T ss_dssp             SS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSC
T ss_pred             cc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcC
Confidence            22 2233455999999999988888999999999999999999999999632   1233344445433221         


Q ss_pred             ------------CChhhhhchhccCCccccccc
Q 039799          325 ------------ISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       325 ------------~~~~~~~d~~l~~~p~~R~~~  345 (346)
                                  ..+.+++.+||..||.+|||+
T Consensus       267 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~  299 (326)
T 3uim_A          267 VDLQGNYKDEEVEQLIQVALLCTQSSPMERPKM  299 (326)
T ss_dssp             TTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCH
T ss_pred             hhhccccCHHHHHHHHHHHHHHhCcCCccCCCH
Confidence                        246789999999999999986

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.3e-43  Score=324.84  Aligned_cols=237  Identities=24%  Similarity=0.318  Sum_probs=197.9

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEE
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALV  177 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  177 (346)
                      .++|.+.+.||+|+||.||++... +++.||+|++....   ....+.+.+|+++++.++||||+++++++...+..++|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            356888999999999999999976 68899999986431   22346788999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccc
Q 039799          178 LEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  257 (346)
Q Consensus       178 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~  257 (346)
                      |||+++|+|.+++.. ...+++..+..++.+++.||+|||   +.+|+||||||+|||++.++.++|+|||+++.+... 
T Consensus        94 ~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-  168 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-  168 (384)
T ss_dssp             ECCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-
T ss_pred             EecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeeccCC-
Confidence            999999999998864 456899999999999999999999   999999999999999999999999999999876432 


Q ss_pred             cccccccccCCcccccCCCCCC---CCCCcchhHHHHHHHHHHHHcCCCCCCccccCc-ccHHHHHh-------hhcCCC
Q 039799          258 QSLTQTQTLATIGYMAPEYGRE---GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE-MTLKRWVN-------DLLPIS  326 (346)
Q Consensus       258 ~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~-~~~~~~~~-------~~~~~~  326 (346)
                        .......||+.|+|||++..   ..++.++|||||||++|||++|+.||....... ........       ..++..
T Consensus       169 --~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~~  246 (384)
T 4fr4_A          169 --TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQE  246 (384)
T ss_dssp             --CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSCHH
T ss_pred             --CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCCHH
Confidence              22345679999999998864   458999999999999999999999997532221 11111111       123447


Q ss_pred             hhhhhchhccCCccccccc
Q 039799          327 VMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       327 ~~~~~d~~l~~~p~~R~~~  345 (346)
                      +.+++.+||..||++||++
T Consensus       247 ~~~li~~lL~~dP~~R~s~  265 (384)
T 4fr4_A          247 MVSLLKKLLEPNPDQRFSQ  265 (384)
T ss_dssp             HHHHHHHHSCSSGGGSCCS
T ss_pred             HHHHHHHHhcCCHhHhccc
Confidence            8899999999999999973

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1e-43  Score=321.95  Aligned_cols=238  Identities=24%  Similarity=0.310  Sum_probs=198.3

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC---CchhHHHHHHHHHHHHhc-CCCCceeeEEEEecCCceeE
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ---YEGAFKSFDIECDVMKRI-CHRNLIKIISSYSNDDFKAL  176 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  176 (346)
                      .++|.+.+.||+|+||.||+|+.+ +++.||+|++...   .....+.+.+|..++.++ +||||+++++++...+..++
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            356888999999999999999976 6889999999753   233456778899999988 89999999999999999999


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcc
Q 039799          177 VLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  256 (346)
Q Consensus       177 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~  256 (346)
                      ||||+++|+|.+++... ..+++..+..++.+++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        88 v~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~  163 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  163 (345)
T ss_dssp             EECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred             EEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence            99999999999988643 46899999999999999999999   999999999999999999999999999999864322


Q ss_pred             ccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCc-------ccHHHHH-h------hh
Q 039799          257 DQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE-------MTLKRWV-N------DL  322 (346)
Q Consensus       257 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~-------~~~~~~~-~------~~  322 (346)
                      .  ......+||+.|+|||.+.+..++.++||||+||++|||++|+.||.......       ....+.+ .      ..
T Consensus       164 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~  241 (345)
T 3a8x_A          164 G--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS  241 (345)
T ss_dssp             T--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTT
T ss_pred             C--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCC
Confidence            2  22345579999999999999899999999999999999999999996522111       0111111 1      12


Q ss_pred             cCCChhhhhchhccCCccccccc
Q 039799          323 LPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       323 ~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ++..+.+++.+||..||++||++
T Consensus       242 ~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          242 LSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             CCHHHHHHHHHHhcCCHhHCCCC
Confidence            34477899999999999999985

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=3.7e-44  Score=313.69  Aligned_cols=238  Identities=25%  Similarity=0.365  Sum_probs=201.3

Q ss_pred             CCCCCCCCcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecC
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYM  181 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  181 (346)
                      .++|.+.+.||+|+||.||+|.++++..||+|++..... ..+.+.+|++++.+++||||+++++++...+..++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            456888899999999999999999888999999976543 3467889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccc
Q 039799          182 PHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT  261 (346)
Q Consensus       182 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~  261 (346)
                      ++++|.+++......+++..++.++.+++.||+|||   +.+++||||||+||+++.++.++|+|||++........ ..
T Consensus        86 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~~  161 (268)
T 3sxs_A           86 SNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY-VS  161 (268)
T ss_dssp             TTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE-EE
T ss_pred             CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchhhh-hc
Confidence            999999999877777999999999999999999999   99999999999999999999999999999987644322 22


Q ss_pred             cccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHH-------hhhcCCChhhhhch
Q 039799          262 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWV-------NDLLPISVMEVVDA  333 (346)
Q Consensus       262 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~d~  333 (346)
                      .....+++.|+|||...+..++.++||||||++++||+| |+.||+.....+. .....       ....++.+.+++.+
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~  240 (268)
T 3sxs_A          162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV-VLKVSQGHRLYRPHLASDTIYQIMYS  240 (268)
T ss_dssp             CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-HHHHHTTCCCCCCTTSCHHHHHHHHH
T ss_pred             ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHH-HHHHHcCCCCCCCCcChHHHHHHHHH
Confidence            233456788999999988889999999999999999999 9999975322211 11111       11124478899999


Q ss_pred             hccCCccccccc
Q 039799          334 NLLSQEDEHFTT  345 (346)
Q Consensus       334 ~l~~~p~~R~~~  345 (346)
                      ||..+|++|||+
T Consensus       241 ~l~~~p~~Rps~  252 (268)
T 3sxs_A          241 CWHELPEKRPTF  252 (268)
T ss_dssp             TTCSSGGGSCCH
T ss_pred             HcCCChhhCcCH
Confidence            999999999986

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.3e-43  Score=317.58  Aligned_cols=236  Identities=22%  Similarity=0.290  Sum_probs=198.3

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCc------hhHHHHHHHHHHHHhcCCCCceeeEEEEecCCcee
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYE------GAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKA  175 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  175 (346)
                      +.|.+.+.||+|+||.||+|... +|+.||+|++.....      ...+.+.+|++++++++||||+++++++...+..+
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            45888899999999999999976 689999999865432      13577889999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCC----cEEEeeecCCc
Q 039799          176 LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM----VAHLSDFGMAK  251 (346)
Q Consensus       176 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~----~~~l~Dfg~~~  251 (346)
                      +||||+++++|.+++.. ...+++..+..++.+++.||+|||   +.+|+||||||+||+++.++    .++|+|||+++
T Consensus        91 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~  166 (326)
T 2y0a_A           91 LILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH  166 (326)
T ss_dssp             EEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             EEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence            99999999999998864 456899999999999999999999   99999999999999999877    89999999998


Q ss_pred             cCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcc---------cHHHHHhhh
Q 039799          252 PLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM---------TLKRWVNDL  322 (346)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~---------~~~~~~~~~  322 (346)
                      ......   ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.         .........
T Consensus       167 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (326)
T 2y0a_A          167 KIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN  243 (326)
T ss_dssp             ECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTT
T ss_pred             ECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCcccccc
Confidence            764322   22345699999999999888999999999999999999999999965321110         011111223


Q ss_pred             cCCChhhhhchhccCCccccccc
Q 039799          323 LPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       323 ~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ++..+.+++.+||..||++|||+
T Consensus       244 ~~~~~~~li~~~L~~dP~~Rpt~  266 (326)
T 2y0a_A          244 TSALAKDFIRRLLVKDPKKRMTI  266 (326)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCCH
T ss_pred             CCHHHHHHHHHHccCChhhCCCH
Confidence            45578899999999999999985

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=6.4e-44  Score=324.37  Aligned_cols=237  Identities=24%  Similarity=0.334  Sum_probs=197.2

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC-----CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCcee
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ-----YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKA  175 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  175 (346)
                      .+.|.+.+.||+|+||.||+|... +++.||+|++...     .....+.+.+|++++++++||||+++++++...+..+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            346888999999999999999876 7899999998532     1123567889999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhhhc---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCc---EEEeeecC
Q 039799          176 LVLEYMPHGSLEKCLYLS---NYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV---AHLSDFGM  249 (346)
Q Consensus       176 lv~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~---~~l~Dfg~  249 (346)
                      +||||+++++|.+.+...   ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            999999999998877543   245899999999999999999999   999999999999999986554   99999999


Q ss_pred             CccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHH----------H
Q 039799          250 AKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRW----------V  319 (346)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~----------~  319 (346)
                      +.......  .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....  ......          .
T Consensus       180 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~i~~~~~~~~~~~  255 (351)
T 3c0i_A          180 AIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE--RLFEGIIKGKYKMNPRQ  255 (351)
T ss_dssp             CEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH--HHHHHHHHTCCCCCHHH
T ss_pred             eeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH--HHHHHHHcCCCCCCccc
Confidence            98764322  223345799999999999988999999999999999999999999975311  111111          1


Q ss_pred             hhhcCCChhhhhchhccCCccccccc
Q 039799          320 NDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       320 ~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ...++..+.+++.+||..||++||++
T Consensus       256 ~~~~s~~~~~li~~~L~~dP~~R~s~  281 (351)
T 3c0i_A          256 WSHISESAKDLVRRMLMLDPAERITV  281 (351)
T ss_dssp             HTTSCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             cccCCHHHHHHHHHHCCCChhHCcCH
Confidence            12345578999999999999999985

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=5.5e-44  Score=316.04  Aligned_cols=236  Identities=24%  Similarity=0.328  Sum_probs=192.2

Q ss_pred             CCCCCCCcccccCceEEEEEEEcCCCEEEEEEecCCCc--hhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEec
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYE--GAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEY  180 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  180 (346)
                      ++|.+.+.||+|+||.||+|...+|+.+|+|++.....  ...+.+.+|++++++++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            45788899999999999999998899999999865432  2246788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccc
Q 039799          181 MPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  260 (346)
Q Consensus       181 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~  260 (346)
                      +++ +|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++......  .
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~  155 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV--R  155 (288)
T ss_dssp             CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc--c
Confidence            975 999988776677999999999999999999999   9999999999999999999999999999998653221  1


Q ss_pred             ccccccCCcccccCCCCCC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh-------------------
Q 039799          261 TQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN-------------------  320 (346)
Q Consensus       261 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~-------------------  320 (346)
                      ......+|+.|+|||.+.+ ..++.++||||+|+++|||+||+.||......+ .......                   
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T 1ob3_A          156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIFRILGTPNSKNWPNVTELPKY  234 (288)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHHCCCChhhchhhhccccc
Confidence            2234468999999998865 458999999999999999999999997532111 0111100                   


Q ss_pred             ----------------hhcCCChhhhhchhccCCccccccc
Q 039799          321 ----------------DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       321 ----------------~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                                      ..++..+.+++.+||..||++|||+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  275 (288)
T 1ob3_A          235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA  275 (288)
T ss_dssp             CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCH
Confidence                            1123356799999999999999986

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.8e-43  Score=322.50  Aligned_cols=234  Identities=21%  Similarity=0.385  Sum_probs=197.6

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEe
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLE  179 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  179 (346)
                      ++|.+.+.||+|+||.||+|... +|+.||+|++....  ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e  108 (362)
T 2bdw_A           29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD  108 (362)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            45888999999999999999976 68999999997543  3345678899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCC---cEEEeeecCCccCCcc
Q 039799          180 YMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM---VAHLSDFGMAKPLLEE  256 (346)
Q Consensus       180 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~---~~~l~Dfg~~~~~~~~  256 (346)
                      |+++|+|.+.+.. ...+++..+..++.+++.||+|||   +.+|+||||||+|||++.++   .+||+|||++......
T Consensus       109 ~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~  184 (362)
T 2bdw_A          109 LVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS  184 (362)
T ss_dssp             CCCSCBHHHHHTT-CSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred             cCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence            9999999998864 346899999999999999999999   99999999999999998654   5999999999876432


Q ss_pred             ccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH-----------hhhcCC
Q 039799          257 DQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV-----------NDLLPI  325 (346)
Q Consensus       257 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~-----------~~~~~~  325 (346)
                      .   ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....  ......+           ...++.
T Consensus       185 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~  259 (362)
T 2bdw_A          185 E---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--HRLYAQIKAGAYDYPSPEWDTVTP  259 (362)
T ss_dssp             C---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHTCCCCCTTGGGGSCH
T ss_pred             c---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHhCCCCCCcccccCCCH
Confidence            2   22345699999999999988999999999999999999999999965321  1111111           123455


Q ss_pred             ChhhhhchhccCCccccccc
Q 039799          326 SVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       326 ~~~~~~d~~l~~~p~~R~~~  345 (346)
                      .+.+++.+||..||++||++
T Consensus       260 ~~~~li~~~L~~dP~~R~t~  279 (362)
T 2bdw_A          260 EAKSLIDSMLTVNPKKRITA  279 (362)
T ss_dssp             HHHHHHHHHSCSSGGGSCCH
T ss_pred             HHHHHHHHHcCCChhhCcCH
Confidence            78899999999999999985

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=2.1e-43  Score=312.96  Aligned_cols=237  Identities=24%  Similarity=0.287  Sum_probs=193.6

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEe
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLE  179 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  179 (346)
                      ++|.+.+.||+|+||+||+|... +++.||+|++....  ......+.+|++++++++||||+++++++...+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            46788899999999999999976 68999999986442  3345778899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccc
Q 039799          180 YMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  259 (346)
Q Consensus       180 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~  259 (346)
                      |+++ ++.+.+......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++......  
T Consensus        82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--  155 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV--  155 (292)
T ss_dssp             CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC--
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc--
Confidence            9975 666666656677999999999999999999999   9999999999999999999999999999998664322  


Q ss_pred             cccccccCCcccccCCCCCCCC-CCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh------------------
Q 039799          260 LTQTQTLATIGYMAPEYGREGR-VSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN------------------  320 (346)
Q Consensus       260 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~------------------  320 (346)
                      .......+|+.|+|||.+.+.. ++.++||||+|+++|||+||..|+.........+.....                  
T Consensus       156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  235 (292)
T 3o0g_A          156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD  235 (292)
T ss_dssp             SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred             ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccc
Confidence            2233456899999999887665 799999999999999999998886332111111111111                  


Q ss_pred             -----------------hhcCCChhhhhchhccCCccccccc
Q 039799          321 -----------------DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       321 -----------------~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                                       ..++..+.+++.+||..||++|||+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  277 (292)
T 3o0g_A          236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISA  277 (292)
T ss_dssp             CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred             ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCH
Confidence                             1123356799999999999999986

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=3e-44  Score=321.21  Aligned_cols=241  Identities=23%  Similarity=0.362  Sum_probs=191.9

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCc---
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDF---  173 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---  173 (346)
                      +.++|.+.+.||+|+||.||+|... +++.||+|++....   ......+.+|++++++++||||+++++++.....   
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~   89 (311)
T 3ork_A           10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   89 (311)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred             ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence            4567999999999999999999974 78999999997542   3345678899999999999999999999876553   


Q ss_pred             -eeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCcc
Q 039799          174 -KALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  252 (346)
Q Consensus       174 -~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~  252 (346)
                       .++||||+++++|.+++... ..+++..++.++.+++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus        90 ~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  165 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARA  165 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred             ccEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence             38999999999999998644 46899999999999999999999   99999999999999999999999999999987


Q ss_pred             CCccccc-cccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCccc---------HHHHHhhh
Q 039799          253 LLEEDQS-LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMT---------LKRWVNDL  322 (346)
Q Consensus       253 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~---------~~~~~~~~  322 (346)
                      +...... .......||+.|+|||.+.+..++.++||||||+++|||+||+.||......+..         ........
T Consensus       166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (311)
T 3ork_A          166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG  245 (311)
T ss_dssp             ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTT
T ss_pred             ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCC
Confidence            6543222 2223456899999999998889999999999999999999999999753221111         11111233


Q ss_pred             cCCChhhhhchhccCCccccccc
Q 039799          323 LPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       323 ~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ++..+.+++.+||..||++||++
T Consensus       246 ~~~~l~~li~~~l~~dP~~R~~~  268 (311)
T 3ork_A          246 LSADLDAVVLKALAKNPENRYQT  268 (311)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCSS
T ss_pred             CCHHHHHHHHHHHhcCHhhChhh
Confidence            55678999999999999999975

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=5.9e-44  Score=327.03  Aligned_cols=239  Identities=23%  Similarity=0.420  Sum_probs=189.1

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc----CCCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeE
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ----DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKAL  176 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  176 (346)
                      ..+|.+.+.||+|+||.||+|++.    ++..||||++.... ....+.+.+|++++++++||||+++++++...+..++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            357999999999999999999865    57789999997543 3445788999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcc
Q 039799          177 VLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  256 (346)
Q Consensus       177 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~  256 (346)
                      ||||+++++|.+++......+++..++.++.++++||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus       124 v~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  200 (373)
T 2qol_A          124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD  200 (373)
T ss_dssp             EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence            99999999999999877778999999999999999999999   999999999999999999999999999999876433


Q ss_pred             ccc-cccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHhh--------hcCCC
Q 039799          257 DQS-LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVND--------LLPIS  326 (346)
Q Consensus       257 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~--------~~~~~  326 (346)
                      ... .......++..|+|||++.+..++.++||||||+++|||++ |+.||.....  ......+..        .++..
T Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~--~~~~~~i~~~~~~~~~~~~~~~  278 (373)
T 2qol_A          201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN--QDVIKAVDEGYRLPPPMDCPAA  278 (373)
T ss_dssp             -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH--HHHHHHHHTTEECCCCTTCBHH
T ss_pred             CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCCCCCCccccHH
Confidence            211 11222335778999999988889999999999999999998 9999975322  122222222        12346


Q ss_pred             hhhhhchhccCCccccccc
Q 039799          327 VMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       327 ~~~~~d~~l~~~p~~R~~~  345 (346)
                      +.+++.+||..+|++||+.
T Consensus       279 l~~li~~cl~~dp~~RPs~  297 (373)
T 2qol_A          279 LYQLMLDCWQKDRNNRPKF  297 (373)
T ss_dssp             HHHHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHHHhCcChhhCcCH
Confidence            8899999999999999985

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-43  Score=317.43  Aligned_cols=232  Identities=24%  Similarity=0.324  Sum_probs=196.6

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEE
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVL  178 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  178 (346)
                      ++|.+.+.||+|+||.||+++.. +|+.||+|++....   ....+.+.+|..+++.++||||+++++++.+.+..++||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            56888899999999999999976 79999999986431   123466778999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccc
Q 039799          179 EYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  258 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~  258 (346)
                      ||+++|+|.+++.. ...+++..+..++.+++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....  
T Consensus        86 e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~--  159 (318)
T 1fot_A           86 DYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--  159 (318)
T ss_dssp             CCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred             eCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCCc--
Confidence            99999999999864 346889999999999999999999   999999999999999999999999999999865321  


Q ss_pred             ccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh------hhcCCChhhhhc
Q 039799          259 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN------DLLPISVMEVVD  332 (346)
Q Consensus       259 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~------~~~~~~~~~~~d  332 (346)
                         .....||+.|+|||.+.+..++.++||||+|+++|||++|+.||...... ........      ..++..+.+++.
T Consensus       160 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~p~~~~~~~~~li~  235 (318)
T 1fot_A          160 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM-KTYEKILNAELRFPPFFNEDVKDLLS  235 (318)
T ss_dssp             ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred             ---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence               23456999999999999899999999999999999999999999653211 11111111      223447899999


Q ss_pred             hhccCCcccccc
Q 039799          333 ANLLSQEDEHFT  344 (346)
Q Consensus       333 ~~l~~~p~~R~~  344 (346)
                      +||..||.+||+
T Consensus       236 ~lL~~dp~~R~~  247 (318)
T 1fot_A          236 RLITRDLSQRLG  247 (318)
T ss_dssp             HHTCSCTTTCTT
T ss_pred             HHhccCHHHcCC
Confidence            999999999994

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=8.3e-44  Score=321.13  Aligned_cols=236  Identities=23%  Similarity=0.340  Sum_probs=196.6

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEE
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALV  177 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  177 (346)
                      -.+|.+.+.||+|+||.||+|... +++.||+|++....   ......+.+|+++++.++||||+++++++...+..++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            357889999999999999999974 78999999986431   12235788999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccc
Q 039799          178 LEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  257 (346)
Q Consensus       178 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~  257 (346)
                      |||+ +|+|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||++.......
T Consensus        88 ~E~~-~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~  162 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN  162 (336)
T ss_dssp             ECCC-CEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred             EECC-CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence            9999 78888887643 46899999999999999999999   9999999999999999999999999999998764332


Q ss_pred             cccccccccCCcccccCCCCCCCCC-CcchhHHHHHHHHHHHHcCCCCCCccccCcc-----cHHHHHhhhcCCChhhhh
Q 039799          258 QSLTQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMEIFTRTKPTDEIFSGEM-----TLKRWVNDLLPISVMEVV  331 (346)
Q Consensus       258 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~s~G~il~elltg~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~  331 (346)
                         ......||+.|+|||.+.+..+ +.++||||+|+++|||++|+.||+.......     .........++..+.+++
T Consensus       163 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li  239 (336)
T 3h4j_B          163 ---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLI  239 (336)
T ss_dssp             ---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHHH
T ss_pred             ---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHHH
Confidence               2234569999999999988776 7899999999999999999999976322111     001112233455789999


Q ss_pred             chhccCCccccccc
Q 039799          332 DANLLSQEDEHFTT  345 (346)
Q Consensus       332 d~~l~~~p~~R~~~  345 (346)
                      .+||..||.+|||+
T Consensus       240 ~~~L~~dP~~Rpt~  253 (336)
T 3h4j_B          240 RRMIVADPMQRITI  253 (336)
T ss_dssp             HTTSCSSGGGSCCH
T ss_pred             HHHcCCChhHCcCH
Confidence            99999999999985

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.2e-43  Score=322.38  Aligned_cols=237  Identities=24%  Similarity=0.344  Sum_probs=184.7

Q ss_pred             CCCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEE
Q 039799          100 PLPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVL  178 (346)
Q Consensus       100 ~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  178 (346)
                      ...+.|.+.+.||+|+||.||+|... +++.||+|++....  ..+.+.+|++++++++||||+++++++...+..++||
T Consensus        50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  127 (349)
T 2w4o_A           50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL  127 (349)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence            34566889999999999999999987 68899999997543  3456778999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC---CCcEEEeeecCCccCCc
Q 039799          179 EYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD---NMVAHLSDFGMAKPLLE  255 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~---~~~~~l~Dfg~~~~~~~  255 (346)
                      ||+++++|.+++.. ...+++..+..++.+++.||+|||   +.+|+||||||+|||++.   ++.+||+|||+++....
T Consensus       128 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~  203 (349)
T 2w4o_A          128 ELVTGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH  203 (349)
T ss_dssp             CCCCSCBHHHHHTT-CSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred             EeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence            99999999998864 345899999999999999999999   999999999999999975   88999999999986533


Q ss_pred             cccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh----------hhcCC
Q 039799          256 EDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN----------DLLPI  325 (346)
Q Consensus       256 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~----------~~~~~  325 (346)
                      ..   ......||+.|+|||++.+..++.++||||||+++|||++|+.||...............          ..++.
T Consensus       204 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  280 (349)
T 2w4o_A          204 QV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSL  280 (349)
T ss_dssp             ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCH
T ss_pred             cc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCH
Confidence            21   223456899999999999889999999999999999999999999653322212222222          12344


Q ss_pred             ChhhhhchhccCCccccccc
Q 039799          326 SVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       326 ~~~~~~d~~l~~~p~~R~~~  345 (346)
                      .+.+++.+||..||++||++
T Consensus       281 ~~~~li~~~L~~dP~~Rpt~  300 (349)
T 2w4o_A          281 NAKDLVRKLIVLDPKKRLTT  300 (349)
T ss_dssp             HHHHHHHTTSCSSGGGSCCH
T ss_pred             HHHHHHHHHccCChhhCcCH
Confidence            77899999999999999986

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.5e-43  Score=321.57  Aligned_cols=238  Identities=21%  Similarity=0.259  Sum_probs=198.3

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhc-CCCCceeeEEEEecCCcee
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRI-CHRNLIKIISSYSNDDFKA  175 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  175 (346)
                      ..++|.+.+.||+|+||.||+|... +++.||+|++....   ....+.+..|.+++..+ +||||+++++++...+..+
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            3467999999999999999999977 57899999986431   22346678899999987 8999999999999999999


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCc
Q 039799          176 LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  255 (346)
Q Consensus       176 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~  255 (346)
                      +||||+++|+|.+++... ..+++..+..++.+++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        98 lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  173 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  173 (353)
T ss_dssp             EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence            999999999999988643 45899999999999999999999   99999999999999999999999999999986432


Q ss_pred             cccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh------hhcCCChhh
Q 039799          256 EDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN------DLLPISVME  329 (346)
Q Consensus       256 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~------~~~~~~~~~  329 (346)
                      ..  ......+||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ........      ..++..+.+
T Consensus       174 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-~~~~~i~~~~~~~p~~~s~~~~~  250 (353)
T 2i0e_A          174 DG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-ELFQSIMEHNVAYPKSMSKEAVA  250 (353)
T ss_dssp             TT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCCCCCCTTSCHHHHH
T ss_pred             CC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH-HHHHHHHhCCCCCCCCCCHHHHH
Confidence            21  2234567999999999999899999999999999999999999999753211 11111111      223447889


Q ss_pred             hhchhccCCccccccc
Q 039799          330 VVDANLLSQEDEHFTT  345 (346)
Q Consensus       330 ~~d~~l~~~p~~R~~~  345 (346)
                      ++.+||..||.+||++
T Consensus       251 li~~lL~~dP~~R~~~  266 (353)
T 2i0e_A          251 ICKGLMTKHPGKRLGC  266 (353)
T ss_dssp             HHHHHTCSCTTSCTTC
T ss_pred             HHHHHhhcCHHHcCCC
Confidence            9999999999999964

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.8e-43  Score=318.45  Aligned_cols=238  Identities=23%  Similarity=0.337  Sum_probs=189.6

Q ss_pred             CCCCCCCCCcccccCceEEEEEEE----cCCCEEEEEEecCCC----chhHHHHHHHHHHHHhcCCCCceeeEEEEecCC
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAII----QDGMEVAVKVFDPQY----EGAFKSFDIECDVMKRICHRNLIKIISSYSNDD  172 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  172 (346)
                      ..++|.+.+.||+|+||.||++..    .+++.||+|++....    ......+.+|++++++++||||+++++++...+
T Consensus        15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   94 (327)
T 3a62_A           15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG   94 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC
Confidence            446799999999999999999986    478999999997542    223456778999999999999999999999999


Q ss_pred             ceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCcc
Q 039799          173 FKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  252 (346)
Q Consensus       173 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~  252 (346)
                      ..++||||+++++|.+++... ..+++..+..++.+++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~  170 (327)
T 3a62_A           95 KLYLILEYLSGGELFMQLERE-GIFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE  170 (327)
T ss_dssp             CEEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred             EEEEEEeCCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence            999999999999999988643 45888899999999999999999   99999999999999999999999999999986


Q ss_pred             CCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh------hhcCCC
Q 039799          253 LLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN------DLLPIS  326 (346)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~------~~~~~~  326 (346)
                      .....  .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+ .......      ..++..
T Consensus       171 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~p~~~~~~  247 (327)
T 3a62_A          171 SIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK-TIDKILKCKLNLPPYLTQE  247 (327)
T ss_dssp             ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHTCCCCCTTSCHH
T ss_pred             cccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhCCCCCCCCCCHH
Confidence            43222  12234568999999999988889999999999999999999999997532111 1111111      223447


Q ss_pred             hhhhhchhccCCccccccc
Q 039799          327 VMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       327 ~~~~~d~~l~~~p~~R~~~  345 (346)
                      +.+++.+||..||.+||++
T Consensus       248 ~~~li~~~L~~dp~~R~~~  266 (327)
T 3a62_A          248 ARDLLKKLLKRNAASRLGA  266 (327)
T ss_dssp             HHHHHHHHSCSCGGGSTTS
T ss_pred             HHHHHHHHHhcCHhhccCC
Confidence            8999999999999999953

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2.2e-44  Score=319.65  Aligned_cols=242  Identities=25%  Similarity=0.381  Sum_probs=196.5

Q ss_pred             CCCCCCCCCcccccCceEEEEEEE-----cCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEec--CCc
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAII-----QDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSN--DDF  173 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~  173 (346)
                      ..++|.+.+.||+|+||+||+|.+     .+++.||+|++........+.+.+|++++++++||||+++++++..  ...
T Consensus         8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   87 (295)
T 3ugc_A            8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN   87 (295)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred             CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence            346788899999999999999984     2688999999987766667889999999999999999999999854  356


Q ss_pred             eeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccC
Q 039799          174 KALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  253 (346)
Q Consensus       174 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~  253 (346)
                      .++||||+++++|.+++......+++..++.++.+++.||+|||   +.+|+||||||+||+++.++.++|+|||+++..
T Consensus        88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~  164 (295)
T 3ugc_A           88 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVL  164 (295)
T ss_dssp             CEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred             eEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence            88999999999999999877777999999999999999999999   999999999999999999999999999999976


Q ss_pred             Cccccc-cccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccC-------c-c------cHHHH
Q 039799          254 LEEDQS-LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSG-------E-M------TLKRW  318 (346)
Q Consensus       254 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~-------~-~------~~~~~  318 (346)
                      ...... .......++..|+|||.+.+..++.++||||||+++|||+||..|+......       . .      .....
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (295)
T 3ugc_A          165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL  244 (295)
T ss_dssp             -----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred             cCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHH
Confidence            443221 2222344777899999998888999999999999999999999998653210       0 0      01111


Q ss_pred             H--------hhhcCCChhhhhchhccCCccccccc
Q 039799          319 V--------NDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       319 ~--------~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      +        ...++..+.+++.+||..||++|||+
T Consensus       245 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  279 (295)
T 3ugc_A          245 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSF  279 (295)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred             HhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCH
Confidence            1        11234578999999999999999986

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=4.2e-43  Score=314.69  Aligned_cols=238  Identities=24%  Similarity=0.332  Sum_probs=181.9

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEe
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLE  179 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  179 (346)
                      .++|.+.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            357999999999999999999865 68999999987543 2334678889999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCC
Q 039799          180 YMPHGSLEKCLYLSN-----YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  254 (346)
Q Consensus       180 ~~~~gsL~~~l~~~~-----~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~  254 (346)
                      |++ ++|.+++....     ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            998 59998876432     45889999999999999999999   9999999999999999999999999999998754


Q ss_pred             ccccccccccccCCcccccCCCCCC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccCcc--------------------
Q 039799          255 EEDQSLTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM--------------------  313 (346)
Q Consensus       255 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~--------------------  313 (346)
                      ...  .......+|+.|+|||.+.+ ..++.++||||||+++|||+||+.||......+.                    
T Consensus       160 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  237 (317)
T 2pmi_A          160 IPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT  237 (317)
T ss_dssp             SCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred             CCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence            321  12234568999999998876 4689999999999999999999999965321110                    


Q ss_pred             ---------------cHHHHHh----hhcCCChhhhhchhccCCccccccc
Q 039799          314 ---------------TLKRWVN----DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       314 ---------------~~~~~~~----~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                                     .+.+...    ..++..+.+++.+||..||++|||+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~  288 (317)
T 2pmi_A          238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSA  288 (317)
T ss_dssp             GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred             hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCH
Confidence                           0011111    1233467899999999999999986

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2e-43  Score=324.73  Aligned_cols=239  Identities=26%  Similarity=0.355  Sum_probs=200.6

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc--------CCCEEEEEEecCCC-chhHHHHHHHHHHHHhc-CCCCceeeEEEEecC
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ--------DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRI-CHRNLIKIISSYSND  171 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  171 (346)
                      .++|.+.+.||+|+||.||+|...        .+..||+|++.... ....+.+.+|+++++++ +||||+++++++...
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            356788899999999999999853        23579999997543 34457788999999999 999999999999999


Q ss_pred             CceeEEEecCCCCChhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEE
Q 039799          172 DFKALVLEYMPHGSLEKCLYLSN---------------YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL  236 (346)
Q Consensus       172 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll  236 (346)
                      +..++||||+++|+|.+++....               ..+++..++.++.+++.||+|||   +.+|+||||||+|||+
T Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll  224 (382)
T 3tt0_A          148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV  224 (382)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEE
T ss_pred             CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceEEE
Confidence            99999999999999999987543               35899999999999999999999   9999999999999999


Q ss_pred             CCCCcEEEeeecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccH
Q 039799          237 DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTL  315 (346)
Q Consensus       237 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~  315 (346)
                      +.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||++++||+| |..||.....  ...
T Consensus       225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~--~~~  302 (382)
T 3tt0_A          225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--EEL  302 (382)
T ss_dssp             CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHH
T ss_pred             cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--HHH
Confidence            9999999999999997654433333344557889999999988899999999999999999999 9999975321  122


Q ss_pred             HHHHhh--------hcCCChhhhhchhccCCccccccc
Q 039799          316 KRWVND--------LLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       316 ~~~~~~--------~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      .+.+..        .++..+.+++.+||..||++||++
T Consensus       303 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~  340 (382)
T 3tt0_A          303 FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTF  340 (382)
T ss_dssp             HHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCH
Confidence            222222        234478999999999999999986

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=4.8e-43  Score=307.80  Aligned_cols=239  Identities=23%  Similarity=0.347  Sum_probs=202.0

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEec
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEY  180 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  180 (346)
                      ++|.+.+.||+|++|.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence            35788899999999999999976 78999999986432 34457888999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccc
Q 039799          181 MPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  260 (346)
Q Consensus       181 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~  260 (346)
                      +++++|.+++.. ...+++..+..++.+++.||+|||   +.+++||||||+||+++.++.++|+|||++..+.......
T Consensus        87 ~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  162 (276)
T 2yex_A           87 CSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  162 (276)
T ss_dssp             CTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             cCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence            999999998853 356899999999999999999999   9999999999999999999999999999998764333222


Q ss_pred             ccccccCCcccccCCCCCCCCC-CcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh--------hhcCCChhhhh
Q 039799          261 TQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN--------DLLPISVMEVV  331 (346)
Q Consensus       261 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~  331 (346)
                      ......+++.|+|||...+..+ +.++||||||+++|||++|+.||+...........|..        ..++..+.+++
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  242 (276)
T 2yex_A          163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL  242 (276)
T ss_dssp             CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred             cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHH
Confidence            3345568999999999887665 77899999999999999999999875444333444433        23455788999


Q ss_pred             chhccCCccccccc
Q 039799          332 DANLLSQEDEHFTT  345 (346)
Q Consensus       332 d~~l~~~p~~R~~~  345 (346)
                      .+||..||++|||+
T Consensus       243 ~~~l~~~p~~Rps~  256 (276)
T 2yex_A          243 HKILVENPSARITI  256 (276)
T ss_dssp             HHHSCSSTTTSCCH
T ss_pred             HHHCCCCchhCCCH
Confidence            99999999999985

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=8.5e-43  Score=313.69  Aligned_cols=230  Identities=20%  Similarity=0.297  Sum_probs=174.6

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcC-CCCceeeEEEEecCCceeEEEecCCCCC
Q 039799          108 PPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRIC-HRNLIKIISSYSNDDFKALVLEYMPHGS  185 (346)
Q Consensus       108 ~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gs  185 (346)
                      .+.||+|+||.||+|... +++.||+|++...   ....+.+|+.+++.+. ||||+++++++.+....++||||+++++
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            478999999999999976 6899999998643   3466778999999997 9999999999999999999999999999


Q ss_pred             hhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCC---cEEEeeecCCccCCcccccccc
Q 039799          186 LEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM---VAHLSDFGMAKPLLEEDQSLTQ  262 (346)
Q Consensus       186 L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~---~~~l~Dfg~~~~~~~~~~~~~~  262 (346)
                      |.+++... ..+++..+..++.+++.||+|||   +.+|+||||||+|||++.++   .++|+|||+++......  ...
T Consensus        93 L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~~~  166 (325)
T 3kn6_A           93 LFERIKKK-KHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QPL  166 (325)
T ss_dssp             HHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred             HHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC--Ccc
Confidence            99998754 56899999999999999999999   99999999999999997665   89999999998654322  222


Q ss_pred             ccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCc-----ccHHHHH-----------hhhcCCC
Q 039799          263 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE-----MTLKRWV-----------NDLLPIS  326 (346)
Q Consensus       263 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~-----~~~~~~~-----------~~~~~~~  326 (346)
                      ....+|+.|+|||.+.+..++.++||||||+++|||++|+.||.......     ......+           ...++..
T Consensus       167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  246 (325)
T 3kn6_A          167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQE  246 (325)
T ss_dssp             -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHH
T ss_pred             cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHH
Confidence            34568999999999999999999999999999999999999997532210     1111111           1234557


Q ss_pred             hhhhhchhccCCcccccccC
Q 039799          327 VMEVVDANLLSQEDEHFTTK  346 (346)
Q Consensus       327 ~~~~~d~~l~~~p~~R~~~k  346 (346)
                      +.+++.+||..||++||+++
T Consensus       247 ~~~li~~~L~~dP~~Rpt~~  266 (325)
T 3kn6_A          247 AKDLIQGLLTVDPNKRLKMS  266 (325)
T ss_dssp             HHHHHHHHHCCCTTTCCCTT
T ss_pred             HHHHHHHHCCCChhHCCCHH
Confidence            88999999999999999864

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.6e-43  Score=329.08  Aligned_cols=235  Identities=19%  Similarity=0.305  Sum_probs=196.7

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEe
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLE  179 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  179 (346)
                      ++|.+.+.||+|+||.||+|... +|+.+|+|++....  ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E   90 (444)
T 3soa_A           11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD   90 (444)
T ss_dssp             HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred             CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence            45888899999999999999865 78999999997653  2345678899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEEC---CCCcEEEeeecCCccCCcc
Q 039799          180 YMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFGMAKPLLEE  256 (346)
Q Consensus       180 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~---~~~~~~l~Dfg~~~~~~~~  256 (346)
                      |+++|+|.+.+... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++   .++.+||+|||++......
T Consensus        91 ~~~gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~  166 (444)
T 3soa_A           91 LVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE  166 (444)
T ss_dssp             CCBCCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred             eCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence            99999999988644 45899999999999999999999   99999999999999998   4678999999999876433


Q ss_pred             ccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh-----------hhcCC
Q 039799          257 DQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN-----------DLLPI  325 (346)
Q Consensus       257 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~-----------~~~~~  325 (346)
                      .  .......||+.|+|||.+.+..++.++||||+|+++|+|++|+.||.....  ....+.+.           ..+++
T Consensus       167 ~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~s~  242 (444)
T 3soa_A          167 Q--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ--HRLYQQIKAGAYDFPSPEWDTVTP  242 (444)
T ss_dssp             C--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred             C--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH--HHHHHHHHhCCCCCCccccccCCH
Confidence            2  222345799999999999988999999999999999999999999965221  11111111           13345


Q ss_pred             ChhhhhchhccCCccccccc
Q 039799          326 SVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       326 ~~~~~~d~~l~~~p~~R~~~  345 (346)
                      .+.+++.+||..||++|||+
T Consensus       243 ~~~~li~~~L~~dP~~Rpta  262 (444)
T 3soa_A          243 EAKDLINKMLTINPSKRITA  262 (444)
T ss_dssp             HHHHHHHHHSCSSTTTSCCH
T ss_pred             HHHHHHHHHcCCChhHCCCH
Confidence            78899999999999999986

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.6e-43  Score=311.58  Aligned_cols=234  Identities=25%  Similarity=0.349  Sum_probs=189.7

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCc--------------------------hhHHHHHHHHHHHHh
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYE--------------------------GAFKSFDIECDVMKR  155 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~e~~~l~~  155 (346)
                      ++|.+.+.||+|+||.||+|... +++.||+|++.....                          ...+.+.+|++++++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   92 (298)
T 2zv2_A           13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK   92 (298)
T ss_dssp             TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred             cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence            57889999999999999999875 688999999865421                          123568889999999


Q ss_pred             cCCCCceeeEEEEec--CCceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCc
Q 039799          156 ICHRNLIKIISSYSN--DDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSN  233 (346)
Q Consensus       156 l~h~niv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~N  233 (346)
                      ++||||+++++++..  .+..++||||+++++|.+++.  ...+++..+..++.|++.||+|||   +.+|+||||||+|
T Consensus        93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~N  167 (298)
T 2zv2_A           93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSN  167 (298)
T ss_dssp             CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGG
T ss_pred             CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHH
Confidence            999999999999986  568899999999999988653  346899999999999999999999   9999999999999


Q ss_pred             eEECCCCcEEEeeecCCccCCccccccccccccCCcccccCCCCCCCC---CCcchhHHHHHHHHHHHHcCCCCCCcccc
Q 039799          234 VLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGR---VSTNGDVYSFGIMLMEIFTRTKPTDEIFS  310 (346)
Q Consensus       234 Ill~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~Dv~s~G~il~elltg~~p~~~~~~  310 (346)
                      ||++.++.+||+|||+++......  .......||+.|+|||.+.+..   ++.++||||||+++|||++|+.||.....
T Consensus       168 il~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~  245 (298)
T 2zv2_A          168 LLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI  245 (298)
T ss_dssp             EEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             EEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence            999999999999999998764322  1223456999999999987655   47889999999999999999999975321


Q ss_pred             CcccHHHHHh---------hhcCCChhhhhchhccCCccccccc
Q 039799          311 GEMTLKRWVN---------DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       311 ~~~~~~~~~~---------~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                        ......+.         ..++..+.+++.+||..||++||++
T Consensus       246 --~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~  287 (298)
T 2zv2_A          246 --MCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVV  287 (298)
T ss_dssp             --HHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCH
T ss_pred             --HHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCH
Confidence              11111111         1234478999999999999999986

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=5.1e-44  Score=325.93  Aligned_cols=240  Identities=22%  Similarity=0.358  Sum_probs=198.1

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc------CCCEEEEEEecCCC-chhHHHHHHHHHHHHhc-CCCCceeeEEEEecCC-
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ------DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRI-CHRNLIKIISSYSNDD-  172 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~-  172 (346)
                      .++|.+.+.||+|+||.||+|.+.      +++.||||++.... ....+.+.+|++++.++ +||||+++++++...+ 
T Consensus        21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~  100 (359)
T 3vhe_A           21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG  100 (359)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred             ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCC
Confidence            456888999999999999999842      45789999997643 33456789999999999 7999999999998755 


Q ss_pred             ceeEEEecCCCCChhhhhhhcCC---------------------------------------------------------
Q 039799          173 FKALVLEYMPHGSLEKCLYLSNY---------------------------------------------------------  195 (346)
Q Consensus       173 ~~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------  195 (346)
                      ..++||||+++|+|.+++.....                                                         
T Consensus       101 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (359)
T 3vhe_A          101 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  180 (359)
T ss_dssp             CCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------------
T ss_pred             ceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcc
Confidence            48899999999999999875432                                                         


Q ss_pred             --------CCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccccccccC
Q 039799          196 --------ILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA  267 (346)
Q Consensus       196 --------~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~  267 (346)
                              .+++..++.++.+++.||+|||   +.+|+||||||+|||++.++.++|+|||+++.+.............+
T Consensus       181 ~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  257 (359)
T 3vhe_A          181 APEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL  257 (359)
T ss_dssp             ---CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEE
T ss_pred             cccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCC
Confidence                    1889999999999999999999   99999999999999999999999999999987654433333445568


Q ss_pred             CcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHhh--------hcCCChhhhhchhccCC
Q 039799          268 TIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVND--------LLPISVMEVVDANLLSQ  338 (346)
Q Consensus       268 ~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~d~~l~~~  338 (346)
                      |+.|+|||++.+..++.++||||||+++|||+| |+.||......+. ....+..        .++..+.+++.+||..|
T Consensus       258 t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d  336 (359)
T 3vhe_A          258 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE  336 (359)
T ss_dssp             CGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH-HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred             CceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH-HHHHHHcCCCCCCCCCCCHHHHHHHHHHccCC
Confidence            899999999888889999999999999999998 9999976433222 2222221        23347899999999999


Q ss_pred             ccccccc
Q 039799          339 EDEHFTT  345 (346)
Q Consensus       339 p~~R~~~  345 (346)
                      |.+||++
T Consensus       337 P~~Rps~  343 (359)
T 3vhe_A          337 PSQRPTF  343 (359)
T ss_dssp             GGGSCCH
T ss_pred             hhhCCCH
Confidence            9999986

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1e-43  Score=313.40  Aligned_cols=237  Identities=24%  Similarity=0.394  Sum_probs=198.3

Q ss_pred             CCCCCCCCcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecC
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYM  181 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  181 (346)
                      .++|.+.+.||+|+||.||++.+.++..||+|++..... ..+.+.+|++++++++||||+++++++...+..++||||+
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  101 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM  101 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence            456888899999999999999999888999999976543 3467889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccc
Q 039799          182 PHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT  261 (346)
Q Consensus       182 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~  261 (346)
                      ++++|.+++......+++..++.++.+++.||+|||   +.+|+||||||+||+++.++.++|+|||+++....... ..
T Consensus       102 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~  177 (283)
T 3gen_A          102 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TS  177 (283)
T ss_dssp             TTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH-HS
T ss_pred             CCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEcccccccccccccc-cc
Confidence            999999999876677999999999999999999999   99999999999999999999999999999987643221 12


Q ss_pred             cccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHhh--------hcCCChhhhhc
Q 039799          262 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVND--------LLPISVMEVVD  332 (346)
Q Consensus       262 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~d  332 (346)
                      .....+++.|+|||.+.+..++.++||||+|+++|||+| |+.||......  .....+..        ..++.+.+++.
T Consensus       178 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~  255 (283)
T 3gen_A          178 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--ETAEHIAQGLRLYRPHLASEKVYTIMY  255 (283)
T ss_dssp             TTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             ccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh--HHHHHHhcccCCCCCCcCCHHHHHHHH
Confidence            233446788999999888889999999999999999998 99999763221  11122211        22347889999


Q ss_pred             hhccCCccccccc
Q 039799          333 ANLLSQEDEHFTT  345 (346)
Q Consensus       333 ~~l~~~p~~R~~~  345 (346)
                      +||..+|++||++
T Consensus       256 ~~l~~~p~~Rps~  268 (283)
T 3gen_A          256 SCWHEKADERPTF  268 (283)
T ss_dssp             HTTCSSGGGSCCH
T ss_pred             HHccCChhHCcCH
Confidence            9999999999986

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=3e-43  Score=315.88  Aligned_cols=239  Identities=22%  Similarity=0.347  Sum_probs=195.2

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCC--ceeE
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDD--FKAL  176 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~l  176 (346)
                      ....|.+.+.||+|+||+||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++...+  ..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   86 (319)
T 4euu_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL   86 (319)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred             CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence            4567889999999999999999977 58999999987432 233567789999999999999999999988765  7789


Q ss_pred             EEecCCCCChhhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEE----CCCCcEEEeeecCC
Q 039799          177 VLEYMPHGSLEKCLYLSN--YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL----DDNMVAHLSDFGMA  250 (346)
Q Consensus       177 v~e~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll----~~~~~~~l~Dfg~~  250 (346)
                      ||||+++++|.+++....  ..+++..++.++.|++.||+|||   +.+|+||||||+|||+    +.++.+||+|||++
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a  163 (319)
T 4euu_A           87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (319)
T ss_dssp             EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred             EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence            999999999999987544  33899999999999999999999   9999999999999999    78889999999999


Q ss_pred             ccCCccccccccccccCCcccccCCCCC--------CCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcc---cHHHHH
Q 039799          251 KPLLEEDQSLTQTQTLATIGYMAPEYGR--------EGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM---TLKRWV  319 (346)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~---~~~~~~  319 (346)
                      +......   ......||+.|+|||.+.        +..++.++||||||+++|||+||+.||........   ......
T Consensus       164 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  240 (319)
T 4euu_A          164 RELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII  240 (319)
T ss_dssp             EECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHH
T ss_pred             eecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHh
Confidence            8764332   223456899999999764        56789999999999999999999999964322111   111111


Q ss_pred             h-------------------------------hhcCCChhhhhchhccCCccccccc
Q 039799          320 N-------------------------------DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       320 ~-------------------------------~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      .                               ..++..+.+++.+||..||++|||+
T Consensus       241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~  297 (319)
T 4euu_A          241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF  297 (319)
T ss_dssp             HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCH
T ss_pred             cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccH
Confidence            1                               1122257889999999999999986

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=5.6e-44  Score=321.75  Aligned_cols=238  Identities=23%  Similarity=0.333  Sum_probs=191.9

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCCE----EEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCcee
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGME----VAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKA  175 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  175 (346)
                      .++|.+.+.||+|+||+||+|.+. +++.    ||+|.+.... ....+.+.+|++++++++||||+++++++.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~   92 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence            356888999999999999999965 4443    5888875432 344578899999999999999999999998765 67


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCc
Q 039799          176 LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  255 (346)
Q Consensus       176 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~  255 (346)
                      +|+||+++|+|.+++......+++..++.++.+++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  169 (327)
T 3poz_A           93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence            899999999999999877778999999999999999999999   99999999999999999999999999999987654


Q ss_pred             cccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHhhh--------cCCC
Q 039799          256 EDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVNDL--------LPIS  326 (346)
Q Consensus       256 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~--------~~~~  326 (346)
                      ...........+|..|+|||++.+..++.++||||||+++|||+| |+.||+.....  .....+...        .+..
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  247 (327)
T 3poz_A          170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILEKGERLPQPPICTID  247 (327)
T ss_dssp             TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHHTTCCCCCCTTBCHH
T ss_pred             CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH--HHHHHHHcCCCCCCCccCCHH
Confidence            433333344557889999999988899999999999999999999 99999764322  233333222        2336


Q ss_pred             hhhhhchhccCCccccccc
Q 039799          327 VMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       327 ~~~~~d~~l~~~p~~R~~~  345 (346)
                      +.+++.+||..+|++||++
T Consensus       248 ~~~li~~~l~~~p~~Rps~  266 (327)
T 3poz_A          248 VYMIMVKCWMIDADSRPKF  266 (327)
T ss_dssp             HHHHHHHHTCSCGGGSCCH
T ss_pred             HHHHHHHHcCCChhhCCCH
Confidence            8899999999999999985

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=3.2e-43  Score=317.20  Aligned_cols=237  Identities=20%  Similarity=0.237  Sum_probs=198.6

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhc-CCCCceeeEEEEecCCceeEEEe
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRI-CHRNLIKIISSYSNDDFKALVLE  179 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  179 (346)
                      .++|.+.+.||+|+||.||+|... +++.||||++.....  .+.+.+|+++++++ +||||+++++++...+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            467889999999999999999964 789999999875432  24577899999999 99999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCc-----EEEeeecCCccCC
Q 039799          180 YMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV-----AHLSDFGMAKPLL  254 (346)
Q Consensus       180 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~-----~~l~Dfg~~~~~~  254 (346)
                      |+ +++|.+++......+++..++.++.+++.||+|||   +.+|+||||||+|||++.++.     ++|+|||+++.+.
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~  161 (330)
T 2izr_A           86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI  161 (330)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred             eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence            99 99999999876678999999999999999999999   999999999999999998887     9999999999764


Q ss_pred             cccccc-----ccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcc-cHHHHH---------
Q 039799          255 EEDQSL-----TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM-TLKRWV---------  319 (346)
Q Consensus       255 ~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~-~~~~~~---------  319 (346)
                      ......     ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ .....+         
T Consensus       162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  241 (330)
T 2izr_A          162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPI  241 (330)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCH
T ss_pred             cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCH
Confidence            432211     12345799999999999999999999999999999999999999986432221 111111         


Q ss_pred             ---hhhcCCChhhhhchhccCCccccccc
Q 039799          320 ---NDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       320 ---~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                         ...+| .+.+++..|+..+|.+||+.
T Consensus       242 ~~~~~~~p-~~~~li~~~l~~~p~~RP~~  269 (330)
T 2izr_A          242 EVLCENFP-EMATYLRYVRRLDFFEKPDY  269 (330)
T ss_dssp             HHHTTTCH-HHHHHHHHHHHCCTTCCCCH
T ss_pred             HHHhccCh-HHHHHHHHHHhCCCCCCCCH
Confidence               11133 78999999999999999985

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=3.3e-43  Score=324.12  Aligned_cols=241  Identities=19%  Similarity=0.242  Sum_probs=198.2

Q ss_pred             CCCCCCCCccccc--CceEEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeE
Q 039799          102 PNDANMPPLIGKG--GFGSVYKAIIQ-DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKAL  176 (346)
Q Consensus       102 ~~~~~~~~~lg~G--~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  176 (346)
                      ..+|.+.+.||+|  +||.||+|... +|+.||||++....  ....+.+.+|++++++++||||+++++++...+..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            3568899999999  99999999977 79999999987442  3445778889999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCc
Q 039799          177 VLEYMPHGSLEKCLYLS-NYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  255 (346)
Q Consensus       177 v~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~  255 (346)
                      ||||+++++|.+++... ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.++|+|||.+.....
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~  180 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS  180 (389)
T ss_dssp             EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred             EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence            99999999999998754 256899999999999999999999   99999999999999999999999999999876533


Q ss_pred             ccc-----ccccccccCCcccccCCCCCC--CCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHH-----------
Q 039799          256 EDQ-----SLTQTQTLATIGYMAPEYGRE--GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKR-----------  317 (346)
Q Consensus       256 ~~~-----~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~-----------  317 (346)
                      ...     ........||+.|+|||.+.+  ..++.++|||||||++|||++|+.||............           
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  260 (389)
T 3gni_B          181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT  260 (389)
T ss_dssp             TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred             ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccc
Confidence            221     111223468999999999877  57899999999999999999999999753222111000           


Q ss_pred             ----------------------------------------HHhhhcCCChhhhhchhccCCccccccc
Q 039799          318 ----------------------------------------WVNDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       318 ----------------------------------------~~~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                                                              .....++..+.+++.+||..||++|||+
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta  328 (389)
T 3gni_B          261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSA  328 (389)
T ss_dssp             ---------------------------------------------CCHHHHHHHHHHTCSCTTTSCCH
T ss_pred             cccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCH
Confidence                                                    0112234468899999999999999986

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=6.8e-44  Score=326.08  Aligned_cols=239  Identities=25%  Similarity=0.377  Sum_probs=198.5

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc------CCCEEEEEEecCC-CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCce
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ------DGMEVAVKVFDPQ-YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFK  174 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  174 (346)
                      .++|.+.+.||+|+||.||+|.+.      +++.||||++... .......+.+|+.++++++||||+++++++......
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            456888999999999999999853      4668999999654 334456788999999999999999999999999999


Q ss_pred             eEEEecCCCCChhhhhhhcC------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCC---cEEEe
Q 039799          175 ALVLEYMPHGSLEKCLYLSN------YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM---VAHLS  245 (346)
Q Consensus       175 ~lv~e~~~~gsL~~~l~~~~------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~---~~~l~  245 (346)
                      ++||||+++|+|.+++....      ..+++..++.++.+++.||+|||   +.+|+||||||+|||++.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEEC
Confidence            99999999999999987543      45899999999999999999999   99999999999999999554   59999


Q ss_pred             eecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHhh---
Q 039799          246 DFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVND---  321 (346)
Q Consensus       246 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~---  321 (346)
                      |||+++.+.............+|+.|+|||.+.+..++.++|||||||++|||+| |+.||.....  ......+..   
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~--~~~~~~i~~~~~  304 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--QEVLEFVTSGGR  304 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHHHHHHTTCC
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCC
Confidence            9999986543333333344568899999999988889999999999999999998 9999976322  222222222   


Q ss_pred             -----hcCCChhhhhchhccCCccccccc
Q 039799          322 -----LLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       322 -----~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                           .++..+.+++.+||..+|++||++
T Consensus       305 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~  333 (367)
T 3l9p_A          305 MDPPKNCPGPVYRIMTQCWQHQPEDRPNF  333 (367)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCCCccCCHHHHHHHHHHcCCCHhHCcCH
Confidence                 234468899999999999999985

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2.2e-43  Score=315.61  Aligned_cols=239  Identities=23%  Similarity=0.371  Sum_probs=200.8

Q ss_pred             CCCCCCCcccccCceEEEEEEE------cCCCEEEEEEecCCCc-hhHHHHHHHHHHHHhc-CCCCceeeEEEEecCCce
Q 039799          103 NDANMPPLIGKGGFGSVYKAII------QDGMEVAVKVFDPQYE-GAFKSFDIECDVMKRI-CHRNLIKIISSYSNDDFK  174 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  174 (346)
                      ++|.+.+.||+|+||.||+|.+      .+++.||+|++..... ...+.+.+|+++++++ +||||+++++++...+..
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~  102 (313)
T 1t46_A           23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT  102 (313)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCc
Confidence            4678889999999999999985      2567899999975543 3457788999999999 999999999999999999


Q ss_pred             eEEEecCCCCChhhhhhhcCC-----------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEEC
Q 039799          175 ALVLEYMPHGSLEKCLYLSNY-----------------ILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD  237 (346)
Q Consensus       175 ~lv~e~~~~gsL~~~l~~~~~-----------------~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~  237 (346)
                      ++||||+++|+|.+++.....                 .+++..++.++.++++||+|||   +.+++||||||+||+++
T Consensus       103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~  179 (313)
T 1t46_A          103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLT  179 (313)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEE
T ss_pred             EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEc
Confidence            999999999999999875432                 4899999999999999999999   99999999999999999


Q ss_pred             CCCcEEEeeecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHH
Q 039799          238 DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLK  316 (346)
Q Consensus       238 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~  316 (346)
                      .++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|||+| |+.||....... ...
T Consensus       180 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-~~~  258 (313)
T 1t46_A          180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS-KFY  258 (313)
T ss_dssp             TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH-HHH
T ss_pred             CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh-HHH
Confidence            999999999999987654433333334557889999999888889999999999999999999 999997643222 222


Q ss_pred             HHHh--------hhcCCChhhhhchhccCCccccccc
Q 039799          317 RWVN--------DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       317 ~~~~--------~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ..+.        ..++..+.+++.+||..||.+||++
T Consensus       259 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  295 (313)
T 1t46_A          259 KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTF  295 (313)
T ss_dssp             HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCH
Confidence            2222        2234478999999999999999985

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.7e-43  Score=323.40  Aligned_cols=238  Identities=28%  Similarity=0.334  Sum_probs=190.0

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHH-HHhcCCCCceeeEEEEecCCcee
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDV-MKRICHRNLIKIISSYSNDDFKA  175 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~  175 (346)
                      ..++|.+.+.||+|+||.||+|+.+ +++.||+|++....   ......+..|..+ ++.++||||+++++++...+..+
T Consensus        36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~  115 (373)
T 2r5t_A           36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY  115 (373)
T ss_dssp             CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence            3467899999999999999999976 68899999986542   2223455566666 56789999999999999999999


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCc
Q 039799          176 LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  255 (346)
Q Consensus       176 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~  255 (346)
                      +||||+++|+|.+++... ..+++..+..++.+++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       116 lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~  191 (373)
T 2r5t_A          116 FVLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE  191 (373)
T ss_dssp             EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred             EEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence            999999999999988643 45788889999999999999999   99999999999999999999999999999986432


Q ss_pred             cccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh------hhcCCChhh
Q 039799          256 EDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN------DLLPISVME  329 (346)
Q Consensus       256 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~------~~~~~~~~~  329 (346)
                      ..  ......+||+.|+|||.+.+..++.++|+||||+++|||++|+.||......+ .......      ..++..+.+
T Consensus       192 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~  268 (373)
T 2r5t_A          192 HN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-MYDNILNKPLQLKPNITNSARH  268 (373)
T ss_dssp             CC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH-HHHHHHHSCCCCCSSSCHHHHH
T ss_pred             CC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHhcccCCCCCCCHHHHH
Confidence            21  22345679999999999999999999999999999999999999997532111 1111111      223447899


Q ss_pred             hhchhccCCccccccc
Q 039799          330 VVDANLLSQEDEHFTT  345 (346)
Q Consensus       330 ~~d~~l~~~p~~R~~~  345 (346)
                      ++.+||..||.+||++
T Consensus       269 li~~lL~~dp~~R~~~  284 (373)
T 2r5t_A          269 LLEGLLQKDRTKRLGA  284 (373)
T ss_dssp             HHHHHTCSSGGGSTTT
T ss_pred             HHHHHcccCHHhCCCC
Confidence            9999999999999986

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.5e-42  Score=306.60  Aligned_cols=235  Identities=27%  Similarity=0.429  Sum_probs=195.1

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchh-------HHHHHHHHHHHHhcCCCCceeeEEEEecCC
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGA-------FKSFDIECDVMKRICHRNLIKIISSYSNDD  172 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  172 (346)
                      ..++|.+.+.||+|+||.||+|... +++.||+|++.......       .+.+.+|++++++++||||+++++++.+..
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   96 (287)
T 4f0f_A           17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP   96 (287)
T ss_dssp             CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred             hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence            4567899999999999999999975 78999999986432211       167889999999999999999999987655


Q ss_pred             ceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeecCCCCCceEECCCCc-----EEEe
Q 039799          173 FKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP--IIHCDLKPSNVLLDDNMV-----AHLS  245 (346)
Q Consensus       173 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~dik~~NIll~~~~~-----~~l~  245 (346)
                        ++||||+++++|.+.+......+++..++.++.+++.||+|||   +.+  |+||||||+||+++.++.     ++|+
T Consensus        97 --~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~  171 (287)
T 4f0f_A           97 --RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA  171 (287)
T ss_dssp             --EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred             --eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence              6999999999999988777778999999999999999999999   888  999999999999987776     9999


Q ss_pred             eecCCccCCccccccccccccCCcccccCCCC--CCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh---
Q 039799          246 DFGMAKPLLEEDQSLTQTQTLATIGYMAPEYG--REGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN---  320 (346)
Q Consensus       246 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~---  320 (346)
                      |||+++....     ......+|+.|+|||.+  ....++.++||||||+++|||++|+.||.............+.   
T Consensus       172 Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  246 (287)
T 4f0f_A          172 DFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG  246 (287)
T ss_dssp             CCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSC
T ss_pred             CCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccC
Confidence            9999985432     22345689999999988  3456789999999999999999999999764433322222221   


Q ss_pred             ------hhcCCChhhhhchhccCCccccccc
Q 039799          321 ------DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       321 ------~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                            ..++..+.+++.+||..||++||++
T Consensus       247 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  277 (287)
T 4f0f_A          247 LRPTIPEDCPPRLRNVIELCWSGDPKKRPHF  277 (287)
T ss_dssp             CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCCCCCcccCHHHHHHHHHHhcCChhhCcCH
Confidence                  2234468999999999999999986

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.5e-43  Score=329.60  Aligned_cols=239  Identities=22%  Similarity=0.310  Sum_probs=196.5

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEE
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALV  177 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  177 (346)
                      .++|.+.+.||+|+||+||+|+.+ +++.||+|++....   ......+.+|..++..++||||+++++++.+.+..++|
T Consensus        73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV  152 (437)
T 4aw2_A           73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLV  152 (437)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEE
Confidence            457889999999999999999987 57899999986421   11223477899999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccc
Q 039799          178 LEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  257 (346)
Q Consensus       178 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~  257 (346)
                      |||+++|+|.+++......+++..+..++.+++.||+|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus       153 ~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~  229 (437)
T 4aw2_A          153 MDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG  229 (437)
T ss_dssp             ECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred             EecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCC
Confidence            9999999999999876677999999999999999999999   9999999999999999999999999999998664332


Q ss_pred             cccccccccCCcccccCCCCC-----CCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh-----------h
Q 039799          258 QSLTQTQTLATIGYMAPEYGR-----EGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN-----------D  321 (346)
Q Consensus       258 ~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~-----------~  321 (346)
                      . ......+||+.|+|||++.     ...++.++|||||||++|||++|+.||......+ .......           .
T Consensus       230 ~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~-~~~~i~~~~~~~~~p~~~~  307 (437)
T 4aw2_A          230 T-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE-TYGKIMNHKERFQFPTQVT  307 (437)
T ss_dssp             C-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHTHHHHCCCCSSCC
T ss_pred             C-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH-HHHhhhhccccccCCcccc
Confidence            2 2233457999999999876     5678999999999999999999999997532111 1111111           1


Q ss_pred             hcCCChhhhhchhccCCccc--cccc
Q 039799          322 LLPISVMEVVDANLLSQEDE--HFTT  345 (346)
Q Consensus       322 ~~~~~~~~~~d~~l~~~p~~--R~~~  345 (346)
                      .++..+.+++.++|..+|+.  |+++
T Consensus       308 ~~s~~~~dLi~~lL~~~~~r~~r~~~  333 (437)
T 4aw2_A          308 DVSENAKDLIRRLICSREHRLGQNGI  333 (437)
T ss_dssp             CSCHHHHHHHHTTSSCGGGCTTTTTT
T ss_pred             cCCHHHHHHHHHHhcccccccCCCCH
Confidence            13447789999999888777  7764

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=3e-43  Score=319.48  Aligned_cols=234  Identities=21%  Similarity=0.241  Sum_probs=198.7

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeE
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKAL  176 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  176 (346)
                      ..++|.+.+.||+|+||.||+++.. +|+.||+|++....   ....+.+.+|+++++.++||||+++++++...+..++
T Consensus        39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l  118 (350)
T 1rdq_E           39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM  118 (350)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence            3467899999999999999999976 78999999986431   2234678889999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcc
Q 039799          177 VLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  256 (346)
Q Consensus       177 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~  256 (346)
                      ||||+++|+|.+++... ..+++..+..++.+++.||+|||   +.+|+||||||+|||++.++.++|+|||+++.....
T Consensus       119 v~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~  194 (350)
T 1rdq_E          119 VMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             EEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             EEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceeccCC
Confidence            99999999999998754 45899999999999999999999   999999999999999999999999999999865332


Q ss_pred             ccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh------hhcCCChhhh
Q 039799          257 DQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN------DLLPISVMEV  330 (346)
Q Consensus       257 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~------~~~~~~~~~~  330 (346)
                           .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ........      ..++..+.++
T Consensus       195 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-~~~~~i~~~~~~~p~~~~~~~~~l  268 (350)
T 1rdq_E          195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKIVSGKVRFPSHFSSDLKDL  268 (350)
T ss_dssp             -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCCCCCCTTCCHHHHHH
T ss_pred             -----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH-HHHHHHHcCCCCCCCCCCHHHHHH
Confidence                 23456899999999999889999999999999999999999999753211 11111111      2344578999


Q ss_pred             hchhccCCcccccc
Q 039799          331 VDANLLSQEDEHFT  344 (346)
Q Consensus       331 ~d~~l~~~p~~R~~  344 (346)
                      +.+||..||.+||+
T Consensus       269 i~~lL~~dp~~R~~  282 (350)
T 1rdq_E          269 LRNLLQVDLTKRFG  282 (350)
T ss_dssp             HHHHSCSCTTTCTT
T ss_pred             HHHHhhcCHHhccC
Confidence            99999999999997

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-43  Score=319.99  Aligned_cols=239  Identities=23%  Similarity=0.374  Sum_probs=198.0

Q ss_pred             CCCCCCCcccccCceEEEEEEEc------CCCEEEEEEecCCC-chhHHHHHHHHHHHHhc-CCCCceeeEEEEecCCce
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ------DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRI-CHRNLIKIISSYSNDDFK  174 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  174 (346)
                      ++|.+.+.||+|+||.||+|...      ++..||+|++.... ....+.+.+|+++++++ +||||+++++++...+..
T Consensus        45 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~  124 (344)
T 1rjb_A           45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  124 (344)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCcc
Confidence            56888899999999999999862      45689999997542 33457788999999999 899999999999999999


Q ss_pred             eEEEecCCCCChhhhhhhcCC----------------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCC
Q 039799          175 ALVLEYMPHGSLEKCLYLSNY----------------------ILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPS  232 (346)
Q Consensus       175 ~lv~e~~~~gsL~~~l~~~~~----------------------~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~  232 (346)
                      ++||||+++|+|.+++.....                      .+++..++.++.+++.||+|||   +.+|+||||||+
T Consensus       125 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~  201 (344)
T 1rjb_A          125 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAAR  201 (344)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSGG
T ss_pred             EEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChh
Confidence            999999999999999875432                      3789999999999999999999   999999999999


Q ss_pred             ceEECCCCcEEEeeecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccC
Q 039799          233 NVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSG  311 (346)
Q Consensus       233 NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~  311 (346)
                      ||+++.++.++|+|||++................+|+.|+|||.+.+..++.++||||||+++|||+| |..||......
T Consensus       202 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~  281 (344)
T 1rjb_A          202 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD  281 (344)
T ss_dssp             GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             hEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcH
Confidence            99999999999999999987654433333344557889999999888889999999999999999998 99999764322


Q ss_pred             cccHHHHHhhh--------cCCChhhhhchhccCCccccccc
Q 039799          312 EMTLKRWVNDL--------LPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       312 ~~~~~~~~~~~--------~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                       ......+...        .+..+.+++.+||..||.+||++
T Consensus       282 -~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  322 (344)
T 1rjb_A          282 -ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSF  322 (344)
T ss_dssp             -HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             -HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCH
Confidence             2222333222        34478999999999999999985

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=5.9e-43  Score=310.66  Aligned_cols=240  Identities=16%  Similarity=0.160  Sum_probs=201.0

Q ss_pred             CCCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhc-CCCCceeeEEEEecCCceeEE
Q 039799          100 PLPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRI-CHRNLIKIISSYSNDDFKALV  177 (346)
Q Consensus       100 ~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  177 (346)
                      ...++|.+.+.||+|+||.||+|... +++.||+|++....  ..+.+.+|+++++++ +|+|++++++++......++|
T Consensus         7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   84 (298)
T 1csn_A            7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV   84 (298)
T ss_dssp             EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred             ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence            34567999999999999999999964 78999999986543  234577899999999 799999999999999999999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCc-----EEEeeecCCcc
Q 039799          178 LEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV-----AHLSDFGMAKP  252 (346)
Q Consensus       178 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~-----~~l~Dfg~~~~  252 (346)
                      |||+ +++|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.     ++|+|||+++.
T Consensus        85 ~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~  160 (298)
T 1csn_A           85 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  160 (298)
T ss_dssp             EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             EEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence            9999 99999999877777999999999999999999999   999999999999999987765     99999999997


Q ss_pred             CCccccc-----cccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcc-cH-HH--------
Q 039799          253 LLEEDQS-----LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM-TL-KR--------  317 (346)
Q Consensus       253 ~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~-~~-~~--------  317 (346)
                      .......     .......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ .. ..        
T Consensus       161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  240 (298)
T 1csn_A          161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST  240 (298)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred             cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence            6543221     123445699999999999988999999999999999999999999976432211 11 11        


Q ss_pred             ---HHhhhcCCChhhhhchhccCCccccccc
Q 039799          318 ---WVNDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       318 ---~~~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                         .....++..+.+++.+||..+|++||+.
T Consensus       241 ~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~  271 (298)
T 1csn_A          241 PLRELCAGFPEEFYKYMHYARNLAFDATPDY  271 (298)
T ss_dssp             CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCH
T ss_pred             cHHHHHhhCcHHHHHHHHHHhcCCcccCCCH
Confidence               1112356688999999999999999985

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=9.5e-44  Score=319.98  Aligned_cols=238  Identities=23%  Similarity=0.355  Sum_probs=195.5

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCCE----EEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCcee
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGME----VAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKA  175 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  175 (346)
                      .++|.+.+.||+|+||.||+|.+. +++.    ||+|.+.... ....+.+.+|+.++++++||||+++++++. .+..+
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   90 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ   90 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence            467888999999999999999965 4443    7888875432 233456678999999999999999999886 45688


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCc
Q 039799          176 LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  255 (346)
Q Consensus       176 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~  255 (346)
                      +||||+++|+|.+++......+++..++.++.+++.||+|||   +.+|+||||||+|||++.++.++|+|||+++.+..
T Consensus        91 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~  167 (325)
T 3kex_A           91 LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP  167 (325)
T ss_dssp             EEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred             EEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence            999999999999999766667899999999999999999999   99999999999999999999999999999998755


Q ss_pred             cccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHhh--------hcCCC
Q 039799          256 EDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVND--------LLPIS  326 (346)
Q Consensus       256 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~--------~~~~~  326 (346)
                      ...........++..|+|||.+.+..++.++||||||+++|||+| |+.||......  .....+..        ..+..
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  245 (325)
T 3kex_A          168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA--EVPDLLEKGERLAQPQICTID  245 (325)
T ss_dssp             CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT--HHHHHHHTTCBCCCCTTBCTT
T ss_pred             ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH--HHHHHHHcCCCCCCCCcCcHH
Confidence            444334445568889999999988889999999999999999999 99999764322  22222222        23458


Q ss_pred             hhhhhchhccCCccccccc
Q 039799          327 VMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       327 ~~~~~d~~l~~~p~~R~~~  345 (346)
                      +.+++.+||..||.+||++
T Consensus       246 ~~~li~~~l~~dp~~Rps~  264 (325)
T 3kex_A          246 VYMVMVKCWMIDENIRPTF  264 (325)
T ss_dssp             TTHHHHHHTCSCTTTSCCH
T ss_pred             HHHHHHHHcCCChhhCcCH
Confidence            8999999999999999985

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2.8e-43  Score=316.51  Aligned_cols=240  Identities=24%  Similarity=0.397  Sum_probs=183.4

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEcC-C---CEEEEEEecCC--CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCce
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQD-G---MEVAVKVFDPQ--YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFK  174 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~~-~---~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  174 (346)
                      ..++|.+.+.||+|+||.||+|.+.. +   ..||+|++...  .....+.+.+|++++++++||||+++++++......
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  100 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK  100 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence            45679999999999999999998653 3   27999998754  344567899999999999999999999999877655


Q ss_pred             ------eEEEecCCCCChhhhhhhcC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEE
Q 039799          175 ------ALVLEYMPHGSLEKCLYLSN-----YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAH  243 (346)
Q Consensus       175 ------~lv~e~~~~gsL~~~l~~~~-----~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~  243 (346)
                            ++||||+++++|.+++....     ..+++..++.++.+++.||+|||   +.+|+||||||+||++++++.++
T Consensus       101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~~k  177 (323)
T 3qup_A          101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVC  177 (323)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEE
T ss_pred             cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCCEE
Confidence                  89999999999999885432     25899999999999999999999   99999999999999999999999


Q ss_pred             EeeecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHh--
Q 039799          244 LSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVN--  320 (346)
Q Consensus       244 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~--  320 (346)
                      |+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+  ....+.  
T Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~~~~~~  255 (323)
T 3qup_A          178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE--IYNYLIGG  255 (323)
T ss_dssp             ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHHHTT
T ss_pred             EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH--HHHHHhcC
Confidence            999999987654433333344557889999999988889999999999999999999 999997643222  222111  


Q ss_pred             ------hhcCCChhhhhchhccCCccccccc
Q 039799          321 ------DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       321 ------~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                            ..++..+.+++.+||..||++||++
T Consensus       256 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  286 (323)
T 3qup_A          256 NRLKQPPECMEEVYDLMYQCWSADPKQRPSF  286 (323)
T ss_dssp             CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCH
T ss_pred             CCCCCCCccCHHHHHHHHHHccCChhhCcCH
Confidence                  1233478899999999999999984

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-43  Score=327.33  Aligned_cols=240  Identities=22%  Similarity=0.330  Sum_probs=198.9

Q ss_pred             CCCCCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCc
Q 039799           98 GKPLPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDF  173 (346)
Q Consensus        98 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  173 (346)
                      .+...++|.+.+.||+|+||.||+++.+ +|+.||+|++.+..   ....+.+.+|.+++..++||||+++++++.+.+.
T Consensus        56 ~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~  135 (412)
T 2vd5_A           56 VRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENY  135 (412)
T ss_dssp             HSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred             ccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence            3445678999999999999999999976 79999999986421   1223457789999999999999999999999999


Q ss_pred             eeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccC
Q 039799          174 KALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  253 (346)
Q Consensus       174 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~  253 (346)
                      .++||||+++|+|.+++......+++..+..++.+++.||+|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       136 ~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~DFGla~~~  212 (412)
T 2vd5_A          136 LYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKL  212 (412)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEeechhheec
Confidence            99999999999999999876667999999999999999999999   999999999999999999999999999999876


Q ss_pred             CccccccccccccCCcccccCCCCC-------CCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH-------
Q 039799          254 LEEDQSLTQTQTLATIGYMAPEYGR-------EGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV-------  319 (346)
Q Consensus       254 ~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~-------  319 (346)
                      ..... ......+||+.|+|||++.       ...++.++|||||||++|||++|+.||......+ .....+       
T Consensus       213 ~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~~~~i~~~~~~~~  290 (412)
T 2vd5_A          213 RADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE-TYGKIVHYKEHLS  290 (412)
T ss_dssp             CTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHTHHHHCC
T ss_pred             cCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH-HHHHHHhcccCcC
Confidence            43321 1223457999999999876       4568999999999999999999999997532211 111111       


Q ss_pred             ----hhhcCCChhhhhchhccCCccccc
Q 039799          320 ----NDLLPISVMEVVDANLLSQEDEHF  343 (346)
Q Consensus       320 ----~~~~~~~~~~~~d~~l~~~p~~R~  343 (346)
                          ...++..+.+++.+||. +|.+|+
T Consensus       291 ~p~~~~~~s~~~~dli~~lL~-~p~~Rl  317 (412)
T 2vd5_A          291 LPLVDEGVPEEARDFIQRLLC-PPETRL  317 (412)
T ss_dssp             CC----CCCHHHHHHHHTTSS-CGGGCT
T ss_pred             CCccccCCCHHHHHHHHHHcC-ChhhcC
Confidence                12345578999999998 999996

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=2.8e-43  Score=315.01  Aligned_cols=239  Identities=25%  Similarity=0.357  Sum_probs=200.7

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc------CCCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCce
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ------DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFK  174 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  174 (346)
                      .++|.+.+.||+|+||.||+|...      +++.||+|++.... ....+.+.+|++++++++||||+++++++...+..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  101 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL  101 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence            356788899999999999999862      45789999997543 34457888999999999999999999999999999


Q ss_pred             eEEEecCCCCChhhhhhhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCC
Q 039799          175 ALVLEYMPHGSLEKCLYLSN-----------------------YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKP  231 (346)
Q Consensus       175 ~lv~e~~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~  231 (346)
                      ++||||+++++|.+++....                       ..+++..++.++.++++||+|||   +.+|+||||||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dikp  178 (314)
T 2ivs_A          102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAA  178 (314)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCCSG
T ss_pred             EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcccccch
Confidence            99999999999999987543                       24889999999999999999999   99999999999


Q ss_pred             CceEECCCCcEEEeeecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccc
Q 039799          232 SNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFS  310 (346)
Q Consensus       232 ~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~  310 (346)
                      +||+++.++.++|+|||+++...............+++.|+|||...+..++.++||||||+++|||+| |+.||.....
T Consensus       179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  258 (314)
T 2ivs_A          179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP  258 (314)
T ss_dssp             GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999987654433333344557889999999888889999999999999999999 9999976432


Q ss_pred             CcccHHHHHhh--------hcCCChhhhhchhccCCccccccc
Q 039799          311 GEMTLKRWVND--------LLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       311 ~~~~~~~~~~~--------~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      .  .....+..        .++..+.+++.+||..||++||++
T Consensus       259 ~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~  299 (314)
T 2ivs_A          259 E--RLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVF  299 (314)
T ss_dssp             G--GHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             H--HHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCH
Confidence            2  22222222        234478899999999999999985

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.4e-42  Score=330.18  Aligned_cols=243  Identities=23%  Similarity=0.304  Sum_probs=202.9

Q ss_pred             CCCCCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCc
Q 039799           98 GKPLPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDF  173 (346)
Q Consensus        98 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  173 (346)
                      .....++|.+.+.||+|+||.||+|+.. +|+.||+|++....   ....+.+..|++++++++||||+++++++...+.
T Consensus       180 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~  259 (543)
T 3c4z_A          180 QPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTD  259 (543)
T ss_dssp             SCCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             ccCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCE
Confidence            4445578999999999999999999986 79999999986432   1234678889999999999999999999999999


Q ss_pred             eeEEEecCCCCChhhhhhhc---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCC
Q 039799          174 KALVLEYMPHGSLEKCLYLS---NYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMA  250 (346)
Q Consensus       174 ~~lv~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~  250 (346)
                      .++||||+++|+|.+++...   ...+++..+..++.+++.||+|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus       260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla  336 (543)
T 3c4z_A          260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLA  336 (543)
T ss_dssp             EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeeccee
Confidence            99999999999999988654   346899999999999999999999   999999999999999999999999999999


Q ss_pred             ccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCc--ccHHHHHh-------h
Q 039799          251 KPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE--MTLKRWVN-------D  321 (346)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~--~~~~~~~~-------~  321 (346)
                      +.+.....  .....+||+.|+|||++.+..++.++|||||||++|||+||+.||.......  ..+.+.+.       .
T Consensus       337 ~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~  414 (543)
T 3c4z_A          337 VELKAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPD  414 (543)
T ss_dssp             EECCTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCT
T ss_pred             eeccCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCc
Confidence            87643321  1234579999999999999899999999999999999999999997642211  11222211       1


Q ss_pred             hcCCChhhhhchhccCCccccccc
Q 039799          322 LLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       322 ~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      .++..+.+++.+||..||.+||+.
T Consensus       415 ~~s~~~~~li~~lL~~dP~~R~~~  438 (543)
T 3c4z_A          415 KFSPASKDFCEALLQKDPEKRLGF  438 (543)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred             ccCHHHHHHHHHhccCCHhHCCCC
Confidence            234478899999999999999974

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-43  Score=320.14  Aligned_cols=240  Identities=25%  Similarity=0.379  Sum_probs=200.0

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEc------CCCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCc
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQ------DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDF  173 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  173 (346)
                      ..++|.+.+.||+|+||.||+|...      +++.||+|++.... ....+.+.+|++++++++||||+++++++...+.
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  124 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP  124 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence            3467899999999999999999975      34789999997653 3445778999999999999999999999999999


Q ss_pred             eeEEEecCCCCChhhhhhhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCC
Q 039799          174 KALVLEYMPHGSLEKCLYLSN-----------------------YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLK  230 (346)
Q Consensus       174 ~~lv~e~~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik  230 (346)
                      .++||||+++++|.+++....                       ..+++..++.++.++++||+|||   +.+|+|||||
T Consensus       125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlk  201 (343)
T 1luf_A          125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLA  201 (343)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCS
T ss_pred             eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCC
Confidence            999999999999999987532                       56899999999999999999999   9999999999


Q ss_pred             CCceEECCCCcEEEeeecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccc
Q 039799          231 PSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIF  309 (346)
Q Consensus       231 ~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~  309 (346)
                      |+||+++.++.++|+|||+++...............+++.|+|||.+.+..++.++||||||+++|||+| |..||....
T Consensus       202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  281 (343)
T 1luf_A          202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA  281 (343)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence            9999999999999999999987644332233344567899999999888889999999999999999999 999997532


Q ss_pred             cCcccHHHHHh--------hhcCCChhhhhchhccCCccccccc
Q 039799          310 SGEMTLKRWVN--------DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       310 ~~~~~~~~~~~--------~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ..  .....+.        ..++..+.+++.+||..||++||++
T Consensus       282 ~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~  323 (343)
T 1luf_A          282 HE--EVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSF  323 (343)
T ss_dssp             HH--HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             hH--HHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCH
Confidence            21  1112211        2234478999999999999999985

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=4e-43  Score=310.70  Aligned_cols=238  Identities=28%  Similarity=0.401  Sum_probs=185.2

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEcCCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEE
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVL  178 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  178 (346)
                      ...+|.+.+.||+|+||.||+|.+.  ..+|+|++....  ....+.+.+|++++++++||||+++++++ .....++||
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~   98 (289)
T 3og7_A           22 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT   98 (289)
T ss_dssp             CTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred             CccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence            4567899999999999999999865  369999987543  34457788999999999999999999965 556688999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccc
Q 039799          179 EYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  258 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~  258 (346)
                      ||+++++|.+++......+++..++.++.+++.||+|||   +.+|+||||||+||+++.++.++|+|||++........
T Consensus        99 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  175 (289)
T 3og7_A           99 QWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG  175 (289)
T ss_dssp             ECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred             EecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceeccccccccc
Confidence            999999999999877778999999999999999999999   99999999999999999999999999999986644333


Q ss_pred             ccccccccCCcccccCCCCC---CCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh------------hhc
Q 039799          259 SLTQTQTLATIGYMAPEYGR---EGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN------------DLL  323 (346)
Q Consensus       259 ~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~------------~~~  323 (346)
                      ........||+.|+|||.+.   ...++.++||||||+++|||++|+.||......+ .....+.            ..+
T Consensus       176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  254 (289)
T 3og7_A          176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-QIIEMVGRGSLSPDLSKVRSNC  254 (289)
T ss_dssp             --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH-HHHHHHHHTSCCCCTTSSCTTS
T ss_pred             cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH-HHHHHhcccccCcchhhccccC
Confidence            33334456899999999876   5668889999999999999999999997643222 1222221            123


Q ss_pred             CCChhhhhchhccCCccccccc
Q 039799          324 PISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       324 ~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      +..+.+++.+||..+|++||++
T Consensus       255 ~~~l~~li~~~l~~~p~~Rps~  276 (289)
T 3og7_A          255 PKRMKRLMAECLKKKRDERPSF  276 (289)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CHHHHHHHHHHccCChhhCCCH
Confidence            4468899999999999999985

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1e-42  Score=311.37  Aligned_cols=235  Identities=22%  Similarity=0.218  Sum_probs=189.8

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCc--hhHHHHHHHHHHHHhc-CCCCceeeEEEEecCCceeEEE
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYE--GAFKSFDIECDVMKRI-CHRNLIKIISSYSNDDFKALVL  178 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  178 (346)
                      ++|.+.+.||+|+||+||+|... +|+.||||++.....  ........|+..+.++ +||||+++++++.+.+..++||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            34778889999999999999987 799999999865432  2334455566555555 8999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccc
Q 039799          179 EYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  258 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~  258 (346)
                      ||+ +++|.+++......+++..++.++.+++.||+|||   +.+|+||||||+|||++.++.+||+|||++....... 
T Consensus       137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~-  211 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG-  211 (311)
T ss_dssp             ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred             ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC-
Confidence            999 77999988777778999999999999999999999   8999999999999999999999999999998654322 


Q ss_pred             ccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCcccc----CcccHHHHHhhhcCCChhhhhchh
Q 039799          259 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFS----GEMTLKRWVNDLLPISVMEVVDAN  334 (346)
Q Consensus       259 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~d~~  334 (346)
                        ......||++|+|||++.+ .++.++||||||+++|||++|..|+.....    ............++..+.+++.+|
T Consensus       212 --~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  288 (311)
T 3p1a_A          212 --AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGLSSELRSVLVMM  288 (311)
T ss_dssp             -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHHTTTCCCHHHHTTSCHHHHHHHHHH
T ss_pred             --CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHhccCCCcccccCCCHHHHHHHHHH
Confidence              2234568999999998875 789999999999999999999766543110    000111223344566889999999


Q ss_pred             ccCCccccccc
Q 039799          335 LLSQEDEHFTT  345 (346)
Q Consensus       335 l~~~p~~R~~~  345 (346)
                      |..||++|||+
T Consensus       289 L~~dP~~Rpt~  299 (311)
T 3p1a_A          289 LEPDPKLRATA  299 (311)
T ss_dssp             SCSSTTTSCCH
T ss_pred             cCCChhhCcCH
Confidence            99999999986

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=9.5e-43  Score=306.23  Aligned_cols=235  Identities=22%  Similarity=0.302  Sum_probs=197.8

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecC
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYM  181 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  181 (346)
                      +.|.+.+.||+|+||.||+|... ++..+|+|++........+.+.+|++++++++||||+++++++...+..++||||+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   88 (277)
T 3f3z_A            9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC   88 (277)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEecc
Confidence            45788899999999999999976 57899999987655555678899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEE---CCCCcEEEeeecCCccCCcccc
Q 039799          182 PHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLEEDQ  258 (346)
Q Consensus       182 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll---~~~~~~~l~Dfg~~~~~~~~~~  258 (346)
                      ++++|.+++... ..+++..+..++.+++.||+|||   +.+++||||||+||++   +.++.++|+|||++....... 
T Consensus        89 ~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~-  163 (277)
T 3f3z_A           89 TGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK-  163 (277)
T ss_dssp             CSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS-
T ss_pred             CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc-
Confidence            999999988643 45899999999999999999999   9999999999999999   788999999999998764322 


Q ss_pred             ccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcc---------cHHHHHhhhcCCChhh
Q 039799          259 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM---------TLKRWVNDLLPISVME  329 (346)
Q Consensus       259 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~---------~~~~~~~~~~~~~~~~  329 (346)
                        ......+|+.|+|||.+.+ .++.++||||||++++||+||+.||......+.         .........++..+.+
T Consensus       164 --~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (277)
T 3f3z_A          164 --MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAES  240 (277)
T ss_dssp             --CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHH
T ss_pred             --chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHH
Confidence              2234568999999998765 489999999999999999999999976332111         0111111234568899


Q ss_pred             hhchhccCCccccccc
Q 039799          330 VVDANLLSQEDEHFTT  345 (346)
Q Consensus       330 ~~d~~l~~~p~~R~~~  345 (346)
                      ++.+||..||++||++
T Consensus       241 li~~~l~~dp~~R~s~  256 (277)
T 3f3z_A          241 LIRRLLTKSPKQRITS  256 (277)
T ss_dssp             HHHHHTCSSTTTSCCH
T ss_pred             HHHHHccCChhhCcCH
Confidence            9999999999999985

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1e-42  Score=311.83  Aligned_cols=242  Identities=21%  Similarity=0.312  Sum_probs=193.2

Q ss_pred             CCCCCCCCC-CcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhc-CCCCceeeEEEEecCCceeE
Q 039799          100 PLPNDANMP-PLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRI-CHRNLIKIISSYSNDDFKAL  176 (346)
Q Consensus       100 ~~~~~~~~~-~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  176 (346)
                      .+.+.|.+. +.||+|+||.||+|... +++.||||++........+.+.+|++++.++ +||||+++++++...+..++
T Consensus         9 ~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~l   88 (316)
T 2ac3_A            9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYL   88 (316)
T ss_dssp             CTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             ccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence            345667774 78999999999999865 7899999999766555567889999999985 79999999999999999999


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCc---EEEeeecCCccC
Q 039799          177 VLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV---AHLSDFGMAKPL  253 (346)
Q Consensus       177 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~---~~l~Dfg~~~~~  253 (346)
                      ||||+++++|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.   ++|+|||++...
T Consensus        89 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~  164 (316)
T 2ac3_A           89 VFEKMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI  164 (316)
T ss_dssp             EEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred             EEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence            99999999999998654 46889999999999999999999   899999999999999998765   999999999865


Q ss_pred             Ccccc-----ccccccccCCcccccCCCCCC-----CCCCcchhHHHHHHHHHHHHcCCCCCCccccCcc----------
Q 039799          254 LEEDQ-----SLTQTQTLATIGYMAPEYGRE-----GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM----------  313 (346)
Q Consensus       254 ~~~~~-----~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~----------  313 (346)
                      .....     ........||+.|+|||.+..     ..++.++||||||+++|||+||+.||......+.          
T Consensus       165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  244 (316)
T 2ac3_A          165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA  244 (316)
T ss_dssp             -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred             ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence            42211     111223458999999998764     4578999999999999999999999976432210          


Q ss_pred             ---cHHHHH-----------hhhcCCChhhhhchhccCCccccccc
Q 039799          314 ---TLKRWV-----------NDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       314 ---~~~~~~-----------~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                         .+.+.+           ...++..+.+++.+||..||++|||+
T Consensus       245 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~  290 (316)
T 2ac3_A          245 CQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSA  290 (316)
T ss_dssp             HHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred             HHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCH
Confidence               011111           12244578899999999999999986

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=4.3e-43  Score=316.05  Aligned_cols=240  Identities=22%  Similarity=0.296  Sum_probs=191.8

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCC--------
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDD--------  172 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--------  172 (346)
                      ++|.+.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+..        
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   85 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM   85 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence            35778899999999999999987 89999999987433 345678899999999999999999999886543        


Q ss_pred             -------------------------------------------------ceeEEEecCCCCChhhhhhhcC--CCCCHHH
Q 039799          173 -------------------------------------------------FKALVLEYMPHGSLEKCLYLSN--YILDIFQ  201 (346)
Q Consensus       173 -------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~--~~l~~~~  201 (346)
                                                                       ..++||||+++++|.+++....  ...++..
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~  165 (332)
T 3qd2_B           86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV  165 (332)
T ss_dssp             HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred             hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence                                                             3789999999999999987544  3467777


Q ss_pred             HHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccc----------cccccccCCccc
Q 039799          202 RLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS----------LTQTQTLATIGY  271 (346)
Q Consensus       202 ~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~----------~~~~~~~~~~~y  271 (346)
                      ++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++........          .......||+.|
T Consensus       166 ~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y  242 (332)
T 3qd2_B          166 CLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY  242 (332)
T ss_dssp             HHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred             HHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence            8999999999999999   999999999999999999999999999999976543211          122345699999


Q ss_pred             ccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCccc----HHHHHhhhcCCChhhhhchhccCCccccccc
Q 039799          272 MAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMT----LKRWVNDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       272 ~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      +|||.+.+..++.++||||||+++|||++|..|+.........    .........+..+.+++.+||..||++||++
T Consensus       243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  320 (332)
T 3qd2_B          243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEA  320 (332)
T ss_dssp             SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCH
T ss_pred             cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCCCH
Confidence            9999998889999999999999999999998886431100000    0001112223467899999999999999986

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=6.4e-43  Score=310.84  Aligned_cols=241  Identities=26%  Similarity=0.389  Sum_probs=191.3

Q ss_pred             CCCCCCCCCCCcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHh--cCCCCceeeEEEEec----CC
Q 039799           99 KPLPNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKR--ICHRNLIKIISSYSN----DD  172 (346)
Q Consensus        99 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~----~~  172 (346)
                      +...++|.+.+.||+|+||+||+|.+ +++.||||++...   ....+..|.+++..  ++||||+++++++..    ..
T Consensus         4 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~   79 (301)
T 3q4u_A            4 RTVARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSST   79 (301)
T ss_dssp             CCCGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred             ccccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence            34567899999999999999999988 5899999998643   23455567776666  799999999998654    34


Q ss_pred             ceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCeeecCCCCCceEECCCCcEEEeee
Q 039799          173 FKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFG-----YSAPIIHCDLKPSNVLLDDNMVAHLSDF  247 (346)
Q Consensus       173 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~i~H~dik~~NIll~~~~~~~l~Df  247 (346)
                      ..++||||+++|+|.+++..  ..+++..++.++.+++.||+|||..     ++.+|+||||||+|||++.++.+||+||
T Consensus        80 ~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  157 (301)
T 3q4u_A           80 QLWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADL  157 (301)
T ss_dssp             EEEEEECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred             eeEEehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeC
Confidence            67899999999999999853  4689999999999999999999943     2679999999999999999999999999


Q ss_pred             cCCccCCccccc--cccccccCCcccccCCCCCCC------CCCcchhHHHHHHHHHHHHcC----------CCCCCccc
Q 039799          248 GMAKPLLEEDQS--LTQTQTLATIGYMAPEYGREG------RVSTNGDVYSFGIMLMEIFTR----------TKPTDEIF  309 (346)
Q Consensus       248 g~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~------~~~~~~Dv~s~G~il~elltg----------~~p~~~~~  309 (346)
                      |+++........  .......||+.|+|||.+.+.      .++.++||||||+++|||+||          +.||....
T Consensus       158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~  237 (301)
T 3q4u_A          158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV  237 (301)
T ss_dssp             TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence            999865432221  112334699999999988766      455799999999999999999          88886654


Q ss_pred             cCcccHHHHHhh-----------------hcCCChhhhhchhccCCccccccc
Q 039799          310 SGEMTLKRWVND-----------------LLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       310 ~~~~~~~~~~~~-----------------~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ............                 ..+..+.+++.+||..||++|||+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~  290 (301)
T 3q4u_A          238 PNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTA  290 (301)
T ss_dssp             CSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCH
T ss_pred             CCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCH
Confidence            433333222221                 112247899999999999999986

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.3e-43  Score=308.59  Aligned_cols=237  Identities=25%  Similarity=0.418  Sum_probs=179.3

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEE
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVL  178 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  178 (346)
                      ++|.+.+.||+|+||.||+|... +|+.||+|++....   ....+.+.+|++++++++||||+++++++...+..++||
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL   90 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence            56888999999999999999974 79999999986432   122467889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccc
Q 039799          179 EYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  258 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~  258 (346)
                      ||+++++|.+++......+++..++.++.++++||+|||   +.+++||||||+||+++.++.++|+|||++........
T Consensus        91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~  167 (278)
T 3cok_A           91 EMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE  167 (278)
T ss_dssp             ECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred             ecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC
Confidence            999999999999876677999999999999999999999   99999999999999999999999999999987643221


Q ss_pred             ccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHH------HhhhcCCChhhhhc
Q 039799          259 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRW------VNDLLPISVMEVVD  332 (346)
Q Consensus       259 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~------~~~~~~~~~~~~~d  332 (346)
                        ......+++.|+|||...+..++.++||||||+++|||++|+.||......+. ....      ....++..+.+++.
T Consensus       168 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~  244 (278)
T 3cok_A          168 --KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-LNKVVLADYEMPSFLSIEAKDLIH  244 (278)
T ss_dssp             --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------CCSSCCCCCTTSCHHHHHHHH
T ss_pred             --cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-HHHHhhcccCCccccCHHHHHHHH
Confidence              12234689999999999888899999999999999999999999975322111 1110      11223447889999


Q ss_pred             hhccCCccccccc
Q 039799          333 ANLLSQEDEHFTT  345 (346)
Q Consensus       333 ~~l~~~p~~R~~~  345 (346)
                      +||..||++||++
T Consensus       245 ~~l~~dp~~Rps~  257 (278)
T 3cok_A          245 QLLRRNPADRLSL  257 (278)
T ss_dssp             HHSCSSGGGSCCH
T ss_pred             HHcccCHhhCCCH
Confidence            9999999999985

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.8e-43  Score=318.35  Aligned_cols=238  Identities=21%  Similarity=0.349  Sum_probs=190.8

Q ss_pred             CCCCCCCCcccccCceEEEEEEEcCCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCC--CCceeeEEEEecCCceeEE
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICH--RNLIKIISSYSNDDFKALV  177 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv  177 (346)
                      ...|.+.+.||+|+||.||++...+++.||+|++....  ....+.+.+|++++.+++|  |||+++++++...+..++|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            35688899999999999999998889999999987442  3445778899999999987  9999999999999999999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccc
Q 039799          178 LEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  257 (346)
Q Consensus       178 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~  257 (346)
                      || +.+++|.+++.. ...+++..+..++.+++.||+|||   +.+|+||||||+|||++ ++.+||+|||+++.+....
T Consensus        88 ~e-~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~  161 (343)
T 3dbq_A           88 ME-CGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  161 (343)
T ss_dssp             EC-CCSEEHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred             Ee-CCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence            99 568899999875 456889999999999999999999   99999999999999997 5789999999999775443


Q ss_pred             cccccccccCCcccccCCCCCC-----------CCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHhhh----
Q 039799          258 QSLTQTQTLATIGYMAPEYGRE-----------GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDL----  322 (346)
Q Consensus       258 ~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~----  322 (346)
                      .........||+.|+|||++.+           ..++.++||||||+++|||++|+.||.............+...    
T Consensus       162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  241 (343)
T 3dbq_A          162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE  241 (343)
T ss_dssp             --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCC
T ss_pred             ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccC
Confidence            3333345679999999998743           6788999999999999999999999976433222222222211    


Q ss_pred             ----cCCChhhhhchhccCCccccccc
Q 039799          323 ----LPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       323 ----~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                          .+..+.+++.+||..||++|||+
T Consensus       242 ~~~~~~~~l~~li~~~L~~dp~~Rpt~  268 (343)
T 3dbq_A          242 FPDIPEKDLQDVLKCCLKRDPKQRISI  268 (343)
T ss_dssp             CCCCSCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             CcccCCHHHHHHHHHHcCCChhHCCCH
Confidence                12267899999999999999985

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.6e-42  Score=330.66  Aligned_cols=243  Identities=25%  Similarity=0.348  Sum_probs=203.3

Q ss_pred             hcCCCCCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhcCCCCceeeEEEEecC
Q 039799           96 KRGKPLPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKIISSYSND  171 (346)
Q Consensus        96 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  171 (346)
                      .+.....++|.+.+.||+|+||.||+|... +|+.||+|++....   ......+.+|++++++++||||+++++++...
T Consensus       177 ~~~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~  256 (576)
T 2acx_A          177 ERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK  256 (576)
T ss_dssp             HTSCCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhcCccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeC
Confidence            344455677999999999999999999976 79999999986431   22345678899999999999999999999999


Q ss_pred             CceeEEEecCCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCC
Q 039799          172 DFKALVLEYMPHGSLEKCLYLSN-YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMA  250 (346)
Q Consensus       172 ~~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~  250 (346)
                      +..++||||+++|+|.+++.... ..+++..+..++.+++.||+|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus       257 ~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla  333 (576)
T 2acx_A          257 DALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLA  333 (576)
T ss_dssp             SEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccc
Confidence            99999999999999999887543 45899999999999999999999   999999999999999999999999999999


Q ss_pred             ccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCc--ccHHHHHh-------h
Q 039799          251 KPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE--MTLKRWVN-------D  321 (346)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~--~~~~~~~~-------~  321 (346)
                      +.+....   ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......  ..+.+.+.       .
T Consensus       334 ~~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~  410 (576)
T 2acx_A          334 VHVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSE  410 (576)
T ss_dssp             EECCTTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCT
T ss_pred             eecccCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCc
Confidence            8764322   2234579999999999998899999999999999999999999997643211  11222221       1


Q ss_pred             hcCCChhhhhchhccCCcccccc
Q 039799          322 LLPISVMEVVDANLLSQEDEHFT  344 (346)
Q Consensus       322 ~~~~~~~~~~d~~l~~~p~~R~~  344 (346)
                      .++..+.+++.+||..||.+||+
T Consensus       411 ~~s~~~~dLI~~lL~~dP~~R~g  433 (576)
T 2acx_A          411 RFSPQARSLCSQLLCKDPAERLG  433 (576)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSTT
T ss_pred             cCCHHHHHHHHHhccCCHHHcCC
Confidence            23447899999999999999994

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=8.2e-43  Score=313.29  Aligned_cols=237  Identities=21%  Similarity=0.307  Sum_probs=199.1

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCc------hhHHHHHHHHHHHHhcCCCCceeeEEEEecCCce
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYE------GAFKSFDIECDVMKRICHRNLIKIISSYSNDDFK  174 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  174 (346)
                      .+.|.+.+.||+|+||.||+|... +|+.||+|++.....      ...+.+.+|++++++++||||+++++++...+..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            345888999999999999999976 689999999865432      1357788999999999999999999999999999


Q ss_pred             eEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCC----cEEEeeecCC
Q 039799          175 ALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM----VAHLSDFGMA  250 (346)
Q Consensus       175 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~----~~~l~Dfg~~  250 (346)
                      ++||||+++++|.+++.. ...+++..+..++.+++.||+|||   +.+|+||||||+||+++.++    .++|+|||++
T Consensus        91 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~  166 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (321)
T ss_dssp             EEEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred             EEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence            999999999999999864 456889999999999999999999   99999999999999999887    7999999999


Q ss_pred             ccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcc---------cHHHHHhh
Q 039799          251 KPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM---------TLKRWVND  321 (346)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~---------~~~~~~~~  321 (346)
                      .......   ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.         ........
T Consensus       167 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  243 (321)
T 2a2a_A          167 HEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFS  243 (321)
T ss_dssp             EECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred             eecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhc
Confidence            8764322   22345689999999999888999999999999999999999999965321110         11111123


Q ss_pred             hcCCChhhhhchhccCCccccccc
Q 039799          322 LLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       322 ~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      .++..+.+++.+||..||++|||+
T Consensus       244 ~~~~~~~~li~~~l~~dp~~Rps~  267 (321)
T 2a2a_A          244 HTSELAKDFIRKLLVKETRKRLTI  267 (321)
T ss_dssp             TCCHHHHHHHHTTSCSSTTTSCCH
T ss_pred             ccCHHHHHHHHHHcCCChhhCcCH
Confidence            345578999999999999999985

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=2.4e-42  Score=304.73  Aligned_cols=238  Identities=21%  Similarity=0.376  Sum_probs=199.5

Q ss_pred             CCCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC--CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeE
Q 039799          100 PLPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ--YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKAL  176 (346)
Q Consensus       100 ~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  176 (346)
                      .+.++|.+.+.||+|+||.||+|... +++.||+|++...  .....+.+.+|++++++++||||+++++++...+..++
T Consensus         3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   82 (284)
T 3kk8_A            3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL   82 (284)
T ss_dssp             TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEE
Confidence            45678999999999999999999976 6899999998643  23345778899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCc---EEEeeecCCccC
Q 039799          177 VLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV---AHLSDFGMAKPL  253 (346)
Q Consensus       177 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~---~~l~Dfg~~~~~  253 (346)
                      ||||+++++|.+.+... ..+++..+..++.+++.||+|||   +.+++||||||+||+++.++.   ++|+|||++...
T Consensus        83 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~  158 (284)
T 3kk8_A           83 VFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  158 (284)
T ss_dssp             EECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             EEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence            99999999998887644 56899999999999999999999   999999999999999986655   999999999865


Q ss_pred             CccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh----------hhc
Q 039799          254 LEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN----------DLL  323 (346)
Q Consensus       254 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~----------~~~  323 (346)
                      ....   ......+++.|+|||.+.+..++.++||||+|+++|||++|+.||....... .......          ..+
T Consensus       159 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~  234 (284)
T 3kk8_A          159 NDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-LYAQIKAGAYDYPSPEWDTV  234 (284)
T ss_dssp             CSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCCCCCTTTTTTS
T ss_pred             ccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH-HHHHHHhccccCCchhhccc
Confidence            4322   2234568999999999999899999999999999999999999996532111 1111111          233


Q ss_pred             CCChhhhhchhccCCccccccc
Q 039799          324 PISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       324 ~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      +..+.+++.+||..||++||++
T Consensus       235 ~~~~~~li~~~l~~dp~~Rps~  256 (284)
T 3kk8_A          235 TPEAKSLIDSMLTVNPKKRITA  256 (284)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCH
T ss_pred             CHHHHHHHHHHcccChhhCCCH
Confidence            4578999999999999999986

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=4.7e-43  Score=320.30  Aligned_cols=240  Identities=19%  Similarity=0.233  Sum_probs=193.3

Q ss_pred             CCCCCCCCcccccCceEEEEEEEcC------CCEEEEEEecCCCchhH-----------HHHHHHHHHHHhcCCCCceee
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQD------GMEVAVKVFDPQYEGAF-----------KSFDIECDVMKRICHRNLIKI  164 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~~------~~~vavK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~niv~~  164 (346)
                      ..+|.+.+.||+|+||.||+|.+..      ++.||+|++........           ..+..|+..++.++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            3468889999999999999998764      47899999876532111           123345566777889999999


Q ss_pred             EEEEecC----CceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEEC--C
Q 039799          165 ISSYSND----DFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD--D  238 (346)
Q Consensus       165 ~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~--~  238 (346)
                      ++++...    ...++||||+ +++|.+++......+++..++.++.|++.||+|||   +.+|+||||||+|||++  .
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~~~~  189 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKN  189 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEESSC
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEecCC
Confidence            9998764    4589999999 99999999877678999999999999999999999   99999999999999999  8


Q ss_pred             CCcEEEeeecCCccCCcccccc-----ccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcc
Q 039799          239 NMVAHLSDFGMAKPLLEEDQSL-----TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM  313 (346)
Q Consensus       239 ~~~~~l~Dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~  313 (346)
                      ++.+||+|||+++.+.......     ......||+.|+|||++.+..++.++||||||+++|||+||+.||........
T Consensus       190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~  269 (364)
T 3op5_A          190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK  269 (364)
T ss_dssp             TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred             CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence            8999999999998765432211     11334599999999999998999999999999999999999999986432221


Q ss_pred             -----------cHHHHHh-----hhcCCChhhhhchhccCCccccccc
Q 039799          314 -----------TLKRWVN-----DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       314 -----------~~~~~~~-----~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                                 ....+..     ..++..+.+++..|+..+|++||+.
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~  317 (364)
T 3op5_A          270 YVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLY  317 (364)
T ss_dssp             HHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCH
T ss_pred             HHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCH
Confidence                       1122222     2235688999999999999999985

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2.7e-43  Score=311.54  Aligned_cols=234  Identities=22%  Similarity=0.340  Sum_probs=195.3

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEc-CC-------CEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCC
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQ-DG-------MEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDD  172 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  172 (346)
                      ..++|.+.+.||+|+||.||+|... ++       ..||+|++........+.+.+|++++++++||||+++++++...+
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (289)
T 4fvq_A            6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD   85 (289)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred             chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence            3467888999999999999999865 33       479999997666666788999999999999999999999999999


Q ss_pred             ceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCc--------EEE
Q 039799          173 FKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV--------AHL  244 (346)
Q Consensus       173 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~--------~~l  244 (346)
                      ..++||||+++++|.+++......+++..++.++.+++.||+|||   +.+|+||||||+|||++.++.        ++|
T Consensus        86 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl  162 (289)
T 4fvq_A           86 ENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKL  162 (289)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred             CCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccceeee
Confidence            999999999999999999877667999999999999999999999   999999999999999998876        999


Q ss_pred             eeecCCccCCccccccccccccCCcccccCCCCCC-CCCCcchhHHHHHHHHHHHHcCCC-CCCccccCcccHHHHHh--
Q 039799          245 SDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMEIFTRTK-PTDEIFSGEMTLKRWVN--  320 (346)
Q Consensus       245 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~-p~~~~~~~~~~~~~~~~--  320 (346)
                      +|||++......      ....+++.|+|||.+.+ ..++.++||||||+++|||++|.. |+... .... ......  
T Consensus       163 ~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~-~~~~-~~~~~~~~  234 (289)
T 4fvq_A          163 SDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL-DSQR-KLQFYEDR  234 (289)
T ss_dssp             CCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTS-CHHH-HHHHHHTT
T ss_pred             ccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcccc-chHH-HHHHhhcc
Confidence            999999865322      22347889999998877 678999999999999999999554 44332 1111 111111  


Q ss_pred             ----hhcCCChhhhhchhccCCccccccc
Q 039799          321 ----DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       321 ----~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                          ...+..+.+++.+||..||++|||+
T Consensus       235 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~  263 (289)
T 4fvq_A          235 HQLPAPKAAELANLINNCMDYEPDHRPSF  263 (289)
T ss_dssp             CCCCCCSSCTTHHHHHHHSCSSGGGSCCH
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhHCcCH
Confidence                1234588999999999999999985

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=4.1e-43  Score=306.78  Aligned_cols=237  Identities=25%  Similarity=0.396  Sum_probs=201.0

Q ss_pred             CCCCCCCCcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecC
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYM  181 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  181 (346)
                      .++|.+.+.||+|+||.||+|.+.+++.||+|++..... ..+.+.+|++++++++||||+++++++...+..++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM   85 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred             hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence            356888899999999999999998889999999976543 3467889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccc
Q 039799          182 PHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT  261 (346)
Q Consensus       182 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~  261 (346)
                      ++++|.+++......+++..++.++.+++.||+|||   +.+++||||||+||+++.++.++|+|||++....... ...
T Consensus        86 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~~  161 (267)
T 3t9t_A           86 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTS  161 (267)
T ss_dssp             TTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHS
T ss_pred             CCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEccccccccccccc-ccc
Confidence            999999999877677899999999999999999999   9999999999999999999999999999998654321 112


Q ss_pred             cccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHhh--------hcCCChhhhhc
Q 039799          262 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVND--------LLPISVMEVVD  332 (346)
Q Consensus       262 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~d  332 (346)
                      .....++..|+|||...+..++.++||||||+++|||++ |+.||......  .....+..        ..+..+.+++.
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~i~~~~~~~~~~~~~~~l~~li~  239 (267)
T 3t9t_A          162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--EVVEDISTGFRLYKPRLASTHVYQIMN  239 (267)
T ss_dssp             TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTTCCCCCCTTSCHHHHHHHH
T ss_pred             cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH--HHHHHHhcCCcCCCCccCcHHHHHHHH
Confidence            233457788999999888889999999999999999999 89999753211  12222221        12347889999


Q ss_pred             hhccCCccccccc
Q 039799          333 ANLLSQEDEHFTT  345 (346)
Q Consensus       333 ~~l~~~p~~R~~~  345 (346)
                      +||..+|++||++
T Consensus       240 ~~l~~~p~~Rps~  252 (267)
T 3t9t_A          240 HCWRERPEDRPAF  252 (267)
T ss_dssp             HHTCSSGGGSCCH
T ss_pred             HHccCChhhCcCH
Confidence            9999999999985

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=8.7e-43  Score=316.36  Aligned_cols=231  Identities=26%  Similarity=0.314  Sum_probs=194.1

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEe
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLE  179 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  179 (346)
                      .|...+.||+|+||.||+|... +++.||||++....   ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus        55 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  134 (348)
T 1u5q_A           55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME  134 (348)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             heeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEe
Confidence            4778889999999999999964 78999999987542   2334678899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccc
Q 039799          180 YMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  259 (346)
Q Consensus       180 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~  259 (346)
                      |++ |+|.+.+......+++..+..++.+++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....   
T Consensus       135 ~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~---  207 (348)
T 1u5q_A          135 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---  207 (348)
T ss_dssp             CCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred             cCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC---
Confidence            997 6888888766678999999999999999999999   899999999999999999999999999999865322   


Q ss_pred             cccccccCCcccccCCCCC---CCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh--------hhcCCChh
Q 039799          260 LTQTQTLATIGYMAPEYGR---EGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN--------DLLPISVM  328 (346)
Q Consensus       260 ~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~~~~  328 (346)
                         ....||+.|+|||++.   ...++.++||||||+++|||+||+.||....... .......        ..++..+.
T Consensus       208 ---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~  283 (348)
T 1u5q_A          208 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNESPALQSGHWSEYFR  283 (348)
T ss_dssp             ---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSCCCCCCCTTSCHHHH
T ss_pred             ---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhcCCCCCCCCCCCHHHH
Confidence               2346899999999873   5678999999999999999999999986532111 1111111        22344688


Q ss_pred             hhhchhccCCccccccc
Q 039799          329 EVVDANLLSQEDEHFTT  345 (346)
Q Consensus       329 ~~~d~~l~~~p~~R~~~  345 (346)
                      +++.+||..||++|||+
T Consensus       284 ~li~~~l~~dP~~Rps~  300 (348)
T 1u5q_A          284 NFVDSCLQKIPQDRPTS  300 (348)
T ss_dssp             HHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHcccChhhCcCH
Confidence            99999999999999986

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.2e-42  Score=320.12  Aligned_cols=236  Identities=20%  Similarity=0.348  Sum_probs=190.5

Q ss_pred             CCCCCCcccccCceEEEEEEEcCCCEEEEEEecCCC--chhHHHHHHHHHHHHhcC--CCCceeeEEEEecCCceeEEEe
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQY--EGAFKSFDIECDVMKRIC--HRNLIKIISSYSNDDFKALVLE  179 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e  179 (346)
                      .|.+.+.||+|+||.||++...+++.||||++....  ....+.+.+|++++++++  ||||+++++++...+..++|||
T Consensus        57 ~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E  136 (390)
T 2zmd_A           57 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME  136 (390)
T ss_dssp             EEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe
Confidence            488889999999999999998889999999986542  345678889999999997  5999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccc
Q 039799          180 YMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  259 (346)
Q Consensus       180 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~  259 (346)
                       +.+++|.+++... ..+++..+..++.+++.||+|||   +.+|+||||||+|||++ ++.+||+|||+++.+......
T Consensus       137 -~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~  210 (390)
T 2zmd_A          137 -CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS  210 (390)
T ss_dssp             -CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred             -cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence             5688999998754 46888899999999999999999   99999999999999996 589999999999977544333


Q ss_pred             cccccccCCcccccCCCCCC-----------CCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHhhh------
Q 039799          260 LTQTQTLATIGYMAPEYGRE-----------GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDL------  322 (346)
Q Consensus       260 ~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~------  322 (346)
                      .......||+.|+|||++.+           ..++.++|||||||++|||++|+.||.........+...+...      
T Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~  290 (390)
T 2zmd_A          211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP  290 (390)
T ss_dssp             ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCC
T ss_pred             ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCC
Confidence            33345679999999998754           3688999999999999999999999976432212222222211      


Q ss_pred             --cCCChhhhhchhccCCccccccc
Q 039799          323 --LPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       323 --~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                        .+..+.+++.+||..||++||++
T Consensus       291 ~~~~~~~~~li~~~L~~dP~~Rps~  315 (390)
T 2zmd_A          291 DIPEKDLQDVLKCCLKRDPKQRISI  315 (390)
T ss_dssp             CCSCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             ccchHHHHHHHHHHcccChhhCCCH
Confidence              12267899999999999999985

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.9e-43  Score=331.35  Aligned_cols=233  Identities=23%  Similarity=0.289  Sum_probs=187.1

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC---CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEE
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ---YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVL  178 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  178 (346)
                      ++|.+.+.||+|+||.||+|... +|+.||+|++...   .......+.+|+++++.++||||+++++++...+..++||
T Consensus       148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  227 (446)
T 4ejn_A          148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM  227 (446)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEE
T ss_pred             HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEE
Confidence            46888899999999999999976 7899999998642   2333456778999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeeecCCCCCceEECCCCcEEEeeecCCccCCccc
Q 039799          179 EYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYS-APIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  257 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~  257 (346)
                      ||+++|+|.+++... ..+++..+..++.+++.||+|||   + .+|+||||||+|||++.++.+||+|||+++......
T Consensus       228 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  303 (446)
T 4ejn_A          228 EYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG  303 (446)
T ss_dssp             CCCSSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred             eeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCC
Confidence            999999999988643 46899999999999999999999   8 899999999999999999999999999998643322


Q ss_pred             cccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH-------hhhcCCChhhh
Q 039799          258 QSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV-------NDLLPISVMEV  330 (346)
Q Consensus       258 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~  330 (346)
                        .......||+.|+|||++.+..++.++||||||+++|||++|+.||.....  ......+       ...++..+.++
T Consensus       304 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~~~i~~~~~~~p~~~~~~~~~l  379 (446)
T 4ejn_A          304 --ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKLFELILMEEIRFPRTLGPEAKSL  379 (446)
T ss_dssp             -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred             --cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH--HHHHHHHHhCCCCCCccCCHHHHHH
Confidence              223456799999999999888999999999999999999999999965321  1111111       12234578999


Q ss_pred             hchhccCCccccc
Q 039799          331 VDANLLSQEDEHF  343 (346)
Q Consensus       331 ~d~~l~~~p~~R~  343 (346)
                      +.+||..||++||
T Consensus       380 i~~~L~~dP~~R~  392 (446)
T 4ejn_A          380 LSGLLKKDPKQRL  392 (446)
T ss_dssp             HHHHTCSSTTTST
T ss_pred             HHHHcccCHHHhC
Confidence            9999999999999

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=4.5e-42  Score=306.40  Aligned_cols=236  Identities=31%  Similarity=0.486  Sum_probs=194.9

Q ss_pred             CCCCCcccccCceEEEEEEEcCCCEEEEEEecCC----CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEec
Q 039799          105 ANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQ----YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEY  180 (346)
Q Consensus       105 ~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  180 (346)
                      |...+.||+|+||.||+|.. +++.+|+|++...    .....+.+.+|++++++++||||+++++++...+..++||||
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  111 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVY  111 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             cccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEe
Confidence            45568999999999999987 4889999998643    234467889999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhc--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccc
Q 039799          181 MPHGSLEKCLYLS--NYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  258 (346)
Q Consensus       181 ~~~gsL~~~l~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~  258 (346)
                      +++++|.+++...  ...+++..++.++.+++.||+|||   +.+++||||||+||+++.++.++|+|||++........
T Consensus       112 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~  188 (307)
T 2nru_A          112 MPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ  188 (307)
T ss_dssp             CTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSS
T ss_pred             cCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEEcCCCcEEEeecccccccccccc
Confidence            9999999988643  346899999999999999999999   99999999999999999999999999999987654333


Q ss_pred             ccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcc-------------cHHHHHhhhc--
Q 039799          259 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM-------------TLKRWVNDLL--  323 (346)
Q Consensus       259 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~-------------~~~~~~~~~~--  323 (346)
                      ........|++.|+|||...+ .++.++||||||+++|||+||+.||+.......             .+..++...+  
T Consensus       189 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (307)
T 2nru_A          189 TVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMND  267 (307)
T ss_dssp             CEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSC
T ss_pred             cccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccc
Confidence            333344568999999998764 588999999999999999999999976432221             1122222111  


Q ss_pred             -----CCChhhhhchhccCCccccccc
Q 039799          324 -----PISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       324 -----~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                           +..+.+++.+||..+|.+||++
T Consensus       268 ~~~~~~~~l~~li~~cl~~~p~~Rps~  294 (307)
T 2nru_A          268 ADSTSVEAMYSVASQCLHEKKNKRPDI  294 (307)
T ss_dssp             CCHHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred             cchHHHHHHHHHHHHHcCCCcccCcCH
Confidence                 1256789999999999999985

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.1e-42  Score=326.36  Aligned_cols=230  Identities=31%  Similarity=0.426  Sum_probs=193.9

Q ss_pred             CCCCCCCcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCC-ceeEEEecC
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDD-FKALVLEYM  181 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~  181 (346)
                      ++|.+.+.||+|+||.||+|.+. |+.||||+++...  ..+.+.+|++++++++||||+++++++...+ ..++||||+
T Consensus       193 ~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~  269 (450)
T 1k9a_A          193 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM  269 (450)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred             HHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence            35677789999999999999987 7899999997653  4578899999999999999999999987665 789999999


Q ss_pred             CCCChhhhhhhcCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccc
Q 039799          182 PHGSLEKCLYLSNY-ILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  260 (346)
Q Consensus       182 ~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~  260 (346)
                      ++|+|.+++..... .+++..++.++.+++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....    
T Consensus       270 ~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----  342 (450)
T 1k9a_A          270 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----  342 (450)
T ss_dssp             TTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC------
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc----
Confidence            99999999976543 4799999999999999999999   999999999999999999999999999999854221    


Q ss_pred             ccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHhh--------hcCCChhhhh
Q 039799          261 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVND--------LLPISVMEVV  331 (346)
Q Consensus       261 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~  331 (346)
                       .....++..|+|||.+.+..++.++||||||+++|||+| |+.||......  ...+.+..        .++..+.+++
T Consensus       343 -~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~--~~~~~i~~~~~~~~p~~~~~~l~~li  419 (450)
T 1k9a_A          343 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRVEKGYKMDAPDGCPPAVYDVM  419 (450)
T ss_dssp             -----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT--THHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred             -ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCCCCCCCcCCHHHHHHH
Confidence             122346889999999988899999999999999999998 99999764322  22233322        2345789999


Q ss_pred             chhccCCccccccc
Q 039799          332 DANLLSQEDEHFTT  345 (346)
Q Consensus       332 d~~l~~~p~~R~~~  345 (346)
                      .+||..||++||+.
T Consensus       420 ~~cl~~dp~~Rpt~  433 (450)
T 1k9a_A          420 KNCWHLDAATRPTF  433 (450)
T ss_dssp             HHHTCSSGGGSCCH
T ss_pred             HHHcCCChhHCcCH
Confidence            99999999999985

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.2e-42  Score=317.01  Aligned_cols=235  Identities=20%  Similarity=0.251  Sum_probs=187.0

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEec
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEY  180 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  180 (346)
                      .++|.+.+.||+|+||.||++... +++.||+|++..... ..+.+.+|+.++++++||||+++++++...+..++||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            467999999999999999999977 789999999975432 236678999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCc--EEEeeecCCccCCcccc
Q 039799          181 MPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV--AHLSDFGMAKPLLEEDQ  258 (346)
Q Consensus       181 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~--~~l~Dfg~~~~~~~~~~  258 (346)
                      +++|+|.+++... ..+++..+..++.+++.||+|||   +.+|+||||||+||+++.++.  +||+|||+++.....  
T Consensus        98 ~~~~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~--  171 (361)
T 3uc3_A           98 ASGGELYERICNA-GRFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--  171 (361)
T ss_dssp             CCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred             CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc--
Confidence            9999999988643 45899999999999999999999   999999999999999987765  999999999853222  


Q ss_pred             ccccccccCCcccccCCCCCCCCCCcc-hhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHhh------------hcCC
Q 039799          259 SLTQTQTLATIGYMAPEYGREGRVSTN-GDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVND------------LLPI  325 (346)
Q Consensus       259 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~------------~~~~  325 (346)
                       .......||+.|+|||.+.+..++.+ +||||+|+++|||++|+.||....... .....+..            .++.
T Consensus       172 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~s~  249 (361)
T 3uc3_A          172 -SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR-DYRKTIQRILSVKYSIPDDIRISP  249 (361)
T ss_dssp             ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC-CHHHHHHHHHTTCCCCCTTSCCCH
T ss_pred             -CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH-HHHHHHHHHhcCCCCCCCcCCCCH
Confidence             12234569999999999887777655 899999999999999999997643222 12222111            1234


Q ss_pred             ChhhhhchhccCCccccccc
Q 039799          326 SVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       326 ~~~~~~d~~l~~~p~~R~~~  345 (346)
                      .+.+++.+||..||++|||+
T Consensus       250 ~~~~li~~~L~~dP~~Rps~  269 (361)
T 3uc3_A          250 ECCHLISRIFVADPATRISI  269 (361)
T ss_dssp             HHHHHHHHHSCSCTTTSCCH
T ss_pred             HHHHHHHHHccCChhHCcCH
Confidence            67899999999999999985

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.3e-42  Score=326.55  Aligned_cols=236  Identities=26%  Similarity=0.338  Sum_probs=199.2

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeE
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKAL  176 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  176 (346)
                      ...+|.+.+.||+|+||.||+|... +|+.||||++....   ....+.+.+|+++++.++||||+++++++...+..++
T Consensus        14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l   93 (476)
T 2y94_A           14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFM   93 (476)
T ss_dssp             EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            4467899999999999999999976 79999999986432   1234678899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcc
Q 039799          177 VLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  256 (346)
Q Consensus       177 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~  256 (346)
                      ||||+++|+|.+++.. ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++......
T Consensus        94 v~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~  169 (476)
T 2y94_A           94 VMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  169 (476)
T ss_dssp             EEECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred             EEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence            9999999999998863 456899999999999999999999   999999999999999999999999999999876432


Q ss_pred             ccccccccccCCcccccCCCCCCCCC-CcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh-------hhcCCChh
Q 039799          257 DQSLTQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN-------DLLPISVM  328 (346)
Q Consensus       257 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~-------~~~~~~~~  328 (346)
                      .   .....+||+.|+|||.+.+..+ +.++||||+|+++|||++|+.||+....  ......+.       ..++..+.
T Consensus       170 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~--~~~~~~i~~~~~~~p~~~s~~~~  244 (476)
T 2y94_A          170 E---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV--PTLFKKICDGIFYTPQYLNPSVI  244 (476)
T ss_dssp             C---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS--HHHHHHHHTTCCCCCTTCCHHHH
T ss_pred             c---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH--HHHHHHHhcCCcCCCccCCHHHH
Confidence            2   2234569999999999887765 6899999999999999999999976321  11222221       12344788


Q ss_pred             hhhchhccCCccccccc
Q 039799          329 EVVDANLLSQEDEHFTT  345 (346)
Q Consensus       329 ~~~d~~l~~~p~~R~~~  345 (346)
                      +++.+||..||++|||+
T Consensus       245 ~Li~~~L~~dP~~Rpt~  261 (476)
T 2y94_A          245 SLLKHMLQVDPMKRATI  261 (476)
T ss_dssp             HHHHHHTCSSTTTSCCH
T ss_pred             HHHHHHcCCCchhCcCH
Confidence            99999999999999985

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.7e-43  Score=317.29  Aligned_cols=239  Identities=25%  Similarity=0.386  Sum_probs=191.2

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC-----CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeE
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ-----YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKAL  176 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  176 (346)
                      ++|.+.+.||+|+||.||+|... +++.||+|++...     .....+.+.+|++++++++||||+++++++.+.+..++
T Consensus        26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  105 (345)
T 3hko_A           26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL  105 (345)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence            35888899999999999999975 7889999998542     23456788999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhc---------------------------------------CCCCCHHHHHHHHHHHHHHHHHHh
Q 039799          177 VLEYMPHGSLEKCLYLS---------------------------------------NYILDIFQRLDIMIDVASALEYLH  217 (346)
Q Consensus       177 v~e~~~~gsL~~~l~~~---------------------------------------~~~l~~~~~~~i~~~i~~~l~~LH  217 (346)
                      ||||+++|+|.+++...                                       ...+++..+..++.+++.||+|||
T Consensus       106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH  185 (345)
T 3hko_A          106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH  185 (345)
T ss_dssp             EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence            99999999999988421                                       112356777889999999999999


Q ss_pred             cCCCCCeeecCCCCCceEECCCC--cEEEeeecCCccCCcccc--ccccccccCCcccccCCCCCC--CCCCcchhHHHH
Q 039799          218 FGYSAPIIHCDLKPSNVLLDDNM--VAHLSDFGMAKPLLEEDQ--SLTQTQTLATIGYMAPEYGRE--GRVSTNGDVYSF  291 (346)
Q Consensus       218 ~~~~~~i~H~dik~~NIll~~~~--~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~s~  291 (346)
                         +.+|+||||||+||+++.++  .++|+|||+++.+.....  ........||+.|+|||.+.+  ..++.++|||||
T Consensus       186 ---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl  262 (345)
T 3hko_A          186 ---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSA  262 (345)
T ss_dssp             ---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHH
T ss_pred             ---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHH
Confidence               99999999999999998766  899999999987643221  112345569999999998765  678899999999


Q ss_pred             HHHHHHHHcCCCCCCccccCcccHHHHHh----------hhcCCChhhhhchhccCCccccccc
Q 039799          292 GIMLMEIFTRTKPTDEIFSGEMTLKRWVN----------DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       292 G~il~elltg~~p~~~~~~~~~~~~~~~~----------~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      |+++|||++|+.||......+ .......          ..++..+.+++.+||..+|++||++
T Consensus       263 G~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  325 (345)
T 3hko_A          263 GVLLHLLLMGAVPFPGVNDAD-TISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDA  325 (345)
T ss_dssp             HHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCH
T ss_pred             HHHHHHHHHCCCCCCCCChHH-HHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCH
Confidence            999999999999997633221 1111111          1245578999999999999999986

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.5e-42  Score=310.05  Aligned_cols=237  Identities=22%  Similarity=0.266  Sum_probs=190.3

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCc--hhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEe
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYE--GAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLE  179 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  179 (346)
                      ++|.+.+.||+|+||.||+|... +|+.||+|++.....  ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            56888899999999999999976 689999999865432  335677889999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccc
Q 039799          180 YMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  259 (346)
Q Consensus       180 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~  259 (346)
                      |+++++|.+++. ....+++..+..++.+++.||+|||   +.+|+||||||+||+++.++.++|+|||++........ 
T Consensus        83 ~~~~~~l~~~~~-~~~~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  157 (311)
T 4agu_A           83 YCDHTVLHELDR-YQRGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD-  157 (311)
T ss_dssp             CCSEEHHHHHHH-TSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             eCCCchHHHHHh-hhcCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc-
Confidence            999999988765 3456899999999999999999999   99999999999999999999999999999987643221 


Q ss_pred             cccccccCCcccccCCCCCC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccH--H--------------------
Q 039799          260 LTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTL--K--------------------  316 (346)
Q Consensus       260 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~--~--------------------  316 (346)
                       ......+|..|+|||.+.+ ..++.++||||+|+++|||+||+.||......+...  .                    
T Consensus       158 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (311)
T 4agu_A          158 -YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF  236 (311)
T ss_dssp             ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred             -ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence             2234568999999998765 567999999999999999999999996532111000  0                    


Q ss_pred             --------------HHHhhhcCCChhhhhchhccCCccccccc
Q 039799          317 --------------RWVNDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       317 --------------~~~~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                                    ......++..+.+++.+||..||++|||+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  279 (311)
T 4agu_A          237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTC  279 (311)
T ss_dssp             TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCH
T ss_pred             ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCH
Confidence                          00001233357889999999999999986

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.4e-42  Score=317.25  Aligned_cols=199  Identities=26%  Similarity=0.397  Sum_probs=161.0

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC--CchhHHHHHHHHHHHHhcC-CCCceeeEEEEecCC--ceeE
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ--YEGAFKSFDIECDVMKRIC-HRNLIKIISSYSNDD--FKAL  176 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~--~~~l  176 (346)
                      ++|.+.+.||+|+||.||+|... +|+.||+|++...  .....+.+.+|+.++.++. ||||+++++++...+  ..++
T Consensus         9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l   88 (388)
T 3oz6_A            9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYL   88 (388)
T ss_dssp             TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEE
T ss_pred             CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEE
Confidence            57888999999999999999875 7899999998643  2344567888999999997 999999999997544  6899


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcc
Q 039799          177 VLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  256 (346)
Q Consensus       177 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~  256 (346)
                      ||||++ ++|.+++..  ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+...
T Consensus        89 v~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  162 (388)
T 3oz6_A           89 VFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI  162 (388)
T ss_dssp             EEECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred             EecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence            999997 589888764  46888999999999999999999   999999999999999999999999999999865321


Q ss_pred             c-------------------cccccccccCCcccccCCCCCC-CCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 039799          257 D-------------------QSLTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMEIFTRTKPTDE  307 (346)
Q Consensus       257 ~-------------------~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~  307 (346)
                      .                   .....+..+||+.|+|||.+.+ ..++.++||||+||+++||++|+.||..
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~  233 (388)
T 3oz6_A          163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPG  233 (388)
T ss_dssp             CCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             ccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCC
Confidence            1                   1112234579999999998876 6789999999999999999999999965

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.5e-43  Score=314.76  Aligned_cols=238  Identities=23%  Similarity=0.336  Sum_probs=191.0

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCCE----EEEEEecCC-CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCcee
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGME----VAVKVFDPQ-YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKA  175 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  175 (346)
                      ..+|.+.+.||+|+||.||+|.+. +++.    ||+|.+... .....+.+.+|++++++++||||+++++++.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            467999999999999999999965 4443    577777543 3345678899999999999999999999998765 77


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCc
Q 039799          176 LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  255 (346)
Q Consensus       176 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~  255 (346)
                      +|++++++|+|.+++......+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.++|+|||+++....
T Consensus        93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~  169 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence            899999999999999877778999999999999999999999   99999999999999999999999999999997654


Q ss_pred             cccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHhhh--------cCCC
Q 039799          256 EDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVNDL--------LPIS  326 (346)
Q Consensus       256 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~--------~~~~  326 (346)
                      ...........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||+.....  .....+...        ++..
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  247 (327)
T 3lzb_A          170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILEKGERLPQPPICTID  247 (327)
T ss_dssp             ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHHTTCCCCCCTTBCHH
T ss_pred             ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH--HHHHHHHcCCCCCCCccCCHH
Confidence            433333344557889999999988899999999999999999999 99999764322  222333222        3347


Q ss_pred             hhhhhchhccCCccccccc
Q 039799          327 VMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       327 ~~~~~d~~l~~~p~~R~~~  345 (346)
                      +.+++.+||..||.+||++
T Consensus       248 l~~li~~~l~~dp~~Rps~  266 (327)
T 3lzb_A          248 VYMIMRKCWMIDADSRPKF  266 (327)
T ss_dssp             HHHHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHHHcCCChhHCcCH
Confidence            8899999999999999985

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=3e-42  Score=314.47  Aligned_cols=199  Identities=29%  Similarity=0.342  Sum_probs=175.4

Q ss_pred             CCCCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcC-----CCCceeeEEEEecCC
Q 039799           99 KPLPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRIC-----HRNLIKIISSYSNDD  172 (346)
Q Consensus        99 ~~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~~~~~~~~~~  172 (346)
                      ....++|.+.+.||+|+||.||+|... +++.||+|++... ......+..|+++++.++     ||||+++++++...+
T Consensus        31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~  109 (360)
T 3llt_A           31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYD  109 (360)
T ss_dssp             CEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETT
T ss_pred             eEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECC
Confidence            345678999999999999999999975 7899999999743 344566778999999996     999999999999999


Q ss_pred             ceeEEEecCCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC-------------
Q 039799          173 FKALVLEYMPHGSLEKCLYLSN-YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD-------------  238 (346)
Q Consensus       173 ~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~-------------  238 (346)
                      ..++||||+ +++|.+++.... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.             
T Consensus       110 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~  185 (360)
T 3llt_A          110 HMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRV  185 (360)
T ss_dssp             EEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTCCEEEEEEECT
T ss_pred             eeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEccccccccccchhcc
Confidence            999999999 999999987654 45899999999999999999999   999999999999999975             


Q ss_pred             ------------CCcEEEeeecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCC
Q 039799          239 ------------NMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTD  306 (346)
Q Consensus       239 ------------~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~  306 (346)
                                  ++.+||+|||+++.....     .....||+.|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus       186 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~  260 (360)
T 3llt_A          186 TDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFR  260 (360)
T ss_dssp             TTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred             cccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCC
Confidence                        789999999999864322     234568999999999999999999999999999999999999996


Q ss_pred             c
Q 039799          307 E  307 (346)
Q Consensus       307 ~  307 (346)
                      .
T Consensus       261 ~  261 (360)
T 3llt_A          261 T  261 (360)
T ss_dssp             C
T ss_pred             C
Confidence            5

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.2e-42  Score=314.03  Aligned_cols=238  Identities=26%  Similarity=0.373  Sum_probs=197.6

Q ss_pred             CCCCCCCcccccCceEEEEEEEc--------CCCEEEEEEecCCC-chhHHHHHHHHHHHHhc-CCCCceeeEEEEecCC
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ--------DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRI-CHRNLIKIISSYSNDD  172 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  172 (346)
                      ++|.+.+.||+|+||.||+|.+.        ++..||+|++.... ....+.+.+|+++++++ +||||+++++++...+
T Consensus        35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  114 (334)
T 2pvf_A           35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG  114 (334)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCC
Confidence            56788899999999999999863        46789999997543 34457788999999999 8999999999999999


Q ss_pred             ceeEEEecCCCCChhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEEC
Q 039799          173 FKALVLEYMPHGSLEKCLYLSN---------------YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD  237 (346)
Q Consensus       173 ~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~  237 (346)
                      ..++||||+++++|.+++....               ..+++..++.++.+++.||+|||   +.+|+||||||+||+++
T Consensus       115 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~  191 (334)
T 2pvf_A          115 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVT  191 (334)
T ss_dssp             CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC
T ss_pred             ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceEEEc
Confidence            9999999999999999987543               24899999999999999999999   99999999999999999


Q ss_pred             CCCcEEEeeecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHH
Q 039799          238 DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLK  316 (346)
Q Consensus       238 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~  316 (346)
                      .++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||+| |+.||......  ...
T Consensus       192 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~  269 (334)
T 2pvf_A          192 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--ELF  269 (334)
T ss_dssp             TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHH
T ss_pred             CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH--HHH
Confidence            999999999999987654332223334457889999999888889999999999999999999 99999753211  122


Q ss_pred             HHHh--------hhcCCChhhhhchhccCCccccccc
Q 039799          317 RWVN--------DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       317 ~~~~--------~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ..+.        ..++..+.+++.+||..+|.+||++
T Consensus       270 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  306 (334)
T 2pvf_A          270 KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF  306 (334)
T ss_dssp             HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCH
Confidence            2222        1234478899999999999999985

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=6.6e-43  Score=317.05  Aligned_cols=239  Identities=18%  Similarity=0.184  Sum_probs=189.8

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc----CCCEEEEEEecCCCchh-----------HHHHHHHHHHHHhcCCCCceeeEE
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ----DGMEVAVKVFDPQYEGA-----------FKSFDIECDVMKRICHRNLIKIIS  166 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~----~~~~vavK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~niv~~~~  166 (346)
                      .++|.+.+.||+|+||.||+|...    ++..+|+|++.......           ...+.+|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            456889999999999999999975    57889999987653221           124567888899999999999999


Q ss_pred             EEec----CCceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCC--
Q 039799          167 SYSN----DDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM--  240 (346)
Q Consensus       167 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~--  240 (346)
                      ++..    ....++||||+ +++|.+++.... .+++..++.++.|++.||+|||   +.+|+||||||+|||++.++  
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~  190 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPD  190 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSSTT
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCCCC
Confidence            9887    77899999999 999999987544 7899999999999999999999   99999999999999998877  


Q ss_pred             cEEEeeecCCccCCccccc-----cccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccH
Q 039799          241 VAHLSDFGMAKPLLEEDQS-----LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTL  315 (346)
Q Consensus       241 ~~~l~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~  315 (346)
                      .++|+|||+++.+......     .......||+.|+|||.+.+..++.++||||||+++|||+||+.||..........
T Consensus       191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~  270 (345)
T 2v62_A          191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV  270 (345)
T ss_dssp             SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH
T ss_pred             cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH
Confidence            9999999999876543211     11234569999999999988889999999999999999999999996533222211


Q ss_pred             H-----------HHHhh-----hcCCChhhhhchhccCCccccccc
Q 039799          316 K-----------RWVND-----LLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       316 ~-----------~~~~~-----~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      .           .....     .++..+.+++.+||..||++||++
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  316 (345)
T 2v62_A          271 QTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNY  316 (345)
T ss_dssp             HHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCH
T ss_pred             HHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCH
Confidence            1           11111     345588999999999999999985

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=3.8e-43  Score=324.53  Aligned_cols=240  Identities=23%  Similarity=0.293  Sum_probs=195.8

Q ss_pred             CCCCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCce
Q 039799           99 KPLPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFK  174 (346)
Q Consensus        99 ~~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  174 (346)
                      +...++|.+.+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|+++++.++||||+++++++.+.+..
T Consensus        65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~  144 (410)
T 3v8s_A           65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL  144 (410)
T ss_dssp             SCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence            345578999999999999999999977 68999999986421   11223477899999999999999999999999999


Q ss_pred             eEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCC
Q 039799          175 ALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  254 (346)
Q Consensus       175 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~  254 (346)
                      ++||||+++|+|.+++..  ..+++..+..++.+++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus       145 ~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~  219 (410)
T 3v8s_A          145 YMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN  219 (410)
T ss_dssp             EEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEeccceeEeec
Confidence            999999999999998864  35888999999999999999999   9999999999999999999999999999998764


Q ss_pred             ccccccccccccCCcccccCCCCCCCC----CCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHhh---------
Q 039799          255 EEDQSLTQTQTLATIGYMAPEYGREGR----VSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVND---------  321 (346)
Q Consensus       255 ~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~---------  321 (346)
                      .... ......+||+.|+|||++.+..    ++.++|||||||++|||+||+.||......+ ........         
T Consensus       220 ~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-~~~~i~~~~~~~~~p~~  297 (410)
T 3v8s_A          220 KEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-TYSKIMNHKNSLTFPDD  297 (410)
T ss_dssp             TTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHTHHHHCCCCTT
T ss_pred             cCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh-HHHHHHhccccccCCCc
Confidence            3321 2233567999999999886654    7899999999999999999999997532111 11111111         


Q ss_pred             -hcCCChhhhhchhccCCccc--cccc
Q 039799          322 -LLPISVMEVVDANLLSQEDE--HFTT  345 (346)
Q Consensus       322 -~~~~~~~~~~d~~l~~~p~~--R~~~  345 (346)
                       .++..+.+++.+||..+|++  |+++
T Consensus       298 ~~~s~~~~~li~~lL~~~~~rlgR~~~  324 (410)
T 3v8s_A          298 NDISKEAKNLICAFLTDREVRLGRNGV  324 (410)
T ss_dssp             CCCCHHHHHHHHHHSSCGGGCTTSSCH
T ss_pred             ccccHHHHHHHHHHccChhhhCCCCCH
Confidence             23346889999999988877  7764

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.1e-42  Score=306.61  Aligned_cols=238  Identities=22%  Similarity=0.355  Sum_probs=187.4

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEcC----CCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCcee
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQD----GMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKA  175 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  175 (346)
                      ..++|.+.+.||+|+||.||+|....    +..+|+|++.... ....+.+.+|+.++++++||||+++++++. .+..+
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   91 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW   91 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence            34568888999999999999998652    4579999987543 344577889999999999999999999984 55788


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCc
Q 039799          176 LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  255 (346)
Q Consensus       176 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~  255 (346)
                      +||||+++++|.+++......+++..++.++.+++.||+|||   +.+++||||||+||+++.++.++|+|||+++....
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  168 (281)
T 1mp8_A           92 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  168 (281)
T ss_dssp             EEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccccccCc
Confidence            999999999999999877777999999999999999999999   99999999999999999999999999999987643


Q ss_pred             cccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHh--------hhcCCC
Q 039799          256 EDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVN--------DLLPIS  326 (346)
Q Consensus       256 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~--------~~~~~~  326 (346)
                      ... .......+++.|+|||...+..++.++||||||+++|||++ |..||......  .....+.        ..++..
T Consensus       169 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~  245 (281)
T 1mp8_A          169 STY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRIENGERLPMPPNCPPT  245 (281)
T ss_dssp             -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHHTTCCCCCCTTCCHH
T ss_pred             ccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH--HHHHHHHcCCCCCCCCCCCHH
Confidence            221 12223346789999999888889999999999999999997 99999764322  2222222        223447


Q ss_pred             hhhhhchhccCCccccccc
Q 039799          327 VMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       327 ~~~~~d~~l~~~p~~R~~~  345 (346)
                      +.+++.+||..||++||++
T Consensus       246 l~~li~~~l~~~p~~Rps~  264 (281)
T 1mp8_A          246 LYSLMTKCWAYDPSRRPRF  264 (281)
T ss_dssp             HHHHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHHHccCChhhCcCH
Confidence            8899999999999999985

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=4.8e-43  Score=316.56  Aligned_cols=235  Identities=25%  Similarity=0.312  Sum_probs=195.0

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCc--------hhHHHHHHHHHHHHhcCCCCceeeEEEEecCCc
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYE--------GAFKSFDIECDVMKRICHRNLIKIISSYSNDDF  173 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  173 (346)
                      ++|.+.+.||+|+||.||+|... +++.||+|++.....        ...+.+.+|++++++++||||+++++++...+.
T Consensus        24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~  103 (335)
T 3dls_A           24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF  103 (335)
T ss_dssp             HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence            45888899999999999999865 788999999875421        123456679999999999999999999999999


Q ss_pred             eeEEEecCCCC-ChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCcc
Q 039799          174 KALVLEYMPHG-SLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  252 (346)
Q Consensus       174 ~~lv~e~~~~g-sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~  252 (346)
                      .++||||+.+| +|.+++.. ...+++..+..++.+++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus       104 ~~lv~e~~~~g~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~  179 (335)
T 3dls_A          104 FQLVMEKHGSGLDLFAFIDR-HPRLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY  179 (335)
T ss_dssp             EEEEEECCTTSCBHHHHHHT-CCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeecccceE
Confidence            99999999776 99988864 346899999999999999999999   99999999999999999999999999999987


Q ss_pred             CCccccccccccccCCcccccCCCCCCCCC-CcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHhhhcCCChhhhh
Q 039799          253 LLEEDQSLTQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPISVMEVV  331 (346)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (346)
                      .....   ......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||........ ........++..+.+++
T Consensus       180 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~l~~li  255 (335)
T 3dls_A          180 LERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVE-AAIHPPYLVSKELMSLV  255 (335)
T ss_dssp             CCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTT-TCCCCSSCCCHHHHHHH
T ss_pred             CCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHh-hccCCCcccCHHHHHHH
Confidence            64332   2233568999999999887776 8899999999999999999999976322110 00111122455889999


Q ss_pred             chhccCCccccccc
Q 039799          332 DANLLSQEDEHFTT  345 (346)
Q Consensus       332 d~~l~~~p~~R~~~  345 (346)
                      .+||..||++||++
T Consensus       256 ~~~L~~dP~~Rps~  269 (335)
T 3dls_A          256 SGLLQPVPERRTTL  269 (335)
T ss_dssp             HHHTCSSGGGSCCH
T ss_pred             HHHccCChhhCcCH
Confidence            99999999999985

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2.6e-42  Score=308.18  Aligned_cols=237  Identities=25%  Similarity=0.295  Sum_probs=189.6

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC-----chhHHHHHHHHHHHHhc---CCCCceeeEEEEecC
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY-----EGAFKSFDIECDVMKRI---CHRNLIKIISSYSND  171 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~  171 (346)
                      ..++|.+.+.||+|+||+||+|... +++.||+|++....     ......+.+|+++++++   +||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            4568999999999999999999964 78999999986321     11234566677777666   499999999999765


Q ss_pred             C-----ceeEEEecCCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEe
Q 039799          172 D-----FKALVLEYMPHGSLEKCLYLSN-YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLS  245 (346)
Q Consensus       172 ~-----~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~  245 (346)
                      .     ..++||||+. ++|.+++.... ..+++..+..++.+++.||+|||   +.+|+||||||+||+++.++.++|+
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~  162 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLA  162 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEEC
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEEe
Confidence            5     4789999997 59999887554 34899999999999999999999   9999999999999999999999999


Q ss_pred             eecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHH-------
Q 039799          246 DFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRW-------  318 (346)
Q Consensus       246 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~-------  318 (346)
                      |||+++......   ......+|+.|+|||.+.+..++.++||||||+++|||++|+.||......+ .....       
T Consensus       163 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~  238 (308)
T 3g33_A          163 DFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLGKIFDLIGLP  238 (308)
T ss_dssp             SCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH-HHHHHHHHHCCC
T ss_pred             eCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCC
Confidence            999998654322   2234568999999999988889999999999999999999999996532111 11111       


Q ss_pred             --------------------------HhhhcCCChhhhhchhccCCccccccc
Q 039799          319 --------------------------VNDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       319 --------------------------~~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                                                ....++..+.+++.+||..||++|||+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  291 (308)
T 3g33_A          239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISA  291 (308)
T ss_dssp             CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCH
Confidence                                      111234467889999999999999986

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.9e-43  Score=314.22  Aligned_cols=235  Identities=21%  Similarity=0.274  Sum_probs=187.4

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCch-hHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEec
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEG-AFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEY  180 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  180 (346)
                      ++|.+.+.||+|+||+||+|... +++.||+|++...... ....+.+|++++++++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            45788899999999999999976 7899999998644321 112345699999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccc
Q 039799          181 MPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  260 (346)
Q Consensus       181 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~  260 (346)
                      ++ ++|.+++......+++..+..++.+++.||+|||   +.+|+||||||+||+++.++.++|+|||+++......  .
T Consensus        82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~--~  155 (324)
T 3mtl_A           82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT--K  155 (324)
T ss_dssp             CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred             cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc--c
Confidence            97 5899988877778999999999999999999999   9999999999999999999999999999998653222  2


Q ss_pred             ccccccCCcccccCCCCCC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH--------------------
Q 039799          261 TQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV--------------------  319 (346)
Q Consensus       261 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~--------------------  319 (346)
                      ......+|+.|+|||.+.+ ..++.++||||+|+++|||++|+.||......+  ....+                    
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~~~  233 (324)
T 3mtl_A          156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE--QLHFIFRILGTPTEETWPGILSNEE  233 (324)
T ss_dssp             -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred             ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChHhchhhhcchh
Confidence            2234568999999998766 568999999999999999999999997532111  11100                    


Q ss_pred             -----------------hhhcCCChhhhhchhccCCccccccc
Q 039799          320 -----------------NDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       320 -----------------~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                                       ...++..+.+++.+||..||++|||+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  276 (324)
T 3mtl_A          234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISA  276 (324)
T ss_dssp             HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCH
T ss_pred             hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCH
Confidence                             01233466899999999999999986

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=7.3e-43  Score=327.99  Aligned_cols=234  Identities=25%  Similarity=0.402  Sum_probs=195.8

Q ss_pred             CCCCCCcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecCCC
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPH  183 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  183 (346)
                      +|.+.+.||+|+||.||+|.++++..||||++.... ...+.+.+|++++++++||||+++++++. .+..++||||+++
T Consensus       189 ~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~  266 (454)
T 1qcf_A          189 SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAK  266 (454)
T ss_dssp             GEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTT
T ss_pred             HeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCC
Confidence            355667899999999999999888999999998654 34678999999999999999999999986 5678999999999


Q ss_pred             CChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccccc
Q 039799          184 GSLEKCLYLSN-YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ  262 (346)
Q Consensus       184 gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~  262 (346)
                      |+|.+++.... ..+++..++.++.+++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...... ....
T Consensus       267 g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~-~~~~  342 (454)
T 1qcf_A          267 GSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-YTAR  342 (454)
T ss_dssp             CBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH-HHTT
T ss_pred             CcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc-eecc
Confidence            99999987443 46889999999999999999999   9999999999999999999999999999998764321 1112


Q ss_pred             ccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHhh--------hcCCChhhhhch
Q 039799          263 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVND--------LLPISVMEVVDA  333 (346)
Q Consensus       263 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~d~  333 (346)
                      ....++..|+|||.+....++.++||||||+++|||+| |+.||......  .....+..        .++..+.+++.+
T Consensus       343 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~--~~~~~i~~~~~~~~~~~~~~~l~~li~~  420 (454)
T 1qcf_A          343 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIRALERGYRMPRPENCPEELYNIMMR  420 (454)
T ss_dssp             CSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHHHHHHHTCCCCCCTTSCHHHHHHHHH
T ss_pred             CCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCCCCCCCCCCHHHHHHHHH
Confidence            33446788999999988889999999999999999999 99999763321  22222222        234578999999


Q ss_pred             hccCCccccccc
Q 039799          334 NLLSQEDEHFTT  345 (346)
Q Consensus       334 ~l~~~p~~R~~~  345 (346)
                      ||..||++|||.
T Consensus       421 cl~~dp~~RPt~  432 (454)
T 1qcf_A          421 CWKNRPEERPTF  432 (454)
T ss_dssp             HTCSSGGGSCCH
T ss_pred             HccCChhHCcCH
Confidence            999999999985

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2.2e-42  Score=309.81  Aligned_cols=240  Identities=21%  Similarity=0.254  Sum_probs=196.2

Q ss_pred             CCCCCCCcccccCceEEEEEEE-cCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEe----cCCceeEE
Q 039799          103 NDANMPPLIGKGGFGSVYKAII-QDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYS----NDDFKALV  177 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~----~~~~~~lv  177 (346)
                      ++|.+.+.||+|+||.||++.. .+++.||+|++........+.+.+|++++++++||||+++++++.    .....++|
T Consensus        29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv  108 (317)
T 2buj_A           29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLL  108 (317)
T ss_dssp             EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEE
T ss_pred             eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEE
Confidence            4688899999999999999997 479999999987666666788999999999999999999999986    34478899


Q ss_pred             EecCCCCChhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCC
Q 039799          178 LEYMPHGSLEKCLYL---SNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  254 (346)
Q Consensus       178 ~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~  254 (346)
                      |||+++++|.+++..   ....+++..++.++.+++.||+|||   +.+|+||||||+||+++.++.++|+|||++....
T Consensus       109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~  185 (317)
T 2buj_A          109 LPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC  185 (317)
T ss_dssp             EECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCEESC
T ss_pred             EEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcchhcc
Confidence            999999999998865   3467899999999999999999999   8999999999999999999999999999988653


Q ss_pred             ccccc-------cccccccCCcccccCCCCCCCC---CCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHhh---
Q 039799          255 EEDQS-------LTQTQTLATIGYMAPEYGREGR---VSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVND---  321 (346)
Q Consensus       255 ~~~~~-------~~~~~~~~~~~y~aPE~~~~~~---~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~---  321 (346)
                      .....       .......||+.|+|||.+....   ++.++||||||+++|||++|+.||+............+..   
T Consensus       186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~  265 (317)
T 2buj_A          186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLS  265 (317)
T ss_dssp             EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC--
T ss_pred             cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccCC
Confidence            21111       0112334799999999887554   6889999999999999999999997643332222222221   


Q ss_pred             -----hcCCChhhhhchhccCCccccccc
Q 039799          322 -----LLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       322 -----~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                           .++..+.+++.+||..||++||++
T Consensus       266 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~  294 (317)
T 2buj_A          266 IPQSPRHSSALWQLLNSMMTVDPHQRPHI  294 (317)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCccccCCHHHHHHHHHHhhcChhhCCCH
Confidence                 234478999999999999999985

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=4.4e-42  Score=317.42  Aligned_cols=232  Identities=22%  Similarity=0.313  Sum_probs=184.2

Q ss_pred             CCCCCC-CcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHH-hcCCCCceeeEEEEec----CCcee
Q 039799          103 NDANMP-PLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMK-RICHRNLIKIISSYSN----DDFKA  175 (346)
Q Consensus       103 ~~~~~~-~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~----~~~~~  175 (346)
                      ++|.+. +.||+|+||+||++... +++.||||++...     ..+.+|++++. ..+||||+++++++..    ....+
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            345554 68999999999999976 7899999998632     45667888774 4589999999998865    56789


Q ss_pred             EEEecCCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC---CCcEEEeeecCCc
Q 039799          176 LVLEYMPHGSLEKCLYLSN-YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD---NMVAHLSDFGMAK  251 (346)
Q Consensus       176 lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~---~~~~~l~Dfg~~~  251 (346)
                      +||||+++|+|.+++.... ..+++..+..++.+++.||+|||   +.+|+||||||+|||++.   ++.+||+|||+++
T Consensus       136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~  212 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  212 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEeccccc
Confidence            9999999999999987543 46899999999999999999999   999999999999999997   7899999999998


Q ss_pred             cCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcc--cHHHHHh---------
Q 039799          252 PLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM--TLKRWVN---------  320 (346)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~--~~~~~~~---------  320 (346)
                      ......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||........  .....+.         
T Consensus       213 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~  289 (400)
T 1nxk_A          213 ETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP  289 (400)
T ss_dssp             ECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTT
T ss_pred             ccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCc
Confidence            654321   22345689999999999999999999999999999999999999976432211  1222221         


Q ss_pred             --hhcCCChhhhhchhccCCccccccc
Q 039799          321 --DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       321 --~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                        ..++..+.+++.+||..||++|||+
T Consensus       290 ~~~~~s~~~~~li~~~L~~dP~~Rpt~  316 (400)
T 1nxk_A          290 EWSEVSEEVKMLIRNLLKTEPTQRMTI  316 (400)
T ss_dssp             TTTTSCHHHHHHHHTTSCSSGGGSCCH
T ss_pred             ccccCCHHHHHHHHHHCCCChhHCcCH
Confidence              1234478999999999999999985

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=2.2e-42  Score=302.59  Aligned_cols=233  Identities=20%  Similarity=0.324  Sum_probs=194.3

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEcCCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEecC--CceeE
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSND--DFKAL  176 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l  176 (346)
                      ..++|.+.+.||+|+||.||+|.++ ++.+|+|++....  ....+.+.+|++++++++||||+++++++...  +..++
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   86 (271)
T 3kmu_A            8 DFKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL   86 (271)
T ss_dssp             CGGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred             CHHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence            4467889999999999999999986 8899999997543  34456789999999999999999999999877  78899


Q ss_pred             EEecCCCCChhhhhhhcCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeecCCCCCceEECCCCcEEEeeecCCccC
Q 039799          177 VLEYMPHGSLEKCLYLSNY-ILDIFQRLDIMIDVASALEYLHFGYSAP--IIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  253 (346)
Q Consensus       177 v~e~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~dik~~NIll~~~~~~~l~Dfg~~~~~  253 (346)
                      ||||+++++|.+++..... .+++..++.++.+++.||+|||   +.+  ++||||||+||+++.++.++++|||++...
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~  163 (271)
T 3kmu_A           87 ITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF  163 (271)
T ss_dssp             EEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred             eecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceeee
Confidence            9999999999999976543 5899999999999999999999   888  999999999999999999999999987643


Q ss_pred             CccccccccccccCCcccccCCCCCCCCCCc---chhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH--------hhh
Q 039799          254 LEEDQSLTQTQTLATIGYMAPEYGREGRVST---NGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV--------NDL  322 (346)
Q Consensus       254 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~--------~~~  322 (346)
                      .       .....+|+.|+|||.+.+..++.   ++||||||+++|||+||+.||......+. .....        ...
T Consensus       164 ~-------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~  235 (271)
T 3kmu_A          164 Q-------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI-GMKVALEGLRPTIPPG  235 (271)
T ss_dssp             S-------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH-HHHHHHSCCCCCCCTT
T ss_pred             c-------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH-HHHHHhcCCCCCCCCC
Confidence            2       12345899999999887665544   79999999999999999999976332211 11111        122


Q ss_pred             cCCChhhhhchhccCCccccccc
Q 039799          323 LPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       323 ~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ++..+.+++.+||..||++||++
T Consensus       236 ~~~~~~~li~~~l~~~p~~Rps~  258 (271)
T 3kmu_A          236 ISPHVSKLMKICMNEDPAKRPKF  258 (271)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCHHHHHHHHHHcCCChhhCcCH
Confidence            34578999999999999999985

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.5e-42  Score=305.28  Aligned_cols=237  Identities=22%  Similarity=0.343  Sum_probs=195.5

Q ss_pred             CCCCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCce
Q 039799           99 KPLPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFK  174 (346)
Q Consensus        99 ~~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  174 (346)
                      ...-++|.+.+.||+|+||.||+|... +++.||+|++....   ......+.+|++++++++||||+++++++...+..
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   84 (279)
T 3fdn_A            5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV   84 (279)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEE
Confidence            444567899999999999999999876 67899999985431   12245688899999999999999999999999999


Q ss_pred             eEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCC
Q 039799          175 ALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  254 (346)
Q Consensus       175 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~  254 (346)
                      ++||||+++++|.+++... ..+++..+..++.+++.||+|||   +.+|+||||||+||+++.++.++|+|||++....
T Consensus        85 ~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~  160 (279)
T 3fdn_A           85 YLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP  160 (279)
T ss_dssp             EEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred             EEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCC
Confidence            9999999999999988643 45899999999999999999999   9999999999999999999999999999987543


Q ss_pred             ccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh-------hhcCCCh
Q 039799          255 EEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN-------DLLPISV  327 (346)
Q Consensus       255 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~-------~~~~~~~  327 (346)
                      ..    ......+++.|+|||.+.+..++.++||||||+++|||++|+.||......  .....+.       ..++..+
T Consensus       161 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  234 (279)
T 3fdn_A          161 SS----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ--ETYKRISRVEFTFPDFVTEGA  234 (279)
T ss_dssp             -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHHTCCCCCTTSCHHH
T ss_pred             cc----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH--HHHHHHHhCCCCCCCcCCHHH
Confidence            22    123456899999999998888999999999999999999999999753211  1111111       1234468


Q ss_pred             hhhhchhccCCccccccc
Q 039799          328 MEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       328 ~~~~d~~l~~~p~~R~~~  345 (346)
                      .+++.+||..||++||++
T Consensus       235 ~~li~~~l~~~p~~Rps~  252 (279)
T 3fdn_A          235 RDLISRLLKHNPSQRPML  252 (279)
T ss_dssp             HHHHHHHCCSSGGGSCCH
T ss_pred             HHHHHHHhccChhhCCCH
Confidence            899999999999999986

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.3e-42  Score=313.57  Aligned_cols=240  Identities=25%  Similarity=0.393  Sum_probs=199.4

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CC-----CEEEEEEecCCC-chhHHHHHHHHHHHHhc-CCCCceeeEEEEecCCc
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DG-----MEVAVKVFDPQY-EGAFKSFDIECDVMKRI-CHRNLIKIISSYSNDDF  173 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  173 (346)
                      .++|.+.+.||+|+||.||+|... .+     ..||+|++.... ....+.+.+|+++++++ +||||+++++++...+.
T Consensus        45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  124 (333)
T 2i1m_A           45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP  124 (333)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence            456888899999999999999865 22     479999997553 33457788999999999 89999999999999999


Q ss_pred             eeEEEecCCCCChhhhhhhc-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCC
Q 039799          174 KALVLEYMPHGSLEKCLYLS-------------NYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM  240 (346)
Q Consensus       174 ~~lv~e~~~~gsL~~~l~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~  240 (346)
                      .++||||+++|+|.+++...             ...+++..++.++.+++.||+|||   +.+|+||||||+||+++.++
T Consensus       125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~  201 (333)
T 2i1m_A          125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGH  201 (333)
T ss_dssp             CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEEEGGG
T ss_pred             eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEECCCC
Confidence            99999999999999998643             235789999999999999999999   99999999999999999999


Q ss_pred             cEEEeeecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHH
Q 039799          241 VAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWV  319 (346)
Q Consensus       241 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~  319 (346)
                      .++|+|||+++...............+++.|+|||.+.+..++.++||||||+++|||+| |..||....... .....+
T Consensus       202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-~~~~~~  280 (333)
T 2i1m_A          202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS-KFYKLV  280 (333)
T ss_dssp             EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH-HHHHHH
T ss_pred             eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH-HHHHHH
Confidence            999999999987654333333334557889999999888889999999999999999999 999997643222 222333


Q ss_pred             hhh--------cCCChhhhhchhccCCccccccc
Q 039799          320 NDL--------LPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       320 ~~~--------~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ...        .+..+.+++.+||..||.+||++
T Consensus       281 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~  314 (333)
T 2i1m_A          281 KDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTF  314 (333)
T ss_dssp             HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             hcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCH
Confidence            222        23478899999999999999985

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-42  Score=305.52  Aligned_cols=237  Identities=24%  Similarity=0.380  Sum_probs=193.7

Q ss_pred             CCCCCcccccCceEEEEEEEc-CCC---EEEEEEecCCCc-hhHHHHHHHHHHHHhcCCCCceeeEEEEecCCce-eEEE
Q 039799          105 ANMPPLIGKGGFGSVYKAIIQ-DGM---EVAVKVFDPQYE-GAFKSFDIECDVMKRICHRNLIKIISSYSNDDFK-ALVL  178 (346)
Q Consensus       105 ~~~~~~lg~G~~g~vy~~~~~-~~~---~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~-~lv~  178 (346)
                      |...+.||+|+||+||+|.+. ++.   .+|+|++..... ...+.+.+|++++++++||||+++++++...+.. ++|+
T Consensus        23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~  102 (298)
T 3pls_A           23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL  102 (298)
T ss_dssp             EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred             EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence            556689999999999999854 233   799999875433 4457888999999999999999999999876655 8999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccc
Q 039799          179 EYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  258 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~  258 (346)
                      ||+.+++|.+++......+++..++.++.+++.||+|||   +.+++||||||+||+++.++.++|+|||+++.......
T Consensus       103 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  179 (298)
T 3pls_A          103 PYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY  179 (298)
T ss_dssp             CCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred             ecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence            999999999999876778899999999999999999999   99999999999999999999999999999987644321


Q ss_pred             --ccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHhhh--------cCCChh
Q 039799          259 --SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDL--------LPISVM  328 (346)
Q Consensus       259 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~--------~~~~~~  328 (346)
                        ........+++.|+|||...+..++.++||||||+++|||+||..|+..... .......+...        ++..+.
T Consensus       180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~  258 (298)
T 3pls_A          180 YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID-PFDLTHFLAQGRRLPQPEYCPDSLY  258 (298)
T ss_dssp             GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-GGGHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC-HHHHHHHhhcCCCCCCCccchHHHH
Confidence              1222344578899999999988999999999999999999996555433221 22233333222        334788


Q ss_pred             hhhchhccCCccccccc
Q 039799          329 EVVDANLLSQEDEHFTT  345 (346)
Q Consensus       329 ~~~d~~l~~~p~~R~~~  345 (346)
                      +++.+||..+|.+|||+
T Consensus       259 ~li~~~l~~~p~~Rps~  275 (298)
T 3pls_A          259 QVMQQCWEADPAVRPTF  275 (298)
T ss_dssp             HHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHccCChhhCcCH
Confidence            99999999999999986

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.1e-42  Score=304.73  Aligned_cols=233  Identities=25%  Similarity=0.384  Sum_probs=184.5

Q ss_pred             CCCCCCCCcccccCceEEEEEEEcCCCEEEEEEecCCC----chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEE
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQY----EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALV  177 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  177 (346)
                      ..+|.+.+.||+|+||.||+|.+. ++.+|+|++....    ....+.+.+|+++++.++||||+++++++...+..++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            357888899999999999999976 8899999986442    22346788999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC---eeecCCCCCceEECC--------CCcEEEee
Q 039799          178 LEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP---IIHCDLKPSNVLLDD--------NMVAHLSD  246 (346)
Q Consensus       178 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~---i~H~dik~~NIll~~--------~~~~~l~D  246 (346)
                      |||+++++|.+++.  ...+++..++.++.+++.||+|||   +.+   ++||||||+||+++.        ++.++|+|
T Consensus        85 ~e~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D  159 (271)
T 3dtc_A           85 MEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD  159 (271)
T ss_dssp             EECCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred             EEcCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence            99999999999885  446899999999999999999999   777   999999999999986        67899999


Q ss_pred             ecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH-------
Q 039799          247 FGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV-------  319 (346)
Q Consensus       247 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~-------  319 (346)
                      ||++.......    .....|++.|+|||...+..++.++||||||++++||++|+.||........ .....       
T Consensus       160 fg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~  234 (271)
T 3dtc_A          160 FGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV-AYGVAMNKLALP  234 (271)
T ss_dssp             CCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH-HHHHHTSCCCCC
T ss_pred             CCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHhhhcCCCCCC
Confidence            99998654322    2234689999999998888899999999999999999999999976322111 11111       


Q ss_pred             -hhhcCCChhhhhchhccCCccccccc
Q 039799          320 -NDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       320 -~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                       ...++..+.+++.+||..+|++||++
T Consensus       235 ~~~~~~~~~~~li~~~l~~~p~~Rps~  261 (271)
T 3dtc_A          235 IPSTCPEPFAKLMEDCWNPDPHSRPSF  261 (271)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCcccCHHHHHHHHHHhcCCcccCcCH
Confidence             12234478999999999999999986

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=3e-42  Score=307.74  Aligned_cols=233  Identities=27%  Similarity=0.411  Sum_probs=186.9

Q ss_pred             CCCCCCCcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecCC
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMP  182 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  182 (346)
                      ++|.+.+.||+|+||.||+|.+. ++.||+|++...  ...+.+.+|++++++++||||+++++++.  +..++||||++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~   82 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE   82 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence            46788899999999999999986 788999998653  34578899999999999999999999876  34789999999


Q ss_pred             CCChhhhhhhcCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCc-EEEeeecCCccCCccccc
Q 039799          183 HGSLEKCLYLSNY--ILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV-AHLSDFGMAKPLLEEDQS  259 (346)
Q Consensus       183 ~gsL~~~l~~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~-~~l~Dfg~~~~~~~~~~~  259 (346)
                      +++|.+++.....  .+++..++.++.++++||+|||.....+|+||||||+||+++.++. +||+|||++......   
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~---  159 (307)
T 2eva_A           83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---  159 (307)
T ss_dssp             TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred             CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence            9999999875542  4788999999999999999999322289999999999999998876 799999999865321   


Q ss_pred             cccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh--------hhcCCChhhhh
Q 039799          260 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN--------DLLPISVMEVV  331 (346)
Q Consensus       260 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~  331 (346)
                        .....||+.|+|||.+.+..++.++||||||+++|||+||+.||+............+.        ..++..+.+++
T Consensus       160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  237 (307)
T 2eva_A          160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLM  237 (307)
T ss_dssp             -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHHHHH
T ss_pred             --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHHHHH
Confidence              12345899999999999889999999999999999999999999764322211111111        22345788999


Q ss_pred             chhccCCccccccc
Q 039799          332 DANLLSQEDEHFTT  345 (346)
Q Consensus       332 d~~l~~~p~~R~~~  345 (346)
                      .+||..||++||++
T Consensus       238 ~~~l~~dp~~Rps~  251 (307)
T 2eva_A          238 TRCWSKDPSQRPSM  251 (307)
T ss_dssp             HHHTCSSGGGSCCH
T ss_pred             HHHhcCChhhCcCH
Confidence            99999999999985

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=5.4e-42  Score=306.85  Aligned_cols=236  Identities=27%  Similarity=0.353  Sum_probs=195.9

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEe
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLE  179 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  179 (346)
                      ..+.|.+.+.||+|+||.||+|... +|+.||+|++....  ..+.+.+|++++++++||||+++++++...+..++|||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  104 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME  104 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence            3467888999999999999999976 68999999997543  34678889999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccc
Q 039799          180 YMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  259 (346)
Q Consensus       180 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~  259 (346)
                      |+++++|.+++......+++..+..++.+++.||.|||   +.+++|+||+|+||+++.++.++|+|||++.......  
T Consensus       105 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~--  179 (314)
T 3com_A          105 YCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM--  179 (314)
T ss_dssp             CCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB--
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc--
Confidence            99999999998766778999999999999999999999   9999999999999999999999999999998664322  


Q ss_pred             cccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH----------hhhcCCChhh
Q 039799          260 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV----------NDLLPISVME  329 (346)
Q Consensus       260 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~----------~~~~~~~~~~  329 (346)
                      .......+++.|+|||.+.+..++.++||||||+++|||++|+.||.......  ....+          ...++..+.+
T Consensus       180 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~  257 (314)
T 3com_A          180 AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR--AIFMIPTNPPPTFRKPELWSDNFTD  257 (314)
T ss_dssp             SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHHSCCCCCSSGGGSCHHHHH
T ss_pred             cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHhcCCCcccCCcccCCHHHHH
Confidence            12234568999999999988889999999999999999999999997532111  01111          1223557899


Q ss_pred             hhchhccCCccccccc
Q 039799          330 VVDANLLSQEDEHFTT  345 (346)
Q Consensus       330 ~~d~~l~~~p~~R~~~  345 (346)
                      ++.+||..||.+||++
T Consensus       258 li~~~l~~dp~~Rpt~  273 (314)
T 3com_A          258 FVKQCLVKSPEQRATA  273 (314)
T ss_dssp             HHHHHTCSCTTTSCCH
T ss_pred             HHHHHccCChhhCcCH
Confidence            9999999999999985

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.8e-42  Score=328.52  Aligned_cols=235  Identities=26%  Similarity=0.379  Sum_probs=198.4

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecCC
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMP  182 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  182 (346)
                      +|.+.+.||+|+||.||+|.+. ++..||||++..... ..+.+.+|++++++++||||+++++++...+..++||||++
T Consensus       221 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~  299 (495)
T 1opk_A          221 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT  299 (495)
T ss_dssp             GEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccC
Confidence            3556678999999999999987 488999999976533 35789999999999999999999999999999999999999


Q ss_pred             CCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccc
Q 039799          183 HGSLEKCLYLSN-YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT  261 (346)
Q Consensus       183 ~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~  261 (346)
                      +|+|.+++.... ..+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...... ...
T Consensus       300 ~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~  375 (495)
T 1opk_A          300 YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT-YTA  375 (495)
T ss_dssp             TCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC-EEC
T ss_pred             CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceeccCCc-eee
Confidence            999999997643 56899999999999999999999   9999999999999999999999999999998764322 112


Q ss_pred             cccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHhhh--------cCCChhhhhc
Q 039799          262 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVNDL--------LPISVMEVVD  332 (346)
Q Consensus       262 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~--------~~~~~~~~~d  332 (346)
                      .....++..|+|||.+....++.++||||||+++|||+| |+.||......  ...+.+...        ++..+.+++.
T Consensus       376 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~  453 (495)
T 1opk_A          376 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYELLEKDYRMERPEGCPEKVYELMR  453 (495)
T ss_dssp             CTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             cCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence            233446788999999988889999999999999999999 99999764322  233333322        3447889999


Q ss_pred             hhccCCccccccc
Q 039799          333 ANLLSQEDEHFTT  345 (346)
Q Consensus       333 ~~l~~~p~~R~~~  345 (346)
                      +||..||++||+.
T Consensus       454 ~cl~~dP~~RPs~  466 (495)
T 1opk_A          454 ACWQWNPSDRPSF  466 (495)
T ss_dssp             HHTCSSGGGSCCH
T ss_pred             HHcCcChhHCcCH
Confidence            9999999999985

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=5.4e-42  Score=306.36  Aligned_cols=238  Identities=24%  Similarity=0.348  Sum_probs=187.7

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC---CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEE
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ---YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVL  178 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  178 (346)
                      .+|.+.+.||+|+||.||+|... +|+.||+|++...   .......+.+|++++++++||||+++++++...+..++||
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  111 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL  111 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence            46888899999999999999975 7899999998743   2345677889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCc
Q 039799          179 EYMPHGSLEKCLYL---SNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  255 (346)
Q Consensus       179 e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~  255 (346)
                      ||+++++|.+++..   ....+++..++.++.+++.||.|||   +.+++||||||+||+++.++.++|+|||++.....
T Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~  188 (310)
T 2wqm_A          112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  188 (310)
T ss_dssp             ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred             ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence            99999999998864   3456899999999999999999999   99999999999999999999999999999986543


Q ss_pred             cccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh---------hhcCCC
Q 039799          256 EDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN---------DLLPIS  326 (346)
Q Consensus       256 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~---------~~~~~~  326 (346)
                      ..  .......+++.|+|||.+.+..++.++||||||+++|||++|+.||.............+.         ..++..
T Consensus       189 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (310)
T 2wqm_A          189 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEE  266 (310)
T ss_dssp             ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHH
T ss_pred             CC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHH
Confidence            22  1123346899999999998889999999999999999999999999653222222222221         223447


Q ss_pred             hhhhhchhccCCccccccc
Q 039799          327 VMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       327 ~~~~~d~~l~~~p~~R~~~  345 (346)
                      +.+++.+||..||++||++
T Consensus       267 l~~li~~~l~~dp~~Rps~  285 (310)
T 2wqm_A          267 LRQLVNMCINPDPEKRPDV  285 (310)
T ss_dssp             HHHHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHHHcCCChhhCCCH
Confidence            8999999999999999985

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=4.9e-42  Score=305.82  Aligned_cols=233  Identities=24%  Similarity=0.322  Sum_probs=194.6

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecC
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYM  181 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  181 (346)
                      ++|.+.+.||+|+||.||++... +|+.||+|++........+.+.+|++++++++||||+++++++...+..++||||+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   88 (304)
T 2jam_A            9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV   88 (304)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence            45788899999999999999976 79999999998655445567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEE---CCCCcEEEeeecCCccCCcccc
Q 039799          182 PHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLEEDQ  258 (346)
Q Consensus       182 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll---~~~~~~~l~Dfg~~~~~~~~~~  258 (346)
                      ++++|.+++... ..+++..+..++.+++.||+|||   +.+++||||||+||++   ++++.++|+|||++......  
T Consensus        89 ~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~--  162 (304)
T 2jam_A           89 SGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG--  162 (304)
T ss_dssp             CSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB--
T ss_pred             CCccHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC--
Confidence            999999988643 45889999999999999999999   9999999999999999   78889999999999854321  


Q ss_pred             ccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh-----------hhcCCCh
Q 039799          259 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN-----------DLLPISV  327 (346)
Q Consensus       259 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~-----------~~~~~~~  327 (346)
                        ......|++.|+|||.+.+..++.++||||+|+++|||++|+.||......  .....+.           ..++..+
T Consensus       163 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~  238 (304)
T 2jam_A          163 --IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES--KLFEKIKEGYYEFESPFWDDISESA  238 (304)
T ss_dssp             --TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHCCCCCCTTTTTTSCHHH
T ss_pred             --ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHcCCCCCCccccccCCHHH
Confidence              123345899999999999989999999999999999999999999753211  1111111           2234578


Q ss_pred             hhhhchhccCCccccccc
Q 039799          328 MEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       328 ~~~~d~~l~~~p~~R~~~  345 (346)
                      .+++.+||..||++||++
T Consensus       239 ~~li~~~l~~dp~~Rps~  256 (304)
T 2jam_A          239 KDFICHLLEKDPNERYTC  256 (304)
T ss_dssp             HHHHHHHHCSSTTTSCCH
T ss_pred             HHHHHHHcCCChhHCcCH
Confidence            999999999999999986

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=4e-42  Score=319.66  Aligned_cols=235  Identities=26%  Similarity=0.338  Sum_probs=185.5

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC--------chhHHHHHHHHHHHHhcCCCCceeeEEEEecCC
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY--------EGAFKSFDIECDVMKRICHRNLIKIISSYSNDD  172 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  172 (346)
                      .++|.+.+.||+|+||.||+|... +++.||+|++....        ......+.+|++++++++||||+++++++.. +
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~  212 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E  212 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence            357889999999999999999876 68999999986431        1122357789999999999999999999865 4


Q ss_pred             ceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCC---CcEEEeeecC
Q 039799          173 FKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDN---MVAHLSDFGM  249 (346)
Q Consensus       173 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~---~~~~l~Dfg~  249 (346)
                      ..++||||+++++|.+++.. ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.+   +.+||+|||+
T Consensus       213 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~  288 (419)
T 3i6u_A          213 DYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGH  288 (419)
T ss_dssp             EEEEEEECCTTCBGGGGTSS-SCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred             ceEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEEeeccc
Confidence            57899999999999998763 456899999999999999999999   9999999999999999754   4599999999


Q ss_pred             CccCCccccccccccccCCcccccCCCCCC---CCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHH--------
Q 039799          250 AKPLLEEDQSLTQTQTLATIGYMAPEYGRE---GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRW--------  318 (346)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~--------  318 (346)
                      ++......   ......||+.|+|||++.+   ..++.++||||||+++|||+||+.||....... .....        
T Consensus       289 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~-~~~~~i~~~~~~~  364 (419)
T 3i6u_A          289 SKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV-SLKDQITSGKYNF  364 (419)
T ss_dssp             TTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC-CHHHHHHTTCCCC
T ss_pred             ceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH-HHHHHHhcCCCCC
Confidence            99764322   2234569999999998853   567889999999999999999999997633222 22222        


Q ss_pred             ---HhhhcCCChhhhhchhccCCccccccc
Q 039799          319 ---VNDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       319 ---~~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                         ....++..+.+++.+||..||++||++
T Consensus       365 ~~~~~~~~~~~~~~li~~~L~~dP~~Rps~  394 (419)
T 3i6u_A          365 IPEVWAEVSEKALDLVKKLLVVDPKARFTT  394 (419)
T ss_dssp             CHHHHTTSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred             CchhhcccCHHHHHHHHHHccCChhHCcCH
Confidence               122345688999999999999999986

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-42  Score=314.05  Aligned_cols=237  Identities=25%  Similarity=0.348  Sum_probs=190.8

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCc-----hhHHHHHHHHHHHHhcCCCCceeeEEEEecCCcee
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYE-----GAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKA  175 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  175 (346)
                      ..+|.+.+.||+|+||.||+|... +|+.||+|++.....     ...+.+.+|++++++++||||+++++++...+..+
T Consensus         9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   88 (346)
T 1ua2_A            9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS   88 (346)
T ss_dssp             ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred             hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence            467999999999999999999976 689999999864321     12346778999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCc
Q 039799          176 LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  255 (346)
Q Consensus       176 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~  255 (346)
                      +||||+++ +|.+++......+++..+..++.++++||+|||   +.+|+||||||+||+++.++.+||+|||+++.+..
T Consensus        89 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  164 (346)
T 1ua2_A           89 LVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS  164 (346)
T ss_dssp             EEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred             EEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEecccceeccC
Confidence            99999986 898888766677888999999999999999999   99999999999999999999999999999987643


Q ss_pred             cccccccccccCCcccccCCCCCCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHH----------------
Q 039799          256 EDQSLTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRW----------------  318 (346)
Q Consensus       256 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~----------------  318 (346)
                      ..  .......+|+.|+|||.+.+. .++.++||||||+++|||++|.+||......+ .+...                
T Consensus       165 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~  241 (346)
T 1ua2_A          165 PN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-QLTRIFETLGTPTEEQWPDMC  241 (346)
T ss_dssp             CC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCTTTSSSTT
T ss_pred             Cc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHcCCCChhhhhhhc
Confidence            22  223345689999999988654 47899999999999999999999986532111 11111                


Q ss_pred             ------------------HhhhcCCChhhhhchhccCCccccccc
Q 039799          319 ------------------VNDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       319 ------------------~~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                                        .....+..+.+++.+||..||++|||+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  286 (346)
T 1ua2_A          242 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITA  286 (346)
T ss_dssp             SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCH
T ss_pred             cCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCH
Confidence                              112233467899999999999999986

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=3.7e-42  Score=321.18  Aligned_cols=202  Identities=25%  Similarity=0.353  Sum_probs=168.6

Q ss_pred             CCCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC--CchhHHHHHHHHHHHHhcCCCCceeeEEEEecC-----
Q 039799          100 PLPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ--YEGAFKSFDIECDVMKRICHRNLIKIISSYSND-----  171 (346)
Q Consensus       100 ~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----  171 (346)
                      ...++|.+.+.||+|+||.||+|... +++.||||++...  .....+++.+|++++++++||||+++++++...     
T Consensus        23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  102 (432)
T 3n9x_A           23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF  102 (432)
T ss_dssp             CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred             eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcC
Confidence            34678999999999999999999976 6889999999753  234457888999999999999999999999766     


Q ss_pred             CceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCc
Q 039799          172 DFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAK  251 (346)
Q Consensus       172 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~  251 (346)
                      +..++||||++ ++|.+++.. ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus       103 ~~~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla~  177 (432)
T 3n9x_A          103 DELYIVLEIAD-SDLKKLFKT-PIFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLAR  177 (432)
T ss_dssp             CCEEEEEECCS-EEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             CeEEEEEecCC-cCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence            57899999986 599998863 456899999999999999999999   9999999999999999999999999999999


Q ss_pred             cCCccccc--------------------cccccccCCcccccCCCC-CCCCCCcchhHHHHHHHHHHHHcCCCCCC
Q 039799          252 PLLEEDQS--------------------LTQTQTLATIGYMAPEYG-REGRVSTNGDVYSFGIMLMEIFTRTKPTD  306 (346)
Q Consensus       252 ~~~~~~~~--------------------~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~s~G~il~elltg~~p~~  306 (346)
                      ........                    ...+..+||+.|+|||++ ....++.++||||+||++|||++|..|+.
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            76433211                    123456789999999974 56679999999999999999999766653

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=5.6e-42  Score=303.98  Aligned_cols=238  Identities=20%  Similarity=0.272  Sum_probs=199.2

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC---CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEE
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ---YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALV  177 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  177 (346)
                      ..+|.+.+.||+|+||.||++... +++.+|+|++...   .....+.+.+|+.++++++||||+++++++...+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            356888999999999999999977 6889999998643   234457788999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccc
Q 039799          178 LEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  257 (346)
Q Consensus       178 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~  257 (346)
                      |||+++++|.+++.. ...+++..+..++.++++||+|||   +.+++||||||+||+++.++.++|+|||++.......
T Consensus        94 ~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  169 (294)
T 2rku_A           94 LELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  169 (294)
T ss_dssp             EECCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence            999999999998754 346899999999999999999999   9999999999999999999999999999998754322


Q ss_pred             cccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh------hhcCCChhhhh
Q 039799          258 QSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN------DLLPISVMEVV  331 (346)
Q Consensus       258 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~------~~~~~~~~~~~  331 (346)
                        .......+++.|+|||...+..++.++||||||+++|||+||+.||......+ .......      ..++..+.+++
T Consensus       170 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li  246 (294)
T 2rku_A          170 --ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-TYLRIKKNEYSIPKHINPVAASLI  246 (294)
T ss_dssp             --CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHTTCCCCCTTSCHHHHHHH
T ss_pred             --cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHhhccCCCccccCHHHHHHH
Confidence              12234568999999999988889999999999999999999999997632211 1111111      12334678999


Q ss_pred             chhccCCcccccccC
Q 039799          332 DANLLSQEDEHFTTK  346 (346)
Q Consensus       332 d~~l~~~p~~R~~~k  346 (346)
                      .+||..||++||+++
T Consensus       247 ~~~l~~~p~~Rps~~  261 (294)
T 2rku_A          247 QKMLQTDPTARPTIN  261 (294)
T ss_dssp             HHHTCSSGGGSCCGG
T ss_pred             HHHcccChhhCcCHH
Confidence            999999999999863

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=6.2e-42  Score=305.95  Aligned_cols=236  Identities=23%  Similarity=0.294  Sum_probs=188.6

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEE
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALV  177 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  177 (346)
                      ..+|.+.+.||+|+||.||+|... +++.||+|++....   ....+.+.+|++++++++||||+++++++...+..++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            467999999999999999999976 78899999987542   23347788999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccc
Q 039799          178 LEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  257 (346)
Q Consensus       178 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~  257 (346)
                      |||+++++|.+++... ..+++..++.++.+++.||+|||   +.+|+||||||+||+++.++.++|+|||++.......
T Consensus       113 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  188 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEK  188 (309)
T ss_dssp             EECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred             EEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence            9999999999988643 46899999999999999999999   9999999999999999999999999999998654322


Q ss_pred             cccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHH----------HhhhcCCCh
Q 039799          258 QSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRW----------VNDLLPISV  327 (346)
Q Consensus       258 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~----------~~~~~~~~~  327 (346)
                      . .......+++.|+|||.+.+..++.++||||||+++|||+||+.||......  .....          ....++..+
T Consensus       189 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l  265 (309)
T 2h34_A          189 L-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--VMGAHINQAIPRPSTVRPGIPVAF  265 (309)
T ss_dssp             ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--HHHHHHHSCCCCGGGTSTTCCTHH
T ss_pred             c-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--HHHHHhccCCCCccccCCCCCHHH
Confidence            1 1223456899999999999889999999999999999999999999753211  11111          123355678


Q ss_pred             hhhhchhccCCcccccc
Q 039799          328 MEVVDANLLSQEDEHFT  344 (346)
Q Consensus       328 ~~~~d~~l~~~p~~R~~  344 (346)
                      .+++.+||..||++||+
T Consensus       266 ~~li~~~l~~dP~~Rp~  282 (309)
T 2h34_A          266 DAVIARGMAKNPEDRYV  282 (309)
T ss_dssp             HHHHHHHTCSSGGGSCS
T ss_pred             HHHHHHhccCCHHHHHH
Confidence            99999999999999994

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=5.5e-43  Score=315.21  Aligned_cols=240  Identities=25%  Similarity=0.345  Sum_probs=200.5

Q ss_pred             CCCCCCCcccccCceEEEEEEE-----cCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEe--cCCcee
Q 039799          103 NDANMPPLIGKGGFGSVYKAII-----QDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYS--NDDFKA  175 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~  175 (346)
                      ++|.+.+.||+|+||.||+|.+     .+++.||+|++........+.+.+|++++++++||||+++++++.  .....+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            5688899999999999999984     368899999998776666778999999999999999999999886  456788


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCc
Q 039799          176 LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  255 (346)
Q Consensus       176 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~  255 (346)
                      +||||+++++|.+++......+++..++.++.+++.||+|||   +.+|+||||||+||+++.++.++|+|||+++....
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~  179 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL  179 (327)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred             EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence            999999999999999876667999999999999999999999   99999999999999999999999999999987643


Q ss_pred             cccc-cccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccC---------cc----cHHHHHh-
Q 039799          256 EDQS-LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSG---------EM----TLKRWVN-  320 (346)
Q Consensus       256 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~---------~~----~~~~~~~-  320 (346)
                      .... .......++..|+|||.+.+..++.++||||||+++|||++|+.||......         ..    .....+. 
T Consensus       180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (327)
T 3lxl_A          180 DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEE  259 (327)
T ss_dssp             TCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHT
T ss_pred             CCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhc
Confidence            3221 2223345888899999998888999999999999999999999998642211         00    1111111 


Q ss_pred             -------hhcCCChhhhhchhccCCccccccc
Q 039799          321 -------DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       321 -------~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                             ..++..+.+++.+||..||++||++
T Consensus       260 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~  291 (327)
T 3lxl_A          260 GQRLPAPPACPAEVHELMKLCWAPSPQDRPSF  291 (327)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             ccCCCCCCcccHHHHHHHHHHcCCChhhCcCH
Confidence                   1234478999999999999999986

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=3.2e-42  Score=304.33  Aligned_cols=234  Identities=23%  Similarity=0.352  Sum_probs=191.2

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEec
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEY  180 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  180 (346)
                      +.|.+.+.||+|+||.||++... ++..+|+|++.... ....+.+.+|++++++++||||+++++++...+..++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            45888899999999999999976 68999999986543 33457888999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhc---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEE---CCCCcEEEeeecCCccCC
Q 039799          181 MPHGSLEKCLYLS---NYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLL  254 (346)
Q Consensus       181 ~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll---~~~~~~~l~Dfg~~~~~~  254 (346)
                      +++++|.+.+...   ...+++..+..++.+++.||+|||   +.+|+||||||+||++   +.++.++|+|||++....
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~  178 (285)
T 3is5_A          102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK  178 (285)
T ss_dssp             CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred             CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence            9999999988543   367999999999999999999999   9999999999999999   456789999999998654


Q ss_pred             ccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh----------hhcC
Q 039799          255 EEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN----------DLLP  324 (346)
Q Consensus       255 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~----------~~~~  324 (346)
                      ...   ......+++.|+|||.+. ..++.++||||||++++||++|+.||......+  ......          ..++
T Consensus       179 ~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~  252 (285)
T 3is5_A          179 SDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE--VQQKATYKEPNYAVECRPLT  252 (285)
T ss_dssp             -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHCCCCCCC--CCCC
T ss_pred             Ccc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH--HHhhhccCCcccccccCcCC
Confidence            322   223456899999999875 568999999999999999999999997532211  111111          1134


Q ss_pred             CChhhhhchhccCCccccccc
Q 039799          325 ISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       325 ~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      +.+.+++.+||..||++||++
T Consensus       253 ~~~~~li~~~L~~dP~~Rps~  273 (285)
T 3is5_A          253 PQAVDLLKQMLTKDPERRPSA  273 (285)
T ss_dssp             HHHHHHHHHHTCSCTTTSCCH
T ss_pred             HHHHHHHHHHccCChhhCcCH
Confidence            467899999999999999986

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.5e-42  Score=310.55  Aligned_cols=241  Identities=22%  Similarity=0.353  Sum_probs=198.4

Q ss_pred             CCCCCCCCcccccCceEEEEEEE------cCCCEEEEEEecCCCc-hhHHHHHHHHHHHHhc-CCCCceeeEEEEecCC-
Q 039799          102 PNDANMPPLIGKGGFGSVYKAII------QDGMEVAVKVFDPQYE-GAFKSFDIECDVMKRI-CHRNLIKIISSYSNDD-  172 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~-  172 (346)
                      .++|.+.+.||+|+||.||+|.+      .+++.||+|++..... ...+.+.+|++++.++ +||||+++++++...+ 
T Consensus        26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~  105 (316)
T 2xir_A           26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG  105 (316)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred             hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCC
Confidence            35688899999999999999984      2468899999976533 3456788999999999 7999999999987654 


Q ss_pred             ceeEEEecCCCCChhhhhhhcCCC---------------CCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEEC
Q 039799          173 FKALVLEYMPHGSLEKCLYLSNYI---------------LDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD  237 (346)
Q Consensus       173 ~~~lv~e~~~~gsL~~~l~~~~~~---------------l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~  237 (346)
                      ..++||||+++++|.+++......               +++..++.++.+++.||+|||   +.+|+||||||+||+++
T Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~  182 (316)
T 2xir_A          106 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLS  182 (316)
T ss_dssp             CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEC
T ss_pred             ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEEC
Confidence            589999999999999998754432               789999999999999999999   99999999999999999


Q ss_pred             CCCcEEEeeecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHH
Q 039799          238 DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLK  316 (346)
Q Consensus       238 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~  316 (346)
                      .++.++|+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||+| |+.||......+....
T Consensus       183 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~  262 (316)
T 2xir_A          183 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR  262 (316)
T ss_dssp             GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHH
T ss_pred             CCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHH
Confidence            999999999999987654433333344567889999999988889999999999999999998 9999976433222111


Q ss_pred             HHHh-------hhcCCChhhhhchhccCCccccccc
Q 039799          317 RWVN-------DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       317 ~~~~-------~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ....       ..++..+.+++.+||..||.+||++
T Consensus       263 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  298 (316)
T 2xir_A          263 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTF  298 (316)
T ss_dssp             HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCH
Confidence            1111       1234478999999999999999985

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-42  Score=304.82  Aligned_cols=237  Identities=21%  Similarity=0.358  Sum_probs=196.9

Q ss_pred             CCCCCCC-cccccCceEEEEEEEc---CCCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEE
Q 039799          103 NDANMPP-LIGKGGFGSVYKAIIQ---DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALV  177 (346)
Q Consensus       103 ~~~~~~~-~lg~G~~g~vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  177 (346)
                      ++|.+.. .||+|+||.||+|.+.   ++..||+|++.... ....+.+.+|++++++++||||+++++++ ..+..++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            3455555 8999999999999854   57889999997643 34567888999999999999999999999 45678999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccc
Q 039799          178 LEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  257 (346)
Q Consensus       178 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~  257 (346)
                      |||+++++|.+++......+++..++.++.+++.||+|||   +.+++||||||+||+++.++.++|+|||++.......
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~  164 (287)
T 1u59_A           88 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD  164 (287)
T ss_dssp             EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred             EEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeeccCc
Confidence            9999999999999766677999999999999999999999   9999999999999999999999999999998764332


Q ss_pred             cc-cccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHh--------hhcCCCh
Q 039799          258 QS-LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVN--------DLLPISV  327 (346)
Q Consensus       258 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~--------~~~~~~~  327 (346)
                      .. .......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||......  .....+.        ..++..+
T Consensus       165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~i~~~~~~~~~~~~~~~l  242 (287)
T 1u59_A          165 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAFIEQGKRMECPPECPPEL  242 (287)
T ss_dssp             CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHHHHHHTTCCCCCCTTCCHHH
T ss_pred             ceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--HHHHHHhcCCcCCCCCCcCHHH
Confidence            21 11223446889999999888889999999999999999999 99999763321  2222222        2334578


Q ss_pred             hhhhchhccCCccccccc
Q 039799          328 MEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       328 ~~~~d~~l~~~p~~R~~~  345 (346)
                      .+++.+||..+|++||++
T Consensus       243 ~~li~~~l~~~p~~Rps~  260 (287)
T 1u59_A          243 YALMSDCWIYKWEDRPDF  260 (287)
T ss_dssp             HHHHHHTTCSSGGGSCCH
T ss_pred             HHHHHHHcCCChhhCcCH
Confidence            999999999999999985

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.3e-42  Score=309.04  Aligned_cols=239  Identities=24%  Similarity=0.352  Sum_probs=195.3

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEe
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLE  179 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  179 (346)
                      ..+.|.+.+.||+|+||.||+|... +++.+|+|++........+.+.+|++++++++||||+++++++...+..++|||
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   96 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE   96 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence            3456888999999999999999987 689999999976655567888999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccc
Q 039799          180 YMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  259 (346)
Q Consensus       180 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~  259 (346)
                      |+++++|.+++......+++..+..++.+++.||.|||   +.+++||||||+||+++.++.++|+|||++......  .
T Consensus        97 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~  171 (302)
T 2j7t_A           97 FCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT--L  171 (302)
T ss_dssp             CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH--H
T ss_pred             eCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc--c
Confidence            99999999998776677999999999999999999999   999999999999999999999999999987643211  1


Q ss_pred             cccccccCCcccccCCCC-----CCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH---------hhhcCC
Q 039799          260 LTQTQTLATIGYMAPEYG-----REGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV---------NDLLPI  325 (346)
Q Consensus       260 ~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~---------~~~~~~  325 (346)
                      .......|++.|+|||.+     ....++.++||||||+++|||++|+.||....... ......         ...++.
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  250 (302)
T 2j7t_A          172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-VLLKIAKSDPPTLLTPSKWSV  250 (302)
T ss_dssp             HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSCCCCCSSGGGSCH
T ss_pred             cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH-HHHHHhccCCcccCCccccCH
Confidence            112334689999999987     46678999999999999999999999997632111 111111         123344


Q ss_pred             ChhhhhchhccCCccccccc
Q 039799          326 SVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       326 ~~~~~~d~~l~~~p~~R~~~  345 (346)
                      .+.+++.+||..||++|||+
T Consensus       251 ~l~~li~~~l~~dp~~Rps~  270 (302)
T 2j7t_A          251 EFRDFLKIALDKNPETRPSA  270 (302)
T ss_dssp             HHHHHHHHHSCSCTTTSCCH
T ss_pred             HHHHHHHHHcccChhhCCCH
Confidence            68899999999999999985

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=4e-42  Score=305.42  Aligned_cols=238  Identities=24%  Similarity=0.408  Sum_probs=193.1

Q ss_pred             CCCCCCCcccccCceEEEEEEEcC----CCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEe-cCCceeE
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQD----GMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYS-NDDFKAL  176 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~l  176 (346)
                      ..|.+.+.||+|+||.||+|.+.+    ...+|+|.+.... ....+.+.+|++++++++||||+++++++. ..+..++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            357888999999999999998642    2358999987543 344578889999999999999999999864 4567889


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcc
Q 039799          177 VLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  256 (346)
Q Consensus       177 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~  256 (346)
                      ||||+++++|.+++......+++..++.++.+++.||+|||   +.+++||||||+||+++.++.++|+|||+++.....
T Consensus       105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  181 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  181 (298)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred             EEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECccccccccccc
Confidence            99999999999999876777899999999999999999999   999999999999999999999999999999876543


Q ss_pred             cc--ccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHh--------hhcCC
Q 039799          257 DQ--SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVN--------DLLPI  325 (346)
Q Consensus       257 ~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~--------~~~~~  325 (346)
                      ..  ........+|+.|+|||...+..++.++||||+|+++|||++ |.+||......+  ....+.        ..++.
T Consensus       182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  259 (298)
T 3f66_A          182 EYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVYLLQGRRLLQPEYCPD  259 (298)
T ss_dssp             GGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT--HHHHHHTTCCCCCCTTCCH
T ss_pred             chhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH--HHHHHhcCCCCCCCccCCH
Confidence            22  122334457889999999988889999999999999999999 556665432222  222221        22344


Q ss_pred             ChhhhhchhccCCccccccc
Q 039799          326 SVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       326 ~~~~~~d~~l~~~p~~R~~~  345 (346)
                      .+.+++.+||..+|++||++
T Consensus       260 ~l~~li~~~l~~~p~~Rps~  279 (298)
T 3f66_A          260 PLYEVMLKCWHPKAEMRPSF  279 (298)
T ss_dssp             HHHHHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHHHHcCCChhhCcCH
Confidence            78999999999999999986

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.1e-41  Score=300.34  Aligned_cols=236  Identities=22%  Similarity=0.301  Sum_probs=195.1

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCc------hhHHHHHHHHHHHHhcCCCCceeeEEEEecCCcee
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYE------GAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKA  175 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  175 (346)
                      ++|.+.+.||+|+||.||+|... +++.+|+|++.....      ...+.+.+|++++++++||||+++++++...+..+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            35778899999999999999977 789999999865421      13578889999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCC----cEEEeeecCCc
Q 039799          176 LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM----VAHLSDFGMAK  251 (346)
Q Consensus       176 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~----~~~l~Dfg~~~  251 (346)
                      +||||+++++|.+++.. ...+++..+..++.+++.||+|||   +.+++||||||+||+++.++    .++|+|||++.
T Consensus        85 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~  160 (283)
T 3bhy_A           85 LILELVSGGELFDFLAE-KESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH  160 (283)
T ss_dssp             EEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             EEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence            99999999999999864 346899999999999999999999   99999999999999998877    89999999998


Q ss_pred             cCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcc---------cHHHHHhhh
Q 039799          252 PLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM---------TLKRWVNDL  322 (346)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~---------~~~~~~~~~  322 (346)
                      ......   ......+++.|+|||.+.+..++.++||||||+++|||++|+.||......+.         .........
T Consensus       161 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T 3bhy_A          161 KIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSN  237 (283)
T ss_dssp             ECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred             eccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhccc
Confidence            764322   12344689999999999888999999999999999999999999975321110         011111223


Q ss_pred             cCCChhhhhchhccCCccccccc
Q 039799          323 LPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       323 ~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      .+..+.+++.+||..||++||++
T Consensus       238 ~~~~~~~li~~~l~~dp~~Rps~  260 (283)
T 3bhy_A          238 TSELAKDFIRRLLVKDPKRRMTI  260 (283)
T ss_dssp             CCHHHHHHHHTTSCSSGGGSCCH
T ss_pred             CCHHHHHHHHHHccCCHhHCcCH
Confidence            45578999999999999999985

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-42  Score=317.63  Aligned_cols=237  Identities=24%  Similarity=0.415  Sum_probs=185.6

Q ss_pred             CCCCCCcccccCceEEEEEEEc--CC--CEEEEEEecCC-CchhHHHHHHHHHHHHhcCCCCceeeEEEEec-CCceeEE
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQ--DG--MEVAVKVFDPQ-YEGAFKSFDIECDVMKRICHRNLIKIISSYSN-DDFKALV  177 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~--~~--~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv  177 (346)
                      .|.+.+.||+|+||.||+|.+.  ++  ..||+|.+... .....+.+.+|+.++++++||||+++++++.. .+..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            3566789999999999999864  22  36899998654 33556789999999999999999999998754 4578899


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccc
Q 039799          178 LEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  257 (346)
Q Consensus       178 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~  257 (346)
                      |||+++|+|.+++......+++..++.++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++.+....
T Consensus       170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~  246 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  246 (373)
T ss_dssp             EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence            9999999999999877777899999999999999999999   9999999999999999999999999999998764332


Q ss_pred             cc--cccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHh--------hhcCCC
Q 039799          258 QS--LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVN--------DLLPIS  326 (346)
Q Consensus       258 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~--------~~~~~~  326 (346)
                      ..  .......+++.|+|||.+.+..++.++||||||+++|||+| |.+||......  .....+.        ..++..
T Consensus       247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~--~~~~~~~~~~~~~~p~~~~~~  324 (373)
T 3c1x_A          247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYLLQGRRLLQPEYCPDP  324 (373)
T ss_dssp             -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS--CHHHHHHTTCCCCCCTTCCHH
T ss_pred             cccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH--HHHHHHHcCCCCCCCCCCCHH
Confidence            11  12233457889999999988889999999999999999999 77788653322  2222222        223457


Q ss_pred             hhhhhchhccCCccccccc
Q 039799          327 VMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       327 ~~~~~d~~l~~~p~~R~~~  345 (346)
                      +.+++.+||..+|++||+.
T Consensus       325 l~~li~~cl~~dp~~RPs~  343 (373)
T 3c1x_A          325 LYEVMLKCWHPKAEMRPSF  343 (373)
T ss_dssp             HHHHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHHHcCCChhhCcCH
Confidence            8999999999999999985

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=5.5e-42  Score=309.24  Aligned_cols=237  Identities=24%  Similarity=0.288  Sum_probs=191.3

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEe
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLE  179 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  179 (346)
                      ++|.+.+.||+|+||.||+|... +|+.||+|++....  ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  104 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE  104 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence            46888899999999999999976 68999999986543  2335667889999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccc
Q 039799          180 YMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  259 (346)
Q Consensus       180 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~  259 (346)
                      |+++++|.++.. ....+++..+..++.+++.||+|||   +.+|+||||||+||+++.++.++|+|||+++......  
T Consensus       105 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--  178 (331)
T 4aaa_A          105 FVDHTILDDLEL-FPNGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--  178 (331)
T ss_dssp             CCSEEHHHHHHH-STTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred             cCCcchHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc--
Confidence            999999888654 3456899999999999999999999   9999999999999999999999999999998654322  


Q ss_pred             cccccccCCcccccCCCCCCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHH--------------------
Q 039799          260 LTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRW--------------------  318 (346)
Q Consensus       260 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~--------------------  318 (346)
                      .......+++.|+|||.+.+. .++.++||||+|+++|||++|+.||......+. ....                    
T Consensus       179 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  257 (331)
T 4aaa_A          179 EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ-LYHIMMCLGNLIPRHQELFNKNPV  257 (331)
T ss_dssp             -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred             cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCChhhhhHhhhccc
Confidence            122345689999999988765 689999999999999999999999965321110 0000                    


Q ss_pred             -----------------HhhhcCCChhhhhchhccCCcccccccC
Q 039799          319 -----------------VNDLLPISVMEVVDANLLSQEDEHFTTK  346 (346)
Q Consensus       319 -----------------~~~~~~~~~~~~~d~~l~~~p~~R~~~k  346 (346)
                                       ....++..+.+++.+||..||++|||++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~  302 (331)
T 4aaa_A          258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCA  302 (331)
T ss_dssp             GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGG
T ss_pred             cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHH
Confidence                             0112345788999999999999999863

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.2e-42  Score=326.19  Aligned_cols=233  Identities=27%  Similarity=0.423  Sum_probs=190.1

Q ss_pred             CCCCCcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecCCCC
Q 039799          105 ANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHG  184 (346)
Q Consensus       105 ~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  184 (346)
                      |.+.+.||+|+||.||+|.++++..||||++..... ..+.+.+|++++++++||||+++++++.+ +..++||||+++|
T Consensus       186 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~g  263 (452)
T 1fmk_A          186 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKG  263 (452)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTC
T ss_pred             ceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCC
Confidence            556678999999999999999888899999976543 35678999999999999999999999876 6789999999999


Q ss_pred             Chhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccccc
Q 039799          185 SLEKCLYLS-NYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT  263 (346)
Q Consensus       185 sL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~~  263 (346)
                      +|.+++... ...+++..++.++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++...... .....
T Consensus       264 sL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~~~~~  339 (452)
T 1fmk_A          264 SLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQ  339 (452)
T ss_dssp             BHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC------------
T ss_pred             CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCCCc-eeccc
Confidence            999999753 356899999999999999999999   9999999999999999999999999999998764322 11222


Q ss_pred             cccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHhh--------hcCCChhhhhchh
Q 039799          264 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVND--------LLPISVMEVVDAN  334 (346)
Q Consensus       264 ~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~d~~  334 (346)
                      ...++..|+|||.+....++.++||||||+++|||+| |+.||......  .....+..        .++..+.+++.+|
T Consensus       340 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~--~~~~~i~~~~~~~~~~~~~~~l~~li~~c  417 (452)
T 1fmk_A          340 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EVLDQVERGYRMPCPPECPESLHDLMCQC  417 (452)
T ss_dssp             ---CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTTCCCCCCTTSCHHHHHHHHHH
T ss_pred             CCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCCCCCCCCCCHHHHHHHHHH
Confidence            3446789999999888889999999999999999999 99999764321  12222221        2344789999999


Q ss_pred             ccCCccccccc
Q 039799          335 LLSQEDEHFTT  345 (346)
Q Consensus       335 l~~~p~~R~~~  345 (346)
                      |..+|++|||.
T Consensus       418 l~~dP~~Rpt~  428 (452)
T 1fmk_A          418 WRKEPEERPTF  428 (452)
T ss_dssp             TCSSGGGSCCH
T ss_pred             ccCChhhCcCH
Confidence            99999999985

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=8.7e-42  Score=302.66  Aligned_cols=237  Identities=23%  Similarity=0.329  Sum_probs=192.7

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecCC
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMP  182 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  182 (346)
                      +|.....||+|+||.||+|... +++.||+|++........+.+.+|+.+++.++||||+++++++...+..++||||++
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  102 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP  102 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence            3455569999999999999965 788999999987666666788999999999999999999999999999999999999


Q ss_pred             CCChhhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC-CCcEEEeeecCCccCCccccc
Q 039799          183 HGSLEKCLYLSN--YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD-NMVAHLSDFGMAKPLLEEDQS  259 (346)
Q Consensus       183 ~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~-~~~~~l~Dfg~~~~~~~~~~~  259 (346)
                      +++|.+++....  ..+++..+..++.+++.||+|||   +.+++||||||+||+++. ++.++|+|||++.......  
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~--  177 (295)
T 2clq_A          103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN--  177 (295)
T ss_dssp             EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred             CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC--
Confidence            999999987553  35678889999999999999999   999999999999999987 8999999999998764322  


Q ss_pred             cccccccCCcccccCCCCCCCC--CCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH--------hhhcCCChhh
Q 039799          260 LTQTQTLATIGYMAPEYGREGR--VSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV--------NDLLPISVME  329 (346)
Q Consensus       260 ~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~  329 (346)
                      .......|++.|+|||.+.+..  ++.++||||||+++|||++|+.||..............        ...++..+.+
T Consensus       178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (295)
T 2clq_A          178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKA  257 (295)
T ss_dssp             ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHH
T ss_pred             CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHH
Confidence            1223456899999999876543  78999999999999999999999975322211111111        1223447789


Q ss_pred             hhchhccCCccccccc
Q 039799          330 VVDANLLSQEDEHFTT  345 (346)
Q Consensus       330 ~~d~~l~~~p~~R~~~  345 (346)
                      ++.+||..||++||++
T Consensus       258 li~~~l~~dp~~Rps~  273 (295)
T 2clq_A          258 FILKCFEPDPDKRACA  273 (295)
T ss_dssp             HHHHTTCSSTTTSCCH
T ss_pred             HHHHHccCChhhCCCH
Confidence            9999999999999985

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2.5e-42  Score=307.25  Aligned_cols=239  Identities=24%  Similarity=0.407  Sum_probs=195.5

Q ss_pred             CCCCCCcccccCceEEEEEEE-----cCCCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecC--Ccee
Q 039799          104 DANMPPLIGKGGFGSVYKAII-----QDGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSND--DFKA  175 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~  175 (346)
                      .|.+.+.||+|+||.||+|.+     .+++.||+|++.... ....+.+.+|++++++++||||+++++++...  ...+
T Consensus        22 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  101 (302)
T 4e5w_A           22 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK  101 (302)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEE
T ss_pred             hhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEE
Confidence            477788999999999999984     368899999997543 23457788999999999999999999999876  6789


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCc
Q 039799          176 LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  255 (346)
Q Consensus       176 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~  255 (346)
                      +||||+++++|.+++......+++..++.++.+++.||+|||   +.+|+||||||+||+++.++.++|+|||++.....
T Consensus       102 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  178 (302)
T 4e5w_A          102 LIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET  178 (302)
T ss_dssp             EEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred             EEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECcccccccccC
Confidence            999999999999999777777999999999999999999999   99999999999999999999999999999987654


Q ss_pred             cccc-cccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccc----------cCcccHHHHHh----
Q 039799          256 EDQS-LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIF----------SGEMTLKRWVN----  320 (346)
Q Consensus       256 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~----------~~~~~~~~~~~----  320 (346)
                      .... .......+|..|+|||.+.+..++.++||||+|+++|||+||..|+....          ...........    
T Consensus       179 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (302)
T 4e5w_A          179 DKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKE  258 (302)
T ss_dssp             TCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHT
T ss_pred             CCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhc
Confidence            3321 22334558888999999988889999999999999999999999875421          11111111111    


Q ss_pred             -------hhcCCChhhhhchhccCCccccccc
Q 039799          321 -------DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       321 -------~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                             ..++..+.+++.+||..||.+|||+
T Consensus       259 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  290 (302)
T 4e5w_A          259 GKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSF  290 (302)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCH
T ss_pred             cCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCH
Confidence                   1234478999999999999999986

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.2e-42  Score=317.10  Aligned_cols=206  Identities=25%  Similarity=0.350  Sum_probs=179.8

Q ss_pred             HHhcCCCCCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecC
Q 039799           94 YQKRGKPLPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSND  171 (346)
Q Consensus        94 ~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  171 (346)
                      ..+......++|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++...
T Consensus        24 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  103 (360)
T 3eqc_A           24 KQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD  103 (360)
T ss_dssp             HHTCCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET
T ss_pred             hhcccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC
Confidence            34455566778999999999999999999977 78999999997653 34457788999999999999999999999999


Q ss_pred             CceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeeecCCCCCceEECCCCcEEEeeecCC
Q 039799          172 DFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSA-PIIHCDLKPSNVLLDDNMVAHLSDFGMA  250 (346)
Q Consensus       172 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~i~H~dik~~NIll~~~~~~~l~Dfg~~  250 (346)
                      +..++||||+++++|.+++... ..+++..+..++.+++.||+|||   +. +|+||||||+||+++.++.++|+|||++
T Consensus       104 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  179 (360)
T 3eqc_A          104 GEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS  179 (360)
T ss_dssp             TEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCC
T ss_pred             CEEEEEEECCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCC
Confidence            9999999999999999998644 45889999999999999999999   75 8999999999999999999999999999


Q ss_pred             ccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 039799          251 KPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDE  307 (346)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~  307 (346)
                      ......    ......||+.|+|||.+.+..++.++||||||+++|||+||+.||..
T Consensus       180 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  232 (360)
T 3eqc_A          180 GQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP  232 (360)
T ss_dssp             HHHHHH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred             cccccc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            755321    12345689999999999988999999999999999999999999965

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=3.8e-42  Score=323.39  Aligned_cols=195  Identities=26%  Similarity=0.293  Sum_probs=163.8

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC--CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCC------c
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ--YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDD------F  173 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~  173 (346)
                      ++|.+.+.||+|+||.||+|... +++.||||++...  .....+++.+|+++++.++||||+++++++....      .
T Consensus        62 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~  141 (464)
T 3ttj_A           62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD  141 (464)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCe
Confidence            56888899999999999999866 6899999999754  3344677889999999999999999999996543      5


Q ss_pred             eeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccC
Q 039799          174 KALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  253 (346)
Q Consensus       174 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~  253 (346)
                      .++||||++++ +.+.+.   ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       142 ~~lv~E~~~~~-l~~~~~---~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~  214 (464)
T 3ttj_A          142 VYLVMELMDAN-LCQVIQ---MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (464)
T ss_dssp             EEEEEECCSEE-HHHHHT---SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred             EEEEEeCCCCC-HHHHHh---hcCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence            69999999765 555443   34889999999999999999999   999999999999999999999999999999865


Q ss_pred             CccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 039799          254 LEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDE  307 (346)
Q Consensus       254 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~  307 (346)
                      ...   .......||+.|+|||++.+..++.++||||+||+++||++|+.||..
T Consensus       215 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g  265 (464)
T 3ttj_A          215 GTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG  265 (464)
T ss_dssp             --C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCC
Confidence            332   223445799999999999999999999999999999999999999965

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.1e-42  Score=311.68  Aligned_cols=237  Identities=25%  Similarity=0.319  Sum_probs=186.4

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCc--hhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEE
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYE--GAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVL  178 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  178 (346)
                      .++|.+.+.||+|+||+||+|... +++.||+|++.....  ...+.+.+|++++++++||||+++++++...+..++||
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  112 (329)
T 3gbz_A           33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF  112 (329)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence            357899999999999999999865 789999999975432  23456778999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEE-----CCCCcEEEeeecCCccC
Q 039799          179 EYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL-----DDNMVAHLSDFGMAKPL  253 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll-----~~~~~~~l~Dfg~~~~~  253 (346)
                      ||+++ +|.+++... ..+++..+..++.+++.||+|||   +.+|+||||||+|||+     ++++.++|+|||+++..
T Consensus       113 e~~~~-~L~~~~~~~-~~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~  187 (329)
T 3gbz_A          113 EYAEN-DLKKYMDKN-PDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF  187 (329)
T ss_dssp             ECCSE-EHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred             ecCCC-CHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence            99975 999988644 45899999999999999999999   9999999999999999     45556999999999865


Q ss_pred             CccccccccccccCCcccccCCCCCCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccCc--------------------
Q 039799          254 LEEDQSLTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE--------------------  312 (346)
Q Consensus       254 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~--------------------  312 (346)
                      ....  .......+|+.|+|||.+.+. .++.++||||||+++|||++|+.||......+                    
T Consensus       188 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (329)
T 3gbz_A          188 GIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGV  265 (329)
T ss_dssp             C-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred             CCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhh
Confidence            3221  222345689999999988764 48999999999999999999999996522111                    


Q ss_pred             ---------------ccHHHHHhhhcCCChhhhhchhccCCccccccc
Q 039799          313 ---------------MTLKRWVNDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       313 ---------------~~~~~~~~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                                     ..+.......++..+.+++.+||..||++|||+
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  313 (329)
T 3gbz_A          266 TALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISA  313 (329)
T ss_dssp             GGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             hhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCH
Confidence                           111222233355677899999999999999986

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.1e-41  Score=320.46  Aligned_cols=197  Identities=25%  Similarity=0.376  Sum_probs=155.6

Q ss_pred             CCCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEec-----C
Q 039799          100 PLPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSN-----D  171 (346)
Q Consensus       100 ~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-----~  171 (346)
                      ...++|.+.+.||+|+||.||+|... +++.||||++....  ....+++.+|++++++++||||+++++++..     .
T Consensus        50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  129 (458)
T 3rp9_A           50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKF  129 (458)
T ss_dssp             CSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred             ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccC
Confidence            34578999999999999999999866 78999999986532  3345788899999999999999999999843     3


Q ss_pred             CceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCc
Q 039799          172 DFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAK  251 (346)
Q Consensus       172 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~  251 (346)
                      ...++||||+ +++|.+++. ....+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus       130 ~~~~lv~e~~-~~~L~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  204 (458)
T 3rp9_A          130 DELYVVLEIA-DSDFKKLFR-TPVYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLAR  204 (458)
T ss_dssp             CCEEEEECCC-SEEHHHHHH-SSCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             ceEEEEEecc-ccchhhhcc-cCCCCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccch
Confidence            5789999998 568988875 3456899999999999999999999   9999999999999999999999999999999


Q ss_pred             cCCccccc-------------------------cccccccCCcccccCCCC-CCCCCCcchhHHHHHHHHHHHHcC
Q 039799          252 PLLEEDQS-------------------------LTQTQTLATIGYMAPEYG-REGRVSTNGDVYSFGIMLMEIFTR  301 (346)
Q Consensus       252 ~~~~~~~~-------------------------~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~s~G~il~elltg  301 (346)
                      ........                         ...+..+||+.|+|||++ ....++.++|||||||++|||+||
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            76432111                         123345689999999975 566799999999999999999994

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.2e-42  Score=309.12  Aligned_cols=240  Identities=26%  Similarity=0.446  Sum_probs=192.7

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEcC-----CCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCce
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQD-----GMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFK  174 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  174 (346)
                      ....|...+.||+|+||.||+|.+..     +..||+|++.... ......+.+|++++++++||||+++++++...+..
T Consensus        42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  121 (333)
T 1mqb_A           42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM  121 (333)
T ss_dssp             CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence            34567788999999999999998653     2359999997543 33456788999999999999999999999999999


Q ss_pred             eEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCC
Q 039799          175 ALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  254 (346)
Q Consensus       175 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~  254 (346)
                      ++||||+++++|.+++......+++..++.++.+++.||+|||   +.+|+||||||+||+++.++.++|+|||+++...
T Consensus       122 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  198 (333)
T 1mqb_A          122 MIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  198 (333)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence            9999999999999999877778999999999999999999999   9999999999999999999999999999998764


Q ss_pred             cccc-ccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHhh--------hcC
Q 039799          255 EEDQ-SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVND--------LLP  324 (346)
Q Consensus       255 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~--------~~~  324 (346)
                      .... ........++..|+|||.+.+..++.++||||||+++|||+| |+.||......  .....+..        .++
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~  276 (333)
T 1mqb_A          199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--EVMKAINDGFRLPTPMDCP  276 (333)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTTCCCCCCTTCB
T ss_pred             cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH--HHHHHHHCCCcCCCcccCC
Confidence            3321 111223346788999999988889999999999999999999 99999653221  12222221        233


Q ss_pred             CChhhhhchhccCCccccccc
Q 039799          325 ISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       325 ~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ..+.+++.+||..+|++||+.
T Consensus       277 ~~l~~li~~~l~~~p~~Rps~  297 (333)
T 1mqb_A          277 SAIYQLMMQCWQQERARRPKF  297 (333)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCH
T ss_pred             HHHHHHHHHHcCCChhhCcCH
Confidence            478899999999999999985

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.7e-43  Score=323.42  Aligned_cols=232  Identities=17%  Similarity=0.214  Sum_probs=184.7

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecC---CCchhHHHHHHHH---HHHHhcCCCCceeeE-------EE
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDP---QYEGAFKSFDIEC---DVMKRICHRNLIKII-------SS  167 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~e~---~~l~~l~h~niv~~~-------~~  167 (346)
                      .++|.+.+.||+|+||.||+|... +|+.||||++..   ......+.+.+|+   +.+++++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            356888899999999999999964 799999999863   2344567888999   555666899999988       66


Q ss_pred             EecCC-----------------ceeEEEecCCCCChhhhhhhcCC------CCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 039799          168 YSNDD-----------------FKALVLEYMPHGSLEKCLYLSNY------ILDIFQRLDIMIDVASALEYLHFGYSAPI  224 (346)
Q Consensus       168 ~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~------~l~~~~~~~i~~~i~~~l~~LH~~~~~~i  224 (346)
                      +...+                 ..++||||+ +|+|.+++.....      .+++..++.++.|++.||+|||   +.+|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCe
Confidence            66553                 278999999 6899999875432      2336888899999999999999   9999


Q ss_pred             eecCCCCCceEECCCCcEEEeeecCCccCCccccccccccccCCcccccCCCCCCC-----------CCCcchhHHHHHH
Q 039799          225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREG-----------RVSTNGDVYSFGI  293 (346)
Q Consensus       225 ~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~~Dv~s~G~  293 (346)
                      +||||||+|||++.++.+||+|||+++....     ......| +.|+|||++.+.           .++.++||||||+
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~  301 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL  301 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence            9999999999999999999999999985322     2234457 999999998877           7899999999999


Q ss_pred             HHHHHHcCCCCCCccccCcccHHHHHh---hhcCCChhhhhchhccCCccccccc
Q 039799          294 MLMEIFTRTKPTDEIFSGEMTLKRWVN---DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       294 il~elltg~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ++|||+||+.||........  ...+.   ..++..+.+++.+||..||++||++
T Consensus       302 il~elltg~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~  354 (377)
T 3byv_A          302 VIYWIWCADLPITKDAALGG--SEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLP  354 (377)
T ss_dssp             HHHHHHHSSCCC------CC--SGGGGSSCCCCCHHHHHHHHHHTCSSGGGCCCH
T ss_pred             HHHHHHHCCCCCcccccccc--hhhhhhhccCCCHHHHHHHHHHcCCCchhCCCH
Confidence            99999999999976332211  11111   3456688999999999999999985

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=7.2e-42  Score=308.96  Aligned_cols=237  Identities=20%  Similarity=0.272  Sum_probs=198.8

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC---CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEE
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ---YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALV  177 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  177 (346)
                      ..+|.+.+.||+|+||.||++... +++.+|+|++...   .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            346888999999999999999976 6889999998643   234567788999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccc
Q 039799          178 LEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  257 (346)
Q Consensus       178 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~  257 (346)
                      |||+++++|.+++.. ...+++..++.++.+++.||+|||   +.+|+||||||+||+++.++.++|+|||++.......
T Consensus       120 ~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  195 (335)
T 2owb_A          120 LELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  195 (335)
T ss_dssp             ECCCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EecCCCCCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence            999999999998764 356899999999999999999999   9999999999999999999999999999998764322


Q ss_pred             cccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh------hhcCCChhhhh
Q 039799          258 QSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN------DLLPISVMEVV  331 (346)
Q Consensus       258 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~------~~~~~~~~~~~  331 (346)
                        .......|+..|+|||.+.+..++.++||||||+++|||++|+.||......+ .......      ..++..+.+++
T Consensus       196 --~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li  272 (335)
T 2owb_A          196 --ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-TYLRIKKNEYSIPKHINPVAASLI  272 (335)
T ss_dssp             --CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHTCCCCCTTSCHHHHHHH
T ss_pred             --ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH-HHHHHhcCCCCCCccCCHHHHHHH
Confidence              12234568999999999988889999999999999999999999997532111 1111111      12334678999


Q ss_pred             chhccCCccccccc
Q 039799          332 DANLLSQEDEHFTT  345 (346)
Q Consensus       332 d~~l~~~p~~R~~~  345 (346)
                      .+||..||++||++
T Consensus       273 ~~~l~~dp~~Rps~  286 (335)
T 2owb_A          273 QKMLQTDPTARPTI  286 (335)
T ss_dssp             HHHTCSSGGGSCCG
T ss_pred             HHHccCChhHCcCH
Confidence            99999999999986

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2.3e-42  Score=310.35  Aligned_cols=238  Identities=23%  Similarity=0.395  Sum_probs=197.6

Q ss_pred             CCCCCCCcccccCceEEEEEEEc------CCCEEEEEEecCCCc-hhHHHHHHHHHHHHhcCCCCceeeEEEEecCCcee
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ------DGMEVAVKVFDPQYE-GAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKA  175 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  175 (346)
                      ++|.+.+.||+|+||.||+|.+.      +++.||+|++..... .....+.+|++++++++||||+++++++...+..+
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~  104 (322)
T 1p4o_A           25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL  104 (322)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred             hheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccE
Confidence            56788899999999999999854      367899999975432 34567889999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhhhcC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEee
Q 039799          176 LVLEYMPHGSLEKCLYLSN---------YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSD  246 (346)
Q Consensus       176 lv~e~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~D  246 (346)
                      +||||+++++|.+++....         ..+++..++.++.+++.||+|||   +.+|+||||||+||+++.++.++|+|
T Consensus       105 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli~~~~~~kl~D  181 (322)
T 1p4o_A          105 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGD  181 (322)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEECC
T ss_pred             EEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEEcCCCeEEECc
Confidence            9999999999999986432         35689999999999999999999   99999999999999999999999999


Q ss_pred             ecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHh-----
Q 039799          247 FGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVN-----  320 (346)
Q Consensus       247 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~-----  320 (346)
                      ||+++...............+++.|+|||.+.+..++.++||||||+++|||+| |+.||......  .....+.     
T Consensus       182 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~~~~~~~  259 (322)
T 1p4o_A          182 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE--QVLRFVMEGGLL  259 (322)
T ss_dssp             TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH--HHHHHHHTTCCC
T ss_pred             CccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH--HHHHHHHcCCcC
Confidence            999987644332222334457889999999888889999999999999999999 89998753211  1222221     


Q ss_pred             ---hhcCCChhhhhchhccCCccccccc
Q 039799          321 ---DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       321 ---~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                         ..++..+.+++.+||..+|.+||++
T Consensus       260 ~~~~~~~~~l~~li~~~l~~dp~~Rps~  287 (322)
T 1p4o_A          260 DKPDNCPDMLFELMRMCWQYNPKMRPSF  287 (322)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCCCCCCHHHHHHHHHHcCCCcccCcCH
Confidence               2234468899999999999999986

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=4.9e-42  Score=307.03  Aligned_cols=238  Identities=23%  Similarity=0.356  Sum_probs=184.8

Q ss_pred             CCCCCCCcccccCceEEEEEEEc----CCCEEEEEEecCC--CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCC----
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ----DGMEVAVKVFDPQ--YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDD----  172 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----  172 (346)
                      ++|.+.+.||+|+||.||+|...    .+..||+|++...  .....+.+.+|++++++++||||+++++++...+    
T Consensus        34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  113 (313)
T 3brb_A           34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGI  113 (313)
T ss_dssp             GGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC------
T ss_pred             HHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCC
Confidence            45788889999999999999865    3457999998754  2344577889999999999999999999997755    


Q ss_pred             -ceeEEEecCCCCChhhhhhh-----cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEee
Q 039799          173 -FKALVLEYMPHGSLEKCLYL-----SNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSD  246 (346)
Q Consensus       173 -~~~lv~e~~~~gsL~~~l~~-----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~D  246 (346)
                       ..++||||+++++|.+++..     ....+++..++.++.++++||.|||   +.+|+||||||+||+++.++.++|+|
T Consensus       114 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kl~D  190 (313)
T 3brb_A          114 PKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTVCVAD  190 (313)
T ss_dssp             -CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSCEEECS
T ss_pred             cccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEEee
Confidence             35899999999999998843     3356899999999999999999999   99999999999999999999999999


Q ss_pred             ecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHh-----
Q 039799          247 FGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVN-----  320 (346)
Q Consensus       247 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~-----  320 (346)
                      ||+++...............+++.|+|||...+..++.++||||||+++|||++ |..||......  .....+.     
T Consensus       191 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~~~~~~~  268 (313)
T 3brb_A          191 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH--EMYDYLLHGHRL  268 (313)
T ss_dssp             CSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHHHHTTCCC
T ss_pred             cCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH--HHHHHHHcCCCC
Confidence            999987654332233334457889999999988889999999999999999999 89998763322  2222221     


Q ss_pred             ---hhcCCChhhhhchhccCCccccccc
Q 039799          321 ---DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       321 ---~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                         ..++..+.+++.+||..+|++||++
T Consensus       269 ~~~~~~~~~l~~li~~~l~~dp~~Rps~  296 (313)
T 3brb_A          269 KQPEDCLDELYEIMYSCWRTDPLDRPTF  296 (313)
T ss_dssp             CCBTTCCHHHHHHHHHTTCSSGGGSCCH
T ss_pred             CCCccccHHHHHHHHHHcCCChhhCcCH
Confidence               1234478999999999999999985

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=9.1e-42  Score=302.58  Aligned_cols=239  Identities=22%  Similarity=0.266  Sum_probs=194.0

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEE-ecCCceeEEE
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSY-SNDDFKALVL  178 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~lv~  178 (346)
                      ..++|.+.+.||+|+||.||+|... +++.||+|++.....  ...+.+|+++++.++|++++..+..+ ...+..++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            4567999999999999999999964 789999998754322  24577899999999998888777655 6677889999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEE---CCCCcEEEeeecCCccCCc
Q 039799          179 EYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLE  255 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll---~~~~~~~l~Dfg~~~~~~~  255 (346)
                      ||+ +++|.+++......+++..+..++.+++.||+|||   +.+|+||||||+|||+   ++++.+||+|||+++....
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~  160 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  160 (296)
T ss_dssp             ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence            999 99999999866777999999999999999999999   9999999999999999   7889999999999987654


Q ss_pred             cccc-----cccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCc--ccHHHHH---------
Q 039799          256 EDQS-----LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE--MTLKRWV---------  319 (346)
Q Consensus       256 ~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~--~~~~~~~---------  319 (346)
                      ....     .......||+.|+|||...+..++.++||||||+++|||++|+.||.......  .......         
T Consensus       161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  240 (296)
T 4hgt_A          161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE  240 (296)
T ss_dssp             TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred             cccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhh
Confidence            3221     12234568999999999999899999999999999999999999997643221  1111111         


Q ss_pred             --hhhcCCChhhhhchhccCCccccccc
Q 039799          320 --NDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       320 --~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                        ...++..+.+++.+||..+|++||++
T Consensus       241 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~  268 (296)
T 4hgt_A          241 VLCKGYPSEFATYLNFCRSLRFDDKPDY  268 (296)
T ss_dssp             HHTTTSCHHHHHHHHHHHTSCTTCCCCH
T ss_pred             hhhccCCHHHHHHHHHHHhcCCCCCCCH
Confidence              13346688999999999999999985

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=4.3e-42  Score=303.70  Aligned_cols=238  Identities=26%  Similarity=0.371  Sum_probs=201.1

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEe
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLE  179 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  179 (346)
                      ..++|.+.+.||+|+||.||+|.+. ++..||+|++.... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   89 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   89 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence            3456888889999999999999987 58899999997653 346788899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccc
Q 039799          180 YMPHGSLEKCLYLSN-YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  258 (346)
Q Consensus       180 ~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~  258 (346)
                      |+++++|.+++.... ..+++..++.++.+++.||+|||   +.+++||||||+||+++.++.++|+|||++........
T Consensus        90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  166 (288)
T 3kfa_A           90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  166 (288)
T ss_dssp             CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS
T ss_pred             cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceeccCCcc
Confidence            999999999987643 56899999999999999999999   99999999999999999999999999999987643321


Q ss_pred             ccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHhh--------hcCCChhh
Q 039799          259 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVND--------LLPISVME  329 (346)
Q Consensus       259 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~  329 (346)
                       .......+++.|+|||...+..++.++||||||+++|||++ |..||......  .....+..        .++..+.+
T Consensus       167 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~  243 (288)
T 3kfa_A          167 -TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYELLEKDYRMERPEGCPEKVYE  243 (288)
T ss_dssp             -EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             -ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHhccCCCCCCCCCCHHHHH
Confidence             22233456888999999988889999999999999999999 99999763222  22222222        23447889


Q ss_pred             hhchhccCCccccccc
Q 039799          330 VVDANLLSQEDEHFTT  345 (346)
Q Consensus       330 ~~d~~l~~~p~~R~~~  345 (346)
                      ++.+||..||.+||++
T Consensus       244 li~~~l~~dp~~Rps~  259 (288)
T 3kfa_A          244 LMRACWQWNPSDRPSF  259 (288)
T ss_dssp             HHHHHTCSSGGGSCCH
T ss_pred             HHHHHhCCChhhCcCH
Confidence            9999999999999986

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=6.5e-42  Score=302.06  Aligned_cols=235  Identities=25%  Similarity=0.364  Sum_probs=197.5

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEE
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALV  177 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  177 (346)
                      .++|.+.+.||+|++|.||+|... +++.||+|++....   ....+.+.+|++++++++||||+++++++...+..++|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            467888999999999999999976 67889999985421   22346788999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccc
Q 039799          178 LEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  257 (346)
Q Consensus       178 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~  257 (346)
                      |||+++++|.+++... ..+++..+..++.+++.||+|||   +.+++||||||+||+++.++.++|+|||++...... 
T Consensus        93 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~-  167 (284)
T 2vgo_A           93 LEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-  167 (284)
T ss_dssp             ECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-
T ss_pred             EEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCccc-
Confidence            9999999999988654 45899999999999999999999   999999999999999999999999999998765322 


Q ss_pred             cccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh------hhcCCChhhhh
Q 039799          258 QSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN------DLLPISVMEVV  331 (346)
Q Consensus       258 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~------~~~~~~~~~~~  331 (346)
                         ......|++.|+|||.+.+..++.++||||||+++|||++|+.||......+ .......      ..++..+.+++
T Consensus       168 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li  243 (284)
T 2vgo_A          168 ---RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE-THRRIVNVDLKFPPFLSDGSKDLI  243 (284)
T ss_dssp             ---CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHTTCCCCCTTSCHHHHHHH
T ss_pred             ---ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH-HHHHHhccccCCCCcCCHHHHHHH
Confidence               1234568999999999998889999999999999999999999997532111 1111111      22345788999


Q ss_pred             chhccCCccccccc
Q 039799          332 DANLLSQEDEHFTT  345 (346)
Q Consensus       332 d~~l~~~p~~R~~~  345 (346)
                      .+||..||++||++
T Consensus       244 ~~~l~~~p~~Rps~  257 (284)
T 2vgo_A          244 SKLLRYHPPQRLPL  257 (284)
T ss_dssp             HHHSCSSGGGSCCH
T ss_pred             HHHhhcCHhhCCCH
Confidence            99999999999985

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=6.5e-42  Score=335.12  Aligned_cols=237  Identities=22%  Similarity=0.270  Sum_probs=198.3

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC---CchhHHHHHHHHHHHHhc-CCCCceeeEEEEecCCceeE
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ---YEGAFKSFDIECDVMKRI-CHRNLIKIISSYSNDDFKAL  176 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  176 (346)
                      .++|.+.+.||+|+||.||+|... +++.||||++...   .....+.+..|.+++..+ +||+|+++++++...+..++
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l  419 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF  419 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence            356888889999999999999976 6889999998642   123346677899999987 79999999999999999999


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcc
Q 039799          177 VLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  256 (346)
Q Consensus       177 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~  256 (346)
                      ||||+++|+|.+++... ..+++..+..++.+++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus       420 V~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~  495 (674)
T 3pfq_A          420 VMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD  495 (674)
T ss_dssp             EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCT
T ss_pred             EEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeeccccC
Confidence            99999999999998754 46899999999999999999999   999999999999999999999999999999864322


Q ss_pred             ccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh------hhcCCChhhh
Q 039799          257 DQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN------DLLPISVMEV  330 (346)
Q Consensus       257 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~------~~~~~~~~~~  330 (346)
                      .  .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ .......      ..++..+.++
T Consensus       496 ~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~-~~~~i~~~~~~~p~~~s~~~~~l  572 (674)
T 3pfq_A          496 G--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-LFQSIMEHNVAYPKSMSKEAVAI  572 (674)
T ss_dssp             T--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHSSCCCCCTTSCHHHHHH
T ss_pred             C--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH-HHHHHHhCCCCCCccCCHHHHHH
Confidence            2  22345679999999999999999999999999999999999999997632111 1111111      2234478999


Q ss_pred             hchhccCCccccccc
Q 039799          331 VDANLLSQEDEHFTT  345 (346)
Q Consensus       331 ~d~~l~~~p~~R~~~  345 (346)
                      +.++|..||++|+++
T Consensus       573 i~~lL~~dP~~R~~~  587 (674)
T 3pfq_A          573 CKGLMTKHPGKRLGC  587 (674)
T ss_dssp             HHHHSCSSSTTCTTC
T ss_pred             HHHHccCCHHHCCCC
Confidence            999999999999985

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=6.7e-42  Score=301.51  Aligned_cols=237  Identities=23%  Similarity=0.362  Sum_probs=193.9

Q ss_pred             CCCCCCCCcccccCceEEEEEEEcC----CCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeE
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQD----GMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKAL  176 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  176 (346)
                      .++|.+.+.||+|+||.||+|.+..    +..||+|++.... ....+.+.+|++++++++||||+++++++.+. ..++
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~   89 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEE
Confidence            3568888999999999999998653    2359999987653 34567888999999999999999999998654 5689


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcc
Q 039799          177 VLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  256 (346)
Q Consensus       177 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~  256 (346)
                      ||||+++++|.+++......+++..++.++.+++.||+|||   +.+++||||||+||+++.++.++|+|||++......
T Consensus        90 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  166 (281)
T 3cc6_A           90 IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE  166 (281)
T ss_dssp             EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred             EEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence            99999999999999877777999999999999999999999   999999999999999999999999999999876432


Q ss_pred             ccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHh--------hhcCCCh
Q 039799          257 DQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVN--------DLLPISV  327 (346)
Q Consensus       257 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~--------~~~~~~~  327 (346)
                      .. .......+++.|+|||...+..++.++||||||+++|||+| |+.||......+  ....+.        ..++..+
T Consensus       167 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l  243 (281)
T 3cc6_A          167 DY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD--VIGVLEKGDRLPKPDLCPPVL  243 (281)
T ss_dssp             -------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG--HHHHHHHTCCCCCCTTCCHHH
T ss_pred             cc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH--HHHHHhcCCCCCCCCCCCHHH
Confidence            21 12233457889999999888889999999999999999998 999997533222  222222        1233468


Q ss_pred             hhhhchhccCCccccccc
Q 039799          328 MEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       328 ~~~~d~~l~~~p~~R~~~  345 (346)
                      .+++.+||..||++||++
T Consensus       244 ~~li~~~l~~~p~~Rps~  261 (281)
T 3cc6_A          244 YTLMTRCWDYDPSDRPRF  261 (281)
T ss_dssp             HHHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHHccCCchhCcCH
Confidence            999999999999999985

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.7e-42  Score=315.28  Aligned_cols=235  Identities=14%  Similarity=0.202  Sum_probs=194.4

Q ss_pred             CCCCCCCCcccccCceEEEEEEEcC---------CCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCcee---------
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQD---------GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIK---------  163 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~---------  163 (346)
                      .++|.+.+.||+|+||.||+|....         ++.||+|++...     +.+.+|++++++++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            3578899999999999999999763         789999998754     35778999999999999987         


Q ss_pred             ------eEEEEec-CCceeEEEecCCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceE
Q 039799          164 ------IISSYSN-DDFKALVLEYMPHGSLEKCLYLS-NYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVL  235 (346)
Q Consensus       164 ------~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIl  235 (346)
                            +++++.. .+..++||||+ +++|.+++... ...+++..++.++.|++.||+|||   +.+|+||||||+||+
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIl  191 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIF  191 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGGEE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEE
Confidence                  6777765 77889999999 99999999765 367999999999999999999999   999999999999999


Q ss_pred             ECCCC--cEEEeeecCCccCCccccc-----cccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 039799          236 LDDNM--VAHLSDFGMAKPLLEEDQS-----LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEI  308 (346)
Q Consensus       236 l~~~~--~~~l~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~  308 (346)
                      ++.++  .++|+|||+++.+......     .......||+.|+|||.+.+..++.++||||||+++|||+||+.||...
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  271 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC  271 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence            99988  9999999999876543221     1123346899999999999889999999999999999999999999875


Q ss_pred             ccCcccHHHHHh---h-------------hcCCChhhhhchhccCCccccccc
Q 039799          309 FSGEMTLKRWVN---D-------------LLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       309 ~~~~~~~~~~~~---~-------------~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ............   .             .++..+.+++.+||..||++||++
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  324 (352)
T 2jii_A          272 LPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPY  324 (352)
T ss_dssp             TTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCH
T ss_pred             CcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCH
Confidence            433322222221   1             235578999999999999999985

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.6e-41  Score=302.33  Aligned_cols=234  Identities=28%  Similarity=0.363  Sum_probs=198.8

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEec
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEY  180 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  180 (346)
                      +.|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  101 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY  101 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence            45888899999999999999865 78999999987543 34467889999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccc
Q 039799          181 MPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  260 (346)
Q Consensus       181 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~  260 (346)
                      +++++|.+++..  ..+++..+..++.+++.||.|||   +.+++||||||+||+++.++.++|+|||++.......  .
T Consensus       102 ~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--~  174 (303)
T 3a7i_A          102 LGGGSALDLLEP--GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--I  174 (303)
T ss_dssp             CTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB--C
T ss_pred             CCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCccc--c
Confidence            999999998853  46899999999999999999999   9999999999999999999999999999998764322  1


Q ss_pred             ccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh--------hhcCCChhhhhc
Q 039799          261 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN--------DLLPISVMEVVD  332 (346)
Q Consensus       261 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~d  332 (346)
                      ......+++.|+|||.+.+..++.++||||||+++|||++|+.||......  .....+.        ..++..+.+++.
T Consensus       175 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~  252 (303)
T 3a7i_A          175 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM--KVLFLIPKNNPPTLEGNYSKPLKEFVE  252 (303)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHSCCCCCCSSCCHHHHHHHH
T ss_pred             ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH--HHHHHhhcCCCCCCccccCHHHHHHHH
Confidence            223456899999999999889999999999999999999999999753211  1111221        123346899999


Q ss_pred             hhccCCccccccc
Q 039799          333 ANLLSQEDEHFTT  345 (346)
Q Consensus       333 ~~l~~~p~~R~~~  345 (346)
                      +||..+|++||++
T Consensus       253 ~~l~~dp~~Rps~  265 (303)
T 3a7i_A          253 ACLNKEPSFRPTA  265 (303)
T ss_dssp             HHCCSSGGGSCCH
T ss_pred             HHcCCChhhCcCH
Confidence            9999999999985

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=3.7e-42  Score=302.75  Aligned_cols=236  Identities=24%  Similarity=0.402  Sum_probs=196.6

Q ss_pred             CCCCCCCCcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecC
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYM  181 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  181 (346)
                      .++|.+.+.||+|+||.||+|...++..||+|++..... ..+.+.+|++++++++||||+++++++. .+..++||||+
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   89 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM   89 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred             HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence            356788899999999999999998888999999975532 3577889999999999999999999986 45688999999


Q ss_pred             CCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccc
Q 039799          182 PHGSLEKCLYLSN-YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  260 (346)
Q Consensus       182 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~  260 (346)
                      ++++|.+++.... ..+++..++.++.+++.||+|||   +.+++||||||+||++++++.++|+|||++........ .
T Consensus        90 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~  165 (279)
T 1qpc_A           90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-T  165 (279)
T ss_dssp             TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-E
T ss_pred             CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc-c
Confidence            9999999986543 36899999999999999999999   99999999999999999999999999999987643321 1


Q ss_pred             ccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHh--------hhcCCChhhhh
Q 039799          261 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVN--------DLLPISVMEVV  331 (346)
Q Consensus       261 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~  331 (346)
                      ......++..|+|||...+..++.++||||||++++||++ |+.||......  ...+.+.        ..++..+.+++
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li  243 (279)
T 1qpc_A          166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--EVIQNLERGYRMVRPDNCPEELYQLM  243 (279)
T ss_dssp             CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred             cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH--HHHHHHhcccCCCCcccccHHHHHHH
Confidence            2233456788999999888889999999999999999999 99999753221  1222221        22345788999


Q ss_pred             chhccCCccccccc
Q 039799          332 DANLLSQEDEHFTT  345 (346)
Q Consensus       332 d~~l~~~p~~R~~~  345 (346)
                      .+||..+|++||+.
T Consensus       244 ~~~l~~~p~~Rps~  257 (279)
T 1qpc_A          244 RLCWKERPEDRPTF  257 (279)
T ss_dssp             HHHTCSSGGGSCCH
T ss_pred             HHHhccChhhCCCH
Confidence            99999999999985

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2e-41  Score=300.53  Aligned_cols=239  Identities=22%  Similarity=0.268  Sum_probs=197.4

Q ss_pred             CCCCCCCCCcccccCceEEEEEEE-cCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEE-ecCCceeEEE
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAII-QDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSY-SNDDFKALVL  178 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~lv~  178 (346)
                      ..++|.+.+.||+|+||.||+|.. .+++.||+|++.....  .+.+.+|+++++.++|++++..+..+ ...+..++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 3uzp_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence            356789999999999999999997 4789999999875432  24678899999999998877766655 5677889999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEE---CCCCcEEEeeecCCccCCc
Q 039799          179 EYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLE  255 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll---~~~~~~~l~Dfg~~~~~~~  255 (346)
                      ||+ +++|.+++......+++..++.++.+++.||+|||   +.+|+||||||+||++   +.++.++|+|||++.....
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  160 (296)
T 3uzp_A           85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  160 (296)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             Eec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence            999 99999999866778999999999999999999999   9999999999999999   4788999999999987654


Q ss_pred             cccc-----cccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCc--ccHHHHH---------
Q 039799          256 EDQS-----LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE--MTLKRWV---------  319 (346)
Q Consensus       256 ~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~--~~~~~~~---------  319 (346)
                      ....     .......||+.|+|||...+..++.++||||||+++|||++|+.||.......  .......         
T Consensus       161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  240 (296)
T 3uzp_A          161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE  240 (296)
T ss_dssp             TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred             cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchH
Confidence            3221     11234568999999999999899999999999999999999999998643221  1111111         


Q ss_pred             --hhhcCCChhhhhchhccCCccccccc
Q 039799          320 --NDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       320 --~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                        ...++..+.+++.+||..||++||++
T Consensus       241 ~~~~~~~~~l~~li~~~l~~dp~~Rps~  268 (296)
T 3uzp_A          241 VLCKGYPSEFATYLNFCRSLRFDDKPDY  268 (296)
T ss_dssp             HHTTTSCHHHHHHHHHHHTSCTTCCCCH
T ss_pred             HHHhhCCHHHHHHHHHHHhcCcCcCCCH
Confidence              13345688999999999999999985

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=4e-42  Score=309.62  Aligned_cols=240  Identities=24%  Similarity=0.375  Sum_probs=194.1

Q ss_pred             CCCCCCCCCcccccCceEEEEEEE------cCCCEEEEEEecCC-CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCc
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAII------QDGMEVAVKVFDPQ-YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDF  173 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  173 (346)
                      ...+|.+.+.||+|+||.||+|.+      .+++.||+|++... .......+.+|+.++++++||||+++++++...+.
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP  107 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence            446789999999999999999984      25778999999744 33455678899999999999999999999999999


Q ss_pred             eeEEEecCCCCChhhhhhhcC------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC---CCcEEE
Q 039799          174 KALVLEYMPHGSLEKCLYLSN------YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD---NMVAHL  244 (346)
Q Consensus       174 ~~lv~e~~~~gsL~~~l~~~~------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~---~~~~~l  244 (346)
                      .++||||+++++|.+++....      ..+++..++.++.+++.||.|||   +.+|+||||||+||+++.   +..++|
T Consensus       108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEE
Confidence            999999999999999997653      45899999999999999999999   999999999999999984   446999


Q ss_pred             eeecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHhh--
Q 039799          245 SDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVND--  321 (346)
Q Consensus       245 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~--  321 (346)
                      +|||++................+++.|+|||.+.+..++.++||||||+++|||+| |+.||.....  ......+..  
T Consensus       185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~~~~~~~~~~  262 (327)
T 2yfx_A          185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--QEVLEFVTSGG  262 (327)
T ss_dssp             CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHHHHHHTTC
T ss_pred             CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH--HHHHHHHhcCC
Confidence            99999986543332222334567899999999888889999999999999999998 9999975321  122222222  


Q ss_pred             ------hcCCChhhhhchhccCCccccccc
Q 039799          322 ------LLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       322 ------~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                            .++..+.+++.+||..||.+||++
T Consensus       263 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  292 (327)
T 2yfx_A          263 RMDPPKNCPGPVYRIMTQCWQHQPEDRPNF  292 (327)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCCCCCCCCHHHHHHHHHHhcCChhhCcCH
Confidence                  234478899999999999999985

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.5e-41  Score=304.63  Aligned_cols=230  Identities=23%  Similarity=0.345  Sum_probs=191.1

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcC-CCCceeeEEEEec--CCceeEEE
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRIC-HRNLIKIISSYSN--DDFKALVL  178 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~--~~~~~lv~  178 (346)
                      ++|.+.+.||+|+||.||+|... +++.||+|++....   .+.+.+|++++++++ ||||+++++++..  ....++||
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~  112 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  112 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence            56888999999999999999864 78999999997543   467889999999997 9999999999987  66789999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCC-cEEEeeecCCccCCccc
Q 039799          179 EYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM-VAHLSDFGMAKPLLEED  257 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~-~~~l~Dfg~~~~~~~~~  257 (346)
                      ||+++++|.+++.    .++...+..++.+++.||+|||   +.+|+||||||+|||++.++ .++|+|||+++......
T Consensus       113 e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~  185 (330)
T 3nsz_A          113 EHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  185 (330)
T ss_dssp             ECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred             eccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence            9999999998874    3788899999999999999999   99999999999999999776 89999999998664332


Q ss_pred             cccccccccCCcccccCCCCCC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccH------------HHHHh----
Q 039799          258 QSLTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTL------------KRWVN----  320 (346)
Q Consensus       258 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~------------~~~~~----  320 (346)
                         ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.........+            ..+..    
T Consensus       186 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  262 (330)
T 3nsz_A          186 ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI  262 (330)
T ss_dssp             ---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred             ---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcc
Confidence               2234568999999998876 668999999999999999999999995422111111            11110    


Q ss_pred             ---------------------------hhcCCChhhhhchhccCCccccccc
Q 039799          321 ---------------------------DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       321 ---------------------------~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                                                 ..++..+.+++.+||..||++|||+
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta  314 (330)
T 3nsz_A          263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA  314 (330)
T ss_dssp             CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCH
T ss_pred             ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCH
Confidence                                       1145578899999999999999986

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=5.5e-42  Score=310.25  Aligned_cols=235  Identities=23%  Similarity=0.366  Sum_probs=192.6

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhc-CCCCceeeEEEEecCCceeEEE
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRI-CHRNLIKIISSYSNDDFKALVL  178 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  178 (346)
                      +.++|.+.+.||+|+||.||++..+ +++.||+|++......    ..+|++++.++ +||||+++++++.+.+..++||
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            3456888999999999999999976 6889999999765332    34588888887 7999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCC----CcEEEeeecCCccCC
Q 039799          179 EYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDN----MVAHLSDFGMAKPLL  254 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~----~~~~l~Dfg~~~~~~  254 (346)
                      ||+++|+|.+++.. ...+++..+..++.+++.||+|||   +.+|+||||||+|||+.++    +.+||+|||+++...
T Consensus        96 E~~~gg~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~  171 (342)
T 2qr7_A           96 ELMKGGELLDKILR-QKFFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR  171 (342)
T ss_dssp             CCCCSCBHHHHHHT-CTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred             eCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence            99999999998864 356899999999999999999999   9999999999999998533    359999999998764


Q ss_pred             ccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccC-cccHHHHHh-----------hh
Q 039799          255 EEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSG-EMTLKRWVN-----------DL  322 (346)
Q Consensus       255 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~-~~~~~~~~~-----------~~  322 (346)
                      ....  ......+|+.|+|||.+.+..++.++||||||+++|||++|+.||...... ...+...+.           ..
T Consensus       172 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  249 (342)
T 2qr7_A          172 AENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNS  249 (342)
T ss_dssp             CTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTT
T ss_pred             CCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcccccc
Confidence            3321  223456899999999988777899999999999999999999999753211 111222211           22


Q ss_pred             cCCChhhhhchhccCCccccccc
Q 039799          323 LPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       323 ~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ++..+.+++.+||..||++||++
T Consensus       250 ~s~~~~~li~~~L~~dP~~R~t~  272 (342)
T 2qr7_A          250 VSDTAKDLVSKMLHVDPHQRLTA  272 (342)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             CCHHHHHHHHHHCCCChhHCcCH
Confidence            44578899999999999999985

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=3.2e-41  Score=298.51  Aligned_cols=233  Identities=24%  Similarity=0.381  Sum_probs=190.8

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC--CchhHHHHHHHHHHHHhcCCCCceeeEEEEec----CCceeE
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ--YEGAFKSFDIECDVMKRICHRNLIKIISSYSN----DDFKAL  176 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~l  176 (346)
                      .|.+.+.||+|+||.||+|... ++..||+|++...  .....+.+.+|++++++++||||+++++++..    ....++
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  106 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence            3667778999999999999876 6889999998643  24456778899999999999999999998865    456889


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeecCCCCCceEEC-CCCcEEEeeecCCccC
Q 039799          177 VLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP--IIHCDLKPSNVLLD-DNMVAHLSDFGMAKPL  253 (346)
Q Consensus       177 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~dik~~NIll~-~~~~~~l~Dfg~~~~~  253 (346)
                      ||||+++++|.+++... ..+++..+..++.+++.||+|||   +.+  ++||||||+||+++ +++.++|+|||++...
T Consensus       107 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~  182 (290)
T 1t4h_A          107 VTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             EEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence            99999999999998643 56889999999999999999999   888  99999999999998 7899999999999754


Q ss_pred             CccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH--------hhhcCC
Q 039799          254 LEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV--------NDLLPI  325 (346)
Q Consensus       254 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~--------~~~~~~  325 (346)
                      ...    ......|++.|+|||.+. +.++.++||||+|+++|||++|+.||..............        ....+.
T Consensus       183 ~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (290)
T 1t4h_A          183 RAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP  257 (290)
T ss_dssp             CTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCH
T ss_pred             ccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCH
Confidence            322    223456899999999876 4589999999999999999999999976332221111111        112234


Q ss_pred             ChhhhhchhccCCccccccc
Q 039799          326 SVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       326 ~~~~~~d~~l~~~p~~R~~~  345 (346)
                      .+.+++.+||..||++||++
T Consensus       258 ~l~~li~~~l~~dp~~Rps~  277 (290)
T 1t4h_A          258 EVKEIIEGCIRQNKDERYSI  277 (290)
T ss_dssp             HHHHHHHHHSCSSGGGSCCH
T ss_pred             HHHHHHHHHccCChhhCCCH
Confidence            68899999999999999985

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=7.9e-42  Score=302.18  Aligned_cols=238  Identities=23%  Similarity=0.252  Sum_probs=181.8

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCc--hhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEE
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYE--GAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALV  177 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  177 (346)
                      ..++|.+.+.||+|+||.||+|... +|+.||+|++.....  ...+.+.++...++.++||||+++++++...+..++|
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv   84 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC   84 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence            3467888999999999999999975 789999999975432  2223344455567888999999999999999999999


Q ss_pred             EecCCCCChhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeeecCCCCCceEECCCCcEEEeeecCCccC
Q 039799          178 LEYMPHGSLEKCLYL---SNYILDIFQRLDIMIDVASALEYLHFGYSA-PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  253 (346)
Q Consensus       178 ~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~  253 (346)
                      |||+++ +|.+++..   ....+++..+..++.+++.||+|||   +. +++||||||+||+++.++.++|+|||+++..
T Consensus        85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            999974 88777643   4567999999999999999999999   87 9999999999999999999999999999876


Q ss_pred             CccccccccccccCCcccccCCCC----CCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHhh--------
Q 039799          254 LEEDQSLTQTQTLATIGYMAPEYG----REGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVND--------  321 (346)
Q Consensus       254 ~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~--------  321 (346)
                      ....   ......||+.|+|||.+    .+..++.++||||+|+++|||+||+.||+...............        
T Consensus       161 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  237 (290)
T 3fme_A          161 VDDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPAD  237 (290)
T ss_dssp             ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTT
T ss_pred             cccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccc
Confidence            4322   22334689999999984    56678999999999999999999999997533222222232222        


Q ss_pred             hcCCChhhhhchhccCCccccccc
Q 039799          322 LLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       322 ~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      .++..+.+++.+||..||++|||+
T Consensus       238 ~~~~~~~~li~~~l~~~p~~Rpt~  261 (290)
T 3fme_A          238 KFSAEFVDFTSQCLKKNSKERPTY  261 (290)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             cCCHHHHHHHHHHhhcChhhCcCH
Confidence            234478899999999999999986

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.6e-42  Score=318.80  Aligned_cols=239  Identities=22%  Similarity=0.346  Sum_probs=194.1

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCC--ceeE
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDD--FKAL  176 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~l  176 (346)
                      ....|.+.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|++++++++||||+++++++...+  ..++
T Consensus         7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l   86 (396)
T 4eut_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL   86 (396)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred             CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence            4567889999999999999999977 58999999987432 233567788999999999999999999998765  7799


Q ss_pred             EEecCCCCChhhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEE----CCCCcEEEeeecCC
Q 039799          177 VLEYMPHGSLEKCLYLSN--YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL----DDNMVAHLSDFGMA  250 (346)
Q Consensus       177 v~e~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll----~~~~~~~l~Dfg~~  250 (346)
                      ||||+++++|.+++....  ..+++..++.++.+++.||+|||   +.+|+||||||+|||+    +.++.+||+|||++
T Consensus        87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a  163 (396)
T 4eut_A           87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (396)
T ss_dssp             EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred             EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence            999999999999987543  33899999999999999999999   9999999999999999    78888999999999


Q ss_pred             ccCCccccccccccccCCcccccCCCCCC--------CCCCcchhHHHHHHHHHHHHcCCCCCCccccCccc---HHHHH
Q 039799          251 KPLLEEDQSLTQTQTLATIGYMAPEYGRE--------GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMT---LKRWV  319 (346)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~---~~~~~  319 (346)
                      +......   ......||+.|+|||.+.+        ..++.++||||||+++|||+||+.||.........   .....
T Consensus       164 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~  240 (396)
T 4eut_A          164 RELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII  240 (396)
T ss_dssp             EECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHH
T ss_pred             eEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHh
Confidence            8764332   2234568999999998654        45788999999999999999999999643221111   11111


Q ss_pred             h-------------------------------hhcCCChhhhhchhccCCccccccc
Q 039799          320 N-------------------------------DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       320 ~-------------------------------~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      .                               ..++..+.+++.+||..||++||++
T Consensus       241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~  297 (396)
T 4eut_A          241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF  297 (396)
T ss_dssp             HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCH
T ss_pred             cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccH
Confidence            1                               1122356789999999999999985

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2.9e-41  Score=306.90  Aligned_cols=237  Identities=22%  Similarity=0.302  Sum_probs=192.0

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEec--------C
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSN--------D  171 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------~  171 (346)
                      ++|.+.+.||+|+||.||+|... +|+.||+|++....  ......+.+|++++++++||||+++++++..        .
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            46888999999999999999975 78999999986442  2234577889999999999999999999876        3


Q ss_pred             CceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCc
Q 039799          172 DFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAK  251 (346)
Q Consensus       172 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~  251 (346)
                      +..++||||+++ +|.+.+......+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.++|+|||+++
T Consensus        97 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~  172 (351)
T 3mi9_A           97 GSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLAR  172 (351)
T ss_dssp             CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             ceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence            468899999975 777777666677999999999999999999999   9999999999999999999999999999998


Q ss_pred             cCCccc--cccccccccCCcccccCCCCCC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh--------
Q 039799          252 PLLEED--QSLTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN--------  320 (346)
Q Consensus       252 ~~~~~~--~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~--------  320 (346)
                      .+....  .........||+.|+|||.+.+ ..++.++||||||+++|||+||+.||......+  ....+.        
T Consensus       173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~i~~~~~~~~~  250 (351)
T 3mi9_A          173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH--QLALISQLCGSITP  250 (351)
T ss_dssp             ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCT
T ss_pred             cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCCh
Confidence            764322  1222344568999999998765 457999999999999999999999997532111  000000        


Q ss_pred             -------------------------------hhcCCChhhhhchhccCCccccccc
Q 039799          321 -------------------------------DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       321 -------------------------------~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                                                     ...+..+.+++.+||..||++|||+
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  306 (351)
T 3mi9_A          251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS  306 (351)
T ss_dssp             TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred             hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCH
Confidence                                           0012347799999999999999986

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-41  Score=310.67  Aligned_cols=234  Identities=24%  Similarity=0.306  Sum_probs=186.3

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEecCC-----
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSNDD-----  172 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----  172 (346)
                      ..+.|.+.+.||+|+||.||+|... +|+.||||++....  ....+++.+|++++++++||||+++++++....     
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  102 (367)
T 1cm8_A           23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF  102 (367)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence            3467888999999999999999975 79999999986432  334577889999999999999999999997653     


Q ss_pred             -ceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCc
Q 039799          173 -FKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAK  251 (346)
Q Consensus       173 -~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~  251 (346)
                       ..++||||+ +++|.+++..  ..+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++
T Consensus       103 ~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  176 (367)
T 1cm8_A          103 TDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR  176 (367)
T ss_dssp             CCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             ceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence             458999999 8899998865  45889999999999999999999   9999999999999999999999999999998


Q ss_pred             cCCccccccccccccCCcccccCCCCCC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccCcc-----------------
Q 039799          252 PLLEEDQSLTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM-----------------  313 (346)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~-----------------  313 (346)
                      .....     .....+|+.|+|||.+.+ ..++.++||||+||+++||++|+.||......+.                 
T Consensus       177 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~  251 (367)
T 1cm8_A          177 QADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ  251 (367)
T ss_dssp             ECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             ccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            65321     234568999999998766 6789999999999999999999999975321100                 


Q ss_pred             -----cHHHHHh--------------hhcCCChhhhhchhccCCccccccc
Q 039799          314 -----TLKRWVN--------------DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       314 -----~~~~~~~--------------~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                           ....+..              ...+..+.+++.+||..||++|||+
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~  302 (367)
T 1cm8_A          252 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTA  302 (367)
T ss_dssp             TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCH
T ss_pred             HhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCH
Confidence                 0000000              1123467899999999999999986

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-40  Score=301.37  Aligned_cols=234  Identities=26%  Similarity=0.383  Sum_probs=185.1

Q ss_pred             CCCCCCCcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhc--CCCCceeeEEEEecC----CceeE
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRI--CHRNLIKIISSYSND----DFKAL  176 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~~~~~~~~~----~~~~l  176 (346)
                      ++|.+.+.||+|+||.||+|+.. ++.||||++....   ...+..|.+++...  +||||+++++++...    ...++
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l  112 (337)
T 3mdy_A           37 KQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYL  112 (337)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEE
T ss_pred             cceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEE
Confidence            56899999999999999999987 8999999986432   23444555555554  899999999999877    68899


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCC--------CeeecCCCCCceEECCCCcEEEeeec
Q 039799          177 VLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSA--------PIIHCDLKPSNVLLDDNMVAHLSDFG  248 (346)
Q Consensus       177 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~--------~i~H~dik~~NIll~~~~~~~l~Dfg  248 (346)
                      ||||+++|+|.+++...  .+++..++.++.+++.||+|||   +.        +|+||||||+|||++.++.+||+|||
T Consensus       113 v~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg  187 (337)
T 3mdy_A          113 ITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  187 (337)
T ss_dssp             EECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             EEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEECCCCCEEEEeCC
Confidence            99999999999998643  5899999999999999999999   77        99999999999999999999999999


Q ss_pred             CCccCCccccc--cccccccCCcccccCCCCCCCCCCcc------hhHHHHHHHHHHHHcC----------CCCCCcccc
Q 039799          249 MAKPLLEEDQS--LTQTQTLATIGYMAPEYGREGRVSTN------GDVYSFGIMLMEIFTR----------TKPTDEIFS  310 (346)
Q Consensus       249 ~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~------~Dv~s~G~il~elltg----------~~p~~~~~~  310 (346)
                      +++.+......  .......||+.|+|||.+.+...+.+      +||||||+++|||+||          +.||.....
T Consensus       188 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~  267 (337)
T 3mdy_A          188 LAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP  267 (337)
T ss_dssp             TCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred             CceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcC
Confidence            99876433221  11234569999999999877766555      9999999999999999          667655433


Q ss_pred             CcccHHHHHh-----------------hhcCCChhhhhchhccCCccccccc
Q 039799          311 GEMTLKRWVN-----------------DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       311 ~~~~~~~~~~-----------------~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ..........                 ...+..+.+++.+||..||.+||++
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~  319 (337)
T 3mdy_A          268 SDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTA  319 (337)
T ss_dssp             SSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCH
T ss_pred             CCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCH
Confidence            3322222211                 1122247899999999999999986

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2.3e-41  Score=309.07  Aligned_cols=233  Identities=27%  Similarity=0.420  Sum_probs=194.4

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCc--------hhHHHHHHHHHHHHhc-CCCCceeeEEEEecCCc
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYE--------GAFKSFDIECDVMKRI-CHRNLIKIISSYSNDDF  173 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  173 (346)
                      +|.+.+.||+|++|.||+|... +|+.||||++.....        ...+.+.+|+++++++ +||||+++++++.....
T Consensus        95 ~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~  174 (365)
T 2y7j_A           95 KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSF  174 (365)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSE
T ss_pred             hcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCE
Confidence            4788899999999999999986 799999999875431        1245678899999999 79999999999999999


Q ss_pred             eeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccC
Q 039799          174 KALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  253 (346)
Q Consensus       174 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~  253 (346)
                      .++||||+++++|.+++.. ...+++..+..++.+++.||.|||   +.+++||||||+||+++.++.++|+|||++..+
T Consensus       175 ~~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~  250 (365)
T 2y7j_A          175 MFLVFDLMRKGELFDYLTE-KVALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHL  250 (365)
T ss_dssp             EEEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEEecCccccc
Confidence            9999999999999998864 356899999999999999999999   899999999999999999999999999999876


Q ss_pred             CccccccccccccCCcccccCCCCC------CCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh-------
Q 039799          254 LEEDQSLTQTQTLATIGYMAPEYGR------EGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN-------  320 (346)
Q Consensus       254 ~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~-------  320 (346)
                      ....   ......||+.|+|||++.      ...++.++||||||+++|||+||+.||.....  ......+.       
T Consensus       251 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~--~~~~~~i~~~~~~~~  325 (365)
T 2y7j_A          251 EPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ--ILMLRMIMEGQYQFS  325 (365)
T ss_dssp             CTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHTCCCCC
T ss_pred             CCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH--HHHHHHHHhCCCCCC
Confidence            4332   223456999999999764      33578999999999999999999999965221  11111111       


Q ss_pred             ----hhcCCChhhhhchhccCCccccccc
Q 039799          321 ----DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       321 ----~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                          ...+..+.+++.+||..||++||++
T Consensus       326 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~  354 (365)
T 2y7j_A          326 SPEWDDRSSTVKDLISRLLQVDPEARLTA  354 (365)
T ss_dssp             HHHHSSSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred             CcccccCCHHHHHHHHHHcCCChhHCcCH
Confidence                1234468999999999999999986

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.5e-41  Score=309.97  Aligned_cols=239  Identities=20%  Similarity=0.262  Sum_probs=187.7

Q ss_pred             CCCCCCCCCCcccccCceEEEEEEEcCCCEEEEEEecCCC-----------chhHHHHHHHHHHHHhcCCCCceeeEEEE
Q 039799          100 PLPNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQY-----------EGAFKSFDIECDVMKRICHRNLIKIISSY  168 (346)
Q Consensus       100 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~-----------~~~~~~~~~e~~~l~~l~h~niv~~~~~~  168 (346)
                      ...+.|.+.+.||+|+||.||+|...+|+.||||++....           ....+.+.+|++++++++||||+++++++
T Consensus        19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   98 (362)
T 3pg1_A           19 AMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF   98 (362)
T ss_dssp             HTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred             HhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence            3567899999999999999999998889999999985422           12247888999999999999999999998


Q ss_pred             ec-----CCceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEE
Q 039799          169 SN-----DDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAH  243 (346)
Q Consensus       169 ~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~  243 (346)
                      ..     ....++||||++ |+|.+.+......+++..+..++.+++.||+|||   +.+|+||||||+||+++.++.++
T Consensus        99 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~k  174 (362)
T 3pg1_A           99 VHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDIT  174 (362)
T ss_dssp             EECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEE
T ss_pred             EeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHEEEcCCCCEE
Confidence            43     336799999997 6888888766678999999999999999999999   99999999999999999999999


Q ss_pred             EeeecCCccCCccccccccccccCCcccccCCCCCC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccCcc---------
Q 039799          244 LSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM---------  313 (346)
Q Consensus       244 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~---------  313 (346)
                      |+|||+++......   ......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+.         
T Consensus       175 l~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~  251 (362)
T 3pg1_A          175 ICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVG  251 (362)
T ss_dssp             ECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             EEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC
Confidence            99999998543222   2234568999999998776 6789999999999999999999999975321110         


Q ss_pred             --c-----------HHHH---------------HhhhcCCChhhhhchhccCCccccccc
Q 039799          314 --T-----------LKRW---------------VNDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       314 --~-----------~~~~---------------~~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                        .           ...+               .....+..+.+++.+||..||.+|||+
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  311 (362)
T 3pg1_A          252 TPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRIST  311 (362)
T ss_dssp             CCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCH
Confidence              0           0000               111223357899999999999999986

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.5e-41  Score=305.15  Aligned_cols=239  Identities=23%  Similarity=0.276  Sum_probs=177.6

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcC-CCCceeeEEEEe--------cCC
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRIC-HRNLIKIISSYS--------NDD  172 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~--------~~~  172 (346)
                      .+|.+.+.||+|+||.||+|... +++.||+|++........+.+.+|+.++.++. ||||+++++++.        ...
T Consensus        28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~  107 (337)
T 3ll6_A           28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA  107 (337)
T ss_dssp             EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred             ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence            35788899999999999999975 78999999987666666778899999999996 999999999984        334


Q ss_pred             ceeEEEecCCCCChhhhhhh--cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeecCCCCCceEECCCCcEEEeeec
Q 039799          173 FKALVLEYMPHGSLEKCLYL--SNYILDIFQRLDIMIDVASALEYLHFGYSAP--IIHCDLKPSNVLLDDNMVAHLSDFG  248 (346)
Q Consensus       173 ~~~lv~e~~~~gsL~~~l~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~dik~~NIll~~~~~~~l~Dfg  248 (346)
                      ..++||||+. |+|.+++..  ....+++..++.++.+++.||+|||   +.+  |+||||||+|||++.++.++|+|||
T Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg  183 (337)
T 3ll6_A          108 EFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKLCDFG  183 (337)
T ss_dssp             EEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred             eEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEEEecCc
Confidence            5789999995 789888754  3456999999999999999999999   888  9999999999999999999999999


Q ss_pred             CCccCCcccccc----------ccccccCCcccccCCCC---CCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccH
Q 039799          249 MAKPLLEEDQSL----------TQTQTLATIGYMAPEYG---REGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTL  315 (346)
Q Consensus       249 ~~~~~~~~~~~~----------~~~~~~~~~~y~aPE~~---~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~  315 (346)
                      +++.........          ......+|+.|+|||.+   .+..++.++||||||+++|||+||+.||..........
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~  263 (337)
T 3ll6_A          184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVN  263 (337)
T ss_dssp             TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred             cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhc
Confidence            998764322110          11134589999999988   56678999999999999999999999997532211100


Q ss_pred             HHH---HhhhcCCChhhhhchhccCCccccccc
Q 039799          316 KRW---VNDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       316 ~~~---~~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ..+   .....+..+.+++.+||..||++||++
T Consensus       264 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  296 (337)
T 3ll6_A          264 GKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSI  296 (337)
T ss_dssp             --CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCH
T ss_pred             CcccCCcccccchHHHHHHHHHccCChhhCcCH
Confidence            000   011223468899999999999999985

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=7e-42  Score=310.47  Aligned_cols=235  Identities=23%  Similarity=0.324  Sum_probs=196.8

Q ss_pred             CCCCCCCCcccccCceEEEEEEEcCCCEEEEEEecCCCch-----------------hHHHHHHHHHHHHhcCCCCceee
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEG-----------------AFKSFDIECDVMKRICHRNLIKI  164 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~e~~~l~~l~h~niv~~  164 (346)
                      .++|.+.+.||+|+||.||+|.. +++.||+|++......                 ..+.+.+|++++++++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            46789999999999999999999 8999999998632111                 12788899999999999999999


Q ss_pred             EEEEecCCceeEEEecCCCCChhhh------hhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeeecCCCCCceEE
Q 039799          165 ISSYSNDDFKALVLEYMPHGSLEKC------LYLS-NYILDIFQRLDIMIDVASALEYLHFGYS-APIIHCDLKPSNVLL  236 (346)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~i~H~dik~~NIll  236 (346)
                      ++++...+..++||||+++++|.++      +... ...+++..++.++.+++.||+|||   + .+++||||||+||++
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Nil~  185 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNILM  185 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGEEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhEEE
Confidence            9999999999999999999999998      5432 467899999999999999999999   8 999999999999999


Q ss_pred             CCCCcEEEeeecCCccCCccccccccccccCCcccccCCCCCCC-CCCc-chhHHHHHHHHHHHHcCCCCCCccccCccc
Q 039799          237 DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREG-RVST-NGDVYSFGIMLMEIFTRTKPTDEIFSGEMT  314 (346)
Q Consensus       237 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~-~~Dv~s~G~il~elltg~~p~~~~~~~~~~  314 (346)
                      +.++.++|+|||++......    ......++..|+|||...+. .++. ++||||||+++|||++|+.||....... .
T Consensus       186 ~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~  260 (348)
T 2pml_X          186 DKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV-E  260 (348)
T ss_dssp             CTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH-H
T ss_pred             cCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH-H
Confidence            99999999999999875332    23445689999999998877 5665 9999999999999999999997533211 1


Q ss_pred             HHHHHh--------------------------hhcCCChhhhhchhccCCccccccc
Q 039799          315 LKRWVN--------------------------DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       315 ~~~~~~--------------------------~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ....+.                          ..++..+.+++.+||..||.+||++
T Consensus       261 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~  317 (348)
T 2pml_X          261 LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITS  317 (348)
T ss_dssp             HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred             HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCH
Confidence            111111                          2345578899999999999999985

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.5e-41  Score=328.00  Aligned_cols=230  Identities=21%  Similarity=0.365  Sum_probs=189.8

Q ss_pred             cccccCceEEEEEEEc---CCCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecCCCCC
Q 039799          110 LIGKGGFGSVYKAIIQ---DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHGS  185 (346)
Q Consensus       110 ~lg~G~~g~vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  185 (346)
                      .||+|+||.||+|.+.   ++..||||+++... ....+.+.+|++++++++||||+++++++.. +..++||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            6999999999999865   45679999997643 3456789999999999999999999999976 56899999999999


Q ss_pred             hhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccc-cccc
Q 039799          186 LEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL-TQTQ  264 (346)
Q Consensus       186 L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~-~~~~  264 (346)
                      |.+++......+++..+..++.+++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+....... ....
T Consensus       422 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~  498 (613)
T 2ozo_A          422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA  498 (613)
T ss_dssp             HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----------
T ss_pred             HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccC
Confidence            99999777777999999999999999999999   9999999999999999999999999999999764332211 1122


Q ss_pred             ccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHhh--------hcCCChhhhhchhc
Q 039799          265 TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVND--------LLPISVMEVVDANL  335 (346)
Q Consensus       265 ~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~d~~l  335 (346)
                      ..+++.|+|||++.+..++.++||||||+++|||+| |+.||......  .....+..        .++..+.+++.+||
T Consensus       499 ~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--~~~~~i~~~~~~~~p~~~~~~l~~li~~cl  576 (613)
T 2ozo_A          499 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAFIEQGKRMECPPECPPELYALMSDCW  576 (613)
T ss_dssp             ---CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH--HHHHHHHTTCCCCCCTTCCHHHHHHHHHTT
T ss_pred             CCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH--HHHHHHHcCCCCCCCCcCCHHHHHHHHHHc
Confidence            335689999999988899999999999999999998 99999764322  23333322        24458899999999


Q ss_pred             cCCccccccc
Q 039799          336 LSQEDEHFTT  345 (346)
Q Consensus       336 ~~~p~~R~~~  345 (346)
                      ..+|++||+.
T Consensus       577 ~~dP~~RPs~  586 (613)
T 2ozo_A          577 IYKWEDRPDF  586 (613)
T ss_dssp             CSSTTTSCCH
T ss_pred             CCChhHCcCH
Confidence            9999999985

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2.2e-42  Score=316.72  Aligned_cols=233  Identities=12%  Similarity=0.094  Sum_probs=175.9

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCc---hhHHHHHHHHHHHHhc--CCCCceeeE-------EEEec
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYE---GAFKSFDIECDVMKRI--CHRNLIKII-------SSYSN  170 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l--~h~niv~~~-------~~~~~  170 (346)
                      .|.+.+.||+|+||.||+|.+. +|+.||+|++.....   ...+.+.+|+++++.+  +|||+++++       +.+..
T Consensus        63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~  142 (371)
T 3q60_A           63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAV  142 (371)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEE
T ss_pred             eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheec
Confidence            4788899999999999999976 789999999986542   3345667775444444  699988755       44432


Q ss_pred             C-----------------CceeEEEecCCCCChhhhhhhcCCCCCHHHH------HHHHHHHHHHHHHHhcCCCCCeeec
Q 039799          171 D-----------------DFKALVLEYMPHGSLEKCLYLSNYILDIFQR------LDIMIDVASALEYLHFGYSAPIIHC  227 (346)
Q Consensus       171 ~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~------~~i~~~i~~~l~~LH~~~~~~i~H~  227 (346)
                      .                 ...++||||++ ++|.+++...+..+++..+      +.++.|++.||+|||   +.+|+||
T Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~ivHr  218 (371)
T 3q60_A          143 QSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHG  218 (371)
T ss_dssp             TTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTTEEET
T ss_pred             CCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHH---HCCCccC
Confidence            2                 33799999998 8999999765545566666      788899999999999   9999999


Q ss_pred             CCCCCceEECCCCcEEEeeecCCccCCccccccccccccCCcccccCCCCCC--CCCCcchhHHHHHHHHHHHHcCCCCC
Q 039799          228 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE--GRVSTNGDVYSFGIMLMEIFTRTKPT  305 (346)
Q Consensus       228 dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~s~G~il~elltg~~p~  305 (346)
                      ||||+|||++.++.+||+|||+++.....     .....+|+.|+|||++.+  ..++.++||||||+++|||+||+.||
T Consensus       219 Dikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf  293 (371)
T 3q60_A          219 HFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF  293 (371)
T ss_dssp             TCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred             cCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence            99999999999999999999999865321     113456799999999987  67899999999999999999999999


Q ss_pred             CccccCcccH-----------HHH---HhhhcCCChhhhhchhccCCccccccc
Q 039799          306 DEIFSGEMTL-----------KRW---VNDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       306 ~~~~~~~~~~-----------~~~---~~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ..........           ..+   ....++..+.+++.+||..||++||++
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  347 (371)
T 3q60_A          294 GLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLP  347 (371)
T ss_dssp             TBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCH
T ss_pred             CCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCH
Confidence            7652211100           000   012345588999999999999999986

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=5.1e-41  Score=299.24  Aligned_cols=239  Identities=22%  Similarity=0.303  Sum_probs=191.9

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC----chhHHHHHHHHHHHHhcCCCCceeeEEEE--ecCCc
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY----EGAFKSFDIECDVMKRICHRNLIKIISSY--SNDDF  173 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~--~~~~~  173 (346)
                      +..+|.+.+.||+|+||.||++... +++.+|+|++....    ....+.+.+|++++++++||||+++++++  .+.+.
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK   82 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence            3467999999999999999999975 78999999986432    23457788999999999999999999998  44568


Q ss_pred             eeEEEecCCCCChhhhhhh-cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCcc
Q 039799          174 KALVLEYMPHGSLEKCLYL-SNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  252 (346)
Q Consensus       174 ~~lv~e~~~~gsL~~~l~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~  252 (346)
                      .++||||++++ |.+.+.. ....+++..+..++.+++.||+|||   +.+++||||||+||+++.++.++|+|||++..
T Consensus        83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~  158 (305)
T 2wtk_C           83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEA  158 (305)
T ss_dssp             EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeeccccccc
Confidence            89999999876 6666654 3457899999999999999999999   99999999999999999999999999999987


Q ss_pred             CCccccccccccccCCcccccCCCCCCCC--CCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh-------hhc
Q 039799          253 LLEEDQSLTQTQTLATIGYMAPEYGREGR--VSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN-------DLL  323 (346)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~-------~~~  323 (346)
                      ..............+++.|+|||...+..  ++.++||||||+++|||++|+.||.....  ......+.       ..+
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~i~~~~~~~~~~~  236 (305)
T 2wtk_C          159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI--YKLFENIGKGSYAIPGDC  236 (305)
T ss_dssp             CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHCCCCCCSSS
T ss_pred             cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH--HHHHHHHhcCCCCCCCcc
Confidence            65433333334556899999999887643  47899999999999999999999975321  11111111       123


Q ss_pred             CCChhhhhchhccCCccccccc
Q 039799          324 PISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       324 ~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      +..+.+++.+||..||++||++
T Consensus       237 ~~~l~~li~~~l~~dp~~Rps~  258 (305)
T 2wtk_C          237 GPPLSDLLKGMLEYEPAKRFSI  258 (305)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCH
T ss_pred             CHHHHHHHHHHccCChhhCCCH
Confidence            3468999999999999999985

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=2.9e-41  Score=321.23  Aligned_cols=236  Identities=22%  Similarity=0.319  Sum_probs=195.5

Q ss_pred             CCCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCc-------------hhHHHHHHHHHHHHhcCCCCceeeE
Q 039799          100 PLPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYE-------------GAFKSFDIECDVMKRICHRNLIKII  165 (346)
Q Consensus       100 ~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~niv~~~  165 (346)
                      ...+.|.+.+.||+|+||+||+|... +++.+|+|++.....             ...+.+.+|++++++++||||++++
T Consensus        33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  112 (504)
T 3q5i_A           33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF  112 (504)
T ss_dssp             CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence            34567999999999999999999976 688999999865321             2346788999999999999999999


Q ss_pred             EEEecCCceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCC---cE
Q 039799          166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM---VA  242 (346)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~---~~  242 (346)
                      +++......++||||+++|+|.+.+... ..+++..+..++.+++.||+|||   +.+|+||||||+|||++.++   .+
T Consensus       113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~  188 (504)
T 3q5i_A          113 DVFEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNI  188 (504)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCSSE
T ss_pred             EEEEcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCccE
Confidence            9999999999999999999999988643 56899999999999999999999   99999999999999998765   69


Q ss_pred             EEeeecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH---
Q 039799          243 HLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV---  319 (346)
Q Consensus       243 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~---  319 (346)
                      +|+|||+++......   ......||+.|+|||.+. ..++.++||||+|+++|+|++|+.||......  .....+   
T Consensus       189 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~~  262 (504)
T 3q5i_A          189 KIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ--DIIKKVEKG  262 (504)
T ss_dssp             EECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHC
T ss_pred             EEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHcC
Confidence            999999998764322   233456999999999876 56899999999999999999999999763221  111111   


Q ss_pred             --------hhhcCCChhhhhchhccCCccccccc
Q 039799          320 --------NDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       320 --------~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                              ...++..+.+++.+||..||.+|||+
T Consensus       263 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~  296 (504)
T 3q5i_A          263 KYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTA  296 (504)
T ss_dssp             CCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             CCCCCccccCCCCHHHHHHHHHHcCCChhHCCCH
Confidence                    12345688999999999999999986

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=2.8e-42  Score=306.92  Aligned_cols=242  Identities=23%  Similarity=0.304  Sum_probs=179.0

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEE
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVL  178 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  178 (346)
                      ..++|.+.+.||+|++|.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   92 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM   92 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence            3567999999999999999999854 78999999986432 334567888999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhh-------cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCc
Q 039799          179 EYMPHGSLEKCLYL-------SNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAK  251 (346)
Q Consensus       179 e~~~~gsL~~~l~~-------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~  251 (346)
                      ||+++++|.+++..       ....+++..++.++.+++.||+|||   +.+++||||||+||+++.++.++|+|||++.
T Consensus        93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~  169 (303)
T 2vwi_A           93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSA  169 (303)
T ss_dssp             ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred             hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence            99999999998864       2356899999999999999999999   9999999999999999999999999999988


Q ss_pred             cCCcccc---ccccccccCCcccccCCCCCC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHH---------
Q 039799          252 PLLEEDQ---SLTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRW---------  318 (346)
Q Consensus       252 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~---------  318 (346)
                      .......   ........+|+.|+|||.+.+ ..++.++||||||+++|||+||+.||.............         
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  249 (303)
T 2vwi_A          170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLET  249 (303)
T ss_dssp             HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC
T ss_pred             eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcccc
Confidence            6543221   111233468999999998765 467899999999999999999999997632211100000         


Q ss_pred             ------HhhhcCCChhhhhchhccCCccccccc
Q 039799          319 ------VNDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       319 ------~~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                            ....++..+.+++.+||..||.+||++
T Consensus       250 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~  282 (303)
T 2vwi_A          250 GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTA  282 (303)
T ss_dssp             -----CCCCCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred             ccccchhhhhhhHHHHHHHHHHccCChhhCcCH
Confidence                  001223367889999999999999985

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.5e-41  Score=298.31  Aligned_cols=236  Identities=25%  Similarity=0.334  Sum_probs=190.3

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeE
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKAL  176 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  176 (346)
                      ..++|.+.+.||+|++|.||+|... +|+.||+|++....   ....+.+.+|+++++.++||||+++++++...+..++
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   88 (276)
T 2h6d_A            9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM   88 (276)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence            3467889999999999999999987 79999999986432   2234678899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcc
Q 039799          177 VLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  256 (346)
Q Consensus       177 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~  256 (346)
                      ||||+++++|.+++... ..+++..+..++.+++.||+|||   +.+++|+||||+||+++.++.++|+|||++......
T Consensus        89 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  164 (276)
T 2h6d_A           89 VMEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  164 (276)
T ss_dssp             EEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred             EEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence            99999999999998644 45889999999999999999999   999999999999999999999999999999876432


Q ss_pred             ccccccccccCCcccccCCCCCCCCC-CcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh-------hhcCCChh
Q 039799          257 DQSLTQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN-------DLLPISVM  328 (346)
Q Consensus       257 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~-------~~~~~~~~  328 (346)
                      .   ......+++.|+|||.+.+..+ +.++||||||++++||++|+.||+....  ....+.+.       ..++..+.
T Consensus       165 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~  239 (276)
T 2h6d_A          165 E---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV--PTLFKKIRGGVFYIPEYLNRSVA  239 (276)
T ss_dssp             ---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCCCCCCTTSCHHHH
T ss_pred             c---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH--HHHHHHhhcCcccCchhcCHHHH
Confidence            2   1233468999999999887665 6899999999999999999999975321  11222221       22344788


Q ss_pred             hhhchhccCCccccccc
Q 039799          329 EVVDANLLSQEDEHFTT  345 (346)
Q Consensus       329 ~~~d~~l~~~p~~R~~~  345 (346)
                      +++.+||..||++||++
T Consensus       240 ~li~~~l~~~p~~Rps~  256 (276)
T 2h6d_A          240 TLLMHMLQVDPLKRATI  256 (276)
T ss_dssp             HHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHccCChhhCCCH
Confidence            99999999999999985

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=4.4e-41  Score=298.65  Aligned_cols=237  Identities=25%  Similarity=0.363  Sum_probs=197.4

Q ss_pred             CCCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---------chhHHHHHHHHHHHHhcC-CCCceeeEEEE
Q 039799          100 PLPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---------EGAFKSFDIECDVMKRIC-HRNLIKIISSY  168 (346)
Q Consensus       100 ~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~niv~~~~~~  168 (346)
                      ...++|.+.+.||+|++|.||+|... +|+.||+|++....         ....+.+.+|+++++++. ||||+++++++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   93 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence            45678999999999999999999976 68999999986542         123456788999999996 99999999999


Q ss_pred             ecCCceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeec
Q 039799          169 SNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFG  248 (346)
Q Consensus       169 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg  248 (346)
                      ...+..++||||+++++|.+++.. ...+++..+..++.+++.||+|||   +.+++||||+|+||+++.++.++|+|||
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg  169 (298)
T 1phk_A           94 ETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFG  169 (298)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             ccCCeEEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEeccc
Confidence            999999999999999999999864 356899999999999999999999   9999999999999999999999999999


Q ss_pred             CCccCCccccccccccccCCcccccCCCCC------CCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH-h-
Q 039799          249 MAKPLLEEDQSLTQTQTLATIGYMAPEYGR------EGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV-N-  320 (346)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~-~-  320 (346)
                      ++.......   ......+++.|+|||.+.      ...++.++||||||++++||++|+.||......  .....+ . 
T Consensus       170 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~  244 (298)
T 1phk_A          170 FSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM--LMLRMIMSG  244 (298)
T ss_dssp             TCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHT
T ss_pred             chhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH--HHHHHHhcC
Confidence            998764322   223456899999999763      456889999999999999999999999653211  111111 1 


Q ss_pred             ---------hhcCCChhhhhchhccCCccccccc
Q 039799          321 ---------DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       321 ---------~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                               ..++..+.+++.+||..||.+||++
T Consensus       245 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  278 (298)
T 1phk_A          245 NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTA  278 (298)
T ss_dssp             CCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCH
T ss_pred             CcccCcccccccCHHHHHHHHHHccCCcccCCCH
Confidence                     2345578999999999999999985

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=2.7e-41  Score=320.68  Aligned_cols=233  Identities=22%  Similarity=0.337  Sum_probs=191.0

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEe
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLE  179 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  179 (346)
                      +.|.+.+.||+|+||+||+|... ++..+|+|++....  ......+.+|+++++.++||||+++++++......++|||
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  116 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME  116 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            45888999999999999999976 78999999987542  2335678899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC---CCcEEEeeecCCccCCcc
Q 039799          180 YMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD---NMVAHLSDFGMAKPLLEE  256 (346)
Q Consensus       180 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~---~~~~~l~Dfg~~~~~~~~  256 (346)
                      |+++|+|.+.+... ..+++..+..++.+++.||+|||   +.+|+||||||+|||++.   ++.+||+|||++......
T Consensus       117 ~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~  192 (494)
T 3lij_A          117 CYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ  192 (494)
T ss_dssp             CCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred             cCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence            99999999887643 45889999999999999999999   999999999999999976   445999999999876432


Q ss_pred             ccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH-h----------hhcCC
Q 039799          257 DQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV-N----------DLLPI  325 (346)
Q Consensus       257 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~-~----------~~~~~  325 (346)
                      .   ......||+.|+|||++. ..++.++||||+||++|+|++|+.||......  .....+ .          ..++.
T Consensus       193 ~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~s~  266 (494)
T 3lij_A          193 K---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ--EILRKVEKGKYTFDSPEWKNVSE  266 (494)
T ss_dssp             B---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHTCCCCCSGGGTTSCH
T ss_pred             c---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCCCCCCchhcccCCH
Confidence            2   233456999999999876 56899999999999999999999999763221  111111 1          22345


Q ss_pred             ChhhhhchhccCCccccccc
Q 039799          326 SVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       326 ~~~~~~d~~l~~~p~~R~~~  345 (346)
                      .+.+++.+||..||.+|||+
T Consensus       267 ~~~~li~~~L~~dp~~R~s~  286 (494)
T 3lij_A          267 GAKDLIKQMLQFDSQRRISA  286 (494)
T ss_dssp             HHHHHHHHHTCSSTTTSCCH
T ss_pred             HHHHHHHHHCCCChhhCccH
Confidence            78899999999999999986

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=6.3e-41  Score=295.81  Aligned_cols=230  Identities=18%  Similarity=0.284  Sum_probs=192.0

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC--CchhHHHHHHHHHHHHhc-CCCCceeeEEEEecCCceeEEE
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ--YEGAFKSFDIECDVMKRI-CHRNLIKIISSYSNDDFKALVL  178 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  178 (346)
                      ++|.+.+.||+|+||.||+|... +++.||+|++...  .......+.+|+..+.++ +||||+++++++.+.+..++||
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~   90 (289)
T 1x8b_A           11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN   90 (289)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred             chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            45788899999999999999976 7999999998754  234456788899999999 9999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC-----------------
Q 039799          179 EYMPHGSLEKCLYLSN---YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD-----------------  238 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~---~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~-----------------  238 (346)
                      ||+++++|.+++....   ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.                 
T Consensus        91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~  167 (289)
T 1x8b_A           91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA  167 (289)
T ss_dssp             ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC------------------
T ss_pred             EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence            9999999999986542   56899999999999999999999   999999999999999984                 


Q ss_pred             --CCcEEEeeecCCccCCccccccccccccCCcccccCCCCCCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccCcccH
Q 039799          239 --NMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTL  315 (346)
Q Consensus       239 --~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~  315 (346)
                        ...++|+|||.+......      ....+|+.|+|||.+.+. .++.++||||||++++||++|.+|+...    ...
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----~~~  237 (289)
T 1x8b_A          168 SNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG----DQW  237 (289)
T ss_dssp             --CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS----HHH
T ss_pred             CCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch----hHH
Confidence              447999999999875432      223489999999988765 5668999999999999999999876431    111


Q ss_pred             HHHHh-------hhcCCChhhhhchhccCCccccccc
Q 039799          316 KRWVN-------DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       316 ~~~~~-------~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      .....       ..++..+.+++.+||..||++||++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~  274 (289)
T 1x8b_A          238 HEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSA  274 (289)
T ss_dssp             HHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCH
Confidence            12221       2234578999999999999999986

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2.9e-42  Score=303.36  Aligned_cols=236  Identities=23%  Similarity=0.317  Sum_probs=193.8

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEe--cCCceeEE
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYS--NDDFKALV  177 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~lv  177 (346)
                      ++|.+.+.||+|+||.||++... +++.||+|++....  ....+.+.+|++++++++||||+++++++.  .....++|
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   85 (279)
T 2w5a_A            6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   85 (279)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred             hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence            56888899999999999999976 78999999987542  344577889999999999999999999874  46688999


Q ss_pred             EecCCCCChhhhhhhcC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCC-----eeecCCCCCceEECCCCcEEEeeecC
Q 039799          178 LEYMPHGSLEKCLYLSN---YILDIFQRLDIMIDVASALEYLHFGYSAP-----IIHCDLKPSNVLLDDNMVAHLSDFGM  249 (346)
Q Consensus       178 ~e~~~~gsL~~~l~~~~---~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-----i~H~dik~~NIll~~~~~~~l~Dfg~  249 (346)
                      |||+++++|.+++....   ..+++..++.++.+++.||+|||   +.+     ++||||||+||+++.++.++|+|||+
T Consensus        86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~  162 (279)
T 2w5a_A           86 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL  162 (279)
T ss_dssp             EECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred             EeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence            99999999999986532   45899999999999999999999   777     99999999999999999999999999


Q ss_pred             CccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh--------h
Q 039799          250 AKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN--------D  321 (346)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~--------~  321 (346)
                      ++.......  ......++..|+|||...+..++.++||||||+++|||+||+.||.....  ......+.        .
T Consensus       163 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~i~~~~~~~~~~  238 (279)
T 2w5a_A          163 ARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--KELAGKIREGKFRRIPY  238 (279)
T ss_dssp             HHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHTCCCCCCT
T ss_pred             heeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH--HHHHHHHhhcccccCCc
Confidence            986543221  12234589999999999888899999999999999999999999976321  11222221        1


Q ss_pred             hcCCChhhhhchhccCCccccccc
Q 039799          322 LLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       322 ~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      .++..+.+++.+||..||++||++
T Consensus       239 ~~~~~l~~li~~~l~~~p~~Rps~  262 (279)
T 2w5a_A          239 RYSDELNEIITRMLNLKDYHRPSV  262 (279)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             ccCHHHHHHHHHHcCCCcccCCCH
Confidence            234578999999999999999985

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=7.9e-42  Score=306.49  Aligned_cols=239  Identities=26%  Similarity=0.368  Sum_probs=194.8

Q ss_pred             CCCC-CCCCcccccCceEEEEEEEc-----CCCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEec--CC
Q 039799          102 PNDA-NMPPLIGKGGFGSVYKAIIQ-----DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSN--DD  172 (346)
Q Consensus       102 ~~~~-~~~~~lg~G~~g~vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~  172 (346)
                      ..+| .+.+.||+|+||+||++.+.     +++.||+|++.... ....+.+.+|++++++++||||+++++++..  ..
T Consensus        29 ~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (318)
T 3lxp_A           29 HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAA  108 (318)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTT
T ss_pred             cHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCc
Confidence            3445 88899999999999998753     67889999997653 3446778899999999999999999999987  45


Q ss_pred             ceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCcc
Q 039799          173 FKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  252 (346)
Q Consensus       173 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~  252 (346)
                      ..++||||+++++|.+++...  .+++..++.++.+++.||+|||   +.+|+||||||+||+++.++.++|+|||++..
T Consensus       109 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~  183 (318)
T 3lxp_A          109 SLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA  183 (318)
T ss_dssp             EEEEEECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             eEEEEEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCcccccc
Confidence            788999999999999988644  4899999999999999999999   99999999999999999999999999999997


Q ss_pred             CCccccc-cccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCc----------c---cHHHH
Q 039799          253 LLEEDQS-LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE----------M---TLKRW  318 (346)
Q Consensus       253 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~----------~---~~~~~  318 (346)
                      ....... .......++..|+|||.+.+..++.++||||||+++|||+||+.||.......          .   .....
T Consensus       184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (318)
T 3lxp_A          184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL  263 (318)
T ss_dssp             CCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHH
T ss_pred             ccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHH
Confidence            6543221 22234457888999999988889999999999999999999999986532110          0   11111


Q ss_pred             Hh--------hhcCCChhhhhchhccCCccccccc
Q 039799          319 VN--------DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       319 ~~--------~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      +.        ..++..+.+++.+||..||++||++
T Consensus       264 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~  298 (318)
T 3lxp_A          264 LERGERLPRPDKCPAEVYHLMKNCWETEASFRPTF  298 (318)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HhcccCCCCCccccHHHHHHHHHHcCCCcccCcCH
Confidence            11        1234478999999999999999985

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.1e-42  Score=308.81  Aligned_cols=242  Identities=25%  Similarity=0.386  Sum_probs=199.9

Q ss_pred             CCCCCCCCCcccccCceEEEEEEE-----cCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCC--c
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAII-----QDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDD--F  173 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~  173 (346)
                      ...+|.+.+.||+|+||.||++.+     .+++.||+|++........+.+.+|++++++++||||+++++++...+  .
T Consensus        39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  118 (326)
T 2w1i_A           39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN  118 (326)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred             CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence            345688889999999999999984     368899999998776677788999999999999999999999987644  7


Q ss_pred             eeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccC
Q 039799          174 KALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  253 (346)
Q Consensus       174 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~  253 (346)
                      .++||||+++++|.+++......+++..++.++.+++.||+|||   +.+|+||||||+||+++.++.++|+|||++...
T Consensus       119 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~  195 (326)
T 2w1i_A          119 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVL  195 (326)
T ss_dssp             CEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence            88999999999999999877677999999999999999999999   999999999999999999999999999999876


Q ss_pred             Cccccc-cccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCcccc-------Ccc-------cHHHH
Q 039799          254 LEEDQS-LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFS-------GEM-------TLKRW  318 (346)
Q Consensus       254 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~-------~~~-------~~~~~  318 (346)
                      ...... .......++..|+|||.+.+..++.++||||||++++||+||..|+.....       ...       .+.+.
T Consensus       196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (326)
T 2w1i_A          196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL  275 (326)
T ss_dssp             CSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred             cccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHH
Confidence            543221 112234577889999998888889999999999999999999999864210       000       11111


Q ss_pred             Hh--------hhcCCChhhhhchhccCCccccccc
Q 039799          319 VN--------DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       319 ~~--------~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      +.        ..++..+.+++.+||..+|++||++
T Consensus       276 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~  310 (326)
T 2w1i_A          276 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSF  310 (326)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred             hhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCH
Confidence            11        1234578999999999999999985

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.8e-42  Score=311.51  Aligned_cols=237  Identities=22%  Similarity=0.316  Sum_probs=191.8

Q ss_pred             CCCCCCCcccccCceEEEEEEE----cCCCEEEEEEecCCC----chhHHHHHHHHHHHHhc-CCCCceeeEEEEecCCc
Q 039799          103 NDANMPPLIGKGGFGSVYKAII----QDGMEVAVKVFDPQY----EGAFKSFDIECDVMKRI-CHRNLIKIISSYSNDDF  173 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  173 (346)
                      ++|.+.+.||+|+||.||+++.    .+++.||||++....    ....+.+.+|+++++++ .||||+++++++...+.
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            5688899999999999999987    378999999986431    12335566799999999 69999999999999999


Q ss_pred             eeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccC
Q 039799          174 KALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  253 (346)
Q Consensus       174 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~  253 (346)
                      .++||||+++++|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+
T Consensus       134 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~  209 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  209 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             EEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence            99999999999999998644 46889999999999999999999   999999999999999999999999999999866


Q ss_pred             CccccccccccccCCcccccCCCCCC--CCCCcchhHHHHHHHHHHHHcCCCCCCccccCcc--cHHHHHh-------hh
Q 039799          254 LEEDQSLTQTQTLATIGYMAPEYGRE--GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM--TLKRWVN-------DL  322 (346)
Q Consensus       254 ~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~--~~~~~~~-------~~  322 (346)
                      ..... .......||+.|+|||++.+  ..++.++||||||+++|||+||+.||........  .+.+.+.       ..
T Consensus       210 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (355)
T 1vzo_A          210 VADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE  288 (355)
T ss_dssp             CGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTT
T ss_pred             ccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCcc
Confidence            43222 22234569999999999875  3478999999999999999999999975322211  1111111       11


Q ss_pred             cCCChhhhhchhccCCcccccc
Q 039799          323 LPISVMEVVDANLLSQEDEHFT  344 (346)
Q Consensus       323 ~~~~~~~~~d~~l~~~p~~R~~  344 (346)
                      ++..+.+++.+||..||++||+
T Consensus       289 ~~~~~~~li~~~L~~dP~~R~~  310 (355)
T 1vzo_A          289 MSALAKDLIQRLLMKDPKKRLG  310 (355)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSTT
T ss_pred             cCHHHHHHHHHHhhhCHHHhcC
Confidence            2336789999999999999993

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.1e-41  Score=309.52  Aligned_cols=234  Identities=22%  Similarity=0.327  Sum_probs=186.5

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEec---------
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSN---------  170 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~---------  170 (346)
                      ...+|.+.+.||+|+||.||+|... +|+.||+|++......    ..+|+++++.++||||+++++++..         
T Consensus         5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~   80 (383)
T 3eb0_A            5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPP   80 (383)
T ss_dssp             -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC--------
T ss_pred             ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccccc
Confidence            3467899999999999999999865 7999999998654322    2369999999999999999998843         


Q ss_pred             -----------------------------CCceeEEEecCCCCChhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHhc
Q 039799          171 -----------------------------DDFKALVLEYMPHGSLEKCLYL---SNYILDIFQRLDIMIDVASALEYLHF  218 (346)
Q Consensus       171 -----------------------------~~~~~lv~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~  218 (346)
                                                   ....++||||++ ++|.+.+..   ....+++..+..++.|+++||+||| 
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH-  158 (383)
T 3eb0_A           81 QPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH-  158 (383)
T ss_dssp             -----------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH-
T ss_pred             ccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-
Confidence                                         334789999998 587776653   3467999999999999999999999 


Q ss_pred             CCCCCeeecCCCCCceEEC-CCCcEEEeeecCCccCCccccccccccccCCcccccCCCCCCC-CCCcchhHHHHHHHHH
Q 039799          219 GYSAPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLM  296 (346)
Q Consensus       219 ~~~~~i~H~dik~~NIll~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~G~il~  296 (346)
                        +.+|+||||||+|||++ .++.+||+|||+++.+....   ......+|+.|+|||.+.+. .++.++||||+|+++|
T Consensus       159 --~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~  233 (383)
T 3eb0_A          159 --SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG  233 (383)
T ss_dssp             --TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred             --HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHH
Confidence              99999999999999998 68899999999998764332   22344689999999987764 4899999999999999


Q ss_pred             HHHcCCCCCCccccCcc----------------------------------cHHHHHhhhcCCChhhhhchhccCCcccc
Q 039799          297 EIFTRTKPTDEIFSGEM----------------------------------TLKRWVNDLLPISVMEVVDANLLSQEDEH  342 (346)
Q Consensus       297 elltg~~p~~~~~~~~~----------------------------------~~~~~~~~~~~~~~~~~~d~~l~~~p~~R  342 (346)
                      ||++|+.||......+.                                  ..........+..+.+++.+||..||.+|
T Consensus       234 ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  313 (383)
T 3eb0_A          234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLR  313 (383)
T ss_dssp             HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGS
T ss_pred             HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhC
Confidence            99999999975321110                                  01111122234468899999999999999


Q ss_pred             ccc
Q 039799          343 FTT  345 (346)
Q Consensus       343 ~~~  345 (346)
                      ||+
T Consensus       314 ~t~  316 (383)
T 3eb0_A          314 INP  316 (383)
T ss_dssp             CCH
T ss_pred             CCH
Confidence            986

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=5.3e-42  Score=328.12  Aligned_cols=233  Identities=27%  Similarity=0.423  Sum_probs=194.9

Q ss_pred             CCCCCcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecCCCC
Q 039799          105 ANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHG  184 (346)
Q Consensus       105 ~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  184 (346)
                      |.+.+.||+|+||.||+|.+.++..||||++..... ..+.+.+|++++++++||||+++++++.+ +..++||||+++|
T Consensus       269 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~g  346 (535)
T 2h8h_A          269 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKG  346 (535)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTE
T ss_pred             hhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCC
Confidence            555678999999999999999888899999976543 35678999999999999999999999876 6789999999999


Q ss_pred             Chhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccccc
Q 039799          185 SLEKCLYLS-NYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT  263 (346)
Q Consensus       185 sL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~~  263 (346)
                      +|.+++... ...+++..++.++.+++.||+|||   +.+|+||||||+|||+++++.+||+|||+++.+.... .....
T Consensus       347 sL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~~  422 (535)
T 2h8h_A          347 SLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQ  422 (535)
T ss_dssp             EHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH-HHTTC
T ss_pred             cHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc-eeccc
Confidence            999999753 356899999999999999999999   9999999999999999999999999999998764321 11122


Q ss_pred             cccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHhh--------hcCCChhhhhchh
Q 039799          264 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVND--------LLPISVMEVVDAN  334 (346)
Q Consensus       264 ~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~d~~  334 (346)
                      ...++..|+|||.+....++.++||||||+++|||+| |+.||......  .....+..        .++..+.+++.+|
T Consensus       423 ~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~--~~~~~i~~~~~~~~~~~~~~~l~~li~~c  500 (535)
T 2h8h_A          423 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EVLDQVERGYRMPCPPECPESLHDLMCQC  500 (535)
T ss_dssp             STTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH--HHHHHHHTTCCCCCCTTCCHHHHHHHHHH
T ss_pred             CCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCCCCCCCCCCHHHHHHHHHH
Confidence            3446788999999888889999999999999999999 99999764321  12222222        2344689999999


Q ss_pred             ccCCccccccc
Q 039799          335 LLSQEDEHFTT  345 (346)
Q Consensus       335 l~~~p~~R~~~  345 (346)
                      |..||++||+.
T Consensus       501 l~~dP~~RPt~  511 (535)
T 2h8h_A          501 WRKEPEERPTF  511 (535)
T ss_dssp             TCSSGGGSCCH
T ss_pred             cCCChhHCcCH
Confidence            99999999985

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2.7e-41  Score=320.12  Aligned_cols=233  Identities=24%  Similarity=0.334  Sum_probs=193.7

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC--CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEe
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ--YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLE  179 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  179 (346)
                      ++|.+.+.||+|+||+||+|... +++.||+|++...  .......+.+|++++++++||||+++++++......++|||
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  101 (486)
T 3mwu_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE  101 (486)
T ss_dssp             HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence            45888999999999999999976 7899999998532  12235678899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEEC---CCCcEEEeeecCCccCCcc
Q 039799          180 YMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFGMAKPLLEE  256 (346)
Q Consensus       180 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~---~~~~~~l~Dfg~~~~~~~~  256 (346)
                      |+++++|.+.+... ..+++..+..++.+++.||.|||   +.+|+||||||+|||++   .++.+||+|||+++.+...
T Consensus       102 ~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~  177 (486)
T 3mwu_A          102 LYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN  177 (486)
T ss_dssp             CCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred             cCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence            99999999888644 46899999999999999999999   99999999999999995   4568999999999865432


Q ss_pred             ccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH-h----------hhcCC
Q 039799          257 DQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV-N----------DLLPI  325 (346)
Q Consensus       257 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~-~----------~~~~~  325 (346)
                      .   ......||+.|+|||.+.+ .++.++||||+||++|+|++|+.||......  .....+ .          ..++.
T Consensus       178 ~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~s~  251 (486)
T 3mwu_A          178 T---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY--DILKRVETGKYAFDLPQWRTISD  251 (486)
T ss_dssp             -------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHTCCCSCSGGGGGSCH
T ss_pred             C---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCCCCCCCcccCCCCH
Confidence            2   2334569999999999865 5899999999999999999999999653211  111111 1          22345


Q ss_pred             ChhhhhchhccCCccccccc
Q 039799          326 SVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       326 ~~~~~~d~~l~~~p~~R~~~  345 (346)
                      .+.+++.+||..||.+|||+
T Consensus       252 ~~~~li~~~L~~dp~~R~t~  271 (486)
T 3mwu_A          252 DAKDLIRKMLTFHPSLRITA  271 (486)
T ss_dssp             HHHHHHHHHTCSSTTTSCCH
T ss_pred             HHHHHHHHHcCCChhhCcCH
Confidence            78999999999999999986

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=6.4e-41  Score=306.17  Aligned_cols=237  Identities=23%  Similarity=0.258  Sum_probs=193.2

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecC-----Cce
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSND-----DFK  174 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~  174 (346)
                      ..+|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            357889999999999999999876 78899999997543 33457788999999999999999999999654     368


Q ss_pred             eEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCC
Q 039799          175 ALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  254 (346)
Q Consensus       175 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~  254 (346)
                      ++||||++ ++|.+++..  ..+++..+..++.+++.||+|||   +.+|+||||||+||+++.++.++|+|||+++...
T Consensus       106 ~iv~e~~~-~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  179 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKT--QHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD  179 (364)
T ss_dssp             EEEEECCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEcccC-cCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence            89999997 589888754  35899999999999999999999   9999999999999999999999999999998765


Q ss_pred             ccccc-cccccccCCcccccCCCCC-CCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHH--------------
Q 039799          255 EEDQS-LTQTQTLATIGYMAPEYGR-EGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRW--------------  318 (346)
Q Consensus       255 ~~~~~-~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~--------------  318 (346)
                      ..... .......||+.|+|||.+. ...++.++||||+|+++|||++|+.||......+. +...              
T Consensus       180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~  258 (364)
T 3qyz_A          180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ-LNHILGILGSPSQEDLNC  258 (364)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH-HHHHHHHHCSCCHHHHHT
T ss_pred             CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH-HHHHHHHhCCCCHHHHHH
Confidence            43221 1123457999999999754 44589999999999999999999999975322111 0000              


Q ss_pred             -----------------------HhhhcCCChhhhhchhccCCccccccc
Q 039799          319 -----------------------VNDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       319 -----------------------~~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                                             ....++..+.+++.+||..||++|||+
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  308 (364)
T 3qyz_A          259 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV  308 (364)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             hhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCH
Confidence                                   012234478899999999999999986

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.5e-41  Score=321.74  Aligned_cols=234  Identities=23%  Similarity=0.344  Sum_probs=196.9

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEE
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALV  177 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  177 (346)
                      .++|.+.+.||+|+||.||+|... +|+.||||++....   ....+.+.+|++++++++||||+++++++...+..++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            356888999999999999999976 78999999986432   33467888999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEE---CCCCcEEEeeecCCccCC
Q 039799          178 LEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLL  254 (346)
Q Consensus       178 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll---~~~~~~~l~Dfg~~~~~~  254 (346)
                      |||+++++|.+.+.. ...+++..+..++.+++.||+|||   +.+|+||||||+|||+   +.++.+||+|||+++.+.
T Consensus       105 ~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  180 (484)
T 3nyv_A          105 GEVYTGGELFDEIIS-RKRFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE  180 (484)
T ss_dssp             ECCCCSCBHHHHHHT-CSCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred             EecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence            999999999998864 356899999999999999999999   9999999999999999   467899999999998664


Q ss_pred             ccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh-----------hhc
Q 039799          255 EEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN-----------DLL  323 (346)
Q Consensus       255 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~-----------~~~  323 (346)
                      ...   ......||+.|+|||.+.+ .++.++||||+|+++|||++|+.||.....  ......+.           ..+
T Consensus       181 ~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~  254 (484)
T 3nyv_A          181 ASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE--YDILKKVEKGKYTFELPQWKKV  254 (484)
T ss_dssp             CCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCCCCCCSGGGGGS
T ss_pred             ccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHcCCCCCCCcccccC
Confidence            322   2234569999999998865 689999999999999999999999975321  11111111           234


Q ss_pred             CCChhhhhchhccCCccccccc
Q 039799          324 PISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       324 ~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      +..+.+++.+||..+|.+|||+
T Consensus       255 s~~~~~li~~~L~~dp~~R~s~  276 (484)
T 3nyv_A          255 SESAKDLIRKMLTYVPSMRISA  276 (484)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CHHHHHHHHHHCCCChhHCcCH
Confidence            5578899999999999999986

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=4e-41  Score=302.75  Aligned_cols=238  Identities=24%  Similarity=0.317  Sum_probs=189.9

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhc-CCCCceeeEEEEec------CC
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRI-CHRNLIKIISSYSN------DD  172 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~------~~  172 (346)
                      ....|.+.+.||+|+||.||+|... +++.||+|++..... ..+.+.+|+.+++++ +||||+++++++..      .+
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~  100 (326)
T 2x7f_A           22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD  100 (326)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCC
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccc
Confidence            4567889999999999999999975 789999999875432 346788999999999 89999999999876      46


Q ss_pred             ceeEEEecCCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCc
Q 039799          173 FKALVLEYMPHGSLEKCLYLSN-YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAK  251 (346)
Q Consensus       173 ~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~  251 (346)
                      ..++||||+++++|.+++.... ..+++..+..++.+++.||+|||   +.+++||||||+||+++.++.++|+|||++.
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  177 (326)
T 2x7f_A          101 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSA  177 (326)
T ss_dssp             EEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCTTTC
T ss_pred             eEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCCEEEeeCcCce
Confidence            7899999999999999987543 56899999999999999999999   9999999999999999999999999999998


Q ss_pred             cCCccccccccccccCCcccccCCCCC-----CCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh------
Q 039799          252 PLLEEDQSLTQTQTLATIGYMAPEYGR-----EGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN------  320 (346)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~------  320 (346)
                      ......  .......+++.|+|||.+.     +..++.++||||||+++|||+||+.||....... .......      
T Consensus       178 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~  254 (326)
T 2x7f_A          178 QLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-ALFLIPRNPAPRL  254 (326)
T ss_dssp             ---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSCCCCC
T ss_pred             ecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH-HHHHhhcCccccC
Confidence            654321  1123346899999999876     5668899999999999999999999996532111 1111111      


Q ss_pred             --hhcCCChhhhhchhccCCccccccc
Q 039799          321 --DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       321 --~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                        ..++..+.+++.+||..||.+||++
T Consensus       255 ~~~~~~~~l~~li~~~l~~dp~~Rps~  281 (326)
T 2x7f_A          255 KSKKWSKKFQSFIESCLVKNHSQRPAT  281 (326)
T ss_dssp             SCSCSCHHHHHHHHHHCCSSGGGSCCH
T ss_pred             CccccCHHHHHHHHHHhccChhhCCCH
Confidence              1234478999999999999999985

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=7.1e-42  Score=301.51  Aligned_cols=230  Identities=24%  Similarity=0.408  Sum_probs=192.7

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEec-----------
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSN-----------  170 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-----------  170 (346)
                      .+|.+.+.||+|+||.||+|... +++.||+|++....    +.+.+|++++++++||||+++++++..           
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   86 (284)
T 2a19_B           11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN   86 (284)
T ss_dssp             HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred             cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence            35778899999999999999987 79999999997653    345679999999999999999998854           


Q ss_pred             -----CCceeEEEecCCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEE
Q 039799          171 -----DDFKALVLEYMPHGSLEKCLYLS-NYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHL  244 (346)
Q Consensus       171 -----~~~~~lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l  244 (346)
                           ....++||||+++++|.+++... ...+++..++.++.+++.||.|||   +.+|+||||||+||++++++.++|
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl  163 (284)
T 2a19_B           87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKI  163 (284)
T ss_dssp             --CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEE
T ss_pred             ccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCCCEEE
Confidence                 44578999999999999998754 357899999999999999999999   999999999999999999999999


Q ss_pred             eeecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH----h
Q 039799          245 SDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV----N  320 (346)
Q Consensus       245 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~----~  320 (346)
                      +|||++.......   ......+++.|+|||...+..++.++||||||+++|||++|..|+.....   ......    .
T Consensus       164 ~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~~~~~~~~~~  237 (284)
T 2a19_B          164 GDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK---FFTDLRDGIIS  237 (284)
T ss_dssp             CCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH---HHHHHHTTCCC
T ss_pred             Ccchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH---HHHHhhccccc
Confidence            9999998764332   22344689999999999888899999999999999999999998754210   111111    1


Q ss_pred             hhcCCChhhhhchhccCCccccccc
Q 039799          321 DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       321 ~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ..++..+.+++.+||..||.+||++
T Consensus       238 ~~~~~~~~~li~~~l~~dp~~Rps~  262 (284)
T 2a19_B          238 DIFDKKEKTLLQKLLSKKPEDRPNT  262 (284)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             ccCCHHHHHHHHHHccCChhhCcCH
Confidence            2344578899999999999999985

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.9e-41  Score=305.23  Aligned_cols=235  Identities=29%  Similarity=0.428  Sum_probs=191.6

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCE--EEEEEecCC-CchhHHHHHHHHHHHHhc-CCCCceeeEEEEecCCceeEE
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGME--VAVKVFDPQ-YEGAFKSFDIECDVMKRI-CHRNLIKIISSYSNDDFKALV  177 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~--vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  177 (346)
                      ++|.+.+.||+|+||.||+|... ++..  +|+|.+... .....+.+.+|+++++++ +||||+++++++...+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            56888899999999999999865 5664  499988643 233456788999999999 899999999999999999999


Q ss_pred             EecCCCCChhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcE
Q 039799          178 LEYMPHGSLEKCLYLSN---------------YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVA  242 (346)
Q Consensus       178 ~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~  242 (346)
                      |||+++++|.+++....               ..+++..++.++.+++.||+|||   +.+|+||||||+||+++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCeE
Confidence            99999999999986543               46899999999999999999999   9999999999999999999999


Q ss_pred             EEeeecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHhh
Q 039799          243 HLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVND  321 (346)
Q Consensus       243 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~  321 (346)
                      +|+|||+++.....   .......+++.|+|||.+.+..++.++||||||+++|||+| |+.||......  .....+..
T Consensus       182 kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~--~~~~~~~~  256 (327)
T 1fvr_A          182 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--ELYEKLPQ  256 (327)
T ss_dssp             EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHGGG
T ss_pred             EEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH--HHHHHhhc
Confidence            99999998753221   11223346889999999888888999999999999999998 99999753211  12222221


Q ss_pred             --------hcCCChhhhhchhccCCccccccc
Q 039799          322 --------LLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       322 --------~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                              .++..+.+++.+||..+|++||++
T Consensus       257 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  288 (327)
T 1fvr_A          257 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSF  288 (327)
T ss_dssp             TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCCCCCCCCCCHHHHHHHHHHccCChhhCcCH
Confidence                    234478899999999999999985

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.2e-41  Score=307.54  Aligned_cols=235  Identities=30%  Similarity=0.420  Sum_probs=179.0

Q ss_pred             CCCCCCCCcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHH--HHhcCCCCceeeEEEEec-----CCce
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDV--MKRICHRNLIKIISSYSN-----DDFK  174 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~--l~~l~h~niv~~~~~~~~-----~~~~  174 (346)
                      .++|.+.+.||+|+||.||+|+. +++.||||++....   ...+..|.++  +..++||||+++++.+..     ....
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            36788899999999999999977 48999999986432   2334444444  556899999999985532     2356


Q ss_pred             eEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCC---------CeeecCCCCCceEECCCCcEEEe
Q 039799          175 ALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSA---------PIIHCDLKPSNVLLDDNMVAHLS  245 (346)
Q Consensus       175 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~---------~i~H~dik~~NIll~~~~~~~l~  245 (346)
                      ++||||+++|+|.+++....  .++..++.++.+++.||+|||   +.         +|+||||||+|||++.++.+||+
T Consensus        88 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~  162 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS  162 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred             EEEEecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcEEEe
Confidence            89999999999999986443  488899999999999999999   77         99999999999999999999999


Q ss_pred             eecCCccCCccc------cccccccccCCcccccCCCCCC-------CCCCcchhHHHHHHHHHHHHcCCCCCCccccCc
Q 039799          246 DFGMAKPLLEED------QSLTQTQTLATIGYMAPEYGRE-------GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE  312 (346)
Q Consensus       246 Dfg~~~~~~~~~------~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~  312 (346)
                      |||+++.+....      .........||+.|+|||.+.+       ..++.++||||||+++|||+||..|+.......
T Consensus       163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~  242 (336)
T 3g2f_A          163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP  242 (336)
T ss_dssp             CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred             eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence            999998764321      1122234569999999998876       356678999999999999999977763321110


Q ss_pred             c-------------cHHH---HHh-----hhcCC----------ChhhhhchhccCCccccccc
Q 039799          313 M-------------TLKR---WVN-----DLLPI----------SVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       313 ~-------------~~~~---~~~-----~~~~~----------~~~~~~d~~l~~~p~~R~~~  345 (346)
                      .             ....   .+.     ..++.          .+.+++.+||..||++|||+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~  306 (336)
T 3g2f_A          243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTA  306 (336)
T ss_dssp             CCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCH
T ss_pred             HHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcch
Confidence            0             0000   010     11111          38899999999999999986

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=5.8e-41  Score=301.34  Aligned_cols=234  Identities=27%  Similarity=0.348  Sum_probs=189.5

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC--------chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCc
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY--------EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDF  173 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  173 (346)
                      ++|.+.+.||+|+||.||+|... +++.||||++....        ......+.+|++++++++||||+++++++...+ 
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   88 (322)
T 2ycf_A           10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-   88 (322)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred             hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence            45888899999999999999976 68899999986432        112345788999999999999999999987665 


Q ss_pred             eeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCc---EEEeeecCC
Q 039799          174 KALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV---AHLSDFGMA  250 (346)
Q Consensus       174 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~---~~l~Dfg~~  250 (346)
                      .++||||+++++|.+++.. ...+++.....++.+++.||+|||   +.+|+||||||+||+++.++.   ++|+|||++
T Consensus        89 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~  164 (322)
T 2ycf_A           89 YYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS  164 (322)
T ss_dssp             EEEEEECCTTEETHHHHST-TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred             eEEEEecCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence            7899999999999998863 456899999999999999999999   999999999999999987654   999999999


Q ss_pred             ccCCccccccccccccCCcccccCCCC---CCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH--------
Q 039799          251 KPLLEEDQSLTQTQTLATIGYMAPEYG---REGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV--------  319 (346)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~y~aPE~~---~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~--------  319 (346)
                      +......   ......||+.|+|||.+   ....++.++||||||+++|||++|+.||....... .+...+        
T Consensus       165 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~  240 (322)
T 2ycf_A          165 KILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV-SLKDQITSGKYNFI  240 (322)
T ss_dssp             EECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS-CHHHHHHHTCCCCC
T ss_pred             eeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH-HHHHHHHhCccccC
Confidence            8764321   12234589999999985   35678899999999999999999999997643222 222221        


Q ss_pred             ---hhhcCCChhhhhchhccCCccccccc
Q 039799          320 ---NDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       320 ---~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                         ...++..+.+++.+||..||++||++
T Consensus       241 ~~~~~~~~~~~~~li~~~l~~dP~~Rps~  269 (322)
T 2ycf_A          241 PEVWAEVSEKALDLVKKLLVVDPKARFTT  269 (322)
T ss_dssp             HHHHTTSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred             chhhhhcCHHHHHHHHHHcccCHhhCCCH
Confidence               22345578999999999999999985

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.2e-40  Score=313.73  Aligned_cols=239  Identities=19%  Similarity=0.245  Sum_probs=197.3

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCC-CceeeEEEEecCCceeEEE
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHR-NLIKIISSYSNDDFKALVL  178 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~lv~  178 (346)
                      ..++|.+.+.||+|+||.||+|... +++.||||++.....  ...+..|+++++.++|+ ++..+..++...+..++||
T Consensus         5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm   82 (483)
T 3sv0_A            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM   82 (483)
T ss_dssp             ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence            3467999999999999999999964 789999999865432  24577899999999874 5555666667888899999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEE---CCCCcEEEeeecCCccCCc
Q 039799          179 EYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLE  255 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll---~~~~~~~l~Dfg~~~~~~~  255 (346)
                      ||+ +++|.+++......+++..++.++.||+.||+|||   +.+|+||||||+|||+   +.++.+||+|||+++.+..
T Consensus        83 e~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~  158 (483)
T 3sv0_A           83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD  158 (483)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             ECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence            999 99999999876778999999999999999999999   9999999999999999   5889999999999997654


Q ss_pred             cccc-----cccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcc--cHH-----------H
Q 039799          256 EDQS-----LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM--TLK-----------R  317 (346)
Q Consensus       256 ~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~--~~~-----------~  317 (346)
                      ....     .......||..|+|||.+.+..++.++|||||||++|||++|+.||........  .+.           .
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~  238 (483)
T 3sv0_A          159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIE  238 (483)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred             CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHH
Confidence            3221     112255699999999999999999999999999999999999999986433221  111           1


Q ss_pred             HHhhhcCCChhhhhchhccCCccccccc
Q 039799          318 WVNDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       318 ~~~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      .....++..+.+++..||..+|++||+.
T Consensus       239 ~l~~~~p~~l~~li~~cl~~dP~~RPs~  266 (483)
T 3sv0_A          239 ALCRGYPTEFASYFHYCRSLRFDDKPDY  266 (483)
T ss_dssp             HHHTTSCHHHHHHHHHHHTCCTTCCCCH
T ss_pred             HHhcCCcHHHHHHHHHHhcCChhhCcCH
Confidence            1123456689999999999999999975

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=3.2e-41  Score=308.12  Aligned_cols=233  Identities=24%  Similarity=0.325  Sum_probs=175.0

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEecC------C
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSND------D  172 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~  172 (346)
                      .++|.+.+.||+|+||.||+|... +|+.||||++....  ....+.+.+|+++++.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            357888999999999999999865 78999999986532  33457788999999999999999999998654      5


Q ss_pred             ceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCcc
Q 039799          173 FKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  252 (346)
Q Consensus       173 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~  252 (346)
                      ..++|+|++ +++|.+++..  ..+++..+..++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~  181 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARH  181 (367)
T ss_dssp             CCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC------
T ss_pred             eEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeecccccc
Confidence            678999999 7899888754  46899999999999999999999   99999999999999999999999999999986


Q ss_pred             CCccccccccccccCCcccccCCCCCC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccCcc------------------
Q 039799          253 LLEEDQSLTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM------------------  313 (346)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~------------------  313 (346)
                      ....     .....+|+.|+|||.+.+ ..++.++||||+||+++||++|+.||......+.                  
T Consensus       182 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~  256 (367)
T 2fst_X          182 TADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK  256 (367)
T ss_dssp             --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred             cccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence            5321     234568999999998876 6789999999999999999999999965321100                  


Q ss_pred             ----cHHHHHh--------------hhcCCChhhhhchhccCCccccccc
Q 039799          314 ----TLKRWVN--------------DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       314 ----~~~~~~~--------------~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                          ....++.              ...+..+.+++.+||..||++|||+
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~  306 (367)
T 2fst_X          257 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA  306 (367)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred             hhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCH
Confidence                0001110              1123357899999999999999986

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=5.6e-41  Score=302.13  Aligned_cols=234  Identities=21%  Similarity=0.297  Sum_probs=191.1

Q ss_pred             CCCC-CcccccCceEEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHHhcC-CCCceeeEEEEecCCceeEEEe
Q 039799          105 ANMP-PLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRIC-HRNLIKIISSYSNDDFKALVLE  179 (346)
Q Consensus       105 ~~~~-~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e  179 (346)
                      |.+. +.||+|+||.||+|... +++.||+|++....  ......+.+|+.++.++. ||||+++++++...+..++|||
T Consensus        30 y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e  109 (327)
T 3lm5_A           30 YILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILE  109 (327)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred             EeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEE
Confidence            4454 78999999999999976 68999999987532  233577889999999995 6999999999999999999999


Q ss_pred             cCCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC---CCcEEEeeecCCccCCc
Q 039799          180 YMPHGSLEKCLYLS-NYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD---NMVAHLSDFGMAKPLLE  255 (346)
Q Consensus       180 ~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~---~~~~~l~Dfg~~~~~~~  255 (346)
                      |+++++|.+++... ...+++..++.++.+++.||+|||   +.+|+||||||+||+++.   ++.++|+|||+++....
T Consensus       110 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~  186 (327)
T 3lm5_A          110 YAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH  186 (327)
T ss_dssp             CCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--
T ss_pred             ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCC
Confidence            99999999987543 356899999999999999999999   999999999999999987   78999999999987643


Q ss_pred             cccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH----------hhhcCC
Q 039799          256 EDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV----------NDLLPI  325 (346)
Q Consensus       256 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~----------~~~~~~  325 (346)
                      ..   ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+. .....          ...++.
T Consensus       187 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~  262 (327)
T 3lm5_A          187 AC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET-YLNISQVNVDYSEETFSSVSQ  262 (327)
T ss_dssp             ----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHTCCCCCTTTTTTSCH
T ss_pred             cc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH-HHHHHhcccccCchhhcccCH
Confidence            22   12345689999999999989999999999999999999999999965322111 11111          112344


Q ss_pred             ChhhhhchhccCCccccccc
Q 039799          326 SVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       326 ~~~~~~d~~l~~~p~~R~~~  345 (346)
                      .+.+++.+||..||++||++
T Consensus       263 ~~~~li~~~L~~dP~~Rpt~  282 (327)
T 3lm5_A          263 LATDFIQSLLVKNPEKRPTA  282 (327)
T ss_dssp             HHHHHHHHHSCSSGGGSCCH
T ss_pred             HHHHHHHHHcCCChhhCcCH
Confidence            68899999999999999986

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.6e-41  Score=314.55  Aligned_cols=205  Identities=21%  Similarity=0.301  Sum_probs=157.1

Q ss_pred             cCCCCCCCCCC-CCcccccCceEEEEEEEc---CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEe--c
Q 039799           97 RGKPLPNDANM-PPLIGKGGFGSVYKAIIQ---DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYS--N  170 (346)
Q Consensus        97 ~~~~~~~~~~~-~~~lg~G~~g~vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~  170 (346)
                      .+....+.|.+ .+.||+|+||.||+|.+.   +++.||+|++....  ....+.+|++++++++||||+++++++.  .
T Consensus        14 ~~~~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~   91 (405)
T 3rgf_A           14 ERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHA   91 (405)
T ss_dssp             HCCCHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETT
T ss_pred             hhhhhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCC
Confidence            34444455666 568999999999999965   57889999997543  2356788999999999999999999994  4


Q ss_pred             CCceeEEEecCCCCChhhhhhhcC--------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEE----CC
Q 039799          171 DDFKALVLEYMPHGSLEKCLYLSN--------YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL----DD  238 (346)
Q Consensus       171 ~~~~~lv~e~~~~gsL~~~l~~~~--------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll----~~  238 (346)
                      ....++||||+++ +|.+++....        ..+++..+..++.+++.||+|||   +.+|+||||||+|||+    +.
T Consensus        92 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~  167 (405)
T 3rgf_A           92 DRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPE  167 (405)
T ss_dssp             TTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTT
T ss_pred             CCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCC
Confidence            6788999999964 7777664221        24899999999999999999999   9999999999999999    67


Q ss_pred             CCcEEEeeecCCccCCcccc-ccccccccCCcccccCCCCCCC-CCCcchhHHHHHHHHHHHHcCCCCCCc
Q 039799          239 NMVAHLSDFGMAKPLLEEDQ-SLTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMEIFTRTKPTDE  307 (346)
Q Consensus       239 ~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~  307 (346)
                      ++.+||+|||+++.+..... ........||+.|+|||.+.+. .++.++|||||||++|||+||+.||..
T Consensus       168 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~  238 (405)
T 3rgf_A          168 RGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  238 (405)
T ss_dssp             TTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             CCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCC
Confidence            78999999999987643221 1223345689999999988764 589999999999999999999999964

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.1e-41  Score=301.49  Aligned_cols=238  Identities=26%  Similarity=0.372  Sum_probs=188.0

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc--CCC--EEEEEEecCC---CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCce
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ--DGM--EVAVKVFDPQ---YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFK  174 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  174 (346)
                      .++|.+.+.||+|+||.||+|.+.  +++  .||+|++...   .....+.+.+|++++++++||||+++++++.... .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            356888999999999999999864  333  6899998754   2345678889999999999999999999998765 7


Q ss_pred             eEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCC
Q 039799          175 ALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  254 (346)
Q Consensus       175 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~  254 (346)
                      ++|+||+++++|.+++......+++..+..++.+++.||+|||   +.+++||||||+||+++.++.++|+|||++....
T Consensus        96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  172 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP  172 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence            8999999999999999876677999999999999999999999   9999999999999999999999999999998765


Q ss_pred             ccccc-cccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHH-h--------hhc
Q 039799          255 EEDQS-LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWV-N--------DLL  323 (346)
Q Consensus       255 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~-~--------~~~  323 (346)
                      ..... .......++..|+|||...+..++.++||||||+++|||++ |+.||......  .....+ .        ..+
T Consensus       173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~  250 (291)
T 1u46_A          173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS--QILHKIDKEGERLPRPEDC  250 (291)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTSCCCCCCCTTC
T ss_pred             ccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH--HHHHHHHccCCCCCCCcCc
Confidence            43322 12233457888999999888888999999999999999999 99999753211  111111 1        223


Q ss_pred             CCChhhhhchhccCCccccccc
Q 039799          324 PISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       324 ~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      +..+.+++.+||..+|++||++
T Consensus       251 ~~~l~~li~~~l~~~p~~Rps~  272 (291)
T 1u46_A          251 PQDIYNVMVQCWAHKPEDRPTF  272 (291)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CHHHHHHHHHHccCCcccCcCH
Confidence            4578999999999999999985

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=9e-41  Score=311.38  Aligned_cols=196  Identities=23%  Similarity=0.307  Sum_probs=170.5

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhc------CCCCceeeEEEEecCCce
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRI------CHRNLIKIISSYSNDDFK  174 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~~~~~~~~~~~~  174 (346)
                      ..+|.+.+.||+|+||.||+|... +++.||||++... ......+.+|+++++.+      .|+||+++++++...+..
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            456888999999999999999876 6889999999754 33446677888888877      577999999999999999


Q ss_pred             eEEEecCCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCc--EEEeeecCCc
Q 039799          175 ALVLEYMPHGSLEKCLYLSN-YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV--AHLSDFGMAK  251 (346)
Q Consensus       175 ~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~--~~l~Dfg~~~  251 (346)
                      ++||||+. ++|.+++.... ..+++..+..++.+++.||+|||   +.+|+||||||+|||++.++.  +||+|||+++
T Consensus       175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~  250 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC  250 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred             EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence            99999996 68988886554 45899999999999999999999   999999999999999999887  9999999997


Q ss_pred             cCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 039799          252 PLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDE  307 (346)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~  307 (346)
                      .....     .....+|+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus       251 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~  301 (429)
T 3kvw_A          251 YEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPG  301 (429)
T ss_dssp             ETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCC
Confidence            54321     2345689999999999888999999999999999999999999965

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.4e-41  Score=299.07  Aligned_cols=231  Identities=32%  Similarity=0.422  Sum_probs=187.4

Q ss_pred             CCCCCCCCcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecC-CceeEEEec
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSND-DFKALVLEY  180 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~  180 (346)
                      .++|.+.+.||+|++|.||++... |+.||+|++....  ..+.+.+|++++++++||||+++++++.+. +..++||||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            356888899999999999999876 8899999987543  457788999999999999999999987654 478999999


Q ss_pred             CCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccc
Q 039799          181 MPHGSLEKCLYLSN-YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  259 (346)
Q Consensus       181 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~  259 (346)
                      +++++|.+++.... ..+++..++.++.+++.||+|||   +.+++||||||+||+++.++.++|+|||++......   
T Consensus        97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~---  170 (278)
T 1byg_A           97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---  170 (278)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeecccccccccc---
Confidence            99999999986543 24788999999999999999999   999999999999999999999999999999865322   


Q ss_pred             cccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHh--------hhcCCChhhh
Q 039799          260 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVN--------DLLPISVMEV  330 (346)
Q Consensus       260 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~  330 (346)
                        .....+++.|+|||...+..++.++||||||+++|||+| |+.||.....  ......+.        ..++..+.++
T Consensus       171 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~l  246 (278)
T 1byg_A          171 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPRVEKGYKMDAPDGCPPAVYEV  246 (278)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG--GGHHHHHTTTCCCCCCTTCCHHHHHH
T ss_pred             --ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHhcCCCCCCcccCCHHHHHH
Confidence              122347889999999888889999999999999999998 9999976322  12222222        2234478999


Q ss_pred             hchhccCCccccccc
Q 039799          331 VDANLLSQEDEHFTT  345 (346)
Q Consensus       331 ~d~~l~~~p~~R~~~  345 (346)
                      +.+||..||++||++
T Consensus       247 i~~~l~~~p~~Rps~  261 (278)
T 1byg_A          247 MKNCWHLDAAMRPSF  261 (278)
T ss_dssp             HHHHTCSSGGGSCCH
T ss_pred             HHHHhcCChhhCCCH
Confidence            999999999999985

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=6.8e-41  Score=306.71  Aligned_cols=195  Identities=26%  Similarity=0.286  Sum_probs=161.6

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC--CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCC------c
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ--YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDD------F  173 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~  173 (346)
                      ++|.+.+.||+|+||.||+|... +++.||||++...  .....+.+.+|+.+++.++||||+++++++...+      .
T Consensus        25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  104 (371)
T 2xrw_A           25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD  104 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred             hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence            57889999999999999999866 6889999998753  2344567889999999999999999999997655      6


Q ss_pred             eeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccC
Q 039799          174 KALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  253 (346)
Q Consensus       174 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~  253 (346)
                      .++||||+++ +|.+.+.   ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       105 ~~lv~e~~~~-~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~  177 (371)
T 2xrw_A          105 VYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  177 (371)
T ss_dssp             EEEEEECCSE-EHHHHHH---SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred             eEEEEEcCCC-CHHHHHh---hccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence            7999999975 7777764   34889999999999999999999   999999999999999999999999999999865


Q ss_pred             CccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 039799          254 LEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDE  307 (346)
Q Consensus       254 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~  307 (346)
                      ...   .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       178 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  228 (371)
T 2xrw_A          178 GTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG  228 (371)
T ss_dssp             ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ccc---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence            322   122345689999999999988999999999999999999999999965

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=5.6e-41  Score=300.70  Aligned_cols=239  Identities=21%  Similarity=0.260  Sum_probs=188.5

Q ss_pred             CCCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEe---------
Q 039799          100 PLPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYS---------  169 (346)
Q Consensus       100 ~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~---------  169 (346)
                      .+.++|.+.+.||+|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++.         
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   87 (320)
T 2i6l_A            8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD   87 (320)
T ss_dssp             EETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred             ccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence            34567899999999999999999977 58999999998776666788999999999999999999999873         


Q ss_pred             -----cCCceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEEC-CCCcEE
Q 039799          170 -----NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD-DNMVAH  243 (346)
Q Consensus       170 -----~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~-~~~~~~  243 (346)
                           +....++||||++ |+|.+++..  ..+++..+..++.+++.||+|||   +.+|+||||||+||+++ +++.+|
T Consensus        88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~k  161 (320)
T 2i6l_A           88 VGSLTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLK  161 (320)
T ss_dssp             ---CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEEE
T ss_pred             cccccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeEE
Confidence                 3467889999997 599998853  45889999999999999999999   99999999999999997 567999


Q ss_pred             EeeecCCccCCcccc-ccccccccCCcccccCCCCCC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHH---
Q 039799          244 LSDFGMAKPLLEEDQ-SLTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRW---  318 (346)
Q Consensus       244 l~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~---  318 (346)
                      |+|||+++....... ........++..|+|||.... ..++.++||||||+++|||+||+.||......+. ....   
T Consensus       162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-~~~~~~~  240 (320)
T 2i6l_A          162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ-MQLILES  240 (320)
T ss_dssp             ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHH
T ss_pred             EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHh
Confidence            999999987643211 112233457899999997654 6789999999999999999999999975321110 0000   


Q ss_pred             ---------------------------------HhhhcCCChhhhhchhccCCccccccc
Q 039799          319 ---------------------------------VNDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       319 ---------------------------------~~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                                                       ....++..+.+++.+||..||++||++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  300 (320)
T 2i6l_A          241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTA  300 (320)
T ss_dssp             SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCH
T ss_pred             cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCH
Confidence                                             012245578999999999999999986

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.8e-41  Score=300.37  Aligned_cols=236  Identities=24%  Similarity=0.343  Sum_probs=192.1

Q ss_pred             CCCCCCC-cccccCceEEEEEEEc---CCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeE
Q 039799          103 NDANMPP-LIGKGGFGSVYKAIIQ---DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKAL  176 (346)
Q Consensus       103 ~~~~~~~-~lg~G~~g~vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  176 (346)
                      .+|.+.+ .||+|+||.||+|.+.   +++.||+|++....  ....+.+.+|++++++++||||+++++++ ..+..++
T Consensus        16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l   94 (291)
T 1xbb_A           16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML   94 (291)
T ss_dssp             GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred             hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence            4566666 9999999999999643   46789999997542  33467889999999999999999999999 5667889


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcc
Q 039799          177 VLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  256 (346)
Q Consensus       177 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~  256 (346)
                      ||||+++++|.+++.. ...+++..++.++.+++.||+|||   +.+++||||||+||+++.++.++|+|||++......
T Consensus        95 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  170 (291)
T 1xbb_A           95 VMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD  170 (291)
T ss_dssp             EEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred             EEEeCCCCCHHHHHHh-CcCCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccC
Confidence            9999999999999875 345899999999999999999999   999999999999999999999999999999876443


Q ss_pred             ccc-cccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHh--------hhcCCC
Q 039799          257 DQS-LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVN--------DLLPIS  326 (346)
Q Consensus       257 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~--------~~~~~~  326 (346)
                      ... .......+++.|+|||.+.+..++.++||||||+++|||+| |+.||.....  ......+.        ..++..
T Consensus       171 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  248 (291)
T 1xbb_A          171 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SEVTAMLEKGERMGCPAGCPRE  248 (291)
T ss_dssp             CSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHHTTCCCCCCTTCCHH
T ss_pred             CCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHHcCCCCCCCCCCCHH
Confidence            221 11222346788999999888888999999999999999999 9999976322  12222222        223457


Q ss_pred             hhhhhchhccCCccccccc
Q 039799          327 VMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       327 ~~~~~d~~l~~~p~~R~~~  345 (346)
                      +.+++.+||..||++||++
T Consensus       249 l~~li~~~l~~dp~~Rps~  267 (291)
T 1xbb_A          249 MYDLMNLCWTYDVENRPGF  267 (291)
T ss_dssp             HHHHHHHHTCSSTTTSCCH
T ss_pred             HHHHHHHHcCCChhhCcCH
Confidence            8999999999999999985

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=4.9e-41  Score=310.06  Aligned_cols=198  Identities=24%  Similarity=0.267  Sum_probs=169.2

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcC--------CCCceeeEEEEe--
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRIC--------HRNLIKIISSYS--  169 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~~~~~~~--  169 (346)
                      ...+|.+.+.||+|+||+||+|... +++.||+|++... ....+.+.+|++++++++        |+||+++++++.  
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~  113 (397)
T 1wak_A           35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS  113 (397)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred             cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence            3467999999999999999999865 6889999999754 344577889999999986        788999999987  


Q ss_pred             --cCCceeEEEecCCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeeecCCCCCceEECCCC-----
Q 039799          170 --NDDFKALVLEYMPHGSLEKCLYLS-NYILDIFQRLDIMIDVASALEYLHFGYSA-PIIHCDLKPSNVLLDDNM-----  240 (346)
Q Consensus       170 --~~~~~~lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~i~H~dik~~NIll~~~~-----  240 (346)
                        .....++||||+ ++++.+.+... ...+++..+..++.|++.||+|||   +. +|+||||||+|||++.++     
T Consensus       114 ~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~~~~  189 (397)
T 1wak_A          114 GVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYIRR  189 (397)
T ss_dssp             ETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHHHHH
T ss_pred             CCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchhhhh
Confidence              566889999999 55665555433 367999999999999999999999   87 999999999999999775     


Q ss_pred             --------------------------------------------cEEEeeecCCccCCccccccccccccCCcccccCCC
Q 039799          241 --------------------------------------------VAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEY  276 (346)
Q Consensus       241 --------------------------------------------~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  276 (346)
                                                                  .++|+|||++......     .....||+.|+|||+
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~  264 (397)
T 1wak_A          190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEV  264 (397)
T ss_dssp             HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHH
T ss_pred             hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChh
Confidence                                                        7999999999865322     234568999999999


Q ss_pred             CCCCCCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 039799          277 GREGRVSTNGDVYSFGIMLMEIFTRTKPTDEI  308 (346)
Q Consensus       277 ~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~  308 (346)
                      +.+..++.++|||||||++|||+||+.||...
T Consensus       265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~  296 (397)
T 1wak_A          265 LIGSGYNTPADIWSTACMAFELATGDYLFEPH  296 (397)
T ss_dssp             HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred             hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCC
Confidence            98888999999999999999999999999753

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=8.1e-41  Score=299.19  Aligned_cols=237  Identities=21%  Similarity=0.353  Sum_probs=189.4

Q ss_pred             CCCCCCCcccccCceEEEEEEEcCCCEEEEEEecCCC--chhHHHHHHHHHHHHhcC--CCCceeeEEEEecCCceeEEE
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQY--EGAFKSFDIECDVMKRIC--HRNLIKIISSYSNDDFKALVL  178 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv~  178 (346)
                      .+|.+.+.||+|+||.||++...+++.||+|++....  ....+.+.+|++++++++  ||||+++++++...+..++||
T Consensus        28 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  107 (313)
T 3cek_A           28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  107 (313)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEE
T ss_pred             ceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEE
Confidence            4588899999999999999998889999999986432  345678889999999997  599999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccc
Q 039799          179 EYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  258 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~  258 (346)
                      | +.+++|.+++... ..+++..+..++.++++||+|||   +.+|+||||||+||++++ +.++|+|||+++.......
T Consensus       108 e-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~  181 (313)
T 3cek_A          108 E-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTT  181 (313)
T ss_dssp             C-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEEECCCSSSCC------
T ss_pred             e-cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEEEeeccccccccCccc
Confidence            9 5688999998744 46889999999999999999999   999999999999999965 8999999999997654333


Q ss_pred             ccccccccCCcccccCCCCCC-----------CCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHhhh-----
Q 039799          259 SLTQTQTLATIGYMAPEYGRE-----------GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDL-----  322 (346)
Q Consensus       259 ~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~-----  322 (346)
                      ........|++.|+|||.+.+           ..++.++||||||+++|||++|+.||.................     
T Consensus       182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  261 (313)
T 3cek_A          182 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF  261 (313)
T ss_dssp             --------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCC
T ss_pred             cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCC
Confidence            323334568999999998765           4678899999999999999999999976433222222222211     


Q ss_pred             ---cCCChhhhhchhccCCccccccc
Q 039799          323 ---LPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       323 ---~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                         .+..+.+++.+||..||++||++
T Consensus       262 ~~~~~~~l~~li~~~l~~dp~~Rps~  287 (313)
T 3cek_A          262 PDIPEKDLQDVLKCCLKRDPKQRISI  287 (313)
T ss_dssp             CCCSCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             cccchHHHHHHHHHHccCCcccCcCH
Confidence               12367899999999999999986

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.8e-40  Score=301.76  Aligned_cols=241  Identities=24%  Similarity=0.301  Sum_probs=193.4

Q ss_pred             CCCCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecC-----
Q 039799           99 KPLPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSND-----  171 (346)
Q Consensus        99 ~~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----  171 (346)
                      ....++|.+.+.||+|+||.||+|... +|+.||||++.... ......+.+|++++++++||||+++++++...     
T Consensus         7 ~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   86 (353)
T 2b9h_A            7 YNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENF   86 (353)
T ss_dssp             CCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTC
T ss_pred             cccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCcc
Confidence            345678999999999999999999976 68999999997543 33456788999999999999999999988654     


Q ss_pred             CceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCc
Q 039799          172 DFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAK  251 (346)
Q Consensus       172 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~  251 (346)
                      ...++||||+. ++|.+++..  ..+++..+..++.+++.||+|||   +.+|+||||||+||+++.++.++|+|||+++
T Consensus        87 ~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (353)
T 2b9h_A           87 NEVYIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLAR  160 (353)
T ss_dssp             CCEEEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             ceEEEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence            67899999997 589888764  45899999999999999999999   9999999999999999999999999999998


Q ss_pred             cCCcccccc--------ccccccCCcccccCCCCC-CCCCCcchhHHHHHHHHHHHHcCCCCCCccccCc----------
Q 039799          252 PLLEEDQSL--------TQTQTLATIGYMAPEYGR-EGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE----------  312 (346)
Q Consensus       252 ~~~~~~~~~--------~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~----------  312 (346)
                      .........        ......||+.|+|||.+. +..++.++||||||+++|||++|+.||......+          
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  240 (353)
T 2b9h_A          161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG  240 (353)
T ss_dssp             ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence            764322111        122346899999999764 4678999999999999999999999996532100          


Q ss_pred             -------------ccHHHHH--------------hhhcCCChhhhhchhccCCccccccc
Q 039799          313 -------------MTLKRWV--------------NDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       313 -------------~~~~~~~--------------~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                                   .....+.              ...++..+.+++.+||..||++|||+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  300 (353)
T 2b9h_A          241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITA  300 (353)
T ss_dssp             CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCH
T ss_pred             CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCH
Confidence                         0001111              12345577899999999999999986

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.1e-40  Score=309.98  Aligned_cols=231  Identities=26%  Similarity=0.361  Sum_probs=183.4

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecC------Ccee
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSND------DFKA  175 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~~  175 (346)
                      ..|.+.+.||+|+||.||+|.+. +|+.||||++.....    ...+|++++++++||||+++++++...      .+.+
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            35888899999999999999986 689999999865422    233699999999999999999988432      2467


Q ss_pred             EEEecCCCCChhhhhh---hcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCC-CcEEEeeecCCc
Q 039799          176 LVLEYMPHGSLEKCLY---LSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDN-MVAHLSDFGMAK  251 (346)
Q Consensus       176 lv~e~~~~gsL~~~l~---~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~-~~~~l~Dfg~~~  251 (346)
                      +||||+++ ++.+.+.   .....+++..+..++.|+++||+|||   +.+|+||||||+|||++.+ +.+||+|||+++
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            89999976 5555443   23467899999999999999999999   9999999999999999955 678999999998


Q ss_pred             cCCccccccccccccCCcccccCCCCCCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHH-------------
Q 039799          252 PLLEEDQSLTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKR-------------  317 (346)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~-------------  317 (346)
                      .+.....   .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||......+ .+..             
T Consensus       206 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~-~l~~i~~~lg~p~~~~~  281 (420)
T 1j1b_A          206 QLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEIIKVLGTPTREQI  281 (420)
T ss_dssp             ECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCSCCHHHH
T ss_pred             hcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHH
Confidence            7643221   2345689999999988664 78999999999999999999999997532111 1111             


Q ss_pred             -------------------H---HhhhcCCChhhhhchhccCCccccccc
Q 039799          318 -------------------W---VNDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       318 -------------------~---~~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                                         |   .....+..+.+++.+||..||++||++
T Consensus       282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~  331 (420)
T 1j1b_A          282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTP  331 (420)
T ss_dssp             HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCH
T ss_pred             HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCH
Confidence                               1   111234478899999999999999985

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.3e-40  Score=304.95  Aligned_cols=233  Identities=24%  Similarity=0.334  Sum_probs=188.3

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCce---
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFK---  174 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~---  174 (346)
                      ++++|.+.+.||+|+||.||+|... +|+.||+|++....  ....+.+.+|+.+++.++||||+++++++...+..   
T Consensus        40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  119 (371)
T 4exu_A           40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  119 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred             ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence            3467888999999999999999876 78999999997542  33457788999999999999999999999877655   


Q ss_pred             ---eEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCc
Q 039799          175 ---ALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAK  251 (346)
Q Consensus       175 ---~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~  251 (346)
                         ++||||+. ++|.+.+.   ..+++..+..++.+++.||+|||   +.+|+||||||+||+++.++.++|+|||+++
T Consensus       120 ~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~  192 (371)
T 4exu_A          120 YDFYLVMPFMQ-TDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR  192 (371)
T ss_dssp             CCCEEEEECCC-EEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred             eeEEEEEcccc-ccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCccc
Confidence               89999997 58877663   34899999999999999999999   9999999999999999999999999999998


Q ss_pred             cCCccccccccccccCCcccccCCCCCC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccCcc-----------------
Q 039799          252 PLLEEDQSLTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM-----------------  313 (346)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~-----------------  313 (346)
                      .....     .....+|+.|+|||.+.+ ..++.++||||||++++||+||+.||......+.                 
T Consensus       193 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  267 (371)
T 4exu_A          193 HADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ  267 (371)
T ss_dssp             ------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred             ccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHH
Confidence            65322     234568999999998876 6789999999999999999999999975321100                 


Q ss_pred             -----cHHHHH--------------hhhcCCChhhhhchhccCCccccccc
Q 039799          314 -----TLKRWV--------------NDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       314 -----~~~~~~--------------~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                           ....+.              ...++..+.+++.+||..||++|||+
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  318 (371)
T 4exu_A          268 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTA  318 (371)
T ss_dssp             TCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCH
T ss_pred             HhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCH
Confidence                 000000              11234578899999999999999986

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=3.7e-40  Score=298.35  Aligned_cols=237  Identities=25%  Similarity=0.429  Sum_probs=190.8

Q ss_pred             CCCCCCCcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHh--cCCCCceeeEEEEecCC----ceeE
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKR--ICHRNLIKIISSYSNDD----FKAL  176 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~----~~~l  176 (346)
                      ++|.+.+.||+|+||.||+|++. ++.||+|++...   ....+.+|.+++..  ++||||+++++++...+    ..++
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~l  117 (342)
T 1b6c_B           42 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL  117 (342)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEE
T ss_pred             ccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEE
Confidence            45888999999999999999985 899999998643   34567788888887  78999999999998776    7899


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCCeeecCCCCCceEECCCCcEEEeeecCCc
Q 039799          177 VLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGY-----SAPIIHCDLKPSNVLLDDNMVAHLSDFGMAK  251 (346)
Q Consensus       177 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~  251 (346)
                      ||||+++|+|.+++..  ..+++..++.++.+++.||+|||...     +.+|+||||||+||+++.++.++|+|||++.
T Consensus       118 v~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~  195 (342)
T 1b6c_B          118 VSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  195 (342)
T ss_dssp             EECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCce
Confidence            9999999999999864  35899999999999999999999321     5789999999999999999999999999998


Q ss_pred             cCCccccc--cccccccCCcccccCCCCCCC------CCCcchhHHHHHHHHHHHHcC----------CCCCCccccCcc
Q 039799          252 PLLEEDQS--LTQTQTLATIGYMAPEYGREG------RVSTNGDVYSFGIMLMEIFTR----------TKPTDEIFSGEM  313 (346)
Q Consensus       252 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~------~~~~~~Dv~s~G~il~elltg----------~~p~~~~~~~~~  313 (346)
                      ........  .......||+.|+|||.+.+.      .++.++||||||+++|||+||          +.||........
T Consensus       196 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~  275 (342)
T 1b6c_B          196 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  275 (342)
T ss_dssp             EEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             eccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcc
Confidence            65433211  122345689999999988765      234789999999999999999          778866443333


Q ss_pred             cHHHHHhhh--------cC---------CChhhhhchhccCCccccccc
Q 039799          314 TLKRWVNDL--------LP---------ISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       314 ~~~~~~~~~--------~~---------~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ....+....        ++         ..+.+++.+||..||++||++
T Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~  324 (342)
T 1b6c_B          276 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA  324 (342)
T ss_dssp             CHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCH
T ss_pred             cHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCH
Confidence            222222211        11         246789999999999999986

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=2e-40  Score=298.41  Aligned_cols=238  Identities=26%  Similarity=0.307  Sum_probs=172.9

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHH-HHHhcCCCCceeeEEEEecCCceeEE
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY-EGAFKSFDIECD-VMKRICHRNLIKIISSYSNDDFKALV  177 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv  177 (346)
                      ..++|.+.+.||+|+||.||+|... +|+.||+|++.... .....++..|+. +++.++||||+++++++...+..++|
T Consensus        20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv   99 (327)
T 3aln_A           20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC   99 (327)
T ss_dssp             CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence            3467889999999999999999976 78999999997653 233445555665 67778999999999999999999999


Q ss_pred             EecCCCCChhhhhhh----cCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeeecCCCCCceEECCCCcEEEeeecCCcc
Q 039799          178 LEYMPHGSLEKCLYL----SNYILDIFQRLDIMIDVASALEYLHFGYSA-PIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  252 (346)
Q Consensus       178 ~e~~~~gsL~~~l~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~i~H~dik~~NIll~~~~~~~l~Dfg~~~~  252 (346)
                      |||+++ +|.+++..    ....+++..+..++.+++.||.|||   +. +++||||||+||+++.++.+||+|||+++.
T Consensus       100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~  175 (327)
T 3aln_A          100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQ  175 (327)
T ss_dssp             ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred             EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence            999975 77776642    2467899999999999999999999   87 999999999999999999999999999987


Q ss_pred             CCccccccccccccCCcccccCCCC----CCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH---------
Q 039799          253 LLEEDQSLTQTQTLATIGYMAPEYG----REGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV---------  319 (346)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~---------  319 (346)
                      .....   ......|++.|+|||.+    .+..++.++||||||+++|||++|+.||..............         
T Consensus       176 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  252 (327)
T 3aln_A          176 LVDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSN  252 (327)
T ss_dssp             ---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCC
T ss_pred             ccccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCC
Confidence            64322   12234689999999998    456689999999999999999999999975321111111111         


Q ss_pred             --hhhcCCChhhhhchhccCCccccccc
Q 039799          320 --NDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       320 --~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                        ...++..+.+++.+||..||++||++
T Consensus       253 ~~~~~~~~~l~~li~~~l~~dp~~Rps~  280 (327)
T 3aln_A          253 SEEREFSPSFINFVNLCLTKDESKRPKY  280 (327)
T ss_dssp             CSSCCCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             cccccCCHHHHHHHHHHhhCChhhCcCH
Confidence              11234478899999999999999985

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.3e-40  Score=307.23  Aligned_cols=233  Identities=24%  Similarity=0.326  Sum_probs=184.5

Q ss_pred             CCCCCCCcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCC------ceeE
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDD------FKAL  176 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~~~l  176 (346)
                      .+|.+.+.||+|+||.||+|....+..+|+|++......    ..+|+++++.++||||+++++++....      ..++
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l  115 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL  115 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence            458889999999999999999887777999987543221    235999999999999999999985433      3789


Q ss_pred             EEecCCCCChhhhhh--hcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEEC-CCCcEEEeeecCCccC
Q 039799          177 VLEYMPHGSLEKCLY--LSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPL  253 (346)
Q Consensus       177 v~e~~~~gsL~~~l~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~-~~~~~~l~Dfg~~~~~  253 (346)
                      ||||++++.+.....  .....+++..+..++.|+++||+|||   +.+|+||||||+|||++ .++.+||+|||+++.+
T Consensus       116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~  192 (394)
T 4e7w_A          116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL  192 (394)
T ss_dssp             EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence            999998755444332  23467899999999999999999999   99999999999999999 7999999999999876


Q ss_pred             CccccccccccccCCcccccCCCCCCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccCcc-------------------
Q 039799          254 LEEDQSLTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM-------------------  313 (346)
Q Consensus       254 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~-------------------  313 (346)
                      .....   .....+|+.|+|||.+.+. .++.++||||+||++|||++|+.||......+.                   
T Consensus       193 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~  269 (394)
T 4e7w_A          193 IAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTM  269 (394)
T ss_dssp             CTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred             cCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence            43322   2345689999999987654 589999999999999999999999975321110                   


Q ss_pred             ---------------cHHHHHhhhcCCChhhhhchhccCCccccccc
Q 039799          314 ---------------TLKRWVNDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       314 ---------------~~~~~~~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                                     ..........+..+.+++.+||..||.+|||+
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  316 (394)
T 4e7w_A          270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTA  316 (394)
T ss_dssp             CGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred             ChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCH
Confidence                           00111112244578899999999999999985

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=6.7e-41  Score=325.83  Aligned_cols=229  Identities=24%  Similarity=0.358  Sum_probs=186.5

Q ss_pred             cccccCceEEEEEEEc---CCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecCCCC
Q 039799          110 LIGKGGFGSVYKAIIQ---DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPHG  184 (346)
Q Consensus       110 ~lg~G~~g~vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  184 (346)
                      .||+|+||.||+|.+.   .++.||||+++...  ....+.+.+|++++++++||||+++++++.. +..++||||+++|
T Consensus       376 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g  454 (635)
T 4fl3_A          376 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELG  454 (635)
T ss_dssp             EEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTE
T ss_pred             EeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCCC
Confidence            6999999999999754   46789999997542  2345789999999999999999999999964 4578999999999


Q ss_pred             ChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccc-cccc
Q 039799          185 SLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS-LTQT  263 (346)
Q Consensus       185 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~-~~~~  263 (346)
                      +|.+++.. ...+++..++.++.+++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+...... ....
T Consensus       455 ~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~  530 (635)
T 4fl3_A          455 PLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT  530 (635)
T ss_dssp             EHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---------
T ss_pred             CHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccccc
Confidence            99999864 456899999999999999999999   999999999999999999999999999999876543221 2222


Q ss_pred             cccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHh--------hhcCCChhhhhchh
Q 039799          264 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVN--------DLLPISVMEVVDAN  334 (346)
Q Consensus       264 ~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~d~~  334 (346)
                      ...+|+.|+|||++.+..++.++||||||+++|||+| |+.||......  .....+.        ..++..+.+++.+|
T Consensus       531 ~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--~~~~~i~~~~~~~~p~~~~~~l~~li~~c  608 (635)
T 4fl3_A          531 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAMLEKGERMGCPAGCPREMYDLMNLC  608 (635)
T ss_dssp             ----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTTCCCCCCTTCCHHHHHHHHHH
T ss_pred             CCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCCCCCCCCCCHHHHHHHHHH
Confidence            3346788999999988899999999999999999998 99999764322  2222222        22344789999999


Q ss_pred             ccCCccccccc
Q 039799          335 LLSQEDEHFTT  345 (346)
Q Consensus       335 l~~~p~~R~~~  345 (346)
                      |..||++||+.
T Consensus       609 l~~dP~~RPs~  619 (635)
T 4fl3_A          609 WTYDVENRPGF  619 (635)
T ss_dssp             TCSSTTTSCCH
T ss_pred             cCCCHhHCcCH
Confidence            99999999985

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2.3e-40  Score=294.35  Aligned_cols=236  Identities=23%  Similarity=0.314  Sum_probs=184.6

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEec-----------
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSN-----------  170 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-----------  170 (346)
                      ++|.+.+.||+|+||.||+|... +++.||+|++... ....+.+.+|++++++++||||+++++++.+           
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV   84 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred             ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence            35778899999999999999975 7899999998643 3445778899999999999999999998854           


Q ss_pred             --CCceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeec
Q 039799          171 --DDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFG  248 (346)
Q Consensus       171 --~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg  248 (346)
                        .+..++||||+++++|.+++......+++..++.++.+++.||+|||   +.+++||||||+||+++.++.++|+|||
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg  161 (303)
T 1zy4_A           85 KKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFG  161 (303)
T ss_dssp             -CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred             ccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEEEeeCc
Confidence              35678999999999999999877777889999999999999999999   9999999999999999999999999999


Q ss_pred             CCccCCcccc------------ccccccccCCcccccCCCCCCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccCcccH
Q 039799          249 MAKPLLEEDQ------------SLTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTL  315 (346)
Q Consensus       249 ~~~~~~~~~~------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~  315 (346)
                      ++........            ........+++.|+|||.+.+. .++.++||||||+++|||++   |+..........
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~  238 (303)
T 1zy4_A          162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNIL  238 (303)
T ss_dssp             CCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred             chhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHH
Confidence            9987642210            1122345689999999988754 68999999999999999998   543211111111


Q ss_pred             HHHHh----------hhcCCChhhhhchhccCCccccccc
Q 039799          316 KRWVN----------DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       316 ~~~~~----------~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      .....          ...+..+.+++.+||..||++||++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~  278 (303)
T 1zy4_A          239 KKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGA  278 (303)
T ss_dssp             HHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HhccccccccCccccccchHHHHHHHHHHHhcCcccCcCH
Confidence            11111          1112246899999999999999986

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=2.1e-40  Score=298.02  Aligned_cols=236  Identities=24%  Similarity=0.294  Sum_probs=189.7

Q ss_pred             CCCCCCCCcccccCceEEEEEEE--cCCCEEEEEEecCCC--chhHHHHHHHHHHHHhc---CCCCceeeEEEEe-----
Q 039799          102 PNDANMPPLIGKGGFGSVYKAII--QDGMEVAVKVFDPQY--EGAFKSFDIECDVMKRI---CHRNLIKIISSYS-----  169 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~--~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~-----  169 (346)
                      .++|.+.+.||+|+||.||+|..  .+|+.||+|++....  ......+.+|+.+++.+   +||||+++++++.     
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~   89 (326)
T 1blx_A           10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   89 (326)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence            36789999999999999999997  367899999986332  11223455677776666   8999999999987     


Q ss_pred             cCCceeEEEecCCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeec
Q 039799          170 NDDFKALVLEYMPHGSLEKCLYLSN-YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFG  248 (346)
Q Consensus       170 ~~~~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg  248 (346)
                      .....++||||++ ++|.+++.... ..+++..+..++.+++.||+|||   +.+|+||||||+||+++.++.++|+|||
T Consensus        90 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~Dfg  165 (326)
T 1blx_A           90 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFG  165 (326)
T ss_dssp             SEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred             CCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEecCc
Confidence            5567899999997 69999887543 45899999999999999999999   9999999999999999999999999999


Q ss_pred             CCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH---------
Q 039799          249 MAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV---------  319 (346)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~---------  319 (346)
                      +++......   ......++..|+|||.+.+..++.++||||||+++|||++|+.||......+ .....+         
T Consensus       166 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~  241 (326)
T 1blx_A          166 LARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIGLPGEE  241 (326)
T ss_dssp             SCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCGG
T ss_pred             ccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHHcCCCCcc
Confidence            998654322   2334568999999999988889999999999999999999999997532111 011110         


Q ss_pred             ------------------------hhhcCCChhhhhchhccCCccccccc
Q 039799          320 ------------------------NDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       320 ------------------------~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                                              ...++..+.+++.+||..||++||++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  291 (326)
T 1blx_A          242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA  291 (326)
T ss_dssp             GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCH
T ss_pred             cCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCH
Confidence                                    11233456799999999999999986

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=4.3e-40  Score=297.17  Aligned_cols=200  Identities=23%  Similarity=0.326  Sum_probs=173.5

Q ss_pred             CCCCCCCCCCCCcccccCceEEEEEEE-c-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCC------ceeeEEEEe
Q 039799           98 GKPLPNDANMPPLIGKGGFGSVYKAII-Q-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRN------LIKIISSYS  169 (346)
Q Consensus        98 ~~~~~~~~~~~~~lg~G~~g~vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~~~~~~~  169 (346)
                      +....++|.+.+.||+|+||.||+|.. . +++.||+|++... ....+.+.+|+++++.++|++      ++++++++.
T Consensus         9 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~   87 (339)
T 1z57_A            9 GDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE   87 (339)
T ss_dssp             TCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE
T ss_pred             CCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc
Confidence            344567899999999999999999986 3 6889999999754 334567888999999887654      999999999


Q ss_pred             cCCceeEEEecCCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC----------
Q 039799          170 NDDFKALVLEYMPHGSLEKCLYLSN-YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD----------  238 (346)
Q Consensus       170 ~~~~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~----------  238 (346)
                      ..+..++||||+ +++|.+++.... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.          
T Consensus        88 ~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~  163 (339)
T 1z57_A           88 HHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPK  163 (339)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC--
T ss_pred             cCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCc
Confidence            999999999999 889999887554 46889999999999999999999   999999999999999987          


Q ss_pred             ---------CCcEEEeeecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 039799          239 ---------NMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDE  307 (346)
Q Consensus       239 ---------~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~  307 (346)
                               ++.++|+|||+++.....     .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  236 (339)
T 1z57_A          164 IKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPT  236 (339)
T ss_dssp             --CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence                     668999999999864321     2345689999999999988999999999999999999999999975

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=5.5e-40  Score=301.91  Aligned_cols=199  Identities=25%  Similarity=0.333  Sum_probs=170.2

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcC-CC-----CceeeEEEEecCCc
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRIC-HR-----NLIKIISSYSNDDF  173 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~~~~~~~~~~~  173 (346)
                      ..++|.+.+.||+|+||+||+|... +++.||||++... ......+..|+++++.++ |+     +++++.+++...+.
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  130 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH  130 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence            3467888999999999999999876 6889999999754 334567778888888885 44     49999999999999


Q ss_pred             eeEEEecCCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEEC--CCCcEEEeeecCC
Q 039799          174 KALVLEYMPHGSLEKCLYLSN-YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD--DNMVAHLSDFGMA  250 (346)
Q Consensus       174 ~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~--~~~~~~l~Dfg~~  250 (346)
                      .++||||++ ++|.+++.... ..+++..+..++.+++.||.|||.. +.+|+||||||+|||++  .++.+||+|||++
T Consensus       131 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a  208 (382)
T 2vx3_A          131 LCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS  208 (382)
T ss_dssp             EEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             eEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence            999999996 59999887654 5689999999999999999999921 47899999999999995  5778999999999


Q ss_pred             ccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 039799          251 KPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDE  307 (346)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~  307 (346)
                      +.....     .....+|+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus       209 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~  260 (382)
T 2vx3_A          209 CQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG  260 (382)
T ss_dssp             EETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             eecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            875322     2345689999999999998999999999999999999999999975

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2.6e-40  Score=298.81  Aligned_cols=234  Identities=22%  Similarity=0.321  Sum_probs=167.4

Q ss_pred             CCCCCCCC-CcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEec----CCce
Q 039799          101 LPNDANMP-PLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSN----DDFK  174 (346)
Q Consensus       101 ~~~~~~~~-~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~  174 (346)
                      ..++|.+. +.||+|+||.||+|... +++.||+|++....    ....+....++.++||||+++++++..    ....
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            44667774 47999999999999977 79999999986532    112223344667799999999999875    4468


Q ss_pred             eEEEecCCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC---CCcEEEeeecCC
Q 039799          175 ALVLEYMPHGSLEKCLYLSN-YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD---NMVAHLSDFGMA  250 (346)
Q Consensus       175 ~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~---~~~~~l~Dfg~~  250 (346)
                      ++||||+++|+|.+++.... ..+++..++.++.+++.||+|||   +.+|+||||||+||+++.   ++.++|+|||++
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~  178 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA  178 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence            89999999999999987654 46899999999999999999999   999999999999999986   456999999999


Q ss_pred             ccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCccc--HHHHH---------
Q 039799          251 KPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMT--LKRWV---------  319 (346)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~--~~~~~---------  319 (346)
                      +.....    ......+|+.|+|||.+.+..++.++||||||+++|||++|+.||.........  ....+         
T Consensus       179 ~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  254 (336)
T 3fhr_A          179 KETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPN  254 (336)
T ss_dssp             EEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCT
T ss_pred             eecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCc
Confidence            865322    123456899999999998888999999999999999999999999653322110  00000         


Q ss_pred             --hhhcCCChhhhhchhccCCccccccc
Q 039799          320 --NDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       320 --~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                        ...++..+.+++.+||..||++|||+
T Consensus       255 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~  282 (336)
T 3fhr_A          255 PEWSEVSEDAKQLIRLLLKTDPTERLTI  282 (336)
T ss_dssp             TTSTTCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred             hhhccCCHHHHHHHHHHCCCChhHCcCH
Confidence              02345578999999999999999986

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=4.3e-40  Score=299.46  Aligned_cols=232  Identities=24%  Similarity=0.335  Sum_probs=187.4

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCc-----
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDF-----  173 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-----  173 (346)
                      ..+|.+.+.||+|+||.||+|... +|+.||||++....  ....+.+.+|+.++++++||||+++++++...+.     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            467889999999999999999976 78999999997542  3345678899999999999999999999987654     


Q ss_pred             -eeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCcc
Q 039799          174 -KALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  252 (346)
Q Consensus       174 -~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~  252 (346)
                       .++||||++ ++|.+++.   ..+++..+..++.+++.||+|||   +.+|+||||||+||+++.++.++|+|||+++.
T Consensus       103 ~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~  175 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARH  175 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred             eEEEEecccc-CCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeecccccC
Confidence             489999997 58887664   34899999999999999999999   99999999999999999999999999999986


Q ss_pred             CCccccccccccccCCcccccCCCCCC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccCcc------------------
Q 039799          253 LLEEDQSLTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM------------------  313 (346)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~------------------  313 (346)
                      ....     .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+.                  
T Consensus       176 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  250 (353)
T 3coi_A          176 ADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK  250 (353)
T ss_dssp             -------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTT
T ss_pred             CCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence            4321     234468999999998776 6789999999999999999999999975321100                  


Q ss_pred             ----cHHHHHh--------------hhcCCChhhhhchhccCCccccccc
Q 039799          314 ----TLKRWVN--------------DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       314 ----~~~~~~~--------------~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                          ....+..              ..++..+.+++.+||..||++|||+
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~  300 (353)
T 3coi_A          251 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTA  300 (353)
T ss_dssp             CSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCH
T ss_pred             HhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCH
Confidence                0000000              1224467899999999999999986

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=7.4e-40  Score=298.52  Aligned_cols=236  Identities=22%  Similarity=0.281  Sum_probs=175.6

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCc-------e
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDF-------K  174 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-------~  174 (346)
                      ++|.+.+.||+|+||.||+|... +|+.||||++.... .......++++.++.++||||+++++++...+.       .
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~  101 (360)
T 3e3p_A           23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYL  101 (360)
T ss_dssp             TTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeE
Confidence            57899999999999999999976 78999999986542 223456678888899999999999999865332       7


Q ss_pred             eEEEecCCCCChhhhhh---hcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC-CCcEEEeeecCC
Q 039799          175 ALVLEYMPHGSLEKCLY---LSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD-NMVAHLSDFGMA  250 (346)
Q Consensus       175 ~lv~e~~~~gsL~~~l~---~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~-~~~~~l~Dfg~~  250 (346)
                      ++||||+++ +|.+.+.   .....+++..+..++.+++.||.|||. ++.+|+||||||+|||++. ++.+||+|||++
T Consensus       102 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a  179 (360)
T 3e3p_A          102 NVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHL-PSVNVCHRDIKPHNVLVNEADGTLKLCDFGSA  179 (360)
T ss_dssp             EEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTS-TTTCCBCSCCCGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhC-CCCCeecCcCCHHHEEEeCCCCcEEEeeCCCc
Confidence            899999976 5544332   244668899999999999999999993 3789999999999999996 899999999999


Q ss_pred             ccCCccccccccccccCCcccccCCCCCCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh---------
Q 039799          251 KPLLEEDQSLTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN---------  320 (346)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~---------  320 (346)
                      +.+....   ......||+.|+|||.+.+. .++.++||||||+++|||+||+.||....... .+...++         
T Consensus       180 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~  255 (360)
T 3e3p_A          180 KKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG-QLHEIVRVLGCPSREV  255 (360)
T ss_dssp             BCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHHH
T ss_pred             eecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH-HHHHHHHHcCCCCHHH
Confidence            8764332   22345689999999987654 48999999999999999999999997532111 1111111         


Q ss_pred             ----------------------hh-------cCCChhhhhchhccCCccccccc
Q 039799          321 ----------------------DL-------LPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       321 ----------------------~~-------~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                                            ..       .+..+.+++.+||..||++|||+
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  309 (360)
T 3e3p_A          256 LRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKP  309 (360)
T ss_dssp             HHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCH
Confidence                                  00       12257899999999999999986

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=4.3e-40  Score=294.88  Aligned_cols=236  Identities=22%  Similarity=0.263  Sum_probs=175.5

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCch--hHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEe
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEG--AFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLE  179 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  179 (346)
                      ++|.+.+.||+|+||.||+|... +|+.||+|++......  ..+.+.++..+++.++||||+++++++...+..++|||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e  104 (318)
T 2dyl_A           25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME  104 (318)
T ss_dssp             GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence            46778889999999999999976 7899999999754322  22334445567888899999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeeecCCCCCceEECCCCcEEEeeecCCccCCcccc
Q 039799          180 YMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSA-PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  258 (346)
Q Consensus       180 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~  258 (346)
                      |+ ++.+..........+++..+..++.+++.||+|||   +. +++||||||+||+++.++.++|+|||++....... 
T Consensus       105 ~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-  179 (318)
T 2dyl_A          105 LM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK-  179 (318)
T ss_dssp             CC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred             cc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc-
Confidence            99 55666665555667899999999999999999999   85 99999999999999999999999999998654322 


Q ss_pred             ccccccccCCcccccCCCCC-----CCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHhh---------hcC
Q 039799          259 SLTQTQTLATIGYMAPEYGR-----EGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVND---------LLP  324 (346)
Q Consensus       259 ~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~---------~~~  324 (346)
                        ......+++.|+|||.+.     ...++.++||||||+++|||++|+.||................         .++
T Consensus       180 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (318)
T 2dyl_A          180 --AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFS  257 (318)
T ss_dssp             ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCC
T ss_pred             --cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCC
Confidence              123346899999999874     4568899999999999999999999997632222222222211         134


Q ss_pred             CChhhhhchhccCCccccccc
Q 039799          325 ISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       325 ~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ..+.+++.+||..||.+||++
T Consensus       258 ~~l~~li~~~l~~dp~~Rps~  278 (318)
T 2dyl_A          258 GDFQSFVKDCLTKDHRKRPKY  278 (318)
T ss_dssp             HHHHHHHHHHTCSCTTTSCCH
T ss_pred             HHHHHHHHHHccCChhHCcCH
Confidence            468999999999999999985

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=5.3e-40  Score=290.31  Aligned_cols=233  Identities=24%  Similarity=0.332  Sum_probs=193.0

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEe
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLE  179 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  179 (346)
                      ++|.+.+.||+|++|.||+|... +++.||+|++....  ....+.+.+|++++++++||||+++++++...+..++|+|
T Consensus        22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  101 (287)
T 2wei_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE  101 (287)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence            45888999999999999999976 78999999986432  2345778899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCC---CcEEEeeecCCccCCcc
Q 039799          180 YMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDN---MVAHLSDFGMAKPLLEE  256 (346)
Q Consensus       180 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~---~~~~l~Dfg~~~~~~~~  256 (346)
                      |+++++|.+.+... ..+++..++.++.+++.||+|||   +.+++||||||+||+++.+   +.++|+|||++......
T Consensus       102 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~  177 (287)
T 2wei_A          102 LYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN  177 (287)
T ss_dssp             CCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred             ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence            99999999887643 46899999999999999999999   9999999999999999754   47999999999865432


Q ss_pred             ccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH-h----------hhcCC
Q 039799          257 DQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV-N----------DLLPI  325 (346)
Q Consensus       257 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~-~----------~~~~~  325 (346)
                      .   ......+++.|+|||.+.+ .++.++||||||+++|||++|+.||......  .....+ .          ..++.
T Consensus       178 ~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  251 (287)
T 2wei_A          178 T---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY--DILKRVETGKYAFDLPQWRTISD  251 (287)
T ss_dssp             S---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCCCCCCSGGGTTSCH
T ss_pred             C---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHcCCCCCCchhhhhcCH
Confidence            2   1223357889999998765 4889999999999999999999999753211  111111 1          22345


Q ss_pred             ChhhhhchhccCCccccccc
Q 039799          326 SVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       326 ~~~~~~d~~l~~~p~~R~~~  345 (346)
                      .+.+++.+||..||++||++
T Consensus       252 ~~~~li~~~l~~dp~~Rps~  271 (287)
T 2wei_A          252 DAKDLIRKMLTFHPSLRITA  271 (287)
T ss_dssp             HHHHHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHHHHcccChhhCcCH
Confidence            78899999999999999986

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.5e-40  Score=297.97  Aligned_cols=238  Identities=22%  Similarity=0.292  Sum_probs=190.2

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEcCCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEE
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVL  178 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  178 (346)
                      ..++|.+.+.||+|+||.||+|.+..  .+|+|++....  ....+.+.+|++++++++||||+++++++...+..++||
T Consensus        31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  108 (319)
T 2y4i_B           31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT  108 (319)
T ss_dssp             CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred             CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence            34678999999999999999998864  49999986432  223355677999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccc-
Q 039799          179 EYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED-  257 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~-  257 (346)
                      ||+++++|.+++......+++..++.++.+++.||+|||   +.+++||||||+||+++ ++.++|+|||+++...... 
T Consensus       109 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~  184 (319)
T 2y4i_B          109 SLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQA  184 (319)
T ss_dssp             BCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCCC-------
T ss_pred             ecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCccccccccc
Confidence            999999999999876667999999999999999999999   99999999999999998 6799999999987653211 


Q ss_pred             --cccccccccCCcccccCCCCCC---------CCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH-------
Q 039799          258 --QSLTQTQTLATIGYMAPEYGRE---------GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV-------  319 (346)
Q Consensus       258 --~~~~~~~~~~~~~y~aPE~~~~---------~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~-------  319 (346)
                        .........|++.|+|||.+..         ..++.++||||||+++|||++|+.||........ .....       
T Consensus       185 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~  263 (319)
T 2y4i_B          185 GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI-IWQMGTGMKPNL  263 (319)
T ss_dssp             ---CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHH-HHHHHTTCCCCC
T ss_pred             cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHhccCCCCCC
Confidence              1122233458999999998764         3578899999999999999999999975322111 11111       


Q ss_pred             -hhhcCCChhhhhchhccCCccccccc
Q 039799          320 -NDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       320 -~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                       ...++..+.+++.+||..+|++||++
T Consensus       264 ~~~~~~~~l~~li~~~l~~~p~~Rpt~  290 (319)
T 2y4i_B          264 SQIGMGKEISDILLFCWAFEQEERPTF  290 (319)
T ss_dssp             CCSSCCTTHHHHHHHHHCSSTTTSCCH
T ss_pred             CcCCCCHHHHHHHHHHhcCChhhCcCH
Confidence             11245688999999999999999985

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=9.3e-40  Score=296.96  Aligned_cols=198  Identities=24%  Similarity=0.317  Sum_probs=170.1

Q ss_pred             CCCCCCCCCCcccccCceEEEEEEEc-CC-CEEEEEEecCCCchhHHHHHHHHHHHHhcCCCC------ceeeEEEEecC
Q 039799          100 PLPNDANMPPLIGKGGFGSVYKAIIQ-DG-MEVAVKVFDPQYEGAFKSFDIECDVMKRICHRN------LIKIISSYSND  171 (346)
Q Consensus       100 ~~~~~~~~~~~lg~G~~g~vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~~~~~~~~~  171 (346)
                      ...++|.+.+.||+|+||.||+|... ++ +.||+|++... ....+.+.+|++++++++|++      ++.+.+++...
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~   94 (355)
T 2eu9_A           16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH   94 (355)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred             eecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence            34578999999999999999999975 44 68999999754 344567888999999997766      89999999999


Q ss_pred             CceeEEEecCCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEE--------------
Q 039799          172 DFKALVLEYMPHGSLEKCLYLSN-YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL--------------  236 (346)
Q Consensus       172 ~~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll--------------  236 (346)
                      +..++||||+ ++++.+.+.... ..+++..+..++.|++.||+|||   +.+|+||||||+|||+              
T Consensus        95 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~  170 (355)
T 2eu9_A           95 GHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKS  170 (355)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred             CeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeccccccccccccc
Confidence            9999999999 566666665443 56899999999999999999999   9999999999999999              


Q ss_pred             -----CCCCcEEEeeecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 039799          237 -----DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDE  307 (346)
Q Consensus       237 -----~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~  307 (346)
                           +.++.++|+|||+++.....     .....||+.|+|||.+.+..++.++||||||+++|||+||+.||..
T Consensus       171 ~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  241 (355)
T 2eu9_A          171 CEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQT  241 (355)
T ss_dssp             CCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             ccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence                 56789999999999864322     2345689999999999988999999999999999999999999975

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=3e-41  Score=302.98  Aligned_cols=240  Identities=23%  Similarity=0.309  Sum_probs=194.2

Q ss_pred             cCCCCCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCc------hhHHHHHHHHHHHHhcC--CCCceeeEEE
Q 039799           97 RGKPLPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYE------GAFKSFDIECDVMKRIC--HRNLIKIISS  167 (346)
Q Consensus        97 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~--h~niv~~~~~  167 (346)
                      ......++|.+.+.||+|+||.||+|... +++.||+|++.....      ...+.+.+|++++++++  |+|+++++++
T Consensus        37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~  116 (320)
T 3a99_A           37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW  116 (320)
T ss_dssp             ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred             ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence            34556788999999999999999999865 789999999864321      12245667999999996  5999999999


Q ss_pred             EecCCceeEEEecCCC-CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEEC-CCCcEEEe
Q 039799          168 YSNDDFKALVLEYMPH-GSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD-DNMVAHLS  245 (346)
Q Consensus       168 ~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~-~~~~~~l~  245 (346)
                      +...+..++|+|++.+ ++|.+++.. ...+++..+..++.+++.||+|||   +.+|+||||||+|||++ +++.+||+
T Consensus       117 ~~~~~~~~lv~e~~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL~  192 (320)
T 3a99_A          117 FERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLI  192 (320)
T ss_dssp             EECSSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEEC
T ss_pred             EecCCcEEEEEEcCCCCccHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEEe
Confidence            9999999999999976 899998864 356889999999999999999999   99999999999999999 78999999


Q ss_pred             eecCCccCCccccccccccccCCcccccCCCCCCCCC-CcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHhhhcC
Q 039799          246 DFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLP  324 (346)
Q Consensus       246 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  324 (346)
                      |||+++.....    ......||+.|+|||.+.+..+ +.++||||||+++|||+||+.||...... ..........++
T Consensus       193 Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~  267 (320)
T 3a99_A          193 DFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI-IRGQVFFRQRVS  267 (320)
T ss_dssp             CCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH-HHCCCCCSSCCC
T ss_pred             eCccccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhh-hcccccccccCC
Confidence            99999876432    1234568999999998876655 67899999999999999999999652110 000001123345


Q ss_pred             CChhhhhchhccCCccccccc
Q 039799          325 ISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       325 ~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ..+.+++.+||..||++||++
T Consensus       268 ~~~~~li~~~l~~dp~~Rps~  288 (320)
T 3a99_A          268 SECQHLIRWCLALRPSDRPTF  288 (320)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHHHHHccCChhhCcCH
Confidence            588999999999999999985

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=4.2e-40  Score=321.37  Aligned_cols=234  Identities=23%  Similarity=0.362  Sum_probs=190.4

Q ss_pred             CCCCCcccccCceEEEEEEEcC----CCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEe
Q 039799          105 ANMPPLIGKGGFGSVYKAIIQD----GMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLE  179 (346)
Q Consensus       105 ~~~~~~lg~G~~g~vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  179 (346)
                      |.+.+.||+|+||.||+|.+..    +..+|+|.+.... ....+.+.+|+.++++++||||+++++++. .+..++|||
T Consensus       392 y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E  470 (656)
T 2j0j_A          392 IELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIME  470 (656)
T ss_dssp             EEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred             EEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEE
Confidence            4455679999999999998752    4579999987543 344578889999999999999999999985 456889999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccc
Q 039799          180 YMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  259 (346)
Q Consensus       180 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~  259 (346)
                      |+++|+|.+++......+++..++.++.+++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....... 
T Consensus       471 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~-  546 (656)
T 2j0j_A          471 LCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY-  546 (656)
T ss_dssp             CCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC----
T ss_pred             cCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCeecCCCcc-
Confidence            99999999999877777999999999999999999999   99999999999999999999999999999987643321 


Q ss_pred             cccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHh--------hhcCCChhhh
Q 039799          260 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVN--------DLLPISVMEV  330 (346)
Q Consensus       260 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~  330 (346)
                      .......+++.|+|||.+.+..++.++||||||+++|||++ |..||......  .....+.        ..++..+.++
T Consensus       547 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~l~~l  624 (656)
T 2j0j_A          547 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRIENGERLPMPPNCPPTLYSL  624 (656)
T ss_dssp             -------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHHTCCCCCCTTCCHHHHHH
T ss_pred             eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHHcCCCCCCCccccHHHHHH
Confidence            12223456789999999888889999999999999999997 99999763221  1222221        2234578999


Q ss_pred             hchhccCCccccccc
Q 039799          331 VDANLLSQEDEHFTT  345 (346)
Q Consensus       331 ~d~~l~~~p~~R~~~  345 (346)
                      +.+||..||++||++
T Consensus       625 i~~~l~~dP~~RPs~  639 (656)
T 2j0j_A          625 MTKCWAYDPSRRPRF  639 (656)
T ss_dssp             HHHHTCSSGGGSCCH
T ss_pred             HHHHcCCChhHCcCH
Confidence            999999999999985

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=3.3e-40  Score=308.10  Aligned_cols=238  Identities=25%  Similarity=0.324  Sum_probs=179.9

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhc-CCCCceeeEEEEecCCceeEEEe
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRI-CHRNLIKIISSYSNDDFKALVLE  179 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  179 (346)
                      ..+.|...+.||+|+||+||.+...+|+.||||++...   ..+.+.+|++++.++ +||||+++++++...+..++|||
T Consensus        13 l~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E   89 (434)
T 2rio_A           13 LKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE   89 (434)
T ss_dssp             CSSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence            44456667889999999998776678999999998643   245677899999886 89999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCC------CCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCC-------------C
Q 039799          180 YMPHGSLEKCLYLSNYI------LDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDN-------------M  240 (346)
Q Consensus       180 ~~~~gsL~~~l~~~~~~------l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~-------------~  240 (346)
                      |+. |+|.+++......      .++..++.++.|++.||+|||   +.+|+||||||+|||++.+             +
T Consensus        90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~  165 (434)
T 2rio_A           90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENL  165 (434)
T ss_dssp             CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred             cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCce
Confidence            995 6999998754321      123345779999999999999   9999999999999999754             4


Q ss_pred             cEEEeeecCCccCCcccccc--ccccccCCcccccCCCCCC-------CCCCcchhHHHHHHHHHHHHc-CCCCCCcccc
Q 039799          241 VAHLSDFGMAKPLLEEDQSL--TQTQTLATIGYMAPEYGRE-------GRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFS  310 (346)
Q Consensus       241 ~~~l~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~  310 (346)
                      .++|+|||+++.+.......  ......||+.|+|||++.+       ..++.++|||||||++|||+| |+.||.....
T Consensus       166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~  245 (434)
T 2rio_A          166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS  245 (434)
T ss_dssp             EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred             EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence            89999999999765432211  1234569999999998765       568999999999999999999 9999975432


Q ss_pred             CcccHHHHH----------hhhcCCChhhhhchhccCCccccccc
Q 039799          311 GEMTLKRWV----------NDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       311 ~~~~~~~~~----------~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      .+.......          ...++..+.+++.+||..||.+||++
T Consensus       246 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~  290 (434)
T 2rio_A          246 RESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTA  290 (434)
T ss_dssp             HHHHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCH
T ss_pred             hHHHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCH
Confidence            211111000          01122357899999999999999986

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=6.1e-40  Score=316.11  Aligned_cols=238  Identities=27%  Similarity=0.391  Sum_probs=190.6

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC-CchhHHHHHHHHHHHHhcCCCCceeeEEEEec------CCce
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ-YEGAFKSFDIECDVMKRICHRNLIKIISSYSN------DDFK  174 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~~  174 (346)
                      .+|.+.+.||+|+||.||+|... +|+.||+|++... .....+.+.+|++++++++||||+++++++..      .+..
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            57999999999999999999875 6899999998754 33446778899999999999999999998765      6778


Q ss_pred             eEEEecCCCCChhhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCc---EEEeeecC
Q 039799          175 ALVLEYMPHGSLEKCLYLSN--YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV---AHLSDFGM  249 (346)
Q Consensus       175 ~lv~e~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~---~~l~Dfg~  249 (346)
                      ++||||+++++|.+++....  ..+++..+..++.+++.||+|||   +.+|+||||||+||+++.++.   ++|+|||+
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~  170 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGY  170 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred             EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence            99999999999999987543  35888899999999999999999   999999999999999996654   99999999


Q ss_pred             CccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCcccc-------------------
Q 039799          250 AKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFS-------------------  310 (346)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~-------------------  310 (346)
                      +.......   ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....                   
T Consensus       171 a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~  247 (676)
T 3qa8_A          171 AKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY  247 (676)
T ss_dssp             CCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSC
T ss_pred             cccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhh
Confidence            99764332   22345689999999999999999999999999999999999999954100                   


Q ss_pred             ----Cccc------HHHHHhhhcCCChhhhhchhccCCcccccccC
Q 039799          311 ----GEMT------LKRWVNDLLPISVMEVVDANLLSQEDEHFTTK  346 (346)
Q Consensus       311 ----~~~~------~~~~~~~~~~~~~~~~~d~~l~~~p~~R~~~k  346 (346)
                          +...      ........++..+.+++.+||..||++|||++
T Consensus       248 ~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~  293 (676)
T 3qa8_A          248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDP  293 (676)
T ss_dssp             CCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCT
T ss_pred             hhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHH
Confidence                0000      00001112334678999999999999999973

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4e-40  Score=324.00  Aligned_cols=231  Identities=22%  Similarity=0.292  Sum_probs=189.6

Q ss_pred             CCCCCCCCCCcccccCceEEEEEEEc--CCCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCc---
Q 039799          100 PLPNDANMPPLIGKGGFGSVYKAIIQ--DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDF---  173 (346)
Q Consensus       100 ~~~~~~~~~~~lg~G~~g~vy~~~~~--~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---  173 (346)
                      ....+|.+.+.||+|+||.||+|.+.  +|+.||||++.... ......+.+|++++++++||||+++++++...+.   
T Consensus        77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~  156 (681)
T 2pzi_A           77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD  156 (681)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred             EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence            34578999999999999999999976  68999999986443 3445678899999999999999999999987665   


Q ss_pred             --eeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCc
Q 039799          174 --KALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAK  251 (346)
Q Consensus       174 --~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~  251 (346)
                        .++||||+++++|.+++..   .+++..++.++.++++||.|||   +.+|+||||||+|||++.+ .+||+|||+++
T Consensus       157 ~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~  229 (681)
T 2pzi_A          157 PVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVS  229 (681)
T ss_dssp             EEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred             ceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccch
Confidence              6999999999999887643   6899999999999999999999   9999999999999999985 89999999998


Q ss_pred             cCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHhhhcCCChhhhh
Q 039799          252 PLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPISVMEVV  331 (346)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (346)
                      .....      ....||++|+|||++.+. ++.++||||||++++||++|..|+........... ......+..+.+++
T Consensus       230 ~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~~~~~~l~~li  301 (681)
T 2pzi_A          230 RINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPED-DPVLKTYDSYGRLL  301 (681)
T ss_dssp             ETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSCCTT-CHHHHHCHHHHHHH
T ss_pred             hcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccccccc-ccccccCHHHHHHH
Confidence            65332      345699999999988654 48899999999999999999999876432222110 01112345788999


Q ss_pred             chhccCCccccccc
Q 039799          332 DANLLSQEDEHFTT  345 (346)
Q Consensus       332 d~~l~~~p~~R~~~  345 (346)
                      .+||..||++||++
T Consensus       302 ~~~l~~dP~~R~~~  315 (681)
T 2pzi_A          302 RRAIDPDPRQRFTT  315 (681)
T ss_dssp             HHHTCSSGGGSCSS
T ss_pred             hhhccCChhhCCCH
Confidence            99999999999975

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.1e-41  Score=299.01  Aligned_cols=239  Identities=22%  Similarity=0.300  Sum_probs=185.1

Q ss_pred             CCCCCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCc------hhHHHHHHHHHHHHhc----CCCCceeeEE
Q 039799           98 GKPLPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYE------GAFKSFDIECDVMKRI----CHRNLIKIIS  166 (346)
Q Consensus        98 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l----~h~niv~~~~  166 (346)
                      .....++|.+.+.||+|+||.||+|... +++.||+|++.....      .....+.+|+.++.++    +||||+++++
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~  105 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD  105 (312)
T ss_dssp             -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred             hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence            3445678999999999999999999865 789999999965432      1223455689999988    8999999999


Q ss_pred             EEecCCceeEEEec-CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEEC-CCCcEEE
Q 039799          167 SYSNDDFKALVLEY-MPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD-DNMVAHL  244 (346)
Q Consensus       167 ~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~-~~~~~~l  244 (346)
                      ++...+..++|+|+ +.+++|.+++... ..+++..++.++.+++.||+|||   +.+|+||||||+||+++ .++.++|
T Consensus       106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl  181 (312)
T 2iwi_A          106 WFETQEGFMLVLERPLPAQDLFDYITEK-GPLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKL  181 (312)
T ss_dssp             EC-----CEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTEEEE
T ss_pred             EEecCCeEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCeEEE
Confidence            99999999999999 7899999998753 45899999999999999999999   99999999999999999 8899999


Q ss_pred             eeecCCccCCccccccccccccCCcccccCCCCCCCCC-CcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHhhhc
Q 039799          245 SDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLL  323 (346)
Q Consensus       245 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~  323 (346)
                      +|||++.......    .....++..|+|||.+.+..+ +.++||||||+++|||++|+.||....... .........+
T Consensus       182 ~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~  256 (312)
T 2iwi_A          182 IDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEIL-EAELHFPAHV  256 (312)
T ss_dssp             CCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH-HTCCCCCTTS
T ss_pred             EEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHh-hhccCCcccC
Confidence            9999998764322    234568999999998776655 458999999999999999999996521100 0000011234


Q ss_pred             CCChhhhhchhccCCccccccc
Q 039799          324 PISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       324 ~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      +..+.+++.+||..+|++||++
T Consensus       257 ~~~~~~li~~~l~~~p~~Rps~  278 (312)
T 2iwi_A          257 SPDCCALIRRCLAPKPSSRPSL  278 (312)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCH
T ss_pred             CHHHHHHHHHHccCChhhCcCH
Confidence            4578999999999999999985

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.1e-39  Score=298.70  Aligned_cols=196  Identities=20%  Similarity=0.299  Sum_probs=167.7

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcC-----------CCCceeeEEEEe
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRIC-----------HRNLIKIISSYS  169 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~~~  169 (346)
                      ..+|.+.+.||+|+||.||+|... +++.||+|++... ....+.+.+|++++++++           ||||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            357889999999999999999975 7899999999754 334567788999999886           899999999987


Q ss_pred             cCC----ceeEEEecCCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeeecCCCCCceEEC------
Q 039799          170 NDD----FKALVLEYMPHGSLEKCLYLS-NYILDIFQRLDIMIDVASALEYLHFGYSA-PIIHCDLKPSNVLLD------  237 (346)
Q Consensus       170 ~~~----~~~lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~i~H~dik~~NIll~------  237 (346)
                      ..+    ..++|||++ +++|.+++... ...+++..+..++.|++.||+|||   +. +|+||||||+|||++      
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~~~  172 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPE  172 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETTT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCCCc
Confidence            644    788999999 89999988754 345899999999999999999999   87 999999999999994      


Q ss_pred             CCCcEEEeeecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 039799          238 DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDE  307 (346)
Q Consensus       238 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~  307 (346)
                      ..+.++|+|||+++.....     .....+|+.|+|||++.+..++.++||||||+++|||+||+.||..
T Consensus       173 ~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  237 (373)
T 1q8y_A          173 NLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP  237 (373)
T ss_dssp             TEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--
T ss_pred             CcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence            4458999999999865322     2344689999999999888899999999999999999999999975

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.5e-39  Score=301.56  Aligned_cols=233  Identities=21%  Similarity=0.332  Sum_probs=179.3

Q ss_pred             CCCCCCcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhc-CCCCceeeEEEEecCCceeEEEecCC
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRI-CHRNLIKIISSYSNDDFKALVLEYMP  182 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~  182 (346)
                      +|...+.||+|+||+||.....+++.||||++.....   ..+.+|+++++++ +||||+++++++.+.+..++||||+.
T Consensus        25 ~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~  101 (432)
T 3p23_A           25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA  101 (432)
T ss_dssp             EEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             EEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC
Confidence            4777889999999997766566799999999975433   2345799999999 79999999999999999999999996


Q ss_pred             CCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC-----CCcEEEeeecCCccCCccc
Q 039799          183 HGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD-----NMVAHLSDFGMAKPLLEED  257 (346)
Q Consensus       183 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~-----~~~~~l~Dfg~~~~~~~~~  257 (346)
                       |+|.+++...........++.++.|++.||+|||   +.+|+||||||+|||++.     ...++|+|||+++......
T Consensus       102 -g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~  177 (432)
T 3p23_A          102 -ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR  177 (432)
T ss_dssp             -EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC----
T ss_pred             -CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCC
Confidence             5999998766655555567789999999999999   999999999999999953     3368899999998765332


Q ss_pred             cc-cccccccCCcccccCCCCC---CCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHhh----hc-----
Q 039799          258 QS-LTQTQTLATIGYMAPEYGR---EGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVND----LL-----  323 (346)
Q Consensus       258 ~~-~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~----~~-----  323 (346)
                      .. .......||+.|+|||.+.   ...++.++|||||||++|||+| |..||.......  .......    ..     
T Consensus       178 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~  255 (432)
T 3p23_A          178 HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ--ANILLGACSLDCLHPEKH  255 (432)
T ss_dssp             --------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH--HHHHTTCCCCTTSCTTCH
T ss_pred             cceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH--HHHHhccCCccccCcccc
Confidence            11 2234456999999999987   4567889999999999999999 999996532111  1111100    00     


Q ss_pred             -CCChhhhhchhccCCccccccc
Q 039799          324 -PISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       324 -~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                       +..+.+++.+||..||++||++
T Consensus       256 ~~~~~~~li~~~L~~dP~~Rps~  278 (432)
T 3p23_A          256 EDVIARELIEKMIAMDPQKRPSA  278 (432)
T ss_dssp             HHHHHHHHHHHHSCSSGGGSCCH
T ss_pred             ccHHHHHHHHHHHhCCHhhCCCH
Confidence             1136789999999999999986

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=6.3e-38  Score=276.81  Aligned_cols=209  Identities=15%  Similarity=0.114  Sum_probs=174.8

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeE
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKAL  176 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  176 (346)
                      ...+|.+.+.||+|+||.||+|... +++.||+|++....   ....+.+.+|++.+++++||||+++++++...+..++
T Consensus        29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  108 (286)
T 3uqc_A           29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV  108 (286)
T ss_dssp             TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence            3467999999999999999999976 58999999997553   2345788899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcc
Q 039799          177 VLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  256 (346)
Q Consensus       177 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~  256 (346)
                      ||||+++++|.+++...   .......+++.|++.||+|||   +.+|+||||||+|||++.++.++|++++        
T Consensus       109 v~e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~--------  174 (286)
T 3uqc_A          109 VAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA--------  174 (286)
T ss_dssp             EEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred             EEEecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEecc--------
Confidence            99999999999998532   355568889999999999999   9999999999999999999999997443        


Q ss_pred             ccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCc------------ccHHHHHhhhcC
Q 039799          257 DQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE------------MTLKRWVNDLLP  324 (346)
Q Consensus       257 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~------------~~~~~~~~~~~~  324 (346)
                                    |++       .++.++||||||+++|||+||+.||.......            ..........++
T Consensus       175 --------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T 3uqc_A          175 --------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIP  233 (286)
T ss_dssp             --------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSC
T ss_pred             --------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCC
Confidence                          222       36889999999999999999999997633211            111223334566


Q ss_pred             CChhhhhchhccCCccccccc
Q 039799          325 ISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       325 ~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ..+.+++.+||..||++| |+
T Consensus       234 ~~l~~li~~~l~~dP~~R-s~  253 (286)
T 3uqc_A          234 FQISAVAARSVQGDGGIR-SA  253 (286)
T ss_dssp             HHHHHHHHHHHCTTSSCC-CH
T ss_pred             HHHHHHHHHHcccCCccC-CH
Confidence            789999999999999999 64

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.1e-38  Score=296.02  Aligned_cols=231  Identities=16%  Similarity=0.165  Sum_probs=175.6

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCc---hhHHHHHHHHHHHHhcCC-CCc---------ee------
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYE---GAFKSFDIECDVMKRICH-RNL---------IK------  163 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h-~ni---------v~------  163 (346)
                      .|...+.||+|+||.||+|.+. +|+.||||++.....   ...+.+.+|+.+++.++| +|.         +.      
T Consensus        79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  158 (413)
T 3dzo_A           79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK  158 (413)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred             eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence            3666788999999999999965 799999999873322   235778899999999987 221         11      


Q ss_pred             ------eEEEEec-----CCceeEEEecCCCCChhhhhh------hcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeee
Q 039799          164 ------IISSYSN-----DDFKALVLEYMPHGSLEKCLY------LSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIH  226 (346)
Q Consensus       164 ------~~~~~~~-----~~~~~lv~e~~~~gsL~~~l~------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H  226 (346)
                            +..++..     ....+++|+++ +++|.+++.      .....+++..++.++.|+++||+|||   +.+|+|
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~iiH  234 (413)
T 3dzo_A          159 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVH  234 (413)
T ss_dssp             CCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEC
T ss_pred             cCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCccc
Confidence                  1111111     22355666665 789998874      22445788899999999999999999   999999


Q ss_pred             cCCCCCceEECCCCcEEEeeecCCccCCccccccccccccCCcccccCCCC----------CCCCCCcchhHHHHHHHHH
Q 039799          227 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYG----------REGRVSTNGDVYSFGIMLM  296 (346)
Q Consensus       227 ~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------~~~~~~~~~Dv~s~G~il~  296 (346)
                      |||||+|||++.++.+||+|||+++.....     .....| +.|+|||++          ....++.++|||||||++|
T Consensus       235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~  308 (413)
T 3dzo_A          235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY  308 (413)
T ss_dssp             SCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred             CCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence            999999999999999999999998865322     334567 999999988          6667889999999999999


Q ss_pred             HHHcCCCCCCccccCcccHHHHH--hhhcCCChhhhhchhccCCccccccc
Q 039799          297 EIFTRTKPTDEIFSGEMTLKRWV--NDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       297 elltg~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ||+||+.||......+.. ....  ...++..+.+++.+||..||++||++
T Consensus       309 elltg~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~  358 (413)
T 3dzo_A          309 WIWCADLPNTDDAALGGS-EWIFRSCKNIPQPVRALLEGFLRYPKEDRLLP  358 (413)
T ss_dssp             HHHHSSCCCCTTGGGSCS-GGGGSSCCCCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HHHHCCCCCCCcchhhhH-HHHHhhcccCCHHHHHHHHHHccCChhhCcCH
Confidence            999999999764322211 1111  12456689999999999999999985

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.6e-37  Score=276.11  Aligned_cols=211  Identities=20%  Similarity=0.303  Sum_probs=173.1

Q ss_pred             CCCCCC-CcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHH-HhcCCCCceeeEEEEec----CCcee
Q 039799          103 NDANMP-PLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVM-KRICHRNLIKIISSYSN----DDFKA  175 (346)
Q Consensus       103 ~~~~~~-~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~----~~~~~  175 (346)
                      ++|.+. +.||+|+||.||++... +++.||+|++...     ..+.+|++++ +..+||||+++++++..    ....+
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   91 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   91 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence            446665 78999999999999975 7899999998642     4566788887 55699999999999876    67889


Q ss_pred             EEEecCCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC---CCcEEEeeecCCc
Q 039799          176 LVLEYMPHGSLEKCLYLSN-YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD---NMVAHLSDFGMAK  251 (346)
Q Consensus       176 lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~---~~~~~l~Dfg~~~  251 (346)
                      +||||+++++|.+++.... ..+++..++.++.+++.||+|||   +.+|+||||||+||+++.   ++.++|+|||++.
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~  168 (299)
T 3m2w_A           92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  168 (299)
T ss_dssp             EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence            9999999999999987654 46899999999999999999999   999999999999999997   7899999999987


Q ss_pred             cCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCc-------------ccHHHH
Q 039799          252 PLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE-------------MTLKRW  318 (346)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~-------------~~~~~~  318 (346)
                      ...                        +..++.++||||||+++|||+||+.||.......             ......
T Consensus       169 ~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (299)
T 3m2w_A          169 ETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP  224 (299)
T ss_dssp             ECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHH
T ss_pred             ccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCch
Confidence            432                        2346789999999999999999999996432110             111122


Q ss_pred             HhhhcCCChhhhhchhccCCccccccc
Q 039799          319 VNDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       319 ~~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ....++..+.+++.+||..||.+||++
T Consensus       225 ~~~~~~~~~~~li~~~l~~dP~~Rps~  251 (299)
T 3m2w_A          225 EWSEVSEEVKMLIRNLLKTEPTQRMTI  251 (299)
T ss_dssp             HHTTSCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             hcccCCHHHHHHHHHHcccChhhCCCH
Confidence            223456689999999999999999985

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.4e-37  Score=280.96  Aligned_cols=223  Identities=17%  Similarity=0.154  Sum_probs=175.3

Q ss_pred             CCCCCCCcccccCceEEEEEEEcCCCEEEEEEecCCC--------chhHHHHHHHHHHHHhcC---------CCCceeeE
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQY--------EGAFKSFDIECDVMKRIC---------HRNLIKII  165 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---------h~niv~~~  165 (346)
                      ++|.+.+.||+|+||+||+|+. +|+.||||++....        ....+.+.+|+++++.++         ||||+++.
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~   98 (336)
T 2vuw_A           20 EKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN   98 (336)
T ss_dssp             HHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred             ccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence            4588899999999999999998 58999999987542        223477888999998886         88888887


Q ss_pred             EEEe------------------------------cCCceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHH
Q 039799          166 SSYS------------------------------NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEY  215 (346)
Q Consensus       166 ~~~~------------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~  215 (346)
                      +.+.                              ..+..++||||+++|++.+.+..  ..+++..+..++.|++.||+|
T Consensus        99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~~  176 (336)
T 2vuw_A           99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLAV  176 (336)
T ss_dssp             EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHHH
T ss_pred             ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHHH
Confidence            7642                              26789999999999976665532  458999999999999999999


Q ss_pred             HhcCCCCCeeecCCCCCceEECCCC--------------------cEEEeeecCCccCCccccccccccccCCcccccCC
Q 039799          216 LHFGYSAPIIHCDLKPSNVLLDDNM--------------------VAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE  275 (346)
Q Consensus       216 LH~~~~~~i~H~dik~~NIll~~~~--------------------~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  275 (346)
                      ||+  +.+|+||||||+|||++.++                    .+||+|||+++....       ....||+.|+|||
T Consensus       177 lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~aPE  247 (336)
T 2vuw_A          177 AEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSMDED  247 (336)
T ss_dssp             HHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTTCSG
T ss_pred             HHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecccChh
Confidence            993  47899999999999999876                    999999999986532       1346999999999


Q ss_pred             CCCCCCCCcchhHHHHHHH-HHHHHcCCCCCCccc-------------cCcccHHHHHhhhcCCChhhhhchhccCC
Q 039799          276 YGREGRVSTNGDVYSFGIM-LMEIFTRTKPTDEIF-------------SGEMTLKRWVNDLLPISVMEVVDANLLSQ  338 (346)
Q Consensus       276 ~~~~~~~~~~~Dv~s~G~i-l~elltg~~p~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  338 (346)
                      ++.+.. +.++||||+|++ .+++++|..||....             .............++..+.+++.+||..|
T Consensus       248 ~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d  323 (336)
T 2vuw_A          248 LFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS  323 (336)
T ss_dssp             GGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS
T ss_pred             hhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC
Confidence            998766 899999998766 788899999986410             00000011122234557899999999876

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=1.6e-32  Score=263.35  Aligned_cols=183  Identities=19%  Similarity=0.097  Sum_probs=129.0

Q ss_pred             ccCceEEEEEE-EcCCCEEEEEEecCCC----------chhHHHHHHHHHHHHhc-CCCCceeeEEEEecCCceeEEEec
Q 039799          113 KGGFGSVYKAI-IQDGMEVAVKVFDPQY----------EGAFKSFDIECDVMKRI-CHRNLIKIISSYSNDDFKALVLEY  180 (346)
Q Consensus       113 ~G~~g~vy~~~-~~~~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~  180 (346)
                      .|+.|.+..+. .-.|+.+++|++....          +...+++.+|+++|+++ .|+||++++++++++...||||||
T Consensus       244 ~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEy  323 (569)
T 4azs_A          244 AGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEK  323 (569)
T ss_dssp             --------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEEC
T ss_pred             cCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEec
Confidence            34444444333 2247889999996531          22346789999999999 799999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccc
Q 039799          181 MPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  260 (346)
Q Consensus       181 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~  260 (346)
                      ++|++|.+.+... ..++..   +|+.||+.||+|+|   +.+|+||||||+|||+++++.+||+|||+|+......  .
T Consensus       324 v~G~~L~d~i~~~-~~l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~--~  394 (569)
T 4azs_A          324 LPGRLLSDMLAAG-EEIDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC--S  394 (569)
T ss_dssp             CCSEEHHHHHHTT-CCCCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-----C
T ss_pred             CCCCcHHHHHHhC-CCCCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC--c
Confidence            9999999999754 345543   48999999999999   9999999999999999999999999999998764332  2


Q ss_pred             ccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCC
Q 039799          261 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPT  305 (346)
Q Consensus       261 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~  305 (346)
                      .....+||++|+|||++.+ .+..++|+||+|++++++.++..|+
T Consensus       395 ~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          395 WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             CSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred             cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence            2344679999999999865 4677899999999988877665543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=8.1e-29  Score=236.40  Aligned_cols=184  Identities=18%  Similarity=0.136  Sum_probs=145.7

Q ss_pred             CCcccccCceEEEEEEEcCCCEEEEEEecCCCc--------hhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEe
Q 039799          108 PPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYE--------GAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLE  179 (346)
Q Consensus       108 ~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  179 (346)
                      .+.||+|+||.||+|.. .++.+++|+......        ...+++.+|++++++++||||+++..++...+..++|||
T Consensus       341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE  419 (540)
T 3en9_A          341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS  419 (540)
T ss_dssp             -------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred             CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence            35899999999999954 478899998654321        113457899999999999999976666667778899999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccc
Q 039799          180 YMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  259 (346)
Q Consensus       180 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~  259 (346)
                      |+++++|.+++..         +..++.|+++||+|||   +.+|+||||||+|||+++  .+||+|||+++........
T Consensus       420 ~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~  485 (540)
T 3en9_A          420 YINGKLAKDVIED---------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDK  485 (540)
T ss_dssp             CCCSEEHHHHSTT---------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHH
T ss_pred             CCCCCCHHHHHHH---------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECCCcccc
Confidence            9999999998864         5679999999999999   999999999999999999  9999999999987543221


Q ss_pred             c-----ccccccCCcccccCCCCCC--CCCCcchhHHHHHHHHHHHHcCCCCCC
Q 039799          260 L-----TQTQTLATIGYMAPEYGRE--GRVSTNGDVYSFGIMLMEIFTRTKPTD  306 (346)
Q Consensus       260 ~-----~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~s~G~il~elltg~~p~~  306 (346)
                      .     ......||+.|+|||++..  ..|+..+|+|+..+-.++-+.++.+|.
T Consensus       486 ~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          486 AVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             ccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            1     1234568999999998876  557788899999999999888887764

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.91  E-value=1.7e-25  Score=196.51  Aligned_cols=132  Identities=17%  Similarity=0.208  Sum_probs=108.3

Q ss_pred             CCCCCcccccCceEEEEEEEcCCCEEEEEEecCCCc------------------hhHHHHHHHHHHHHhcCCCCceeeEE
Q 039799          105 ANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYE------------------GAFKSFDIECDVMKRICHRNLIKIIS  166 (346)
Q Consensus       105 ~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~niv~~~~  166 (346)
                      |.+.+.||+|+||.||+|.+.+|+.||+|++.....                  .....+.+|++++++++|   +++.+
T Consensus        92 ~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v~~  168 (282)
T 1zar_A           92 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAVPK  168 (282)
T ss_dssp             SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSSCC
T ss_pred             EEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCcCe
Confidence            455699999999999999997799999999864321                  134678899999999994   55555


Q ss_pred             EEecCCceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEee
Q 039799          167 SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSD  246 (346)
Q Consensus       167 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~D  246 (346)
                      ++.. +..++||||+++++|.+ +..       .....++.+++.|++|||   +.+|+||||||+|||++ ++.++|+|
T Consensus       169 ~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl~-~~~vkl~D  235 (282)
T 1zar_A          169 VYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVS-EEGIWIID  235 (282)
T ss_dssp             EEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE-TTEEEECC
T ss_pred             EEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEEE-CCcEEEEE
Confidence            4433 56689999999999988 421       124469999999999999   99999999999999999 99999999


Q ss_pred             ecCCcc
Q 039799          247 FGMAKP  252 (346)
Q Consensus       247 fg~~~~  252 (346)
                      ||+++.
T Consensus       236 FG~a~~  241 (282)
T 1zar_A          236 FPQSVE  241 (282)
T ss_dssp             CTTCEE
T ss_pred             CCCCeE
Confidence            999874

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.83  E-value=3.4e-21  Score=166.99  Aligned_cols=137  Identities=23%  Similarity=0.241  Sum_probs=105.3

Q ss_pred             CCCCCcccccCceEEEEEEE-cCCCE--EEEEEecCCCch------------------------hHHHHHHHHHHHHhcC
Q 039799          105 ANMPPLIGKGGFGSVYKAII-QDGME--VAVKVFDPQYEG------------------------AFKSFDIECDVMKRIC  157 (346)
Q Consensus       105 ~~~~~~lg~G~~g~vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l~  157 (346)
                      |.+.+.||+|+||.||+|.. .+|+.  ||||++......                        ....+.+|++.+.++.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            56678999999999999998 68889  999997543111                        1236788999999998


Q ss_pred             CCCc--eeeEEEEecCCceeEEEecCCC-C----ChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCC
Q 039799          158 HRNL--IKIISSYSNDDFKALVLEYMPH-G----SLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLK  230 (346)
Q Consensus       158 h~ni--v~~~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik  230 (346)
                      |+++  ..+++.    +..++||||+.+ |    +|.+....    .++.....++.+++.++.|||.  +.+|+|||||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~--~~givHrDlk  198 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQ--EAELVHADLS  198 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHH--TSCEECSSCS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHH--HCCEEeCCCC
Confidence            8764  334432    356899999942 4    66665422    1233567899999999999994  5689999999


Q ss_pred             CCceEECCCCcEEEeeecCCccC
Q 039799          231 PSNVLLDDNMVAHLSDFGMAKPL  253 (346)
Q Consensus       231 ~~NIll~~~~~~~l~Dfg~~~~~  253 (346)
                      |+|||+++  .++|+|||+|...
T Consensus       199 p~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          199 EYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             TTSEEESS--SEEECCCTTCEET
T ss_pred             HHHEEEcC--cEEEEECcccccC
Confidence            99999998  9999999999864

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.73  E-value=4.3e-18  Score=153.65  Aligned_cols=137  Identities=12%  Similarity=0.124  Sum_probs=101.0

Q ss_pred             CCCCCcccccCceEEEEEEEcCCCEEEEEEecCCCc----------------h------hHHHHHHHHHHHHhcCCCCce
Q 039799          105 ANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYE----------------G------AFKSFDIECDVMKRICHRNLI  162 (346)
Q Consensus       105 ~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~----------------~------~~~~~~~e~~~l~~l~h~niv  162 (346)
                      |.+...||+|++|.||+|...+|+.||||++.....                .      .......|...+.++.+.++.
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~  176 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP  176 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred             EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            888999999999999999998999999999753210                0      001123466777777555443


Q ss_pred             eeEEEEecCCceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCC--
Q 039799          163 KIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM--  240 (346)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~--  240 (346)
                      ...-+...  ..++||||++|++|.+.....       ....++.|++.++.+||   ..+|+||||||.|||+++++  
T Consensus       177 vp~p~~~~--~~~LVME~i~G~~L~~l~~~~-------~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~~dgd~  244 (397)
T 4gyi_A          177 VPEPIAQS--RHTIVMSLVDALPMRQVSSVP-------DPASLYADLIALILRLA---KHGLIHGDFNEFNILIREEKDA  244 (397)
T ss_dssp             CCCEEEEE--TTEEEEECCSCEEGGGCCCCS-------CHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEEEEECS
T ss_pred             CCeeeecc--CceEEEEecCCccHhhhcccH-------HHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeCCCCc
Confidence            22111111  236999999999887654311       23467899999999999   89999999999999998766  


Q ss_pred             --------cEEEeeecCCccC
Q 039799          241 --------VAHLSDFGMAKPL  253 (346)
Q Consensus       241 --------~~~l~Dfg~~~~~  253 (346)
                              .+.|+||+.+...
T Consensus       245 ~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          245 EDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             SCTTSEEEEEEECCCTTCEET
T ss_pred             ccccccccceEEEEeCCcccC
Confidence                    4899999988754

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.41  E-value=3.8e-13  Score=116.36  Aligned_cols=142  Identities=18%  Similarity=0.156  Sum_probs=109.1

Q ss_pred             CCCCCCcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcC-CCCceeeEEEEecCCceeEEEecCC
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRIC-HRNLIKIISSYSNDDFKALVLEYMP  182 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~  182 (346)
                      .|.+...++.|+.+.||++... ++.+++|+...........+.+|+++++.+. +..+.++++++...+..++||||++
T Consensus        15 ~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~   93 (263)
T 3tm0_A           15 KYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEAD   93 (263)
T ss_dssp             TSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCS
T ss_pred             cceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecC
Confidence            4666677888888999999755 6899999986422122345778999999884 6678889999988889999999999


Q ss_pred             CCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcC-------------------------------------------
Q 039799          183 HGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFG-------------------------------------------  219 (346)
Q Consensus       183 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-------------------------------------------  219 (346)
                      |.+|.+...      +......++.+++++++.||.-                                           
T Consensus        94 G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (263)
T 3tm0_A           94 GVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDP  167 (263)
T ss_dssp             SEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSH
T ss_pred             CeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCH
Confidence            999977531      1112346888999999999950                                           


Q ss_pred             -------------CCCCeeecCCCCCceEECCCCcEEEeeecCCcc
Q 039799          220 -------------YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  252 (346)
Q Consensus       220 -------------~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~  252 (346)
                                   ....++|+|+++.||+++++..+.|+||+.+..
T Consensus       168 ~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          168 RELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             HHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                         014589999999999998766667999998763

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.35  E-value=2.1e-12  Score=111.33  Aligned_cols=136  Identities=15%  Similarity=0.090  Sum_probs=99.9

Q ss_pred             CCCCCcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCC--ceeeEEEEecCCceeEEEecCC
Q 039799          105 ANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRN--LIKIISSYSNDDFKALVLEYMP  182 (346)
Q Consensus       105 ~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~  182 (346)
                      +.+..+.+.|..+.||++...+|..+++|+....   ....+..|+++++.+.+.+  +.+++++....+..++||||++
T Consensus        22 ~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~   98 (264)
T 1nd4_A           22 YDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP   98 (264)
T ss_dssp             CEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred             CceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecC
Confidence            3333333466679999998777888999997654   2245677999998886545  4568888888788899999999


Q ss_pred             CCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC------------------------------------------
Q 039799          183 HGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGY------------------------------------------  220 (346)
Q Consensus       183 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------------------------------------------  220 (346)
                      |.++.  ...    .+   ...++.++++.++.||...                                          
T Consensus        99 G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (264)
T 1nd4_A           99 GQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAE  169 (264)
T ss_dssp             SEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHH
T ss_pred             CcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHH
Confidence            98884  211    11   2356778888888888321                                          


Q ss_pred             -------------CCCeeecCCCCCceEECCCCcEEEeeecCCcc
Q 039799          221 -------------SAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  252 (346)
Q Consensus       221 -------------~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~  252 (346)
                                   ...++|+|++|.||+++++..+.|+||+.+..
T Consensus       170 ~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          170 LFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             HHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                         11299999999999998776677999998763

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=99.29  E-value=1.7e-12  Score=129.24  Aligned_cols=75  Identities=36%  Similarity=0.543  Sum_probs=42.4

Q ss_pred             CccCcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCC-CCCcccccccccCCcchhhcc
Q 039799            2 GSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSVKSFEGNELLCEIV   76 (346)
Q Consensus         2 g~ip~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~~~~~~~   76 (346)
                      |.||.+|++|++|+.||||+|+|+|.||.++++|++|+.||||+|+|+|.+|.. ..+++++.+++++|++...+|
T Consensus       646 g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP  721 (768)
T 3rgz_A          646 GYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIP  721 (768)
T ss_dssp             SCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECC
T ss_pred             ccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCC
Confidence            555555555555555555555555555555555555555555555555555543 444555555555555554444

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.19  E-value=9.1e-11  Score=106.19  Aligned_cols=141  Identities=13%  Similarity=0.146  Sum_probs=105.0

Q ss_pred             CCcccccCceEEEEEEEcCCCEEEEEEec--CCC-chhHHHHHHHHHHHHhcCC--CCceeeEEEEecC---CceeEEEe
Q 039799          108 PPLIGKGGFGSVYKAIIQDGMEVAVKVFD--PQY-EGAFKSFDIECDVMKRICH--RNLIKIISSYSND---DFKALVLE  179 (346)
Q Consensus       108 ~~~lg~G~~g~vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~---~~~~lv~e  179 (346)
                      .+.++.|.++.||+.... +..+++|+..  ... ......+.+|.++++.+.+  ..+.+++.++.+.   +..++|||
T Consensus        43 ~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme  121 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME  121 (359)
T ss_dssp             EEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred             EEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence            456889999999998876 4688899875  322 1223567789999999874  4577888888766   45889999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---------------------------------------
Q 039799          180 YMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGY---------------------------------------  220 (346)
Q Consensus       180 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---------------------------------------  220 (346)
                      |++|.++.+.   ....++...+..++.++++.|+.||...                                       
T Consensus       122 ~v~G~~l~~~---~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  198 (359)
T 3dxp_A          122 FVSGRVLWDQ---SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD  198 (359)
T ss_dssp             CCCCBCCCCT---TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred             ecCCeecCCC---ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence            9999887541   1123677788889999999999999420                                       


Q ss_pred             ----------------CCCeeecCCCCCceEECCCCc--EEEeeecCCcc
Q 039799          221 ----------------SAPIIHCDLKPSNVLLDDNMV--AHLSDFGMAKP  252 (346)
Q Consensus       221 ----------------~~~i~H~dik~~NIll~~~~~--~~l~Dfg~~~~  252 (346)
                                      ...++|+|+++.||+++.++.  +.|+||+.+..
T Consensus       199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                            256999999999999997653  68999999874

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=99.18  E-value=1.1e-11  Score=123.40  Aligned_cols=77  Identities=43%  Similarity=0.692  Sum_probs=55.5

Q ss_pred             CCccCcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCCCCCcccccccccCCcchhhccc
Q 039799            1 QGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNELLCEIVL   77 (346)
Q Consensus         1 ~g~ip~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~l~~l~~~~n~~~~~~~~   77 (346)
                      +|.||++|++|++|+.||||+|+|+|.||.++++|++|+.||||+|+|+|.+|..+.+..+....+.+|+.+|+.|+
T Consensus       669 ~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l  745 (768)
T 3rgz_A          669 SGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPL  745 (768)
T ss_dssp             CSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTS
T ss_pred             CCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCC
Confidence            46677777777777777777777777777777777777777777777777777776666777777777777776554

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.16  E-value=3.3e-13  Score=127.34  Aligned_cols=155  Identities=15%  Similarity=0.139  Sum_probs=86.9

Q ss_pred             CCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCCCCCcccccccccCCcchhhcccchhhH-HHHHHH
Q 039799           10 DLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNELLCEIVLPLSTI-FMIVMI   88 (346)
Q Consensus        10 ~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~l~~l~~~~n~~~~~~~~~~~~~-~~~~~~   88 (346)
                      .+++|+.|+|++|+|+ .+|+.+..+++|+.|+|++|+|++.++....++++..+++++|++.|..+...... ..+..+
T Consensus       189 ~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~Ls~N~l~~lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l  267 (487)
T 3oja_A          189 VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTV  267 (487)
T ss_dssp             CCTTCCEEECCSSCCC-EECGGGGGGTTCSEEECTTSCCCEECTTCCCCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHH
T ss_pred             cCCCCCEEECCCCCCC-CCCHhHcCCCCccEEEecCCcCcccchhhccCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEE
Confidence            4778888888888888 56767888899999999999999877666778889999999999987643221110 001001


Q ss_pred             HHH-HHHHhcCCCCCCCCCCCCcc-----cccCceEEEEEEEcCCCEEEEEEecC--CCchhHHHHHHHHHHHHhcCCCC
Q 039799           89 LLI-LRYQKRGKPLPNDANMPPLI-----GKGGFGSVYKAIIQDGMEVAVKVFDP--QYEGAFKSFDIECDVMKRICHRN  160 (346)
Q Consensus        89 ~~~-~~~~~~~~~~~~~~~~~~~l-----g~G~~g~vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~n  160 (346)
                      .+. .........  .........     +.+..+.+|..     +.+++|....  ......++|..|++++.+++|+|
T Consensus       268 ~~~~~~~~~~~~~--~~c~~~~~~~~~~~~~~~~~~~~~~-----~l~~~~~~~~~~~~~~g~~eF~~Eve~L~~i~HrN  340 (487)
T 3oja_A          268 AKQTVKKLTGQNE--EECTVPTLGHYGAYCCEDLPAPFAD-----RLIALKRKEHALLSGQGSETERLECERENQARQRE  340 (487)
T ss_dssp             HHHHHHHHTSSSS--CCCSSTTCEEETTEEECCCSCHHHH-----HHHHHHHHHHCSCC-----CHHHHHHHHHHHHHHH
T ss_pred             eccccccccCCCc--ccccCCccccccccccccccchhhh-----HHHHHHHHhhhhcccccHHHHHHHHHHHhcccccc
Confidence            111 111111111  111111111     11111111110     0011111110  01223568999999999999999


Q ss_pred             ceeeEEEEecCC
Q 039799          161 LIKIISSYSNDD  172 (346)
Q Consensus       161 iv~~~~~~~~~~  172 (346)
                      +|+++|||....
T Consensus       341 LV~L~gyC~s~~  352 (487)
T 3oja_A          341 IDALKEQYRTVI  352 (487)
T ss_dssp             HHHHHHHTCCCC
T ss_pred             hhhHHHHhcChH
Confidence            999999986553

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.09  E-value=1.6e-10  Score=93.03  Aligned_cols=74  Identities=22%  Similarity=0.234  Sum_probs=62.6

Q ss_pred             ccCcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCC-CCCCcccccccccCCcchhhcc
Q 039799            3 SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPR-EGPFRNLSVKSFEGNELLCEIV   76 (346)
Q Consensus         3 ~ip~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~-~~~~~~l~~l~~~~n~~~~~~~   76 (346)
                      -.|..+++|++|+.|+|++|+|++..|..+..+++|+.|+|++|+|++.++. ...+++|+.+++++|++.|..+
T Consensus        45 ~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~  119 (170)
T 3g39_A           45 LEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWLLNNPWDCACS  119 (170)
T ss_dssp             CCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred             cChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence            3477789999999999999999944444568999999999999999998886 4778899999999999998754

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.08  E-value=1.3e-10  Score=95.47  Aligned_cols=74  Identities=18%  Similarity=0.280  Sum_probs=49.8

Q ss_pred             ccCcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCC-CCCcccccccccCCcchhhcc
Q 039799            3 SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSVKSFEGNELLCEIV   76 (346)
Q Consensus         3 ~ip~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~~~~~~~   76 (346)
                      ..|..++++++|+.|+|++|+|++..|..+..+++|+.|+|++|++++.+|.. ..+++++.+++++|++.|..+
T Consensus        69 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~  143 (192)
T 1w8a_A           69 IEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH  143 (192)
T ss_dssp             BCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred             cCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence            34566666677777777777777555555666777777777777777765544 556677777788887777654

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.08  E-value=1.9e-10  Score=92.90  Aligned_cols=73  Identities=25%  Similarity=0.374  Sum_probs=59.8

Q ss_pred             ccCcchhCCCCCCEEEeecCcccccCCcc-ccCcCCCCeEECcCCcCcCCCCC-CCCCcccccccccCCcchhhcc
Q 039799            3 SIPDSIGDLINLKSLNLSNNNLSGTIPIS-LEKLLDLKDINVSFNKLEGEIPR-EGPFRNLSVKSFEGNELLCEIV   76 (346)
Q Consensus         3 ~ip~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~l~~l~~l~l~~N~l~~~~p~-~~~~~~l~~l~~~~n~~~~~~~   76 (346)
                      -.|..|+++++|+.|+|++|+|+ .+|.. +.++++|+.|+|++|+|++.++. ...+++|+.+++++|++.|...
T Consensus        48 ~~~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~  122 (174)
T 2r9u_A           48 LEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYLYNNPWDCECR  122 (174)
T ss_dssp             CCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCBCTTBG
T ss_pred             cCHHHhcCCcCCCEEECCCCCCC-ccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEeCCCCcccccc
Confidence            34677888999999999999999 56654 58899999999999999988776 4678889999999999888653

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.06  E-value=1e-10  Score=103.85  Aligned_cols=72  Identities=42%  Similarity=0.699  Sum_probs=66.3

Q ss_pred             chhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCCCCCcccccccccCCcchhhcccc
Q 039799            7 SIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNELLCEIVLP   78 (346)
Q Consensus         7 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~l~~l~~~~n~~~~~~~~~   78 (346)
                      .++.+++|+.|+|++|+++|.+|..+.++++|+.|+|++|+++|.+|....+++++.+++++|+..|+.|.+
T Consensus       239 ~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p~~  310 (313)
T 1ogq_A          239 KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP  310 (313)
T ss_dssp             GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSS
T ss_pred             cccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCCCccCCCCC
Confidence            478889999999999999999999999999999999999999999999888999999999999999987664

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.03  E-value=9.8e-11  Score=103.48  Aligned_cols=188  Identities=16%  Similarity=0.147  Sum_probs=119.2

Q ss_pred             CCcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcC-CCC--ceeeEEEEecCC---ceeEEEecC
Q 039799          108 PPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRIC-HRN--LIKIISSYSNDD---FKALVLEYM  181 (346)
Q Consensus       108 ~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~~~~~~~~~~---~~~lv~e~~  181 (346)
                      .+.++.|....||+..    ..+++|+....  .....+.+|.++++.+. +..  +.+++......+   ..++||+++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            4568999999999863    56889986432  34567888999998884 333  334444433333   457899999


Q ss_pred             CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcC------------------------------------------
Q 039799          182 PHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFG------------------------------------------  219 (346)
Q Consensus       182 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~------------------------------------------  219 (346)
                      +|.++.+...   ..++...+..++.++++.++.||..                                          
T Consensus        99 ~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  175 (304)
T 3sg8_A           99 KGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD  175 (304)
T ss_dssp             CCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred             CCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence            9988865322   2355666677777888877777731                                          


Q ss_pred             -------------CCCCeeecCCCCCceEECC--CCcEEEeeecCCccCCccccccccccc---cCC-------ccc--c
Q 039799          220 -------------YSAPIIHCDLKPSNVLLDD--NMVAHLSDFGMAKPLLEEDQSLTQTQT---LAT-------IGY--M  272 (346)
Q Consensus       220 -------------~~~~i~H~dik~~NIll~~--~~~~~l~Dfg~~~~~~~~~~~~~~~~~---~~~-------~~y--~  272 (346)
                                   ....++|+|+++.||++++  ...+.++||+.+..-.+...-......   .+.       ..|  .
T Consensus       176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~  255 (304)
T 3sg8_A          176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHK  255 (304)
T ss_dssp             HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCS
T ss_pred             HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCC
Confidence                         1245899999999999998  556789999998753211000000000   000       001  0


Q ss_pred             c-CCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCC
Q 039799          273 A-PEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTD  306 (346)
Q Consensus       273 a-PE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~  306 (346)
                      . |+...  ......+.|+++.+++++.+|..++-
T Consensus       256 ~~~~~~~--r~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          256 DIPTVLE--KYRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             CHHHHHH--HHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             CcHHHHH--HHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence            0 11000  01122589999999999999998864

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=98.96  E-value=8.4e-10  Score=92.71  Aligned_cols=73  Identities=21%  Similarity=0.233  Sum_probs=54.2

Q ss_pred             CcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCC-CCCcccccccccCCcchhhccc
Q 039799            5 PDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSVKSFEGNELLCEIVL   77 (346)
Q Consensus         5 p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~~~~~~~~   77 (346)
                      |..++++++|+.|+|++|++++..|..+..+++|+.|+|++|++++.+|.. ..+++++.+++++|++.|...+
T Consensus        98 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l  171 (220)
T 2v70_A           98 HKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCYL  171 (220)
T ss_dssp             GGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGGG
T ss_pred             HhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCch
Confidence            344777777777777777777666777777788888888888888776644 5677788888888888876543

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=98.96  E-value=6.3e-10  Score=100.07  Aligned_cols=70  Identities=24%  Similarity=0.269  Sum_probs=51.0

Q ss_pred             cchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCCCCCcccccccccCCcchhhc
Q 039799            6 DSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNELLCEI   75 (346)
Q Consensus         6 ~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~l~~l~~~~n~~~~~~   75 (346)
                      ..|++|++|+.|+|++|+|+|..|..|.+|++|+.|+|++|+|++.++.......|+.+++.+|++.|..
T Consensus        50 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~L~~l~l~~N~~~c~c  119 (347)
T 2ifg_A           50 RDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSC  119 (347)
T ss_dssp             GGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCCCCEEECCSSCCCCCG
T ss_pred             hHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccceeCHHHcccCCceEEEeeCCCccCCC
Confidence            5577777888888888888766666777788888888888888777766533334777788888877753

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=98.94  E-value=1.2e-09  Score=89.87  Aligned_cols=67  Identities=22%  Similarity=0.294  Sum_probs=33.7

Q ss_pred             hhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCC-CCCcccccccccCCcchhh
Q 039799            8 IGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSVKSFEGNELLCE   74 (346)
Q Consensus         8 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~~~~~   74 (346)
                      |++|++|+.|+|++|+|++..|..+..+++|+.|+|++|++++.++.. ..+++++.+++++|++.|.
T Consensus        74 f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~  141 (193)
T 2wfh_A           74 FSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCD  141 (193)
T ss_dssp             TTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred             ccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecC
Confidence            444444444555555444333334445555555555555555444432 3455566666666666654

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=98.92  E-value=1.4e-09  Score=87.73  Aligned_cols=70  Identities=23%  Similarity=0.324  Sum_probs=63.0

Q ss_pred             CccCcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCC-CCCcccccccccCCcchh
Q 039799            2 GSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSVKSFEGNELLC   73 (346)
Q Consensus         2 g~ip~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~~~~   73 (346)
                      +.||..+.  ++|+.|+|++|+|++..|..+.++++|+.|+|++|+|++.++.. ..+.+|+.+++++|.+..
T Consensus        25 ~~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~   95 (174)
T 2r9u_A           25 ASVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKS   95 (174)
T ss_dssp             SSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred             CccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccce
Confidence            57888775  89999999999999777889999999999999999999988875 678999999999998764

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=98.92  E-value=6.6e-10  Score=98.54  Aligned_cols=70  Identities=31%  Similarity=0.501  Sum_probs=41.3

Q ss_pred             ccCcchhCCCCCCEEEeec-CcccccCCccccCcCCCCeEECcCCcCcCCCCCC-CCCcccccccccCCcch
Q 039799            3 SIPDSIGDLINLKSLNLSN-NNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSVKSFEGNELL   72 (346)
Q Consensus         3 ~ip~~~~~l~~L~~l~l~~-N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~~~   72 (346)
                      .+|+.++++++|++|+|++ |+++|.+|..++++++|+.|+|++|++++.+|.. ..+++++.+++++|.+.
T Consensus        67 ~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~  138 (313)
T 1ogq_A           67 PIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALS  138 (313)
T ss_dssp             ECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEE
T ss_pred             ccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccC
Confidence            4566666666666666663 6666666666666666666666666666555542 44555556666665554

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=98.90  E-value=1.4e-09  Score=89.26  Aligned_cols=67  Identities=22%  Similarity=0.360  Sum_probs=52.9

Q ss_pred             hhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCC-CCCcccccccccCCcchhh
Q 039799            8 IGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSVKSFEGNELLCE   74 (346)
Q Consensus         8 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~~~~~   74 (346)
                      ++++++|+.|+|++|+|++..|..+..+++|+.|+|++|+|++.+|.. ..+++|+.+++++|.+...
T Consensus        50 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  117 (192)
T 1w8a_A           50 FGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCV  117 (192)
T ss_dssp             GGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEE
T ss_pred             cccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCee
Confidence            778888888888888888777778888888888888888888877763 5677888888888876654

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=98.90  E-value=2.1e-09  Score=88.28  Aligned_cols=70  Identities=26%  Similarity=0.445  Sum_probs=47.8

Q ss_pred             ccCcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCC-CCCcccccccccCCcch
Q 039799            3 SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSVKSFEGNELL   72 (346)
Q Consensus         3 ~ip~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~~~   72 (346)
                      .||..++++++|+.|+|++|++++..|..|..+++|+.|+|++|+|++.+|.. ..+++|+.+++++|.+.
T Consensus        45 ~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~  115 (193)
T 2wfh_A           45 LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDIS  115 (193)
T ss_dssp             SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCC
T ss_pred             hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCC
Confidence            45666777777777777777777444456777777777777777777766643 55667777777777655

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=98.85  E-value=3.6e-09  Score=88.81  Aligned_cols=68  Identities=21%  Similarity=0.325  Sum_probs=42.5

Q ss_pred             hhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCC-CCCcccccccccCCcchhhc
Q 039799            8 IGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSVKSFEGNELLCEI   75 (346)
Q Consensus         8 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~~~~~~   75 (346)
                      ++++++|+.|+|++|++++..|..+..+++|+.|+|++|+|++.++.. ..+++++.+++++|++.|..
T Consensus       100 f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c  168 (220)
T 2v9t_B          100 FEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDC  168 (220)
T ss_dssp             TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred             ccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCC
Confidence            355666666666666666444555666666666666666666665542 45666777777777777653

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=98.85  E-value=4.3e-09  Score=85.07  Aligned_cols=68  Identities=22%  Similarity=0.246  Sum_probs=39.5

Q ss_pred             hhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCC-CCCcccccccccCCcchhhc
Q 039799            8 IGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSVKSFEGNELLCEI   75 (346)
Q Consensus         8 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~~~~~~   75 (346)
                      ++++++|+.|+|++|++++..|..+..+++|+.|++++|++++.++.. ..+++++.+++++|++.|..
T Consensus        72 ~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~  140 (177)
T 2o6r_A           72 FDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC  140 (177)
T ss_dssp             TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred             ccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccC
Confidence            455666666666666666333333556666666666666666555543 44566666666667666543

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=98.84  E-value=4.7e-09  Score=88.68  Aligned_cols=69  Identities=25%  Similarity=0.372  Sum_probs=52.3

Q ss_pred             chhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCC-CCCcccccccccCCcchhhcc
Q 039799            7 SIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSVKSFEGNELLCEIV   76 (346)
Q Consensus         7 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~~~~~~~   76 (346)
                      .++.+++|+.|+|++|+|+ .||..+..+++|+.|+|++|+|++.++.. ..+++++.+++++|++.|..+
T Consensus       107 ~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  176 (229)
T 3e6j_A          107 VFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR  176 (229)
T ss_dssp             TTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred             HhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence            3567777777777777777 77777778888888888888888776643 567788888888888887653

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=98.83  E-value=2.1e-09  Score=96.58  Aligned_cols=71  Identities=21%  Similarity=0.144  Sum_probs=64.1

Q ss_pred             ccCcchhCCCCCCEEEeec-CcccccCCccccCcCCCCeEECcCCcCcCCCCCC-CCCcccccccccCCcchhh
Q 039799            3 SIPDSIGDLINLKSLNLSN-NNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSVKSFEGNELLCE   74 (346)
Q Consensus         3 ~ip~~~~~l~~L~~l~l~~-N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~~~~~   74 (346)
                      .||. |+.+++|+.|+|++ |+|++..|..|..|++|+.|+|++|+|++.+|.. ..+++|+.|++++|.+...
T Consensus        23 ~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~   95 (347)
T 2ifg_A           23 SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESL   95 (347)
T ss_dssp             TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCC
T ss_pred             ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCcccee
Confidence            5899 99999999999996 9999666678999999999999999999999875 7799999999999998743

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=98.82  E-value=2.7e-09  Score=103.86  Aligned_cols=70  Identities=16%  Similarity=0.231  Sum_probs=65.1

Q ss_pred             cCcchhCCCCCCEEEeecCccccc-----------------CCcccc--CcCCCCeEECcCCcCcCCCCCC-CCCccccc
Q 039799            4 IPDSIGDLINLKSLNLSNNNLSGT-----------------IPISLE--KLLDLKDINVSFNKLEGEIPRE-GPFRNLSV   63 (346)
Q Consensus         4 ip~~~~~l~~L~~l~l~~N~l~g~-----------------~p~~~~--~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~   63 (346)
                      ||+++++|++|++|+|++|+|+|.                 +|++++  +|++|+.|+|++|++.|.+|.. +.+++|+.
T Consensus       198 ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~  277 (636)
T 4eco_A          198 VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQL  277 (636)
T ss_dssp             ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCE
T ss_pred             CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCE
Confidence            999999999999999999999986                 999999  9999999999999999998865 78899999


Q ss_pred             ccccCCc-chh
Q 039799           64 KSFEGNE-LLC   73 (346)
Q Consensus        64 l~~~~n~-~~~   73 (346)
                      +++++|. +..
T Consensus       278 L~Ls~n~~l~~  288 (636)
T 4eco_A          278 INVACNRGISG  288 (636)
T ss_dssp             EECTTCTTSCH
T ss_pred             EECcCCCCCcc
Confidence            9999998 654

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=98.81  E-value=5.4e-09  Score=84.01  Aligned_cols=69  Identities=22%  Similarity=0.296  Sum_probs=61.7

Q ss_pred             ccCcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCC-CCCcccccccccCCcchh
Q 039799            3 SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSVKSFEGNELLC   73 (346)
Q Consensus         3 ~ip~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~~~~   73 (346)
                      .||..+.  ++|+.|+|++|+|++..|..+..+++|+.|+|++|+|++.+|.. ..+++|+.+++++|.+..
T Consensus        23 ~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~   92 (170)
T 3g39_A           23 SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKS   92 (170)
T ss_dssp             SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred             ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCE
Confidence            5787764  89999999999999777888999999999999999999988876 678999999999998764

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=98.80  E-value=4.7e-09  Score=101.73  Aligned_cols=74  Identities=23%  Similarity=0.341  Sum_probs=56.6

Q ss_pred             ccCcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCC-CCC-cccccccccCCcchhhcc
Q 039799            3 SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPF-RNLSVKSFEGNELLCEIV   76 (346)
Q Consensus         3 ~ip~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~-~~l~~l~~~~n~~~~~~~   76 (346)
                      -.|..|++|++|+.|+|++|+|++..|..+..+++|+.|||++|+|++.+|.. ..+ .+++.+++++|++.|...
T Consensus       509 l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~  584 (635)
T 4g8a_A          509 LSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE  584 (635)
T ss_dssp             ECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred             cChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence            34667788888888888888888666667788888888888888888887765 334 578888888998888643

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=98.79  E-value=7.5e-09  Score=102.13  Aligned_cols=73  Identities=30%  Similarity=0.370  Sum_probs=63.0

Q ss_pred             ccCcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCCCCCcccccccccCCcchhhcc
Q 039799            3 SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNELLCEIV   76 (346)
Q Consensus         3 ~ip~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~l~~l~~~~n~~~~~~~   76 (346)
                      .||++|++|++|+.|||++|+|+ .||.+|++|++|+.|+|++|+|+..++..+.+++|+.|++++|.+...++
T Consensus       261 ~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~L~~N~l~~~~p  333 (727)
T 4b8c_D          261 ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVTTLPWEFGNLCNLQFLGVEGNPLEKQFL  333 (727)
T ss_dssp             CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCCCCCSSTTSCTTCCCEECTTSCCCSHHH
T ss_pred             ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCCccChhhhcCCCccEEeCCCCccCCCCh
Confidence            68888999999999999999999 89999999999999999999998666666888899999999998876544

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=98.77  E-value=7.3e-09  Score=92.42  Aligned_cols=73  Identities=26%  Similarity=0.310  Sum_probs=57.0

Q ss_pred             ccCcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCC-CCCcccccccccCCcchhhcc
Q 039799            3 SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSVKSFEGNELLCEIV   76 (346)
Q Consensus         3 ~ip~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~~~~~~~   76 (346)
                      .+|..++++++|+.|+|++|+++ .+|+.++++++|+.|+|++|++.+.+|.. +.+++|+.+++++|.....+|
T Consensus       197 ~lp~~l~~l~~L~~L~L~~N~l~-~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p  270 (328)
T 4fcg_A          197 SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLP  270 (328)
T ss_dssp             CCCGGGGGCTTCCEEEEESSCCC-CCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCC
T ss_pred             cchHhhcCCCCCCEEEccCCCCC-cCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcc
Confidence            57888888888888888888888 57778888888888888888888877764 667778888888877665544

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=98.77  E-value=5.6e-09  Score=100.01  Aligned_cols=70  Identities=23%  Similarity=0.336  Sum_probs=39.6

Q ss_pred             ccCcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCC-C-CCCCCcccccccccCCcchhh
Q 039799            3 SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEI-P-REGPFRNLSVKSFEGNELLCE   74 (346)
Q Consensus         3 ~ip~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~-p-~~~~~~~l~~l~~~~n~~~~~   74 (346)
                      .||..|++|++|+.|+|++|+|+ .|| .+++|++|+.|+|++|+|++.+ | ..+.+++|+.+++++|++...
T Consensus       477 ~lp~~~~~l~~L~~L~Ls~N~l~-~lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~  548 (567)
T 1dce_A          477 ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE  548 (567)
T ss_dssp             CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGS
T ss_pred             ccchhhhcCCCCCEEECCCCCCC-CCc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCC
Confidence            45555556666666666666665 355 5555666666666666666553 2 234555566666666655443

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=98.77  E-value=8.6e-09  Score=86.46  Aligned_cols=69  Identities=20%  Similarity=0.277  Sum_probs=49.9

Q ss_pred             chhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCC-CCCcccccccccCCcchhhc
Q 039799            7 SIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSVKSFEGNELLCEI   75 (346)
Q Consensus         7 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~~~~~~   75 (346)
                      .++++++|+.|+|++|++++..|..+..+++|+.|+|++|++++.+|.. ..+++|+.+++++|.+....
T Consensus        52 ~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  121 (220)
T 2v70_A           52 IFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVG  121 (220)
T ss_dssp             CGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBC
T ss_pred             hhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeEC
Confidence            3677788888888888887555557777788888888888887776653 55677777777777766543

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=98.75  E-value=4.1e-09  Score=102.61  Aligned_cols=53  Identities=9%  Similarity=0.124  Sum_probs=45.7

Q ss_pred             cccccCCccccCcCCCCeEECcCCcCcC------------------CCCCCC--CCcccccccccCCcchhhcc
Q 039799           23 NLSGTIPISLEKLLDLKDINVSFNKLEG------------------EIPREG--PFRNLSVKSFEGNELLCEIV   76 (346)
Q Consensus        23 ~l~g~~p~~~~~l~~l~~l~l~~N~l~~------------------~~p~~~--~~~~l~~l~~~~n~~~~~~~   76 (346)
                      +|+| ||++++++++|+.|+|++|+|+|                  .|+..+  .+++|+.+++++|.+...+|
T Consensus       194 ~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p  266 (636)
T 4eco_A          194 NITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLP  266 (636)
T ss_dssp             EEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCC
T ss_pred             CCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccCh
Confidence            5566 99999999999999999999999                  455557  89999999999998776555

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=98.73  E-value=1.6e-08  Score=90.12  Aligned_cols=74  Identities=23%  Similarity=0.381  Sum_probs=61.2

Q ss_pred             CccCcchhC---------CCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCCCCCcccccccccCCcch
Q 039799            2 GSIPDSIGD---------LINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNELL   72 (346)
Q Consensus         2 g~ip~~~~~---------l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~l~~l~~~~n~~~   72 (346)
                      |.+|..++.         +++|+.|+|++|+++ .+|..++++++|+.|+|++|++++.++....+++|+.+++++|.+.
T Consensus       164 ~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~l~~~l~~l~~L~~L~Ls~n~~~  242 (328)
T 4fcg_A          164 TELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTAL  242 (328)
T ss_dssp             CCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCCCCGGGGGCTTCCEEECTTCTTC
T ss_pred             cccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCcCchhhccCCCCCEEECcCCcch
Confidence            567766654         899999999999998 8998899999999999999999987777677888888899888876


Q ss_pred             hhcc
Q 039799           73 CEIV   76 (346)
Q Consensus        73 ~~~~   76 (346)
                      ..+|
T Consensus       243 ~~~p  246 (328)
T 4fcg_A          243 RNYP  246 (328)
T ss_dssp             CBCC
T ss_pred             hhhH
Confidence            6554

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=98.73  E-value=1.7e-08  Score=87.53  Aligned_cols=70  Identities=26%  Similarity=0.278  Sum_probs=48.7

Q ss_pred             chhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCC-CCCcccccccccCCcchhhcc
Q 039799            7 SIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSVKSFEGNELLCEIV   76 (346)
Q Consensus         7 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~~~~~~~   76 (346)
                      .++++++|+.|+|++|++++..|..++.+++|+.|++++|++++.+|.. ..+++++.+++++|++.|..+
T Consensus       152 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  222 (272)
T 3rfs_A          152 VFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP  222 (272)
T ss_dssp             TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred             HhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccCc
Confidence            3566777777777777777444445677777777777777777766654 566777778888887777644

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=98.73  E-value=1.8e-08  Score=86.21  Aligned_cols=67  Identities=25%  Similarity=0.389  Sum_probs=44.9

Q ss_pred             hhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCC-CCCcccccccccCCcchhh
Q 039799            8 IGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSVKSFEGNELLCE   74 (346)
Q Consensus         8 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~~~~~   74 (346)
                      ++++++|+.|+|++|+|++..|..+..+++|+.|+|++|++++.++.. ..+++++.+++++|++.|.
T Consensus       127 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~  194 (251)
T 3m19_A          127 FDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS  194 (251)
T ss_dssp             TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred             hccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence            466777777777777777333335667777777777777777666643 5566777777777777765

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=98.72  E-value=2.1e-08  Score=83.13  Aligned_cols=68  Identities=25%  Similarity=0.290  Sum_probs=39.4

Q ss_pred             hhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCC-CCCcccccccccCCcchhhc
Q 039799            8 IGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSVKSFEGNELLCEI   75 (346)
Q Consensus         8 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~~~~~~   75 (346)
                      ++++++|+.|+|++|++++..|..+.++++|+.|++++|++++.++.. ..+++++.+++++|++.|..
T Consensus        96 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~  164 (208)
T 2o6s_A           96 FDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTC  164 (208)
T ss_dssp             TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCT
T ss_pred             hcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecCC
Confidence            455666666666666666333333556666666666666666555542 44566666666666666543

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=98.71  E-value=5.6e-09  Score=81.81  Aligned_cols=69  Identities=26%  Similarity=0.359  Sum_probs=47.9

Q ss_pred             CccCcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCC-CCCcccccccccCCcch
Q 039799            2 GSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSVKSFEGNELL   72 (346)
Q Consensus         2 g~ip~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~~~   72 (346)
                      |.+|..++.+++|+.|+|++|++++ + ..++++++|+.|++++|++++.+|.. ..+++++.+++++|.+.
T Consensus        32 ~~~~~~~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~  101 (149)
T 2je0_A           32 GKLEGLTDEFEELEFLSTINVGLTS-I-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIK  101 (149)
T ss_dssp             TBCCSCCTTCTTCCEEECTTSCCCC-C-TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCC
T ss_pred             hHHHHHHhhcCCCcEEECcCCCCCC-c-hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCC
Confidence            5677777777777777777777773 3 56777777777777777777755544 33667777777777654

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=98.71  E-value=5.2e-09  Score=104.71  Aligned_cols=70  Identities=19%  Similarity=0.196  Sum_probs=57.8

Q ss_pred             cCcchhCCCCCCEEEeecCcccc-----------------cCCcccc--CcCCCCeEECcCCcCcCCCCCC-CCCccccc
Q 039799            4 IPDSIGDLINLKSLNLSNNNLSG-----------------TIPISLE--KLLDLKDINVSFNKLEGEIPRE-GPFRNLSV   63 (346)
Q Consensus         4 ip~~~~~l~~L~~l~l~~N~l~g-----------------~~p~~~~--~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~   63 (346)
                      ||++|++|++|+.|+|++|+|+|                 .||++++  +|++|+.|+|++|++.|.+|.. +.+++|+.
T Consensus       440 IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~  519 (876)
T 4ecn_A          440 ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQS  519 (876)
T ss_dssp             ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCE
T ss_pred             hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCE
Confidence            88888888888888888888887                 3888887  8888888888888888887754 67788888


Q ss_pred             ccccCCc-chh
Q 039799           64 KSFEGNE-LLC   73 (346)
Q Consensus        64 l~~~~n~-~~~   73 (346)
                      +++++|. +..
T Consensus       520 L~Ls~N~~lsg  530 (876)
T 4ecn_A          520 LNIACNRGISA  530 (876)
T ss_dssp             EECTTCTTSCH
T ss_pred             EECcCCCCccc
Confidence            8888887 554

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=98.71  E-value=6.6e-09  Score=103.93  Aligned_cols=71  Identities=17%  Similarity=0.237  Sum_probs=63.6

Q ss_pred             CccCcchh--CCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCc-CcC-CCCCC-C-------CCcccccccccCC
Q 039799            2 GSIPDSIG--DLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNK-LEG-EIPRE-G-------PFRNLSVKSFEGN   69 (346)
Q Consensus         2 g~ip~~~~--~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~-l~~-~~p~~-~-------~~~~l~~l~~~~n   69 (346)
                      |.||++++  +|++|+.|+|++|+++|.+|..+++|++|+.|+|++|+ |+| .+|.. +       .+++|+.+++++|
T Consensus       479 g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N  558 (876)
T 4ecn_A          479 QYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYN  558 (876)
T ss_dssp             HHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSS
T ss_pred             ccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCC
Confidence            35999998  99999999999999999999999999999999999998 998 66642 3       3458999999999


Q ss_pred             cch
Q 039799           70 ELL   72 (346)
Q Consensus        70 ~~~   72 (346)
                      .+.
T Consensus       559 ~L~  561 (876)
T 4ecn_A          559 NLE  561 (876)
T ss_dssp             CCC
T ss_pred             cCC
Confidence            988

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=98.70  E-value=1.8e-08  Score=84.48  Aligned_cols=69  Identities=20%  Similarity=0.267  Sum_probs=52.6

Q ss_pred             cchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCC-CCCcccccccccCCcchhh
Q 039799            6 DSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSVKSFEGNELLCE   74 (346)
Q Consensus         6 ~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~~~~~   74 (346)
                      ..++.+++|+.|+|++|++++..|..+..+++|+.|+|++|+|++.++.. ..+.+|+.+++++|.+...
T Consensus        50 ~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~  119 (220)
T 2v9t_B           50 GAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCL  119 (220)
T ss_dssp             TSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred             hHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEe
Confidence            35777888888888888888666778888888888888888888766654 5677788888888876543

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=98.70  E-value=2.7e-08  Score=80.28  Aligned_cols=65  Identities=23%  Similarity=0.248  Sum_probs=39.0

Q ss_pred             hhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCC-CCCcccccccccCCcch
Q 039799            8 IGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSVKSFEGNELL   72 (346)
Q Consensus         8 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~~~   72 (346)
                      ++++++|+.|+|++|+|++..|..+..+++|+.|++++|++++.++.. ..+++++.+++++|.+.
T Consensus        48 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~  113 (177)
T 2o6r_A           48 FDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLK  113 (177)
T ss_dssp             TTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred             hcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcce
Confidence            456666666666666666322333566666666666666666655543 45566666666666554

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=98.69  E-value=1.7e-08  Score=93.98  Aligned_cols=74  Identities=20%  Similarity=0.170  Sum_probs=62.0

Q ss_pred             cCcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCC-CCCcccccccccCCcchhhccc
Q 039799            4 IPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSVKSFEGNELLCEIVL   77 (346)
Q Consensus         4 ip~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~~~~~~~~   77 (346)
                      .|..++++++|+.|+|++|++++..|..+..+++|+.|+|++|++++.++.. ..+++++.+++++|++.|..+.
T Consensus       339 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~  413 (455)
T 3v47_A          339 DSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  413 (455)
T ss_dssp             CGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred             ChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCc
Confidence            4667788888999999999988777888888999999999999998877755 6778899999999999987663

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=98.69  E-value=1.5e-08  Score=97.02  Aligned_cols=70  Identities=24%  Similarity=0.251  Sum_probs=64.0

Q ss_pred             ccCcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCCCCCcccccccccCCcchhhc
Q 039799            3 SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNELLCEI   75 (346)
Q Consensus         3 ~ip~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~l~~l~~~~n~~~~~~   75 (346)
                      .||. +++|++|+.|+|++|+|+ .||..+++|++|+.|+|++|+|++. |..+.+++|+.+++++|.+....
T Consensus       455 ~lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~l-p~l~~l~~L~~L~Ls~N~l~~~~  524 (567)
T 1dce_A          455 VLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-DGVANLPRLQELLLCNNRLQQSA  524 (567)
T ss_dssp             SCCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-GGGTTCSSCCEEECCSSCCCSSS
T ss_pred             CCcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCCC-cccCCCCCCcEEECCCCCCCCCC
Confidence            4787 999999999999999999 9999999999999999999999994 57788999999999999887653

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=98.68  E-value=1.6e-08  Score=96.97  Aligned_cols=76  Identities=24%  Similarity=0.275  Sum_probs=67.6

Q ss_pred             CccCcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCC-CCCcccccccccCCcchhhccc
Q 039799            2 GSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSVKSFEGNELLCEIVL   77 (346)
Q Consensus         2 g~ip~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~~~~~~~~   77 (346)
                      |.+|..++.+++|+.|+|++|++++..|..+.++++|+.|++++|++++.+|.. ..+++++.+++++|++.|..+.
T Consensus       460 ~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~  536 (570)
T 2z63_A          460 NFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  536 (570)
T ss_dssp             GEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred             ccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcc
Confidence            568889999999999999999999877999999999999999999999988764 6788999999999999987654

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=98.68  E-value=1.5e-08  Score=81.10  Aligned_cols=68  Identities=31%  Similarity=0.442  Sum_probs=35.2

Q ss_pred             CccCcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCC-CCCcccccccccCCcc
Q 039799            2 GSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSVKSFEGNEL   71 (346)
Q Consensus         2 g~ip~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~~   71 (346)
                      |.+|..++.+++|+.|+|++|+++ .+ ..+..+++|+.|++++|++++.+|.. ..+++++.+++++|.+
T Consensus        39 ~~i~~~~~~l~~L~~L~l~~n~l~-~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  107 (168)
T 2ell_A           39 GKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKL  107 (168)
T ss_dssp             TBCSSCCGGGGGCCEEEEESSCCC-CC-SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSC
T ss_pred             hhHHHHHHhCCCCCEEeCcCCCCC-Ch-hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCcc
Confidence            455655555555555555555555 23 44555555555555555555544433 2244455555555544

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=98.67  E-value=7.2e-09  Score=82.93  Aligned_cols=62  Identities=15%  Similarity=0.126  Sum_probs=38.0

Q ss_pred             CCCCCEEEeecCccc-ccCCccccCcCCCCeEECcCCcCcCCCCCCCCCcccccccccCCcchh
Q 039799           11 LINLKSLNLSNNNLS-GTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNELLC   73 (346)
Q Consensus        11 l~~L~~l~l~~N~l~-g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~l~~l~~~~n~~~~   73 (346)
                      .++|+.|+|++|+++ |.+|..+..+++|+.|++++|.+++. +....+++++.+++++|.+..
T Consensus        23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~   85 (168)
T 2ell_A           23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV-SNLPKLPKLKKLELSENRIFG   85 (168)
T ss_dssp             TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC-SSCCCCSSCCEEEEESCCCCS
T ss_pred             cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh-hhhccCCCCCEEECcCCcCch
Confidence            355666666666666 66666666666666666666666655 444555666666666665543

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=98.67  E-value=3.2e-08  Score=83.51  Aligned_cols=67  Identities=27%  Similarity=0.362  Sum_probs=31.1

Q ss_pred             CcchhCCCCCCEEEeecCcccccCCc-cccCcCCCCeEECcCCcCcCCCCCC-CCCcccccccccCCcch
Q 039799            5 PDSIGDLINLKSLNLSNNNLSGTIPI-SLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSVKSFEGNELL   72 (346)
Q Consensus         5 p~~~~~l~~L~~l~l~~N~l~g~~p~-~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~~~   72 (346)
                      |..++++++|+.|+|++|+|+ .+|. .+..+++|+.|+|++|+|++.++.. ..+.+|+.+++++|.+.
T Consensus        57 ~~~~~~l~~L~~L~L~~N~l~-~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~  125 (229)
T 3e6j_A           57 PGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT  125 (229)
T ss_dssp             TTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred             HHHhhCccCCcEEECCCCCCC-CcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc
Confidence            344444555555555555554 3332 2344555555555555555444432 33444555555554443

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=98.66  E-value=7.2e-09  Score=81.18  Aligned_cols=70  Identities=27%  Similarity=0.275  Sum_probs=61.5

Q ss_pred             cchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCC--CCCCCCcccccccccCCcchhhc
Q 039799            6 DSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEI--PREGPFRNLSVKSFEGNELLCEI   75 (346)
Q Consensus         6 ~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~--p~~~~~~~l~~l~~~~n~~~~~~   75 (346)
                      ..++++++|+.|+|++|++++.+|..+..+++|+.|++++|++++.+  +....+++++.+++++|.+....
T Consensus        58 ~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~  129 (149)
T 2je0_A           58 ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLN  129 (149)
T ss_dssp             TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGST
T ss_pred             hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchH
Confidence            56889999999999999999779998889999999999999999854  55577889999999999876543

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.65  E-value=2.7e-07  Score=79.68  Aligned_cols=134  Identities=17%  Similarity=0.109  Sum_probs=93.8

Q ss_pred             ccccCce-EEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcC-CCCceeeEEEEecCCceeEEEecCCCCChh
Q 039799          111 IGKGGFG-SVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRIC-HRNLIKIISSYSNDDFKALVLEYMPHGSLE  187 (346)
Q Consensus       111 lg~G~~g-~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~  187 (346)
                      +..|..+ .||+.... ++..+++|+-..   .....+..|...++.+. +--+.++++++...+..++|||+++|.++.
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~  108 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF  108 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence            3445444 68988765 567899998653   34566788999998874 223567888888889999999999998887


Q ss_pred             hhhhhcCCCCCHHHHHHHHHHHHHHHHHHhc-------------------------------------------------
Q 039799          188 KCLYLSNYILDIFQRLDIMIDVASALEYLHF-------------------------------------------------  218 (346)
Q Consensus       188 ~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~-------------------------------------------------  218 (346)
                      +......     .....+..+++..|+.||.                                                 
T Consensus       109 ~~~~~~~-----~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  183 (272)
T 4gkh_A          109 QVLEEYP-----DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEM  183 (272)
T ss_dssp             HHHHHCG-----GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHH
T ss_pred             ccccCCH-----HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHH
Confidence            6543211     1223355555566666652                                                 


Q ss_pred             ------CCCCCeeecCCCCCceEECCCCcEEEeeecCCcc
Q 039799          219 ------GYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  252 (346)
Q Consensus       219 ------~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~  252 (346)
                            .....++|+|+.+.||++++++.+-|+||+.+..
T Consensus       184 ~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          184 HKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                  0122379999999999999887778999998774

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=98.64  E-value=3.9e-08  Score=84.13  Aligned_cols=68  Identities=22%  Similarity=0.232  Sum_probs=44.5

Q ss_pred             CcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCC-CCCcccccccccCCcch
Q 039799            5 PDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSVKSFEGNELL   72 (346)
Q Consensus         5 p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~~~   72 (346)
                      |..++++++|+.|+|++|++++..|..+..+++|+.|+|++|++++.++.. ..+++|+.+++++|.+.
T Consensus        52 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~  120 (251)
T 3m19_A           52 DATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLK  120 (251)
T ss_dssp             TTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred             HhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCC
Confidence            345666677777777777777555555666777777777777777665544 45666667777776654

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.63  E-value=3.2e-07  Score=80.89  Aligned_cols=137  Identities=15%  Similarity=0.101  Sum_probs=92.6

Q ss_pred             CCcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCC---CceeeEEEEe-cCCceeEEEecCCC
Q 039799          108 PPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHR---NLIKIISSYS-NDDFKALVLEYMPH  183 (346)
Q Consensus       108 ~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~-~~~~~~lv~e~~~~  183 (346)
                      ...++.|....||+.    |..+++|+..  .......+..|.++++.+.+.   .+.+++.++. ..+..++|||+++|
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            345788888899988    5778899853  233456788999999999753   2456666664 45567899999999


Q ss_pred             CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcC--------------------------------------------
Q 039799          184 GSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFG--------------------------------------------  219 (346)
Q Consensus       184 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~--------------------------------------------  219 (346)
                      .++.+...   ..++...+..++.++++.|+.||..                                            
T Consensus        98 ~~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  174 (306)
T 3tdw_A           98 QILGEDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL  174 (306)
T ss_dssp             EECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred             eECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence            88865211   1123333334444444444444411                                            


Q ss_pred             -------------CCCCeeecCCCCCceEECC---CCc-EEEeeecCCccC
Q 039799          220 -------------YSAPIIHCDLKPSNVLLDD---NMV-AHLSDFGMAKPL  253 (346)
Q Consensus       220 -------------~~~~i~H~dik~~NIll~~---~~~-~~l~Dfg~~~~~  253 (346)
                                   ....++|+|+++.||+++.   ++. ..|+||+.+..-
T Consensus       175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                         2446799999999999987   455 489999988753

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=98.61  E-value=1.9e-08  Score=82.73  Aligned_cols=67  Identities=16%  Similarity=0.197  Sum_probs=54.1

Q ss_pred             cCcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCC-CCCCcccccccccCCc
Q 039799            4 IPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPR-EGPFRNLSVKSFEGNE   70 (346)
Q Consensus         4 ip~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~-~~~~~~l~~l~~~~n~   70 (346)
                      .++.++.+++|+.|+|++|++++..|..++.|++|+.|++++|++++..|. ...+++++.+++++|.
T Consensus        80 ~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~  147 (197)
T 4ezg_A           80 NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNG  147 (197)
T ss_dssp             CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCT
T ss_pred             cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCC
Confidence            455788888888888888888877888888888888888888888875544 3667788888888887

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=98.61  E-value=2.4e-08  Score=96.70  Aligned_cols=73  Identities=25%  Similarity=0.296  Sum_probs=61.8

Q ss_pred             ccCcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCC-CCCcccccccccCCcchhhc
Q 039799            3 SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSVKSFEGNELLCEI   75 (346)
Q Consensus         3 ~ip~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~~~~~~   75 (346)
                      .+|..++.|++|+.|||++|+|++..|..|..|++|+.|+|++|+|++.+|.. ..+++|+.+++++|.+....
T Consensus       485 ~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~  558 (635)
T 4g8a_A          485 FLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSK  558 (635)
T ss_dssp             EECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCC
T ss_pred             cCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCC
Confidence            36778889999999999999999777888999999999999999999888764 66788999999999876544

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=98.61  E-value=3.7e-08  Score=91.79  Aligned_cols=75  Identities=24%  Similarity=0.272  Sum_probs=63.1

Q ss_pred             ccCcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCC-CCCcccccccccCCcchhhccc
Q 039799            3 SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSVKSFEGNELLCEIVL   77 (346)
Q Consensus         3 ~ip~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~~~~~~~~   77 (346)
                      ..|..++++++|+.|+|++|++++..|..+..+++|+.|+|++|+|++.++.. ..+++++.+++++|++.|...+
T Consensus       233 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~~  308 (452)
T 3zyi_A          233 IRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDCDI  308 (452)
T ss_dssp             ECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECSTTT
T ss_pred             cCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCCCCc
Confidence            34677888899999999999999777888899999999999999999877765 6678899999999999887543

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=98.59  E-value=4.3e-08  Score=91.06  Aligned_cols=73  Identities=21%  Similarity=0.258  Sum_probs=60.5

Q ss_pred             cCcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCC-CCCcccccccccCCcchhhcc
Q 039799            4 IPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSVKSFEGNELLCEIV   76 (346)
Q Consensus         4 ip~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~~~~~~~   76 (346)
                      .|..+.++++|+.|+|++|++++..|..+.++++|+.|+|++|+|++.++.. ..+++++.+++++|++.|.-.
T Consensus       223 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~  296 (440)
T 3zyj_A          223 RPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCNCD  296 (440)
T ss_dssp             CTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECSST
T ss_pred             ChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCCCC
Confidence            4677888888888888888888777778888899999999999999877765 667889999999999988653

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=98.57  E-value=7.8e-08  Score=84.16  Aligned_cols=63  Identities=33%  Similarity=0.432  Sum_probs=37.2

Q ss_pred             hCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCC-CCCcccccccccCCcch
Q 039799            9 GDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSVKSFEGNELL   72 (346)
Q Consensus         9 ~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~~~   72 (346)
                      +.+++|+.|+|++|+|+ .+|..+..+++|+.|++++|++++.+|.. ..+++|+.+++++|.+.
T Consensus        74 ~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~  137 (290)
T 1p9a_G           74 GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK  137 (290)
T ss_dssp             SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCC
T ss_pred             CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCC
Confidence            45566666666666666 56666666666666666666666555442 44555666666666554

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=98.57  E-value=4.1e-08  Score=86.85  Aligned_cols=70  Identities=23%  Similarity=0.214  Sum_probs=42.7

Q ss_pred             CccCcch--hCCCCCCEEEeecCcccccCCccccCc-----CCCCeEECcCCcCcCCCCCC-CCCcccccccccCCcch
Q 039799            2 GSIPDSI--GDLINLKSLNLSNNNLSGTIPISLEKL-----LDLKDINVSFNKLEGEIPRE-GPFRNLSVKSFEGNELL   72 (346)
Q Consensus         2 g~ip~~~--~~l~~L~~l~l~~N~l~g~~p~~~~~l-----~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~~~   72 (346)
                      |.+|..+  +.+++|+.|+|++|++++. |..++.+     ++|+.|+|++|++++.+|.. ..+++++.+++++|.+.
T Consensus       109 ~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  186 (312)
T 1wwl_A          109 GTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPEL  186 (312)
T ss_dssp             SCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTC
T ss_pred             chhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcC
Confidence            4555554  5666666666666666643 6555555     66666666666666655433 55666667777766644

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=98.57  E-value=1e-07  Score=78.99  Aligned_cols=69  Identities=23%  Similarity=0.239  Sum_probs=53.8

Q ss_pred             cchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCC-CCCcccccccccCCcchhh
Q 039799            6 DSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSVKSFEGNELLCE   74 (346)
Q Consensus         6 ~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~~~~~   74 (346)
                      ..++++++|+.|+|++|++++..|..+..+++|+.|++++|++++.++.. ..+++++.+++++|.+...
T Consensus        46 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  115 (208)
T 2o6s_A           46 GVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSL  115 (208)
T ss_dssp             TTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred             hhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCccc
Confidence            34678889999999999998433345688889999999999988877764 6778888888888877643

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=98.56  E-value=7e-08  Score=84.99  Aligned_cols=71  Identities=24%  Similarity=0.382  Sum_probs=40.8

Q ss_pred             CcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCC-CCC-cccccccccCCcchhhc
Q 039799            5 PDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPF-RNLSVKSFEGNELLCEI   75 (346)
Q Consensus         5 p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~-~~l~~l~~~~n~~~~~~   75 (346)
                      |..++++++|+.|+|++|++++..+..+..+++|+.|+|++|++++.+|.. ..+ ++++.+++++|++.|..
T Consensus       192 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c  264 (306)
T 2z66_A          192 PTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTC  264 (306)
T ss_dssp             TTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSG
T ss_pred             HHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeeccc
Confidence            445555555566666666555333334555666666666666666655543 333 36667777777776654

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=98.56  E-value=3.7e-08  Score=85.83  Aligned_cols=70  Identities=21%  Similarity=0.285  Sum_probs=46.3

Q ss_pred             hhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCC-CCCCcccccccccCCcchhhccc
Q 039799            8 IGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPR-EGPFRNLSVKSFEGNELLCEIVL   77 (346)
Q Consensus         8 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~-~~~~~~l~~l~~~~n~~~~~~~~   77 (346)
                      ++++++|+.|+|++|++++..|..+.++++|+.|++++|++++.++. ...+++++.+++++|++.|....
T Consensus       173 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~  243 (285)
T 1ozn_A          173 FRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA  243 (285)
T ss_dssp             TTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG
T ss_pred             hcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCc
Confidence            56666666666666666655566666667777777777777665544 25566777777777777765443

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=98.56  E-value=5.2e-08  Score=80.12  Aligned_cols=68  Identities=15%  Similarity=0.216  Sum_probs=54.9

Q ss_pred             ccCcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCC-CCCCCCCcccccccccCCcchh
Q 039799            3 SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGE-IPREGPFRNLSVKSFEGNELLC   73 (346)
Q Consensus         3 ~ip~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~-~p~~~~~~~l~~l~~~~n~~~~   73 (346)
                      .+| .+..+++|+.|+|++|.++ .+ +.+..+++|+.|++++|++++. ++....+++++.+++++|.+..
T Consensus        58 ~l~-~l~~l~~L~~L~l~~n~~~-~~-~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~  126 (197)
T 4ezg_A           58 DLT-GIEYAHNIKDLTINNIHAT-NY-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDD  126 (197)
T ss_dssp             CCT-TGGGCTTCSEEEEESCCCS-CC-GGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBG
T ss_pred             ChH-HHhcCCCCCEEEccCCCCC-cc-hhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCc
Confidence            466 6888999999999999776 44 4788899999999999999884 4445778889999999988764

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=98.55  E-value=1e-07  Score=82.50  Aligned_cols=70  Identities=26%  Similarity=0.266  Sum_probs=54.4

Q ss_pred             CcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCC-CCCcccccccccCCcchhh
Q 039799            5 PDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSVKSFEGNELLCE   74 (346)
Q Consensus         5 p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~~~~~   74 (346)
                      |..++++++|+.|+|++|++++..|..++.+++|+.|++++|++++.+|.. ..+++++.+++++|.+...
T Consensus       102 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~  172 (272)
T 3rfs_A          102 NGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSL  172 (272)
T ss_dssp             TTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred             hhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCcc
Confidence            344688888888888888888555556788888888888888888877765 5678888888888876643

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=98.55  E-value=3.8e-08  Score=95.07  Aligned_cols=72  Identities=25%  Similarity=0.284  Sum_probs=38.0

Q ss_pred             CcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCCCCCc-ccccccccCCcchhhcc
Q 039799            5 PDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFR-NLSVKSFEGNELLCEIV   76 (346)
Q Consensus         5 p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~-~l~~l~~~~n~~~~~~~   76 (346)
                      |..++++++|+.|+|++|++++.+|..+.++++|+.|++++|+++..++....+. +++.+++++|++.|..+
T Consensus       490 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~l~~N~~~c~c~  562 (606)
T 3vq2_A          490 WGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACICE  562 (606)
T ss_dssp             TTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSCTTCCEEECCSCCCCCSST
T ss_pred             hhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCcccCHhHhhhcccCcEEEccCCCcccCCc
Confidence            4445555555555555555554445555555555555555555554333333333 35666666666666543

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=98.54  E-value=3.8e-08  Score=97.09  Aligned_cols=69  Identities=25%  Similarity=0.301  Sum_probs=63.0

Q ss_pred             ccCcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCCCCCcccccccccCCcch
Q 039799            3 SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNELL   72 (346)
Q Consensus         3 ~ip~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~l~~l~~~~n~~~   72 (346)
                      .||..+++|++|+.|+|++|+|+ .||.+|++|++|+.|+|++|+|+..++..+.+.+|+.|++++|.+.
T Consensus       238 ~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~L~~N~l~  306 (727)
T 4b8c_D          238 NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLTSLPAELGSCFQLKYFYFFDNMVT  306 (727)
T ss_dssp             CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCSSCCSSGGGGTTCSEEECCSSCCC
T ss_pred             CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCCccChhhcCCCCCCEEECCCCCCC
Confidence            68999999999999999999999 9999999999999999999999965555588899999999999875

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=98.54  E-value=1.2e-07  Score=81.96  Aligned_cols=68  Identities=25%  Similarity=0.348  Sum_probs=44.4

Q ss_pred             hhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCC-CCCcccccccccCCcchhhc
Q 039799            8 IGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSVKSFEGNELLCEI   75 (346)
Q Consensus         8 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~~~~~~   75 (346)
                      ++.+++|+.|+|++|++++..|..+..+++|+.|+|++|++++.++.. ..+++++.+++++|++.|..
T Consensus       153 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c  221 (270)
T 2o6q_A          153 FDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTC  221 (270)
T ss_dssp             TTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSS
T ss_pred             ccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCC
Confidence            566666666666666666333334666777777777777777665543 45667777777777777654

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=98.54  E-value=4.1e-08  Score=79.19  Aligned_cols=65  Identities=23%  Similarity=0.222  Sum_probs=31.4

Q ss_pred             chhCCCCCCEEEeecCcccccCCccc-cCcCCCCeEECcCCcCcCCCC--CCCCCcccccccccCCcch
Q 039799            7 SIGDLINLKSLNLSNNNLSGTIPISL-EKLLDLKDINVSFNKLEGEIP--REGPFRNLSVKSFEGNELL   72 (346)
Q Consensus         7 ~~~~l~~L~~l~l~~N~l~g~~p~~~-~~l~~l~~l~l~~N~l~~~~p--~~~~~~~l~~l~~~~n~~~   72 (346)
                      .++.+++|+.|+|++|+++ .+|+.+ ..+++|+.|++++|+++..++  ....+++++.+++++|++.
T Consensus        59 ~l~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~l~~N~i~  126 (176)
T 1a9n_A           59 GFPLLRRLKTLLVNNNRIC-RIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT  126 (176)
T ss_dssp             CCCCCSSCCEEECCSSCCC-EECSCHHHHCTTCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred             ccccCCCCCEEECCCCccc-ccCcchhhcCCCCCEEECCCCcCCcchhhHhhhcCCCCCEEEecCCCCC
Confidence            3444555555555555555 334332 555555555555555543332  2234445555555555543

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=98.51  E-value=1.5e-07  Score=82.38  Aligned_cols=65  Identities=22%  Similarity=0.215  Sum_probs=34.9

Q ss_pred             cchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCC-CCCcccccccccCCc
Q 039799            6 DSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSVKSFEGNE   70 (346)
Q Consensus         6 ~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~   70 (346)
                      ..++++++|+.|+|++|+|++..|..+..+++|+.|+|++|+|++.++.. ..+++++.+++++|.
T Consensus       118 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~  183 (290)
T 1p9a_G          118 GALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENS  183 (290)
T ss_dssp             STTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSC
T ss_pred             HHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCc
Confidence            44666666666666666666333333456666666666666666554433 334444444444433

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.49  E-value=4.6e-08  Score=83.99  Aligned_cols=65  Identities=32%  Similarity=0.357  Sum_probs=54.7

Q ss_pred             hCCCCCCEEEeecCcccc--cCCccccCcCCCCeEECcCCcCcCCCCCCCCCc--ccccccccCCcchhh
Q 039799            9 GDLINLKSLNLSNNNLSG--TIPISLEKLLDLKDINVSFNKLEGEIPREGPFR--NLSVKSFEGNELLCE   74 (346)
Q Consensus         9 ~~l~~L~~l~l~~N~l~g--~~p~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~--~l~~l~~~~n~~~~~   74 (346)
                      .++++|+.|+||+|+|++  .+|..+..+++|+.|+|++|+|++. .....++  +|+.+++++|++...
T Consensus       167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~-~~l~~l~~l~L~~L~L~~Npl~~~  235 (267)
T 3rw6_A          167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE-RELDKIKGLKLEELWLDGNSLCDT  235 (267)
T ss_dssp             HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG-GGGGGGTTSCCSEEECTTSTTGGG
T ss_pred             hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc-hhhhhcccCCcceEEccCCcCccc
Confidence            468999999999999997  7788889999999999999999986 2233333  899999999997643

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.48  E-value=3e-07  Score=82.81  Aligned_cols=80  Identities=6%  Similarity=-0.004  Sum_probs=54.9

Q ss_pred             Ccc-cccCceEEEEEEEc-------CCCEEEEEEecCCC---chhHHHHHHHHHHHHhcCC---CCceeeEEEEecC---
Q 039799          109 PLI-GKGGFGSVYKAIIQ-------DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICH---RNLIKIISSYSND---  171 (346)
Q Consensus       109 ~~l-g~G~~g~vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h---~niv~~~~~~~~~---  171 (346)
                      +.| +.|....+|+....       ++..+++|+.....   ......+..|..+++.+..   -.+.+++.++...   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            456 78889999998754       26789999865422   0012456678888887742   3466788877655   


Q ss_pred             CceeEEEecCCCCChhh
Q 039799          172 DFKALVLEYMPHGSLEK  188 (346)
Q Consensus       172 ~~~~lv~e~~~~gsL~~  188 (346)
                      +..++||||++|.++.+
T Consensus       106 g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             SSCEEEEECCCCBCCCB
T ss_pred             CCceEEEEecCCCChhh
Confidence            35689999999877653

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=98.48  E-value=1.1e-07  Score=83.82  Aligned_cols=72  Identities=19%  Similarity=0.301  Sum_probs=56.0

Q ss_pred             ccCcchhCCCCCCEEEeecCcccc-cCCccccCcCCCCeEECcCCcCcCCCCCC-CCCcccccccccCCcchhh
Q 039799            3 SIPDSIGDLINLKSLNLSNNNLSG-TIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSVKSFEGNELLCE   74 (346)
Q Consensus         3 ~ip~~~~~l~~L~~l~l~~N~l~g-~~p~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~~~~~   74 (346)
                      .+|..++++++|+.|+|++|++++ .+|..+..+++|+.|++++|++++.+|.. ..+++++.+++++|.+...
T Consensus       141 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  214 (306)
T 2z66_A          141 AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSL  214 (306)
T ss_dssp             CSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBC
T ss_pred             cchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCcc
Confidence            356667888888888888888886 57888888888888888888888876654 5677888888888876543

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=98.46  E-value=6.1e-08  Score=93.66  Aligned_cols=72  Identities=18%  Similarity=0.225  Sum_probs=46.2

Q ss_pred             cCcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCC-CCCcccccccccCCcchhhcc
Q 039799            4 IPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSVKSFEGNELLCEIV   76 (346)
Q Consensus         4 ip~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~~~~~~~   76 (346)
                      .|..++++++|+.|||++|++++..|..+.++++| .|++++|++++.+|.. ..+++++.+++++|++.|..+
T Consensus       492 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  564 (606)
T 3t6q_A          492 DQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCS  564 (606)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGG
T ss_pred             ChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCC
Confidence            35556666666666666666666666666666666 6666666666665553 445667777777777777543

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=98.45  E-value=1.5e-07  Score=87.61  Aligned_cols=72  Identities=19%  Similarity=0.185  Sum_probs=48.2

Q ss_pred             ccCcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCC-CCCcccccccccCCcchhh
Q 039799            3 SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSVKSFEGNELLCE   74 (346)
Q Consensus         3 ~ip~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~~~~~   74 (346)
                      .+|..++++++|+.|+|++|++++..|..+..+++|+.|+|++|++++.+|.. ..+++++.+++++|.+...
T Consensus       290 ~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  362 (455)
T 3v47_A          290 LLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRAL  362 (455)
T ss_dssp             ECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEE
T ss_pred             cchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCccccc
Confidence            35666777777777777777777666667777777777777777776665543 5566677777777765433

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=98.45  E-value=1.7e-07  Score=89.85  Aligned_cols=64  Identities=25%  Similarity=0.334  Sum_probs=55.2

Q ss_pred             CCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCC-CCCCcccccccccCCcchhhcc
Q 039799           12 INLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPR-EGPFRNLSVKSFEGNELLCEIV   76 (346)
Q Consensus        12 ~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~-~~~~~~l~~l~~~~n~~~~~~~   76 (346)
                      ++|+.|+|++|+++ .||..+..+++|+.|+|++|+|++.++. ...+++++.+++++|++.|..+
T Consensus       450 ~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~  514 (562)
T 3a79_B          450 PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP  514 (562)
T ss_dssp             TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBCCCHH
T ss_pred             CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcCCCcc
Confidence            68888888888888 8888888999999999999999977666 5778889999999999998754

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=98.44  E-value=2.8e-07  Score=81.62  Aligned_cols=65  Identities=25%  Similarity=0.224  Sum_probs=56.7

Q ss_pred             CCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCCCCCcccccccccCCcchhhc
Q 039799           10 DLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNELLCEI   75 (346)
Q Consensus        10 ~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~l~~l~~~~n~~~~~~   75 (346)
                      .+++|+.|+|++|+++ .+|+.+..+++|+.|+|++|++++.++....+++++.+++++|++.|..
T Consensus       189 ~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~L~~N~l~~l~~~~~~l~~L~~L~l~~N~~~~~~  253 (317)
T 3o53_A          189 VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCGT  253 (317)
T ss_dssp             CCTTCCEEECCSSCCC-EECGGGGGGTTCSEEECTTSCCCEECTTCCCCTTCCEEECTTCCCBHHH
T ss_pred             ccccCCEEECCCCcCC-cchhhhcccCcccEEECcCCcccchhhHhhcCCCCCEEEccCCCccCcC
Confidence            4888999999999999 6888899999999999999999987666677889999999999998763

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=98.44  E-value=5.3e-08  Score=86.13  Aligned_cols=72  Identities=25%  Similarity=0.245  Sum_probs=61.0

Q ss_pred             CccCcchh-------CCCCCCEEEeecCcccccCCccc--cCcCCCCeEECcCCcCcCCCCCCCCC-----ccccccccc
Q 039799            2 GSIPDSIG-------DLINLKSLNLSNNNLSGTIPISL--EKLLDLKDINVSFNKLEGEIPREGPF-----RNLSVKSFE   67 (346)
Q Consensus         2 g~ip~~~~-------~l~~L~~l~l~~N~l~g~~p~~~--~~l~~l~~l~l~~N~l~~~~p~~~~~-----~~l~~l~~~   67 (346)
                      +.+|..++       ++++|++|+|++|+++|.+|..+  ..+++|+.|+|++|++++.++....+     ++++.++++
T Consensus        78 ~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~~~~~~L~~L~L~  157 (312)
T 1wwl_A           78 ARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIA  157 (312)
T ss_dssp             EECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSSSSHHHHHHTTCCTTCCEEEEE
T ss_pred             CCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcchhHHHHHHHHhhcCCCcEEEee
Confidence            35677776       89999999999999999999987  99999999999999999984333334     789999999


Q ss_pred             CCcchh
Q 039799           68 GNELLC   73 (346)
Q Consensus        68 ~n~~~~   73 (346)
                      +|.+..
T Consensus       158 ~N~l~~  163 (312)
T 1wwl_A          158 QAHSLN  163 (312)
T ss_dssp             SCSCCC
T ss_pred             CCCCcc
Confidence            998754

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=98.44  E-value=2.2e-07  Score=82.06  Aligned_cols=64  Identities=28%  Similarity=0.263  Sum_probs=48.2

Q ss_pred             hhCCCCCCEEEeecCcccccCCccccCc---CCCCeEECcCCcCcCCCCCCCCCcccccccccCCcchh
Q 039799            8 IGDLINLKSLNLSNNNLSGTIPISLEKL---LDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNELLC   73 (346)
Q Consensus         8 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l---~~l~~l~l~~N~l~~~~p~~~~~~~l~~l~~~~n~~~~   73 (346)
                      ++++++|+.||||+|++++.+|+.+..+   ++|+.|+|++|+|+..++..  .++++.+++++|.+..
T Consensus       220 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~--~~~L~~L~Ls~N~l~~  286 (310)
T 4glp_A          220 AAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLEQVPKGL--PAKLRVLDLSSNRLNR  286 (310)
T ss_dssp             HHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCCSCCSCC--CSCCSCEECCSCCCCS
T ss_pred             HhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCCchhhhh--cCCCCEEECCCCcCCC
Confidence            4677888888888888887778777777   58888888888888543333  2678888888887764

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=98.43  E-value=2.7e-07  Score=82.14  Aligned_cols=69  Identities=25%  Similarity=0.237  Sum_probs=46.0

Q ss_pred             CcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCCCCCcccccccccCCcchh
Q 039799            5 PDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNELLC   73 (346)
Q Consensus         5 p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~l~~l~~~~n~~~~   73 (346)
                      |..++.+++|+.|+|++|++++..|..+..+++|+.|++++|+++..+.....+++++.+++++|.+..
T Consensus       209 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~L~~L~l~~N~i~~  277 (330)
T 1xku_A          209 AASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISA  277 (330)
T ss_dssp             TGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCTTTTTCSSCCEEECCSSCCCC
T ss_pred             HHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCccCChhhccCCCcCEEECCCCcCCc
Confidence            556667777777777777777555556677777777777777777554445566667777777776543

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=98.43  E-value=2e-07  Score=84.18  Aligned_cols=64  Identities=25%  Similarity=0.230  Sum_probs=41.1

Q ss_pred             CCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCC-CCCcccccccccCCcchh
Q 039799           10 DLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSVKSFEGNELLC   73 (346)
Q Consensus        10 ~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~~~~   73 (346)
                      ++++|+.|+|++|+|++..|..+..+++|+.|+|++|+|++.++.. ..+.+|+.+++++|.+..
T Consensus        62 ~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~  126 (361)
T 2xot_A           62 RLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVV  126 (361)
T ss_dssp             CCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE
T ss_pred             cccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccE
Confidence            6677777777777777444455667777777777777776665543 455666666666666543

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=98.42  E-value=2.5e-07  Score=86.12  Aligned_cols=70  Identities=17%  Similarity=0.116  Sum_probs=58.1

Q ss_pred             cCcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCC-CCCcccccccccCCcchh
Q 039799            4 IPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSVKSFEGNELLC   73 (346)
Q Consensus         4 ip~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~~~~   73 (346)
                      .|..|++|++|+.|+|++|++++..|..+..+++|+.|+|++|++++.++.. ..+++|+.+++++|.+..
T Consensus        91 ~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~  161 (452)
T 3zyi_A           91 QADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIES  161 (452)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCE
T ss_pred             CHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECCCCCcce
Confidence            4677888999999999999999777788888999999999999998877764 667888888898887653

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=98.42  E-value=3.2e-07  Score=79.88  Aligned_cols=68  Identities=22%  Similarity=0.237  Sum_probs=47.2

Q ss_pred             CcchhCCCCCCEEEeecCc-ccccCCccccCcCCCCeEECcCCcCcCCCCCC-CCCcccccccccCCcch
Q 039799            5 PDSIGDLINLKSLNLSNNN-LSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSVKSFEGNELL   72 (346)
Q Consensus         5 p~~~~~l~~L~~l~l~~N~-l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~~~   72 (346)
                      |..++++++|+.|+|++|+ +++..|..+..+++|+.|++++|++++.+|.. ..+++++.+++++|.+.
T Consensus        73 ~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~  142 (285)
T 1ozn_A           73 AAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ  142 (285)
T ss_dssp             TTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred             HhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCccc
Confidence            5667777777777777776 66333666777777777777777777766553 55667777777777655

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=98.42  E-value=2.5e-07  Score=89.29  Aligned_cols=67  Identities=15%  Similarity=0.064  Sum_probs=35.5

Q ss_pred             cchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCC-CCCcccccccccCCcch
Q 039799            6 DSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSVKSFEGNELL   72 (346)
Q Consensus         6 ~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~~~   72 (346)
                      ..|+++++|+.|+|++|.+++..|..++++++|+.|+|++|.|++.++.. ..+++|..+++++|.+.
T Consensus        93 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~  160 (597)
T 3oja_B           93 YAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE  160 (597)
T ss_dssp             TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred             HHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCC
Confidence            34555555555555555555444444455555555555555555544443 44555555555555543

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=98.42  E-value=1.2e-08  Score=83.97  Aligned_cols=70  Identities=24%  Similarity=0.283  Sum_probs=59.3

Q ss_pred             CccCc------chhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCCCCCcccccccccCCcchh
Q 039799            2 GSIPD------SIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNELLC   73 (346)
Q Consensus         2 g~ip~------~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~l~~l~~~~n~~~~   73 (346)
                      |.+|.      .++.+++|+.|+|++|+++ .+| .+.++++|+.|++++|+++..++....+++++.+++++|.+..
T Consensus        32 ~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~-~l~-~~~~l~~L~~L~l~~n~l~~l~~~~~~~~~L~~L~L~~N~l~~  107 (198)
T 1ds9_A           32 GMIPPIEKMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIAS  107 (198)
T ss_dssp             BCCTTCCCCHHHHHHTTTCSEEECSEEEES-CCC-CHHHHTTCCEEEEEEEEECSCSSHHHHHHHCSEEEEEEEECCC
T ss_pred             cccCcHhhhhHHHhcCCCCCEEECCCCCCc-ccc-ccccCCCCCEEECCCCCcccccchhhcCCcCCEEECcCCcCCc
Confidence            55665      9999999999999999999 599 8999999999999999999654433456789999999998764

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=98.41  E-value=2.6e-07  Score=87.54  Aligned_cols=64  Identities=25%  Similarity=0.321  Sum_probs=55.5

Q ss_pred             CCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCC-CCCCcccccccccCCcchhhcc
Q 039799           12 INLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPR-EGPFRNLSVKSFEGNELLCEIV   76 (346)
Q Consensus        12 ~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~-~~~~~~l~~l~~~~n~~~~~~~   76 (346)
                      ++|+.|||++|+++ .||..+..+++|+.|++++|+|++.++. ...+++++.+++++|++.|..+
T Consensus       421 ~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~  485 (520)
T 2z7x_B          421 PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  485 (520)
T ss_dssp             TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCcccCC
Confidence            68888888888888 8998888999999999999999976665 4678899999999999998754

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=98.41  E-value=1.8e-07  Score=87.72  Aligned_cols=72  Identities=24%  Similarity=0.299  Sum_probs=55.6

Q ss_pred             CcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCC-CCCcccccccccCCcchhhcc
Q 039799            5 PDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSVKSFEGNELLCEIV   76 (346)
Q Consensus         5 p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~~~~~~~   76 (346)
                      |..++++++|+.|+|++|++++..|..+..+++|+.|+|++|++++.++.. ..+++++.+++++|++.|...
T Consensus       265 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~  337 (477)
T 2id5_A          265 GSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCR  337 (477)
T ss_dssp             TTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGG
T ss_pred             hhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccc
Confidence            345677777888888888888766778888888888888888888776654 567788888899998887653

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=98.41  E-value=9.3e-08  Score=89.96  Aligned_cols=71  Identities=17%  Similarity=0.102  Sum_probs=54.9

Q ss_pred             CccCcchhCCCCCCEEEeecCcccccCCcccc-CcCCCCeEECcCCcCcCCCCCCCCCcccccccccCCcchh
Q 039799            2 GSIPDSIGDLINLKSLNLSNNNLSGTIPISLE-KLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNELLC   73 (346)
Q Consensus         2 g~ip~~~~~l~~L~~l~l~~N~l~g~~p~~~~-~l~~l~~l~l~~N~l~~~~p~~~~~~~l~~l~~~~n~~~~   73 (346)
                      |..|..++++++|+.|+|++|+|+|.+|..+. .+++|+.|+|++|.|++.++. ..+++|..+++++|.+..
T Consensus       134 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~~-~~l~~L~~L~Ls~N~l~~  205 (487)
T 3oja_A          134 MLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQ-VVFAKLKTLDLSSNKLAF  205 (487)
T ss_dssp             SGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEECC-CCCTTCCEEECCSSCCCE
T ss_pred             CCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCcccccccc-ccCCCCCEEECCCCCCCC
Confidence            44567788888888888888888877787775 788888888888888877443 357788888888887764

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=98.40  E-value=1.4e-07  Score=90.04  Aligned_cols=68  Identities=21%  Similarity=0.231  Sum_probs=43.2

Q ss_pred             CcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCC-CCCCcccccccccCCcch
Q 039799            5 PDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPR-EGPFRNLSVKSFEGNELL   72 (346)
Q Consensus         5 p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~-~~~~~~l~~l~~~~n~~~   72 (346)
                      |..++++++|++|+|++|++++..|..++++++|+.|+|++|++++.+|. .+.+++++.+++++|.+.
T Consensus        43 ~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~  111 (549)
T 2z81_A           43 HGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQ  111 (549)
T ss_dssp             SSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCS
T ss_pred             hhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCccc
Confidence            45566666666666666666655556666666666666666666666655 355666666666666554

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=98.39  E-value=5e-07  Score=78.01  Aligned_cols=69  Identities=22%  Similarity=0.300  Sum_probs=54.1

Q ss_pred             cchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCC-CCCcccccccccCCcchhh
Q 039799            6 DSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSVKSFEGNELLCE   74 (346)
Q Consensus         6 ~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~~~~~   74 (346)
                      ..++++++|+.|+|++|++++..|..+..+++|+.|+|++|++++.++.. ..+++|+.+++++|.+...
T Consensus       103 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~  172 (270)
T 2o6q_A          103 GVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRV  172 (270)
T ss_dssp             TTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred             hHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEe
Confidence            34678888888888888888555566788888888888888888877663 6678888888888876543

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=98.38  E-value=1.7e-07  Score=88.85  Aligned_cols=68  Identities=22%  Similarity=0.123  Sum_probs=53.3

Q ss_pred             cCcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCCCCCcccccccccCCcchh
Q 039799            4 IPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNELLC   73 (346)
Q Consensus         4 ip~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~l~~l~~~~n~~~~   73 (346)
                      .|..++++++|++|+|++|++++..|..++++++|++|+|++|++++.++.  .+++++.+++++|.+..
T Consensus        37 ~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~--~l~~L~~L~L~~N~l~~  104 (520)
T 2z7x_B           37 WTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKISCH--PTVNLKHLDLSFNAFDA  104 (520)
T ss_dssp             CHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCCEEECC--CCCCCSEEECCSSCCSS
T ss_pred             ChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCceeecCcc--ccCCccEEeccCCcccc
Confidence            346788888888888888888876688888888888888888888854444  67788888888887654

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=98.37  E-value=2.7e-07  Score=92.72  Aligned_cols=71  Identities=18%  Similarity=0.313  Sum_probs=52.7

Q ss_pred             cc-CcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCC---CCCCcccccccccCCcchh
Q 039799            3 SI-PDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPR---EGPFRNLSVKSFEGNELLC   73 (346)
Q Consensus         3 ~i-p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~---~~~~~~l~~l~~~~n~~~~   73 (346)
                      .| |..|++|++|++|+|++|++++..|..+++|++|+.|+|++|++++.+|.   ...+++|+.+++++|.+..
T Consensus        63 ~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~  137 (844)
T 3j0a_A           63 TIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRS  137 (844)
T ss_dssp             EECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCC
T ss_pred             ccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccc
Confidence            45 56678888888888888888877788888888888888888888875544   3566777777777776543

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=98.37  E-value=3e-07  Score=83.02  Aligned_cols=58  Identities=29%  Similarity=0.252  Sum_probs=27.4

Q ss_pred             CCEEEeecCcccccCCcccc-CcCCCCeEECcCCcCcCCCCC-CCCCcccccccccCCcc
Q 039799           14 LKSLNLSNNNLSGTIPISLE-KLLDLKDINVSFNKLEGEIPR-EGPFRNLSVKSFEGNEL   71 (346)
Q Consensus        14 L~~l~l~~N~l~g~~p~~~~-~l~~l~~l~l~~N~l~~~~p~-~~~~~~l~~l~~~~n~~   71 (346)
                      |+.|+|++|+|++..|..+. .+++|+.|+|++|+|++.+|. ...+++|+.|++++|.+
T Consensus        41 l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l  100 (361)
T 2xot_A           41 TALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHL  100 (361)
T ss_dssp             CSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred             CCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcC
Confidence            45555555555532233333 455555555555555544443 23444555555555544

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=98.36  E-value=2.6e-07  Score=82.32  Aligned_cols=67  Identities=21%  Similarity=0.188  Sum_probs=35.6

Q ss_pred             cchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCCCCCcccccccccCCcch
Q 039799            6 DSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNELL   72 (346)
Q Consensus         6 ~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~l~~l~~~~n~~~   72 (346)
                      ..++++++|+.|+|++|++++..|..+..+++|+.|++++|+++..++....+++++.+++++|.+.
T Consensus       211 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~L~~L~l~~N~l~  277 (332)
T 2ft3_A          211 EDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSRVPAGLPDLKLLQVVYLHTNNIT  277 (332)
T ss_dssp             TSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCCBCCTTGGGCTTCCEEECCSSCCC
T ss_pred             HHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCeecChhhhcCccCCEEECCCCCCC
Confidence            4455555555555555555544444555555555555555555533333344555555555555544

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=98.36  E-value=3.1e-07  Score=88.71  Aligned_cols=69  Identities=16%  Similarity=0.086  Sum_probs=47.9

Q ss_pred             CcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCC-CCCcccccccccCCcchh
Q 039799            5 PDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSVKSFEGNELLC   73 (346)
Q Consensus         5 p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~~~~   73 (346)
                      |..|+++++|++|||++|++++..|..|+++++|+.|+|++|++++.+|.. +.+++++.+++++|.+..
T Consensus        50 ~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~  119 (606)
T 3t6q_A           50 NTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISS  119 (606)
T ss_dssp             TTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCSC
T ss_pred             hhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeeccccCccc
Confidence            556777777777777777777666777777777777777777777765543 556666666666666544

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=98.36  E-value=2.1e-07  Score=74.94  Aligned_cols=57  Identities=18%  Similarity=0.224  Sum_probs=32.5

Q ss_pred             CCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCC-CCCcccccccccCCcc
Q 039799           13 NLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSVKSFEGNEL   71 (346)
Q Consensus        13 ~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~~   71 (346)
                      +|+.|||++|+++ .+ ..+..+++|+.|++++|++++.+|.. ..+++++.+++++|.+
T Consensus        43 ~L~~L~Ls~N~l~-~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i  100 (176)
T 1a9n_A           43 QFDAIDFSDNEIR-KL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSL  100 (176)
T ss_dssp             CCSEEECCSSCCC-EE-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCC
T ss_pred             CCCEEECCCCCCC-cc-cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcC
Confidence            5666666666666 23 35556666666666666666554443 4455566666666654

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=98.35  E-value=2.3e-07  Score=83.42  Aligned_cols=66  Identities=23%  Similarity=0.326  Sum_probs=39.8

Q ss_pred             chhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCC-CCCCcccccccccCCcch
Q 039799            7 SIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPR-EGPFRNLSVKSFEGNELL   72 (346)
Q Consensus         7 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~-~~~~~~l~~l~~~~n~~~   72 (346)
                      .++++++|+.|+|++|++++..|..+.++++|+.|++++|++++.++. ...+++++.+++++|.+.
T Consensus        71 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~  137 (353)
T 2z80_A           71 DLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK  137 (353)
T ss_dssp             TTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS
T ss_pred             HhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCc
Confidence            456666666666666666644455566666666666666666655544 244556666666666554

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=98.35  E-value=3.7e-07  Score=87.42  Aligned_cols=67  Identities=24%  Similarity=0.179  Sum_probs=54.5

Q ss_pred             CcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCCCCCcccccccccCCcchh
Q 039799            5 PDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNELLC   73 (346)
Q Consensus         5 p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~l~~l~~~~n~~~~   73 (346)
                      |..++++++|++|+|++|++++..|..+..+++|+.|+|++|+++..++.  .+++|+.+++++|.+..
T Consensus        69 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~--~l~~L~~L~Ls~N~l~~  135 (562)
T 3a79_B           69 MPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQNISCC--PMASLRHLDLSFNDFDV  135 (562)
T ss_dssp             GGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCCEECSC--CCTTCSEEECCSSCCSB
T ss_pred             hhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCCccCcc--ccccCCEEECCCCCccc
Confidence            46788889999999999999876688888888999999999988854444  68888888888887654

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=98.34  E-value=4.5e-07  Score=84.96  Aligned_cols=70  Identities=20%  Similarity=0.283  Sum_probs=54.0

Q ss_pred             CcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCC-CCCcccccccccCCcchhh
Q 039799            5 PDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSVKSFEGNELLCE   74 (346)
Q Consensus         5 p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~~~~~   74 (346)
                      |..|+++++|+.|+|++|++++..|..+.++++|+.|+|++|++++.++.. ..+++|+.+++++|.+...
T Consensus        49 ~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~  119 (477)
T 2id5_A           49 QDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVIL  119 (477)
T ss_dssp             TTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEE
T ss_pred             HhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccC
Confidence            567788888888888888888666778888888888888888888776654 5677788888888776543

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=98.34  E-value=5.6e-07  Score=77.93  Aligned_cols=70  Identities=14%  Similarity=0.045  Sum_probs=54.1

Q ss_pred             cchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCC-CCCcccccccccCCcchhhc
Q 039799            6 DSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSVKSFEGNELLCEI   75 (346)
Q Consensus         6 ~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~~~~~~   75 (346)
                      ..++++++|+.|+|++|++++..|..+.++++|+.|++++|++++.+|.. ..+.+++.+++++|.+....
T Consensus        46 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~  116 (276)
T 2z62_A           46 YSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLE  116 (276)
T ss_dssp             TTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCST
T ss_pred             hHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccC
Confidence            36788888888888888888555557888888888888888888877653 66778888888888765443

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=98.34  E-value=4.6e-07  Score=87.48  Aligned_cols=68  Identities=21%  Similarity=0.160  Sum_probs=32.4

Q ss_pred             CcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCC-CCCCcccccccccCCcch
Q 039799            5 PDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPR-EGPFRNLSVKSFEGNELL   72 (346)
Q Consensus         5 p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~-~~~~~~l~~l~~~~n~~~   72 (346)
                      |..|++|++|++|+|++|++++..|..+++|++|++|++++|++++.+|. .+.+.+++.+++++|.+.
T Consensus        73 ~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~  141 (606)
T 3vq2_A           73 DKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIH  141 (606)
T ss_dssp             TTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCC
T ss_pred             HHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCccc
Confidence            33444445555555555555433344445555555555555555444422 244445555555555443

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=98.34  E-value=3.2e-07  Score=80.95  Aligned_cols=71  Identities=18%  Similarity=0.141  Sum_probs=52.2

Q ss_pred             CccCcch--hCCCCCCEEEeecCcccccCC----ccccCcCCCCeEECcCCcCcCCCCCC-CCCcccccccccCCcch
Q 039799            2 GSIPDSI--GDLINLKSLNLSNNNLSGTIP----ISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSVKSFEGNELL   72 (346)
Q Consensus         2 g~ip~~~--~~l~~L~~l~l~~N~l~g~~p----~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~~~   72 (346)
                      |.+|..+  +.+++|+.|+|++|++++.+|    ..+..+++|+.|+|++|++++.+|.. ..+++++.+++++|.+.
T Consensus       105 ~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~  182 (310)
T 4glp_A          105 GTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGL  182 (310)
T ss_dssp             SCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTC
T ss_pred             cchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCc
Confidence            4566666  778888888888888886655    34456778888888888887777654 56778888888888754

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=98.33  E-value=1.1e-06  Score=78.35  Aligned_cols=70  Identities=23%  Similarity=0.162  Sum_probs=60.4

Q ss_pred             cCcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCC-C------CCcccccccccCCcchhh
Q 039799            4 IPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-G------PFRNLSVKSFEGNELLCE   74 (346)
Q Consensus         4 ip~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~-~------~~~~l~~l~~~~n~~~~~   74 (346)
                      .|..++.+++|+.|+|++|+++ .+|..+..+++|+.|++++|++++.++.. .      ...++..+++.+|++.+.
T Consensus       233 ~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~  309 (332)
T 2ft3_A          233 ENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYW  309 (332)
T ss_dssp             CTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGG
T ss_pred             ChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCccccc
Confidence            4457999999999999999999 99999999999999999999999887654 1      145678899999998754

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=98.33  E-value=6.7e-07  Score=77.00  Aligned_cols=64  Identities=30%  Similarity=0.371  Sum_probs=39.1

Q ss_pred             cCcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCCCCCcccccccccCCcch
Q 039799            4 IPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNELL   72 (346)
Q Consensus         4 ip~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~l~~l~~~~n~~~   72 (346)
                      +| .++.+++|+.|+|++|+++ .+|+ +.++++|+.|+|++|++++.++...  .+++.+++++|.+.
T Consensus        56 l~-~l~~l~~L~~L~L~~N~i~-~~~~-l~~l~~L~~L~L~~N~l~~l~~~~~--~~L~~L~L~~N~l~  119 (263)
T 1xeu_A           56 LA-GMQFFTNLKELHLSHNQIS-DLSP-LKDLTKLEELSVNRNRLKNLNGIPS--ACLSRLFLDNNELR  119 (263)
T ss_dssp             CT-TGGGCTTCCEEECCSSCCC-CCGG-GTTCSSCCEEECCSSCCSCCTTCCC--SSCCEEECCSSCCS
T ss_pred             ch-HHhhCCCCCEEECCCCccC-CChh-hccCCCCCEEECCCCccCCcCcccc--CcccEEEccCCccC
Confidence            44 4566666666666666666 4444 6666666666666666666433222  56666666666554

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=98.32  E-value=4.9e-07  Score=78.29  Aligned_cols=70  Identities=23%  Similarity=0.244  Sum_probs=58.0

Q ss_pred             ccCcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCC-CCCCcccccccccCCcchhh
Q 039799            3 SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPR-EGPFRNLSVKSFEGNELLCE   74 (346)
Q Consensus         3 ~ip~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~-~~~~~~l~~l~~~~n~~~~~   74 (346)
                      .||..+.  ++|+.|+|++|++++..|..+.++++|+.|++++|++++.++. ...+++++.+++++|.+...
T Consensus        21 ~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~   91 (276)
T 2z62_A           21 KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSL   91 (276)
T ss_dssp             SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEE
T ss_pred             ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCcc
Confidence            4676653  5799999999999955555899999999999999999988774 47788999999999987644

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=98.32  E-value=3.5e-07  Score=87.55  Aligned_cols=69  Identities=22%  Similarity=0.328  Sum_probs=36.0

Q ss_pred             cCcchhCCCCCCEEEeecCccc-ccCCccccCcCCCCeEECcCCcCcCCCCCC-CCCcccccccccCCcch
Q 039799            4 IPDSIGDLINLKSLNLSNNNLS-GTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSVKSFEGNELL   72 (346)
Q Consensus         4 ip~~~~~l~~L~~l~l~~N~l~-g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~~~   72 (346)
                      +|..++++++|+.|+|++|+++ |.+|..+..+++|+.|++++|++++.+|.. ..+++++.+++++|.+.
T Consensus       437 ~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~  507 (570)
T 2z63_A          437 FNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK  507 (570)
T ss_dssp             CTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCS
T ss_pred             chhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCC
Confidence            3444555555555555555554 445555555555555555555555554432 44455555555555443

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=98.31  E-value=7.3e-07  Score=86.06  Aligned_cols=71  Identities=23%  Similarity=0.207  Sum_probs=61.3

Q ss_pred             CccCcchhCCCCCCEEEeecCcccccCCcc-ccCcCCCCeEECcCCcCcCCCCC-CCCCcccccccccCCcchh
Q 039799            2 GSIPDSIGDLINLKSLNLSNNNLSGTIPIS-LEKLLDLKDINVSFNKLEGEIPR-EGPFRNLSVKSFEGNELLC   73 (346)
Q Consensus         2 g~ip~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~l~~l~~l~l~~N~l~~~~p~-~~~~~~l~~l~~~~n~~~~   73 (346)
                      +-.|..+++|++|++|+|++|+|+ .+|+. ++++++|+.|+|++|.+++.+|. ...+++|+.+++++|.+..
T Consensus       113 ~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  185 (597)
T 3oja_B          113 YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH  185 (597)
T ss_dssp             CCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSB
T ss_pred             CCCHHHHcCCCCCCEEEeeCCCCC-CCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCC
Confidence            334566899999999999999999 67765 59999999999999999999886 4778999999999998764

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=98.31  E-value=7.3e-07  Score=81.24  Aligned_cols=63  Identities=17%  Similarity=0.231  Sum_probs=28.3

Q ss_pred             hCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCC-CCCcccccccccCCcc
Q 039799            9 GDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSVKSFEGNEL   71 (346)
Q Consensus         9 ~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~~   71 (346)
                      +++++|+.|+|++|++++..|..+..+++|+.|+|++|++++.+|.. ..+++++.+++++|.+
T Consensus        66 ~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l  129 (390)
T 3o6n_A           66 DSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDL  129 (390)
T ss_dssp             HHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred             cccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCcc
Confidence            44444444444444444322334444444444444444444444432 3344444444444443

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=98.30  E-value=9.2e-07  Score=80.58  Aligned_cols=68  Identities=15%  Similarity=0.052  Sum_probs=47.3

Q ss_pred             cchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCC-CCCcccccccccCCcchh
Q 039799            6 DSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSVKSFEGNELLC   73 (346)
Q Consensus         6 ~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~~~~   73 (346)
                      ..++++++|+.|+|++|++++..|..++++++|+.|++++|+++..++.. ..+++++.+++++|.+..
T Consensus        87 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~  155 (390)
T 3o6n_A           87 YAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLER  155 (390)
T ss_dssp             TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCB
T ss_pred             hhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCc
Confidence            46777777777777777777555566777777777777777777665554 556677777777776543

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=98.30  E-value=7.1e-07  Score=82.76  Aligned_cols=69  Identities=19%  Similarity=0.121  Sum_probs=57.0

Q ss_pred             CcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCC-CCCCcccccccccCCcchh
Q 039799            5 PDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPR-EGPFRNLSVKSFEGNELLC   73 (346)
Q Consensus         5 p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~-~~~~~~l~~l~~~~n~~~~   73 (346)
                      |..|+++++|+.|+|++|++++..|..+..+++|+.|+|++|++++.++. ...+++|+.+++++|.+..
T Consensus        81 ~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~  150 (440)
T 3zyj_A           81 VNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIES  150 (440)
T ss_dssp             TTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCE
T ss_pred             HHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccc
Confidence            46788899999999999999965557888899999999999999987775 4677888889998887654

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=98.29  E-value=4.7e-07  Score=77.98  Aligned_cols=65  Identities=23%  Similarity=0.286  Sum_probs=49.9

Q ss_pred             chhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCCCCCcccccccccCCcchhh
Q 039799            7 SIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNELLCE   74 (346)
Q Consensus         7 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~l~~l~~~~n~~~~~   74 (346)
                      .++++++|+.|+|++|+++ .+| .+..+++|+.|++++|++++. +....+++++.+++++|++.+.
T Consensus       123 ~l~~l~~L~~L~Ls~N~i~-~~~-~l~~l~~L~~L~L~~N~i~~~-~~l~~l~~L~~L~l~~N~~~~~  187 (263)
T 1xeu_A          123 SLIHLKNLEILSIRNNKLK-SIV-MLGFLSKLEVLDLHGNEITNT-GGLTRLKKVNWIDLTGQKCVNE  187 (263)
T ss_dssp             GGTTCTTCCEEECTTSCCC-BCG-GGGGCTTCCEEECTTSCCCBC-TTSTTCCCCCEEEEEEEEEECC
T ss_pred             hhcCcccccEEECCCCcCC-CCh-HHccCCCCCEEECCCCcCcch-HHhccCCCCCEEeCCCCcccCC
Confidence            4777888888888888888 455 577888888888888888877 5556677788888888877665

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=98.27  E-value=4.4e-07  Score=86.53  Aligned_cols=70  Identities=24%  Similarity=0.157  Sum_probs=55.5

Q ss_pred             ccCcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCC--CCCCCCCcccccccccCCcch
Q 039799            3 SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGE--IPREGPFRNLSVKSFEGNELL   72 (346)
Q Consensus         3 ~ip~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~--~p~~~~~~~l~~l~~~~n~~~   72 (346)
                      ..|..|+++++|++|||++|++++..|..++++++|+.|++++|++++.  ++....+++++.+++++|...
T Consensus        65 ~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~  136 (549)
T 2z81_A           65 IEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETF  136 (549)
T ss_dssp             ECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSC
T ss_pred             cChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccc
Confidence            3457789999999999999999965555689999999999999999863  344577788888888887643

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=98.27  E-value=1.1e-06  Score=78.11  Aligned_cols=64  Identities=27%  Similarity=0.309  Sum_probs=38.2

Q ss_pred             chhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCCCCCcccccccccCCcch
Q 039799            7 SIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNELL   72 (346)
Q Consensus         7 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~l~~l~~~~n~~~   72 (346)
                      .++++++|++|+|++|++++..|..++++++|+.|++++|+++..+...  .++++.+++++|.+.
T Consensus        71 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~l~~~~--~~~L~~L~l~~n~l~  134 (330)
T 1xku_A           71 DFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKM--PKTLQELRVHENEIT  134 (330)
T ss_dssp             TTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSBCCSSC--CTTCCEEECCSSCCC
T ss_pred             hhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCCccChhh--cccccEEECCCCccc
Confidence            4666666666666666666544666666666666666666666433332  245666666666544

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=98.24  E-value=5.5e-07  Score=80.63  Aligned_cols=66  Identities=29%  Similarity=0.363  Sum_probs=34.5

Q ss_pred             chhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCC-CCCcccccccccCCcchhh
Q 039799            7 SIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSVKSFEGNELLCE   74 (346)
Q Consensus         7 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~~~~~   74 (346)
                      .++.+++|+.|+|++|+++ .+| .+..+++|+.|++++|++++.+|.. ..+++++.+++++|++...
T Consensus       260 ~~~~l~~L~~L~l~~n~l~-~~~-~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~  326 (347)
T 4fmz_A          260 AVKDLTKLKMLNVGSNQIS-DIS-VLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDI  326 (347)
T ss_dssp             GGTTCTTCCEEECCSSCCC-CCG-GGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCC
T ss_pred             hHhcCCCcCEEEccCCccC-CCh-hhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccc
Confidence            3455555555555555555 333 3555555555555555555544432 3345555555555554443

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.24  E-value=5.1e-06  Score=75.87  Aligned_cols=75  Identities=20%  Similarity=0.241  Sum_probs=49.0

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEecCCCc-------hhHHHHHHHHHHHHhcCC--CCc-eeeEEEEecCCceeE
Q 039799          108 PPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYE-------GAFKSFDIECDVMKRICH--RNL-IKIISSYSNDDFKAL  176 (346)
Q Consensus       108 ~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~ni-v~~~~~~~~~~~~~l  176 (346)
                      .+.+|.|..+.||++... +++.+++|...+...       ....++..|.++++.+..  +.. .+++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            457899999999999754 568899998653211       123456778888887742  333 345544  3445679


Q ss_pred             EEecCCCC
Q 039799          177 VLEYMPHG  184 (346)
Q Consensus       177 v~e~~~~g  184 (346)
                      |||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999864

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=98.24  E-value=8.2e-07  Score=79.77  Aligned_cols=66  Identities=24%  Similarity=0.188  Sum_probs=58.0

Q ss_pred             cCcchhCCCCCCEEEeecCcccccCCcc-ccCcCCCCeEECcCCcCcCCCC--CCCCCcccccccccCCc
Q 039799            4 IPDSIGDLINLKSLNLSNNNLSGTIPIS-LEKLLDLKDINVSFNKLEGEIP--REGPFRNLSVKSFEGNE   70 (346)
Q Consensus         4 ip~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~l~~l~~l~l~~N~l~~~~p--~~~~~~~l~~l~~~~n~   70 (346)
                      .|..++++++|++|||++|+++ .+|.. +.++++|+.|++++|++++.++  ....+++++.+++++|.
T Consensus        92 ~~~~~~~l~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~  160 (353)
T 2z80_A           92 EEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMD  160 (353)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCS-SCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESS
T ss_pred             CHhhcCCCCCCCEEECCCCcCC-cCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCc
Confidence            4567999999999999999999 67766 8999999999999999998766  34778999999999985

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=98.23  E-value=1.1e-06  Score=86.01  Aligned_cols=65  Identities=23%  Similarity=0.237  Sum_probs=26.5

Q ss_pred             CcchhCCCCCCEEEeecCcccccCCc-cccCcCCCCeEECcCCcCcCCCCC-CCCCcccccccccCCc
Q 039799            5 PDSIGDLINLKSLNLSNNNLSGTIPI-SLEKLLDLKDINVSFNKLEGEIPR-EGPFRNLSVKSFEGNE   70 (346)
Q Consensus         5 p~~~~~l~~L~~l~l~~N~l~g~~p~-~~~~l~~l~~l~l~~N~l~~~~p~-~~~~~~l~~l~~~~n~   70 (346)
                      |..+++|++|++|+|++|+++ .+|+ .++++++|+.|++++|++++.+|. ...+++|+.+++++|.
T Consensus        66 ~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~  132 (680)
T 1ziw_A           66 PELCQKLPMLKVLNLQHNELS-QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNG  132 (680)
T ss_dssp             TTHHHHCTTCCEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSC
T ss_pred             HHHHhcccCcCEEECCCCccC-ccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCc
Confidence            333444444444444444444 3332 244444444444444444443332 1333344444444443

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=98.22  E-value=8.8e-07  Score=89.03  Aligned_cols=71  Identities=18%  Similarity=0.052  Sum_probs=63.4

Q ss_pred             ccCcchhCCCCCCEEEeecCcccccC-CccccCcCCCCeEECcCCcCcCCCCCC-CCCcccccccccCCcchh
Q 039799            3 SIPDSIGDLINLKSLNLSNNNLSGTI-PISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSVKSFEGNELLC   73 (346)
Q Consensus         3 ~ip~~~~~l~~L~~l~l~~N~l~g~~-p~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~~~~   73 (346)
                      -.|..|++|++|++|||++|++.+.| |..+.+|++|+.|+|++|++++.+|.. ..+++|+.+++++|.+..
T Consensus        39 i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~  111 (844)
T 3j0a_A           39 VTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSD  111 (844)
T ss_dssp             ECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSS
T ss_pred             cChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCc
Confidence            45788999999999999999888888 778999999999999999999987764 788999999999998764

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=98.21  E-value=8.9e-07  Score=74.92  Aligned_cols=66  Identities=17%  Similarity=0.157  Sum_probs=46.2

Q ss_pred             chhCCCCCCEEEeecCc-ccccCCc-cccCcCCCCeEECcC-CcCcCCCCCC-CCCcccccccccCCcchh
Q 039799            7 SIGDLINLKSLNLSNNN-LSGTIPI-SLEKLLDLKDINVSF-NKLEGEIPRE-GPFRNLSVKSFEGNELLC   73 (346)
Q Consensus         7 ~~~~l~~L~~l~l~~N~-l~g~~p~-~~~~l~~l~~l~l~~-N~l~~~~p~~-~~~~~l~~l~~~~n~~~~   73 (346)
                      .++++++|+.|+|++|+ ++ .+|+ .+..+++|+.|++++ |++++.++.. ..+++++.+++++|.+..
T Consensus        50 ~~~~l~~L~~L~l~~n~~l~-~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~  119 (239)
T 2xwt_C           50 AFSNLPNISRIYVSIDVTLQ-QLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM  119 (239)
T ss_dssp             TTTTCTTCCEEEEECCSSCC-EECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS
T ss_pred             HccCCCCCcEEeCCCCCCcc-eeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc
Confidence            57777778888888776 76 4543 677777777777777 7777766543 456677777777776554

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.20  E-value=1.2e-05  Score=71.67  Aligned_cols=139  Identities=17%  Similarity=0.172  Sum_probs=79.1

Q ss_pred             CcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCC--CCceeeEE------EEecCCceeEEEec
Q 039799          109 PLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICH--RNLIKIIS------SYSNDDFKALVLEY  180 (346)
Q Consensus       109 ~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~------~~~~~~~~~lv~e~  180 (346)
                      ..|+.|..+.||+....+| .+++|+.... .   ..+..|.++++.+..  -.+.+++.      +....+..+++|+|
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP-E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSC-H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCC-H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            3456677889999987655 5899998752 1   333345555554421  12233332      11235667899999


Q ss_pred             CCCCChh-----h---------hhhhcC--C-----------CCCHHHHH------------------------------
Q 039799          181 MPHGSLE-----K---------CLYLSN--Y-----------ILDIFQRL------------------------------  203 (346)
Q Consensus       181 ~~~gsL~-----~---------~l~~~~--~-----------~l~~~~~~------------------------------  203 (346)
                      ++|.++.     .         .++...  .           ...|...+                              
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            9986542     0         111110  0           11232211                              


Q ss_pred             -HHHHHHHHHHHHHhc----------CCCCCeeecCCCCCceEECCCCcEEEeeecCCcc
Q 039799          204 -DIMIDVASALEYLHF----------GYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  252 (346)
Q Consensus       204 -~i~~~i~~~l~~LH~----------~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~  252 (346)
                       .+...+..++++|+.          .....++|+|+++.||+++.++.+.|+||+.+..
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence             011123345566652          1257899999999999998888999999998864

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=98.18  E-value=3e-08  Score=81.63  Aligned_cols=64  Identities=23%  Similarity=0.275  Sum_probs=35.1

Q ss_pred             cCcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCCCCCcccccccccCCc
Q 039799            4 IPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNE   70 (346)
Q Consensus         4 ip~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~l~~l~~~~n~   70 (346)
                      +| .++++++|+.|+|++|+++ .+|..+..+++|+.|++++|++++. |....+++++.+++++|.
T Consensus        63 l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~l-~~~~~l~~L~~L~l~~N~  126 (198)
T 1ds9_A           63 IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL-SGIEKLVNLRVLYMSNNK  126 (198)
T ss_dssp             CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCCH-HHHHHHHHSSEEEESEEE
T ss_pred             cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCcC-CccccCCCCCEEECCCCc
Confidence            45 5666666666666666666 6666555556666666666666553 222233334444444443

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=98.17  E-value=2e-06  Score=84.25  Aligned_cols=70  Identities=20%  Similarity=0.220  Sum_probs=53.5

Q ss_pred             ccCc-chhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCC-CCCcccccccccCCcch
Q 039799            3 SIPD-SIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSVKSFEGNELL   72 (346)
Q Consensus         3 ~ip~-~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~~~   72 (346)
                      .+|+ .|+++++|++|+|++|++++..|..++++++|+.|++++|++++.+|.. ..+++++.+++++|.+.
T Consensus        87 ~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~  158 (680)
T 1ziw_A           87 QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQ  158 (680)
T ss_dssp             CCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCC
T ss_pred             ccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCccc
Confidence            4565 5888888888888888888555567888888888888888888877654 56777777777777654

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=98.17  E-value=1.7e-06  Score=76.31  Aligned_cols=63  Identities=21%  Similarity=0.304  Sum_probs=46.3

Q ss_pred             hhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCCCCCcccccccccCCcchh
Q 039799            8 IGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNELLC   73 (346)
Q Consensus         8 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~l~~l~~~~n~~~~   73 (346)
                      ++.+++|+.|+|++|+++ .+|. +..+++|+.|++++|++++.++ ...+++++.+++++|.+..
T Consensus       125 l~~l~~L~~L~l~~n~l~-~~~~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~  187 (308)
T 1h6u_A          125 LAGLSNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVSDLTP-LANLSKLTTLKADDNKISD  187 (308)
T ss_dssp             GTTCTTCCEEECCSSCCC-CCGG-GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCC
T ss_pred             hcCCCCCCEEECCCCccC-cCcc-ccCCCCccEEEccCCcCCCChh-hcCCCCCCEEECCCCccCc
Confidence            777888888888888887 4554 7777888888888888877655 5566777777777776654

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=98.16  E-value=1.7e-06  Score=75.58  Aligned_cols=64  Identities=27%  Similarity=0.241  Sum_probs=47.4

Q ss_pred             chhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCCCCCcccccccccCCcchh
Q 039799            7 SIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNELLC   73 (346)
Q Consensus         7 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~l~~l~~~~n~~~~   73 (346)
                      .++.+++|+.|+|++|+++ .+|. +.++++|+.|++++|++++. |....+++++.+++++|.+..
T Consensus        63 ~~~~l~~L~~L~L~~n~l~-~~~~-l~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~~n~i~~  126 (291)
T 1h6t_A           63 GIQYLPNVTKLFLNGNKLT-DIKP-LANLKNLGWLFLDENKVKDL-SSLKDLKKLKSLSLEHNGISD  126 (291)
T ss_dssp             TGGGCTTCCEEECCSSCCC-CCGG-GTTCTTCCEEECCSSCCCCG-GGGTTCTTCCEEECTTSCCCC
T ss_pred             hHhcCCCCCEEEccCCccC-CCcc-cccCCCCCEEECCCCcCCCC-hhhccCCCCCEEECCCCcCCC
Confidence            3677888888888888888 4555 77888888888888888773 445667777888888776553

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=98.15  E-value=2e-06  Score=75.17  Aligned_cols=63  Identities=30%  Similarity=0.376  Sum_probs=40.0

Q ss_pred             hhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCCCCCcccccccccCCcchh
Q 039799            8 IGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNELLC   73 (346)
Q Consensus         8 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~l~~l~~~~n~~~~   73 (346)
                      ++.+++|+.|+|++|+++ .+| .+..+++|+.|++++|++++. +....+++|+.+++++|.+..
T Consensus       108 l~~l~~L~~L~L~~n~i~-~~~-~l~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~~N~l~~  170 (291)
T 1h6t_A          108 LKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISD  170 (291)
T ss_dssp             GTTCTTCCEEECTTSCCC-CCG-GGGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCC
T ss_pred             hccCCCCCEEECCCCcCC-CCh-hhcCCCCCCEEEccCCcCCcc-hhhccCCCCCEEEccCCcccc
Confidence            666777777777777776 343 466666677777777766665 444555666666666665543

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=98.13  E-value=1.1e-06  Score=74.41  Aligned_cols=68  Identities=16%  Similarity=0.215  Sum_probs=52.0

Q ss_pred             ccCcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCc-CcCCCCCC-CCCcccccccccC-Ccchh
Q 039799            3 SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNK-LEGEIPRE-GPFRNLSVKSFEG-NELLC   73 (346)
Q Consensus         3 ~ip~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~-l~~~~p~~-~~~~~l~~l~~~~-n~~~~   73 (346)
                      .||. +.  ++|+.|+|++|++++..|..+..+++|+.|++++|+ +++.++.. ..+++++.+++++ |.+..
T Consensus        25 ~ip~-~~--~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~   95 (239)
T 2xwt_C           25 RIPS-LP--PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTY   95 (239)
T ss_dssp             SCCC-CC--TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCE
T ss_pred             ccCC-CC--CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeE
Confidence            5666 33  388999999999994444478889999999999997 77766643 6678888888987 77654

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=98.13  E-value=2.4e-06  Score=75.22  Aligned_cols=66  Identities=20%  Similarity=0.313  Sum_probs=57.7

Q ss_pred             chhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCCCCCcccccccccCCcchhhc
Q 039799            7 SIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNELLCEI   75 (346)
Q Consensus         7 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~l~~l~~~~n~~~~~~   75 (346)
                      .++.+++|+.|+|++|+++ .+|. +..+++|+.|++++|++++.++ ...+++++.+++++|.+....
T Consensus       102 ~~~~l~~L~~L~l~~n~l~-~~~~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~~  167 (308)
T 1h6u_A          102 AIAGLQSIKTLDLTSTQIT-DVTP-LAGLSNLQVLYLDLNQITNISP-LAGLTNLQYLSIGNAQVSDLT  167 (308)
T ss_dssp             GGTTCTTCCEEECTTSCCC-CCGG-GTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCCCG
T ss_pred             hhcCCCCCCEEECCCCCCC-Cchh-hcCCCCCCEEECCCCccCcCcc-ccCCCCccEEEccCCcCCCCh
Confidence            6889999999999999999 5775 9999999999999999998766 667889999999999876533

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=98.11  E-value=1.5e-07  Score=87.73  Aligned_cols=49  Identities=6%  Similarity=0.075  Sum_probs=29.1

Q ss_pred             CccCcchhCCCCCCEEEeecCcccccCCccccCcCCC-------------CeEECcCCcCcC
Q 039799            2 GSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDL-------------KDINVSFNKLEG   50 (346)
Q Consensus         2 g~ip~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l-------------~~l~l~~N~l~~   50 (346)
                      |.||++|++|++|++|+|++|+++|.+|.+++++.+|             +.|++++|.+++
T Consensus        24 ~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~   85 (454)
T 1jl5_A           24 TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS   85 (454)
T ss_dssp             ----------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC
T ss_pred             hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc
Confidence            6788888888888888888888888888888776643             555555555555

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=98.08  E-value=3.1e-06  Score=81.51  Aligned_cols=60  Identities=25%  Similarity=0.366  Sum_probs=26.5

Q ss_pred             hhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCCCCCcccccccccCCc
Q 039799            8 IGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNE   70 (346)
Q Consensus         8 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~l~~l~~~~n~   70 (346)
                      +++|++|+.|+|++|+|+ .+ ..+..|++|+.|+|++|+|++.+| ...+++|+.|++++|.
T Consensus       127 l~~l~~L~~L~Ls~N~l~-~l-~~l~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~  186 (605)
T 1m9s_A          127 LVHLPQLESLYLGNNKIT-DI-TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNH  186 (605)
T ss_dssp             GGGCTTCSEEECCSSCCC-CC-GGGGSCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSC
T ss_pred             ccCCCccCEEECCCCccC-Cc-hhhcccCCCCEEECcCCcCCCchh-hccCCCCCEEECcCCC
Confidence            444444444444444444 22 234444444444444444444443 3334444444444443

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=98.07  E-value=2.2e-06  Score=82.57  Aligned_cols=66  Identities=26%  Similarity=0.393  Sum_probs=58.3

Q ss_pred             cchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCCCCCcccccccccCCcchhh
Q 039799            6 DSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNELLCE   74 (346)
Q Consensus         6 ~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~l~~l~~~~n~~~~~   74 (346)
                      +.++.|++|+.|+|++|+|++..|  +..|++|+.|+|++|+|++. |....+++|+.|++++|++...
T Consensus       147 ~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l-~~l~~l~~L~~L~L~~N~l~~~  212 (605)
T 1m9s_A          147 TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFSQECLNK  212 (605)
T ss_dssp             GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-GGGTTCTTCSEEECCSEEEECC
T ss_pred             hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCCC-hHHccCCCCCEEEccCCcCcCC
Confidence            578899999999999999996555  99999999999999999986 5677889999999999987653

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=98.07  E-value=1.5e-06  Score=76.90  Aligned_cols=67  Identities=18%  Similarity=0.156  Sum_probs=40.7

Q ss_pred             CcchhCCCCCCEEEeecCcccccCCccc-cCcCCCCeEECcCCcCcCCCCCCCCCcccccccccCCcch
Q 039799            5 PDSIGDLINLKSLNLSNNNLSGTIPISL-EKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNELL   72 (346)
Q Consensus         5 p~~~~~l~~L~~l~l~~N~l~g~~p~~~-~~l~~l~~l~l~~N~l~~~~p~~~~~~~l~~l~~~~n~~~   72 (346)
                      |..++.+++|+.|+|++|++++..|..+ ..+++|+.|+|++|++++.+ ....+++++.+++++|.+.
T Consensus       137 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~l~~L~~L~Ls~N~l~  204 (317)
T 3o53_A          137 DLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVK-GQVVFAKLKTLDLSSNKLA  204 (317)
T ss_dssp             GBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEE-CCCCCTTCCEEECCSSCCC
T ss_pred             chhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCcccc-cccccccCCEEECCCCcCC
Confidence            3455666666666666666665555555 35666666666666666553 2233566666666666654

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=98.06  E-value=2.9e-05  Score=67.50  Aligned_cols=75  Identities=13%  Similarity=0.113  Sum_probs=54.3

Q ss_pred             CCcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCC---CceeeEEEEecCCceeEEEecCCCC
Q 039799          108 PPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHR---NLIKIISSYSNDDFKALVLEYMPHG  184 (346)
Q Consensus       108 ~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~~~~~~~lv~e~~~~g  184 (346)
                      ...+|.|..+.||+.+..+|+.+++|+...........+..|.+.|+.+...   -+.++++..    ..++||||++++
T Consensus        20 v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~~   95 (288)
T 3f7w_A           20 VAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDER   95 (288)
T ss_dssp             EEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCCC
T ss_pred             EEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeeccc
Confidence            4568999999999999999999999987654433345677899988887422   234445432    346899999876


Q ss_pred             Ch
Q 039799          185 SL  186 (346)
Q Consensus       185 sL  186 (346)
                      ..
T Consensus        96 ~~   97 (288)
T 3f7w_A           96 PP   97 (288)
T ss_dssp             CC
T ss_pred             CC
Confidence            53

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=98.02  E-value=6.2e-06  Score=76.85  Aligned_cols=61  Identities=25%  Similarity=0.323  Sum_probs=32.8

Q ss_pred             chhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCCCCCcccccccccCCcch
Q 039799            7 SIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNELL   72 (346)
Q Consensus         7 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~l~~l~~~~n~~~   72 (346)
                      +++.+++|++|+|++|+++| +|  ++.+++|+.|++++|++++. | .+.+++++.+++++|.+.
T Consensus        59 ~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~~-~-~~~l~~L~~L~L~~N~l~  119 (457)
T 3bz5_A           59 GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTNL-D-VTPLTKLTYLNCDTNKLT  119 (457)
T ss_dssp             TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCC-C-CTTCTTCCEEECCSSCCS
T ss_pred             hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCcee-e-cCCCCcCCEEECCCCcCC
Confidence            45555555555555555552 44  55555555555555555554 1 344555555555555443

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=98.01  E-value=4.1e-06  Score=78.03  Aligned_cols=68  Identities=22%  Similarity=0.244  Sum_probs=60.0

Q ss_pred             CccCcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCCCCCcccccccccCCcchh
Q 039799            2 GSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNELLC   73 (346)
Q Consensus         2 g~ip~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~l~~l~~~~n~~~~   73 (346)
                      +..|..++++++|+.|||++|+++ .+| .++.+++|+.|++++|++++. | .+.+++++.+++++|.+..
T Consensus        32 ~~~~~~~~~l~~L~~L~Ls~n~l~-~~~-~l~~l~~L~~L~Ls~n~l~~~-~-~~~l~~L~~L~Ls~N~l~~   99 (457)
T 3bz5_A           32 ATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNITTL-D-LSQNTNLTYLACDSNKLTN   99 (457)
T ss_dssp             TTSEEEHHHHTTCCEEECCSSCCC-CCT-TGGGCTTCSEEECCSSCCSCC-C-CTTCTTCSEEECCSSCCSC
T ss_pred             cccccChhHcCCCCEEEccCCCcc-cCh-hhcccCCCCEEEccCCcCCeE-c-cccCCCCCEEECcCCCCce
Confidence            445678899999999999999999 567 799999999999999999996 3 6778999999999998765

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=98.01  E-value=2.7e-06  Score=81.26  Aligned_cols=59  Identities=17%  Similarity=0.120  Sum_probs=26.5

Q ss_pred             CCCCEEEeecCcccccCCccccCcCCC-------CeEECcCCcCcCCCCCCCCCcccccccccCCcchhh
Q 039799           12 INLKSLNLSNNNLSGTIPISLEKLLDL-------KDINVSFNKLEGEIPREGPFRNLSVKSFEGNELLCE   74 (346)
Q Consensus        12 ~~L~~l~l~~N~l~g~~p~~~~~l~~l-------~~l~l~~N~l~~~~p~~~~~~~l~~l~~~~n~~~~~   74 (346)
                      ++|+.|+|++|+|+ .||. +..  +|       +.|+|++|+|+..++....++++..+++++|++.+.
T Consensus       180 ~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~~lp~~l~~l~~L~~L~L~~N~l~~~  245 (571)
T 3cvr_A          180 ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRITHIPENILSLDPTCTIILEDNPLSSR  245 (571)
T ss_dssp             TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCCCCCGGGGGSCTTEEEECCSSSCCHH
T ss_pred             CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcceecCHHHhcCCCCCEEEeeCCcCCCc
Confidence            44444444444444 4444 332  34       445555555544333333455555555555555443

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=97.95  E-value=7.5e-06  Score=76.42  Aligned_cols=66  Identities=30%  Similarity=0.375  Sum_probs=46.4

Q ss_pred             cCcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCCCCCcccccccccCCcchh
Q 039799            4 IPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNELLC   73 (346)
Q Consensus         4 ip~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~l~~l~~~~n~~~~   73 (346)
                      +| .+..+++|++|||++|+++ .+|+ +.++++|+.|++++|++++.+| ...+++++.+++++|.+..
T Consensus        61 l~-~~~~l~~L~~L~Ls~n~l~-~~~~-~~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~L~~n~l~~  126 (466)
T 1o6v_A           61 ID-GVEYLNNLTQINFSNNQLT-DITP-LKNLTKLVDILMNNNQIADITP-LANLTNLTGLTLFNNQITD  126 (466)
T ss_dssp             CT-TGGGCTTCCEEECCSSCCC-CCGG-GTTCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCC
T ss_pred             Cc-chhhhcCCCEEECCCCccC-Cchh-hhccccCCEEECCCCccccChh-hcCCCCCCEEECCCCCCCC
Confidence            44 3667777788888877777 4554 7777777777777777777666 5566777777777776543

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=97.94  E-value=7.9e-06  Score=72.99  Aligned_cols=63  Identities=25%  Similarity=0.336  Sum_probs=47.6

Q ss_pred             hhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCCCCCcccccccccCCcchh
Q 039799            8 IGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNELLC   73 (346)
Q Consensus         8 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~l~~l~~~~n~~~~   73 (346)
                      ++.+++|++|+|++|+++ .+|. +..+++|+.|++++|++++. |....+++++.+++++|.+..
T Consensus        62 ~~~~~~L~~L~l~~n~i~-~~~~-~~~l~~L~~L~L~~n~i~~~-~~~~~l~~L~~L~l~~n~i~~  124 (347)
T 4fmz_A           62 IEYLTNLEYLNLNGNQIT-DISP-LSNLVKLTNLYIGTNKITDI-SALQNLTNLRELYLNEDNISD  124 (347)
T ss_dssp             GGGCTTCCEEECCSSCCC-CCGG-GTTCTTCCEEECCSSCCCCC-GGGTTCTTCSEEECTTSCCCC
T ss_pred             hhhcCCccEEEccCCccc-cchh-hhcCCcCCEEEccCCcccCc-hHHcCCCcCCEEECcCCcccC
Confidence            677888888888888888 5665 77888888888888888764 455667777788888777553

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=97.92  E-value=7.9e-06  Score=76.27  Aligned_cols=64  Identities=27%  Similarity=0.251  Sum_probs=37.1

Q ss_pred             hhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCCCCCcccccccccCCcchhh
Q 039799            8 IGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNELLCE   74 (346)
Q Consensus         8 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~l~~l~~~~n~~~~~   74 (346)
                      ++.+++|+.|+|++|+++|..|  +..+++|+.|++++|++++. +....+++++.+++++|.+...
T Consensus       305 ~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~l~~n~l~~~  368 (466)
T 1o6v_A          305 ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV-SSLANLTNINWLSAGHNQISDL  368 (466)
T ss_dssp             GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC-GGGTTCTTCCEEECCSSCCCBC
T ss_pred             hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc-hhhccCCCCCEEeCCCCccCcc
Confidence            5666666666666666664433  55666666666666666654 3334455555555555555433

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=97.92  E-value=1.1e-05  Score=77.10  Aligned_cols=41  Identities=24%  Similarity=0.455  Sum_probs=19.1

Q ss_pred             cCcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcC
Q 039799            4 IPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEG   50 (346)
Q Consensus         4 ip~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~   50 (346)
                      ||..+.  ++|+.|+|++|+|+ .||   ..+++|+.|+|++|+|++
T Consensus        74 lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~  114 (571)
T 3cvr_A           74 LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST  114 (571)
T ss_dssp             CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC
T ss_pred             cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC
Confidence            444442  44555555555554 444   233444444444444444

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=97.89  E-value=1.4e-05  Score=74.27  Aligned_cols=63  Identities=25%  Similarity=0.317  Sum_probs=32.5

Q ss_pred             cCcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCCCCCcccccccccCCcch
Q 039799            4 IPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNELL   72 (346)
Q Consensus         4 ip~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~l~~l~~~~n~~~   72 (346)
                      || +++++++|++|+|++|+++ .+|..+   .+|+.|++++|++++ +|....+++++.+++++|.+.
T Consensus       146 lp-~~~~l~~L~~L~l~~N~l~-~lp~~~---~~L~~L~L~~n~l~~-l~~~~~l~~L~~L~l~~N~l~  208 (454)
T 1jl5_A          146 LP-ELQNSSFLKIIDVDNNSLK-KLPDLP---PSLEFIAAGNNQLEE-LPELQNLPFLTAIYADNNSLK  208 (454)
T ss_dssp             CC-CCTTCTTCCEEECCSSCCS-CCCCCC---TTCCEEECCSSCCSS-CCCCTTCTTCCEEECCSSCCS
T ss_pred             Cc-ccCCCCCCCEEECCCCcCc-ccCCCc---ccccEEECcCCcCCc-CccccCCCCCCEEECCCCcCC
Confidence            44 3555555555555555555 355432   255555555555555 234445555555566655544

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.89  E-value=0.00014  Score=64.00  Aligned_cols=136  Identities=14%  Similarity=0.076  Sum_probs=91.4

Q ss_pred             CCcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcC---CCCceeeEEEEecCCceeEEEecCCCC
Q 039799          108 PPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRIC---HRNLIKIISSYSNDDFKALVLEYMPHG  184 (346)
Q Consensus       108 ~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~g  184 (346)
                      .+.|+.|....+|+.... +..+++|+....   ....+..|.+.++.+.   ...+.+++..+...+..++||||+++.
T Consensus        41 ~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~  116 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLINDE-VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS  116 (312)
T ss_dssp             EEEECCSSSSEEEEEESS-SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred             eEEeCCccceeeeEEEEC-CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence            456899999999998764 678999987542   3466788988888874   356778888888788899999999987


Q ss_pred             Chhh-----------hhhhcCC---------------------CCCHHHHH---HHHH----------------HHH-HH
Q 039799          185 SLEK-----------CLYLSNY---------------------ILDIFQRL---DIMI----------------DVA-SA  212 (346)
Q Consensus       185 sL~~-----------~l~~~~~---------------------~l~~~~~~---~i~~----------------~i~-~~  212 (346)
                      .+..           .++....                     .-+|....   ++..                .+. ..
T Consensus       117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l  196 (312)
T 3jr1_A          117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV  196 (312)
T ss_dssp             CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred             CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence            6521           1221110                     12454322   1111                111 11


Q ss_pred             HHHHh-cCCCCCeeecCCCCCceEECCCCcEEEeeec
Q 039799          213 LEYLH-FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFG  248 (346)
Q Consensus       213 l~~LH-~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg  248 (346)
                      ...|. ....+.++|+|+.+.|++++.++ +.|.|+.
T Consensus       197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            22342 12356799999999999999887 8999984

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=97.89  E-value=9.5e-06  Score=78.37  Aligned_cols=58  Identities=26%  Similarity=0.251  Sum_probs=29.7

Q ss_pred             CCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCCCCCcccccccccCCcchh
Q 039799           12 INLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNELLC   73 (346)
Q Consensus        12 ~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~l~~l~~~~n~~~~   73 (346)
                      ++|+.|+|++|+|+ .||.   .+++|+.|+|++|+|+..++....++++..+++++|++..
T Consensus       241 ~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~~lp~~l~~l~~L~~L~L~~N~l~~  298 (622)
T 3g06_A          241 SELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLTRLPESLIHLSSETTVNLEGNPLSE  298 (622)
T ss_dssp             TTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCCSCCGGGGGSCTTCEEECCSCCCCH
T ss_pred             CcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCCcCCHHHhhccccCEEEecCCCCCC
Confidence            44455555555554 4444   3445555555555555333333445555566666665543

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=97.84  E-value=1e-05  Score=72.62  Aligned_cols=49  Identities=24%  Similarity=0.287  Sum_probs=38.0

Q ss_pred             ccCcchhCCCCCCEEEeecCcccccCCc-cccCcCCCCeEECcCCcCcCCCCC
Q 039799            3 SIPDSIGDLINLKSLNLSNNNLSGTIPI-SLEKLLDLKDINVSFNKLEGEIPR   54 (346)
Q Consensus         3 ~ip~~~~~l~~L~~l~l~~N~l~g~~p~-~~~~l~~l~~l~l~~N~l~~~~p~   54 (346)
                      +||..|  .++|+.|+|++|+|+ .||+ .|.+|++|+.|+|++|++.+.+|.
T Consensus        23 ~iP~~l--~~~l~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~   72 (350)
T 4ay9_X           23 EIPSDL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEA   72 (350)
T ss_dssp             SCCTTC--CTTCSEEEEESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECT
T ss_pred             ccCcCc--CCCCCEEEccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccCh
Confidence            467666  367888888888888 7775 578888888888888888776654

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.83  E-value=9.1e-05  Score=68.08  Aligned_cols=80  Identities=11%  Similarity=0.072  Sum_probs=46.7

Q ss_pred             CCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccccccccCCcccccCCCCCCC---CCCcchhHHHHHHHHHH
Q 039799          221 SAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREG---RVSTNGDVYSFGIMLME  297 (346)
Q Consensus       221 ~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Dv~s~G~il~e  297 (346)
                      ...++|+|+++.|||++.++ +.++||+.+..-.+.. ........-...|.+|+.....   ......++.+....+|+
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~-Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF-DIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH-HHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH-HHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            77899999999999998776 9999999988532110 0000000001235555443211   11223455577777777


Q ss_pred             HHcCC
Q 039799          298 IFTRT  302 (346)
Q Consensus       298 lltg~  302 (346)
                      .+++.
T Consensus       309 ~y~~~  313 (420)
T 2pyw_A          309 LFNKR  313 (420)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            76653

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=97.82  E-value=2.7e-06  Score=75.60  Aligned_cols=66  Identities=15%  Similarity=0.139  Sum_probs=51.2

Q ss_pred             CcchhCCCCCCEEEeecCccccc-CCccccCcCCCCeEECcCCcCcCCCCCC-CCCcccccccccCCc
Q 039799            5 PDSIGDLINLKSLNLSNNNLSGT-IPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSVKSFEGNE   70 (346)
Q Consensus         5 p~~~~~l~~L~~l~l~~N~l~g~-~p~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~   70 (346)
                      +..+.++++|+.|+|++|++++. +|..+.++++|+.|++++|++++..|.. +.+++++.+++++|.
T Consensus        86 ~~~~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~  153 (336)
T 2ast_B           86 LAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCS  153 (336)
T ss_dssp             CCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCB
T ss_pred             chhhccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCC
Confidence            34466788888888888888866 8888888888888888888887655543 557788888888883

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=97.79  E-value=3.2e-06  Score=76.23  Aligned_cols=73  Identities=22%  Similarity=0.160  Sum_probs=55.1

Q ss_pred             CCccCcchhCCCCCCEEEeecCcccccCC----ccccCcC-CCCeEECcCCcCcCCCCCC-CC-----CcccccccccCC
Q 039799            1 QGSIPDSIGDLINLKSLNLSNNNLSGTIP----ISLEKLL-DLKDINVSFNKLEGEIPRE-GP-----FRNLSVKSFEGN   69 (346)
Q Consensus         1 ~g~ip~~~~~l~~L~~l~l~~N~l~g~~p----~~~~~l~-~l~~l~l~~N~l~~~~p~~-~~-----~~~l~~l~~~~n   69 (346)
                      +|.+|..+...++|+.|||++|++++.-+    ..+.+++ +|+.|+|++|++++..+.. ..     .++++.+++++|
T Consensus        11 ~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n   90 (362)
T 3goz_A           11 SNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGN   90 (362)
T ss_dssp             CCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSS
T ss_pred             hHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCC
Confidence            46677777777789999999999984444    6677888 8999999999988875543 22     267888888888


Q ss_pred             cchh
Q 039799           70 ELLC   73 (346)
Q Consensus        70 ~~~~   73 (346)
                      .+..
T Consensus        91 ~l~~   94 (362)
T 3goz_A           91 FLSY   94 (362)
T ss_dssp             CGGG
T ss_pred             cCCh
Confidence            7654

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=97.79  E-value=2.8e-06  Score=77.25  Aligned_cols=66  Identities=18%  Similarity=0.258  Sum_probs=36.4

Q ss_pred             chhCCCCCCEEEeecCccc----ccCCccccCcCCCCeEECcCCcCcCC----CCCC---CCCcccccccccCCcch
Q 039799            7 SIGDLINLKSLNLSNNNLS----GTIPISLEKLLDLKDINVSFNKLEGE----IPRE---GPFRNLSVKSFEGNELL   72 (346)
Q Consensus         7 ~~~~l~~L~~l~l~~N~l~----g~~p~~~~~l~~l~~l~l~~N~l~~~----~p~~---~~~~~l~~l~~~~n~~~   72 (346)
                      .+.++++|+.|+|++|+++    +.+|..+..+++|+.|+|++|++++.    +|..   +.+++++.+++++|.+.
T Consensus       211 ~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~  287 (386)
T 2ca6_A          211 GLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIE  287 (386)
T ss_dssp             TGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCB
T ss_pred             HhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCC
Confidence            4555666666666666664    45565666666666666666666543    2221   22455556666666543

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=97.76  E-value=1.2e-05  Score=71.98  Aligned_cols=72  Identities=17%  Similarity=0.160  Sum_probs=59.4

Q ss_pred             ccCc-chhCCCCCCEEEeecCcccccCCc-cccCcCCCCe-EECcCCcCcCCCCCC-CCCcccccccccCCcchhh
Q 039799            3 SIPD-SIGDLINLKSLNLSNNNLSGTIPI-SLEKLLDLKD-INVSFNKLEGEIPRE-GPFRNLSVKSFEGNELLCE   74 (346)
Q Consensus         3 ~ip~-~~~~l~~L~~l~l~~N~l~g~~p~-~~~~l~~l~~-l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~~~~~   74 (346)
                      .||+ .|++|++|+.|||++|++.+.+|. .|.+|++|.. +++++|++++.+|.. ..+++|+.+++++|.+...
T Consensus        44 ~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~  119 (350)
T 4ay9_X           44 VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHL  119 (350)
T ss_dssp             EECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSC
T ss_pred             CcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccccccccccccC
Confidence            5675 589999999999999999878886 5688988775 677789999988775 6788999999999887644

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=97.76  E-value=1.5e-06  Score=78.97  Aligned_cols=74  Identities=18%  Similarity=0.264  Sum_probs=62.1

Q ss_pred             CccCcchhCCCCCCEEEeecCccccc----CCccc--cCcCCCCeEECcCCcCcC----CCCCC--CCCcccccccccCC
Q 039799            2 GSIPDSIGDLINLKSLNLSNNNLSGT----IPISL--EKLLDLKDINVSFNKLEG----EIPRE--GPFRNLSVKSFEGN   69 (346)
Q Consensus         2 g~ip~~~~~l~~L~~l~l~~N~l~g~----~p~~~--~~l~~l~~l~l~~N~l~~----~~p~~--~~~~~l~~l~~~~n   69 (346)
                      +.+|..+..+++|+.|+|++|++++.    +|..+  +++++|+.|+|++|.+++    .+|..  ..+++++.+++++|
T Consensus       234 ~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N  313 (386)
T 2ca6_A          234 SALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGN  313 (386)
T ss_dssp             HHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTS
T ss_pred             HHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCC
Confidence            35788899999999999999999976    67777  449999999999999998    35543  34689999999999


Q ss_pred             cchhhc
Q 039799           70 ELLCEI   75 (346)
Q Consensus        70 ~~~~~~   75 (346)
                      ++....
T Consensus       314 ~l~~~~  319 (386)
T 2ca6_A          314 RFSEED  319 (386)
T ss_dssp             BSCTTS
T ss_pred             cCCcch
Confidence            987554

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=97.76  E-value=1.2e-05  Score=68.88  Aligned_cols=50  Identities=28%  Similarity=0.327  Sum_probs=43.1

Q ss_pred             ccCcchhCCCCCCEEEeecCcccccCCccccCcC--CCCeEECcCCcCcCCCCC
Q 039799            3 SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLL--DLKDINVSFNKLEGEIPR   54 (346)
Q Consensus         3 ~ip~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~--~l~~l~l~~N~l~~~~p~   54 (346)
                      .||..++.|++|+.||||+|+|++ + .++..+.  +|+.|+|++|.+++.+|.
T Consensus       187 ~l~~~~~~l~~L~~L~Ls~N~i~~-~-~~l~~l~~l~L~~L~L~~Npl~~~~~~  238 (267)
T 3rw6_A          187 DMSSIVQKAPNLKILNLSGNELKS-E-RELDKIKGLKLEELWLDGNSLCDTFRD  238 (267)
T ss_dssp             GGTTHHHHSTTCCEEECTTSCCCS-G-GGGGGGTTSCCSEEECTTSTTGGGCSS
T ss_pred             cchhHHhhCCCCCEEECCCCccCC-c-hhhhhcccCCcceEEccCCcCccccCc
Confidence            567888899999999999999995 4 4566666  999999999999998774

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.73  E-value=7.5e-05  Score=65.32  Aligned_cols=136  Identities=16%  Similarity=0.205  Sum_probs=75.1

Q ss_pred             CCcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCc-eeeEEEEecCCceeEEEecC-CCCC
Q 039799          108 PPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNL-IKIISSYSNDDFKALVLEYM-PHGS  185 (346)
Q Consensus       108 ~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~-~~gs  185 (346)
                      .+.|+.|....+|+.     ..+++|+....... ......|...++.+....+ .++++.  ..+..++++||+ ++.+
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence            677888999999998     56889988653221 1123457777776643333 355544  344457899999 6554


Q ss_pred             hhhh------------------hhhcCCC----CCHHHHH-HHHH--------------HHHHHH----HHHh-cCCCCC
Q 039799          186 LEKC------------------LYLSNYI----LDIFQRL-DIMI--------------DVASAL----EYLH-FGYSAP  223 (346)
Q Consensus       186 L~~~------------------l~~~~~~----l~~~~~~-~i~~--------------~i~~~l----~~LH-~~~~~~  223 (346)
                      +...                  ++.....    .+....+ .+..              .+.+.+    +.+. ......
T Consensus        95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~  174 (301)
T 3dxq_A           95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA  174 (301)
T ss_dssp             CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred             CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence            4320                  0111100    1111110 0000              011111    1111 122445


Q ss_pred             eeecCCCCCceEECCCCcEEEeeecCCcc
Q 039799          224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKP  252 (346)
Q Consensus       224 i~H~dik~~NIll~~~~~~~l~Dfg~~~~  252 (346)
                      ++|+|+.+.||+ ..++.+.++||..+..
T Consensus       175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          175 ACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            899999999999 5667789999998874

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=97.70  E-value=3.1e-05  Score=74.78  Aligned_cols=59  Identities=25%  Similarity=0.327  Sum_probs=30.3

Q ss_pred             ccCcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCCCCCcccccccccCCc
Q 039799            3 SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNE   70 (346)
Q Consensus         3 ~ip~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~l~~l~~~~n~   70 (346)
                      .||..+.  ++|+.|+|++|+|+ .||.   .+++|+.|+|++|+|++.++   .+++|+.+++++|.
T Consensus        54 ~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~~lp~---~l~~L~~L~Ls~N~  112 (622)
T 3g06_A           54 TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTSLPV---LPPGLLELSIFSNP  112 (622)
T ss_dssp             CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCSCCCC---CCTTCCEEEECSCC
T ss_pred             ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCCcCCC---CCCCCCEEECcCCc
Confidence            3455444  55666666666665 5554   34555555555555554333   23444444444443

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.63  E-value=6.1e-05  Score=57.12  Aligned_cols=59  Identities=15%  Similarity=0.315  Sum_probs=48.2

Q ss_pred             CEEEeecCccc-ccCCccccCcCCCCeEECcCCcCcCCCCCC-CCCcccccccccCCcchhhc
Q 039799           15 KSLNLSNNNLS-GTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSVKSFEGNELLCEI   75 (346)
Q Consensus        15 ~~l~l~~N~l~-g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~~~~~~   75 (346)
                      ..+|.++|+|+ ..+|..+.  ++|+.|+|++|+|+..++.. ..+.+++.+++.+|++.|.-
T Consensus        11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~CdC   71 (130)
T 3rfe_A           11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCDC   71 (130)
T ss_dssp             TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBCSG
T ss_pred             CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeeccC
Confidence            47899999987 57887654  47999999999999887765 55778889999999998854

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.62  E-value=0.0006  Score=60.40  Aligned_cols=139  Identities=12%  Similarity=0.059  Sum_probs=72.6

Q ss_pred             CcccccCceE-EEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCC--CCceeeEEEEecCCceeEEEecCCCCC
Q 039799          109 PLIGKGGFGS-VYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICH--RNLIKIISSYSNDDFKALVLEYMPHGS  185 (346)
Q Consensus       109 ~~lg~G~~g~-vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~gs  185 (346)
                      +.++.|.... +|+....+|..+++|...+...   ..+..|+.+++.+..  -.+.+++.+....  .+++||++.+.+
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~   98 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDAL   98 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCB
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcc
Confidence            3455554444 6677654477888887654321   223346666666532  2345566664333  378999998766


Q ss_pred             hhhhhhhcC-------------------------CCCCHHHHH-------H-H------------HHHHHHHHHHHh---
Q 039799          186 LEKCLYLSN-------------------------YILDIFQRL-------D-I------------MIDVASALEYLH---  217 (346)
Q Consensus       186 L~~~l~~~~-------------------------~~l~~~~~~-------~-i------------~~~i~~~l~~LH---  217 (346)
                      +.+.+....                         ...+.....       . +            ...+...++.+.   
T Consensus        99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~  178 (333)
T 3csv_A           99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ  178 (333)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence            654332100                         011111100       0 0            001112222221   


Q ss_pred             cCCCCCeeecCCCCCceEECCC----CcEEEeeecCCcc
Q 039799          218 FGYSAPIIHCDLKPSNVLLDDN----MVAHLSDFGMAKP  252 (346)
Q Consensus       218 ~~~~~~i~H~dik~~NIll~~~----~~~~l~Dfg~~~~  252 (346)
                      ......++|||+.+.||+++.+    ..+.|+||+.+..
T Consensus       179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            1125679999999999999874    6899999999875

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.62  E-value=0.00012  Score=67.57  Aligned_cols=72  Identities=18%  Similarity=0.255  Sum_probs=49.4

Q ss_pred             CcccccCceEEEEEEEcC--------CCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCc-eeeEEEEecCCceeEEEe
Q 039799          109 PLIGKGGFGSVYKAIIQD--------GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNL-IKIISSYSNDDFKALVLE  179 (346)
Q Consensus       109 ~~lg~G~~g~vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e  179 (346)
                      +.|+.|....+|+....+        +..+++|+.....  ....+..|..+++.+...++ .++++.+.+    .+|+|
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e  152 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  152 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence            457788889999998753        5789999985421  12445578888888753344 566666542    38999


Q ss_pred             cCCCCCh
Q 039799          180 YMPHGSL  186 (346)
Q Consensus       180 ~~~~gsL  186 (346)
                      |++|.++
T Consensus       153 ~l~G~~l  159 (429)
T 1nw1_A          153 YIPSRPL  159 (429)
T ss_dssp             CCCEEEC
T ss_pred             EeCCccc
Confidence            9986544

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=97.61  E-value=1.8e-05  Score=70.20  Aligned_cols=65  Identities=17%  Similarity=0.207  Sum_probs=31.8

Q ss_pred             CcchhCCC-CCCEEEeecC--ccc-ccCCccccCcCCCCeEECcCCc-CcCC-CCCCCCCcccccccccCC
Q 039799            5 PDSIGDLI-NLKSLNLSNN--NLS-GTIPISLEKLLDLKDINVSFNK-LEGE-IPREGPFRNLSVKSFEGN   69 (346)
Q Consensus         5 p~~~~~l~-~L~~l~l~~N--~l~-g~~p~~~~~l~~l~~l~l~~N~-l~~~-~p~~~~~~~l~~l~~~~n   69 (346)
                      |..+++++ +|+.|+|++|  .++ +.+|..+.++++|+.|++++|. +++. ++....+++++.+++++|
T Consensus       187 ~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~  257 (336)
T 2ast_B          187 QVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRC  257 (336)
T ss_dssp             HHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTC
T ss_pred             HHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCC
Confidence            34445555 5555555555  333 3455555555555555555555 3332 222234445555555554

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=97.56  E-value=1.8e-05  Score=71.28  Aligned_cols=68  Identities=22%  Similarity=0.233  Sum_probs=55.4

Q ss_pred             cchhCCC-CCCEEEeecCcccccCCccccCc-----CCCCeEECcCCcCcCCCCCC-----CCC-cccccccccCCcchh
Q 039799            6 DSIGDLI-NLKSLNLSNNNLSGTIPISLEKL-----LDLKDINVSFNKLEGEIPRE-----GPF-RNLSVKSFEGNELLC   73 (346)
Q Consensus         6 ~~~~~l~-~L~~l~l~~N~l~g~~p~~~~~l-----~~l~~l~l~~N~l~~~~p~~-----~~~-~~l~~l~~~~n~~~~   73 (346)
                      ..+.+++ +|+.|+|++|++++..|..+..+     ++|+.|+|++|++++..+..     ... ++++.+++++|.+..
T Consensus        44 ~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~  123 (362)
T 3goz_A           44 QAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSS  123 (362)
T ss_dssp             HHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGG
T ss_pred             HHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCc
Confidence            5567888 89999999999997778888776     99999999999999877652     223 688899999998654

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.55  E-value=0.0001  Score=65.03  Aligned_cols=141  Identities=16%  Similarity=0.191  Sum_probs=78.7

Q ss_pred             CcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCC--ceeeEEE------EecCCceeEEEec
Q 039799          109 PLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRN--LIKIISS------YSNDDFKALVLEY  180 (346)
Q Consensus       109 ~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~------~~~~~~~~lv~e~  180 (346)
                      +.|+.|....+|+....+| .+++|+.....  ....+..|..+++.+....  +.+++..      ....+..+++++|
T Consensus        28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~  104 (322)
T 2ppq_A           28 KGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF  104 (322)
T ss_dssp             EEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred             eccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence            3567788889999987765 68899987521  1234455777776664222  2233321      1123556899999


Q ss_pred             CCCCChhh-----h---------hhhc--C---CC------CCHHHHHH------------HHHHHHHHHHHHhc----C
Q 039799          181 MPHGSLEK-----C---------LYLS--N---YI------LDIFQRLD------------IMIDVASALEYLHF----G  219 (346)
Q Consensus       181 ~~~gsL~~-----~---------l~~~--~---~~------l~~~~~~~------------i~~~i~~~l~~LH~----~  219 (346)
                      ++|..+..     +         ++..  .   ..      ..|.....            +...+.+.++++..    .
T Consensus       105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~  184 (322)
T 2ppq_A          105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD  184 (322)
T ss_dssp             CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred             CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence            99865421     0         1111  0   00      11222110            00113344555542    1


Q ss_pred             CCCCeeecCCCCCceEECCCCcEEEeeecCCcc
Q 039799          220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  252 (346)
Q Consensus       220 ~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~  252 (346)
                      ....++|+|+.+.||+++++..+.++||+.+..
T Consensus       185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             SCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             CCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            245789999999999999876668999998874

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.39  E-value=0.00057  Score=63.35  Aligned_cols=73  Identities=15%  Similarity=0.231  Sum_probs=48.1

Q ss_pred             CcccccCceEEEEEEEcC-CCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCc-eeeEEEEecCCceeEEEecCCCCCh
Q 039799          109 PLIGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNL-IKIISSYSNDDFKALVLEYMPHGSL  186 (346)
Q Consensus       109 ~~lg~G~~g~vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~gsL  186 (346)
                      +.|+.|-...+|+....+ +..+++|+......... ....|..+++.+...++ .++++.+.  +  .+|+||++|.++
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l  188 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL  188 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence            467788889999998775 57899999854322211 12468888888865555 46676663  2  359999987554

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.38  E-value=0.00093  Score=58.93  Aligned_cols=140  Identities=11%  Similarity=0.136  Sum_probs=80.9

Q ss_pred             CcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCC--ceeeEEE-----EecCCceeEEEecC
Q 039799          109 PLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRN--LIKIISS-----YSNDDFKALVLEYM  181 (346)
Q Consensus       109 ~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~-----~~~~~~~~lv~e~~  181 (346)
                      ..++ |....||+....+|+.+++|+..+... ....+..|..+++.+....  +.+++..     ....+..+++++++
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i  109 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV  109 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence            3466 788899998877787899999874321 2345666888777774222  3344432     11244567899999


Q ss_pred             CCCChh-----hh---------hhh--c------CCCCCHHHH----HHH---------------HHHHHHHHHHHhc--
Q 039799          182 PHGSLE-----KC---------LYL--S------NYILDIFQR----LDI---------------MIDVASALEYLHF--  218 (346)
Q Consensus       182 ~~gsL~-----~~---------l~~--~------~~~l~~~~~----~~i---------------~~~i~~~l~~LH~--  218 (346)
                      +|.++.     ..         ++.  .      ....++...    ..+               ...+...++.+..  
T Consensus       110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  189 (328)
T 1zyl_A          110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW  189 (328)
T ss_dssp             CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence            875432     11         111  0      011222211    000               0011112222221  


Q ss_pred             --CCCCCeeecCCCCCceEECCCCcEEEeeecCCcc
Q 039799          219 --GYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  252 (346)
Q Consensus       219 --~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~  252 (346)
                        .....++|+|+++.||+++ + .+.++||+.+..
T Consensus       190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence              1256689999999999999 4 899999998774

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.36  E-value=0.00088  Score=60.45  Aligned_cols=139  Identities=13%  Similarity=0.168  Sum_probs=81.3

Q ss_pred             CcccccCceEEEEEEEc--------CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCC-ceeeEEEEecCCceeEEEe
Q 039799          109 PLIGKGGFGSVYKAIIQ--------DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRN-LIKIISSYSNDDFKALVLE  179 (346)
Q Consensus       109 ~~lg~G~~g~vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e  179 (346)
                      +.+..|-...+|+....        +++.+++|+..... .......+|.++++.+...+ ..++++.+.+    .+|+|
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e  130 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ  130 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence            45667888889998864        35789999974422 22455668999888874323 3466666543    28999


Q ss_pred             cCCCCChhhh-----------------hhhcC----CCCC--HHHHHHHHHHHH-------------------HHHHHHh
Q 039799          180 YMPHGSLEKC-----------------LYLSN----YILD--IFQRLDIMIDVA-------------------SALEYLH  217 (346)
Q Consensus       180 ~~~~gsL~~~-----------------l~~~~----~~l~--~~~~~~i~~~i~-------------------~~l~~LH  217 (346)
                      |++|.++..-                 ++...    ....  |.+..++..++.                   ..+..|.
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            9998655311                 11111    1122  233333333221                   1222222


Q ss_pred             -----cCCCCCeeecCCCCCceEECCC----CcEEEeeecCCcc
Q 039799          218 -----FGYSAPIIHCDLKPSNVLLDDN----MVAHLSDFGMAKP  252 (346)
Q Consensus       218 -----~~~~~~i~H~dik~~NIll~~~----~~~~l~Dfg~~~~  252 (346)
                           ......++|+|+.+.||+++.+    +.+.++||..+..
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence                 1224568999999999999876    7899999998874

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.32  E-value=0.00055  Score=61.61  Aligned_cols=73  Identities=11%  Similarity=0.231  Sum_probs=44.5

Q ss_pred             CcccccCceEEEEEEEcC---------CCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCC-ceeeEEEEecCCceeEEE
Q 039799          109 PLIGKGGFGSVYKAIIQD---------GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRN-LIKIISSYSNDDFKALVL  178 (346)
Q Consensus       109 ~~lg~G~~g~vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~  178 (346)
                      ..++.|....+|+....+         +..+++|+....... ......|.++++.+...+ ..++++..  .  .++||
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~  113 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE  113 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence            456778888999998764         268999987653222 112356788888775334 34666544  2  36899


Q ss_pred             ecCCCCCh
Q 039799          179 EYMPHGSL  186 (346)
Q Consensus       179 e~~~~gsL  186 (346)
                      ||++|.++
T Consensus       114 e~i~G~~l  121 (369)
T 3c5i_A          114 EWLYGDPL  121 (369)
T ss_dssp             ECCCSEEC
T ss_pred             EEecCCcC
Confidence            99987544

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=97.13  E-value=2.4e-05  Score=72.60  Aligned_cols=61  Identities=23%  Similarity=0.206  Sum_probs=31.9

Q ss_pred             CCCCEEEeecCccccc----CCccccCcCCCCeEECcCCcCcCCCCCC-C-----CCcccccccccCCcch
Q 039799           12 INLKSLNLSNNNLSGT----IPISLEKLLDLKDINVSFNKLEGEIPRE-G-----PFRNLSVKSFEGNELL   72 (346)
Q Consensus        12 ~~L~~l~l~~N~l~g~----~p~~~~~l~~l~~l~l~~N~l~~~~p~~-~-----~~~~l~~l~~~~n~~~   72 (346)
                      ++|+.|+|++|++++.    +|..+..+++|+.|++++|++++..+.. .     ..++++.+++++|.+.
T Consensus       313 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~  383 (461)
T 1z7x_W          313 CQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVS  383 (461)
T ss_dssp             CCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCC
T ss_pred             ccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCC
Confidence            4666666666666543    4555555566666666666655432211 0     1335555555555443

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.00  E-value=0.00064  Score=51.39  Aligned_cols=45  Identities=27%  Similarity=0.459  Sum_probs=36.7

Q ss_pred             ccCcchhCCCCCCEEEeecCcccccCCcc-ccCcCCCCeEECcCCcCcC
Q 039799            3 SIPDSIGDLINLKSLNLSNNNLSGTIPIS-LEKLLDLKDINVSFNKLEG   50 (346)
Q Consensus         3 ~ip~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~l~~l~~l~l~~N~l~~   50 (346)
                      +||..|  -++|+.|||++|+|+ .||.. |..+++|+.|+|++|.+.-
T Consensus        24 ~vP~~l--p~~l~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~NP~~C   69 (130)
T 3rfe_A           24 SLPTAF--PVDTTELVLTGNNLT-ALPPGLLDALPALRTAHLGANPWRC   69 (130)
T ss_dssp             TSCSCC--CTTCSEEECTTSCCS-SCCTTTGGGCTTCCEEECCSSCCBC
T ss_pred             cCCCCC--CcCCCEEECCCCcCC-ccChhhhhhccccCEEEecCCCeec
Confidence            466543  247999999999999 88764 6889999999999998863

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.99  E-value=0.0036  Score=55.59  Aligned_cols=32  Identities=19%  Similarity=0.282  Sum_probs=28.4

Q ss_pred             CCCeeecCCCCCceEECCCCcEEEeeecCCcc
Q 039799          221 SAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  252 (346)
Q Consensus       221 ~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~  252 (346)
                      ...++|+|+.+.||++++++.+.++||+.+..
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            45689999999999999888899999988774

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.93  E-value=0.0041  Score=50.93  Aligned_cols=124  Identities=15%  Similarity=0.076  Sum_probs=79.6

Q ss_pred             CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccccc
Q 039799          184 GSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT  263 (346)
Q Consensus       184 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~~  263 (346)
                      -||.++|...+..++..++|.++.|.+.+|.-+-.  ...-..+=+.|..|++..+|.+...+ ..+.            
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------   97 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------   97 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceeccc-cccc------------
Confidence            48999999999999999999999999999887620  11111333567899999999987653 1110            


Q ss_pred             cccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHhhhcCCChhhhhchhccC
Q 039799          264 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPISVMEVVDANLLS  337 (346)
Q Consensus       264 ~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  337 (346)
                        .....+.|||... ...+.+.-|||+|+++|.-+--..|-+..            ..+++.+.++|+.|...
T Consensus        98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~eE------------~eLS~~LE~LL~~Mt~~  156 (229)
T 2yle_A           98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKENEE------------RELSPPLEQLIDHMANT  156 (229)
T ss_dssp             -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTTEE------------ECCCHHHHHHHHHHTTC
T ss_pred             --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCcccc------------hhhCHHHHHHHHHHHhc
Confidence              1223466888763 34567889999999999999755554331            22344566666666544

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=96.83  E-value=8.8e-05  Score=67.02  Aligned_cols=63  Identities=21%  Similarity=0.150  Sum_probs=42.1

Q ss_pred             CCCCCCEEEeecCcccc----cCCccccCcCCCCeEECcCCcCcCCC----CC-CCCCcccccccccCCcch
Q 039799           10 DLINLKSLNLSNNNLSG----TIPISLEKLLDLKDINVSFNKLEGEI----PR-EGPFRNLSVKSFEGNELL   72 (346)
Q Consensus        10 ~l~~L~~l~l~~N~l~g----~~p~~~~~l~~l~~l~l~~N~l~~~~----p~-~~~~~~l~~l~~~~n~~~   72 (346)
                      ..++|+.|+|++|+|+.    .++..+..+++|+.|||++|.++..-    +. ....++++.+++++|.+.
T Consensus       153 ~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~  224 (372)
T 3un9_A          153 DQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAG  224 (372)
T ss_dssp             TTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCC
T ss_pred             cCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCC
Confidence            45778888888888863    35556677788888888888876421    11 122346777788887654

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=96.83  E-value=0.00014  Score=67.48  Aligned_cols=68  Identities=19%  Similarity=0.181  Sum_probs=34.4

Q ss_pred             cCcchhCCCCCCEEEeecCcccccCCcccc-CcC----CCCeEECcCCcCcC----CCCC-CCCCcccccccccCCcc
Q 039799            4 IPDSIGDLINLKSLNLSNNNLSGTIPISLE-KLL----DLKDINVSFNKLEG----EIPR-EGPFRNLSVKSFEGNEL   71 (346)
Q Consensus         4 ip~~~~~l~~L~~l~l~~N~l~g~~p~~~~-~l~----~l~~l~l~~N~l~~----~~p~-~~~~~~l~~l~~~~n~~   71 (346)
                      +|..+..+++|++|||++|++++..+..+. .++    +|+.|+|++|+++.    .+|. ...+++++.+++++|.+
T Consensus        48 l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i  125 (461)
T 1z7x_W           48 ISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLL  125 (461)
T ss_dssp             HHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBC
T ss_pred             HHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcC
Confidence            344455556666666666666543333332 233    46666666666553    1222 23445566666666654

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=96.74  E-value=8.2e-05  Score=71.33  Aligned_cols=67  Identities=7%  Similarity=-0.015  Sum_probs=43.3

Q ss_pred             CcchhCCCCCCEEEeecC--cccccCCccccC-cCCCCeEECcCCcCcC-CCCCC-CCCcccccccccCCcc
Q 039799            5 PDSIGDLINLKSLNLSNN--NLSGTIPISLEK-LLDLKDINVSFNKLEG-EIPRE-GPFRNLSVKSFEGNEL   71 (346)
Q Consensus         5 p~~~~~l~~L~~l~l~~N--~l~g~~p~~~~~-l~~l~~l~l~~N~l~~-~~p~~-~~~~~l~~l~~~~n~~   71 (346)
                      +..+.++++|+.|+|++|  .+++..+..++. +++|+.|++++|++++ .++.. ..+++|+.+++++|.+
T Consensus       429 ~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l  500 (592)
T 3ogk_B          429 RSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCF  500 (592)
T ss_dssp             HHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCC
T ss_pred             HHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCC
Confidence            334566788888888743  466666665544 7778888888887765 22222 3456777777777764

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.35  E-value=0.0058  Score=55.90  Aligned_cols=73  Identities=16%  Similarity=0.283  Sum_probs=47.7

Q ss_pred             CcccccCceEEEEEEEcC--------CCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCC-ceeeEEEEecCCceeEEEe
Q 039799          109 PLIGKGGFGSVYKAIIQD--------GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRN-LIKIISSYSNDDFKALVLE  179 (346)
Q Consensus       109 ~~lg~G~~g~vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e  179 (346)
                      +.+..|-...+|+....+        +..+++|+....... .-...+|.++++.+...+ ..++++.+.    .++|+|
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e  150 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE  150 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence            456678888999998763        588999997554322 122356888887774333 345555432    368999


Q ss_pred             cCCCCCh
Q 039799          180 YMPHGSL  186 (346)
Q Consensus       180 ~~~~gsL  186 (346)
                      |++|.+|
T Consensus       151 fI~G~~l  157 (424)
T 3mes_A          151 FIDGEPL  157 (424)
T ss_dssp             CCCSEEC
T ss_pred             EeCCccC
Confidence            9998664

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=96.15  E-value=0.00031  Score=67.24  Aligned_cols=61  Identities=5%  Similarity=-0.026  Sum_probs=39.7

Q ss_pred             CCCCCEEEeecCcccccCCccc-cCcCCCCeEECcCCcCcCCCCC-C-CCCcccccccccCCcc
Q 039799           11 LINLKSLNLSNNNLSGTIPISL-EKLLDLKDINVSFNKLEGEIPR-E-GPFRNLSVKSFEGNEL   71 (346)
Q Consensus        11 l~~L~~l~l~~N~l~g~~p~~~-~~l~~l~~l~l~~N~l~~~~p~-~-~~~~~l~~l~~~~n~~   71 (346)
                      +++|+.|+|++|.+++..+..+ ..+++|+.|+|++|.+++.... . ..+++|+.+++++|+.
T Consensus       455 ~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~  518 (594)
T 2p1m_B          455 AKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSV  518 (594)
T ss_dssp             CTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCC
T ss_pred             chhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCC
Confidence            6777777777777765555444 5677777777777777543221 1 3356777777777765

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=96.10  E-value=0.00068  Score=54.65  Aligned_cols=41  Identities=17%  Similarity=0.177  Sum_probs=21.0

Q ss_pred             hCCCCCCEEEeecC-cccc----cCCccccCcCCCCeEECcCCcCc
Q 039799            9 GDLINLKSLNLSNN-NLSG----TIPISLEKLLDLKDINVSFNKLE   49 (346)
Q Consensus         9 ~~l~~L~~l~l~~N-~l~g----~~p~~~~~l~~l~~l~l~~N~l~   49 (346)
                      ...++|+.|+|++| .++.    .+...+...++|+.|+|++|.+.
T Consensus        33 ~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~   78 (185)
T 1io0_A           33 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSN   78 (185)
T ss_dssp             TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCC
T ss_pred             hcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCC
Confidence            34555556666555 5542    13333444555555555555553

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=96.02  E-value=0.00083  Score=60.30  Aligned_cols=38  Identities=11%  Similarity=0.128  Sum_probs=19.5

Q ss_pred             CcCCCCeEECcCCcCcCCCC----CCCCCcccccccccCCcc
Q 039799           34 KLLDLKDINVSFNKLEGEIP----REGPFRNLSVKSFEGNEL   71 (346)
Q Consensus        34 ~l~~l~~l~l~~N~l~~~~p----~~~~~~~l~~l~~~~n~~   71 (346)
                      .+++|+.|+|++|.+.+..+    ....+++|+.|+++.|.+
T Consensus       250 ~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L  291 (362)
T 2ra8_A          250 RFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVL  291 (362)
T ss_dssp             TCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCC
T ss_pred             CCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCC
Confidence            35666666666666553211    112345566666665543

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=95.86  E-value=0.00057  Score=65.41  Aligned_cols=65  Identities=14%  Similarity=0.128  Sum_probs=44.9

Q ss_pred             hhCCCCCCEEEeecCccccc----CCccccCcCCCCeEECcCCcCcCCC----CCC-CCCcccccccccCCcch
Q 039799            8 IGDLINLKSLNLSNNNLSGT----IPISLEKLLDLKDINVSFNKLEGEI----PRE-GPFRNLSVKSFEGNELL   72 (346)
Q Consensus         8 ~~~l~~L~~l~l~~N~l~g~----~p~~~~~l~~l~~l~l~~N~l~~~~----p~~-~~~~~l~~l~~~~n~~~   72 (346)
                      +.++++|+.|+|++|.+++.    ++..+.++++|+.|++++|.+++..    +.. ..+++|+.+++++|.+.
T Consensus       160 ~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~  233 (592)
T 3ogk_B          160 VTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEIL  233 (592)
T ss_dssp             HHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGG
T ss_pred             HhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHH
Confidence            34678888888888888755    5555667788888888888887432    211 34567777888777544

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=95.70  E-value=0.0025  Score=57.42  Aligned_cols=70  Identities=17%  Similarity=0.257  Sum_probs=54.3

Q ss_pred             cCcchhCCCCCCEEEeecCcccc----cCCccccCcCCCCeEECcCCcCcCCCCC-----CCCCcccccccccCCcchh
Q 039799            4 IPDSIGDLINLKSLNLSNNNLSG----TIPISLEKLLDLKDINVSFNKLEGEIPR-----EGPFRNLSVKSFEGNELLC   73 (346)
Q Consensus         4 ip~~~~~l~~L~~l~l~~N~l~g----~~p~~~~~l~~l~~l~l~~N~l~~~~p~-----~~~~~~l~~l~~~~n~~~~   73 (346)
                      ++..+..+++|++|||++|++++    .|+..+..+++|+.|+|++|.++..-..     ....++++.+++++|.+.-
T Consensus       175 l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~  253 (372)
T 3un9_A          175 LMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSS  253 (372)
T ss_dssp             HHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCH
T ss_pred             HHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCH
Confidence            45566789999999999999984    3567788889999999999999753211     1234678999999997643

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=95.54  E-value=0.0011  Score=53.42  Aligned_cols=67  Identities=15%  Similarity=0.150  Sum_probs=42.6

Q ss_pred             cchhCCCCCCEEEeecCcccc----cCCccccCcCCCCeEECcCCcCcCC----C-CCCCCCcccccccc--cCCcch
Q 039799            6 DSIGDLINLKSLNLSNNNLSG----TIPISLEKLLDLKDINVSFNKLEGE----I-PREGPFRNLSVKSF--EGNELL   72 (346)
Q Consensus         6 ~~~~~l~~L~~l~l~~N~l~g----~~p~~~~~l~~l~~l~l~~N~l~~~----~-p~~~~~~~l~~l~~--~~n~~~   72 (346)
                      ..+...++|+.|||++|+++.    .|...+...++|+.|+|++|.+...    + ......+.++.+++  ++|.+.
T Consensus        59 ~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~  136 (185)
T 1io0_A           59 EALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLG  136 (185)
T ss_dssp             HHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCC
T ss_pred             HHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCC
Confidence            345566788888888888863    2445556667888888888887642    1 11122345777777  667654

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=95.29  E-value=0.02  Score=52.06  Aligned_cols=30  Identities=27%  Similarity=0.352  Sum_probs=25.6

Q ss_pred             CeeecCCCCCceEE------CCCCcEEEeeecCCcc
Q 039799          223 PIIHCDLKPSNVLL------DDNMVAHLSDFGMAKP  252 (346)
Q Consensus       223 ~i~H~dik~~NIll------~~~~~~~l~Dfg~~~~  252 (346)
                      .++|+|+.+.||++      +++..+.++||..|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            46899999999999      4566899999999874

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=95.11  E-value=0.018  Score=50.63  Aligned_cols=57  Identities=26%  Similarity=0.273  Sum_probs=44.4

Q ss_pred             CCCCCCEEEeecCcccccCCc-cccCcCCCCeEECcCCcCcCCCCCC-CCCcccc-cccccC
Q 039799           10 DLINLKSLNLSNNNLSGTIPI-SLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLS-VKSFEG   68 (346)
Q Consensus        10 ~l~~L~~l~l~~N~l~g~~p~-~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~-~l~~~~   68 (346)
                      .+++|+.|+|++|+++ .||+ .|..|++|+.|+|++| ++...+.. ..+.+|+ .+.+.+
T Consensus       224 ~~~~L~~l~L~~n~i~-~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~  283 (329)
T 3sb4_A          224 YMPNLVSLDISKTNAT-TIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA  283 (329)
T ss_dssp             HCTTCCEEECTTBCCC-EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT
T ss_pred             hcCCCeEEECCCCCcc-eecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc
Confidence            3899999999999999 8886 5899999999999998 66544433 4456666 666655

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=94.81  E-value=0.0057  Score=58.41  Aligned_cols=61  Identities=15%  Similarity=0.165  Sum_probs=32.9

Q ss_pred             CCCCCCEEEeecC-ccccc-CCccccCcCCCCeEECcCCcCcCCCCC----C-CCCcccccccccCCc
Q 039799           10 DLINLKSLNLSNN-NLSGT-IPISLEKLLDLKDINVSFNKLEGEIPR----E-GPFRNLSVKSFEGNE   70 (346)
Q Consensus        10 ~l~~L~~l~l~~N-~l~g~-~p~~~~~l~~l~~l~l~~N~l~~~~p~----~-~~~~~l~~l~~~~n~   70 (346)
                      ++++|+.|+|++| .+++. ++..+.++++|+.|+|++|.+++..+.    . ..+++|+.+++++|.
T Consensus       128 ~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~  195 (594)
T 2p1m_B          128 SFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLA  195 (594)
T ss_dssp             HCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCC
T ss_pred             hCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccC
Confidence            4566666666666 44421 444444666677777776666553221    1 134456666666553

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=94.35  E-value=0.0093  Score=53.40  Aligned_cols=64  Identities=19%  Similarity=0.208  Sum_probs=50.1

Q ss_pred             hCCCCCCEEEeecCcccccCCcccc---CcCCCCeEECcCCcCcCC----CCCC-CCCcccccccccCCcch
Q 039799            9 GDLINLKSLNLSNNNLSGTIPISLE---KLLDLKDINVSFNKLEGE----IPRE-GPFRNLSVKSFEGNELL   72 (346)
Q Consensus         9 ~~l~~L~~l~l~~N~l~g~~p~~~~---~l~~l~~l~l~~N~l~~~----~p~~-~~~~~l~~l~~~~n~~~   72 (346)
                      +.+++|+.|+|++|.+++..+..+.   .+++|+.|+||.|.+++.    ++.. ..+++|+.+++++|.+.
T Consensus       249 ~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~  320 (362)
T 2ra8_A          249 DRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS  320 (362)
T ss_dssp             TTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCC
T ss_pred             CCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCC
Confidence            3589999999999999866655554   588999999999999873    3332 35678899999988643

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=93.95  E-value=0.2  Score=40.84  Aligned_cols=123  Identities=11%  Similarity=0.154  Sum_probs=82.2

Q ss_pred             CCCCceeeEEEEecCCceeEEEecCCCC-ChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceE
Q 039799          157 CHRNLIKIISSYSNDDFKALVLEYMPHG-SLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVL  235 (346)
Q Consensus       157 ~h~niv~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIl  235 (346)
                      .||++++. ..-...+...+.++.-+.+ ++..     -...+...+++++.+++....+++   .  =+|--++|+|++
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-----ik~~~~~eKlr~l~ni~~l~~~~~---~--r~tf~L~P~NL~  111 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-----IKSFTKNEKLRYLLNIKNLEEVNR---T--RYTFVLAPDELF  111 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-----GGGSCHHHHHHHHHHGGGGGGGGG---S--SEECCCSGGGEE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-----HHhcCHHHHHHHHHHHHHHHHHhc---C--ceEEEEecceEE
Confidence            68888876 4555666655555543322 2222     134778889999999998886665   2  357789999999


Q ss_pred             ECCCCcEEEeeecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCccc
Q 039799          236 LDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMT  314 (346)
Q Consensus       236 l~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~  314 (346)
                      ++.++.+++.-.|+-..+                   +|.     ..+...=.-.+=+++..+++++..|++...+...
T Consensus       112 f~~~~~p~i~~RGik~~l-------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~l~~G~le  166 (215)
T 4ann_A          112 FTRDGLPIAKTRGLQNVV-------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFDALVEGNLE  166 (215)
T ss_dssp             ECTTSCEEESCCEETTTB-------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHHHHHSCGG
T ss_pred             EcCCCCEEEEEccCccCC-------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHHHHcChHh
Confidence            999999999877764432                   221     1122222345788899999999999875544433

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=93.43  E-value=0.071  Score=46.75  Aligned_cols=66  Identities=20%  Similarity=0.191  Sum_probs=51.1

Q ss_pred             cCc-chhCCCCCCEEEeecCcccccCCc-cccCcCCCC-eEECcCCcCcCCCCCC-CCCcccccccccCCcch
Q 039799            4 IPD-SIGDLINLKSLNLSNNNLSGTIPI-SLEKLLDLK-DINVSFNKLEGEIPRE-GPFRNLSVKSFEGNELL   72 (346)
Q Consensus         4 ip~-~~~~l~~L~~l~l~~N~l~g~~p~-~~~~l~~l~-~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~~~   72 (346)
                      ||+ .|.++++|+.|+|++| ++ .|++ .|..|++|+ .+++++ +++...+.. ..+.+|+.+.+.+|.+.
T Consensus       241 I~~~aF~~~~~L~~l~l~~n-i~-~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~  310 (329)
T 3sb4_A          241 IPDFTFAQKKYLLKIKLPHN-LK-TIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKIT  310 (329)
T ss_dssp             ECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCC
T ss_pred             ecHhhhhCCCCCCEEECCcc-cc-eehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccC
Confidence            443 4788999999999998 88 7775 589999999 999988 676554443 55678888888777654

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=91.68  E-value=0.2  Score=45.38  Aligned_cols=53  Identities=9%  Similarity=0.087  Sum_probs=25.7

Q ss_pred             CCCEEEeecCcccccCC-ccccCcCCCCeEECcCCcCcCCCCCCCCCccccccccc
Q 039799           13 NLKSLNLSNNNLSGTIP-ISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFE   67 (346)
Q Consensus        13 ~L~~l~l~~N~l~g~~p-~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~l~~l~~~   67 (346)
                      +|+.++|.+ +++ .|+ ..|..|++|+.++|++|+++......-...+++.+.+.
T Consensus       158 ~L~~i~lp~-~l~-~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~~~~L~~l~lp  211 (401)
T 4fdw_A          158 TVQEIVFPS-TLE-QLKEDIFYYCYNLKKADLSKTKITKLPASTFVYAGIEEVLLP  211 (401)
T ss_dssp             CCCEEECCT-TCC-EECSSTTTTCTTCCEEECTTSCCSEECTTTTTTCCCSEEECC
T ss_pred             CceEEEeCC-Ccc-EehHHHhhCcccCCeeecCCCcceEechhhEeecccCEEEeC
Confidence            455565554 444 344 34555566666666655555443333222334444443

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=91.07  E-value=0.025  Score=44.82  Aligned_cols=67  Identities=10%  Similarity=0.136  Sum_probs=37.5

Q ss_pred             cCcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCc-CcCC-CCCCCCC----cccccccccCCc
Q 039799            4 IPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNK-LEGE-IPREGPF----RNLSVKSFEGNE   70 (346)
Q Consensus         4 ip~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~-l~~~-~p~~~~~----~~l~~l~~~~n~   70 (346)
                      +|...-.--+|+.||||++.++..==..+..|++|+.|+|+++. ++.. +......    ++|+.|+++++.
T Consensus        53 LP~~~~~~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~  125 (176)
T 3e4g_A           53 LPTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCG  125 (176)
T ss_dssp             SCCCSTTCCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCT
T ss_pred             CCcccCCCceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCC
Confidence            45433223467888888887773322346778888888888774 4421 1111111    246666666653

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=89.90  E-value=0.23  Score=39.21  Aligned_cols=63  Identities=14%  Similarity=0.148  Sum_probs=37.2

Q ss_pred             hhCCCCCCEEEeecC-cccccCCccccCc----CCCCeEECcCCc-CcCC-CCCCCCCcccccccccCCc
Q 039799            8 IGDLINLKSLNLSNN-NLSGTIPISLEKL----LDLKDINVSFNK-LEGE-IPREGPFRNLSVKSFEGNE   70 (346)
Q Consensus         8 ~~~l~~L~~l~l~~N-~l~g~~p~~~~~l----~~l~~l~l~~N~-l~~~-~p~~~~~~~l~~l~~~~n~   70 (346)
                      ++++++|+.|+|+++ +++..==..++.+    ++|+.|+|+++. ++.. +.....+++|+.|++++.+
T Consensus        81 L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L~~L~L~~c~  150 (176)
T 3e4g_A           81 MEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNLKYLFLSDLP  150 (176)
T ss_dssp             GTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTCCEEEEESCT
T ss_pred             hcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCCCEEECCCCC
Confidence            567788888888887 4663322334443    368888887764 5431 1122345677777776553

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=86.38  E-value=3  Score=33.95  Aligned_cols=115  Identities=10%  Similarity=0.158  Sum_probs=77.0

Q ss_pred             CCCCceeeEEEEecCCceeEEEecCCCC-ChhhhhhhcCCCCCHHHHHHHHHHHHHHHH-HHhcCCCCCeeecCCCCCce
Q 039799          157 CHRNLIKIISSYSNDDFKALVLEYMPHG-SLEKCLYLSNYILDIFQRLDIMIDVASALE-YLHFGYSAPIIHCDLKPSNV  234 (346)
Q Consensus       157 ~h~niv~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~-~LH~~~~~~i~H~dik~~NI  234 (346)
                      .||.+  -...-.+.+...+.++.-+++ ++.. +    ..++...+++++.+++.... +++     .-+|--++|+||
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~-i----~~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~NL  115 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAA-I----RKTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPENL  115 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHH-H----HTSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGGGE
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHH-H----HhcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCceE
Confidence            68888  344446667766666654333 3332 2    34777889999988888766 444     356778999999


Q ss_pred             EECCCCcEEEeeecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHH-HHHHHHHHHHcCCCCCCcc
Q 039799          235 LLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY-SFGIMLMEIFTRTKPTDEI  308 (346)
Q Consensus       235 ll~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~-s~G~il~elltg~~p~~~~  308 (346)
                      ++|.++.+++.-.|+-..+                   +|.-     .+ ..|.+ ++=+++..++.++..|++.
T Consensus       116 ~f~~~~~p~i~hRGi~~~l-------------------pP~e-----~~-ee~fl~qyKali~all~~K~~Fe~l  165 (219)
T 4ano_A          116 MFNRALEPFFLHVGVKESL-------------------PPDE-----WD-DERLLREVKATVLALTEGEYRFDEY  165 (219)
T ss_dssp             EECTTCCEEESCCEETTTB-------------------SSCS-----CC-HHHHHHHHHHHHHHHTTCSSCHHHH
T ss_pred             EEeCCCcEEEEEcCCcccC-------------------CCCC-----CC-HHHHHHHHHHHHHHHHcCCCCHHHH
Confidence            9999999999888764432                   2221     11 22333 5777888899998888763

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=85.68  E-value=0.99  Score=40.74  Aligned_cols=36  Identities=11%  Similarity=0.210  Sum_probs=21.9

Q ss_pred             CCCCEEEeecCcccccCC-ccccCcCCCCeEECcCCcCc
Q 039799           12 INLKSLNLSNNNLSGTIP-ISLEKLLDLKDINVSFNKLE   49 (346)
Q Consensus        12 ~~L~~l~l~~N~l~g~~p-~~~~~l~~l~~l~l~~N~l~   49 (346)
                      .+|+.++| .|+++ .|+ ..|.+|++|+.+++++|.+.
T Consensus       248 ~~L~~i~l-p~~i~-~I~~~aF~~c~~L~~l~l~~~~~~  284 (401)
T 4fdw_A          248 SGITTVKL-PNGVT-NIASRAFYYCPELAEVTTYGSTFN  284 (401)
T ss_dssp             CCCSEEEE-ETTCC-EECTTTTTTCTTCCEEEEESSCCC
T ss_pred             CCccEEEe-CCCcc-EEChhHhhCCCCCCEEEeCCcccc
Confidence            56666766 34455 453 45666677777776666654

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=84.64  E-value=0.39  Score=38.70  Aligned_cols=64  Identities=19%  Similarity=0.179  Sum_probs=44.4

Q ss_pred             CCCCCCEEEeecC-cccc----cCCccccCcCCCCeEECcCCcCcCCCCCC-----CCCcccccccccCCcchh
Q 039799           10 DLINLKSLNLSNN-NLSG----TIPISLEKLLDLKDINVSFNKLEGEIPRE-----GPFRNLSVKSFEGNELLC   73 (346)
Q Consensus        10 ~l~~L~~l~l~~N-~l~g----~~p~~~~~l~~l~~l~l~~N~l~~~~p~~-----~~~~~l~~l~~~~n~~~~   73 (346)
                      +=+.|+.|+|++| ++..    .|-..+..-+.|+.|+|++|.+...--..     ..-+.|+.|+++.|.+.-
T Consensus        39 ~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~  112 (197)
T 1pgv_A           39 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTP  112 (197)
T ss_dssp             TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCH
T ss_pred             cCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCH
Confidence            4578999999986 7752    24455667789999999999997421111     112467889999998653

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	346
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-57
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-54
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-52
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-51
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-51
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-51
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	4e-50
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	7e-50
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	8e-50
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-49
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	6e-49
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	9e-49
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-47
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-47
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-47
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-47
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	5e-47
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-46
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-46
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-46
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-46
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-46
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	4e-46
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	7e-46
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	9e-46
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-45
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	5e-45
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-44
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-43
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-43
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	5e-43
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	6e-43
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	6e-42
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	7e-40
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-39
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	4e-39
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-38
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-38
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-38
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-37
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-37
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	5e-37
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-36
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	3e-36
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	4e-36
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-35
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-35
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-35
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	4e-35
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-34
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-33
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-33
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	6e-33
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	7e-33
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-32
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	6e-32
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	4e-30
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-29
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	8e-29
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	5e-27
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-25
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-25
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-20
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-15
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	6e-06
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-05
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-04
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	0.001
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	0.002
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	7e-05
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	8e-04
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	0.004
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	3e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.004
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	4e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	9e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	0.002
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.003
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	0.003

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (472), Expect = 1e-57
 Identities = 63/228 (27%), Positives = 104/228 (45%), Gaps = 11/228 (4%)

Query: 110 LIGKGGFGSVYKAIIQDGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISS 167
            IG G FG+VYK       +VAVK+ +         ++F  E  V+++  H N++  +  
Sbjct: 15  RIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG- 71

Query: 168 YSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHC 227
           YS     A+V ++    SL   L++     ++ + +DI    A  ++YLH      IIH 
Sbjct: 72  YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHR 128

Query: 228 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEY---GREGRVST 284
           DLK +N+ L +++   + DFG+A        S    Q   +I +MAPE      +   S 
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188

Query: 285 NGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPISVMEVVD 332
             DVY+FGI+L E+ T   P   I + +  +       L   + +V  
Sbjct: 189 QSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS 236

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 2e-54
 Identities = 56/217 (25%), Positives = 104/217 (47%), Gaps = 7/217 (3%)

Query: 110 LIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYS 169
            +G G FG V+        +VAVK           +F  E ++MK++ H+ L+++ +  +
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAVVT 78

Query: 170 NDDFKALVLEYMPHGSLEKCLYLSNYI-LDIFQRLDIMIDVASALEYLHFGYSAPIIHCD 228
            +    ++ EYM +GSL   L   + I L I + LD+   +A  + ++        IH D
Sbjct: 79  QEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRD 134

Query: 229 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDV 288
           L+ +N+L+ D +   ++DFG+A+ L+E+++   +      I + APE    G  +   DV
Sbjct: 135 LRAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 193

Query: 289 YSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPI 325
           +SFGI+L EI T  +      +    ++        +
Sbjct: 194 WSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV 230

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 2e-52
 Identities = 55/223 (24%), Positives = 98/223 (43%), Gaps = 5/223 (2%)

Query: 102 PNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNL 161
           P D      +G G FG V     +   +VA+K+           F  E  VM  + H  L
Sbjct: 3   PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKL 61

Query: 162 IKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYS 221
           +++    +      ++ EYM +G L   L    +     Q L++  DV  A+EYL     
Sbjct: 62  VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES--- 118

Query: 222 APIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGR 281
              +H DL   N L++D  V  +SDFG+++  + +D+  +   +   + +  PE     +
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSK 177

Query: 282 VSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLP 324
            S+  D+++FG+++ EI++  K   E F+   T +     L  
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL 220

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 1e-51
 Identities = 50/208 (24%), Positives = 92/208 (44%), Gaps = 9/208 (4%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKS-FDIECDVMKRICHRNLIKIISS 167
            +G G  G V+K      G+ +A K+   + + A ++    E  V+       ++    +
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 72

Query: 168 YSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHC 227
           + +D   ++ +E+M  GSL++ L      +       + I V   L YL       I+H 
Sbjct: 73  FYSDGEISICMEHMDGGSLDQVLK-KAGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHR 129

Query: 228 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGD 287
           D+KPSN+L++      L DFG++  L++          + T  YM+PE  +    S   D
Sbjct: 130 DVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSD 185

Query: 288 VYSFGIMLMEIFTRTKPTDEIFSGEMTL 315
           ++S G+ L+E+     P     + E+ L
Sbjct: 186 IWSMGLSLVEMAVGRYPIPPPDAKELEL 213

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (430), Expect = 1e-51
 Identities = 61/223 (27%), Positives = 99/223 (44%), Gaps = 5/223 (2%)

Query: 102 PNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNL 161
           P++      IG G FG V+     +  +VA+K          + F  E +VM ++ H  L
Sbjct: 4   PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKL 62

Query: 162 IKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYS 221
           +++           LV E+M HG L   L     +      L + +DV   + YL     
Sbjct: 63  VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---E 119

Query: 222 APIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGR 281
           A +IH DL   N L+ +N V  +SDFGM +  + +DQ  + T T   + + +PE     R
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSR 178

Query: 282 VSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLP 324
            S+  DV+SFG+++ E+F+  K   E  S    ++        
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL 221

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (432), Expect = 2e-51
 Identities = 59/215 (27%), Positives = 102/215 (47%), Gaps = 7/215 (3%)

Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSN 170
           +G+G FG V+         VA+K   P      ++F  E  VMK++ H  L+++ +  S 
Sbjct: 25  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 83

Query: 171 DDFKALVLEYMPHGSLEKCLYLSNYILDIF-QRLDIMIDVASALEYLHFGYSAPIIHCDL 229
           +    +V EYM  GSL   L           Q +D+   +AS + Y+        +H DL
Sbjct: 84  EPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDL 139

Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVY 289
           + +N+L+ +N+V  ++DFG+A+ L+E+++   +      I + APE    GR +   DV+
Sbjct: 140 RAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 198

Query: 290 SFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLP 324
           SFGI+L E+ T+ +           L +       
Sbjct: 199 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM 233

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (422), Expect = 4e-50
 Identities = 49/219 (22%), Positives = 94/219 (42%), Gaps = 9/219 (4%)

Query: 111 IGKGGFGSVYKAIIQ---DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIIS 166
           +G G FGSV + + +     ++VA+KV      +   +    E  +M ++ +  ++++I 
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76

Query: 167 SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIH 226
               +    LV+E    G L K L      + +    +++  V+  ++YL        +H
Sbjct: 77  VCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVH 132

Query: 227 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA-TIGYMAPEYGREGRVSTN 285
            DL   NVLL +   A +SDFG++K L  +D   T        + + APE     + S+ 
Sbjct: 133 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR 192

Query: 286 GDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLP 324
            DV+S+G+ + E  +  +   +   G   +         
Sbjct: 193 SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM 231

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  166 bits (422), Expect = 7e-50
 Identities = 55/232 (23%), Positives = 108/232 (46%), Gaps = 11/232 (4%)

Query: 110 LIGKGGFGSVYKAII----QDGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKI 164
           +IG G FG V    +    +  + VA+K     Y E   + F  E  +M +  H N+I +
Sbjct: 33  VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHL 92

Query: 165 ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPI 224
               +      ++ E+M +GSL+  L  ++    + Q + ++  +A+ ++YL        
Sbjct: 93  EGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD---MNY 149

Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL---ATIGYMAPEYGREGR 281
           +H DL   N+L++ N+V  +SDFG+++ L ++    T T  L     I + APE  +  +
Sbjct: 150 VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRK 209

Query: 282 VSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPISVMEVVDA 333
            ++  DV+S+GI++ E+ +  +      + +  +     D      M+   A
Sbjct: 210 FTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSA 261

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 8e-50
 Identities = 54/231 (23%), Positives = 95/231 (41%), Gaps = 7/231 (3%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISS 167
            +G+G +G V  A+       VAVK+ D +      ++   E  + K + H N++K    
Sbjct: 12  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 71

Query: 168 YSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHC 227
               + + L LEY   G L   +   +  +           + + + YLH      I H 
Sbjct: 72  RREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHR 127

Query: 228 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNG- 286
           D+KP N+LLD+     +SDFG+A      ++     +   T+ Y+APE  +         
Sbjct: 128 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 187

Query: 287 DVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPISVMEVVDANLLS 337
           DV+S GI+L  +     P D+          W      ++  + +D+  L+
Sbjct: 188 DVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 238

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (417), Expect = 2e-49
 Identities = 57/231 (24%), Positives = 101/231 (43%), Gaps = 11/231 (4%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYS 169
           +G G FG VYKA   +  +  A KV D + E   + + +E D++    H N++K++ ++ 
Sbjct: 20  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 79

Query: 170 NDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDL 229
            ++   +++E+   G+++  +      L   Q   +      AL YLH      IIH DL
Sbjct: 80  YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDL 136

Query: 230 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEY-----GREGRVST 284
           K  N+L   +    L+DFG++       Q         T  +MAPE       ++     
Sbjct: 137 KAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI--GTPYWMAPEVVMCETSKDRPYDY 194

Query: 285 NGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPISVMEVVDANL 335
             DV+S GI L+E+     P  E+    + LK   ++   ++      +N 
Sbjct: 195 KADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNF 245

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (413), Expect = 6e-49
 Identities = 58/233 (24%), Positives = 103/233 (44%), Gaps = 15/233 (6%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISS 167
           IG+G F +VYK +  +  +EVA      +   +   + F  E +++K + H N+++   S
Sbjct: 17  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76

Query: 168 Y----SNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
           +           LV E M  G+L+  L     ++ I         +   L++LH   + P
Sbjct: 77  WESTVKGKKCIVLVTELMTSGTLKTYLK-RFKVMKIKVLRSWCRQILKGLQFLHT-RTPP 134

Query: 224 IIHCDLKPSNVLLDD-NMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRV 282
           IIH DLK  N+ +        + D G+A     +  S  +   + T  +MAPE   E + 
Sbjct: 135 IIHRDLKCDNIFITGPTGSVKIGDLGLAT---LKRASFAKA-VIGTPEFMAPEM-YEEKY 189

Query: 283 STNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPISVMEVVDANL 335
             + DVY+FG+ ++E+ T   P  E  +     +R  + + P S  +V    +
Sbjct: 190 DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV 242

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 9e-49
 Identities = 68/217 (31%), Positives = 100/217 (46%), Gaps = 13/217 (5%)

Query: 110 LIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYS 169
            IGKG FG V       G +VAVK      +   ++F  E  VM ++ H NL++++    
Sbjct: 14  TIGKGEFGDVMLGD-YRGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVIV 70

Query: 170 NDDFK-ALVLEYMPHGSLEKCLYLSNY-ILDIFQRLDIMIDVASALEYLHFGYSAPIIHC 227
            +     +V EYM  GSL   L      +L     L   +DV  A+EYL        +H 
Sbjct: 71  EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHR 127

Query: 228 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGD 287
           DL   NVL+ ++ VA +SDFG+ K     + S TQ      + + APE  RE + ST  D
Sbjct: 128 DLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSD 182

Query: 288 VYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLP 324
           V+SFGI+L EI++  +        +  + R       
Sbjct: 183 VWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM 219

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 2e-47
 Identities = 60/227 (26%), Positives = 96/227 (42%), Gaps = 8/227 (3%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
            IG+G  G+VY A+ +  G EVA++  + Q +   +    E  VM+   + N++  + SY
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86

Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCD 228
              D   +V+EY+  GSL   +      +D  Q   +  +   ALE+LH   S  +IH D
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLH---SNQVIHRD 141

Query: 229 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDV 288
           +K  N+LL  +    L+DFG    +  E    +      T  +MAPE           D+
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVG--TPYWMAPEVVTRKAYGPKVDI 199

Query: 289 YSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPISVMEVVDANL 335
           +S GIM +E+     P               N    +   E + A  
Sbjct: 200 WSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF 246

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (403), Expect = 2e-47
 Identities = 60/231 (25%), Positives = 113/231 (48%), Gaps = 10/231 (4%)

Query: 110 LIGKGGFGSVYKAIIQDG-----MEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIK 163
           +IG G FG VYK +++       + VA+K     Y E     F  E  +M +  H N+I+
Sbjct: 14  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 73

Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
           +    S      ++ EYM +G+L+K L   +    + Q + ++  +A+ ++YL    +  
Sbjct: 74  LEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMN 130

Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE-DQSLTQTQTLATIGYMAPEYGREGRV 282
            +H DL   N+L++ N+V  +SDFG+++ L ++ + + T +     I + APE     + 
Sbjct: 131 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKF 190

Query: 283 STNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPISVMEVVDA 333
           ++  DV+SFGI++ E+ T  +      S    +K   +     + M+   A
Sbjct: 191 TSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSA 241

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (402), Expect = 3e-47
 Identities = 55/225 (24%), Positives = 88/225 (39%), Gaps = 13/225 (5%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIIS 166
            IG G +G   K     DG  +  K  D     E   +    E ++++ + H N+++   
Sbjct: 11  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 70

Query: 167 SY--SNDDFKALVLEYMPHGSLEKCLY---LSNYILDIFQRLDIMIDVASALEYLH--FG 219
                 +    +V+EY   G L   +         LD    L +M  +  AL+  H    
Sbjct: 71  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 130

Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
               ++H DLKP+NV LD      L DFG+A+ +L  D S  +     T  YM+PE    
Sbjct: 131 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR-ILNHDTSFAKAFV-GTPYYMSPEQMNR 188

Query: 280 GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLP 324
              +   D++S G +L E+     P    FS +    +       
Sbjct: 189 MSYNEKSDIWSLGCLLYELCALMPPFTA-FSQKELAGKIREGKFR 232

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  160 bits (405), Expect = 3e-47
 Identities = 55/222 (24%), Positives = 89/222 (40%), Gaps = 17/222 (7%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDP---QYEGAFKSFDIECDVMKRICHRNLIKIIS 166
           IG G FG+VY A  +++   VA+K       Q    ++    E   ++++ H N I+   
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82

Query: 167 SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIH 226
            Y  +    LV+EY    + +         L   +   +       L YLH   S  +IH
Sbjct: 83  CYLREHTAWLVMEYCLGSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLH---SHNMIH 138

Query: 227 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEY---GREGRVS 283
            D+K  N+LL +  +  L DFG A  +            + T  +MAPE      EG+  
Sbjct: 139 RDVKAGNILLSEPGLVKLGDFGSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYD 192

Query: 284 TNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPI 325
              DV+S GI  +E+  R  P   + +         N+   +
Sbjct: 193 GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL 234

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (404), Expect = 5e-47
 Identities = 52/256 (20%), Positives = 97/256 (37%), Gaps = 33/256 (12%)

Query: 110 LIGKGGFGSVYKAI------IQDGMEVAVKVFDPQY-EGAFKSFDIECDVMKRIC-HRNL 161
           ++G G FG V  A           ++VAVK+   +      ++   E  +M ++  H N+
Sbjct: 44  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103

Query: 162 IKIISSYSNDDFKALVLEYMPHGSLEKCLY----------------------LSNYILDI 199
           + ++ + +      L+ EY  +G L   L                           +L  
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163

Query: 200 FQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS 259
              L     VA  +E+L        +H DL   NVL+    V  + DFG+A+ ++ +   
Sbjct: 164 EDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220

Query: 260 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV 319
           + +      + +MAPE   EG  +   DV+S+GI+L EIF+           +    + +
Sbjct: 221 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLI 280

Query: 320 NDLLPISVMEVVDANL 335
            +   +         +
Sbjct: 281 QNGFKMDQPFYATEEI 296

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 1e-46
 Identities = 52/199 (26%), Positives = 88/199 (44%), Gaps = 12/199 (6%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKII 165
            +GKG FG+VY A   Q    +A+KV         G       E ++   + H N++++ 
Sbjct: 13  PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 72

Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
             + +     L+LEY P G++ + L   +   D  +    + ++A+AL Y H   S  +I
Sbjct: 73  GYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH---SKRVI 128

Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
           H D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE          
Sbjct: 129 HRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPPEMIEGRMHDEK 184

Query: 286 GDVYSFGIMLMEIFTRTKP 304
            D++S G++  E      P
Sbjct: 185 VDLWSLGVLCYEFLVGKPP 203

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (399), Expect = 1e-46
 Identities = 56/199 (28%), Positives = 95/199 (47%), Gaps = 8/199 (4%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKII 165
           ++G+G F +V  A  +    E A+K+ + ++   E        E DVM R+ H   +K+ 
Sbjct: 15  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 74

Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
            ++ +D+     L Y  +G L K +       D         ++ SALEYLH      II
Sbjct: 75  FTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTAEIVSALEYLH---GKGII 130

Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
           H DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++PE   E     +
Sbjct: 131 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKS 190

Query: 286 GDVYSFGIMLMEIFTRTKP 304
            D+++ G ++ ++     P
Sbjct: 191 SDLWALGCIIYQLVAGLPP 209

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 1e-46
 Identities = 52/220 (23%), Positives = 93/220 (42%), Gaps = 11/220 (5%)

Query: 111 IGKGGFGSVYKAIIQD---GMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKII 165
           +G G FG+V K   Q       VAVK+   +            E +VM+++ +  ++++I
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74

Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
                + +  LV+E    G L K L   N  +     ++++  V+  ++YL     +  +
Sbjct: 75  GICEAESW-MLVMEMAELGPLNKYLQ-QNRHVKDKNIIELVHQVSMGMKYLEE---SNFV 129

Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA-TIGYMAPEYGREGRVST 284
           H DL   NVLL     A +SDFG++K L  ++            + + APE     + S+
Sbjct: 130 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 189

Query: 285 NGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLP 324
             DV+SFG+++ E F+  +       G             
Sbjct: 190 KSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM 229

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 3e-46
 Identities = 60/235 (25%), Positives = 98/235 (41%), Gaps = 21/235 (8%)

Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSN 170
           IGKG FG V++     G EVAVK+F  + E ++   + E      + H N++  I++ + 
Sbjct: 11  IGKGRFGEVWRGK-WRGEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAADNK 68

Query: 171 DDFKA----LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLH-----FGYS 221
           D+       LV +Y  HGSL    YL+ Y + +   + + +  AS L +LH         
Sbjct: 69  DNGTWTQLWLVSDYHEHGSLFD--YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 126

Query: 222 APIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT--QTQTLATIGYMAPEY--- 276
             I H DLK  N+L+  N    ++D G+A        ++       + T  YMAPE    
Sbjct: 127 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 186

Query: 277 ---GREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPISVM 328
               +        D+Y+ G++  EI  R          ++     V     +  M
Sbjct: 187 SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  156 bits (396), Expect = 3e-46
 Identities = 56/217 (25%), Positives = 95/217 (43%), Gaps = 7/217 (3%)

Query: 110 LIGKGGFGSVYKAIIQD-GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
            +G G +G VY+ + +   + VAVK          + F  E  VMK I H NL++++   
Sbjct: 24  KLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVC 82

Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSN-YILDIFQRLDIMIDVASALEYLHFGYSAPIIHC 227
           + +    ++ E+M +G+L   L   N   +     L +   ++SA+EYL        IH 
Sbjct: 83  TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHR 139

Query: 228 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGD 287
           DL   N L+ +N +  ++DFG+++ L+  D           I + APE     + S   D
Sbjct: 140 DLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 198

Query: 288 VYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLP 324
           V++FG++L EI T               +    D   
Sbjct: 199 VWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 235

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  156 bits (396), Expect = 4e-46
 Identities = 56/244 (22%), Positives = 97/244 (39%), Gaps = 33/244 (13%)

Query: 111 IGKGGFGSVYKAI------IQDGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIK 163
           IG+G FG V++A        +    VAVK+   +        F  E  +M    + N++K
Sbjct: 21  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 80

Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLY-----------------------LSNYILDIF 200
           ++   +      L+ EYM +G L + L                             L   
Sbjct: 81  LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 140

Query: 201 QRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL 260
           ++L I   VA+ + YL        +H DL   N L+ +NMV  ++DFG+++ +   D   
Sbjct: 141 EQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 197

Query: 261 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN 320
                   I +M PE     R +T  DV+++G++L EIF+         + E  +    +
Sbjct: 198 ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRD 257

Query: 321 DLLP 324
             + 
Sbjct: 258 GNIL 261

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 7e-46
 Identities = 53/253 (20%), Positives = 95/253 (37%), Gaps = 28/253 (11%)

Query: 110 LIGKGGFGSVYKAII------QDGMEVAVKVFDP-QYEGAFKSFDIECDVMKRIC-HRNL 161
            +G G FG V +A           M VAVK+  P  +    ++   E  V+  +  H N+
Sbjct: 30  TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89

Query: 162 IKIISSYSNDDFKALVLEYMPHGSLEKCLY-----------------LSNYILDIFQRLD 204
           + ++ + +      ++ EY  +G L   L                       LD+   L 
Sbjct: 90  VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149

Query: 205 IMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ 264
               VA  + +L    S   IH DL   N+LL    +  + DFG+A+ +  +   + +  
Sbjct: 150 FSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206

Query: 265 TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLP 324
               + +MAPE       +   DV+S+GI L E+F+           +    + + +   
Sbjct: 207 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFR 266

Query: 325 ISVMEVVDANLLS 337
           +   E   A +  
Sbjct: 267 MLSPEHAPAEMYD 279

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  157 bits (398), Expect = 9e-46
 Identities = 43/198 (21%), Positives = 81/198 (40%), Gaps = 9/198 (4%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
            +G G FG V++      G   A K     +E   ++   E   M  + H  L+ +  ++
Sbjct: 33  ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92

Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCD 228
            +D+   ++ E+M  G L + +   +  +   + ++ M  V   L ++H       +H D
Sbjct: 93  EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLD 149

Query: 229 LKPSNVLL--DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNG 286
           LKP N++     +    L DFG+   L  +      T T     + APE      V    
Sbjct: 150 LKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTA---EFAAPEVAEGKPVGYYT 206

Query: 287 DVYSFGIMLMEIFTRTKP 304
           D++S G++   + +   P
Sbjct: 207 DMWSVGVLSYILLSGLSP 224

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  156 bits (395), Expect = 2e-45
 Identities = 43/198 (21%), Positives = 85/198 (42%), Gaps = 9/198 (4%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
            +G G FG V++ +    G     K  +  Y     +   E  +M ++ H  LI +  ++
Sbjct: 36  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95

Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCD 228
            +     L+LE++  G L   +   +Y +   + ++ M      L+++H      I+H D
Sbjct: 96  EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLD 152

Query: 229 LKPSNVLLD--DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNG 286
           +KP N++ +        + DFG+A  L  ++       T AT  + APE      V    
Sbjct: 153 IKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYT 209

Query: 287 DVYSFGIMLMEIFTRTKP 304
           D+++ G++   + +   P
Sbjct: 210 DMWAIGVLGYVLLSGLSP 227

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (389), Expect = 5e-45
 Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 11/224 (4%)

Query: 110 LIGKGGFGSVYKAIIQD----GMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKI 164
           +IG+G FG VY   + D     +  AVK  +     G    F  E  +MK   H N++ +
Sbjct: 34  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93

Query: 165 ISSYSNDDFKA-LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
           +      +    +VL YM HG L   +    +   +   +   + VA  +++L       
Sbjct: 94  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KK 150

Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL--EEDQSLTQTQTLATIGYMAPEYGREGR 281
            +H DL   N +LD+     ++DFG+A+ +   E D    +T     + +MA E  +  +
Sbjct: 151 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK 210

Query: 282 VSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPI 325
            +T  DV+SFG++L E+ TR  P     +        +     +
Sbjct: 211 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL 254

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 2e-44
 Identities = 59/235 (25%), Positives = 91/235 (38%), Gaps = 12/235 (5%)

Query: 111 IGKGGFGSVYKAII----QDGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIK 163
           +G G FG V +          + VAVK   P       A   F  E + M  + HRNLI+
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75

Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
           +         K +V E  P GSL   L        +       + VA  + YL    S  
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKR 131

Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE-EDQSLTQTQTLATIGYMAPEYGREGRV 282
            IH DL   N+LL    +  + DFG+ + L + +D  + Q        + APE  +    
Sbjct: 132 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF 191

Query: 283 STNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPISVMEVVDANLLS 337
           S   D + FG+ L E+FT  +      +G   L +   +   +   E    ++ +
Sbjct: 192 SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYN 246

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 1e-43
 Identities = 53/220 (24%), Positives = 96/220 (43%), Gaps = 10/220 (4%)

Query: 110 LIGKGGFGSVYKAII----QDGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKI 164
            IG+G FG V++ I        + VA+K       +   + F  E   M++  H +++K+
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73

Query: 165 ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPI 224
           I   + ++   +++E    G L   L +  Y LD+   +     +++AL YL    S   
Sbjct: 74  IGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRF 129

Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVST 284
           +H D+   NVL+  N    L DFG+++  +E+      ++    I +MAPE     R ++
Sbjct: 130 VHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFTS 188

Query: 285 NGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLP 324
             DV+ FG+ + EI        +       + R  N    
Sbjct: 189 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL 228

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  149 bits (376), Expect = 2e-43
 Identities = 54/226 (23%), Positives = 99/226 (43%), Gaps = 13/226 (5%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKII 165
           ++G GG   V+ A  ++   +VAVKV           +  F  E      + H  ++ + 
Sbjct: 14  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73

Query: 166 SSYSNDDFKA----LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYS 221
            +   +        +V+EY+   +L   ++     +   + ++++ D   AL + H    
Sbjct: 74  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQALNFSH---Q 129

Query: 222 APIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA-TIGYMAPEYGREG 280
             IIH D+KP+N+++       + DFG+A+ + +   S+TQT  +  T  Y++PE  R  
Sbjct: 130 NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 189

Query: 281 RVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPIS 326
            V    DVYS G +L E+ T   P        +  +    D +P S
Sbjct: 190 SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS 235

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 5e-43
 Identities = 52/230 (22%), Positives = 100/230 (43%), Gaps = 19/230 (8%)

Query: 111 IGKGGFGSVYKAI------IQDGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIK 163
           +G+G FG VY+ +       +    VA+K  +          F  E  VMK     ++++
Sbjct: 28  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 87

Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYI---------LDIFQRLDIMIDVASALE 214
           ++   S      +++E M  G L+  L                 + + + +  ++A  + 
Sbjct: 88  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 147

Query: 215 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 274
           YL+   +   +H DL   N ++ ++    + DFGM + + E D      + L  + +M+P
Sbjct: 148 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 204

Query: 275 EYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLP 324
           E  ++G  +T  DV+SFG++L EI T  +   +  S E  L+  +   L 
Sbjct: 205 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 254

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (375), Expect = 6e-43
 Identities = 60/235 (25%), Positives = 105/235 (44%), Gaps = 26/235 (11%)

Query: 110 LIGKGGFGSVYKAIIQDG---MEVAVKVFDPQY-EGAFKSFDIECDVMKRIC-HRNLIKI 164
           +IG+G FG V KA I+     M+ A+K       +   + F  E +V+ ++  H N+I +
Sbjct: 17  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 76

Query: 165 ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYI---------------LDIFQRLDIMIDV 209
           + +  +  +  L +EY PHG+L   L  S  +               L   Q L    DV
Sbjct: 77  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 136

Query: 210 ASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATI 269
           A  ++YL        IH DL   N+L+ +N VA ++DFG+++    ++  + +T     +
Sbjct: 137 ARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPV 190

Query: 270 GYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLP 324
            +MA E       +TN DV+S+G++L EI +         +     ++       
Sbjct: 191 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL 245

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 6e-42
 Identities = 48/221 (21%), Positives = 88/221 (39%), Gaps = 10/221 (4%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKV-----FDPQYEGAFKSFDIECDVMKRICHRNLIK 163
           ++G G FG+VYK + I +G +V + V      +     A K    E  VM  + + ++ +
Sbjct: 16  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 75

Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
           ++        + L+ + MP G L   +      +     L+  + +A  + YL       
Sbjct: 76  LLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RR 131

Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVS 283
           ++H DL   NVL+       ++DFG+AK L  E++          I +MA E       +
Sbjct: 132 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 191

Query: 284 TNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLP 324
              DV+S+G+ + E+ T      +                 
Sbjct: 192 HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 232

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 7e-40
 Identities = 61/240 (25%), Positives = 96/240 (40%), Gaps = 28/240 (11%)

Query: 110 LIGKGGFGSVYKAI--------IQDGMEVAVKVFDPQY-EGAFKSFDIECDVMKRIC-HR 159
            +G+G FG V  A              +VAVK+      E        E ++MK I  H+
Sbjct: 20  PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79

Query: 160 NLIKIISSYSNDDFKALVLEYMPHGSLEKCL---------------YLSNYILDIFQRLD 204
           N+I ++ + + D    +++EY   G+L + L               +     L     + 
Sbjct: 80  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 139

Query: 205 IMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ 264
               VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ +   D     T 
Sbjct: 140 CAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196

Query: 265 TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLP 324
               + +MAPE   +   +   DV+SFG++L EIFT           E   K        
Sbjct: 197 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRM 256

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 1e-39
 Identities = 40/198 (20%), Positives = 83/198 (41%), Gaps = 10/198 (5%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
            +G+G FG V++ +          K    +          E  ++    HRN++ +  S+
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-VLVKKEISILNIARHRNILHLHESF 70

Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCD 228
            + +   ++ E++    + + +  S + L+  + +  +  V  AL++LH   S  I H D
Sbjct: 71  ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFD 127

Query: 229 LKPSNVLLD--DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNG 286
           ++P N++     +    + +FG A+ L                 Y APE  +   VST  
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQL---KPGDNFRLLFTAPEYYAPEVHQHDVVSTAT 184

Query: 287 DVYSFGIMLMEIFTRTKP 304
           D++S G ++  + +   P
Sbjct: 185 DMWSLGTLVYVLLSGINP 202

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  139 bits (350), Expect = 4e-39
 Identities = 54/199 (27%), Positives = 90/199 (45%), Gaps = 13/199 (6%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKII 165
            +G G FG V+      +G   A+KV   +        +  + E  ++  + H  +I++ 
Sbjct: 11  TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 70

Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
            ++ +     ++++Y+  G L   L  S              +V  ALEYLH   S  II
Sbjct: 71  GTFQDAQQIFMIMDYIEGGELFSLLRKSQRF-PNPVAKFYAAEVCLALEYLH---SKDII 126

Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
           + DLKP N+LLD N    ++DFG AK + +   +L       T  Y+APE       + +
Sbjct: 127 YRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCG-----TPDYIAPEVVSTKPYNKS 181

Query: 286 GDVYSFGIMLMEIFTRTKP 304
            D +SFGI++ E+     P
Sbjct: 182 IDWWSFGILIYEMLAGYTP 200

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  136 bits (344), Expect = 1e-38
 Identities = 56/212 (26%), Positives = 94/212 (44%), Gaps = 24/212 (11%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDI---------ECDVMKRI-CH 158
           ++G+G    V + I      E AVK+ D    G+F + ++         E D+++++  H
Sbjct: 10  ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 69

Query: 159 RNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHF 218
            N+I++  +Y  + F  LV + M  G L   L      L   +   IM  +   +  LH 
Sbjct: 70  PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT-EKVTLSEKETRKIMRALLEVICALH- 127

Query: 219 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGR 278
                I+H DLKP N+LLDD+M   L+DFG +  L   D      +   T  Y+APE   
Sbjct: 128 --KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGEKLREVCGTPSYLAPEIIE 182

Query: 279 EGRVSTNG------DVYSFGIMLMEIFTRTKP 304
                 +       D++S G+++  +   + P
Sbjct: 183 CSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 214

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  137 bits (346), Expect = 1e-38
 Identities = 45/197 (22%), Positives = 78/197 (39%), Gaps = 6/197 (3%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISS 167
           ++G G F  V  A   +    VA+K    +  EG   S + E  V+ +I H N++ +   
Sbjct: 16  VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI 75

Query: 168 YSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHC 227
           Y +     L+++ +  G L   +              ++  V  A++YLH          
Sbjct: 76  YESGGHLYLIMQLVSGGELFDRIV-EKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLK 134

Query: 228 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGD 287
                   LD++    +SDFG++K    ED     +    T GY+APE   +   S   D
Sbjct: 135 PENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVD 191

Query: 288 VYSFGIMLMEIFTRTKP 304
            +S G++   +     P
Sbjct: 192 CWSIGVIAYILLCGYPP 208

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 2e-38
 Identities = 50/252 (19%), Positives = 94/252 (37%), Gaps = 27/252 (10%)

Query: 110 LIGKGGFGSVYKAI------IQDGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLI 162
            +G+G FG V +A             VAVK+          ++   E  ++  I H   +
Sbjct: 20  PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79

Query: 163 KII--SSYSNDDFKALVLEYMPHGSLEKCLY---------------LSNYILDIFQRLDI 205
             +  +         +++E+   G+L   L                L    L +   +  
Sbjct: 80  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139

Query: 206 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 265
              VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+ + ++   + +   
Sbjct: 140 SFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 196

Query: 266 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPI 325
              + +MAPE   +   +   DV+SFG++L EIF+           +    R + +   +
Sbjct: 197 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 256

Query: 326 SVMEVVDANLLS 337
              +     +  
Sbjct: 257 RAPDYTTPEMYQ 268

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 1e-37
 Identities = 50/200 (25%), Positives = 88/200 (44%), Gaps = 11/200 (5%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFDPQY---EGAFKSFDIECDVMKRIC-HRNLIKI 164
           ++GKG FG V+ A   +     A+K         +   +   +E  V+     H  L  +
Sbjct: 9   MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 68

Query: 165 ISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPI 224
             ++   +    V+EY+  G L   +  S +  D+ +      ++   L++LH   S  I
Sbjct: 69  FCTFQTKENLFFVMEYLNGGDLMYHIQ-SCHKFDLSRATFYAAEIILGLQFLH---SKGI 124

Query: 225 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVST 284
           ++ DLK  N+LLD +    ++DFGM K  +  D          T  Y+APE     + + 
Sbjct: 125 VYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNH 182

Query: 285 NGDVYSFGIMLMEIFTRTKP 304
           + D +SFG++L E+     P
Sbjct: 183 SVDWWSFGVLLYEMLIGQSP 202

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  135 bits (341), Expect = 2e-37
 Identities = 51/234 (21%), Positives = 100/234 (42%), Gaps = 16/234 (6%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFDP------QYEGAFKSFDIECDVMKRICHRNLI 162
           +IG+GGFG VY       G   A+K  D       Q E    +  I   ++       ++
Sbjct: 11  IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 70

Query: 163 KIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSA 222
            +  ++   D  + +L+ M  G L   L   + +           ++   LE++H   + 
Sbjct: 71  CMSYAFHTPDKLSFILDLMNGGDLHYHLS-QHGVFSEADMRFYAAEIILGLEHMH---NR 126

Query: 223 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGR- 281
            +++ DLKP+N+LLD++    +SD G+A    ++        ++ T GYMAPE  ++G  
Sbjct: 127 FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASVGTHGYMAPEVLQKGVA 182

Query: 282 VSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPISVMEVVDANL 335
             ++ D +S G ML ++     P  +  + +      +   + + + +     L
Sbjct: 183 YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL 236

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (334), Expect = 5e-37
 Identities = 55/202 (27%), Positives = 96/202 (47%), Gaps = 13/202 (6%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFDPQY-----EGAFKSFDIECDVMKRICHRNLIK 163
            +G+G F +VYKA        VA+K     +     +G  ++   E  +++ + H N+I 
Sbjct: 5   FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64

Query: 164 IISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP 223
           ++ ++ +    +LV ++M        +  ++ +L        M+     LEYLH      
Sbjct: 65  LLDAFGHKSNISLVFDFMETDLE-VIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHW 120

Query: 224 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRV- 282
           I+H DLKP+N+LLD+N V  L+DFG+AK     ++    T  + T  Y APE     R+ 
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMY 178

Query: 283 STNGDVYSFGIMLMEIFTRTKP 304
               D+++ G +L E+  R   
Sbjct: 179 GVGVDMWAVGCILAELLLRVPF 200

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 2e-36
 Identities = 56/238 (23%), Positives = 96/238 (40%), Gaps = 21/238 (8%)

Query: 100 PLPNDANMPPLIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAF------KSFDIECDV 152
           PL +   + PL+G GGFGSVY  I + D + VA+K  +      +          +E  +
Sbjct: 1   PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVL 60

Query: 153 MKRI--CHRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVA 210
           +K++      +I+++  +   D   L+LE                 L           V 
Sbjct: 61  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVL 120

Query: 211 SALEYLHFGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATI 269
            A+ + H   +  ++H D+K  N+L+D +     L DFG    L +       T    T 
Sbjct: 121 EAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTR 173

Query: 270 GYMAPEYGREGRVSTNG-DVYSFGIMLMEIFTRTKP---TDEIFSGEMTLKRWVNDLL 323
            Y  PE+ R  R       V+S GI+L ++     P    +EI  G++  ++ V+   
Sbjct: 174 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSEC 231

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 3e-36
 Identities = 49/206 (23%), Positives = 82/206 (39%), Gaps = 18/206 (8%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFDPQY------EGAFKSFDIECDVMKRICHRNLI 162
            +G G F  V K      G++ A K    +         + +  + E  ++K I H N+I
Sbjct: 17  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76

Query: 163 KIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSA 222
            +   Y N     L+LE +  G L          L   +  + +  + + + YLH   S 
Sbjct: 77  TLHEVYENKTDVILILELVAGGELFDF-LAEKESLTEEEATEFLKQILNGVYYLH---SL 132

Query: 223 PIIHCDLKPSNVLLDDNMVA----HLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGR 278
            I H DLKP N++L D  V      + DFG+A  +   D          T  ++APE   
Sbjct: 133 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEFVAPEIVN 189

Query: 279 EGRVSTNGDVYSFGIMLMEIFTRTKP 304
              +    D++S G++   + +   P
Sbjct: 190 YEPLGLEADMWSIGVITYILLSGASP 215

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 4e-36
 Identities = 45/205 (21%), Positives = 85/205 (41%), Gaps = 21/205 (10%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRIC-HRNLIKII-- 165
           ++G G  G V +    +   + A+K+              E ++  R     ++++I+  
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDV 73

Query: 166 --SSYSNDDFKALVLEYMPHGSLEKCLY-LSNYILDIFQRLDIMIDVASALEYLHFGYSA 222
             + Y+      +V+E +  G L   +    +      +  +IM  +  A++YLH   S 
Sbjct: 74  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SI 130

Query: 223 PIIHCDLKPSNVLLD---DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
            I H D+KP N+L      N +  L+DFG AK     +   T      T  Y+APE    
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEVLGP 187

Query: 280 GRVSTNGDVYSFGIMLMEIFTRTKP 304
            +   + D++S G+++  +     P
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYPP 212

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  129 bits (324), Expect = 2e-35
 Identities = 51/243 (20%), Positives = 82/243 (33%), Gaps = 14/243 (5%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
            IG G FG +Y    I  G EVA+K+     +       IE  + K +     I  I   
Sbjct: 14  KIGSGSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVGIPTIRWC 71

Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCD 228
             +    +++  +   SLE      +    +   L +   + S +EY+H   S   IH D
Sbjct: 72  GAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRD 128

Query: 229 LKPSNVL---LDDNMVAHLSDFGMAKPLLEED-----QSLTQTQTLATIGYMAPEYGREG 280
           +KP N L        + ++ DFG+AK   +                 T  Y +       
Sbjct: 129 VKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI 188

Query: 281 RVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPISVMEVVDANLLSQED 340
             S   D+ S G +LM     + P   + +     K        +S    V       E 
Sbjct: 189 EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEF 248

Query: 341 EHF 343
             +
Sbjct: 249 ATY 251

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 2e-35
 Identities = 53/201 (26%), Positives = 90/201 (44%), Gaps = 9/201 (4%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFDP-QYEGAFKSFDIECDVMKRICHRNLIKIISS 167
            IG+G +G V  A    + + VA+K   P +++   +    E  ++ R  H N+I I   
Sbjct: 15  YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 74

Query: 168 YSNDDFKALVLEYMPHGSLEKCLY--LSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
                 + +   Y+    +   LY  L    L        +  +   L+Y+H   SA ++
Sbjct: 75  IRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVL 131

Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLL-EEDQSLTQTQTLATIGYMAPEYGREGRVST 284
           H DLKPSN+LL+      + DFG+A+    + D +   T+ +AT  Y APE     +  T
Sbjct: 132 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 191

Query: 285 N-GDVYSFGIMLMEIFTRTKP 304
              D++S G +L E+ +    
Sbjct: 192 KSIDIWSVGCILAEMLSNRPI 212

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 2e-35
 Identities = 53/199 (26%), Positives = 91/199 (45%), Gaps = 9/199 (4%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVF--DPQYEGAFKSFDIECDVMKRICHRNLIKIIS 166
            IG+G +G VYKA     G  VA+K    D + EG   +   E  ++K + H N++K++ 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68

Query: 167 SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIH 226
               ++   LV E++     +     +   + +      +  +   L + H   S  ++H
Sbjct: 69  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 125

Query: 227 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE-YGREGRVSTN 285
            DLKP N+L++      L+DFG+A+      +  T T  + T+ Y APE        ST 
Sbjct: 126 RDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTA 183

Query: 286 GDVYSFGIMLMEIFTRTKP 304
            D++S G +  E+ TR   
Sbjct: 184 VDIWSLGCIFAEMVTRRAL 202

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  127 bits (319), Expect = 4e-35
 Identities = 50/197 (25%), Positives = 89/197 (45%), Gaps = 9/197 (4%)

Query: 111 IGKGGFGSVYKAIIQDGMEVAVKVFDP--QYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
           IG+G +G VYKA    G   A+K      + EG   +   E  ++K + H N++K+    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69

Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCD 228
                  LV E++    L+K L +    L+       ++ + + + Y H      ++H D
Sbjct: 70  HTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRD 125

Query: 229 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE-YGREGRVSTNGD 287
           LKP N+L++      ++DFG+A+      +    T  + T+ Y AP+      + ST  D
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTID 183

Query: 288 VYSFGIMLMEIFTRTKP 304
           ++S G +  E+   T  
Sbjct: 184 IWSVGCIFAEMVNGTPL 200

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 2e-34
 Identities = 54/206 (26%), Positives = 92/206 (44%), Gaps = 18/206 (8%)

Query: 111 IGKGGFGSVYKA--IIQDGMEVAVKVFDPQY--EGAFKSFDIECDVMKRIC---HRNLIK 163
           IG+G +G V+KA  +   G  VA+K    Q   EG   S   E  V++ +    H N+++
Sbjct: 15  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 74

Query: 164 II-----SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHF 218
           +      S    +    LV E++          +    +      D+M  +   L++LH 
Sbjct: 75  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH- 133

Query: 219 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGR 278
             S  ++H DLKP N+L+  +    L+DFG+A+        +  T  + T+ Y APE   
Sbjct: 134 --SHRVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMALTSVVVTLWYRAPEVLL 188

Query: 279 EGRVSTNGDVYSFGIMLMEIFTRTKP 304
           +   +T  D++S G +  E+F R   
Sbjct: 189 QSSYATPVDLWSVGCIFAEMFRRKPL 214

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (311), Expect = 2e-33
 Identities = 47/199 (23%), Positives = 83/199 (41%), Gaps = 10/199 (5%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKII 165
           L+GKG FG V        G   A+K+   +    +        E  V++   H  L  + 
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71

Query: 166 SSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
            ++   D    V+EY   G L   L     +    +      ++ SALEYLH   S  ++
Sbjct: 72  YAFQTHDRLCFVMEYANGGELFFHLS-RERVFTEERARFYGAEIVSALEYLH---SRDVV 127

Query: 226 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTN 285
           + D+K  N++LD +    ++DFG+ K  + +  ++       T  Y+APE   +      
Sbjct: 128 YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYLAPEVLEDNDYGRA 185

Query: 286 GDVYSFGIMLMEIFTRTKP 304
            D +  G+++ E+     P
Sbjct: 186 VDWWGLGVVMYEMMCGRLP 204

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (311), Expect = 3e-33
 Identities = 52/205 (25%), Positives = 86/205 (41%), Gaps = 19/205 (9%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
           +IG G FG VY+A     G  VA+K          +  + E  +M+++ H N++++   +
Sbjct: 27  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFF 82

Query: 169 ------SNDDFKALVLEYMPHGSLEKCLYLS--NYILDIFQRLDIMIDVASALEYLHFGY 220
                  ++ +  LVL+Y+P        + S     L +      M  +  +L Y+H   
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH--- 139

Query: 221 SAPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGRE 279
           S  I H D+KP N+LLD D  V  L DFG AK L         +   +            
Sbjct: 140 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRYYRAPELIFGA 197

Query: 280 GRVSTNGDVYSFGIMLMEIFTRTKP 304
              +++ DV+S G +L E+      
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQPI 222

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  121 bits (305), Expect = 6e-33
 Identities = 34/202 (16%), Positives = 70/202 (34%), Gaps = 16/202 (7%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
            IG+G FG +++   + +  +VA+K    + +        E    K +     I  +  +
Sbjct: 12  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYF 69

Query: 169 SNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCD 228
             +    +++  +   SLE  L L      +         + + ++ +H      +++ D
Sbjct: 70  GQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRD 126

Query: 229 LKPSNVLLDDNMVAH-----LSDFGMAKPLLEEDQSLTQ-----TQTLATIGYMAPEYGR 278
           +KP N L+      +     + DFGM K   +                 T  YM+     
Sbjct: 127 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHL 186

Query: 279 EGRVSTNGDVYSFGIMLMEIFT 300
               S   D+ + G + M    
Sbjct: 187 GREQSRRDDLEALGHVFMYFLR 208

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (304), Expect = 7e-33
 Identities = 51/236 (21%), Positives = 97/236 (41%), Gaps = 10/236 (4%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQ--YEGAFKSFDIECDVMKRICHRNLIKIISS 167
           IG+G +G+V+KA   +    VA+K        EG   S   E  ++K + H+N++++   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69

Query: 168 YSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHC 227
             +D    LV E+      +     +  + D       +  +   L + H      ++H 
Sbjct: 70  LHSDKKLTLVFEFCDQDLKKYFDSCNGDL-DPEIVKSFLFQLLKGLGFCHS---RNVLHR 125

Query: 228 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPE-YGREGRVSTNG 286
           DLKP N+L++ N    L++FG+A+      +    +  + T+ Y  P+        ST+ 
Sbjct: 126 DLKPQNLLINRNGELKLANFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSI 183

Query: 287 DVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPISVMEVVDANLLSQEDEH 342
           D++S G +  E+    +P       +  LKR    L   +  +      L     +
Sbjct: 184 DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  122 bits (307), Expect = 1e-32
 Identities = 46/198 (23%), Positives = 81/198 (40%), Gaps = 13/198 (6%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKIIS 166
           +G G FG V      + G   A+K+ D Q        +    E  +++ +    L+K+  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108

Query: 167 SYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIH 226
           S+ ++    +V+EY+  G +   L                  +    EYLH   S  +I+
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQIVLTFEYLH---SLDLIY 164

Query: 227 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNG 286
            DLKP N+L+D      ++DFG AK +     +L       T   +APE       +   
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCG-----TPEALAPEIILSKGYNKAV 219

Query: 287 DVYSFGIMLMEIFTRTKP 304
           D ++ G+++ E+     P
Sbjct: 220 DWWALGVLIYEMAAGYPP 237

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (300), Expect = 6e-32
 Identities = 51/208 (24%), Positives = 90/208 (43%), Gaps = 18/208 (8%)

Query: 111 IGKGGFGSVYKAI-IQDGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISS 167
           IG+G FG V+KA   + G +VA+K    +   EG   +   E  +++ + H N++ +I  
Sbjct: 18  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 77

Query: 168 YSNDDFKA--------LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFG 219
                           LV ++  H            +L  F   +I   +   L  L++ 
Sbjct: 78  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN----VLVKFTLSEIKRVMQMLLNGLYYI 133

Query: 220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT--LATIGYMAPEYG 277
           +   I+H D+K +NVL+  + V  L+DFG+A+       S     T  + T+ Y  PE  
Sbjct: 134 HRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELL 193

Query: 278 REGR-VSTNGDVYSFGIMLMEIFTRTKP 304
              R      D++  G ++ E++TR+  
Sbjct: 194 LGERDYGPPIDLWGAGCIMAEMWTRSPI 221

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  115 bits (288), Expect = 4e-30
 Identities = 51/229 (22%), Positives = 99/229 (43%), Gaps = 19/229 (8%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRI-CHRNLIKIISS 167
            +G+G +  V++AI I +  +V VK+  P  +   K    E  +++ +    N+I +   
Sbjct: 42  KLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPNIITLADI 98

Query: 168 YSNDDFK--ALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPII 225
             +   +  ALV E++ +   ++        L  +     M ++  AL+Y H   S  I+
Sbjct: 99  VKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCH---SMGIM 151

Query: 226 HCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGR-VS 283
           H D+KP NV++D ++    L D+G+A+              +A+  +  PE   + +   
Sbjct: 152 HRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELLVDYQMYD 208

Query: 284 TNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPISVMEVVD 332
            + D++S G ML  +  R +P          L R    L    + + +D
Sbjct: 209 YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 257

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (282), Expect = 3e-29
 Identities = 44/204 (21%), Positives = 88/204 (43%), Gaps = 19/204 (9%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIIS 166
            +G G +G+V  A+  + G +VA+K     +  E   K    E  ++K + H N+I ++ 
Sbjct: 25  PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84

Query: 167 SYSNDDFKA------LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGY 220
            ++ D+         LV+ +M     +    + +  L   +   ++  +   L Y+H   
Sbjct: 85  VFTPDETLDDFTDFYLVMPFMGTDLGK---LMKHEKLGEDRIQFLVYQMLKGLRYIH--- 138

Query: 221 SAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREG 280
           +A IIH DLKP N+ ++++    + DFG+A+    +  S      +              
Sbjct: 139 AAGIIHRDLKPGNLAVNEDCELKILDFGLAR----QADSEMTGYVVTRWYRAPEVILNWM 194

Query: 281 RVSTNGDVYSFGIMLMEIFTRTKP 304
           R +   D++S G ++ E+ T    
Sbjct: 195 RYTQTVDIWSVGCIMAEMITGKTL 218

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (278), Expect = 8e-29
 Identities = 51/206 (24%), Positives = 87/206 (42%), Gaps = 16/206 (7%)

Query: 110 LIGKGGFGSVYKAI----IQDGMEVAVKVFDP----QYEGAFKSFDIECDVMKRICHR-N 160
           ++G G +G V+          G   A+KV       Q     +    E  V++ I     
Sbjct: 31  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 90

Query: 161 LIKIISSYSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGY 220
           L+ +  ++  +    L+L+Y+  G L   L         F   ++ I V   +  L   +
Sbjct: 91  LVTLHYAFQTETKLHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIVLALEHLH 146

Query: 221 SAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREG 280
              II+ D+K  N+LLD N    L+DFG++K  + ++          TI YMAP+  R G
Sbjct: 147 KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC-GTIEYMAPDIVRGG 205

Query: 281 RVSTNG--DVYSFGIMLMEIFTRTKP 304
               +   D +S G+++ E+ T   P
Sbjct: 206 DSGHDKAVDWWSLGVLMYELLTGASP 231

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (266), Expect = 5e-27
 Identities = 51/204 (25%), Positives = 85/204 (41%), Gaps = 19/204 (9%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIIS 166
            IG G  G V  A        VA+K     +  +   K    E  +MK + H+N+I +++
Sbjct: 24  PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83

Query: 167 SYSNDDFK------ALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGY 220
            ++            LV+E M     +         LD  +   ++  +   +++LH   
Sbjct: 84  VFTPQKTLEEFQDVYLVMELMDANLCQVI----QMELDHERMSYLLYQMLCGIKHLH--- 136

Query: 221 SAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREG 280
           SA IIH DLKPSN+++  +    + DFG+A+       S   T  + T  Y APE     
Sbjct: 137 SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGM 193

Query: 281 RVSTNGDVYSFGIMLMEIFTRTKP 304
               N D++S G ++ E+      
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHKIL 217

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (255), Expect = 2e-25
 Identities = 46/202 (22%), Positives = 83/202 (41%), Gaps = 15/202 (7%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIIS 166
            +G G +GSV  A   + G+ VAVK     +      K    E  ++K + H N+I ++ 
Sbjct: 25  PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84

Query: 167 SYSND----DFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSA 222
            ++      +F  + L     G+    +      L       ++  +   L+Y+H   SA
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIH---SA 140

Query: 223 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRV 282
            IIH DLKPSN+ ++++    + DFG+A+   +E      T                   
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT----RWYRAPEIMLNWMHY 196

Query: 283 STNGDVYSFGIMLMEIFTRTKP 304
           +   D++S G ++ E+ T    
Sbjct: 197 NQTVDIWSVGCIMAELLTGRTL 218

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  102 bits (255), Expect = 2e-25
 Identities = 41/212 (19%), Positives = 80/212 (37%), Gaps = 20/212 (9%)

Query: 110 LIGKGGFGSVYKAI-IQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSY 168
            +G G F +V+ A  + +   VA+K+     +   ++ + E  +++R+   +  K  S  
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMG 78

Query: 169 SNDDFK---------------ALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASAL 213
           +N   K                +V E +    L       +  + +     I   +   L
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 214 EYLHFGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYM 272
           +Y+H      IIH D+KP NVL++  +   +L    +A            T ++ T  Y 
Sbjct: 139 DYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196

Query: 273 APEYGREGRVSTNGDVYSFGIMLMEIFTRTKP 304
           +PE           D++S   ++ E+ T    
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFL 228

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 86.0 bits (212), Expect = 1e-20
 Identities = 26/162 (16%), Positives = 55/162 (33%), Gaps = 26/162 (16%)

Query: 110 LIGKGGFGSVYKAIIQDGMEVAVKVFDP----------QYEGAFKSFDIECDVMKRICHR 159
           L+G+G   +V+    +   E  VK              + +     F +      R   R
Sbjct: 7   LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66

Query: 160 NLIKIISSYSNDDF----KALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEY 215
            L K+        +     A+++E +    L +          +    +++  +   +  
Sbjct: 67  ALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV--------RVENPDEVLDMILEEVAK 118

Query: 216 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED 257
            +      I+H DL   NVL+ +  +  + DF  +  + EE 
Sbjct: 119 FY---HRGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEG 156

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 74.0 bits (180), Expect = 2e-15
 Identities = 26/61 (42%), Positives = 36/61 (59%)

Query: 18  NLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNELLCEIVL 77
           +L NN + GT+P  L +L  L  +NVSFN L GEIP+ G  +   V ++  N+ LC   L
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPL 309

Query: 78  P 78
           P
Sbjct: 310 P 310

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 45.4 bits (106), Expect = 6e-06
 Identities = 11/47 (23%), Positives = 21/47 (44%), Gaps = 2/47 (4%)

Query: 7   SIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIP 53
            +  L  L+ L  +NN +S     SL  L ++  ++   N++    P
Sbjct: 324 PVSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP 368

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 43.5 bits (101), Expect = 2e-05
 Identities = 9/44 (20%), Positives = 21/44 (47%), Gaps = 2/44 (4%)

Query: 3   SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFN 46
           S   S+ +L N+  L+  +N +S   P++   L  +  + ++  
Sbjct: 342 SDVSSLANLTNINWLSAGHNQISDLTPLA--NLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.8 bits (94), Expect = 2e-04
 Identities = 17/61 (27%), Positives = 28/61 (45%), Gaps = 3/61 (4%)

Query: 11  LINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNE 70
           L NL  L L  NN+S   P+S   L  L+ +  + NK+   +       N++  S   N+
Sbjct: 306 LKNLTYLTLYFNNISDISPVS--SLTKLQRLFFANNKVSD-VSSLANLTNINWLSAGHNQ 362

Query: 71  L 71
           +
Sbjct: 363 I 363

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.1 bits (87), Expect = 0.001
 Identities = 14/34 (41%), Positives = 20/34 (58%), Gaps = 1/34 (2%)

Query: 6  DSIGDLINLKSLNLSNNNLSGTIPIS-LEKLLDL 38
          D +  L NL  +N SNN L+   P+  L KL+D+
Sbjct: 60 DGVEYLNNLTQINFSNNQLTDITPLKNLTKLVDI 93

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 37.7 bits (86), Expect = 0.002
 Identities = 14/47 (29%), Positives = 21/47 (44%), Gaps = 2/47 (4%)

Query: 7  SIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIP 53
          S  DL  + +L      +  +I   +E L +L  IN S N+L    P
Sbjct: 39 SQTDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDITP 83

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 41.6 bits (96), Expect = 7e-05
 Identities = 14/70 (20%), Positives = 26/70 (37%), Gaps = 3/70 (4%)

Query: 3  SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNL 61
           +P  +    +   L+L NN ++       + L +L  + +  NK+    P    P   L
Sbjct: 24 KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81

Query: 62 SVKSFEGNEL 71
                 N+L
Sbjct: 82 ERLYLSKNQL 91

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 38.5 bits (88), Expect = 8e-04
 Identities = 13/67 (19%), Positives = 27/67 (40%), Gaps = 6/67 (8%)

Query: 5   PDSIGDLINLKSLNLSNNNLSG------TIPISLEKLLDLKDINVSFNKLEGEIPREGPF 58
           P  + D   ++ + L NNN+S         P    K      +++  N ++    +   F
Sbjct: 235 PGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTF 294

Query: 59  RNLSVKS 65
           R + V++
Sbjct: 295 RCVYVRA 301

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 36.2 bits (82), Expect = 0.004
 Identities = 14/50 (28%), Positives = 24/50 (48%)

Query: 1  QGSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEG 50
                   +L NL +L L NN +S   P +   L+ L+ + +S N+L+ 
Sbjct: 44 TEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKE 93

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 40.6 bits (93), Expect = 2e-04
 Identities = 20/61 (32%), Positives = 29/61 (47%), Gaps = 7/61 (11%)

Query: 11  LINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNE 70
             +L+ LN+SNN L   +P    +   L+ +  SFN L  E+P     +NL     E N 
Sbjct: 283 PPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVPEL--PQNLKQLHVEYNP 335

Query: 71  L 71
           L
Sbjct: 336 L 336

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 39.8 bits (91), Expect = 3e-04
 Identities = 16/65 (24%), Positives = 28/65 (43%), Gaps = 11/65 (16%)

Query: 3   SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEG--EIPREGPFRN 60
            +P        L+ L  S N+L+  +P   +    LK ++V +N L    +IP      +
Sbjct: 298 ELPALPP---RLERLIASFNHLA-EVPELPQN---LKQLHVEYNPLREFPDIPES--VED 348

Query: 61  LSVKS 65
           L + S
Sbjct: 349 LRMNS 353

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.7 bits (93), Expect = 2e-04
 Identities = 11/58 (18%), Positives = 24/58 (41%), Gaps = 5/58 (8%)

Query: 3   SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLL-----DLKDINVSFNKLEGEIPRE 55
           S+  ++    +L+ L+LSNN L     + L + +      L+ + +       E+   
Sbjct: 388 SLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDR 445

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.2 bits (89), Expect = 5e-04
 Identities = 9/57 (15%), Positives = 20/57 (35%), Gaps = 4/57 (7%)

Query: 3  SIPDSIGDLINLKSLNLSNNNLSG----TIPISLEKLLDLKDINVSFNKLEGEIPRE 55
             + +  L   + + L +  L+      I  +L     L ++N+  N+L       
Sbjct: 18 RWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHC 74

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 36.5 bits (82), Expect = 0.004
 Identities = 9/47 (19%), Positives = 23/47 (48%), Gaps = 4/47 (8%)

Query: 13  NLKSLNLSNNNLSGT----IPISLEKLLDLKDINVSFNKLEGEIPRE 55
            L+ L L++ ++S +    +  +L     L+++++S N L      +
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQ 416

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.3 bits (90), Expect = 4e-04
 Identities = 9/42 (21%), Positives = 17/42 (40%), Gaps = 2/42 (4%)

Query: 3  SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVS 44
          ++P  +    +   L+LS N L      +L     L  +N+ 
Sbjct: 24 ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.0 bits (86), Expect = 9e-04
 Identities = 8/44 (18%), Positives = 13/44 (29%)

Query: 4   IPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNK 47
             D          L++S   +       LE L  L+  +    K
Sbjct: 193 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 37.3 bits (85), Expect = 0.002
 Identities = 10/39 (25%), Positives = 18/39 (46%), Gaps = 2/39 (5%)

Query: 6   DSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVS 44
             +  L NL  ++L NN +S   P  L    +L  + ++
Sbjct: 189 SPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 36.8 bits (83), Expect = 0.003
 Identities = 14/64 (21%), Positives = 24/64 (37%), Gaps = 5/64 (7%)

Query: 11  LINLKSLNLSNNNLSGTIPISL-----EKLLDLKDINVSFNKLEGEIPREGPFRNLSVKS 65
            I L++L L  N +      +L     EK+ DL  + ++ N+   E       R +    
Sbjct: 272 NIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTR 331

Query: 66  FEGN 69
             G 
Sbjct: 332 GRGE 335

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 35.1 bits (80), Expect = 0.003
 Identities = 14/47 (29%), Positives = 26/47 (55%), Gaps = 2/47 (4%)

Query: 15 KSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNL 61
          + L+L++ +L  T+   LE+LL +  +++S N+L    P     R L
Sbjct: 1  RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCL 45

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	346
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.91
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.37
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.03
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	98.93
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	98.9
d2ifga3	156	High affinity nerve growth factor receptor, N-term	98.88
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	98.83
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	98.68
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	98.66
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.63
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	98.57
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	98.49
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	98.46
d2ifga3	156	High affinity nerve growth factor receptor, N-term	98.43
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	98.41
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	98.39
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.34
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	98.33
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	98.32
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	98.26
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	98.23
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	98.09
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	98.05
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	98.05
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	98.03
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.03
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	98.0
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.89
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	97.86
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	97.85
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	97.82
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	97.81
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	97.61
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	97.56
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.56
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.23
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	97.08
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	97.03
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.52
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	96.31
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	95.67
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	95.2
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	95.18
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	95.0
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	94.19
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	91.47
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	90.48
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	83.72
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	81.95

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-55  Score=378.29  Aligned_cols=241  Identities=23%  Similarity=0.348  Sum_probs=202.9

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEE
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVL  178 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  178 (346)
                      .-++|++.+.||+|+||+||+|..+ +|+.||||+++... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm   82 (271)
T d1nvra_           3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   82 (271)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence            4467999999999999999999976 79999999987543 234467889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccc
Q 039799          179 EYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  258 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~  258 (346)
                      ||+++|+|.+++. ....+++..+..++.|+++||+|||   +.+|+||||||+|||+++++.+||+|||+|+.......
T Consensus        83 Ey~~gg~L~~~l~-~~~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~  158 (271)
T d1nvra_          83 EYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  158 (271)
T ss_dssp             ECCTTEEGGGGSB-TTTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             eccCCCcHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence            9999999999886 3457899999999999999999999   99999999999999999999999999999998755444


Q ss_pred             ccccccccCCcccccCCCCCCCCC-CcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh--------hhcCCChhh
Q 039799          259 SLTQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN--------DLLPISVME  329 (346)
Q Consensus       259 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~  329 (346)
                      .......+||+.|+|||++.+..+ +.++||||+||++|||+||+.||............+..        ..++..+.+
T Consensus       159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  238 (271)
T d1nvra_         159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA  238 (271)
T ss_dssp             ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHH
T ss_pred             cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHH
Confidence            444456779999999999887776 57899999999999999999999764433333333322        223457789


Q ss_pred             hhchhccCCccccccc
Q 039799          330 VVDANLLSQEDEHFTT  345 (346)
Q Consensus       330 ~~d~~l~~~p~~R~~~  345 (346)
                      ++.+||..||++|||+
T Consensus       239 li~~~L~~dP~~R~t~  254 (271)
T d1nvra_         239 LLHKILVENPSARITI  254 (271)
T ss_dssp             HHHHHSCSSTTTSCCH
T ss_pred             HHHHHcCCChhHCcCH
Confidence            9999999999999986

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-53  Score=372.11  Aligned_cols=238  Identities=27%  Similarity=0.402  Sum_probs=193.9

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEcCCCEEEEEEecCC--CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEE
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQ--YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVL  178 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  178 (346)
                      ..++|.+.+.||+|+||+||+|+++  ..||||+++..  .....+.+.+|++++++++||||+++++++.+ +..++||
T Consensus         6 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~   82 (276)
T d1uwha_           6 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT   82 (276)
T ss_dssp             CTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             ccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence            3467999999999999999999865  36999998643  34556789999999999999999999998754 5678999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccc
Q 039799          179 EYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  258 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~  258 (346)
                      ||+++|+|.+++......+++..+..++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+|+.......
T Consensus        83 Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~  159 (276)
T d1uwha_          83 QWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG  159 (276)
T ss_dssp             ECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence            999999999999877778999999999999999999999   99999999999999999999999999999987654433


Q ss_pred             ccccccccCCcccccCCCCCC---CCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH------------hhhc
Q 039799          259 SLTQTQTLATIGYMAPEYGRE---GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV------------NDLL  323 (346)
Q Consensus       259 ~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~------------~~~~  323 (346)
                      ........||+.|+|||++.+   ..++.++|||||||++|||+||+.||........ ....+            ...+
T Consensus       160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~-~~~~~~~~~~~p~~~~~~~~~  238 (276)
T d1uwha_         160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-IIFMVGRGYLSPDLSKVRSNC  238 (276)
T ss_dssp             ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-HHHHHHHTSCCCCGGGSCTTC
T ss_pred             cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH-HHHHHhcCCCCCcchhccccc
Confidence            334455679999999998764   3578999999999999999999999976432211 11111            1223


Q ss_pred             CCChhhhhchhccCCccccccc
Q 039799          324 PISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       324 ~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ++.+.+++.+||..||++|||.
T Consensus       239 ~~~l~~li~~cl~~dp~~RPt~  260 (276)
T d1uwha_         239 PKAMKRLMAECLKKKRDERPLF  260 (276)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCH
T ss_pred             hHHHHHHHHHHcCCCHhHCcCH
Confidence            4478999999999999999985

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-53  Score=371.32  Aligned_cols=236  Identities=25%  Similarity=0.311  Sum_probs=202.4

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEec
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEY  180 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  180 (346)
                      ..+|.+.+.||+|+||+||+|... +|+.||||++........+.+.+|++++++++||||+++++++...+..++||||
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy   98 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence            457999999999999999999965 7999999999765555567899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccc
Q 039799          181 MPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  260 (346)
Q Consensus       181 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~  260 (346)
                      +++|+|.+++..  ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.+....  .
T Consensus        99 ~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~--~  171 (293)
T d1yhwa1          99 LAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--S  171 (293)
T ss_dssp             CTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--C
T ss_pred             cCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeecccc--c
Confidence            999999987754  35899999999999999999999   9999999999999999999999999999999764332  2


Q ss_pred             ccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH---------hhhcCCChhhhh
Q 039799          261 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV---------NDLLPISVMEVV  331 (346)
Q Consensus       261 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~---------~~~~~~~~~~~~  331 (346)
                      ......||+.|+|||.+.+..++.++||||+||++|||+||+.||....... .+....         ...+++.+.+++
T Consensus       172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~s~~~~~li  250 (293)
T d1yhwa1         172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-ALYLIATNGTPELQNPEKLSAIFRDFL  250 (293)
T ss_dssp             CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHHCSCCCSSGGGSCHHHHHHH
T ss_pred             cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH-HHHHHHhCCCCCCCCcccCCHHHHHHH
Confidence            2345679999999999999999999999999999999999999996532111 111111         122345788999


Q ss_pred             chhccCCccccccc
Q 039799          332 DANLLSQEDEHFTT  345 (346)
Q Consensus       332 d~~l~~~p~~R~~~  345 (346)
                      .+||..||++|||+
T Consensus       251 ~~~L~~dP~~R~s~  264 (293)
T d1yhwa1         251 NRCLDMDVEKRGSA  264 (293)
T ss_dssp             HHHTCSSTTTSCCH
T ss_pred             HHHccCChhHCcCH
Confidence            99999999999985

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-53  Score=373.53  Aligned_cols=243  Identities=25%  Similarity=0.370  Sum_probs=201.1

Q ss_pred             CCCCCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC---CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCc
Q 039799           98 GKPLPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ---YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDF  173 (346)
Q Consensus        98 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  173 (346)
                      ++..+++|.+.+.||+|+||+||+|... +|+.||||++...   .....+.+.+|++++++++||||+++++++.+.+.
T Consensus         3 ~~~~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~   82 (288)
T d1uu3a_           3 RKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEK   82 (288)
T ss_dssp             CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSE
T ss_pred             CCCCCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCE
Confidence            3445678999999999999999999975 7999999998642   12345678899999999999999999999999999


Q ss_pred             eeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccC
Q 039799          174 KALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  253 (346)
Q Consensus       174 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~  253 (346)
                      .++||||+++|+|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+|+.+
T Consensus        83 ~~ivmEy~~gg~L~~~~~~~-~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~  158 (288)
T d1uu3a_          83 LYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVL  158 (288)
T ss_dssp             EEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEEEccCCCCHHHhhhcc-CCCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceec
Confidence            99999999999999987643 56899999999999999999999   999999999999999999999999999999977


Q ss_pred             CccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh------hhcCCCh
Q 039799          254 LEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN------DLLPISV  327 (346)
Q Consensus       254 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~------~~~~~~~  327 (346)
                      .............||+.|+|||++.+..++.++||||+||++|||+||+.||......+ ......+      ..+++.+
T Consensus       159 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-~~~~i~~~~~~~p~~~s~~~  237 (288)
T d1uu3a_         159 SPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-IFQKIIKLEYDFPEKFFPKA  237 (288)
T ss_dssp             C----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHTTCCCCCTTCCHHH
T ss_pred             ccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH-HHHHHHcCCCCCCccCCHHH
Confidence            54443333445679999999999999999999999999999999999999997532111 1111111      2234477


Q ss_pred             hhhhchhccCCccccccc
Q 039799          328 MEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       328 ~~~~d~~l~~~p~~R~~~  345 (346)
                      .+++.+||..||++|||+
T Consensus       238 ~~li~~~L~~dP~~R~t~  255 (288)
T d1uu3a_         238 RDLVEKLLVLDATKRLGC  255 (288)
T ss_dssp             HHHHHTTSCSSGGGSTTS
T ss_pred             HHHHHHHccCCHhHCcCH
Confidence            899999999999999986

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-53  Score=371.68  Aligned_cols=237  Identities=24%  Similarity=0.350  Sum_probs=202.7

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecC
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYM  181 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  181 (346)
                      +.|++.+.||+|+||+||+|... +|+.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            45788899999999999999976 78999999998776666788999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccc
Q 039799          182 PHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT  261 (346)
Q Consensus       182 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~  261 (346)
                      ++|+|.+++......+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+|+......  ..
T Consensus        92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--~~  166 (288)
T d2jfla1          92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QR  166 (288)
T ss_dssp             TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--HH
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCCc--cc
Confidence            999999988766677999999999999999999999   9999999999999999999999999999998653321  12


Q ss_pred             cccccCCcccccCCCCC-----CCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh---------hhcCCCh
Q 039799          262 QTQTLATIGYMAPEYGR-----EGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN---------DLLPISV  327 (346)
Q Consensus       262 ~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~---------~~~~~~~  327 (346)
                      .....||+.|+|||++.     +..++.++|||||||++|||+||+.||......+ .+.....         ..++..+
T Consensus       167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~s~~~  245 (288)
T d2jfla1         167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-VLLKIAKSEPPTLAQPSRWSSNF  245 (288)
T ss_dssp             HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-HHHHHHHSCCCCCSSGGGSCHHH
T ss_pred             ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH-HHHHHHcCCCCCCCccccCCHHH
Confidence            33467999999999863     4567899999999999999999999997643222 1112221         2344578


Q ss_pred             hhhhchhccCCccccccc
Q 039799          328 MEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       328 ~~~~d~~l~~~p~~R~~~  345 (346)
                      .+++.+||..||++|||+
T Consensus       246 ~~li~~~L~~dp~~R~t~  263 (288)
T d2jfla1         246 KDFLKKCLEKNVDARWTT  263 (288)
T ss_dssp             HHHHHHHSCSSTTTSCCH
T ss_pred             HHHHHHHccCChhHCcCH
Confidence            899999999999999986

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-53  Score=365.65  Aligned_cols=237  Identities=25%  Similarity=0.393  Sum_probs=192.6

Q ss_pred             CCCCCCCCcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecC
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYM  181 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  181 (346)
                      +++|++.+.||+|+||+||+|.+.+++.||||+++.... ..+++.+|++++++++||||++++++|...+..++||||+
T Consensus         4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~   82 (263)
T d1sm2a_           4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   82 (263)
T ss_dssp             CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcC-cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence            467888999999999999999999889999999976433 3578999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccc
Q 039799          182 PHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT  261 (346)
Q Consensus       182 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~  261 (346)
                      ++|+|.+++......+++..++.++.|+++||+|||   +.+|+||||||+|||+++++.+||+|||+++....... ..
T Consensus        83 ~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~~  158 (263)
T d1sm2a_          83 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TS  158 (263)
T ss_dssp             TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred             CCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCCc-ee
Confidence            999999998877788999999999999999999999   99999999999999999999999999999987644322 22


Q ss_pred             cccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcC-CCCCCccccCcccHHHHHhhh--------cCCChhhhhc
Q 039799          262 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTR-TKPTDEIFSGEMTLKRWVNDL--------LPISVMEVVD  332 (346)
Q Consensus       262 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg-~~p~~~~~~~~~~~~~~~~~~--------~~~~~~~~~d  332 (346)
                      .....||+.|+|||.+.+..++.++|||||||++|||+|+ ++|+...  ......+.+...        .+..+.+++.
T Consensus       159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~--~~~~~~~~i~~~~~~~~p~~~~~~l~~li~  236 (263)
T d1sm2a_         159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR--SNSEVVEDISTGFRLYKPRLASTHVYQIMN  236 (263)
T ss_dssp             ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC--CHHHHHHHHHHTCCCCCCTTSCHHHHHHHH
T ss_pred             ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC--CHHHHHHHHHhcCCCCCccccCHHHHHHHH
Confidence            2345689999999999999999999999999999999995 5555432  112222333222        2347899999


Q ss_pred             hhccCCccccccc
Q 039799          333 ANLLSQEDEHFTT  345 (346)
Q Consensus       333 ~~l~~~p~~R~~~  345 (346)
                      +||..||++|||.
T Consensus       237 ~cl~~~p~~Rps~  249 (263)
T d1sm2a_         237 HCWKERPEDRPAF  249 (263)
T ss_dssp             HHTCSSGGGSCCH
T ss_pred             HHccCCHhHCcCH
Confidence            9999999999985

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-53  Score=363.92  Aligned_cols=234  Identities=24%  Similarity=0.368  Sum_probs=199.2

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC---CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEE
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ---YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVL  178 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  178 (346)
                      ++|.+.+.||+|+||+||+|+.+ +++.||+|++...   .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            57888999999999999999976 7899999998632   1233567889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccc
Q 039799          179 EYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  258 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~  258 (346)
                      ||+++|+|.+++.. ...+++..+..++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++.....  
T Consensus        86 Ey~~~g~L~~~l~~-~~~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~--  159 (263)
T d2j4za1          86 EYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--  159 (263)
T ss_dssp             ECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC--
T ss_pred             eecCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecCCC--
Confidence            99999999998864 346899999999999999999999   999999999999999999999999999999865432  


Q ss_pred             ccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh------hhcCCChhhhhc
Q 039799          259 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN------DLLPISVMEVVD  332 (346)
Q Consensus       259 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~------~~~~~~~~~~~d  332 (346)
                        ......||+.|+|||++.+..++.++|||||||++|||+||+.||......+ ......+      ..+++.+.+++.
T Consensus       160 --~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-~~~~i~~~~~~~p~~~s~~~~~li~  236 (263)
T d2j4za1         160 --RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-TYKRISRVEFTFPDFVTEGARDLIS  236 (263)
T ss_dssp             --CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHTTCCCCCTTSCHHHHHHHH
T ss_pred             --cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH-HHHHHHcCCCCCCccCCHHHHHHHH
Confidence              1234569999999999999999999999999999999999999997532111 1111111      223447889999


Q ss_pred             hhccCCccccccc
Q 039799          333 ANLLSQEDEHFTT  345 (346)
Q Consensus       333 ~~l~~~p~~R~~~  345 (346)
                      +||..||++|||+
T Consensus       237 ~~L~~dp~~R~t~  249 (263)
T d2j4za1         237 RLLKHNPSQRPML  249 (263)
T ss_dssp             HHTCSSGGGSCCH
T ss_pred             HHccCCHhHCcCH
Confidence            9999999999986

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-52  Score=359.29  Aligned_cols=237  Identities=24%  Similarity=0.387  Sum_probs=205.8

Q ss_pred             CCCCCCCCcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecC
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYM  181 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  181 (346)
                      +++|++.+.||+|+||+||+|++++++.||||+++.... ..+.+.+|++++++++||||++++++|.+++..++||||+
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~   81 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM   81 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred             hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence            578999999999999999999999888999999986543 3478999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccc
Q 039799          182 PHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT  261 (346)
Q Consensus       182 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~  261 (346)
                      ++|+|.+++......+++..+.+++.|+++||+|||   +.+|+||||||+|||+++++.+||+|||+++.+.... ...
T Consensus        82 ~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~-~~~  157 (258)
T d1k2pa_          82 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTS  157 (258)
T ss_dssp             TTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS-CCC
T ss_pred             CCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCC-cee
Confidence            999999998877788999999999999999999999   9999999999999999999999999999998765432 223


Q ss_pred             cccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHhhh--------cCCChhhhhc
Q 039799          262 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVNDL--------LPISVMEVVD  332 (346)
Q Consensus       262 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~--------~~~~~~~~~d  332 (346)
                      .....+|+.|+|||.+.+..++.++||||||+++|||+| |+.||......+  ....+...        .+..+.+++.
T Consensus       158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~--~~~~i~~~~~~~~p~~~~~~l~~li~  235 (258)
T d1k2pa_         158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--TAEHIAQGLRLYRPHLASEKVYTIMY  235 (258)
T ss_dssp             CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--HHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH--HHHHHHhCCCCCCcccccHHHHHHHH
Confidence            344668999999999998999999999999999999998 899998643222  22222221        2337889999


Q ss_pred             hhccCCccccccc
Q 039799          333 ANLLSQEDEHFTT  345 (346)
Q Consensus       333 ~~l~~~p~~R~~~  345 (346)
                      +||..||++|||.
T Consensus       236 ~cl~~dP~~RPt~  248 (258)
T d1k2pa_         236 SCWHEKADERPTF  248 (258)
T ss_dssp             HTTCSSGGGSCCH
T ss_pred             HHccCCHhHCcCH
Confidence            9999999999985

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-52  Score=364.48  Aligned_cols=240  Identities=23%  Similarity=0.303  Sum_probs=187.4

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEec--CCceeE
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSN--DDFKAL  176 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~l  176 (346)
                      .++|++.+.||+|+||+||+|..+ +|+.||+|++....  +...+.+.+|++++++++||||+++++++.+  .+..++
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence            467999999999999999999976 78999999987543  3445678899999999999999999999864  456899


Q ss_pred             EEecCCCCChhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeeecCCCCCceEECCCCcEEEeeecCCc
Q 039799          177 VLEYMPHGSLEKCLYL---SNYILDIFQRLDIMIDVASALEYLHFGY--SAPIIHCDLKPSNVLLDDNMVAHLSDFGMAK  251 (346)
Q Consensus       177 v~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~  251 (346)
                      ||||+++|+|.+++..   ....+++..++.++.|++.||+|||...  ..+|+||||||+|||++.++.+||+|||+++
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence            9999999999998864   2457999999999999999999999311  2349999999999999999999999999999


Q ss_pred             cCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH-h-------hhc
Q 039799          252 PLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV-N-------DLL  323 (346)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~-~-------~~~  323 (346)
                      .+....  .......||+.|+|||++.+..++.++|||||||++|||+||+.||.....  ..+...+ .       ..+
T Consensus       163 ~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~--~~~~~~i~~~~~~~~~~~~  238 (269)
T d2java1         163 ILNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--KELAGKIREGKFRRIPYRY  238 (269)
T ss_dssp             HC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHTCCCCCCTTS
T ss_pred             ecccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH--HHHHHHHHcCCCCCCCccc
Confidence            764322  222346799999999999999999999999999999999999999976322  1121111 1       223


Q ss_pred             CCChhhhhchhccCCccccccc
Q 039799          324 PISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       324 ~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ++.+.+++.+||..||++|||+
T Consensus       239 s~~l~~li~~~L~~dp~~Rps~  260 (269)
T d2java1         239 SDELNEIITRMLNLKDYHRPSV  260 (269)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CHHHHHHHHHHcCCChhHCcCH
Confidence            4478999999999999999985

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-52  Score=363.74  Aligned_cols=236  Identities=24%  Similarity=0.393  Sum_probs=195.9

Q ss_pred             CCCCCCCcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecCC
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMP  182 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  182 (346)
                      ++|.+.+.||+|+||+||+|.+++++.||||+++.... ..+.+.+|++++++++||||+++++++.+ +..++||||++
T Consensus        13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~   90 (272)
T d1qpca_          13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME   90 (272)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred             HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC-CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCC
Confidence            46777889999999999999999888999999976533 35779999999999999999999998755 56789999999


Q ss_pred             CCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccc
Q 039799          183 HGSLEKCLYLSN-YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT  261 (346)
Q Consensus       183 ~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~  261 (346)
                      +|+|.+++.... ..+++..++.++.|+++||+|||   +.+|+||||||+|||+++++.+||+|||+|+.+.... ...
T Consensus        91 ~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~-~~~  166 (272)
T d1qpca_          91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YTA  166 (272)
T ss_dssp             TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-EEC
T ss_pred             CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCCc-ccc
Confidence            999998775443 46899999999999999999999   9999999999999999999999999999999764332 223


Q ss_pred             cccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh--------hhcCCChhhhhch
Q 039799          262 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN--------DLLPISVMEVVDA  333 (346)
Q Consensus       262 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~d~  333 (346)
                      .....||+.|+|||++.+..++.++|||||||++|||+||..|+..... .....+.+.        ..+++.+.+++.+
T Consensus       167 ~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~-~~~~~~~i~~~~~~~~p~~~~~~l~~li~~  245 (272)
T d1qpca_         167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-NPEVIQNLERGYRMVRPDNCPEELYQLMRL  245 (272)
T ss_dssp             CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC-HHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred             ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC-HHHHHHHHHhcCCCCCcccChHHHHHHHHH
Confidence            3445689999999999888999999999999999999996655433221 112222222        2234478999999


Q ss_pred             hccCCccccccc
Q 039799          334 NLLSQEDEHFTT  345 (346)
Q Consensus       334 ~l~~~p~~R~~~  345 (346)
                      ||..||++|||.
T Consensus       246 cl~~~P~~Rpt~  257 (272)
T d1qpca_         246 CWKERPEDRPTF  257 (272)
T ss_dssp             HTCSSGGGSCCH
T ss_pred             HcCCCHhHCcCH
Confidence            999999999985

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.4e-52  Score=369.45  Aligned_cols=241  Identities=23%  Similarity=0.313  Sum_probs=187.8

Q ss_pred             hcCCCCCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCc
Q 039799           96 KRGKPLPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDF  173 (346)
Q Consensus        96 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  173 (346)
                      +......+.|++.+.||+|+||+||+|..+ +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+.
T Consensus         2 ~~~edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~   81 (307)
T d1a06a_           2 KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGH   81 (307)
T ss_dssp             EECSCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             CCCCCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            344556677999999999999999999976 78999999987543 2334567889999999999999999999999999


Q ss_pred             eeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEEC---CCCcEEEeeecCC
Q 039799          174 KALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFGMA  250 (346)
Q Consensus       174 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~---~~~~~~l~Dfg~~  250 (346)
                      .++||||+++|+|.+++.. ...+++..+..++.|++.||+|||   +.+|+||||||+|||+.   +++.+||+|||++
T Consensus        82 ~~lvmE~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a  157 (307)
T d1a06a_          82 LYLIMQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLS  157 (307)
T ss_dssp             EEEEECCCCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC---
T ss_pred             EEEEEeccCCCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEecccee
Confidence            9999999999999999864 456999999999999999999999   99999999999999994   5789999999999


Q ss_pred             ccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH-----------
Q 039799          251 KPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV-----------  319 (346)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~-----------  319 (346)
                      +......   .....+||+.|+|||++.+..++.++||||+||++|||+||+.||......  .....+           
T Consensus       158 ~~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--~~~~~i~~~~~~~~~~~  232 (307)
T d1a06a_         158 KMEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA--KLFEQILKAEYEFDSPY  232 (307)
T ss_dssp             ------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHTTCCCCCTTT
T ss_pred             EEccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH--HHHHHHhccCCCCCCcc
Confidence            8654322   223456999999999999999999999999999999999999999753211  111111           


Q ss_pred             hhhcCCChhhhhchhccCCccccccc
Q 039799          320 NDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       320 ~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ...+++.+.+++.+||..||++|||+
T Consensus       233 ~~~~s~~~~~li~~~L~~dP~~R~s~  258 (307)
T d1a06a_         233 WDDISDSAKDFIRHLMEKDPEKRFTC  258 (307)
T ss_dssp             TTTSCHHHHHHHHHHSCSSGGGSCCH
T ss_pred             ccCCCHHHHHHHHHHccCCHhHCcCH
Confidence            12344467899999999999999986

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.8e-52  Score=365.57  Aligned_cols=239  Identities=22%  Similarity=0.378  Sum_probs=190.8

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CC---CEEEEEEecCC-CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeE
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DG---MEVAVKVFDPQ-YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKAL  176 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  176 (346)
                      .++|++.+.||+|+||+||+|.++ ++   ..||||.+... .....+.|.+|++++++++|||||++++++...+..++
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i  104 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI  104 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            456888899999999999999975 33   25899988654 34456789999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcc
Q 039799          177 VLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  256 (346)
Q Consensus       177 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~  256 (346)
                      ||||+++|+|.+++......+++..+..++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++.+...
T Consensus       105 v~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  181 (299)
T d1jpaa_         105 ITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  181 (299)
T ss_dssp             EEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCCcEEECCcccceEccCC
Confidence            99999999999988877778999999999999999999999   999999999999999999999999999999977543


Q ss_pred             ccccc---cccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHhhh--------cC
Q 039799          257 DQSLT---QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVNDL--------LP  324 (346)
Q Consensus       257 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~--------~~  324 (346)
                      .....   .....+|+.|+|||.+.+..++.++|||||||++|||+| |+.||.....  ..+...+...        ++
T Consensus       182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~--~~~~~~i~~~~~~~~~~~~~  259 (299)
T d1jpaa_         182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN--QDVINAIEQDYRLPPPMDCP  259 (299)
T ss_dssp             --------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHHHTTCCCCCCTTCC
T ss_pred             CCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCCCCCCccch
Confidence            32211   223457899999999988999999999999999999998 8999976432  2233333222        33


Q ss_pred             CChhhhhchhccCCccccccc
Q 039799          325 ISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       325 ~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ..+.+++.+||..||++|||+
T Consensus       260 ~~l~~li~~cl~~~P~~RPs~  280 (299)
T d1jpaa_         260 SALHQLMLDCWQKDRNHRPKF  280 (299)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCH
T ss_pred             HHHHHHHHHHcCCCHhHCcCH
Confidence            478999999999999999985

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.1e-52  Score=364.90  Aligned_cols=237  Identities=24%  Similarity=0.354  Sum_probs=199.6

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecC
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYM  181 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  181 (346)
                      ++|.+.+.||+|+||+||+|.++ +++.||||+++.... ..+++.+|++++++++||||++++++|.+.+..++||||+
T Consensus        17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~   95 (287)
T d1opja_          17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   95 (287)
T ss_dssp             GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecc
Confidence            45677789999999999999986 688999999975533 4578999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccc
Q 039799          182 PHGSLEKCLYLS-NYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  260 (346)
Q Consensus       182 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~  260 (346)
                      ++|+|.+++... ...+++..+..++.|+++||+|||   +.+|+||||||+|||+++++.+||+|||+++...... ..
T Consensus        96 ~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~-~~  171 (287)
T d1opja_          96 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YT  171 (287)
T ss_dssp             TTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS-SE
T ss_pred             cCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeecCCCC-ce
Confidence            999999998654 467899999999999999999999   8999999999999999999999999999999764432 22


Q ss_pred             ccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHhh--------hcCCChhhhhc
Q 039799          261 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVND--------LLPISVMEVVD  332 (346)
Q Consensus       261 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~d  332 (346)
                      ......|++.|+|||++.+..++.++|||||||++|||++|..|+..... .....+.+..        .+++.+.+++.
T Consensus       172 ~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~-~~~~~~~i~~~~~~~~~~~~~~~l~~li~  250 (287)
T d1opja_         172 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEGCPEKVYELMR  250 (287)
T ss_dssp             EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-HHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch-HHHHHHHHhcCCCCCCCccchHHHHHHHH
Confidence            23345588999999999889999999999999999999997776543221 1122233322        23447899999


Q ss_pred             hhccCCccccccc
Q 039799          333 ANLLSQEDEHFTT  345 (346)
Q Consensus       333 ~~l~~~p~~R~~~  345 (346)
                      +||..||++|||+
T Consensus       251 ~cl~~dP~~Rps~  263 (287)
T d1opja_         251 ACWQWNPSDRPSF  263 (287)
T ss_dssp             HHTCSSGGGSCCH
T ss_pred             HHcCCCHhHCcCH
Confidence            9999999999985

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-52  Score=372.92  Aligned_cols=199  Identities=24%  Similarity=0.347  Sum_probs=176.8

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC-CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEE
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ-YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVL  178 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  178 (346)
                      .+++|.+.+.||+|+||+||+|... +|+.||+|+++.. .....+++.+|++++++++||||++++++|.+.+..++||
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm   83 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   83 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            3567999999999999999999976 7899999998754 3344578899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeeecCCCCCceEECCCCcEEEeeecCCccCCccc
Q 039799          179 EYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSA-PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  257 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~  257 (346)
                      ||+++|+|.+++... ..+++..+..++.|++.||.|||   ++ +|+||||||+|||+++++.+||+|||+|+.+.+. 
T Consensus        84 Ey~~gg~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yLH---~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-  158 (322)
T d1s9ja_          84 EHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  158 (322)
T ss_dssp             ECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred             EcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHH---HhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC-
Confidence            999999999998644 46899999999999999999999   74 8999999999999999999999999999965332 


Q ss_pred             cccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 039799          258 QSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDE  307 (346)
Q Consensus       258 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~  307 (346)
                         .....+||+.|+|||++.+..++.++||||+||++|||+||+.||..
T Consensus       159 ---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~  205 (322)
T d1s9ja_         159 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP  205 (322)
T ss_dssp             ---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSC
T ss_pred             ---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence               22345799999999999999999999999999999999999999964

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-51  Score=355.21  Aligned_cols=230  Identities=25%  Similarity=0.406  Sum_probs=189.6

Q ss_pred             CCCCcccccCceEEEEEEEc-CCCEEEEEEecCC--CchhHHHHHHHHHHHHhcCCCCceeeEEEEec----CCceeEEE
Q 039799          106 NMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ--YEGAFKSFDIECDVMKRICHRNLIKIISSYSN----DDFKALVL  178 (346)
Q Consensus       106 ~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~  178 (346)
                      ++.+.||+|+||+||+|... +++.||+|++...  .....+.+.+|++++++++||||+++++++..    ....++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            55668999999999999976 6889999998643  33446778999999999999999999999864    34678999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeecCCCCCceEEC-CCCcEEEeeecCCccCCc
Q 039799          179 EYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAP--IIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLE  255 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~dik~~NIll~-~~~~~~l~Dfg~~~~~~~  255 (346)
                      ||+++|+|.+++.. ...+++..+..++.|+++||+|||   +.+  |+||||||+|||++ +++.+||+|||+++....
T Consensus        92 E~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~  167 (270)
T d1t4ha_          92 ELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  167 (270)
T ss_dssp             ECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCcHHHHHhc-cccccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence            99999999999864 356899999999999999999999   777  99999999999997 578999999999985422


Q ss_pred             cccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH---------hhhcCCC
Q 039799          256 EDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV---------NDLLPIS  326 (346)
Q Consensus       256 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~---------~~~~~~~  326 (346)
                      .    ......||+.|+|||++.+ .++.++|||||||++|||+||+.||....... .+.+.+         ....++.
T Consensus       168 ~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~-~~~~~i~~~~~~~~~~~~~~~~  241 (270)
T d1t4ha_         168 S----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-QIYRRVTSGVKPASFDKVAIPE  241 (270)
T ss_dssp             T----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-HHHHHHTTTCCCGGGGGCCCHH
T ss_pred             C----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH-HHHHHHHcCCCCcccCccCCHH
Confidence            1    2234579999999998865 69999999999999999999999997532221 111111         1223346


Q ss_pred             hhhhhchhccCCccccccc
Q 039799          327 VMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       327 ~~~~~d~~l~~~p~~R~~~  345 (346)
                      +.+++.+||..||++|||+
T Consensus       242 ~~~li~~~l~~dp~~R~s~  260 (270)
T d1t4ha_         242 VKEIIEGCIRQNKDERYSI  260 (270)
T ss_dssp             HHHHHHHHSCSSGGGSCCH
T ss_pred             HHHHHHHHccCCHhHCcCH
Confidence            8899999999999999986

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.4e-51  Score=370.68  Aligned_cols=236  Identities=21%  Similarity=0.306  Sum_probs=202.9

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecC
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYM  181 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  181 (346)
                      ++|.+.+.||+|+||.||+|... +|+.||||++........+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  105 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  105 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            46889999999999999999975 78999999998776666788899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEEC--CCCcEEEeeecCCccCCccccc
Q 039799          182 PHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD--DNMVAHLSDFGMAKPLLEEDQS  259 (346)
Q Consensus       182 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~--~~~~~~l~Dfg~~~~~~~~~~~  259 (346)
                      ++|+|.+++......+++..+..++.||+.||+|||   +.+|+||||||+|||++  .++.+||+|||+++.+....  
T Consensus       106 ~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~--  180 (350)
T d1koaa2         106 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--  180 (350)
T ss_dssp             CSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS--
T ss_pred             CCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc--
Confidence            999999998766677999999999999999999999   99999999999999996  46789999999999764332  


Q ss_pred             cccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH----------hhhcCCChhh
Q 039799          260 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV----------NDLLPISVME  329 (346)
Q Consensus       260 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~----------~~~~~~~~~~  329 (346)
                       ......||+.|+|||++.+..++.++||||+||++|||+||+.||......+ .+....          ...+++.+.+
T Consensus       181 -~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s~~~~~  258 (350)
T d1koaa2         181 -SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE-TLRNVKSCDWNMDDSAFSGISEDGKD  258 (350)
T ss_dssp             -CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCCCSCCGGGGGCCHHHHH
T ss_pred             -ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCCCCcccccCCCHHHHH
Confidence             2234569999999999999999999999999999999999999997532111 111111          1234457789


Q ss_pred             hhchhccCCccccccc
Q 039799          330 VVDANLLSQEDEHFTT  345 (346)
Q Consensus       330 ~~d~~l~~~p~~R~~~  345 (346)
                      ++.+||..||++|||+
T Consensus       259 li~~~L~~dP~~R~t~  274 (350)
T d1koaa2         259 FIRKLLLADPNTRMTI  274 (350)
T ss_dssp             HHHHHCCSSGGGSCCH
T ss_pred             HHHHHccCChhHCcCH
Confidence            9999999999999986

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.3e-51  Score=369.51  Aligned_cols=236  Identities=20%  Similarity=0.336  Sum_probs=203.1

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecC
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYM  181 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  181 (346)
                      +.|++.+.||+|+||.||+|... +|+.||||++........+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            46889999999999999999975 79999999998766556678889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEEC--CCCcEEEeeecCCccCCccccc
Q 039799          182 PHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD--DNMVAHLSDFGMAKPLLEEDQS  259 (346)
Q Consensus       182 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~--~~~~~~l~Dfg~~~~~~~~~~~  259 (346)
                      ++|+|.+.+......+++..+..++.|++.||+|||   +.+|+||||||+|||++  .++.+||+|||+|+.+....  
T Consensus       109 ~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~--  183 (352)
T d1koba_         109 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--  183 (352)
T ss_dssp             CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS--
T ss_pred             CCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecCCCC--
Confidence            999999888766677999999999999999999999   99999999999999998  67899999999999775432  


Q ss_pred             cccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh----------hhcCCChhh
Q 039799          260 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN----------DLLPISVME  329 (346)
Q Consensus       260 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~----------~~~~~~~~~  329 (346)
                       ......||+.|+|||++.+..++.++||||+||++|||+||+.||......+ .+.....          ..++..+.+
T Consensus       184 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s~~~~~  261 (352)
T d1koba_         184 -IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-TLQNVKRCDWEFDEDAFSSVSPEAKD  261 (352)
T ss_dssp             -CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHHHHCCCCCCSSTTTTSCHHHHH
T ss_pred             -ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCCCCcccccCCCHHHHH
Confidence             2234568999999999999999999999999999999999999997532111 1111111          123447789


Q ss_pred             hhchhccCCccccccc
Q 039799          330 VVDANLLSQEDEHFTT  345 (346)
Q Consensus       330 ~~d~~l~~~p~~R~~~  345 (346)
                      ++.+||..||++|||+
T Consensus       262 li~~~L~~dp~~R~s~  277 (352)
T d1koba_         262 FIKNLLQKEPRKRLTV  277 (352)
T ss_dssp             HHHTTSCSSGGGSCCH
T ss_pred             HHHHHccCChhHCcCH
Confidence            9999999999999985

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-52  Score=362.17  Aligned_cols=236  Identities=21%  Similarity=0.363  Sum_probs=197.3

Q ss_pred             CCCCCCc-ccccCceEEEEEEEc---CCCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEE
Q 039799          104 DANMPPL-IGKGGFGSVYKAIIQ---DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVL  178 (346)
Q Consensus       104 ~~~~~~~-lg~G~~g~vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  178 (346)
                      ++.+.+. ||+|+||+||+|.++   ++..||||+++... ....+++.+|++++++++||||+++++++.. +..++||
T Consensus         9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvm   87 (285)
T d1u59a_           9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM   87 (285)
T ss_dssp             GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEE
T ss_pred             CeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEE
Confidence            4555554 999999999999864   35579999997543 3456789999999999999999999999865 5678999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccc
Q 039799          179 EYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  258 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~  258 (346)
                      ||+++|+|.+++......+++..+..++.|+++||+|||   +++|+||||||+|||++.++.+||+|||+++.+.....
T Consensus        88 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~  164 (285)
T d1u59a_          88 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS  164 (285)
T ss_dssp             ECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred             EeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhccccccc
Confidence            999999999998777778999999999999999999999   99999999999999999999999999999997754332


Q ss_pred             c-cccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHh--------hhcCCChh
Q 039799          259 S-LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVN--------DLLPISVM  328 (346)
Q Consensus       259 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~  328 (346)
                      . .......||+.|+|||++.+..++.++|||||||++|||+| |+.||......  ++...+.        ..+++.+.
T Consensus       165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~--~~~~~i~~~~~~~~p~~~~~~l~  242 (285)
T d1u59a_         165 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAFIEQGKRMECPPECPPELY  242 (285)
T ss_dssp             EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             ccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCCCCCCCcCCHHHH
Confidence            2 22334568999999999988899999999999999999998 99999764322  2223332        22344789


Q ss_pred             hhhchhccCCccccccc
Q 039799          329 EVVDANLLSQEDEHFTT  345 (346)
Q Consensus       329 ~~~d~~l~~~p~~R~~~  345 (346)
                      +++.+||..+|++|||.
T Consensus       243 ~li~~cl~~~p~~RPs~  259 (285)
T d1u59a_         243 ALMSDCWIYKWEDRPDF  259 (285)
T ss_dssp             HHHHHTTCSSGGGSCCH
T ss_pred             HHHHHHcCCCHhHCcCH
Confidence            99999999999999984

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-51  Score=358.34  Aligned_cols=241  Identities=25%  Similarity=0.426  Sum_probs=193.4

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEcCC-----CEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCce
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQDG-----MEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFK  174 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  174 (346)
                      .++.|+..++||+|+||+||+|.++..     ..||||++.... .....++.+|++++++++||||+++++++.+.+..
T Consensus         5 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~   84 (283)
T d1mqba_           5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM   84 (283)
T ss_dssp             CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             CHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCce
Confidence            346788899999999999999997632     369999997543 33456788999999999999999999999999999


Q ss_pred             eEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCC
Q 039799          175 ALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  254 (346)
Q Consensus       175 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~  254 (346)
                      ++||||+.++++.+.+......+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+.
T Consensus        85 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          85 MIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhccc
Confidence            9999999999999988877788999999999999999999999   9999999999999999999999999999999765


Q ss_pred             cccc-ccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHhhh--------cCC
Q 039799          255 EEDQ-SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDL--------LPI  325 (346)
Q Consensus       255 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~--------~~~  325 (346)
                      .... ........||+.|+|||++.+..++.++|||||||++|||+||..|+...... ....+.+...        ++.
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~  240 (283)
T d1mqba_         162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-HEVMKAINDGFRLPTPMDCPS  240 (283)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HHHHHHHHTTCCCCCCTTCBH
T ss_pred             CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH-HHHHHHHhccCCCCCchhhHH
Confidence            4322 22233456899999999999999999999999999999999976665432222 2233333322        233


Q ss_pred             ChhhhhchhccCCccccccc
Q 039799          326 SVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       326 ~~~~~~d~~l~~~p~~R~~~  345 (346)
                      .+.+++.+||..+|++||+.
T Consensus       241 ~l~~li~~cl~~~p~~RPt~  260 (283)
T d1mqba_         241 AIYQLMMQCWQQERARRPKF  260 (283)
T ss_dssp             HHHHHHHHHTCSSTTTSCCH
T ss_pred             HHHHHHHHHCcCCHhHCcCH
Confidence            68999999999999999985

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-50  Score=357.00  Aligned_cols=241  Identities=21%  Similarity=0.283  Sum_probs=202.4

Q ss_pred             CCCCCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC------chhHHHHHHHHHHHHhcCCCCceeeEEEEec
Q 039799           98 GKPLPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY------EGAFKSFDIECDVMKRICHRNLIKIISSYSN  170 (346)
Q Consensus        98 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  170 (346)
                      +....+.|++.+.||+|+||+||+|..+ +|+.||||++....      ....+.+.+|++++++++||||+++++++.+
T Consensus         5 ~~~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~   84 (293)
T d1jksa_           5 QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN   84 (293)
T ss_dssp             CSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             CCCcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence            3345567999999999999999999975 79999999986432      2235788999999999999999999999999


Q ss_pred             CCceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCC----cEEEee
Q 039799          171 DDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM----VAHLSD  246 (346)
Q Consensus       171 ~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~----~~~l~D  246 (346)
                      .+..++||||+++|+|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++    .+|++|
T Consensus        85 ~~~~~iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~D  160 (293)
T d1jksa_          85 KTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIID  160 (293)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECC
T ss_pred             CCEEEEEEEcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecc
Confidence            99999999999999999998644 46899999999999999999999   99999999999999998776    599999


Q ss_pred             ecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCc---------ccHHH
Q 039799          247 FGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE---------MTLKR  317 (346)
Q Consensus       247 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~---------~~~~~  317 (346)
                      ||+++......   ......+|+.|+|||.+.+..++.++||||+||++|||+||+.||......+         .....
T Consensus       161 fG~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~  237 (293)
T d1jksa_         161 FGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED  237 (293)
T ss_dssp             CTTCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCH
T ss_pred             hhhhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCc
Confidence            99998764332   2334568999999999999999999999999999999999999997532111         11112


Q ss_pred             HHhhhcCCChhhhhchhccCCccccccc
Q 039799          318 WVNDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       318 ~~~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      -....++..+.+++.+||..||++|||+
T Consensus       238 ~~~~~~s~~~~~li~~~L~~dP~~R~s~  265 (293)
T d1jksa_         238 EYFSNTSALAKDFIRRLLVKDPKKRMTI  265 (293)
T ss_dssp             HHHTTSCHHHHHHHHTTSCSSGGGSCCH
T ss_pred             hhcCCCCHHHHHHHHHHccCChhHCcCH
Confidence            2223345578899999999999999986

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-51  Score=365.58  Aligned_cols=239  Identities=23%  Similarity=0.385  Sum_probs=198.2

Q ss_pred             CCCCCCCcccccCceEEEEEEEcC-C-----CEEEEEEecCC-CchhHHHHHHHHHHHHhc-CCCCceeeEEEEecCCce
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQD-G-----MEVAVKVFDPQ-YEGAFKSFDIECDVMKRI-CHRNLIKIISSYSNDDFK  174 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  174 (346)
                      ++|.+.+.||+|+||+||+|++.. +     ..||+|.+... .......+.+|+.++.++ +|||||++++++.+.+..
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~  116 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  116 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence            568888999999999999998652 2     36999998643 234456788999999998 899999999999999999


Q ss_pred             eEEEecCCCCChhhhhhhcC----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCC
Q 039799          175 ALVLEYMPHGSLEKCLYLSN----------------------YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPS  232 (346)
Q Consensus       175 ~lv~e~~~~gsL~~~l~~~~----------------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~  232 (346)
                      ++||||+++|+|.+++....                      ..+++..++.++.|+++||+|||   +.+|+||||||+
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlKp~  193 (325)
T d1rjba_         117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAAR  193 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSGG
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCchh
Confidence            99999999999999986543                      24889999999999999999999   999999999999


Q ss_pred             ceEECCCCcEEEeeecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccC
Q 039799          233 NVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSG  311 (346)
Q Consensus       233 NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~  311 (346)
                      |||++.++.+||+|||+|+...............||+.|+|||.+.++.++.++|||||||++|||+| |+.||......
T Consensus       194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~  273 (325)
T d1rjba_         194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD  273 (325)
T ss_dssp             GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999997655444333445568999999999988999999999999999999998 89999764322


Q ss_pred             cccHHHHHhh--------hcCCChhhhhchhccCCccccccc
Q 039799          312 EMTLKRWVND--------LLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       312 ~~~~~~~~~~--------~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                       ..+.+.+..        .+++.+.+++.+||..||++|||+
T Consensus       274 -~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~  314 (325)
T d1rjba_         274 -ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSF  314 (325)
T ss_dssp             -HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             -HHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCH
Confidence             223333332        233478999999999999999985

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-50  Score=358.31  Aligned_cols=230  Identities=25%  Similarity=0.292  Sum_probs=193.7

Q ss_pred             CCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEec
Q 039799          105 ANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEY  180 (346)
Q Consensus       105 ~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  180 (346)
                      |+..+.||+|+||+||+|... +|+.||||++....   ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus        17 y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~   96 (309)
T d1u5ra_          17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY   96 (309)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEe
Confidence            788889999999999999965 78899999987543   23346788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccc
Q 039799          181 MPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  260 (346)
Q Consensus       181 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~  260 (346)
                      +++|+|..++. ....+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....    
T Consensus        97 ~~~g~l~~~~~-~~~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~----  168 (309)
T d1u5ra_          97 CLGSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----  168 (309)
T ss_dssp             CSEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB----
T ss_pred             cCCCchHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCCC----
Confidence            99999976554 3456899999999999999999999   999999999999999999999999999999865332    


Q ss_pred             ccccccCCcccccCCCCCC---CCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH--------hhhcCCChhh
Q 039799          261 TQTQTLATIGYMAPEYGRE---GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV--------NDLLPISVME  329 (346)
Q Consensus       261 ~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~  329 (346)
                        ....||+.|+|||++.+   +.++.++|||||||++|||++|+.||......+ .+....        ...+++.+.+
T Consensus       169 --~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~s~~~~~  245 (309)
T d1u5ra_         169 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNESPALQSGHWSEYFRN  245 (309)
T ss_dssp             --CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSCCCCCSCTTSCHHHHH
T ss_pred             --CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhCCCCCCCCCCCCHHHHH
Confidence              24569999999998753   468999999999999999999999996532211 111111        1223447899


Q ss_pred             hhchhccCCccccccc
Q 039799          330 VVDANLLSQEDEHFTT  345 (346)
Q Consensus       330 ~~d~~l~~~p~~R~~~  345 (346)
                      ++.+||..||++|||+
T Consensus       246 li~~~L~~dP~~Rpt~  261 (309)
T d1u5ra_         246 FVDSCLQKIPQDRPTS  261 (309)
T ss_dssp             HHHHHTCSSGGGSCCH
T ss_pred             HHHHHCcCChhHCcCH
Confidence            9999999999999985

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-50  Score=353.31  Aligned_cols=230  Identities=24%  Similarity=0.355  Sum_probs=189.2

Q ss_pred             CcccccCceEEEEEEEcC---CCEEEEEEecCC--CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecCCC
Q 039799          109 PLIGKGGFGSVYKAIIQD---GMEVAVKVFDPQ--YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYMPH  183 (346)
Q Consensus       109 ~~lg~G~~g~vy~~~~~~---~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  183 (346)
                      +.||+|+||+||+|.+++   ++.||||+++..  .....+++.+|++++++++||||++++++|.. +..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            469999999999998753   467999998643  23446789999999999999999999999865 467899999999


Q ss_pred             CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccc-ccc
Q 039799          184 GSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS-LTQ  262 (346)
Q Consensus       184 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~-~~~  262 (346)
                      |+|.+++.. ...+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+...... ...
T Consensus        92 g~L~~~l~~-~~~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~  167 (277)
T d1xbba_          92 GPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  167 (277)
T ss_dssp             EEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred             CcHHHHHhh-ccCCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence            999998864 456899999999999999999999   999999999999999999999999999999876543322 223


Q ss_pred             ccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHh--------hhcCCChhhhhch
Q 039799          263 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVN--------DLLPISVMEVVDA  333 (346)
Q Consensus       263 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~d~  333 (346)
                      ....||+.|+|||.+.+..++.++|||||||++|||+| |+.||......  .+...+.        ..++..+.+++.+
T Consensus       168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~--~~~~~i~~~~~~~~p~~~~~~~~~li~~  245 (277)
T d1xbba_         168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAMLEKGERMGCPAGCPREMYDLMNL  245 (277)
T ss_dssp             ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred             cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH--HHHHHHHcCCCCCCCcccCHHHHHHHHH
Confidence            34568999999999988899999999999999999998 89999764322  2222222        2234478999999


Q ss_pred             hccCCccccccc
Q 039799          334 NLLSQEDEHFTT  345 (346)
Q Consensus       334 ~l~~~p~~R~~~  345 (346)
                      ||..||++|||.
T Consensus       246 cl~~dp~~RPs~  257 (277)
T d1xbba_         246 CWTYDVENRPGF  257 (277)
T ss_dssp             HTCSSTTTSCCH
T ss_pred             HcCCCHhHCcCH
Confidence            999999999985

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-50  Score=358.33  Aligned_cols=235  Identities=22%  Similarity=0.289  Sum_probs=199.6

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEE
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVL  178 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  178 (346)
                      ++|++.+.||+|+||.||+|+.+ +|+.||+|++.+..   ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            56889999999999999999975 79999999986431   234577889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccc
Q 039799          179 EYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  258 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~  258 (346)
                      ||+++|+|.+++... ..++......++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+|+...... 
T Consensus        85 ey~~gg~L~~~~~~~-~~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~-  159 (337)
T d1o6la_          85 EYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-  159 (337)
T ss_dssp             ECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-
T ss_pred             eccCCCchhhhhhcc-cCCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccccccccCC-
Confidence            999999999988643 45788889999999999999999   9999999999999999999999999999999764322 


Q ss_pred             ccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh------hhcCCChhhhhc
Q 039799          259 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN------DLLPISVMEVVD  332 (346)
Q Consensus       259 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~------~~~~~~~~~~~d  332 (346)
                       ......+||+.|+|||++.+..++.++||||+||++|||++|+.||......+ .......      ..++..+.+++.
T Consensus       160 -~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~-~~~~i~~~~~~~p~~~s~~~~dli~  237 (337)
T d1o6la_         160 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-LFELILMEEIRFPRTLSPEAKSLLA  237 (337)
T ss_dssp             -CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred             -cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH-HHHHHhcCCCCCCccCCHHHHHHHH
Confidence             22345679999999999999999999999999999999999999997632211 1111111      223447789999


Q ss_pred             hhccCCcccccc
Q 039799          333 ANLLSQEDEHFT  344 (346)
Q Consensus       333 ~~l~~~p~~R~~  344 (346)
                      +||..||++|++
T Consensus       238 ~~L~~dP~~R~~  249 (337)
T d1o6la_         238 GLLKKDPKQRLG  249 (337)
T ss_dssp             HHTCSSTTTSTT
T ss_pred             hhccCCchhhcc
Confidence            999999999996

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.1e-49  Score=353.83  Aligned_cols=232  Identities=24%  Similarity=0.328  Sum_probs=196.8

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEE
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVL  178 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  178 (346)
                      ++|++.+.||+|+||+||+|+.+ +|+.||||++....   ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            46888999999999999999975 79999999986431   233567889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccc
Q 039799          179 EYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  258 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~  258 (346)
                      ||+++|+|..++.. ...+++.....++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+|+.....  
T Consensus        84 E~~~gg~l~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--  157 (316)
T d1fota_          84 DYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--  157 (316)
T ss_dssp             CCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred             eecCCccccccccc-cccccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEeccc--
Confidence            99999999988764 445788888899999999999999   999999999999999999999999999999876432  


Q ss_pred             ccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh------hhcCCChhhhhc
Q 039799          259 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN------DLLPISVMEVVD  332 (346)
Q Consensus       259 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~------~~~~~~~~~~~d  332 (346)
                         .....||+.|+|||++.+..++.++||||+||++|||+||+.||......+ .......      ..++..+.+++.
T Consensus       158 ---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~i~~~~~~~p~~~s~~~~~li~  233 (316)
T d1fota_         158 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK-TYEKILNAELRFPPFFNEDVKDLLS  233 (316)
T ss_dssp             ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred             ---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH-HHHHHHcCCCCCCCCCCHHHHHHHH
Confidence               234679999999999999999999999999999999999999997632111 1111111      223447899999


Q ss_pred             hhccCCcccccc
Q 039799          333 ANLLSQEDEHFT  344 (346)
Q Consensus       333 ~~l~~~p~~R~~  344 (346)
                      +||..||.+|++
T Consensus       234 ~~L~~dp~~R~~  245 (316)
T d1fota_         234 RLITRDLSQRLG  245 (316)
T ss_dssp             HHTCSCTTTCTT
T ss_pred             HHhhhCHHhccc
Confidence            999999999974

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-50  Score=352.22  Aligned_cols=237  Identities=26%  Similarity=0.400  Sum_probs=191.5

Q ss_pred             CCCCCCCCcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecC
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYM  181 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  181 (346)
                      .++|.+.+.||+|+||.||+|.+++++.||||+++... ...+.|.+|+.++++++|||||++++++.+ +..++||||+
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~   93 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   93 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence            35677888999999999999999988899999997553 345789999999999999999999999855 5678999999


Q ss_pred             CCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccc
Q 039799          182 PHGSLEKCLYLSN-YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  260 (346)
Q Consensus       182 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~  260 (346)
                      ++|+|.+++.... ..++|..++.++.+++.||+|||   +.+|+||||||+|||+|.++.+||+|||+++.+.+.. ..
T Consensus        94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~-~~  169 (285)
T d1fmka3          94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YT  169 (285)
T ss_dssp             TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred             CCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCCC-ce
Confidence            9999998876543 56999999999999999999999   9999999999999999999999999999998764322 22


Q ss_pred             ccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh--------hhcCCChhhhhc
Q 039799          261 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN--------DLLPISVMEVVD  332 (346)
Q Consensus       261 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~d  332 (346)
                      ......||+.|+|||++.++.++.++||||||+++|||+||..|+...... ......+.        ..+++.+.+++.
T Consensus       170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~l~~li~  248 (285)
T d1fmka3         170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCPPECPESLHDLMC  248 (285)
T ss_dssp             ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HHHHHHHHTTCCCCCCTTSCHHHHHHHH
T ss_pred             eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH-HHHHHHHHhcCCCCCCcccCHHHHHHHH
Confidence            334456899999999999999999999999999999999976665432221 22223222        223347899999


Q ss_pred             hhccCCccccccc
Q 039799          333 ANLLSQEDEHFTT  345 (346)
Q Consensus       333 ~~l~~~p~~R~~~  345 (346)
                      +||..||++||+.
T Consensus       249 ~cl~~dP~~Rps~  261 (285)
T d1fmka3         249 QCWRKEPEERPTF  261 (285)
T ss_dssp             HHTCSSGGGSCCH
T ss_pred             HHcccCHhHCcCH
Confidence            9999999999985

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-49  Score=354.17  Aligned_cols=239  Identities=21%  Similarity=0.317  Sum_probs=202.2

Q ss_pred             CCCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEE
Q 039799          100 PLPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVL  178 (346)
Q Consensus       100 ~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  178 (346)
                      .+.++|.+.+.||+|+||+||+|... +|+.||+|+++.... ....+.+|++++++++||||+++++++.+.+..++||
T Consensus         2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvm   80 (321)
T d1tkia_           2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIF   80 (321)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence            35577999999999999999999976 788999999976543 3456789999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC--CCcEEEeeecCCccCCcc
Q 039799          179 EYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD--NMVAHLSDFGMAKPLLEE  256 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~--~~~~~l~Dfg~~~~~~~~  256 (346)
                      ||+++|+|.+++......+++..+..++.|++.||+|||   +.+|+||||||+|||++.  ...++|+|||+++.....
T Consensus        81 E~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~  157 (321)
T d1tkia_          81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhccccC
Confidence            999999999999776667999999999999999999999   999999999999999984  458999999999876432


Q ss_pred             ccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCc---------ccHHHHHhhhcCCCh
Q 039799          257 DQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE---------MTLKRWVNDLLPISV  327 (346)
Q Consensus       257 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~---------~~~~~~~~~~~~~~~  327 (346)
                      .   ......+|+.|+|||...+..++.++||||+||++|||++|+.||......+         ..........++..+
T Consensus       158 ~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  234 (321)
T d1tkia_         158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA  234 (321)
T ss_dssp             C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred             C---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHH
Confidence            2   2234568999999999999999999999999999999999999997632211         111111122345578


Q ss_pred             hhhhchhccCCccccccc
Q 039799          328 MEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       328 ~~~~d~~l~~~p~~R~~~  345 (346)
                      .+++.+||..||++|||+
T Consensus       235 ~~li~~~L~~dp~~R~s~  252 (321)
T d1tkia_         235 MDFVDRLLVKERKSRMTA  252 (321)
T ss_dssp             HHHHHTTSCSSGGGSCCH
T ss_pred             HHHHHHHccCChhHCcCH
Confidence            899999999999999985

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-50  Score=357.18  Aligned_cols=238  Identities=24%  Similarity=0.342  Sum_probs=195.0

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCC----EEEEEEecCC-CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCcee
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGM----EVAVKVFDPQ-YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKA  175 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  175 (346)
                      ..+|++.+.||+|+||+||+|.+. +|+    .||+|.+... .....+.+.+|++++++++||||++++++|.+. ..+
T Consensus         8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~   86 (317)
T d1xkka_           8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ   86 (317)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred             HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Cee
Confidence            357999999999999999999875 444    5899988643 334567899999999999999999999999875 567


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCc
Q 039799          176 LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  255 (346)
Q Consensus       176 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~  255 (346)
                      +++|++.+|+|.+.+......+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        87 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~  163 (317)
T d1xkka_          87 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  163 (317)
T ss_dssp             EEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred             EEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence            889999999999988888888999999999999999999999   99999999999999999999999999999998755


Q ss_pred             cccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHhh--------hcCCC
Q 039799          256 EDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVND--------LLPIS  326 (346)
Q Consensus       256 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~--------~~~~~  326 (346)
                      ...........||+.|+|||.+.++.++.++|||||||++|||+| |+.||+.....+  +...+..        .++..
T Consensus       164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~--~~~~i~~~~~~~~p~~~~~~  241 (317)
T d1xkka_         164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSILEKGERLPQPPICTID  241 (317)
T ss_dssp             TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG--HHHHHHHTCCCCCCTTBCHH
T ss_pred             ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH--HHHHHHcCCCCCCCcccCHH
Confidence            444444445568999999999998999999999999999999998 899997643222  2223322        23347


Q ss_pred             hhhhhchhccCCccccccc
Q 039799          327 VMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       327 ~~~~~d~~l~~~p~~R~~~  345 (346)
                      +.+++.+||..||++|||.
T Consensus       242 ~~~li~~cl~~dP~~RPs~  260 (317)
T d1xkka_         242 VYMIMVKCWMIDADSRPKF  260 (317)
T ss_dssp             HHHHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHHhCCCChhhCcCH
Confidence            8999999999999999985

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=8.7e-50  Score=349.00  Aligned_cols=240  Identities=22%  Similarity=0.357  Sum_probs=192.3

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhcCCCCceeeEEEEecCC----
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKIISSYSNDD----  172 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----  172 (346)
                      +.++|.+.+.||+|+||+||+|... +|+.||||++....   ....+.+.+|++++++++||||+++++++...+    
T Consensus         5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~   84 (277)
T d1o6ya_           5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   84 (277)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred             ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence            4567999999999999999999975 79999999997543   334567899999999999999999999887644    


Q ss_pred             ceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCcc
Q 039799          173 FKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  252 (346)
Q Consensus       173 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~  252 (346)
                      ..++||||+++++|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++..+++|||.+..
T Consensus        85 ~~~lvmE~~~g~~L~~~~~~~-~~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~  160 (277)
T d1o6ya_          85 LPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARA  160 (277)
T ss_dssp             EEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred             eEEEEEECCCCCEehhhhccc-CCCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhhh
Confidence            478999999999999887643 46899999999999999999999   99999999999999999999999999999886


Q ss_pred             CCccc-cccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHH----------Hhh
Q 039799          253 LLEED-QSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRW----------VND  321 (346)
Q Consensus       253 ~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~----------~~~  321 (346)
                      ..... .........||+.|+|||++.+..++.++||||+||++|||+||+.||......+ ...+.          ...
T Consensus       161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~  239 (277)
T d1o6ya_         161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS-VAYQHVREDPIPPSARHE  239 (277)
T ss_dssp             CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHCCCCCGGGTSS
T ss_pred             hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH-HHHHHHhcCCCCCchhcc
Confidence            54322 2223345679999999999999999999999999999999999999997532111 11111          122


Q ss_pred             hcCCChhhhhchhccCCccccccc
Q 039799          322 LLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       322 ~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      .+++.+.+++.+||..||++||++
T Consensus       240 ~~s~~l~~li~~~L~~dp~~R~~s  263 (277)
T d1o6ya_         240 GLSADLDAVVLKALAKNPENRYQT  263 (277)
T ss_dssp             SCCHHHHHHHHHHTCSSGGGSCSS
T ss_pred             CCCHHHHHHHHHHccCCHhHCHhH
Confidence            345578999999999999999953

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-49  Score=352.39  Aligned_cols=235  Identities=22%  Similarity=0.324  Sum_probs=196.8

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHH-hcCCCCceeeEEEEecCCceeEE
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMK-RICHRNLIKIISSYSNDDFKALV  177 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~~~~~~lv  177 (346)
                      ++|.+.+.||+|+||+||+|+.. +|+.||||++....   ....+.+..|..++. .++||||+++++++.+++..++|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            46888999999999999999976 78999999986421   223455666777665 68999999999999999999999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccc
Q 039799          178 LEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  257 (346)
Q Consensus       178 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~  257 (346)
                      |||+++|+|.+++.. ...++...+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++......
T Consensus        82 mEy~~~g~L~~~i~~-~~~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~  157 (320)
T d1xjda_          82 MEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD  157 (320)
T ss_dssp             EECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EeecCCCcHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhccccc
Confidence            999999999999864 345888899999999999999999   9999999999999999999999999999998654322


Q ss_pred             cccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh-------hhcCCChhhh
Q 039799          258 QSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN-------DLLPISVMEV  330 (346)
Q Consensus       258 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~-------~~~~~~~~~~  330 (346)
                        .......||+.|+|||.+.+..++.++||||+||++|||+||+.||.....  ..+...+.       ..++..+.++
T Consensus       158 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~--~~~~~~i~~~~~~~p~~~s~~~~dl  233 (320)
T d1xjda_         158 --AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--EELFHSIRMDNPFYPRWLEKEAKDL  233 (320)
T ss_dssp             --CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred             --ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH--HHHHHHHHcCCCCCCccCCHHHHHH
Confidence              223445799999999999999999999999999999999999999975321  11111111       2234588999


Q ss_pred             hchhccCCccccccc
Q 039799          331 VDANLLSQEDEHFTT  345 (346)
Q Consensus       331 ~d~~l~~~p~~R~~~  345 (346)
                      +.+||..||++||++
T Consensus       234 i~~~L~~dP~~R~s~  248 (320)
T d1xjda_         234 LVKLFVREPEKRLGV  248 (320)
T ss_dssp             HHHHSCSSGGGSBTT
T ss_pred             HHHhcccCCCCCcCH
Confidence            999999999999986

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.1e-50  Score=352.80  Aligned_cols=239  Identities=25%  Similarity=0.382  Sum_probs=199.3

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc------CCCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCce
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ------DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFK  174 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  174 (346)
                      .++|++.+.||+|+||+||+|+++      +++.||||+++... ....+++.+|++++++++||||++++++|...+..
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~   91 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM   91 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred             HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCce
Confidence            357899999999999999999864      35789999997543 33457799999999999999999999999999999


Q ss_pred             eEEEecCCCCChhhhhhhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCC
Q 039799          175 ALVLEYMPHGSLEKCLYLSN-----------------------YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKP  231 (346)
Q Consensus       175 ~lv~e~~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~  231 (346)
                      +++|||+++|+|.++++...                       ..+++..++.++.|++.||+|||   +.+++||||||
T Consensus        92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivHrDlKp  168 (301)
T d1lufa_          92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLAT  168 (301)
T ss_dssp             EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSG
T ss_pred             EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeEeeEEcc
Confidence            99999999999999986432                       24889999999999999999999   99999999999


Q ss_pred             CceEECCCCcEEEeeecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCC-CCCCcccc
Q 039799          232 SNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRT-KPTDEIFS  310 (346)
Q Consensus       232 ~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~-~p~~~~~~  310 (346)
                      +|||+|.++.+||+|||+++.+.+...........+++.|+|||.+.+..++.++|||||||++|||++|. +||.....
T Consensus       169 ~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~  248 (301)
T d1lufa_         169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH  248 (301)
T ss_dssp             GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred             cceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCH
Confidence            99999999999999999998765544444445567899999999999999999999999999999999996 56765322


Q ss_pred             CcccHHHHHh--------hhcCCChhhhhchhccCCccccccc
Q 039799          311 GEMTLKRWVN--------DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       311 ~~~~~~~~~~--------~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                        ......+.        ..++..+.+++.+||..+|++|||+
T Consensus       249 --~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~  289 (301)
T d1lufa_         249 --EEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSF  289 (301)
T ss_dssp             --HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             --HHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCH
Confidence              22222222        1234478999999999999999986

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=4.5e-49  Score=356.28  Aligned_cols=235  Identities=23%  Similarity=0.333  Sum_probs=192.7

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC------chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCcee
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY------EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKA  175 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  175 (346)
                      ++|++.+.||+|+||.||+|+.. +|+.||||++....      .........|+++++.++||||+++++++...+..+
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            57899999999999999999976 79999999985321      111222234567777888999999999999999999


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCc
Q 039799          176 LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  255 (346)
Q Consensus       176 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~  255 (346)
                      +||||+++|+|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.+..
T Consensus        84 ivmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~  159 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK  159 (364)
T ss_dssp             EEECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred             EEEEecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence            999999999999998643 56788999999999999999999   99999999999999999999999999999987643


Q ss_pred             cccccccccccCCcccccCCCCCC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccCcc-cHHHHH-------hhhcCCC
Q 039799          256 EDQSLTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM-TLKRWV-------NDLLPIS  326 (346)
Q Consensus       256 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~-~~~~~~-------~~~~~~~  326 (346)
                      .    ......||+.|+|||++.. ..++.++|||||||++|||+||+.||........ .+.+..       ...+++.
T Consensus       160 ~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  235 (364)
T d1omwa3         160 K----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPE  235 (364)
T ss_dssp             S----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHH
T ss_pred             C----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHH
Confidence            2    2234579999999998864 5689999999999999999999999976332221 111111       1123447


Q ss_pred             hhhhhchhccCCccccccc
Q 039799          327 VMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       327 ~~~~~d~~l~~~p~~R~~~  345 (346)
                      +.+++.+||..||++|||+
T Consensus       236 ~~~li~~~L~~dP~~R~t~  254 (364)
T d1omwa3         236 LRSLLEGLLQRDVNRRLGC  254 (364)
T ss_dssp             HHHHHHHHTCSSTTTSTTT
T ss_pred             HHHHHHHHcccCHHHhCCC
Confidence            8999999999999999983

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=6.4e-49  Score=342.37  Aligned_cols=236  Identities=25%  Similarity=0.356  Sum_probs=198.3

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---------chhHHHHHHHHHHHHhcC-CCCceeeEEEEec
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---------EGAFKSFDIECDVMKRIC-HRNLIKIISSYSN  170 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~  170 (346)
                      .++|++.+.||+|+||+||+|+.. +|+.||||++....         ....+.+.+|++++++++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            467899999999999999999975 78999999986542         122346888999999997 9999999999999


Q ss_pred             CCceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCC
Q 039799          171 DDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMA  250 (346)
Q Consensus       171 ~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~  250 (346)
                      ++..++||||+++|+|.+++... ..+++..+..++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a  157 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFS  157 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             CcceEEEEEcCCCchHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccchhe
Confidence            99999999999999999999754 46899999999999999999999   999999999999999999999999999999


Q ss_pred             ccCCccccccccccccCCcccccCCCCC------CCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh----
Q 039799          251 KPLLEEDQSLTQTQTLATIGYMAPEYGR------EGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN----  320 (346)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~----  320 (346)
                      +.+.+..   ......||+.|+|||.+.      ...++.++||||+||++|||+||+.||......+ .......    
T Consensus       158 ~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~-~~~~i~~~~~~  233 (277)
T d1phka_         158 CQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-MLRMIMSGNYQ  233 (277)
T ss_dssp             EECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCCC
T ss_pred             eEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH-HHHHHHhCCCC
Confidence            9764432   234467999999999764      3457889999999999999999999997643211 1111111    


Q ss_pred             ------hhcCCChhhhhchhccCCccccccc
Q 039799          321 ------DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       321 ------~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                            ..+++.+.+++.+||..||++|||+
T Consensus       234 ~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~  264 (277)
T d1phka_         234 FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTA  264 (277)
T ss_dssp             CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCH
T ss_pred             CCCcccccCCHHHHHHHHHHccCChhHCcCH
Confidence                  2345578899999999999999985

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-49  Score=344.63  Aligned_cols=236  Identities=22%  Similarity=0.362  Sum_probs=187.9

Q ss_pred             CCCCCCCcccccCceEEEEEEEcC----CCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEE
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQD----GMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALV  177 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  177 (346)
                      ++|.+.+.||+|+||.||+|.+..    +..||||.+.... ....+.+.+|++++++++||||+++++++. .+..++|
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv   85 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII   85 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence            568888999999999999998652    3568999986543 344577999999999999999999999986 4678999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccc
Q 039799          178 LEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  257 (346)
Q Consensus       178 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~  257 (346)
                      |||+++|+|.+++......+++..++.++.|+++||+|||   +.+|+||||||+||++++++.+||+|||+++......
T Consensus        86 ~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~  162 (273)
T d1mp8a_          86 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST  162 (273)
T ss_dssp             EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred             EEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheeccCCc
Confidence            9999999999988777778999999999999999999999   9999999999999999999999999999998764322


Q ss_pred             cccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHh--------hhcCCChh
Q 039799          258 QSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVN--------DLLPISVM  328 (346)
Q Consensus       258 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~  328 (346)
                       ........||+.|+|||.+.+..++.++|||||||++|||+| |.+||......  .+...+.        ..+++.+.
T Consensus       163 -~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~  239 (273)
T d1mp8a_         163 -YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRIENGERLPMPPNCPPTLY  239 (273)
T ss_dssp             ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             -ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH--HHHHHHHcCCCCCCCCCCCHHHH
Confidence             222334568999999999998999999999999999999998 89999764322  2222222        22344789


Q ss_pred             hhhchhccCCccccccc
Q 039799          329 EVVDANLLSQEDEHFTT  345 (346)
Q Consensus       329 ~~~d~~l~~~p~~R~~~  345 (346)
                      +++.+||..||++|||+
T Consensus       240 ~li~~cl~~dp~~Rps~  256 (273)
T d1mp8a_         240 SLMTKCWAYDPSRRPRF  256 (273)
T ss_dssp             HHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHcCCCHhHCcCH
Confidence            99999999999999985

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-49  Score=342.56  Aligned_cols=230  Identities=31%  Similarity=0.421  Sum_probs=188.2

Q ss_pred             CCCCCCCcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEec-CCceeEEEecC
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSN-DDFKALVLEYM  181 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~  181 (346)
                      ++|++.+.||+|+||.||+|.++ |..||||+++..  ...+.+.+|++++++++||||+++++++.+ .+..++||||+
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~   83 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   83 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence            46778889999999999999986 789999999654  345788999999999999999999999865 45689999999


Q ss_pred             CCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccc
Q 039799          182 PHGSLEKCLYLSN-YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  260 (346)
Q Consensus       182 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~  260 (346)
                      ++|+|.+++.... ..+++..+++++.|++.||+|||   +.+|+||||||+|||++.++.+|++|||+++.....    
T Consensus        84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~----  156 (262)
T d1byga_          84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----  156 (262)
T ss_dssp             TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred             CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCCC----
Confidence            9999999986543 45899999999999999999999   999999999999999999999999999999865322    


Q ss_pred             ccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHHhhh--------cCCChhhhh
Q 039799          261 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWVNDL--------LPISVMEVV  331 (346)
Q Consensus       261 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~--------~~~~~~~~~  331 (346)
                       .....++..|+|||++.+..++.++||||||+++|||+| |+.|+....  ..+...++...        +++.+.+++
T Consensus       157 -~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~li  233 (262)
T d1byga_         157 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--LKDVVPRVEKGYKMDAPDGCPPAVYEVM  233 (262)
T ss_dssp             ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC--GGGHHHHHTTTCCCCCCTTCCHHHHHHH
T ss_pred             -CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCC--HHHHHHHHHcCCCCCCCccCCHHHHHHH
Confidence             233457899999999988899999999999999999998 788876532  22344444322        334889999


Q ss_pred             chhccCCccccccc
Q 039799          332 DANLLSQEDEHFTT  345 (346)
Q Consensus       332 d~~l~~~p~~R~~~  345 (346)
                      .+||..||++|||+
T Consensus       234 ~~cl~~dP~~Rps~  247 (262)
T d1byga_         234 KNCWHLDAAMRPSF  247 (262)
T ss_dssp             HHHTCSSGGGSCCH
T ss_pred             HHHcccCHhHCcCH
Confidence            99999999999986

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-49  Score=345.84  Aligned_cols=237  Identities=26%  Similarity=0.372  Sum_probs=189.1

Q ss_pred             CCCCCCCcccccCceEEEEEEEc--CC--CEEEEEEecCC---CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCCcee
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ--DG--MEVAVKVFDPQ---YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKA  175 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~--~~--~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  175 (346)
                      ++|++.+.||+|+||.||+|++.  ++  ..||||+++..   .....++|.+|++++++++||||+++++++.+ +..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            56888899999999999999864  22  36899998653   34456789999999999999999999999965 4678


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCc
Q 039799          176 LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  255 (346)
Q Consensus       176 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~  255 (346)
                      +||||+++|++.+.+......+++..++.++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus        87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~  163 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  163 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence            999999999999988877778999999999999999999999   99999999999999999999999999999998754


Q ss_pred             cccc-cccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccHHHHH---------hhhcC
Q 039799          256 EDQS-LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTLKRWV---------NDLLP  324 (346)
Q Consensus       256 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~---------~~~~~  324 (346)
                      .... .......++..|+|||.+.+..++.++||||||+++|||+| |+.||......  ....++         ...++
T Consensus       164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~--~~~~~i~~~~~~~~~~~~~~  241 (273)
T d1u46a_         164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS--QILHKIDKEGERLPRPEDCP  241 (273)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTSCCCCCCCTTCC
T ss_pred             CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH--HHHHHHHhCCCCCCCccccc
Confidence            4322 22234457889999999999999999999999999999998 89999753211  122222         12234


Q ss_pred             CChhhhhchhccCCccccccc
Q 039799          325 ISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       325 ~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ..+.+++.+||..||++|||.
T Consensus       242 ~~l~~li~~cl~~dp~~RPt~  262 (273)
T d1u46a_         242 QDIYNVMVQCWAHKPEDRPTF  262 (273)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHHHHHcCCChhHCcCH
Confidence            588899999999999999985

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-48  Score=344.75  Aligned_cols=234  Identities=24%  Similarity=0.417  Sum_probs=194.0

Q ss_pred             CCcccccCceEEEEEEEcCC----CEEEEEEecCC-CchhHHHHHHHHHHHHhcCCCCceeeEEEEec-CCceeEEEecC
Q 039799          108 PPLIGKGGFGSVYKAIIQDG----MEVAVKVFDPQ-YEGAFKSFDIECDVMKRICHRNLIKIISSYSN-DDFKALVLEYM  181 (346)
Q Consensus       108 ~~~lg~G~~g~vy~~~~~~~----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~  181 (346)
                      .++||+|+||+||+|.+.++    ..||||+++.. .....+++.+|++++++++||||++++|++.. +...++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            57899999999999997532    25899999743 45556889999999999999999999999875 55789999999


Q ss_pred             CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccc--
Q 039799          182 PHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS--  259 (346)
Q Consensus       182 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~--  259 (346)
                      ++|+|.+++.......++..++.++.|+++||.|||   +.+|+||||||+|||+++++.+||+|||+++........  
T Consensus       112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~  188 (311)
T d1r0pa_         112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV  188 (311)
T ss_dssp             TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred             ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence            999999998877778889999999999999999999   999999999999999999999999999999976543322  


Q ss_pred             cccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHh--------hhcCCChhhhh
Q 039799          260 LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVN--------DLLPISVMEVV  331 (346)
Q Consensus       260 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~  331 (346)
                      .......||+.|+|||.+.+..++.++||||||+++|||+||..||...... .+...++.        ...++.+.+++
T Consensus       189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~-~~~~~~i~~g~~~~~p~~~~~~l~~li  267 (311)
T d1r0pa_         189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVYLLQGRRLLQPEYCPDPLYEVM  267 (311)
T ss_dssp             TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred             eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH-HHHHHHHHcCCCCCCcccCcHHHHHHH
Confidence            2223456899999999998899999999999999999999988887653222 22233332        22344789999


Q ss_pred             chhccCCccccccc
Q 039799          332 DANLLSQEDEHFTT  345 (346)
Q Consensus       332 d~~l~~~p~~R~~~  345 (346)
                      .+||..||++||++
T Consensus       268 ~~cl~~dP~~RPs~  281 (311)
T d1r0pa_         268 LKCWHPKAEMRPSF  281 (311)
T ss_dssp             HHHTCSSGGGSCCH
T ss_pred             HHHcCCCHhHCcCH
Confidence            99999999999986

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.9e-48  Score=350.26  Aligned_cols=230  Identities=20%  Similarity=0.257  Sum_probs=197.4

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEE
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY---EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVL  178 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  178 (346)
                      ++|++.+.||+|+||.||+|..+ +|+.||||++....   ....+.+.+|+++++.++||||+++++++...+..++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            56999999999999999999976 79999999986421   233567889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccc
Q 039799          179 EYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  258 (346)
Q Consensus       179 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~  258 (346)
                      ||+.+|+|.+++... ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+|+.+...  
T Consensus       121 e~~~~g~l~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--  194 (350)
T ss_dssp             ECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred             ccccccchhhhHhhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--
Confidence            999999999988644 46899999999999999999999   999999999999999999999999999999976432  


Q ss_pred             ccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH-h------hhcCCChhhhh
Q 039799          259 SLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV-N------DLLPISVMEVV  331 (346)
Q Consensus       259 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~-~------~~~~~~~~~~~  331 (346)
                         .....||+.|+|||++.+..++.++|||||||++|||+||+.||....  .......+ .      ..+++.+.+++
T Consensus       195 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~--~~~~~~~i~~~~~~~p~~~s~~~~~li  269 (350)
T d1rdqe_         195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ--PIQIYEKIVSGKVRFPSHFSSDLKDLL  269 (350)
T ss_dssp             ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHCCCCCCTTCCHHHHHHH
T ss_pred             ---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC--HHHHHHHHhcCCCCCCccCCHHHHHHH
Confidence               234569999999999999999999999999999999999999997532  11111111 1      22345789999


Q ss_pred             chhccCCccccc
Q 039799          332 DANLLSQEDEHF  343 (346)
Q Consensus       332 d~~l~~~p~~R~  343 (346)
                      .+||..||.+|+
T Consensus       270 ~~~L~~dP~kR~  281 (350)
T d1rdqe_         270 RNLLQVDLTKRF  281 (350)
T ss_dssp             HHHSCSCTTTCT
T ss_pred             HHHhhhCHHhcc
Confidence            999999999996

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-48  Score=348.03  Aligned_cols=233  Identities=21%  Similarity=0.292  Sum_probs=192.6

Q ss_pred             CCCCCCC-CcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhc-CCCCceeeEEEEec----CCce
Q 039799          102 PNDANMP-PLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRI-CHRNLIKIISSYSN----DDFK  174 (346)
Q Consensus       102 ~~~~~~~-~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~----~~~~  174 (346)
                      -++|.+. +.||+|+||+||+|... +++.||||+++..     ..+.+|++++.++ +||||+++++++.+    +...
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            3568775 46999999999999975 7899999998642     4566799887655 89999999998864    4678


Q ss_pred             eEEEecCCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC---CCcEEEeeecCC
Q 039799          175 ALVLEYMPHGSLEKCLYLSN-YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD---NMVAHLSDFGMA  250 (346)
Q Consensus       175 ~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~---~~~~~l~Dfg~~  250 (346)
                      ++||||++||+|.+++.... ..+++..+..++.|++.||+|||   +.+|+||||||+|||+++   .+.+||+|||+|
T Consensus        85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a  161 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  161 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH---HcCCcccccccccccccccccccccccccccee
Confidence            99999999999999997543 56999999999999999999999   999999999999999985   567999999999


Q ss_pred             ccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCc-------------ccHHH
Q 039799          251 KPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE-------------MTLKR  317 (346)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~-------------~~~~~  317 (346)
                      +......   ......||+.|+|||++.+..++.++||||+||++|||+||+.||.......             .....
T Consensus       162 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~  238 (335)
T d2ozaa1         162 KETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN  238 (335)
T ss_dssp             EECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCT
T ss_pred             eeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCC
Confidence            8764432   2344579999999999999999999999999999999999999996532111             11111


Q ss_pred             HHhhhcCCChhhhhchhccCCccccccc
Q 039799          318 WVNDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       318 ~~~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      .....+++.+.+++.+||..||++|||+
T Consensus       239 ~~~~~~s~~~~~li~~~L~~dP~~R~s~  266 (335)
T d2ozaa1         239 PEWSEVSEEVKMLIRNLLKTEPTQRMTI  266 (335)
T ss_dssp             THHHHSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred             cccccCCHHHHHHHHHHccCChhHCcCH
Confidence            2233456688999999999999999985

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-48  Score=342.50  Aligned_cols=240  Identities=22%  Similarity=0.347  Sum_probs=188.2

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc------CCCEEEEEEecCCC-chhHHHHHHHHHHHHhc-CCCCceeeEEEEecC-C
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ------DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRI-CHRNLIKIISSYSND-D  172 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-~  172 (346)
                      .++|.+.+.||+|+||.||+|.+.      +++.||||+++... ....+.+.+|...+.++ +|+||+.+++++.+. .
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~   91 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   91 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence            357889999999999999999864      24689999987543 34456777888888877 689999999988664 4


Q ss_pred             ceeEEEecCCCCChhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEEC
Q 039799          173 FKALVLEYMPHGSLEKCLYLSN---------------YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD  237 (346)
Q Consensus       173 ~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~  237 (346)
                      ..++||||+++|+|.++++...               ..+++..+..++.|+++||+|||   +.+|+||||||+|||++
T Consensus        92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~NILl~  168 (299)
T d1ywna1          92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLS  168 (299)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEC
T ss_pred             eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCccceeEC
Confidence            6889999999999999986432               34889999999999999999999   99999999999999999


Q ss_pred             CCCcEEEeeecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCC-CCCCccccCcccHH
Q 039799          238 DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRT-KPTDEIFSGEMTLK  316 (346)
Q Consensus       238 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~-~p~~~~~~~~~~~~  316 (346)
                      +++.+||+|||+|+...............||+.|+|||.+.+..++.++|||||||++|||+||. .||...... ..+.
T Consensus       169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~-~~~~  247 (299)
T d1ywna1         169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-EEFC  247 (299)
T ss_dssp             GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS-HHHH
T ss_pred             CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH-HHHH
Confidence            99999999999998765544444445567999999999999999999999999999999999975 577653222 2222


Q ss_pred             HHHhh--------hcCCChhhhhchhccCCccccccc
Q 039799          317 RWVND--------LLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       317 ~~~~~--------~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ..+..        .+++.+.+++.+||..||++|||+
T Consensus       248 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~  284 (299)
T d1ywna1         248 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTF  284 (299)
T ss_dssp             HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCH
Confidence            33322        233478899999999999999985

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-48  Score=341.29  Aligned_cols=238  Identities=23%  Similarity=0.266  Sum_probs=191.4

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEe
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLE  179 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  179 (346)
                      ++|.+.+.||+|+||+||+|... +|+.||||++....  +...+++.+|++++++++||||+++++++.+.+..++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            46888899999999999999975 79999999986442  2235788899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccc
Q 039799          180 YMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  259 (346)
Q Consensus       180 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~  259 (346)
                      |+.++.+..........+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||.|+......  
T Consensus        82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~--  156 (298)
T d1gz8a_          82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--  156 (298)
T ss_dssp             CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS--
T ss_pred             ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccCCc--
Confidence            99765554443444567999999999999999999999   9999999999999999999999999999998654322  


Q ss_pred             cccccccCCcccccCCCCCCCC-CCcchhHHHHHHHHHHHHcCCCCCCccccCcc-------------------------
Q 039799          260 LTQTQTLATIGYMAPEYGREGR-VSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM-------------------------  313 (346)
Q Consensus       260 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~-------------------------  313 (346)
                      .......||+.|+|||...... ++.++||||+||++|||++|+.||......+.                         
T Consensus       157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  236 (298)
T d1gz8a_         157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY  236 (298)
T ss_dssp             BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccc
Confidence            2334457999999999766554 57899999999999999999999964211000                         


Q ss_pred             ---------cHHHHHhhhcCCChhhhhchhccCCccccccc
Q 039799          314 ---------TLKRWVNDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       314 ---------~~~~~~~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                               .........++..+.+++.+||..||++|||+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~  277 (298)
T d1gz8a_         237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA  277 (298)
T ss_dssp             CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCH
Confidence                     00001111233467889999999999999986

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-48  Score=342.76  Aligned_cols=239  Identities=23%  Similarity=0.365  Sum_probs=201.0

Q ss_pred             CCCCCCCcccccCceEEEEEEEc------CCCEEEEEEecCCC-chhHHHHHHHHHHHHhc-CCCCceeeEEEEecCCce
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ------DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRI-CHRNLIKIISSYSNDDFK  174 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  174 (346)
                      ++|.+.+.||+|+||.||+|++.      +++.||||+++... ......+.+|+.+++++ +||||+++++++.+.+..
T Consensus        23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~  102 (311)
T d1t46a_          23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT  102 (311)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence            56778899999999999999863      45689999997643 34456788999999999 699999999999999999


Q ss_pred             eEEEecCCCCChhhhhhhcC-----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEEC
Q 039799          175 ALVLEYMPHGSLEKCLYLSN-----------------YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD  237 (346)
Q Consensus       175 ~lv~e~~~~gsL~~~l~~~~-----------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~  237 (346)
                      ++||||+++|+|.+++....                 ..+++..+..++.|+++|++|||   +++++||||||+||+++
T Consensus       103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NIl~~  179 (311)
T d1t46a_         103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLT  179 (311)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEE
T ss_pred             EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccccccccccc
Confidence            99999999999999986432                 35889999999999999999999   99999999999999999


Q ss_pred             CCCcEEEeeecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcC-CCCCCccccCcccHH
Q 039799          238 DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTR-TKPTDEIFSGEMTLK  316 (346)
Q Consensus       238 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg-~~p~~~~~~~~~~~~  316 (346)
                      .++.++++|||.++...............||+.|+|||.+.+..++.++||||||+++|||+|+ .+|+.. ......+.
T Consensus       180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~-~~~~~~~~  258 (311)
T d1t46a_         180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG-MPVDSKFY  258 (311)
T ss_dssp             TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT-CCSSHHHH
T ss_pred             ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCC-CCHHHHHH
Confidence            9999999999999987654444444556789999999999989999999999999999999995 554543 33333344


Q ss_pred             HHHhhh--------cCCChhhhhchhccCCccccccc
Q 039799          317 RWVNDL--------LPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       317 ~~~~~~--------~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      +.+...        ++..+.+++.+||..||++|||+
T Consensus       259 ~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~  295 (311)
T d1t46a_         259 KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTF  295 (311)
T ss_dssp             HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCH
Confidence            444332        34478899999999999999985

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-48  Score=342.52  Aligned_cols=232  Identities=24%  Similarity=0.311  Sum_probs=186.1

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEecCCCc-----hhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEecC
Q 039799          108 PPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYE-----GAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEYM  181 (346)
Q Consensus       108 ~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  181 (346)
                      .++||+|+||+||+|..+ +|+.||||+++....     ...+.+.+|++++++++||||+++++++...+..++||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            357999999999999975 799999999864322     12346889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccccc
Q 039799          182 PHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT  261 (346)
Q Consensus       182 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~~  261 (346)
                      .++++.... .....+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++......  ..
T Consensus        83 ~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~--~~  156 (299)
T d1ua2a_          83 ETDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--RA  156 (299)
T ss_dssp             SEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC--CC
T ss_pred             cchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCCc--cc
Confidence            888776654 34566888889999999999999999   9999999999999999999999999999998764432  22


Q ss_pred             cccccCCcccccCCCCCC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccCcc---------------------------
Q 039799          262 QTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM---------------------------  313 (346)
Q Consensus       262 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~---------------------------  313 (346)
                      ....+||+.|+|||.+.. ..++.++||||+||++|||+||+.||......+.                           
T Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~  236 (299)
T d1ua2a_         157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT  236 (299)
T ss_dssp             CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCC
T ss_pred             ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhh
Confidence            234569999999998764 4579999999999999999999999964221100                           


Q ss_pred             ------cHHHHHhhhcCCChhhhhchhccCCccccccc
Q 039799          314 ------TLKRWVNDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       314 ------~~~~~~~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                            .-........++.+.+++.+||..||++|||+
T Consensus       237 ~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa  274 (299)
T d1ua2a_         237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITA  274 (299)
T ss_dssp             CCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCH
T ss_pred             hccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCH
Confidence                  00011112234477889999999999999986

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-48  Score=339.53  Aligned_cols=239  Identities=26%  Similarity=0.350  Sum_probs=196.2

Q ss_pred             CCCCCCCCcccccCceEEEEEEEcC--------CCEEEEEEecCCCc-hhHHHHHHHHHHHHhc-CCCCceeeEEEEecC
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQD--------GMEVAVKVFDPQYE-GAFKSFDIECDVMKRI-CHRNLIKIISSYSND  171 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  171 (346)
                      .++|.+.+.||+|+||.||+|+...        +..||||+++.... .....+.+|...+.++ +||||++++++|.++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            3567888999999999999998532        24799999976543 3457788899999888 899999999999999


Q ss_pred             CceeEEEecCCCCChhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEE
Q 039799          172 DFKALVLEYMPHGSLEKCLYLSN---------------YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL  236 (346)
Q Consensus       172 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll  236 (346)
                      +..++||||+++|+|.+++....               ..+++..++.++.|++.||+|||   +.+|+||||||+|||+
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccceee
Confidence            99999999999999999986443               35899999999999999999999   9999999999999999


Q ss_pred             CCCCcEEEeeecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccCcccH
Q 039799          237 DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFT-RTKPTDEIFSGEMTL  315 (346)
Q Consensus       237 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~  315 (346)
                      +.++.+||+|||+++...............+++.|+|||.+.++.++.++||||||+++|||+| |..||......  ..
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~--~~  246 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--EL  246 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HH
T ss_pred             cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH--HH
Confidence            9999999999999998765544444455678999999999999999999999999999999998 78888653321  22


Q ss_pred             HHHHhhh--------cCCChhhhhchhccCCccccccc
Q 039799          316 KRWVNDL--------LPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       316 ~~~~~~~--------~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      .+.+...        +++.+.+++.+||..||.+|||+
T Consensus       247 ~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~  284 (299)
T d1fgka_         247 FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTF  284 (299)
T ss_dssp             HHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCH
Confidence            3333222        33478999999999999999986

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-48  Score=344.16  Aligned_cols=235  Identities=29%  Similarity=0.416  Sum_probs=192.2

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCC--EEEEEEecCC-CchhHHHHHHHHHHHHhc-CCCCceeeEEEEecCCceeEE
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGM--EVAVKVFDPQ-YEGAFKSFDIECDVMKRI-CHRNLIKIISSYSNDDFKALV  177 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  177 (346)
                      ++|++.+.||+|+||+||+|.++ +|.  .||||.+... .....+.+.+|++++.++ +||||+++++++.+.+..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            57888899999999999999976 444  4788887543 333456789999999998 799999999999999999999


Q ss_pred             EecCCCCChhhhhhhc---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcE
Q 039799          178 LEYMPHGSLEKCLYLS---------------NYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVA  242 (346)
Q Consensus       178 ~e~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~  242 (346)
                      |||+++|+|.++++..               ...+++..++.++.|+++|+.|||   +.+|+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCce
Confidence            9999999999998643               357899999999999999999999   9999999999999999999999


Q ss_pred             EEeeecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCC-CCCCccccCcccHHHHHhh
Q 039799          243 HLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRT-KPTDEIFSGEMTLKRWVND  321 (346)
Q Consensus       243 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~-~p~~~~~~~~~~~~~~~~~  321 (346)
                      ||+|||+++......   ......||..|+|||.+.+..++.++|||||||++|||++|. +||....  ...+...+..
T Consensus       167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~--~~~~~~~i~~  241 (309)
T d1fvra_         167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--CAELYEKLPQ  241 (309)
T ss_dssp             EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHHGGG
T ss_pred             EEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC--HHHHHHHHHh
Confidence            999999998653322   223345899999999999999999999999999999999976 4665422  2222233322


Q ss_pred             --------hcCCChhhhhchhccCCccccccc
Q 039799          322 --------LLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       322 --------~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                              .+++.+.+++.+||..||++|||+
T Consensus       242 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~  273 (309)
T d1fvra_         242 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSF  273 (309)
T ss_dssp             TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             cCCCCCCccCCHHHHHHHHHHcCCChhHCcCH
Confidence                    244578999999999999999986

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-49  Score=343.17  Aligned_cols=237  Identities=23%  Similarity=0.304  Sum_probs=192.6

Q ss_pred             CCCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCc------hhHHHHHHHHHHHHhcC--CCCceeeEEEEec
Q 039799          100 PLPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYE------GAFKSFDIECDVMKRIC--HRNLIKIISSYSN  170 (346)
Q Consensus       100 ~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~  170 (346)
                      ++.++|.+.+.||+|+||+||+|... +|+.||||++.....      ....++.+|+.++++++  ||||+++++++.+
T Consensus         1 pl~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~   80 (273)
T d1xwsa_           1 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER   80 (273)
T ss_dssp             CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred             CCCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEee
Confidence            35678999999999999999999975 789999999864311      11234567999999996  8999999999999


Q ss_pred             CCceeEEEecCCC-CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC-CCcEEEeeec
Q 039799          171 DDFKALVLEYMPH-GSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD-NMVAHLSDFG  248 (346)
Q Consensus       171 ~~~~~lv~e~~~~-gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~-~~~~~l~Dfg  248 (346)
                      .+..++||||+.+ +++.+++.. ...+++..+..++.|++.||+|||   +.+|+||||||+|||++. ++.+||+|||
T Consensus        81 ~~~~~lv~e~~~~~~~l~~~~~~-~~~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG  156 (273)
T d1xwsa_          81 PDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFG  156 (273)
T ss_dssp             SSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             CCeEEEEEEeccCcchHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECccc
Confidence            9999999999976 577776653 456899999999999999999999   999999999999999985 5799999999


Q ss_pred             CCccCCccccccccccccCCcccccCCCCCCCCC-CcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHHhhhcCCCh
Q 039799          249 MAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWVNDLLPISV  327 (346)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  327 (346)
                      +++.....    ......||+.|+|||++.+..+ +.++||||+||++|||+||+.||.....- .......+..+++.+
T Consensus       157 ~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i-~~~~~~~~~~~s~~~  231 (273)
T d1xwsa_         157 SGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI-IRGQVFFRQRVSSEC  231 (273)
T ss_dssp             TCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH-HHCCCCCSSCCCHHH
T ss_pred             cceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHH-hhcccCCCCCCCHHH
Confidence            99865322    2345679999999998876665 57789999999999999999999752100 000011223456688


Q ss_pred             hhhhchhccCCccccccc
Q 039799          328 MEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       328 ~~~~d~~l~~~p~~R~~~  345 (346)
                      .+++.+||..||++|||+
T Consensus       232 ~~li~~~L~~dp~~R~s~  249 (273)
T d1xwsa_         232 QHLIRWCLALRPSDRPTF  249 (273)
T ss_dssp             HHHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHHccCCHhHCcCH
Confidence            999999999999999986

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-48  Score=340.92  Aligned_cols=239  Identities=23%  Similarity=0.386  Sum_probs=198.1

Q ss_pred             CCCCCCCcccccCceEEEEEEEc------CCCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCcee
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ------DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKA  175 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  175 (346)
                      ++|.+.+.||+|+||+||+|.+.      ++..||||+++... ......+.+|++++++++||||+++++++...+..+
T Consensus        20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~   99 (308)
T d1p4oa_          20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL   99 (308)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence            45677788999999999999864      35789999997543 344567889999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhhhcC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEee
Q 039799          176 LVLEYMPHGSLEKCLYLSN---------YILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSD  246 (346)
Q Consensus       176 lv~e~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~D  246 (346)
                      +||||+++|+|.+++....         ..+++..+..++.++++||.|||   +.+|+||||||+|||+++++.+||+|
T Consensus       100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~Kl~D  176 (308)
T d1p4oa_         100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGD  176 (308)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEECC
T ss_pred             EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceEEEee
Confidence            9999999999999876432         34789999999999999999999   89999999999999999999999999


Q ss_pred             ecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCC-CCCCccccCcccHHHHHh-----
Q 039799          247 FGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRT-KPTDEIFSGEMTLKRWVN-----  320 (346)
Q Consensus       247 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~-~p~~~~~~~~~~~~~~~~-----  320 (346)
                      ||+++.+.............+|+.|+|||.+.+..++.++||||||+++|||+||. .||..... ...+....+     
T Consensus       177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~-~~~~~~i~~~~~~~  255 (308)
T d1p4oa_         177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-EQVLRFVMEGGLLD  255 (308)
T ss_dssp             TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-HHHHHHHHTTCCCC
T ss_pred             cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHhCCCCC
Confidence            99999775554444445556899999999999999999999999999999999985 66654221 111111111     


Q ss_pred             --hhcCCChhhhhchhccCCccccccc
Q 039799          321 --DLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       321 --~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                        ..++..+.+++.+||..+|++|||+
T Consensus       256 ~p~~~~~~l~~li~~cl~~~P~~RPs~  282 (308)
T d1p4oa_         256 KPDNCPDMLFELMRMCWQYNPKMRPSF  282 (308)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CcccchHHHHHHHHHHcCCChhHCcCH
Confidence              2233478999999999999999985

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-47  Score=338.31  Aligned_cols=238  Identities=24%  Similarity=0.332  Sum_probs=181.6

Q ss_pred             CCCCCCcccccCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEecCC----ceeEEEe
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSNDD----FKALVLE  179 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~lv~e  179 (346)
                      +|.+.+.||+|+||.||+|+++ |+.||||+++... ......+.|+..+.+++||||+++++++...+    ..++|||
T Consensus         4 ~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E   81 (303)
T d1vjya_           4 TIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD   81 (303)
T ss_dssp             GEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccc-hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence            4556778999999999999975 8899999996432 21222334555666789999999999997654    5789999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCeeecCCCCCceEECCCCcEEEeeecCCccCC
Q 039799          180 YMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFG-----YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  254 (346)
Q Consensus       180 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~  254 (346)
                      |+++|+|.++++..  .++|..++.++.++|.||+|||..     .+++|+||||||+|||++.++.+||+|||+++...
T Consensus        82 y~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~  159 (303)
T d1vjya_          82 YHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD  159 (303)
T ss_dssp             CCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred             cccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccccc
Confidence            99999999999753  589999999999999999999942     24699999999999999999999999999999765


Q ss_pred             ccccc--cccccccCCcccccCCCCCCCC------CCcchhHHHHHHHHHHHHcCCCCCCccccCc----------ccHH
Q 039799          255 EEDQS--LTQTQTLATIGYMAPEYGREGR------VSTNGDVYSFGIMLMEIFTRTKPTDEIFSGE----------MTLK  316 (346)
Q Consensus       255 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~------~~~~~Dv~s~G~il~elltg~~p~~~~~~~~----------~~~~  316 (346)
                      .....  .......||+.|+|||++.+..      ++.++|||||||++|||+||..|+.......          ....
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~  239 (303)
T d1vjya_         160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE  239 (303)
T ss_dssp             TTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred             CCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHH
Confidence            43221  2234567999999999876542      5778999999999999999998874321111          1111


Q ss_pred             HHHh----hhc----C---------CChhhhhchhccCCccccccc
Q 039799          317 RWVN----DLL----P---------ISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       317 ~~~~----~~~----~---------~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ....    ...    +         ..+.+++.+||..||++|||+
T Consensus       240 ~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~  285 (303)
T d1vjya_         240 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA  285 (303)
T ss_dssp             HHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCH
T ss_pred             HHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCH
Confidence            1111    011    1         137789999999999999985

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=3e-47  Score=334.52  Aligned_cols=236  Identities=22%  Similarity=0.297  Sum_probs=190.8

Q ss_pred             CCCCCCCcccccCceEEEEEEEcCCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEec
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLEY  180 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  180 (346)
                      ++|.+.+.||+|+||+||+|++++|+.||||+++...  ....+++.+|+.++++++||||+++++++...+..++++|+
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            4688889999999999999999999999999996543  22357889999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCcccccc
Q 039799          181 MPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  260 (346)
Q Consensus       181 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~~  260 (346)
                      +.++.+..+. .....++...+..++.|++.||+|||   +.+|+||||||+|||++.++.+|++|||.+.......  .
T Consensus        82 ~~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~--~  155 (286)
T d1ob3a_          82 LDQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV--R  155 (286)
T ss_dssp             CSEEHHHHHH-TSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             ehhhhHHHHH-hhcCCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccCc--c
Confidence            9877666554 45567999999999999999999999   9999999999999999999999999999998754322  2


Q ss_pred             ccccccCCcccccCCCCCCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHH---------------------
Q 039799          261 TQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRW---------------------  318 (346)
Q Consensus       261 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~---------------------  318 (346)
                      ......+++.|+|||.+.+. .++.++||||+||+++||++|+.||......+. +.+.                     
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~  234 (286)
T d1ob3a_         156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ-LMRIFRILGTPNSKNWPNVTELPKY  234 (286)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH-HHHHHHhhCCCChhhccchhhhhhc
Confidence            23344689999999987654 568999999999999999999999965321110 0000                     


Q ss_pred             --------------HhhhcCCChhhhhchhccCCccccccc
Q 039799          319 --------------VNDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       319 --------------~~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                                    ....++..+.+++.+||..||++|||+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~  275 (286)
T d1ob3a_         235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA  275 (286)
T ss_dssp             CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCH
Confidence                          001122356789999999999999986

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-46  Score=333.69  Aligned_cols=237  Identities=23%  Similarity=0.282  Sum_probs=189.0

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-C-CCEEEEEEecCCC--chhHHHHHHHHHHHHhc---CCCCceeeEEEEec----
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-D-GMEVAVKVFDPQY--EGAFKSFDIECDVMKRI---CHRNLIKIISSYSN----  170 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~----  170 (346)
                      .++|++.+.||+|+||+||+|... + ++.||||++....  ......+.+|+.+++.+   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            367999999999999999999974 4 5679999985422  22233455677776655   79999999998853    


Q ss_pred             -CCceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecC
Q 039799          171 -DDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGM  249 (346)
Q Consensus       171 -~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~  249 (346)
                       ....+++|||++++++..........+++.....++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~dfg~  162 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGL  162 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred             cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecchhh
Confidence             34778999999988877666656677999999999999999999999   99999999999999999999999999999


Q ss_pred             CccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHH-----------
Q 039799          250 AKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRW-----------  318 (346)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~-----------  318 (346)
                      ++.....   .......||+.|+|||++.+..++.++||||+||++|||+||+.||......+ .+...           
T Consensus       163 ~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~  238 (305)
T d1blxa_         163 ARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIGLPGEED  238 (305)
T ss_dssp             CCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCGGG
T ss_pred             hhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH-HHHHHHHhhCCCchhc
Confidence            9865332   23345679999999999999999999999999999999999999997532110 00000           


Q ss_pred             ----------------------HhhhcCCChhhhhchhccCCccccccc
Q 039799          319 ----------------------VNDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       319 ----------------------~~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                                            ....+++.+.+++.+||..||++|||+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa  287 (305)
T d1blxa_         239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA  287 (305)
T ss_dssp             SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCH
T ss_pred             ccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCH
Confidence                                  011123356789999999999999986

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-44  Score=326.05  Aligned_cols=239  Identities=22%  Similarity=0.259  Sum_probs=188.7

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHHhcCCCCceeeEEEEecCC----cee
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY-EGAFKSFDIECDVMKRICHRNLIKIISSYSNDD----FKA  175 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~  175 (346)
                      .++|.+.+.||+|+||+||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            456889999999999999999865 89999999997543 344678889999999999999999999986543    234


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCc
Q 039799          176 LVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  255 (346)
Q Consensus       176 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~  255 (346)
                      ++++++.+|+|.+++...  .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        87 ~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~  161 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP  161 (345)
T ss_dssp             EEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred             EEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence            555667799999998643  5899999999999999999999   99999999999999999999999999999987654


Q ss_pred             cccc-cccccccCCcccccCCCCCC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccH------------------
Q 039799          256 EDQS-LTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTL------------------  315 (346)
Q Consensus       256 ~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~------------------  315 (346)
                      .... .......||+.|+|||.+.. ..++.++||||+||+++||++|+.||......+...                  
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (345)
T d1pmea_         162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII  241 (345)
T ss_dssp             GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCC
T ss_pred             CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhh
Confidence            3322 22344669999999998754 467899999999999999999999996532110000                  


Q ss_pred             ----------------HHH--HhhhcCCChhhhhchhccCCccccccc
Q 039799          316 ----------------KRW--VNDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       316 ----------------~~~--~~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                                      ..|  ....++..+.+++.+||..||++|||+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta  289 (345)
T d1pmea_         242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV  289 (345)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred             hhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCH
Confidence                            000  011123357899999999999999986

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=9e-45  Score=319.28  Aligned_cols=236  Identities=16%  Similarity=0.173  Sum_probs=195.7

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCC-CCceeeEEEEecCCceeEEEec
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICH-RNLIKIISSYSNDDFKALVLEY  180 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~  180 (346)
                      ..|.+.+.||+|+||+||+|++. +|+.||||++.....  ...+.+|++.++.+.| +|++.+++++......++||||
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~   82 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL   82 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence            56888999999999999999976 789999999865432  2456678899999975 8999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC-----CCcEEEeeecCCccCCc
Q 039799          181 MPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD-----NMVAHLSDFGMAKPLLE  255 (346)
Q Consensus       181 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~-----~~~~~l~Dfg~~~~~~~  255 (346)
                      + +++|.+++......+++..+..++.+++.||+|||   +.+|+||||||+|||++.     ++.++|+|||+|+.+..
T Consensus        83 ~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~  158 (293)
T d1csna_          83 L-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD  158 (293)
T ss_dssp             C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred             c-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence            9 78999988877778999999999999999999999   999999999999999974     57899999999997654


Q ss_pred             cccc-----cccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcc-cHHHH-----------
Q 039799          256 EDQS-----LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM-TLKRW-----------  318 (346)
Q Consensus       256 ~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~-~~~~~-----------  318 (346)
                      ....     .......||+.|+|||++.+..++.++||||||+++|||+||+.||........ .....           
T Consensus       159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~  238 (293)
T d1csna_         159 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR  238 (293)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHH
T ss_pred             CccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChH
Confidence            3211     123345799999999999999999999999999999999999999975332211 11111           


Q ss_pred             -HhhhcCCChhhhhchhccCCcccccc
Q 039799          319 -VNDLLPISVMEVVDANLLSQEDEHFT  344 (346)
Q Consensus       319 -~~~~~~~~~~~~~d~~l~~~p~~R~~  344 (346)
                       ....+|+.+.+++..|+..+|++||+
T Consensus       239 ~l~~~~p~~l~~ii~~~~~~~~~~rP~  265 (293)
T d1csna_         239 ELCAGFPEEFYKYMHYARNLAFDATPD  265 (293)
T ss_dssp             HHTTTSCHHHHHHHHHHHHCCTTCCCC
T ss_pred             HhcCCCCHHHHHHHHHHhcCCcccCcC
Confidence             11235668899999999999999996

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-45  Score=329.60  Aligned_cols=231  Identities=25%  Similarity=0.333  Sum_probs=183.7

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceeeEEEEec------CCceeE
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKIISSYSN------DDFKAL  176 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~~~l  176 (346)
                      +|+..++||+|+||+||+|+.. +|+.||||++......    ..+|++++++++||||+++++++..      ..+.++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            5888899999999999999976 7999999999754322    2369999999999999999998853      235789


Q ss_pred             EEecCCCCChhhhhh--hcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCC-cEEEeeecCCccC
Q 039799          177 VLEYMPHGSLEKCLY--LSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM-VAHLSDFGMAKPL  253 (346)
Q Consensus       177 v~e~~~~gsL~~~l~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~-~~~l~Dfg~~~~~  253 (346)
                      ||||++++.+....+  .....+++..+..++.|++.||+|||   +.+|+||||||+|||++.++ .+||+|||+++..
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence            999998765444432  23457999999999999999999999   99999999999999999775 8999999999876


Q ss_pred             CccccccccccccCCcccccCCCCCC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHH-----------H--
Q 039799          254 LEEDQSLTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRW-----------V--  319 (346)
Q Consensus       254 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~-----------~--  319 (346)
                      ....   ......|++.|+|||...+ ..++.++||||+||++|||++|+.||......+ .+...           .  
T Consensus       174 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~-~l~~i~~~~g~~~~~~~~~  249 (350)
T d1q5ka_         174 VRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEIIKVLGTPTREQIRE  249 (350)
T ss_dssp             CTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH-HHHHHHHHHCCCCHHHHHH
T ss_pred             cCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH-HHHHHHHHhCCChHHhhhh
Confidence            4332   2234569999999997654 568999999999999999999999996532111 00000           0  


Q ss_pred             ----------------------hhhcCCChhhhhchhccCCccccccc
Q 039799          320 ----------------------NDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       320 ----------------------~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                                            ....++.+.+++.+||..||++|||+
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta  297 (350)
T d1q5ka_         250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTP  297 (350)
T ss_dssp             HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCH
T ss_pred             hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCH
Confidence                                  11123357789999999999999986

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.1e-45  Score=320.60  Aligned_cols=237  Identities=22%  Similarity=0.257  Sum_probs=190.7

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCceee-EEEEecCCceeEEEec
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLIKI-ISSYSNDDFKALVLEY  180 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~-~~~~~~~~~~~lv~e~  180 (346)
                      ++|.+.+.||+|+||+||+|.+. +|+.||||++.....  .+++..|++++++++|+|++.. .++..+.+..++||||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            56899999999999999999975 789999999875432  2457789999999987776655 4555777888899999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEEC---CCCcEEEeeecCCccCCccc
Q 039799          181 MPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFGMAKPLLEED  257 (346)
Q Consensus       181 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~---~~~~~~l~Dfg~~~~~~~~~  257 (346)
                      + ++++.+.+......+++..+..++.|++.||+|||   +.+|+||||||+|||++   .+..++++|||+|+.+....
T Consensus        85 ~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~  160 (299)
T d1ckia_          85 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  160 (299)
T ss_dssp             C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred             c-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence            9 56777777666778999999999999999999999   99999999999999986   35579999999999875432


Q ss_pred             cc-----cccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCccccCcc--cHHHH-----------H
Q 039799          258 QS-----LTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM--TLKRW-----------V  319 (346)
Q Consensus       258 ~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~--~~~~~-----------~  319 (346)
                      ..     .......||+.|+|||...+..++.++|||||||++|||+||+.||........  ....+           .
T Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (299)
T d1ckia_         161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL  240 (299)
T ss_dssp             TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHH
T ss_pred             cccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHh
Confidence            21     123345799999999999999999999999999999999999999976432221  11111           1


Q ss_pred             hhhcCCChhhhhchhccCCccccccc
Q 039799          320 NDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       320 ~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ...+|+.+.+++.+|+..+|++||+.
T Consensus       241 ~~~~p~~~~~li~~cl~~~p~~RP~~  266 (299)
T d1ckia_         241 CKGYPSEFATYLNFCRSLRFDDKPDY  266 (299)
T ss_dssp             TTTSCHHHHHHHHHHHHSCTTCCCCH
T ss_pred             ccCCCHHHHHHHHHHccCChhHCcCH
Confidence            22355678999999999999999974

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-45  Score=323.27  Aligned_cols=240  Identities=21%  Similarity=0.283  Sum_probs=187.1

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC--CchhHHHHHHHHHHHHhcCCCCceeeEEEEec--------C
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ--YEGAFKSFDIECDVMKRICHRNLIKIISSYSN--------D  171 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------~  171 (346)
                      ++|++.+.||+|+||+||+|+.. +|+.||||++...  .....+++.+|++++++++|||++++++.+..        .
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            56888999999999999999975 7999999998543  23345678899999999999999999998855        3


Q ss_pred             CceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCc
Q 039799          172 DFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAK  251 (346)
Q Consensus       172 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~  251 (346)
                      +..++||||++++.+.... .....++......++.|++.||.|||   +.+|+||||||+|||++.++.+|++|||+++
T Consensus        90 ~~~~iv~e~~~~~~~~~~~-~~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~  165 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLAR  165 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHT-CTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             ceEEEEEeccCCCccchhh-hcccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeecceee
Confidence            4678999999887666443 34456888899999999999999999   9999999999999999999999999999998


Q ss_pred             cCCcccc--ccccccccCCcccccCCCCCCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccCcc---------------
Q 039799          252 PLLEEDQ--SLTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM---------------  313 (346)
Q Consensus       252 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~---------------  313 (346)
                      .+.....  ........||+.|+|||.+.+. .++.++||||+||++|||++|+.||+.....+.               
T Consensus       166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  245 (318)
T d3blha1         166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV  245 (318)
T ss_dssp             ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence            7653321  1222335699999999987655 689999999999999999999999964221100               


Q ss_pred             ---------------------cHHHHH-hhhcCCChhhhhchhccCCcccccccC
Q 039799          314 ---------------------TLKRWV-NDLLPISVMEVVDANLLSQEDEHFTTK  346 (346)
Q Consensus       314 ---------------------~~~~~~-~~~~~~~~~~~~d~~l~~~p~~R~~~k  346 (346)
                                           ...... .......+.+++.+||..||++|||++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~  300 (318)
T d3blha1         246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSD  300 (318)
T ss_dssp             STTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred             ccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHH
Confidence                                 000000 011122456899999999999999863

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-45  Score=327.41  Aligned_cols=233  Identities=24%  Similarity=0.292  Sum_probs=184.6

Q ss_pred             CCCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCC--CchhHHHHHHHHHHHHhcCCCCceeeEEEEecCC-----
Q 039799          101 LPNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ--YEGAFKSFDIECDVMKRICHRNLIKIISSYSNDD-----  172 (346)
Q Consensus       101 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----  172 (346)
                      +.+.|.+.+.||+|+||+||+|... +|+.||||++...  .....+.+.+|++++++++||||++++++|...+     
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~   95 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF   95 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence            4677889999999999999999975 7999999999753  2344578889999999999999999999997654     


Q ss_pred             -ceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCc
Q 039799          173 -FKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAK  251 (346)
Q Consensus       173 -~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~  251 (346)
                       ..++||||+ +.+|....+.  ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.++++|||+++
T Consensus        96 ~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~  169 (346)
T d1cm8a_          96 TDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR  169 (346)
T ss_dssp             CCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             ceEEEEEecc-cccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhccccccccccccccee
Confidence             568999999 6677776643  45899999999999999999999   9999999999999999999999999999998


Q ss_pred             cCCccccccccccccCCcccccCCCCCC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH-----------
Q 039799          252 PLLEEDQSLTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV-----------  319 (346)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~-----------  319 (346)
                      .....     .+...||+.|+|||.+.+ ..++.++||||+||++|||++|+.||....... .+....           
T Consensus       170 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~  243 (346)
T d1cm8a_         170 QADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD-QLKEIMKVTGTPPAEFV  243 (346)
T ss_dssp             ECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHHHH
T ss_pred             ccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHH-HHHHHHhccCCCcHHHH
Confidence            65322     245679999999998765 456899999999999999999999996531110 000000           


Q ss_pred             --------------------------hhhcCCChhhhhchhccCCccccccc
Q 039799          320 --------------------------NDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       320 --------------------------~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                                                ....++.+.+++.+||..||++|||+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta  295 (346)
T d1cm8a_         244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTA  295 (346)
T ss_dssp             HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCH
T ss_pred             hhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCH
Confidence                                      01122356789999999999999986

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-45  Score=325.64  Aligned_cols=238  Identities=22%  Similarity=0.331  Sum_probs=193.0

Q ss_pred             CCCCCCCcccccCceEEEEEEEc----CCCEEEEEEecCCC----chhHHHHHHHHHHHHhcCC-CCceeeEEEEecCCc
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ----DGMEVAVKVFDPQY----EGAFKSFDIECDVMKRICH-RNLIKIISSYSNDDF  173 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~  173 (346)
                      ++|++.+.||+|+||+||+|...    +|+.||||+++...    ....+.+.+|++++++++| |||+++++++.....
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            56888999999999999999852    57899999986432    2234567789999999977 899999999999999


Q ss_pred             eeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccC
Q 039799          174 KALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  253 (346)
Q Consensus       174 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~  253 (346)
                      .+++|||+.+|+|.+++.... .++......++.|++.|++|||   +.+|+||||||+|||++.++.++|+|||+++.+
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~  179 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  179 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             eeeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence            999999999999999887544 4567888889999999999999   999999999999999999999999999999876


Q ss_pred             CccccccccccccCCcccccCCCCCCC--CCCcchhHHHHHHHHHHHHcCCCCCCccccCcccH---HHHHh------hh
Q 039799          254 LEEDQSLTQTQTLATIGYMAPEYGREG--RVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTL---KRWVN------DL  322 (346)
Q Consensus       254 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~---~~~~~------~~  322 (346)
                      ...... ......|++.|+|||...+.  .++.++||||+||+||||+||+.||......+...   .....      ..
T Consensus       180 ~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~  258 (322)
T d1vzoa_         180 VADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE  258 (322)
T ss_dssp             CGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTT
T ss_pred             cccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCccc
Confidence            443222 23345699999999987654  46889999999999999999999997643332211   11111      12


Q ss_pred             cCCChhhhhchhccCCccccccc
Q 039799          323 LPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       323 ~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                      ++..+.+++.+||..||++|||+
T Consensus       259 ~s~~~~~li~~~l~~dP~~R~s~  281 (322)
T d1vzoa_         259 MSALAKDLIQRLLMKDPKKRLGC  281 (322)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSTTS
T ss_pred             CCHHHHHHHHHHcccCHHHcCCC
Confidence            34478899999999999999973

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-44  Score=313.59  Aligned_cols=237  Identities=23%  Similarity=0.264  Sum_probs=192.8

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEecCCceeEEEe
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSNDDFKALVLE  179 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  179 (346)
                      ++|++.+.||+|+||+||+|+.. +|+.||||+++...  .....++.+|+.++++++||||+++++++...+..+++++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            46888899999999999999975 78999999986432  3456788999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccCCccccc
Q 039799          180 YMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  259 (346)
Q Consensus       180 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~~~~~~~  259 (346)
                      ++.++++..++. ....+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||.++....... 
T Consensus        82 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~-  156 (292)
T d1unla_          82 FCDQDLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-  156 (292)
T ss_dssp             CCSEEHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-
T ss_pred             eccccccccccc-cccccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCCCc-
Confidence            999998887665 4566888999999999999999999   99999999999999999999999999999997643322 


Q ss_pred             cccccccCCcccccCCCCCCCC-CCcchhHHHHHHHHHHHHcCCCCCCccccCcccHHHHH-------------------
Q 039799          260 LTQTQTLATIGYMAPEYGREGR-VSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMTLKRWV-------------------  319 (346)
Q Consensus       260 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~-------------------  319 (346)
                       ......++..|.|||.+.... ++.++||||+||++|||++|+.||..............                   
T Consensus       157 -~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (292)
T d1unla_         157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD  235 (292)
T ss_dssp             -CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred             -cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccc
Confidence             223345788899999877655 68999999999999999999999743111111010000                   


Q ss_pred             ----------------hhhcCCChhhhhchhccCCccccccc
Q 039799          320 ----------------NDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       320 ----------------~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                                      ...++..+.+++.+||..||++|||+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa  277 (292)
T d1unla_         236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISA  277 (292)
T ss_dssp             CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred             ccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCH
Confidence                            00112245689999999999999986

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=5.4e-44  Score=319.71  Aligned_cols=232  Identities=22%  Similarity=0.339  Sum_probs=187.9

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcC-CCCceeeEEEEec--CCceeEE
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRIC-HRNLIKIISSYSN--DDFKALV  177 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~--~~~~~lv  177 (346)
                      .++|.+.+.||+|+||+||+|+.. +|+.||||+++...   .+++.+|++++++++ ||||+++++++..  ....++|
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v  110 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  110 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence            356899999999999999999975 78999999997543   467888999999995 9999999999874  4568999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCC-cEEEeeecCCccCCcc
Q 039799          178 LEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM-VAHLSDFGMAKPLLEE  256 (346)
Q Consensus       178 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~-~~~l~Dfg~~~~~~~~  256 (346)
                      |||+++++|.+..    ..++...+..++.|++.||+|||   +.+|+||||||+|||++.++ .++|+|||+|+...+.
T Consensus       111 ~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~  183 (328)
T d3bqca1         111 FEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  183 (328)
T ss_dssp             EECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred             EeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceeccCC
Confidence            9999999997753    35889999999999999999999   99999999999999998654 6999999999876433


Q ss_pred             ccccccccccCCcccccCCCCCCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccCccc------------HHHHH----
Q 039799          257 DQSLTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEMT------------LKRWV----  319 (346)
Q Consensus       257 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~------------~~~~~----  319 (346)
                      .   ......+|+.|+|||.+.+. .++.++||||+||+++||++|+.||.........            ...+.    
T Consensus       184 ~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  260 (328)
T d3bqca1         184 Q---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN  260 (328)
T ss_dssp             C---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred             C---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence            2   23445689999999987665 4799999999999999999999998643211100            00000    


Q ss_pred             ---------------------------hhhcCCChhhhhchhccCCcccccccC
Q 039799          320 ---------------------------NDLLPISVMEVVDANLLSQEDEHFTTK  346 (346)
Q Consensus       320 ---------------------------~~~~~~~~~~~~d~~l~~~p~~R~~~k  346 (346)
                                                 ...++..+.|++.+||..||++|||++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~  314 (328)
T d3bqca1         261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR  314 (328)
T ss_dssp             CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred             cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHH
Confidence                                       011233567899999999999999863

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-43  Score=317.87  Aligned_cols=234  Identities=23%  Similarity=0.288  Sum_probs=186.0

Q ss_pred             CCCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEec-----CCc
Q 039799          102 PNDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSN-----DDF  173 (346)
Q Consensus       102 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-----~~~  173 (346)
                      +++|.+.+.||+|+||+||+|... +|+.||||++....  ....+++.+|++++++++|||++++++++..     ...
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            467899999999999999999965 79999999997543  3345678899999999999999999999863     334


Q ss_pred             eeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccC
Q 039799          174 KALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  253 (346)
Q Consensus       174 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~  253 (346)
                      .+++++++.+|+|.+++..  ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.++++|||++...
T Consensus        97 ~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~  171 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT  171 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred             eEEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchhccc
Confidence            5677788889999998853  45899999999999999999999   999999999999999999999999999999865


Q ss_pred             CccccccccccccCCcccccCCCCCCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccCcc-------------------
Q 039799          254 LEEDQSLTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMEIFTRTKPTDEIFSGEM-------------------  313 (346)
Q Consensus       254 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~-------------------  313 (346)
                      ..     ......|++.|+|||...+. .++.++||||+||++|||++|+.||........                   
T Consensus       172 ~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~  246 (348)
T d2gfsa1         172 DD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI  246 (348)
T ss_dssp             TG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred             Cc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhc
Confidence            32     22345689999999976654 468999999999999999999999964210000                   


Q ss_pred             ---cHHH--------------HHhhhcCCChhhhhchhccCCccccccc
Q 039799          314 ---TLKR--------------WVNDLLPISVMEVVDANLLSQEDEHFTT  345 (346)
Q Consensus       314 ---~~~~--------------~~~~~~~~~~~~~~d~~l~~~p~~R~~~  345 (346)
                         ....              .....++..+.+++.+||..||++|||+
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta  295 (348)
T d2gfsa1         247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA  295 (348)
T ss_dssp             CCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred             cchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCH
Confidence               0000              0011234467899999999999999986

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-43  Score=317.68  Aligned_cols=195  Identities=26%  Similarity=0.289  Sum_probs=159.1

Q ss_pred             CCCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHHhcCCCCceeeEEEEec------CCc
Q 039799          103 NDANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQY--EGAFKSFDIECDVMKRICHRNLIKIISSYSN------DDF  173 (346)
Q Consensus       103 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~  173 (346)
                      ++|++.+.||+|+||+||+|.+. +|+.||||++....  ....+++.+|+.++++++||||+++++++..      ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            56889999999999999999976 79999999997543  3445678899999999999999999999963      467


Q ss_pred             eeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeeecCCccC
Q 039799          174 KALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  253 (346)
Q Consensus       174 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~~  253 (346)
                      .++||||+.++.+.. +   ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.++++|||+++..
T Consensus        97 ~~iv~Ey~~~~l~~~-~---~~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~  169 (355)
T d2b1pa1          97 VYLVMELMDANLCQV-I---QMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  169 (355)
T ss_dssp             EEEEEECCSEEHHHH-H---TSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             eEEEEeccchHHHHh-h---hcCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhhhcc
Confidence            899999997765544 3   245889999999999999999999   999999999999999999999999999998865


Q ss_pred             CccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 039799          254 LEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDE  307 (346)
Q Consensus       254 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~  307 (346)
                      ...   .......+|+.|+|||.+.+..++.++||||+||+++||++|+.||..
T Consensus       170 ~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~  220 (355)
T d2b1pa1         170 GTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG  220 (355)
T ss_dssp             --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ccc---cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCC
Confidence            332   223445689999999999999999999999999999999999999953

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.4e-38  Score=285.69  Aligned_cols=195  Identities=20%  Similarity=0.258  Sum_probs=157.5

Q ss_pred             CCCCCCcccccCceEEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHHhcC-----------CCCceeeEEEEec-
Q 039799          104 DANMPPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQYEGAFKSFDIECDVMKRIC-----------HRNLIKIISSYSN-  170 (346)
Q Consensus       104 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~~~~-  170 (346)
                      +|.+.+.||+|+||+||+|+.. +|+.||||+++... ...+.+.+|+++++.+.           |+||+++++++.. 
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~   92 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   92 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence            5999999999999999999975 79999999997542 33467788999888775           5789999988754 


Q ss_pred             -CCceeEEEecCCCCChhhh--hhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeeecCCCCCceEECCCC------
Q 039799          171 -DDFKALVLEYMPHGSLEKC--LYLSNYILDIFQRLDIMIDVASALEYLHFGYS-APIIHCDLKPSNVLLDDNM------  240 (346)
Q Consensus       171 -~~~~~lv~e~~~~gsL~~~--l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~i~H~dik~~NIll~~~~------  240 (346)
                       ....++++++...+.....  .......++...+..++.+++.|++|||   + .+|+||||||+|||++.++      
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh---~~~~IvHrDlKp~NIll~~~~~~~~~~  169 (362)
T d1q8ya_          93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPENLI  169 (362)
T ss_dssp             ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred             cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHh---hhcCcccccCChhHeeeeccCcccccc
Confidence             3455666666654433222  2233467888999999999999999999   6 8999999999999998654      


Q ss_pred             cEEEeeecCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 039799          241 VAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMEIFTRTKPTDE  307 (346)
Q Consensus       241 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~  307 (346)
                      .++++|||.+.....     ......||+.|+|||......++.++||||+||+++||++|+.||..
T Consensus       170 ~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~  231 (362)
T d1q8ya_         170 QIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP  231 (362)
T ss_dssp             EEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--
T ss_pred             eeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCC
Confidence            499999999986432     22345699999999999888999999999999999999999999864

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.91  E-value=9.3e-26  Score=184.83  Aligned_cols=168  Identities=17%  Similarity=0.139  Sum_probs=118.7

Q ss_pred             CCCCcccccCceEEEEEEEcCCCEEEEEEecCCCc------------------hhHHHHHHHHHHHHhcCCCCceeeEEE
Q 039799          106 NMPPLIGKGGFGSVYKAIIQDGMEVAVKVFDPQYE------------------GAFKSFDIECDVMKRICHRNLIKIISS  167 (346)
Q Consensus       106 ~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~niv~~~~~  167 (346)
                      .+.+.||+|+||+||+|...+|+.||||++.....                  ........|...+.++.|.+++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            45678999999999999988999999998753210                  112344568889999999999988766


Q ss_pred             EecCCceeEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCcEEEeee
Q 039799          168 YSNDDFKALVLEYMPHGSLEKCLYLSNYILDIFQRLDIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDF  247 (346)
Q Consensus       168 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dik~~NIll~~~~~~~l~Df  247 (346)
                      .    ..+++|||+++..+.+        ++......++.+++++++|||   +.+|+||||||+|||++++ .++|+||
T Consensus        83 ~----~~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~~liDF  146 (191)
T d1zara2          83 E----GNAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GIWIIDF  146 (191)
T ss_dssp             E----TTEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EEEECCC
T ss_pred             c----CCEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-CEEEEEC
Confidence            3    2369999998866543        233345678999999999999   9999999999999999965 5899999


Q ss_pred             cCCccCCccccccccccccCCcccccCCCCCCCCCCcchhHHHHHHH
Q 039799          248 GMAKPLLEEDQSLTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIM  294 (346)
Q Consensus       248 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G~i  294 (346)
                      |+|.....+....-..   ..... -.+.+ ...|+.++|+||..--
T Consensus       147 G~a~~~~~~~~~~~l~---rd~~~-~~~~f-~r~y~~~~d~~s~~~~  188 (191)
T d1zara2         147 PQSVEVGEEGWREILE---RDVRN-IITYF-SRTYRTEKDINSAIDR  188 (191)
T ss_dssp             TTCEETTSTTHHHHHH---HHHHH-HHHHH-HHHHCCCCCHHHHHHH
T ss_pred             CCcccCCCCCcHHHHH---HHHHH-HHHHH-cCCCCCcccHHHHHHH
Confidence            9998653221100000   00000 00111 2457788999997543

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.37  E-value=1.3e-13  Score=120.46  Aligned_cols=77  Identities=39%  Similarity=0.641  Sum_probs=71.5

Q ss_pred             CccCcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCCCCCcccccccccCCcchhhcccch
Q 039799            2 GSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNELLCEIVLPL   79 (346)
Q Consensus         2 g~ip~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~l~~l~~~~n~~~~~~~~~~   79 (346)
                      |.+ ++++.+++|+.|||++|+|+|.+|++|++|++|+.|||++|+|+|.+|+.+.+++++.+++.+|+.+|+.|+|.
T Consensus       235 ~~~-~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~plp~  311 (313)
T d1ogqa_         235 FDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLPA  311 (313)
T ss_dssp             CBG-GGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSSC
T ss_pred             ccc-cccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCCCCC
Confidence            444 46889999999999999999999999999999999999999999999998889999999999999999988775

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.03  E-value=3.7e-11  Score=104.44  Aligned_cols=75  Identities=29%  Similarity=0.453  Sum_probs=67.2

Q ss_pred             ccCcchhCCCCCCEEEeec-CcccccCCccccCcCCCCeEECcCCcCcCCCCCC-CCCcccccccccCCcchhhccc
Q 039799            3 SIPDSIGDLINLKSLNLSN-NNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSVKSFEGNELLCEIVL   77 (346)
Q Consensus         3 ~ip~~~~~l~~L~~l~l~~-N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~~~~~~~~   77 (346)
                      .||++|++|++|++|||++ |+|+|.||++|++|++|++|+|++|++++.+|.. ..+.++..++++.|.....+|.
T Consensus        67 ~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~  143 (313)
T d1ogqa_          67 PIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPP  143 (313)
T ss_dssp             ECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCG
T ss_pred             CCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCch
Confidence            6999999999999999997 8999999999999999999999999999988875 6677888999999987765543

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=98.93  E-value=4.9e-10  Score=83.25  Aligned_cols=65  Identities=26%  Similarity=0.276  Sum_probs=52.0

Q ss_pred             chhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCCCCCcccccccccCCcchh
Q 039799            7 SIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNELLC   73 (346)
Q Consensus         7 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~l~~l~~~~n~~~~   73 (346)
                      .+++|++|++|||++|+|+ .+|+.++.+++|+.|++++|++++. |....+++++.+++++|.+.-
T Consensus        15 ~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l-~~~~~l~~L~~L~l~~N~i~~   79 (124)
T d1dcea3          15 HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-DGVANLPRLQELLLCNNRLQQ   79 (124)
T ss_dssp             CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-GGGTTCSSCCEEECCSSCCCS
T ss_pred             ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccccc-CccccccccCeEECCCCccCC
Confidence            4788888888888888888 7888888888888888888888865 446677788888888887653

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=98.90  E-value=1.2e-09  Score=81.16  Aligned_cols=71  Identities=23%  Similarity=0.332  Sum_probs=62.1

Q ss_pred             ccCcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCC--CCCCCcccccccccCCcchhhc
Q 039799            3 SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIP--REGPFRNLSVKSFEGNELLCEI   75 (346)
Q Consensus         3 ~ip~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p--~~~~~~~l~~l~~~~n~~~~~~   75 (346)
                      .||++++.+++|+.|+|++|+++ .+| .++++++|+.|++++|+++..+.  ....+++++.+++++|++....
T Consensus        34 ~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~  106 (124)
T d1dcea3          34 ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEE  106 (124)
T ss_dssp             CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSS
T ss_pred             cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCCccCCCCCchhhcCCCCCCEEECCCCcCCcCc
Confidence            68999999999999999999999 787 49999999999999999997654  3466788999999999987543

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.88  E-value=1.2e-09  Score=84.63  Aligned_cols=72  Identities=24%  Similarity=0.272  Sum_probs=59.8

Q ss_pred             cC-cchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCCCCCcccccccccCCcchhhc
Q 039799            4 IP-DSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNELLCEI   75 (346)
Q Consensus         4 ip-~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~l~~l~~~~n~~~~~~   75 (346)
                      || ..|.+|++|+.|+|++|+|++--|..|..+++|+.|+|++|+|+..++......++..+++++|++.|.-
T Consensus        47 i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~~~l~~L~L~~Np~~C~C  119 (156)
T d2ifga3          47 LELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSC  119 (156)
T ss_dssp             ECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCCCCEEECCSSCCCCCG
T ss_pred             cCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCcccChhhhccccccccccCCCcccCCc
Confidence            44 4588899999999999999943356689999999999999999987777655557889999999998754

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=98.83  E-value=2.2e-09  Score=86.16  Aligned_cols=73  Identities=18%  Similarity=0.292  Sum_probs=52.1

Q ss_pred             cCcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCC-CCCcccccccccCCcchhhcc
Q 039799            4 IPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSVKSFEGNELLCEIV   76 (346)
Q Consensus         4 ip~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~~~~~~~   76 (346)
                      .|..+..+++|+.|+|++|+|++-.|..|.++++|+.|+|++|+|++.+|.. ..+++++.+++++|++.|...
T Consensus        70 ~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~  143 (192)
T d1w8aa_          70 EPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH  143 (192)
T ss_dssp             CTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred             cccccccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccc
Confidence            4556667777777777777777433445777788888888888887776664 556777788888888776543

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.68  E-value=1.3e-08  Score=85.82  Aligned_cols=72  Identities=25%  Similarity=0.218  Sum_probs=61.9

Q ss_pred             cC-cchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCCCCCcccccccccCCcchhhc
Q 039799            4 IP-DSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNELLCEI   75 (346)
Q Consensus         4 ip-~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~l~~l~~~~n~~~~~~   75 (346)
                      +| ..+..+++|+.|++++|+|++..|..+..+++|+.|+|++|+|+..++....+++++.+++++|++.|.-
T Consensus       139 l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~~lp~~~~~~~~L~~L~L~~Np~~CdC  211 (266)
T d1p9ag_         139 LPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNC  211 (266)
T ss_dssp             CCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred             eccccccccccchhcccccccccccCccccccccccceeecccCCCcccChhHCCCCCCCEEEecCCCCCCCc
Confidence            44 4457799999999999999966666789999999999999999966666677889999999999999864

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=98.66  E-value=1.1e-08  Score=81.82  Aligned_cols=61  Identities=18%  Similarity=0.230  Sum_probs=30.0

Q ss_pred             CCCCEEEeecCcccccCC-ccccCcCCCCeEECcCCcCcCCCCCC-CCCcccccccccCCcch
Q 039799           12 INLKSLNLSNNNLSGTIP-ISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSVKSFEGNELL   72 (346)
Q Consensus        12 ~~L~~l~l~~N~l~g~~p-~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~~~   72 (346)
                      ++++.|+|++|+|++.++ ..+..+++|+.|++++|++++.++.. ..+.+++.+++++|.+.
T Consensus        29 ~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~   91 (192)
T d1w8aa_          29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK   91 (192)
T ss_dssp             TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCC
T ss_pred             CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecccccc
Confidence            455555555555553332 23455555555555555555544433 33445555555555444

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.63  E-value=5.1e-08  Score=81.76  Aligned_cols=132  Identities=19%  Similarity=0.184  Sum_probs=89.6

Q ss_pred             cCceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcC-CCCceeeEEEEecCCceeEEEecCCCCChhhhhhh
Q 039799          114 GGFGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRIC-HRNLIKIISSYSNDDFKALVLEYMPHGSLEKCLYL  192 (346)
Q Consensus       114 G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~  192 (346)
                      ++.+.||+...+ +..+++|+...........+.+|...+..+. +--+.+++.+....+..++||++++|.++.+....
T Consensus        25 ~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~  103 (263)
T d1j7la_          25 MSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED  103 (263)
T ss_dssp             CSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTT
T ss_pred             CCCCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccc
Confidence            445689988644 6678889876554444455677888887774 33356778888888889999999999887653321


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHhcC-----------------------------------------------------
Q 039799          193 SNYILDIFQRLDIMIDVASALEYLHFG-----------------------------------------------------  219 (346)
Q Consensus       193 ~~~~l~~~~~~~i~~~i~~~l~~LH~~-----------------------------------------------------  219 (346)
                      .   ..   ...++.++++.++.||..                                                     
T Consensus       104 ~---~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  177 (263)
T d1j7la_         104 E---QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTE  177 (263)
T ss_dssp             C---SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHS
T ss_pred             c---cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhc
Confidence            1   11   222444555555555520                                                     


Q ss_pred             ---CCCCeeecCCCCCceEECCCCcEEEeeecCCcc
Q 039799          220 ---YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  252 (346)
Q Consensus       220 ---~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~  252 (346)
                         ....++|+|+.|.||++++++..-|+||+.+..
T Consensus       178 ~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         178 KPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             CCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             CCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence               022378999999999999877777999998773

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.57  E-value=1.5e-08  Score=78.79  Aligned_cols=66  Identities=18%  Similarity=0.208  Sum_probs=31.8

Q ss_pred             cCcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCC-CCCcccccccccCCcc
Q 039799            4 IPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSVKSFEGNEL   71 (346)
Q Consensus         4 ip~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~~   71 (346)
                      ||..+..+++|+.||||+|+++ .++ .+..+++|+.|++++|+++..++.. ..+++++.+++++|.+
T Consensus        33 i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i   99 (162)
T d1a9na_          33 IENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSL   99 (162)
T ss_dssp             CCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCC
T ss_pred             cCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccccceeccccc
Confidence            3433344555555555555555 443 2445555555555555555444332 2344455555555543

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.49  E-value=3.1e-08  Score=84.31  Aligned_cols=72  Identities=21%  Similarity=0.297  Sum_probs=57.4

Q ss_pred             CcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCC-CCCcccccccccCCcchhhcc
Q 039799            5 PDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSVKSFEGNELLCEIV   76 (346)
Q Consensus         5 p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~~~~~~~   76 (346)
                      |..+.++++|+.|++++|++++..|..|..+++|+.||+++|++++.+|.. ..+.+++.+++++|++.|...
T Consensus       170 ~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~  242 (284)
T d1ozna_         170 ERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR  242 (284)
T ss_dssp             TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred             hhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCcc
Confidence            455677888888888888888777888888888888888888888877654 567788889999999888643

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=98.46  E-value=1.4e-07  Score=80.94  Aligned_cols=69  Identities=19%  Similarity=0.170  Sum_probs=50.8

Q ss_pred             CcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCC-------CCCcccccccccCCcchhh
Q 039799            5 PDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-------GPFRNLSVKSFEGNELLCE   74 (346)
Q Consensus         5 p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~-------~~~~~l~~l~~~~n~~~~~   74 (346)
                      |..+.++++|++|+|++|+|+ .||..+.++++|+.|+|++|+|+......       ....++..+++++|++.+.
T Consensus       212 ~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~  287 (305)
T d1xkua_         212 NGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYW  287 (305)
T ss_dssp             TTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGG
T ss_pred             cccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCccC
Confidence            556777888888888888888 78888888888888888888887653321       2345677788888887543

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.43  E-value=9.4e-08  Score=73.56  Aligned_cols=69  Identities=20%  Similarity=0.171  Sum_probs=60.6

Q ss_pred             ccCcchhCCCCCCEEEeecC-cccccCC-ccccCcCCCCeEECcCCcCcCCCCCC-CCCcccccccccCCcch
Q 039799            3 SIPDSIGDLINLKSLNLSNN-NLSGTIP-ISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSVKSFEGNELL   72 (346)
Q Consensus         3 ~ip~~~~~l~~L~~l~l~~N-~l~g~~p-~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~~~   72 (346)
                      ++|..+..+++|+.|+|++| .|+ .|| ..|..+++|+.|+|++|+|+...|.. ..+++++.+++++|.+.
T Consensus        22 ~~p~~l~~l~~l~~L~l~~n~~l~-~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~   93 (156)
T d2ifga3          22 DSLHHLPGAENLTELYIENQQHLQ-HLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE   93 (156)
T ss_dssp             TTTTTSCSCSCCSEEECCSCSSCC-EECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS
T ss_pred             cCcccccCccccCeeecCCCcccc-ccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCc
Confidence            56888999999999999877 488 777 46899999999999999999987774 67889999999999876

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.41  E-value=9.3e-08  Score=74.09  Aligned_cols=65  Identities=15%  Similarity=0.118  Sum_probs=57.4

Q ss_pred             chhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCCCCCcccccccccCCcchh
Q 039799            7 SIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNELLC   73 (346)
Q Consensus         7 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~l~~l~~~~n~~~~   73 (346)
                      ++.++.+|+.|||++|+++ .||..+..+++|+.||||+|+++.. +....+++++.+++++|.+..
T Consensus        13 ~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l-~~~~~l~~L~~L~ls~N~i~~   77 (162)
T d1a9na_          13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRICR   77 (162)
T ss_dssp             EEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCCE
T ss_pred             hccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCcc-CCcccCcchhhhhcccccccC
Confidence            4568889999999999999 8998778999999999999999965 556778899999999998764

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.39  E-value=8.4e-08  Score=80.75  Aligned_cols=68  Identities=22%  Similarity=0.275  Sum_probs=55.8

Q ss_pred             ccCcchhCCCCCCEEEeecCcccccCC-ccccCcCCCCeEECcCCcCcCCCCCCCCCcccccccccCCcchhh
Q 039799            3 SIPDSIGDLINLKSLNLSNNNLSGTIP-ISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNELLCE   74 (346)
Q Consensus         3 ~ip~~~~~l~~L~~l~l~~N~l~g~~p-~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~l~~l~~~~n~~~~~   74 (346)
                      +||++|.  ++|+.|||++|+++ .+| ..|.++++|+.|+|++|+|+.. |..+.+++|+.+++++|++...
T Consensus        24 ~iP~~lp--~~l~~L~Ls~N~i~-~l~~~~f~~l~~L~~L~L~~N~l~~l-~~~~~l~~L~~L~Ls~N~l~~~   92 (266)
T d1p9ag_          24 ALPPDLP--KDTTILHLSENLLY-TFSLATLMPYTRLTQLNLDRAELTKL-QVDGTLPVLGTLDLSHNQLQSL   92 (266)
T ss_dssp             SCCSCCC--TTCCEEECTTSCCS-EEEGGGGTTCTTCCEEECTTSCCCEE-ECCSCCTTCCEEECCSSCCSSC
T ss_pred             eeCcCcC--cCCCEEECcCCcCC-CcCHHHhhcccccccccccccccccc-cccccccccccccccccccccc
Confidence            5787764  68999999999999 555 6789999999999999999854 4556788999999999987643

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.34  E-value=1.5e-06  Score=72.07  Aligned_cols=130  Identities=16%  Similarity=0.126  Sum_probs=84.4

Q ss_pred             ccccC-ceEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCC--CceeeEEEEecCCceeEEEecCCCCChh
Q 039799          111 IGKGG-FGSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHR--NLIKIISSYSNDDFKALVLEYMPHGSLE  187 (346)
Q Consensus       111 lg~G~-~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~~~~~~~~~~lv~e~~~~gsL~  187 (346)
                      +..|. .+.||+...+++..+++|.......   ..+..|...++.+...  .+.+++......+..++||++++|.++.
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~   94 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL   94 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence            34444 3678999888888899998765433   3455677777766433  3556788888888899999999887654


Q ss_pred             hhhhhcCCCCCHHHHHHHHHHHHHHHHHHh--------------------------------------------------
Q 039799          188 KCLYLSNYILDIFQRLDIMIDVASALEYLH--------------------------------------------------  217 (346)
Q Consensus       188 ~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH--------------------------------------------------  217 (346)
                      +..      ...   ...+.++++.++-||                                                  
T Consensus        95 ~~~------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  165 (255)
T d1nd4a_          95 SSH------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARL  165 (255)
T ss_dssp             TSC------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHH
T ss_pred             ccc------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHH
Confidence            311      000   011122222222222                                                  


Q ss_pred             -c----CCCCCeeecCCCCCceEECCCCcEEEeeecCCcc
Q 039799          218 -F----GYSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  252 (346)
Q Consensus       218 -~----~~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~  252 (346)
                       .    .....++|+|+.|.||+++++..+-|+||+.+..
T Consensus       166 ~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         166 KARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             HHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence             1    1123479999999999999877778999998763

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=98.33  E-value=3.4e-07  Score=78.40  Aligned_cols=72  Identities=24%  Similarity=0.200  Sum_probs=62.8

Q ss_pred             CccCcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCCCCCcccccccccCCcchh
Q 039799            2 GSIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNELLC   73 (346)
Q Consensus         2 g~ip~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~l~~l~~~~n~~~~   73 (346)
                      +.+|..+.+++.++.|++++|++++..|..+..+++|+.|+|++|+|+..++....+++|+.+++++|.+..
T Consensus       185 ~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~lp~~l~~l~~L~~L~Ls~N~i~~  256 (305)
T d1xkua_         185 KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISA  256 (305)
T ss_dssp             EECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCTTTTTCSSCCEEECCSSCCCC
T ss_pred             CCChhHhhccccccccccccccccccccccccccccceeeecccccccccccccccccCCCEEECCCCccCc
Confidence            456778899999999999999999766788899999999999999999876666788999999999998664

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.32  E-value=1.7e-07  Score=82.71  Aligned_cols=62  Identities=27%  Similarity=0.305  Sum_probs=28.2

Q ss_pred             hhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCCCCCcccccccccCCcch
Q 039799            8 IGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNELL   72 (346)
Q Consensus         8 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~l~~l~~~~n~~~   72 (346)
                      +..+++|+.|+|++|+++ .++ .+..+++|+.|++++|++++. |....+++|+.+++++|+++
T Consensus       303 ~~~~~~l~~L~ls~n~l~-~l~-~l~~l~~L~~L~L~~n~l~~l-~~l~~l~~L~~L~l~~N~l~  364 (384)
T d2omza2         303 ISNLKNLTYLTLYFNNIS-DIS-PVSSLTKLQRLFFANNKVSDV-SSLANLTNINWLSAGHNQIS  364 (384)
T ss_dssp             GGGCTTCSEEECCSSCCS-CCG-GGGGCTTCCEEECCSSCCCCC-GGGGGCTTCCEEECCSSCCC
T ss_pred             cchhcccCeEECCCCCCC-CCc-ccccCCCCCEEECCCCCCCCC-hhHcCCCCCCEEECCCCcCC
Confidence            344445555555555554 232 144445555555555554432 22333444444555544443

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=98.26  E-value=2.2e-08  Score=80.46  Aligned_cols=68  Identities=21%  Similarity=0.220  Sum_probs=56.9

Q ss_pred             cCcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCCCCCcccccccccCCcchh
Q 039799            4 IPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNELLC   73 (346)
Q Consensus         4 ip~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~l~~l~~~~n~~~~   73 (346)
                      +|.+++.|++|+.|+|++|+++ .|| .+..|++|+.|+|++|+++..++....+.+++.+++++|.+..
T Consensus        40 l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~~i~~~~~~~~~L~~L~l~~N~i~~  107 (198)
T d1m9la_          40 MDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIAS  107 (198)
T ss_dssp             CHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEECSCSSHHHHHHHCCEEECSEEECCC
T ss_pred             hhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccccccccccccccccccccccccccc
Confidence            4568999999999999999999 887 5999999999999999998654333445678899999997653

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.23  E-value=3.6e-07  Score=74.73  Aligned_cols=62  Identities=23%  Similarity=0.323  Sum_probs=36.8

Q ss_pred             hhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCCCCCcccccccccCCcch
Q 039799            8 IGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNELL   72 (346)
Q Consensus         8 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~l~~l~~~~n~~~   72 (346)
                      +.+.++|+.|++++|.++ .++. ++++++|+.|+|++|++++. |....+++|+.+++++|+++
T Consensus       147 ~~~~~~L~~L~l~~n~~~-~~~~-l~~l~~L~~L~Ls~n~l~~l-~~l~~l~~L~~L~Ls~N~lt  208 (227)
T d1h6ua2         147 LAGLTNLQYLSIGNAQVS-DLTP-LANLSKLTTLKADDNKISDI-SPLASLPNLIEVHLKNNQIS  208 (227)
T ss_dssp             GGGCTTCCEEECCSSCCC-CCGG-GTTCTTCCEEECCSSCCCCC-GGGGGCTTCCEEECTTSCCC
T ss_pred             hccccccccccccccccc-cchh-hcccccceecccCCCccCCC-hhhcCCCCCCEEECcCCcCC
Confidence            455666666666666666 3332 56666666666666666653 33445566666666666544

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.09  E-value=1.7e-06  Score=73.09  Aligned_cols=65  Identities=23%  Similarity=0.224  Sum_probs=34.1

Q ss_pred             hhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCC-CCCcccccccccCCcch
Q 039799            8 IGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSVKSFEGNELL   72 (346)
Q Consensus         8 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~~~   72 (346)
                      +..+++|+.|+|++|+|++-.|..+..+++|+.+++++|++++..|.. ..+.++..+++++|.+.
T Consensus       149 f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~  214 (284)
T d1ozna_         149 FRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS  214 (284)
T ss_dssp             TTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCS
T ss_pred             hccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccc
Confidence            445555555555555555333444555555555555555555554443 34445555555555543

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.05  E-value=1.7e-06  Score=76.05  Aligned_cols=63  Identities=30%  Similarity=0.392  Sum_probs=44.5

Q ss_pred             chhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCCCCCcccccccccCCcch
Q 039799            7 SIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNELL   72 (346)
Q Consensus         7 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~l~~l~~~~n~~~   72 (346)
                      .|..|++|++|||++|+++ .+|+ +++|++|+.|++++|++++..| .+.+++++.+++.+|...
T Consensus        61 gl~~L~nL~~L~Ls~N~l~-~l~~-l~~L~~L~~L~L~~n~i~~i~~-l~~l~~L~~L~~~~~~~~  123 (384)
T d2omza2          61 GVEYLNNLTQINFSNNQLT-DITP-LKNLTKLVDILMNNNQIADITP-LANLTNLTGLTLFNNQIT  123 (384)
T ss_dssp             TGGGCTTCCEEECCSSCCC-CCGG-GTTCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCC
T ss_pred             ccccCCCCCEEeCcCCcCC-CCcc-ccCCcccccccccccccccccc-cccccccccccccccccc
Confidence            4667777788888888777 5663 7777778888888777776543 455667777777666554

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.05  E-value=2e-06  Score=69.37  Aligned_cols=61  Identities=28%  Similarity=0.296  Sum_probs=36.5

Q ss_pred             hhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCCCCCcccccccccCCcc
Q 039799            8 IGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNEL   71 (346)
Q Consensus         8 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~l~~l~~~~n~~   71 (346)
                      +..+++|+.|+|++|+++ .+| .+++|++|+.|++++|++++. |....+++++.+++++|..
T Consensus        64 l~~l~~L~~L~L~~n~i~-~l~-~~~~l~~L~~L~l~~n~i~~l-~~l~~l~~L~~L~l~~~~~  124 (210)
T d1h6ta2          64 IQYLPNVTKLFLNGNKLT-DIK-PLANLKNLGWLFLDENKVKDL-SSLKDLKKLKSLSLEHNGI  124 (210)
T ss_dssp             GGGCTTCCEEECCSSCCC-CCG-GGTTCTTCCEEECCSSCCCCG-GGGTTCTTCCEEECTTSCC
T ss_pred             HhhCCCCCEEeCCCcccc-Ccc-ccccCcccccccccccccccc-ccccccccccccccccccc
Confidence            556666666666666666 344 256666666666666666653 3344455666666666554

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.03  E-value=1.5e-06  Score=70.02  Aligned_cols=63  Identities=24%  Similarity=0.358  Sum_probs=35.1

Q ss_pred             chhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCCCCCcccccccccCCcch
Q 039799            7 SIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNELL   72 (346)
Q Consensus         7 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~l~~l~~~~n~~~   72 (346)
                      .+.++++|+.+++++|.++ .++ .+.++++|+.+++++|++++..+ ...+++++.+++++|.+.
T Consensus       129 ~l~~l~~l~~l~~~~n~l~-~~~-~~~~l~~L~~l~l~~n~l~~i~~-l~~l~~L~~L~Ls~N~i~  191 (210)
T d1h6ta2         129 GLVHLPQLESLYLGNNKIT-DIT-VLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHIS  191 (210)
T ss_dssp             GGGGCTTCCEEECCSSCCC-CCG-GGGGCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCC
T ss_pred             ccccccccccccccccccc-ccc-ccccccccccccccccccccccc-ccCCCCCCEEECCCCCCC
Confidence            4555666666666666665 222 35556666666666666655332 344555666666666543

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.03  E-value=1.9e-07  Score=72.25  Aligned_cols=65  Identities=32%  Similarity=0.278  Sum_probs=52.2

Q ss_pred             hCCCCCCEEEeecCcccccCC---ccccCcCCCCeEECcCCcCcCCCCCC-CCCcccccccccCCcchhh
Q 039799            9 GDLINLKSLNLSNNNLSGTIP---ISLEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSVKSFEGNELLCE   74 (346)
Q Consensus         9 ~~l~~L~~l~l~~N~l~g~~p---~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~~~n~~~~~   74 (346)
                      .++++|+.||||+|+++ .++   ..+..+++|+.|+||+|+++...+-. ....++..+++++|++...
T Consensus        62 ~~~~~L~~L~Ls~N~i~-~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~  130 (162)
T d1koha1          62 ENIPELLSLNLSNNRLY-RLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDT  130 (162)
T ss_dssp             HHCTTCCCCCCCSSCCC-CCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSS
T ss_pred             HhCCCCCEeeCCCcccc-CCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcC
Confidence            56899999999999999 554   45778999999999999999765421 2344688999999987654

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.00  E-value=3e-06  Score=67.60  Aligned_cols=60  Identities=25%  Similarity=0.305  Sum_probs=33.2

Q ss_pred             CCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCCCCCcccccccccCCcch
Q 039799           10 DLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNELL   72 (346)
Q Consensus        10 ~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~l~~l~~~~n~~~   72 (346)
                      .+.+|+.|++++|.++ .++ .+..+++|+.|++++|++++..| ...+++++.+++++|...
T Consensus        38 ~l~~l~~L~l~~~~i~-~l~-~l~~l~nL~~L~Ls~N~l~~~~~-l~~l~~L~~L~l~~n~~~   97 (199)
T d2omxa2          38 DLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDITP-LKNLTKLVDILMNNNQIA   97 (199)
T ss_dssp             HHTTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCC
T ss_pred             HhcCCCEEECCCCCCC-Ccc-ccccCCCcCcCccccccccCccc-ccCCcccccccccccccc
Confidence            4555666666666655 453 35556666666666666655443 344555555555555443

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.89  E-value=3.8e-05  Score=67.76  Aligned_cols=77  Identities=19%  Similarity=0.270  Sum_probs=48.4

Q ss_pred             CCcccccCceEEEEEEEc-CCCEEEEEEecCC-------CchhHHHHHHHHHHHHhcC-C--CCceeeEEEEecCCceeE
Q 039799          108 PPLIGKGGFGSVYKAIIQ-DGMEVAVKVFDPQ-------YEGAFKSFDIECDVMKRIC-H--RNLIKIISSYSNDDFKAL  176 (346)
Q Consensus       108 ~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~-------~~~~~~~~~~e~~~l~~l~-h--~niv~~~~~~~~~~~~~l  176 (346)
                      .+.||.|....||+.... +++.+++|.-.+.       .+....+...|.+.++.+. +  ..+.+++.+  +.+..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            346899999999999865 4678999975321       1112344556887777662 2  334455544  3445679


Q ss_pred             EEecCCCCCh
Q 039799          177 VLEYMPHGSL  186 (346)
Q Consensus       177 v~e~~~~gsL  186 (346)
                      |||++++..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999987543

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=97.86  E-value=9e-06  Score=70.20  Aligned_cols=64  Identities=31%  Similarity=0.276  Sum_probs=51.4

Q ss_pred             cCcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCCCCCcccccccccCCcchhh
Q 039799            4 IPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNELLCE   74 (346)
Q Consensus         4 ip~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~l~~l~~~~n~~~~~   74 (346)
                      ++.....+++|++|+|++|+|+ .||..   +++|+.|++++|+|+. +|..  +.+++.+++++|++...
T Consensus       276 ~~~~~~~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~~-l~~~--~~~L~~L~L~~N~L~~l  339 (353)
T d1jl5a_         276 IRSLCDLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLAE-VPEL--PQNLKQLHVEYNPLREF  339 (353)
T ss_dssp             CSEECCCCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCSC-CCCC--CTTCCEEECCSSCCSSC
T ss_pred             cccccccCCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCCc-cccc--cCCCCEEECcCCcCCCC
Confidence            3333445689999999999999 99965   5789999999999995 4543  46889999999997654

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=97.85  E-value=7.5e-06  Score=66.58  Aligned_cols=59  Identities=22%  Similarity=0.365  Sum_probs=50.4

Q ss_pred             cchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCCCCCccccccccc
Q 039799            6 DSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFE   67 (346)
Q Consensus         6 ~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~l~~l~~~   67 (346)
                      ..++++++|+.|||++|+++ .+|+ ++++++|+.|+|++|++++.+| ...+++|..++++
T Consensus       167 ~~l~~l~~L~~L~Ls~n~l~-~l~~-l~~l~~L~~L~Ls~N~lt~i~~-l~~l~~L~~L~ls  225 (227)
T d1h6ua2         167 TPLANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQISDVSP-LANTSNLFIVTLT  225 (227)
T ss_dssp             GGGTTCTTCCEEECCSSCCC-CCGG-GGGCTTCCEEECTTSCCCBCGG-GTTCTTCCEEEEE
T ss_pred             hhhcccccceecccCCCccC-CChh-hcCCCCCCEEECcCCcCCCCcc-cccCCCCCEEEee
Confidence            34889999999999999999 6765 8999999999999999997654 5567888888775

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=97.82  E-value=9.5e-06  Score=64.57  Aligned_cols=63  Identities=29%  Similarity=0.411  Sum_probs=47.0

Q ss_pred             chhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCCCCCcccccccccCCcch
Q 039799            7 SIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNELL   72 (346)
Q Consensus         7 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~l~~l~~~~n~~~   72 (346)
                      .+.++++|+.|++++|+++ .+| .+..+++|+.|++++|++++..+ ...+++++.+++++|++.
T Consensus       123 ~~~~l~~L~~L~l~~n~l~-~~~-~l~~~~~L~~L~l~~n~l~~l~~-l~~l~~L~~L~ls~N~i~  185 (199)
T d2omxa2         123 PLKNLTNLNRLELSSNTIS-DIS-ALSGLTSLQQLNFSSNQVTDLKP-LANLTTLERLDISSNKVS  185 (199)
T ss_dssp             GGTTCTTCSEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCC
T ss_pred             ccchhhhhHHhhhhhhhhc-ccc-cccccccccccccccccccCCcc-ccCCCCCCEEECCCCCCC
Confidence            4667788888888888887 555 47778888888888888876543 456778888888888754

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=97.81  E-value=2e-07  Score=74.74  Aligned_cols=67  Identities=22%  Similarity=0.271  Sum_probs=50.0

Q ss_pred             ccCcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCcCCCCCCCCCcccccccccCCcch
Q 039799            3 SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLEGEIPREGPFRNLSVKSFEGNELL   72 (346)
Q Consensus         3 ~ip~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~l~~l~~~~n~~~   72 (346)
                      .|| .+++|++|+.|+|++|+++ .||.....+++|+.|++++|+++.. +....+++++.+++++|.+.
T Consensus        62 ~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l-~~~~~l~~L~~L~L~~N~i~  128 (198)
T d1m9la_          62 KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL-SGIEKLVNLRVLYMSNNKIT  128 (198)
T ss_dssp             CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH-HHHHHHHHSSEEEESEEECC
T ss_pred             Ccc-cccCCccccChhhcccccc-ccccccccccccccccccccccccc-ccccccccccccccccchhc
Confidence            344 5788899999999999998 8887666677888888888888754 33344566777777777654

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.61  E-value=1.9e-05  Score=64.59  Aligned_cols=63  Identities=22%  Similarity=0.266  Sum_probs=49.0

Q ss_pred             ccCcchhCCCCCCEEEeecCcccccCCc-cccCcCCCCeEECcCCcCcCCCCCC--CCCcccccccccC
Q 039799            3 SIPDSIGDLINLKSLNLSNNNLSGTIPI-SLEKLLDLKDINVSFNKLEGEIPRE--GPFRNLSVKSFEG   68 (346)
Q Consensus         3 ~ip~~~~~l~~L~~l~l~~N~l~g~~p~-~~~~l~~l~~l~l~~N~l~~~~p~~--~~~~~l~~l~~~~   68 (346)
                      +||+++.  +++++|||++|+++ .||. .|.++++|+.|++++|.+...+|..  ..+.++..+.+..
T Consensus        22 ~iP~~l~--~~l~~L~Ls~n~i~-~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~   87 (242)
T d1xwdc1          22 EIPSDLP--RNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK   87 (242)
T ss_dssp             SCCSCSC--SCCSEEEEESCCCC-EECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred             CcCCCCC--CCCCEEECcCCcCC-ccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence            5777653  58999999999999 7776 5899999999999999998876653  3455666665543

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=97.56  E-value=5.5e-05  Score=65.03  Aligned_cols=40  Identities=35%  Similarity=0.431  Sum_probs=25.7

Q ss_pred             ccCcchhCCCCCCEEEeecCcccccCCccccCcCCCCeEECcCCcCc
Q 039799            3 SIPDSIGDLINLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNKLE   49 (346)
Q Consensus         3 ~ip~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~l~l~~N~l~   49 (346)
                      +||+.   +++|++|+||+|+|+ +||+.++   +|+.|++++|+++
T Consensus        52 ~lp~~---~~~L~~L~Ls~N~l~-~lp~~~~---~L~~L~l~~n~l~   91 (353)
T d1jl5a_          52 SLPEL---PPHLESLVASCNSLT-ELPELPQ---SLKSLLVDNNNLK   91 (353)
T ss_dssp             CCCSC---CTTCSEEECCSSCCS-SCCCCCT---TCCEEECCSSCCS
T ss_pred             CCCCC---CCCCCEEECCCCCCc-ccccchh---hhhhhhhhhcccc
Confidence            56643   467888888888888 8887643   4455555555544

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.56  E-value=0.00011  Score=62.87  Aligned_cols=133  Identities=14%  Similarity=0.159  Sum_probs=78.1

Q ss_pred             eEEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCce--eeE-----EEEecCCceeEEEecCCCCChh--
Q 039799          117 GSVYKAIIQDGMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNLI--KII-----SSYSNDDFKALVLEYMPHGSLE--  187 (346)
Q Consensus       117 g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv--~~~-----~~~~~~~~~~lv~e~~~~gsL~--  187 (346)
                      -.||++..++|+.+++|+..+... ..+++..|...+..|....+.  ..+     ......+..+.++++++|..+.  
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~  114 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD  114 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence            589999999999999999876533 346677788888877532221  111     1223456678899999764331  


Q ss_pred             ---hhh---------hh----c----CCCCCHHH----------------------HHHHHHHHHHHHHHH-hcCCCCCe
Q 039799          188 ---KCL---------YL----S----NYILDIFQ----------------------RLDIMIDVASALEYL-HFGYSAPI  224 (346)
Q Consensus       188 ---~~l---------~~----~----~~~l~~~~----------------------~~~i~~~i~~~l~~L-H~~~~~~i  224 (346)
                         .+-         +.    .    ....++..                      ....+..+...+.-. ......++
T Consensus       115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l  194 (325)
T d1zyla1         115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR  194 (325)
T ss_dssp             CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred             CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence               110         00    0    01112111                      111222222222222 12235678


Q ss_pred             eecCCCCCceEECCCCcEEEeeecCCcc
Q 039799          225 IHCDLKPSNVLLDDNMVAHLSDFGMAKP  252 (346)
Q Consensus       225 ~H~dik~~NIll~~~~~~~l~Dfg~~~~  252 (346)
                      +|+|+.+.|||++++  ..++||+-+..
T Consensus       195 iHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         195 LHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             ecCCCCcccEEEeCC--ceEEechhccc
Confidence            999999999999754  45899998874

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.23  E-value=0.0006  Score=59.85  Aligned_cols=72  Identities=19%  Similarity=0.276  Sum_probs=49.4

Q ss_pred             CcccccCceEEEEEEEcC--------CCEEEEEEecCCCchhHHHHHHHHHHHHhcCCCCc-eeeEEEEecCCceeEEEe
Q 039799          109 PLIGKGGFGSVYKAIIQD--------GMEVAVKVFDPQYEGAFKSFDIECDVMKRICHRNL-IKIISSYSNDDFKALVLE  179 (346)
Q Consensus       109 ~~lg~G~~g~vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e  179 (346)
                      +.|+.|-.-.+|+....+        .+.+.+++.... .. .....+|..+++.+.-.++ .++++++.+    .+|+|
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e  121 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ET-ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  121 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CC-HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-ch-hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence            457778888999998654        356888887632 22 2345678888888753344 477777643    58999


Q ss_pred             cCCCCCh
Q 039799          180 YMPHGSL  186 (346)
Q Consensus       180 ~~~~gsL  186 (346)
                      |++|.++
T Consensus       122 fi~g~~l  128 (395)
T d1nw1a_         122 YIPSRPL  128 (395)
T ss_dssp             CCCEEEC
T ss_pred             EeccccC
Confidence            9987654

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.08  E-value=0.00017  Score=58.69  Aligned_cols=62  Identities=18%  Similarity=0.173  Sum_probs=33.8

Q ss_pred             cCcchhCCCCCCEE-EeecCcccccCCcc-ccCcCCCCeEECcCCcCcCCCCCC-CCCcccccccc
Q 039799            4 IPDSIGDLINLKSL-NLSNNNLSGTIPIS-LEKLLDLKDINVSFNKLEGEIPRE-GPFRNLSVKSF   66 (346)
Q Consensus         4 ip~~~~~l~~L~~l-~l~~N~l~g~~p~~-~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~l~~l~~   66 (346)
                      ||....+.++++.+ ++++|+++ .||.. +..+++|+.|+|++|+++..++.. ..+++|+.+++
T Consensus       168 i~~~~~~~~~l~~~~~l~~n~l~-~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~  232 (242)
T d1xwdc1         168 IHNCAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST  232 (242)
T ss_dssp             ECTTTTTTCCEEEEECTTCTTCC-CCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSE
T ss_pred             cccccccchhhhccccccccccc-cccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcC
Confidence            44444445554444 45666666 66643 566777777777777777554432 33334444333

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.03  E-value=4.9e-05  Score=58.15  Aligned_cols=50  Identities=28%  Similarity=0.262  Sum_probs=40.9

Q ss_pred             cCcchhCCCCCCEEEeecCcccccCCc-cccCcCCCCeEECcCCcCcCCCCC
Q 039799            4 IPDSIGDLINLKSLNLSNNNLSGTIPI-SLEKLLDLKDINVSFNKLEGEIPR   54 (346)
Q Consensus         4 ip~~~~~l~~L~~l~l~~N~l~g~~p~-~~~~l~~l~~l~l~~N~l~~~~p~   54 (346)
                      ++..+..|++|+.||||+|+++ .+++ ......+|+.|++++|.++.....
T Consensus        83 ~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~~~~~  133 (162)
T d1koha1          83 MSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSLSDTFRD  133 (162)
T ss_dssp             GGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTSSSSSS
T ss_pred             hHHHHhhCCcccccccccCccc-cchhhhhhhccccceeecCCCCcCcCccc
Confidence            4556788999999999999999 7775 334556899999999999987654

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.52  E-value=0.011  Score=49.54  Aligned_cols=33  Identities=33%  Similarity=0.402  Sum_probs=29.4

Q ss_pred             CCCCeeecCCCCCceEECCCCcEEEeeecCCcc
Q 039799          220 YSAPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  252 (346)
Q Consensus       220 ~~~~i~H~dik~~NIll~~~~~~~l~Dfg~~~~  252 (346)
                      ...++||+|+.++||+++++...-|+||+.+..
T Consensus       181 L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         181 LPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             SCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cccccccCCcchhhhhcccccceeEeccccccc
Confidence            467899999999999999988788999999874

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.31  E-value=0.00068  Score=56.60  Aligned_cols=62  Identities=21%  Similarity=0.151  Sum_probs=48.4

Q ss_pred             hhCCCCCCEEEeecC-cccccCCccccCcCCCCeEECcC-CcCcCCCC-CCCCCcccccccccCC
Q 039799            8 IGDLINLKSLNLSNN-NLSGTIPISLEKLLDLKDINVSF-NKLEGEIP-REGPFRNLSVKSFEGN   69 (346)
Q Consensus         8 ~~~l~~L~~l~l~~N-~l~g~~p~~~~~l~~l~~l~l~~-N~l~~~~p-~~~~~~~l~~l~~~~n   69 (346)
                      ..++++|+.|||++| .+++..+..++++++|+.|++++ +.+++.-. ..+.+++|+.+++.++
T Consensus       171 ~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~  235 (284)
T d2astb2         171 VRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI  235 (284)
T ss_dssp             HHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred             ccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence            356899999999986 68888888999999999999999 56765322 2355678888888765

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=95.67  E-value=0.001  Score=58.71  Aligned_cols=68  Identities=18%  Similarity=0.190  Sum_probs=37.3

Q ss_pred             CcchhCCCCCCEEEeecCcccc----cCCcccc-CcCCCCeEECcCCcCcCC----CCC-CCCCcccccccccCCcch
Q 039799            5 PDSIGDLINLKSLNLSNNNLSG----TIPISLE-KLLDLKDINVSFNKLEGE----IPR-EGPFRNLSVKSFEGNELL   72 (346)
Q Consensus         5 p~~~~~l~~L~~l~l~~N~l~g----~~p~~~~-~l~~l~~l~l~~N~l~~~----~p~-~~~~~~l~~l~~~~n~~~   72 (346)
                      +..+..+++|+.|||++|+++.    .+...+. ...+|+.|+|++|+++..    ++. ....++++.+++++|.+.
T Consensus        48 ~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~  125 (460)
T d1z7xw1          48 SSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG  125 (460)
T ss_dssp             HHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred             HHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCCCCCCEEECCCCCccccccccccchhhccccccccccccccch
Confidence            3445566777777777776651    1222221 224577777777776543    111 234556777777777643

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=95.20  E-value=0.0014  Score=56.06  Aligned_cols=41  Identities=15%  Similarity=0.171  Sum_probs=19.5

Q ss_pred             hCCCCCCEEEeecCccccc-----CCccccCcCCCCeEECcCCcCc
Q 039799            9 GDLINLKSLNLSNNNLSGT-----IPISLEKLLDLKDINVSFNKLE   49 (346)
Q Consensus         9 ~~l~~L~~l~l~~N~l~g~-----~p~~~~~l~~l~~l~l~~N~l~   49 (346)
                      ...+.|+.|+|++|+++..     +...+..+++|+.|+|++|.++
T Consensus       183 ~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~  228 (344)
T d2ca6a1         183 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFT  228 (344)
T ss_dssp             HHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCH
T ss_pred             hhhhhhcccccccccccccccccchhhhhcchhhhccccccccccc
Confidence            3445555555555554411     2233444555555555555543

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=95.18  E-value=0.0074  Score=49.95  Aligned_cols=45  Identities=20%  Similarity=0.141  Sum_probs=39.2

Q ss_pred             CccCcchhCCCCCCEEEeec-CcccccCCccccCcCCCCeEECcCC
Q 039799            2 GSIPDSIGDLINLKSLNLSN-NNLSGTIPISLEKLLDLKDINVSFN   46 (346)
Q Consensus         2 g~ip~~~~~l~~L~~l~l~~-N~l~g~~p~~~~~l~~l~~l~l~~N   46 (346)
                      +..+..++++++|++|+|++ +++++.-...++++++|+.|+++++
T Consensus       190 d~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~  235 (284)
T d2astb2         190 NDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI  235 (284)
T ss_dssp             GGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred             chhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence            34567788999999999999 5888888888999999999999876

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=95.00  E-value=0.0037  Score=54.98  Aligned_cols=65  Identities=18%  Similarity=0.191  Sum_probs=49.3

Q ss_pred             hhCCCCCCEEEeecCccc----ccCCccccCcCCCCeEECcCCcCcCC----CCCC--CCCcccccccccCCcch
Q 039799            8 IGDLINLKSLNLSNNNLS----GTIPISLEKLLDLKDINVSFNKLEGE----IPRE--GPFRNLSVKSFEGNELL   72 (346)
Q Consensus         8 ~~~l~~L~~l~l~~N~l~----g~~p~~~~~l~~l~~l~l~~N~l~~~----~p~~--~~~~~l~~l~~~~n~~~   72 (346)
                      +..+++|+.|+|++|.++    ..|+..+..+++|+.|||++|+++..    +...  ....+++.+++++|.++
T Consensus        23 ~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it   97 (460)
T d1z7xw1          23 LPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLT   97 (460)
T ss_dssp             HHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCB
T ss_pred             HHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCCCCCCEEECCCCCcc
Confidence            456899999999999998    35667788999999999999998631    1111  12346889999999764

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=94.19  E-value=0.0031  Score=53.86  Aligned_cols=63  Identities=16%  Similarity=0.182  Sum_probs=36.9

Q ss_pred             hCCCCCCEEEeecCcccc----cCCccccCcCCCCeEECcCCcCcCC-----C-CCCCCCcccccccccCCcc
Q 039799            9 GDLINLKSLNLSNNNLSG----TIPISLEKLLDLKDINVSFNKLEGE-----I-PREGPFRNLSVKSFEGNEL   71 (346)
Q Consensus         9 ~~l~~L~~l~l~~N~l~g----~~p~~~~~l~~l~~l~l~~N~l~~~-----~-p~~~~~~~l~~l~~~~n~~   71 (346)
                      ...+.|+.|++++|+++.    .+...+..+++|+.|++++|.++..     + ......+++..+++++|.+
T Consensus       155 ~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i  227 (344)
T d2ca6a1         155 KNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTF  227 (344)
T ss_dssp             HTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCC
T ss_pred             ccCcccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccc
Confidence            345677777777776651    2334455667777777777776531     1 1123345666677777654

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=91.47  E-value=0.02  Score=43.12  Aligned_cols=65  Identities=18%  Similarity=0.164  Sum_probs=44.6

Q ss_pred             hCCCCCCEEEeecC-ccccc----CCccccCcCCCCeEECcCCcCcCCCCCC-----CCCcccccccccCCcchh
Q 039799            9 GDLINLKSLNLSNN-NLSGT----IPISLEKLLDLKDINVSFNKLEGEIPRE-----GPFRNLSVKSFEGNELLC   73 (346)
Q Consensus         9 ~~l~~L~~l~l~~N-~l~g~----~p~~~~~l~~l~~l~l~~N~l~~~~p~~-----~~~~~l~~l~~~~n~~~~   73 (346)
                      .+.++|+.|+|+++ .++..    +-..+...++|+.|+|++|.+...-...     ...+.++.+++++|.+..
T Consensus        12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~   86 (167)
T d1pgva_          12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTP   86 (167)
T ss_dssp             TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCH
T ss_pred             hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcch
Confidence            35689999999974 56522    3345677889999999999886422111     123568888999887553

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=90.48  E-value=0.052  Score=40.70  Aligned_cols=65  Identities=15%  Similarity=0.141  Sum_probs=45.6

Q ss_pred             chhCCCCCCEEEeecCccccc----CCccccCcCCCCeEECcCCcCcCCCC-----CCCCCcccccccccCCcc
Q 039799            7 SIGDLINLKSLNLSNNNLSGT----IPISLEKLLDLKDINVSFNKLEGEIP-----REGPFRNLSVKSFEGNEL   71 (346)
Q Consensus         7 ~~~~l~~L~~l~l~~N~l~g~----~p~~~~~l~~l~~l~l~~N~l~~~~p-----~~~~~~~l~~l~~~~n~~   71 (346)
                      .+...++|+.|+|++|.++..    +-..+...++|+.|+|++|.++..--     ....-+.++.+++++|..
T Consensus        39 ~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~  112 (167)
T d1pgva_          39 AACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQ  112 (167)
T ss_dssp             HHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSS
T ss_pred             HHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcC
Confidence            355678899999999999832    22345567899999999999975211     112235677888887753

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=83.72  E-value=0.24  Score=36.63  Aligned_cols=63  Identities=16%  Similarity=0.134  Sum_probs=40.0

Q ss_pred             hCCCCCCEEEeec-Cccccc----CCccccCcCCCCeEECcCCcCcCCCCCC-----CCCcccccccccCCcc
Q 039799            9 GDLINLKSLNLSN-NNLSGT----IPISLEKLLDLKDINVSFNKLEGEIPRE-----GPFRNLSVKSFEGNEL   71 (346)
Q Consensus         9 ~~l~~L~~l~l~~-N~l~g~----~p~~~~~l~~l~~l~l~~N~l~~~~p~~-----~~~~~l~~l~~~~n~~   71 (346)
                      .+.++|+.|+|++ |+++..    +-..+...++|+.|++++|.++..--..     ...+.+..+.+.+|.+
T Consensus        14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~   86 (166)
T d1io0a_          14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFI   86 (166)
T ss_dssp             TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCC
T ss_pred             hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccc
Confidence            4678999999998 567511    3344567889999999999886421110     1123455566665544

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=81.95  E-value=0.25  Score=36.51  Aligned_cols=43  Identities=19%  Similarity=0.222  Sum_probs=34.0

Q ss_pred             hhCCCCCCEEEeecCccccc----CCccccCcCCCCeEECcCCcCcC
Q 039799            8 IGDLINLKSLNLSNNNLSGT----IPISLEKLLDLKDINVSFNKLEG   50 (346)
Q Consensus         8 ~~~l~~L~~l~l~~N~l~g~----~p~~~~~l~~l~~l~l~~N~l~~   50 (346)
                      +...++|+.|+|++|.++..    |-..+...++|+.+++++|.++.
T Consensus        42 l~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~   88 (166)
T d1io0a_          42 LKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISG   88 (166)
T ss_dssp             HTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCH
T ss_pred             HhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccc
Confidence            45678999999999998743    22345677999999999998864